Phenotypic 0
analysis 0
demonstrates 0
that 0
trio B-gene
and 0
Abl B-gene
cooperate 0
in 0
regulating 0
axon 0
outgrowth 0
in 0
the 0
embryonic 0
central 0
nervous 0
system 0
( 0
CNS 0
) 0
. 0

In 0
the 0
cervical 0
enlargement 0
they 0
were 0
located 0
in 0
the 0
middle 0
part 0
of 0
lamina 0
VII 0
and 0
in 0
lamina 0
VIII 0
, 0
accounting 0
for 0
about 0
25 0
% 0
of 0
the 0
total 0
labeled 0
neurons 0
. 0

We 0
measured 0
electromyograms 0
( 0
EMG 0
) 0
of 0
the 0
alae 0
nasi 0
to 0
determine 0
the 0
relationship 0
between 0
their 0
activity 0
and 0
timing 0
to 0
contraction 0
of 0
the 0
rib 0
cage 0
muscles 0
and 0
diaphragm 0
during 0
obstructive 0
apnea 0
in 0
nine 0
patients 0
. 0

A 0
case 0
control 0
study 0
( 0
1:2 0
) 0
of 0
182 0
pairs 0
of 0
Hepatitis 0
A 0
was 0
carried 0
out 0
in 0
Weng 0
- 0
ling 0
Zhe 0
- 0
jiang 0
during 0
April 0
1988 0
. 0

In 0
the 0
absence 0
of 0
shock 0
, 0
sepsis 0
, 0
or 0
other 0
identifiable 0
causes 0
of 0
lactic 0
acidosis 0
, 0
the 0
severe 0
anemia 0
( 0
hemoglobin B-gene
1.2 0
g/dl 0
) 0
appeared 0
to 0
be 0
the 0
primary 0
etiologic 0
factor 0
. 0

However 0
the 0
precise 0
function 0
of 0
DNA B-gene
- I-gene
PK I-gene
in 0
DNA 0
double 0
- 0
strand 0
break 0
repair 0
is 0
not 0
known 0
. 0

The 0
COR B-gene
biosynthetic 0
gene 0
cluster 0
in 0
P. 0
syringae 0
pv 0
. 0
glycinea 0
PG4180 0
is 0
encoded 0
by 0
a 0
32 0
- 0
kb 0
region 0
which 0
contains 0
both 0
the 0
structural 0
and 0
regulatory 0
genes 0
needed 0
for 0
COR B-gene
synthesis 0
. 0

Substitution 0
of 0
cholinergic 0
drugs 0
in 0
the 0
treatment 0
of 0
Alzheimer 0
type 0
dementia 0
( 0
AD/SDAT 0
) 0
has 0
hitherto 0
not 0
been 0
very 0
successful 0
. 0

FEurea 0
was 0
also 0
measured 0
during 0
stable 0
graft 0
function 0
, 0
7 0
- 0
14 0
days 0
prior 0
to 0
allograft 0
dysfunction 0
. 0

The 0
findings 0
are 0
discussed 0
with 0
reference 0
to 0
possible 0
mechanisms 0
by 0
which 0
parasite 0
development 0
might 0
be 0
controlled 0
. 0

Interestingly 0
, 0
basal 0
MAPK B-gene
, 0
but 0
not 0
Raf B-gene
- I-gene
1 I-gene
, 0
activity 0
was 0
constitutively 0
enhanced 0
in 0
Jak1 B-gene
- 0
deficient 0
HeLa 0
cells 0
. 0

On 0
the 0
other 0
hand 0
hypokalemia 0
, 0
induced 0
by 0
diuretics 0
, 0
may 0
also 0
be 0
accompanied 0
by 0
a 0
significant 0
depletion 0
of 0
total 0
body 0
K 0
, 0
bringing 0
about 0
more 0
general 0
consequences 0
. 0

We 0
present 0
here 0
the 0
complete 0
primary 0
structure 0
of 0
human B-gene
gp330 I-gene
, 0
the 0
human 0
variant 0
of 0
the 0
principal 0
kidney 0
autoantigen 0
causing 0
Heymann 0
membranous 0
glomerulonephritis 0
in 0
rats 0
. 0

A 0
series 0
of 0
deletion 0
mutants 0
was 0
expressed 0
transiently 0
in 0
two 0
human 0
hepatocytes 0
, 0
HepG2 0
and 0
PLC 0
. 0

Biol 0
. 0

Copyright 0
2000 0
Academic 0
Press 0
. 0

No 0
patient 0
demonstrated 0
a 0
decrease 0
in 0
bone 0
marrow 0
fibrosis 0
as 0
determined 0
by 0
serial 0
procollagen B-gene
( 0
PC B-gene
III I-gene
) 0
serum 0
level 0
analysis 0
. 0

In 0
four 0
calves 0
given 0
Haemonchus 0
contortus 0
larvae 0
, 0
the 0
serum B-gene
pepsinogen I-gene
concentration 0
rose 0
quickly 0
to 0
reach 0
a 0
mean 0
of 0
3.5 0
iu 0
tyrosine 0
on 0
day 0
14 0
after 0
infection 0
. 0

The 0
P B-gene
- I-gene
ITIM I-gene
- I-gene
compelled I-gene
multi I-gene
- I-gene
phosphoprotein I-gene
complex I-gene
binds 0
to 0
and 0
activates 0
SHP B-gene
- I-gene
2 I-gene
, 0
which 0
in 0
turn 0
dephosphorylates 0
SHIP B-gene
and 0
Shc B-gene
and 0
probably 0
other 0
substrates 0
. 0

Paradoxically 0
, 0
loop 0
3i 0
from 0
the 0
M1Ach B-gene
- I-gene
muscarinic I-gene
receptor I-gene
also 0
maximally 0
inhibited 0
GnRH B-gene
agonist 0
- 0
stimulated 0
cAMP 0
accumulation 0
and 0
PRL B-gene
release 0
by 0
40 0
% 0
( 0
both 0
effects 0
mediated 0
through 0
activation 0
of 0
the 0
Gs B-gene
protein I-gene
) 0
. 0

Electrophoretic 0
mobility 0
- 0
shift 0
assays 0
with 0
nuclear 0
extracts 0
from 0
COS 0
- 0
1 0
cells 0
transfected 0
with 0
expression 0
vectors 0
for 0
SMADs B-gene
1 I-gene
- I-gene
5 I-gene
indicate 0
that 0
SMAD3 B-gene
forms 0
a 0
complex 0
with 0
a 0
migration 0
similar 0
to 0
that 0
of 0
the 0
endogenous B-gene
TGF I-gene
- I-gene
beta I-gene
- I-gene
specific I-gene
complex I-gene
observed 0
in 0
fibroblast 0
extracts 0
. 0

Oligomers 0
corresponding 0
to 0
the 0
region 0
of 0
the 0
mlc B-gene
- I-gene
1/3 I-gene
enhancer I-gene
, 0
which 0
encompasses 0
this 0
conserved 0
sequence 0
, 0
bound 0
MEF B-gene
- I-gene
2 I-gene
and 0
competed 0
for 0
its 0
binding 0
to 0
the 0
mck B-gene
enhancer 0
. 0

cDNA 0
cloning 0
and 0
transcriptional 0
properties 0
of 0
a 0
novel 0
GC B-gene
box I-gene
- I-gene
binding I-gene
protein I-gene
, 0
BTEB2 B-gene
. 0

N0 0
disease 0
is 0
more 0
favorable 0
than 0
N1 0
or 0
N2 0
disease 0
. 0

Elimination 0
of 0
brush 0
border 0
as 0
well 0
as 0
of 0
glomerular 0
marker 0
proteins 0
was 0
significantly 0
lower 0
after 0
intravenous 0
injection 0
of 0
low 0
- 0
osmolar 0
CM 0
iopamidol 0
370 0
( 0
832 0
mOsm/kg 0
) 0
than 0
after 0
meglumine 0
diatrizoate 0
76 0
( 0
2100 0
mOsm/kg 0
) 0
. 0

Overall 0
graft 0
and 0
patient 0
survival 0
after 0
HAT 0
were 0
33.3 0
% 0
and 0
75 0
% 0
, 0
respectively 0
. 0

Of 0
81 0
girls 0
cured 0
from 0
the 0
bacteriuria 0
24 0
recurred 0
, 0
5 0
with 0
a 0
symptomatic 0
pyelonephritis 0
and 0
3 0
with 0
cystitis 0
. 0

Partial 0
hepatectomy 0
in 0
metastatic 0
Wilms 0
' 0
tumor 0
. 0

MRS 0
allowed 0
the 0
differentiation 0
of 0
the 0
following 0
metabolites 0
in 0
5 0
patients 0
: 0
N 0
- 0
acetyl 0
- 0
aspartate 0
( 0
NAA 0
) 0
, 0
creatine 0
and 0
phosphocreatine 0
, 0
phosphorylcholine 0
and 0
glycerophosphorylcholine 0
, 0
beta 0
- 0
and 0
gamma 0
- 0
glutamate 0
( 0
GLU 0
) 0
. 0

Plasma 0
prolactin B-gene
in 0
patients 0
with 0
colorectal 0
cancer 0
. 0

Studies 0
of 0
fetal 0
maturity 0

A 0
comparison 0
of 0
the 0
rate 0
of 0
recovery 0
and 0
time 0
for 0
detection 0
of 0
mycobacteria 0
from 0
clinical 0
specimens 0
of 0
the 0
newly 0
developed 0
Mycobacteria 0
Growth 0
Indicator 0
Tube 0
( 0
MGIT 0
) 0
, 0
the 0
biphasic 0
Septi 0
- 0
Chek 0
, 0
and 0
the 0
egg 0
- 0
based 0
Ogawa 0
medium 0
was 0
made 0
. 0

E2A B-gene
- 0
HLF B-gene
- 0
mediated 0
cell 0
transformation 0
requires 0
both 0
the 0
trans 0
- 0
activation 0
domains 0
of 0
E2A B-gene
and 0
the 0
leucine 0
zipper 0
dimerization 0
domain 0
of 0
HLF B-gene
. 0

In 0
transient 0
transfections 0
using 0
luciferase B-gene
reporter I-gene
genes I-gene
driven 0
by 0
1 0
kb 0
of 0
the 0
5 0
' 0
flanking 0
DNA 0
of 0
the 0
three 0
CALM B-gene
genes I-gene
, 0
the 0
promoter 0
activity 0
correlated 0
with 0
the 0
endogenous B-gene
CALM I-gene
transcriptional 0
activity 0
, 0
but 0
only 0
when 0
the 0
5 0
' 0
untranslated 0
regions 0
were 0
included 0
in 0
the 0
constructs 0
. 0

In 0
this 0
report 0
, 0
several 0
health 0
behaviors 0
were 0
investigated 0
in 0
relation 0
to 0
maintaining 0
mobility 0
during 0
4 0
years 0
of 0
follow 0
- 0
up 0
among 0
6,981 0
men 0
and 0
women 0
aged 0
65 0
years 0
and 0
older 0
with 0
intact 0
mobility 0
at 0
baseline 0
between 0
1981 0
and 0
1983 0
who 0
lived 0
in 0
one 0
of 0
three 0
communities 0
: 0
East 0
Boston 0
, 0
Massachusetts 0
; 0
Iowa 0
and 0
Washington 0
counties 0
, 0
Iowa 0
; 0
and 0
New 0
Haven 0
, 0
Connecticut 0
. 0

Binding 0
of 0
ZAP B-gene
- I-gene
70 I-gene
to 0
phospho 0
- 0
TAMs 0
is 0
notable 0
for 0
the 0
high 0
level 0
of 0
cooperativity 0
between 0
the 0
two 0
SH2 B-gene
domains I-gene
, 0
which 0
individually 0
demonstrate 0
low 0
affinity 0
interaction 0
with 0
the 0
ligand 0
. 0

A 0
clinical 0
study 0
. 0

Two 0
- 0
dimensional 0
echocardiographic 0
parasternal 0
long 0
- 0
and 0
short 0
- 0
axis 0
views 0
were 0
obtained 0
during 0
graded 0
bleeding 0
by 0
rapid 0
withdrawal 0
of 0
blood 0
from 0
an 0
arterial 0
cannula 0
, 0
with 0
increments 0
of 0
5 0
% 0
each 0
up 0
to 0
30 0
% 0
of 0
calculated 0
blood 0
volume 0
. 0

Comparative 0
analyses 0
indicate 0
that 0
the 0
5' 0
- 0
peripheral 0
domain 0
exhibits 0
a 0
75 0
- 0
bp 0
length 0
polymorphism 0
near 0
sequences 0
associated 0
with 0
the 0
termination 0
of 0
the 0
H 0
- 0
strand 0
replication 0
. 0

Thirty 0
- 0
five 0
pts 0
were 0
transplanted 0
for 0
constitutional 0
disease 0
: 0
Fanconi 0
anemia 0
( 0
FA 0
) 0
( 0
26 0
pts 0
) 0
, 0
Dyskeratosis 0
congenita 0
( 0
2 0
pts 0
) 0
, 0
Blackfan 0
- 0
Diamond 0
erythroblastopenia 0
( 0
2 0
pts 0
) 0
, 0
Glanzmann 0
thrombasthenia 0
( 0
1 0
pt 0
) 0
, 0
osteopetrosis 0
( 0
1 0
pt 0
) 0
and 0
Gaucher 0
's 0
disease 0
( 0
1 0
pt 0
) 0
. 0

One 0
patient 0
exhibited 0
a 0
non 0
- 0
sense 0
mutation 0
( 0
codon 0
388 0
) 0
, 0
which 0
changed 0
a 0
glutamine 0
codon 0
( 0
CAG 0
) 0
to 0
a 0
stop 0
codon 0
( 0
TAG 0
) 0
. 0

Using 0
the 0
same 0
approach 0
we 0
have 0
shown 0
that 0
hFIRE B-gene
binds 0
the 0
stimulatory 0
proteins 0
Sp1 B-gene
and 0
Sp3 B-gene
in 0
addition 0
to 0
CBF B-gene
. 0

Cellular 0
fractionation 0
and 0
Percoll 0
gradient 0
centrifugation 0
combined 0
with 0
immunoblotting 0
show 0
that 0
p67 B-gene
cofractionates 0
with 0
nuclei 0
and 0
is 0
enriched 0
in 0
resistant 0
structure 0
that 0
is 0
insoluble 0
in 0
2 0
M 0
NaCl 0
, 0
25 0
mM 0
lithium 0
3,5' 0
- 0
diiodosalicylate 0
, 0
and 0
1 0
% 0
Triton 0
but 0
is 0
soluble 0
in 0
8 0
M 0
urea 0
. 0

Gene 0
expression 0
is 0
in 0
part 0
controlled 0
by 0
chromatin 0
remodeling 0
factors 0
and 0
the 0
acetylation 0
state 0
of 0
nucleosomal B-gene
histones I-gene
. 0

Corticosteroid 0
treatment 0
before 0
, 0
during 0
, 0
or 0
after 0
fludarabine 0
treatment 0
in 0
patients 0
with 0
alkylator 0
- 0
resistant 0
, 0
low 0
- 0
grade 0
lymphoid 0
malignancies 0
who 0
have 0
not 0
received 0
PCP 0
prophylaxis 0
is 0
associated 0
with 0
an 0
increased 0
risk 0
of 0
opportunistic 0
pulmonary 0
infections 0
. 0

Here 0
we 0
demonstrate 0
that 0
several 0
genes 0
associated 0
with 0
NHEJ 0
perform 0
essential 0
functions 0
in 0
the 0
repair 0
of 0
endonuclease 0
- 0
induced 0
DSBs 0
in 0
vivo 0
. 0

The 0
primary 0
structure 0
of 0
cholesterol B-gene
esterase I-gene
displayed 0
no 0
significant 0
homology 0
with 0
other 0
lipases B-gene
, 0
although 0
the 0
putative 0
lipid 0
interfacial 0
recognition 0
site 0
of 0
G 0
- 0
X 0
- 0
S 0
- 0
X 0
- 0
G 0
is 0
present 0
in 0
the 0
cholesterol B-gene
esterase I-gene
sequence I-gene
. 0

Subtype 0
- 0
and 0
response 0
element 0
- 0
dependent 0
differences 0
in 0
transactivation 0
by 0
peroxisome B-gene
proliferator I-gene
- I-gene
activated I-gene
receptors I-gene
alpha I-gene
and I-gene
gamma I-gene
. 0

Monoclonal 0
antibodies 0
to 0
the 0
hapten 0
phenyloxazolone 0
were 0
raised 0
7 0
days 0
after 0
immunization 0
in 0
mice 0
of 0
six 0
strains 0
( 0
BALB/c 0
, 0
C57BL 0
- 0
Igha 0
, 0
DBA2 0
, 0
RF 0
, 0
A/J 0
, 0
and 0
CE 0
) 0
. 0

PMA 0
produced 0
similar 0
results 0
, 0
but 0
the 0
induction 0
of 0
the 0
WT B-gene
AP1 I-gene
c B-gene
- I-gene
jun I-gene
promoter 0
- 0
CAT 0
plasmid 0
was 0
smaller 0
. 0

Although 0
the 0
QT 0
duration 0
was 0
higher 0
( 0
p 0
= 0
0.0001 0
) 0
at 0
night 0
, 0
the 0
beat 0
- 0
to 0
- 0
beat 0
variability 0
of 0
this 0
interval 0
was 0
lower 0
: 0
in 0
the 0
time 0
domain 0
( 0
decreased 0
standard 0
deviation 0
, 0
p 0
= 0
0.0005 0
) 0
, 0
in 0
the 0
frequency 0
domain 0
( 0
decreased 0
low 0
- 0
frequency 0
power 0
of 0
the 0
spectra 0
, 0
p 0
= 0
0.004 0
) 0
, 0
and 0
the 0
chaotic 0
domain 0
( 0
tighter 0
clustering 0
of 0
the 0
points 0
in 0
the 0
Poincare 0
plots 0
) 0
. 0

J 0
. 0

Student 0
health 0

In 0
both 0
study 0
stages 0
. 0
post 0
- 0
exposure 0
treatment 0
consisted 0
of 0
five 0
injections 0
of 0
vaccine 0
[ 0
( 0
D 0
) 0
ays 0
0 0
, 0
3 0
, 0
7 0
, 0
14 0
, 0
28 0
] 0
, 0
together 0
with 0
a 0
dose 0
of 0
rabies B-gene
immunoglobulin I-gene
( 0
RIG B-gene
) 0
of 0
equine 0
or 0
human 0
origin 0
on 0
D0 0
. 0

Essential 0
fatty 0
acid 0
deficiency 0
in 0
childhood 0

We 0
have 0
earlier 0
proposed 0
that 0
CG 0
rich 0
sequences 0
resembling 0
CpG 0
islands 0
, 0
which 0
are 0
associated 0
with 0
many 0
imprinted 0
genes 0
and 0
often 0
subject 0
to 0
parental 0
- 0
specific 0
methylation 0
, 0
could 0
act 0
as 0
a 0
common 0
imprinting 0
element 0
. 0

Electrophoretic 0
mobility 0
- 0
shift 0
assays 0
showed 0
a 0
rapid 0
induction 0
of 0
nuclear 0
proteins 0
that 0
bound 0
to 0
the 0
consensus B-gene
kappa I-gene
B I-gene
motif I-gene
. 0

The 0
thalamic 0
SD 0
was 0
regularly 0
triggered 0
by 0
short 0
( 0
0.02 0
- 0
0.05 0
s 0
) 0
high 0
- 0
frequency 0
( 0
200 0
- 0
500 0
Hz 0
) 0
ES 0
of 0
the 0
parietal 0
cortical 0
surface 0
. 0

As 0
in 0
IncP 0
alpha 0
plasmids 0
, 0
these 0
operons 0
are 0
transcribed 0
from 0
a 0
bidirectional 0
promoter 0
region 0
consisting 0
of 0
trfAp B-gene
for 0
the 0
trfA B-gene
operon I-gene
and 0
trbAp B-gene
and 0
trbBp B-gene
for 0
the 0
trb B-gene
operon I-gene
. 0

Comparison 0
of 0
the 0
encoded 0
ERCC3Dm B-gene
protein I-gene
with 0
the 0
homologous 0
proteins 0
of 0
mouse 0
and 0
man 0
shows 0
a 0
strong 0
amino 0
acid 0
conservation 0
( 0
71 0
% 0
identity 0
) 0
, 0
especially 0
in 0
the 0
postulated 0
DNA 0
binding 0
region 0
and 0
seven 0
'helicase B-gene
' I-gene
domains I-gene
. 0

Genetic 0
analysis 0
places 0
CWH43 B-gene
upstream 0
of 0
the 0
BCK2 B-gene
branch 0
of 0
the 0
PKC1 B-gene
signalling 0
pathway 0
, 0
since 0
cwh43 B-gene
mutations 0
were 0
synthetic 0
lethal 0
with 0
pkc1 B-gene
deletion 0
, 0
whereas 0
the 0
cwh43 B-gene
defects 0
could 0
be 0
rescued 0
by 0
overexpression 0
of 0
BCK2 B-gene
and 0
not 0
by 0
high 0
- 0
copy 0
- 0
number 0
expression 0
of 0
genes 0
encoding 0
downstream 0
proteins 0
of 0
the 0
PKC1 B-gene
pathway 0
However 0
, 0
unlike 0
BCK2 B-gene
, 0
whose 0
disruption 0
in 0
a 0
cln3 B-gene
mutant I-gene
resulted 0
in 0
growth 0
arrest 0
in 0
G 0
( 0
1 0
) 0
, 0
no 0
growth 0
defect 0
was 0
observed 0
in 0
a 0
double 0
cwh43 B-gene
cln3 B-gene
mutants I-gene
. 0

Expression 0
of 0
the 0
E2 B-gene
protein I-gene
resulted 0
in 0
rapid 0
repression 0
of 0
HPV B-gene
E6 I-gene
and 0
E7 B-gene
expression 0
, 0
followed 0
approximately 0
12 0
h 0
later 0
by 0
profound 0
inhibition 0
of 0
cellular 0
DNA 0
synthesis 0
. 0

Peak 0
reactive 0
hyperemia 0
( 0
mL.min 0
- 0
1.100 0
mL 0
- 0
1 0
) 0
was 0
determined 0
in 0
the 0
calf 0
and 0
forearm 0
immediately 0
before 0
and 0
after 0
12 0
weeks 0
of 0
training 0
. 0

The 0
hematopoietic 0
form 0
of 0
PTPN6 B-gene
transcript I-gene
is 0
initiated 0
at 0
a 0
downstream 0
promoter 0
separated 0
by 0
7 0
kb 0
from 0
the 0
first 0
. 0

Reversal 0
of 0
biliary 0
sphincter 0
spasm 0
with 0
low 0
dose 0
glucagon B-gene
during 0
operative 0
cholangiography 0
. 0

In 0
ten 0
other 0
endotoxin 0
- 0
albumin B-gene
- 0
treated 0
pigs 0
PGE1 0
infusion 0
( 0
0.25 0
micrograms 0
X 0
kg 0
- 0
1 0
X 0
min 0
- 0
1 0
) 0
was 0
begun 0
after 0
established 0
pulmonary 0
and 0
cardiovascular 0
dysfunction 0
, 0
for 0
closer 0
mimicking 0
of 0
clinical 0
use 0
. 0

In 0
particular 0
, 0
MF 0
males 0
receiving 0
either 0
a 0
5.0 0
- 0
mg/kg 0
CDP 0
dose 0
or 0
a 0
3.0 0
- 0
mg/kg 0
RO 0
dose 0
explored 0
the 0
object 0
more 0
often 0
than 0
MM 0
males 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
250 0
WORDS 0
) 0

A 0
single 0
HD 0
session 0
using 0
cellulose 0
triacetate 0
or 0
polysulfone 0
membrane 0
significantly 0
increased 0
water 0
content 0
both 0
at 0
forearm 0
and 0
lower 0
leg 0
( 0
p 0
< 0
0.05 0
) 0
. 0

In 0
the 0
yeast 0
two 0
- 0
hybrid 0
assays 0
, 0
PNRC B-gene
interacted 0
with 0
the 0
orphan 0
receptors 0
SF1 B-gene
and 0
ERRalpha1 B-gene
in 0
a 0
ligand 0
- 0
independent 0
manner 0
. 0

Further 0
, 0
we 0
will 0
review 0
our 0
evaluation 0
of 0
the 0
survival 0
rate 0
and 0
prognostic 0
factors 0
for 0
9,262 0
patients 0
from 0
1981 0
to 0
1996 0
. 0

Kaposi 0
's 0
eruptive 0
disease 0
. 0

The 0
results 0
were 0
subjected 0
to 0
analysis 0
of 0
23 0
autopsies 0
carried 0
out 0
in 0
children 0
dying 0
of 0
intoxication 0
with 0
Amanita 0
phalloides 0
. 0

Microscopic 0
examination 0
of 0
these 0
colonies 0
showed 0
a 0
high 0
percentage 0
of 0
histiocytes 0
identical 0
to 0
those 0
seen 0
in 0
the 0
patient 0
's 0
bone 0
marrow 0
. 0

Diffusion 0
epidemic 0
models 0
with 0
incubation 0
and 0
crisscross 0
dynamics 0
. 0

Additional 0
genetic 0
analyses 0
described 0
herein 0
suggest 0
that 0
Skb1 B-gene
is 0
a 0
component 0
of 0
the 0
morphology 0
control 0
branch 0
of 0
the 0
Ras B-gene
signaling 0
cascade 0
in 0
S. 0
pombe 0
and 0
that 0
it 0
positively 0
modulates 0
Shk1 B-gene
function 0
. 0

Transient 0
transfection 0
assays 0
indicated 0
that 0
the 0
( 0
- 0
4551 0
) 0
UCP1 B-gene
- 0
CAT B-gene
construct 0
, 0
containing 0
the 0
5' 0
- 0
regulatory 0
region 0
of 0
the 0
rat B-gene
ucp I-gene
- I-gene
1 I-gene
gene I-gene
, 0
was 0
activated 0
by 0
PPARalpha B-gene
co 0
- 0
transfection 0
in 0
a 0
dose 0
- 0
dependent 0
manner 0
and 0
this 0
activation 0
was 0
potentiated 0
by 0
Wy 0
14,643 0
and 0
retinoid B-gene
X I-gene
receptor I-gene
alpha I-gene
. 0

CRKL B-gene
, 0
an 0
SH2 B-gene
- 0
SH3 B-gene
- 0
SH3 B-gene
adapter 0
protein 0
, 0
is 0
one 0
of 0
the 0
major 0
tyrosine B-gene
phosphoproteins I-gene
detected 0
in 0
primary 0
leukemic 0
neutrophils 0
from 0
patients 0
with 0
CML 0
. 0

Idealized 0
versus 0
realized 0
overall 0
treatment 0
times 0
. 0

Serum B-gene
C3 I-gene
was 0
measured 0
in 0
1,282 0
school 0
children 0
with 0
abnormal 0
urinary 0
findings 0
between 0
1980 0
and 0
1997 0
. 0

Tc 0
- 0
99m 0
HMPAO 0
brain 0
SPECT 0
compared 0
to 0
CT 0
and 0
EEG 0
after 0
seizures 0
in 0
childhood 0
. 0

The 0
adenovirus B-gene
E1B I-gene
19,000 I-gene
- I-gene
molecular I-gene
- I-gene
weight I-gene
( I-gene
19K I-gene
) I-gene
protein I-gene
is 0
a 0
potent 0
inhibitor 0
of 0
apoptosis 0
and 0
cooperates 0
with 0
E1A B-gene
to 0
transform 0
primary 0
rodent 0
cells 0
. 0

Subclones 0
of 0
R15 0
which 0
reverted 0
to 0
kappa B-gene
light I-gene
chain I-gene
production 0
contained 0
genomic 0
deletions 0
of 0
R15ns 0
and/or 0
the 0
surrounding 0
intron 0
. 0

Previous 0
data 0
suggested 0
a 0
subtle 0
increase 0
in 0
serum 0
P 0
at 0
the 0
time 0
of 0
hCG B-gene
injection 0
without 0
LH B-gene
surge 0
reduces 0
the 0
PR 0
of 0
women 0
having 0
oocyte 0
retrievals 0
for 0
IVF 0
; 0
this 0
study 0
compared 0
PRs 0
of 0
recipients 0
in 0
a 0
shared 0
oocyte 0
program 0
according 0
to 0
the 0
donors 0
' 0
pre B-gene
- I-gene
hCG I-gene
P 0
level 0
. 0

Scleraxis B-gene
overexpression 0
enhanced 0
expression 0
of 0
the 0
aggrecan B-gene
gene I-gene
, 0
which 0
is 0
not 0
normally 0
expressed 0
at 0
high 0
levels 0
in 0
these 0
osteoblastic 0
cells 0
. 0

Region 0
- 0
specific 0
enhancers 0
near 0
two 0
mammalian B-gene
homeo I-gene
box I-gene
genes I-gene
define 0
adjacent 0
rostrocaudal 0
domains 0
in 0
the 0
central 0
nervous 0
system 0
. 0

Cells 0
were 0
cotransfected 0
with 0
this 0
plasmid 0
, 0
and 0
the 0
appropriate 0
responder 0
plasmids 0
and 0
clonies 0
were 0
selected 0
on 0
the 0
basis 0
of 0
their 0
resistance 0
to 0
Geneticin 0
( 0
via 0
the 0
neomycin B-gene
aminoglycoside I-gene
phosphotransferase I-gene
gene I-gene
) 0
. 0

To 0
clone 0
cDNAs 0
for 0
the 0
beta 0
subunit 0
of 0
rabbit B-gene
eIF I-gene
- I-gene
2B I-gene
, 0
amino 0
acid 0
sequence 0
data 0
was 0
first 0
obtained 0
and 0
used 0
to 0
design 0
redundant 0
oligonucleotide 0
primers 0
for 0
use 0
in 0
PCR 0
. 0

Deletion 0
analysis 0
of 0
the 0
3.5kb 0
DNA 0
fragment 0
revealed 0
that 0
the 0
region 0
between 0
- 0
125 0
to 0
+1 0
, 0
containing 0
a 0
single 0
Sp1 B-gene
binding I-gene
site I-gene
, 0
is 0
essential 0
for 0
transcription 0
of 0
the 0
embigin B-gene
gene I-gene
. 0

A 0
29.425 0
kb 0
segment 0
on 0
the 0
left 0
arm 0
of 0
yeast 0
chromosome 0
XV 0
contains 0
more 0
than 0
twice 0
as 0
many 0
unknown 0
as 0
known 0
open 0
reading 0
frames 0
. 0

By 0
applying 0
a 0
sufficiently 0
strong 0
crusher 0
gradient 0
in 0
the 0
EPI 0
pulse 0
sequence 0
, 0
the 0
temporal 0
variation 0
induced 0
by 0
SSFP 0
disturbance 0
can 0
be 0
suppressed 0
due 0
to 0
diffusion 0
. 0

The 0
cdc42W97R B-gene
temperature I-gene
- I-gene
sensitive I-gene
allele I-gene
in 0
S. 0
cerevisiae 0
displayed 0
the 0
same 0
cell 0
- 0
division 0
- 0
cycle 0
arrest 0
phenotype 0
( 0
large 0
, 0
round 0
unbudded 0
cells 0
) 0
as 0
the 0
cdc42 B-gene
- I-gene
1ts I-gene
mutant I-gene
. 0

Wolf 0
- 0
Hirschhorn 0
syndrome 0
( 0
WHS 0
) 0
is 0
a 0
malformation 0
syndrome 0
associated 0
with 0
a 0
hemizygous 0
deletion 0
of 0
the 0
distal 0
short 0
arm 0
of 0
chromosome 0
4 0
( 0
4p16.3 0
) 0
. 0

To 0
address 0
this 0
question 0
with 0
respect 0
to 0
skeletal 0
muscle 0
, 0
we 0
have 0
examined 0
the 0
effects 0
of 0
the 0
Providence 0
mutation 0
in 0
cultured 0
muscle 0
cells 0
, 0
after 0
adoptive 0
gene 0
transfer 0
to 0
adult 0
mice 0
, 0
and 0
in 0
two 0
infants 0
homozygous 0
for 0
spectrin B-gene
Providence I-gene
. 0

Adenovirus 0
- 0
mediated 0
gene 0
transfer 0
of 0
MMAC1/PTEN B-gene
to 0
glioblastoma 0
cells 0
inhibits 0
S 0
phase 0
entry 0
by 0
the 0
recruitment 0
of 0
MMAC1/PTEN I-gene

Increasing 0
insulin B-gene
sensitivity 0
in 0
type 0
I 0
diabetic 0
patients 0
should 0
alert 0
clinicians 0
to 0
the 0
possibility 0
of 0
glucocorticoid 0
deficiency 0
. 0

Experiment 0
B 0
: 0
Clinical 0
, 0
biochemical 0
, 0
and 0
histological 0
variables 0
were 0
measured 0
over 0
a 0
12 0
- 0
day 0
period 0
after 0
the 0
zymosan 0
had 0
been 0
given 0
. 0

Lesions 0
of 0
this 0
kind 0
resemble 0
those 0
in 0
vitamin 0
A 0
- 0
deficient 0
chickens 0
and 0
are 0
the 0
first 0
to 0
be 0
induced 0
by 0
excess 0
vitamin 0
E 0
. 0

Immunoblotting 0
using 0
a 0
phosphospecific B-gene
anti I-gene
- I-gene
Src I-gene
( I-gene
416Y I-gene
) I-gene
antibody I-gene
showed 0
a 0
ceramide 0
- 0
induced 0
increase 0
in 0
pp60 B-gene
( 0
src B-gene
) 0
tyrosine 0
phosphorylation 0
. 0

Spinophilin B-gene
, 0
a 0
novel 0
protein B-gene
phosphatase I-gene
1 I-gene
binding I-gene
protein I-gene
localized 0
to 0
dendritic 0
spines 0
. 0

The 0
Htf9 B-gene
- I-gene
a I-gene
gene I-gene
encodes 0
the 0
RanBP1 B-gene
protein I-gene
, 0
a 0
major 0
partner 0
of 0
the 0
Ran B-gene
GTPase I-gene
. 0

Membrane 0
extraction 0
has 0
been 0
interfaced 0
with 0
gas 0
chromatography 0
and 0
mass 0
spectroscopy 0
for 0
the 0
analysis 0
of 0
volatile 0
organics 0
in 0
water 0
. 0

We 0
have 0
produced 0
the 0
Ure2 B-gene
protein I-gene
to 0
high 0
yield 0
in 0
Escherichia 0
coli 0
from 0
a 0
synthetic 0
gene 0
. 0

Triethylene 0
glycol 0
. 0

The 0
SM 0
- 0
specific 0
selection 0
of 0
exon 0
2 0
results 0
from 0
the 0
inhibition 0
of 0
exon 0
3 0
. 0

Ultimobranchial 0
body 0
and 0
parathyroid 0
glands 0
of 0
the 0
freshwater 0
snake 0
Natrix 0
piscator 0
in 0
response 0
to 0
vitamin 0
D3 0
administration 0
. 0

In 0
contrast 0
to 0
the 0
p16 B-gene
- 0
mediated 0
G1 0
block 0
, 0
G1 0
arrest 0
mediated 0
by 0
the 0
cdk B-gene
inhibitors 0
p21Cip1 B-gene
or 0
p27Kip1 B-gene
can 0
not 0
be 0
bypassed 0
either 0
by 0
inactivation 0
of 0
pRb B-gene
or 0
overexpression 0
of 0
E2F B-gene
family I-gene
members I-gene
. 0

More 0
than 0
80 0
% 0
appropriate 0
lever 0
responding 0
was 0
established 0
after 0
27 0
, 0
38 0
and 0
44 0
daily 0
training 0
sessions 0
with 0
DN 0
- 0
2327 0
, 0
diazepam 0
and 0
PTZ 0
, 0
respectively 0
, 0
as 0
the 0
training 0
drug 0
. 0

In 0
the 0
present 0
study 0
, 0
we 0
have 0
investigated 0
the 0
effects 0
of 0
SDZ 0
ENA 0
713 0
on 0
spatial 0
learning 0
deficits 0
in 0
aged 0
rats 0
. 0

A 0
retrospective 0
analysis 0
of 0
data 0
accumulated 0
over 0
a 0
21 0
- 0
month 0
period 0
, 0
from 0
December 0
1989 0
to 0
September 0
1991 0
, 0
regarding 0
investigational 0
use 0
of 0
a 0
308 0
nanometer 0
Xenon 0
Chloride 0
Excimer 0
Laser 0
Coronary 0
Angioplasty 0
( 0
ELCA 0
) 0
system 0
( 0
Advanced 0
Interventional 0
Systems 0
, 0
Inc. 0
, 0
Irvine 0
, 0
CA 0
) 0
was 0
performed 0
. 0

Upon 0
increasing 0
the 0
Marangoni 0
number 0
beyond 0
this 0
threshold 0
, 0
the 0
initially 0
stationary 0
flow 0
becomes 0
quickly 0
time 0
dependent 0
. 0

Investigation 0
on 0
the 0
asymmetrical 0
induced 0
yields 0
in 0
90Sr 0
- 0
90Y 0
- 0
beta 0
- 0
irradiated 0
D 0
- 0
and 0
L 0
- 0
alanines 0
. 0

One 0
of 0
the 0
major 0
transcripts 0
encodes 0
MEQ B-gene
, 0
a 0
339 0
- 0
amino 0
- 0
acid 0
bZIP B-gene
protein I-gene
which 0
is 0
homologous 0
to 0
the 0
Jun/Fos B-gene
family 0
of 0
transcription 0
factors 0
. 0

Given 0
a 0
rapid 0
induction 0
of 0
Egr B-gene
- I-gene
1 I-gene
on 0
stimulation 0
with 0
growth 0
factors 0
or 0
injury 0
, 0
these 0
findings 0
may 0
represent 0
at 0
least 0
one 0
of 0
the 0
molecular 0
mechanisms 0
underlying 0
phenotypic 0
modulation 0
of 0
smooth 0
muscles 0
after 0
vascular 0
injury 0
. 0

An 0
identical 0
polypeptide 0
was 0
detected 0
by 0
Western 0
blot 0
analysis 0
of 0
K1F 0
virions 0
. 0

The 0
predictive 0
value 0
of 0
the 0
remotely 0
sensed 0
map 0
based 0
on 0
NDVI 0
data 0
appears 0
to 0
be 0
better 0
than 0
that 0
from 0
forecast 0
indices 0
based 0
only 0
on 0
climatic 0
data 0
. 0

The 0
concentration 0
of 0
vitamin 0
B1 0
, 0
B2 0
and 0
B6 0
are 0
found 0
to 0
be 0
9.96 0
, 0
9.92 0
and 0
3.01 0
mg 0
, 0
respectively 0
in 0
240 0
mg 0
of 0
capsule 0
powder 0
of 0
a 0
standard 0
company 0
( 0
name 0
has 0
not 0
been 0
disclosed 0
due 0
to 0
secrecy 0
purpose 0
) 0
. 0

We 0
have 0
shown 0
that 0
the 0
human 0
cell 0
MRC 0
closely 0
resembles 0
the 0
murine 0
cell 0
MRC 0
, 0
in 0
both 0
its 0
protein 0
composition 0
and 0
its 0
fractionation 0
and 0
chromatographic 0
profile 0
. 0

Red 0
blood 0
cell 0
binding 0
of 0
99mTc 0
- 0
EC 0
and 0
131I 0
- 0
OIH 0
was 0
6.1 0
% 0
and 0
20 0
% 0
, 0
respectively 0
. 0

Identification 0
of 0
a 0
68 B-gene
- I-gene
kilodalton I-gene
nuclear I-gene
ATP I-gene
- I-gene
binding I-gene
phosphoprotein I-gene
encoded 0
by 0
bovine 0
papillomavirus 0
type 0
1 0
. 0

To 0
identify 0
the 0
GRK6 B-gene
homologue I-gene
on 0
chromsome 0
13 0
, 0
several 0
sets 0
of 0
closely 0
- 0
spaced 0
primers 0
were 0
designed 0
based 0
on 0
the 0
GRK6 B-gene
cDNA I-gene
sequence I-gene
and 0
then 0
used 0
to 0
amplify 0
human 0
genomic 0
DNA 0
by 0
PCR 0
. 0

During 0
the 0
burst 0
period 0
( 0
approximately 0
5 0
- 0
10 0
min 0
) 0
, 0
local 0
blood 0
H2O2 0
concentrations 0
and 0
xanthine B-gene
oxidase I-gene
activities 0
were 0
highly 0
correlated 0
( 0
r 0
= 0
0.999 0
) 0
. 0

This 0
mutant 0
also 0
functions 0
in 0
vivo 0
as 0
a 0
trans 0
- 0
acting 0
dominant 0
negative 0
regulator 0
: 0
the 0
transcriptional 0
inducibility 0
of 0
the 0
HIV B-gene
long I-gene
terminal I-gene
repeat I-gene
( 0
which 0
contains 0
two 0
potential 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
binding I-gene
sites I-gene
) 0
by 0
phorbol 0
ester 0
( 0
PMA 0
) 0
is 0
inhibited 0
when 0
it 0
is 0
co 0
- 0
transfected 0
into 0
CD4+ B-gene
T 0
cells 0
with 0
the 0
delta 0
SP 0
mutant 0
. 0

We 0
demonstrate 0
that 0
the 0
WRM B-gene
- I-gene
1 I-gene
protein I-gene
binds 0
to 0
LIT B-gene
- I-gene
1 I-gene
in 0
vivo 0
and 0
that 0
WRM B-gene
- I-gene
1 I-gene
can 0
activate 0
the 0
LIT B-gene
- I-gene
1 I-gene
protein I-gene
kinase I-gene
when 0
coexpressed 0
in 0
vertebrate 0
tissue 0
culture 0
cells 0
. 0

To 0
assess 0
the 0
safety 0
of 0
the 0
angiotensin B-gene
converting I-gene
enzyme I-gene
inhibitor 0
enalapril 0
a 0
multicenter 0
, 0
open 0
, 0
randomized 0
, 0
prazosin 0
- 0
controlled 0
trial 0
was 0
designed 0
comparing 0
the 0
incidence 0
and 0
severity 0
of 0
symptomatic 0
hypotension 0
on 0
the 0
first 0
day 0
of 0
treatment 0
. 0

Mutating 0
bases 0
- 0
142 0
to 0
- 0
151 0
abolishes 0
formation 0
of 0
complex 0
VII 0
and 0
partially 0
inhibits 0
complex 0
IV 0
, 0
suggesting 0
that 0
the 0
proteins 0
forming 0
these 0
complexes 0
bind 0
neighboring 0
segments 0
of 0
DNA 0
. 0

In 0
this 0
study 0
, 0
we 0
report 0
the 0
cloning 0
and 0
sequencing 0
of 0
several 0
overlapping 0
cDNAs 0
encoding 0
approximately 0
4.1 0
kb 0
of 0
the 0
human B-gene
homologue I-gene
of I-gene
Wnt I-gene
- I-gene
5A I-gene
. 0

We 0
provided 0
evidence 0
that 0
CaM B-gene
kinase I-gene
II I-gene
played 0
a 0
role 0
in 0
regulating 0
neurite 0
outgrowth 0
and 0
growth 0
cone 0
motility 0
in 0
these 0
cells 0
, 0
and 0
that 0
the 0
autophosphorylation 0
is 0
essential 0
for 0
the 0
kinase 0
to 0
sufficiently 0
exert 0
its 0
cellular 0
function 0
in 0
vivo 0
[ 0
Y 0
. 0

We 0
propose 0
that 0
GCD7 B-gene
and 0
GCD2 B-gene
play 0
important 0
roles 0
in 0
the 0
regulatory 0
interaction 0
between 0
eIF B-gene
- I-gene
2 I-gene
and 0
eIF B-gene
- I-gene
2B I-gene
and 0
that 0
the 0
suppressor 0
mutations 0
we 0
isolated 0
in 0
these 0
genes 0
decrease 0
the 0
susceptibility 0
of 0
eIF B-gene
- I-gene
2B I-gene
to 0
the 0
inhibitory 0
effects 0
of 0
phosphorylated 0
eIF B-gene
- I-gene
2 I-gene
without 0
impairing 0
the 0
essential 0
catalytic 0
function 0
of 0
eIF B-gene
- I-gene
2B I-gene
in 0
translation 0
initiation 0
. 0

Furthermore 0
, 0
we 0
demonstrate 0
that 0
in 0
myeloid 0
and 0
B 0
cell 0
extracts 0
, 0
PU.1 B-gene
forms 0
a 0
novel 0
, 0
specific 0
, 0
more 0
slowly 0
migrating 0
complex 0
( 0
PU B-gene
- I-gene
SF I-gene
) 0
when 0
binding 0
the 0
GM B-gene
- I-gene
CSF I-gene
receptor I-gene
alpha I-gene
promoter 0
PU.1 B-gene
site 0
. 0

The 0
antiserum 0
used 0
for 0
immunoblotting 0
specifically 0
supershifts 0
uteroglobin B-gene
promoter I-gene
- I-gene
protein I-gene
complexes I-gene
in 0
gel 0
shift 0
experiments 0
. 0

Plasma B-gene
LH I-gene
and 0
progesterone 0
levels 0
after 0
single 0
or 0
multiple 0
injections 0
of 0
synthetic 0
LH B-gene
- 0
RH B-gene
in 0
anoestrous 0
ewes 0
and 0
comparison 0
with 0
levels 0
during 0
the 0
oestrous 0
cycle 0
. 0

Soluble 0
recombinant 0
RI B-gene
and 0
soluble 0
recombinant 0
C B-gene
alpha I-gene
can 0
associate 0
in 0
vitro 0
and 0
be 0
activated 0
by 0
cyclic 0
AMP 0
. 0

We 0
have 0
isolated 0
and 0
structurally 0
characterized 0
genomic 0
DNA 0
and 0
cDNA 0
sequences 0
encoding 0
ribulose B-gene
- I-gene
1,5 I-gene
- I-gene
bisphosphate I-gene
carboxylase/oxygenase I-gene
( I-gene
Rbu I-gene
- I-gene
P2 I-gene
carboxylase I-gene
) I-gene
activase I-gene
from 0
barley 0
( 0
Hordeum 0
vulgare 0
L. 0
) 0
. 0

Cytokine 0
inducibility 0
of 0
VCAM1 B-gene
in 0
endothelial 0
cells 0
utilizes 0
the 0
interaction 0
of 0
heterodimeric 0
p50/p65 B-gene
proteins 0
with 0
p50/p65 I-gene

The 0
cases 0
with 0
terminal 0
forces 0
of 0
left 0
ventricular 0
activation 0
in 0
the 0
same 0
direction 0
as 0
the 0
delta 0
wave 0
, 0
superiorly 0
and 0
to 0
the 0
left 0
at 0
- 0
60 0
degrees 0
or 0
inferiorly 0
and 0
to 0
the 0
right 0
at 0
+120 0
degrees 0
, 0
forming 0
a 0
single 0
deflection 0
of 0
over 0
0,12 0
seconds 0
' 0
duration 0
, 0
are 0
the 0
result 0
of 0
delayed 0
activation 0
of 0
the 0
anterior 0
or 0
posterior 0
fascicle 0
of 0
the 0
left 0
bundle 0
after 0
a 0
long 0
delay 0
. 0

From 0
a 0
chromosomal 0
cosmid 0
library 0
of 0
Streptomyces 0
argillaceus 0
, 0
a 0
Mtm B-gene
producer 0
, 0
a 0
clone 0
( 0
cosAR7 0
) 0
was 0
isolated 0
by 0
homology 0
to 0
the 0
actI/III B-gene
region I-gene
of 0
S. 0
coelicolor 0
and 0
the 0
strDEM B-gene
genes I-gene
of 0
S. 0
griseus 0
. 0

A 0
31 0
- 0
year 0
- 0
old 0
man 0
with 0
primary 0
myelofibrosis 0
initially 0
received 0
low 0
dose 0
Ara 0
C 0
. 0

The 0
factors 0
defective 0
in 0
groups 0
A 0
( 0
CIITA B-gene
) 0
, 0
C 0
( 0
RFX5 B-gene
) 0
and 0
D 0
( 0
RFXAP B-gene
) 0
have 0
been 0
identified 0
. 0

Manifestation 0
of 0
superfluidity 0
in 0
an 0
evolving 0
bose 0
- 0
einstein 0
condensed 0
Gas 0
We 0
study 0
the 0
generation 0
of 0
excitations 0
due 0
to 0
an 0
`` 0
impurity 0
'' 0
( 0
static 0
perturbation 0
) 0
placed 0
into 0
an 0
oscillating 0
Bose 0
- 0
Einstein 0
condensed 0
gas 0
in 0
the 0
time 0
- 0
dependent 0
trapping 0
field 0
. 0

By 0
sequencing 0
of 0
exonuclease B-gene
III I-gene
deletion 0
clones 0
an 0
open 0
reading 0
frame 0
of 0
405 0
nucleotides 0
was 0
found 0
coding 0
for 0
a 0
protein 0
of 0
135 0
amino 0
acids 0
with 0
a 0
molecular 0
mass 0
of 0
15 0
kDa 0
. 0

The 0
c B-gene
- I-gene
raf I-gene
- I-gene
1 I-gene
proto I-gene
- I-gene
oncogene I-gene
is 0
the 0
cellular B-gene
homologue I-gene
of I-gene
v I-gene
- I-gene
raf I-gene
, 0
the 0
oncogene 0
of 0
the 0
acutely 0
transforming 0
retrovirus 0
3611 0
- 0
MSV 0
. 0

We 0
report 0
the 0
genomic 0
organization 0
of 0
the 0
mouse 0
orphan B-gene
receptor I-gene
related I-gene
to I-gene
tyrosine I-gene
kinases I-gene
( 0
Ryk B-gene
) 0
, 0
a 0
structurally 0
unclassified 0
member 0
of 0
the 0
growth B-gene
factor I-gene
receptor I-gene
family 0
. 0

Electrophoretic 0
mobility 0
- 0
shift 0
assays 0
between 0
viral 0
RNA 0
and 0
BMV B-gene
CP I-gene
peptides I-gene
with 0
either 0
proline 0
or 0
alanine 0
substitutions 0
revealed 0
that 0
the 0
interaction 0
is 0
nonspecific 0
. 0

Furthermore 0
, 0
we 0
detect 0
hCoch B-gene
- I-gene
5B2 I-gene
on 0
three 0
overlapping 0
YACs 0
, 0
two 0
of 0
which 0
also 0
contain 0
one 0
of 0
the 0
markers 0
linked 0
to 0
DFNA9 B-gene
. 0
mCoch B-gene
- I-gene
5B2 I-gene
was 0
genetically 0
mapped 0
in 0
the 0
mouse 0
to 0
chromosome 0
12 0
, 0
in 0
a 0
region 0
of 0
homologous 0
synteny 0
with 0
human 0
14q11.2 0
- 0
q13 0
, 0
which 0
contains 0
the 0
asp1 B-gene
( 0
audiogenic B-gene
seizure I-gene
prone I-gene
) 0
locus 0
in 0
the 0
mouse 0
. 0

Reasons 0
are 0
given 0
for 0
suggesting 0
that 0
tiapamil 0
warrants 0
further 0
clinical 0
evaluation 0
, 0
after 0
which 0
it 0
may 0
join 0
the 0
more 0
established 0
calcium 0
antagonists 0
as 0
a 0
valuable 0
therapeutic 0
agent 0
. 0

Histopathologic 0
studies 0
displaying 0
spongiform 0
changes 0
in 0
the 0
gray 0
matter 0
, 0
neuronal 0
loss 0
, 0
and 0
atrogliosis 0
confirmed 0
the 0
clinical 0
diagnosis 0
of 0
Creutzfeldt 0
- 0
Jakob 0
disease 0
. 0

Current 0
body 0
size 0
( 0
wt/ht2 0
) 0
was 0
significantly 0
associated 0
with 0
life 0
- 0
time 0
weight 0
dissatisfaction 0
in 0
both 0
sexes 0
( 0
P 0
less 0
than 0
0.0005 0
) 0
. 0

Our 0
results 0
are 0
consistent 0
with 0
TCOF1 B-gene
mutations I-gene
leading 0
to 0
the 0
Treacher 0
Collins 0
syndrome 0
phenotype 0
. 0

Mannich 0
bases 0
of 0
vanillin 0
oxime 0
. 0

Its 0
activity 0
was 0
twice 0
that 0
of 0
a 0
construct 0
where 0
the 0
CAT B-gene
gene I-gene
was 0
driven 0
by 0
the 0
H B-gene
- I-gene
2Kb I-gene
5 I-gene
' I-gene
enhancer I-gene
region I-gene
( 0
H2TF1/KBF1 B-gene
site 0
) 0
and 0
comparable 0
to 0
that 0
of 0
pRSVCAT 0
H2TF1/KBF1 I-gene

CONCLUSIONS 0
: 0
These 0
findings 0
imply 0
that 0
the 0
spinal 0
cord 0
is 0
not 0
a 0
simple 0
command 0
- 0
carrying 0
medium 0
from 0
the 0
brain 0
to 0
the 0
limbs 0
, 0
and 0
implies 0
that 0
some 0
computational 0
activities 0
take 0
place 0
at 0
the 0
spinal 0
cord 0
level 0
. 0

The 0
dipper 0
( 0
RONF 0
of 0
BP 0
( 0
or 0
HR 0
) 0
> 0
or 0
= 0
10 0
% 0
2 0
. 0

I 0
. 0

Acute 0
spontaneous 0
subdural 0
haematoma 0
. 0

Nonsuicidal 0
mortality 0
in 0
late 0
- 0
life 0
depression 0
. 0

DSS4 B-gene
- I-gene
1 I-gene
is 0
a 0
dominant 0
suppressor 0
of 0
sec4 B-gene
- I-gene
8 I-gene
that 0
encodes 0
a 0
nucleotide 0
exchange 0
protein 0
that 0
aids 0
Sec4p B-gene
function 0
. 0

A 0
study 0
of 0
characteristics 0
in 0
adult 0
asthmatics 0
who 0
are 0
sensitized 0
by 0
cats 0
and 0
dogs 0
allergens 0

The 0
failure 0
suggests 0
that 0
these 0
assembly 0
competent 0
but 0
complementation 0
- 0
negative 0
alpha 0
mutants 0
lack 0
an 0
as 0
yet 0
unidentified 0
function 0
( 0
s 0
) 0
. 0

Ciprofloxacin 0
levels 0
in 0
serum 0
and 0
blister 0
fluid 0
at 0
the 0
end 0
of 0
the 0
dosing 0
interval 0
( 0
8 0
h 0
) 0
were 0
superior 0
or 0
almost 0
superior 0
to 0
MICs 0
for 0
sensitive 0
organisms 0
including 0
Pseudomonas 0
aeruginosa 0
. 0

However 0
, 0
both 0
peptides 0
1 0
- 0
49 0
and 0
63 0
- 0
87 0
bound 0
to 0
PDE B-gene
alpha/beta I-gene
in 0
a 0
solid 0
- 0
phase 0
binding 0
assay 0
. 0

SETTING 0
: 0
A 0
private 0
office 0
- 0
based 0
fertility 0
program 0
. 0

Our 0
results 0
showed 0
that 0
direct 0
enantiomeric 0
separation 0
of 0
mephenytoin 0
was 0
obtained 0
by 0
using 0
a 0
chiral 0
capillary 0
column 0
, 0
the 0
retention 0
times 0
for 0
S 0
- 0
and 0
R 0
- 0
mephenytoin 0
were 0
25.5 0
and 0
26.2 0
min 0
respectively 0
, 0
with 0
a 0
detection 0
limit 0
less 0
than 0
50 0
ng/ml 0
of 0
mephenytoin 0
. 0

The 0
consensus 0
mammalian 0
ER 0
stress 0
response 0
element 0
( 0
ERSE 0
) 0
conserved 0
among 0
grp B-gene
promoters I-gene
consists 0
of 0
a 0
tripartite 0
structure 0
CCAAT 0
( 0
N9 0
) 0
CCACG 0
, 0
with 0
N 0
being 0
a 0
strikingly 0
GC 0
- 0
rich 0
region 0
of 0
9 0
bp 0
. 0

Further 0
, 0
we 0
find 0
that 0
the 0
BMI1 B-gene
protein I-gene
can 0
also 0
interact 0
with 0
itself 0
. 0

These 0
data 0
suggest 0
that 0
certain 0
of 0
the 0
nuclear 0
protein 0
import 0
functions 0
of 0
NTF2 B-gene
and 0
Ran/TC4 B-gene
are 0
closely 0
linked 0
and 0
that 0
Ran/TC4 I-gene

Our 0
analysis 0
indicates 0
that 0
a 0
gene 0
correction 0
mechanism 0
has 0
been 0
operating 0
on 0
the 0
Hbbs B-gene
chromosome 0
to 0
keep 0
beta B-gene
s I-gene
and 0
beta B-gene
t I-gene
evolving 0
in 0
concert 0
, 0
whereas 0
on 0
the 0
Hbbd B-gene
chromosome 0
, 0
beta B-gene
dmin I-gene
has 0
diverged 0
considerably 0
from 0
beta B-gene
dmaj I-gene
. 0

The 0
prosomal B-gene
RNA I-gene
- I-gene
binding I-gene
protein I-gene
p27K I-gene
is 0
a 0
member 0
of 0
the 0
alpha B-gene
- I-gene
type I-gene
human I-gene
prosomal I-gene
gene I-gene
family I-gene
. 0

Because 0
controlled 0
- 0
release 0
niacin 0
seems 0
to 0
be 0
more 0
potent 0
than 0
crystalline 0
niacin 0
, 0
product 0
substitution 0
without 0
dose 0
adjustment 0
should 0
be 0
avoided 0
. 0

Expression 0
of 0
the 0
gene 0
encoding 0
transcription B-gene
factor I-gene
cyclic I-gene
adenosine I-gene
3',5' I-gene
- I-gene
monophosphate I-gene
( I-gene
cAMP I-gene
) I-gene
response I-gene
element I-gene
- I-gene
binding I-gene
protein I-gene
( 0
CREB B-gene
) 0
: 0
regulation 0
by 0
follicle B-gene
- I-gene
stimulating I-gene
hormone I-gene
- 0
induced 0
cAMP 0
signaling 0
in 0
primary 0
rat 0
Sertoli 0
cells 0
. 0

Comparison 0
of 0
the 0
therapeutic 0
effectiveness 0
of 0
membrane 0
and 0
centrifugation 0
plasmapheresis 0

Number 0
of 0
warm 0
- 0
units 0
with 0
higher 0
rates 0
of 0
firing 0
and 0
greater 0
thermal 0
coefficients 0
, 0
comparable 0
to 0
those 0
of 0
warm 0
- 0
units 0
in 0
the 0
adult 0
, 0
gradually 0
increased 0
with 0
growth 0
. 0

To 0
investigate 0
the 0
effect 0
of 0
hyperthyroidism 0
on 0
the 0
pattern 0
and 0
time 0
course 0
of 0
O2 0
uptake 0
( 0
VO2 0
) 0
following 0
the 0
transition 0
from 0
rest 0
to 0
exercise 0
, 0
six 0
patients 0
and 0
six 0
healthy 0
subjects 0
performed 0
cycle 0
exercise 0
at 0
an 0
average 0
work 0
rate 0
( 0
WR 0
) 0
of 0
18 0
and 0
20 0
W 0
respectively 0
. 0

88 0
, 0
3739 0
- 0
3743 0
) 0
) 0
. 0

CHIEF 0
OUTCOME 0
MEASURES 0
: 0
Endoluminal 0
release 0
of 0
prostacyclin 0
( 0
6 0
- 0
Keto 0
- 0
PGF1 0
alpha 0
) 0
and 0
thromboxane 0
B2 0
( 0
TxB2 0
) 0
, 0
patency 0
, 0
EC 0
coverage 0
and 0
cell 0
identity 0
. 0

Elevated 0
systolic 0
blood 0
pressure 0
and 0
high 0
postglucose 0
serum B-gene
insulin I-gene
levels 0
showed 0
an 0
independent 0
, 0
significant 0
association 0
with 0
left 0
ventricular 0
mass 0
in 0
female 0
diabetic 0
subjects 0
. 0

Seasonal 0
variation 0
of 0
the 0
cadmium 0
content 0
of 0
Murex 0
trunculus 0
in 0
a 0
non 0
- 0
cadmium 0
polluted 0
environment 0
. 0

The 0
total 0
area 0
under 0
the 0
blood 0
glucose 0
curve 0
over 0
the 0
initial 0
value 0
was 0
not 0
altered 0
2 0
h 0
after 0
treatment 0
with 0
SH 0
B 0
209 0
AB 0
or 0
Neogynon 0
. 0

Serum B-gene
IgM I-gene
levels 0
showed 0
a 0
highly 0
significant 0
increase 0
in 0
all 0
types 0
of 0
brain 0
tumour 0
when 0
compared 0
to 0
controls 0
. 0

Here 0
we 0
describe 0
the 0
characterization 0
of 0
cDNAs 0
encoding 0
two 0
unusual 0
E2Fs B-gene
, 0
E2F B-gene
- I-gene
4 I-gene
and 0
E2F B-gene
- I-gene
5 I-gene
, 0
each 0
identified 0
by 0
the 0
ability 0
of 0
their 0
gene 0
product 0
to 0
interact 0
with 0
p130 B-gene
in 0
a 0
yeast 0
two 0
- 0
hybrid 0
system 0
. 0

Ultra 0
- 0
energy 0
( 0
UHE 0
) 0
imaging 0
is 0
usually 0
performed 0
in 0
simultaneous 0
F 0
- 0
18 0
FDG/Tc 0
- 0
99m 0
MIBI 0
studies 0
. 0

However 0
, 0
electron 0
microscopy 0
revealed 0
that 0
while 0
sec4 B-gene
mutant I-gene
cells 0
accumulate 0
secretory 0
vesicles 0
, 0
ypt31/32 B-gene
mutant I-gene
cells 0
accumulate 0
aberrant 0
Golgi 0
structures 0
. 0

Furthermore 0
, 0
Grap B-gene
is 0
associated 0
with 0
a 0
Ras B-gene
guanine I-gene
nucleotide I-gene
exchange I-gene
factor I-gene
mSos1 B-gene
, 0
primarily 0
through 0
its 0
N B-gene
- I-gene
terminal I-gene
SH3 I-gene
domain I-gene
. 0

Correlation 0
of 0
nitrogen 0
, 0
carbohydrate 0
and 0
lipid 0
metabolic 0
indices 0
in 0
rats 0
cooled 0
under 0
conditions 0
of 0
an 0
altered 0
gaseous 0
environment 0

Transfer 0
of 0
F 0
- 0
like 0
plasmids 0
is 0
regulated 0
by 0
the 0
FinOP B-gene
system 0
, 0
which 0
controls 0
the 0
expression 0
of 0
traJ B-gene
, 0
a 0
positive 0
regulator 0
of 0
the 0
transfer 0
operon 0
. 0

This 0
regimen 0
may 0
be 0
considered 0
front 0
- 0
line 0
therapy 0
when 0
autologous 0
stem 0
cell 0
transplantation 0
is 0
not 0
feasible 0
and 0
when 0
a 0
rapid 0
response 0
is 0
particularly 0
important 0
. 0

To 0
investigate 0
this 0
issue 0
, 0
we 0
used 0
a 0
recognition 0
task 0
in 0
which 0
two 0
strings 0
of 0
letters 0
are 0
presented 0
sequentially 0
. 0

Comparison 0
to 0
the 0
murine 0
homologues 0
of 0
these 0
molecules 0
reveals 0
a 0
high 0
degree 0
of 0
conservation 0
between 0
the 0
products 0
of 0
one 0
of 0
these 0
genes 0
, 0
Fc B-gene
gamma I-gene
RIIb I-gene
, 0
and 0
the 0
murine B-gene
beta I-gene
gene I-gene
in 0
primary 0
sequence 0
, 0
splicing 0
pattern 0
, 0
and 0
tissue 0
distribution 0
. 0

A 0
rabbit 0
antiserum 0
raised 0
against 0
a 0
unique 0
( 0
V3 0
domain 0
) 0
bacterially 0
expressed 0
PKC B-gene
theta I-gene
fragment I-gene
immunoprecipitated 0
specifically 0
an 0
82 0
- 0
kDa 0
protein 0
from 0
Jurkat 0
cell 0
lysates 0
. 0

These 0
changes 0
persisted 0
during 0
the 0
first 0
week 0
. 0

Hematological 0
parameters 0
( 0
leukocyte 0
, 0
neutrophil 0
and 0
platelet 0
counts 0
) 0
and 0
liver 0
function 0
tests 0
were 0
determined 0
by 0
standard 0
procedures 0
. 0

( 0
1993 0
) 0
8 0
, 0
94 0
- 0
99 0
) 0
. 0

The 0
effect 0
of 0
betamethasone 0
on 0
duodenal 0
calcium 0
absorption 0
and 0
1,25 0
- 0
dihydroxy 0
vitamin 0
D3 0
production 0
in 0
the 0
chick 0
. 0

Phosphate 0
compounds 0
in 0
isolated 0
, 0
perfused 0
hearts 0
during 0
pH 0
variation 0
due 0
to 0
changes 0
in 0
extracellular 0
PCO2 0
and 0
bicarbonate 0

We 0
report 0
on 0
a 0
case 0
discovered 0
in 0
a 0
13 0
year 0
- 0
old 0
girl 0
presenting 0
with 0
anaemia 0
. 0

Although 0
analysis 0
of 0
the 0
similarity 0
between 0
the 0
44 0
- 0
kDa 0
protein 0
and 0
the 0
E. B-gene
coli I-gene
RecA I-gene
protein I-gene
did 0
not 0
show 0
any 0
significant 0
homology 0
between 0
them 0
, 0
it 0
revealed 0
their 0
identity 0
by 0
five 0
amino 0
- 0
acid 0
residues 0
involved 0
in 0
the 0
formation 0
of 0
the 0
epitope 0
that 0
recognized 0
the 0
paratope 0
of 0
the 0
RecA B-gene
protein I-gene
antibody I-gene
for 0
subsequent 0
epitope 0
- 0
paratope 0
binding 0
of 0
these 0
proteins 0
. 0

It 0
would 0
seem 0
that 0
caution 0
should 0
be 0
exercised 0
in 0
using 0
HPL B-gene
values 0
as 0
an 0
index 0
of 0
placental 0
function 0
in 0
anaemic 0
women 0
. 0

No 0
IORT 0
related 0
mortality 0
has 0
been 0
observed 0
. 0

Characterization 0
of 0
a 0
tonB B-gene
- 0
phoA B-gene
gene 0
fusion 0
suggests 0
that 0
the 0
amino 0
- 0
terminal 0
41 0
amino 0
acids 0
of 0
TonB B-gene
are 0
sufficient 0
to 0
promote 0
export 0
of 0
the 0
fusion 0
protein 0
and 0
presumably 0
TonB B-gene
as 0
well 0
. 0

Characterization 0
of 0
a 0
unique 0
protein 0
component 0
of 0
yeast B-gene
RNase I-gene
MRP I-gene
: 0
an 0
RNA 0
- 0
binding 0
protein 0
with 0
a 0
zinc 0
- 0
cluster 0
domain 0
. 0

This 0
raises 0
the 0
possibility 0
that 0
recombination 0
occurred 0
between 0
corresponding 0
LTR 0
and 0
vif B-gene
loci I-gene
of 0
the 0
quasi 0
- 0
species 0
present 0
in 0
the 0
isolates 0
described 0
here 0
. 0

2 0
. 0

The 0
antihypertensive 0
action 0
corresponds 0
to 0
those 0
of 0
established 0
diuretics 0
. 0

These 0
results 0
are 0
discussed 0
in 0
relation 0
to 0
predicted 0
isoform 0
L 0
diversity 0
across 0
human 0
tissues 0
and 0
cells 0
. 0

In 0
the 0
healing 0
tendons 0
, 0
the 0
rate 0
of 0
collagen B-gene
synthesis 0
decreased 0
and 0
the 0
rate 0
of 0
noncollagen 0
protein 0
synthesis 0
remained 0
unchanged 0
. 0

The 0
aromatic B-gene
hydrocarbon I-gene
receptor I-gene
( 0
AHR B-gene
) 0
is 0
a 0
ligand 0
- 0
activated 0
transcription 0
factor 0
that 0
regulates 0
the 0
expression 0
of 0
several 0
drug 0
- 0
metabolizing 0
enzymes 0
and 0
has 0
been 0
implicated 0
in 0
immunosuppression 0
, 0
teratogenesis 0
, 0
cell 0
- 0
specific 0
hyperplasia 0
, 0
and 0
certain 0
types 0
of 0
malignancies 0
and 0
toxicities 0
. 0

Fluctuations 0
of 0
the 0
measured 0
ECF 0
energy 0
- 0
related 0
substances 0
corresponded 0
to 0
various 0
clinical 0
events 0
presumably 0
involving 0
hypoxia/ischemia 0
. 0

After 0
3 0
months 0
of 0
intervention 0
, 0
sustained 0
physical 0
training 0
was 0
associated 0
with 0
the 0
decrease 0
of 0
FVII B-gene
and 0
PAI B-gene
- I-gene
1 I-gene
levels 0
. 0

The 0
metalloproteinase B-gene
mediating 0
Met B-gene
cleavage 0
was 0
specifically 0
inhibited 0
by 0
the 0
tissue B-gene
inhibitor I-gene
of I-gene
metalloproteinases I-gene
( I-gene
TIMP I-gene
) I-gene
- I-gene
3 I-gene
, 0
but 0
not 0
by 0
TIMP B-gene
- I-gene
1 I-gene
or 0
TIMP B-gene
- I-gene
2 I-gene
. 0

This 0
constant 0
expression 0
profile 0
, 0
coupled 0
with 0
the 0
observation 0
that 0
over 0
- 0
expression 0
of 0
mSin3A B-gene
does 0
not 0
augment 0
the 0
anti B-gene
- I-gene
Myc I-gene
activity 0
of 0
Mxi1 B-gene
- 0
SR 0
in 0
the 0
rat 0
embryo 0
fibroblast 0
( 0
REF 0
) 0
transformation 0
assay 0
, 0
suggests 0
that 0
mSin3A B-gene
is 0
not 0
a 0
limiting 0
factor 0
in 0
the 0
regulation 0
of 0
Myc B-gene
superfamily I-gene
function 0
. 0

METHODS 0
AND 0
RESULTS 0
: 0
The 0
effect 0
of 0
prolonged 0
nitrate 0
therapy 0
between 0
2 0
days 0
and 0
6 0
weeks 0
during 0
healing 0
after 0
infarction 0
on 0
serial 0
parameters 0
of 0
ventricular 0
remodeling 0
( 0
scar 0
expansion 0
, 0
scar 0
thinning 0
, 0
ventricular 0
dilation 0
, 0
and 0
hypertrophy 0
) 0
and 0
function 0
( 0
asynergy 0
or 0
akinesis 0
plus 0
dyskinesis 0
and 0
ejection 0
fraction 0
) 0
by 0
serial 0
two 0
- 0
dimensional 0
echocardiography 0
, 0
hemodynamics 0
, 0
postmortem 0
topography 0
( 0
computerized 0
planimetry 0
, 0
geometric 0
maps 0
, 0
and 0
radiographs 0
) 0
, 0
and 0
collagen B-gene
content 0
( 0
hydroxyproline 0
) 0
was 0
studied 0
in 0
64 0
instrumented 0
dogs 0
randomized 0
2 0
days 0
after 0
left 0
anterior 0
descending 0
coronary 0
artery 0
ligation 0
to 0
various 0
nitrate 0
regimens 0
( 0
n 0
= 0
32 0
) 0
over 0
the 0
first 0
2 0
weeks 0
( 0
subgroup 0
1 0
: 0
2 0
% 0
transdermal 0
nitroglycerin 0
at 0
8 0
AM 0
and 0
4 0
PM 0
, 0
n 0
= 0
6 0
; 0
subgroup 0
2 0
: 0
2 0
% 0
transdermal 0
nitroglycerin 0
plus 0
2.6 0
mg 0
of 0
sustained 0
- 0
release 0
oral 0
nitroglycerin 0
at 0
8 0
AM 0
, 0
3 0
PM 0
, 0
and 0
10 0
PM 0
, 0
n 0
= 0
5 0
; 0
subgroup 0
3 0
: 0
oral 0
isosorbide 0
dinitrate 0
, 0
30 0
mg 0
at 0
8 0
AM 0
and 0
4 0
PM 0
, 0
n 0
= 0
11 0
) 0
or 0
6 0
weeks 0
( 0
subgroup 0
4 0
: 0
isosorbide 0
dinitrate 0
, 0
n 0
= 0
10 0
) 0
and 0
in 0
matching 0
controls 0
( 0
n 0
= 0
32 0
) 0
. 0

A 0
nationwide 0
survey 0
uncovered 0
a 0
tenfold 0
variation 0
between 0
counties 0
in 0
the 0
prescribing 0
of 0
IFNB B-gene
. 0

We 0
have 0
demonstrated 0
that 0
a 0
putative 0
HOX B-gene
cofactor I-gene
, 0
PBX1A B-gene
, 0
participates 0
in 0
cooperative 0
DNA 0
binding 0
with 0
HOXA B-gene
- I-gene
1 I-gene
and 0
the 0
Deformed B-gene
group 0
protein 0
HOXD B-gene
- I-gene
4 I-gene
. 0

RESULTS 0
- 0
- 0
261 0
patients 0
were 0
enrolled 0
into 0
this 0
study 0
; 0
of 0
these 0
, 0
138 0
( 0
53 0
% 0
) 0
patients 0
attended 0
for 0
repeat 0
colposcopy 0
and 0
cytology 0
at 0
one 0
year 0
. 0

We 0
have 0
found 0
that 0
pro B-gene
- I-gene
IGF I-gene
- I-gene
2 I-gene
can 0
initially 0
form 0
two 0
disulfide 0
isomers 0
that 0
undergo 0
rearrangement 0
to 0
a 0
single 0
conformation 0
in 0
vivo 0
. 0

Thus 0
, 0
primate 0
vs. 0
rodent 0
promoter 0
selectivity 0
mediated 0
by 0
the 0
TBP B-gene
- 0
TAFI B-gene
complex 0
is 0
likely 0
to 0
be 0
the 0
result 0
of 0
cumulative 0
subtle 0
differences 0
between 0
individual 0
subunits 0
that 0
lead 0
to 0
species 0
- 0
specific 0
properties 0
of 0
RNA B-gene
polymerase I-gene
I I-gene
transcription 0
. 0

Anti B-gene
- I-gene
Jo I-gene
- I-gene
1 I-gene
antibody I-gene
was 0
not 0
present 0
. 0

The 0
structure 0
and 0
expression 0
of 0
the 0
murine B-gene
gene I-gene
encoding I-gene
granulocyte I-gene
- I-gene
macrophage I-gene
colony I-gene
stimulating I-gene
factor I-gene
: 0
evidence 0
for 0
utilisation 0
of 0
alternative 0
promoters 0
. 0

Cotransfection 0
of 0
pINV 0
- 0
2473 0
, 0
a 0
construct 0
containing 0
2473 0
base 0
pairs 0
of 0
hINV B-gene
upstream I-gene
sequence I-gene
linked 0
to 0
luciferase B-gene
, 0
with 0
POU B-gene
homeodomain I-gene
transcription I-gene
factors I-gene
Oct1 B-gene
, 0
Oct2 B-gene
, 0
Brn4 B-gene
, 0
SCIP B-gene
, 0
Skn1a B-gene
or 0
Skn1i B-gene
, 0
results 0
in 0
a 0
strong 0
suppression 0
of 0
basal 0
promoter 0
activity 0
. 0

Central 0
treatment 0
unit 0
saves 0
nurses 0
, 0
adds 0
income 0
, 0
improves 0
care 0
. 0

The 0
Grb2 B-gene
SH3 B-gene
( I-gene
C I-gene
) I-gene
binding I-gene
region I-gene
of 0
Gab1 B-gene
has 0
significant 0
homology 0
to 0
a 0
region 0
of 0
the 0
adapter B-gene
protein I-gene
SLP I-gene
- I-gene
76 I-gene
. 0

The 0
QCS 0
appears 0
comparable 0
with 0
the 0
MMSE 0
and 0
is 0
quicker 0
to 0
administer 0
. 0

A 0
positive 0
FTA B-gene
- I-gene
ABS I-gene
FTA I-gene
- I-gene
ABS I-gene
- I-gene
19S I-gene
- I-gene
IgM I-gene
test 0
indicates 0
the 0
necessity 0
of 0
treatment 0
. 0

A 0
DNA 0
binding 0
protein 0
was 0
identified 0
which 0
binds 0
to 0
two 0
novel 0
target 0
- 0
like 0
sequences 0
: 0
( 0
i 0
) 0
at 0
the 0
5 0
' 0
flanking 0
site 0
of 0
the 0
breakpoint 0
junction 0
of 0
chromosome 0
8 0
in 0
a 0
patient 0
with 0
T 0
- 0
acute 0
lymphoblastic 0
leukemia 0
( 0
ALL 0
) 0
carrying 0
the 0
t 0
( 0
8 0
; 0
14 0
) 0
( 0
q24 0
; 0
q11 0
) 0
rearrangement 0
and 0
( 0
ii 0
) 0
on 0
chromosome 0
1 0
in 0
three 0
of 0
five 0
T 0
- 0
ALL 0
patients 0
with 0
the 0
t 0
( 0
1 0
; 0
14 0
) 0
( 0
p32 0
; 0
q11 0
) 0
rearrangement 0
. 0

1988 0
) 0
. 0

The 0
effect 0
of 0
iron 0
on 0
the 0
toxigenicity 0
of 0
Vibrio 0
cholerae 0
. 0

The 0
rest 0
of 0
the 0
3 0
' 0
untranslated 0
sequences 0
were 0
common 0
to 0
both 0
cDNA 0
clones 0
. 0

The 0
anesthesiologist 0
and 0
the 0
cardiac 0
surgeon 0
. 0

The 0
three 0
proteins 0
copurified 0
through 0
several 0
biochemical 0
fractionation 0
steps 0
and 0
could 0
be 0
coimmunoprecipitated 0
by 0
using 0
antibodies 0
against 0
GCD1 B-gene
or 0
GCD2 B-gene
. 0

From 0
1998 0
to 0
1999 0
, 0
a 0
large 0
number 0
of 0
community 0
- 0
acquired 0
respiratory 0
tract 0
isolates 0
of 0
Streptococcus 0
pneumoniae 0
( 0
n=566 0
) 0
, 0
Haemophilus 0
influenzae 0
( 0
n=513 0
) 0
and 0
Moraxella 0
catarrhalis 0
( 0
n=228 0
) 0
were 0
collected 0
from 0
15 0
centres 0
in 0
Australia 0
, 0
Hong 0
Kong 0
, 0
Japan 0
, 0
China 0
, 0
the 0
Philippines 0
, 0
Singapore 0
, 0
South 0
Africa 0
and 0
Taiwan 0
through 0
the 0
SENTRY 0
Antimicrobial 0
Surveillance 0
Program 0
. 0

Rats 0
on 0
the 0
multiple 0
oral 0
dosage 0
regimen 0
were 0
given 0
unlabelled 0
HMCF 0
in 0
their 0
drinking 0
water 0
for 0
13 0
days 0
before 0
the 0
administration 0
of 0
a 0
bolus 0
dose 0
of 0
[ 0
14C 0
] 0
HMCF 0
on 0
day 0
14 0
. 0

In 0
order 0
to 0
search 0
for 0
mutations 0
in 0
the 0
multicopy B-gene
RBM I-gene
genes I-gene
that 0
might 0
be 0
associated 0
with 0
male 0
infertility 0
, 0
we 0
have 0
used 0
sequence 0
data 0
from 0
the 0
reported 0
cDNA 0
clone 0
to 0
determine 0
the 0
intron 0
exon 0
boundaries 0
of 0
the 0
YRRM B-gene
1 I-gene
gene I-gene
. 0

Uterine 0
contractions 0
began 0
with 0
a 0
mean 0
latency 0
of 0
62 0
min 0
in 0
the 0
PGF2 0
alpha 0
infused 0
women 0
, 0
in 0
controls 0
uterine 0
activity 0
remained 0
unchanged 0
. 0

The 0
implication 0
of 0
Rac B-gene
and 0
Cdc42 B-gene
was 0
analyzed 0
in 0
transient 0
transfection 0
experiments 0
using 0
either 0
constitutively 0
active 0
( 0
V12 0
) 0
or 0
dominant 0
- 0
interfering 0
( 0
N17 0
) 0
mutants 0
. 0

The 0
evolutionary 0
significance 0
of 0
the 0
similarities 0
of 0
intron 0
secondary 0
structures 0
and 0
open 0
reading 0
frames 0
of 0
the 0
ND3 B-gene
, I-gene
4 I-gene
and I-gene
ATPase I-gene
6 I-gene
genes I-gene
is 0
discussed 0
, 0
including 0
the 0
possible 0
separate 0
evolution 0
of 0
structural 0
and 0
coding 0
sequences 0
. 0

Although 0
there 0
is 0
evidence 0
that 0
cone 0
ratios 0
do 0
determine 0
colour 0
appearance 0
under 0
many 0
conditions 0
, 0
the 0
site 0
or 0
sites 0
of 0
their 0
computation 0
is 0
unknown 0
. 0

Procedures 0
with 0
perfected 0
method 0

In 0
an 0
effort 0
to 0
identify 0
factors 0
involved 0
in 0
the 0
expression 0
of 0
this 0
important 0
erythroid 0
- 0
specific 0
regulatory 0
protein 0
, 0
we 0
have 0
isolated 0
the 0
mouse B-gene
EKLF I-gene
gene I-gene
and 0
systematically 0
analyzed 0
the 0
promoter 0
region 0
. 0

Accordingly 0
, 0
superpeptide 0
antigenic 0
material 0
was 0
readily 0
detected 0
by 0
immunoblotting 0
cell 0
extracts 0
and 0
enriched 0
in 0
vacuolar 0
preparations 0
of 0
PrA B-gene
deficient 0
mutant 0
cells 0
. 0

RESULTS 0
: 0
All 0
primary 0
tumors 0
were 0
positive 0
for 0
CAM5.2 B-gene
. 0

However 0
massive 0
necrosis 0
of 0
the 0
renal 0
tubules 0
had 0
been 0
found 0
with 0
more 0
than 0
15mg 0
of 0
DSM 0
administration 0
. 0

A 0
case 0
of 0
functioning 0
parathyroid 0
carcinoma 0
with 0
hypereninemic 0
hypertension 0
. 0

Together 0
with 0
a 0
number 0
of 0
phase 0
II 0
trials 0
, 0
phase 0
I 0
trials 0
utilizing 0
escalating 0
doses 0
of 0
carboplatin 0
and 0
paclitaxel 0
with 0
growth 0
factor 0
or 0
growth 0
factor 0
and 0
blood 0
stem 0
- 0
cell 0
support 0
have 0
shown 0
that 0
substantial 0
increases 0
in 0
dose 0
intensity 0
can 0
be 0
achieved 0
. 0

The 0
study 0
was 0
performed 0
in 0
a 0
class 0
100 0
laminar 0
flow 0
clean 0
bench 0
in 0
order 0
to 0
minimize 0
particulate 0
contamination 0
from 0
extraneous 0
sources 0
. 0

Moreover 0
, 0
since 0
the 0
integrated 0
transforming 0
DNA 0
was 0
not 0
altered 0
or 0
lost 0
expression 0
of 0
the 0
RbcS2 B-gene
: 0
:aadA B-gene
: 0
:RbcS2 B-gene
gene I-gene
( I-gene
s I-gene
) I-gene
appears 0
to 0
be 0
repressed 0
. 0

In 0
contrast 0
, 0
the 0
holo B-gene
- I-gene
dTFIIA I-gene
( 0
L/S 0
) 0
binds 0
TBP B-gene
with 0
high 0
affinity 0
. 0

In 0
one 0
trial 0
, 0
116 0
subjects 0
with 0
transfusion 0
- 0
related 0
chronic 0
hepatitis 0
C 0
were 0
treated 0
with 0
lymphoblastoid B-gene
interferon I-gene
( 0
5 0
MU/m2 0
three 0
times 0
a 0
week 0
for 0
2 0
mo 0
, 0
then 0
3 0
MU/m2 0
three 0
times 0
a 0
week 0
for 0
4 0
or 0
10 0
mo 0
) 0
. 0

These 0
results 0
demonstrate 0
the 0
preferential 0
endometrial 0
cell 0
- 0
type 0
expression 0
of 0
BTEB B-gene
and 0
suggest 0
its 0
regulatory 0
role 0
in 0
pregnancy 0
- 0
associated 0
endometrial 0
epithelial 0
gene 0
expression 0
. 0

The 0
sequence 0
of 0
LZ321 B-gene
matched 0
that 0
of 0
RREB1 B-gene
, 0
a 0
transcription 0
factor 0
that 0
bound 0
to 0
a 0
Ras B-gene
responsive I-gene
element I-gene
( 0
RRE B-gene
) 0
very 0
different 0
from 0
the 0
sequence 0
with 0
which 0
we 0
isolated 0
LZ321 B-gene
. 0

Phosphorylation 0
at 0
Ser 0
( 0
670 0
) 0
impairs 0
the 0
ability 0
of 0
GRK2 B-gene
to 0
phosphorylate 0
both 0
soluble 0
and 0
membrane 0
- 0
incorporated 0
receptor 0
substrates 0
and 0
dramatically 0
attenuates 0
Gbetagamma B-gene
- 0
mediated 0
activation 0
of 0
this 0
enzyme 0
. 0

However 0
, 0
the 0
sequence 0
of 0
mRAR B-gene
- I-gene
beta I-gene
3 I-gene
region I-gene
A I-gene
differs 0
from 0
that 0
of 0
mRAR B-gene
- I-gene
beta I-gene
1 I-gene
by 0
an 0
additional 0
27 0
C 0
- 0
terminal 0
amino 0
acids 0
encoded 0
in 0
an 0
81 0
nucleotide 0
- 0
long 0
putative 0
exon 0
which 0
is 0
spliced 0
in 0
between 0
the 0
exons 0
encoding 0
the 0
A B-gene
and I-gene
B I-gene
regions I-gene
of I-gene
mRAR I-gene
- I-gene
beta I-gene
1 I-gene
. 0

Rad18 B-gene
is 0
required 0
for 0
DNA 0
repair 0
and 0
checkpoint 0
responses 0
in 0
fission 0
yeast 0
. 0

The 0
longest 0
S1 0
- 0
S2 0
interval 0
at 0
which 0
S2 0
failed 0
to 0
capture 0
( 0
effective 0
refractory 0
period 0
) 0
was 0
longer 0
by 0
5.5 0
+/ 0
- 0
8.2 0
msec 0
at 0
twice 0
threshold 0
( 0
0.05 0
less 0
than 0
p 0
less 0
than 0
0.10 0
) 0
and 0
5.5 0
+/ 0
- 0
3.5 0
msec 0
at 0
5 0
times 0
threshold 0
stimulation 0
( 0
p 0
less 0
than 0
0.01 0
) 0
when 0
the 0
basic 0
drive 0
and 0
extrastimuli 0
were 0
delivered 0
to 0
separate 0
sites 0
. 0

Using 0
lasers 0
, 0
PRK 0
involves 0
reshaping 0
the 0
cornea 0
so 0
that 0
its 0
refractive 0
power 0
is 0
increased 0
. 0

Using 0
in 0
vivo 0
screening 0
, 0
we 0
first 0
identified 0
a 0
gene 0
that 0
appeared 0
to 0
interfere 0
with 0
the 0
His 0
- 0
Asp 0
phosphorelay 0
between 0
the 0
HPt 0
domain 0
and 0
the 0
receiver 0
domain 0
of 0
OmpR B-gene
, 0
provided 0
that 0
the 0
gene 0
product 0
was 0
expressed 0
through 0
a 0
multicopy 0
plasmid 0
. 0

In 0
addition 0
, 0
six 0
other 0
landmarks 0
favored 0
the 0
xeroradiograph 0
but 0
not 0
to 0
the 0
degree 0
of 0
statistical 0
significance 0
. 0

Coronary 0
vasoconstriction 0
caused 0
by 0
endothelin B-gene
- I-gene
1 I-gene
is 0
enhanced 0
by 0
ischemia 0
- 0
reperfusion 0
and 0
by 0
norepinephrine 0
present 0
in 0
concentrations 0
typically 0
observed 0
after 0
neonatal 0
cardiopulmonary 0
bypass 0
. 0

Inhibition 0
of 0
Raf B-gene
- I-gene
1 I-gene
signaling 0
by 0
a 0
monoclonal 0
antibody 0
, 0
which 0
interferes 0
with 0
Raf B-gene
- I-gene
1 I-gene
activation 0
and 0
with 0
Mek B-gene
substrate 0
binding 0
. 0

Laparoscopic 0
examination 0
1 0
year 0
after 0
surgery 0
revealed 0
an 0
enlarged 0
, 0
thin 0
- 0
walled 0
, 0
and 0
fluid 0
- 0
filled 0
uterine 0
segment 0
cranial 0
to 0
the 0
midcornus 0
occlusion 0
sites 0
in 0
all 0
animals 0
. 0

NBSII 0
is 0
essential 0
for 0
ribosome 0
- 0
stimulated 0
activity 0
. 0

Gel 0
shift 0
and 0
southwestern 0
experiments 0
revealed 0
nuclear 0
proteins 0
of 0
43 0
kDa 0
and 0
30 0
kDa 0
in 0
GC 0
and 0
fish 0
cells 0
, 0
respectively 0
, 0
that 0
bind 0
specifically 0
to 0
the 0
tGH B-gene
CRE 0
, 0
suggesting 0
the 0
involvement 0
of 0
CRE B-gene
- I-gene
binding I-gene
- I-gene
protein/activating I-gene
protein/activating I-gene
- I-gene
transcription I-gene
- I-gene
factor I-gene
- I-gene
l I-gene
- 0
related 0
peptides 0
in 0
cAMP 0
response 0
. 0

Moreover 0
, 0
such 0
mutations 0
lead 0
to 0
a 0
dramatic 0
transition 0
in 0
chromatin 0
structure 0
: 0
the 0
DNase B-gene
I I-gene
hypersensitive I-gene
region I-gene
is 0
replaced 0
by 0
two 0
stable 0
, 0
sequence 0
- 0
positioned 0
nucleosomes 0
. 0

Two 0
measures 0
of 0
sensory 0
inhibition 0
were 0
employed 0
, 0
S2/S1 0
x 0
100 0
amplitude 0
ratio 0
and 0
S1 0
- 0
S2 0
amplitude 0
difference 0
. 0

The 0
transcriptional 0
start 0
site 0
, 0
identified 0
by 0
primer 0
extension 0
and 0
S1 B-gene
nuclease I-gene
assay 0
, 0
is 0
34 0
nt 0
upstream 0
of 0
the 0
translation 0
initiation 0
codon 0
. 0

The 0
clinical 0
effects 0
of 0
valproate 0
and 0
ethosuximide 0
can 0
be 0
related 0
to 0
this 0
differential 0
modulation 0
of 0
thalamocortical 0
excitability 0
. 0

Central 0
projections 0
of 0
gastric 0
afferent 0
vagal 0
inputs 0
. 0

Our 0
results 0
suggest 0
a 0
biological 0
role 0
for 0
Elf B-gene
- I-gene
1 I-gene
in 0
the 0
regulation 0
of 0
IgH B-gene
gene I-gene
expression 0
, 0
attribute 0
a 0
functional 0
role 0
for 0
receptor 0
- 0
induced 0
AP B-gene
- I-gene
1 I-gene
proteins I-gene
in 0
B 0
lymphocytes 0
and 0
provide 0
evidence 0
for 0
a 0
direct 0
link 0
between 0
IgM B-gene
receptor I-gene
- 0
mediated 0
signalling 0
and 0
3 0
' 0
enhancer 0
activation 0
. 0

Like 0
Mdm2 B-gene
, 0
MdmX B-gene
is 0
able 0
to 0
bind 0
p53 B-gene
and 0
inhibit 0
p53 B-gene
transactivation 0
; 0
however 0
, 0
the 0
ability 0
of 0
MdmX B-gene
to 0
degrade 0
p53 B-gene
has 0
yet 0
to 0
be 0
examined 0
. 0

The 0
structure 0
of 0
the 0
mAR B-gene
ORF 0
was 0
confirmed 0
by 0
sequence 0
analysis 0
of 0
mAR B-gene
cDNA 0
fragments 0
, 0
which 0
were 0
obtained 0
by 0
PCR 0
amplification 0
of 0
mouse 0
testis 0
cDNA 0
, 0
using 0
mAR B-gene
specific 0
primers 0
. 0

Transforming B-gene
growth I-gene
factor I-gene
- I-gene
beta I-gene
( 0
TGF B-gene
- I-gene
beta I-gene
) 0
inhibits 0
cell 0
cycle 0
progression 0
, 0
in 0
part 0
through 0
up 0
- 0
regulation 0
of 0
gene 0
expression 0
of 0
the 0
p21 B-gene
( 0
WAF1/Cip1 B-gene
) 0
( 0
WAF1/Cip1 I-gene

Decreased 0
plasma 0
level 0
of 0
antithrombin B-gene
III I-gene
was 0
assumed 0
to 0
be 0
one 0
of 0
the 0
major 0
factors 0
underlying 0
hypercoagulable 0
state 0
in 0
nephrotic 0
syndrome 0
. 0

In 0
both 0
RAW 0
cells 0
and 0
the 0
microglia 0
cell 0
line 0
EOC20 0
, 0
two 0
IFN B-gene
- I-gene
gamma I-gene
- 0
activated 0
transcription 0
factors 0
, 0
STAT B-gene
- I-gene
1alpha I-gene
and 0
IRF B-gene
- I-gene
1 I-gene
, 0
bind 0
the 0
GAS B-gene
and 0
IRF B-gene
elements I-gene
, 0
respectively 0
. 0

All 0
patients 0
received 0
marrow 0
from 0
HLA B-gene
- 0
identical 0
sibling 0
donors 0
, 0
underwent 0
similar 0
myeloablative 0
regimens 0
, 0
and 0
had 0
similar 0
pretreatment 0
characteristics 0
. 0

In 0
Types 0
I 0
and 0
II 0
, 0
capillary 0
walls 0
became 0
thinner 0
and 0
more 0
capillary 0
lumens 0
were 0
visiable 0
. 0

Immunoblot 0
analyses 0
revealed 0
that 0
the 0
loss 0
of 0
activator 0
function 0
coincides 0
with 0
selective 0
removal 0
of 0
the 0
C B-gene
- I-gene
terminal I-gene
domain I-gene
( I-gene
CTD I-gene
) I-gene
- I-gene
hyperphosphorylated I-gene
RNAP I-gene
IIO I-gene
along 0
with 0
NC2 B-gene
. 0

In 0
bell 0
pepper 0
, 0
a 0
gene 0
encoding 0
a 0
major 0
plastid 0
- 0
lipid 0
associated 0
protein 0
is 0
expressed 0
as 0
both 0
partially 0
and 0
totally 0
spliced 0
transcripts 0
( 0
respectively 0
PAP2 B-gene
and 0
PAP1 B-gene
) 0
. 0

Aggregation 0
in 0
washed 0
platelets 0
from 0
rats 0
with 0
diabetes 0
was 0
enhanced 0
. 0

Instead 0
, 0
the 0
large 0
difference 0
in 0
ssDNA 0
- 0
binding 0
affinities 0
reflects 0
the 0
loss 0
of 0
hexamerization 0
ability 0
by 0
uvsY B-gene
, 0
suggesting 0
that 0
a 0
form 0
of 0
intrahexamer 0
synergism 0
or 0
cooperativity 0
between 0
binding 0
sites 0
within 0
the 0
uvsY B-gene
hexamer I-gene
leads 0
to 0
its 0
high 0
observed 0
affinity 0
for 0
ssDNA 0
. 0

The 0
authors 0
investigate 0
in 0
a 0
group 0
of 0
211 0
children 0
aged 0
2 0
- 0
6 0
years 0
, 0
incl 0
. 0
in 0
particular 0
a 0
group 0
of 0
33 0
2 0
- 0
year 0
- 0
old 0
ones 0
, 0
in 0
1990 0
and 0
checked 0
in 0
1991 0
at 0
two 0
sites 0
in 0
Bratislava 0
- 0
- 0
a 0
town 0
with 0
a 0
varying 0
concentration 0
of 0
NOX 0
, 0
SO2 0
, 0
dustiness 0
and 0
dust 0
fallout 0
- 0
- 0
their 0
influence 0
on 0
the 0
incidence 0
, 0
type 0
and 0
course 0
of 0
relapsing 0
respiratory 0
disease 0
. 0

Such 0
results 0
suggest 0
that 0
there 0
are 0
no 0
differences 0
in 0
the 0
BMR 0
of 0
age 0
- 0
and 0
weight 0
- 0
matched 0
Asian 0
Indian 0
males 0
, 0
other 0
tropical 0
populations 0
and 0
Americans 0
. 0

CONCLUSION 0
: 0
DaunoXome 0
has 0
an 0
improved 0
pharmacokinetic 0
profile 0
compared 0
with 0
free 0
daunorubicin 0
, 0
and 0
is 0
well 0
tolerated 0
. 0

Furthermore 0
, 0
the 0
zincon 0
- 0
loaded 0
resin 0
was 0
applied 0
to 0
the 0
selective 0
concentration 0
of 0
trace 0
amounts 0
of 0
chalcophile 0
elements 0
in 0
natural 0
water 0
samples 0
prior 0
to 0
neutron 0
activation 0
analysis 0
. 0

Analyses 0
focused 0
on 0
two 0
platyrrhine 0
( 0
New 0
World 0
monkey 0
) 0
species 0
: 0
the 0
common 0
marmoset 0
( 0
Callithrix 0
jacchus 0
) 0
and 0
the 0
brown 0
capuchin 0
monkey 0
( 0
Cebus 0
apella 0
) 0
, 0
each 0
of 0
which 0
has 0
paired 0
, 0
non 0
- 0
allelic 0
gamma 0
loci 0
( 0
5' 0
- 0
gamma 0
1 0
- 0
gamma 0
2 0
- 0
3 0
' 0
) 0
. 0

Over 0
half 0
of 0
the 0
children 0
initially 0
unresponsive 0
to 0
H. 0
influenzae 0
type 0
b 0
meningitis 0
subsequently 0
developed 0
specific 0
antibodies 0
. 0

The 0
electron 0
spin 0
resonance 0
study 0
also 0
demonstrated 0
that 0
the 0
formation 0
of 0
superoxide 0
- 0
DMPO 0
spin 0
adduct 0
was 0
strongly 0
inhibited 0
by 0
a 0
selective 0
cyclooxygenase B-gene
- I-gene
2 I-gene
inhibitor 0
, 0
etodolac 0
, 0
in 0
a 0
concentration 0
- 0
dependent 0
manner 0
. 0

Sox8 B-gene
maps 0
to 0
the 0
t B-gene
complex I-gene
on 0
mouse 0
chromosome 0
17 0
and 0
to 0
human 0
chromosome 0
16p13.3 0
, 0
a 0
region 0
associated 0
with 0
the 0
microphthalmia 0
- 0
cataract 0
syndrome 0
CATM 0
and 0
the 0
alpha 0
- 0
thalassemia/mental 0
retardation 0
syndrome 0
ATR 0
- 0
16 0
. 0

If 0
vascular 0
induction 0
between 0
a 0
vascular 0
carrier 0
and 0
the 0
selected 0
jejunal 0
segment 0
is 0
done 0
as 0
a 0
kind 0
of 0
flap 0
prefabrication 0
, 0
the 0
jejunal 0
interposition 0
flap 0
can 0
be 0
used 0
without 0
the 0
need 0
for 0
complex 0
microsurgery 0
. 0

There 0
was 0
no 0
difference 0
in 0
the 0
day 0
- 0
42 0
cure 0
rates 0
between 0
the 0
QC7 0
( 0
n 0
= 0
65 0
) 0
and 0
A7 0
( 0
n 0
= 0
64 0
) 0
regimens 0
with 0
an 0
efficacy 0
of 0
100 0
% 0
in 0
both 0
, 0
confirmed 0
by 0
parasite 0
genotyping 0
. 0

Acetyl B-gene
- I-gene
CoA I-gene
carboxylase I-gene
from 0
yeast 0
is 0
an 0
essential 0
enzyme 0
and 0
is 0
regulated 0
by 0
factors 0
that 0
control 0
phospholipid 0
metabolism 0
. 0

The 0
NH 0
( 0
2 0
) 0
- 0
terminus 0
of 0
all 0
three 0
proteins 0
contains 0
a 0
POZ 0
domain 0
, 0
a 0
conserved 0
120 0
amino 0
acid 0
motif 0
involved 0
in 0
transcriptional 0
repression 0
and 0
protein 0
dimerization 0
. 0

Recognition 0
of 0
DNA 0
by 0
single 0
- 0
chain 0
derivatives 0
of 0
the 0
phage 0
434 0
repressor 0
: 0
high 0
affinity 0
binding 0
depends 0
on 0
both 0
the 0
contacted 0
and 0
non 0
- 0
contacted 0
base 0
pairs 0
. 0

In 0
the 0
absence 0
of 0
Mg2+ 0
, 0
the 0
extent 0
of 0
destabilization 0
of 0
tRNAPhe B-gene
is 0
greater 0
but 0
appears 0
to 0
be 0
confined 0
to 0
internal 0
regions 0
of 0
the 0
acceptor 0
and 0
T 0
psi 0
C 0
helices 0
, 0
as 0
evidenced 0
by 0
the 0
selectively 0
enhanced 0
exchange 0
rates 0
for 0
imino 0
protons 0
associated 0
with 0
these 0
base 0
pairs 0
. 0

This 0
gene 0
is 0
named 0
PKNOX1 B-gene
by 0
the 0
Human 0
Nomenclature 0
Committee 0
. 0

The 0
carboxyl 0
- 0
terminal 0
75 0
amino 0
acids 0
of 0
the 0
two 0
proteins 0
contain 0
the 0
bHLH 0
motif 0
and 0
differ 0
from 0
each 0
other 0
by 0
only 0
three 0
conservative 0
amino 0
acid 0
changes 0
, 0
while 0
the 0
amino 0
- 0
terminal 0
portions 0
are 0
markedly 0
divergent 0
from 0
each 0
other 0
. 0

A 0
Drosophila 0
subobscura 0
genomic 0
fragment 0
containing 0
all 0
the 0
exons 0
and 0
the 0
late 0
and 0
early 0
promotors 0
in 0
the 0
Sxl B-gene
gene I-gene
of I-gene
D. I-gene
melanogaster I-gene
was 0
isolated 0
. 0

The 0
data 0
from 0
animal 0
experiments 0
indicate 0
that 0
the 0
incidence 0
of 0
solid 0
tumors 0
in 0
marrow 0
transplant 0
patients 0
may 0
still 0
rise 0
in 0
the 0
coming 0
decades 0
. 0

The 0
results 0
of 0
the 0
transient 0
- 0
transfection 0
assay 0
showed 0
that 0
the 0
Sp1 B-gene
binding I-gene
element I-gene
located 0
in 0
the 0
core 0
region 0
( 0
positions 0
- 0
- 0
64 0
to 0
+1 0
) 0
of 0
the 0
alpha2 B-gene
- I-gene
integrin I-gene
promoter I-gene
plays 0
an 0
essential 0
role 0
in 0
the 0
alpha2 B-gene
- I-gene
integrin I-gene
promoter I-gene
activity 0
and 0
its 0
downregulation 0
by 0
Erb B-gene
- 0
B2 B-gene
. 0

These 0
observations 0
suggest 0
that 0
the 0
AF 0
- 0
1 0
region 0
of 0
PPARalpha B-gene
is 0
partially 0
silenced 0
by 0
corepressor 0
proteins 0
, 0
which 0
might 0
interact 0
in 0
a 0
phosphorylation 0
- 0
dependent 0
manner 0
. 0

Evaluation 0
of 0
the 0
effects 0
of 0
chelation 0
therapy 0
with 0
time 0
following 0
strontium 0
exposure 0
to 0
mice 0
. 0

Insertion 0
of 0
alternatively 0
spliced 0
exon 0
W 0
into 0
CREB B-gene
mRNA I-gene
during 0
spermatogenesis 0
results 0
in 0
a 0
polycistronic 0
RNA 0
that 0
encodes 0
two 0
novel 0
internally 0
translated 0
CREB B-gene
repressor I-gene
isoforms I-gene
called 0
I B-gene
- I-gene
CREBs I-gene
, 0
consisting 0
of 0
the 0
carboxy 0
- 0
terminal 0
DNA 0
- 0
binding 0
domain 0
devoid 0
of 0
the 0
transactivation 0
domains 0
. 0

The 0
human B-gene
BRCA1 I-gene
promoter I-gene
also 0
contains 0
a 0
conserved 0
E2F B-gene
site I-gene
and 0
is 0
similarly 0
regulated 0
by 0
E2F1 B-gene
and 0
Rb B-gene
. 0

In 0
the 0
studies 0
described 0
in 0
this 0
report 0
, 0
we 0
have 0
identified 0
two 0
potential 0
Ets B-gene
binding 0
sites 0
, 0
EBS1 B-gene
and 0
EBS2 B-gene
, 0
which 0
are 0
conserved 0
in 0
both 0
the 0
human 0
and 0
murine 0
interleukin B-gene
- I-gene
2 I-gene
enhancers 0
. 0

An 0
enhancement 0
of 0
benign 0
liver 0
tumors 0
( 0
tumorigenic 0
effect 0
) 0
was 0
observed 0
only 0
in 0
CF1 0
male 0
mice 0
( 0
17/56 0
at 0
the 0
only 0
tested 0
dose 0
: 0
400 0
ppm 0
vs 0
. 0

Stamps 0
in 0
cardiology 0
: 0
de 0
Musset 0
sign 0
. 0

Here 0
, 0
we 0
analyzed 0
the 0
interaction 0
of 0
CYT B-gene
- I-gene
18 I-gene
with 0
a 0
small 0
RNA 0
( 0
P4 B-gene
- I-gene
P6 I-gene
RNA I-gene
) 0
corresponding 0
to 0
the 0
isolated 0
P4 B-gene
- I-gene
P6 I-gene
domain I-gene
of 0
the 0
N. B-gene
crassa I-gene
mitochondrial I-gene
large I-gene
subunit I-gene
ribosomal I-gene
RNA I-gene
intron I-gene
. 0

268 0
, 0
6858 0
- 0
6861 0
) 0
. 0

Polyglutamine 0
- 0
containing 0
protein 0
fragments 0
have 0
been 0
shown 0
to 0
accumulate 0
as 0
aggregates 0
in 0
the 0
nucleus 0
and 0
in 0
the 0
cytoplasm 0
, 0
and 0
to 0
induce 0
cell 0
death 0
when 0
expressed 0
in 0
cultured 0
cells 0
, 0
leading 0
to 0
the 0
proposal 0
that 0
polyglutamine 0
aggregation 0
is 0
an 0
important 0
step 0
in 0
the 0
pathogenesis 0
. 0

We 0
have 0
previously 0
shown 0
that 0
the 0
transcriptional 0
activator 0
CREM B-gene
is 0
highly 0
expressed 0
in 0
postmeiotic 0
cells 0
. 0

For 0
more 0
detailed 0
mapping 0
, 0
we 0
constructed 0
mouse 0
A9 0
cells 0
containing 0
STFs 0
derived 0
from 0
human 0
chromosome 0
2 0
tagged 0
with 0
pSTneo 0
at 0
different 0
regions 0
in 0
2q31 0
- 0
qter 0
. 0

We 0
therefore 0
propose 0
that 0
PRR2 B-gene
, 0
and 0
not 0
PVR B-gene
, 0
is 0
the 0
true 0
human 0
homolog 0
of 0
MPH B-gene
. 0

We 0
have 0
analyzed 0
herein 0
the 0
roles 0
that 0
four 0
different 0
PIAS B-gene
proteins I-gene
( 0
ARIP3/PIASx B-gene
ARIP3/PIASx I-gene
alpha I-gene
, 0
Miz1/PIASx B-gene
Miz1/PIASx I-gene
beta I-gene
, 0
GBP/PIAS1 B-gene
, 0
and 0
GBP/PIAS1 I-gene

Yet 0
testosterone 0
was 0
predominant 0
in 0
the 0
plasma 0
of 0
the 0
Type 0
II 0
male 0
morph 0
which 0
neither 0
courts 0
females 0
nor 0
nests 0
, 0
but 0
instead 0
parasitizes 0
Type 0
I 0
males 0
with 0
sneak 0
or 0
satellite 0
spawning 0
tactics 0
. 0

To 0
better 0
understand 0
the 0
relationship 0
between 0
expression 0
of 0
an 0
oncogene 0
and 0
genetic 0
instability 0
, 0
we 0
have 0
studied 0
a 0
cell 0
line 0
expressing 0
an 0
activated B-gene
human I-gene
Ha I-gene
- I-gene
ras I-gene
under 0
the 0
control 0
of 0
bacterial B-gene
lactose I-gene
operon I-gene
regulatory I-gene
elements I-gene
for 0
changes 0
in 0
methotrexate 0
resistance 0
and 0
dihydrofolate B-gene
reductase I-gene
( 0
dhfr B-gene
) 0
gene 0
amplification 0
following 0
mutant B-gene
Ha I-gene
- I-gene
ras I-gene
induction 0
. 0

Cbl B-gene
is 0
a 0
signaling 0
molecule 0
with 0
multiple 0
functional 0
domains 0
: 0
an 0
SH2 B-gene
domain I-gene
which 0
binds 0
phosphotyrosine 0
residues 0
, 0
a 0
RING 0
finger 0
domain 0
which 0
acts 0
as 0
a 0
ubiquitin B-gene
ligase I-gene
, 0
a 0
proline 0
- 0
rich 0
region 0
which 0
serves 0
as 0
a 0
docking 0
site 0
for 0
SH3 B-gene
- I-gene
containing I-gene
proteins I-gene
, 0
phosphotyrosine 0
residues 0
which 0
serve 0
as 0
docking 0
sites 0
for 0
SH2 B-gene
- I-gene
containing I-gene
proteins I-gene
such 0
a 0
CrkL B-gene
and 0
the 0
p85 B-gene
subunit I-gene
of 0
PI B-gene
3 I-gene
- I-gene
kinase I-gene
, 0
and 0
a 0
nuclear 0
localization 0
signal 0
. 0

No 0
interaction 0
with 0
epidural 0
anesthesia 0
was 0
observed 0
. 0

Region 0
I 0
includes 0
the 0
two 0
cysteine 0
- 0
cysteine 0
zinc 0
fingers 0
that 0
comprise 0
a 0
DNA 0
- 0
binding 0
domain 0
which 0
typifies 0
all 0
members 0
of 0
the 0
superfamily 0
. 0

Leukocytoclasic 0
vasculitis 0
during 0
treatment 0
with 0
low 0
- 0
dose 0
captopril 0

In 0
contrast 0
to 0
Phase 0
III 0
, 0
which 0
has 0
a 0
single 0
study 0
design 0
- 0
- 0
the 0
controlled 0
, 0
randomized 0
, 0
double 0
- 0
blind 0
study 0
- 0
- 0
Phase 0
IV 0
requires 0
different 0
designs 0
for 0
each 0
of 0
the 0
many 0
different 0
questions 0
. 0

The 0
results 0
suggest 0
that 0
both 0
superficial 0
and 0
deep 0
cortical 0
venous 0
drainage 0
of 0
the 0
cat 0
kidney 0
should 0
be 0
considered 0
when 0
measuring 0
renal B-gene
renin I-gene
release 0
. 0

The 0
aim 0
of 0
this 0
work 0
was 0
to 0
organize 0
chemical 0
data 0
in 0
a 0
client 0
- 0
server 0
environment 0
using 0
Database 0
Management 0
System 0
and 0
Web 0
fashion 0
for 0
the 0
client 0
interface 0
. 0

This 0
bound 0
[ 0
3H 0
] 0
iloprost 0
with 0
high 0
affinity 0
and 0
stimulated 0
cAMP 0
production 0
when 0
exposed 0
to 0
agonist 0
. 0

The 0
deduced 0
amino 0
acid 0
sequence 0
exhibits 0
95.3 0
and 0
76.1 0
% 0
identity 0
with 0
the 0
CAD B-gene
sequences I-gene
of I-gene
hamster I-gene
and I-gene
Squalus I-gene
acanthias I-gene
. 0

Juvenile 0
idiopathic 0
inflammatory 0
myopathies 0
: 0
the 0
value 0
of 0
magnetic 0
resonance 0
imaging 0
in 0
the 0
detection 0
of 0
muscle 0
involvement 0
. 0

The 0
methods 0
used 0
were 0
the 0
AOAC 0
method 0
of 0
dilution 0
and 0
heating 0
; 0
the 0
addition 0
of 0
mercuric 0
chloride 0
, 0
charcoal 0
, 0
and 0
Carrez 0
reagents 0
at 0
2 0
different 0
pH 0
values 0
; 0
and 0
direct 0
analysis 0
of 0
sample 0
supernatants 0
with 0
no 0
treatment 0
( 0
control 0
) 0
. 0

In 0
src B-gene
- 0
transformed 0
cells 0
GAP B-gene
forms 0
heteromeric 0
complexes 0
, 0
notably 0
with 0
a 0
highly 0
tyrosine 0
phosphorylated 0
62 B-gene
- I-gene
kDa I-gene
protein I-gene
( I-gene
p62 I-gene
) I-gene
. 0

Genomic 0
Southern 0
analysis 0
reveals 0
10 0
to 0
15 0
hybridising 0
fragments 0
, 0
suggesting 0
that 0
maize 0
contains 0
a 0
small 0
gene 0
family 0
. 0

The 0
signal 0
- 0
to 0
- 0
noise 0
ratio 0
( 0
SNR 0
) 0
was 0
calculated 0
in 0
the 0
T2 0
- 0
weighted 0
sequence 0
. 0

The 0
MIC90 0
of 0
ABK 0
against 0
coagulase B-gene
type I-gene
IV I-gene
strains 0
was 0
rather 0
high 0
, 0
12.5 0
micrograms/ml 0
. 0

A 0
review 0
of 0
156 0
patients 0
younger 0
than 0
40 0
treated 0
at 0
our 0
Department 0
between 0
1960 0
and 0
1991 0
with 0
transitional 0
cell 0
carcinoma 0
of 0
the 0
bladder 0
revealed 0
that 0
89.1 0
% 0
had 0
superficial 0
( 0
Ta/T1 0
) 0
disease 0
and 0
the 0
remaining 0
10.9 0
% 0
presented 0
with 0
invasive 0
disease 0
. 0

Expression 0
of 0
the 0
Asp 0
but 0
not 0
the 0
Ala 0
gB B-gene
mutation 0
resulted 0
in 0
an 0
increase 0
in 0
the 0
steady 0
- 0
state 0
expression 0
of 0
gB B-gene
at 0
the 0
plasma 0
membrane 0
( 0
PM 0
) 0
in 0
U373 0
cells 0
. 0

Large 0
volumes 0
of 0
bone 0
marrow 0
may 0
be 0
required 0
for 0
certain 0
types 0
of 0
autologous 0
bone 0
marrow 0
transplants 0
. 0

These 0
results 0
suggest 0
that 0
dauricine 0
and 0
verapamil 0
have 0
a 0
salutary 0
effect 0
in 0
extracorporeal 0
circulation 0
. 0

Central 0
- 0
venous 0
- 0
catheter 0
- 0
related 0
infection 0
is 0
readily 0
diagnosed 0
by 0
comparing 0
simultaneous 0
quantitative 0
cultures 0
of 0
blood 0
samples 0
obtained 0
via 0
the 0
catheter 0
and 0
a 0
peripheral 0
vein 0
. 0

For 0
evaluation 0
of 0
the 0
model 0
, 0
simulations 0
of 0
physiological 0
excitation 0
and 0
of 0
pathologies 0
( 0
Wolff 0
- 0
Parkinson 0
- 0
White 0
syndrome 0
, 0
complete 0
AV 0
- 0
block 0
, 0
inferior 0
wall 0
ischaemia 0
) 0
were 0
examined 0
. 0

For 0
rotating 0
stimuli 0
presented 0
to 0
the 0
dominant 0
eye 0
, 0
this 0
class 0
of 0
neurons 0
responded 0
best 0
to 0
rotation 0
of 0
the 0
visual 0
world 0
about 0
an 0
axis 0
oriented 0
near 0
the 0
horizontal 0
plane 0
and 0
approximately 0
45 0
degrees 0
azimuth 0
. 0

Protein B-gene
kinase I-gene
C I-gene
transiently 0
activated 0
heteromeric B-gene
N I-gene
- I-gene
methyl I-gene
- I-gene
D I-gene
- I-gene
aspartate I-gene
receptor I-gene
channels I-gene
independent 0
of 0
the 0
phosphorylatable 0
C 0
- 0
terminal 0
splice 0
domain 0
and 0
of 0
consensus 0
phosphorylation 0
sites 0
. 0

The 0
incidence 0
of 0
the 0
variability 0
of 0
the 0
free 0
PSA/total B-gene
PSA B-gene
ratio 0
on 0
the 0
early 0
diagnosis 0
of 0
prostate 0
cancer 0

Moreover 0
, 0
we 0
show 0
that 0
ectopic 0
expression 0
of 0
the 0
E2A B-gene
protein I-gene
E12 B-gene
in 0
this 0
macrophage 0
line 0
results 0
in 0
the 0
induction 0
of 0
many 0
B 0
lineage 0
genes 0
, 0
including 0
EBF B-gene
, 0
IL7Ralpha B-gene
, 0
lambda5 B-gene
, 0
and 0
Rag B-gene
- I-gene
1 I-gene
, 0
and 0
the 0
ability 0
to 0
induce 0
kappa B-gene
light I-gene
chain I-gene
in 0
response 0
to 0
mitogen 0
. 0

A 0
TAAATA 0
sequence 0
is 0
present 0
26 0
nt 0
upstream 0
from 0
the 0
major 0
CAP 0
site 0
, 0
and 0
within 0
the 0
5' 0
- 0
flanking 0
region 0
there 0
are 0
several 0
putative 0
transcription 0
factor 0
binding 0
sites 0
. 0

OBJECTIVES 0
: 0
The 0
present 0
study 0
tested 0
the 0
hypothesis 0
that 0
stimulating 0
the 0
central 0
noradrenergic 0
system 0
using 0
the 0
new 0
noradrenaline 0
re 0
- 0
uptake 0
inhibitor 0
reboxetine 0
would 0
result 0
in 0
a 0
dose 0
- 0
dependent 0
enhancement 0
of 0
memory 0
for 0
emotional 0
material 0
in 0
man 0
. 0

Iris 0
binding 0
and 0
bioavailability 0
. 0

The 0
dopamine B-gene
D1 I-gene
dopamine I-gene
receptor I-gene
antagonist 0
SCH 0
23390 0
dose 0
dependently 0
( 0
7.5 0
- 0
30 0
micrograms/kg 0
s.c. 0
) 0
antagonized 0
the 0
stimulant 0
locomotor 0
effect 0
on 0
both 0
drugs 0
but 0
did 0
not 0
prevent 0
their 0
antiimmobility 0
effect 0
on 0
the 0
behavioral 0
despair 0
test 0
. 0

Neither 0
symptoms 0
, 0
virions 0
, 0
nor 0
viral 0
RNA 0
was 0
detectable 0
in 0
plants 0
inoculated 0
with 0
this 0
mutant 0
or 0
a 0
mutant 0
with 0
a 0
frameshift 0
mutation 0
in 0
the 0
coat B-gene
gene I-gene
. 0

Chromaffin 0
cells 0
transfected 0
with 0
a 0
plasmid 0
with 0
the 0
entire 0
coding 0
sequence 0
of 0
c B-gene
- I-gene
Rabphilin3a I-gene
inserted 0
in 0
the 0
antisense 0
orientation 0
inhibited 0
secretion 0
of 0
co 0
- 0
expressed 0
GH B-gene
by 0
approximately 0
30 0
% 0
. 0

A 0
sequence 0
- 0
ready 0
3 0
- 0
Mb 0
PAC 0
contig 0
covering 0
16 0
breakpoints 0
of 0
the 0
Wilms B-gene
tumor/anirida I-gene
region I-gene
of 0
human 0
chromosome 0
11p13 0
. 0

Compression 0
of 0
pulmonary 0
artery 0
and 0
right 0
ventricular 0
outflow 0
tract 0
by 0
aneurysm 0
of 0
ascending 0
aorta 0
. 0

The 0
sulfur 0
species 0
could 0
be 0
separated 0
within 0
less 0
than 0
4 0
min 0
by 0
CZE 0
with 0
a 0
pyromellitic 0
acid 0
electrolyte 0
at 0
pH 0
3.5 0
to 0
5.0 0
. 0

High 0
expression 0
of 0
p51A B-gene
( 0
TAp63gamma B-gene
) 0
in 0
the 0
skeletal 0
muscle 0
tissue 0
drove 0
us 0
to 0
investigate 0
a 0
differentiation 0
- 0
inducible 0
myoblastic 0
cell 0
line 0
which 0
showed 0
increased 0
p51A B-gene
expression 0
after 0
differentiation 0
induction 0
. 0

Nosographic 0
problems 0

Since 0
UmuD B-gene
protein I-gene
is 0
proteolytically 0
processed 0
to 0
an 0
active 0
form 0
( 0
UmuD* B-gene
) 0
in 0
a 0
RecA* B-gene
- 0
dependent 0
fashion 0
, 0
and 0
MucA B-gene
shares 0
extensive 0
amino 0
acid 0
homology 0
with 0
UmuD B-gene
, 0
we 0
examined 0
whether 0
MucA B-gene
is 0
similarly 0
processed 0
in 0
the 0
cell 0
, 0
using 0
antiserum 0
against 0
a 0
LacZ' B-gene
- 0
'MucA B-gene
fusion 0
protein 0
. 0

Changes 0
in 0
BHR 0
were 0
found 0
to 0
correlate 0
significantly 0
with 0
changes 0
in 0
the 0
levels 0
of 0
24 0
h 0
mean 0
SO2 0
, 0
NO2 0
and 0
smoke 0
; 0
48 0
h 0
mean 0
NO2 0
and 0
smoke 0
; 0
24 0
h 0
lag 0
NO2 0
; 0
although 0
the 0
effect 0
was 0
only 0
small 0
, 0
accounting 0
for 0
approximately 0
10 0
% 0
of 0
the 0
variability 0
in 0
within 0
- 0
subject 0
BHR 0
between 0
visits 0
. 0

50 0
- 0
nucleotide 0
) 0
intron 0
to 0
AA 0
. 0

Foamy 0
viruses 0
( 0
FVs 0
) 0
express 0
the 0
Gag B-gene
protein I-gene
as 0
a 0
precursor 0
with 0
a 0
molecular 0
mass 0
of 0
74 0
kDa 0
( 0
pr74 B-gene
) 0
from 0
which 0
a 0
70 0
- 0
kDa 0
protein 0
( 0
p70 B-gene
) 0
is 0
cleaved 0
by 0
the 0
viral 0
protease 0
. 0

Identification 0
of 0
domains 0
mediating 0
transcription 0
activation 0
, 0
repression 0
, 0
and 0
inhibition 0
in 0
the 0
paired B-gene
- I-gene
related I-gene
homeobox I-gene
protein I-gene
, 0
Prx2 B-gene
( 0
S8 B-gene
) 0
. 0

Because 0
of 0
the 0
structural 0
similarities 0
the 0
new 0
gene 0
will 0
be 0
termed 0
scERV2 B-gene
from 0
now 0
on 0
. 0

Where 0
the 0
resonator 0
has 0
two 0
holes 0
, 0
these 0
terms 0
should 0
be 0
somewhat 0
modified 0
: 0
A 0
is 0
the 0
combined 0
area 0
of 0
the 0
two 0
holes 0
, 0
L 0
is 0
16/3pi 0
r 0
( 0
~1.7r 0
) 0
for 0
a 0
simple 0
hole 0
in 0
a 0
thin 0
- 0
walled 0
vessel 0
and 0
r 0
is 0
the 0
radius 0
of 0
one 0
hole 0
( 0
Seto 0
, 0
1971 0
) 0
. 0

The 0
most 0
distal 0
active 0
site 0
in 0
TIGA B-gene
is 0
created 0
by 0
excision 0
of 0
a 0
66 0
- 0
bp 0
intron 0
. 0

GeneCalling 0
analysis 0
was 0
successful 0
in 0
detecting 0
members 0
of 0
complex 0
metabolic 0
pathways 0
and 0
uncovering 0
novel 0
genes 0
that 0
were 0
either 0
coincidentally 0
regulated 0
or 0
directly 0
involved 0
in 0
such 0
pathways 0
. 0

Cerebellar 0
functional 0
compensation 0
after 0
its 0
complete 0
destruction 0
by 0
a 0
neoplasm 0

Analysis 0
of 0
the 0
DNA 0
sequence 0
upstream 0
of 0
the 0
narQ B-gene
gene I-gene
, 0
which 0
encodes 0
the 0
second 0
nitrate 0
- 0
responsive 0
sensor 0
- 0
transmitter 0
protein 0
in 0
Escherichia 0
coli 0
, 0
revealed 0
an 0
open 0
reading 0
frame 0
( 0
ORF 0
) 0
whose 0
product 0
shows 0
a 0
high 0
degree 0
of 0
similarity 0
to 0
a 0
number 0
of 0
iron B-gene
- I-gene
sulfur I-gene
proteins I-gene
as 0
well 0
as 0
to 0
the 0
beta 0
subunit 0
of 0
glutamate B-gene
synthase I-gene
( 0
gltD B-gene
) 0
of 0
E. 0
coli 0
. 0

Thus 0
, 0
the 0
antibody 0
class 0
switch 0
appears 0
to 0
be 0
directed 0
by 0
induction 0
of 0
accessibility 0
, 0
as 0
assayed 0
by 0
transcription 0
of 0
germ 0
line 0
CH B-gene
genes 0
. 0

With 0
repetitive 0
intermittent 0
exercise 0
, 0
gradual 0
increases 0
in 0
blood 0
lactate 0
concentration 0
[ 0
( 0
LA 0
] 0
b 0
) 0
occurred 0
, 0
whereas 0
its 0
rate 0
of 0
accumulation 0
( 0
delta 0
[ 0
LA 0
] 0
b 0
) 0
decreased 0
. 0

Wingless/Wnt B-gene
signaling 0
directs 0
cell 0
- 0
fate 0
choices 0
during 0
embryonic 0
development 0
. 0

In 0
CYP7A1 B-gene
transgenic 0
mice 0
, 0
livers 0
contained 0
approximately 0
3 0
- 0
fold 0
more 0
sterol B-gene
response I-gene
element I-gene
- I-gene
binding I-gene
protein I-gene
- I-gene
2 I-gene
mRNA I-gene
. 0

Patients 0
with 0
the 0
chronic 0
photosensitivity 0
dermatitis 0
with 0
actinic 0
reticuloid 0
syndrome 0
have 0
high 0
total 0
serum 0
IgE B-gene
concentrations 0
. 0

Furthermore 0
, 0
the 0
cognate 0
binding 0
protein 0
is 0
present 0
in 0
both 0
rat 0
and 0
human 0
( 0
HeLa 0
) 0
cell 0
nuclear 0
extracts 0
. 0

The 0
effect 0
of 0
stimulation 0
of 0
the 0
entopeduncular 0
nucleus 0
( 0
EP 0
) 0
on 0
the 0
jaw 0
- 0
opening 0
reflex 0
( 0
JOR 0
) 0
was 0
studied 0
in 0
the 0
cat 0
anesthetized 0
with 0
sodium 0
pentobarbital 0
. 0

We 0
cloned 0
the 0
BamHI B-gene
- I-gene
F I-gene
fragment I-gene
from 0
the 0
left 0
end 0
of 0
Ad4 0
in 0
pUC13 0
- 0
1 0
between 0
the 0
SalI B-gene
and 0
BamHI B-gene
sites I-gene
in 0
order 0
to 0
carry 0
out 0
the 0
structural 0
analysis 0
of 0
the 0
E1A B-gene
region I-gene
of I-gene
Ad4 I-gene
. 0

Results 0
of 0
this 0
study 0
indicate 0
that 0
when 0
amniotic 0
fluid 0
samples 0
are 0
stored 0
frozen 0
and 0
strict 0
quality 0
control 0
is 0
maintained 0
in 0
analytic 0
procedures 0
, 0
only 0
minimal 0
changes 0
occur 0
in 0
phospholipid 0
concentrations 0
over 0
12 0
months 0
. 0

The 0
objective 0
of 0
this 0
research 0
was 0
to 0
determine 0
if 0
ergotamine 0
, 0
an 0
ergopeptine 0
alkaloid 0
isolated 0
from 0
Neotyphodium 0
- 0
infected 0
grasses 0
and 0
associated 0
with 0
toxicoses 0
in 0
livestock 0
, 0
altered 0
plasma 0
concentrations 0
of 0
reproductive 0
hormones 0
in 0
follicular 0
phase 0
heifers 0
and 0
in 0
cows 0
given 0
a 0
progestin 0
implant 0
. 0

The 0
following 0
parameters 0
were 0
measured 0
: 0
onset 0
time 0
( 0
time 0
interval 0
from 0
injection 0
to 0
maximal 0
or 0
total 0
block 0
) 0
, 0
T125/75 0
( 0
time 0
for 0
T1 0
to 0
reach 0
25 0
% 0
or 0
75 0
% 0
of 0
control 0
) 0
, 0
TOF70 0
( 0
time 0
for 0
TOF 0
ratio 0
to 0
reach 0
70 0
% 0
of 0
control 0
) 0
, 0
heart 0
rate 0
and 0
blood 0
pressure 0
. 0

Ectopic 0
Xbra B-gene
can 0
induce 0
Xegr B-gene
- I-gene
1 I-gene
transcription 0
by 0
an 0
indirect 0
mechanism 0
that 0
appears 0
to 0
operate 0
via 0
primary 0
activation 0
of 0
fibroblast B-gene
growth I-gene
factor I-gene
secretion 0
. 0

A 0
total 0
of 0
10,763 0
men 0
and 0
3,118 0
women 0
has 0
been 0
studied 0
, 0
of 0
whom 0
97 0
% 0
and 0
89 0
% 0
, 0
respectively 0
, 0
have 0
been 0
traced 0
and 0
36 0
% 0
and 0
16 0
% 0
have 0
died 0
. 0

The 0
association 0
of 0
I B-gene
- I-gene
92 I-gene
with 0
p92 B-gene
, 0
p84 B-gene
, 0
p75 B-gene
, 0
p73 B-gene
, 0
p69 B-gene
, 0
and 0
p57 B-gene
was 0
completely 0
reversible 0
after 0
treatment 0
with 0
the 0
detergent 0
deoxycholate 0
( 0
DOC 0
) 0
. 0

Although 0
the 0
elevated 0
signalling 0
is 0
eliminated 0
by 0
deletion 0
of 0
Ste20p B-gene
( 0
or 0
components 0
downstream 0
of 0
Ste20p B-gene
) 0
, 0
the 0
growth 0
and 0
morphological 0
abnormalities 0
of 0
cells 0
lacking 0
Akr1p B-gene
are 0
not 0
rescued 0
by 0
deletion 0
of 0
any 0
of 0
the 0
known 0
pheromone 0
response 0
pathway 0
components 0
. 0

2 0
) 0
Depending 0
on 0
the 0
structure 0
, 0
certain 0
compounds 0
are 0
sequestered 0
in 0
the 0
cornea 0
( 0
presumably 0
the 0
stroma 0
) 0
and 0
form 0
a 0
release 0
system 0
into 0
the 0
anterior 0
aqueous 0
. 0

To 0
gain 0
further 0
insights 0
into 0
these 0
events 0
, 0
the 0
porcine B-gene
G I-gene
alpha I-gene
i I-gene
- I-gene
3 I-gene
gene I-gene
minimal I-gene
promoter I-gene
was 0
characterized 0
and 0
found 0
67 0
base 0
pairs 0
upstream 0
from 0
the 0
major 0
transcription 0
start 0
site 0
. 0

Two 0
authors 0
, 0
two 0
journal 0
titles 0
, 0
two 0
drug 0
names 0
, 0
and 0
two 0
topics 0
of 0
a 0
general 0
medical 0
nature 0
were 0
retrieved 0
under 0
identical 0
circumstances 0
and 0
conditions 0
on 0
the 0
hosts 0
DATA 0
- 0
STAR 0
, 0
DIALOG 0
, 0
DIMDI 0
, 0
and 0
STN 0
. 0

For 0
example 0
, 0
the 0
presence 0
of 0
two 0
related 0
genes 0
, 0
b B-gene
and 0
b B-gene
' I-gene
, 0
in 0
the 0
cyanobacterium 0
suggests 0
that 0
its 0
ATP B-gene
synthase I-gene
is 0
a 0
complex 0
of 0
nine 0
polypeptides 0
, 0
and 0
that 0
it 0
may 0
have 0
single 0
copies 0
of 0
related 0
b B-gene
and 0
b B-gene
' I-gene
proteins I-gene
rather 0
than 0
two 0
copies 0
of 0
identical 0
b B-gene
subunits I-gene
as 0
found 0
in 0
the 0
E. 0
coli 0
enzyme.4+off 0

DDD 0
( 0
R 0
) 0
pacing 0
with 0
automatic 0
mode 0
switch 0
in 0
patients 0
with 0
paroxysmal 0
atrial 0
fibrillation 0
following 0
AV 0
nodal 0
ablation 0
. 0

These 0
events 0
were 0
only 0
weakly 0
stimulated 0
by 0
the 0
activated B-gene
PDGF I-gene
alpha I-gene
- I-gene
receptor I-gene
. 0

These 0
results 0
establish 0
that 0
the 0
DNA 0
fragment 0
we 0
have 0
isolated 0
contains 0
the 0
human B-gene
gp130 I-gene
promoter I-gene
and 0
that 0
interleukin B-gene
- I-gene
6 I-gene
type I-gene
cytokines I-gene
may 0
influence 0
the 0
activity 0
of 0
this 0
promoter 0
via 0
activated 0
STATs B-gene
. 0

Only 0
53 0
% 0
of 0
all 0
injuries 0
and 0
12.5 0
% 0
of 0
serious 0
injuries 0
involved 0
children 0
, 0
and 0
in 0
contrast 0
to 0
the 0
1950s 0
and 0
early 0
1960s 0
, 0
young 0
adults 0
appear 0
at 0
greatest 0
risk 0
in 0
the 0
1980s 0
. 0

Three 0
simple 0
methods 0
of 0
detecting 0
malnutrition 0
on 0
medical 0
wards 0
. 0

We 0
also 0
show 0
that 0
an 0
internal 0
fragment 0
of 0
U24 B-gene
methylation I-gene
guide I-gene
snoRNA I-gene
, 0
encompassing 0
the 0
upstream 0
antisense 0
element 0
and 0
the 0
D 0
' 0
and 0
C 0
' 0
box 0
motifs 0
, 0
can 0
support 0
the 0
site 0
- 0
specific 0
methylation 0
of 0
rRNA 0
. 0

The 0
gap B-gene
protein 0
knirps B-gene
mediates 0
both 0
quenching 0
and 0
direct 0
repression 0
in 0
the 0
Drosophila 0
embryo 0
. 0

One 0
of 0
them 0
is 0
its 0
limited 0
sensitivity 0
to 0
weak 0
interactions 0
, 0
which 0
are 0
common 0
in 0
the 0
mammalian 0
cerebral 0
cortex 0
. 0

An 0
infant 0
of 0
8 0
months 0
with 0
congenital 0
glaucoma 0
and 0
hemophilia 0
A 0
lost 0
one 0
eye 0
due 0
to 0
haemorrhages 0
after 0
trabeculotomy 0
in 0
an 0
eye 0
hospital 0
. 0

Encapsulation 0
of 0
sodium 0
fluorescein 0
for 0
dye 0
release 0
studies 0
. 0

Ethanol 0
preference 0
in 0
strains 0
of 0
rats 0
selectively 0
bred 0
for 0
behavioral 0
characteristics 0
. 0

VAV B-gene
and 0
SOCS1 B-gene
form 0
a 0
protein 0
complex 0
through 0
interactions 0
between 0
the 0
VAV B-gene
NH I-gene
( I-gene
2 I-gene
) I-gene
- I-gene
terminal I-gene
regulatory I-gene
region I-gene
and 0
the 0
SH2 B-gene
domain I-gene
of 0
SOCS1 B-gene
in 0
a 0
phosphotyrosine 0
- 0
independent 0
manner 0
. 0

Incubation 0
of 0
HeLa 0
cell 0
cytoplasmic 0
extracts 0
with 0
a 0
purified 0
recombinant 0
glutathione B-gene
S I-gene
- I-gene
transferase I-gene
- 0
raf B-gene
fusion 0
protein 0
in 0
the 0
presence 0
of 0
ATP 0
released 0
active 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
that 0
could 0
be 0
detected 0
by 0
electrophoretic 0
gel 0
mobility 0
shift 0
assay 0
. 0

Cefminox 0
shows 0
greater 0
in 0
vivo 0
activity 0
than 0
that 0
expected 0
for 0
the 0
MICs 0
, 0
excellent 0
efficacy 0
and 0
safety 0
. 0

Both 0
the 0
p38 B-gene
kinase I-gene
inhibitor 0
SB205380 0
( 0
SB 0
) 0
and 0
cotransfection 0
of 0
a 0
dominant 0
- 0
negative 0
mutant 0
of 0
p38 B-gene
kinase I-gene
reduced 0
IL B-gene
- I-gene
1beta I-gene
stimulation 0
of 0
the 0
hBNP B-gene
promoter I-gene
. 0

Recent 0
geological 0
studies 0
focusing 0
on 0
the 0
Davie 0
Fracture 0
Zone 0
of 0
the 0
Mozambique 0
Channel 0
offer 0
a 0
resolution 0
to 0
this 0
situation 0
, 0
by 0
suggesting 0
the 0
presence 0
of 0
a 0
land 0
- 0
bridge 0
from 0
the 0
mid 0
- 0
Eocene 0
to 0
the 0
early 0
Miocene 0
, 0
an 0
interval 0
that 0
matches 0
the 0
ages 0
of 0
Madagascar 0
's 0
mammalian 0
groups 0
. 0

We 0
have 0
previously 0
demonstrated 0
that 0
pyrene 0
in 0
diesel 0
- 0
exhaust 0
particles 0
( 0
DEP 0
) 0
has 0
an 0
adjuvant 0
activity 0
on 0
immunoglobulin B-gene
E I-gene
( 0
IgE B-gene
) 0
antibody 0
production 0
in 0
mice 0
immunized 0
with 0
Japanese 0
cedar 0
pollen 0
allergen 0
( 0
JCPA 0
) 0
or 0
ovalbumin B-gene
( 0
OA B-gene
) 0
intraperitoneally 0
. 0

On 0
the 0
basis 0
of 0
8 0
cases 0
, 0
the 0
authors 0
report 0
different 0
clinical 0
pictures 0
all 0
caused 0
by 0
cardiac 0
toxicity 0
of 0
5FU 0
. 0

The 0
immunoprofile 0
of 0
60 0
adult 0
patients 0
of 0
pulmonary 0
tuberculosis 0
was 0
studied 0
and 0
compared 0
with 0
22 0
normal 0
controls 0
. 0

Effects 0
of 0
long 0
- 0
term 0
use 0
of 0
raloxifene 0
, 0
a 0
selective 0
estrogen B-gene
receptor I-gene
modulator 0
, 0
on 0
thyroid 0
function 0
test 0
profiles 0
. 0

Module 0
2 0
of 0
RifA B-gene
lacks 0
a 0
beta B-gene
- I-gene
ketoacyl I-gene
: I-gene
acyl I-gene
carrier I-gene
protein I-gene
reductase I-gene
( 0
KR B-gene
) 0
domain 0
and 0
the 0
one 0
in 0
module 0
3 0
has 0
an 0
apparently 0
inactive 0
NADPH B-gene
binding I-gene
motif I-gene
, 0
similar 0
to 0
one 0
found 0
in 0
the 0
Er B-gene
PKS I-gene
, 0
while 0
the 0
other 0
eight 0
KR B-gene
domains I-gene
of 0
the 0
Rf B-gene
PKS I-gene
should 0
be 0
functional 0
. 0

Synergy 0
between 0
interferon B-gene
- I-gene
gamma I-gene
and 0
tumor B-gene
necrosis I-gene
factor I-gene
- I-gene
alpha I-gene
in 0
transcriptional 0
activation 0
is 0
mediated 0
by 0
cooperation 0
between 0
signal B-gene
transducer I-gene
and I-gene
activator I-gene
of I-gene
transcription I-gene
1 I-gene
and 0
nuclear B-gene
factor I-gene
kappaB I-gene
. 0

The 0
corresponding 0
tetrapeptide 0
sequences 0
SSPD 0
and 0
SATD 0
for 0
human B-gene
and I-gene
mouse I-gene
PKC I-gene
- I-gene
epsilon I-gene
, 0
respectively 0
, 0
are 0
unusual 0
for 0
caspase B-gene
- I-gene
3 I-gene
. 0

The 0
effect 0
of 0
pneumoperitoneum 0
on 0
dissemination 0
and 0
scar 0
implantation 0
of 0
intra 0
- 0
abdominal 0
tumor 0
cells 0
. 0

CONCLUSIONS 0
: 0
In 0
the 0
results 0
of 0
this 0
study 0
, 0
SDB 0
, 0
even 0
snoring 0
, 0
was 0
independently 0
associated 0
with 0
hypertension 0
in 0
both 0
men 0
and 0
women 0
. 0

A 0
poly 0
( 0
ortho 0
ester 0
) 0
designed 0
for 0
combined 0
ocular 0
delivery 0
of 0
dexamethasone 0
sodium 0
phosphate 0
and 0
5 0
- 0
fluorouracil 0
: 0
subconjunctival 0
tolerance 0
and 0
in 0
vitro 0
release 0
. 0

Subclones 0
stably 0
expressing 0
alpha1A B-gene
- 0
, 0
alpha1B B-gene
- 0
, 0
and 0
alpha1D B-gene
- 0
ARs 0
under 0
control 0
of 0
an 0
inducible 0
promoter 0
, 0
or 0
at 0
high 0
and 0
low 0
receptor 0
density 0
, 0
were 0
isolated 0
and 0
characterized 0
. 0

Transfection 0
of 0
both 0
Calu 0
- 0
6 0
and 0
JEG 0
- 0
3 0
cells 0
with 0
a 0
PKA B-gene
expression 0
vector 0
resulted 0
in 0
a 0
10 0
- 0
fold 0
induction 0
of 0
human B-gene
renin I-gene
transcriptional 0
activity 0
in 0
constructs 0
containing 0
the 0
native 0
or 0
consensus 0
CRE 0
and 0
5 0
- 0
fold 0
activation 0
in 0
a 0
construct 0
containing 0
a 0
nonfunctional 0
CRE 0
. 0

In 0
renal 0
vein 0
thrombosis 0
, 0
similar 0
pattern 0
to 0
acute 0
tubular 0
necrosis 0
was 0
found 0
but 0
RI 0
venography 0
was 0
helpful 0
. 0

Restricted 0
expression 0
of 0
a 0
novel 0
murine B-gene
atonal I-gene
- I-gene
related I-gene
bHLH I-gene
protein I-gene
in 0
undifferentiated 0
neural 0
precursors 0
. 0

Oligo 0
- 0
[ 0
alpha 0
] 0
- 0
deoxynucleotides 0
can 0
be 0
derived 0
by 0
stabilizing 0
( 0
intercalating 0
) 0
agents 0
or 0
reactive 0
groups 0
( 0
cleaving 0
reagents 0
, 0
cross 0
- 0
linkers 0
... 0
) 0
. 0

Electronic 0
structure 0
of 0
Si 0
( 0
111 0
) 0
- 0
NiSi2 0
( 0
111 0
) 0
A 0
- 0
type 0
and 0
B 0
- 0
type 0
interfaces 0
. 0

In 0
addition 0
, 0
two 0
cis 0
- 0
acting 0
elements 0
direct 0
the 0
first 0
zygotic 0
expression 0
of 0
Kr B-gene
in 0
a 0
striped 0
subpattern 0
within 0
the 0
central 0
region 0
of 0
the 0
blastoderm 0
embryo 0
. 0

Embryonal 0
mortality 0

Regardless 0
of 0
muscle 0
tensioning 0
or 0
marination 0
treatments 0
, 0
aging 0
of 0
the 0
carcass 0
for 0
24 0
h 0
( 0
T1 0
, 0
T2 0
, 0
and 0
T3 0
) 0
produced 0
meats 0
with 0
lower 0
shear 0
values 0
than 0
those 0
from 0
hot 0
- 0
boned 0
carcasses 0
( 0
T4 0
and 0
T5 0
) 0
. 0

This 0
effect 0
was 0
stronger 0
after 0
multiple 0
predoses 0
of 0
sertraline 0
, 0
when 0
imipramine 0
Cmax 0
and 0
AUC 0
( 0
0 0
- 0
infinity 0
) 0
were 0
increased 0
by 0
39 0
% 0
and 0
68 0
% 0
, 0
respectively 0
. 0

For 0
capsules 0
containing 0
only 0
the 0
drug 0
, 0
the 0
value 0
of 0
T50 0
increased 0
as 0
the 0
particle 0
size 0
of 0
the 0
drug 0
decreased 0
. 0

Its 0
prognostic 0
impact 0
is 0
superior 0
to 0
the 0
T1/2 0
one 0
( 0
RR 0
= 0
2.9 0
; 0
p 0
= 0
0.0010 0
) 0
. 0

We 0
also 0
show 0
that 0
in 0
fusions 0
with 0
the 0
DNA 0
binding 0
domain 0
of 0
GAL4 B-gene
, 0
full 0
activity 0
requires 0
the 0
entire 0
BHV B-gene
- I-gene
alpha I-gene
TIF I-gene
, 0
although 0
both 0
amino 0
and 0
carboxyl 0
termini 0
display 0
some 0
activity 0
on 0
their 0
own 0
. 0

As 0
well 0
, 0
variation 0
in 0
capillary 0
size 0
and 0
density 0
was 0
apparent 0
between 0
ventricles 0
in 0
the 0
fetal 0
and 0
neonatal 0
periods 0
. 0

Previous 0
studies 0
have 0
demonstrated 0
that 0
the 0
21 0
- 0
or 0
the 0
72 0
- 0
bp 0
repeat 0
transcriptional 0
control 0
elements 0
enhance 0
the 0
efficiency 0
of 0
SV40 0
DNA 0
replication 0
in 0
vivo 0
, 0
provided 0
either 0
of 0
these 0
repeats 0
is 0
located 0
near 0
the 0
end 0
of 0
the 0
core 0
replication 0
origin 0
containing 0
the 0
17 0
- 0
bp 0
A 0
+ 0
T 0
- 0
containing 0
sequence 0
. 0

It 0
is 0
pathogenetically 0
proved 0
to 0
use 0
antithrombin B-gene
III I-gene
concentrate 0
preparations 0
with 0
anti 0
- 0
and 0
dysaggregatory 0
properties 0
, 0
fibronectin B-gene
preparations 0
, 0
trasylol 0
or 0
its 0
analogs 0
during 0
complex 0
preoperative 0
preparation 0
of 0
patients 0
. 0

ER 0
and 0
DR 0
were 0
significantly 0
correlated 0
with 0
MIB B-gene
- I-gene
1 I-gene
LI 0
( 0
P 0
< 0
0.01 0
and 0
P 0
< 0
0.05 0
, 0
respectively 0
) 0
, 0
but 0
RI 0
and 0
Td/Te 0
were 0
not 0
. 0

D. 0
, 0
and 0
Long 0
, 0
C 0
. 0

A 0
lead 0
phthalocyanin 0
method 0
for 0
the 0
demonstration 0
of 0
acid B-gene
hydrolases I-gene
in 0
plant 0
and 0
animal 0
tissues 0
. 0

On 0
the 0
sixth 0
postirradiation 0
day 0
the 0
absorption 0
of 0
phenobarbitone 0
, 0
sulphafurazole 0
and 0
mecamylamine 0
had 0
returned 0
to 0
the 0
control 0
level 0
, 0
but 0
the 0
absorption 0
of 0
quinidine 0
and 0
isoniazid 0
was 0
still 0
retarded 0
. 0

Here 0
, 0
we 0
describe 0
the 0
three 0
- 0
dimensional 0
structure 0
of 0
the 0
enzyme 0
from 0
Escherichia 0
colidetermined 0
and 0
refined 0
to 0
2.0 0
A 0
resolution 0
. 0

cDNA 0
cloning 0
, 0
sequencing 0
and 0
chromosome 0
mapping 0
of 0
a 0
non B-gene
- I-gene
erythroid I-gene
spectrin I-gene
, 0
human B-gene
alpha I-gene
- I-gene
fodrin I-gene
. 0

In 0
serial 0
recall 0
from 0
short 0
- 0
term 0
memory 0
, 0
repeated 0
items 0
are 0
recalled 0
well 0
when 0
close 0
together 0
( 0
repetition 0
facilitation 0
) 0
, 0
but 0
not 0
when 0
far 0
apart 0
( 0
repetition 0
inhibition 0
; 0
the 0
Ranschburg 0
effect 0
) 0
. 0

Posterior 0
osteophytes 0
around 0
the 0
posterior 0
edges 0
of 0
vertebral 0
body 0
resulted 0
in 0
intervertebral 0
insufficiency 0
, 0
and 0
corresponded 0
to 0
hypertrophic 0
spur 0
in 0
osteochondrosis 0
. 0

LV 0
compliance 0
was 0
determined 0
from 0
the 0
slope 0
of 0
the 0
LV 0
end 0
- 0
diastolic 0
pressure 0
( 0
LVEDP 0
) 0
vs 0
. 0

Biol 0
. 0

There 0
was 0
no 0
significant 0
correlation 0
between 0
serum 0
amiodarone 0
or 0
desethylamiodarone 0
levels 0
and 0
dosage 0
of 0
amiodarone 0
. 0

Nuclear 0
extracts 0
from 0
Sertoli 0
cells 0
were 0
found 0
to 0
cause 0
an 0
E 0
- 0
box 0
gel 0
shift 0
when 0
the 0
cells 0
were 0
stimulated 0
to 0
differentiate 0
in 0
culture 0
, 0
but 0
not 0
under 0
basal 0
conditions 0
. 0

The 0
combination 0
of 0
ICP47 B-gene
and 0
US11 B-gene
rendered 0
fibroblasts 0
negative 0
for 0
surface B-gene
class I-gene
I I-gene
MHC I-gene
and 0
allowed 0
a 0
class B-gene
I I-gene
MHC I-gene
- 0
low 0
population 0
of 0
T 0
cells 0
to 0
be 0
sorted 0
by 0
flow 0
cytometry 0
. 0

The 0
recovery 0
of 0
adults 0
schistosomes 0
by 0
extracorporeal 0
filtration 0
. 0

Biochemical 0
studies 0
and 0
studies 0
of 0
cells 0
expressing 0
mutant 0
IL B-gene
- I-gene
2 I-gene
receptors I-gene
indicate 0
that 0
IL B-gene
- I-gene
2 I-gene
- 0
induced 0
tyrosine B-gene
kinase I-gene
activation 0
initiates 0
a 0
complex 0
signaling 0
cascade 0
. 0

Serum 0
levels 0
of 0
angiotensin B-gene
converting I-gene
enzyme I-gene
were 0
well 0
maintained 0
. 0

We 0
tested 0
the 0
effects 0
of 0
antifungal 0
drugs 0
on 0
adherence 0
of 0
Candida 0
albicans 0
in 0
vitro 0
. 0

The 0
sections 0
were 0
stained 0
with 0
anti 0
- 0
polymorphonuclear 0
leukocyte 0
antibody 0
, 0
the 0
endothelial 0
marker 0
factor B-gene
VIII I-gene
- I-gene
related I-gene
antigen I-gene
, 0
and 0
with 0
hematoxylin 0
and 0
eosin 0
. 0

Portions 0
of 0
the 0
3' 0
- 0
coding 0
and 0
3' 0
- 0
untranslated 0
regions 0
were 0
found 0
to 0
be 0
missing 0
from 0
the 0
7.2 B-gene
- I-gene
and I-gene
4.8 I-gene
- I-gene
kb I-gene
topo I-gene
II I-gene
alpha I-gene
mRNAs I-gene
by 0
Northern 0
blot 0
analysis 0
. 0

The 0
combined 0
in 0
vitro 0
effects 0
of 0
ethanol 0
wih 0
methaqualone 0
, 0
phenobarbital 0
, 0
pyrazole 0
or 0
disulfiram 0
were 0
studied 0
using 0
rat B-gene
brain I-gene
microsomal I-gene
NA I-gene
- I-gene
K I-gene
- I-gene
ATPase I-gene
. 0

An 0
analogue 0
of 0
calcium 0
, 0
strontium 0
chloride 0
Sr 0
89 0
is 0
rapidly 0
cleared 0
from 0
the 0
blood 0
after 0
i.v 0
. 0
injection 0
. 0

These 0
mutants 0
, 0
assayed 0
by 0
injection 0
into 0
Xenopus 0
oocyte 0
nuclei 0
, 0
delimit 0
the 0
promoter 0
to 0
36 0
bp 0
of 0
DNA 0
upstream 0
of 0
the 0
cap 0
site 0
and 0
73 0
bp 0
of 0
the 0
untranslated 0
mRNA 0
leader 0
. 0

The 0
ARE 0
is 0
loosely 0
defined 0
as 0
the 0
five 0
- 0
nucleotide 0
sequence 0
AUUUA 0
embedded 0
in 0
a 0
uracil 0
- 0
rich 0
region 0
. 0

The 0
essential 0
oil 0
composition 0
of 0
three 0
Zingiberaceae 0
widely 0
used 0
as 0
medicinal 0
aromatic 0
plants 0
from 0
S 0
. 0

( 0
3 0
) 0
With 0
the 0
exception 0
of 0
the 0
anteroposterior 0
direction 0
of 0
layers 0
II 0
- 0
- 0
III 0
and 0
the 0
mediolateral 0
direction 0
of 0
layer 0
IV 0
, 0
the 0
vertical 0
conductivity 0
of 0
the 0
cortex 0
was 0
always 0
greater 0
than 0
either 0
of 0
the 0
horizontal 0
conductivities 0
. 0

Acad 0
. 0

To 0
obtain 0
information 0
on 0
the 0
functional 0
role 0
of 0
the 0
Rac1/p38/MAPKAPK B-gene
Rac1/p38/MAPKAPK I-gene

A 0
regulatory 0
element 0
of 0
the 0
empty B-gene
spiracles I-gene
homeobox 0
gene 0
is 0
composed 0
of 0
three 0
distinct 0
conserved 0
regions 0
that 0
bind 0
regulatory 0
proteins 0
. 0

CONCLUSIONS 0
: 0
The 0
MC/UA 0
ratio 0
improves 0
the 0
sensitivity 0
for 0
the 0
prediction 0
of 0
poor 0
perinatal 0
outcome 0
when 0
it 0
is 0
combined 0
with 0
the 0
NST 0
. 0

Together 0
with 0
previous 0
work 0
our 0
results 0
suggest 0
that 0
C/EBP B-gene
may 0
be 0
a 0
general 0
cooperation 0
partner 0
for 0
v B-gene
- I-gene
Myb I-gene
in 0
myelomonocytic 0
cells 0
. 0

Evolution 0
of 0
cytomegalovirus 0
antibodies 0
of 0
maternal 0
origin 0
and 0
acquired 0
, 0
throughout 0
the 0
first 0
year 0
of 0
life 0

IENF 0
density 0
at 0
the 0
calf 0
was 0
lower 0
than 0
that 0
obtained 0
from 0
skin 0
at 0
more 0
proximal 0
sites 0
, 0
indicating 0
the 0
length 0
dependency 0
of 0
small 0
- 0
fiber 0
loss 0
in 0
these 0
neuropathies 0
. 0

The 0
sequence 0
contained 0
five 0
repeats 0
of 0
the 0
hypothetical 0
leucine 0
zipper 0
motif 0
: 0
one 0
is 0
in 0
the 0
N 0
- 0
terminal 0
globular 0
domain 0
, 0
and 0
four 0
are 0
in 0
the 0
central 0
alpha 0
- 0
helical 0
stalk 0
. 0

This 0
paper 0
reports 0
estimates 0
of 0
the 0
prevalence 0
of 0
mental 0
retardation 0
and 0
associated 0
factors 0
based 0
on 0
a 0
population 0
survey 0
of 0
2 0
- 0
to 0
9 0
- 0
year 0
- 0
old 0
children 0
in 0
Greater 0
Karachi 0
, 0
Pakistan 0
. 0

Zta B-gene
stimulated 0
the 0
HAT B-gene
activity 0
of 0
CBP B-gene
that 0
had 0
been 0
partially 0
purified 0
or 0
immunoprecipitated 0
from 0
mammalian 0
cells 0
as 0
well 0
as 0
from 0
affinity 0
- 0
purified 0
, 0
baculovirus 0
expressed 0
CBP B-gene
. 0

Previous 0
studies 0
using 0
partial 0
sequences 0
have 0
suggested 0
the 0
potential 0
of 0
26S B-gene
or 0
large B-gene
- I-gene
subunit I-gene
( 0
LSU B-gene
) 0
rDNA 0
for 0
phylogeny 0
retrieval 0
at 0
taxonomic 0
levels 0
comparable 0
to 0
those 0
investigated 0
with 0
18S B-gene
rDNA I-gene
. 0

P53 B-gene
mutations I-gene
also 0
offer 0
new 0
approaches 0
to 0
the 0
study 0
of 0
the 0
origins 0
of 0
mutations 0
in 0
human 0
cancer 0
. 0

Due 0
to 0
significant 0
homology 0
to 0
the 0
C 0
- 0
terminus 0
of 0
the 0
Mutator B-gene
transposase I-gene
this 0
alternative 0
gene 0
product 0
was 0
named 0
Trap B-gene
( 0
transposon B-gene
- I-gene
associated I-gene
protein I-gene
) 0
. 0

RT 0
- 0
PCR 0
analysis 0
of 0
FGFR B-gene
- I-gene
3 I-gene
mRNA I-gene
showed 0
the 0
presence 0
of 0
a 0
splice 0
variant 0
in 0
which 0
exons 0
7 0
and 0
8 0
are 0
deleted 0
. 0

A 0
novel 0
serine B-gene
kinase I-gene
activated 0
by 0
rac1/CDC42Hs B-gene
- 0
dependent 0
autophosphorylation 0
is 0
related 0
to 0
rac1/CDC42Hs I-gene

CYP51P1 B-gene
is 0
96.5 0
% 0
identical 0
to 0
the 0
human B-gene
CYP51 I-gene
coding 0
sequence 0
and 0
is 0
not 0
interrupted 0
with 0
introns 0
but 0
has 0
six 0
in 0
- 0
frame 0
stop 0
codons 0
resulting 0
from 0
point 0
mutations 0
. 0

Patients 0
with 0
risk 0
factors 0
were 0
compared 0
with 0
those 0
without 0
risk 0
factors 0
. 0

Mutations 0
in 0
glnB B-gene
, 0
nifR1 B-gene
( 0
ntrC B-gene
) 0
, 0
and 0
NifR4 B-gene
( 0
ntrA B-gene
encoding 0
sigma B-gene
54 I-gene
) 0
had 0
no 0
influence 0
on 0
put B-gene
gene I-gene
expression 0
. 0

This 0
bud 0
morphology 0
results 0
at 0
least 0
in 0
part 0
from 0
a 0
cell 0
cycle 0
delay 0
imposed 0
by 0
the 0
Cdc28p B-gene
- 0
inhibitory 0
kinase 0
Swe1p B-gene
. 0

IgE B-gene
- I-gene
binding I-gene
proteins I-gene
of 0
Psocoptera 0
were 0
determined 0
by 0
immunoblotting 0
experiments 0
. 0

174 0
, 0
233 0
- 0
247 0
) 0
and 0
Serrate 0
( 0
Serrate1 0
and 0
2 0
; 0
Myat 0
, 0
A. 0
, 0
Henrique 0
, 0
D. 0
, 0
Ish 0
- 0
Horowicz 0
, 0
D. 0
and 0
Lewis 0
, 0
J. 0
, 0
1996 0
. 0

A 0
new 0
technique 0
for 0
the 0
identification 0
of 0
phases 0
contained 0
within 0
a 0
polymer 0
blend 0
is 0
described 0
in 0
this 0
paper 0
. 0

Nonlethal 0
sec71 B-gene
- I-gene
1 I-gene
and 0
sec72 B-gene
- I-gene
1 I-gene
mutations I-gene
eliminate 0
proteins 0
associated 0
with 0
the 0
Sec63p B-gene
- 0
BiP B-gene
complex 0
from 0
S. 0
cerevisiae 0
. 0

Our 0
studies 0
indicate 0
no 0
single 0
trans 0
- 0
acting 0
factor 0
is 0
absolutely 0
essential 0
for 0
enhancer 0
activity 0
, 0
and 0
that 0
the 0
enhancer 0
activity 0
of 0
MerI B-gene
is 0
mediated 0
via 0
a 0
combinatorial 0
and 0
additive 0
mechanism 0
. 0

We 0
recently 0
reported 0
the 0
cloning 0
and 0
sequencing 0
of 0
the 0
alpha B-gene
7 I-gene
integrin I-gene
chain I-gene
and 0
its 0
regulated 0
expression 0
during 0
the 0
development 0
of 0
skeletal 0
muscle 0
( 0
Song 0
et 0
al 0
. 0

Analytical 0
scanning 0
isoelectrofocusing 0
. 0

A 0
structural 0
model 0
for 0
Vpu B-gene
is 0
proposed 0
in 0
which 0
the 0
membrane 0
anchor 0
precedes 0
a 0
region 0
comprising 0
two 0
amphipathic 0
alpha 0
- 0
helices 0
of 0
opposed 0
polarity 0
, 0
joined 0
by 0
a 0
strongly 0
acidic 0
turn 0
that 0
protrudes 0
into 0
the 0
cytoplasm 0
and 0
contains 0
the 0
CK B-gene
- I-gene
2 I-gene
phosphorylation I-gene
sites I-gene
. 0

Primer 0
extension 0
analysis 0
and 0
subcloning 0
of 0
the 0
virJ B-gene
- 0
phoA B-gene
fusion 0
indicate 0
that 0
the 0
acetosyringone 0
- 0
inducible 0
promoter 0
lies 0
directly 0
upstream 0
of 0
the 0
virJ B-gene
structural I-gene
gene I-gene
. 0

This 0
novel 0
TRPC7 B-gene
gene I-gene
could 0
be 0
a 0
candidate 0
gene 0
for 0
genetic 0
disorders 0
such 0
as 0
bipolar 0
affective 0
disorder 0
, 0
nonsyndromic 0
hereditary 0
deafness 0
, 0
Knobloch 0
syndrome 0
, 0
and 0
holoprosencephaly 0
, 0
which 0
were 0
mapped 0
to 0
this 0
region 0
. 0

In 0
the 0
future 0
, 0
transoesophageal 0
echocardiography 0
may 0
be 0
used 0
to 0
measure 0
variations 0
in 0
wall 0
thickness 0
which 0
change 0
the 0
global 0
loading 0
conditions 0
in 0
the 0
basal 0
midwall 0
compartments 0
of 0
the 0
left 0
ventricle 0
. 0

METHODS 0
: 0
A 0
discriminant 0
function 0
predicting 0
surgery 0
outcome 0
( 0
seizure 0
- 0
free 0
vs. 0
non 0
- 0
seizure 0
- 0
free 0
) 0
was 0
computed 0
separately 0
for 0
samples 0
of 0
patients 0
with 0
left 0
( 0
n 0
= 0
79 0
) 0
and 0
right 0
( 0
n 0
= 0
62 0
) 0
temporal 0
lobectomy 0
( 0
LATL 0
, 0
RATL 0
) 0
. 0

A 0
porcine 0
model 0
of 0
diffuse 0
axonal 0
injury 0
, 0
developed 0
with 0
information 0
from 0
these 0
physical 0
models 0
and 0
earlier 0
in 0
vitro 0
tissue 0
modeling 0
studies 0
, 0
is 0
used 0
to 0
correlate 0
histologic 0
and 0
radiologic 0
evidence 0
of 0
axonal 0
injury 0
to 0
predicted 0
regions 0
of 0
injury 0
from 0
the 0
experimental 0
and 0
theoretical 0
analysis 0
. 0

Control 0
of 0
ovulation 0
in 0
mares 0
in 0
the 0
early 0
breeding 0
season 0
with 0
ovarian 0
steroids 0
and 0
prostaglandin 0
. 0

The 0
aim 0
of 0
this 0
study 0
was 0
to 0
determine 0
the 0
response 0
properties 0
of 0
the 0
human 0
visual 0
cortex 0
to 0
chromatic 0
stimuli 0
using 0
magnetoencephalography 0
( 0
MEG 0
) 0
. 0

By 0
subtractive 0
and 0
differential 0
screening 0
, 0
we 0
have 0
cloned 0
12 0
of 0
these 0
sequences 0
, 0
2 0
of 0
which 0
were 0
c B-gene
- I-gene
fos I-gene
and 0
krox B-gene
- I-gene
24 I-gene
. 0

Basal 0
level 0
expression 0
was 0
reduced 0
to 0
20 0
and 0
50 0
% 0
when 0
the 0
UGA 0
stop 0
codon 0
was 0
replaced 0
by 0
UAG 0
or 0
UAA 0
, 0
respectively 0
, 0
consistent 0
with 0
the 0
finding 0
that 0
in 0
E. 0
coli 0
translation 0
terminates 0
more 0
efficiently 0
at 0
UAG 0
and 0
UAA 0
than 0
at 0
UGA 0
. 0

3 0
. 0

The 0
root 0
- 0
mean 0
- 0
square 0
deviation 0
of 0
bond 0
lengths 0
from 0
the 0
ideal 0
values 0
is 0
0.02 0
A 0
. 0

Sugar 0
analysis 0
was 0
performed 0
on 0
alpha B-gene
- I-gene
TM I-gene
to 0
investigate 0
a 0
possible 0
biosynthetic 0
mechanism 0
for 0
part 0
- 0
time 0
PGs 0
. 0

To 0
our 0
knowledge 0
no 0
transcription 0
factors 0
have 0
previously 0
been 0
identified 0
that 0
exhibit 0
androgen 0
- 0
dependent 0
expression 0
in 0
the 0
epididymis 0
. 0

4 0
. 0

Proceedings 0
: 0
Influence 0
of 0
halothane 0
on 0
mortality 0
from 0
murine 0
hepatitis 0
virus 0
( 0
MHV3 0
) 0
. 0

Prevalence 0
of 0
rheumatic 0
diseases 0
in 0
a 0
rural 0
population 0
in 0
western 0
India 0
: 0
a 0
WHO 0
- 0
ILAR 0
COPCORD 0
Study 0
. 0

Finally 0
, 0
in 0
samples 0
obtained 0
from 0
two 0
patients 0
with 0
drug 0
refractory 0
ALL 0
, 0
BAC 0
- 0
derived 0
probes 0
applied 0
to 0
archived 0
marrow 0
cells 0
demonstrated 0
that 0
a 0
breakpoint 0
occurred 0
between 0
MDR1 B-gene
and 0
sequences 0
500 0
- 0
1000 0
KB 0
telomeric 0
to 0
MDR1 B-gene
, 0
consistent 0
with 0
a 0
random 0
chromosomal 0
rearrangement 0
. 0

We 0
conclude 0
that 0
clonidine 0
3 0
micrograms/kg 0
produces 0
sedation 0
comparable 0
to 0
diazepam 0
0.2 0
mg/kg 0
and 0
also 0
attenuates 0
the 0
intubation 0
response 0
without 0
increasing 0
the 0
incidence 0
of 0
complications 0
. 0

The 0
other 0
regions 0
include 0
potential 0
binding 0
sites 0
for 0
transcription 0
factors 0
ATF B-gene
, 0
NF1 B-gene
, 0
and 0
a 0
CCAAT B-gene
- I-gene
binding I-gene
protein I-gene
. 0

The 0
analysis 0
predicted 0
that 0
progressive 0
increases 0
in 0
serum 0
creatinine 0
or 0
aspartate B-gene
transaminase I-gene
activity 0
will 0
result 0
in 0
only 0
a 0
50 0
% 0
reduction 0
of 0
clearance 0
. 0

5 0
Intravenous 0
prizidilol 0
hydrochloride 0
decreases 0
resting 0
blood 0
pressure 0
and 0
left 0
ventricular 0
area 0
, 0
increases 0
pulse 0
rate 0
and 0
has 0
virtually 0
no 0
effect 0
on 0
left 0
ventricular 0
ejection 0
fraction 0
. 0

The 0
Saccharomyces 0
cerevisiae 0
targets 0
of 0
rapamycin 0
, 0
TOR1 B-gene
and 0
TOR2 B-gene
, 0
signal 0
activation 0
of 0
cell 0
growth 0
in 0
response 0
to 0
nutrient 0
availability 0
. 0

This 0
50 0
- 0
kDa 0
protein 0
contains 0
two 0
SH2 B-gene
domains I-gene
and 0
an 0
inter B-gene
- I-gene
SH2 I-gene
domain I-gene
of 0
p85alpha B-gene
, 0
but 0
the 0
SH3 B-gene
and 0
bcr B-gene
homology I-gene
domains I-gene
of 0
p85alpha B-gene
were 0
replaced 0
by 0
a 0
unique 0
6 0
- 0
amino 0
acid 0
sequence 0
. 0

Gene 0
structure 0
and 0
precursor 0
processing 0
. 0

This 0
effect 0
is 0
independent 0
of 0
the 0
Gal4 B-gene
protein I-gene
, 0
as 0
it 0
operates 0
in 0
a 0
gal4 B-gene
mutant I-gene
background 0
as 0
well 0
. 0

Thus 0
, 0
d 0
- 0
delta3 0
- 0
carene 0
was 0
about 0
four 0
times 0
more 0
potent 0
as 0
a 0
sensory 0
irritant 0
than 0
I 0
- 0
beta 0
- 0
pinene 0
, 0
whereas 0
the 0
difference 0
with 0
I 0
- 0
alpha 0
- 0
pinene 0
was 0
more 0
marked 0
; 0
as 0
a 0
sensory 0
irritant 0
, 0
I 0
- 0
alpha 0
- 0
pinene 0
is 0
almost 0
inactive 0
. 0

Blood 0
and 0
whole 0
- 0
brain 0
mercury 0
concentrations 0
were 0
determined 0
in 0
pups 0
on 0
PN 0
0 0
( 0
birth 0
) 0
and 0
PN 0
21 0
( 0
weaning 0
) 0
. 0

Multiple 0
copies 0
of 0
this 0
binding 0
site 0
are 0
found 0
in 0
the 0
viral 0
genomes 0
. 0

Tubular 0
dysfunction 0
in 0
renal 0
lithiasis 0
: 0
cause 0
or 0
consequence 0
? 0
] 0
To 0
investigate 0
whether 0
overall 0
tubular 0
dysfunction 0
is 0
encountered 0
in 0
a 0
particular 0
subgroup 0
of 0
patients 0
with 0
urolithiasis 0
, 0
the 0
following 0
parameters 0
of 0
renal 0
tubular 0
function 0
have 0
been 0
measured 0
in 0
fasting 0
morning 0
urine 0
in 0
124 0
male 0
stone 0
formers 0
: 0
excretion 0
of 0
lysozyme B-gene
and 0
gamma B-gene
- I-gene
glutamyl I-gene
transpeptidase I-gene
( 0
gamma B-gene
- I-gene
GT I-gene
) 0
, 0
fractional 0
excretion 0
( 0
FE 0
) 0
or 0
glucose 0
, 0
insulin B-gene
, 0
bicarbonate 0
after 0
an 0
alkali 0
load 0
, 0
and 0
theoretical 0
phosphate 0
threshold 0
( 0
TmP/GFR 0
) 0
. 0

The 0
blood 0
pressures 0
in 0
43 0
subjects 0
were 0
compared 0
during 0
rapid 0
weight 0
loss 0
and 0
at 0
identical 0
weights 0
during 0
post 0
- 0
fast 0
weight 0
gain 0
( 0
Study 0
A 0
) 0
. 0

Mol 0
. 0

Arg 0
- 0
130 0
, 0
Gly 0
- 0
132 0
and 0
Lys 0
- 0
167 0
are 0
conserved 0
in 0
all 0
members 0
of 0
the 0
type B-gene
IB I-gene
topoisomerase I-gene
family I-gene
. 0

The 0
maximal 0
rise 0
in 0
plasma 0
adrenaline 0
was 0
of 0
similar 0
magnitude 0
in 0
all 0
three 0
groups 0
but 0
a 0
lower 0
plasma 0
glucose 0
was 0
required 0
to 0
stimulate 0
this 0
hormonal 0
response 0
in 0
the 0
'unaware 0
' 0
patients 0
, 0
in 0
whom 0
the 0
plasma 0
adrenaline 0
concentration 0
was 0
lower 0
at 0
the 0
time 0
of 0
the 0
reaction 0
. 0

PATIENTS 0
- 0
- 0
125 0
women 0
consulting 0
the 0
general 0
practitioner 0
for 0
symptomatic 0
bacterial 0
vaginosis 0
. 0

Patients 0
with 0
advanced 0
ovarian 0
carcinoma 0
, 0
Stage 0
III 0
or 0
IV 0
( 0
International 0
Federation 0
of 0
Gynaecology 0
and 0
Obstetrics 0
) 0
, 0
were 0
randomized 0
to 0
primary 0
chemotherapy 0
with 0
doxorubicin 0
( 0
Adriamycin 0
) 0
and 0
cisplatin 0
plus 0
or 0
minus 0
hexamethylmelamine 0
, 0
and 0
cyclophosphamide 0
( 0
CHAP 0
) 0
. 0

Promoter 0
activity 0
of 0
the 0
proliferating B-gene
- I-gene
cell I-gene
nuclear I-gene
antigen I-gene
gene I-gene
is 0
associated 0
with 0
inducible 0
CRE B-gene
- I-gene
binding I-gene
proteins I-gene
in 0
interleukin B-gene
2 I-gene
- 0
stimulated 0
T 0
lymphocytes 0
. 0

Sequence 0
analysis 0
revealed 0
100 0
% 0
homology 0
of 0
all 0
RA 0
- 0
derived 0
PTEN B-gene
fragments I-gene
to 0
those 0
from 0
normal 0
SF 0
as 0
well 0
as 0
to 0
the 0
published 0
GenBank 0
sequence 0
( 0
accession 0
number 0
U93051 B-gene
) 0
. 0

The 0
mutation 0
also 0
preferentially 0
limits 0
( 0
compared 0
with 0
total 0
protein 0
synthesis 0
) 0
translation 0
of 0
an 0
induced 0
gene 0
that 0
depends 0
on 0
five 0
AGA 0
codons 0
, 0
i.e. 0
, 0
the 0
lambda B-gene
cI I-gene
repressor I-gene
gene I-gene
. 0

The 0
influence 0
of 0
a 0
high 0
n 0
- 0
3 0
PUFA 0
intake 0
on 0
measures 0
of 0
lipid 0
peroxidation 0
has 0
been 0
equivocal 0
. 0

In 0
contrast 0
, 0
inhibition 0
of 0
MAPK B-gene
activity 0
by 0
MAPK B-gene
kinase I-gene
inhibitor 0
( 0
PD 0
98059 0
) 0
or 0
by 0
overexpression 0
of 0
kinase 0
- 0
deficient 0
MAPKs B-gene
activated 0
basal 0
and 0
GnRH B-gene
- I-gene
A I-gene
- 0
stimulated 0
GnRHR B-gene
- 0
Luc B-gene
activity 0
. 0

For 0
the 0
first 0
, 0
short 0
- 0
term 0
( 0
concurrent 0
) 0
TAL 0
, 0
two 0
different 0
- 0
flavored 0
stimuli 0
were 0
presented 0
at 0
the 0
same 0
time 0
, 0
one 0
associated 0
with 0
simultaneous 0
intragastric 0
administration 0
of 0
an 0
aversive 0
product 0
, 0
hypertonic 0
NaCl 0
, 0
and 0
the 0
other 0
with 0
saline 0
. 0

CONCLUSIONS 0
: 0
LHB 0
is 0
simple 0
, 0
easy 0
and 0
safe 0
to 0
implement 0
, 0
and 0
is 0
the 0
only 0
technique 0
capable 0
of 0
maintaining 0
independent 0
upper 0
and 0
lower 0
body 0
perfusion 0
pressure 0
. 0

Heterodimerization B-gene
mutant I-gene
RXR I-gene
failed 0
to 0
alter 0
GFP B-gene
- 0
VDR B-gene
and 0
nlsGFP B-gene
- 0
VDR B-gene
distribution 0
or 0
activity 0
. 0

New 0
TB 0
respirator 0
standards 0
mean 0
more 0
choices 0
at 0
less 0
cost 0
. 0

After 0
first 0
strand 0
cDNA 0
synthesis 0
from 0
fetal 0
brain 0
mRNAs 0
, 0
short 0
fragment 0
cDNAs 0
( 0
sf 0
- 0
cDNAs 0
) 0
were 0
synthesized 0
with 0
a 0
two 0
- 0
step 0
amplification 0
system 0
by 0
use 0
of 0
our 0
modified 0
Degenerate 0
Oligonucleotide 0
Primed 0
Shuttle 0
Polymerase 0
Chain 0
Reaction 0
( 0
DOP 0
- 0
Shuttle 0
- 0
PCR 0
) 0
method 0
. 0

Fulminant 0
hepatic 0
failure 0
in 0
these 0
cases 0
could 0
be 0
characterized 0
by 0
: 0
( 0
1 0
) 0
rapid 0
decrease 0
in 0
serum B-gene
alanine I-gene
transaminase I-gene
( 0
ALT B-gene
) 0
level 0
after 0
discontinuation 0
of 0
ecarazine 0
, 0
( 0
2 0
) 0
prolonged 0
jaundice 0
despite 0
discontinuation 0
of 0
ecarazine 0
, 0
( 0
3 0
) 0
high 0
incidence 0
of 0
anti B-gene
- I-gene
nuclear I-gene
antibody I-gene
( 0
ANA B-gene
) 0
( 0
57 0
% 0
) 0
, 0
and 0
( 0
4 0
) 0
histological 0
findings 0
of 0
extensive 0
hepatocellular 0
necrosis 0
ranging 0
from 0
bridging 0
necrosis 0
to 0
massive 0
necrosis 0
. 0

Smectic 0
- 0
A 0
ordering 0
at 0
a 0
liquid 0
- 0
vapor 0
interface 0
. 0

Simulation 0
results 0
based 0
on 0
the 0
presented 0
model 0
are 0
compared 0
with 0
the 0
experimental 0
data 0
for 0
two 0
types 0
of 0
cMUTs 0
reported 0
in 0
the 0
recent 0
literature 0
. 0

These 0
results 0
demonstrate 0
that 0
the 0
entire 0
E3L B-gene
gene I-gene
is 0
required 0
for 0
pathogenesis 0
in 0
the 0
mouse 0
model 0
. 0

Parelaphostrongylus 0
odocoilei 0
is 0
redescribed 0
from 0
worms 0
collected 0
from 0
the 0
type 0
host 0
( 0
Odocoileus 0
hemionus 0
columbianus 0
) 0
in 0
California 0
, 0
as 0
well 0
as 0
material 0
from 0
experimentally 0
infected 0
mule 0
deer 0
( 0
O. 0
h. 0
heminus 0
) 0
in 0
Alberta 0
. 0

Sodium 0
dodecylsulfate 0
polyacrylamide 0
gel 0
electrophoresis 0
( 0
SDS 0
- 0
PAGE 0
) 0
showed 0
two 0
bands 0
of 0
about 0
the 0
same 0
intensity 0
with 0
apparent 0
molecular 0
masses 0
of 0
24.5 0
and 0
22.5 0
kDa 0
. 0

Particle 0
bombardment 0
of 0
barley 0
aleurone 0
with 0
a 0
B22EL8 B-gene
promoter I-gene
- 0
GUS B-gene
( 0
beta B-gene
- I-gene
glucuronidase I-gene
) 0
construct 0
demonstrates 0
that 0
the 0
promoter 0
( 0
3 0
kb 0
) 0
is 0
active 0
in 0
developing 0
barley 0
grains 0
. 0

The 0
cloning 0
of 0
CWH43 B-gene
showed 0
that 0
it 0
corresponds 0
to 0
YCR017c B-gene
and 0
encodes 0
a 0
protein 0
with 0
14 0
- 0
16 0
transmembrane 0
segments 0
containing 0
several 0
putative 0
phosphorylation 0
and 0
glycosylation 0
sites 0
. 0

They 0
elicit 0
similar 0
regional 0
cerebral 0
blood 0
flow 0
( 0
rCBF 0
) 0
patterns 0
, 0
even 0
though 0
sign 0
language 0
is 0
dependent 0
on 0
spatial 0
information 0
. 0

However 0
, 0
at 0
the 0
time 0
of 0
salvage 0
treatment 0
, 0
the 0
mean 0
serum B-gene
PSA I-gene
levels 0
were 0
9.1 0
and 0
1.1 0
ng/mL 0
for 0
the 0
salvage 0
RP 0
and 0
salvage 0
RT 0
groups 0
, 0
respectively 0
( 0
P 0
= 0
0.0001 0
) 0
. 0

First 0
, 0
a 0
GATA B-gene
- I-gene
1 I-gene
motif I-gene
was 0
found 0
to 0
bind 0
nuclear 0
factor 0
( 0
s 0
) 0
, 0
presumably 0
the 0
GATA B-gene
- I-gene
1 I-gene
factor I-gene
, 0
present 0
in 0
K 0
- 0
562 0
cell 0
extracts 0
and 0
in 0
living 0
K 0
- 0
562 0
cells 0
. 0

There 0
was 0
a 0
direct 0
proportional 0
relationship 0
between 0
the 0
spiral 0
artery 0
flow 0
and 0
the 0
pressure 0
difference 0
between 0
the 0
spiral 0
artery 0
and 0
the 0
amniotic 0
fluid 0
; 0
the 0
pressure 0
difference 0
per 0
flow 0
( 0
the 0
resistance 0
of 0
the 0
cotyledonary 0
unit 0
) 0
was 0
found 0
to 0
be 0
1 0
- 0
- 0
3 0
mm 0
Hg 0
. 0
ml 0
- 0
1 0
. 0
min 0
( 0
8 0
- 0
- 0
24kPa 0
. 0
ml 0
- 0
1 0
. 0
s 0
) 0
. 0

Truncations 0
from 0
Hip B-gene
's 0
N 0
terminus 0
resulted 0
in 0
an 0
apparent 0
loss 0
of 0
Hip B-gene
homo 0
- 0
oligomerization 0
, 0
but 0
these 0
mutants 0
retained 0
association 0
with 0
hsp70 B-gene
and 0
were 0
recovered 0
in 0
receptor 0
complexes 0
. 0

An 0
oligomer 0
synthesized 0
to 0
this 0
region 0
of 0
homology 0
produced 0
two 0
DNA 0
- 0
protein 0
complexes 0
with 0
oviduct 0
nuclear 0
proteins 0
. 0

The 0
myeloid B-gene
zinc I-gene
finger I-gene
gene I-gene
1 I-gene
( 0
MZF1 B-gene
) 0
encodes 0
a 0
C B-gene
( I-gene
2 I-gene
) I-gene
H I-gene
( I-gene
2 I-gene
) I-gene
zinc I-gene
finger I-gene
transcription I-gene
factor I-gene
that 0
regulates 0
granulopoiesis 0
and 0
may 0
have 0
a 0
regulatory 0
role 0
in 0
cellular 0
proliferation 0
and 0
oncogenesis 0
. 0

3 0
. 0

The 0
rate 0
of 0
collagen B-gene
synthesis 0
in 0
normal 0
scar 0
was 0
approximately 0
constant 0
between 0
6 0
months 0
and 0
20 0
years 0
after 0
the 0
initial 0
wounding 0
, 0
but 0
in 0
both 0
hypertrophic 0
scar 0
and 0
keloid 0
the 0
rate 0
was 0
initially 0
approximately 0
twice 0
that 0
in 0
normal 0
scar 0
, 0
and 0
2 0
- 0
3 0
years 0
after 0
wounding 0
it 0
fell 0
to 0
approximately 0
the 0
same 0
level 0
as 0
in 0
normal 0
scar 0
. 0

When 0
phentermine 0
was 0
mixed 0
with 0
other 0
unlabeled 0
reversible 0
MAO B-gene
inhibitors 0
( 0
e.g 0
. 0
pseudoephedrine 0
, 0
ephedrine 0
, 0
norephedrine 0
; 0
estradiol 0
benzoate 0
) 0
, 0
the 0
degree 0
of 0
MAO B-gene
inhibition 0
was 0
additive 0
. 0

W. 0
, 0
and 0
Touster 0
, 0
O 0
. 0

There 0
was 0
a 0
57 0
% 0
reduction 0
in 0
IGF B-gene
IR I-gene
mRNA I-gene
levels 0
in 0
clone 0
CA9 0
after 0
confluence 0
compared 0
with 0
clone 0
ME10 0
. 0

Uncoupling 0
gene 0
activity 0
from 0
chromatin 0
structure 0
: 0
promoter 0
mutations 0
can 0
inactivate 0
transcription 0
of 0
the 0
yeast B-gene
HSP82 I-gene
gene I-gene
without 0
eliminating 0
nucleosome 0
- 0
free 0
regions 0
. 0

Heating 0
had 0
no 0
effect 0
upon 0
either 0
force 0
decline 0
or 0
slowing 0
of 0
relaxation 0
during 0
fatiguing 0
contractions 0
. 0

Uncertainty 0
exists 0
about 0
the 0
function 0
of 0
these 0
potential 0
isoforms 0
of 0
the 0
Cbfa1 B-gene
gene I-gene
. 0

The 0
RTI40 B-gene
gene I-gene
spans 0
35 0
kilobase 0
pairs 0
; 0
it 0
contains 0
6 0
exons 0
and 0
at 0
least 0
6 0
rat 0
Identifier 0
repetitive 0
elements 0
. 0

The 0
characteristics 0
of 0
a 0
simple 0
apparatus 0
for 0
clinical 0
use 0
to 0
measure 0
DEOAEs 0
are 0
described 0
together 0
with 0
typical 0
examples 0
of 0
emissions 0
. 0

Anatomical 0
considerations 0
in 0
transsphenoidal 0
hypophysectomy 0
. 0

It 0
has 0
been 0
confirmed 0
in 0
animal 0
experiments 0
that 0
the 0
number 0
of 0
microspheres 0
in 0
a 0
myocardial 0
sample 0
approximately 0
follows 0
a 0
Poisson 0
distribution 0
, 0
under 0
adequate 0
experimental 0
conditions 0
. 0

Maximal 0
exercise 0
duration 0
and 0
peak 0
oxygen 0
consumption 0
were 0
not 0
changed 0
. 0

Hard 0
methacrylic 0
polymers 0
. 0

Validity 0
of 0
the 0
short 0
- 0
form 0
QIF 0
was 0
assessed 0
by 0
correlation 0
with 0
motor 0
scores 0
and 0
using 0
analysis 0
of 0
variance 0
by 0
motor 0
levels 0
and 0
motor 0
score 0
groupings 0
. 0

An 0
81 0
- 0
nt 0
tandem 0
duplication 0
of 0
the 0
C 0
- 0
terminal 0
coding 0
region 0
is 0
located 0
adjacent 0
to 0
the 0
termination 0
codon 0
of 0
the 0
CyIIIb B-gene
gene I-gene
, 0
a 0
potential 0
relic 0
of 0
a 0
slipped 0
mispairing 0
and 0
replication 0
event 0
. 0

During 0
seed 0
maturation 0
, 0
the 0
transcriptional 0
activity 0
of 0
napin B-gene
genes I-gene
is 0
regulated 0
by 0
developmental 0
signals 0
involving 0
the 0
transcriptional B-gene
activator I-gene
ABI3 I-gene
and 0
abscisic 0
acid 0
( 0
ABA 0
) 0
. 0

Here 0
we 0
report 0
the 0
cloning 0
, 0
by 0
either 0
peptide 0
sequencing 0
or 0
by 0
sequence 0
similarity 0
to 0
the 0
human 0
cDNAs 0
, 0
of 0
the 0
S. 0
cerevisiae 0
genes 0
RFC1 B-gene
, 0
RFC2 B-gene
, 0
RFC3 B-gene
, 0
RFC4 B-gene
, 0
and 0
RFC5 B-gene
. 0

On 0
the 0
other 0
hand 0
, 0
V3 0
'' 0
values 0
were 0
not 0
significantly 0
correlated 0
with 0
the 0
degree 0
of 0
tremor 0
, 0
seborrhea 0
, 0
and 0
duration 0
of 0
the 0
illness 0
. 0

The 0
isomerization 0
of 0
the 0
pre 0
- 0
existing 0
closed 0
complex 0
to 0
an 0
open 0
promoter 0
form 0
, 0
as 0
judged 0
by 0
the 0
local 0
denaturation 0
of 0
promoter 0
DNA 0
which 0
rendered 0
sequences 0
from 0
+5 0
to 0
- 0
10 0
reactive 0
towards 0
KMnO4 0
, 0
was 0
shown 0
to 0
be 0
fully 0
dependent 0
on 0
NifA B-gene
. 0

Mouse B-gene
macrophage I-gene
beta I-gene
subunit I-gene
( I-gene
CD11b I-gene
) I-gene
cDNA I-gene
for 0
the 0
CR3 B-gene
complement I-gene
receptor/Mac I-gene
receptor/Mac I-gene
- I-gene
1 I-gene
antigen I-gene
. 0

The 0
predicted 0
product 0
exhibits 0
91 0
% 0
amino 0
acid 0
identity 0
to 0
the 0
murine B-gene
voltage I-gene
- I-gene
gated I-gene
potassium I-gene
channel I-gene
protein I-gene
Kv1.7 I-gene
( 0
Kcna7 B-gene
) 0
, 0
which 0
plays 0
an 0
important 0
role 0
in 0
the 0
repolarization 0
of 0
cell 0
membranes 0
. 0

Elective 0
replacement 0
of 0
the 0
aortic 0
root 0
in 0
Marfan 0
's 0
syndrome 0
. 0

Principles 0
of 0
thyroid 0
hormone 0
treatment 0

Their 0
main 0
representatives 0
are 0
the 0
American 0
diagnostic 0
and 0
statistical 0
manual 0
of 0
mental 0
disorders 0
, 0
DSM 0
- 0
III 0
, 0
its 0
revised 0
version 0
DSM 0
- 0
III 0
- 0
R 0
and 0
the 0
new 0
international 0
classification 0
of 0
mental 0
disorders 0
iCD 0
- 0
10 0
. 0

Each 0
received 0
20 0
mL 0
of 0
one 0
of 0
three 0
test 0
solutions 0
: 0
levobupivacaine 0
control 0
, 0
levobupivacaine 0
and 0
fentanyl 0
2 0
microg/mL 0
, 0
or 0
levobupivacaine 0
and 0
fentanyl 0
3 0
microg/mL 0
. 0

Time 0
for 0
action 0
on 0
hepatitis 0
B 0
immunisation 0
. 0

Kramer 0
Hamburg 0
1988 0
, 0
ISBN 0
: 0
3 0
926952 0
07 0
5 0
) 0
, 0
the 0
syndromatic 0
day 0
- 0
to 0
- 0
day 0
shifting 0
of 0
the 0
psychopathological 0
features 0
with 0
manic 0
, 0
depressive 0
and 0
several 0
mixed 0
states 0
has 0
a 0
well 0
- 0
defined 0
time 0
structure 0
, 0
as 0
in 0
25 0
patients 0
studied 0
and 0
reported 0
on 0
in 0
this 0
paper 0
. 0

Internal 0
controls 0
over 0
the 0
volume 0
of 0
milk 0
suckled 0
do 0
not 0
appear 0
until 0
infant 0
rats 0
are 0
about 0
2 0
weeks 0
of 0
age 0
at 0
which 0
time 0
gastric 0
distension 0
, 0
milk 0
, 0
systemic 0
dehydration 0
, 0
and 0
intestinal B-gene
hormone I-gene
cholecystokinin I-gene
suppress 0
milk 0
intake 0
derived 0
through 0
suckling 0
. 0

In 0
the 0
HIV B-gene
LTR I-gene
, 0
this 0
region 0
has 0
been 0
demonstrated 0
to 0
have 0
both 0
positive 0
and 0
negative 0
regulatory 0
effects 0
on 0
HIV 0
gene 0
expression 0
. 0

Analysis 0
of 0
rat 0
brain 0
, 0
heart 0
, 0
lung 0
, 0
liver 0
, 0
kidney 0
and 0
skeletal 0
muscle 0
revealed 0
psi B-gene
PKC I-gene
zeta I-gene
mRNA I-gene
only 0
in 0
brain 0
. 0

To 0
identify 0
and 0
determine 0
the 0
function 0
of 0
Ino2p B-gene
in 0
yeast 0
cells 0
, 0
we 0
raised 0
antibodies 0
to 0
a 0
beta B-gene
- I-gene
galactosidase/Ino2 I-gene
fusion 0
protein 0
. 0

In 0
addition 0
, 0
WR 0
- 0
3689 0
, 0
WR 0
- 0
109342 0
, 0
and 0
WR 0
- 0
168643 0
were 0
used 0
with 0
per 0
os 0
administration 0
to 0
determine 0
hematopoietic 0
lethality 0
. 0

Isolation 0
and 0
characterization 0
of 0
human 0
orthologs 0
of 0
yeast 0
CCR4 B-gene
- 0
NOT B-gene
complex 0
subunits 0
. 0

Serum 0
AFP B-gene
is 0
a 0
useful 0
tumor 0
marker 0
for 0
monitoring 0
the 0
results 0
of 0
therapy 0
. 0

The 0
paper 0
calls 0
for 0
standardized 0
question 0
formats 0
and 0
a 0
centralized 0
body 0
to 0
monitor 0
changes 0
in 0
these 0
parameters 0
of 0
sexual 0
behaviour 0
. 0

A 0
heterologous 0
promoter 0
construct 0
containing 0
three 0
repeats 0
of 0
a 0
consensus 0
Sp1 B-gene
site I-gene
, 0
cloned 0
upstream 0
of 0
a 0
single 0
copy 0
of 0
the 0
ZII B-gene
( 0
CREB/ B-gene
AP1 B-gene
) 0
element 0
from 0
the 0
BZLF1 B-gene
promoter I-gene
linked 0
to 0
the 0
beta B-gene
- I-gene
globin I-gene
TATA 0
box 0
, 0
exhibited 0
phorbol 0
ester 0
inducibility 0
. 0

A 0
long 0
- 0
term 0
follow 0
- 0
up 0
study 0
of 0
a 0
children 0
's 0
psychiatric 0
day 0
treatment 0
center 0
. 0

Risk 0
factors 0
for 0
atherosclerosis 0
related 0
to 0
nutrition 0
are 0
hypercholesterolemia 0
, 0
hyperglycemia 0
- 0
diabetes 0
, 0
and 0
for 0
hypertension 0
, 0
obesity 0
, 0
high 0
salt 0
intake 0
, 0
and 0
excessive 0
use 0
of 0
alcohol 0
. 0

We 0
demonstrate 0
that 0
the 0
recently 0
proposed 0
synthetic 0
imaging 0
technique 0
[ 0
J 0
. 0

We 0
compared 0
the 0
quantities 0
collected 0
with 0
both 0
pollen 0
traps 0
during 0
February 0
, 0
March 0
and 0
April 0
1988 0
and 0
1989 0
. 0

Of 0
the 0
CSF 0
tested 0
, 0
24 0
stimulated 0
oxygen 0
consumption 0
above 0
our 0
cut 0
off 0
, 0
and 0
8 0
did 0
not 0
( 0
0.84 0
+/ 0
- 0
0.34 0
, 0
n 0
= 0
24 0
compared 0
with 0
the 0
rate 0
of 0
0.27 0
+/ 0
- 0
0.1 0
mumol/min/g 0
dry 0
wt 0
, 0
respectively 0
; 0
SD 0
n 0
= 0
8 0
) 0
at 0
180 0
minutes 0
. 0

These 0
psoralens 0
are 0
being 0
used 0
in 0
research 0
projects 0
sponsored 0
by 0
the 0
National 0
Toxicology 0
Program 0
. 0

Four 0
of 0
15 0
patients 0
with 0
R2 B-gene
had 0
rheumatoid 0
arthritis 0
and 0
in 0
two 0
of 0
these 0
four 0
cases 0
the 0
antibody 0
was 0
of 0
the 0
IgA B-gene
class 0
. 0

Seventy 0
- 0
nine 0
percent 0
of 0
the 0
children 0
screened 0
and 0
91.0 0
% 0
of 0
the 0
children 0
with 0
PbB 0
at 0
least 0
10 0
micrograms/dL 0
were 0
Hispanic 0
. 0

We 0
report 0
here 0
on 0
an 0
eight 0
- 0
year 0
- 0
old 0
boy 0
who 0
first 0
developed 0
acute 0
intravascular 0
hemolysis 0
following 0
therapy 0
with 0
amphotericin 0
B 0
( 0
AmB 0
) 0
and 0
subsequently 0
a 0
delayed 0
hemolytic 0
transfusion 0
reaction 0
due 0
to 0
alloantibodies 0
. 0

However 0
, 0
no 0
significant 0
difference 0
in 0
either 0
the 0
Valsalva 0
ratio 0
or 0
delta 0
SBP 0
was 0
found 0
between 0
diabetic 0
patients 0
and 0
controls 0
. 0

The 0
PDSS 0
identified 0
17 0
( 0
94 0
% 0
) 0
of 0
the 0
women 0
diagnosed 0
with 0
major 0
postpartum 0
depression 0
, 0
the 0
EPDS 0
identified 0
14 0
of 0
these 0
women 0
( 0
78 0
% 0
) 0
, 0
and 0
the 0
BDI 0
- 0
II 0
identified 0
10 0
of 0
the 0
18 0
women 0
( 0
56 0
% 0
) 0
. 0

One 0
ORF 0
extends 0
from 0
nucleotides 0
415 0
to 0
1620 0
, 0
encodes 0
402 0
amino 0
acids 0
, 0
and 0
is 0
preceded 0
by 0
a 0
ribosome 0
- 0
binding 0
site 0
. 0

Blood B-gene
coagulation I-gene
Factor I-gene
X I-gene
and 0
its 0
activated 0
form 0
Factor B-gene
Xa I-gene
play 0
an 0
essential 0
role 0
in 0
the 0
midphase 0
of 0
the 0
clotting 0
cascade 0
. 0

The 0
Ras B-gene
GTPase I-gene
- I-gene
activating I-gene
- I-gene
protein I-gene
- I-gene
related I-gene
human I-gene
protein I-gene
IQGAP2 B-gene
harbors 0
a 0
potential 0
actin B-gene
binding I-gene
domain I-gene
and 0
interacts 0
with 0
calmodulin B-gene
and 0
Rho B-gene
family I-gene
GTPases I-gene
. 0

On 0
a 0
national 0
level 0
, 0
undiscounted 0
costs 0
are 0
expected 0
to 0
increase 0
up 0
to 0
approximately 0
DF1 0
42 0
million 0
annually 0
during 0
the 0
first 0
40 0
years 0
after 0
introduction 0
of 0
the 0
preventative 0
strategy 0
. 0

Reduction 0
of 0
p53 B-gene
protein I-gene
was 0
detected 0
after 0
1 0
day 0
of 0
OM B-gene
treatment 0
and 0
reached 0
maximal 0
suppression 0
of 0
10 0
- 0
20 0
% 0
of 0
control 0
after 0
3 0
days 0
in 0
H3922 0
and 0
40 0
% 0
of 0
control 0
after 0
4 0
days 0
in 0
MCF 0
- 0
7 0
cells 0
. 0

This 0
seems 0
to 0
take 0
place 0
in 0
the 0
same 0
nuclear 0
compartment 0
as 0
normal 0
cis 0
splicing 0
and 0
proceeds 0
through 0
Y 0
- 0
branched 0
intermediates 0
analogous 0
to 0
the 0
lariats 0
formed 0
in 0
cis 0
splicing 0
. 0

Production 0
of 0
a 0
chicken 0
meat 0
infusion 0
broth 0
suitable 0
for 0
the 0
mass 0
production 0
of 0
a 0
Haemophilus 0
gallinarum 0
bacterin 0
. 0

The 0
maternal B-gene
par I-gene
genes I-gene
and 0
the 0
segregation 0
of 0
cell 0
fate 0
specification 0
activities 0
in 0
early 0
Caenorhabditis 0
elegans 0
embryos 0
. 0

These 0
results 0
suggest 0
that 0
E6010 B-gene
may 0
be 0
of 0
clinical 0
value 0
in 0
the 0
treatment 0
of 0
coronary 0
occlusion 0
. 0

Real 0
- 0
time 0
two 0
- 0
dimensional 0
echocardiographic 0
studies 0
of 0
the 0
mitral 0
valve 0
in 0
short 0
- 0
axis 0
view 0
were 0
obtained 0
from 0
10 0
normal 0
subjects 0
. 0

We 0
determined 0
their 0
N 0
- 0
terminal 0
amino 0
acid 0
sequence 0
and 0
found 0
that 0
these 0
polypeptides 0
were 0
CotT B-gene
, 0
YeeK B-gene
, 0
YxeE B-gene
, 0
CotF B-gene
, 0
YrbA B-gene
( 0
31 0
and 0
45 0
kDa 0
) 0
, 0
and 0
SpoIVA B-gene
, 0
respectively 0
. 0

The 0
determination 0
of 0
diacetyl 0
, 0
2,3 0
- 0
pentanedione 0
and 0
acetoin 0
was 0
performed 0
in 0
two 0
steps 0
. 0

The 0
same 0
pattern 0
of 0
firing 0
was 0
seen 0
with 0
saccades 0
in 0
light 0
and 0
in 0
complete 0
darkness 0
. 0

The 0
critical 0
obstacle 0
in 0
modeling 0
psychiatric 0
disorders 0
has 0
been 0
limited 0
information 0
about 0
their 0
origin 0
and 0
underlying 0
neural 0
mechanisms 0
. 0

These 0
results 0
suggest 0
that 0
both 0
the 0
distinct 0
DNA 0
binding 0
properties 0
of 0
PMLRAR B-gene
homodimers I-gene
and 0
the 0
sequestration 0
of 0
RXR B-gene
by 0
PMLRARs B-gene
may 0
contribute 0
to 0
the 0
molecular 0
mechanisms 0
which 0
underlie 0
the 0
pathogenesis 0
of 0
APL 0
. 0

CONCLUSIONS 0
: 0
Patients 0
' 0
attainment 0
of 0
TGB 0
monotherapy 0
was 0
associated 0
with 0
their 0
achievement 0
of 0
positive 0
changes 0
of 0
varying 0
degree 0
on 0
psychological 0
tests 0
. 0

In 0
alfalfa 0
, 0
the 0
insecticides 0
caused 0
significant 0
mortality 0
to 0
most 0
of 0
the 0
insects 0
evaluated 0
. 0

Sixtieth 0
anniversary 0
of 0
Angiotensin B-gene
. 0

In 0
addition 0
, 0
we 0
found 0
that 0
the 0
transactivation 0
mediated 0
by 0
the 0
p68c B-gene
- I-gene
ets I-gene
- I-gene
1 I-gene
pr I-gene
p55erg B-gene
through 0
the 0
Polyomavirus B-gene
enhancer I-gene
sequence I-gene
is 0
specifically 0
inhibited 0
by 0
the 0
p46kDaPax B-gene
- I-gene
QNR I-gene
in 0
transient 0
transfection 0
assay 0
. 0

SCAN B-gene
boxes 0
are 0
found 0
in 0
eight 0
other 0
genes 0
in 0
the 0
GenBank 0
database 0
, 0
five 0
of 0
which 0
are 0
also 0
in 0
the 0
Kruppel B-gene
family I-gene
of 0
zinc B-gene
finger I-gene
proteins I-gene
lacking 0
KRAB B-gene
A I-gene
and I-gene
B I-gene
domains 0
and 0
thereby 0
define 0
a 0
new 0
subclass 0
of 0
zinc B-gene
finger I-gene
proteins I-gene
. 0

The 0
in 0
- 0
plane 0
orientational 0
anisotropy 0
of 0
the 0
8CB 0
films 0
grown 0
on 0
unidirectionally 0
photopolymerized 0
PVCN 0
substrates 0
is 0
considerably 0
lower 0
than 0
the 0
intrinsic 0
surface 0
orientational 0
anisotropy 0
of 0
these 0
substrates 0
, 0
which 0
can 0
explain 0
the 0
generally 0
found 0
weak 0
surface 0
anchoring 0
of 0
liquid 0
crystals 0
on 0
PVCN 0
alignment 0
layers 0
. 0

The 0
introduction 0
of 0
FWD1 B-gene
into 0
cells 0
significantly 0
promotes 0
ubiquitination 0
and 0
degradation 0
of 0
IkappaBalpha B-gene
in 0
concert 0
with 0
IkappaB B-gene
kinases I-gene
, 0
resulting 0
in 0
nuclear 0
translocation 0
of 0
NF B-gene
- I-gene
kappaB I-gene
. 0

Since 0
blood 0
serotonin 0
is 0
primarily 0
produced 0
peripherally 0
, 0
these 0
results 0
suggest 0
that 0
some 0
aspect 0
of 0
peripheral 0
serotonin 0
metabolism 0
is 0
abnormal 0
in 0
major 0
depression 0
. 0

She 0
had 0
been 0
diagnosed 0
with 0
severe 0
aplastic 0
anemia 0
1 0
year 0
previously 0
and 0
, 0
while 0
hospitalized 0
, 0
had 0
received 0
methyl 0
prednisolone 0
pulse 0
therapy 0
, 0
which 0
was 0
not 0
successful 0
. 0

We 0
next 0
developed 0
a 0
rapid 0
purification 0
method 0
for 0
bacterial B-gene
recombinant I-gene
MyoD I-gene
- I-gene
bHLH I-gene
domain I-gene
by 0
affinity 0
chromatography 0
using 0
a 0
calmodulin B-gene
- 0
Sepharose 0
column 0
and 0
investigated 0
the 0
phosphorylation 0
of 0
that 0
peptide 0
by 0
PKC B-gene
and 0
its 0
interactions 0
with 0
calmodulin B-gene
and 0
S100a B-gene
. 0

The 0
22 0
- 0
d 0
orbital 0
flight 0
of 0
rats 0
onboard 0
the 0
Cosmos 0
- 0
605 0
biosatellite 0
was 0
followed 0
by 0
inhibition 0
of 0
erythroblastosis 0
, 0
alteration 0
in 0
the 0
morphology 0
of 0
megakaryocytes 0
, 0
and 0
stimulation 0
of 0
myelopoiesis 0
. 0

Partial 0
albinism 0
and 0
immunodeficiency 0
: 0
ultrastructural 0
study 0
of 0
haemophagocytosis 0
and 0
bone 0
marrow 0
erythroblasts 0
in 0
one 0
case 0
. 0

Optical 0
rotation 0
of 0
the 0
second 0
harmonic 0
radiation 0
from 0
retinal 0
in 0
bacteriorhodopsin B-gene
monomers I-gene
in 0
Langmuir 0
- 0
Blodgett 0
film 0
: 0
evidence 0
for 0
nonplanar 0
retinal 0
structure 0
. 0

RESULTS 0
: 0
Twenty 0
- 0
two 0
patients 0
( 0
30 0
% 0
) 0
showed 0
ST 0
- 0
segment 0
depression 0
during 0
AEM 0
and 0
34 0
( 0
49 0
% 0
) 0
on 0
ExT 0
. 0

Enhanced 0
quantum 0
correlations 0
in 0
bound 0
higher 0
- 0
order 0
solitons 0
Quantum 0
effects 0
in 0
N 0
- 0
bound 0
solitons 0
can 0
be 0
drastically 0
enhanced 0
compared 0
to 0
the 0
fundamental 0
soliton 0
. 0

Acute 0
intoxication 0
with 0
cypermethrin 0
( 0
NRDC 0
149 0
) 0
. 0

Anesthesia 0
in 0
the 0
radical 0
surgery 0
of 0
arteriosclerotic 0
coronary 0
disease 0

Whereas 0
the 0
sequence 0
of 0
alpha B-gene
- I-gene
actinin I-gene
( 0
Noegel 0
, 0
A. 0
, 0
W 0
. 0

Overall 0
, 0
it 0
appears 0
that 0
prenatal 0
exposure 0
to 0
androgen 0
- 0
based 0
synthetic 0
progestin 0
exerted 0
a 0
masculinizing 0
and/or 0
defeminizing 0
influence 0
on 0
human 0
behavioral 0
development 0
, 0
whereas 0
prenatal 0
exposure 0
to 0
natural 0
progesterone 0
and 0
progesterone 0
- 0
based 0
synthetic 0
progestin 0
had 0
a 0
feminizing 0
and/or 0
demasculinizing 0
influence 0
, 0
particularly 0
among 0
female 0
subjects 0
. 0

CONCLUSION 0
: 0
In 0
an 0
acute 0
canine 0
model 0
of 0
progressive 0
LCX 0
coronary 0
stenosis 0
, 0
CFR 0
was 0
impaired 0
in 0
both 0
ischemic 0
and 0
remote 0
nonischemic 0
regions 0
in 0
association 0
with 0
mild 0
to 0
moderate 0
ischemic 0
- 0
induced 0
regional 0
myocardial 0
dysfunction 0
. 0

Parathyroid B-gene
hormone I-gene
responses 0
of 0
cyclic 0
AMP 0
- 0
, 0
serum 0
- 0
and 0
phorbol 0
ester 0
- 0
responsive 0
reporter 0
genes 0
in 0
osteoblast 0
- 0
like 0
UMR 0
- 0
106 0
cells 0
. 0

Genome 0
timeline 0
. 0

The 0
`` 0
Ulm 0
Zucker 0
Uhr 0
System 0
'' 0
comprises 0
a 0
microdialysis 0
probe 0
, 0
a 0
biosensor 0
( 0
Glucosensor 0
Unitec 0
Ulm 0
s.c. 0
) 0
, 0
a 0
sender 0
transferring 0
telemetrically 0
the 0
glucose 0
concentrations 0
, 0
and 0
a 0
receiving 0
indicator 0
. 0

Previous 0
work 0
has 0
shown 0
that 0
glucose 0
repression 0
of 0
PRB1 B-gene
transcription 0
is 0
not 0
mediated 0
by 0
HXK2 B-gene
or 0
by 0
the 0
SNF1 B-gene
, 0
SNF4 B-gene
, 0
and 0
SNF6 B-gene
genes I-gene
( 0
C 0
. 0

The 0
cumulative 0
experience 0
in 0
liver 0
transplantation 0
since 0
the 0
introduction 0
of 0
cyclosporine 0
A 0
has 0
confirmed 0
its 0
efficacy 0
in 0
the 0
treatment 0
of 0
diverse 0
liver 0
diseases 0
in 0
children 0
and 0
adults 0
. 0

Our 0
objective 0
was 0
to 0
find 0
possible 0
predictors 0
for 0
the 0
expression 0
and 0
progression 0
of 0
LJM 0
and 0
to 0
evaluate 0
the 0
relationship 0
between 0
LJM 0
and 0
other 0
long 0
- 0
term 0
complications 0
of 0
insulin B-gene
- 0
dependent 0
diabetes 0
mellitus 0
. 0

To 0
test 0
this 0
hypothesis 0
, 0
we 0
developed 0
a 0
system 0
of 0
transient 0
transfection 0
of 0
rat 0
adipocytes 0
with 0
constructs 0
containing 0
glyceraldehyde B-gene
- I-gene
3 I-gene
- I-gene
phosphate I-gene
dehydrogenase I-gene
( 0
GAPDH B-gene
) 0
and 0
fatty B-gene
acid I-gene
synthetase I-gene
( 0
FAS B-gene
) 0
promoters 0
fused 0
to 0
gene B-gene
reporter I-gene
CAT I-gene
. 0

Comparison 0
of 0
this 0
gene 0
with 0
the 0
available 0
databases 0
reveals 0
very 0
significant 0
homology 0
to 0
the 0
ETS B-gene
factor I-gene
PE B-gene
- I-gene
1 I-gene
and 0
probable 0
near 0
- 0
identity 0
with 0
the 0
recently 0
cloned 0
factor 0
ERF B-gene
. 0

Eight 0
of 0
these 0
suppressors 0
for 0
into 0
two 0
complementation 0
groups 0
, 0
designated 0
KCS1 B-gene
and 0
KCS2 B-gene
. 0

Also 0
, 0
the 0
absence 0
of 0
PdNi 0
between 0
the 0
segments 0
reduces 0
the 0
heat 0
production 0
of 0
the 0
seed 0
. 0

Further 0
analysis 0
of 0
the 0
CAP59 B-gene
locus I-gene
of I-gene
Cryptococcus I-gene
neoformans I-gene
: 0
structure 0
defined 0
by 0
forced 0
expression 0
and 0
description 0
of 0
a 0
new 0
ribosomal B-gene
protein I-gene
- I-gene
encoding I-gene
gene I-gene
. 0

The 0
results 0
showed 0
a 0
significant 0
group 0
effect 0
only 0
on 0
the 0
active 0
task 0
. 0

Localization 0
of 0
the 0
porcine 0
enzyme 0
in 0
the 0
endoplasmic 0
reticulum 0
is 0
consistent 0
with 0
immuno 0
- 0
electron 0
- 0
microscopic 0
studies 0
using 0
pig 0
hepatocytes 0
. 0

These 0
larger 0
sizes 0
, 0
however 0
, 0
are 0
consistent 0
with 0
predictions 0
from 0
the 0
DNA 0
sequence 0
of 0
the 0
pol B-gene
gene I-gene
. 0

More 0
important 0
, 0
ligand 0
- 0
activated 0
insulin B-gene
and 0
IGF B-gene
- I-gene
I I-gene
receptors I-gene
phosphorylate 0
SHC B-gene
proteins I-gene
in 0
vitro 0
, 0
indicating 0
that 0
SHC B-gene
proteins I-gene
could 0
be 0
direct 0
substrates 0
for 0
insulin B-gene
and 0
IGF B-gene
- I-gene
I I-gene
receptors I-gene
. 0

International 0
efforts 0
are 0
now 0
being 0
made 0
to 0
standardize 0
haemolytic 0
test 0
conditions 0
and 0
the 0
present 0
study 0
is 0
meant 0
as 0
a 0
contribution 0
to 0
this 0
. 0

The 0
DFA 0
slide 0
prepared 0
from 0
the 0
ThinPrep 0
Test 0
and 0
the 0
conventional 0
DFA 0
sample 0
prepared 0
from 0
the 0
endocervical 0
swab 0
were 0
evaluated 0
independently 0
. 0

We 0
suggest 0
that 0
the 0
responses 0
to 0
types B-gene
I I-gene
and I-gene
II I-gene
collagen I-gene
were 0
caused 0
by 0
a 0
cross 0
- 0
reaction 0
with 0
type B-gene
III I-gene
collagen I-gene
peptides 0
. 0

The 0
nucleotide 0
sequence 0
of 0
the 0
estrogen B-gene
receptor I-gene
gene I-gene
of I-gene
Oreochromis I-gene
aureus I-gene
( 0
OaER B-gene
) 0
indicates 0
that 0
the 0
hormone 0
- 0
binding 0
E 0
domain 0
is 0
composed 0
of 0
4 0
exons 0
interspersed 0
by 0
short 0
introns 0
of 0
only 0
0.18 0
- 0
1.3 0
kb 0
each 0
. 0

To 0
test 0
for 0
progesterone B-gene
receptor I-gene
- 0
mediated 0
activation 0
of 0
transcription 0
in 0
yeast 0
, 0
reporter 0
plasmids 0
were 0
constructed 0
to 0
transform 0
yeast 0
cells 0
expressing 0
PRB B-gene
or 0
C1C2 B-gene
receptors I-gene
. 0

Beyond 0
the 0
first 0
year 0
post 0
- 0
renal 0
transplantation 0
there 0
was 0
no 0
difference 0
in 0
C 0
( 0
IO 0
) 0
between 0
LRD 0
and 0
CAD 0
allografts 0
. 0

TAF B-gene
- I-gene
1 I-gene
activates 0
transcription 0
constitutively 0
and 0
was 0
mapped 0
to 0
the 0
first 0
32 0
amino 0
acids 0
of 0
the 0
A 0
- 0
region 0
. 0

The 0
ventricular 0
demand 0
pacemaker 0
( 0
VVI 0
) 0
was 0
implanted 0
three 0
years 0
ago 0
and 0
because 0
of 0
further 0
impairment 0
of 0
cardiac 0
performance 0
an 0
av 0
- 0
sequential 0
pacemaker 0
( 0
DDD 0
) 0
was 0
used 0
to 0
restore 0
atrio 0
- 0
ventricular 0
synchronisation 0
. 0

In 0
the 0
present 0
study 0
we 0
found 0
that 0
CD34 B-gene
downregulation 0
during 0
hematopoiesis 0
occured 0
at 0
the 0
level 0
of 0
transcriptional 0
initiation 0
. 0

Following 0
replicate 0
control 0
measurements 0
, 0
test 0
ramps 0
were 0
repeated 0
in 0
the 0
presence 0
of 0
sodium 0
nitroprusside 0
( 0
1 0
microM 0
) 0
and 0
phentolamine 0
( 0
1 0
microM 0
) 0
to 0
eliminate 0
potential 0
smooth 0
muscle 0
and 0
alpha B-gene
1 I-gene
- I-gene
adrenoceptor I-gene
effects 0
, 0
respectively 0
. 0

Individual 0
and 0
combined 0
effects 0
of 0
fumonisin B-gene
B1 I-gene
present 0
in 0
Fusarium 0
moniliforme 0
culture 0
material 0
and 0
diacetoxyscirpenol 0
or 0
ochratoxin 0
A 0
in 0
turkey 0
poults 0
. 0

This 0
C 0
- 0
terminal 0
domain 0
contains 0
several 0
YxxI/L 0
motifs 0
reminiscent 0
of 0
LMP2A B-gene
and 0
a 0
putative 0
TRAF B-gene
binding I-gene
site I-gene
as 0
in 0
LMP1 B-gene
. 0

Possibilities 0
and 0
limints 0
of 0
immunofluorescence 0
in 0
the 0
laboratory 0
diagnosis 0
of 0
rabies 0

The 0
4 0
- 0
nt 0
sequence 0
of 0
the 0
rotavirus 0
3 0
' 0
TE 0
represents 0
by 0
far 0
the 0
shortest 0
of 0
any 0
of 0
the 0
sequence 0
enhancers 0
known 0
to 0
stimulate 0
translation 0
. 0

Muscle 0
and 0
liver 0
biopsies 0
demonstrated 0
the 0
same 0
anomalies 0
, 0
again 0
without 0
branching B-gene
enzyme I-gene
deficiency 0
in 0
the 0
liver 0
. 0

The 0
1031 B-gene
- I-gene
bp I-gene
wild I-gene
- I-gene
type I-gene
HIT1 I-gene
DNA I-gene
which 0
contained 0
an 0
open 0
reading 0
frame 0
encoding 0
a 0
protein 0
of 0
164 0
amino 0
acids 0
and 0
the 0
AGG B-gene
arginine I-gene
tRNA I-gene
gene I-gene
complemented 0
all 0
hit1 B-gene
- I-gene
1 I-gene
mutant I-gene
phenotypes I-gene
, 0
indicating 0
that 0
the 0
mutant 0
phenotypes 0
were 0
caused 0
by 0
the 0
deletion 0
of 0
these 0
genes 0
. 0

The 0
chicken 0
genome 0
contains 0
two 0
functional 0
nonallelic 0
beta1,4 B-gene
- I-gene
galactosyltransferase I-gene
genes I-gene
. 0

Human B-gene
CR2 I-gene
has 0
a 0
restricted 0
cellular 0
distribution 0
, 0
being 0
expressed 0
on 0
B 0
lymphocytes 0
, 0
dendritic 0
cells 0
of 0
the 0
spleen 0
, 0
pharyngeal 0
epithelial 0
cells 0
, 0
and 0
at 0
low 0
levels 0
on 0
some 0
T 0
lymphocytes 0
. 0

Heterotrimeric 0
guanine B-gene
nucleotide I-gene
- I-gene
binding I-gene
proteins I-gene
( 0
G B-gene
- I-gene
proteins I-gene
) 0
function 0
as 0
signal 0
transducers 0
for 0
a 0
variety 0
of 0
hormone 0
- 0
coupled 0
enzyme 0
and 0
ion 0
transport 0
systems 0
in 0
eukaryotic 0
cells 0
. 0

The 0
enzyme B-gene
ACC I-gene
oxidase I-gene
catalyses 0
the 0
last 0
step 0
of 0
ethylene 0
biosynthesis 0
in 0
plants 0
, 0
converting 0
1 0
- 0
aminocyclopropane 0
- 0
1 0
- 0
carboxylic 0
acid 0
( 0
ACC 0
) 0
to 0
ethylene 0
. 0

Virol 0
. 0

Mibefradil 0
( 0
Ro 0
40 0
- 0
5967 0
) 0
is 0
a 0
novel 0
nondihydropyridine 0
calcium 0
antagonist 0
. 0

We 0
have 0
used 0
the 0
chloramphenicol B-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
reporter 0
gene 0
system 0
to 0
study 0
the 0
effect 0
of 0
T B-gene
on 0
the 0
long 0
terminal 0
repeats 0
( 0
LTRs 0
) 0
of 0
a 0
large 0
family 0
of 0
human 0
endogenous 0
retrovirus 0
- 0
like 0
sequences 0
, 0
RTVL 0
- 0
H 0
. 0

They 0
contain 0
a 0
large 0
( 0
0.9 0
X 0
10 0
( 0
3 0
) 0
to 0
1.88 0
X 0
10 0
( 0
3 0
) 0
base 0
- 0
pairs 0
) 0
intron 0
in 0
the 0
middle 0
of 0
the 0
gene 0
and 0
are 0
further 0
interrupted 0
close 0
to 0
the 0
5 0
' 0
end 0
of 0
the 0
gene 0
. 0

The 0
recombinant 0
containing 0
the 0
full 0
- 0
length 0
polyhedrin B-gene
leader 0
sequence 0
gave 0
levels 0
of 0
N B-gene
mRNA I-gene
comparable 0
to 0
those 0
of 0
AcNPV B-gene
polyhedrin I-gene
mRNA I-gene
. 0

Long 0
- 0
term 0
results 0
and 0
curative 0
mechanisms 0
of 0
vesicoureteral 0
reflux 0
by 0
endoscopic 0
injection 0
of 0
blood 0
. 0

Primer 0
extension 0
experiments 0
using 0
dbcAMP 0
- 0
differentiated 0
U937 0
RNA 0
indicated 0
a 0
single 0
transcriptional 0
initiation 0
site 0
. 0

Sequences 0
within 0
and 0
flanking 0
hypersensitive 0
sites 0
3 0
and 0
2 0
of 0
the 0
beta B-gene
- I-gene
globin I-gene
locus 0
control 0
region 0
required 0
for 0
synergistic 0
versus 0
additive 0
interaction 0
with 0
the 0
epsilon B-gene
- I-gene
globin I-gene
gene I-gene
promoter I-gene
. 0

Four 0
of 0
12 0
patients 0
( 0
33 0
% 0
) 0
were 0
initially 0
diagnosed 0
as 0
having 0
a 0
benign 0
disease 0
( 0
false 0
- 0
negatives 0
) 0
. 0

The 0
mean 0
was 0
66 0
cells/mm2 0
in 0
the 0
laser 0
group 0
and 0
63.7 0
cells/mm2 0
in 0
the 0
control 0
group 0
. 0

Using 0
reporter 0
gene 0
constructs 0
driven 0
by 0
the 0
CD4 B-gene
promoter I-gene
, 0
we 0
report 0
that 0
HHV 0
- 0
6 0
can 0
efficiently 0
transactivate 0
such 0
genetic 0
elements 0
. 0

Through 0
genomic 0
library 0
screening 0
and 0
PCR 0
- 0
based 0
genomic 0
walking 0
we 0
have 0
now 0
cloned 0
the 0
mouse B-gene
E I-gene
- I-gene
Tmod I-gene
gene I-gene
, 0
whose 0
coding 0
region 0
spans 0
approximately 0
60kb 0
containing 0
nine 0
exons 0
and 0
eight 0
introns 0
. 0

On 0
a 0
variety 0
of 0
fronts 0
, 0
chronic 0
bacterial 0
infection 0
is 0
being 0
found 0
to 0
be 0
significantly 0
associated 0
with 0
the 0
development 0
of 0
atherosclerosis 0
and 0
the 0
clinical 0
complications 0
of 0
unstable 0
angina 0
, 0
myocardial 0
infarction 0
, 0
and 0
stroke 0
. 0

Cost 0
analysis 0
and 0
the 0
HSA 0
: 0
a 0
framework 0
. 0

Removal 0
of 0
ink4a B-gene
dramatically 0
reduces 0
the 0
lymphoid 0
and 0
neurological 0
defects 0
seen 0
in 0
bmi B-gene
- I-gene
1 I-gene
- 0
deficient 0
mice 0
, 0
indicating 0
that 0
ink4a B-gene
is 0
a 0
critical 0
in 0
vivo 0
target 0
for 0
Bmi B-gene
- I-gene
1 I-gene
. 0

In 0
fifty 0
non 0
selected 0
ductal 0
carcinomas 0
of 0
the 0
breast 0
we 0
found 0
that 0
a 0
marked 0
tumoral 0
inflammatory 0
infiltrate 0
( 0
P 0
less 0
than 0
0.025 0
) 0
, 0
perinodal 0
tumoral 0
infiltrate 0
( 0
P 0
less 0
than 0
0.01 0
) 0
, 0
sinus 0
catarrh 0
( 0
P 0
less 0
than 0
0.05 0
) 0
, 0
follicular 0
hyperplasia 0
( 0
P 0
less 0
than 0
0.025 0
) 0
, 0
mixed 0
pattern 0
in 0
lymph 0
nodes 0
( 0
P 0
less 0
than 0
0.01 0
) 0
and 0
with 0
54 0
years 0
of 0
age 0
or 0
younger 0
( 0
P 0
less 0
than 0
0.01 0
) 0
correlated 0
significantly 0
with 0
lymph 0
node 0
metastases 0
and/or 0
high 0
histologic 0
grade 0
. 0

The 0
herpesvirus B-gene
entry I-gene
mediator I-gene
C I-gene
( 0
HveC B-gene
) 0
, 0
previously 0
known 0
as 0
poliovirus B-gene
receptor I-gene
- I-gene
related I-gene
protein I-gene
1 I-gene
( 0
PRR1 B-gene
) 0
, 0
and 0
the 0
herpesvirus B-gene
Ig I-gene
- I-gene
like I-gene
receptor I-gene
( 0
HIgR B-gene
) 0
are 0
the 0
bona 0
fide 0
receptors 0
employed 0
by 0
herpes 0
simplex 0
virus 0
- 0
1 0
and 0
- 0
2 0
( 0
HSV 0
- 0
1 0
and 0
- 0
2 0
) 0
for 0
entry 0
into 0
the 0
human 0
cell 0
lines 0
most 0
frequently 0
used 0
in 0
HSV 0
studies 0
. 0

Spinal 0
injuries 0
in 0
a 0
multiple 0
trauma 0
patient 0
. 0

Creatinine 0
and 0
creatine B-gene
phosphokinase I-gene
( 0
CPK B-gene
) 0
. 0

The 0
glyoxysomal 0
and 0
plastid 0
molecular 0
chaperones 0
( 0
70 B-gene
- I-gene
kDa I-gene
heat I-gene
shock I-gene
protein I-gene
) 0
of 0
watermelon 0
cotyledons 0
are 0
encoded 0
by 0
a 0
single 0
gene 0
. 0

Thus 0
, 0
cross 0
- 0
resistance 0
between 0
fluoroquinolones 0
was 0
shown 0
for 0
both 0
enterococci 0
and 0
MRSA 0
. 0

Furthermore 0
we 0
elucidate 0
the 0
subtle 0
highly 0
anisotropic 0
interchain 0
correlations 0
and 0
reveal 0
the 0
detailed 0
atomic 0
structure 0
of 0
the 0
low 0
- 0
temperature 0
( 0
8x2 0
) 0
phase 0
. 0

025 0
) 0
. 0

With 0
stimulation 0
beyond 0
the 0
theta 0
- 0
range 0
three 0
phenomena 0
occurred 0
: 0
shift 0
of 0
the 0
burst 0
frequencies 0
to 0
higher 0
or 0
lower 0
harmonics 0
of 0
stimulation 0
frequencies 0
; 0
complex 0
interactions 0
of 0
basic 0
background 0
frequency 0
with 0
rhythm 0
of 0
stimulation 0
( 0
`` 0
beating 0
'' 0
) 0
; 0
return 0
to 0
background 0
theta 0
- 0
burst 0
frequency 0
in 0
spite 0
of 0
continuing 0
stimulation 0
( 0
`` 0
escape 0
'' 0
) 0
. 0

Incorporation 0
of 0
this 0
information 0
in 0
the 0
data 0
brought 0
about 0
a 0
revised 0
five 0
- 0
year 0
survival 0
estimate 0
of 0
55 0
percent 0
. 0

Using 0
a 0
dominant 0
negative 0
form 0
of 0
Sp3 B-gene
and 0
transcriptional 0
activation 0
assays 0
in 0
Schneider 0
SL 0
- 0
2 0
insect 0
cells 0
, 0
it 0
was 0
confirmed 0
that 0
ERalpha B-gene
- 0
Sp3 B-gene
interactions 0
define 0
a 0
pathway 0
for 0
E2 B-gene
- 0
mediated 0
inhibition 0
of 0
gene 0
expression 0
, 0
and 0
this 0
represents 0
a 0
new 0
mechanism 0
for 0
decreased 0
gene 0
expression 0
by 0
E2 B-gene
. 0

While 0
these 0
could 0
be 0
unusual 0
cases 0
of 0
chronic 0
non 0
- 0
A 0
, 0
non 0
- 0
B 0
hepatitis 0
, 0
this 0
can 0
be 0
only 0
speculation 0
until 0
a 0
serologic 0
test 0
for 0
non 0
- 0
A 0
, 0
non 0
- 0
B 0
hepatitis 0
becomes 0
available 0
. 0

Our 0
previous 0
studies 0
demonstrated 0
that 0
the 0
promyelocytic 0
leukemia 0
gene 0
, 0
PML B-gene
which 0
involved 0
in 0
the 0
15 0
; 0
17 0
translocation 0
in 0
acute 0
promyelocytic 0
leukemia 0
( 0
APL 0
) 0
is 0
a 0
growth 0
and 0
transformation 0
suppressor 0
. 0

These 0
characteristics 0
add 0
to 0
the 0
suitability 0
of 0
NM441 0
as 0
an 0
effective 0
prodrug 0
of 0
NM394 0
. 0

Sequence 0
analysis 0
of 0
cDNA 0
clones 0
encoding 0
human 0
gamma 0
revealed 0
an 0
open 0
reading 0
frame 0
predicting 0
a 0
protein 0
of 0
299 0
amino 0
acids 0
( 0
approximately 0
32 0
kDa 0
) 0
, 0
half 0
the 0
size 0
of 0
the 0
bovine 0
gamma 0
subunit 0
. 0

DISCUSSION 0
: 0
The 0
higher 0
absolute 0
knee 0
extension 0
strength 0
measures 0
of 0
leg 0
and 0
the 0
similar 0
extension 0
strength 0
of 0
the 0
trunk 0
in 0
the 0
obese 0
sample 0
compared 0
to 0
the 0
lean 0
might 0
be 0
explained 0
by 0
the 0
training 0
effect 0
of 0
weight 0
bearing 0
and 0
support 0
of 0
a 0
larger 0
body 0
mass 0
. 0

Measuring 0
the 0
dim 0
light 0
melatonin 0
onset 0
( 0
DLMO 0
) 0
is 0
a 0
useful 0
and 0
practical 0
way 0
to 0
assess 0
circadian 0
phase 0
position 0
in 0
humans 0
. 0

Although 0
the 0
energy 0
- 0
based 0
DFT 0
was 0
not 0
affected 0
by 0
isoproterenol 0
( 0
from 0
6.1 0
+/ 0
- 0
1.5 0
to 0
6.0 0
+/ 0
- 0
1.7 0
J 0
) 0
, 0
it 0
was 0
decreased 0
to 0
3.7 0
+/ 0
- 0
1.6 0
J 0
in 0
the 0
third 0
stage 0
by 0
infusion 0
of 0
E4031 0
and 0
isoproterenol 0
( 0
p 0
< 0
0.01 0
vs. 0
baseline 0
and 0
vs. 0
isoproterenol 0
) 0
. 0

This 0
communication 0
presents 0
two 0
patients 0
with 0
clinically 0
massive 0
PE 0
of 0
recent 0
onset 0
( 0
confirmed 0
by 0
lung 0
perfusion 0
scans 0
) 0
who 0
were 0
successfully 0
treated 0
with 0
a 0
single 0
i.v 0
. 0
dose 0
of 0
30 0
mg 0
of 0
anisoylated B-gene
lys I-gene
- I-gene
plasminogen I-gene
streptokinase I-gene
activator I-gene
complex I-gene
( 0
APSAC B-gene
, 0
comparable 0
to 0
1,500,000 0
U 0
of 0
streptokinase B-gene
) 0
followed 0
by 0
systemic 0
heparinization 0
for 0
7 0
days 0
. 0

Capillary 0
tortuosity 0
was 0
a 0
function 0
of 0
sarcomere 0
length 0
in 0
all 0
animals 0
and 0
this 0
relationship 0
was 0
not 0
changed 0
by 0
hypoxia 0
. 0

A 0
survey 0
of 0
children 0
with 0
HBsAg B-gene
markers I-gene
related 0
to 0
their 0
parents 0
HBV 0
markers 0
. 0

In 0
cases 0
of 0
intracapsular 0
prostatic 0
cancer 0
the 0
level 0
of 0
prostatic B-gene
acid I-gene
phosphatase I-gene
( 0
PAP B-gene
) 0
measured 0
by 0
radioimmunoassay 0
was 0
1.4 0
+/ 0
- 0
0.8 0
micrograms/l 0
. 0

Rv 0
was 0
7.7 0
+/ 0
- 0
1.4 0
mmHg.ml 0
- 0
1.min.100 0
g 0
- 0
1 0
and 0
Cv 0
was 0
0.59 0
+/ 0
- 0
0.25 0
ml/mmHg 0
, 0
tau 0
v 0
calculated 0
from 0
the 0
product 0
of 0
Rv 0
and 0
Cv 0
was 0
4.20 0
+/ 0
- 0
1.58 0
s 0
and 0
from 0
the 0
ratio 0
of 0
delta 0
V 0
to 0
delta 0
Q 0
was 0
4.95 0
+/ 0
- 0
1.53 0
s 0
( 0
P 0
= 0
NS 0
) 0
at 0
a 0
mean 0
Pel 0
of 0
17.6 0
+/ 0
- 0
3.7 0
mmHg 0
. 0
delta 0
V 0
was 0
also 0
produced 0
by 0
changing 0
Pv 0
; 0
the 0
average 0
tau 0
v 0
( 0
1.95 0
+/ 0
- 0
0.37 0
s 0
) 0
, 0
was 0
shorter 0
than 0
that 0
with 0
changes 0
in 0
flow 0
. 0

Peripheral 0
neuropathy 0
in 0
the 0
cherry 0
- 0
red 0
spot 0
- 0
myoclonus 0
syndrome 0
( 0
sialidosis 0
type 0
I 0
) 0
. 0

The 0
meaning 0
of 0
hope 0
in 0
health 0
and 0
illness 0
. 0

For 0
O3 0
, 0
the 0
correlation 0
between 0
personal 0
exposures 0
and 0
ambient 0
levels 0
was 0
weakest 0
in 0
the 0
winter 0
for 0
residential 0
microenvironments 0
( 0
rs 0
= 0
0.05 0
, 0
p 0
> 0
0.05 0
) 0
, 0
and 0
was 0
strongest 0
in 0
the 0
summer 0
for 0
outdoor 0
near 0
- 0
roadway 0
microenvironments 0
( 0
rs 0
= 0
0.91 0
, 0
p 0
< 0
0.05 0
) 0
. 0

The 0
myb B-gene
proto I-gene
oncogene I-gene
product I-gene
( 0
c B-gene
- I-gene
Myb I-gene
) 0
is 0
a 0
transcriptional 0
regulator 0
and 0
its 0
expression 0
and 0
function 0
are 0
tightly 0
linked 0
to 0
the 0
cellular 0
entry 0
into 0
S 0
phase 0
and 0
DNA 0
synthesis 0
. 0

However 0
, 0
and 0
in 0
contrast 0
to 0
other 0
MMP B-gene
genes I-gene
, 0
no 0
significative 0
synergistic 0
effect 0
on 0
CAT B-gene
activity 0
between 0
the 0
AP B-gene
- I-gene
1 I-gene
and 0
PEA B-gene
- I-gene
3 I-gene
elements I-gene
found 0
in 0
the 0
collagenase B-gene
- I-gene
3 I-gene
gene I-gene
promoter I-gene
was 0
found 0
. 0

CONCLUSIONS 0
: 0
The 0
number 0
of 0
Spanish 0
articles 0
published 0
in 0
Anesthesiology 0
, 0
BJA 0
, 0
and 0
Anesth 0
Analg 0
is 0
low 0
, 0
although 0
the 0
comparison 0
of 0
our 0
productivity 0
with 0
that 0
of 0
other 0
EU 0
countries 0
in 0
function 0
of 0
GNPpc 0
places 0
us 0
in 0
an 0
intermediate 0
position 0
. 0

This 0
fragment 0
contains 0
two 0
complete 0
endo B-gene
- I-gene
beta I-gene
- I-gene
1,4 I-gene
- I-gene
glucanase I-gene
- I-gene
encoding I-gene
genes I-gene
, 0
designated 0
celCCC B-gene
and 0
celCCG B-gene
. 0

The 0
`` 0
Gregg 0
phenomenon 0
'' 0
implies 0
that 0
myocardial 0
function 0
and 0
oxygen 0
consumption 0
( 0
MVO2 0
) 0
increase 0
when 0
coronary 0
perfusion 0
is 0
enhanced 0
within 0
or 0
above 0
the 0
autoregulatory 0
range 0
. 0

Pollinosis 0
in 0
the 0
U.A.R 0
. 0

The 0
use 0
of 0
sigma B-gene
54 I-gene
promoters I-gene
, 0
known 0
to 0
require 0
cognate 0
binding 0
proteins 0
, 0
could 0
allow 0
the 0
fine 0
- 0
tuning 0
that 0
provides 0
the 0
temporal 0
ordering 0
of 0
flagellar 0
gene 0
transcription 0
. 0

Over 0
a 0
period 0
of 0
five 0
training 0
sessions 0
( 0
2.5 0
days 0
) 0
, 0
the 0
animals 0
learned 0
not 0
to 0
breathe 0
, 0
and 0
the 0
number 0
of 0
stimuli 0
received 0
in 0
the 0
fifth 0
session 0
was 0
significantly 0
lower 0
than 0
in 0
the 0
first 0
session 0
. 0

The 0
genes 0
on 0
each 0
chromosome 0
involved 0
in 0
this 0
translocation 0
have 0
been 0
identified 0
as 0
the 0
transcription 0
factor 0
- 0
encoding 0
genes 0
PAX3 B-gene
and 0
FKHR B-gene
. 0

We 0
found 0
that 0
the 0
PRP20 B-gene
gene I-gene
is 0
identical 0
to 0
the 0
yeast B-gene
SRM1 I-gene
gene I-gene
( 0
Clark 0
and 0
Sprague 0
1989 0
) 0
. 0

Transcriptional 0
activation 0
of 0
the 0
proopiomelanocortin B-gene
gene I-gene
by 0
cyclic B-gene
AMP I-gene
- I-gene
responsive I-gene
element I-gene
binding I-gene
protein I-gene
. 0

Recombinant B-gene
Human I-gene
Erythropoietin I-gene
and 0
Platinum 0
- 0
Based 0
Chemotherapy 0
In 0
Advanced 0
Ovarian 0
Cancer 0

After 0
discharge 0
, 0
he 0
was 0
finally 0
given 0
a 0
diagnosis 0
of 0
PCH 0
because 0
a 0
Donath 0
- 0
Landsteiner 0
test 0
was 0
positive 0
. 0

Human 0
forearm 0
was 0
used 0
as 0
a 0
dummy 0
ear 0
and 0
the 0
electrode 0
HN 0
- 0
5 0
was 0
fixed 0
thereon 0
, 0
and 0
a 0
sound 0
stimulus 0
of 0
90dBnHL 0
was 0
delivered 0
by 0
the 0
earphone 0
( 0
NC 0
- 0
3 0
) 0
. 0

Neonatal 0
hyperthyroidism 0

We 0
found 0
that 0
the 0
frequency 0
spectrum 0
of 0
physiologic 0
chest 0
sounds 0
is 0
contained 0
entirely 0
within 0
that 0
of 0
jet 0
rotocraft 0
noise 0
. 0

However 0
, 0
their 0
stability 0
was 0
low 0
as 0
already 0
reported 0
for 0
the 0
ARS 0
in 0
S. 0
occidentalis 0
. 0

When 0
gene 0
conversion 0
is 0
initiated 0
by 0
a 0
double 0
- 0
strand 0
break 0
( 0
DSB 0
) 0
, 0
any 0
nonhomologous 0
DNA 0
that 0
may 0
be 0
present 0
at 0
the 0
ends 0
must 0
be 0
removed 0
before 0
new 0
DNA 0
synthesis 0
can 0
be 0
initiated 0
. 0

MRI 0
visualization 0
of 0
proteoglycan 0
depletion 0
in 0
articular 0
cartilage 0
via 0
intravenous 0
administration 0
of 0
Gd 0
- 0
DTPA 0
. 0

Furthermore 0
, 0
the 0
GC 0
- 0
rich 0
sequences 0
could 0
confer 0
Sp1 B-gene
- 0
dependent 0
transactivation 0
to 0
a 0
heterologous 0
prolactin B-gene
minimal I-gene
promoter I-gene
. 0

Neuronal 0
activity 0
of 0
58 0
dopaminergic 0
( 0
DA 0
) 0
and 0
200 0
non 0
- 0
dopaminergic 0
( 0
non 0
- 0
DA 0
) 0
neurons 0
in 0
the 0
ventral 0
tegmental 0
area 0
( 0
VTA 0
) 0
of 0
female 0
monkeys 0
was 0
recorded 0
, 0
and 0
correlation 0
to 0
bar 0
press 0
feeding 0
, 0
sensory 0
stimulation 0
and 0
change 0
in 0
motivation 0
was 0
investigated 0
. 0

Serum 0
prolactin B-gene
rapidly 0
decreased 0
after 0
institution 0
of 0
treatment 0
, 0
with 0
actual 0
normalization 0
( 0
less 0
than 0
20 0
ng/ml 0
) 0
by 0
the 0
3rd 0
month 0
. 0

It 0
is 0
required 0
for 0
correct 0
expression 0
of 0
both 0
genes 0
. 0

Cloning 0
the 0
cDNA 0
for 0
a 0
new 0
human B-gene
zinc I-gene
finger I-gene
protein I-gene
defines 0
a 0
group 0
of 0
closely 0
related 0
Kruppel B-gene
- I-gene
like I-gene
transcription I-gene
factors I-gene
. 0

Recently 0
, 0
we 0
and 0
other 0
laboratories 0
have 0
identified 0
a 0
family 0
of 0
caveolin B-gene
- I-gene
related I-gene
proteins I-gene
; 0
caveolin B-gene
has 0
been 0
re 0
- 0
termed 0
caveolin B-gene
- I-gene
1 I-gene
. 0

Six 0
cDNAs 0
represent 0
human 0
homologs 0
of 0
genes 0
known 0
in 0
other 0
species 0
, 0
namely 0
, 0
mouse B-gene
HSPE71 I-gene
, 0
Rat B-gene
RhoGAP I-gene
protein I-gene
, 0
S B-gene
cerevisiae I-gene
leucyl I-gene
tRNA I-gene
synthetase I-gene
and 0
S B-gene
cerevisiae I-gene
chromosome I-gene
II I-gene
ORF I-gene
YBLO44W I-gene
. 0

Three 0
high 0
- 0
amylose 0
rice 0
varieties 0
, 0
IR42 0
, 0
IR36 0
, 0
and 0
IR62 0
, 0
with 0
similar 0
chemical 0
composition 0
including 0
amylose 0
content 0
( 0
26.7 0
- 0
27.0 0
% 0
) 0
, 0
were 0
cooked 0
under 0
the 0
same 0
conditions 0
and 0
tested 0
for 0
in 0
vitro 0
digestibility 0
as 0
well 0
as 0
blood 0
glucose 0
and 0
insulin B-gene
responses 0
in 0
healthy 0
human 0
volunteers 0
. 0

The 0
hepatic 0
isoform 0
of 0
6 B-gene
- I-gene
phosphofructo I-gene
- I-gene
2 I-gene
- I-gene
kinase/fructose I-gene
kinase/fructose I-gene
- I-gene
2,6 I-gene
- I-gene
bisphosphatase I-gene
( 0
PF2K/Fru B-gene
PF2K/Fru I-gene
- I-gene
2,6 I-gene
- I-gene
BPase I-gene
) 0
is 0
transcriptionally 0
stimulated 0
by 0
glucocorticoids 0
, 0
whereas 0
insulin B-gene
blocks 0
this 0
stimulatory 0
effect 0
. 0

I 0
. 0

Such 0
simple 0
injuries 0
may 0
however 0
be 0
accompanied 0
by 0
far 0
reaching 0
consequences 0
. 0

The 0
132 B-gene
- I-gene
bp I-gene
PHO8p I-gene
fragment I-gene
, 0
connected 0
at 0
position 0
- 0
281 0
of 0
the 0
5 0
' 0
upstream 0
region 0
of 0
a 0
HIS5' B-gene
- 0
'lacZ B-gene
fused 0
gene 0
, 0
could 0
sense 0
Pi 0
signals 0
in 0
vivo 0
, 0
but 0
a 0
20 0
- 0
bp 0
synthetic 0
oligonucleotide 0
having 0
the 0
same 0
sequence 0
from 0
- 0
544 0
to 0
- 0
525 0
of 0
the 0
PHO8p B-gene
DNA I-gene
could 0
not 0
. 0

Antibiotic 0
prophylaxis 0
in 0
a 0
surgical 0
setting 0

In 0
resume 0
response 0
to 0
treatment 0
with 0
usual 0
regimens 0
, 0
doxycycline 0
plus 0
streptomycin 0
of 0
doxycycline 0
rifampicin 0
is 0
good 0
, 0
being 0
however 0
time 0
elapsed 0
until 0
pain 0
ceases 0
of 0
mean 0
length 0
in 0
hospital 0
stay 0
shorter 0
in 0
the 0
group 0
receiving 0
doxycycline 0
plus 0
streptomycin 0
. 0

This 0
indicates 0
changes 0
in 0
postvaccination 0
allergy 0
to 0
BCG 0
. 0

Having 0
demonstrated 0
proper 0
localization 0
of 0
GFP B-gene
- 0
calmodulin B-gene
in 0
budding 0
yeast 0
, 0
we 0
examined 0
the 0
localization 0
of 0
a 0
fusion 0
between 0
GFP B-gene
and 0
calmodulin B-gene
( 0
GFP B-gene
- I-gene
Camlp I-gene
) 0
in 0
fission 0
yeast 0
, 0
where 0
calmodulin B-gene
had 0
not 0
been 0
localized 0
by 0
any 0
method 0
. 0

The 0
most 0
common 0
hosts 0
were 0
equines 0
( 0
31 0
% 0
) 0
, 0
bovines 0
( 0
25 0
% 0
) 0
and 0
raccoons 0
( 0
19 0
% 0
) 0
. 0

Between 0
the 0
RNA 0
initiation 0
site 0
and 0
the 0
coding 0
region 0
is 0
a 0
GC 0
- 0
rich 0
hairpin 0
structure 0
followed 0
by 0
8 0
T 0
residues 0
that 0
looks 0
like 0
a 0
rho B-gene
- I-gene
independent I-gene
transcription I-gene
terminator I-gene
. 0

In 0
the 0
conscious 0
animals 0
the 0
increase 0
reached 0
statistical 0
significance 0
when 0
the 0
animals 0
were 0
exposed 0
to 0
12 0
% 0
oxygen 0
in 0
nitrogen 0
, 0
which 0
produced 0
a 0
fall 0
in 0
arterial 0
PaO2 0
of 0
44.7 0
+/ 0
- 0
5.0 0
% 0
. 0

Fourteen 0
eyes 0
( 0
38.9 0
% 0
) 0
developed 0
DLK 0
after 0
an 0
epithelial 0
defect 0
, 0
representing 0
an 0
odds 0
ratio 0
of 0
13 0
times 0
. 0

Each 0
subject 0
was 0
injected 0
in 0
the 0
antecubital 0
vein 0
with 0
7 0
mg/kg 0
of 0
sodium 0
fluorescein 0
( 0
25 0
% 0
solution 0
) 0
and 0
measurements 0
were 0
taken 0
1 0
hr 0
postinjection 0
at 0
4.5 0
mm 0
and 0
7.5 0
mm 0
from 0
the 0
retina 0
. 0

Such 0
tetranucleotides 0
are 0
common 0
in 0
promoter 0
regions 0
, 0
particularly 0
in 0
activating B-gene
transcription I-gene
factor/cyclic I-gene
factor/cyclic I-gene
AMP I-gene
response I-gene
element I-gene
- I-gene
binding I-gene
protein I-gene
( 0
ATF/CREB B-gene
) 0
and 0
E 0
- 0
box 0
motifs 0
, 0
suggesting 0
that 0
ATF/CREB I-gene

The 0
long 0
terminal 0
repeat 0
is 0
590 0
bp 0
in 0
length 0
, 0
with 0
the 0
U3 0
region 0
containing 0
consensus 0
sequences 0
likely 0
to 0
be 0
involved 0
in 0
viral 0
gene 0
expression 0
. 0

A 0
pathogenetic 0
relation 0
with 0
the 0
Eisenmenger 0
's 0
syndrome 0
is 0
discussed 0
. 0

Twenty 0
- 0
six 0
calves 0
were 0
subjected 0
to 0
a 0
technique 0
of 0
cryoablation 0
in 0
order 0
to 0
establish 0
an 0
animal 0
model 0
of 0
complete 0
cardiac 0
denervation 0
. 0

The 0
PHO5 B-gene
gene I-gene
is 0
activated 0
by 0
the 0
Pho4p B-gene
transcription I-gene
factor I-gene
, 0
which 0
itself 0
is 0
negatively 0
regulated 0
through 0
phosphorylation 0
by 0
the 0
products 0
of 0
PHO80 B-gene
and 0
PHO85 B-gene
. 0

CNS 0
preventive 0
treatment 0
without 0
cranial 0
irradiation 0
was 0
effective 0
in 0
all 0
the 0
groups 0
of 0
ALL 0
patients 0
. 0

This 0
deletion 0
disrupts 0
the 0
PU.1 B-gene
Ets B-gene
domain I-gene
. 0

Basal 0
urinary 0
17 0
- 0
hydroxycorticoid 0
( 0
17 0
- 0
OHCS 0
) 0
values 0
were 0
elevated 0
in 0
9/12 0
patients 0
and 0
low 0
dose 0
dexamethasone 0
suppression 0
test 0
favoured 0
Cushing 0
's 0
syndrome 0
in 0
8/9 0
patients 0
. 0

In 0
this 0
cross 0
- 0
over 0
controlled 0
study 0
, 0
five 0
male 0
volunteers 0
donated 0
one 0
unit 0
of 0
red 0
cells 0
by 0
MCS 0
and 0
one 0
unit 0
of 0
whole 0
blood 0
by 0
the 0
conventional 0
manual 0
method 0
, 0
3 0
months 0
apart 0
. 0

The 0
derepressed 0
expression 0
of 0
fixN B-gene
was 0
not 0
observed 0
in 0
a 0
purH B-gene
mutant I-gene
. 0

The 0
lipopolysaccharide 0
- 0
binding 0
protein 0
is 0
a 0
secretory B-gene
class I-gene
1 I-gene
acute I-gene
- I-gene
phase I-gene
protein I-gene
whose 0
gene 0
is 0
transcriptionally 0
activated 0
by 0
APRF/STAT/3 B-gene
and 0
other 0
cytokine 0
- 0
inducible 0
nuclear 0
proteins 0
. 0

D 0
. 0

Acute 0
renal 0
vein 0
thrombosis 0
in 0
renal 0
allografts 0
: 0
detection 0
with 0
duplex 0
Doppler 0
US 0
. 0

Thus 0
, 0
Shp2 B-gene
regulates 0
phosphotyrosine 0
- 0
signalling 0
events 0
during 0
the 0
complex 0
ectodermal 0
- 0
mesenchymal 0
interactions 0
that 0
regulate 0
mammalian 0
budding 0
morphogenesis 0
. 0

1 0
. 0

In 0
conclusion 0
, 0
in 0
coronary 0
artery 0
disease 0
patients 0
, 0
exercise 0
- 0
redistribution 0
201Thallium 0
cardiac 0
imaging 0
with 0
reinjection 0
at 0
rest 0
can 0
identify 0
severely 0
ischemic 0
but 0
still 0
viable 0
myocardium 0
and 0
may 0
be 0
particularly 0
useful 0
in 0
the 0
prognosis 0
of 0
such 0
patients 0
. 0

To 0
this 0
effect 0
, 0
the 0
present 0
survey 0
puts 0
in 0
evidence 0
that 0
the 0
maximum 0
delay 0
of 0
stream 0
that 0
guarantees 0
the 0
good 0
dimensional 0
stability 0
of 0
these 0
class 0
A 0
alginates 0
is 0
of 0
45 0
minutes 0
in 0
the 0
hot 0
and 0
humid 0
climatic 0
tropical 0
country 0
conditions 0
. 0

1995 0
. 0

The 0
term 0
Kartagener 0
syndrome 0
applies 0
to 0
this 0
syndrome 0
when 0
accompanied 0
by 0
infertility 0
and 0
dextrocardia 0
or 0
situs 0
inversus 0
. 0

Although 0
immunoglobulin B-gene
and 0
CRP B-gene
concentration 0
increased 0
, 0
anemia 0
obviously 0
improved 0
with 0
hemoglobin B-gene
levels 0
increasing 0
from 0
4.8 0
g/dl 0
to 0
8.5 0
g/dl 0
without 0
any 0
side 0
effects 0
. 0

These 0
data 0
also 0
demonstrate 0
that 0
insulin B-gene
and 0
TPA 0
activate 0
MBP/MAP2 B-gene
kinase 0
activity 0
by 0
de 0
novo 0
phosphorylation 0
of 0
threonine 0
and 0
tyrosine 0
residues 0
via 0
a 0
very 0
similar 0
pathway 0
. 0

100 0
and 0
51 0
p 0
. 0

As 0
regards 0
the 0
short 0
stature 0
, 0
they 0
have 0
proved 0
that 0
the 0
syndrome 0
is 0
related 0
to 0
low 0
levels 0
of 0
somatomedin B-gene
C I-gene
( 0
SmC B-gene
) 0
. 0

The 0
results 0
obtained 0
with 0
[ B-gene
F304 I-gene
] I-gene
R2 I-gene
indicate 0
that 0
structural 0
changes 0
in 0
E. B-gene
coli I-gene
R2 I-gene
in 0
the 0
vicinity 0
of 0
this 0
helix 0
distortion 0
can 0
influence 0
the 0
catalytic 0
activity 0
of 0
the 0
holoenzyme 0
. 0

This 0
result 0
is 0
consistent 0
with 0
the 0
previous 0
observation 0
that 0
expression 0
of 0
the 0
hsp70 B-gene
genes I-gene
in I-gene
T. I-gene
brucei I-gene
is 0
mainly 0
controlled 0
at 0
the 0
posttranscriptional 0
level 0
. 0

The 0
cloned 0
rRNA 0
operon 0
was 0
transcribed 0
in 0
vitro 0
by 0
using 0
purified B-gene
RNA I-gene
polymerase I-gene
of I-gene
Escherichia I-gene
coli I-gene
. 0

To 0
test 0
whether 0
Cd 0
exposure 0
would 0
increase 0
Ca 0
release 0
from 0
bone 0
during 0
pregnancy 0
and 0
lactation 0
in 0
relation 0
to 0
the 0
etiological 0
mechanism 0
of 0
Itai 0
- 0
Itai 0
disease 0
, 0
virgin 0
female 0
mice 0
with 0
45Ca 0
prelabeled 0
skeletons 0
( 0
15 0
microCi/mouse 0
) 0
were 0
subjected 0
to 0
one 0
round 0
of 0
pregnancy/lactation 0
and 0
were 0
exposed 0
to 0
a 0
Ca 0
- 0
deficient 0
diet 0
containing 0
0 0
, 0
5 0
, 0
or 0
25 0
ppm 0
Cd 0
or 0
25 0
ppm 0
Pb 0
for 0
32 0
days 0
, 0
from 0
conception 0
until 0
Lactation 0
Day 0
14 0
. 0

G B-gene
- I-gene
box I-gene
binding I-gene
factors I-gene
( 0
GBFs B-gene
) 0
constitute 0
a 0
family 0
of 0
plant 0
DNA 0
- 0
binding 0
proteins 0
that 0
bind 0
to 0
the 0
G 0
- 0
box 0
motif 0
, 0
a 0
regulatory 0
cis 0
element 0
present 0
in 0
many 0
plant 0
genes 0
with 0
a 0
palindromic 0
DNA 0
motif 0
of 0
CACGTG 0
. 0

The 0
ferric B-gene
uptake I-gene
regulation I-gene
( 0
fur B-gene
) 0
gene 0
product 0
participates 0
in 0
regulating 0
expression 0
of 0
the 0
manganese 0
- 0
and 0
iron 0
- 0
containing 0
superoxide B-gene
dismutase I-gene
genes I-gene
of I-gene
Escherichia I-gene
coli I-gene
. 0

This 0
was 0
further 0
suggested 0
by 0
transactivation 0
assays 0
in 0
which 0
mouse 0
fibroblasts 0
were 0
transiently 0
transfected 0
with 0
a 0
human B-gene
beta I-gene
- I-gene
globin I-gene
reporter I-gene
gene I-gene
in 0
the 0
absence 0
and 0
presence 0
of 0
an 0
LKLF B-gene
cDNA I-gene
construct I-gene
. 0

On 0
average 0
these 0
maximum 0
potency 0
estimates 0
were 0
within 0
one 0
order 0
of 0
magnitude 0
of 0
the 0
inverse 0
maximum 0
dose 0
tested 0
. 0

Anovulatory 0
cycles 0
with 0
an 0
apparently 0
normal 0
level 0
of 0
blood 0
prolactin B-gene
. 0

Furthermore 0
, 0
CL100 B-gene
suppresses 0
the 0
[ 0
val12 0
] 0
ras B-gene
- 0
induced 0
activation 0
of 0
MAP B-gene
kinase I-gene
in 0
a 0
cell 0
- 0
free 0
system 0
from 0
Xenopus 0
oocytes 0
. 0

The 0
maximum 0
levels 0
of 0
reporter 0
proteins 0
attained 0
in 0
transformed 0
cells 0
after 0
prolonged 0
induction 0
represented 0
from 0
1 0
% 0
to 0
7 0
% 0
of 0
total 0
cellular 0
protein 0
. 0

Cardiovascular 0
drug 0
use 0
and 0
hospitalizations 0
attributable 0
to 0
type 0
2 0
diabetes 0
. 0

The 0
PK 0
domain 0
showed 0
pairwise 0
in 0
vitro 0
binding 0
interactions 0
with 0
the 0
pseudokinase 0
, 0
HisRS B-gene
, 0
and 0
C 0
- 0
term 0
domains 0
; 0
additionally 0
, 0
the 0
HisRS B-gene
domain I-gene
interacted 0
with 0
the 0
C 0
- 0
term 0
region 0
. 0

Renal 0
cell 0
carcinoma 0
induced 0
Coombs 0
negative 0
autoimmune 0
hemolytic 0
anemia 0
and 0
severe 0
thrombocytopenia 0
responsive 0
to 0
nephrectomy 0
. 0

The 0
c B-gene
- I-gene
Jun I-gene
delta I-gene
- I-gene
domain I-gene
inhibits 0
neuroendocrine 0
promoter 0
activity 0
in 0
a 0
DNA 0
sequence 0
- 0
and 0
pituitary 0
- 0
specific 0
manner 0
. 0

Finally 0
, 0
antisense 0
mediated 0
reduction 0
of 0
Elk B-gene
- I-gene
1 I-gene
in 0
GH4 0
cells 0
decreased 0
insulin B-gene
- 0
increased 0
prolactin B-gene
gene I-gene
expression 0
and 0
confirmed 0
the 0
requirement 0
for 0
Elk B-gene
- I-gene
1 I-gene
for 0
insulin B-gene
- 0
increased 0
prolactin B-gene
gene I-gene
expression 0
. 0

Smooth 0
pursuit 0
gain 0
and 0
the 0
percentage 0
of 0
total 0
eye 0
movement 0
due 0
to 0
various 0
saccadic 0
subtypes 0
were 0
computed 0
using 0
infrared 0
oculography 0
and 0
computerized 0
pattern 0
recognition 0
software 0
. 0

This 0
is 0
similar 0
to 0
previous 0
reports 0
of 0
muscle B-gene
creatine I-gene
phosphokinase I-gene
release 0
in 0
psychiatric 0
patients 0
. 0

The 0
TaqI B-gene
and 0
HaeIII B-gene
RFLPs 0
will 0
provide 0
tools 0
for 0
the 0
genetic 0
analysis 0
of 0
CR2 B-gene
. 0

A 0
transient 0
induction 0
of 0
both 0
c B-gene
- I-gene
fos I-gene
and 0
c B-gene
- I-gene
jun I-gene
mRNAs I-gene
by 0
TPA 0
was 0
observed 0
in 0
both 0
cell 0
populations 0
, 0
together 0
with 0
an 0
associated 0
suppression 0
of 0
BSP B-gene
mRNA I-gene
in 0
the 0
fetal 0
rat 0
calvarial 0
cells 0
. 0

Mitoxantrone 0
plus 0
ara 0
- 0
C 0
is 0
an 0
active 0
combination 0
with 0
great 0
promise 0
for 0
the 0
therapy 0
of 0
previously 0
untreated 0
patients 0
with 0
AML 0
. 0

During 0
an 0
observation 0
period 0
of 0
12 0
weeks 0
after 0
halving 0
atenolol 0
from 0
a 0
mean 0
dose 0
of 0
82 0
mg 0
to 0
41 0
mg 0
, 0
no 0
significant 0
changes 0
in 0
systolic 0
and 0
diastolic 0
blood 0
pressure 0
or 0
in 0
response 0
rate 0
( 0
defined 0
as 0
a 0
diastolic 0
blood 0
pressure 0
of 0
95 0
mm 0
Hg 0
or 0
less 0
) 0
were 0
observed 0
. 0

Diet 0
imbalances 0
and 0
aflatoxicosis 0

WBC 0
differential 0
( 0
SEG 0
, 0
BAND 0
, 0
LYMPH 0
, 0
MONO 0
, 0
EOSINO 0
, 0
BASO 0
) 0
usually 0
showed 0
log 0
- 0
normal 0
distribution 0
. 0

The 0
majority 0
of 0
the 0
respondents 0
( 0
83.4 0
% 0
) 0
considered 0
that 0
coitus 0
should 0
not 0
be 0
stopped 0
during 0
pregnancy 0
. 0

Genetic 0
analyses 0
indicate 0
that 0
most 0
of 0
the 0
dominant 0
mutants 0
are 0
cis 0
- 0
acting 0
and 0
that 0
the 0
recessive 0
mutants 0
define 0
a 0
minimum 0
of 0
three 0
complementation 0
groups 0
, 0
indicating 0
that 0
defects 0
in 0
several 0
different 0
genes 0
can 0
restore 0
higher 0
levels 0
of 0
HIS4C B-gene
expression 0
. 0

During 0
normoxic 0
exercise 0
, 0
at 0
a 0
mean 0
O2 0
uptake 0
( 0
VO2 0
) 0
of 0
4.0 0
l/min 0
, 0
almitrine 0
increased 0
arterial 0
PO2 0
( 0
PaO2 0
) 0
( 0
P 0
< 0
0.05 0
) 0
, 0
SaO2 0
( 0
P 0
< 0
0.01 0
) 0
, 0
and 0
VE 0
( 0
P 0
< 0
0.05 0
) 0
and 0
decreased 0
arterial 0
PCO2 0
( 0
P 0
< 0
0.01 0
) 0
, 0
without 0
affecting 0
pulmonary 0
hemodynamics 0
or 0
ventilation 0
- 0
perfusion 0
distributions 0
. 0

Recombinant 0
protein 0
encoded 0
by 0
ESX B-gene
( 0
for 0
epithelial B-gene
- I-gene
restricted I-gene
with I-gene
serine I-gene
box I-gene
) 0
exhibits 0
Ets B-gene
- I-gene
like I-gene
DNA 0
binding 0
specificity 0
in 0
electrophoretic 0
mobility 0
shift 0
assays 0
and 0
, 0
in 0
transient 0
transfection 0
assays 0
, 0
transactivates 0
Ets B-gene
- I-gene
responsive I-gene
promoter I-gene
elements I-gene
including 0
that 0
found 0
in 0
the 0
HER2/neu B-gene
oncogene 0
. 0

Static 0
and 0
dynamic 0
MRI 0
of 0
the 0
normal 0
and 0
pathological 0
female 0
pelvic 0
floor 0

Crystals 0
of 0
the 0
triple 0
mutant 0
A42D/D47P/A63L B-gene
, 0
which 0
are 0
stable 0
for 0
days 0
in 0
its 0
oxidized 0
form 0
, 0
were 0
grown 0
from 0
ammonium 0
sulfate 0
, 0
with 0
the 0
cell 0
constants 0
a 0
= 0
b 0
= 0
34.3 0
A 0
and 0
c 0
= 0
111.8 0
A 0
belonging 0
to 0
space 0
group 0
P3 0
( 0
2 0
) 0
21 0
. 0

Two 0
adjacent 0
, 0
highly 0
homologous B-gene
endoglucanase I-gene
genes I-gene
, 0
celD B-gene
and 0
celE B-gene
from 0
Fibrobacter 0
succinogenes 0
S85 0
, 0
which 0
were 0
separated 0
by 0
an 0
AT 0
- 0
rich 0
223 0
- 0
nucleotide 0
intergenic 0
region 0
were 0
characterized 0
. 0

Sequence 0
analysis 0
of 0
this 0
region 0
showed 0
it 0
contained 0
five 0
potential 0
copies 0
of 0
the 0
sterol 0
regulatory 0
element 0
( 0
SRE 0
- 0
1 0
) 0
( 0
Smith 0
, 0
J.R. 0
, 0
Osborne 0
, 0
T.F. 0
, 0
Brown 0
, 0
M.S. 0
, 0
Goldstein 0
, 0
J.L. 0
, 0
and 0
Gil 0
, 0
G 0
. 0

Toxicity 0
of 0
benzoyl 0
chloride 0
( 0
2,4,6 0
- 0
trichlorophenyl 0
) 0
hydrazone 0
( 0
Banamite 0
) 0
and 0
potential 0
metabolites 0
to 0
twospotted 0
spider 0
mites 0
and 0
potency 0
as 0
inhibitors 0
of 0
rat B-gene
liver I-gene
monoamine I-gene
oxidase I-gene
. 0

Fetal 0
PaO2 0
fell 0
somewhat 0
during 0
the 0
recovery 0
stages 0
in 0
both 0
NIT 0
and 0
control 0
groups 0
. 0

It 0
also 0
showed 0
which 0
amino 0
acid 0
residues 0
would 0
contact 0
an 0
extended 0
TATA 0
box 0
with 0
a 0
B B-gene
recognition I-gene
element I-gene
, 0
and 0
evolutionary 0
conservation 0
of 0
the 0
TBP B-gene
- 0
TFB B-gene
- 0
DNA 0
complex 0
orientation 0
between 0
two 0
archaeal 0
organisms 0
with 0
widely 0
different 0
optimal 0
temperature 0
for 0
growth 0
( 0
37 0
and 0
100 0
degrees 0
C 0
) 0
. 0

The 0
average 0
progression 0
was 0
11.6 0
( 0
SD 0
9.0 0
) 0
. 0

14.9 0
x 0
109 0
L 0
- 0
1 0
) 0
was 0
equal 0
for 0
both 0
groups 0
, 0
but 0
CCI 0
values 0
were 0
significantly 0
higher 0
for 0
the 0
bedside 0
filtered 0
PC 0
( 0
14.1 0
+/ 0
- 0
9.5 0
vs 0
. 0

Result 0
were 0
as 0
followed 0
: 0
1 0
) 0
Early 0
cancer 0
- 0
like 0
advanced 0
cancers 0
were 0
consisted 0
of 0
133 0
lesions 0
, 0
of 0
which 0
128 0
lesions 0
( 0
96.2 0
% 0
) 0
had 0
peptic 0
ulcer 0
in 0
cancerous 0
lesion 0
( 0
73 0
lesions 0
were 0
active 0
stage 0
and 0
55 0
lesions 0
were 0
scarring 0
stage 0
) 0
. 0

The 0
median 0
cumulative 0
incidence 0
rates 0
were 0
found 0
to 0
be 0
341 0
per 0
million 0
for 0
males 0
and 0
296 0
per 0
million 0
for 0
females 0
. 0

The 0
unexpected 0
prevalence 0
of 0
c B-gene
- I-gene
myc I-gene
and 0
alpha B-gene
- I-gene
tubulin I-gene
in 0
the 0
S 0
- 0
phase 0
library 0
is 0
supported 0
by 0
Northern 0
analysis 0
of 0
RNA 0
from 0
phase 0
- 0
synchronous 0
cells 0
. 0

A 0
spectrophotometric 0
method 0
for 0
the 0
microdetermination 0
of 0
periodate 0
. 0

Satisfactory 0
correlation 0
was 0
also 0
obtained 0
between 0
the 0
in 0
vivo 0
and 0
the 0
in 0
vitro 0
results 0
. 0

Eleven 0
of 0
the 0
12 0
exons 0
have 0
complete 0
sequence 0
homology 0
with 0
the 0
RBM B-gene
- I-gene
1 I-gene
sequence I-gene
. 0

Polyoma 0
virus 0
in 0
urine 0
during 0
pregnancy 0
. 0

Using 0
probes 0
from 0
these 0
regions 0
, 0
rearrangements 0
have 0
been 0
identified 0
in 0
each 0
of 0
nine 0
cases 0
of 0
t 0
( 0
8 0
; 0
21 0
) 0
AML 0
examined 0
. 0

The 0
delta 0
G 0
values 0
of 0
these 0
regions 0
were 0
higher 0
, 0
i.e 0
. 0
potential 0
secondary 0
structural 0
elements 0
were 0
fewer 0
, 0
than 0
in 0
TIR 0
of 0
genes 0
from 0
E. 0
coli 0
. 0

In 0
each 0
patient 0
, 0
MBF 0
was 0
quantified 0
in 0
the 0
three 0
major 0
vascular 0
territories 0
: 0
the 0
left 0
anterior 0
descending 0
and 0
left 0
circumflex 0
coronary 0
artery 0
territories 0
and 0
the 0
right 0
coronary 0
artery 0
( 0
control 0
region 0
) 0
territory 0
. 0

Effects 0
of 0
shosaikoto 0
, 0
an 0
oriental 0
herbal 0
medicinal 0
mixture 0
, 0
on 0
restraint 0
- 0
stressed 0
mice 0
. 0

We 0
conclude 0
that 0
99mTc 0
- 0
HL91 0
is 0
a 0
potent 0
marker 0
of 0
myocardial 0
viability 0
when 0
used 0
during 0
the 0
early 0
acute 0
phase 0
after 0
reperfusion 0
. 0

Glucose 0
may 0
reduce 0
slightly 0
the 0
pool 0
of 0
amino 0
nitrogen 0
available 0
for 0
albumin B-gene
and 0
urea 0
synthesis 0
by 0
diverting 0
some 0
of 0
the 0
infused 0
amino 0
acids 0
from 0
protein 0
synthesis 0
by 0
the 0
liver 0
to 0
muscle 0
. 0

The 0
community 0
- 0
acquired 0
bacteremia 0
was 0
mainly 0
due 0
to 0
E. 0
coli 0
. 0

The 0
benzo 0
- 0
pyrone 0
drug 0
Venalot 0
had 0
a 0
considerable 0
effect 0
in 0
reducing 0
the 0
protein 0
concentration 0
in 0
the 0
air 0
spaces 0
and 0
the 0
interstitial 0
tissue 0
, 0
and 0
of 0
the 0
oedema 0
in 0
the 0
latter 0
. 0

The 0
brains 0
were 0
bisected 0
and 0
T1 0
and 0
T2 0
relaxation 0
times 0
were 0
determined 0
for 0
the 0
right 0
and 0
left 0
hemispheres 0
by 0
MR 0
spectroscopy 0
immediately 0
after 0
dissection 0
. 0

The 0
exact 0
function 0
of 0
IP B-gene
- I-gene
30 I-gene
is 0
not 0
yet 0
known 0
, 0
but 0
it 0
may 0
play 0
a 0
role 0
in 0
gamma B-gene
- I-gene
interferon I-gene
mediated 0
immune 0
reactions 0
. 0

Indeed 0
, 0
ectopic 0
expression 0
of 0
MOX4 B-gene
in 0
aerobic 0
cells 0
resulted 0
in 0
partially 0
constitutive 0
expression 0
of 0
DAN1 B-gene
. 0

Finally 0
, 0
gel 0
shift 0
assays 0
showed 0
that 0
ORF2 0
was 0
able 0
to 0
bind 0
to 0
promoter 0
fragment 0
566 0
- 0
888 0
. 0

Mutation 0
of 0
K14 0
in 0
H3 B-gene
, 0
which 0
serves 0
as 0
the 0
major 0
target 0
of 0
recombinant B-gene
Gcn5p I-gene
acetylation 0
in 0
vitro 0
, 0
confers 0
a 0
strong 0
, 0
synthetic 0
growth 0
defect 0
in 0
gcn5 B-gene
cells 0
. 0

Histological 0
examination 0
revealed 0
variable 0
loss 0
of 0
motor 0
neurons 0
limited 0
to 0
the 0
injection 0
site 0
. 0

In 0
normal 0
B 0
cells 0
stimulated 0
by 0
LPS 0
or 0
IL B-gene
- I-gene
4 I-gene
, 0
new 0
complexes 0
appear 0
that 0
bind 0
to 0
C/EBP B-gene
and 0
NF B-gene
- I-gene
IL I-gene
- I-gene
4 I-gene
elements I-gene
, 0
respectively 0
, 0
located 0
within 0
the 0
- 0
125/ 0
- 0
101 0
region 0
. 0

Phylogenetic 0
analysis 0
using 0
a 0
neighbor 0
- 0
joining 0
algorithm 0
showed 0
closest 0
similarity 0
of 0
the 0
horse B-gene
mu I-gene
chain I-gene
- I-gene
encoding I-gene
constant I-gene
region I-gene
gene I-gene
to 0
human 0
and 0
dog 0
sequences 0
. 0

Progressive 0
immunodeficiency 0
in 0
a 0
patient 0
with 0
IgA B-gene
deficiency 0

Mouse 0
embryo 0
cells 0
( 0
C57BL/6 0
, 0
H 0
- 0
2b 0
) 0
transformed 0
by 0
the 0
E1A B-gene
and 0
E1B B-gene
genes 0
of 0
adenovirus 0
type 0
5 0
( 0
Ad5E1 0
MEC 0
) 0
are 0
highly 0
immunogenic 0
. 0

We 0
hypothesized 0
that 0
subjects 0
would 0
demonstrate 0
PKAR 0
during 0
both 0
hopping 0
and 0
stepping 0
, 0
adding 0
support 0
to 0
the 0
hypothesis 0
that 0
PKAR 0
is 0
a 0
centrally 0
mediated 0
adaptation 0
of 0
general 0
locomotor 0
trajectory 0
that 0
is 0
not 0
specific 0
to 0
the 0
form 0
of 0
locomotion 0
used 0
while 0
on 0
the 0
rotating 0
disk 0
. 0

The 0
major 0
open 0
reading 0
frame 0
of 0
the 0
cDNA 0
predicts 0
a 0
protein 0
of 0
59 0
kD 0
, 0
with 0
a 0
leucine 0
zipper 0
situated 0
adjacent 0
to 0
an 0
myc B-gene
- I-gene
related I-gene
motif I-gene
that 0
has 0
been 0
proposed 0
to 0
assume 0
a 0
helix 0
- 0
loop 0
- 0
helix 0
structure 0
. 0

Medical 0
management 0
of 0
early 0
- 0
stage 0
breast 0
cancer 0
. 0

Other 0
Fischer 0
- 0
344 0
rats 0
were 0
also 0
exposed 0
for 0
1 0
hr 0
to 0
0.0 0
or 0
to 0
0.6 0
ppm 0
O3 0
. 0

Evidence 0
from 0
four 0
areas 0
- 0
- 0
sensory 0
deprivation 0
, 0
enriched 0
environments 0
, 0
nervous 0
system 0
plasticity 0
, 0
and 0
sensitive 0
periods 0
of 0
neurodevelopment 0
- 0
- 0
suggests 0
that 0
sensory 0
stimulation 0
programs 0
are 0
potentially 0
beneficial 0
for 0
STR 0
patients 0
. 0

The 0
limb 0
defects 0
, 0
oligodactyly 0
and 0
syndactyly 0
, 0
have 0
been 0
traced 0
to 0
improper 0
differentiation 0
of 0
the 0
apical 0
ectodermal 0
ridge 0
( 0
AER 0
) 0
and 0
shortening 0
of 0
the 0
anteroposterior 0
limb 0
axis 0
. 0

Action 0
against 0
Vibrio 0
cholerae 0
O1 0
Tox+ B-gene
of 0
chemical 0
products 0
used 0
in 0
the 0
lemon 0
production 0
. 0

Sera 0
collected 0
in 0
1973 0
- 0
1975 0
from 0
3053 0
residents 0
of 0
12 0
selected 0
Alaskan 0
Eskimo 0
villages 0
were 0
tested 0
for 0
evidence 0
of 0
hepatitis 0
B 0
virus 0
infection 0
. 0

Donehower 0
and 0
H 0
. 0

We 0
have 0
studied 0
some 0
of 0
the 0
parameters 0
governing 0
the 0
expression 0
of 0
a 0
foreign 0
promoter 0
- 0
reporter 0
gene 0
construct 0
incorporated 0
into 0
herpes 0
simplex 0
virus 0
( 0
HSV 0
) 0
type 0
1 0
. 0

cDNA 0
cloning 0
reveals 0
two 0
mouse B-gene
beta5 I-gene
integrin I-gene
transcripts I-gene
distinct 0
in 0
cytoplasmic 0
domains 0
as 0
a 0
result 0
of 0
alternative 0
splicing 0
. 0

Children 0
with 0
repeated 0
proteinuria 0
during 0
follow 0
- 0
up 0
tend 0
to 0
have 0
a 0
higher 0
incidence 0
of 0
pathologic 0
findings 0
on 0
the 0
i.v. 0
- 0
pyelogram 0
. 0

From 0
the 0
Centers 0
for 0
Disease 0
Control 0
and 0
Prevention 0
. 0

The 0
translated 0
sequence 0
of 0
the 0
FLI B-gene
LRR I-gene
associated I-gene
protein I-gene
( 0
FLAP B-gene
) 0
encodes 0
a 0
novel 0
protein 0
not 0
represented 0
in 0
the 0
data 0
base 0
. 0

The 0
analysis 0
of 0
the 0
effects 0
of 0
eight 0
signaling 0
molecules 0
in 0
the 0
TGFbeta B-gene
, 0
FGF B-gene
, 0
Hh B-gene
, 0
Wnt B-gene
, 0
and 0
EGF B-gene
families I-gene
in 0
tooth 0
explant 0
cultures 0
revealed 0
that 0
the 0
expression 0
of 0
edar B-gene
was 0
induced 0
by 0
activinbetaA B-gene
, 0
whereas 0
Wnt6 B-gene
induced 0
ectodysplasin B-gene
expression 0
. 0

In 0
two 0
separate 0
studies 0
, 0
specimens 0
of 0
saliva 0
from 0
57 0
individuals 0
over 0
the 0
age 0
of 0
65 0
years 0
( 0
mean 0
age 0
, 0
76.7 0
years 0
) 0
and 0
37 0
persons 0
under 0
the 0
age 0
of 0
40 0
years 0
( 0
mean 0
age 0
, 0
28.8 0
years 0
) 0
were 0
examined 0
for 0
concentrations 0
of 0
IgA B-gene
as 0
functions 0
of 0
volume 0
, 0
total 0
protein 0
, 0
and 0
electrolyte 0
conductivity 0
; 0
some 0
were 0
also 0
tested 0
for 0
IgG B-gene
and 0
IgM B-gene
content 0
. 0

In 0
the 0
plant B-gene
malate I-gene
synthases I-gene
, 0
the 0
extension 0
is 0
probably 0
involved 0
in 0
routing 0
to 0
the 0
microbodies 0
, 0
since 0
it 0
contains 0
the 0
potential 0
peroxisomal 0
targeting 0
signal 0
, 0
Ser 0
- 0
Arg/Lys 0
- 0
Leu 0
, 0
at 0
the 0
carboxy 0
terminus 0
. 0

These 0
motifs 0
, 0
and 0
their 0
cognate 0
transcription 0
factors 0
, 0
appear 0
to 0
act 0
in 0
concert 0
, 0
with 0
partial 0
redundancy 0
, 0
so 0
that 0
discrete 0
mutations 0
were 0
only 0
partially 0
effective 0
in 0
reducing 0
transcriptional 0
activity 0
. 0

Upon 0
incubation 0
of 0
the 0
most 0
highly 0
purified 0
fractions 0
with 0
Mn 0
- 0
ATP 0
or 0
Mg 0
- 0
ATP 0
, 0
p40 B-gene
was 0
the 0
only 0
protein 0
phosphorylated 0
on 0
tyrosine 0
. 0

CLINICAL 0
FEATURES 0
: 0
This 0
30 0
- 0
yr 0
- 0
old 0
gravida 0
V 0
para 0
0 0
woman 0
presented 0
to 0
the 0
anaesthesia 0
consultation 0
clinic 0
at 0
37 0
- 0
wk 0
gestation 0
to 0
discuss 0
pain 0
relief 0
options 0
for 0
labour 0
and 0
delivery 0
. 0

Judge 0
Christian 0
Byk 0
renders 0
service 0
to 0
the 0
Steering 0
Committee 0
on 0
Bioethics 0
of 0
the 0
Council 0
of 0
Europe 0
( 0
CDBI 0
) 0
by 0
proposing 0
a 0
draft 0
of 0
the 0
protocol 0
destined 0
to 0
fill 0
in 0
a 0
gap 0
in 0
international 0
law 0
on 0
the 0
status 0
of 0
the 0
human 0
embryo 0
. 0

In 0
agreement 0
with 0
this 0
model 0
, 0
elimination 0
of 0
the 0
ADAM13 B-gene
cytoplasmic I-gene
domain I-gene
increased 0
developmental 0
alterations 0
attributable 0
to 0
ADAM13 B-gene
proteolytic 0
activity 0
. 0

Studies 0
in 0
B. 0
glabrata 0
, 0
B. 0
straminea 0
and 0
B. 0
tenagophila 0
under 0
outdoor 0
conditions 0
. 0

E.R.C.P 0
. 0
is 0
an 0
important 0
advance 0
in 0
diagnosis 0
. 0

It 0
also 0
appears 0
that 0
in 0
patients 0
with 0
laboratory 0
diagnosis 0
of 0
prerenal 0
acute 0
renal 0
failure 0
( 0
i.e. 0
, 0
a 0
RFT 0
less 0
than 0
1.0 0
) 0
, 0
the 0
response 0
to 0
treatment 0
is 0
unpredictable 0
and 0
in 0
fact 0
may 0
have 0
a 0
worse 0
prognosis 0
than 0
in 0
those 0
with 0
a 0
RFI 0
greater 0
than 0
1.0 0
( 0
5/7 0
deaths 0
vs 0
10/48 0
deaths 0
) 0
. 0

The 0
strangulated 0
intestinal 0
pathologies 0
of 0
horses 0
are 0
accompanied 0
by 0
a 0
local 0
activation 0
of 0
the 0
neutrophils 0
, 0
that 0
can 0
be 0
revealed 0
by 0
measuring 0
the 0
tissular 0
enzymatic 0
activity 0
of 0
the 0
granulocytic 0
enzyme 0
myeloperoxidase B-gene
( 0
MPO B-gene
) 0
. 0

The 0
human 0
protein 0
is 0
encoded 0
by 0
a 0
900 0
- 0
base 0
pair 0
- 0
long 0
mRNA 0
that 0
is 0
expressed 0
in 0
the 0
glandular 0
epithelial 0
cells 0
of 0
the 0
endometrium 0
in 0
a 0
cyclic 0
manner 0
; 0
in 0
addition 0
, 0
it 0
is 0
found 0
in 0
the 0
mucosal 0
epithelial 0
cells 0
of 0
the 0
fallopian 0
tubes 0
. 0

The 0
80 0
kb 0
preceding 0
the 0
expression 0
site 0
has 0
few 0
, 0
if 0
any 0
, 0
functional 0
ORFs 0
, 0
but 0
contains 0
50 0
bp 0
repeats 0
, 0
INGI B-gene
retrotransposon I-gene
- I-gene
like I-gene
elements I-gene
, 0
and 0
novel 0
4 0
- 0
12 0
kb 0
repeats 0
found 0
near 0
other 0
telomeres 0
. 0

Rather 0
than 0
seeking 0
a 0
blanket 0
characterization 0
of 0
an 0
essentially 0
heterogeneous 0
group 0
, 0
it 0
may 0
be 0
more 0
useful 0
to 0
consider 0
idiom 0
comprehension 0
a 0
secondary 0
manifestation 0
of 0
semantic 0
and/or 0
pragmatic 0
difficulties 0
. 0

The 0
two 0
redox 0
centers 0
in 0
the 0
protein 0
, 0
FAD 0
and 0
a 0
[ 0
4Fe4S 0
] 0
+2 0
, 0
+1 0
cluster 0
, 0
are 0
present 0
in 0
a 0
64 0
- 0
kDa 0
monomer 0
. 0

The 0
BDU 0
neurons 0
and 0
the 0
ALM 0
touch 0
neurons 0
are 0
lineal 0
sister 0
cells 0
in 0
the 0
AB.a 0
lineage 0
and 0
the 0
VA 0
and 0
VB 0
motor 0
neurons 0
are 0
lineal 0
sister 0
cells 0
in 0
the 0
AB.p 0
lineage 0
. 0

We 0
conclude 0
that 0
a 0
0.25 0
mg 0
dose 0
of 0
triazolam 0
does 0
not 0
effectively 0
counteract 0
a 0
posture 0
- 0
induced 0
sleep 0
disturbance 0
, 0
but 0
induces 0
changes 0
in 0
the 0
EEG 0
spectra 0
which 0
are 0
typical 0
for 0
benzodiazepine B-gene
receptor I-gene
agonists 0
. 0

The 0
biological 0
actions 0
of 0
VHR B-gene
in 0
oocytes 0
clearly 0
distinguish 0
it 0
from 0
other 0
dual 0
specificity 0
phosphatases 0
, 0
which 0
have 0
shown 0
inhibitory 0
effects 0
when 0
tested 0
in 0
oocytes 0
. 0

Discriminant 0
function 0
analysis 0
suggests 0
that 0
AUDIT 0
scores 0
can 0
successfully 0
identify 0
SAT 0
- 0
positive 0
and 0
SAT 0
- 0
negative 0
patients 0
; 0
the 0
analysis 0
accounted 0
for 0
42.5 0
% 0
of 0
the 0
variance 0
and 0
correctly 0
classified 0
84.6 0
% 0
of 0
the 0
sample 0
. 0

Failure 0
to 0
demonstrate 0
a 0
major 0
anti 0
- 0
inflammatory 0
effect 0
with 0
alpha 0
tocopherol 0
supplementation 0
( 0
400 0
IU/day 0
) 0
in 0
normal 0
subjects 0
. 0

The 0
flanking 0
open 0
reading 0
frames 0
in 0
pARGC2 0
showed 0
no 0
homologies 0
to 0
arginine 0
biosynthetic 0
genes 0
. 0

Estrogen 0
pretreated 0
castrated 0
males 0
also 0
showed 0
no 0
change 0
in 0
myocardial 0
blood 0
flow 0
after 0
17 0
beta 0
- 0
estradiol 0
, 0
but 0
coronary 0
flow 0
velocity 0
decreased 0
( 0
P 0
< 0
0.05 0
) 0
compared 0
with 0
baseline 0
1 0
h 0
after 0
the 0
200 0
ng/kg 0
dose 0
( 0
from 0
1.69 0
+/ 0
- 0
0.61 0
to 0
1.41 0
+/ 0
- 0
0.42 0
kHz 0
) 0
and 0
diastolic 0
coronary 0
resistance 0
increased 0
significantly 0
( 0
P 0
< 0
0.01 0
) 0
compared 0
with 0
control 0
at 0
this 0
time 0
( 0
51 0
+/ 0
- 0
15 0
compared 0
with 0
39 0
+/ 0
- 0
14 0
mmHg/mkHz 0
) 0
. 0

The 0
studies 0
permit 0
considering 0
the 0
detected 0
shifts 0
in 0
the 0
immunity 0
system 0
an 0
important 0
component 0
of 0
the 0
pathogenesis 0
of 0
chronic 0
nontumorous 0
diseases 0
of 0
the 0
parotid 0
glands 0
. 0

The 0
interaction 0
of 0
different 0
protein 0
systems 0
with 0
microtubules 0
is 0
a 0
critical 0
step 0
in 0
the 0
cellular 0
function 0
of 0
these 0
organelles 0
. 0

Northern 0
blot 0
analysis 0
of 0
liver 0
, 0
muscle 0
, 0
fat 0
, 0
and 0
pituitary 0
RNA 0
from 0
normal 0
( 0
DwDw 0
) 0
chickens 0
shows 0
a 0
major 0
transcript 0
of 0
4.3 0
kilobases 0
( 0
kb 0
) 0
and 0
three 0
minor 0
transcripts 0
( 0
0.8 0
, 0
1.7 0
, 0
and 0
3.2 0
kb 0
) 0
, 0
which 0
correspond 0
to 0
the 0
cGHR B-gene
. 0

SHBG B-gene
concentrations 0
in 0
women 0
were 0
also 0
significantly 0
higher 0
at 0
T 0
- 0
2 0
and 0
T 0
- 0
3 0
when 0
compared 0
to 0
T 0
- 0
1 0
values 0
. 0

Chromosome 0
- 0
specific 0
STSs 0
for 0
27 0
telomeres 0
were 0
identified 0
from 0
the 0
196 0
TYACs 0
. 0

The 0
patient 0
groups 0
consisted 0
of 0
31 0
with 0
dilated 0
cardiomyopathy 0
, 0
22 0
with 0
hypertrophic 0
cardiomyopathy 0
, 0
38 0
with 0
myocardial 0
infarction 0
, 0
15 0
with 0
angina 0
pectoris 0
and 0
26 0
with 0
rheumatic 0
valvular 0
disease 0
. 0

The 0
two 0
yeast B-gene
pheromone I-gene
receptors I-gene
, 0
the 0
a B-gene
and I-gene
alpha I-gene
- I-gene
factor I-gene
receptors I-gene
, 0
share 0
many 0
functional 0
similarities 0
: 0
both 0
G B-gene
protein I-gene
- I-gene
coupled I-gene
receptors I-gene
couple 0
to 0
the 0
same 0
downstream 0
signal 0
transduction 0
pathway 0
, 0
and 0
both 0
receptors 0
undergo 0
feedback 0
regulation 0
involving 0
increased 0
phosphorylation 0
on 0
their 0
C 0
- 0
terminal 0
domains 0
in 0
response 0
to 0
ligand 0
challenge 0
. 0

Heart 0
rate 0
and 0
oxygen 0
consumption 0
increased 0
75+/ 0
- 0
4 0
bpm 0
and 0
26.3+/ 0
- 0
1.4 0
ml 0
O2/kg 0
x 0
min 0
( 0
- 0
1 0
) 0
from 0
supine 0
resting 0
values 0
, 0
respectively 0
. 0

It 0
also 0
produces 0
an 0
NH2 0
terminus 0
that 0
corresponds 0
to 0
an 0
equivalent 0
NH2 0
terminus 0
on 0
the 0
processed 0
matrix 0
form 0
of 0
the 0
similar 0
alpha1 B-gene
( I-gene
XI I-gene
) I-gene
chain I-gene
, 0
thus 0
suggesting 0
physiological 0
significance 0
. 0

To 0
determine 0
the 0
transactivation 0
potential 0
of 0
each 0
of 0
the 0
four 0
Ahr B-gene
Sp1 B-gene
sites I-gene
, 0
we 0
fused 0
the 0
Ahr B-gene
promoter I-gene
to 0
a 0
luciferase B-gene
( 0
LUC B-gene
) 0
reporter 0
gene 0
and 0
transfected 0
the 0
construct 0
into 0
the 0
Drosophila 0
cell 0
line 0
Schneider 0
- 0
2 0
, 0
which 0
contains 0
no 0
Sp1 B-gene
or 0
Sp1 B-gene
- I-gene
like I-gene
factors I-gene
. 0

Based 0
on 0
the 0
results 0
of 0
this 0
analysis 0
, 0
we 0
also 0
predict 0
that 0
the 0
budding B-gene
yeast I-gene
arsenate I-gene
resistance I-gene
protein I-gene
Acr2 B-gene
and 0
the 0
ORF B-gene
Ygr203w I-gene
encode 0
protein 0
phosphatases 0
with 0
catalytic 0
properties 0
similar 0
to 0
that 0
of 0
the 0
Cdc25 B-gene
family I-gene
. 0

However 0
, 0
in 0
7 0
patients 0
with 0
normal 0
CT 0
results 0
the 0
latter 0
method 0
showed 0
areas 0
of 0
cerebral 0
activity 0
anatomically 0
correlated 0
with 0
neurological 0
signs 0
or 0
vascular 0
lesions 0
. 0

Signal 0
transduction 0
in 0
fibroblasts 0
stably 0
transformed 0
by 0
[ 0
Val12 0
] 0
Ras 0
- 0
- 0
the 0
activities 0
of 0
extracellular B-gene
- I-gene
signal I-gene
- I-gene
regulated I-gene
kinase I-gene
and 0
Jun B-gene
N I-gene
- I-gene
terminal I-gene
kinase I-gene
are 0
only 0
moderately 0
increased 0
, 0
and 0
the 0
activity 0
of 0
the 0
delta 0
- 0
inhibitor 0
of 0
c B-gene
- I-gene
Jun I-gene
is 0
not 0
alleviated 0
. 0

Avian B-gene
EMILIN I-gene
was 0
extracted 0
from 0
19 0
- 0
day 0
- 0
old 0
embryonic 0
chick 0
aortas 0
and 0
associated 0
blood 0
vessels 0
and 0
purified 0
by 0
ion 0
- 0
exchange 0
chromatography 0
and 0
gel 0
filtration 0
. 0

Asymptomatic 0
ischaemia 0
during 0
daily 0
life 0
in 0
stable 0
coronary 0
artery 0
disease 0
: 0
relevant 0
or 0
redundant 0
? 0

Individual 0
intolerance 0
to 0
betaxolol 0
will 0
continue 0
to 0
occur 0
and 0
care 0
is 0
always 0
required 0
when 0
patients 0
with 0
cardiac 0
or 0
respiratory 0
dysfunction 0
are 0
exposed 0
to 0
any 0
beta 0
- 0
antagonist 0
. 0

DESIGN 0
: 0
Prospective 0
case 0
study 0
( 0
Canadian 0
Task 0
Force 0
classification 0
II 0
- 0
2 0
) 0
. 0

The 0
highest 0
incidence 0
was 0
observed 0
for 0
V. 0
alginolyticus 0
( 0
92 0
- 0
100 0
% 0
) 0
, 0
followed 0
by 0
V. 0
parahaemolyticus 0
( 0
67 0
- 0
92 0
% 0
) 0
, 0
V. 0
fluvialis 0
( 0
34 0
- 0
67 0
% 0
) 0
, 0
V. 0
vulnificus 0
( 0
8 0
- 0
17 0
% 0
) 0
, 0
V. 0
furnissii 0
( 0
0 0
- 0
17 0
% 0
) 0
, 0
V. 0
mimicus 0
( 0
0 0
- 0
17 0
% 0
) 0
and 0
V. 0
cholerae 0
non 0
- 0
O1 0
( 0
0 0
- 0
8 0
% 0
) 0
. 0

Self 0
- 0
consistent 0
calculation 0
of 0
the 0
surface 0
electronic 0
structure 0
of 0
the 0
( 0
1 0
x 0
2 0
) 0
reconstructed 0
Au 0
( 0
110 0
) 0
surface 0
. 0

In 0
contrast 0
, 0
polypropylene 0
glycol 0
, 0
PG 0
- 0
C 0
, 0
and 0
corn 0
oil 0
all 0
removed 0
68 0
- 0
86 0
% 0
of 0
the 0
MDI 0
in 0
the 0
first 0
h 0
, 0
74 0
- 0
79 0
% 0
at 0
4 0
h 0
, 0
and 0
72 0
- 0
86 0
% 0
at 0
8 0
h 0
. 0

Peak 0
insulin B-gene
response 0
to 0
glucose 0
infusion 0
declined 0
from 0
Groups 0
1 0
to 0
3 0
( 0
51 0
+/ 0
- 0
14 0
, 0
42.4 0
+/ 0
- 0
31 0
, 0
20.4 0
+/ 0
- 0
6.8 0
microU/ml 0
, 0
respectively 0
) 0
with 0
Group 0
3 0
exhibiting 0
a 0
significantly 0
decreased 0
mean 0
peak 0
level 0
compared 0
to 0
the 0
other 0
groups 0
. 0

Chemical 0
structure 0
of 0
antibiotic 0
SF 0
- 0
837 0
. 0

Reexamination 0
of 0
the 0
cdc4 B-gene
- I-gene
1 I-gene
mutant I-gene
revealed 0
that 0
, 0
in 0
addition 0
to 0
being 0
defective 0
in 0
the 0
onset 0
of 0
S 0
phase 0
, 0
it 0
is 0
also 0
defective 0
in 0
G 0
( 0
2 0
) 0
/M 0
transition 0
when 0
released 0
from 0
hydroxyurea 0
- 0
induced 0
S 0
- 0
phase 0
arrest 0
. 0

Structure 0
and 0
regulation 0
of 0
the 0
luteinizing B-gene
hormone I-gene
receptor I-gene
gene I-gene
. 0

The 0
procedure 0
was 0
technically 0
successful 0
in 0
12 0
of 0
14 0
( 0
86 0
% 0
) 0
stenoses 0
in 0
the 0
fibromuscular 0
dysplasia 0
subgroup 0
but 0
in 0
only 0
one 0
of 0
five 0
( 0
20 0
% 0
) 0
lesions 0
in 0
the 0
neurofibromatosis 0
subgroup 0
. 0

Amplitude 0
of 0
late 0
surface 0
( 0
P2 0
and 0
N2 0
) 0
and 0
depth 0
( 0
B 0
and 0
C 0
) 0
components 0
significantly 0
decreased 0
when 0
patients 0
shifted 0
from 0
SWS 0
IV 0
to 0
PS 0
and 0
increased 0
from 0
PS 0
to 0
W2 0
. 0

Unconventional 0
mRNA 0
processing 0
in 0
the 0
expression 0
of 0
two 0
calcineurin B-gene
B I-gene
isoforms I-gene
in 0
Dictyostelium 0
. 0

T1 0
and 0
T2 0
values 0
were 0
calculated 0
from 0
guinea 0
pig 0
brain 0
in 0
vivo 0
at 0
0.5 0
T 0
. 0

A 0
chest 0
- 0
X 0
ray 0
film 0
showed 0
infiltrative 0
shadows 0
in 0
the 0
right 0
middle 0
and 0
lower 0
lung 0
fields 0
, 0
but 0
a 0
chest 0
CT 0
scan 0
showed 0
an 0
abnormal 0
lung 0
density 0
in 0
the 0
right 0
lower 0
lobe 0
. 0

Transcription 0
of 0
the 0
inserted 0
gene 0
into 0
the 0
predicted 0
subgenomic 0
polyadenylated 0
mRNA 0
was 0
demonstrated 0
by 0
Northern 0
( 0
RNA 0
) 0
blot 0
hybridization 0
analysis 0
, 0
and 0
the 0
encoded 0
protein 0
was 0
detected 0
by 0
enzyme 0
assay 0
and 0
by 0
radioimmunoprecipitation 0
. 0

We 0
then 0
supplemented 0
these 0
spliceosomes 0
with 0
purified 0
proteins 0
or 0
yeast 0
extract 0
fractions 0
as 0
a 0
functional 0
assay 0
for 0
second 0
- 0
step 0
splicing 0
factors 0
. 0

The 0
severity 0
of 0
the 0
psychomotor 0
retardation 0
varied 0
from 0
mild 0
to 0
severe 0
. 0

Plasma B-gene
insulin I-gene
responses 0
to 0
glucose 0
in 0
femoral 0
, 0
hepatic 0
, 0
and 0
pancreatic 0
veins 0
in 0
dogs 0
. 0

The 0
reading 0
achievement 0
of 0
students 0
with 0
learning 0
disabilities 0
who 0
received 0
reading 0
instruction 0
through 0
the 0
DISTAR 0
program 0
was 0
compared 0
to 0
that 0
of 0
similar 0
students 0
using 0
basal 0
reader 0
materials 0
. 0

We 0
discuss 0
the 0
possibility 0
that 0
DNA 0
- 0
protein 0
interactions 0
at 0
homologous 0
nucleotide 0
sequences 0
like 0
those 0
identified 0
in 0
PII 0
are 0
part 0
of 0
a 0
regulatory 0
gene 0
cascade 0
that 0
participates 0
in 0
timing 0
fla B-gene
gene I-gene
expression 0
in 0
the 0
C. 0
crescentus 0
cell 0
cycle 0
. 0

Here 0
we 0
demonstrate 0
that 0
a 0
region 0
of 0
high 0
homology 0
between 0
the 0
members 0
of 0
this 0
class 0
of 0
proteins 0
contains 0
a 0
type 0
A 0
nucleotide 0
binding 0
site 0
consensus 0
sequence 0
which 0
has 0
ATPase B-gene
activity 0
and 0
is 0
sufficient 0
to 0
bind 0
DNA 0
containing 0
specific 0
mismatched 0
residues 0
. 0

The 0
detergent 0
- 0
solubilized 0
complex 0
oxidizes 0
caldariella 0
quinol 0
at 0
high 0
rates 0
and 0
is 0
completely 0
inhibited 0
by 0
cyanide 0
and 0
by 0
quinolone 0
analogs 0
, 0
potent 0
inhibitors 0
of 0
quinol B-gene
oxidases I-gene
. 0

Significantly 0
, 0
the 0
murine B-gene
P I-gene
- I-gene
selectin I-gene
gene I-gene
had 0
several 0
features 0
not 0
found 0
in 0
the 0
human 0
gene 0
. 0

Consistently 0
, 0
we 0
show 0
that 0
phosphorylation 0
by 0
protein B-gene
kinase I-gene
A I-gene
inhibits 0
Sfl1 B-gene
DNA 0
binding 0
in 0
vitro 0
, 0
and 0
that 0
a 0
tpk2Delta B-gene
mutation 0
increases 0
the 0
levels 0
of 0
Sfl1 B-gene
protein I-gene
associated 0
with 0
specific 0
promoter 0
elements 0
in 0
vivo 0
. 0

This 0
region 0
was 0
unfavourable 0
, 0
due 0
to 0
malaria 0
in 0
the 0
past 0
. 0

SM B-gene
binds 0
RNA 0
in 0
vitro 0
, 0
suggesting 0
that 0
sequence 0
- 0
or 0
structure 0
- 0
specific 0
mRNA 0
interactions 0
might 0
mediate 0
SM B-gene
specificity 0
. 0

Stress 0
- 0
induced 0
suppression 0
of 0
the 0
prolactin B-gene
afternoon 0
surge 0
in 0
ovariectomized 0
, 0
estrogen 0
- 0
treated 0
rats 0
and 0
the 0
nocturnal 0
surge 0
in 0
pseudopregnant 0
rats 0
are 0
accompanied 0
by 0
an 0
increase 0
in 0
median 0
eminence 0
dihydroxyphenylacetic 0
acid 0
concentrations 0
. 0

In 0
vitro 0
kinase 0
assays 0
on 0
isolated 0
microvilli 0
and 0
microvillar 0
fractions 0
enriched 0
in 0
the 0
putative 0
signal 0
transduction 0
particle 0
showed 0
a 0
high 0
specific 0
activity 0
of 0
tyrosine B-gene
kinase I-gene
activity 0
compared 0
to 0
that 0
of 0
membranes 0
from 0
EGF B-gene
receptor I-gene
- 0
overexpressing 0
A431 0
cells 0
maximally 0
activated 0
by 0
EGF B-gene
. 0

Among 0
these 0
, 0
four 0
patients 0
had 0
the 0
AIDS 0
syndrome 0
, 0
while 0
42 0
individuals 0
were 0
HIV 0
carriers 0
. 0

Carcinogenic 0
action 0
of 0
groundnut 0
meal 0
containing 0
aflatoxin 0
in 0
rats 0
. 0

The 0
UASB 0
reactors 0
treated 0
a 0
VFA 0
mixture 0
( 0
with 0
an 0
acetate 0
: 0
propionate 0
: 0
butyrate 0
ratio 0
of 0
5:3:2 0
on 0
COD 0
basis 0
) 0
or 0
acetate 0
as 0
the 0
sole 0
substrate 0
at 0
different 0
COD 0
: 0
sulfate 0
ratios 0
. 0

Lack 0
of 0
changes 0
in 0
milk 0
production 0
and 0
milk 0
composition 0
suggest 0
that 0
acute 0
increases 0
in 0
somatotropin B-gene
with 0
concomitant 0
increases 0
in 0
insulin B-gene
are 0
not 0
sufficient 0
to 0
stimulate 0
synthesis 0
of 0
milk 0
and 0
milk 0
components 0
by 0
cows 0
during 0
established 0
lactation 0
. 0

The 0
initial 0
oral 0
administration 0
of 0
the 0
1 0
and 0
2 0
mg/kg 0
doses 0
of 0
enoximone 0
improved 0
central 0
hemodynamic 0
parameters 0
with 0
apparent 0
preferential 0
reduction 0
of 0
limb 0
vascular 0
resistance 0
and 0
augmentation 0
of 0
blood 0
flow 0
to 0
the 0
limb 0
region 0
( 0
peripheral 0
musculoskeletal 0
system 0
) 0
. 0

Genomic 0
clones 0
containing 0
the 0
C. 0
briggsae 0
gene 0
are 0
able 0
to 0
completely 0
rescue 0
the 0
unc B-gene
- I-gene
119 I-gene
phenotype I-gene
in 0
transgenic 0
C. 0
elegans 0
mutants 0
. 0

Copyright 0
1999 0
Academic 0
Press 0
. 0

The 0
role 0
of 0
phosphorylation 0
on 0
receptor 0
desensitization 0
was 0
assessed 0
using 0
receptor 0
mutants 0
expressed 0
in 0
COS 0
cells 0
or 0
Chinese 0
hamster 0
lung 0
fibroblasts 0
. 0

For 0
il8ra B-gene
, 0
it 0
is 0
formed 0
from 0
two 0
exons 0
, 0
whereas 0
for 0
il8rb B-gene
, 0
seven 0
distinct 0
neutrophil 0
mRNAs 0
are 0
formed 0
by 0
alternative 0
splicing 0
of 0
11 0
exons 0
. 0

The 0
coding 0
sequence 0
of 0
rat B-gene
MEK I-gene
kinase I-gene
1 I-gene
( 0
MEKK1 B-gene
) 0
has 0
been 0
determined 0
from 0
multiple 0
, 0
independent 0
cDNA 0
clones 0
. 0

By 0
deletion 0
analysis 0
, 0
we 0
identified 0
the 0
regions 0
of 0
c B-gene
- I-gene
Jun I-gene
encoding 0
transformation 0
and 0
transactivation 0
functions 0
. 0

Several 0
waveforms 0
of 0
both 0
the 0
somatosensory 0
( 0
N20 0
, 0
P/N 0
30 0
, 0
and 0
P200 0
) 0
and 0
the 0
brainstem 0
auditory 0
- 0
evoked 0
response 0
( 0
I 0
, 0
III 0
, 0
IV 0
, 0
and 0
V 0
) 0
demonstrated 0
shorter 0
( 0
p 0
less 0
than 0
0.05 0
) 0
latencies 0
in 0
growth 0
- 0
retarded 0
fetuses 0
relative 0
to 0
normal 0
- 0
sized 0
fetuses 0
. 0

The 0
response 0
to 0
nitroglycerin 0
, 0
however 0
, 0
remained 0
intact 0
regardless 0
of 0
initial 0
reperfusion 0
pressure 0
. 0

Interactions 0
were 0
also 0
detected 0
between 0
full 0
- 0
length 0
HSF1 B-gene
and 0
the 0
small 0
subunit 0
( 0
gamma 0
) 0
of 0
TFIIA B-gene
. 0

Pyknotic 0
osteocytes 0
increased 0
at 0
12 0
h 0
( 0
p 0
less 0
than 0
0.01 0
) 0
and 0
2 0
days 0
( 0
p 0
less 0
than 0
0.001 0
) 0
of 0
ischemia 0
. 0

Northern 0
blot 0
analysis 0
indicated 0
that 0
both 0
human 0
and 0
murine 0
genes 0
encode 0
approximately 0
6 0
- 0
kb 0
transcripts 0
. 0

ALT B-gene
( 0
alanine B-gene
aminotransferase I-gene
) 0
and 0
Hb B-gene
( 0
hemoglobin B-gene
) 0
appeared 0
to 0
be 0
predictive 0
for 0
efficacy 0
. 0

Maternal 0
behavior 0
was 0
assessed 0
using 0
observational 0
techniques 0
. 0

Effects 0
of 0
timepidium 0
bromide 0
( 0
TB 0
; 0
anticholinergic 0
agent 0
) 0
, 0
acetylcholine 0
( 0
ACh 0
) 0
and 0
neostigmine 0
( 0
Neost 0
) 0
on 0
gastric 0
and 0
duodenal 0
blood 0
flow 0
distribution 0
were 0
studied 0
by 0
the 0
use 0
of 0
131I 0
- 0
labeled 0
macroaggregated 0
human 0
serum 0
albumin 0
( 0
MAA B-gene
) 0
in 0
rabbits 0
. 0

Nucleotide 0
sequence 0
of 0
the 0
gag B-gene
gene I-gene
and 0
gag B-gene
- 0
pol B-gene
junction 0
of 0
feline 0
leukemia 0
virus 0
. 0

When 0
using 0
the 0
high 0
- 0
impedance 0
testing 0
device 0
, 0
the 0
post 0
shock 0
rhythm 0
was 0
initially 0
displayed 0
as 0
'no 0
signal 0
' 0
( 0
Hewlett 0
Packard 0
XL 0
) 0
or 0
'asystole 0
' 0
( 0
Physio 0
- 0
Control 0
LIFEPAK 0
9 0
) 0
. 0

The 0
plasma 0
steroid 0
levels 0
in 0
the 0
CAPD 0
patients 0
after 0
each 0
infusion 0
rate 0
were 0
equal 0
to 0
or 0
greater 0
than 0
the 0
levels 0
in 0
normal 0
subjects 0
. 0

Nramp2 B-gene
contains 0
a 0
classical 0
iron 0
responsive 0
element 0
in 0
the 0
3 0
' 0
untranslated 0
region 0
that 0
confers 0
iron 0
dependent 0
mRNA 0
stabilization 0
. 0

In 0
addition 0
, 0
reduced 0
metabolism 0
to 0
cotinine 0
from 0
the 0
proliposomes 0
and 0
MP 0
was 0
apparently 0
responsible 0
for 0
the 0
sustained 0
plasma 0
nicotine 0
levels 0
. 0

D 0
. 0

BCR B-gene
- 0
ABL B-gene
expression 0
confers 0
cross 0
- 0
resistance 0
to 0
multiple 0
genotoxic 0
anticancer 0
drugs 0
by 0
inhibition 0
of 0
the 0
apoptotic 0
response 0
to 0
DNA 0
damage 0
in 0
association 0
with 0
cell 0
cycle 0
arrest 0
at 0
the 0
G2 0
- 0
M 0
restriction 0
point 0
. 0

When 0
a 0
longer 0
- 0
714 0
to 0
+78 0
fragment 0
of 0
the 0
PBGD B-gene
promoter I-gene
is 0
used 0
, 0
the 0
- 0
70 0
GATA 0
mutant 0
still 0
displays 0
erythroid 0
- 0
specific 0
activity 0
and 0
is 0
cis 0
- 0
activated 0
by 0
the 0
5'HS B-gene
- I-gene
2 I-gene
enhancer I-gene
, 0
while 0
the 0
- 0
100 0
CCACC 0
mutant 0
is 0
completely 0
inactive 0
in 0
the 0
absence 0
or 0
in 0
the 0
presence 0
of 0
the 0
5'HS B-gene
- I-gene
2 I-gene
enhancer I-gene
. 0

Deletion 0
analysis 0
revealed 0
that 0
only 0
the 0
TM 0
domain 0
of 0
E2 B-gene
was 0
required 0
for 0
Golgi 0
targeting 0
. 0

In 0
area 0
CA1 0
of 0
the 0
hippocampus 0
, 0
numbers 0
of 0
normal 0
neurons 0
were 0
increased 0
11 0
- 0
to 0
14 0
- 0
fold 0
by 0
MK 0
- 0
801 0
treatment 0
( 0
p 0
< 0
0.01 0
) 0
. 0

Considering 0
these 0
two 0
facts 0
together 0
, 0
we 0
propose 0
that 0
vasectomy 0
may 0
lead 0
to 0
decrease 0
in 0
the 0
incidence 0
of 0
prostatic 0
tumors 0
- 0
a 0
disease 0
that 0
claims 0
nearly 0
22,000 0
lives 0
each 0
year 0
in 0
the 0
United 0
States 0
alone 0
. 0

Further 0
studies 0
aim 0
at 0
characterizing 0
the 0
trans 0
- 0
acting 0
factors 0
that 0
mediate 0
the 0
spatial 0
and 0
temporal 0
expression 0
of 0
Hox B-gene
genes I-gene
in 0
the 0
developing 0
embryo 0
. 0

The 0
protein 0
was 0
overexpressed 0
in 0
Escherichia 0
coli 0
and 0
purified 0
to 0
homogeneity 0
. 0

At 0
least 0
one 0
such 0
complex 0
is 0
eliminated 0
by 0
preincubating 0
the 0
nuclear 0
extract 0
with 0
an 0
antibody 0
with 0
broad 0
cross 0
- 0
reactivity 0
with 0
Ets B-gene
- I-gene
1 I-gene
and 0
Ets B-gene
- I-gene
2 I-gene
proteins I-gene
, 0
thus 0
confirming 0
that 0
an 0
ETS B-gene
transcription I-gene
factor I-gene
( I-gene
s I-gene
) I-gene
recognizes 0
the 0
- 0
12 0
motif 0
. 0

Paraplegia 0
associated 0
with 0
intraaortic 0
balloon 0
pump 0
counterpulsation 0
. 0

Gas 0
exchange 0
was 0
measured 0
breath 0
by 0
breath 0
. 0

BACKGROUND 0
: 0
Peripheral 0
kappa B-gene
receptor I-gene
agonists 0
may 0
provide 0
a 0
new 0
therapeutic 0
approach 0
for 0
the 0
treatment 0
of 0
functional 0
dyspepsia 0
. 0

Checking 0
for 0
patient 0
compliance 0
, 0
samples 0
( 0
n 0
= 0
10 0
) 0
with 0
a 0
FK 0
I 0
concentration 0
of 0
0 0
ng/mL 0
were 0
re 0
- 0
analyzed 0
. 0

The 0
Robert 0
Wood 0
Johnson 0
Foundation 0
: 0
billion 0
dollar 0
force 0
for 0
health 0
- 0
care 0
change 0
. 0

These 0
results 0
support 0
an 0
in 0
vivo 0
interaction 0
between 0
Nck B-gene
and 0
CKI B-gene
- I-gene
gamma2 I-gene
and 0
suggest 0
that 0
CKI B-gene
- I-gene
gamma2 I-gene
could 0
be 0
involved 0
in 0
signaling 0
pathways 0
downstream 0
of 0
RTKs B-gene
. 0

4 0
- 0
Hydroxyproline 0
assays 0
were 0
performed 0
to 0
determine 0
collagen B-gene
content 0
. 0

The 0
biological 0
basis 0
for 0
the 0
changes 0
in 0
CNAPs 0
produced 0
by 0
CS2 0
is 0
under 0
investigation 0
. 0

Non 0
- 0
suppressed 0
thyroidal 0
radioactive 0
iodine 0
uptake 0
( 0
RAIU 0
) 0
in 0
thyrotoxic 0
phase 0
in 0
a 0
case 0
of 0
subacute 0
thyroiditis 0
with 0
thyroid 0
- 0
stimulating 0
antibodies 0
( 0
TSAb 0
) 0
. 0

Blotting 0
analysis 0
of 0
intestinal 0
RNA 0
and 0
hybridization 0
of 0
the 0
blots 0
with 0
carboxy 0
apoB B-gene
cDNA 0
probes 0
produced 0
a 0
single 0
15 0
- 0
kb 0
hybridization 0
band 0
whereas 0
hybridization 0
with 0
amino 0
terminal 0
probes 0
produced 0
two 0
hybridization 0
bands 0
of 0
15 0
and 0
8 0
kb 0
. 0

The 0
temporal 0
expression 0
of 0
CRAlBP B-gene
is 0
similar 0
to 0
IRBP B-gene
while 0
bFGF B-gene
is 0
not 0
expressed 0
until 0
after 0
photoreceptor 0
differentiation 0
is 0
complete 0
. 0

Several 0
components 0
in 0
cytokine 0
signaling 0
remain 0
unidentified 0
. 0

Virgin 0
, 0
P 0
. 0

The 0
present 0
report 0
shows 0
that 0
a 0
cis 0
- 0
acting 0
element 0
between 0
- 0
189 0
and 0
- 0
175 0
bp 0
, 0
which 0
binds 0
thyroid B-gene
transcription I-gene
factor I-gene
- I-gene
1 I-gene
( 0
TTF B-gene
- I-gene
1 I-gene
) 0
, 0
is 0
involved 0
in 0
both 0
activities 0
. 0

No 0
universally 0
accepted 0
standardized 0
classification 0
system 0
for 0
acne 0
vulgaris 0
exists 0
, 0
although 0
there 0
is 0
a 0
strong 0
need 0
for 0
it 0
. 0

Constant 0
slowing 0
of 0
median 0
MNCV 0
and 0
SNCV 0
and 0
ulnar 0
SNCV 0
without 0
changes 0
in 0
morphology 0
, 0
amplitude 0
and 0
duration 0
of 0
MAP 0
and 0
SAP 0
have 0
been 0
observed 0
in 0
92 0
patients 0
, 0
with 0
persistent 0
abnormalities 0
in 0
64 0
cases 0
after 0
six 0
months 0
. 0

Kudzu 0
extract 0
shows 0
potential 0
for 0
moderating 0
alcohol 0
abuse 0
. 0

Serum 0
IgG B-gene
and 0
IgA B-gene
level 0
were 0
decreased 0
. 0

A 0
novel 0
zinc 0
finger 0
- 0
containing 0
RNA 0
- 0
binding 0
protein 0
conserved 0
from 0
fruitflies 0
to 0
humans 0
. 0

High 0
- 0
affinity 0
binding 0
was 0
also 0
observed 0
with 0
recombinant B-gene
SH2 I-gene
domains I-gene
from 0
v B-gene
- I-gene
src I-gene
and 0
v B-gene
- I-gene
fps I-gene
, 0
raising 0
the 0
possibility 0
of 0
protein 0
- 0
protein 0
interactions 0
between 0
various 0
members 0
of 0
the 0
cytoplasmic B-gene
PTK I-gene
family I-gene
. 0

The 0
M 0
- 0
phase 0
induction 0
activity 0
of 0
Cdc2 B-gene
- 0
Cdc13 B-gene
is 0
inhibited 0
by 0
Wee1 B-gene
tyrosine I-gene
kinase I-gene
, 0
which 0
phosphorylates 0
Cdc2 B-gene
on 0
tyrosine 0
- 0
15 0
. 0

Youssoufian 0
, 0
A 0
. 0

Since 0
1988 0
Modulit 0
- 0
SZ 0
- 0
20 0
has 0
been 0
tested 0
for 0
localization 0
of 0
nephroliths 0
and 0
ureteroliths 0
. 0

Lactate 0
, 0
pyruvate 0
and 0
actual 0
pH 0
values 0
in 0
the 0
venous 0
blood 0
of 0
newborn 0
calves 0

The 0
steady 0
- 0
state 0
levels 0
of 0
Cdk2 B-gene
, 0
Cdk4 B-gene
and 0
Cyclin B-gene
A I-gene
proteins I-gene
were 0
unaffected 0
by 0
HPR 0
, 0
while 0
those 0
of 0
Cyclin B-gene
D1 I-gene
were 0
significantly 0
reduced 0
in 0
all 0
three 0
cell 0
lines 0
. 0

The 0
dermatoglyphic 0
pattern 0
demostrates 0
a 0
distal 0
triradius 0
and 0
small 0
whorl 0
abnormalities 0
. 0

The 0
experimental 0
results 0
suggest 0
equilibrium 0
complex 0
formation 0
between 0
OTC 0
and 0
PVP 0
, 0
it 0
being 0
mainly 0
the 0
complex 0
which 0
is 0
i.v 0
. 0
injected 0
when 0
both 0
products 0
are 0
combined 0
in 0
an 0
injection 0
formulation 0
. 0

The 0
MI 0
site 0
is 0
predictive 0
of 0
hemodynamic 0
left 0
ventricular 0
dysfunction 0
both 0
at 0
rest 0
and 0
during 0
exercise 0
: 0
anterior 0
MIs 0
are 0
more 0
impaired 0
than 0
inferior 0
MIs 0
. 0

The 0
median 0
survival 0
time 0
was 0
18 0
months 0
. 0

Studies 0
with 0
and 0
without 0
attenuating 0
media 0
were 0
performed 0
, 0
and 0
myocardium 0
- 0
to 0
- 0
defect 0
count 0
ratios 0
and 0
defect 0
sizes 0
from 0
dual 0
- 0
isotope 0
SPECT 0
images 0
were 0
compared 0
to 0
myocardium 0
- 0
to 0
- 0
defect 0
count 0
ratios 0
and 0
defect 0
sizes 0
from 0
single 0
- 0
isotope 0
( 0
201Tl 0
and 0
99mTc 0
) 0
SPECT 0
images 0
. 0

Biology 0
of 0
Anopheles 0
quadrimaculatus 0
under 0
field 0
conditions 0
in 0
central 0
Florida 0
. 0

This 0
transformation 0
suppression 0
by 0
Rb B-gene
was 0
further 0
shown 0
to 0
be 0
due 0
to 0
transcriptional 0
repression 0
of 0
neu B-gene
using 0
Rb B-gene
expressing 0
effector 0
plasmid 0
and 0
neu B-gene
promoter 0
- 0
chloramphenicol B-gene
acetyltransferase I-gene
reporter 0
gene 0
. 0

Collectively 0
, 0
a 0
unique 0
mechanism 0
involving 0
NF B-gene
- I-gene
ATp I-gene
appears 0
to 0
regulate 0
the 0
cell 0
type 0
- 0
specific 0
and 0
activation 0
- 0
dependent 0
expression 0
of 0
the 0
SCM B-gene
- I-gene
1 I-gene
genes I-gene
. 0

In 0
seven 0
patients 0
( 0
7.8 0
% 0
) 0
with 0
new 0
Q 0
- 0
waves 0
and 0
a 0
pathologic 0
CK B-gene
- I-gene
MB I-gene
profile 0
( 0
group 0
II 0
) 0
troponin B-gene
T I-gene
reached 0
median 0
levels 0
of 0
10.47 0
micrograms/l 0
( 0
quartile 0
6.34 0
- 0
12.50 0
micrograms/l 0
) 0
( 0
P 0
< 0
0.001 0
I 0
vs 0
II 0
) 0
. 0

EMG 0
- 0
based 0
measures 0
of 0
fatigue 0
during 0
a 0
repetitive 0
squat 0
exercise 0
. 0

CONCLUSIONS 0
: 0
The 0
results 0
show 0
that 0
intranasal 0
challenge 0
with 0
FLU 0
induces 0
changes 0
in 0
leukocyte 0
histamine 0
release 0
, 0
but 0
not 0
other 0
systemic 0
immune 0
and 0
inflammatory 0
responses 0
. 0

Southern 0
blot 0
analysis 0
revealed 0
that 0
CCaMK B-gene
is 0
encoded 0
by 0
a 0
single 0
gene 0
. 0

The 0
gamma B-gene
- I-gene
GCS I-gene
gene I-gene
is 0
expressed 0
ubiquitously 0
and 0
induced 0
coordinately 0
with 0
NAD B-gene
( I-gene
P I-gene
) I-gene
H I-gene
: I-gene
quinone I-gene
oxidoreductase I-gene
( I-gene
1 I-gene
) I-gene
( 0
NQO1 B-gene
) 0
and 0
glutathione B-gene
S I-gene
- I-gene
transferase I-gene
Ya I-gene
( 0
GST B-gene
Ya I-gene
) 0
in 0
response 0
to 0
xenobiotics 0
and 0
antioxidants 0
. 0

A 0
fine 0
- 0
structure 0
radiation 0
hybrid 0
map 0
for 0
the 0
region 0
that 0
extends 0
from 0
D8S520 B-gene
( 0
distal 0
) 0
to 0
D8S1759 B-gene
( 0
proximal 0
) 0
was 0
prepared 0
, 0
followed 0
by 0
construction 0
of 0
a 0
single 0
, 0
integrated 0
YAC/BAC 0
contig 0
for 0
the 0
interval 0
. 0

The 0
N1 0
- 0
P2 0
amplitudes 0
of 0
the 0
AEP 0
decreased 0
with 0
increasing 0
strength 0
of 0
muscular 0
innervation 0
. 0

Measurements 0
in 0
rats 0
given 0
a 0
dose 0
of 0
propranolol 0
that 0
partially 0
inhibited 0
the 0
NA 0
- 0
induced 0
increase 0
in 0
Q 0
to 0
IBAT 0
indicated 0
that 0
the 0
decline 0
in 0
ENAIBAT 0
was 0
attributable 0
primarily 0
to 0
the 0
increase 0
in 0
Q 0
rather 0
than 0
to 0
increasing 0
saturation 0
of 0
uptake 0
mechanisms 0
. 0

Messenger 0
RNA 0
for 0
the 0
Ad2 B-gene
DNA I-gene
binding I-gene
protein I-gene
: 0
DNA 0
sequences 0
encoding 0
the 0
first 0
leader 0
and 0
heterogenity 0
at 0
the 0
mRNA 0
5 0
' 0
end 0
. 0

All 0
rights 0
reserved 0
. 0

These 0
results 0
were 0
not 0
obtained 0
using 0
either 0
preimmune 0
sera 0
or 0
antiserum 0
specific 0
for 0
the 0
luminal 0
portion 0
of 0
the 0
glycoprotein 0
precursor 0
. 0

The 0
yeast 0
genome 0
contains 0
a 0
single 0
ORD1 B-gene
gene I-gene
that 0
resides 0
on 0
chromosome 0
XI 0
. 0

HNF4alpha7 B-gene
mRNA I-gene
is 0
also 0
found 0
in 0
totipotent 0
embryonic 0
stem 0
cells 0
. 0

Northern 0
( 0
RNA 0
) 0
blot 0
hybridization 0
analysis 0
with 0
the 0
p68c B-gene
- I-gene
ets I-gene
- I-gene
1 I-gene
- 0
specific 0
sequence 0
and 0
RNase B-gene
protection 0
experiments 0
showed 0
that 0
the 0
corresponding 0
mRNA 0
was 0
expressed 0
in 0
normal 0
chicken 0
spleen 0
and 0
not 0
in 0
normal 0
chicken 0
thymus 0
or 0
in 0
various 0
T 0
lymphoid 0
cell 0
lines 0
. 0

The 0
fz B-gene
- I-gene
1 I-gene
and 0
fz B-gene
- I-gene
2 I-gene
genes I-gene
are 0
widely 0
expressed 0
in 0
rat 0
tissues 0
with 0
the 0
highest 0
steady 0
- 0
state 0
levels 0
of 0
mRNA 0
in 0
kidney 0
, 0
liver 0
, 0
heart 0
, 0
uterus 0
, 0
and 0
ovary 0
. 0
fz B-gene
- I-gene
1 I-gene
and I-gene
- I-gene
2 I-gene
mRNA I-gene
levels 0
were 0
greater 0
in 0
neonatal 0
than 0
in 0
corresponding 0
adult 0
tissues 0
. 0

We 0
carried 0
out 0
two 0
experiments 0
to 0
investigate 0
this 0
problem 0
. 0

Mean 0
concentration 0
of 0
insulin B-gene
in 0
maternal 0
plasma 0
across 0
all 0
sampling 0
times 0
was 0
higher 0
in 0
ethanol 0
treated 0
animals 0
. 0

Steady 0
- 0
state 0
levels 0
of 0
murine B-gene
MMR I-gene
mRNA I-gene
were 0
measured 0
in 0
the 0
macrophage 0
cell 0
line 0
J774E 0
, 0
which 0
is 0
known 0
to 0
express 0
the 0
protein 0
at 0
the 0
cell 0
surface 0
. 0

In 0
this 0
work 0
, 0
we 0
have 0
used 0
Xenopus 0
oocyte 0
maturation 0
as 0
a 0
read 0
- 0
out 0
for 0
examining 0
the 0
ability 0
of 0
the 0
neu B-gene
tyrosine B-gene
kinase I-gene
( 0
p185neu B-gene
) 0
to 0
participate 0
with 0
the 0
epidermal B-gene
growth I-gene
factor I-gene
( I-gene
EGF I-gene
) I-gene
receptor I-gene
in 0
a 0
common 0
signal 0
transduction 0
pathway 0
. 0

Triaxiality 0
in 0
the 0
proton 0
- 0
neutron 0
interacting 0
boson 0
model 0
: 0
Perturbed 0
O 0
( 0
6 0
) 0
symmetry 0
with 0
application 0
to 0
the 0
mass 0
A 0

Role 0
of 0
distinct 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
pathways 0
and 0
cooperation 0
between 0
Ets B-gene
- I-gene
2 I-gene
, 0
ATF B-gene
- I-gene
2 I-gene
, 0
and 0
Jun B-gene
family I-gene
members I-gene
in 0
human B-gene
urokinase I-gene
- I-gene
type I-gene
plasminogen I-gene
activator I-gene
gene I-gene
induction 0
by 0
interleukin B-gene
- I-gene
1 I-gene
and 0
tetradecanoyl 0
phorbol 0
acetate 0
. 0

Comparative 0
volumetric 0
analysis 0
is 0
defined 0
as 0
the 0
difference 0
between 0
mean 0
corpuscular 0
erythrocyte 0
volume 0
in 0
peripheral 0
blood 0
( 0
MCVB 0
) 0
diluted 0
in 0
urine 0
supernatant 0
after 0
centrifugation 0
and 0
mean 0
corpuscular 0
volume 0
of 0
urinary 0
erythrocytes 0
( 0
MCVU 0
) 0
. 0

To 0
assess 0
whether 0
thallium 0
- 0
201 0
thallous 0
chloride 0
( 0
Tl 0
) 0
can 0
detect 0
childhood 0
tumors 0
and 0
whether 0
diagnostic 0
effectiveness 0
improves 0
with 0
combined 0
blood 0
flow 0
imaging 0
, 0
28 0
children 0
( 0
1.0 0
- 0
18.6 0
years 0
) 0
were 0
studied 0
using 0
single 0
photon 0
emission 0
computed 0
tomography 0
( 0
SPECT 0
) 0
: 0
Tl 0
( 0
1.3 0
- 0
1.8 0
mCi 0
intravenously 0
) 0
, 0
followed 0
in 0
13 0
of 0
the 0
patients 0
by 0
technetium 0
- 0
99m 0
- 0
hexamethylpropyleneamine 0
oxime 0
( 0
99mTc 0
- 0
HMPAO 0
; 0
8 0
- 0
18 0
mCi 0
intravenously 0
) 0
. 0

The 0
role 0
of 0
NUT1 B-gene
and 0
regulation 0
of 0
nitrogen 0
metabolism 0
in 0
the 0
disease 0
process 0
was 0
evaluated 0
by 0
pathogenicity 0
assays 0
. 0

Analysis 0
of 0
tobacco 0
mRNA 0
using 0
the 0
ACBF B-gene
cDNA I-gene
as 0
probe 0
showed 0
that 0
while 0
ACBF B-gene
mRNA I-gene
was 0
present 0
in 0
all 0
tissues 0
examined 0
, 0
the 0
highest 0
transcript 0
accumulation 0
occurred 0
in 0
stem 0
tissues 0
. 0

When 0
PCR 0
was 0
used 0
to 0
amplify 0
agar 0
cultures 0
which 0
do 0
not 0
express 0
the 0
fimbriae 0
, 0
the 0
switch 0
region 0
was 0
OFF 0
only 0
. 0

We 0
therefore 0
investigated 0
whether 0
the 0
promoter 0
activity 0
of 0
the 0
mouse B-gene
TRH I-gene
gene I-gene
is 0
directly 0
regulated 0
by 0
RA 0
using 0
a 0
transient 0
transfection 0
assay 0
into 0
CV 0
- 0
1 0
cells 0
. 0

This 0
study 0
tests 0
the 0
hypothesis 0
that 0
O2 0
is 0
a 0
critical 0
component 0
in 0
myocardial 0
protection 0
afforded 0
by 0
BCP 0
. 0

Sin4 B-gene
and 0
Srb10 B-gene
, 0
components 0
of 0
specific 0
RNA B-gene
polymerase I-gene
II I-gene
sub I-gene
- I-gene
complexes I-gene
that 0
are 0
required 0
for 0
Ssn6 B-gene
- 0
Tup1 B-gene
repression 0
activity 0
, 0
are 0
found 0
to 0
be 0
required 0
for 0
Sfl1 B-gene
repression 0
function 0
. 0

Functional 0
PET 0
scanning 0
in 0
the 0
preoperative 0
assessment 0
of 0
cerebral 0
arteriovenous 0
malformations 0
. 0

The 0
MEE 0
was 0
significantly 0
greater 0
than 0
the 0
BEE 0
and 0
significantly 0
less 0
than 0
the 0
calculated 0
energy 0
expenditure 0
. 0

Differences 0
were 0
not 0
found 0
in 0
colons 0
by 0
SEM 0
. 0

Consistent 0
with 0
this 0
, 0
rh5 B-gene
expression 0
in 0
R8 B-gene
disappears 0
when 0
R7 0
cells 0
are 0
absent 0
( 0
in 0
sevenless B-gene
mutant I-gene
) 0
. 0

The 0
human 0
RIL B-gene
gene I-gene
: 0
mapping 0
to 0
human 0
chromosome 0
5q31.1 0
, 0
genomic 0
organization 0
and 0
alternative 0
transcripts 0
. 0

These 0
findings 0
indicated 0
that 0
p35 B-gene
is 0
a 0
trans 0
- 0
dominant 0
factor 0
that 0
facilitates 0
AcMNPV 0
growth 0
in 0
a 0
cell 0
line 0
- 0
specific 0
manner 0
. 0

We 0
found 0
remarkable 0
differences 0
in 0
the 0
expression 0
patterns 0
of 0
MTB B-gene
- I-gene
Zf I-gene
mRNA I-gene
and 0
two 0
other 0
hybridizable 0
mRNAs 0
of 0
5kb 0
and 0
8.5 0
kb 0
when 0
human 0
brain 0
and 0
primary 0
brain 0
tumors 0
were 0
compared 0
. 0

We 0
have 0
recently 0
shown 0
that 0
induced 0
expression 0
of 0
a 0
CDK B-gene
target 0
site 0
- 0
deficient 0
mutant 0
, 0
Op18 B-gene
- 0
S25A 0
, 0
S38A 0
, 0
blocks 0
human 0
cell 0
lines 0
during 0
G2/M 0
transition 0
. 0

ATF6 B-gene
, 0
a 0
basic B-gene
- I-gene
leucine I-gene
zipper I-gene
protein I-gene
, 0
was 0
isolated 0
by 0
binding 0
to 0
SRF B-gene
and 0
in 0
particular 0
to 0
its 0
transcriptional 0
activation 0
domain 0
. 0

An 0
ICU 0
length 0
of 0
stay 0
shorter 0
than 0
24 0
h 0
was 0
not 0
related 0
to 0
the 0
frequency 0
of 0
group 0
C 0
errors 0
. 0

Primers 0
were 0
developed 0
for 0
specific 0
amplification 0
of 0
9804 B-gene
gene I-gene
fragments I-gene
. 0

These 0
results 0
demonstrate 0
that 0
GGTase B-gene
- I-gene
I I-gene
inhibitors 0
arrest 0
cells 0
in 0
G0/G1 0
and 0
induce 0
accumulation 0
of 0
p21WAF B-gene
in 0
a 0
p53 B-gene
- 0
independent 0
manner 0
and 0
that 0
FTase B-gene
inhibitors 0
can 0
interfere 0
with 0
cell 0
cycle 0
events 0
by 0
a 0
mechanism 0
that 0
involves 0
neither 0
p21WAF B-gene
nor 0
p27KIP B-gene
. 0

These 0
results 0
provide 0
strong 0
evidence 0
that 0
conserved 0
interhelical 0
packing 0
interactions 0
in 0
the 0
gp41 B-gene
core I-gene
are 0
important 0
determinants 0
of 0
HIV 0
- 0
1 0
entry 0
and 0
its 0
inhibition 0
. 0

Thus 0
, 0
CR2 B-gene
possesses 0
an 0
essential 0
function 0
besides 0
pRb B-gene
- 0
binding 0
. 0

Injection 0
of 0
horseradish B-gene
peroxidase I-gene
( 0
HRP B-gene
) 0
into 0
the 0
cerebellar 0
flocculus 0
of 0
the 0
rat 0
was 0
employed 0
to 0
identify 0
neurons 0
in 0
the 0
abducens 0
nucleus 0
that 0
project 0
to 0
the 0
flocculus 0
. 0

Natl 0
. 0

In 0
contrast 0
, 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
activation 0
was 0
observed 0
in 0
these 0
cells 0
after 0
PMA 0
stimulation 0
. 0

From 0
our 0
own 0
investigations 0
on 0
phantoms 0
, 0
the 0
smallest 0
signal 0
- 0
to 0
- 0
noise 0
ratio 0
( 0
delta 0
S 0
min/delta 0
R 0
) 0
was 0
obtained 0
which 0
determines 0
the 0
minimal 0
contrast 0
, 0
given 0
the 0
film 0
properties 0
( 0
film 0
response 0
S 0
, 0
film 0
gradient 0
gamma 0
) 0
and 0
the 0
amount 0
of 0
scatter 0
. 0

It 0
encodes 0
a 0
sequence 0
- 0
specific 0
transcription 0
factor 0
that 0
controls 0
, 0
in 0
concert 0
with 0
other 0
gene 0
products 0
, 0
differentiative 0
pathways 0
of 0
tissues 0
in 0
which 0
Scr B-gene
is 0
expressed 0
. 0

We 0
functionally 0
characterised 0
AtXPO1 B-gene
by 0
its 0
interaction 0
with 0
NESs 0
of 0
animal 0
and 0
plant 0
proteins 0
, 0
which 0
is 0
inhibited 0
by 0
the 0
cytotoxin 0
leptomycin 0
B 0
( 0
LMB 0
) 0
, 0
and 0
also 0
by 0
its 0
interaction 0
with 0
the 0
small B-gene
GTPase I-gene
Ran1 B-gene
in 0
the 0
yeast 0
two 0
- 0
hybrid 0
system 0
. 0

The 0
use 0
of 0
self 0
- 0
measured 0
blood 0
pressure 0
determinations 0
in 0
assessing 0
dynamics 0
of 0
drug 0
compliance 0
in 0
a 0
study 0
with 0
amlodipine 0
once 0
a 0
day 0
, 0
morning 0
versus 0
evening 0
. 0

The 0
enzyme 0
encoded 0
by 0
the 0
cloned 0
fragment 0
is 0
equally 0
active 0
on 0
pyruvate 0
and 0
hydroxypyruvate 0
, 0
indicating 0
that 0
the 0
enzyme 0
has 0
both 0
D B-gene
- I-gene
lactate I-gene
and I-gene
D I-gene
- I-gene
glycerate I-gene
dehydrogenase I-gene
activities 0
. 0

We 0
propose 0
that 0
unc B-gene
- I-gene
37 I-gene
may 0
be 0
regulated 0
by 0
unc B-gene
- I-gene
4 I-gene
. 0

The 0
gag B-gene
- 0
myc B-gene
proteins 0
encoded 0
by 0
these 0
variants 0
efficiently 0
localized 0
to 0
the 0
cell 0
nucleus 0
. 0

From 0
the 0
supposition 0
that 0
there 0
exists 0
a 0
possible 0
connection 0
between 0
certain 0
psychopathological 0
symptoms 0
, 0
and/or 0
syndromes 0
( 0
e.g. 0
, 0
hallucinations 0
) 0
and 0
regional 0
cerebral 0
dysfunction 0
, 0
patients 0
suffering 0
from 0
auditory 0
and 0
tactile 0
hallucinations 0
were 0
investigated 0
, 0
in 0
a 0
symptom 0
- 0
oriented 0
study 0
, 0
using 0
the 0
method 0
of 0
technetium 0
- 0
99m 0
- 0
Hexamethyl 0
- 0
propylenamine 0
Oxime 0
( 0
99m 0
- 0
Tc 0
- 0
HMPAO 0
) 0
- 0
Single 0
Photon 0
Emission 0
Computed 0
Tomography 0
( 0
SPECT 0
) 0
and 0
compared 0
with 0
normal 0
controls 0
. 0

The 0
encoded 0
260 B-gene
- I-gene
amino I-gene
- I-gene
acid I-gene
( I-gene
aa I-gene
) I-gene
( I-gene
H1 I-gene
- I-gene
I I-gene
) I-gene
and 0
240 B-gene
- I-gene
aa I-gene
( I-gene
H1 I-gene
- I-gene
II I-gene
) I-gene
polypeptides I-gene
possess 0
the 0
typical 0
tripartite 0
organization 0
of 0
animal B-gene
H1 I-gene
histones I-gene
, 0
with 0
variable 0
N 0
- 0
and 0
C 0
- 0
terminal 0
domains 0
flanking 0
a 0
conserved 0
'globular 0
' 0
DNA 0
- 0
binding 0
domain 0
. 0

The 0
best 0
- 0
studied 0
neurotrophin 0
, 0
nerve B-gene
growth I-gene
factor I-gene
( 0
NGF B-gene
) 0
, 0
is 0
a 0
major 0
survival 0
factor 0
in 0
sympathetic 0
and 0
sensory 0
neurons 0
and 0
promotes 0
differentiation 0
in 0
a 0
well 0
- 0
studied 0
model 0
system 0
, 0
PC12 0
cells 0
. 0

In 0
a 0
subsequent 0
phase 0
- 0
II 0
clinical 0
trial 0
safety 0
and 0
efficacy 0
of 0
transrectal 0
HIFU 0
as 0
a 0
novel 0
minimally 0
invasive 0
treatment 0
modality 0
for 0
patients 0
with 0
symptomatic 0
benign 0
prostatic 0
hyperplasia 0
( 0
BPH 0
; 0
n 0
= 0
102 0
) 0
was 0
determined 0
. 0

A 0
novel 0
alternative 0
spliced 0
variant 0
of 0
the 0
transcription 0
factor 0
AP2alpha B-gene
is 0
expressed 0
in 0
the 0
murine 0
ocular 0
lens 0
. 0

CONCLUSION 0
: 0
high 0
resolution 0
MF 0
- 0
ERG 0
seems 0
more 0
sensitive 0
than 0
low 0
resolution 0
MF 0
- 0
ERG 0
. 0

The 0
residual 0
small 0
rRNAs 0
in 0
[ 0
poky 0
] 0
appear 0
to 0
be 0
synthesized 0
via 0
the 0
upstream 0
promoter 0
( 0
s 0
) 0
, 0
but 0
are 0
missing 0
37 0
- 0
44 0
nucleotides 0
from 0
their 0
5 0
' 0
ends 0
, 0
indicating 0
either 0
that 0
pre 0
- 0
rRNAs 0
are 0
processed 0
abnormally 0
or 0
that 0
abnormal 0
5 0
' 0
RNA 0
ends 0
are 0
unstable 0
. 0

Homology 0
is 0
much 0
higher 0
( 0
64 0
% 0
) 0
between 0
the 0
28 0
- 0
kDa 0
protein 0
and 0
regions 0
that 0
are 0
strongly 0
conserved 0
among 0
the 0
members 0
of 0
the 0
serine B-gene
protease I-gene
family I-gene
. 0

In 0
contrast 0
, 0
inactivation 0
of 0
the 0
Sir4p B-gene
- I-gene
interacting I-gene
protein I-gene
Rap1p I-gene
reduces 0
partitioning 0
by 0
a 0
LexA B-gene
- 0
Sir4p B-gene
fusion 0
. 0

Childbirth 0
and 0
authoritative 0
knowledge 0
. 0

Thus 0
, 0
the 0
end 0
of 0
a 0
linearized 0
DNA 0
fragment 0
can 0
initiate 0
new 0
DNA 0
synthesis 0
by 0
BIR 0
in 0
which 0
the 0
newly 0
synthesized 0
DNA 0
is 0
displaced 0
and 0
subsequently 0
forms 0
circles 0
by 0
NHEJ 0
. 0

The 0
relationship 0
between 0
polymorphonuclear 0
granulocytes 0
and 0
cartilage 0
destruction 0
in 0
rheumatoid 0
arthritis 0
. 0

From 0
the 0
deduced 0
amino 0
acid 0
sequence 0
, 0
a 0
molecular 0
weight 0
of 0
38,549 0
was 0
calculated 0
for 0
the 0
ADH B-gene
subunit I-gene
. 0

Nine 0
months 0
after 0
the 0
end 0
of 0
the 0
vaccination 0
anti B-gene
- I-gene
HBsAg I-gene
levels 0
had 0
dropped 0
to 0
9 0
+/ 0
- 0
4 0
IU/1 0
( 0
M 0
+/ 0
- 0
SE 0
) 0
, 0
with 0
a 0
geometric 0
mean 0
of 0
5 0
IU/1 0
, 0
in 0
the 0
nine 0
remaining 0
evaluable 0
patients 0
. 0

The 0
point 0
mutation 0
Asp 0
- 0
316 0
- 0
- 0
> 0
Asn 0
in 0
the 0
C 0
- 0
terminus 0
of 0
p38 B-gene
, 0
analogous 0
to 0
the 0
ERK2 B-gene
( 0
extracellular B-gene
- I-gene
signal I-gene
- I-gene
regulated I-gene
kinase I-gene
2 I-gene
) 0
sevenmaker B-gene
mutation 0
, 0
dramatically 0
decreases 0
its 0
binding 0
to 0
MKP B-gene
- I-gene
1 I-gene
and 0
substantially 0
compromises 0
its 0
stimulatory 0
effect 0
on 0
the 0
catalytic 0
activity 0
of 0
this 0
phosphatase 0
. 0

Cortical 0
somatosensory 0
evoked 0
potentials 0
to 0
median 0
nerve 0
stimulation 0
revealed 0
significantly 0
delayed 0
peak 0
latencies 0
of 0
N20 0
, 0
P20 0
, 0
P25 0
, 0
and 0
N26 0
, 0
although 0
N16 0
latency 0
was 0
normal 0
. 0

Catalase B-gene
plays 0
a 0
key 0
role 0
as 0
an 0
antioxidant 0
, 0
protecting 0
aerobic 0
organisms 0
from 0
the 0
toxic 0
effects 0
of 0
hydrogen 0
peroxide 0
, 0
and 0
in 0
some 0
cases 0
has 0
been 0
postulated 0
to 0
be 0
a 0
virulence 0
factor 0
. 0

Prazosin 0
in 0
the 0
treatment 0
of 0
high 0
blood 0
pressure 0

The 0
results 0
suggest 0
that 0
proenzyme 0
processing 0
is 0
not 0
essential 0
for 0
secretion 0
of 0
PC2 B-gene
, 0
but 0
peptides 0
containing 0
mutations 0
that 0
affect 0
the 0
ability 0
of 0
the 0
propeptide 0
( 0
and 0
cleavage 0
sites 0
) 0
to 0
fold 0
within 0
the 0
catalytic 0
pocket 0
are 0
not 0
transferred 0
beyond 0
the 0
early 0
stages 0
of 0
the 0
secretory 0
pathway 0
. 0

Cloning 0
, 0
sequence 0
analysis 0
, 0
and 0
expression 0
of 0
the 0
gene B-gene
encoding I-gene
formaldehyde I-gene
dismutase I-gene
from I-gene
Pseudomonas I-gene
putida I-gene
F61 I-gene
. 0

Taking 0
into 0
account 0
certain 0
well 0
defined 0
conditions 0
( 0
frequent 0
feedings 0
, 0
no 0
supplementary 0
feeding 0
before 0
4 0
- 0
6 0
months 0
, 0
method 0
only 0
to 0
be 0
used 0
in 0
the 0
absence 0
of 0
menstruation 0
) 0
, 0
LAM 0
can 0
be 0
relied 0
on 0
for 0
contraceptive 0
protection 0
for 0
up 0
to 0
1 0
year 0
post 0
partum 0
. 0

The 0
bioconversion 0
of 0
penicillin 0
G 0
, 0
an 0
inexpensive 0
substrate 0
, 0
to 0
the 0
valuable 0
intermediate 0
for 0
semisynthetic 0
cephalosporin 0
production 0
, 0
deacetoxycephalosporin 0
G 0
( 0
DAOG 0
) 0
, 0
had 0
been 0
recently 0
shown 0
to 0
be 0
increased 0
by 0
eliminating 0
agitation 0
and 0
adding 0
decane 0
. 0

Doctors 0
given 0
intrathecal 0
methotrexate 0
had 0
headache 0
when 0
20 0
gauge 0
standard 0
needle 0
was 0
used 0
. 0

The 0
IGFBP B-gene
- I-gene
1 I-gene
IRS B-gene
and 0
PEPCK B-gene
IRS B-gene
both 0
bind 0
the 0
alpha 0
and 0
beta 0
forms 0
of 0
hepatic B-gene
nuclear I-gene
factor I-gene
3 I-gene
( 0
HNF B-gene
- I-gene
3 I-gene
) 0
, 0
although 0
the 0
latter 0
does 0
so 0
with 0
a 0
sixfold 0
- 0
lower 0
relative 0
affinity 0
. 0

Free 0
protein B-gene
S I-gene
deficiency 0
in 0
acute 0
ischemic 0
stroke 0
. 0

Low 0
- 0
affinity 0
E2 B-gene
- I-gene
binding I-gene
site I-gene
mediates 0
downmodulation 0
of 0
E2 B-gene
transactivation 0
of 0
the 0
human B-gene
papillomavirus I-gene
type I-gene
8 I-gene
late I-gene
promoter I-gene
. 0

This 0
domain 0
encompasses 0
the 0
region 0
of 0
ARP B-gene
- I-gene
1/COUP I-gene
1/COUP I-gene
- I-gene
TFII I-gene
corresponding 0
to 0
helices 0
3 0
to 0
12 0
in 0
the 0
recently 0
published 0
crystal 0
structure 0
of 0
other 0
members 0
of 0
the 0
nuclear B-gene
receptor I-gene
superfamily I-gene
. 0

Our 0
data 0
suggest 0
that 0
the 0
ZF B-gene
- I-gene
HD I-gene
class 0
of 0
homeodomain B-gene
proteins I-gene
may 0
be 0
involved 0
in 0
the 0
establishment 0
of 0
the 0
characteristic 0
expression 0
pattern 0
of 0
the 0
C4 B-gene
PEPCase I-gene
gene I-gene
. 0

When 0
medical 0
aid 0
was 0
sought 0
a 0
false 0
history 0
was 0
given 0
and 0
the 0
true 0
nature 0
of 0
the 0
child 0
's 0
illness 0
, 0
heat 0
stroke 0
, 0
was 0
not 0
determined 0
until 0
after 0
death 0
. 0

BACKGROUND 0
. 0

To 0
test 0
the 0
role 0
of 0
myb B-gene
family I-gene
members I-gene
in 0
progression 0
through 0
the 0
cell 0
cycle 0
, 0
we 0
comicroinjected 0
c B-gene
- I-gene
myc I-gene
and 0
myb B-gene
expression 0
vectors 0
into 0
serum 0
- 0
deprived 0
quiescent 0
SMCs 0
. 0

Previous 0
studies 0
have 0
shown 0
that 0
the 0
IME1 B-gene
gene I-gene
is 0
required 0
for 0
sporulation 0
and 0
the 0
expression 0
of 0
meiosis 0
specific 0
genes 0
in 0
Saccharomyces 0
cerevisiae 0
. 0

Cytogenetic 0
structures 0
showed 0
a 0
mixte 0
karyotype 0
: 0
mosaicim 0
46 0
XX/46 0
XY 0
with 0
a 0
ratio 0
of 0
a 0
80/20 0
. 0

CONCLUSION 0
: 0
Ultrasound 0
biomicroscopy 0
is 0
a 0
useful 0
tool 0
for 0
the 0
evaluation 0
of 0
APVR 0
, 0
which 0
is 0
difficult 0
by 0
ordinary 0
methods 0
. 0

Morphological 0
- 0
functional 0
status 0
of 0
the 0
edentulous 0
mandible 0
and 0
selection 0
of 0
the 0
most 0
effective 0
method 0
for 0
functional 0
impression 0
- 0
taking 0

Eight 0
of 0
the 0
17 0
seropositive 0
patients 0
failed 0
to 0
develop 0
detectable 0
hepatitis B-gene
B I-gene
surface I-gene
antibody I-gene
within 0
three 0
months 0
of 0
the 0
third 0
injection 0
compared 0
with 0
only 0
one 0
of 0
the 0
18 0
seronegative 0
patients 0
( 0
p 0
less 0
than 0
0.01 0
) 0
. 0

Like 0
the 0
human 0
gene 0
, 0
the 0
Drosophila 0
gene 0
encodes 0
at 0
least 0
three 0
isoforms 0
of 0
full B-gene
length I-gene
dystrophin I-gene
- I-gene
like I-gene
proteins I-gene
( 0
dmDLP1 B-gene
, 0
dmDLP2 B-gene
and 0
dmDLP3 B-gene
, 0
) 0
, 0
regulated 0
by 0
different 0
promoters 0
located 0
at 0
the 0
5 0
' 0
end 0
of 0
the 0
gene 0
, 0
and 0
a 0
smaller 0
product 0
regulated 0
by 0
an 0
internal 0
promoter 0
( 0
dmDp186 B-gene
) 0
. 0

In 0
this 0
study 0
, 0
the 0
case 0
of 0
a 0
patient 0
presenting 0
a 0
second 0
hepatocellular 0
carcinoma 0
13 0
years 0
after 0
resection 0
of 0
a 0
first 0
tumor 0
of 0
the 0
same 0
type 0
is 0
reported 0
. 0

The 0
equation 0
for 0
mean 0
trabecular 0
number 0
passed 0
the 0
test 0
, 0
whereas 0
the 0
validity 0
of 0
the 0
equations 0
for 0
mean 0
trabecular 0
separation 0
and 0
Tb.Wi 0
appeared 0
limited 0
. 0

Although 0
the 0
only 0
authoritative 0
way 0
to 0
determine 0
the 0
effect 0
of 0
diet 0
on 0
urinary 0
pH 0
is 0
a 0
feeding 0
trial 0
, 0
there 0
is 0
no 0
universally 0
accepted 0
protocol 0
for 0
measuring 0
urinary 0
pH 0
. 0

The 0
performances 0
of 0
two 0
tests 0
, 0
the 0
ProstAsure 0
index 0
and 0
the 0
percent 0
free 0
PSA B-gene
test 0
, 0
were 0
evaluated 0
in 0
detecting 0
cancer 0
. 0

But 0
if 0
one 0
equalizes 0
the 0
upper 0
limits 0
of 0
normal 0
for 0
both 0
markers 0
to 0
a 0
common 0
95 0
% 0
specificity 0
, 0
the 0
tumour 0
- 0
indicating 0
sensitivity 0
of 0
CA B-gene
19 I-gene
- I-gene
9 I-gene
clearly 0
surpasses 0
that 0
of 0
CA B-gene
50 I-gene
. 0

For 0
economical 0
reasons 0
, 0
we 0
could 0
not 0
send 0
a 0
questionnaire 0
to 0
all 0
the 0
35,779 0
individuals 0
, 0
but 0
based 0
the 0
investigation 0
on 0
a 0
SRS 0
of 0
4,000 0
men 0
, 0
post 0
- 0
stratified 0
in 0
a 0
high 0
- 0
risk 0
and 0
a 0
low 0
- 0
risk 0
group 0
. 0

Thus 0
, 0
over 0
a 0
wide 0
range 0
of 0
arterial 0
dimensions 0
, 0
results 0
obtained 0
with 0
caliper 0
estimates 0
of 0
luminal 0
area 0
and 0
diameter 0
are 0
comparable 0
to 0
those 0
obtained 0
with 0
videodensitometry 0
using 0
the 0
XR 0
- 0
70 0
system 0
. 0

Oncogenic 0
activation 0
of 0
RET B-gene
is 0
detected 0
in 0
human 0
papillary 0
thyroid 0
tumours 0
and 0
in 0
multiple 0
endocrine 0
neoplasia 0
type 0
2 0
syndromes 0
. 0

Evasion 0
of 0
host 0
immunity 0
by 0
Toxocara 0
canis 0
infective 0
larvae 0
is 0
mediated 0
by 0
the 0
nematode 0
surface 0
coat 0
, 0
which 0
is 0
shed 0
in 0
response 0
to 0
binding 0
by 0
host 0
antibody 0
molecules 0
or 0
effector 0
cells 0
. 0

These 0
data 0
show 0
that 0
the 0
processing 0
of 0
specific 0
target 0
transcripts 0
, 0
such 0
as 0
the 0
P B-gene
- I-gene
element I-gene
mRNA I-gene
, 0
is 0
regulated 0
by 0
a 0
functional 0
PSI B-gene
- 0
U1 B-gene
snRNP 0
interaction 0
in 0
Drosophila 0
. 0

The 0
predicted 0
proteins 0
show 0
strong 0
homology 0
to 0
an 0
ABA B-gene
- I-gene
inducible I-gene
glycine I-gene
- I-gene
rich I-gene
protein I-gene
from 0
maize 0
embryos 0
and 0
to 0
the 0
mammalian B-gene
RNA I-gene
- I-gene
binding I-gene
protein I-gene
A1 I-gene
of 0
the 0
heterogeneous 0
nuclear 0
ribonucleoprotein 0
complex 0
involved 0
in 0
pre 0
- 0
mRNA 0
splicing 0
. 0

Ptx1 B-gene
belongs 0
to 0
an 0
expanding 0
family 0
of 0
bicoid B-gene
- I-gene
related I-gene
vertebrate 0
homeobox 0
genes 0
. 0

Reactive 0
mesothelial 0
cells 0
, 0
usually 0
seen 0
as 0
exfoliated 0
cells 0
, 0
were 0
consistently 0
strongly 0
positive 0
for 0
alpha B-gene
1 I-gene
- I-gene
antichymotrypsin I-gene
and 0
more 0
variably 0
for 0
alpha B-gene
1 I-gene
- I-gene
antitrypsin I-gene
and 0
lysozyme B-gene
. 0

However 0
, 0
all 0
pathophysiologic 0
assessments 0
reported 0
to 0
date 0
have 0
been 0
carried 0
out 0
during 0
or 0
immediately 0
after 0
IVOX 0
utilization 0
. 0

The 0
wet 0
and 0
dry 0
methods 0
of 0
the 0
HA 0
synthesis 0
are 0
considered 0
. 0

In 0
agreement 0
with 0
other 0
authors 0
, 0
we 0
recommend 0
the 0
procedure 0
as 0
a 0
safe 0
one 0
, 0
providing 0
satisfactory 0
results 0
. 0

In 0
several 0
steps 0
we 0
converted 0
the 0
retinoid 0
specific 0
response 0
element 0
of 0
the 0
human B-gene
retinoic I-gene
acid I-gene
receptor I-gene
beta I-gene
promoter I-gene
into 0
the 0
vitamin 0
D/retinoic 0
acid 0
response 0
element 0
of 0
the 0
human B-gene
osteocalcin I-gene
promoter I-gene
. 0

Our 0
data 0
define 0
Ile 0
( 0
16 0
) 0
, 0
Val 0
( 0
18 0
) 0
, 0
Val 0
( 0
31 0
) 0
, 0
and 0
Ile 0
( 0
33 0
) 0
as 0
crucial 0
for 0
protein B-gene
S I-gene
binding 0
, 0
with 0
secondary 0
effects 0
from 0
Leu 0
( 0
38 0
) 0
and 0
Val 0
( 0
39 0
) 0
. 0

Synthesis 0
of 0
22 0
- 0
oxavitamin 0
D3 0
analogues 0
. 0

The 0
plasmid 0
was 0
found 0
to 0
confer 0
drug 0
resistance 0
specifically 0
to 0
LMB 0
. 0

Our 0
results 0
suggest 0
that 0
at 0
least 0
some 0
chloroplast B-gene
- I-gene
like I-gene
tRNA I-gene
genes I-gene
in 0
wheat 0
mtDNA 0
are 0
transcribed 0
, 0
with 0
transcripts 0
undergoing 0
processing 0
, 0
post 0
- 0
transcriptional 0
modification 0
and 0
3' 0
- 0
CCA 0
addition 0
, 0
to 0
produce 0
mature 0
tRNAs 0
that 0
may 0
participate 0
in 0
mitochondrial 0
protein 0
synthesis 0
. 0

Previously 0
identified 0
mutations 0
in 0
this 0
variant 0
have 0
been 0
within 0
or 0
close 0
to 0
the 0
coding 0
region 0
of 0
exon 0
1 0
of 0
the 0
HMBS B-gene
gene I-gene
, 0
the 0
only 0
exon 0
that 0
is 0
expressed 0
solely 0
in 0
the 0
ubiquitous 0
isoform 0
. 0

Immunologic 0
tolerance 0
in 0
rats 0
during 0
13 0
weeks 0
of 0
inhalation 0
exposure 0
to 0
trimellitic 0
anhydride 0
. 0

In 0
stage 0
I 0
, 0
histochemistry 0
for 0
copper 0
was 0
positive 0
in 0
11 0
out 0
of 0
21 0
cases 0
: 0
6 0
cases 0
were 0
T+ 0
; 0
1 0
case 0
R+ 0
and 0
2 0
cases 0
O+ 0
; 0
2 0
cases 0
were 0
T+ 0
, 0
R+ 0
, 0
O+ 0
. 0

Rat B-gene
cholesterol I-gene
side I-gene
- I-gene
chain I-gene
cleavage I-gene
cytochrome I-gene
P I-gene
- I-gene
450 I-gene
( 0
P B-gene
- I-gene
450scc I-gene
) 0
gene 0
. 0

Almost 0
every 0
image 0
that 0
appears 0
during 0
a 0
therapy 0
session 0
reveals 0
a 0
symbolic 0
nature 0
, 0
but 0
the 0
very 0
concept 0
of 0
symbol 0
is 0
not 0
free 0
from 0
ambiguity 0
some 0
positions 0
originated 0
in 0
different 0
areas 0
of 0
investigation 0
are 0
mentioned 0
, 0
ending 0
with 0
a 0
description 0
of 0
the 0
traits 0
that 0
, 0
according 0
to 0
the 0
writer 0
, 0
bestow 0
a 0
symbolic 0
character 0
to 0
images 0
. 0

We 0
have 0
mapped 0
the 0
specific 0
domains 0
within 0
each 0
of 0
the 0
proteins 0
responsible 0
for 0
this 0
interaction 0
. 0

A 0
trend 0
was 0
observed 0
toward 0
increased 0
graft 0
half 0
- 0
life 0
in 0
era 0
2 0
( 0
p 0
= 0
NS 0
) 0
. 0

After 0
15 0
min 0
of 0
hemorrhage 0
the 0
cardiovascular 0
parameters 0
were 0
the 0
same 0
in 0
fed 0
and 0
starved 0
animals 0
, 0
but 0
at 0
45 0
min 0
striking 0
differences 0
were 0
observed 0
. 0

A 0
24 0
- 0
year 0
- 0
old 0
pregnant 0
woman 0
started 0
to 0
have 0
hyperemesis 0
gravidarum 0
6 0
weeks 0
before 0
admission 0
. 0

The 0
nucleoporin B-gene
98 I-gene
gene I-gene
( 0
NUP98 B-gene
) 0
, 0
which 0
is 0
rearranged 0
in 0
several 0
acute 0
myeloid 0
leukemia 0
translocations 0
, 0
is 0
located 0
within 0
this 0
region 0
. 0

Human B-gene
CD38 I-gene
, 0
a 0
leukocyte 0
receptor 0
and 0
ectoenzyme 0
, 0
is 0
a 0
member 0
of 0
a 0
novel 0
eukaryotic 0
gene 0
family 0
of 0
nicotinamide B-gene
adenine I-gene
dinucleotide+ I-gene
- I-gene
converting I-gene
enzymes I-gene
: 0
extensive 0
structural 0
homology 0
with 0
the 0
genes 0
for 0
murine B-gene
bone I-gene
marrow I-gene
stromal I-gene
cell I-gene
antigen I-gene
1 I-gene
and 0
aplysian B-gene
ADP I-gene
- I-gene
ribosyl I-gene
cyclase I-gene
. 0

Juvenile 0
angiofibromas 0
. 0

Mutation 0
of 0
the 0
HNF3 B-gene
element I-gene
significantly 0
reduced 0
promoter 0
activity 0
in 0
HepG2 0
cells 0
, 0
whereas 0
this 0
element 0
in 0
isolation 0
conferred 0
HNF3beta B-gene
responsiveness 0
to 0
a 0
heterologous 0
promoter 0
. 0

CONCLUSION 0
: 0
Detection 0
of 0
recurrent 0
head 0
and 0
neck 0
cancer 0
is 0
feasible 0
with 0
FDG 0
PET 0
. 0

The 0
role 0
of 0
haptoglobin B-gene
in 0
asphyxia 0
mechanism 0
( 0
II 0
) 0
- 0
- 0
Acute 0
drowning 0
and 0
hanging 0

Patients 0
adopt 0
new 0
sets 0
based 0
partly 0
on 0
the 0
original 0
topic 0
and 0
partly 0
on 0
their 0
own 0
personal 0
idiosyncratic 0
concerns 0
. 0

RESULTS 0
: 0
PET 0
revealed 0
wide 0
variations 0
in 0
CBF 0
between 0
regions 0
during 0
isoflurane 0
anaesthesia 0
, 0
particularly 0
in 0
comparison 0
with 0
propofol 0
anaesthesia 0
, 0
while 0
rCMRO2 0
decreased 0
globally 0
in 0
a 0
dose 0
- 0
dependent 0
manner 0
during 0
both 0
isoflurane 0
and 0
propofol 0
anaesthesia 0
. 0

Long 0
chain 0
acyl 0
- 0
CoA 0
esters 0
are 0
important 0
intermediates 0
in 0
degradation 0
and 0
synthesis 0
of 0
fatty 0
acids 0
, 0
as 0
well 0
as 0
having 0
important 0
functions 0
in 0
regulation 0
of 0
intermediary 0
metabolism 0
and 0
gene 0
expression 0
. 0

The 0
results 0
of 0
this 0
study 0
indicate 0
that 0
the 0
Improved 0
Crest 0
Complete 0
with 0
longer 0
rippled 0
outer 0
bristles 0
provided 0
significantly 0
superior 0
( 0
p 0
< 0
0.05 0
) 0
interproximal 0
penetration 0
overall 0
and 0
at 0
the 0
gumline 0
than 0
the 0
Colgate 0
Total 0
and 0
Oral 0
- 0
B 0
Advantage 0
brushes 0
. 0

Buchstein 0
, 0
L. 0
- 0
L 0
. 0

The 0
model 0
of 0
the 0
complex 0
provides 0
a 0
rationale 0
for 0
conserved 0
ITAM B-gene
residues 0
, 0
substrate 0
specificity 0
, 0
and 0
suggests 0
that 0
substrate 0
binds 0
only 0
the 0
active 0
conformation 0
of 0
the 0
Src B-gene
family I-gene
tyrosine I-gene
kinase I-gene
, 0
unlike 0
the 0
ATP 0
cofactor 0
, 0
which 0
can 0
bind 0
the 0
inactive 0
form 0
. 0

Sucrose 0
- 0
specific 0
signalling 0
represses 0
translation 0
of 0
the 0
Arabidopsis B-gene
ATB2 I-gene
bZIP I-gene
transcription I-gene
factor I-gene
gene I-gene
. 0

This 0
is 0
probably 0
because 0
, 0
in 0
vivo 0
, 0
some 0
bacteria 0
( 0
perhaps 0
dormant 0
forms 0
) 0
are 0
not 0
entirely 0
dependent 0
upon 0
urease B-gene
for 0
survival 0
. 0

Our 0
aim 0
was 0
to 0
evaluate 0
this 0
technique 0
by 0
cross 0
- 0
calibrating 0
the 0
DXA 0
method 0
with 0
the 0
carcass 0
chemical 0
analysis 0
in 0
a 0
heterogeneous 0
population 0
of 0
nondiabetic 0
Wistar 0
and 0
diabetic 0
GK 0
rats 0
( 0
21 0
animals 0
were 0
used 0
for 0
precision 0
error 0
and 0
reproducibility 0
determinations 0
and 0
26 0
were 0
used 0
for 0
accuracy 0
studies 0
) 0
. 0

Biopsy 0
of 0
the 0
lesion 0
revealed 0
granulomatous 0
inflammation 0
and 0
numerous 0
septate 0
hyphae 0
. 0

There 0
was 0
a 0
highly 0
significant 0
decrease 0
in 0
serum B-gene
eosinophil I-gene
cationic I-gene
protein I-gene
in 0
patients 0
with 0
elevated 0
AGA B-gene
. 0

The 0
prototype 0
now 0
structures 0
oncology 0
- 0
related 0
information 0
available 0
on 0
the 0
Internet 0
and 0
also 0
places 0
resources 0
maintained 0
locally 0
at 0
users 0
' 0
disposal 0
. 0

Ischaemia 0
and 0
reperfusion 0
injury 0
in 0
the 0
kidney 0
: 0
current 0
status 0
and 0
future 0
direction 0
. 0

No 0
viral 0
RNA 0
replication 0
could 0
be 0
detected 0
in 0
cells 0
transfected 0
with 0
mutant 0
RNAs 0
. 0

As 0
to 0
the 0
side 0
effects 0
of 0
SISO 0
, 0
cylindruria 0
with 0
aggravation 0
of 0
microscopic 0
hematuria 0
and 0
elevations 0
of 0
GOT B-gene
, 0
GPT B-gene
and 0
A1 B-gene
- I-gene
P I-gene
were 0
observed 0
each 0
one 0
of 0
them 0
, 0
respectively 0
. 0

However 0
, 0
to 0
date 0
, 0
no 0
viable 0
in 0
vitro 0
- 0
generated 0
deletion 0
mutant 0
of 0
PSTVd 0
has 0
been 0
reported 0
. 0

Reduced 0
cell 0
numbers 0
72 0
h 0
after 0
insonation 0
were 0
recorded 0
when 0
the 0
cells 0
were 0
insonated 0
at 0
an 0
antinode 0
but 0
not 0
when 0
they 0
were 0
at 0
a 0
node 0
. 0

We 0
have 0
now 0
isolated 0
cDNA 0
for 0
an 0
invertebrate B-gene
Pax I-gene
- I-gene
6 I-gene
protein I-gene
from I-gene
sea I-gene
urchin I-gene
embryos I-gene
. 0

Mating 0
response 0
, 0
ovulation 0
rate 0
, 0
follicle 0
and 0
corpus 0
luteum 0
size 0
, 0
gestation 0
length 0
, 0
pregnancy 0
rate 0
, 0
lambing 0
rate 0
, 0
and 0
lamb 0
birth 0
weight 0
were 0
recorded 0
. 0

From 0
1981 0
to 0
1989 0
, 0
a 0
total 0
of 0
26 0
women 0
with 0
locally 0
or 0
regionally 0
advanced 0
carcinoma 0
of 0
the 0
uterine 0
cervix 0
were 0
treated 0
with 0
radiotherapy 0
( 0
RT 0
) 0
and 0
pelvic 0
regional 0
hyperthermia 0
( 0
HT 0
) 0
, 0
in 0
the 0
Divisions 0
of 0
Radiation 0
Oncology 0
at 0
the 0
University 0
of 0
Utah 0
Medical 0
Center 0
( 0
UU 0
) 0
and 0
the 0
Kenneth 0
Norris 0
Jr 0
Cancer 0
Hospital 0
of 0
the 0
University 0
of 0
Southern 0
California 0
( 0
USC 0
) 0
. 0

These 0
proteins 0
were 0
detected 0
by 0
an 0
antibody 0
which 0
recognizes 0
the 0
N 0
- 0
terminus 0
of 0
SRK3 B-gene
and 0
, 0
in 0
an 0
F2 0
progeny 0
segregating 0
for 0
the 0
S3 B-gene
haplotype I-gene
, 0
were 0
only 0
expressed 0
in 0
plants 0
possessing 0
the 0
S3 B-gene
haplotype I-gene
. 0

For 0
all 0
samples 0
, 0
the 0
sensitivity 0
of 0
the 0
blast 0
flag 0
on 0
the 0
CD3500 0
was 0
85 0
% 0
with 0
a 0
specificity 0
of 0
91 0
% 0
( 0
STKS 0
: 0
sensitivity 0
, 0
75 0
% 0
; 0
specificity 0
, 0
85 0
% 0
) 0
; 0
the 0
sensitivity 0
of 0
the 0
CD3500 0
IG 0
flag 0
was 0
72 0
% 0
with 0
a 0
specificity 0
of 0
76 0
% 0
( 0
STKS 0
: 0
sensitivity 0
, 0
75 0
% 0
: 0
specificity 0
, 0
73 0
% 0
) 0
; 0
and 0
the 0
sensitivity 0
of 0
the 0
NRBC 0
flag 0
was 0
43 0
% 0
with 0
a 0
specificity 0
of 0
94 0
% 0
( 0
STKS 0
sensitivity 0
, 0
37 0
% 0
; 0
specificity 0
, 0
88 0
% 0
) 0
. 0

Like 0
other 0
IAPs B-gene
, 0
ch B-gene
- I-gene
IAP1 I-gene
contains 0
the 0
N B-gene
- I-gene
terminal I-gene
baculovirus I-gene
IAP I-gene
repeats I-gene
and 0
C 0
- 0
terminal 0
RING 0
finger 0
motifs 0
. 0

As 0
in 0
the 0
case 0
of 0
the 0
chicken 0
homologue 0
, 0
there 0
are 0
two 0
hPR B-gene
forms 0
, 0
A 0
and 0
B 0
, 0
which 0
originate 0
from 0
translational 0
initiation 0
at 0
AUG2 0
( 0
codon 0
165 0
) 0
and 0
AUG1 0
, 0
respectively 0
. 0

A 0
biopsy 0
specimen 0
taken 0
from 0
the 0
frontal 0
branch 0
of 0
the 0
right 0
superficial 0
artery 0
revealed 0
segmental 0
intimal 0
thickening 0
consistent 0
with 0
intimal 0
fibroplasia 0
type 0
FMD 0
upon 0
histological 0
examination 0
. 0

Serum B-gene
alkaline I-gene
phosphatase I-gene
and 0
creatine B-gene
kinase I-gene
activities 0
were 0
significantly 0
increased 0
in 0
the 0
A 0
praelongus 0
- 0
fed 0
pigs 0
and 0
significantly 0
decreased 0
in 0
Na2SeO4 0
- 0
fed 0
pigs 0
. 0

The 0
activity 0
of 0
gamma B-gene
- I-gene
glutamyl I-gene
transpeptidase I-gene
in 0
the 0
serum 0
of 0
problem 0
drinkers 0
. 0

The 0
content 0
of 0
monoamine 0
metabolites 0
, 0
5 0
- 0
hydroxyindoleacetic 0
acid 0
, 0
5 0
- 0
HIAA 0
, 0
and 0
homovanillic 0
acid 0
( 0
HVA 0
) 0
, 0
and 0
- 0
- 0
for 0
17 0
patients 0
- 0
- 0
tryptophan 0
, 0
in 0
the 0
cerebrospinal 0
fluid 0
was 0
determined 0
. 0

Reduced 0
risk 0
of 0
upper 0
gastrointestinal 0
ulcer 0
complications 0
with 0
celecoxib 0
, 0
a 0
novel 0
COX B-gene
- I-gene
2 I-gene
inhibitor 0
. 0

Mutations 0
in 0
Saccharomyces 0
cerevisiae 0
that 0
block 0
meiotic 0
prophase 0
chromosome 0
metabolism 0
and 0
confer 0
cell 0
cycle 0
arrest 0
at 0
pachytene 0
identify 0
two 0
new 0
meiosis B-gene
- I-gene
specific I-gene
genes I-gene
SAE1 I-gene
and 0
SAE3 B-gene
. 0

The 0
transfer 0
by 0
conjugation 0
to 0
E. 0
coli 0
K12 0
of 0
ampicillin 0
and 0
carbenicillin 0
resistance 0
was 0
obtained 0
with 0
14 0
strains 0
: 0
( 0
E. 0
coli 0
: 0
9 0
, 0
C. 0
freundii 0
: 0
1 0
, 0
K. 0
pneumoniae 0
: 0
1 0
, 0
E. 0
cloacae 0
: 0
2 0
, 0
P. 0
stuartii 0
: 0
1 0
) 0
. 0

Over 0
9 0
kb 0
of 0
DNA 0
sequence 0
was 0
obtained 0
for 0
one 0
clone 0
( 0
A1 0
) 0
with 0
a 0
total 0
IGS 0
length 0
of 0
approximately 0
12.4 0
kb 0
. 0

Following 0
EGF B-gene
or 0
NGF B-gene
stimulation 0
of 0
the 0
v 0
- 0
CrkPC12 0
cells 0
, 0
the 0
v B-gene
- I-gene
Crk I-gene
protein 0
itself 0
became 0
tyrosine 0
phosphorylated 0
within 0
1 0
min 0
. 0

After 0
nine 0
months 0
GFR 0
improved 0
spontaneously 0
to 0
32 0
ml/min/1.73 0
m2 0
despite 0
no 0
improvement 0
in 0
his 0
hypertension 0
. 0

Insulin B-gene
- 0
stimulated 0
autophosphorylation 0
at 0
specific 0
sites 0
in 0
the 0
tyrosine B-gene
kinase I-gene
domain I-gene
of 0
the 0
receptor 0
's 0
beta 0
- 0
subunit 0
is 0
correlated 0
kinetically 0
with 0
activation 0
of 0
kinase 0
- 0
catalyzed 0
phosphorylation 0
of 0
a 0
model 0
substrate 0
( 0
reduced 0
and 0
carboxyamidomethylated 0
lysozyme B-gene
; 0
RCAM B-gene
- I-gene
lysozyme I-gene
) 0
. 0

Likewise 0
, 0
the 0
consensus 0
signal 0
believed 0
to 0
be 0
involved 0
in 0
terminating 0
VV B-gene
early I-gene
gene I-gene
transcription 0
, 0
TTTTTNT 0
, 0
was 0
evident 0
at 0
the 0
3' 0
- 0
boundary 0
of 0
both 0
the 0
N2 0
and 0
M1 0
ORFs 0
suggesting 0
that 0
these 0
genes 0
may 0
be 0
VV B-gene
early I-gene
genes I-gene
. 0

Enzymatic 0
and 0
chemical 0
structure 0
probing 0
revealed 0
mainly 0
the 0
conserved 0
terminal 0
part 0
( 0
termed 0
3'C 0
) 0
of 0
the 0
DI9c 0
3 0
' 0
UTR 0
containing 0
distinctive 0
RNA 0
motifs 0
, 0
i.e. 0
, 0
a 0
stable 0
stem 0
- 0
loop 0
, 0
SL 0
I 0
, 0
near 0
the 0
RNA 0
3 0
' 0
terminus 0
and 0
a 0
considerably 0
less 0
stable 0
stem 0
- 0
loop 0
, 0
SL 0
II 0
, 0
that 0
forms 0
the 0
5 0
' 0
portion 0
of 0
3'C 0
. 0

Attention 0
is 0
devoted 0
in 0
particular 0
to 0
the 0
action 0
of 0
thermoregulating 0
nervous 0
and 0
hormonal 0
mechanisms 0
. 0

ES 0
cells 0
in 0
which 0
the 0
gene 0
for 0
the 0
erythroid 0
transcription 0
factor 0
GATA B-gene
- I-gene
1 I-gene
has 0
been 0
disrupted 0
fail 0
to 0
produce 0
mature 0
erythroid 0
cells 0
either 0
in 0
vivo 0
or 0
in 0
vitro 0
. 0

Acidic 0
carboxyl 0
- 0
terminal 0
domain 0
of 0
gene B-gene
2.5 I-gene
protein I-gene
of I-gene
bacteriophage I-gene
T7 I-gene
is 0
essential 0
for 0
protein 0
- 0
protein 0
interactions 0
. 0

They 0
encode 0
proteins 0
whose 0
core 0
regions 0
display 0
great 0
similarity 0
to 0
Aspergillus B-gene
HAPB I-gene
, 0
HAPC B-gene
and 0
HAPE B-gene
and 0
to 0
known 0
HAP B-gene
homologs I-gene
from 0
other 0
organisms 0
. 0

Three 0
of 0
these 0
positions 0
are 0
novel 0
in 0
that 0
they 0
had 0
not 0
been 0
identified 0
to 0
be 0
important 0
for 0
binding 0
PC 0
by 0
previous 0
crystallographic 0
analysis 0
. 0

Three 0
transcriptional 0
control 0
elements 0
within 0
300 0
base 0
pairs 0
of 0
the 0
5' 0
- 0
flanking 0
region 0
of 0
the 0
rat B-gene
glucagon I-gene
gene I-gene
interact 0
with 0
regulatory 0
cellular 0
proteins 0
and 0
direct 0
transcription 0
only 0
in 0
glucagon B-gene
- 0
producing 0
islet 0
cells 0
. 0

Fusion 0
proteins 0
were 0
isolated 0
by 0
affinity 0
chromatography 0
on 0
APTG 0
- 0
Sepharose 0
. 0

( 0
99m 0
) 0
Tc 0
Ethyl 0
Cysteinate 0
Dimer 0
stable 0
during 0
6h 0
has 0
contributed 0
to 0
develop 0
ictal 0
studies 0
to 0
evaluate 0
the 0
location 0
of 0
partial 0
seizure 0
. 0

The 0
results 0
of 0
a 0
study 0
to 0
investigate 0
the 0
effectiveness 0
of 0
a 0
propolis 0
- 0
containing 0
mouthrinse 0
in 0
the 0
inhibition 0
of 0
de 0
novo 0
plaque 0
formation 0
are 0
presented 0
. 0

We 0
suggest 0
that 0
this 0
effect 0
of 0
Myc B-gene
is 0
mediated 0
by 0
its 0
action 0
upstream 0
of 0
cyclin B-gene
E I-gene
- 0
CDK2 B-gene
, 0
and 0
occurs 0
via 0
the 0
neutralization 0
of 0
p27 B-gene
( 0
Kip1 B-gene
) 0
family 0
proteins 0
, 0
rather 0
than 0
induction 0
of 0
Cdc25A B-gene
. 0

A 0
less 0
common 0
and 0
much 0
more 0
perplexing 0
circumstance 0
occurs 0
when 0
evaluating 0
patients 0
with 0
sarcoidosis 0
established 0
for 0
several 0
years 0
present 0
with 0
evidence 0
of 0
progressive 0
or 0
chronic 0
pulmonary 0
involvement 0
and 0
dyspnea 0
. 0

The 0
training 0
programs 0
had 0
a 0
duration 0
of 0
30 0
days 0
, 0
5 0
days/week 0
, 0
and 0
was 0
performed 0
on 0
a 0
motor 0
- 0
driven 0
treadmill 0
. 0

( 0
1992 0
) 0
J 0
. 0

The 0
avian 0
carcinoma 0
virus 0
MH2 0
contains 0
a 0
hybrid 0
gene 0
delta B-gene
gag I-gene
- 0
mht B-gene
with 0
a 0
contiguous 0
open 0
reading 0
frame 0
of 0
2682 0
base 0
pairs 0
as 0
well 0
as 0
v B-gene
- I-gene
myc I-gene
and 0
avian 0
helper 0
virus 0
- 0
related 0
sequences 0
. 0
delta B-gene
gag I-gene
is 0
a 0
partial 0
retroviral B-gene
core I-gene
protein I-gene
gene I-gene
while 0
v B-gene
- I-gene
mht I-gene
and 0
v B-gene
- I-gene
myc I-gene
are 0
cell 0
- 0
drived 0
sequences 0
. 0

The 0
DW 0
directions 0
uniformly 0
sampled 0
the 0
diffusion 0
ellipsoid 0
surface 0
. 0

The 0
recent 0
concept 0
of 0
a 0
bioartificial 0
organ 0
is 0
an 0
attempt 0
to 0
avoid 0
such 0
disadvantages 0
. 0

The 0
pressure 0
measurements 0
under 0
steady 0
flow 0
conditions 0
showed 0
that 0
the 0
hemodynamic 0
performance 0
( 0
including 0
pressure 0
gradient 0
and 0
effective 0
orifice 0
area 0
) 0
of 0
SPAB 0
is 0
superior 0
to 0
that 0
of 0
its 0
stented 0
counterpart 0
, 0
especially 0
in 0
the 0
smaller 0
sizes 0
. 0

Recent 0
, 0
highly 0
visible 0
reviews 0
on 0
the 0
subject 0
have 0
clearly 0
pointed 0
out 0
that 0
little 0
is 0
known 0
about 0
the 0
cellular 0
mechanisms 0
through 0
which 0
inhaled 0
asbestos 0
fibers 0
cause 0
the 0
well 0
known 0
, 0
debilitating 0
lung 0
disease 0
- 0
asbestosis 0
( 0
i.e 0
. 0
interstitial 0
pulmonary 0
fibrosis 0
) 0
. 0

During 0
chronic 0
treatment 0
with 0
salmon B-gene
calcitonin I-gene
, 0
alkaline B-gene
phosphatase I-gene
activity 0
and 0
urinary 0
hydroxyproline 0
excretion 0
decrease 0
on 0
an 0
average 0
of 0
50 0
% 0
in 0
patients 0
with 0
Paget 0
's 0
disease 0
. 0

Cerebral 0
blood 0
flow 0
was 0
measured 0
using 0
the 0
iv 0
method 0
of 0
133 0
- 0
Xe 0
CBF 0
determination 0
and 0
AVDO2 0
was 0
measured 0
using 0
systemic 0
arterial 0
- 0
jugular 0
venous 0
oxygen 0
content 0
differences 0
. 0

Expression 0
of 0
FNCAT B-gene
increased 0
on 0
serum 0
treatment 0
indicating 0
that 0
the 0
region 0
of 0
the 0
FN B-gene
gene I-gene
between 0
positions 0
+69 0
and 0
- 0
510 0
bp 0
mediated 0
serum 0
responsiveness 0
. 0

Gallstone 0
- 0
formation 0
has 0
traditionally 0
been 0
attributed 0
to 0
supersaturation 0
of 0
bile 0
with 0
cholesterol 0
. 0

Possible 0
consequences 0
of 0
such 0
binder 0
distribution 0
through 0
powder 0
aggregates 0
are 0
discussed 0
. 0

Bile 0
salts 0
, 0
hormonal 0
control 0
, 0
and 0
the 0
male 0
disadvantage 0
. 0

The 0
fusion 0
gene 0
cassette 0
was 0
placed 0
under 0
the 0
control 0
of 0
a 0
vaccinia B-gene
virus I-gene
early I-gene
promoter I-gene
and 0
cloned 0
in 0
a 0
host 0
- 0
restricted 0
fowlpox 0
viral 0
vector 0
. 0

We 0
describe 0
a 0
novel 0
stat B-gene
- I-gene
related I-gene
factor I-gene
, 0
p93 B-gene
, 0
that 0
is 0
found 0
in 0
EGF B-gene
- 0
treated 0
A431 0
cell 0
extracts 0
but 0
appears 0
to 0
be 0
absent 0
in 0
bovine B-gene
fibroblast I-gene
growth I-gene
factor I-gene
( 0
bFGF B-gene
) 0
, 0
IFN B-gene
- I-gene
gamma I-gene
, 0
tumor B-gene
necrosis I-gene
factor I-gene
- I-gene
alpha I-gene
( 0
TNF B-gene
- I-gene
alpha I-gene
) 0
, 0
and 0
untreated 0
cells 0
. 0
p93 B-gene
appears 0
to 0
be 0
antigenically 0
related 0
to 0
stat91 B-gene
. 0
p185c B-gene
- 0
neu+ B-gene
, 0
EGFr+ B-gene
( 0
M1 B-gene
) 0
, 0
and 0
p185c B-gene
- 0
neu B-gene
- 0
kinase 0
inactive 0
, 0
EGFr+ B-gene
( 0
NEN757 B-gene
) 0
expressing 0
cells 0
undergo 0
different 0
mitotic 0
responses 0
to 0
EGF B-gene
. 0

MRI 0
measurements 0
of 0
the 0
brain 0
. 0

Phosphorylation 0
by 0
Cdc28 B-gene
activates 0
the 0
Cdc20 B-gene
- 0
dependent 0
activity 0
of 0
the 0
anaphase 0
- 0
promoting 0
complex 0
. 0

Phosphorylated 0
tyrosine 0
residues 0
were 0
subsequently 0
identified 0
by 0
sequencing 0
the 0
separated 0
phosphopeptides 0
by 0
matrix 0
assisted 0
laser 0
desorption 0
ionization 0
mass 0
spectrometry 0
( 0
MALDI 0
- 0
MS 0
) 0
and 0
Edman 0
degradation 0
. 0

Superovulation 0
with 0
intrauterine 0
insemination 0
( 0
SO 0
- 0
IUI 0
) 0
has 0
been 0
suggested 0
as 0
an 0
alternative 0
to 0
gamete 0
intrafallopian 0
transfer 0
( 0
GIFT 0
) 0
, 0
despite 0
the 0
absence 0
of 0
controlled 0
or 0
comparative 0
trials 0
. 0

One 0
of 0
these 0
elements 0
resembles 0
the 0
binding 0
site 0
of 0
a 0
previously 0
identified 0
cellular 0
`` 0
transcription 0
'' 0
factor 0
. 0

The 0
Rep78 B-gene
protein I-gene
of 0
adeno 0
- 0
associated 0
virus 0
( 0
AAV 0
) 0
contains 0
amino 0
acid 0
sequence 0
motifs 0
common 0
to 0
rolling B-gene
- I-gene
circle I-gene
replication I-gene
( I-gene
RCR I-gene
) I-gene
initiator I-gene
proteins I-gene
. 0

METHODS 0
: 0
CD4 B-gene
cell 0
counts 0
and 0
interview 0
data 0
were 0
recorded 0
in 0
a 0
survey 0
of 0
136 0
adult 0
patients 0
attending 0
a 0
community 0
hospital 0
- 0
based 0
HIV 0
outpatient 0
clinic 0
. 0

Based 0
on 0
29 0
determinations 0
of 0
the 0
glucose 0
from 0
sinigrin 0
, 0
analyzed 0
under 0
different 0
conditions 0
, 0
accuracy 0
of 0
the 0
total 0
glucosinolate 0
determination 0
was 0
94.8 0
+/ 0
- 0
7.3 0
% 0
. 0

Transcriptional 0
analysis 0
of 0
this 0
gene 0
cluster 0
was 0
performed 0
by 0
detecting 0
the 0
presence 0
of 0
mRNAs 0
spanning 0
adjacent 0
genes 0
as 0
well 0
as 0
by 0
using 0
a 0
promoterless 0
lacZ B-gene
reporter I-gene
gene I-gene
fused 0
to 0
each 0
of 0
the 0
seven 0
genes 0
contained 0
in 0
the 0
tol B-gene
- 0
oprL B-gene
locus 0
. 0

The 0
regions 0
encoding 0
the 0
mature 0
proteinases 0
were 0
cloned 0
into 0
an 0
expression 0
vector 0
and 0
recombinant 0
protein 0
produced 0
in 0
Escherichia 0
coli 0
. 0

H 0
. 0

Rhinovirus B-gene
2A I-gene
protease I-gene
and 0
foot B-gene
- I-gene
and I-gene
- I-gene
mouth I-gene
- I-gene
disease I-gene
virus I-gene
L I-gene
protease I-gene
were 0
used 0
to 0
analyze 0
the 0
association 0
of 0
eIF4G B-gene
with 0
eIF4A B-gene
, 0
eIF4E B-gene
, 0
and 0
eIF3 B-gene
. 0

METHODS 0
: 0
Two 0
patients 0
developed 0
cervical 0
myelopathy 0
or 0
radiculopathy 0
after 0
spinal 0
manipulation 0
therapy 0
, 0
and 0
magnetic 0
resonance 0
imaging 0
showed 0
herniated 0
cervical 0
discs 0
at 0
C4 0
- 0
C5 0
and 0
C6 0
- 0
C7 0
, 0
respectively 0
. 0

This 0
increased 0
frequency 0
of 0
infection 0
has 0
been 0
accompanied 0
by 0
significant 0
excess 0
mortality 0
. 0

One 0
of 0
the 0
repeating 0
domains 0
( 0
Yheb1 B-gene
) 0
, 0
consisting 0
of 0
67 0
amino 0
acids 0
, 0
was 0
cloned 0
from 0
the 0
E. 0
coli 0
chromosome 0
and 0
purified 0
by 0
metal 0
chelating 0
chromatography 0
. 0

Assessment 0
of 0
two 0
anion 0
- 0
exchange 0
resins 0
for 0
direct 0
use 0
in 0
the 0
screening 0
method 0
for 0
urinary 0
porphobilinogen 0
. 0

These 0
studies 0
define 0
a 0
class 0
of 0
DNA 0
elements 0
with 0
a 0
mode 0
of 0
action 0
that 0
has 0
not 0
been 0
heretofore 0
described 0
. 0

Using 0
lacZ B-gene
- 0
inducible 0
T 0
cells 0
as 0
a 0
probe 0
, 0
we 0
screened 0
a 0
splenic 0
cDNA 0
library 0
in 0
transiently 0
transfected 0
antigen 0
- 0
presenting 0
cells 0
( 0
APCs 0
) 0
and 0
isolated 0
a 0
cDNA 0
clone 0
that 0
allowed 0
expression 0
of 0
the 0
appropriate 0
peptide/Kb B-gene
MHC I-gene
complex I-gene
in 0
APC 0
. 0

This 0
results 0
in 0
a 0
decreased 0
secretion 0
of 0
immunoglobulin B-gene
A I-gene
, 0
and 0
, 0
consequently 0
, 0
a 0
decreased 0
resistance 0
against 0
infections 0
. 0

A 0
previously 0
developed 0
kinetic 0
model 0
was 0
used 0
to 0
identify 0
major 0
chemical 0
reaction 0
pathways 0
involving 0
PAH 0
in 0
the 0
afterburner 0
. 0

Regulation 0
of 0
the 0
p21 B-gene
- I-gene
activated I-gene
kinase I-gene
( 0
PAK B-gene
) 0
by 0
a 0
human B-gene
Gbeta I-gene
- I-gene
like I-gene
WD 0
- 0
repeat 0
protein 0
, 0
hPIP1 B-gene
. 0

Activation 0
of 0
HIV 0
- 0
1 0
requires 0
the 0
binding 0
of 0
host 0
cell 0
transcription 0
factors 0
to 0
cis 0
elements 0
in 0
the 0
proviral 0
long 0
terminal 0
repeat 0
( 0
LTR 0
) 0
. 0

Based 0
on 0
the 0
ratios 0
of 0
the 0
areas 0
under 0
the 0
concentration 0
- 0
time 0
curves 0
in 0
CSF 0
and 0
serum 0
, 0
the 0
overall 0
penetration 0
of 0
rifampicin 0
into 0
CSF 0
was 0
0.13 0
- 0
0.42 0
( 0
median 0
= 0
0.22 0
) 0
. 0

Adaptability 0
of 0
Nippostrongylus 0
brasiliensis 0
( 0
Travassos 0
, 0
1914 0
) 0
to 0
lead 0
contamination 0

In 0
early 0
midgestation 0
embryos 0
it 0
is 0
expressed 0
in 0
telencephalic 0
, 0
diencephalic 0
and 0
mesencephalic 0
regions 0
but 0
from 0
day 0
11.75 0
of 0
gestation 0
its 0
expression 0
disappears 0
from 0
dorsal 0
telencephalon 0
and 0
is 0
confined 0
to 0
diencephalic 0
and 0
mesencephalic 0
regions 0
. 0

A 0
child 0
presumed 0
to 0
have 0
the 0
21 B-gene
- I-gene
hydroxylase I-gene
deficiency 0
form 0
of 0
congenital 0
adrenal 0
hyperplasia 0
was 0
studied 0
extensively 0
as 0
an 0
infant 0
. 0

The 0
size 0
and 0
the 0
predicted 0
N 0
- 0
terminal 0
sequence 0
of 0
the 0
mouse 0
protein 0
were 0
confirmed 0
experimentally 0
. 0

It 0
was 0
found 0
that 0
Nopp140 B-gene
binds 0
primarily 0
to 0
the 0
CK2 B-gene
regulatory I-gene
subunit I-gene
, I-gene
beta I-gene
. 0

Further 0
, 0
more 0
recent 0
communications 0
suggest 0
that 0
liver 0
disease 0
led 0
to 0
a 0
differential 0
alteration 0
of 0
the 0
cytochrome B-gene
P I-gene
- I-gene
450s I-gene
with 0
regard 0
to 0
protein 0
content 0
and 0
activity 0
. 0

A 0
constructed 0
phylogenetic 0
tree 0
suggests 0
that 0
the 0
UbcP1 B-gene
protein I-gene
may 0
represent 0
a 0
member 0
of 0
a 0
distinct 0
subfamily 0
of 0
E2s B-gene
. 0

Isolates 0
of 0
B. 0
burgdorferi 0
from 0
humans 0
, 0
rodents 0
, 0
and 0
I. 0
dammini 0
are 0
usually 0
indistinguishable 0
, 0
but 0
strains 0
of 0
B. 0
burgdorferi 0
with 0
different 0
major 0
proteins 0
have 0
been 0
identified 0
. 0

Alignment 0
of 0
the 0
rat B-gene
and I-gene
human I-gene
WIN I-gene
cDNAs I-gene
and 0
their 0
comparison 0
with 0
mouse 0
genomic 0
sequence 0
revealed 0
that 0
the 0
WIN B-gene
DNA I-gene
binding I-gene
domain I-gene
is 0
encoded 0
by 0
four 0
exons 0
, 0
two 0
of 0
which 0
( 0
exons 0
4 0
and 0
6 0
) 0
are 0
alternatively 0
spliced 0
to 0
generate 0
at 0
least 0
three 0
classes 0
of 0
mRNA 0
transcripts 0
. 0

25 0
patients 0
received 0
20 0
mgs 0
of 0
hyoscine 0
N 0
- 0
butyl 0
bromide 0
and 0
the 0
rest 0
5 0
mgs 0
propinoxate 0
, 0
i.v 0
. 0
plus 0
diazepam 0
. 0

The 0
activity 0
of 0
plasminogen B-gene
activator I-gene
has 0
been 0
measured 0
in 0
tissue 0
sections 0
with 0
the 0
aid 0
of 0
a 0
modified 0
Todd 0
technique 0
. 0

These 0
sequences 0
were 0
further 0
tested 0
for 0
the 0
presence 0
of 0
an 0
enhancer 0
element 0
, 0
by 0
their 0
ability 0
to 0
activate 0
a 0
fusion 0
reporter 0
gene 0
consisting 0
of 0
the 0
CAT B-gene
gene I-gene
linked 0
to 0
the 0
gamma B-gene
- I-gene
globin I-gene
gene I-gene
promoter I-gene
, 0
in 0
erythroid 0
( 0
K562 0
) 0
and 0
non 0
- 0
erythroid 0
( 0
HeLa 0
) 0
cells 0
. 0

Here 0
we 0
demonstrate 0
that 0
CD40 B-gene
or 0
IgM B-gene
receptor I-gene
stimulation 0
of 0
primary 0
B 0
cells 0
results 0
in 0
transactivation 0
of 0
this 0
enhancer 0
. 0

DESIGN 0
, 0
SETTING 0
AND 0
SUBJECTS 0
: 0
The 0
analysis 0
is 0
based 0
on 0
data 0
collected 0
in 0
the 0
first 0
two 0
rounds 0
of 0
the 0
nationally 0
representative 0
Ghana 0
Living 0
Standards 0
Survey 0
, 0
held 0
in 0
1987/88 0
( 0
GLSS 0
- 0
I 0
) 0
and 0
1988/89 0
( 0
GLSS 0
- 0
II 0
) 0
, 0
with 0
both 0
surveys 0
covering 0
approximately 0
3000 0
households 0
. 0

Genetic 0
and 0
physiological 0
experiments 0
suggest 0
a 0
close 0
relationship 0
between 0
cdc27+ B-gene
and 0
the 0
cdc2+ B-gene
gene I-gene
, 0
a 0
key 0
regulator 0
of 0
mitosis 0
in 0
yeast 0
and 0
also 0
in 0
higher 0
eukaryotic 0
cells 0
. 0

Association 0
of 0
Syk B-gene
protein B-gene
tyrosine I-gene
kinase I-gene
( 0
PTK B-gene
) 0
with 0
LMP2A B-gene
occurs 0
at 0
the 0
two 0
tyrosines 0
of 0
the 0
LMP2A B-gene
immunoreceptor I-gene
tyrosine 0
- 0
based 0
activation 0
motif 0
, 0
and 0
it 0
is 0
hypothesized 0
that 0
Lyn B-gene
PTK B-gene
associates 0
with 0
the 0
YEEA 0
amino 0
acid 0
motif 0
at 0
LMP2A B-gene
tyrosine 0
112 0
( 0
Y112 0
) 0
. 0

Theoretical 0
mechanisms 0
of 0
hyperuricemia 0
. 0

As 0
a 0
result 0
, 0
relative 0
biological 0
effects 0
( 0
RBE 0
) 0
of 0
2.3 0
- 0
2.7 0
was 0
obtained 0
from 0
the 0
straight 0
line 0
that 0
was 0
given 0
by 0
modifying 0
by 0
the 0
method 0
of 0
least 0
squares 0
the 0
curves 0
of 0
the 0
frequency 0
of 0
anomalous 0
fetuses 0
in 0
total 0
implants 0
and 0
survived 0
embryos 0
irradiated 0
from 0
20 0
to 0
120 0
rad 0
by 0
Cf 0
- 0
252 0
and 0
from 0
80 0
to 0
220 0
rad 0
by 0
Co 0
- 0
60 0
on 0
day 0
8 0
of 0
pregnancy 0
. 0

Moclobemide 0
is 0
a 0
well 0
- 0
tolerated 0
alternative 0
antidepressant 0
, 0
but 0
there 0
is 0
a 0
need 0
for 0
prospective 0
controlled 0
trials 0
to 0
evaluate 0
its 0
long 0
- 0
term 0
efficacy 0
. 0

In 0
a 0
pilot 0
study 0
in 0
which 0
two 0
dogs 0
were 0
given 0
parenteral 0
rifampin 0
before 0
and 0
after 0
operation 0
and 0
grafts 0
were 0
preclotted 0
with 0
blood 0
that 0
contained 0
rifampin 0
, 0
it 0
was 0
suggested 0
that 0
there 0
was 0
a 0
slight 0
increase 0
in 0
inhibition 0
at 0
24 0
hours 0
( 0
93 0
% 0
) 0
. 0

Northern 0
blot 0
analyses 0
were 0
used 0
to 0
examine 0
the 0
regulated 0
expression 0
of 0
the 0
cys B-gene
- I-gene
14+ I-gene
gene I-gene
. 0

The 0
mouse B-gene
tapasin I-gene
gene I-gene
was 0
mapped 0
about 0
70 0
kilobases 0
from 0
H2 B-gene
- I-gene
K I-gene
at 0
the 0
centromeric 0
end 0
of 0
the 0
mouse B-gene
MHC I-gene
. 0

Conversion 0
of 0
glucose 0
phosphate 0
- 0
14C 0
to 0
glucose 0
- 0
14C 0
in 0
passage 0
through 0
human 0
brain 0
in 0
vivo 0
. 0

New 0
, 0
selective 0
catechol B-gene
- I-gene
O I-gene
- I-gene
methyltransferase I-gene
inhibitors 0
as 0
therapeutic 0
agents 0
in 0
Parkinson 0
's 0
disease 0
. 0

The 0
sequence 0
of 0
the 0
gene 0
upstream 0
to 0
the 0
cap 0
site 0
contains 0
characteristic 0
RNA B-gene
polymerase I-gene
II I-gene
promoter I-gene
- I-gene
binding I-gene
sites I-gene
: 0
a 0
putative 0
TATA 0
box 0
at 0
position 0
- 0
29 0
and 0
a 0
Sp B-gene
1 I-gene
binding I-gene
site I-gene
( 0
GGGGCGGAGA 0
) 0
at 0
position 0
- 0
48 0
. 0

We 0
propose 0
that 0
, 0
while 0
Y. 0
lipolytica 0
CEN 0
DNA 0
is 0
essential 0
for 0
plasmid 0
maintenance 0
, 0
this 0
function 0
can 0
be 0
supplied 0
by 0
several 0
sub 0
- 0
fragments 0
which 0
, 0
together 0
, 0
form 0
the 0
active 0
chromosomal 0
centromere 0
. 0

These 0
three 0
groups 0
were 0
further 0
examined 0
with 0
regard 0
to 0
the 0
modulation 0
of 0
discharge 0
rate 0
i 0
) 0
during 0
motor 0
activity 0
in 0
W 0
, 0
ii 0
) 0
at 0
the 0
transitional 0
phase 0
from 0
SS 0
to 0
paradoxical 0
sleep 0
( 0
PS 0
) 0
, 0
iii 0
) 0
during 0
rapid 0
eye 0
movements 0
( 0
REMs 0
) 0
in 0
PS 0
, 0
and 0
iv 0
) 0
following 0
electrical 0
stimulation 0
of 0
the 0
midbrain 0
reticular 0
formation 0
( 0
MRF 0
) 0
. 0

Benzyl 0
alcohol 0
administration 0
in 0
neonates 0
. 0

Id B-gene
- I-gene
1H I-gene
and 0
Id B-gene
- I-gene
2H I-gene
seem 0
to 0
be 0
human 0
homologues 0
of 0
mouse B-gene
Id I-gene
- I-gene
1 I-gene
and 0
Id B-gene
- I-gene
2 I-gene
, 0
respectively 0
, 0
and 0
have 0
potential 0
to 0
encode 0
154 0
and 0
135 0
amino 0
acid 0
proteins 0
. 0

Normal 0
dogs 0
were 0
exposed 0
to 0
either 0
10 0
, 0
15 0
, 0
or 0
30 0
Gy 0
of 0
X 0
rays 0
to 0
a 0
single 0
hemisphere 0
and 0
the 0
gross 0
and 0
histopathologic 0
changes 0
were 0
evaluated 0
qualitatively 0
. 0

The 0
characterization 0
of 0
fly 0
receptors 0
with 0
features 0
similar 0
to 0
mammalian B-gene
glycoprotein I-gene
hormone I-gene
receptors I-gene
allows 0
a 0
better 0
understanding 0
of 0
the 0
evolution 0
of 0
this 0
unique 0
group 0
of 0
GPCRs B-gene
and 0
future 0
elucidation 0
of 0
their 0
ligand 0
signaling 0
mechanisms 0
. 0

To 0
study 0
the 0
mechanisms 0
and 0
the 0
signaling 0
pathways 0
involved 0
, 0
IGF B-gene
- I-gene
1R I-gene
promoter I-gene
reporter I-gene
constructs I-gene
were 0
transiently 0
transfected 0
in 0
CHO 0
- 0
AT1 0
cells 0
that 0
overexpress 0
angiotensin B-gene
AT1 I-gene
receptors I-gene
. 0

Importin B-gene
beta I-gene
mediates 0
nuclear 0
translocation 0
of 0
Smad B-gene
3 I-gene
. 0

In 0
summary 0
, 0
the 0
only 0
treatment 0
- 0
related 0
effect 0
noted 0
in 0
this 0
study 0
was 0
hydrocarbon 0
nephropathy 0
in 0
male 0
rats 0
, 0
which 0
is 0
not 0
considered 0
relevant 0
for 0
human 0
health 0
. 0

Characterization 0
of 0
an 0
unusual 0
tRNA 0
- 0
like 0
sequence 0
found 0
inserted 0
in 0
a 0
Neurospora 0
retroplasmid 0
. 0

Gel 0
shift 0
analysis 0
of 0
protein 0
binding 0
from 0
nuclear 0
extracts 0
to 0
these 0
caveolin B-gene
promoter I-gene
DNA I-gene
sequences I-gene
, 0
together 0
with 0
DNase B-gene
I I-gene
footprinting 0
, 0
confirmed 0
nucleoprotein 0
binding 0
to 0
the 0
SRE 0
- 0
like 0
elements 0
as 0
part 0
of 0
the 0
transcriptional 0
response 0
to 0
LDL B-gene
- I-gene
FC I-gene
. 0

The 0
Ca2+ 0
concentration 0
in 0
rats 0
serum 0
after 0
intragastrically 0
fenarimol 0
administration 0
( 0
doses 0
1/40 0
, 0
1/20 0
and 0
1/10 0
LD50 0
) 0
during 0
5 0
days 0
was 0
investigated 0
. 0

Furthermore 0
, 0
deletion 0
of 0
two 0
potential 0
Ste11 B-gene
recognition I-gene
sites I-gene
in 0
the 0
fus1 B-gene
promoter I-gene
region 0
abolished 0
transcription 0
, 0
and 0
expression 0
could 0
be 0
restored 0
when 0
we 0
inserted 0
a 0
different 0
Ste11 B-gene
site I-gene
from 0
the 0
mat1 B-gene
- I-gene
P I-gene
promoter I-gene
. 0

J. 0
, 0
& 0
Olefsky 0
, 0
J 0
. 0

Early 0
attempts 0
for 0
modifying 0
growth 0
functions 0
to 0
annual 0
variations 0
dating 0
back 0
up 0
to 0
2 0
decades 0
are 0
recalled 0
together 0
with 0
examples 0
for 0
their 0
application 0
showing 0
rather 0
different 0
degrees 0
of 0
approximation 0
. 0

PRIP B-gene
contains 0
two 0
LXXLL 0
signature 0
motifs 0
. 0

BPN 0
can 0
be 0
experimentally 0
produced 0
by 0
intratracheal 0
inoculation 0
of 0
microorganisms 0
in 0
high 0
concentrations 0
and 0
ventilator 0
- 0
associated 0
BPN 0
by 0
ventilating 0
baboons 0
with 0
oleic 0
- 0
acid 0
lung 0
injury 0
. 0

Coexpression 0
of 0
a 0
dominant B-gene
negative I-gene
c I-gene
- I-gene
jun I-gene
antagonized 0
the 0
ras B-gene
- 0
dependent 0
stimulation 0
of 0
the 0
92 B-gene
- I-gene
kDa I-gene
gelatinase I-gene
B I-gene
promoter 0
- 0
driven 0
CAT B-gene
reporter I-gene
. 0

However 0
, 0
the 0
safety 0
of 0
design 0
4 0
was 0
assured 0
as 0
long 0
as 0
all 0
patients 0
received 0
three 0
courses 0
of 0
chemotherapy 0
, 0
which 0
is 0
unusual 0
in 0
phase 0
I 0
studies 0
in 0
Japan 0
. 0

The 0
plants 0
were 0
then 0
brought 0
to 0
our 0
Houston 0
laboratory 0
where 0
they 0
were 0
measured 0
and 0
analyzed 0
for 0
lignin 0
and 0
protein 0
content 0
and 0
for 0
phenylalanine B-gene
ammonia I-gene
- I-gene
lyase I-gene
( 0
PAL B-gene
) 0
and 0
peroxidase B-gene
activities 0
. 0

The 0
nucleotide 0
sequence 0
of 0
a 0
PCR 0
- 0
amplified 0
SMT3A B-gene
genomic 0
DNA 0
fragment 0
was 0
found 0
to 0
be 0
identical 0
to 0
that 0
of 0
SMT3A B-gene
cDNA I-gene
, 0
indicating 0
the 0
absence 0
of 0
intron 0
( 0
s 0
) 0
in 0
its 0
protein 0
coding 0
region 0
. 0

Activation 0
of 0
tyrosine B-gene
kinase I-gene
- I-gene
containing I-gene
receptors I-gene
, 0
heterotrimeric B-gene
G I-gene
proteins I-gene
, 0
and 0
protein B-gene
kinase I-gene
C I-gene
enhanced 0
the 0
activities 0
of 0
both 0
MEK B-gene
isoforms I-gene
in 0
293 0
and 0
PC12 0
cells 0
. 0

CONCLUSIONS 0
: 0
Transpulmonary 0
stable 0
air 0
microbubbles 0
bound 0
to 0
a 0
galactose 0
carrier 0
represent 0
a 0
useful 0
and 0
safe 0
contrast 0
agent 0
in 0
case 0
of 0
an 0
insufficient 0
native 0
signal 0
in 0
transcranial 0
Doppler 0
investigation 0
. 0

DP B-gene
- I-gene
1 I-gene
and 0
DP B-gene
- I-gene
2 I-gene
encode 0
maternally 0
stored 0
transcripts 0
that 0
are 0
expressed 0
during 0
early 0
development 0
. 0

Human B-gene
recombinant I-gene
erythropoietin I-gene
( 0
r B-gene
- I-gene
HuEPO I-gene
, 0
EprexR B-gene
) 0
was 0
administered 0
to 0
8 0
children 0
with 0
chronic 0
renal 0
failure 0
and 0
high 0
transfusion 0
requirement 0
. 0

Specifically 0
, 0
we 0
engineered 0
two 0
chimeras 0
in 0
which 0
the 0
N 0
- 0
terminal 0
lobe 0
of 0
the 0
SH1 B-gene
domain I-gene
of 0
c B-gene
- I-gene
Abl I-gene
was 0
swapped 0
with 0
that 0
of 0
v B-gene
- I-gene
Src I-gene
. 0

Indications 0
for 0
therapy 0
using 0
MAO B-gene
inhibitors 0

Although 0
IL B-gene
- I-gene
6 I-gene
can 0
activate 0
ERK B-gene
- I-gene
1 I-gene
in 0
HepG2 0
cells 0
, 0
STAT3 B-gene
transactivation 0
and 0
Ser 0
( 0
727 0
) 0
phosphorylation 0
were 0
not 0
reduced 0
by 0
using 0
the 0
MAP B-gene
kinase/ERK I-gene
kinase/ERK I-gene
kinase I-gene
( 0
MEK B-gene
) 0
inhibitor 0
PD98059 0
or 0
by 0
overexpression 0
of 0
dominant 0
- 0
negative 0
Raf B-gene
. 0

Mean 0
disposition 0
constants 0
( 0
+/ 0
- 0
SD 0
) 0
were 0
obtained 0
from 0
individualized 0
fits 0
( 0
V1 0
: 0
0.398 0
+/ 0
- 0
0.336 0
LITER/KG 0
, 0
Vdarea 0
: 0
2.53 0
+/ 0
- 0
0.72 0
liter/kg 0
, 0
alpha 0
: 0
0.316 0
+/ 0
- 0
0.294 0
min 0
- 0
1 0
, 0
beta 0
: 0
0.00204 0
+/ 0
- 0
0.00262 0
min 0
- 0
1 0
, 0
k2 0
: 0
0.0305 0
+/ 0
- 0
0.0101 0
min 0
- 0
1 0
) 0
. 0

Clinical 0
trials 0
bring 0
informations 0
for 0
pharmacology 0
and 0
epidemiology 0
. 0

We 0
have 0
compared 0
the 0
ability 0
of 0
GST B-gene
- 0
Bem3 B-gene
to 0
serve 0
as 0
a 0
GAP B-gene
for 0
Cdc42Hs B-gene
relative 0
to 0
other 0
members 0
of 0
the 0
rho B-gene
- 0
GAP B-gene
subfamily 0
and 0
found 0
the 0
following 0
order 0
of 0
potency 0
: 0
human B-gene
platelet I-gene
Cdc42Hs I-gene
GAP I-gene
> 0
p190 B-gene
> 0
Bem3 B-gene
> 0
break B-gene
point I-gene
cluster I-gene
region I-gene
protein I-gene
, 0
whereas 0
p85 B-gene
, 0
like 0
Bem2 B-gene
, 0
shows 0
no 0
GAP B-gene
activity 0
or 0
any 0
ability 0
to 0
bind 0
to 0
the 0
GTP 0
- 0
bound 0
form 0
of 0
Cdc42Hs B-gene
. 0

Through 0
effective 0
use 0
of 0
laboratory 0
testing 0
database 0
, 0
it 0
will 0
be 0
possible 0
to 0
shift 0
away 0
our 0
vague 0
management 0
of 0
pre 0
- 0
analytic 0
phase 0
of 0
quality 0
control 0
so 0
far 0
to 0
its 0
established 0
system 0
based 0
on 0
objective 0
evaluation 0
. 0

Nonlinearities 0
in 0
cochlear 0
hydrodynamics 0
. 0

The 0
peptides 0
are 0
generated 0
in 0
the 0
cytosol 0
, 0
then 0
translocated 0
across 0
the 0
membrane 0
of 0
the 0
endoplasmic 0
reticulum 0
by 0
the 0
transporter B-gene
associated I-gene
with I-gene
antigen I-gene
processing I-gene
( 0
TAP B-gene
) 0
. 0

An 0
in 0
vitro 0
'glass 0
stomach 0
' 0
( 0
containing 0
various 0
volumes 0
of 0
hydrochloric 0
acid 0
[ 0
HCl 0
] 0
and 0
ammonium 0
chloride 0
[ 0
NH4Cl 0
] 0
) 0
was 0
used 0
to 0
evaluate 0
the 0
means 0
of 0
increasing 0
'gastric 0
' 0
pH 0
to 0
that 0
of 0
the 0
NH4+ 0
- 0
- 0
> 0
NH3 0
transition 0
that 0
occurs 0
significantly 0
at 0
pH 0
9.24 0
. 0

Moreover 0
, 0
a 0
hybrid 0
protein 0
composed 0
of 0
a 0
PvALF B-gene
activation I-gene
domain I-gene
and 0
the 0
DNA 0
binding 0
and 0
dimerization 0
domain 0
of 0
ROM2 B-gene
activated 0
gene 0
expression 0
, 0
indicating 0
that 0
ROM2 B-gene
recognizes 0
the 0
DLEC2 B-gene
enhancer I-gene
in 0
vivo 0
; 0
consequently 0
, 0
ROM2 B-gene
functions 0
as 0
a 0
DNA 0
binding 0
site 0
- 0
dependent 0
repressor 0
. 0

Northern 0
analyses 0
further 0
confirm 0
that 0
the 0
expression 0
of 0
endogenous 0
alpha B-gene
- I-gene
ENaC I-gene
gene I-gene
in 0
salivary 0
Pa 0
- 0
4 0
cells 0
is 0
suppressed 0
by 0
an 0
ectopic 0
HMGI B-gene
- I-gene
C I-gene
overexpression 0
. 0

Finally 0
, 0
we 0
demonstrated 0
that 0
although 0
the 0
DNA 0
- 0
binding 0
domain 0
of 0
c B-gene
- I-gene
myb I-gene
is 0
required 0
for 0
both 0
the 0
differentiation 0
block 0
and 0
the 0
shift 0
in 0
cell 0
cycle 0
after 0
PMA 0
treatment 0
, 0
phosphorylation 0
by 0
casein B-gene
kinase I-gene
II I-gene
and 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
at 0
positions 0
11 0
and 0
12 0
or 0
532 0
of 0
c B-gene
- I-gene
myb I-gene
, 0
respectively 0
, 0
are 0
not 0
. 0

We 0
found 0
that 0
RXR B-gene
and 0
VDR B-gene
transactivated 0
selectively 0
from 0
VDRE 0
- 0
linked 0
templates 0
exclusively 0
as 0
a 0
heterodimeric 0
complex 0
, 0
since 0
neither 0
receptor 0
alone 0
enhanced 0
transcription 0
in 0
vitro 0
. 0

We 0
found 0
a 0
significant 0
increase 0
of 0
thromboxane 0
as 0
evidenced 0
by 0
the 0
major 0
urinary 0
metabolite 0
2,3 0
- 0
dinorthromboxane 0
B2 0
in 0
the 0
oestrogen 0
group 0
as 0
compared 0
to 0
the 0
orchidectomy 0
group 0
. 0

Assays 0
of 0
APRE 0
- 0
luciferase B-gene
reporter 0
plasmids 0
transfected 0
into 0
HepG2 0
cells 0
show 0
that 0
a 0
mutated 0
APRE 0
that 0
binds 0
only 0
BPi B-gene
functions 0
as 0
an 0
IL B-gene
- I-gene
1 I-gene
alpha I-gene
inducible 0
enhancer 0
, 0
whereas 0
a 0
mutated 0
APRE 0
that 0
binds 0
only 0
BPc B-gene
does 0
not 0
. 0

Compared 0
with 0
controls 0
, 0
patients 0
in 0
the 0
unmedicated 0
state 0
had 0
low 0
smooth 0
pursuit 0
gain 0
, 0
had 0
a 0
higher 0
rate 0
of 0
corrective 0
catch 0
- 0
up 0
saccades 0
, 0
and 0
tended 0
to 0
spend 0
less 0
time 0
engaged 0
in 0
the 0
tracking 0
task 0
. 0

Epstein B-gene
- I-gene
Barr I-gene
virus I-gene
nuclear I-gene
antigen I-gene
2 I-gene
exerts 0
its 0
transactivating 0
function 0
through 0
interaction 0
with 0
recombination B-gene
signal I-gene
binding I-gene
protein I-gene
RBP I-gene
- I-gene
J I-gene
kappa I-gene
, 0
the 0
homologue 0
of 0
Drosophila B-gene
Suppressor I-gene
of I-gene
Hairless I-gene
. 0

A. B-gene
thaliana I-gene
cystathionine I-gene
beta I-gene
- I-gene
lyase I-gene
exhibits 0
22 0
% 0
sequence 0
identity 0
with 0
the 0
E. 0
coli 0
corresponding 0
enzyme 0
and 0
contains 0
a 0
70 0
amino 0
acid 0
N 0
- 0
terminal 0
additional 0
sequence 0
compared 0
with 0
the 0
bacterial 0
protein 0
. 0

The 0
three 0
- 0
dimensional 0
structure 0
of 0
the 0
E. 0
coli 0
CR 0
domain 0
indicates 0
that 0
this 0
sequence 0
conservation 0
is 0
likely 0
to 0
result 0
in 0
a 0
conserved 0
structural 0
motif 0
. 0

Co 0
- 0
expression 0
of 0
PLD1 B-gene
in 0
COS 0
- 0
7 0
cells 0
with 0
the 0
two 0
recombinant B-gene
CK2 I-gene
subunits I-gene
, 0
alpha 0
or 0
beta 0
, 0
suggests 0
that 0
the 0
association 0
of 0
PLD1 B-gene
with 0
the 0
kinase 0
is 0
through 0
the 0
beta 0
subunit 0
. 0

Despite 0
this 0
dependency 0
, 0
however 0
, 0
a 0
B. B-gene
japonicum I-gene
fixK I-gene
mutant I-gene
did 0
not 0
have 0
the 0
phenotypic 0
characteristics 0
of 0
B. B-gene
japonicum I-gene
fixL I-gene
and 0
fixJ B-gene
mutants I-gene
: 0
the 0
fixK B-gene
mutant I-gene
was 0
neither 0
Fix 0
- 0
in 0
symbiosis 0
with 0
soybean 0
plants 0
nor 0
defective 0
in 0
anaerobic 0
respiration 0
with 0
nitrate 0
as 0
the 0
terminal 0
electron 0
acceptor 0
. 0

The 0
predicted 0
amino 0
acid 0
sequence 0
of 0
Pst1p B-gene
possessed 0
high 0
sequence 0
homology 0
with 0
the 0
Sin3 B-gene
family I-gene
of 0
proteins 0
, 0
known 0
for 0
their 0
interaction 0
with 0
histone B-gene
deacetylases I-gene
. 0

This 0
selective 0
squelching 0
activity 0
suggests 0
that 0
GRIM B-gene
can 0
interact 0
with 0
an 0
essential 0
component 0
of 0
the 0
RNA B-gene
polymerase I-gene
II I-gene
transcription 0
machinery 0
. 0

A 0
third 0
group 0
( 0
n 0
= 0
10 0
) 0
was 0
assigned 0
to 0
receive 0
the 0
canalith 0
repositioning 0
maneuver 0
without 0
mastoid 0
vibration 0
. 0

With 0
the 0
help 0
of 0
partially 0
overlapping 0
parenchymatous 0
sutures 0
, 0
different 0
renal 0
segments 0
were 0
devitalized 0
. 0

The 0
S. B-gene
typhimurium I-gene
aspartyl/asparaginyl I-gene
beta I-gene
- I-gene
hydroxylase I-gene
homologue I-gene
( 0
designated 0
lpxO B-gene
) 0
was 0
cloned 0
into 0
pBluescriptSK 0
and 0
expressed 0
in 0
Escherichia 0
coli 0
K 0
- 0
12 0
, 0
which 0
does 0
not 0
contain 0
lpxO B-gene
. 0

Cardiac 0
NE 0
spillover 0
was 0
higher 0
( 0
P 0
< 0
.05 0
) 0
at 0
baseline 0
in 0
the 0
patient 0
group 0
than 0
in 0
healthy 0
subjects 0
, 0
whereas 0
renal 0
and 0
whole 0
- 0
body 0
NE 0
spillovers 0
were 0
similar 0
between 0
the 0
study 0
groups 0
. 0

Translation 0
of 0
mok B-gene
is 0
tightly 0
regulated 0
by 0
Sok B-gene
RNA I-gene
, 0
and 0
Sok B-gene
RNA I-gene
thus 0
regulates 0
hok B-gene
translation 0
indirectly 0
through 0
mok B-gene
. 0

In 0
this 0
work 0
, 0
we 0
determined 0
the 0
sequences 0
of 0
eight 0
VirF B-gene
- I-gene
binding I-gene
sites I-gene
from 0
four 0
different 0
genes 0
, 0
by 0
DNase B-gene
I I-gene
or 0
hydroxyl 0
radical 0
footprinting 0
. 0

Treatment 0
with 0
ACE B-gene
inhibitors 0
after 0
acute 0
myocardial 0
infarction 0

One 0
- 0
hour 0
O3 0
, 0
NO2 0
, 0
and 0
SO2 0
personal 0
exposures 0
were 0
measured 0
using 0
samplers 0
developed 0
in 0
our 0
laboratory 0
, 0
while 0
short 0
- 0
term 0
PM2.5 0
, 0
CO 0
, 0
and 0
VOCs 0
exposures 0
were 0
measured 0
using 0
currently 0
available 0
monitors 0
. 0

Recombinant B-gene
MsERK1 I-gene
( 0
rMsERK1 B-gene
) 0
, 0
when 0
overexpressed 0
in 0
Escherichia 0
coli 0
, 0
is 0
recognized 0
by 0
antibodies 0
raised 0
against 0
MAP B-gene
kinases I-gene
from I-gene
rat I-gene
, I-gene
Xenopus I-gene
, I-gene
and I-gene
sea I-gene
star I-gene
and 0
by 0
anti B-gene
- I-gene
phosphotyrosine I-gene
antibodies I-gene
. 0

However 0
, 0
UV 0
resistance 0
is 0
only 0
minimally 0
restored 0
, 0
and 0
mutant 0
cells 0
remain 0
sensitive 0
to 0
gamma 0
radiation 0
. 0

The 0
melanoma B-gene
growth I-gene
stimulatory I-gene
activity/growth I-gene
- I-gene
regulated I-gene
protein I-gene
, 0
CXCL1 B-gene
, 0
is 0
constitutively 0
expressed 0
at 0
high 0
levels 0
during 0
inflammation 0
and 0
progression 0
of 0
melanocytes 0
into 0
malignant 0
melanoma 0
. 0

The 0
activated 0
glucocorticoid B-gene
receptor I-gene
forms 0
a 0
complex 0
with 0
Stat5 B-gene
and 0
enhances 0
Stat5 B-gene
- 0
mediated 0
transcriptional 0
induction 0
. 0

A 0
simple 0
procedure 0
for 0
accurate 0
quantitation 0
of 0
factor B-gene
VIII I-gene
inhibitors 0
. 0

Diagnostic 0
importance 0
of 0
determining 0
leucine B-gene
aminotransferase I-gene
activity 0
in 0
acute 0
pancreatitis 0

In 0
contrast 0
, 0
T229E B-gene
- I-gene
p70s6k I-gene
migrated 0
more 0
slowly 0
in 0
SDS 0
- 0
polyacrylamide 0
gels 0
, 0
but 0
demonstrated 0
partial 0
kinase 0
activity 0
( 0
approximately 0
20 0
% 0
compared 0
with 0
the 0
wild 0
type 0
) 0
. 0

Transcription B-gene
factor I-gene
IIIC I-gene
( 0
TFIIIC B-gene
) 0
is 0
required 0
for 0
the 0
assembly 0
of 0
a 0
preinitiation 0
complex 0
on 0
5S B-gene
RNA I-gene
, 0
tRNA 0
, 0
and 0
adenovirus B-gene
VA I-gene
RNA 0
genes 0
and 0
contains 0
two 0
separable 0
components 0
, 0
TFIIIC1 B-gene
and 0
TFIIIC2 B-gene
. 0

Synchronous 0
multicentric 0
giant 0
cell 0
tumour 0
: 0
a 0
case 0
report 0
with 0
review 0
of 0
literature 0
. 0

Lysates 0
of 0
COS 0
cells 0
transfected 0
with 0
modified B-gene
hGrzB I-gene
cDNA I-gene
were 0
able 0
to 0
hydrolyze 0
tert 0
- 0
butyloxycarbonyl 0
- 0
Ala 0
- 0
Ala 0
- 0
Asp 0
- 0
thiobenzyl 0
ester 0
( 0
Boc 0
- 0
Ala 0
- 0
Ala 0
- 0
Asp 0
- 0
SBzl 0
) 0
, 0
whereas 0
lysates 0
transfected 0
with 0
unmodified B-gene
hGrzB I-gene
cDNA I-gene
were 0
inactive 0
. 0

Mutant B-gene
M I-gene
proteins I-gene
were 0
tested 0
for 0
their 0
ability 0
to 0
complement 0
growth 0
of 0
the 0
temperature 0
- 0
sensitive 0
M B-gene
protein I-gene
mutant I-gene
virus 0
tsO23 0
at 0
the 0
nonpermissive 0
temperature 0
. 0

The 0
POU B-gene
- 0
specific 0
domain 0
of 0
Pit B-gene
- I-gene
1 I-gene
is 0
essential 0
for 0
sequence 0
- 0
specific 0
, 0
high 0
affinity 0
DNA 0
binding 0
and 0
DNA 0
- 0
dependent 0
Pit B-gene
- I-gene
1 I-gene
- 0
Pit B-gene
- I-gene
1 I-gene
interactions 0
. 0

It 0
competes 0
with 0
the 0
calcium 0
ion 0
which 0
brings 0
about 0
inhibition 0
of 0
myosine B-gene
kinase I-gene
, 0
and 0
therefore 0
a 0
drop 0
in 0
phosphorylated 0
myosine 0
. 0

It 0
appears 0
to 0
be 0
useful 0
in 0
untreated 0
patients 0
with 0
stage 0
I 0
or 0
II 0
NHL 0
but 0
no 0
definite 0
radiographic 0
abnormalities 0
, 0
or 0
with 0
abnormal 0
radiographs 0
but 0
no 0
extrathoracic 0
spread 0
, 0
and 0
in 0
treated 0
patients 0
with 0
questionable 0
radiographs 0
. 0

We 0
conclude 0
that 0
LGCS 0
is 0
successful 0
in 0
treating 0
esophageal 0
varices 0
in 0
the 0
setting 0
of 0
hyperdynamic 0
portal 0
circulation 0
with 0
acceptable 0
liver 0
function 0
. 0

3 0
) 0
The 0
progress 0
of 0
fibrinolysis 0
was 0
observed 0
by 0
serial 0
collection 0
of 0
middle 0
ear 0
fluid 0
in 0
the 0
same 0
side 0
ear 0
of 0
5 0
cases 0
out 0
of 0
17 0
cases 0
having 0
much 0
activity 0
for 0
fibrin B-gene
degradation 0
, 0
and 0
lowering 0
of 0
fibrinolytic 0
activity 0
was 0
revealed 0
in 0
4 0
out 0
of 0
these 0
5 0
cases 0
as 0
the 0
result 0
. 0

In 0
lyzozyme B-gene
activity 0
there 0
was 0
periodicity 0
in 0
three 0
groups 0
but 0
not 0
in 0
the 0
youngest 0
foals 0
. 0

Alternative 0
roles 0
of 0
these 0
DNA 0
motifs 0
as 0
activators 0
of 0
early 0
mRNA 0
transcription 0
and 0
as 0
an 0
initiator 0
element 0
for 0
late 0
mRNA 0
transcription 0
help 0
explain 0
how 0
polyomavirus 0
gene 0
expression 0
is 0
regulated 0
during 0
lytic 0
growth 0
and 0
provides 0
a 0
model 0
for 0
cellular 0
transcription 0
during 0
development 0
. 0

The 0
median 0
levels 0
of 0
t B-gene
- I-gene
PA I-gene
Ag I-gene
and 0
PAI B-gene
in 0
plasma 0
were 0
respectively 0
10.7 0
ng/ml 0
( 0
interquartile 0
range 0
8.6 0
ng/ml 0
) 0
and 0
15.7 0
IU/ml 0
( 0
interquartile 0
range 0
12.2 0
IU/ml 0
) 0
. 0

The 0
Mer1 B-gene
protein I-gene
contains 0
the 0
KH 0
motif 0
found 0
in 0
some 0
RNA 0
- 0
binding 0
proteins 0
, 0
and 0
RNA 0
gel 0
mobility 0
shift 0
assays 0
demonstrate 0
that 0
Mer1 B-gene
binds 0
specifically 0
to 0
MER2 B-gene
RNA I-gene
. 0

Collectively 0
, 0
these 0
studies 0
suggest 0
that 0
the 0
major 0
EGF B-gene
- 0
stimulated 0
mitotic 0
growth 0
pathways 0
may 0
not 0
be 0
absolutely 0
linked 0
to 0
the 0
stat91 B-gene
signaling 0
pathways 0
and 0
that 0
such 0
transcription 0
complexes 0
are 0
more 0
complex 0
than 0
previously 0
reported 0
. 0

A 0
procaryotic 0
regulatory 0
factor 0
with 0
a 0
histone B-gene
H1 I-gene
- I-gene
like I-gene
carboxy I-gene
- I-gene
terminal I-gene
domain I-gene
: 0
clonal 0
variation 0
of 0
repeats 0
within 0
algP B-gene
, 0
a 0
gene 0
involved 0
in 0
regulation 0
of 0
mucoidy 0
in 0
Pseudomonas 0
aeruginosa 0
. 0

Innervation 0
of 0
reticular 0
papillae 0
in 0
sheep 0
and 0
goats 0
. 0

The 0
monkeys 0
had 0
been 0
administered 0
a 0
common 0
lead 0
isotope 0
`` 0
mix 0
'' 0
at 0
the 0
rate 0
of 0
about 0
1300 0
micrograms 0
Pb/kg 0
body 0
wt/day 0
from 0
age 0
10 0
months 0
until 0
the 0
start 0
of 0
the 0
study 0
. 0

Previous 0
studies 0
showed 0
that 0
a 0
palindromic 0
sequence 0
located 0
at 0
- 0
159 0
base 0
pairs 0
is 0
essential 0
for 0
induction 0
of 0
cutinase B-gene
gene I-gene
in 0
Fusarium 0
solani 0
f. 0
sp 0
. 0
pisi 0
( 0
Nectria 0
haematococca 0
mating 0
type 0
VI 0
) 0
by 0
the 0
hydroxy 0
fatty 0
acids 0
from 0
plant 0
cutin 0
and 0
that 0
a 0
50 0
- 0
kDa 0
nuclear 0
protein 0
binds 0
to 0
a 0
promoter 0
that 0
contains 0
this 0
element 0
. 0

In 0
cells 0
co 0
- 0
expressing 0
high 0
levels 0
of 0
the 0
p38 B-gene
( 0
MAPK B-gene
) 0
kinase 0
( 0
MKK3 B-gene
) 0
together 0
with 0
the 0
p38 B-gene
( 0
MAPK B-gene
) 0
, 0
a 0
significant 0
inhibition 0
of 0
mitogen 0
- 0
induced 0
cyclin B-gene
D1 I-gene
expression 0
was 0
observed 0
. 0

ANL 0
- 0
7535 0
. 0

Pig 0
uPA B-gene
promoter 0
- 0
CAT B-gene
constructs 0
were 0
more 0
active 0
than 0
mouse 0
constructs 0
in 0
this 0
assay 0
. 0

Thermal 0
changes 0
of 0
the 0
bovine 0
uterus 0
following 0
administration 0
of 0
estradiol 0
- 0
17beta 0
. 0

Elements 0
regulating 0
cell 0
- 0
and 0
stage 0
- 0
specific 0
expression 0
of 0
the 0
C. 0
elegans 0
MyoD B-gene
family 0
homolog 0
hlh B-gene
- I-gene
1 I-gene
. 0

Restriction 0
analysis 0
of 0
the 0
isolated 0
genomic 0
clones 0
indicated 0
that 0
the 0
endogenous 0
sequences 0
abutting 0
the 0
3 0
' 0
ends 0
of 0
the 0
94 0
- 0
A 0
and 0
94 0
- 0
K 0
transgenes 0
are 0
separated 0
by 0
less 0
than 0
20 0
kb 0
, 0
providing 0
strong 0
support 0
for 0
the 0
single 0
integration 0
model 0
. 0

The 0
sensitivity 0
for 0
ergometry 0
and 0
treadmill 0
testing 0
was 0
75 0
and 0
62 0
% 0
respectively 0
. 0

All 0
these 0
abnormalities 0
returned 0
to 0
normal 0
after 0
removal 0
of 0
the 0
tumor 0
. 0

The 0
STS B-gene
sequence I-gene
WI I-gene
- I-gene
14920 I-gene
is 0
in 0
fact 0
derived 0
from 0
the 0
3' 0
- 0
untranslated 0
region 0
of 0
the 0
human B-gene
PUNC I-gene
gene I-gene
. 0

Four 0
antifungal 0
agents 0
were 0
compared 0
: 0
amphotericin 0
B 0
, 0
flucytosine 0
, 0
miconazole 0
, 0
and 0
ketoconazole 0
. 0

Phylogenetic 0
analysis 0
of 0
yeast 0
, 0
invertebrate 0
, 0
and 0
multiple 0
mammalian 0
isoforms 0
of 0
SNF4 B-gene
shows 0
that 0
the 0
gene 0
duplication 0
likely 0
occurred 0
early 0
in 0
the 0
metazoan 0
lineage 0
, 0
as 0
the 0
protein 0
products 0
of 0
the 0
different 0
loci 0
are 0
relatively 0
divergent 0
. 0

Blood 0
samples 0
( 0
30 0
ml 0
) 0
were 0
collected 0
via 0
an 0
indwelling 0
arm 0
catheter 0
at 0
rest 0
, 0
and 0
at 0
minutes 0
13 0
and 0
28 0
of 0
exercise 0
for 0
determinations 0
of 0
plasma 0
EPI 0
, 0
serum 0
free 0
fatty 0
acid 0
( 0
FFA 0
) 0
, 0
serum 0
glycerol 0
( 0
GLY 0
) 0
, 0
blood 0
glucose 0
( 0
GLU 0
) 0
, 0
and 0
blood 0
lactate 0
( 0
LA 0
) 0
concentrations 0
. 0

The 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
precursor 0
p100 B-gene
( 0
lyt B-gene
- I-gene
10 I-gene
, 0
p97 B-gene
, 0
p98 B-gene
) 0
generates 0
after 0
proteolytic 0
processing 0
a 0
52 0
kDa 0
subunit 0
, 0
which 0
can 0
bind 0
to 0
kappa B-gene
B I-gene
- I-gene
motifs I-gene
. 0

The 0
delta 0
mean 0
VAF 0
and 0
delta 0
mean 0
SABP 0
indicated 0
varied 0
mean 0
values 0
of 0
VAF 0
and 0
SABP 0
, 0
respectively 0
. 0

Gel 0
mobility 0
shift 0
analyses 0
reveal 0
that 0
FRTL 0
- 0
5 0
thyroid 0
cell 0
nuclear 0
extracts 0
form 0
a 0
specific 0
protein/DNA 0
complex 0
with 0
this 0
region 0
, 0
which 0
is 0
prevented 0
by 0
the 0
TTF B-gene
- I-gene
1 I-gene
binding I-gene
element I-gene
from 0
the 0
TG B-gene
promoter I-gene
; 0
FRT 0
and 0
BRL 0
cell 0
nuclear 0
extracts 0
do 0
not 0
have 0
TTF B-gene
- I-gene
1 I-gene
and 0
do 0
not 0
form 0
this 0
complex 0
. 0

The 0
rice 0
gene 0
consists 0
of 0
four 0
exons 0
. 0

Thallium 0
- 0
201 0
scintigraphy 0
after 0
dipyridamole 0
infusion 0
with 0
low 0
level 0
exercise 0
. 0

Dominant 0
- 0
negative 0
upf1 B-gene
mutations 0
were 0
isolated 0
following 0
in 0
vitro 0
mutagenesis 0
of 0
a 0
plasmid 0
containing 0
the 0
UPF1 B-gene
gene I-gene
. 0

One 0
of 0
the 0
ORFs 0
in 0
the 0
Methanococcus 0
jannaschii 0
genome 0
possesses 0
high 0
similarity 0
to 0
the 0
M. B-gene
aeolicus I-gene
ilvB I-gene
, 0
indicating 0
that 0
it 0
is 0
an 0
authentic 0
AHAS B-gene
. 0

It 0
differed 0
from 0
cued 0
recall 0
only 0
in 0
the 0
instructions 0
, 0
which 0
directed 0
subjects 0
away 0
from 0
the 0
memory 0
aspects 0
of 0
the 0
test 0
and 0
asked 0
them 0
to 0
complete 0
each 0
three 0
- 0
letter 0
cue 0
with 0
the 0
first 0
word 0
that 0
came 0
to 0
mind 0
. 0

Such 0
saturation 0
often 0
occurs 0
for 0
several 0
recording 0
sweeps 0
after 0
large 0
amplitude 0
signals 0
such 0
as 0
eye 0
blinks 0
are 0
rejected 0
. 0

To 0
define 0
the 0
molecular 0
mechanism 0
regulating 0
FGFR B-gene
- I-gene
1 I-gene
gene I-gene
expression 0
in 0
proliferating 0
myoblasts 0
and 0
post 0
- 0
mitotic 0
muscle 0
fibers 0
, 0
we 0
have 0
isolated 0
and 0
partially 0
characterized 0
the 0
avian 0
FGFR B-gene
- I-gene
1 I-gene
gene I-gene
promoter 0
. 0

Samarium 0
- 0
153 0
for 0
intravascular 0
irradiation 0
therapy 0
with 0
liquid 0
- 0
filled 0
balloons 0
to 0
prevent 0
restenosis 0
: 0
acute 0
and 0
long 0
- 0
term 0
results 0
in 0
a 0
hypercholesterolemic 0
rabbit 0
restenosis 0
model 0
. 0

This 0
element 0
was 0
required 0
for 0
both 0
basal 0
and 0
activated 0
expression 0
and 0
almost 0
certainly 0
functions 0
as 0
a 0
TATA B-gene
- I-gene
binding I-gene
protein I-gene
interaction 0
site 0
. 0

This 0
report 0
establishes 0
that 0
the 0
effect 0
of 0
homozygous 0
sickle 0
cell 0
disease 0
on 0
growth 0
patterns 0
in 0
childhood 0
is 0
apparent 0
before 0
the 0
age 0
of 0
6 0
years 0
. 0

But 0
it 0
is 0
possible 0
that 0
the 0
two 0
hemispheres 0
differ 0
in 0
the 0
manner 0
in 0
which 0
they 0
make 0
use 0
of 0
semantic 0
structures 0
: 0
the 0
left 0
hemisphere 0
in 0
a 0
selective 0
manner 0
, 0
appropriate 0
for 0
the 0
solution 0
of 0
a 0
specific 0
task 0
, 0
and 0
the 0
right 0
hemisphere 0
in 0
a 0
more 0
diffuse 0
and 0
global 0
manner 0
. 0

The 0
results 0
reveal 0
preferences 0
for 0
particular 0
initiating 0
nucleotides 0
( 0
ATP 0
> 0
or 0
= 0
GTP 0
> 0
UTP 0
> 0
> 0
CTP 0
) 0
and 0
for 0
starting 0
positions 0
downstream 0
of 0
the 0
Pribnow 0
box 0
( 0
7 0
> 0
> 0
6 0
and 0
8 0
> 0
9 0
> 0
10 0
) 0
. 0

We 0
determined 0
that 0
Hop B-gene
( I-gene
T42 I-gene
) I-gene
contains 0
a 0
glutamic 0
acid 0
- 0
to 0
- 0
lysine 0
substitution 0
at 0
amino 0
acid 0
residue 0
695 0
( 0
E695K 0
) 0
. 0

Androgen 0
ablation 0
- 0
- 0
50 0
years 0
later 0
. 0

It 0
is 0
suggested 0
that 0
on 0
presentation 0
of 0
tail 0
tip 0
necrosis 0
in 0
kittens 0
a 0
diagnosis 0
of 0
neonatal 0
isoerythrolysis 0
or 0
isoagglutination 0
should 0
be 0
considered 0
. 0

Men 0
and 0
women 0
entering 0
psychotherapy 0
more 0
often 0
had 0
negative 0
Wish 0
elements 0
than 0
others 0
. 0

This 0
clone 0
will 0
be 0
useful 0
for 0
identifying 0
the 0
genetic 0
determinants 0
of 0
FIV 0
- 0
Oma 0
's 0
biological 0
activities 0
. 0

Serum B-gene
prolactin I-gene
and 0
oestradiol 0
levels 0
at 0
different 0
stages 0
of 0
puberty 0
. 0

The 0
sequence 0
of 0
three 0
of 0
them 0
revealed 0
pure 0
CAG 0
stretches 0
. 0

Total 0
body 0
BMD 0
( 0
r 0
= 0
0.30 0
; 0
P 0
= 0
0.02 0
) 0
and 0
femoral 0
neck 0
BMD 0
( 0
r 0
= 0
0.39 0
; 0
P 0
= 0
0.002 0
) 0
were 0
positively 0
correlated 0
with 0
weight 0
- 0
bearing 0
activity 0
but 0
not 0
with 0
non 0
- 0
weight 0
- 0
bearing 0
activity 0
. 0

PCC 0
6803 0
mutant 0
impaired 0
in 0
cytochrome B-gene
c I-gene
maturation 0
. 0

Ureases B-gene
were 0
purified 0
from 0
the 0
recombinant 0
cells 0
and 0
shown 0
to 0
be 0
identical 0
to 0
control 0
enzyme 0
when 0
analyzed 0
by 0
gel 0
filtration 0
chromatography 0
and 0
sodium 0
dodecyl 0
sulfate 0
- 0
polyacrylamide 0
gel 0
electrophoresis 0
; 0
however 0
, 0
in 0
every 0
case 0
the 0
activity 0
levels 0
correlated 0
to 0
nickel 0
contents 0
as 0
analyzed 0
by 0
atomic 0
absorption 0
analysis 0
. 0

Sequence 0
analysis 0
of 0
the 0
catfish 0
JH B-gene
- 0
CH B-gene
intron 0
suggests 0
that 0
several 0
sequences 0
are 0
present 0
which 0
appear 0
similar 0
to 0
important 0
transcriptional 0
regulatory 0
elements 0
found 0
within 0
JH B-gene
- 0
CH B-gene
introns 0
of 0
higher 0
vertebrates 0
. 0

Seroconversion 0
after 0
hepatitis 0
B 0
vaccination 0
. 0

On 0
day 0
1 0
at 0
3500 0
m 0
, 0
RI 0
showed 0
a 0
significant 0
fall 0
in 0
body 0
weight 0
( 0
BW 0
) 0
with 0
respect 0
to 0
SL 0
but 0
AI 0
maintained 0
it 0
. 0

Expression 0
of 0
CBP/p300 B-gene
potentiated 0
HS2 0
- 0
mediated 0
transactivation 0
. 0

The 0
perforated 0
splint 0
gives 0
superior 0
results 0
by 0
virtue 0
of 0
the 0
fact 0
that 0
it 0
does 0
not 0
require 0
to 0
be 0
removed 0
for 0
purposes 0
of 0
hygiene 0
and 0
can 0
thus 0
produce 0
a 0
satisfactory 0
result 0
even 0
in 0
those 0
patients 0
who 0
fail 0
to 0
grasp 0
the 0
technique 0
of 0
removal 0
and 0
replacement 0
of 0
the 0
splint 0
. 0

Using 0
lasers 0
in 0
diabetic 0
wound 0
healing 0
. 0

Protein 0
metabolism 0
disorders 0
in 0
burns 0

In 0
contrast 0
, 0
MAPK B-gene
activation 0
stimulated 0
by 0
the 0
Gq B-gene
- 0
coupled 0
alpha 0
1B 0
AR 0
or 0
M1 B-gene
muscarinic B-gene
cholinergic I-gene
receptor I-gene
is 0
unaffected 0
by 0
expression 0
of 0
beta B-gene
ARKct I-gene
or 0
RasN17 B-gene
expression 0
or 0
by 0
PTK B-gene
inhibitors 0
, 0
but 0
is 0
blocked 0
by 0
expression 0
of 0
N B-gene
delta I-gene
Raf I-gene
or 0
by 0
PKC B-gene
depletion 0
. 0

RNA 0
unwinding 0
in 0
U4/U6 B-gene
snRNPs 0
requires 0
ATP 0
hydrolysis 0
and 0
the 0
DEIH 0
- 0
box 0
splicing 0
factor 0
U4/U6 I-gene

Extra 0
dose 0
due 0
to 0
extravehicular 0
activity 0
during 0
the 0
NASA4 0
mission 0
measured 0
by 0
an 0
on 0
- 0
board 0
TLD 0
system 0
. 0

Preface 0
and 0
acknowledgements 0
. 0

G B-gene
- I-gene
CSF I-gene
( 0
10 0
microg/kg 0
) 0
was 0
started 0
on 0
day 0
+1 0
and 0
all 0
patients 0
engrafted 0
within 0
a 0
median 0
day 0
number 0
of 0
12 0
( 0
range 0
, 0
10 0
- 0
22 0
) 0
until 0
leukocytes 0
> 0
1.0 0
x 0
10 0
( 0
9 0
) 0
/l 0
and 0
a 0
median 0
day 0
number 0
of 0
56 0
( 0
range 0
, 0
10 0
- 0
180 0
) 0
until 0
platelets 0
> 0
20.0 0
x 0
10 0
( 0
9 0
) 0
/l 0
( 0
ie 0
platelet 0
transfusion 0
independence 0
) 0
. 0

The 0
present 0
study 0
indicates 0
that 0
the 0
high 0
- 0
dose 0
5 0
- 0
fluorouracil 0
regimen 0
shows 0
weak 0
activity 0
in 0
advanced 0
pancreatic 0
cancer 0
which 0
seems 0
comparable 0
to 0
gemcitabine 0
. 0

At 0
D28 0
, 0
149 0
of 0
386 0
patients 0
( 0
49 0
% 0
) 0
had 0
had 0
episodes 0
of 0
automatic 0
mode 0
switch 0
prompted 0
by 0
atrial 0
arrhythmias 0
. 0

Thus 0
, 0
the 0
rates 0
of 0
a B-gene
- I-gene
factor I-gene
receptor I-gene
endocytosis 0
and 0
consequent 0
vacuolar 0
turnover 0
depend 0
on 0
the 0
available 0
level 0
of 0
ubiquitin B-gene
in 0
the 0
cell 0
. 0

Early 0
diagnosis 0
and 0
early 0
surgical 0
division 0
of 0
the 0
biliary 0
tract 0
and 0
pancreatic 0
duct 0
is 0
recommended 0
for 0
children 0
with 0
AAPBD 0
. 0

This 0
approach 0
allowed 0
examination 0
of 0
baseline 0
factors 0
as 0
well 0
as 0
the 0
effect 0
of 0
change 0
in 0
mileage 0
, 0
the 0
occurrence 0
of 0
a 0
musculoskeletal 0
problem 0
, 0
or 0
the 0
occurrence 0
of 0
another 0
health 0
problem 0
on 0
the 0
rate 0
of 0
dropout 0
. 0

Increased 0
gliadin B-gene
antibody I-gene
levels 0
were 0
found 0
more 0
frequently 0
in 0
patients 0
with 0
subtotal 0
villous 0
atrophy 0
( 0
9 0
out 0
of 0
17 0
patients 0
, 0
or 0
53 0
% 0
; 0
p 0
less 0
than 0
0.05 0
) 0
than 0
in 0
patients 0
with 0
partial 0
villous 0
atrophy 0
( 0
2 0
out 0
of 0
13 0
patients 0
, 0
or 0
15 0
% 0
) 0
or 0
normal 0
villous 0
appearance 0
( 0
2 0
out 0
of 0
10 0
patients 0
, 0
or 0
20 0
% 0
) 0
. 0

The 0
effects 0
of 0
cefazolin 0
, 0
given 0
into 0
the 0
III 0
cerebral 0
ventricle 0
at 0
different 0
doses 0
were 0
studied 0
on 0
GABA 0
content 0
, 0
GAD 0
and 0
GABA 0
- 0
T 0
in 0
the 0
brain 0
- 0
stem 0
of 0
young 0
chickens 0
( 0
Gallus 0
domesticus 0
) 0
. 0

This 0
sequence 0
was 0
sufficient 0
to 0
confer 0
p53 B-gene
- 0
dependent 0
activation 0
to 0
a 0
heterologous 0
promoter 0
and 0
p53 B-gene
was 0
capable 0
of 0
binding 0
to 0
this 0
sequence 0
as 0
assessed 0
by 0
gel 0
shift 0
analysis 0
. 0

CAT B-gene
assays 0
demonstrated 0
that 0
overexpression 0
of 0
RXRalpha B-gene
conferred 0
the 0
best 0
RA 0
response 0
, 0
consistent 0
with 0
our 0
previous 0
observation 0
that 0
9 0
- 0
cis 0
- 0
RA 0
is 0
more 0
potent 0
than 0
all 0
- 0
trans 0
- 0
RA 0
for 0
inducing 0
the 0
expression 0
of 0
the 0
AFP B-gene
gene I-gene
. 0

In 0
addition 0
, 0
the 0
results 0
suggest 0
that 0
N 0
region 0
diversity 0
at 0
V B-gene
( 0
D B-gene
) 0
J B-gene
junctions 0
within 0
rearranged 0
immunoglobulin B-gene
and 0
T B-gene
cell I-gene
receptor I-gene
gene I-gene
loci I-gene
can 0
only 0
be 0
introduced 0
after 0
the 0
generation 0
of 0
RAG B-gene
- 0
catalyzed 0
DNA 0
double 0
- 0
strand 0
breaks 0
, 0
i.e 0
. 0
during 0
the 0
DNA 0
end 0
joining 0
phase 0
of 0
the 0
V B-gene
( 0
D B-gene
) 0
J B-gene
recombination 0
reaction 0
. 0

The 0
pra2 B-gene
gene I-gene
encodes 0
a 0
pea B-gene
( I-gene
Pisum I-gene
sativum I-gene
) I-gene
small I-gene
GTPase I-gene
belonging 0
to 0
the 0
YPT/rab B-gene
family 0
, 0
and 0
its 0
expression 0
is 0
down 0
- 0
regulated 0
by 0
light 0
, 0
mediated 0
by 0
YPT/rab I-gene

To 0
directly 0
address 0
this 0
issue 0
, 0
we 0
used 0
a 0
tetracycline 0
- 0
regulated 0
system 0
in 0
human 0
U2OS 0
osteosarcoma 0
cells 0
and 0
thus 0
found 0
that 0
BCL6 B-gene
mediates 0
growth 0
suppression 0
associated 0
with 0
impaired 0
S 0
phase 0
progression 0
and 0
apoptosis 0
. 0

Changes 0
in 0
water 0
and 0
electrolyte 0
content 0
of 0
the 0
brain 0
and 0
edema 0
formation 0
after 0
acute 0
, 0
drug 0
- 0
induced 0
hypertension 0
were 0
studied 0
in 0
albino 0
rabbits 0
. 0

The 0
amino B-gene
- I-gene
terminal I-gene
gag I-gene
- I-gene
encoded I-gene
region I-gene
of 0
P140gag B-gene
- 0
fps B-gene
contains 0
a 0
phosphotyrosine 0
residue 0
in 0
addition 0
to 0
normal 0
gag B-gene
phosphorylation 0
sites 0
. 0

To 0
explore 0
the 0
effect 0
of 0
persistent 0
cardiomegaly 0
on 0
cardiovascular 0
function 0
, 0
groups 0
of 0
newborn 0
rats 0
inhaled 0
up 0
to 0
500 0
ppm 0
CO 0
for 0
33 0
days 0
, 0
after 0
which 0
development 0
continued 0
in 0
ambient 0
air 0
. 0

The 0
subjects 0
' 0
lungs 0
were 0
ventilated 0
with 0
N2O 0
in 0
O2 0
( 0
FIO2 0
0.3 0
) 0
to 0
the 0
end 0
- 0
tidal 0
CO2 0
present 0
before 0
anesthesia 0
, 0
and 0
then 0
CBF 0
was 0
measured 0
using 0
intravenous 0
133Xe 0
and 0
ten 0
scintillation 0
counters 0
, 0
five 0
over 0
each 0
cerebral 0
hemisphere 0
. 0

Cutaneous 0
melanoma 0
and 0
bilateral 0
retinoblastoma 0
. 0

This 0
complex 0
was 0
eliminated 0
by 0
mutation 0
of 0
either 0
half 0
- 0
site 0
, 0
and 0
it 0
was 0
supershifted 0
by 0
antibodies 0
against 0
chicken B-gene
ovalbumin I-gene
upstream I-gene
promoter I-gene
- I-gene
transcription I-gene
factor I-gene
( 0
COUP B-gene
- I-gene
TF I-gene
) 0
. 0

Polymorphisms 0
in 0
the 0
CCR5 B-gene
genes I-gene
of 0
African 0
green 0
monkeys 0
and 0
mice 0
implicate 0
specific 0
amino 0
acids 0
in 0
infections 0
by 0
simian 0
and 0
human 0
immunodeficiency 0
viruses 0
. 0

The 0
transcription 0
start 0
site 0
was 0
localized 0
224 0
bp 0
upstream 0
the 0
ATG 0
codon 0
by 0
RNase B-gene
protection 0
and 0
primer 0
extension 0
mapping 0
. 0

Statistical 0
aspects 0
of 0
the 0
relation 0
of 0
the 0
radioprotective 0
action 0
of 0
mercaptoethylamine 0
derivatives 0
and 0
analogs 0
to 0
their 0
electron 0
parameters 0

Six 0
patients 0
( 0
24 0
% 0
) 0
developed 0
sepsis 0
and 0
only 0
one 0
survived 0
. 0

The 0
material 0
then 0
was 0
cut 0
with 0
a 0
diamond 0
saw 0
into 0
sheets 0
of 0
8 0
x 0
10 0
x 0
3 0
mm 0
, 0
and 0
the 0
upper 0
surface 0
was 0
polished 0
by 0
colloidal 0
SiO2 0
and/or 0
covered 0
with 0
a 0
carbon 0
- 0
titanium 0
( 0
C 0
: 0
Ti 0
) 0
layer 0
( 0
3.3 0
microm 0
) 0
using 0
the 0
plasma 0
- 0
enhanced 0
physical 0
vapor 0
deposition 0
method 0
. 0

We 0
present 0
here 0
a 0
statistical 0
technique 0
we 0
developed 0
to 0
identify 0
the 0
sequence 0
elements 0
that 0
may 0
be 0
responsible 0
for 0
this 0
cell 0
cycle 0
regulation 0
. 0

Diabetic 0
osteopenia 0
, 0
a 0
known 0
chronic 0
complication 0
of 0
diabetes 0
, 0
has 0
been 0
demonstrated 0
with 0
alterations 0
in 0
the 0
calcium 0
- 0
vitamin 0
D 0
endocrine 0
system 0
. 0

From 0
the 0
comparison 0
of 0
the 0
nod B-gene
box I-gene
sequences I-gene
of 0
( 0
brady 0
) 0
rhizobia 0
with 0
a 0
more 0
divergent 0
nod B-gene
box I-gene
from 0
Azorhizobium 0
caulinodans 0
, 0
we 0
now 0
propose 0
a 0
modular 0
build 0
- 0
up 0
of 0
the 0
nod B-gene
box I-gene
with 0
the 0
sequence 0
A 0
- 0
T 0
- 0
C 0
- 0
N9 0
- 0
G 0
- 0
A 0
- 0
T 0
as 0
the 0
binding 0
target 0
of 0
the 0
NodD B-gene
protein I-gene
( 0
the 0
NodD B-gene
box I-gene
) 0
. 0

This 0
dip 0
also 0
occurred 0
during 0
prednisone 0
and 0
vitamin 0
D 0
treatment 0
, 0
but 0
did 0
not 0
occur 0
when 0
calcium 0
was 0
added 0
to 0
prednisone 0
, 0
although 0
the 0
baseline 0
value 0
was 0
lower 0
at 0
the 0
start 0
of 0
combined 0
treatment 0
with 0
prednisone 0
and 0
calcium 0
. 0

Highly 0
conserved 0
regions 0
called 0
src B-gene
homology I-gene
2 I-gene
and 0
3 0
( 0
SH2 B-gene
and 0
SH3 B-gene
) 0
, 0
comprising 0
amino 0
acid 0
residues 0
88 0
to 0
250 0
, 0
are 0
believed 0
to 0
modulate 0
the 0
protein B-gene
- I-gene
tyrosine I-gene
kinase I-gene
activity 0
present 0
in 0
the 0
carboxy 0
- 0
terminal 0
halves 0
of 0
the 0
src B-gene
proteins I-gene
. 0

The 0
addition 0
of 0
novel 0
techniques 0
, 0
such 0
as 0
histopathologic 0
ultrastaging 0
, 0
immunohistochemistry 0
staining 0
, 0
and 0
reverse B-gene
transcriptase I-gene
polymerase 0
chain 0
reaction 0
assays 0
, 0
will 0
help 0
increase 0
the 0
accuracy 0
and 0
rate 0
of 0
detection 0
of 0
disease 0
. 0

Acanthamoeba B-gene
myosin I-gene
I I-gene
heavy I-gene
chain I-gene
kinase I-gene
( 0
MIHCK B-gene
) 0
phosphorylates 0
the 0
heavy 0
chains 0
of 0
amoeba B-gene
myosins I-gene
I I-gene
, 0
increasing 0
their 0
actin B-gene
- 0
activated 0
ATPase B-gene
activities 0
. 0

Two 0
different 0
genes 0
( 0
polA B-gene
and 0
polB B-gene
) 0
encoding 0
family B-gene
B I-gene
DNA I-gene
polymerases I-gene
were 0
cloned 0
from 0
the 0
organism 0
by 0
PCR 0
using 0
degenerated 0
primers 0
based 0
on 0
the 0
two 0
conserved 0
motifs 0
( 0
motif 0
A 0
and 0
B 0
) 0
. 0

In 0
this 0
reconstituted 0
system 0
, 0
RNAP B-gene
IIA I-gene
, 0
but 0
not 0
RNAP B-gene
IIB I-gene
, 0
can 0
transcribe 0
from 0
the 0
DHFR B-gene
promoter I-gene
. 0

Furthermore 0
, 0
the 0
data 0
suggest 0
an 0
immunological 0
non 0
- 0
responsiveness 0
to 0
enterotoxin B-gene
A I-gene
in 0
a 0
considerable 0
portion 0
of 0
the 0
patients 0
. 0

The 0
polypeptide 0
encoded 0
by 0
the 0
cDNA 0
contained 0
450 0
amino 0
acids 0
with 0
a 0
calculated 0
M 0
( 0
r 0
) 0
of 0
52,057 0
, 0
and 0
showed 0
significant 0
homology 0
with 0
human 0
and 0
mouse B-gene
CAD I-gene
( 0
22 0
% 0
identity 0
) 0
. 0

Focal 0
or 0
regional 0
8 0
- 0
to 0
20 0
- 0
Hz 0
low 0
- 0
voltage 0
epileptiform 0
paroxysms 0
in 0
either 0
hippocampus 0
( 0
10 0
patients 0
) 0
, 0
amygdala 0
( 0
1 0
patient 0
) 0
, 0
or 0
both 0
( 0
1 0
patient 0
) 0
preceded 0
initial 0
motionless 0
staring 0
. 0

Cytokine 0
- 0
mediated 0
I B-gene
kappa I-gene
B I-gene
alpha I-gene
reappearance 0
was 0
completely 0
blocked 0
by 0
the 0
protein 0
synthesis 0
inhibitor 0
cycloheximide 0
. 0

In 0
addition 0
, 0
the 0
authors 0
found 0
one 0
an3 B-gene
allele I-gene
( 0
an3 B-gene
- I-gene
W138A I-gene
) 0
in 0
which 0
a 0
dTph1 B-gene
element I-gene
had 0
inserted 0
30 0
bp 0
upstream 0
the 0
translation 0
start 0
, 0
without 0
inactivating 0
the 0
gene 0
. 0

The 0
right 0
cornea 0
of 0
rats 0
was 0
cauterized 0
by 0
drops 0
of 0
1.5 0
N 0
HC1 0
over 0
30 0
s 0
; 0
the 0
left 0
one 0
served 0
as 0
a 0
control 0
. 0

The 0
difference 0
between 0
the 0
effects 0
of 0
the 0
two 0
dose 0
levels 0
of 0
Z 0
. 0

The 0
purpose 0
of 0
this 0
presentation 0
is 0
to 0
review 0
the 0
current 0
state 0
of 0
knowledge 0
regarding 0
5,8,11,14 0
- 0
eicosatetraynoic 0
acid 0
( 0
ETYA 0
, 0
Ro 0
3 0
- 0
1428 0
) 0
and 0
its 0
effects 0
on 0
lipid 0
metabolism 0
. 0

Pathophysiologic 0
mechanisms 0
underlying 0
spatial 0
disorientation 0
in 0
patients 0
with 0
Alzheimer 0
's 0
disease 0
. 0

Secretion 0
of 0
cuticle 0
over 0
and 0
between 0
the 0
domed 0
apical 0
surfaces 0
of 0
these 0
cells 0
leads 0
to 0
a 0
honeycomb 0
- 0
like 0
structure 0
and 0
gives 0
the 0
superficial 0
wart 0
- 0
like 0
phenotype 0
of 0
mitotic 0
clones 0
on 0
the 0
adult 0
. 0

The 0
sequences 0
of 0
two 0
previously 0
known 0
tail B-gene
genes I-gene
, 0
R B-gene
and 0
S B-gene
, 0
of 0
the 0
temperate 0
bacteriophage 0
P2 0
and 0
the 0
sequence 0
of 0
an 0
additional 0
open 0
reading 0
frame 0
( 0
orf 0
- 0
30 0
) 0
located 0
between 0
S B-gene
and 0
V B-gene
, 0
were 0
determined 0
. 0

NGF B-gene
also 0
induced 0
a 0
synthetic 0
promoter 0
with 0
repeated 0
Sp1 B-gene
sites I-gene
linked 0
to 0
a 0
core 0
promoter 0
, 0
and 0
a 0
plasmid 0
regulated 0
by 0
a 0
chimeric 0
transactivator 0
in 0
which 0
the 0
Gal4 B-gene
DNA I-gene
binding I-gene
domain I-gene
is 0
fused 0
to 0
the 0
Sp1 B-gene
transactivation I-gene
domain I-gene
, 0
indicating 0
that 0
this 0
transactivation 0
domain 0
is 0
regulated 0
by 0
NGF B-gene
. 0

Nuclear 0
transcription 0
assays 0
confirmed 0
that 0
cys B-gene
- I-gene
3+ I-gene
was 0
under 0
sulfur 0
- 0
regulated 0
transcriptional 0
control 0
and 0
that 0
cys B-gene
- I-gene
3+ I-gene
transcription 0
was 0
constitutive 0
in 0
sulfur B-gene
controller I-gene
( 0
scon B-gene
) 0
- 0
negative 0
regulator 0
mutants 0
. 0

These 0
results 0
suggest 0
that 0
UvrA B-gene
is 0
involved 0
in 0
triplet 0
repeat 0
instability 0
in 0
cells 0
. 0

We 0
conclude 0
, 0
therefore 0
, 0
that 0
in 0
the 0
absence 0
of 0
E1A B-gene
, 0
E4orf4 B-gene
is 0
sufficient 0
by 0
itself 0
to 0
trigger 0
a 0
p53 B-gene
- 0
independent 0
apoptosis 0
pathway 0
that 0
may 0
operate 0
independently 0
of 0
the 0
known 0
zVAD 0
- 0
inhibitable 0
caspases B-gene
, 0
and 0
that 0
may 0
involve 0
an 0
as 0
yet 0
uncharacterized 0
mechanism 0
. 0

CONCLUSIONS 0
: 0
The 0
system 0
developed 0
in 0
this 0
study 0
can 0
be 0
used 0
as 0
a 0
method 0
to 0
detect 0
air 0
- 0
trapping 0
during 0
TGI 0
. 0

The 0
nucleotide 0
sequence 0
of 0
the 0
gene 0
encoding 0
this 0
product 0
was 0
determined 0
and 0
the 0
amino 0
acid 0
sequence 0
deduced 0
. 0

After 0
a 0
shift 0
to 0
37 0
degrees 0
C 0
, 0
the 0
mutant 0
Rat7 B-gene
- I-gene
1p/Nup159 I-gene
1p/Nup159 I-gene
- I-gene
1p I-gene
is 0
lost 0
from 0
the 0
nuclear 0
rim 0
of 0
rat7 0
- 0
1 0
cells 0
and 0
NPCs 0
, 0
which 0
are 0
clustered 0
together 0
in 0
these 0
cells 0
grown 0
under 0
permissive 0
conditions 0
become 0
substantially 0
less 0
clustered 0
. 0

Evidence 0
for 0
Gcr1p/Gcr2p B-gene
interaction 0
has 0
been 0
presented 0
earlier 0
and 0
is 0
now 0
supported 0
by 0
the 0
isolation 0
of 0
mutations 0
in 0
Gcr1p/Gcr2p I-gene

Renal 0
function 0
was 0
evaluated 0
in 0
a 0
group 0
of 0
24 0
patients 0
( 0
21 0
men 0
and 0
3 0
women 0
, 0
mean 0
age 0
47 0
years 0
) 0
who 0
had 0
survived 0
the 0
malignant 0
phase 0
of 0
hypertension 0
during 0
the 0
period 0
of 0
1969 0
- 0
1979 0
. 0

Mammalian 0
ribonucleotide B-gene
reductase I-gene
shows 0
S 0
- 0
phase 0
specific 0
expression 0
and 0
consists 0
of 0
two 0
non 0
- 0
identical 0
subunits 0
, 0
proteins B-gene
R1 I-gene
( 0
large 0
subunit 0
) 0
and 0
R2 B-gene
( 0
small 0
subunit 0
) 0
. 0

Azoospermia 0
was 0
graded 0
in 0
the 0
following 0
way 0
: 0
adequate 0
spermatozoa 0
( 0
A1 0
) 0
, 0
low 0
, 0
scanty 0
or 0
rare 0
spermatozoa 0
( 0
A2 0
) 0
, 0
spermatid 0
arrest 0
( 0
B1 0
) 0
, 0
spermatocyte 0
arrest 0
( 0
B2 0
) 0
, 0
Sertoli 0
cell 0
- 0
only 0
pattern 0
( 0
C 0
) 0
and 0
sclerosis 0
( 0
D 0
) 0
. 0

This 0
paper 0
describes 0
a 0
course 0
of 0
therapy 0
with 0
an 0
agoraphobic 0
female 0
patient 0
. 0

Plasmids 0
bearing 0
the 0
P. B-gene
stipitis I-gene
URA3 I-gene
gene I-gene
and 0
ARS2 0
element 0
produced 0
more 0
than 0
30,000 0
transformants 0
per 0
micrograms 0
of 0
plasmid 0
DNA 0
. 0

The 0
activation 0
of 0
NF B-gene
- I-gene
kappaB I-gene
- 0
dependent 0
reporter 0
gene 0
transcription 0
by 0
E1A B-gene
was 0
potently 0
suppressed 0
upon 0
coexpression 0
of 0
the 0
E1B B-gene
19 I-gene
- I-gene
kDa I-gene
protein I-gene
( I-gene
19K I-gene
) I-gene
. 0

We 0
analyzed 0
the 0
effects 0
of 0
light 0
on 0
tubulin B-gene
mRNA I-gene
abundance 0
in 0
Arabidopsis 0
seedlings 0
using 0
RNA 0
gel 0
blot 0
hybridizations 0
and 0
gene 0
- 0
specific 0
probes 0
. 0

We 0
conclude 0
that 0
transcription 0
of 0
both 0
SCD1 B-gene
and 0
SCD2 B-gene
genes I-gene
is 0
responsive 0
to 0
cellular 0
sterol 0
levels 0
and 0
to 0
the 0
levels 0
of 0
nuclear 0
SREBP/ADD1 B-gene
and 0
that 0
transcriptional 0
induction 0
requires 0
three 0
spatially 0
conserved 0
cis 0
elements 0
, 0
that 0
bind 0
SREBP/ADD1 I-gene

BACKGROUND 0
: 0
Recent 0
iterative 0
methods 0
for 0
sequence 0
alignment 0
have 0
indicated 0
that 0
the 0
380 0
kDa 0
motor 0
unit 0
of 0
dynein B-gene
belongs 0
to 0
the 0
AAA B-gene
class I-gene
of 0
chaperone B-gene
- I-gene
like I-gene
ATPases I-gene
. 0

It 0
is 0
suggested 0
that 0
death 0
of 0
S. 0
mansoni 0
cercariae 0
during 0
penetration 0
of 0
mammalian 0
host 0
skin 0
is 0
probably 0
due 0
to 0
exhaustion 0
of 0
their 0
energy 0
reserves 0
. 0

In 0
particular 0
, 0
lacZ B-gene
transcripts I-gene
synthesised 0
this 0
way 0
are 0
highly 0
unstable 0
and 0
yield 0
little 0
beta B-gene
- I-gene
galactosidase I-gene
. 0

Recent 0
research 0
on 0
lipolysis 0
. 0

Instead 0
, 0
HBx B-gene
is 0
shown 0
to 0
activate 0
the 0
cyclin B-gene
A I-gene
promoter I-gene
, 0
induce 0
cyclin B-gene
A I-gene
- 0
cyclin B-gene
- I-gene
dependent I-gene
kinase I-gene
2 I-gene
complexes 0
, 0
and 0
promote 0
cycling 0
of 0
growth 0
- 0
arrested 0
cells 0
into 0
G1 0
through 0
a 0
pathway 0
involving 0
activation 0
of 0
Src B-gene
tyrosine I-gene
kinases I-gene
. 0

Fifty 0
- 0
seven 0
per 0
cent 0
of 0
the 0
primary 0
patients 0
reporting 0
mild 0
symptoms 0
had 0
abnormal 0
levels 0
of 0
leucocytes 0
in 0
their 0
CSF 0
. 0

The 0
vertebrate B-gene
transcription I-gene
factors I-gene
TCF I-gene
( 0
T B-gene
cell I-gene
factor I-gene
) 0
and 0
LEF B-gene
( 0
lymphocyte B-gene
enhancer I-gene
binding I-gene
factor I-gene
) 0
interact 0
with 0
beta B-gene
- I-gene
catenin I-gene
and 0
are 0
hypothesized 0
to 0
mediate 0
Wingless/Wnt B-gene
signaling 0
. 0

DESIGN 0
: 0
Activating B-gene
protein I-gene
- I-gene
1 I-gene
( 0
AP B-gene
- I-gene
1 I-gene
) 0
and 0
Tat B-gene
- 0
induced 0
transcription 0
were 0
assessed 0
using 0
Jun B-gene
and 0
hybrid 0
Tat/Jun B-gene
- 0
expression 0
plasmids 0
and 0
reporter 0
gene 0
constructs 0
which 0
contained 0
Tat/Jun I-gene

The 0
PRP4 B-gene
protein I-gene
of I-gene
Saccharomyces I-gene
cerevisiae I-gene
is 0
an 0
essential 0
part 0
of 0
the 0
U4/U6 B-gene
snRNP 0
, 0
a 0
component 0
of 0
the 0
mRNA 0
splicing 0
apparatus 0
. 0

According 0
to 0
the 0
penetration 0
of 0
Ca 0
- 0
45 0
, 0
the 0
microleakage 0
level 0
was 0
scored 0
for 0
each 0
section 0
. 0

Endothelial 0
purine 0
content 0
. 0

Binding 0
of 0
transformed 0
Ah B-gene
receptor I-gene
complex I-gene
to 0
a 0
dioxin 0
responsive 0
transcriptional 0
enhancer 0
: 0
evidence 0
for 0
two 0
distinct 0
heteromeric 0
DNA 0
- 0
binding 0
forms 0
. 0

KatA B-gene
, 0
AhpCF B-gene
, 0
heme 0
biosynthesis 0
enzymes 0
, 0
and 0
MrgA B-gene
are 0
also 0
induced 0
upon 0
entry 0
into 0
stationary 0
phase 0
under 0
conditions 0
of 0
iron 0
and 0
manganese 0
limitation 0
. 0

Characterization 0
of 0
the 0
chromosome 0
19 0
breakpoint 0
region 0
revealed 0
that 0
the 0
transcription B-gene
factor I-gene
- I-gene
encoding I-gene
USF2 I-gene
gene I-gene
is 0
affected 0
. 0

Analysis 0
of 0
pseudo B-gene
VH I-gene
gene I-gene
segment I-gene
recombination I-gene
products I-gene
reveals 0
no 0
bias 0
in 0
D B-gene
gene I-gene
segment I-gene
reading 0
frame 0
utilization 0
. 0

It 0
is 0
dangerous 0
to 0
label 0
such 0
conditions 0
as 0
'inappropriate 0
' 0
secretion 0
of 0
ADH B-gene
since 0
the 0
maintenance 0
of 0
circulating 0
volume 0
is 0
at 0
least 0
as 0
important 0
a 0
physiological 0
requirement 0
as 0
the 0
defence 0
of 0
tonicity 0
. 0

The 0
in 0
vitro 0
activity 0
of 0
KP 0
- 0
103 0
, 0
a 0
novel 0
triazole 0
derivative 0
, 0
against 0
pathogenic 0
fungi 0
that 0
cause 0
dermatomycoses 0
and 0
its 0
therapeutic 0
efficacy 0
against 0
plantar 0
tinea 0
pedis 0
and 0
cutaneous 0
candidiasis 0
in 0
guinea 0
pigs 0
were 0
investigated 0
. 0

Using 0
a 0
simulated 0
cough 0
machine 0
, 0
we 0
analyzed 0
the 0
effect 0
of 0
adding 0
tensio 0
- 0
active 0
liquids 0
as 0
sol 0
phase 0
simulant 0
on 0
the 0
clearance 0
of 0
gel 0
mucus 0
simulant 0
by 0
cough 0
. 0

The 0
effects 0
of 0
4 0
weeks 0
of 0
cyclosporin 0
A 0
( 0
7 0
mg/kg 0
per 0
day 0
) 0
( 0
CyA 0
) 0
on 0
the 0
survival 0
of 0
vascularized 0
osteochondral 0
grafts 0
between 0
rat 0
strains 0
[ 0
DA 0
( 0
donor 0
) 0
and 0
Lewis 0
( 0
recipient 0
) 0
] 0
and 0
the 0
presence 0
and 0
significance 0
of 0
host 0
immune 0
tolerance 0
and 0
graft 0
antigen 0
modulation 0
after 0
cessation 0
of 0
immunosuppression 0
have 0
been 0
examined 0
. 0

Insulin B-gene
binding 0
to 0
the 0
alpha 0
- 0
subunit 0
of 0
its 0
receptor 0
stimulates 0
the 0
receptor B-gene
tyrosine I-gene
kinase I-gene
to 0
phosphorylate 0
the 0
beta 0
- 0
subunit 0
and 0
several 0
endogenous 0
protein 0
substrates 0
, 0
including 0
pp120/HA4 B-gene
, 0
a 0
liver 0
- 0
specific 0
plasma 0
membrane 0
glycoprotein 0
of 0
M 0
( 0
r 0
) 0
20,000 0
. 0

The 0
second 0
intron 0
is 0
the 0
smallest 0
of 0
all 0
the 0
introns 0
( 0
116 0
bp 0
) 0
. 0

Moreover 0
, 0
our 0
recent 0
findings 0
on 0
the 0
Tc52 B-gene
encoding I-gene
gene I-gene
underline 0
the 0
interest 0
of 0
genetic 0
manipulation 0
of 0
T. 0
cruzi 0
, 0
not 0
only 0
making 0
it 0
possible 0
to 0
use 0
more 0
closely 0
an 0
in 0
vitro 0
approach 0
to 0
find 0
out 0
how 0
genes 0
function 0
, 0
but 0
also 0
to 0
obtain 0
'attenuated 0
' 0
strains 0
that 0
could 0
be 0
used 0
in 0
the 0
development 0
of 0
vaccinal 0
strategies 0
. 0

Pretreatment 0
of 0
rats 0
with 0
different 0
dose 0
levels 0
of 0
CCl4 0
resulted 0
in 0
a 0
prolongation 0
of 0
TMO 0
half 0
- 0
life 0
, 0
and 0
increase 0
of 0
the 0
area 0
under 0
the 0
curve 0
( 0
AUC 0
) 0
, 0
and 0
a 0
decrease 0
of 0
clearance 0
, 0
but 0
the 0
apparent 0
volume 0
of 0
distribution 0
( 0
Vd 0
) 0
was 0
not 0
significantly 0
decreased 0
. 0

Healthy 0
preterm 0
infants 0
of 0
gestational 0
age 0
26 0
- 0
29 0
weeks 0
showed 0
a 0
'mature 0
' 0
pattern 0
of 0
permeability 0
at 0
birth 0
, 0
followed 0
by 0
a 0
temporary 0
period 0
of 0
enhanced 0
permeability 0
after 0
3 0
- 0
4 0
weeks 0
of 0
life 0
. 0

The 0
promoter 0
for 0
HMG B-gene
- I-gene
CoA I-gene
synthase I-gene
contains 0
two 0
binding 0
sites 0
for 0
the 0
sterol B-gene
regulatory I-gene
element I-gene
- I-gene
binding I-gene
proteins I-gene
( 0
SREBPs B-gene
) 0
. 0

Using 0
the 0
same 0
electrical 0
analog 0
, 0
we 0
present 0
an 0
analysis 0
that 0
allows 0
calculation 0
of 0
these 0
parameters 0
, 0
as 0
well 0
as 0
the 0
corner 0
frequency 0
of 0
the 0
network 0
( 0
f1 0
) 0
, 0
without 0
need 0
for 0
similar 0
assumptions 0
. 0

These 0
results 0
suggest 0
that 0
transcription 0
influences 0
aspects 0
of 0
gene 0
conversion 0
after 0
initiation 0
, 0
such 0
as 0
strand 0
invasion 0
and/or 0
mismatch 0
repair 0
( 0
MMR 0
) 0
. 0

In 0
contrast 0
, 0
a 0
similar 0
fusion 0
protein 0
( 0
hGH B-gene
- 0
LDLR B-gene
- 0
DAF17 B-gene
, 0
abbreviated 0
HLD B-gene
) 0
containing 0
a 0
fragment 0
of 0
the 0
serine/threonine 0
- 0
rich 0
domain 0
of 0
the 0
LDL B-gene
receptor I-gene
( 0
LDLR B-gene
) 0
in 0
place 0
of 0
the 0
DAF B-gene
- I-gene
derived I-gene
serine/threonine I-gene
- I-gene
rich I-gene
sequences I-gene
, 0
does 0
not 0
become 0
GPI 0
anchored 0
. 0

Ocular 0
injuries 0
during 0
general 0
anesthesia 0
. 0

Of 0
concern 0
is 0
the 0
high 0
, 0
unexplained 0
prevalence 0
of 0
BV 0
among 0
African 0
- 0
American 0
women 0
, 0
who 0
are 0
also 0
at 0
extremely 0
high 0
risk 0
for 0
preterm 0
birth 0
. 0

The 0
RAG B-gene
- I-gene
2 I-gene
gene I-gene
encodes 0
a 0
component 0
of 0
the 0
V B-gene
( I-gene
D I-gene
) I-gene
J I-gene
recombinase I-gene
which 0
is 0
essential 0
for 0
the 0
assembly 0
of 0
antigen 0
receptor 0
genes 0
in 0
B 0
and 0
T 0
lymphocytes 0
. 0

The 0
LAB 0
in 0
the 0
cecum 0
( 0
mean 0
9.4 0
log 0
CFU/g 0
) 0
increased 0
slightly 0
with 0
increasing 0
abattoir 0
holding 0
time 0
. 0

Reproduction 0
and 0
maternal 0
response 0
of 0
the 0
rat 0
when 0
thiamine 0
intake 0
is 0
limited 0
. 0

Activated B-gene
Ki I-gene
- I-gene
Ras I-gene
suppresses 0
12 0
- 0
O 0
- 0
tetradecanoylphorbol 0
- 0
13 0
- 0
acetate 0
- 0
induced 0
activation 0
of 0
the 0
c B-gene
- I-gene
Jun I-gene
NH2 I-gene
- I-gene
terminal I-gene
kinase I-gene
pathway I-gene
in 0
human 0
colon 0
cancer 0
cells 0
. 0

11:5801 0
- 0
5812 0
, 0
1991 0
) 0
present 0
evidence 0
that 0
the 0
Vps18/Pep3 B-gene
protein 0
colocalizes 0
with 0
the 0
Vps18/Pep3 I-gene

Cell 0
- 0
free 0
extracts 0
of 0
E. 0
coli 0
( 0
fpg B-gene
mutY B-gene
) 0
harboring 0
pYSB10 0
possess 0
an 0
enzymatic 0
activity 0
that 0
cleaves 0
a 0
34 0
- 0
mer 0
oligonucleotide 0
containing 0
a 0
single 0
8 0
- 0
oxoG 0
opposite 0
a 0
cytosine 0
( 0
8 0
- 0
OxoG/C 0
) 0
. 0

The 0
authors 0
discussed 0
their 0
experience 0
in 0
investigating 0
20 0
patients 0
with 0
maxillary 0
malignant 0
tumors 0
using 0
routine 0
x 0
- 0
ray 0
studies 0
and 0
MR 0
- 0
tomography 0
, 0
and 0
13 0
patients 0
, 0
investigated 0
in 0
the 0
same 0
way 0
plus 0
CT 0
. 0

Magnification 0
- 0
corrected 0
planimetry 0
of 0
the 0
parapapillary 0
region 0
was 0
performed 0
according 0
to 0
Littmann 0
's 0
method 0
in 0
312 0
unselected 0
eyes 0
with 0
chronic 0
primary 0
open 0
- 0
angle 0
glaucoma 0
and 0
in 0
125 0
normal 0
eyes 0
of 0
an 0
age 0
- 0
and 0
refraction 0
- 0
matched 0
control 0
group 0
using 0
optic 0
disk 0
photographs 0
. 0

Both 0
merR B-gene
genes I-gene
consist 0
of 0
a 0
408 0
bp 0
ORF 0
coding 0
for 0
135 0
amino 0
acids 0
. 0

The 0
1.3 0
- 0
kb 0
DNA 0
, 0
when 0
placed 0
upstream 0
of 0
the 0
chloramphenicol B-gene
acetyltransferase I-gene
gene I-gene
, 0
was 0
shown 0
to 0
be 0
functionally 0
active 0
. 0

We 0
show 0
that 0
Fos B-gene
down 0
regulates 0
several 0
immediate B-gene
- I-gene
early I-gene
genes I-gene
( 0
c B-gene
- I-gene
fos I-gene
, 0
Egr B-gene
- I-gene
1 I-gene
, 0
and 0
Egr B-gene
- I-gene
2 I-gene
) 0
after 0
mitogenic 0
stimulation 0
. 0

Polar 0
effects 0
of 0
transposon 0
insertions 0
demonstrated 0
that 0
all 0
of 0
these 0
mRNAs 0
arose 0
from 0
a 0
single 0
promoter 0
region 0
, 0
where 0
transcription 0
initiated 0
80 0
bp 0
5 0
' 0
to 0
nifH B-gene
. 0

Heart 0
disease 0
. 0

A 0
definitive 0
answer 0
to 0
the 0
question 0
must 0
come 0
from 0
large 0
scale 0
mortality 0
studies 0
of 0
patients 0
in 0
whom 0
the 0
risk/benefit 0
ratio 0
of 0
thrombolysis 0
is 0
not 0
unacceptably 0
high 0
, 0
in 0
whom 0
electrocardiographic 0
criteria 0
of 0
infarction 0
are 0
unequivocal 0
, 0
and 0
in 0
whom 0
treatment 0
can 0
be 0
initiated 0
early 0
after 0
the 0
onset 0
of 0
symptoms 0
with 0
regimens 0
that 0
will 0
induce 0
not 0
only 0
early 0
recanalization 0
, 0
but 0
also 0
sustained 0
patency 0
in 0
infarct 0
- 0
related 0
arteries 0
. 0

Sonography 0
depicted 0
the 0
true 0
morphology 0
of 0
these 0
cystic 0
lesions 0
more 0
clearly 0
than 0
CT 0
, 0
and 0
the 0
sonographic 0
findings 0
virtually 0
excluded 0
uncomplicated 0
hepatic 0
cyst 0
as 0
a 0
diagnosis 0
. 0

The 0
formation 0
of 0
tumorlike 0
lesions 0
in 0
the 0
cockroach 0
leucophaea 0
maderae 0
after 0
anal 0
blockage 0
. 0

Here 0
, 0
we 0
identify 0
the 0
analytical 0
form 0
of 0
the 0
PDF 0
of 0
one 0
such 0
measure 0
, 0
the 0
order 0
parameter 0
in 0
the 0
low 0
temperature 0
phase 0
of 0
the 0
2D 0
XY 0
model 0
. 0

The 0
determination 0
of 0
antithrombin B-gene
III I-gene
( 0
AT B-gene
III I-gene
) 0
and 0
its 0
clinical 0
significance 0

In 0
each 0
of 0
the 0
studied 0
HPV 0
types 0
, 0
the 0
two 0
CDP/Cut B-gene
binding 0
sites 0
of 0
CDP/Cut I-gene

With 0
this 0
study 0
, 0
a 0
total 0
of 0
13 0
operators 0
for 0
the 0
glp B-gene
regulon I-gene
have 0
been 0
characterized 0
. 0

Located 0
between 0
the 0
3 0
' 0
trans 0
- 0
spliced 0
leader 0
acceptor 0
site 0
and 0
the 0
translational 0
initiation 0
codon 0
of 0
the 0
GP63 B-gene
gene I-gene
is 0
an 0
area 0
of 0
conserved 0
hexanucleotide 0
direct 0
repeats 0
( 0
CTCGCC 0
) 0
which 0
vary 0
in 0
number 0
according 0
to 0
species 0
. 0

The 0
aim 0
of 0
this 0
study 0
was 0
to 0
evaluate 0
the 0
impact 0
of 0
the 0
ESRD 0
treatment 0
modality 0
on 0
the 0
quality 0
of 0
life 0
in 0
patients 0
with 0
Type 0
I 0
( 0
insulin B-gene
- 0
dependent 0
) 0
diabetes 0
mellitus 0
. 0

MDA 0
- 0
MB 0
- 0
468 0
cells 0
were 0
stably 0
transfected 0
with 0
either 0
a 0
plasmid 0
having 0
a 0
CMV B-gene
promoter I-gene
- 0
driven 0
rabbit B-gene
beta I-gene
- I-gene
globin I-gene
gene I-gene
or 0
plasmids 0
having 0
a 0
CMV B-gene
promoter I-gene
- 0
driven 0
chimeric 0
gadd45 B-gene
5 0
'' 0
- 0
UTR 0
- B-gene
rabbit I-gene
beta I-gene
- I-gene
globin I-gene
gene 0
, 0
where 0
the B-gene
entire I-gene
gadd45 I-gene
5 I-gene
'' I-gene
- I-gene
UTR I-gene
( I-gene
from I-gene
+1 I-gene
to I-gene
+298 I-gene
) 0
or 0
a 0
45 0
bp 0
subfragment 0
of 0
the B-gene
gadd45 I-gene
5 I-gene
'' I-gene
- I-gene
UTR I-gene
( I-gene
from I-gene
+10 I-gene
to I-gene
+55 I-gene
) 0
was 0
positioned 0
at 0
the 0
5 0
'' 0
- 0
end 0
of B-gene
the I-gene
rabbit I-gene
beta I-gene
- I-gene
globin I-gene
gene 0
. 0

RESULTS 0
: 0
BMK B-gene
- I-gene
1 I-gene
and 0
other 0
19 0
contents 0
significantly 0
decreased 0
depolarization 0
parameters 0
Vmax 0
, 0
APA 0
, 0
OS 0
, 0
and 0
MDP 0
, 0
which 0
was 0
similar 0
to 0
that 0
of 0
TTX B-gene
and 0
different 0
from 0
that 0
of 0
Nim 0
and 0
BaCl2 0
. 0

Fourteen 0
samples 0
, 0
seven 0
each 0
of 0
IR64 0
and 0
IR66 0
were 0
studied 0
with 0
regard 0
to 0
moisture 0
content 0
, 0
germination 0
test 0
, 0
abnormal 0
seedlings 0
, 0
speed 0
of 0
germination 0
, 0
conductance 0
of 0
leachates 0
, 0
total 0
dehydrogenase 0
activity 0
, 0
total 0
free 0
amino 0
acids 0
, 0
total 0
soluble 0
sugar 0
, 0
fat 0
acidity 0
, 0
gelatinization 0
temperature 0
, 0
gel 0
consistency 0
, 0
amylose 0
content 0
, 0
translucency 0
, 0
and 0
per 0
cent 0
whiteness 0
. 0

Southern 0
zoo 0
blot 0
analysis 0
indicated 0
that 0
ZNF236 B-gene
is 0
conserved 0
in 0
the 0
genomes 0
of 0
all 0
mammalian 0
species 0
tested 0
, 0
but 0
not 0
in 0
yeast 0
. 0

3 0
. 0

This 0
alternative 0
splice 0
acceptor 0
site 0
is 0
also 0
used 0
by 0
a 0
biologically 0
active 0
provirus 0
with 0
an 0
efficiency 0
of 0
approximately 0
5 0
% 0
compared 0
with 0
the 0
upstream 0
site 0
. 0

In 0
addition 0
to 0
loss 0
of 0
digit 0
identity 0
and 0
varying 0
degrees 0
of 0
polydactyly 0
, 0
proximal 0
skeletal 0
elements 0
are 0
severely 0
shortened 0
in 0
Xt B-gene
; 0
ld B-gene
double 0
homozygous 0
limbs 0
. 0

In 0
turn 0
, 0
production 0
of 0
sufficient 0
amounts 0
of 0
TraR B-gene
apparently 0
is 0
sensitive 0
to 0
a 0
cellular 0
function 0
requiring 0
RNase B-gene
D I-gene
. 0

In 0
this 0
study 0
, 0
the 0
effect 0
of 0
the 0
antibiotic 0
lasalocid 0
on 0
the 0
rumen 0
anaerobic 0
fungus 0
Neocallimastix 0
frontalis 0
RK 0
21 0
was 0
examined 0
. 0

4 0
382 0
new 0
mothers 0
were 0
examined 0
retrospectively 0
with 0
the 0
enzyme 0
- 0
linked 0
immunosorbent 0
assay 0
( 0
ELISA 0
) 0
for 0
IgG B-gene
activity 0
to 0
cytomegalovirus 0
( 0
CMV 0
) 0
during 0
pregnancy 0
. 0

Promoter 0
, 0
spliced 0
leader 0
, 0
and 0
coding 0
sequence 0
for 0
BICP4 B-gene
, 0
the 0
largest 0
of 0
the 0
immediate B-gene
- I-gene
early I-gene
proteins I-gene
of I-gene
bovine I-gene
herpesvirus I-gene
1 I-gene
. 0

ER B-gene
beta I-gene
was 0
less 0
potent 0
than 0
ER B-gene
alpha I-gene
in 0
activating 0
E2 0
- 0
stimulated 0
ERELuc B-gene
activity 0
( 0
4 0
- 0
vs 0
. 0

Our 0
results 0
suggest 0
a 0
dose 0
- 0
dependent 0
activity 0
of 0
lysine B-gene
vasopressin I-gene
on 0
the 0
EEG 0
, 0
which 0
might 0
be 0
similar 0
to 0
that 0
observed 0
in 0
animal 0
and 0
man 0
after 0
administration 0
of 0
nicotine 0
. 0

However 0
, 0
elimination 0
of 0
the 0
kinase 0
activity 0
of 0
DCAMKL1 B-gene
has 0
no 0
detectable 0
effect 0
on 0
its 0
microtubule 0
polymerization 0
activity 0
. 0

Sequencing 0
and 0
restriction 0
enzyme 0
analysis 0
demonstrated 0
that 0
this 0
single 0
- 0
copy 0
gene 0
contains 0
11 0
exons 0
and 0
spans 0
9596 0
base 0
pairs 0
. 0

Effects 0
of 0
prolonged 0
inhibition 0
of 0
labour 0
pains 0
with 0
Th 0
1165a 0
and 0
Isoptin 0
on 0
the 0
heart 0
, 0
circulation 0
, 0
organ 0
- 0
and 0
metabolic 0
parameters 0
of 0
the 0
mother 0

The 0
anaesthetic 0
management 0
of 0
41 0
patients 0
who 0
underwent 0
cardiac 0
transplantation 0
during 0
a 0
40 0
month 0
period 0
at 0
Clinica 0
Puerta 0
de 0
Hierro 0
is 0
reviewed 0
. 0

In 0
uraemic 0
patients 0
, 0
similar 0
maximum 0
serum 0
concentrations 0
were 0
found 0
after 0
a 0
single 0
7.5 0
mg/kg 0
iv 0
dose 0
. 0

In 0
the 0
unit 0
housing 0
of 0
a 0
compact 0
cyclotron 0
and 0
positron 0
emission 0
CT 0
( 0
PET 0
) 0
, 0
positron 0
emitting 0
gas 0
such 0
as 0
15O 0
, 0
11C 0
, 0
C15O2 0
, 0
C15O 0
etc 0
. 0
is 0
supplied 0
from 0
a 0
cyclotron 0
to 0
a 0
PET 0
room 0
through 0
a 0
transportation 0
pipe 0
with 0
an 0
appropriate 0
shield 0
to 0
reduce 0
positron 0
annihilation 0
radiation 0
. 0

Although 0
CB 0
- 0
4 0
isolates 0
were 0
less 0
resistant 0
to 0
chlorine 0
than 0
CB 0
- 0
5 0
isolates 0
, 0
after 0
1,000 0
min 0
of 0
contact 0
0.01 0
% 0
of 0
the 0
input 0
virus 0
was 0
still 0
infectious 0
. 0

Here 0
we 0
describe 0
the 0
cloning 0
and 0
initial 0
characterization 0
of 0
IPP B-gene
, 0
a 0
novel 0
human 0
gene 0
that 0
predicts 0
a 0
kelch B-gene
family I-gene
protein I-gene
homologous 0
to 0
the 0
mouse B-gene
Ipp I-gene
gene I-gene
, 0
a 0
previously 0
described 0
kelch B-gene
family I-gene
member I-gene
. 0

Sequence 0
analysis 0
identifies 0
a 0
ras B-gene
- I-gene
associating I-gene
( 0
RA B-gene
) 0
- 0
like 0
domain 0
in 0
the 0
N 0
- 0
termini 0
of 0
band B-gene
4.1/JEF I-gene
domains I-gene
and 0
in 0
the 0
Grb7/10/14 B-gene
adapter I-gene
family I-gene
. 0

Sleeping 0
position 0
and 0
sudden 0
infant 0
death 0
syndrome 0
( 0
SIDS 0
) 0
: 0
effect 0
of 0
an 0
intervention 0
programme 0
to 0
avoid 0
prone 0
sleeping 0
. 0

Statistical 0
conservation 0
laws 0
in 0
turbulent 0
transport 0
. 0

Characterization 0
and 0
targeted 0
disruption 0
of 0
murine B-gene
Nup50 I-gene
, 0
a 0
p27 B-gene
( 0
Kip1 B-gene
) 0
- 0
interacting 0
component 0
of 0
the 0
nuclear 0
pore 0
complex 0
. 0
p27 B-gene
( 0
Kip1 B-gene
) 0
is 0
a 0
member 0
of 0
the 0
Cip B-gene
- 0
Kip B-gene
family 0
of 0
cyclin B-gene
- I-gene
dependent I-gene
kinase I-gene
( 0
Cdk B-gene
) 0
inhibitors 0
that 0
binds 0
to 0
cyclin B-gene
- 0
Cdk B-gene
complexes 0
and 0
inhibits 0
their 0
catalytic 0
activity 0
in 0
response 0
to 0
antiproliferative 0
stimuli 0
. 0
p27 B-gene
( 0
Kip1 B-gene
) 0
is 0
regulated 0
by 0
several 0
posttranscriptional 0
mechanisms 0
, 0
including 0
subcellular 0
localization 0
. 0

Further 0
studies 0
are 0
warranted 0
to 0
determine 0
whether 0
these 0
findings 0
are 0
idiosyncratic 0
, 0
coincidental 0
, 0
or 0
a 0
more 0
general 0
phenomenon 0
. 0

We 0
have 0
identified 0
the 0
gene 0
encoding 0
sigma B-gene
E I-gene
using 0
a 0
genetic 0
screen 0
designed 0
to 0
isolate 0
trans 0
- 0
acting 0
mutations 0
that 0
abolish 0
expression 0
from 0
either 0
htrA B-gene
or 0
rpoHP3 B-gene
, 0
two 0
promoters 0
recognized 0
uniquely 0
by 0
sigma B-gene
E I-gene
- 0
containing 0
RNA B-gene
polymerase I-gene
. 0

METHODOLOGY 0
: 0
A 0
case 0
control 0
study 0
of 0
survivors 0
with 0
gestational 0
age 0
( 0
GA 0
) 0
< 0
28 0
weeks 0
or 0
birthweight 0
( 0
BW 0
) 0
< 0
1000 0
g 0
using 0
data 0
collected 0
prospectively 0
in 0
our 0
Neonatal 0
Intensive 0
Care 0
Unit 0
database 0
. 0

Based 0
on 0
these 0
results 0
, 0
it 0
has 0
been 0
concluded 0
that 0
an 0
IPFSA 0
can 0
promote 0
the 0
healing 0
process 0
in 0
the 0
avascular 0
zone 0
of 0
a 0
torn 0
meniscus 0
in 0
rabbits 0
and 0
that 0
systemic 0
vascularity 0
to 0
the 0
synovium 0
or 0
the 0
meniscus 0
is 0
not 0
essential 0
for 0
healing 0
to 0
occur 0
. 0

Biomass 0
growth 0
monitoring 0
using 0
pressure 0
drop 0
in 0
a 0
cocurrent 0
biofilter 0

Mutant 0
p53 B-gene
DNA I-gene
clones 0
from 0
human 0
colon 0
carcinomas 0
cooperate 0
with 0
ras B-gene
in 0
transforming 0
primary 0
rat 0
cells 0
: 0
a 0
comparison 0
of 0
the 0
`` 0
hot 0
spot 0
'' 0
mutant 0
phenotypes 0
. 0

The 0
RHO1 B-gene
gene I-gene
encodes 0
a 0
homolog 0
of 0
the 0
mammalian 0
RhoA B-gene
small I-gene
GTP I-gene
- I-gene
binding I-gene
protein I-gene
in 0
the 0
yeast 0
Saccharomyces 0
cerevisiae 0
. 0

Inspection 0
of 0
X. B-gene
tropicalis I-gene
, I-gene
mouse I-gene
and I-gene
human I-gene
U6 I-gene
DNA I-gene
upstream I-gene
sequences I-gene
revealed 0
the 0
presence 0
of 0
a 0
TATA 0
box 0
as 0
well 0
as 0
of 0
the 0
proximal 0
and 0
enhancer 0
( 0
octamer 0
motif 0
) 0
elements 0
contained 0
in 0
snRNA 0
genes 0
transcribed 0
by 0
RNA B-gene
polymerase I-gene
II I-gene
. 0

RESULTS 0
: 0
In 0
men 0
, 0
weight/height2 0
met 0
the 0
criteria 0
for 0
a 0
satisfactory 0
index 0
in 0
that 0
there 0
was 0
a 0
very 0
strong 0
correlation 0
with 0
triceps 0
skinfold 0
, 0
and 0
a 0
negligible 0
correlation 0
with 0
height 0
. 0

When 0
expressed 0
in 0
thymidine B-gene
kinase I-gene
- 0
deficient 0
L 0
cells 0
or 0
3T3 0
cells 0
, 0
C/EBPalpha B-gene
is 0
detected 0
in 0
a 0
protein 0
complex 0
which 0
binds 0
to 0
the 0
E2F B-gene
binding I-gene
sites I-gene
found 0
in 0
the 0
promoters 0
of 0
the 0
genes 0
for 0
E2F B-gene
- I-gene
1 I-gene
and 0
dihydrofolate B-gene
reductase I-gene
( 0
DHFR B-gene
) 0
. 0

Phenylalanine 0
and 0
tyrosine 0
levels 0
were 0
higher 0
in 0
those 0
who 0
received 0
Vamin 0
9 0
glucose 0
but 0
55 0
% 0
of 0
infants 0
given 0
Vamin 0
Infant 0
had 0
tyrosine 0
levels 0
below 0
the 0
lower 0
limit 0
of 0
the 0
target 0
range 0
. 0

Identification 0
of 0
an 0
osteocalcin B-gene
gene I-gene
promoter I-gene
sequence I-gene
that 0
binds 0
AP1 B-gene
. 0

CONCLUSIONS 0
: 0
Neurodevelopmental 0
assessment 0
at 0
1 0
year 0
is 0
predictive 0
of 0
school 0
performance 0
and 0
outcome 0
in 0
the 0
adolescent 0
period 0
. 0

Phenotypic 0
responses 0
of 0
additional 0
mutants 0
, 0
including 0
exo1 B-gene
, 0
srs2 B-gene
, 0
rad5 B-gene
, 0
and 0
rdh54 B-gene
strains 0
, 0
suggest 0
roles 0
in 0
recombinational 0
repair 0
, 0
but 0
not 0
in 0
NHEJ 0
. 0

Although 0
hSSTR5 B-gene
displays 0
approximately 0
75 0
% 0
sequence 0
identity 0
with 0
rat B-gene
SSTR5 I-gene
, 0
the 0
two 0
receptors 0
display 0
significantly 0
different 0
pharmacological 0
profiles 0
, 0
especially 0
with 0
respect 0
to 0
their 0
binding 0
affinities 0
for 0
the 0
SST B-gene
analogue 0
SMS 0
201 0
- 0
995 0
. 0

These 0
findings 0
suggest 0
that 0
IL B-gene
- I-gene
1 I-gene
- 0
stimulated 0
, 0
Rho B-gene
- 0
dependent 0
cytoskeletal 0
reorganization 0
may 0
cluster 0
signaling 0
molecules 0
in 0
specific 0
architectures 0
that 0
are 0
necessary 0
for 0
persistent 0
cell 0
activation 0
in 0
chronic 0
inflammatory 0
disease 0
. 0

Deletion 0
mutants 0
of 0
the 0
human B-gene
CHOP I-gene
promoter I-gene
identify 0
a 0
region 0
comprising 0
nucleotides 0
- 0
75 0
to 0
- 0
104 0
required 0
for 0
both 0
constitutive 0
and 0
ER 0
- 0
stress 0
- 0
inducible 0
expression 0
. 0

Anderson 0
Hospital 0
and 0
Tumor 0
Institute 0
at 0
Houston 0
during 0
a 0
30 0
- 0
year 0
interval 0
( 0
1944 0
to 0
1974 0
) 0
, 0
with 0
a 0
minimum 0
of 0
ten 0
years 0
of 0
follow 0
- 0
up 0
, 0
we 0
determined 0
that 0
the 0
major 0
prognostic 0
factor 0
of 0
survival 0
was 0
the 0
number 0
of 0
positive 0
nodes 0
. 0

It 0
is 0
concluded 0
that 0
the 0
atherogenic 0
process 0
includes 0
stimulation 0
of 0
collagen B-gene
and 0
elastin B-gene
synthesis 0
. 0

We 0
report 0
nine 0
consecutive 0
cases 0
of 0
ACB 0
, 0
which 0
occurred 0
in 0
five 0
males 0
and 0
four 0
females 0
and 0
were 0
detected 0
in 0
11,159 0
routine 0
spiral 0
CT 0
examinations 0
of 0
the 0
chest 0
, 0
performed 0
between 0
1994 0
and 0
1998 0
. 0

The 0
absolute 0
CD4 B-gene
count 0
of 0
patients 0
with 0
de 0
novo 0
IBD 0
was 0
210 0
- 0
700 0
cells/ml 0
at 0
the 0
time 0
of 0
IBD 0
. 0

Four 0
of 0
these 0
fibroblast 0
clones 0
were 0
infected 0
with 0
a 0
retrovirus 0
containing 0
the 0
cDNA B-gene
encoding I-gene
myoD I-gene
and 0
a 0
puromycin 0
selection 0
marker 0
. 0

Sexual 0
adventurism 0
, 0
high 0
- 0
risk 0
behavior 0
, 0
and 0
human 0
immunodeficiency 0
virus 0
- 0
1 0
seroconversion 0
among 0
the 0
Chicago 0
MACS 0
- 0
CCS 0
cohort 0
, 0
1984 0
to 0
1992 0
. 0

As 0
already 0
available 0
for 0
the 0
other 0
known 0
mammalian 0
members 0
of 0
this 0
enzyme 0
family 0
, 0
we 0
here 0
define 0
structural 0
and 0
functional 0
features 0
of 0
human B-gene
lymphoma I-gene
proprotein I-gene
convertase I-gene
( 0
LPC B-gene
) 0
. 0

This 0
study 0
demonstrates 0
the 0
feasibility 0
and 0
potential 0
usefulness 0
of 0
syngeneic 0
BM 0
Txp 0
in 0
myeloma 0
. 0

It 0
is 0
important 0
to 0
understand 0
the 0
etiology 0
of 0
HITT 0
because 0
of 0
its 0
devastating 0
clinical 0
consequences 0
. 0

Results 0
obtained 0
from 0
the 0
tritium 0
test 0
and 0
direct 0
chemical 0
analysis 0
were 0
compared 0
. 0

Relation 0
between 0
clinical 0
and 0
roentgenological 0
scores 0
and 0
measures 0
of 0
lung 0
function 0
in 0
cystic 0
fibrosis 0
, 0
with 0
special 0
reference 0
to 0
pulmonary 0
Xenon133 0
elimination 0
. 0

Phytohemagglutinin B-gene
( 0
PHA B-gene
) 0
, 0
the 0
seed B-gene
lectin I-gene
of 0
the 0
common 0
bean 0
, 0
accumulates 0
in 0
protein 0
storage 0
vacuoles 0
of 0
storage 0
parenchyma 0
cells 0
in 0
cotyledons 0
. 0

New 0
concepts 0
of 0
condyloma 0
acuminata 0
in 0
children 0
. 0

When 0
recombinant B-gene
gE I-gene
produced 0
in 0
HeLa 0
cells 0
was 0
probed 0
with 0
the 0
same 0
antiphosphotyrosine 0
antibody 0
, 0
a 0
dimeric B-gene
gE I-gene
form 0
at 0
130 0
kDa 0
was 0
detected 0
on 0
the 0
cell 0
surface 0
. 0

The 0
levels 0
of 0
soluble 0
L B-gene
- I-gene
selectin I-gene
and 0
ICAM B-gene
- I-gene
1 I-gene
in 0
the 0
serum 0
were 0
determined 0
by 0
the 0
ELISA 0
method 0
. 0

The 0
effect 0
of 0
lung 0
edema 0
on 0
pulmonary 0
vasoactivity 0
of 0
furosemide 0
. 0

Within 0
the 0
last 0
few 0
years 0
, 0
the 0
WWW 0
has 0
grown 0
enormously 0
. 0

Characterization 0
of 0
insertion 0
mutations 0
in 0
the 0
Saccharomyces B-gene
cerevisiae I-gene
MSH1 I-gene
and 0
MSH2 B-gene
genes I-gene
: 0
evidence 0
for 0
separate 0
mitochondrial 0
and 0
nuclear 0
functions 0
. 0

These 0
cells 0
also 0
showed 0
an 0
increase 0
in 0
cyclin B-gene
A I-gene
and 0
cyclin B-gene
A I-gene
- I-gene
and I-gene
E I-gene
- I-gene
associated I-gene
kinase I-gene
activities 0
characteristic 0
of 0
S 0
phase 0
induction 0
. 0

Anisotropy 0
of 0
Hc2 0
and 0
the 0
breadth 0
of 0
the 0
resistive 0
transition 0
of 0
polycrystalline 0
YBa2Cu 0

TGF B-gene
- I-gene
beta1 I-gene
induced 0
phosphorylation 0
of 0
Smad2 B-gene
and 0
Smad3 B-gene
in 0
Mv1Lu 0
mink 0
lung 0
epithelial 0
cells 0
. 0

Changes 0
in 0
the 0
frequency 0
of 0
X 0
- 0
chromatin 0
in 0
women 0
under 0
Prednisone 0
therapy 0

Obtaining 0
kidney 0
cells 0
from 0
a 0
beagle 0
puppy 0
( 0
RPB 0
- 0
1 0
) 0
and 0
the 0
establishment 0
of 0
a 0
cryopreservation 0
bank 0

Microscopically 0
, 0
cartilage 0
showed 0
markedly 0
stunted 0
and 0
disorganized 0
endochondral 0
ossification 0
. 0

When 0
incubated 0
with 0
infective 0
larvae 0
which 0
had 0
penetrated 0
mouse 0
skin 0
, 0
both 0
normal 0
and 0
immune 0
cells 0
attached 0
to 0
larvae 0
in 0
the 0
absence 0
of 0
serum 0
. 0

During 0
each 0
step 0
of 0
the 0
pulse 0
infusion 0
the 0
osteocalcin B-gene
responses 0
to 0
changes 0
in 0
CaI 0
in 0
general 0
were 0
parallel 0
to 0
the 0
changes 0
in 0
PTH B-gene
( 0
r 0
= 0
0.462 0
; 0
P 0
= 0
0.02 0
) 0
and 0
were 0
inversely 0
correlated 0
to 0
CaI 0
( 0
r 0
= 0
- 0
0.562 0
; 0
P 0
= 0
0.003 0
) 0
. 0

GH B-gene
signals 0
by 0
interacting 0
with 0
GH B-gene
receptor I-gene
( 0
GHR B-gene
) 0
. 0

These 0
data 0
suggest 0
that 0
overexpression 0
of 0
MT B-gene
potentiates 0
the 0
growth 0
of 0
MCF7 0
cells 0
, 0
whereas 0
downregulation 0
of 0
MT B-gene
elicits 0
antiproliferative 0
effects 0
. 0

The 0
induction 0
by 0
dexamethasone 0
of 0
rat B-gene
liver I-gene
CYP3A1 I-gene
differs 0
from 0
classical 0
glucocorticoid 0
gene 0
regulation 0
in 0
part 0
because 0
both 0
glucocorticoids 0
and 0
antiglucocorticoids 0
such 0
as 0
pregnenolone 0
16 0
alpha 0
- 0
carbonitrile 0
( 0
PCN 0
) 0
induce 0
CYP3A1 B-gene
through 0
transcriptional 0
gene 0
activation 0
. 0

A 0
pharmacokinetic 0
interaction 0
between 0
LY354740 0
and 0
diazepam 0
, 0
leading 0
to 0
the 0
lowering 0
of 0
the 0
plasma 0
level 0
of 0
free 0
diazepam 0
, 0
was 0
also 0
demonstrated 0
. 0

Also 0
, 0
in 0
patients 0
with 0
MYD 0
, 0
there 0
was 0
a 0
significant 0
decrease 0
in 0
arterial 0
PO2 0
from 0
the 0
seated 0
posture 0
to 0
the 0
supine 0
posture 0
, 0
without 0
a 0
significant 0
change 0
in 0
the 0
arterial 0
PCO2 0
. 0

The 0
animals 0
were 0
followed 0
over 0
a 0
1 0
- 0
to 0
6 0
- 0
h 0
posttraumatic 0
course 0
, 0
and 0
processed 0
for 0
the 0
LM 0
and 0
TEM 0
visualization 0
of 0
HRP B-gene
. 0

Glucose 0
consumption 0
of 0
the 0
human 0
brain 0
under 0
the 0
influence 0
of 0
intravenous 0
infusions 0
of 0
glucose 0
, 0
glucagon B-gene
and 0
glucose 0
- 0
insulin B-gene

The 0
signs 0
of 0
enterocolitis 0
, 0
pathological 0
microbial 0
flora 0
in 0
the 0
stool 0
and 0
changes 0
in 0
the 0
colon 0
mucosa 0
were 0
absent 0
. 0

This 0
study 0
was 0
undertaken 0
to 0
evaluate 0
the 0
physical 0
and 0
biological 0
characteristics 0
of 0
nebulized 0
interleukin B-gene
2 I-gene
liposomes 0
. 0

Although 0
mutant B-gene
pex5delta I-gene
cells 0
expressing 0
a 0
yeast/tobacco B-gene
Pex5p I-gene
chimaera I-gene
failed 0
to 0
import 0
a 0
GFP B-gene
- 0
Eci1p B-gene
reporter 0
protein 0
, 0
they 0
were 0
able 0
to 0
grow 0
on 0
oleic 0
acid 0
. 0

Two 0
human B-gene
beta I-gene
- I-gene
1,6 I-gene
- I-gene
N I-gene
- I-gene
acetylglucosaminyltransferases I-gene
forming 0
the 0
core 0
2 0
O 0
- 0
glycan 0
branch 0
, 0
C2GnT 0
and 0
the 0
I B-gene
antigen I-gene
, 0
IGnT B-gene
, 0
are 0
homologous 0
to 0
each 0
other 0
in 0
three 0
regions 0
of 0
the 0
catalytic 0
domain 0
( 0
A 0
, 0
B 0
, 0
C 0
) 0
and 0
their 0
genes 0
reside 0
at 0
the 0
same 0
locus 0
, 0
chromosome 0
9 0
, 0
band 0
q21 0
( 0
Bierhuizen 0
, 0
M.F.A. 0
, 0
Mattei 0
, 0
M. 0
- 0
G. 0
and 0
Fukuda 0
, 0
M. 0
, 0
Genes 0
Dev. 0
, 0
7 0
, 0
468 0
- 0
478 0
, 0
1993 0
) 0
. 0

Previously 0
, 0
we 0
had 0
shown 0
that 0
interleukin B-gene
8 I-gene
( 0
IL B-gene
- I-gene
8 I-gene
) 0
is 0
constitutively 0
expressed 0
in 0
HTLV 0
- 0
I 0
- 0
infected 0
cells 0
and 0
in 0
cells 0
transiently 0
expressing 0
Tax B-gene
. 0

We 0
undertook 0
this 0
study 0
to 0
examine 0
the 0
relationship 0
between 0
systemic 0
oxygen 0
delivery 0
( 0
DO2 0
) 0
and 0
tissue 0
oxygen 0
tension 0
( 0
TPO2 0
) 0
in 0
hypovolemic 0
shock 0
. 0

The 0
lowest 0
PaCO2 0
values 0
were 0
significantly 0
lower 0
in 0
MCE 0
than 0
in 0
the 0
F 0
, 0
W 0
, 0
and 0
D 0
( 0
F 0
+ 0
W 0
+ 0
D 0
) 0
group 0
or 0
controls 0
. 0

The 0
psychosomatic 0
approach 0
to 0
temporomandibular 0
arthrosis 0

Detection 0
of 0
sinusoidal 0
gratings 0
by 0
pattern 0
- 0
specific 0
detectors 0
: 0
further 0
evidence 0
for 0
the 0
correlation 0
principle 0
in 0
human 0
vision 0
. 0

The 0
transcriptional 0
start 0
site 0
( 0
s 0
) 0
of 0
the 0
IA B-gene
- I-gene
2 I-gene
gene I-gene
was 0
mapped 0
by 0
5 0
' 0
rapid 0
amplification 0
of 0
cDNA 0
ends 0
to 0
97 0
bp 0
upstream 0
of 0
the 0
translational 0
start 0
site 0
. 0

Function 0
was 0
retained 0
when 0
one 0
copy 0
of 0
the 0
sequence 0
was 0
present 0
, 0
suggesting 0
that 0
this 0
sequence 0
represents 0
an 0
essential 0
element 0
. 0

The 0
data 0
also 0
suggest 0
that 0
gamma B-gene
CACCC I-gene
box I-gene
binding I-gene
factors I-gene
mediate 0
LCR B-gene
- I-gene
gamma I-gene
interactions 0
which 0
normally 0
enhance 0
gamma B-gene
- I-gene
globin I-gene
and 0
suppress 0
beta B-gene
- I-gene
globin I-gene
gene I-gene
expression 0
in 0
fetal 0
erythroid 0
cells 0
. 0

Left 0
ventricle 0
to 0
coronary 0
sinus 0
fistula 0
. 0

No 0
other 0
transcripts 0
of 0
different 0
length 0
could 0
be 0
detected 0
after 0
prolonged 0
exposure 0
. 0

We 0
have 0
isolated 0
and 0
sequenced 0
cDNA 0
sequences 0
corresponding 0
to 0
two 0
novel 0
genes 0
that 0
map 0
to 0
Xq28 0
. 0

The 0
vaccinia 0
virus 0
D6R B-gene
open 0
reading 0
frame 0
encodes 0
the 0
small 0
subunit 0
of 0
the 0
heterodimeric 0
vaccinia B-gene
virus I-gene
early I-gene
transcription I-gene
factor I-gene
( 0
VETF B-gene
) 0
that 0
activates 0
transcription 0
of 0
early B-gene
genes I-gene
in 0
vitro 0
. 0

We 0
have 0
used 0
nuclear 0
magnetic 0
resonance 0
( 0
NMR 0
) 0
to 0
obtain 0
the 0
structure 0
of 0
an 0
RNA 0
`` 0
kissing 0
'' 0
hairpin 0
complex 0
formed 0
between 0
the 0
HIV 0
- 0
2 0
TAR 0
hairpin 0
loop 0
and 0
a 0
hairpin 0
with 0
a 0
complementary 0
loop 0
sequence 0
. 0

Xnr3 B-gene
is 0
transcriptionally 0
activated 0
by 0
wnt B-gene
signaling 0
during 0
gastrulation 0
in 0
the 0
Xenopus 0
embryo 0
. 0

In 0
this 0
report 0
, 0
we 0
identify 0
Tyr319 0
as 0
a 0
functionally 0
important 0
phosphorylation 0
site 0
in 0
the 0
ZAP B-gene
- I-gene
70 I-gene
interdomain I-gene
B I-gene
region I-gene
. 0

Renal 0
dysplasia 0
with 0
multisystem 0
malformation 0
- 0
- 0
a 0
study 0
of 0
9 0
cases 0
. 0

Brome B-gene
mosaic I-gene
virus I-gene
polymerase I-gene
- 0
like 0
protein B-gene
2a I-gene
is 0
directed 0
to 0
the 0
endoplasmic 0
reticulum 0
by 0
helicase B-gene
- 0
like 0
viral B-gene
protein I-gene
1a I-gene
. 0

Mutations 0
abolishing 0
MalK B-gene
function 0
not 0
only 0
result 0
in 0
inability 0
to 0
transport 0
maltose 0
but 0
also 0
cause 0
constitutive 0
expression 0
of 0
the 0
maltose B-gene
regulon I-gene
. 0

The 0
D. 0
discoideum 0
proteins 0
were 0
entirely 0
conserved 0
over 0
the 0
four 0
regions 0
known 0
to 0
be 0
important 0
for 0
GTP 0
binding 0
and 0
all 0
contained 0
the 0
C 0
- 0
terminal 0
CAAX 0
aa 0
motifs 0
shared 0
by 0
other 0
Rho B-gene
proteins I-gene
. 0

The 0
lack 0
of 0
chronically 0
depressed 0
LCBF 0
( 0
after 0
1 0
day 0
) 0
may 0
be 0
related 0
to 0
the 0
quick 0
structural 0
repair 0
of 0
endothelium 0
. 0

Functional 0
uncoupling 0
of 0
the 0
Janus B-gene
kinase I-gene
3 I-gene
- 0
Stat5 B-gene
pathway 0
in 0
malignant 0
growth 0
of 0
human 0
T 0
cell 0
leukemia 0
virus 0
type 0
1 0
- 0
transformed 0
human 0
T 0
cells 0
. 0

An 0
environmental 0
investigation 0
found 0
evidence 0
of 0
suboptimal 0
food 0
storage 0
and 0
cooking 0
temperatures 0
at 0
Restaurant 0
A 0
; 0
cross 0
contamination 0
of 0
foods 0
may 0
have 0
contributed 0
to 0
the 0
low 0
attributable 0
risk 0
identified 0
for 0
chile 0
rellenos 0
. 0

We 0
used 0
event 0
- 0
related 0
functional 0
magnetic 0
resonance 0
imaging 0
( 0
fMRI 0
) 0
during 0
a 0
cued 0
spatial 0
- 0
attention 0
task 0
to 0
dissociate 0
brain 0
activity 0
related 0
to 0
attentional 0
control 0
from 0
that 0
related 0
to 0
selective 0
processing 0
of 0
target 0
stimuli 0
. 0

However 0
, 0
microinjection 0
of 0
reconstituted 0
mRNPs 0
into 0
Xenopus 0
oocytes 0
demonstrates 0
that 0
although 0
translational 0
repression 0
occurs 0
in 0
the 0
absence 0
of 0
consensus 0
RNA 0
binding 0
sequences 0
for 0
FRGY2 B-gene
, 0
the 0
presence 0
of 0
FRGY2 B-gene
recognition I-gene
elements I-gene
within 0
mRNA 0
potentiates 0
translational 0
repression 0
. 0

Results 0
of 0
the 0
study 0
suggest 0
that 0
Chinese 0
medicine 0
use 0
among 0
this 0
population 0
depends 0
on 0
health 0
conditions 0
, 0
and 0
that 0
having 0
a 0
regular 0
source 0
of 0
care 0
for 0
Chinese 0
medicine 0
as 0
well 0
as 0
a 0
preference 0
for 0
Chinese 0
medicine 0
are 0
two 0
predictors 0
for 0
its 0
use 0
. 0

A 0
V1 B-gene
mutant I-gene
generated 0
in 0
vivo 0
with 0
11 0
of 0
the 0
14 0
N 0
- 0
terminal 0
amino 0
acids 0
altered 0
, 0
was 0
viable 0
and 0
produced 0
symptoms 0
typical 0
of 0
a 0
wild 0
- 0
type 0
infection 0
. 0

These 0
observations 0
suggest 0
that 0
clr4+ B-gene
and 0
rik1+ B-gene
must 0
play 0
a 0
role 0
in 0
the 0
assembly 0
of 0
Swi6p B-gene
into 0
a 0
transcriptionally 0
silent 0
, 0
inaccessible 0
chromatin 0
structure 0
at 0
fission 0
yeast 0
centromeres 0
which 0
is 0
required 0
to 0
facilitate 0
interactions 0
with 0
spindle 0
microtubules 0
and 0
to 0
ensure 0
normal 0
chromosome 0
segregation 0
. 0

The 0
gene 0
sequence 0
predicts 0
a 0
150,825 0
mol 0
wt 0
apoprotein 0
of 0
1363 0
amino 0
acids 0
having 0
an 0
N 0
- 0
terminal 0
hydrophobic 0
signal 0
sequence 0
of 0
17 0
amino 0
acids 0
, 0
19 0
potential 0
N 0
- 0
linked 0
glycosylation 0
sites 0
, 0
a 0
hydrophobic 0
anchor 0
sequence 0
of 0
approximately 0
17 0
amino 0
acids 0
near 0
the 0
C 0
terminus 0
, 0
and 0
a 0
hydrophilic 0
cysteine 0
- 0
rich 0
C 0
terminus 0
of 0
35 0
amino 0
acids 0
. 0

Likewise 0
, 0
epidural 0
morphine 0
does 0
not 0
modify 0
the 0
intraoperative 0
metabolic 0
and 0
hormonal 0
responses 0
. 0

Only 0
the 0
native 0
structure 0
of 0
phosphorylated 0
ERK B-gene
was 0
recognized 0
by 0
VHR B-gene
and 0
was 0
inactivated 0
with 0
a 0
second 0
- 0
order 0
rate 0
constant 0
of 0
40,000 0
M 0
- 0
1 0
s 0
- 0
1 0
. 0

Omitting 0
part 0
of 0
the 0
experimental 0
NOE 0
- 0
derived 0
distances 0
results 0
in 0
reduced 0
restraint 0
violations 0
and 0
lower 0
R 0
factors 0
but 0
impairs 0
structural 0
convergence 0
in 0
the 0
rMD 0
refinement 0
. 0

The 0
region 0
immediately 0
following 0
the 0
promoter 0
and 0
5 0
' 0
to 0
ORF1 0
has 0
a 0
potential 0
transcription 0
terminator 0
sequence 0
. 0

Cell 0
cycle 0
regulatory 0
components 0
have 0
been 0
largely 0
conserved 0
in 0
eukaryotes 0
; 0
however 0
, 0
orthologs 0
of 0
neither 0
CAK1 B-gene
nor 0
csk1 B-gene
have 0
been 0
identified 0
in 0
other 0
species 0
to 0
date 0
. 0

Within 0
any 0
cell 0
line 0
, 0
several 0
Tcfs B-gene
and 0
TLEs B-gene
are 0
co 0
- 0
expressed 0
. 0

In 0
marked 0
contrast 0
to 0
the 0
previously 0
published 0
human B-gene
CD6 I-gene
sequence I-gene
, 0
the 0
mouse 0
sequence 0
predicts 0
a 0
long 0
cytoplasmic 0
tail 0
that 0
is 0
not 0
closely 0
related 0
to 0
other 0
proteins 0
and 0
possesses 0
two 0
proline 0
- 0
rich 0
motifs 0
containing 0
the 0
SH3 B-gene
- I-gene
domain I-gene
binding I-gene
consensus I-gene
sequence I-gene
, 0
three 0
protein B-gene
kinase I-gene
C I-gene
phosphorylation I-gene
site I-gene
motifs I-gene
, 0
nine 0
casein B-gene
kinase I-gene
- I-gene
2 I-gene
phosphorylation I-gene
site I-gene
motifs I-gene
, 0
and 0
a 0
serine 0
- 0
threonine 0
- 0
rich 0
motif 0
repeated 0
three 0
times 0
. 0

The 0
Xenopus B-gene
homeobox I-gene
gene I-gene
twin I-gene
mediates 0
Wnt B-gene
induction 0
of 0
goosecoid B-gene
in 0
establishment 0
of 0
Spemann 0
's 0
organizer 0
. 0

Quinethazone 0

Divergent 0
regions 0
of 0
the 0
posterior 0
left 0
hemisphere 0
used 0
for 0
decoding 0
and 0
storage 0
of 0
information 0
emerged 0
in 0
each 0
working 0
memory 0
versus 0
control 0
task 0
comparison 0
. 0

Among 0
the 0
different 0
epithelial 0
cell 0
lines 0
tested 0
, 0
only 0
RTS3b 0
cells 0
allowed 0
an 0
expression 0
pattern 0
similar 0
to 0
that 0
observed 0
in 0
naturally 0
infected 0
benign 0
condylomas 0
. 0

These 0
involve 0
( 0
1 0
) 0
subcloning 0
a 0
promoterless 0
sucCD B-gene
fragment I-gene
downstream 0
of 0
the 0
lac B-gene
promoter I-gene
in 0
M13mp10 0
, 0
and 0
( 0
2 0
) 0
precise 0
splicing 0
of 0
the 0
suc B-gene
coding I-gene
regions I-gene
with 0
the 0
efficient 0
atpE B-gene
ribosome I-gene
- I-gene
binding I-gene
site I-gene
and 0
expression 0
from 0
the 0
thermoinducible 0
lambda 0
promoters 0
in 0
the 0
pJLA503 0
vector 0
. 0

Increase 0
in 0
[ 0
Ca++ 0
] 0
counteracted 0
the 0
effects 0
of 0
verapamil 0
on 0
RAD 0
. 0

Evidence 0
for 0
involvement 0
of 0
proteins 0
HU B-gene
and 0
RpoS B-gene
in 0
transcription 0
of 0
the 0
osmoresponsive 0
proU B-gene
operon I-gene
in 0
Escherichia 0
coli 0
. 0

In 0
comparison 0
to 0
a 0
silent 0
baseline 0
, 0
CBF 0
increases 0
were 0
observed 0
in 0
auditory 0
cortex 0
bilaterally 0
and 0
in 0
the 0
right 0
superior 0
parietal 0
, 0
right 0
dorsolateral 0
frontal 0
, 0
and 0
right 0
premotor 0
regions 0
, 0
with 0
no 0
modulation 0
as 0
a 0
function 0
of 0
attentional 0
condition 0
. 0

Detonation 0
- 0
traumatic 0
load 0
during 0
military 0
service 0

Deletion 0
of 0
CDC5 B-gene
was 0
lethal 0
and 0
resulted 0
in 0
a 0
dumbbell 0
- 0
shaped 0
terminal 0
morphology 0
, 0
with 0
the 0
nuclei 0
almost 0
divided 0
but 0
still 0
connected 0
. 0

Thus 0
, 0
the 0
pathway 0
to 0
Fc B-gene
epsilonRI I-gene
- 0
mediated 0
MEK/ERK B-gene
and 0
MEK/ERK I-gene

Bovine 0
anaplasmosis 0
: 0
susceptibility 0
of 0
seronegative 0
cows 0
from 0
an 0
infected 0
herd 0
to 0
experimental 0
infection 0
with 0
Anaplasma 0
marginale 0
. 0

The 0
starting 0
dose 0
was 0
8 0
mg/m2 0
administered 0
intravenously 0
( 0
IV 0
) 0
as 0
a 0
short 0
infusion 0
daily 0
for 0
5 0
days 0
, 0
repeated 0
every 0
3 0
weeks 0
with 0
dose 0
adjustments 0
depending 0
on 0
patient 0
tolerance 0
. 0

The 0
related 0
adhesion B-gene
focal I-gene
tyrosine I-gene
kinase I-gene
is 0
tyrosine 0
- 0
phosphorylated 0
after 0
beta1 B-gene
- I-gene
integrin I-gene
stimulation 0
in 0
B 0
cells 0
and 0
binds 0
to 0
p130cas B-gene
. 0

The 0
cerebellar 0
cortical 0
vessels 0
: 0
they 0
are 0
compared 0
to 0
the 0
cerebral 0
vessels 0
. 0

Plasma B-gene
prolactin I-gene
concentrations 0
in 0
pinealectomized 0
ewes 0
receiving 0
melatonin 0
treatment 0
and 0
in 0
pineal 0
intact 0
ewes 0
maintained 0
under 0
a 0
non 0
- 0
24 0
- 0
hour 0
photoperiod 0
. 0

After 0
5 0
days 0
stimulation 0
with 0
G B-gene
- I-gene
CSF I-gene
( 0
10 0
micrograms/kg 0
) 0
1l 0
of 0
blood 0
was 0
drawn 0
, 0
kept 0
unprocessed 0
for 0
3 0
days 0
and 0
reinfused 0
24 0
h 0
after 0
completion 0
of 0
chemotherapy 0
. 0

The 0
species 0
composition 0
and 0
abundance 0
upon 0
treatment 0
of 0
manure 0
with 0
polyethylene 0
, 0
polystyrene 0
and 0
glass 0
particles 0
was 0
similar 0
to 0
that 0
of 0
the 0
treatment 0
control 0
, 0
i.e 0
. 0
natural 0
and 0
inert 0
sand 0
. 0

We 0
present 0
the 0
case 0
of 0
a 0
patient 0
who 0
presented 0
an 0
unusually 0
large 0
mucoid 0
cyst 0
measuring 0
38 0
x 0
25 0
mm 0
in 0
an 0
uncommon 0
localization 0
, 0
the 0
right 0
maxillary 0
. 0

Twenty 0
male 0
volunteers 0
were 0
studied 0
during 0
almokalant 0
infusion 0
aiming 0
at 0
plasma 0
concentrations 0
( 0
Cpl 0
) 0
of 0
20 0
, 0
50 0
, 0
100 0
, 0
and 0
150 0
nmol/l 0
. 0

Previous 0
studies 0
have 0
shown 0
that 0
TGFbeta1 B-gene
expression 0
is 0
upregulated 0
in 0
mouse 0
keratinocytes 0
infected 0
with 0
a 0
v B-gene
- I-gene
rasHa I-gene
retrovirus 0
, 0
although 0
the 0
functional 0
significance 0
of 0
this 0
has 0
not 0
been 0
clear 0
. 0

A 0
significant 0
difference 0
in 0
the 0
distribution 0
of 0
antibodies 0
to 0
thyroglobulin B-gene
and 0
thyroid B-gene
peroxidase I-gene
was 0
found 0
in 0
subgroup 0
2 0
. 0

Protein B-gene
kinase I-gene
C I-gene
( 0
PKC B-gene
) 0
activation 0
after 0
treatment 0
of 0
human 0
neuroblastoma 0
SK 0
- 0
N 0
- 0
BE 0
( 0
2 0
) 0
C 0
cells 0
with 0
phorbol 0
12 0
- 0
myristate 0
13 0
- 0
acetate 0
( 0
PMA 0
) 0
was 0
found 0
to 0
enhance 0
transcription 0
of 0
the 0
human 0
dopamine B-gene
beta I-gene
- I-gene
hydroxylase I-gene
( 0
DBH B-gene
) 0
in 0
those 0
cells 0
. 0

Radiographic 0
spatial 0
frequencies 0
essential 0
to 0
the 0
diagnosis 0
of 0
incipient 0
interproximal 0
lesions 0
. 0

The 0
originally 0
embryonic B-gene
gamma I-gene
- I-gene
globin I-gene
locus I-gene
duplicated 0
and 0
acquired 0
a 0
novel 0
( 0
fetal 0
) 0
pattern 0
of 0
expression 0
in 0
a 0
defined 0
time 0
period 0
( 0
55 0
- 0
40 0
million 0
years 0
ago 0
) 0
during 0
primate 0
phylogeny 0
. 0

The 0
pcaR B-gene
regulatory I-gene
locus I-gene
has 0
been 0
found 0
to 0
be 0
required 0
for 0
both 0
induction 0
of 0
all 0
of 0
the 0
genes 0
within 0
the 0
pca B-gene
regulon I-gene
( 0
pcaBDC B-gene
, 0
pcaIJ B-gene
, 0
and 0
pcaF B-gene
) 0
and 0
the 0
chemotactic 0
response 0
of 0
the 0
bacteria 0
to 0
aromatic 0
compounds 0
. 0

Thus 0
, 0
the 0
i B-gene
- I-gene
leader I-gene
protein I-gene
is 0
a 0
viral 0
gene 0
product 0
of 0
unknown 0
function 0
and 0
high 0
stability 0
that 0
is 0
made 0
in 0
large 0
quantities 0
at 0
intermediate 0
times 0
of 0
productive 0
infection 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
400 0
WORDS 0
) 0

Consequently 0
, 0
during 0
the 0
evolution 0
of 0
mammals 0
, 0
it 0
is 0
the 0
CKbeta4GT B-gene
- I-gene
I I-gene
gene I-gene
lineage 0
that 0
has 0
been 0
recruited 0
for 0
the 0
biosynthesis 0
of 0
lactose 0
. 0

The 0
Pi 0
signals 0
are 0
conveyed 0
to 0
PHO8 B-gene
by 0
binding 0
of 0
PHO4 B-gene
protein I-gene
, 0
a 0
positive 0
regulatory 0
factor 0
, 0
to 0
a 0
promoter 0
region 0
of 0
PHO8 B-gene
( 0
PHO8p B-gene
) 0
under 0
the 0
influence 0
of 0
the 0
PHO B-gene
regulatory 0
circuit 0
. 0

Direct 0
saturation 0
analysis 0

The 0
results 0
of 0
the 0
neural 0
network 0
were 0
compared 0
with 0
those 0
of 0
a 0
density 0
mask 0
( 0
thresholds 0
, 0
- 0
750/ 0
- 0
300 0
H 0
) 0
, 0
with 0
a 0
radiologist 0
serving 0
as 0
the 0
gold 0
standard 0
. 0

Mutational 0
analysis 0
of 0
the 0
IME2 B-gene
UAS I-gene
reveals 0
two 0
critical 0
sequence 0
elements 0
: 0
a 0
G+C 0
- 0
rich 0
sequence 0
( 0
called 0
URS1 0
) 0
, 0
previously 0
identified 0
at 0
many 0
meiotic 0
genes 0
, 0
and 0
a 0
newly 0
described 0
element 0
, 0
the 0
T4C 0
site 0
, 0
that 0
we 0
found 0
at 0
a 0
subset 0
of 0
meiotic 0
genes 0
. 0

We 0
analyzed 0
right 0
ventricular 0
size 0
and 0
function 0
and 0
201Tl 0
uptake 0
to 0
determine 0
if 0
there 0
was 0
a 0
relationship 0
between 0
201Tl 0
uptake 0
and 0
systolic 0
function 0
in 0
19 0
patients 0
with 0
pulmonary 0
artery 0
hypertension 0
who 0
were 0
being 0
evaluated 0
for 0
heart 0
- 0
lung 0
transplantation 0
. 0

Clinical 0
findings 0
plaque 0
index 0
, 0
PI 0
; 0
gingival 0
index 0
, 0
GI 0
; 0
bleeding 0
on 0
probing 0
, 0
BOP 0
; 0
pus 0
discharge 0
, 0
pus 0
; 0
and 0
probing 0
depth 0
, 0
PD 0
at 0
both 0
PT 0
- 0
01 0
and 0
control 0
sites 0
were 0
measured 0
at 0
every 0
visit 0
for 0
4 0
weeks 0
. 0

Therefore 0
the 0
effect 0
of 0
GAL11 B-gene
on 0
PGK B-gene
transcription 0
must 0
be 0
mediated 0
at 0
the 0
PGK B-gene
UAS I-gene
, 0
presumably 0
as 0
part 0
of 0
the 0
activation 0
complex 0
. 0

The 0
authors 0
recommend 0
in 0
cases 0
with 0
an 0
elevated 0
transaminase 0
serum 0
activity 0
more 0
frequent 0
check 0
- 0
up 0
examinations 0
to 0
avoid 0
missing 0
of 0
a 0
relapse 0
, 0
and 0
to 0
examine 0
repeatedly 0
IgM B-gene
anti B-gene
- I-gene
HAV I-gene
as 0
in 0
protracted 0
forms 0
of 0
hepatitis 0
IgM B-gene
anti B-gene
- I-gene
HAV I-gene
may 0
persist 0
even 0
when 0
the 0
transaminase 0
activity 0
is 0
normal 0
. 0

Effects 0
were 0
studied 0
of 0
extremely 0
high 0
- 0
frequency 0
electromagnetic 0
radiation 0
( 0
EHF 0
EMR 0
) 0
on 0
indices 0
for 0
the 0
immune 0
and 0
endocrine 0
systems 0
in 0
a 0
series 0
of 0
48 0
patients 0
presenting 0
with 0
hyperplastic 0
processes 0
in 0
endometrium 0
. 0

Management 0
of 0
patients 0
with 0
Ewing 0
's 0
sarcoma 0
has 0
been 0
discussed 0
with 0
reference 0
to 0
the 0
need 0
to 0
achieve 0
an 0
excellent 0
local 0
result 0
from 0
radiation 0
therapy 0
now 0
that 0
patients 0
are 0
experiencing 0
long 0
- 0
term 0
survival 0
. 0

Effect 0
of 0
hyperaemia 0
on 0
thallium 0
- 0
201 0
redistribution 0
in 0
normal 0
canine 0
myocardium 0
. 0

After 0
dialysis 0
online 0
, 0
lactate 0
was 0
converted 0
by 0
means 0
of 0
lactate B-gene
oxidase I-gene
immobilized 0
to 0
porous 0
glass 0
, 0
and 0
the 0
depletion 0
of 0
oxygen 0
was 0
registered 0
by 0
means 0
of 0
a 0
Clark 0
electrode 0
. 0

These 0
data 0
show 0
that 0
both 0
Sp1 B-gene
and 0
Sp3 B-gene
transcription I-gene
factors I-gene
upregulate 0
HGF B-gene
promoter I-gene
activity 0
by 0
binding 0
to 0
the 0
Sp1 B-gene
binding I-gene
site I-gene
at 0
position 0
- 0
318 0
to 0
- 0
303 0
bp 0
in 0
the 0
HGF B-gene
gene I-gene
promoter I-gene
. 0

As 0
a 0
member 0
of 0
the 0
uncoupling B-gene
protein I-gene
family I-gene
, 0
UCP2 B-gene
is 0
ubiquitously 0
expressed 0
in 0
rodents 0
and 0
humans 0
, 0
implicating 0
a 0
major 0
role 0
in 0
thermogenesis 0
. 0

99Tcm 0
- 0
labelled 0
albumin B-gene
colloid 0
, 0
albures 0
( 0
radius 0
250 0
nm 0
) 0
or 0
nanocoll 0
( 0
radius 0
25 0
nm 0
) 0
, 0
or 0
both 0
were 0
used 0
as 0
test 0
substances 0
to 0
study 0
the 0
kinetics 0
of 0
vascular 0
clearance 0
after 0
RES 0
stimulation 0
. 0

Hepatitis 0
B 0
markers 0
in 0
Lancashire 0
police 0
officers 0
. 0

Xa4 B-gene
is 0
a 0
dominantly 0
inherited 0
rice 0
gene 0
that 0
confers 0
resistance 0
to 0
Philippine 0
race 0
1 0
of 0
the 0
bacterial 0
blight 0
pathogen 0
Xanthomonas 0
oryzae 0
pv 0
. 0
oryzae 0
in 0
rice 0
. 0

Screening 0
of 0
human 0
cDNA 0
libraries 0
has 0
identified 0
two 0
different 0
5' 0
- 0
termini 0
and 0
alternatively 0
spliced 0
forms 0
of 0
the 0
human B-gene
Fli I-gene
- I-gene
1 I-gene
gene I-gene
( 0
Fli B-gene
- I-gene
1b I-gene
) 0
, 0
suggesting 0
the 0
possible 0
existence 0
of 0
two 0
independent 0
promoters 0
. 0

We 0
were 0
unable 0
to 0
construct 0
chvI B-gene
or 0
chvG B-gene
insertion I-gene
mutants I-gene
of 0
R. 0
meliloti 0
, 0
whereas 0
mutants 0
carrying 0
insertions 0
outside 0
of 0
these 0
genes 0
were 0
readily 0
obtained 0
. 0

Consistent 0
with 0
an 0
effect 0
on 0
transcription 0
, 0
p21 B-gene
was 0
localized 0
in 0
nuclei 0
of 0
transfected 0
cells 0
. 0

When 0
yeast 0
cells 0
reach 0
a 0
critical 0
size 0
in 0
late 0
G1 0
they 0
simultaneously 0
start 0
budding 0
, 0
initiate 0
DNA 0
synthesis 0
, 0
and 0
activate 0
transcription 0
of 0
a 0
set 0
of 0
genes 0
that 0
includes 0
G1 B-gene
cyclins I-gene
CLN1 B-gene
, 0
CLN2 B-gene
, 0
and 0
many 0
DNA 0
synthesis 0
genes 0
. 0

After 0
a 0
1 0
- 0
h 0
rest 0
( 0
for 0
T2 0
return 0
to 0
baseline 0
) 0
, 0
subjects 0
repeated 0
the 0
5 0
- 0
min 0
protocol 0
, 0
followed 0
by 0
a 0
final 0
MRI/MRS 0
. 0

Use 0
of 0
ELISAs 0
for 0
the 0
diagnosis 0
of 0
canine 0
atopy 0
. 0

In 0
situ 0
localization 0
of 0
PCP B-gene
- I-gene
A1 I-gene
transcripts I-gene
revealed 0
that 0
they 0
accumulate 0
specifically 0
in 0
pollen 0
at 0
the 0
late 0
binucleate/trinucleate 0
stage 0
of 0
development 0
rather 0
than 0
in 0
the 0
tapetum 0
, 0
which 0
previously 0
was 0
taken 0
to 0
be 0
the 0
principal 0
source 0
of 0
the 0
pollen 0
coat 0
. 0

A 0
single 0
dose 0
of 0
Cef 0
was 0
administered 0
intravenously 0
to 0
11 0
patients 0
with 0
autoimmune 0
diseases 0
and 0
varying 0
degrees 0
of 0
renal 0
impairment 0
( 0
Group 0
I 0
CLCR 0
less 0
than 0
50 0
ml/min 0
, 0
Group 0
II 0
CLCR 0
greater 0
than 0
50 0
ml/min 0
) 0
. 0

Postheparin 0
lipoprotein B-gene
lipase I-gene
, 0
measured 0
using 0
fat 0
emulsion 0
as 0
substrate 0
, 0
also 0
was 0
significantly 0
greater 0
in 0
female 0
rats 0
compared 0
with 0
males 0
. 0

RESULTS 0
: 0
Here 0
, 0
we 0
report 0
the 0
identification 0
of 0
two 0
major 0
and 0
novel 0
Shc B-gene
tyrosine 0
phosphorylation 0
sites 0
, 0
Y239 0
and 0
Y240 0
. 0

The 0
results 0
obtained 0
demonstrate 0
the 0
applicability 0
of 0
countercurrent 0
chromatography 0
to 0
the 0
determination 0
of 0
ultratrace 0
elements 0
. 0

Based 0
on 0
our 0
sequence 0
data 0
, 0
ORF2 0
from 0
most 0
isolates 0
excluding 0
G1 0
encode 0
truncated 0
49 0
aa 0
( 0
pORF2a 0
) 0
because 0
of 0
an 0
in 0
- 0
frame 0
stop 0
codon 0
, 0
although 0
ORF2s 0
from 0
most 0
G1 0
isolates 0
encode 0
202 0
aa 0
( 0
pORF2ab 0
) 0
. 0

Fusions 0
between 0
the 0
GAL B-gene
DNA I-gene
binding I-gene
domain I-gene
and 0
full B-gene
- I-gene
length I-gene
mSin3 I-gene
were 0
also 0
capable 0
of 0
repression 0
. 0

Clinical 0
evidence 0
provides 0
tentative 0
suggestions 0
on 0
( 0
a 0
) 0
possible 0
additional 0
risk 0
of 0
cigarette 0
smoking 0
( 0
b 0
) 0
avoidance 0
of 0
venography 0
( 0
c 0
) 0
avoidance 0
of 0
varicose 0
vein 0
surgery 0
. 0

We 0
examined 0
the 0
contribution 0
of 0
a 0
cryptic 0
plasmid 0
, 0
pRmeGR4b 0
, 0
to 0
the 0
nodulation 0
of 0
Medicago 0
sativa 0
by 0
strain 0
GR4 0
of 0
Rhizobium 0
meliloti 0
. 0

It 0
is 0
concluded 0
that 0
the 0
predominant 0
action 0
of 0
LSD 0
on 0
the 0
female 0
copulatory 0
response 0
is 0
not 0
mediated 0
by 0
increased 0
dopamine B-gene
receptor I-gene
activity 0
but 0
that 0
the 0
LSD 0
effect 0
might 0
be 0
modulated 0
by 0
decreased 0
dopaminergic 0
activity 0
. 0

The 0
frequency 0
of 0
severe 0
congestive 0
heart 0
failure 0
( 0
Killip 0
class 0
III 0
or 0
IV 0
) 0
at 0
admission 0
was 0
significantly 0
higher 0
in 0
patients 0
with 0
early 0
presentation 0
, 0
than 0
with 0
late 0
presentation 0
( 0
30.7 0
% 0
vs 0
7.6 0
% 0
, 0
p 0
less 0
than 0
0.05 0
) 0
. 0

These 0
findings 0
also 0
demonstrate 0
that 0
unless 0
excluded 0
by 0
other 0
factors 0
, 0
the 0
C B-gene
proteins I-gene
are 0
likely 0
to 0
be 0
located 0
along 0
the 0
length 0
of 0
nascent 0
transcripts 0
. 0

ADR1 B-gene
in 0
extracts 0
made 0
from 0
glucose 0
- 0
repressed 0
and 0
- 0
derepressed 0
cells 0
bound 0
UAS1 0
DNA 0
with 0
similar 0
affinities 0
despite 0
having 0
greatly 0
different 0
abilities 0
to 0
activate 0
ADH2 B-gene
gene I-gene
expression 0
in 0
vivo 0
. 0

Comparing 0
the 0
outcome 0
of 0
the 0
group 0
having 0
histologically 0
normal 0
biopsies 0
with 0
the 0
group 0
having 0
nonspecifically 0
abnormal 0
ones 0
it 0
is 0
concluded 0
that 0
frontal 0
biopsy 0
is 0
not 0
of 0
such 0
high 0
prognostic 0
value 0
as 0
has 0
been 0
claimed 0
in 0
previous 0
reports 0
. 0

However 0
, 0
using 0
wet 0
weight/dry 0
weight 0
methodology 0
, 0
we 0
found 0
that 0
administration 0
of 0
U74006F 0
significantly 0
reduced 0
water 0
content 0
in 0
the 0
right 0
hippocampus 0
( 0
contralateral 0
to 0
the 0
site 0
of 0
injury 0
) 0
compared 0
to 0
saline 0
- 0
treated 0
animals 0
( 0
p 0
less 0
than 0
0.05 0
) 0
. 0

A 0
ready 0
- 0
made 0
prosthesis 0
is 0
placed 0
on 0
the 0
external 0
side 0
of 0
the 0
ribs 0
vertically 0
bridging 0
the 0
flailed 0
chest 0
segment 0
, 0
and 0
fixed 0
to 0
the 0
first 0
upper 0
and 0
first 0
lower 0
intact 0
rib 0
as 0
well 0
as 0
to 0
the 0
mobile 0
segments 0
of 0
the 0
affected 0
ribs 0
. 0

The 0
authors 0
suggest 0
that 0
alprazolam 0
may 0
have 0
enhanced 0
specificity 0
for 0
a 0
subpopulation 0
of 0
benzodiazepine B-gene
receptors I-gene
. 0

They 0
showed 0
moderate 0
in 0
vitro 0
antifungal 0
activity 0
against 0
a 0
wide 0
variety 0
of 0
fungi 0
and 0
yeasts 0
including 0
clinically 0
important 0
pathogens 0
, 0
and 0
were 0
highly 0
effective 0
in 0
systemic 0
infection 0
with 0
Candida 0
albicans 0
in 0
mice 0
after 0
iv 0
and 0
im 0
administrations 0
. 0

Central 0
( 0
heart 0
rate 0
, 0
VE 0
, 0
VO2 0
) 0
or 0
local 0
( 0
muscle 0
and 0
blood 0
lactate 0
, 0
adenosine 0
triphosphate 0
, 0
creatine B-gene
phosphokinase I-gene
, 0
glycogen 0
) 0
cues 0
highlighted 0
in 0
these 0
studies 0
demonstrate 0
both 0
the 0
complexity 0
of 0
effort 0
perception 0
, 0
and 0
the 0
need 0
for 0
better 0
understanding 0
of 0
the 0
physiological 0
components 0
upon 0
which 0
it 0
is 0
based 0
. 0

The 0
method 0
was 0
tested 0
on 0
7 0
rats 0
with 0
48 0
- 0
hr 0
- 0
old 0
myocardial 0
infarction 0
and 0
4 0
sham 0
- 0
operated 0
controls 0
. 0

Disruption 0
and 0
reconstruction 0
: 0
narrative 0
insights 0
into 0
the 0
experience 0
of 0
family 0
members 0
caring 0
for 0
a 0
relative 0
diagnosed 0
with 0
serious 0
mental 0
illness 0
. 0

Transcription 0
start 0
sites 0
of 0
sal B-gene
and 0
salR B-gene
genes I-gene
were 0
determined 0
to 0
lie 0
30 0
- 0
and 0
24 0
- 0
bp 0
upstream 0
of 0
the 0
respective 0
initiation 0
codons 0
and 0
separated 0
from 0
each 0
other 0
by 0
78 0
nucleotides 0
. 0

Co 0
- 0
operativity 0
of 0
functional 0
domains 0
in 0
the 0
muscle B-gene
- I-gene
specific I-gene
transcription I-gene
factor I-gene
Myf I-gene
- I-gene
5 I-gene
. 0

Henry 0
Quastler 0
brought 0
experience 0
from 0
an 0
actual 0
x 0
- 0
ray 0
treatment 0
, 0
and 0
Dr 0
. 0

Hybridization 0
was 0
detected 0
between 0
polyadenylated B-gene
H I-gene
chain I-gene
mRNA I-gene
, 0
isolated 0
from 0
the 0
majority 0
of 0
the 0
hybridomas 0
, 0
and 0
the 0
VH B-gene
probe 0
. 0

The 0
general 0
concept 0
of 0
RARE B-gene
- 0
cleavage 0
mapping 0
as 0
well 0
as 0
its 0
applications 0
and 0
limitations 0
are 0
discussed 0
. 0

( 0
4 0
) 0
Expression 0
in 0
different 0
sites 0
in 0
the 0
central 0
nervous 0
system 0
is 0
driven 0
by 0
separable 0
elements 0
widely 0
dispersed 0
throughout 0
8 0
kb 0
3 0
' 0
of 0
the 0
gene 0
. 0

Thus 0
, 0
an 0
increase 0
in 0
lactate 0
concentration 0
of 0
the 0
magnitude 0
observed 0
during 0
alkali 0
therapy 0
need 0
not 0
indicate 0
a 0
worsening 0
of 0
the 0
metabolic 0
picture 0
in 0
lactic 0
acidosis 0
. 0

The 0
virus 0
must 0
progress 0
past 0
the 0
immediate 0
- 0
early 0
phase 0
and 0
express 0
an 0
early B-gene
gene I-gene
product I-gene
( I-gene
s I-gene
) I-gene
for 0
activation 0
of 0
cyclin B-gene
E I-gene
expression 0
. 0

The 0
software 0
is 0
in 0
BASIC 0
adapted 0
for 0
the 0
Hewlett 0
- 0
Packard 0
calculators 0
HP 0
- 0
9845B 0
and 0
HP 0
- 0
85A 0
. 0

Genealogical 0
analysis 0
suggested 0
mainly 0
a 0
mother 0
- 0
to 0
- 0
offspring 0
transmission 0
of 0
this 0
STLV 0
- 0
1 0
. 0

The 0
deduced 0
amino 0
- 0
acid 0
sequence 0
of 0
the 0
mature 0
enzyme 0
showed 0
very 0
low 0
homology 0
( 0
< 0
20.4 0
% 0
identity 0
) 0
to 0
those 0
of 0
known 0
pectinolytic 0
enzymes 0
in 0
the 0
large 0
pectate B-gene
lyase I-gene
superfamily I-gene
( 0
the 0
polysaccharide B-gene
lyase I-gene
family I-gene
1 I-gene
) 0
. 0

The 0
pineal 0
hormone 0
melatonin 0
( 0
MLT 0
) 0
is 0
able 0
to 0
exert 0
an 0
oncostatic 0
action 0
. 0

Patients 0
commonly 0
considered 0
the 0
external 0
frame 0
cumbersome 0
. 0

A 0
wound 0
model 0
for 0
decubitus 0
and 0
leg 0
ulcers 0
consisting 0
of 0
human 0
dermal 0
fibroblasts 0
in 0
type B-gene
I I-gene
collagen I-gene
dermal 0
`` 0
equivalent 0
'' 0
matrix 0
( 0
DEM 0
) 0
was 0
exposed 0
in 0
vitro 0
to 0
electric 0
fields 0
similar 0
to 0
postulated 0
endogenous 0
fields 0
in 0
wounds 0
. 0

In 0
contrast 0
to 0
the 0
effect 0
on 0
DNA 0
replication 0
, 0
the 0
L13V 0
substitution 0
in 0
large B-gene
T I-gene
antigen I-gene
did 0
not 0
prevent 0
complex 0
formation 0
with 0
Hsc70 B-gene
and 0
the 0
Rb B-gene
protein I-gene
. 0

In 0
contrast 0
, 0
the 0
tail 0
deviated 0
ipsilaterally 0
in 0
cats 0
with 0
a 0
hemisection 0
, 0
and 0
the 0
tail 0
was 0
ventroflexed 0
in 0
cats 0
with 0
a 0
transection 0
. 0

Lastly 0
, 0
several 0
restriction 0
length 0
polymorphisms 0
were 0
identified 0
and 0
mapped 0
within 0
a 0
1 0
kb 0
region 0
located 0
immediately 0
upstream 0
from 0
the 0
JH B-gene
cluster I-gene
. 0

Peak 0
plasma 0
ACTH B-gene
responses 0
were 0
not 0
significantly 0
different 0
between 0
control 0
and 0
patient 0
groups 0
. 0

We 0
demonstrate 0
inhibition 0
of 0
2 0
- 0
deoxyglucose 0
uptake 0
in 0
isolated 0
primary 0
rat 0
adipocytes 0
and 0
3T3 0
- 0
L1 0
adipocytes 0
pretreated 0
with 0
U73122 0
. 0

It 0
is 0
likely 0
that 0
these 0
recordings 0
are 0
incomplete 0
; 0
the 0
actual 0
number 0
of 0
activated 0
neurons 0
is 0
estimated 0
to 0
be 0
about 0
300 0
in 0
the 0
acutely 0
sensitized 0
preparation 0
. 0

In 0
this 0
report 0
we 0
describe 0
the 0
structure 0
and 0
DNA 0
sequence 0
of 0
transcriptional 0
control 0
regions 0
from 0
both 0
human B-gene
and I-gene
Wistar I-gene
- I-gene
rat I-gene
single I-gene
copy I-gene
EGF I-gene
genes I-gene
and 0
their 0
functional 0
analysis 0
in 0
epithelial 0
cell 0
cultures 0
. 0

Along 0
with 0
these 0
species 0
, 0
F. 0
graminearum 0
group 0
2 0
( 0
ZON 0
, 0
DON 0
and/or 0
3AcDON 0
or 0
15AcDON 0
) 0
; 0
F. 0
chlamydosporum 0
; 0
F. 0
acuminatum 0
( 0
type 0
- 0
A 0
trichothecene 0
derivatives 0
) 0
; 0
and 0
F. 0
semitectum 0
were 0
often 0
found 0
to 0
be 0
associated 0
. 0

C. 0
glabrata 0
cells 0
containing 0
the 0
CBF1 B-gene
gene I-gene
under 0
the 0
influence 0
of 0
a 0
shutdown 0
promoter 0
( 0
tetO 0
- 0
ScHOP 0
) 0
arrested 0
their 0
growth 0
after 0
5 0
h 0
of 0
cultivation 0
in 0
the 0
presence 0
of 0
the 0
reactive 0
drug 0
doxycycline 0
. 0

It 0
was 0
observed 0
that 0
muscle 0
infarction 0
in 0
the 0
IPC 0
( 0
24 0
+/ 0
- 0
2 0
% 0
) 0
and 0
preischemic 0
LMK 0
( 0
21 0
+/ 0
- 0
2 0
% 0
) 0
groups 0
were 0
smaller 0
( 0
P 0
< 0
0.05 0
) 0
than 0
that 0
in 0
the 0
control 0
( 0
42 0
+/ 0
- 0
2 0
% 0
) 0
. 0

A 0
characteristic 0
feature 0
is 0
their 0
tendency 0
to 0
form 0
homo 0
- 0
and/or 0
heterodimeric 0
complexes 0
. 0

Copyright 0
1999 0
Academic 0
Press 0
. 0

A 0
female 0
infant 0
with 0
isolated 0
noncompaction 0
of 0
ventricular 0
myocardium 0
who 0
developed 0
ventricular 0
tachyarrhythmia 0
is 0
described 0
. 0

Methodological 0
considerations 0
limiting 0
causal 0
assertions 0
permissible 0
with 0
nonexperimental 0
data 0
are 0
discussed 0
. 0

Skytthe 0
, 0
and 0
K 0
. 0

Y1 B-gene
, 0
Y2 B-gene
, 0
and 0
Y4/PP1 B-gene
. 0

S 0
- 0
phase 0
- 0
promoting 0
cyclin B-gene
- I-gene
dependent I-gene
kinases I-gene
( 0
Cdks B-gene
) 0
and 0
the 0
kinase 0
Dbf4 B-gene
- 0
Cdc7 B-gene
then 0
act 0
to 0
initiate 0
replication 0
. 0

The 0
cleft 0
walls 0
are 0
lined 0
with 0
highly 0
conserved 0
residues 0
and 0
NADP 0
is 0
bound 0
along 0
one 0
wall 0
. 0

The 0
primary 0
conditions 0
for 0
acceptable 0
hospital 0
use 0
were 0
that 0
exhaled 0
- 0
volume 0
monitoring 0
be 0
performed 0
for 0
all 0
patients 0
and 0
that 0
O2 0
monitoring 0
be 0
performed 0
both 0
when 0
setting 0
FIO2 0
and 0
continuously 0
when 0
FIO2 0
levels 0
are 0
critical 0
. 0

Genetic 0
mutation 0
or 0
loss 0
of 0
activin/transforming B-gene
activin/transforming I-gene
growth I-gene
factor I-gene
- I-gene
beta I-gene
( I-gene
TGFbeta I-gene
) I-gene
receptor I-gene
function 0
has 0
been 0
shown 0
in 0
human 0
lymphoid 0
, 0
breast 0
, 0
and 0
colorectal 0
tumors 0
as 0
well 0
as 0
Hep2B 0
and 0
Mv1Lu 0
cell 0
lines 0
. 0

Non 0
- 0
specific 0
immunological 0
abnormalities 0
were 0
detected 0
in 0
8 0
of 0
the 0
13 0
patients 0
in 0
whom 0
they 0
were 0
looked 0
for 0
. 0

No 0
cleavage 0
of 0
gp B-gene
130 I-gene
was 0
observed 0
in 0
analogous 0
pulse 0
- 0
chase 0
radiolabelling 0
of 0
Ad 0
- 0
gB B-gene
- 0
infected 0
human 0
fibroblasts 0
, 0
even 0
though 0
these 0
cells 0
are 0
permissive 0
for 0
HCMV 0
replication 0
and 0
can 0
process 0
the 0
native B-gene
gB I-gene
molecule I-gene
. 0

Because 0
levels 0
of 0
Vo2DIR 0
and 0
Vo2INDIR 0
were 0
similar 0
in 0
both 0
groups 0
, 0
we 0
pooled 0
data 0
from 0
septic 0
and 0
control 0
animals 0
. 0

A 0
case 0
comparison 0
of 0
acquired 0
immune 0
deficiency 0
syndrome 0
( 0
AIDS 0
) 0
in 0
homosexual 0
males 0
with 0
spindle 0
- 0
endothelial 0
cell 0
abnormalities 0
and 0
with 0
recrudescent 0
melioidosis 0
. 0

OBJECTIVE 0
: 0
To 0
assess 0
laboratory 0
practice 0
in 0
the 0
examination 0
of 0
blood 0
films 0
for 0
malarial 0
parasites 0
. 0

Little 0
honoured 0
in 0
his 0
own 0
country 0
: 0
statues 0
in 0
recognition 0
of 0
Edward 0
Jenner 0
MD 0
FRS 0
. 0

We 0
conclude 0
that 0
GRF1 B-gene
and 0
GRF2 B-gene
can 0
form 0
homo 0
- 0
and 0
hetero 0
- 0
oligomers 0
via 0
their 0
DH B-gene
domains I-gene
, 0
that 0
mutational 0
inactivation 0
of 0
oligomer 0
formation 0
by 0
GRF1 B-gene
is 0
associated 0
with 0
impaired 0
biological 0
and 0
signaling 0
activities 0
, 0
and 0
that 0
in 0
293T 0
cells 0
GRF1 B-gene
mediates 0
at 0
least 0
two 0
pathways 0
for 0
Raf B-gene
activation 0
: 0
one 0
a 0
constitutive 0
signal 0
that 0
is 0
mainly 0
Ras B-gene
- 0
dependent 0
, 0
and 0
one 0
an 0
ionomycin 0
- 0
induced 0
signal 0
that 0
cooperates 0
with 0
the 0
constitutive 0
signal 0
without 0
further 0
augmenting 0
the 0
level 0
of 0
GTP B-gene
- I-gene
Ras I-gene
. 0

The 0
significance 0
of 0
these 0
changes 0
in 0
relation 0
to 0
the 0
control 0
of 0
phosphorus 0
balance 0
in 0
ruminants 0
is 0
discussed 0
. 0

These 0
results 0
extend 0
our 0
knowledge 0
of 0
this 0
SNF2 B-gene
- I-gene
like I-gene
family I-gene
member I-gene
and 0
suggest 0
a 0
role 0
for 0
PASG B-gene
in 0
leukemogenesis 0
. 0

In 0
the 0
absence 0
of 0
c B-gene
- I-gene
fos I-gene
gene I-gene
expression 0
, 0
c B-gene
- I-gene
Fos I-gene
protein I-gene
appears 0
to 0
be 0
replaced 0
by 0
proteins 0
of 0
Fos B-gene
family I-gene
( 0
Fra B-gene
- I-gene
1 I-gene
) 0
and 0
ATF B-gene
family I-gene
( 0
ATF B-gene
- I-gene
2 I-gene
and 0
ATFa B-gene
) 0
. 0

The 0
interaction 0
obtained 0
with 0
DBM 0
scores 0
was 0
further 0
qualified 0
by 0
a 0
three 0
- 0
way 0
interaction 0
that 0
limited 0
this 0
pattern 0
to 0
participants 0
scoring 0
higher 0
on 0
self 0
- 0
deception 0
. 0

To 0
elucidate 0
the 0
molecular 0
mechanism 0
by 0
which 0
the 0
Ras B-gene
signaling 0
pathway 0
activates 0
a 0
cell 0
- 0
type 0
- 0
specific 0
gene 0
, 0
we 0
have 0
used 0
the 0
pituitary B-gene
- I-gene
specific I-gene
rat I-gene
prolactin I-gene
( 0
rPRL B-gene
) 0
promoter 0
as 0
a 0
target 0
of 0
oncogenic B-gene
Ras I-gene
and 0
Raf B-gene
in 0
GH4 0
rat 0
pituitary 0
cells 0
. 0

The 0
results 0
indicate 0
that 0
expression 0
of 0
proU B-gene
in 0
E. 0
coli 0
is 0
directed 0
from 0
two 0
promoters 0
, 0
one 0
( 0
P2 0
) 0
characterized 0
earlier 0
by 0
other 0
workers 0
with 0
the 0
start 0
site 0
of 0
transcription 0
60 0
nucleotides 0
upstream 0
of 0
the 0
initiation 0
codon 0
of 0
the 0
first 0
structural 0
gene 0
( 0
proV B-gene
) 0
, 0
and 0
the 0
other 0
( 0
P1 0
) 0
situated 0
250 0
nucleotides 0
upstream 0
of 0
proV B-gene
. 0

Coexpression 0
of 0
CREB B-gene
- I-gene
binding I-gene
protein I-gene
( 0
CBP B-gene
) 0
/p300 B-gene
with 0
TReP B-gene
- I-gene
132 I-gene
has 0
an 0
additive 0
effect 0
on 0
promoter 0
activity 0
, 0
and 0
the 0
proteins 0
were 0
demonstrated 0
to 0
interact 0
physically 0
. 0

Thirty 0
minutes 0
after 0
reperfusion 0
, 0
lung 0
lymph 0
flow 0
( 0
QL 0
) 0
increased 0
from 0
4.3 0
to 0
8.3 0
ml/30 0
minutes 0
( 0
p 0
less 0
than 0
0.05 0
) 0
, 0
lymph/plasma 0
protein 0
ratio 0
was 0
unchanged 0
from 0
0.6 0
, 0
and 0
the 0
lymph 0
protein 0
clearance 0
increased 0
from 0
2.6 0
to 0
4.6 0
ml/30 0
minutes 0
( 0
p 0
less 0
than 0
0.05 0
) 0
, 0
data 0
consistent 0
with 0
increased 0
microvascular 0
permeability 0
. 0

The 0
shift 0
from 0
complex 0
I 0
to 0
complex 0
II 0
seen 0
only 0
in 0
SCM B-gene
- I-gene
1 I-gene
- 0
producer 0
T 0
cell 0
lines 0
upon 0
activation 0
was 0
completely 0
suppressed 0
by 0
cyclosporin 0
A 0
. 0

Database 0
searches 0
revealed 0
a 0
50 0
- 0
63 0
% 0
similarity 0
and 0
34 0
- 0
42 0
% 0
identity 0
with 0
several 0
families 0
of 0
serine B-gene
proteases I-gene
, 0
in 0
particular 0
the 0
trypsin B-gene
- I-gene
like I-gene
proteases I-gene
, 0
members 0
of 0
the 0
glandular B-gene
kallikrein I-gene
family I-gene
( 0
including 0
prostate B-gene
- I-gene
specific I-gene
antigen I-gene
, 0
nerve B-gene
growth I-gene
factor I-gene
gamma I-gene
, 0
and 0
epidermal B-gene
growth I-gene
factor I-gene
- I-gene
binding I-gene
protein I-gene
) 0
and 0
the 0
activators 0
for 0
the 0
kringle B-gene
family I-gene
proteins I-gene
( 0
including 0
the 0
human B-gene
tissue I-gene
plasminogen I-gene
activator I-gene
and 0
human B-gene
hepatocyte I-gene
growth I-gene
factor I-gene
activator I-gene
) 0
. 0

UPR 0
elements 0
present 0
in 0
other 0
ER 0
chaperone 0
genes 0
, 0
such 0
as 0
yeast B-gene
KAR2 I-gene
( 0
BiP B-gene
) 0
, 0
mammalian B-gene
GRP78 I-gene
( 0
BiP B-gene
) 0
, 0
and 0
GRP94 B-gene
, 0
function 0
in 0
an 0
analogous 0
manner 0
to 0
that 0
in 0
FKB2 B-gene
. 0

No 0
bafilomycin 0
- 0
sensitive 0
ATPase B-gene
is 0
detected 0
in 0
a 0
vacuolar 0
fraction 0
. 0

The 0
kinase 0
domains 0
encoded 0
in 0
the 0
COOH 0
- 0
terminal 0
moiety 0
are 0
94 0
% 0
conserved 0
; 0
the 0
NH2 0
- 0
terminal 0
moieties 0
are 0
approximately 0
65 0
% 0
homologous 0
, 0
suggesting 0
this 0
region 0
may 0
encode 0
sequences 0
conferring 0
differential 0
regulation 0
of 0
the 0
two 0
kinases 0
. 0

From 0
this 0
asymmetry 0
, 0
we 0
suggested 0
previously 0
that 0
GCN4 B-gene
interacts 0
with 0
nonequivalent 0
and 0
possibly 0
overlapping 0
half 0
- 0
sites 0
( 0
ATGAC 0
and 0
ATGAG 0
) 0
that 0
have 0
different 0
affinities 0
. 0

The 0
essential 0
questions 0
about 0
hepatitis 0
C 0

DRAP27 B-gene
is 0
recognized 0
by 0
CD9 B-gene
antibodies I-gene
. 0

YACs 0
selected 0
from 0
our 0
contig 0
will 0
be 0
the 0
starting 0
point 0
for 0
the 0
cloning 0
of 0
the 0
LGMD2B B-gene
gene I-gene
and 0
thereby 0
establish 0
the 0
biological 0
basis 0
for 0
this 0
form 0
of 0
muscular 0
dystrophy 0
and 0
its 0
relationship 0
with 0
the 0
other 0
limb 0
- 0
girdle 0
muscular 0
dystrophies 0
. 0

Acceptability 0
of 0
home 0
monitoring 0
as 0
an 0
aid 0
to 0
conception 0
. 0

Starches 0
had 0
no 0
effect 0
. 0

The 0
dominant 0
inhibitory 0
biological 0
activity 0
of 0
the 0
N 0
terminus 0
correlated 0
with 0
its 0
ability 0
to 0
impair 0
EGF B-gene
- 0
dependent 0
activation 0
of 0
GTP B-gene
- I-gene
Ras I-gene
and 0
of 0
MAP B-gene
kinase I-gene
, 0
as 0
well 0
with 0
the 0
ability 0
of 0
endogenous 0
Sos B-gene
to 0
form 0
a 0
stable 0
complex 0
with 0
activated 0
EGF B-gene
receptors I-gene
. 0

The 0
tensile 0
strengths 0
of 0
an 0
adhesive 0
luting 0
resin 0
'Panavia 0
EX 0
' 0
to 0
the 0
bovine 0
dentin 0
decreased 0
significantly 0
by 0
the 0
zinc 0
iontophoresis 0
. 0

The 0
Giessener 0
Tumordokumentationssystem 0
( 0
GTDS 0
) 0
is 0
such 0
a 0
disease 0
specific 0
system 0
. 0

In 0
addition 0
, 0
renal 0
sympathetic 0
activity 0
was 0
measured 0
in 0
a 0
separate 0
group 0
of 0
rats 0
. 0

A 0
4.0 0
- 0
kb 0
Nlk B-gene
message I-gene
is 0
also 0
present 0
during 0
embryogenesis 0
, 0
detectable 0
at 0
day 0
E10 0
. 0

The 0
5 B-gene
- I-gene
HT3 I-gene
antagonist 0
ondansetron 0
reduced 0
alcohol 0
intake 0
in 0
both 0
the 0
medium 0
and 0
high 0
alcohol 0
preferring 0
rats 0
at 0
doses 0
between 0
0.01 0
and 0
0.16 0
mg/kg 0
. 0

In 0
humans 0
, 0
there 0
was 0
a 0
statistically 0
significant 0
decrease 0
of 0
TEWL 0
on 0
both 0
forearm 0
and 0
thigh 0
in 0
CS 0
- 0
treated 0
patients 0
compared 0
to 0
non 0
- 0
CS 0
- 0
treated 0
patients 0
and 0
controls 0
( 0
p 0
less 0
than 0
0.05 0
) 0
. 0

Southern 0
hybridization 0
of 0
genomic 0
DNA 0
from 0
WT 0
and 0
Lp/Lp B-gene
embryos 0
failed 0
to 0
identify 0
specific 0
rearrangements 0
at 0
or 0
near 0
the 0
Lp/Lp I-gene

Mutations 0
of 0
the 0
human B-gene
PTEN I-gene
gene I-gene
. 0

Heart 0
rate 0
during 0
the 0
behavioral 0
avoidance 0
test 0
was 0
shown 0
to 0
be 0
as 0
susceptible 0
to 0
experimental 0
demand 0
as 0
other 0
studies 0
have 0
shown 0
approach 0
behaviors 0
to 0
be 0
influenced 0
. 0

In 0
addition 0
, 0
we 0
mapped 0
a 0
putative 0
hnRNP B-gene
A1 I-gene
binding I-gene
site I-gene
in 0
U5 B-gene
RNA I-gene
and 0
demonstrated 0
that 0
p40CRS B-gene
( 0
hnRNP B-gene
A1 I-gene
) 0
binding 0
to 0
that 0
site 0
correlates 0
with 0
CRS B-gene
function 0
. 0

Biochemical 0
experiments 0
and 0
genome 0
sequencing 0
have 0
shown 0
that 0
, 0
despite 0
the 0
prokaryotic 0
cell 0
and 0
genome 0
organization 0
, 0
basal 0
transcriptional 0
elements 0
of 0
members 0
of 0
the 0
domain 0
Archaea 0
( 0
i.e. 0
, 0
TATA 0
box 0
- 0
like 0
sequences 0
, 0
RNA B-gene
polymerase I-gene
, 0
and 0
transcription 0
factors 0
TBP B-gene
, 0
TFIIB B-gene
, 0
and 0
TFIIS B-gene
) 0
are 0
of 0
the 0
eukaryotic 0
type 0
. 0

MGF B-gene
is 0
a 0
novel 0
member 0
of 0
the 0
cytokine B-gene
- I-gene
regulated I-gene
transcription I-gene
factor I-gene
gene I-gene
family I-gene
. 0

One 0
month 0
after 0
administration 0
of 0
131I 0
, 0
the 0
29 0
cats 0
evaluated 0
were 0
clinically 0
improved 0
, 0
and 0
24 0
( 0
83 0
% 0
) 0
of 0
the 0
29 0
cats 0
evaluated 0
had 0
normal 0
serum 0
T4 0
concentrations 0
, 0
3 0
cats 0
( 0
10 0
% 0
) 0
remained 0
hyperthyroxinemic 0
, 0
and 0
2 0
cats 0
( 0
7 0
% 0
) 0
were 0
hypothyroxinemic 0
. 0

Csk B-gene
( 0
C B-gene
- I-gene
terminal I-gene
Src I-gene
kinase I-gene
) 0
is 0
a 0
protein B-gene
tyrosine I-gene
kinase I-gene
that 0
phosphorylates 0
Src B-gene
family I-gene
member I-gene
C I-gene
- I-gene
terminal I-gene
tails I-gene
, 0
resulting 0
in 0
downregulation 0
of 0
Src B-gene
family 0
members 0
. 0

Northern 0
blot 0
analysis 0
of 0
enoyl B-gene
- I-gene
ACP I-gene
reductase I-gene
mRNA I-gene
steady 0
- 0
state 0
levels 0
during 0
seed 0
development 0
suggests 0
that 0
the 0
increase 0
in 0
enzyme 0
activity 0
during 0
the 0
phase 0
of 0
storage 0
lipid 0
accumulation 0
is 0
regulated 0
at 0
the 0
level 0
of 0
gene 0
expression 0
. 0

Lung 0
transplantation 0
is 0
warranted 0
for 0
stable 0
, 0
ventilator 0
- 0
dependent 0
recipients 0
. 0

A 0
new 0
myocyte B-gene
- I-gene
specific I-gene
enhancer I-gene
- I-gene
binding I-gene
factor I-gene
that 0
recognizes 0
a 0
conserved 0
element 0
associated 0
with 0
multiple 0
muscle 0
- 0
specific 0
genes 0
. 0

The 0
magnesium 0
content 0
in 0
leukocytes 0
could 0
not 0
be 0
estimated 0
because 0
of 0
interaction 0
between 0
the 0
ion 0
and 0
the 0
Percoll 0
( 0
R 0
) 0
media 0
. 0

The 0
need 0
for 0
such 0
guidelines 0
is 0
clear 0
on 0
both 0
clinical 0
and 0
scientific 0
grounds 0
. 0

This 0
activity 0
creates 0
a 0
4 0
- 0
bp 0
staggered 0
cut 0
with 0
3 0
' 0
OH 0
overhangs 0
within 0
a 0
specific 0
sequence 0
of 0
the 0
21S B-gene
rRNA I-gene
gene I-gene
of 0
omega 0
- 0
strains 0
. 0

Herewith 0
C. 0
psittaci 0
could 0
be 0
diagnosed 0
in 0
all 0
positive 0
samples 0
. 0

Chem 0
. 0

The 0
gene 0
responsible 0
for 0
multiple 0
endocrine 0
neoplasia 0
type 0
1 0
( 0
MEN1 B-gene
) 0
, 0
a 0
heritable 0
predisposition 0
to 0
endocrine 0
tumours 0
in 0
man 0
, 0
has 0
recently 0
been 0
identified 0
. 0

Is 0
it 0
time 0
for 0
a 0
wine 0
trial 0
? 0

We 0
previously 0
identified 0
a 0
highly 0
conserved 0
L 0
- 0
X 0
- 0
X 0
- 0
L 0
- 0
F 0
sequence 0
near 0
the 0
C 0
terminus 0
of 0
the 0
p6 B-gene
domain I-gene
of 0
the 0
Gag B-gene
precursor I-gene
as 0
the 0
major 0
virion 0
association 0
motif 0
for 0
HIV B-gene
- I-gene
1 I-gene
Vpr I-gene
. 0

Three 0
patients 0
treated 0
with 0
amphotericin 0
B 0
, 0
single 0
course 0
as 0
well 0
as 0
multiple 0
courses 0
, 0
and 0
other 0
antifungal 0
agents 0
( 0
hydroxystilbamidine 0
and 0
miconazole 0
) 0
have 0
all 0
relapsed 0
. 0

The 0
site 0
of 0
acetylation 0
of 0
Tat B-gene
was 0
mapped 0
to 0
the 0
double 0
- 0
lysine 0
motif 0
in 0
a 0
highly 0
conserved 0
region 0
, 0
( 0
49 0
) 0
RKKRRQ 0
( 0
54 0
) 0
, 0
of 0
the 0
basic 0
RNA 0
- 0
binding 0
motif 0
of 0
Tat B-gene
. 0

In 0
contrast 0
to 0
Torpedo 0
, 0
where 0
only 0
a 0
single 0
transcript 0
is 0
seen 0
, 0
the 0
mouse 0
expresses 0
several 0
mRNAs 0
encoding 0
different 0
isoforms 0
. 0

trans 0
- 0
activation 0
of 0
the 0
HIV B-gene
- I-gene
1 I-gene
LTR I-gene
by 0
the 0
HIV B-gene
- I-gene
1 I-gene
Tat I-gene
and 0
HTLV B-gene
- I-gene
I I-gene
Tax I-gene
proteins I-gene
is 0
mediated 0
by 0
different 0
cis 0
- 0
acting 0
sequences 0
. 0

NSD1 B-gene
contains 0
a 0
SET B-gene
domain I-gene
and 0
multiple 0
PHD 0
fingers 0
. 0

After 0
1 0
day 0
, 0
none 0
of 0
the 0
labeled 0
erythrocytes 0
were 0
detected 0
. 0

Latex 0
products 0
( 0
gloves 0
, 0
balloons 0
, 0
and 0
condoms 0
) 0
directly 0
bound 0
IgE B-gene
from 0
all 0
four 0
patients 0
. 0

The 0
results 0
indicate 0
that 0
the 0
RNA 0
in 0
T7 B-gene
RNA I-gene
polymerase I-gene
is 0
not 0
free 0
of 0
steric 0
interactions 0
in 0
the 0
ternary 0
complex 0
and 0
not 0
available 0
for 0
structure 0
formation 0
until 0
it 0
is 0
at 0
least 0
10 0
bases 0
away 0
from 0
the 0
site 0
of 0
polymerization 0
. 0

Effect 0
of 0
infantile 0
undernutrition 0
on 0
adult 0
sucrose 0
solution 0
consumption 0
in 0
the 0
rat 0
. 0

The 0
transcriptional 0
activity 0
of 0
P B-gene
- I-gene
450 I-gene
( I-gene
11 I-gene
beta I-gene
) I-gene
gene I-gene
was 0
studied 0
with 0
an 0
in 0
vitro 0
transcription 0
system 0
using 0
nuclear 0
extracts 0
prepared 0
from 0
bovine 0
adrenal 0
cortex 0
. 0

The 0
analysis 0
showed 0
that 0
the 0
morning 0
active 0
( 0
MA 0
) 0
individuals 0
rose 0
earlier 0
and 0
went 0
to 0
bed 0
earlier 0
than 0
the 0
evening 0
active 0
( 0
EA 0
) 0
individuals 0
, 0
and 0
the 0
former 0
had 0
a 0
longer 0
sleep 0
length 0
than 0
the 0
latter 0
during 0
days 0
with 0
a 0
morning 0
shift 0
, 0
while 0
the 0
opposite 0
was 0
true 0
for 0
afternoon 0
and 0
night 0
shifts 0
. 0

Appl 0
. 0

The 0
CHED B-gene
protein I-gene
includes 0
the 0
consensus 0
ATP 0
binding 0
and 0
phosphorylation 0
domains 0
characteristic 0
of 0
kinases 0
, 0
displays 0
34 0
- 0
42 0
% 0
identically 0
aligned 0
amino 0
acid 0
residues 0
with 0
other 0
cdc2 B-gene
- I-gene
related I-gene
kinases I-gene
, 0
and 0
is 0
considerably 0
longer 0
at 0
its 0
amino 0
and 0
carboxyl 0
termini 0
. 0

These 0
include 0
urinalysis 0
, 0
chest 0
X 0
- 0
P 0
, 0
ECG 0
, 0
hematological 0
examinations 0
( 0
RBC 0
, 0
WBC 0
, 0
Ht 0
, 0
Hb B-gene
, 0
PLT 0
and 0
ESR 0
) 0
and 0
biochemical 0
tests 0
( 0
AST B-gene
, 0
ALT B-gene
, 0
ALP B-gene
, 0
gamma B-gene
GTP I-gene
, 0
LDH B-gene
, 0
CPK B-gene
, 0
Chol 0
, 0
T 0
- 0
Bil 0
, 0
TP 0
, 0
Alb B-gene
, 0
TG 0
, 0
BUN 0
, 0
Cr 0
, 0
Glu 0
, 0
Na 0
, 0
K 0
, 0
Ca 0
, 0
P 0
and 0
CRP B-gene
) 0
. 0

We 0
challenge 0
each 0
of 0
55 0
consecutive 0
ragweed 0
( 0
RW 0
) 0
- 0
allergic 0
patients 0
with 0
hay 0
fever 0
and 0
with 0
graded 0
increasing 0
doses 0
of 0
ragweed 0
extract 0
to 0
investigate 0
the 0
frequency 0
and 0
relationship 0
between 0
the 0
early 0
( 0
ER 0
) 0
, 0
late 0
( 0
LPR 0
) 0
, 0
and 0
rechallenge 0
reactions 0
( 0
RCRs 0
) 0
to 0
nasal 0
challenge 0
. 0

Vasodilator 0
and 0
hypotensive 0
effects 0
of 0
the 0
optical 0
isomers 0
of 0
nicardipine 0
( 0
YC 0
- 0
93 0
) 0
, 0
a 0
new 0
Ca2+ 0
- 0
antagonist 0
. 0

The 0
encoded 0
protein 0
contains 0
an 0
amino 0
terminal 0
PDZ B-gene
domain 0
, 0
followed 0
by 0
a 0
predicted 0
coiled 0
- 0
coil 0
region 0
, 0
a 0
PEST 0
domain 0
, 0
and 0
a 0
carboxy 0
- 0
terminal 0
SAM 0
domain 0
. 0

The 0
5 0
' 0
ends 0
of 0
the 0
P B-gene
and 0
O B-gene
gene I-gene
mRNAs I-gene
are 0
separated 0
by 0
109 0
nucleotide 0
pairs 0
in 0
the 0
DNA 0
template 0
. 0

Those 0
diagnosed 0
as 0
having 0
affective 0
disorder 0
( 0
n 0
= 0
96 0
) 0
, 0
according 0
to 0
DSM 0
- 0
IIIR 0
criteria 0
, 0
were 0
compared 0
with 0
the 0
other 0
non 0
- 0
affective 0
suicide 0
attempters 0
( 0
n 0
= 0
161 0
) 0
. 0

The 0
leukotriene B-gene
receptor I-gene
antagonist 0
zafirlukast 0
inhibits 0
sulfur 0
dioxide 0
- 0
induced 0
bronchoconstriction 0
in 0
patients 0
with 0
asthma 0
. 0

The 0
p63 B-gene
sequence I-gene
also 0
features 0
an 0
acidic 0
domain 0
characteristic 0
of 0
transcriptional 0
activation 0
factors 0
, 0
as 0
well 0
as 0
sequence 0
blocks 0
displaying 0
limited 0
similarity 0
to 0
positionally 0
equivalent 0
regions 0
in 0
sigma B-gene
factors I-gene
from 0
eubacteria 0
related 0
to 0
mitochondria 0
. 0

We 0
have 0
thus 0
cloned 0
two 0
yeast 0
homologs 0
of 0
mammalian B-gene
p220 I-gene
. 0

A 0
phase 0
II 0
clinical 0
trial 0
on 0
MDS 0
was 0
conducted 0
in 0
a 0
cooperative 0
study 0
with 0
orally 0
administrable 0
ara 0
- 0
C 0
analogue 0
, 0
PLAC 0
, 0
which 0
is 0
resistant 0
to 0
cytidine B-gene
deaminase I-gene
and 0
had 0
shown 0
an 0
anti 0
- 0
tumor 0
activity 0
on 0
various 0
experimental 0
tumors 0
by 0
oral 0
route 0
. 0

The 0
arrangement 0
of 0
amino 0
acids 0
in 0
the 0
helix 0
1 0
and 0
helix 0
2 0
regions 0
is 0
quite 0
similar 0
to 0
those 0
of 0
Mxi B-gene
and 0
Mad B-gene
, 0
but 0
different 0
from 0
those 0
of 0
E2F B-gene
- I-gene
1 I-gene
and 0
DP B-gene
- I-gene
1 I-gene
. 0

Platelets 0
and 0
RBCs 0
from 0
each 0
animal 0
were 0
labeled 0
with 0
51Cr 0
and 0
99mTc 0
, 0
respectively 0
, 0
and 0
were 0
rapidly 0
injected 0
into 0
the 0
right 0
atrium 0
while 0
blood 0
was 0
sampled 0
from 0
the 0
ascending 0
aorta 0
. 0

PDGF B-gene
stimulated 0
CDK2 B-gene
activity 0
in 0
mesangial 0
cells 0
and 0
decreased 0
the 0
level 0
of 0
p27 B-gene
( 0
kip1 B-gene
) 0
cyclin 0
kinase 0
inhibitor 0
protein 0
. 0

Furthermore 0
, 0
the 0
induction 0
of 0
cytochrome B-gene
P I-gene
- I-gene
450 I-gene
1A1 I-gene
observed 0
in 0
the 0
cormorant 0
indicates 0
that 0
the 0
Ah B-gene
receptor I-gene
- 0
mediated 0
process 0
, 0
by 0
which 0
TCDD 0
and 0
related 0
chemicals 0
exert 0
many 0
of 0
their 0
toxicities 0
, 0
has 0
been 0
activated 0
. 0

In 0
gel 0
mobility 0
shift 0
assays 0
, 0
high 0
binding 0
activities 0
of 0
ATPC B-gene
- I-gene
2 I-gene
and 0
low 0
binding 0
activities 0
of 0
CBF B-gene
were 0
observed 0
with 0
nuclear 0
extracts 0
from 0
tissue 0
with 0
low 0
AtpC B-gene
expression 0
levels 0
, 0
and 0
the 0
opposite 0
was 0
observed 0
with 0
extracts 0
from 0
tissues 0
with 0
high 0
AtpC B-gene
expression 0
levels 0
. 0

A 0
case 0
of 0
bilateral 0
testicular 0
germ 0
cell 0
tumors 0
in 0
a 0
23 0
- 0
year 0
- 0
old 0
male 0
is 0
reported 0
. 0

Using 0
green B-gene
fluorescent I-gene
protein I-gene
fusions 0
we 0
demonstrate 0
that 0
the 0
SYT B-gene
, 0
SSX B-gene
and 0
the 0
SYT B-gene
- 0
SSX B-gene
proteins 0
are 0
nuclear 0
proteins 0
. 0

Thus 0
, 0
the 0
mutants 0
are 0
deficient 0
in 0
production 0
of 0
the 0
O B-gene
- I-gene
antigen I-gene
polymerase I-gene
and 0
were 0
termed 0
rfc B-gene
mutants I-gene
. 0

The 0
program 0
for 0
myogenic 0
differentiation 0
is 0
subject 0
to 0
negative 0
control 0
by 0
several 0
peptide 0
growth 0
factors 0
and 0
by 0
the 0
products 0
of 0
mutationally 0
activated 0
ras B-gene
oncogenes I-gene
, 0
which 0
persistently 0
activate 0
intracellular 0
cascades 0
normally 0
triggered 0
by 0
specific 0
growth 0
factors 0
. 0

The 0
p58 B-gene
( 0
PITSLRE B-gene
beta I-gene
1 I-gene
) 0
protein 0
kinase 0
( 0
PK 0
) 0
is 0
a 0
member 0
of 0
a 0
large 0
supergene 0
family 0
related 0
to 0
the 0
master B-gene
mitotic I-gene
protein I-gene
kinase I-gene
, 0
p34cdc2 B-gene
. 0

By 0
a 0
combination 0
of 0
alternative 0
promoter 0
usage 0
and 0
exon 0
splicing 0
, 0
each 0
ROR B-gene
gene I-gene
generates 0
several 0
isoforms 0
that 0
differ 0
only 0
in 0
their 0
amino 0
terminus 0
. 0

The 0
expression 0
pattern 0
of 0
LjEmx B-gene
changed 0
dramatically 0
during 0
embryogenesis 0
; 0
expression 0
was 0
seen 0
initially 0
in 0
the 0
entire 0
neural 0
tube 0
and 0
mesoderm 0
, 0
which 0
were 0
secondarily 0
downregulated 0
, 0
and 0
secondarily 0
in 0
cranial 0
nerve 0
ganglia 0
and 0
in 0
the 0
craniofacial 0
mesenchyme 0
. 0

Similarly 0
, 0
antisense B-gene
TGF I-gene
- I-gene
beta I-gene
type I-gene
II I-gene
receptor I-gene
oligodeoxynucleotides I-gene
( I-gene
40 I-gene
microM I-gene
) I-gene
resulted 0
in 0
a 0
58 0
% 0
increase 0
in 0
branching 0
, 0
compared 0
to 0
scrambled 0
and 0
mismatched 0
sequence 0
controls 0
, 0
while 0
TGF B-gene
- I-gene
beta I-gene
, I-gene
type I-gene
II I-gene
receptor I-gene
mRNA I-gene
and 0
its 0
protein 0
expression 0
levels 0
were 0
suppressed 0
by 0
95 0
and 0
84 0
% 0
, 0
respectively 0
. 0

Despite 0
this 0
loss 0
, 0
YEpFAS1 B-gene
is 0
still 0
able 0
to 0
complement 0
a 0
fas1 B-gene
mutation 0
at 0
the 0
enoyl B-gene
reductase I-gene
domain 0
. 0

In 0
this 0
study 0
, 0
a 0
site 0
of 0
PDGF B-gene
- 0
induced 0
tyrosine 0
phosphorylation 0
was 0
mapped 0
to 0
Tyr 0
138 0
in 0
the 0
SH3 B-gene
domain I-gene
; 0
Tyr 0
138 0
is 0
exposed 0
on 0
the 0
SH3 B-gene
peptide I-gene
binding I-gene
surface I-gene
. 0

Our 0
results 0
showed 0
that 0
the 0
5 0
- 0
hydroxytryptamine 0
( 0
5 0
- 0
HT 0
) 0
content 0
in 0
platelets 0
was 0
: 0
( 0
1 0
) 0
increased 0
in 0
the 0
subgroup 0
of 0
anti 0
- 0
social 0
alcoholics 0
; 0
( 0
2 0
) 0
transiently 0
and 0
differently 0
altered 0
in 0
alcoholics 0
compared 0
to 0
opiate 0
addicts 0
; 0
and 0
( 0
3 0
) 0
lowered 0
in 0
drinking 0
alcoholics 0
and 0
normal 0
in 0
alcoholics 0
who 0
were 0
drinking 0
as 0
well 0
as 0
smoking 0
( 0
that 0
may 0
occur 0
via 0
MAO B-gene
- I-gene
B I-gene
inhibition 0
by 0
smoke 0
) 0
. 0

Recently 0
, 0
we 0
reported 0
that 0
SMRT B-gene
also 0
directly 0
associates 0
with 0
LAZ3 B-gene
( 0
BCL B-gene
- I-gene
6 I-gene
) 0
, 0
a 0
POZ/Zn 0
finger 0
transcriptional 0
repressor 0
involvedin 0
the 0
pathogenesis 0
of 0
non 0
- 0
Hodgkin 0
lymphomas 0
. 0

Regulation 0
of 0
activating B-gene
transcription I-gene
factor I-gene
- I-gene
1 I-gene
and 0
the 0
cAMP B-gene
response I-gene
element I-gene
- I-gene
binding I-gene
protein I-gene
by 0
Ca2+/calmodulin B-gene
- I-gene
dependent I-gene
protein I-gene
kinases I-gene
type I-gene
I I-gene
, I-gene
II I-gene
, I-gene
and I-gene
IV I-gene
. 0

Accordingly 0
, 0
constitutive 0
downregulation 0
of 0
expression 0
of 0
accessory 0
molecules 0
of 0
the 0
MHC B-gene
class I-gene
I I-gene
pathway I-gene
can 0
reveal 0
differences 0
between 0
H2 B-gene
class I-gene
I I-gene
alleles I-gene
in 0
antigen 0
presentation 0
not 0
encountered 0
when 0
the 0
expression 0
levels 0
are 0
augmented 0
. 0

Cross 0
- 0
sectional 0
studies 0
continue 0
to 0
dominate 0
. 0

G6620 B-gene
is 0
the 0
3 0
' 0
end 0
of 0
the 0
MOL1 B-gene
gene I-gene
coding 0
for 0
a 0
polypeptide 0
similar 0
to 0
stress 0
- 0
inducible 0
proteins 0
from 0
Fusarium 0
; 0
G6630 B-gene
is 0
the 0
NAT2 B-gene
gene I-gene
which 0
encodes 0
a 0
methionine B-gene
N I-gene
- I-gene
acetyltransferase I-gene
; 0
G6635 B-gene
is 0
the 0
RPL30B B-gene
gene I-gene
coding 0
for 0
the 0
ribosomal B-gene
protein I-gene
L30 I-gene
; 0
G6658 B-gene
is 0
RSR1 B-gene
encoding 0
a 0
ras B-gene
- I-gene
related I-gene
protein I-gene
; 0
G6667 B-gene
is 0
CYS4 B-gene
, 0
the 0
gene 0
for 0
cystathionine B-gene
beta I-gene
- I-gene
synthase I-gene
; 0
G6670 B-gene
is 0
identical 0
to 0
ORF2 0
located 0
close 0
to 0
CYS4 B-gene
; 0
G6673 B-gene
is 0
PEM1/CHO2 B-gene
encoding 0
a 0
PEM1/CHO2 I-gene

The 0
tau 0
v 0
at 0
rest 0
was 0
4.06 0
+/ 0
- 0
2.16 0
s 0
and 0
decreased 0
to 0
2.44 0
+/ 0
- 0
1.07 0
s 0
( 0
P 0
< 0
0.05 0
) 0
at 0
1 0
Hz 0
and 0
to 0
1.81 0
+/ 0
- 0
0.4 0
s 0
at 0
5 0
Hz 0
. 0

This 0
action 0
could 0
be 0
antagonized 0
by 0
aminophylline 0
, 0
a 0
competitive 0
antagonist 0
on 0
P1 B-gene
purinoceptors I-gene
. 0

In 0
the 0
predicted 0
amino 0
acid 0
sequence 0
of 0
NPS1 B-gene
, 0
sequences 0
homologous 0
to 0
the 0
catalytic 0
domain 0
of 0
protein 0
kinases 0
were 0
found 0
. 0

The 0
cDNA 0
contains 0
a 0
reading 0
frame 0
for 0
a 0
145 0
- 0
amino 0
- 0
acid 0
protein 0
and 0
it 0
lacks 0
the 0
UGA 0
codons 0
, 0
which 0
have 0
been 0
found 0
in 0
the 0
reading 0
frame 0
of 0
the 0
mouse B-gene
MCS I-gene
cDNA I-gene
and 0
have 0
been 0
presumed 0
to 0
encode 0
the 0
selenocysteine 0
in 0
the 0
amino 0
terminal 0
of 0
the 0
deduced 0
mouse 0
amino 0
acid 0
sequence 0
. 0

It 0
differed 0
significantly 0
by 0
country 0
( 0
from 0
2.4 0
% 0
in 0
the 0
United 0
Kingdom 0
to 0
24.7 0
% 0
in 0
Portugal 0
) 0
and 0
by 0
transmission 0
category 0
( 0
2.7 0
% 0
among 0
homo/bisexuals 0
, 0
5.8 0
% 0
among 0
injecting 0
drug 0
users 0
, 0
13.6 0
% 0
among 0
heterosexual 0
subgroup 0
1 0
) 0
. 0

A 0
definition 0
of 0
bias 0
founded 0
on 0
the 0
concept 0
of 0
the 0
study 0
base 0
. 0

The 0
results 0
showed 0
differential 0
activation 0
of 0
each 0
parahippocampal 0
region 0
during 0
verbal 0
memory 0
tasks 0
in 0
which 0
the 0
side 0
activated 0
shifted 0
depending 0
on 0
the 0
nature 0
of 0
the 0
task 0
employed 0
; 0
an 0
increase 0
in 0
rCBF 0
in 0
the 0
left 0
parahippocampal 0
gyrus 0
was 0
associated 0
with 0
retrieval 0
strategy 0
of 0
non 0
- 0
matching 0
, 0
and 0
an 0
increase 0
in 0
rCBF 0
in 0
the 0
right 0
parahippocampal 0
gyrus 0
was 0
associated 0
with 0
retrieval 0
strategy 0
of 0
matching 0
. 0

Cells 0
were 0
co 0
- 0
infected 0
simultaneously 0
with 0
IBV 0
, 0
the 0
recombinant 0
FPV 0
( 0
rFPV 0
) 0
containing 0
the 0
D 0
- 0
RNA 0
sequence 0
and 0
a 0
second 0
rFPV 0
expressing 0
T7 B-gene
RNA I-gene
polymerase I-gene
for 0
the 0
initial 0
expression 0
of 0
the 0
D 0
- 0
RNA 0
transcript 0
, 0
subsequently 0
rescued 0
by 0
helper 0
IBV 0
. 0

Antigen 0
dose 0
- 0
response 0
curves 0
were 0
drawn 0
, 0
and 0
the 0
cumulative 0
dose 0
required 0
for 0
a 0
35 0
% 0
reduction 0
in 0
specific 0
airway 0
conductance 0
was 0
calculated 0
and 0
designated 0
Provocation 0
Dose 0
( 0
PD35 0
) 0
. 0

The 0
use 0
of 0
the 0
two 0
pharmacokinetic 0
parameters 0
, 0
t1/2 0
and 0
Cltp 0
, 0
as 0
indices 0
of 0
drug 0
elimination 0
ability 0
are 0
discussed 0
. 0

The 0
rapid 0
decrease 0
of 0
plasma 0
potassium 0
during 0
the 0
first 0
two 0
hours 0
of 0
standard 0
HD 0
causes 0
a 0
membrane 0
hyperpolarization 0
. 0

The 0
more 0
sustained 0
effect 0
of 0
cyclofenil 0
on 0
prolactin B-gene
secretion 0
with 0
a 0
reduced 0
frequency 0
of 0
relapse 0
, 0
and 0
the 0
lower 0
oestradiol 0
level 0
, 0
which 0
might 0
indicate 0
a 0
reduced 0
risk 0
of 0
thromboembolism 0
, 0
suggest 0
that 0
this 0
drug 0
has 0
some 0
advantage 0
over 0
bromocriptine 0
in 0
the 0
inhibition 0
of 0
postpartum 0
lactation 0
. 0

Therefore 0
prostaglandin 0
E2 0
is 0
characterized 0
in 0
relation 0
to 0
prostaglandin 0
F2 0
- 0
alpha 0
not 0
only 0
by 0
a 0
stronger 0
uterine 0
effectiveness 0
, 0
but 0
also 0
at 0
the 0
same 0
time 0
a 0
pronounced 0
influence 0
on 0
the 0
cardiovascular 0
system 0
. 0

Epithelial 0
cell 0
- 0
specific 0
activation 0
is 0
achieved 0
by 0
the 0
cooperative 0
interaction 0
of 0
apparently 0
ubiquitous 0
transcriptional 0
factors 0
. 0

This 0
set 0
of 0
genetic 0
and 0
physical 0
interactions 0
suggests 0
a 0
role 0
for 0
yeast 0
RNA 0
- 0
binding 0
proteins 0
in 0
transcriptional 0
regulation 0
. 0

In 0
group 0
1 0
, 0
mean 0
z 0
- 0
score 0
for 0
GFR 0
was 0
- 0
0.27 0
( 0
94.6 0
% 0
of 0
normal 0
) 0
and 0
in 0
group 0
2 0
mean 0
z 0
- 0
score 0
was 0
- 0
1.51 0
( 0
72.7 0
% 0
of 0
normal 0
for 0
two 0
kidneys 0
) 0
( 0
P 0
= 0
0.022 0
, 0
Mann 0
- 0
Whitney 0
U 0
- 0
test 0
) 0
. 0

A 0
new 0
B 0
- 0
cell 0
- 0
specific 0
enhancer 0
element 0
has 0
been 0
identified 0
3 0
' 0
of 0
E4 B-gene
and 0
the 0
octamerlike 0
motifs 0
in 0
the 0
human B-gene
immunoglobulin I-gene
heavy I-gene
- I-gene
chain I-gene
gene I-gene
enhancer I-gene
. 0

The 0
mutants 0
retained 0
the 0
parental 0
ability 0
to 0
participate 0
in 0
intergeneric 0
coaggregation 0
with 0
human 0
oral 0
actinomyces 0
, 0
indicating 0
the 0
specificity 0
of 0
the 0
mutation 0
in 0
altering 0
intrageneric 0
coaggregations 0
. 0

Electrically 0
induced 0
undulations 0
and 0
their 0
competition 0
with 0
electrically 0
induced 0
convection 0
in 0
cholesteric 0
liquid 0
crystals 0
. 0

Critical 0
review 0
of 0
general 0
results 0

A 0
visibly 0
distinct 0
muscular 0
hypertrophy 0
( 0
mh 0
) 0
, 0
commonly 0
known 0
as 0
double 0
muscling 0
, 0
occurs 0
with 0
high 0
frequency 0
in 0
the 0
Belgian 0
Blue 0
and 0
Piedmontese 0
cattle 0
breeds 0
. 0

The 0
LS B-gene
gene I-gene
promoter I-gene
sequence I-gene
has 0
homology 0
with 0
Escherichia 0
coli 0
promoter 0
sequences 0
; 0
its 0
terminator 0
sequence 0
is 0
capable 0
of 0
forming 0
a 0
stem 0
- 0
and 0
- 0
loop 0
structure 0
. 0

The 0
apparent 0
binding 0
constant 0
of 0
6 0
to 0
calf 0
thymus 0
DNA 0
is 0
1.68 0
X 0
10 0
( 0
5 0
) 0
M 0
- 0
1 0
whereas 0
netropsin B-gene
under 0
similar 0
conditions 0
gives 0
a 0
value 0
of 0
1.85 0
X 0
10 0
( 0
7 0
) 0
M 0
- 0
1 0
. 0

Computed 0
tomographic 0
( 0
CT 0
) 0
findings 0
of 0
pancreatic 0
ductal 0
adenocarcinoma 0
were 0
studied 0
with 0
the 0
combined 0
method 0
of 0
early 0
enhancement 0
CT 0
and 0
high 0
dose 0
enhancement 0
CT 0
in 0
72 0
carcinomas 0
. 0

Southern 0
hybridization 0
analysis 0
of 0
BenR B-gene
and 0
BenS B-gene
transformants I-gene
suggested 0
that 0
plasmid 0
integration 0
occurred 0
most 0
frequently 0
at 0
the 0
chromosomal 0
bens B-gene
locus I-gene
, 0
however 0
evidence 0
for 0
gene 0
conversion 0
and 0
heterologous 0
recombination 0
was 0
also 0
observed 0
. 0

Recombinant B-gene
mouse I-gene
GSTT1 I-gene
- I-gene
1 I-gene
was 0
catalytically 0
active 0
towards 0
1 0
, 0
2 0
- 0
epoxy 0
- 0
3 0
- 0
( 0
p 0
- 0
nitrophenoxy 0
) 0
propane 0
, 0
4 0
- 0
nitrobenzyl 0
chloride 0
and 0
dichloromethane 0
. 0

The 0
amount 0
of 0
overlap 0
in 0
VFI 0
, 0
EF 0
, 0
and 0
RVF 0
values 0
among 0
the 0
clinical 0
groups 0
was 0
considerable 0
. 0

In 0
pituitary 0
GH3 0
cells 0
, 0
vitamin 0
D 0
increases 0
the 0
levels 0
of 0
PRL B-gene
transcripts I-gene
and 0
stimulates 0
the 0
PRL B-gene
promoter I-gene
. 0

Neonatal 0
masculinization 0
affects 0
maternal 0
behavior 0
sensitivity 0
in 0
female 0
rats 0
. 0

The 0
Thrombolysis 0
in 0
Myocardial 0
Infarction 0
( 0
TIMI 0
) 0
Phase 0
II 0
Trial 0
randomized 0
3,339 0
patients 0
to 0
either 0
an 0
invasive 0
( 0
INV 0
, 0
n 0
= 0
1,681 0
) 0
or 0
a 0
conservative 0
( 0
CON 0
, 0
n 0
= 0
1,658 0
) 0
strategy 0
after 0
intravenous 0
recombinant B-gene
tissue I-gene
- I-gene
type I-gene
plasminogen I-gene
activator I-gene
( 0
rt B-gene
- I-gene
PA I-gene
) 0
for 0
acute 0
myocardial 0
infarction 0
. 0

Present 0
investigation 0
was 0
undertaken 0
to 0
elucidate 0
what 0
pharmacokinetic 0
parameters 0
in 0
animal 0
experiment 0
could 0
be 0
of 0
more 0
predictable 0
for 0
human 0
clinical 0
trial 0
of 0
beta 0
- 0
blocking 0
agents 0
. 0

Association 0
of 0
Smads B-gene
with 0
lymphoid B-gene
enhancer I-gene
binding I-gene
factor I-gene
1/T I-gene
1/T I-gene
cell I-gene
- I-gene
specific I-gene
factor I-gene
mediates 0
cooperative 0
signaling 0
by 0
the 0
transforming B-gene
growth I-gene
factor I-gene
- I-gene
beta I-gene
and 0
wnt B-gene
pathways 0
. 0

In 0
the 0
univariate 0
models 0
of 0
either 0
fixed 0
or 0
time 0
dependent 0
covariates 0
, 0
many 0
variables 0
were 0
significantly 0
associated 0
with 0
risk 0
of 0
progression 0
to 0
AIDS 0
( 0
T4 0
cell 0
count 0
, 0
T4/T8 0
ratio 0
, 0
blastogenic 0
responses 0
to 0
phytohemagglutinin B-gene
, 0
concanavalin B-gene
A I-gene
, 0
and 0
pokeweed B-gene
mitogen I-gene
, 0
serum B-gene
IgA I-gene
, 0
appearance 0
of 0
p24 B-gene
antigen I-gene
, 0
and 0
the 0
development 0
of 0
oral 0
hairy 0
leukoplakia 0
, 0
thrush 0
, 0
or 0
herpes 0
zoster 0
) 0
. 0

But 0
, 0
when 0
mated 0
males 0
built 0
nests 0
in 0
the 0
absence 0
of 0
young 0
, 0
T 0
levels 0
were 0
higher 0
than 0
in 0
all 0
other 0
conditions 0
, 0
though 0
only 0
for 0
early 0
broods 0
. 0

RESULTS 0
: 0
At 0
short 0
dwell 0
times 0
, 0
uncorrected 0
( 0
whole 0
plasma 0
) 0
D/P 0
and 0
Cp 0
of 0
urea 0
values 0
were 0
higher 0
than 0
the 0
corrected 0
( 0
plasma 0
water 0
) 0
values 0
by 0
5.7 0
% 0
- 0
5.9 0
% 0
. 0

However 0
, 0
there 0
are 0
some 0
cows 0
that 0
fail 0
to 0
produce 0
adequate 0
1,25 0
- 0
dihydroxyvitamin 0
D 0
at 0
the 0
onset 0
of 0
lactation 0
. 0

The 0
AmyI B-gene
specific 0
3' 0
- 0
UTR 0
is 0
characterized 0
by 0
the 0
absence 0
of 0
IR 0
sequences 0
and 0
the 0
presence 0
of 0
a 0
putative 0
'AATAAA 0
' 0
polyadenylation 0
signal 0
. 0

Off 0
- 0
shell 0
effect 0
in 0
Rydberg 0
- 0
atom 0
- 0
alkali 0
- 0
metal 0
- 0
atom 0
scattering 0
. 0

We 0
examined 0
the 0
mechanisms 0
by 0
which 0
two 0
different 0
types 0
of 0
photonic 0
radiation 0
, 0
short 0
wavelength 0
UV 0
( 0
UV 0
- 0
C 0
) 0
and 0
gamma 0
radiation 0
, 0
activate 0
transcription 0
factor 0
NF B-gene
- I-gene
kappaB I-gene
. 0

To 0
examine 0
the 0
biochemical 0
mechanism 0
of 0
Tax1 B-gene
transactivation 0
, 0
we 0
have 0
developed 0
an 0
in 0
vitro 0
transactivation 0
assay 0
in 0
which 0
wild 0
- 0
type 0
Tax1 B-gene
is 0
able 0
to 0
specifically 0
transactivate 0
a 0
polymerase B-gene
II I-gene
promoter 0
through 0
upstream 0
Tax1 B-gene
- I-gene
responsive I-gene
elements I-gene
. 0

The 0
atf1+ B-gene
gene I-gene
of I-gene
Schizosaccharomyces I-gene
pombe I-gene
encodes 0
a 0
bZIP B-gene
transcription I-gene
factor I-gene
with 0
strong 0
homology 0
to 0
the 0
mammalian B-gene
factor I-gene
ATF I-gene
- I-gene
2 I-gene
. 0

Cotransfection 0
experiments 0
revealed 0
that 0
both 0
hGATA B-gene
- I-gene
4 I-gene
and 0
PMA/A23187 0
stimulation 0
are 0
necessary 0
for 0
the 0
IL B-gene
- I-gene
5 I-gene
promoter I-gene
activation 0
. 0

( 0
5 0
) 0
. 0

Prenatal 0
diagnosis 0
of 0
genetic 0
diseases 0
. 0

1 0
. 0

Mortality 0
rates 0
were 0
not 0
different 0
( 0
chi2 0
: 0
0.0298 0
, 0
p 0
> 0
0.5 0
) 0
. 0

M. 0
, 0
Apps 0
, 0
D 0
. 0

Cox 0
proportional 0
hazard 0
analysis 0
identified 0
dialysis 0
modality 0
and 0
pre 0
- 0
dialysis 0
UV 0
of 0
less 0
than 0
1,000 0
ml/m2 0
per 0
24 0
h 0
as 0
the 0
only 0
significant 0
risk 0
factors 0
for 0
UV 0
survival 0
. 0

The 0
sequence 0
of 0
the 0
25 0
- 0
kDa 0
chain 0
of 0
the 0
alpha 0
subunit 0
was 0
found 0
in 0
a 0
cDNA 0
clone 0
, 0
and 0
the 0
amino 0
acid 0
sequence 0
deduced 0
from 0
the 0
cDNA 0
establishes 0
the 0
complete 0
amino 0
acid 0
sequence 0
of 0
the 0
25 0
- 0
kDa 0
chain 0
. 0

The 0
Gastrointestinal 0
Tumor 0
Study 0
Group 0
( 0
GITSG 0
) 0
protocol 0
GI 0
- 0
7175 0
randomized 0
227 0
patients 0
between 0
1975 0
and 0
1980 0
following 0
complete 0
surgical 0
resection 0
of 0
stages 0
B2 0
and 0
C 0
rectal 0
adenocarcinoma 0
to 0
four 0
treatment 0
arms 0
: 0
( 0
1 0
) 0
no 0
adjuvant 0
therapy 0
, 0
( 0
2 0
) 0
chemotherapy 0
only 0
, 0
( 0
3 0
) 0
radiotherapy 0
only 0
, 0
and 0
( 0
4 0
) 0
radiotherapy 0
and 0
chemotherapy 0
( 0
combined 0
modality 0
) 0
. 0

Samples 0
( 0
1 0
g 0
) 0
were 0
extracted 0
with 0
0.5 0
% 0
potassium 0
chloride 0
( 0
KCl 0
) 0
in 0
70 0
% 0
methanol 0
( 0
5 0
ml 0
) 0
and 0
diluted 0
subsequently 0
to 0
give 0
two 0
- 0
fold 0
to 0
ten 0
- 0
fold 0
step 0
- 0
wise 0
dilutions 0
in 0
phosphate 0
- 0
buffered 0
saline 0
containing 0
0.05 0
% 0
Tween 0
20 0
and 0
0.2 0
% 0
bovine B-gene
serum I-gene
albumin I-gene
( 0
PBS 0
- 0
T 0
BSA B-gene
) 0
. 0

A 0
total 0
of 0
4,916 0
children 0
were 0
examined 0
and 0
the 0
questionnaire 0
satisfactorily 0
completed 0
by 0
a 0
relative 0
or 0
guardian 0
( 0
usually 0
the 0
mother 0
) 0
of 0
4,651 0
. 0

Using 0
community 0
development 0
approaches 0
. 0

Cell 0
lines 0
expressing 0
single 0
amino 0
acid 0
substitutions 0
of 0
the 0
carboxyl 0
- 0
terminal 0
asparagine 0
of 0
CD2 B-gene
are 0
incapable 0
of 0
avidity 0
regulation 0
by 0
TCR B-gene
signaling 0
, 0
PMA 0
treatment 0
, 0
or 0
elevation 0
of 0
intracellular 0
cAMP 0
levels 0
, 0
demonstrating 0
that 0
each 0
of 0
these 0
stimuli 0
utilizes 0
a 0
common 0
structural 0
element 0
for 0
regulating 0
CD2 B-gene
avidity 0
. 0

Iomazenil 0
- 0
SPECT 0
revealed 0
a 0
highly 0
significant 0
increase 0
in 0
the 0
benzodiazepine B-gene
receptor I-gene
uptake 0
in 0
all 0
studied 0
cortical 0
regions 0
except 0
temporal 0
cortices 0
. 0

These 0
findings 0
suggest 0
that 0
PGE1 0
is 0
effective 0
in 0
increasing 0
PVF 0
in 0
the 0
liver 0
transplanted 0
condition 0
; 0
however 0
, 0
the 0
hepatic 0
circulatory 0
improvement 0
attributed 0
to 0
this 0
agent 0
would 0
be 0
limited 0
to 0
the 0
first 0
few 0
days 0
following 0
transplantation 0
. 0

However 0
, 0
in 0
a 0
variation 0
of 0
this 0
assay 0
in 0
which 0
the 0
protease 0
is 0
omitted 0
, 0
the 0
mutant 0
enzymes 0
exhibited 0
substantial 0
levels 0
of 0
prolyl B-gene
isomerase I-gene
activity 0
( 0
5 0
- 0
20 0
% 0
of 0
wild 0
- 0
type 0
) 0
, 0
revealing 0
that 0
these 0
mutations 0
confer 0
sensitivity 0
to 0
protease 0
digestion 0
and 0
that 0
the 0
classic 0
in 0
vitro 0
assay 0
for 0
prolyl B-gene
isomerase I-gene
activity 0
may 0
be 0
misleading 0
. 0

The 0
WEB2 B-gene
gene I-gene
encodes 0
a 0
1,522 0
- 0
amino 0
- 0
acid 0
protein 0
with 0
homology 0
to 0
nucleic B-gene
acid I-gene
- I-gene
dependent I-gene
ATPases I-gene
. 0

V B-gene
- I-gene
ErbB I-gene
- I-gene
mediated I-gene
complex I-gene
formation 0
and 0
transformation 0
have 0
been 0
shown 0
to 0
occur 0
independently 0
of 0
Ras B-gene
activation 0
. 0

The 0
three 0
OAS B-gene
genes I-gene
are 0
flanked 0
by 0
markers B-gene
WI I-gene
- I-gene
10614 I-gene
( 0
cen B-gene
) 0
and 0
D12S2293 B-gene
( 0
tel B-gene
) 0
and 0
are 0
contained 0
within 0
three 0
sets 0
of 0
overlapping 0
cosmid 0
clones 0
. 0

5' 0
- 0
Deletion 0
of 0
the 0
Stat B-gene
- I-gene
binding I-gene
sites I-gene
abolished 0
all 0
promoter 0
- 0
reporter 0
activity 0
in 0
response 0
to 0
PRL B-gene
. 0

Increasing 0
the 0
height 0
of 0
the 0
agar 0
column 0
overlying 0
the 0
SN 0
fabric 0
diminished 0
the 0
inhibitory 0
effect 0
of 0
SN 0
on 0
microbial 0
growth 0
. 0

However 0
, 0
differential 0
utilization 0
of 0
these 0
determinants 0
mediate 0
RAR B-gene
- 0
RXR B-gene
heterodimer 0
binding 0
to 0
DR 0
- 0
2 0
and 0
DR 0
- 0
5 0
RAREs 0
. 0

Biochem 0
. 0

Conversely 0
, 0
as 0
a 0
GAL B-gene
- I-gene
4 I-gene
chimera I-gene
, 0
the 0
isolated 0
LAZ3/BCL6 B-gene
LAZ3/BCL6 I-gene

When 0
expressed 0
in 0
Escherichia 0
coli 0
, 0
SH B-gene
- I-gene
PTP2 I-gene
displays 0
tyrosine B-gene
- I-gene
specific I-gene
phosphatase I-gene
activity 0
. 0

It 0
is 0
hypothesized 0
this 0
occurs 0
through 0
antagonism 0
of 0
PML/RAR B-gene
PML/RAR I-gene
alpha I-gene
actions 0
in 0
these 0
leukemic 0
cells 0
. 0

The 0
main 0
new 0
features 0
of 0
this 0
version 0
are 0
that 0
end 0
- 0
tidal 0
PO2 0
instead 0
of 0
inspiratory 0
PO2 0
can 0
be 0
kept 0
constant 0
, 0
and 0
that 0
the 0
correcting 0
activity 0
of 0
both 0
controllers 0
( 0
capnostat 0
and 0
oxystat 0
) 0
is 0
proportional 0
to 0
the 0
magnitude 0
of 0
the 0
difference 0
between 0
the 0
actual 0
and 0
the 0
adjusted 0
end 0
- 0
tidal 0
PCO2 0
or 0
PO2 0
. 0

Fli B-gene
- I-gene
1 I-gene
is 0
a 0
proto 0
- 0
oncogene 0
which 0
is 0
rearranged 0
in 0
tumors 0
induced 0
by 0
three 0
different 0
retroviruses 0
, 0
Cas 0
- 0
Br 0
- 0
E 0
, 0
F 0
- 0
MuLV 0
, 0
and 0
10A1 0
. 0

Routine 0
imaging 0
modalities 0
revealed 0
a 0
total 0
of 0
79 0
metastases 0
. 0

Cervical 0
CT 0
revealed 0
an 0
irregular 0
low 0
density 0
at 0
the 0
periphery 0
of 0
the 0
cervical 0
vertebra 0
from 0
the 0
C2 0
to 0
C4 0
level 0
. 0

Human B-gene
myotonic I-gene
dystrophy I-gene
protein I-gene
kinase I-gene
( 0
DMPK B-gene
) 0
is 0
a 0
member 0
of 0
a 0
novel 0
class 0
of 0
multidomain 0
protein 0
kinases 0
that 0
regulate 0
cell 0
size 0
and 0
shape 0
in 0
a 0
variety 0
of 0
organisms 0
. 0

The 0
MAP B-gene
kinase I-gene
kinase I-gene
kinase I-gene
MLK2 B-gene
co 0
- 0
localizes 0
with 0
activated 0
JNK B-gene
along 0
microtubules 0
and 0
associates 0
with 0
kinesin B-gene
superfamily I-gene
motor 0
KIF3 B-gene
. 0

Sequential 0
immunoprecipitation 0
showed 0
all 0
detectable 0
p53 B-gene
to 0
be 0
of 0
the 0
PAb246+ B-gene
class 0
in 0
each 0
LPV 0
- 0
transformed 0
cell 0
line 0
, 0
suggesting 0
that 0
the 0
stable 0
p53 B-gene
was 0
indeed 0
wild 0
type 0
. 0

In 0
this 0
study 0
, 0
transcriptional 0
fusions 0
were 0
constructed 0
between 0
the 0
xcpP B-gene
and 0
xcpR B-gene
genes I-gene
and 0
the 0
lacZ B-gene
reporter I-gene
. 0

Increased 0
platelet B-gene
- I-gene
derived I-gene
growth I-gene
factor I-gene
production 0
and 0
intimal 0
thickening 0
during 0
healing 0
of 0
Dacron 0
grafts 0
in 0
a 0
canine 0
model 0
. 0

Interestingly 0
, 0
the 0
NES B-gene
mutant I-gene
proteins I-gene
appeared 0
to 0
have 0
altered 0
interactions 0
with 0
the 0
splicing 0
complex 0
, 0
binding 0
more 0
tightly 0
to 0
SC35 B-gene
in 0
co 0
- 0
immunoprecipitation 0
assays 0
. 0

The 0
results 0
of 0
these 0
studies 0
indicate 0
that 0
EHV B-gene
- I-gene
1 I-gene
gp13 I-gene
is 0
the 0
structural 0
homolog 0
of 0
herpes B-gene
simplex I-gene
virus I-gene
glycoprotein I-gene
C I-gene
and 0
further 0
suggest 0
that 0
the 0
epitope 0
- 0
containing 0
N 0
- 0
terminal 0
amino 0
acid 0
sequences 0
of 0
the 0
herpesvirus B-gene
gC I-gene
- I-gene
like I-gene
glycoproteins I-gene
have 0
undergone 0
more 0
extensive 0
evolutionary 0
divergence 0
than 0
the 0
C 0
- 0
terminal 0
sequences 0
. 0

Previously 0
, 0
a 0
cDNA 0
( 0
GT2 B-gene
) 0
encoding 0
this 0
protein 0
was 0
isolated 0
from 0
a 0
mouse 0
3T3 0
- 0
L1 0
adipocyte 0
library 0
and 0
was 0
sequenced 0
. 0

By 0
RT 0
- 0
PCR 0
, 0
different 0
levels 0
of 0
E75 B-gene
expression 0
can 0
be 0
detected 0
in 0
the 0
epidermis 0
, 0
nerve 0
cord 0
and 0
the 0
eyestalk 0
of 0
early 0
pre 0
- 0
molt 0
shrimp 0
. 0

PATIENTS 0
: 0
33 0
HIV 0
- 0
infected 0
, 0
zidovudine 0
- 0
experienced 0
patients 0
with 0
serum 0
HIV 0
RNA 0
levels 0
of 0
at 0
least 0
20,000 0
copies/mL 0
and 0
CD4 B-gene
counts 0
ranging 0
from 0
50 0
to 0
400 0
cells/mm3 0
. 0

The 0
potential 0
biological 0
significance 0
of 0
the 0
identified 0
structural 0
motif 0
shared 0
by 0
the 0
human B-gene
CCR5 I-gene
, 0
CCR3 B-gene
, 0
CCR2B B-gene
and 0
other 0
GPCRs B-gene
is 0
discussed 0
. 0

Materials 0
are 0
presented 0
of 0
a 0
comparative 0
study 0
of 0
morphological 0
and 0
cultural 0
properties 0
and 0
virulence 0
of 0
liophylized 0
cultures 0
of 0
Leishmania 0
tropica 0
major 0
after 0
their 0
rehydration 0
or 0
after 0
a 0
long 0
passage 0
on 0
the 0
NNN 0
medium 0
. 0

The 0
chromosomal 0
location 0
of 0
these 0
YACs 0
was 0
verified 0
using 0
FISH 0
, 0
which 0
also 0
demonstrated 0
their 0
nonchimeric 0
nature 0
. 0

There 0
is 0
no 0
indication 0
from 0
these 0
experiments 0
that 0
linker B-gene
histones I-gene
bind 0
fundamentally 0
differently 0
to 0
5 B-gene
S I-gene
and 0
bulk 0
nucleosomes 0
. 0

Gas 0
chromatographic 0
analysis 0
of 0
headspace 0
samples 0
of 0
alkalinized 0
vaginal 0
discharges 0
indicated 0
the 0
presence 0
of 0
trimethylamine 0
in 0
all 0
11 0
samples 0
with 0
the 0
fishy 0
odor 0
but 0
not 0
in 0
the 0
other 0
samples 0
. 0

To 0
investigate 0
the 0
step 0
of 0
spliceosome 0
assembly 0
at 0
which 0
Snu17p B-gene
acts 0
, 0
we 0
have 0
used 0
nondenaturing 0
gel 0
electrophoresis 0
. 0

The 0
transcription 0
start 0
site 0
was 0
identified 0
by 0
primer 0
extension 0
analysis 0
and 0
over 0
800 0
bp 0
of 0
5 0
' 0
flanking 0
DNA 0
was 0
sequenced 0
. 0

PURPOSE 0
: 0
To 0
evaluate 0
the 0
effect 0
of 0
adding 0
a 0
pulsating 0
bristle 0
action 0
to 0
the 0
established 0
oscillating/rotating 0
action 0
of 0
the 0
Braun 0
Oral 0
- 0
B 0
Ultra 0
Plaque 0
Remover 0
( 0
D9 0
) 0
on 0
plaque 0
removal 0
. 0

In 0
contrast 0
, 0
postmitotic 0
neurons 0
possessed 0
extremely 0
low 0
levels 0
of 0
E2F1 B-gene
protein I-gene
as 0
assessed 0
by 0
the 0
electrophoretic 0
mobility 0
shift 0
assay 0
and 0
Western 0
blotting 0
. 0

The 0
high 0
degree 0
of 0
sequence 0
conservation 0
together 0
with 0
the 0
ability 0
to 0
direct 0
nucleolar 0
protein 0
transport 0
supports 0
the 0
hypothesis 0
that 0
MAK16 B-gene
proteins I-gene
play 0
a 0
key 0
role 0
in 0
the 0
biogenesis 0
of 0
60S B-gene
subunits I-gene
. 0

NO2 0
pollution 0
on 0
major 0
trunk 0
roads 0
frequently 0
exceeded 0
British 0
and 0
European 0
Union 0
air 0
quality 0
standards 0
, 0
while 0
particle 0
pollution 0
was 0
lower 0
. 0

The 0
human 0
RFC B-gene
- I-gene
1 I-gene
gene I-gene
differs 0
from 0
the 0
mouse 0
and 0
hamster 0
genes 0
both 0
in 0
terms 0
of 0
the 0
total 0
number 0
of 0
exons 0
and 0
in 0
regard 0
to 0
alternatives 0
of 0
exon 0
1 0
which 0
encode 0
5 0
' 0
end 0
heterogeneity 0
. 0

Computer 0
analysis 0
, 0
simple 0
correlation 0
hypothesis 0
, 0
and 0
distribution 0
method 0
with 0
1 0
degree 0
of 0
freedom 0
revealed 0
significant 0
correlation 0
between 0
vertical 0
root 0
fracture 0
and 0
the 0
technique 0
of 0
instrumentation 0
and 0
obturation 0
of 0
the 0
canal 0
( 0
p 0
= 0
0.025 0
) 0
, 0
the 0
length 0
of 0
the 0
post 0
( 0
p 0
= 0
0.05 0
) 0
, 0
and 0
the 0
existence 0
of 0
the 0
post 0
( 0
p 0
= 0
0.05 0
) 0
. 0

CrkII B-gene
and 0
CrkL B-gene
constitutively 0
formed 0
complex 0
with 0
the 0
guanine B-gene
nucleotide I-gene
exchange I-gene
factor I-gene
C3G B-gene
, 0
in 0
unstimulated 0
as 0
well 0
as 0
PDGF B-gene
- 0
stimulated 0
cells 0
. 0

Plasmid 0
subclones 0
of 0
recombinant 0
phage 0
lambda 0
Asm152 0
were 0
able 0
to 0
complement 0
both 0
Escherichia B-gene
coli I-gene
gltB I-gene
and 0
A. 0
sesbaniae 0
Asm 0
- 0
Vi 0
mutants 0
; 0
NADPH B-gene
- I-gene
glutamate I-gene
synthase I-gene
activity 0
was 0
detected 0
in 0
all 0
such 0
strains 0
complemented 0
to 0
Asm+ 0
. 0

Any 0
respectative 0
material 0
( 0
class 0
0 0
) 0
was 0
not 0
obtained 0
from 0
334 0
patients 0
( 0
4.2 0
% 0
) 0
, 0
class 0
I 0
- 0
II 0
findings 0
belonged 0
to 0
6m141 0
patients 0
( 0
76.7 0
% 0
) 0
, 0
950 0
patients 0
( 0
11.9 0
% 0
) 0
were 0
classified 0
as 0
class 0
HII 0
and 0
IV 0
, 0
578 0
patients 0
( 0
7.2 0
% 0
) 0
as 0
class 0
V 0
. 0

DSIP 0
was 0
found 0
to 0
significantly 0
increase 0
slow 0
- 0
waves 0
( 0
delta 0
sleep 0
) 0
in 0
the 0
sleep 0
EEG 0
. 0

YDL003w B-gene
( 0
also 0
termed 0
MCD1 B-gene
) 0
is 0
a 0
homologue 0
of 0
Schizosaccharomyces B-gene
pombe I-gene
rad21 I-gene
, 0
an 0
essential 0
gene 0
implicated 0
in 0
DNA 0
double 0
- 0
strand 0
break 0
repair 0
and 0
nuclear 0
organization 0
in 0
fission 0
yeast 0
. 0

The 0
oral 0
movements 0
which 0
did 0
occur 0
in 0
the 0
HAL 0
- 0
treated 0
rats 0
were 0
slower 0
than 0
normal 0
. 0

The 0
recombinant B-gene
L/F I-gene
- I-gene
transferase I-gene
is 0
as 0
active 0
as 0
the 0
previously 0
purified 0
wild 0
type 0
enzyme 0
and 0
contains 0
no 0
detectable 0
RNA 0
component 0
. 0

AST B-gene
activity 0
in 0
PMNs 0
was 0
significantly 0
low 0
, 0
approximately 0
2 0
% 0
of 0
that 0
observed 0
in 0
HPLFs 0
. 0

Two 0
courses 0
of 0
chemotherapy 0
( 0
CBCDA 0
+ 0
VDS 0
) 0
failed 0
to 0
gain 0
any 0
improvement 0
, 0
and 0
the 0
pain 0
resulting 0
from 0
recurrent 0
bone 0
metastases 0
was 0
managed 0
mainly 0
by 0
the 0
administration 0
of 0
the 0
best 0
supportive 0
care 0
. 0

Intraspinal 0
and 0
mediastinal 0
foregut 0
cyst 0
compressing 0
the 0
spinal 0
cord 0
. 0

The 0
H5 B-gene
mutants I-gene
were 0
: 0
DH5 B-gene
( 0
all 0
amino 0
acids 0
in 0
D 0
configuration 0
) 0
and 0
H5F B-gene
( 0
where 0
all 0
His 0
are 0
replaced 0
by 0
Phe 0
at 0
positions 0
3 0
, 0
7 0
, 0
8 0
, 0
15 0
, 0
18 0
, 0
19 0
, 0
21 0
) 0
. 0

Accordingly 0
, 0
infection 0
of 0
IFN B-gene
- 0
pretreated 0
HeLa 0
S3 0
cells 0
with 0
an 0
E3L 0
- 0
deficient 0
VV 0
( 0
VVDeltaE3L 0
) 0
resulted 0
in 0
increased 0
phosphorylation 0
levels 0
of 0
both 0
PKR B-gene
and 0
eIF2alpha B-gene
. 0

The 0
human 0
sequence 0
contains 0
the 0
element 0
TGACTCT 0
that 0
also 0
is 0
found 0
in 0
a 0
murine B-gene
ras I-gene
- I-gene
responsive I-gene
enhancer I-gene
. 0

GAGA B-gene
factor I-gene
is 0
known 0
to 0
remodel 0
the 0
chromatin 0
structure 0
in 0
concert 0
with 0
nucleosome B-gene
- I-gene
remodeling I-gene
factor I-gene
NURF B-gene
in 0
a 0
Drosophila 0
embryonic 0
S150 0
extract 0
. 0

We 0
report 0
the 0
complete 0
nucleotide 0
sequence 0
of 0
the 0
camC B-gene
gene I-gene
along 0
with 0
155 0
base 0
pairs 0
of 0
5 0
' 0
and 0
175 0
base 0
pairs 0
of 0
3 0
' 0
flanking 0
sequence 0
. 0

After 0
30 0
weeks 0
of 0
amifostine 0
therapy 0
, 0
the 0
morphology 0
of 0
the 0
MDS 0
switched 0
to 0
a 0
chronic 0
myelomonocytic 0
leukemia 0
( 0
CMML 0
) 0
- 0
like 0
appearance 0
, 0
with 0
continuously 0
increasing 0
leukocytes 0
, 0
so 0
that 0
we 0
discontinued 0
amifostine 0
therapy 0
for 0
1 0
month 0
to 0
exclude 0
a 0
possible 0
side 0
effect 0
of 0
amifostine 0
. 0

A 0
gene 0
with 0
a 0
high 0
degree 0
of 0
sequence 0
identity 0
with 0
mammalian B-gene
ADP I-gene
- I-gene
ribosylation I-gene
factors I-gene
( 0
ARFs B-gene
) 0
, 0
believed 0
to 0
be 0
important 0
in 0
vesicular 0
transport 0
, 0
was 0
identified 0
. 0

Theophylline 0
QID 0
, 0
TID 0
, 0
BID 0
and 0
now 0
QD 0
? 0
A 0
report 0
on 0
24 0
- 0
hour 0
dosing 0
with 0
slow 0
- 0
release 0
theophylline 0
formulations 0
with 0
emphasis 0
on 0
analyses 0
of 0
data 0
used 0
to 0
obtain 0
Food 0
and 0
Drug 0
Administration 0
approval 0
for 0
Theo 0
- 0
24 0
. 0

We 0
anticipated 0
SNS 0
function 0
after 0
CVA 0
to 0
be 0
asymmetric 0
and 0
selected 0
null 0
hypotheses 0
of 0
bilaterally 0
symmetric 0
SSR 0
latencies 0
and 0
amplitudes 0
irrespective 0
of 0
side 0
of 0
stimulation 0
and/or 0
recording 0
. 0

Taken 0
together 0
, 0
these 0
results 0
demonstrate 0
that 0
the 0
BSMV B-gene
coat I-gene
protein I-gene
is 0
the 0
sole 0
translation 0
product 0
of 0
the 0
genomic B-gene
RNA I-gene
beta I-gene
, 0
whereas 0
sgRNA B-gene
beta I-gene
1 I-gene
serves 0
as 0
a 0
messenger 0
for 0
translation 0
of 0
the 0
beta B-gene
b I-gene
protein I-gene
, 0
and 0
sgRNA B-gene
beta I-gene
2 I-gene
functions 0
as 0
a 0
messenger 0
for 0
translation 0
of 0
beta B-gene
c I-gene
and 0
beta B-gene
d I-gene
and 0
the 0
newly 0
discovered 0
beta B-gene
d I-gene
' I-gene
protein I-gene
. 0

Without 0
a 0
team 0
, 0
there 0
is 0
little 0
hope 0
for 0
fetal 0
survival 0
; 0
mortality 0
will 0
be 0
80 0
- 0
100 0
% 0
. 0

Thus 0
, 0
the 0
search 0
for 0
genetic 0
and 0
acquired 0
susceptibility 0
to 0
nontuberculous 0
mycobacteria 0
is 0
also 0
a 0
search 0
for 0
susceptibility 0
factors 0
for 0
MTB 0
as 0
well 0
as 0
an 0
opportunity 0
to 0
recognize 0
endogenous 0
pathways 0
that 0
can 0
be 0
exploited 0
therapeutically 0
. 0

This 0
gene 0
is 0
divided 0
into 0
six 0
exons 0
spanning 0
about 0
3kb 0
, 0
and 0
encodes 0
a 0
175 0
amino 0
acid 0
protein 0
with 0
40 0
- 0
52 0
% 0
identity 0
with 0
the 0
other 0
five 0
mouse B-gene
Reg I-gene
( 0
regenerating B-gene
gene I-gene
product I-gene
) 0
proteins 0
. 0

The 0
RNA 0
, 0
whether 0
antisense 0
, 0
ribozyme 0
, 0
or 0
RNA 0
aptamer 0
, 0
must 0
be 0
efficiently 0
transcribed 0
, 0
stabilized 0
against 0
rapid 0
degradation 0
, 0
folded 0
correctly 0
, 0
and 0
directed 0
to 0
the 0
part 0
of 0
the 0
cell 0
where 0
it 0
can 0
be 0
most 0
effective 0
. 0

Interconversions 0
between 0
haloperidol 0
and 0
reduced 0
haloperidol 0
in 0
schizophrenic 0
patients 0
and 0
guinea 0
pigs 0
: 0
a 0
steady 0
- 0
state 0
study 0
. 0

PEAP 0
was 0
significantly 0
higher 0
in 0
IDC 0
patients 0
compared 0
to 0
controls 0
( 0
48.7 0
+/ 0
- 0
32.6 0
vs 0
. 0

Recurrent 0
infections 0
, 0
episodic 0
lymphopenia 0
and 0
impaired 0
cellular 0
immunity 0
. 0

Bilirubin 0
and 0
red 0
cell 0
metabolism 0
in 0
relation 0
to 0
neonatal 0
jaundice 0
. 0

In 0
this 0
report 0
, 0
we 0
describe 0
a 0
patient 0
with 0
renal 0
cell 0
carcinoma 0
who 0
experienced 0
ventricular 0
tachycardia 0
while 0
undergoing 0
treatment 0
with 0
high 0
- 0
dose 0
bolus 0
IL B-gene
- I-gene
2 I-gene
. 0

We 0
report 0
the 0
cloning 0
of 0
the 0
ade1 B-gene
gene I-gene
on 0
a 0
4.4 B-gene
kb I-gene
Sau3A I-gene
insert I-gene
in 0
the 0
yeast 0
shuttle 0
vector 0
pWH5 0
. 0

We 0
found 0
that 0
secretion 0
of 0
chitinolytic 0
enzymes 0
by 0
cultured 0
L. 0
major 0
parasites 0
is 0
inhibited 0
by 0
blood 0
or 0
hemoglobin B-gene
, 0
and 0
hence 0
these 0
enzymes 0
are 0
apparently 0
absent 0
from 0
the 0
blood 0
- 0
fed 0
infected 0
flies 0
, 0
where 0
the 0
cardiac 0
valve 0
appears 0
undamaged 0
. 0

Oral 0
hypoglycemic 0
agents 0

Identification 0
and 0
characterization 0
of 0
a 0
yeast 0
gene 0
encoding 0
the 0
U2 B-gene
small I-gene
nuclear I-gene
ribonucleoprotein I-gene
particle I-gene
B I-gene
'' I-gene
protein I-gene
. 0

The 0
false 0
positive 0
fraction 0
( 0
FPF 0
) 0
decreased 0
significantly 0
if 0
the 0
count 0
density 0
increased 0
; 0
no 0
difference 0
in 0
FPF 0
was 0
found 0
for 0
a 0
change 0
in 0
lesion 0
tracer 0
concentration 0
. 0

Members 0
of 0
the 0
CRE B-gene
- I-gene
binding I-gene
protein I-gene
( 0
CREB B-gene
) 0
/activating B-gene
transcription I-gene
factor I-gene
transcription 0
family 0
as 0
well 0
as 0
members 0
of 0
the 0
Jun/Fos B-gene
family 0
have 0
been 0
shown 0
to 0
bind 0
to 0
this 0
sequence 0
. 0

Nature 0
of 0
the 0
thermopower 0
in 0
bipolar 0
semiconductors 0
. 0

Overexpression 0
of 0
SNURF B-gene
in 0
cultured 0
mammalian 0
cells 0
enhanced 0
not 0
only 0
androgen 0
, 0
glucocorticoid 0
, 0
and 0
progesterone B-gene
receptor I-gene
- 0
dependent 0
transactivation 0
but 0
also 0
basal 0
transcription 0
from 0
steroid 0
- 0
regulated 0
promoters 0
. 0

Long 0
- 0
range 0
mapping 0
by 0
pulse 0
- 0
field 0
gel 0
electrophoresis 0
indicated 0
that 0
the 0
three 0
mdr B-gene
genes I-gene
are 0
closely 0
linked 0
on 0
a 0
genomic 0
DNA 0
segment 0
of 0
approximately 0
625 0
kilobases 0
. 0

Oral 0
basal 0
body 0
temperature 0
( 0
BBT 0
) 0
recordings 0
of 0
46 0
women 0
that 0
conceived 0
by 0
donor 0
insemination 0
and 0
who 0
had 0
midcycle 0
monitoring 0
of 0
luteinising B-gene
hormone I-gene
( 0
LH B-gene
) 0
were 0
analysed 0
to 0
establish 0
features 0
associated 0
with 0
an 0
optimal 0
cycle 0
. 0

At 0
the 0
start 0
of 0
the 0
performance 0
ride 0
, 0
plasma 0
glucose 0
averaged 0
4.2 0
+/ 0
- 0
0.2 0
, 0
5.2 0
+/ 0
- 0
0.1 0
, 0
and 0
5.7 0
+/ 0
- 0
0.2 0
mmol.l 0
- 0
1 0
in 0
CON 0
, 0
CHO 0
- 0
7 0
, 0
and 0
CHO 0
- 0
0/21 0
, 0
respectively 0
( 0
all 0
different 0
, 0
P 0
< 0
0.05 0
) 0
. 0

Adhesion 0
was 0
inhibited 0
by 0
mAbs 0
against 0
the 0
COOH 0
- 0
terminus 0
and 0
central 0
cell 0
binding 0
domains 0
of 0
fibronectin B-gene
, 0
as 0
well 0
as 0
by 0
the 0
corresponding 0
CS1 B-gene
and 0
RGD B-gene
peptides I-gene
. 0

Usher 0
syndrome 0
1C 0
( 0
USH1C 0
) 0
is 0
a 0
congenital 0
condition 0
manifesting 0
profound 0
hearing 0
loss 0
, 0
the 0
absence 0
of 0
vestibular 0
function 0
, 0
and 0
eventual 0
retinal 0
degeneration 0
. 0

We 0
have 0
determined 0
the 0
complete 0
cDNA 0
sequence 0
of 0
rat B-gene
plectin I-gene
from 0
a 0
number 0
of 0
well 0
- 0
characterized 0
overlapping 0
lambda 0
gt11 0
clones 0
. 0

Minute B-gene
virus I-gene
of I-gene
mice I-gene
NS1 I-gene
, 0
an 0
83 0
- 0
kDa 0
mainly 0
nuclear 0
phosphoprotein 0
, 0
is 0
the 0
only 0
viral 0
nonstructural 0
protein 0
required 0
in 0
all 0
cell 0
types 0
and 0
it 0
is 0
involved 0
in 0
multiple 0
processes 0
necessary 0
for 0
virus 0
propagation 0
. 0

On 0
the 0
basis 0
of 0
these 0
findings 0
we 0
suggest 0
that 0
the 0
acceptor 0
peptide 0
binds 0
the 0
transferase 0
in 0
a 0
beta 0
- 0
like 0
conformation 0
and 0
that 0
penultimate 0
residue 0
side 0
chain 0
steric 0
interactions 0
may 0
play 0
a 0
role 0
in 0
determining 0
extent 0
that 0
a 0
given 0
Ser 0
or 0
Thr 0
is 0
glycosylated 0
. 0

A 0
higher 0
median 0
proportion 0
of 0
spirochaetes 0
was 0
observed 0
in 0
sites 0
after 0
diagnosis 0
of 0
loss 0
of 0
attachment 0
. 0

Conventional 0
and 0
digital 0
radiography 0
of 0
the 0
heart 0
, 0
aorta 0
, 0
and 0
pulmonary 0
vascularity 0
. 0

Copyright 0
1998 0
Academic 0
Press 0
. 0

Although 0
cDNA 0
encoding 0
a 0
human B-gene
phagocyte I-gene
formyl I-gene
peptide I-gene
- I-gene
binding I-gene
protein I-gene
has 0
been 0
reported 0
recently 0
( 0
Boulay 0
, 0
F. 0
, 0
Tardif 0
, 0
M. 0
, 0
Brouchon 0
, 0
L. 0
, 0
and 0
Vignais 0
, 0
P 0
. 0

These 0
results 0
suggest 0
that 0
the 0
PVB 0
therapy 0
is 0
not 0
sufficient 0
to 0
cure 0
the 0
cases 0
with 0
choriocarcinoma 0
element 0
or 0
bulky 0
metastasis 0
. 0

METHODS 0
: 0
A 0
spatial 0
counting 0
approach 0
in 0
which 0
the 0
location 0
of 0
each 0
and 0
every 0
PN 0
and 0
NP 0
in 0
the 0
stratum 0
pyramidale 0
of 0
sectors 0
CA1 0
- 0
4 0
was 0
applied 0
to 0
11 0
normal 0
control 0
( 0
CONs 0
) 0
and 0
10 0
SZs 0
matched 0
for 0
age 0
and 0
postmortem 0
interval 0
, 0
as 0
well 0
as 0
4 0
manic 0
depressive 0
( 0
MD 0
) 0
subjects 0
matched 0
for 0
age 0
. 0

No 0
effect 0
of 0
4 0
beta 0
- 0
phorbol 0
12 0
- 0
myristate 0
13 0
- 0
acetate 0
was 0
observed 0
on 0
the 0
expression 0
of 0
hnRNP B-gene
H I-gene
. 0

For 0
large 0
breasts 0
( 0
> 0
70 0
mm 0
) 0
the 0
use 0
of 0
X 0
- 0
ray 0
sets 0
such 0
as 0
the 0
IGE 0
DMR 0
, 0
which 0
automatically 0
select 0
the 0
beam 0
quality 0
for 0
each 0
breast 0
, 0
resulted 0
in 0
lower 0
doses 0
compared 0
with 0
sets 0
using 0
manual 0
tube 0
potential 0
selection 0
. 0

First 0
, 0
ste12Delta B-gene
cells 0
differ 0
from 0
cells 0
with 0
disruptions 0
of 0
the 0
upstream 0
signaling 0
elements 0
( 0
e.g. 0
, 0
ste4Delta B-gene
, 0
ste20Delta B-gene
, 0
ste5Delta B-gene
, 0
ste11Delta B-gene
, 0
ste7Delta B-gene
, 0
or 0
fus3Delta B-gene
kss1Delta B-gene
cells 0
) 0
in 0
that 0
they 0
clearly 0
retain 0
some 0
capacity 0
for 0
inducing 0
Ste3p B-gene
phosphorylation 0
. 0

The 0
Valpha B-gene
and 0
Vbeta B-gene
domains I-gene
have 0
the 0
canonical 0
features 0
of 0
known 0
teleost B-gene
and I-gene
mammalian I-gene
TCR I-gene
V I-gene
domains I-gene
, 0
including 0
conserved 0
residues 0
in 0
the 0
beginning 0
of 0
FR2 B-gene
and 0
at 0
the 0
end 0
of 0
FR3 B-gene
. 0

Asthma 0
diagnoses 0
were 0
made 0
according 0
to 0
recommended 0
National 0
Asthma 0
Expert 0
Panel 0
Guidelines 0
. 0

The 0
atpA B-gene
reading 0
frame 0
ends 0
with 0
four 0
tandem 0
UGA 0
codons 0
which 0
overlap 0
four 0
tandem 0
AUG 0
codons 0
initiating 0
an 0
unidentified 0
reading 0
frame 0
, 0
orf214 0
. 0

Deletion 0
mutagenesis 0
of 0
the 0
promoter 0
indicated 0
that 0
a 0
positive 0
regulatory 0
element 0
( 0
PRE 0
) 0
was 0
likely 0
to 0
exist 0
downstream 0
of 0
the 0
UL94 B-gene
mRNA I-gene
start I-gene
site I-gene
, 0
while 0
a 0
negative 0
regulatory 0
element 0
( 0
NRE 0
) 0
was 0
present 0
upstream 0
of 0
the 0
TATA 0
box 0
. 0

An 0
ERp60 B-gene
- I-gene
like I-gene
protein I-gene
from 0
the 0
filarial 0
parasite 0
Dirofilaria 0
immitis 0
has 0
both 0
transglutaminase 0
and 0
protein 0
disulfide 0
isomerase 0
activity 0
. 0

Fos/Jun B-gene
bound 0
to 0
an 0
unacetylated 0
nucleosome 0
with 0
only 0
a 0
4 0
- 0
to 0
5 0
- 0
fold 0
reduction 0
in 0
DNA 0
binding 0
affinity 0
compared 0
with 0
naked 0
DNA 0
. 0

Pediatric 0
patients 0
- 0
- 0
handle 0
with 0
care 0
. 0

K 0
. 0

The 0
extent 0
of 0
myocardial 0
ischemia 0
in 0
the 0
coronary 0
sinus 0
study 0
was 0
significantly 0
correlated 0
to 0
the 0
coronary 0
diameters 0
of 0
the 0
proximal 0
and 0
middle 0
segments 0
of 0
the 0
Ramus 0
interventricularis 0
anterior 0
and 0
the 0
middle 0
segment 0
of 0
the 0
Ramus 0
circumflexus 0
( 0
r 0
= 0
0.87 0
, 0
p 0
< 0
0.02 0
) 0
. 0

S1 B-gene
nuclease I-gene
analysis 0
of 0
the 0
RNA 0
from 0
a 0
number 0
of 0
QT6 0
- 0
LD 0
clones 0
gave 0
similar 0
results 0
, 0
indicating 0
that 0
the 0
LD 0
population 0
was 0
composed 0
of 0
viruses 0
with 0
similar 0
but 0
not 0
identical 0
deletion 0
endpoints 0
. 0

The 0
prevalence 0
of 0
ocular/adnexal 0
SCC 0
was 0
significantly 0
greater 0
for 0
all 0
hair 0
colors 0
when 0
compared 0
with 0
bay 0
, 0
brown 0
, 0
or 0
black 0
( 0
P 0
less 0
than 0
0.01 0
) 0
. 0

ZNS 0
, 0
in 0
the 0
mmolar 0
range 0
, 0
scavenged 0
hydroxyl 0
and 0
nitric 0
oxide 0
radicals 0
in 0
a 0
dose 0
- 0
dependent 0
manner 0
. 0

Murine B-gene
ELAM I-gene
- I-gene
1 I-gene
is 0
encoded 0
by 0
a 0
single 0
- 0
copy 0
gene 0
, 0
spanning 0
about 0
13 0
kb 0
, 0
which 0
is 0
structurally 0
organized 0
into 0
14 0
exons 0
and 0
13 0
introns 0
; 0
very 0
similar 0
to 0
that 0
of 0
its 0
human 0
counterpart 0
. 0

The 0
three 0
more 0
slower 0
migrating 0
Stat5B B-gene
bands 0
observed 0
in 0
response 0
to 0
GH B-gene
contain 0
phosphorylated 0
tyrosyl 0
residues 0
. 0

Protection 0
levels 0
of 0
33.3 0
% 0
, 0
36.6 0
% 0
and 0
37.0 0
% 0
were 0
achieved 0
in 0
groups 0
which 0
had 0
received 0
, 0
respectively 0
, 0
1000 0
20 0
- 0
krad 0
cercariae 0
, 0
1000 0
10 0
- 0
krad 0
cercariae 0
, 0
2000 0
40 0
- 0
krad 0
cercariae 0
and 0
2000 0
60 0
- 0
krad 0
cercariae 0
. 0

During 0
the 0
1st 0
week 0
of 0
treatment 0
all 0
subjects 0
received 0
either 0
mianserin 0
30 0
mg 0
or 0
clomipramine 0
75 0
mg 0
once 0
daily 0
. 0

EMBO 0
( 0
Eur 0
. 0

When 0
stratifying 0
FLM 0
values 0
< 0
34 0
and 0
> 0
34 0
wks 0
' 0
gestation 0
, 0
again 0
no 0
difference 0
was 0
found 0
in 0
mean 0
difference 0
of 0
L/S 0
and 0
LB 0
before 0
and 0
after 0
34 0
wks 0
. 0

Are 0
there 0
any 0
lessons 0
to 0
be 0
learnt 0
? 0

The 0
other 0
five 0
from 0
within 0
the 0
SRO 0
may 0
provide 0
an 0
entrance 0
point 0
for 0
the 0
cloning 0
of 0
candidate 0
genes 0
for 0
neuroblastoma 0
. 0

Three 0
distinct 0
human B-gene
HDACs I-gene
are 0
homologous 0
to 0
RPD3 B-gene
, 0
a 0
yeast 0
transcriptional 0
regulator 0
. 0

The 0
longest 0
cDNA 0
insert 0
identified 0
was 0
2.2 0
kb 0
and 0
encoded 0
the 0
entire 0
462 0
- 0
amino 0
acid 0
open 0
reading 0
frame 0
of 0
rat B-gene
CgA I-gene
including 0
an 0
18 0
- 0
amino 0
acid 0
hydrophobic 0
signal 0
peptide 0
. 0

The 0
vaccine 0
was 0
at 0
least 0
80 0
% 0
efficacious 0
against 0
Chlamydia 0
and 0
Campylobacter 0
spp 0
and 0
appeared 0
to 0
be 0
protective 0
. 0

The 0
RPC31 B-gene
gene I-gene
encoding 0
the 0
C31 B-gene
subunit I-gene
of I-gene
Saccharomyces I-gene
cerevisiae I-gene
RNA I-gene
polymerase I-gene
C I-gene
( I-gene
III I-gene
) I-gene
has 0
been 0
isolated 0
, 0
starting 0
from 0
a 0
C 0
- 0
terminal 0
fragment 0
cloned 0
on 0
a 0
lambda 0
gt11 0
library 0
. 0

Slowly 0
adapting 0
type 0
I 0
mechanoreceptor 0
discharge 0
as 0
a 0
function 0
of 0
dynamic 0
force 0
versus 0
dynamic 0
displacement 0
of 0
glabrous 0
skin 0
of 0
raccoon 0
and 0
squirrel 0
monkey 0
hand 0
. 0

The 0
goal 0
of 0
this 0
investigation 0
was 0
to 0
determine 0
whether 0
BMIPP 0
uptake 0
can 0
be 0
used 0
to 0
differentiate 0
viable 0
myocardium 0
from 0
scar 0
tissue 0
soon 0
after 0
coronary 0
thrombolysis 0
for 0
acute 0
myocardial 0
infarction 0
. 0

The 0
same 0
slice 0
was 0
imaged 0
three 0
times 0
each 0
with 0
sequences 0
using 0
spatial 0
presaturation 0
or 0
not 0
. 0

IRIS/GAS B-gene
DNA 0
also 0
formed 0
a 0
number 0
of 0
specific 0
complexes 0
with 0
constitutively 0
expressed 0
factors 0
, 0
none 0
of 0
which 0
were 0
affected 0
by 0
the 0
above 0
Abs 0
. 0

Making 0
sense 0
out 0
of 0
oxygen 0
sensor 0
. 0

Recovery 0
rates 0
of 0
energy 0
level 0
and 0
intracellular 0
pH 0
during 0
stimulation 0
at 0
100Hz 0
were 0
greater 0
than 0
those 0
observed 0
during 0
stimulation 0
at 0
30Hz 0
. 0

The 0
Zn B-gene
- I-gene
15 I-gene
DNA I-gene
- I-gene
binding I-gene
domain I-gene
comprises 0
three 0
zinc 0
fingers 0
separated 0
by 0
unusually 0
long 0
linker 0
sequences 0
that 0
would 0
be 0
expected 0
to 0
interrupt 0
specific 0
DNA 0
site 0
recognition 0
. 0

The 0
data 0
obtained 0
included 0
1 0
) 0
the 0
mean 0
frequency 0
of 0
abnormal 0
teased 0
myelinated 0
fibers 0
and 0
its 0
upper 0
limit 0
value 0
of 0
95 0
% 0
confidence 0
interval 0
, 0
and 0
2 0
) 0
the 0
mean 0
densities 0
of 0
total 0
, 0
large 0
and 0
small 0
myelinated 0
fibers 0
and 0
of 0
unmyelinated 0
fibers 0
and 0
their 0
lower 0
limit 0
value 0
of 0
95 0
% 0
confidence 0
interval 0
for 0
each 0
decade 0
. 0

The 0
yield 0
of 0
endocervical 0
cells 0
and 0
the 0
incidence 0
of 0
dysplasia 0
was 0
determined 0
for 0
both 0
the 0
prenatal 0
and 0
the 0
postpartum 0
Pap 0
smears 0
performed 0
for 0
this 0
group 0
of 0
patients 0
. 0

Others 0
as 0
for 0
example 0
C 0
- 0
11 0
labeled 0
short 0
chain 0
fatty 0
acids 0
are 0
on 0
the 0
horizon 0
. 0

We 0
conclude 0
that 0
the 0
BR B-gene
- I-gene
C I-gene
early I-gene
gene I-gene
directly 0
activates 0
late B-gene
gene I-gene
transcription 0
by 0
interacting 0
with 0
late B-gene
gene I-gene
cis 0
- 0
acting 0
regulatory 0
elements 0
and 0
that 0
this 0
interaction 0
is 0
responsible 0
for 0
the 0
temporal 0
linkage 0
of 0
early 0
and 0
late 0
ecdysone 0
- 0
induced 0
gene 0
expression 0
. 0

Exogenous 0
heart 0
stress 0
raised 0
log 0
circulating 0
NE 0
concentration 0
in 0
proportion 0
to 0
the 0
rise 0
in 0
heart 0
rate 0
at 0
a 0
given 0
work 0
load 0
so 0
that 0
the 0
usual 0
relationship 0
between 0
these 0
variables 0
, 0
previously 0
observed 0
during 0
other 0
stresses 0
, 0
was 0
preserved 0
. 0

We 0
tested 0
the 0
hypothesis 0
that 0
PEH 0
is 0
associated 0
with 0
reductions 0
in 0
TPR 0
and 0
sympathetic 0
nerve 0
activity 0
( 0
SNA 0
) 0
. 0

A 0
short 0
conserved 0
motif 0
is 0
required 0
for 0
repressor 0
domain 0
function 0
in 0
the 0
myeloid 0
- 0
specific 0
transcription 0
factor 0
CCAAT/enhancer B-gene
- I-gene
binding I-gene
protein I-gene
epsilon I-gene
. 0

Purified 0
fER B-gene
exhibited 0
a 0
distribution 0
constant 0
( 0
KD 0
) 0
for 0
17 0
beta 0
- 0
estradiol 0
of 0
0.45 0
nM 0
. 0

However 0
, 0
strains 0
in 0
which 0
both 0
of 0
the 0
two 0
most 0
highly 0
related 0
genes 0
, 0
DdPIK1 B-gene
and 0
DdPIK2 B-gene
, 0
were 0
disrupted 0
showed 0
both 0
growth 0
and 0
developmental 0
defects 0
, 0
while 0
double 0
knockouts 0
of 0
DdPIK1 B-gene
and 0
DdPIK3 B-gene
and 0
DdPIK2 B-gene
and 0
DdPIK3 B-gene
appear 0
to 0
be 0
lethal 0
. 0

The 0
exon 0
sequences 0
determined 0
from 0
genomic 0
DNA 0
sequencing 0
showed 0
some 0
differences 0
when 0
compared 0
to 0
the 0
published 0
rat B-gene
GLUT2 I-gene
cDNA I-gene
. 0

48.35 0
+/ 0
- 0
5.07 0
mg/l 0
in 0
R3 0
; 0
p 0
< 0
0.05 0
) 0
and 0
in 0
the 0
AUC 0
( 0
0.50 0
h 0
) 0
( 0
1429.92 0
+/ 0
- 0
284.23 0
in 0
PR 0
vs 0
. 0

This 0
integration 0
results 0
in 0
the 0
production 0
of 0
MMTV/mdr3 B-gene
fusion I-gene
transcripts I-gene
that 0
originate 0
from 0
the 0
antisense 0
5'LTR B-gene
of 0
the 0
provirus 0
. 0

This 0
surface 0
in 0
specimens 0
from 0
unfertilized 0
eggs 0
is 0
almost 0
flat 0
. 0

Following 0
40 0
min 0
`` 0
ischemia 0
'' 0
, 0
preparations 0
treated 0
with 0
PC 0
recovered 0
from 0
transmural 0
conduction 0
block 0
more 0
rapidly 0
( 0
PC1 0
group 0
, 0
4 0
min 0
, 0
P 0
less 0
than 0
0.05 0
; 0
PC2 0
group 0
, 0
23 0
min 0
, 0
ns 0
) 0
, 0
compared 0
to 0
control 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
250 0
WORDS 0
) 0

These 0
results 0
are 0
discussed 0
in 0
the 0
context 0
of 0
a 0
model 0
of 0
the 0
myogenic 0
lineage 0
that 0
is 0
based 0
on 0
the 0
expression 0
of 0
desmin B-gene
. 0

Characterization 0
of 0
a 0
DEAD B-gene
box I-gene
ATPase/RNA I-gene
ATPase/RNA I-gene
helicase I-gene
protein 0
of 0
Arabidopsis 0
thaliana 0
. 0

The 0
host 0
range 0
( 0
HR 0
) 0
of 0
poliovirus 0
is 0
thought 0
to 0
be 0
primarily 0
determined 0
by 0
a 0
cell 0
surface 0
molecule 0
that 0
functions 0
as 0
poliovirus B-gene
receptor I-gene
( 0
PVR B-gene
) 0
, 0
since 0
it 0
has 0
been 0
shown 0
that 0
transgenic 0
mice 0
are 0
made 0
poliovirus 0
sensitive 0
by 0
introducing 0
the 0
human B-gene
PVR I-gene
gene I-gene
into 0
the 0
genome 0
. 0

In 0
this 0
paper 0
, 0
the 0
authors 0
used 0
measured 0
weight 0
for 0
1,259 0
white 0
women 0
aged 0
65 0
- 0
74 0
years 0
from 0
the 0
Epidemiologic 0
Follow 0
- 0
up 0
Study 0
of 0
the 0
First 0
National 0
Health 0
and 0
Nutrition 0
Examination 0
Survey 0
to 0
examine 0
the 0
effect 0
of 0
overweight 0
on 0
coronary 0
heart 0
disease 0
incidence 0
( 0
mean 0
length 0
of 0
follow 0
- 0
up 0
, 0
14 0
years 0
) 0
. 0

In 0
contrast 0
to 0
the 0
reciprocal 0
effects 0
of 0
Gab1 B-gene
and 0
Gab2 B-gene
in 0
mediating 0
Elk B-gene
- I-gene
1 I-gene
induction 0
, 0
these 0
two 0
molecules 0
have 0
a 0
similar 0
function 0
in 0
extracellular B-gene
signal I-gene
- I-gene
regulated I-gene
kinase I-gene
activation 0
induced 0
by 0
either 0
oncogenic 0
Ras B-gene
or 0
growth 0
factor 0
stimulation 0
. 0

We 0
were 0
able 0
to 0
demonstrate 0
a 0
significant 0
statistical 0
interaction 0
effect 0
between 0
gender 0
and 0
globulin B-gene
protein I-gene
concentration 0
on 0
Vu 0
( 0
p 0
= 0
0.022 0
) 0
. 0

The 0
NS B-gene
- I-gene
2 I-gene
isoforms I-gene
were 0
resolved 0
at 0
a 0
pI 0
value 0
close 0
to 0
5.5 0
as 0
three 0
groups 0
of 0
unevenly 0
phosphorylated 0
polypeptides 0
, 0
each 0
composed 0
of 0
at 0
least 0
two 0
protein 0
species 0
. 0

Effect 0
of 0
isobarin 0
on 0
electrocardiographic 0
indices 0
in 0
hypertensive 0
disease 0

The 0
column 0
densities 0
of 0
frozen 0
molecular 0
hydrogen 0
and 0
methanol 0
are 0
inferred 0
to 0
be 0
about 0
2.5 0
x 0
10 0
( 0
18 0
) 0
and 0
3.0 0
x 0
10 0
( 0
19 0
) 0
, 0
respectively 0
. 0

TAAG 0
sites 0
that 0
serve 0
as 0
functional 0
late 0
promoters 0
in 0
OpMNPV 0
were 0
found 0
to 0
mediate 0
transcription 0
initiation 0
at 0
only 0
basal 0
levels 0
in 0
the 0
context 0
of 0
the 0
AcMNPV 0
genome 0
, 0
suggesting 0
that 0
late 0
promoter 0
activation 0
may 0
be 0
virus 0
specific 0
within 0
the 0
family 0
Baculoviridae 0
. 0

The 0
carboxyl 0
globular 0
domain 0
was 0
found 0
to 0
be 0
encoded 0
by 0
six 0
exons 0
which 0
appear 0
to 0
delineate 0
its 0
structural 0
subdomains 0
. 0

In 0
3 0
of 0
the 0
5 0
patients 0
with 0
AVNRT 0
and 0
AJR 0
, 0
junctional 0
beats 0
served 0
as 0
a 0
trigger 0
for 0
reentry 0
. 0

Fus3p B-gene
and 0
Kss1p B-gene
together 0
increase 0
the 0
expression 0
of 0
CLN3 B-gene
and 0
PCL2 B-gene
genes I-gene
that 0
promote 0
budding 0
, 0
and 0
Kss1p B-gene
inhibits 0
the 0
MAP B-gene
kinase I-gene
cascade 0
. 0

Measurement 0
of 0
the 0
spectral 0
sensitivity 0
and 0
the 0
ERG 0
can 0
thus 0
help 0
in 0
the 0
diagnosis 0
of 0
these 0
three 0
hereditary 0
diseases 0
. 0

On 0
both 0
indocyanine 0
green 0
video 0
and 0
fluorescein 0
angiography 0
, 0
hypofluorescent 0
lesions 0
were 0
almost 0
the 0
same 0
size 0
as 0
the 0
light 0
yellow 0
area 0
and 0
the 0
dark 0
yellow 0
center 0
of 0
a 0
placoid 0
lesion 0
. 0

Other 0
similar 0
patients 0
must 0
be 0
found 0
before 0
it 0
is 0
established 0
that 0
the 0
colloid 0
cyst 0
is 0
part 0
of 0
the 0
nevoid 0
basal 0
cell 0
carcinoma 0
syndrome 0
. 0

Coexpression 0
of 0
C/EBP B-gene
alpha I-gene
altered 0
the 0
cell 0
specificity 0
. 0

Dominant 0
- 0
negative 0
mutations 0
in 0
the 0
G B-gene
- I-gene
protein I-gene
- I-gene
coupled I-gene
alpha I-gene
- I-gene
factor I-gene
receptor I-gene
map 0
to 0
the 0
extracellular 0
ends 0
of 0
the 0
transmembrane 0
segments 0
. 0

Possibility 0
of 0
using 0
gynecologic 0
nurses 0
in 0
the 0
independently 0
administered 0
health 0
centers 0

Platelet 0
count 0
and 0
plasma 0
volume 0
were 0
significantly 0
higher 0
in 0
group 0
A 0
than 0
in 0
group 0
B 0
throughout 0
pregnancy 0
. 0

The 0
complexity 0
of 0
some 0
of 0
the 0
reports 0
of 0
VACURG 0
studies 0
has 0
led 0
some 0
to 0
believe 0
that 0
this 0
group 0
was 0
opposed 0
to 0
estrogens 0
, 0
but 0
that 0
is 0
not 0
true 0
. 0

This 0
increase 0
is 0
not 0
the 0
result 0
of 0
alterations 0
in 0
the 0
deposition 0
of 0
inhaled 0
particles 0
of 0
capsaicin 0
brought 0
about 0
by 0
volume 0
restriction 0
. 0

Mycobacterium 0
tuberculosis 0
inhibits 0
IFN B-gene
- I-gene
gamma I-gene
transcriptional 0
responses 0
without 0
inhibiting 0
activation 0
of 0
STAT1 B-gene
. 0

Pituitary 0
thyrotropic 0
adenoma 0
associated 0
with 0
congenital 0
hypothyroidism 0
. 0

Upstream 0
of 0
the 0
afa B-gene
- I-gene
3 I-gene
gene I-gene
cluster I-gene
, 0
a 0
1.2 0
- 0
kb 0
region 0
was 0
found 0
to 0
be 0
96 0
% 0
identical 0
to 0
the 0
RepFIB B-gene
sequence I-gene
of 0
one 0
of 0
the 0
enterotoxigenic 0
E. 0
coli 0
plasmids 0
( 0
P307 0
) 0
, 0
suggesting 0
a 0
common 0
ancestor 0
plasmid 0
. 0

Maintenance 0
metabolizable 0
- 0
energy 0
( 0
ME 0
) 0
requirement 0
averaged 0
31.0 0
kcal/kg 0
body 0
wt 0
. 0

Interferon B-gene
- I-gene
alpha I-gene
inducibility 0
of 0
IFI16 B-gene
may 0
be 0
regulated 0
by 0
an 0
interferon B-gene
- I-gene
alpha/beta I-gene
- 0
stimulated 0
response 0
consensus 0
element 0
in 0
the 0
5 0
' 0
UT 0
exon 0
, 0
as 0
a 0
similar 0
motif 0
is 0
conserved 0
in 0
the 0
corresponding 0
position 0
in 0
the 0
related 0
myeloid B-gene
cell I-gene
nuclear I-gene
differentiation I-gene
antigen I-gene
gene 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
400 0
WORDS 0
) 0

The 0
secondary 0
end 0
points 0
included 0
creatine B-gene
kinase I-gene
peak 0
, 0
ventricular 0
fibrillation/tachycardia 0
within 0
the 0
first 0
24 0
hours 0
, 0
death 0
and 0
congestive 0
heart 0
failure 0
within 0
the 0
30 0
- 0
day 0
follow 0
- 0
up 0
, 0
and 0
30 0
- 0
day 0
left 0
ventricular 0
ejection 0
fraction 0
. 0

For 0
the 0
population 0
of 0
patients 0
with 0
melanoma 0
levels 0
III 0
and 0
IV 0
significant 0
differences 0
in 0
survival 0
rate 0
were 0
associated 0
with 0
thickness 0
( 0
less 0
than 0
2 0
mm 0
or 0
greater 0
than 0
or 0
equal 0
to 0
2 0
mm 0
; 0
p 0
less 0
than 0
0,001 0
) 0
, 0
though 0
not 0
with 0
level 0
. 0

Here 0
we 0
show 0
that 0
the 0
sck1 B-gene
gene I-gene
, 0
cloned 0
as 0
a 0
high 0
copy 0
number 0
suppressor 0
of 0
a 0
mutation 0
in 0
git3 B-gene
, 0
is 0
able 0
to 0
suppress 0
the 0
defects 0
conferred 0
by 0
a 0
mutation 0
in 0
any 0
of 0
these 0
git B-gene
genes I-gene
. 0

The 0
contribution 0
of 0
reviewers 0
and 0
editors 0
to 0
the 0
scientific 0
work 0
of 0
the 0
authors 0

Comparisons 0
of 0
defective 0
HTLV 0
- 0
I 0
proviruses 0
predict 0
the 0
mode 0
of 0
origin 0
and 0
coding 0
potential 0
of 0
internally 0
deleted 0
genomes 0
. 0

When 0
proper 0
controls 0
were 0
used 0
, 0
the 0
psychophysical 0
data 0
and 0
computer 0
simulation 0
gave 0
remarkably 0
comparable 0
results 0
. 0

Results 0
of 0
these 0
in 0
vitro 0
studies 0
may 0
be 0
relevant 0
to 0
the 0
pathogenesis 0
of 0
alveolitis 0
in 0
organic 0
dust 0
- 0
induced 0
lung 0
diseases 0
. 0

However 0
, 0
the 0
in 0
vivo 0
attachment 0
strength 0
of 0
the 0
CSTi 0
- 0
2 0
coating 0
was 0
comparable 0
both 0
to 0
CSTi 0
- 0
1 0
and 0
to 0
an 0
HA 0
- 0
coated 0
control 0
after 0
8 0
weeks 0
. 0

The 0
phosphoprotein B-gene
pUL69 I-gene
of 0
human 0
cytomegalovirus 0
( 0
HCMV 0
) 0
, 0
which 0
is 0
a 0
herpesvirus 0
of 0
considerable 0
medical 0
importance 0
in 0
immunosuppressed 0
patients 0
and 0
newborns 0
, 0
has 0
previously 0
been 0
identified 0
as 0
an 0
early B-gene
- I-gene
late I-gene
viral I-gene
protein I-gene
that 0
can 0
stimulate 0
several 0
viral 0
and 0
cellular 0
promoters 0
and 0
thus 0
exerts 0
a 0
rather 0
broad 0
activation 0
pattern 0
. 0

Effects 0
of 0
acute 0
exposure 0
to 0
cold 0
on 0
pulmonary 0
arterial 0
blood 0
pressure 0
in 0
awake 0
rats 0
. 0

RNase B-gene
protection 0
analysis 0
reveals 0
a 0
10 0
- 0
fold 0
increase 0
in 0
the 0
expression 0
of 0
SCD2 B-gene
mRNA I-gene
during 0
3T3 0
- 0
L1 0
preadipocyte 0
differentiation 0
. 0

Spontaneous 0
fracture 0
of 0
the 0
tarsal 0
bone 0
in 0
2 0
cases 0
of 0
leprosy 0

CERIP B-gene
interaction 0
. 0

The 0
response 0
sequences 0
were 0
localized 0
between 0
- 0
67 0
and 0
+30 0
in 0
the 0
simian 0
cytomegalovirus 0
IE94 B-gene
promoter I-gene
and 0
upstream 0
of 0
position 0
+9 0
in 0
the 0
HCMV B-gene
IE68 I-gene
promoter I-gene
. 0

The 0
expression 0
of 0
Scmh1 B-gene
and 0
rae28/mph1 B-gene
is 0
well 0
correlated 0
in 0
most 0
tissues 0
of 0
embryos 0
. 0

Our 0
results 0
suggest 0
that 0
it 0
might 0
be 0
possible 0
to 0
augment 0
IN B-gene
function 0
in 0
vivo 0
through 0
a 0
heterologous 0
domain 0
. 0

Retinoic 0
acid 0
, 0
which 0
inhibits 0
the 0
progression 0
of 0
certain 0
cancers 0
, 0
repressed 0
v B-gene
- I-gene
src I-gene
- 0
induced 0
MMP B-gene
- I-gene
1 I-gene
transcription 0
. 0

Untransformed 0
3T3 0
cells 0
carry 0
abundant 0
1.9 0
kb 0
Hox B-gene
1.3 I-gene
RNA 0
, 0
whereas 0
the 0
methylcholanthrene 0
- 0
transformed 0
MB66 0
and 0
LTK 0
- 0
cells 0
or 0
3T3 0
cells 0
transformed 0
by 0
the 0
oncogenes 0
src B-gene
, 0
fos B-gene
or 0
SV40 B-gene
T I-gene
antigen I-gene
express 0
only 0
low 0
levels 0
. 0

Furthermore 0
, 0
it 0
is 0
also 0
established 0
that 0
serine 0
phosphorylation 0
of 0
STAT5a B-gene
transactivation 0
domain 0
, 0
via 0
the 0
MAPK B-gene
pathway 0
, 0
is 0
a 0
means 0
of 0
modifying 0
GH B-gene
- 0
induced 0
transcriptional 0
activation 0
. 0

Prevention 0
of 0
gravid 0
Rhesus 0
isoimmunization 0

Expression 0
of 0
medical 0
efficiency 0
by 0
integration 0
indicators 0
with 0
the 0
rational 0
utilization 0
of 0
budgeted 0
funds 0

We 0
infer 0
that 0
RecA B-gene
- 0
mediated 0
cleavage 0
of 0
UmuD B-gene
is 0
another 0
role 0
for 0
RecA B-gene
in 0
SOS 0
mutagenesis 0
, 0
probably 0
activating 0
UmuD B-gene
for 0
its 0
mutagenic 0
function 0
. 0

Blood 0
pressure 0
was 0
controlled 0
long 0
term 0
( 0
with/without 0
diuretics/beta B-gene
- I-gene
adrenoreceptor I-gene
blocking 0
drugs 0
) 0
in 0
sixteen 0
out 0
of 0
nineteen 0
patients 0
with 0
mild 0
- 0
moderate 0
hypertension 0
. 0

METHODS 0
: 0
Autocapture 0
devices 0
( 0
Pacesetter 0
Microny 0
SR+/ 0
- 0
and 0
Regency 0
SR+/ 0
- 0
; 0
Pacesetter 0
, 0
Solna 0
, 0
Sweden 0
) 0
and 0
steroid 0
- 0
eluting 0
epicardial 0
pacing 0
leads 0
( 0
Medtronic 0
CapSure 0
Epi 0
10366 0
; 0
Medtronic 0
, 0
Inc 0
, 0
Minneapolis 0
, 0
MN 0
) 0
were 0
implanted 0
in 0
14 0
children 0
. 0

This 0
may 0
be 0
another 0
example 0
of 0
the 0
principle 0
- 0
- 0
less 0
is 0
more 0
. 0

The 0
predicted 0
amino 0
- 0
acid 0
sequence 0
includes 0
an 0
N 0
- 0
terminal 0
signal 0
sequence 0
of 0
27 0
amino 0
acids 0
, 0
a 0
27 0
amino 0
- 0
acid 0
pro 0
- 0
region 0
, 0
a 0
251 0
amino 0
- 0
acid 0
catalytic 0
domain 0
typical 0
of 0
a 0
serine B-gene
protease I-gene
with 0
trypsin B-gene
- 0
like 0
specificity 0
, 0
and 0
a 0
C 0
- 0
terminal 0
hydrophobic 0
extension 0
which 0
is 0
predicted 0
to 0
function 0
as 0
a 0
membrane 0
anchor 0
. 0

Effects 0
of 0
negative 0
pi 0
mesons 0
on 0
mouse 0
bone 0
marrow 0
cells 0
. 0

Phenotypic 0
and 0
molecular 0
analyses 0
of 0
patients 0
with 0
partial 0
chromosome 0
21 0
monosomy 0
enabled 0
us 0
to 0
define 0
a 0
region 0
, 0
spanning 0
2.4 0
Mb 0
between 0
D21S190 B-gene
and 0
D21S226 B-gene
, 0
associated 0
with 0
arthrogryposis 0
, 0
mental 0
retardation 0
, 0
hypertonia 0
, 0
and 0
several 0
facial 0
anomalies 0
. 0

Relation 0
between 0
circulating 0
immune 0
complexes 0
and 0
serum B-gene
ferritin I-gene
in 0
hemosiderosis 0
of 0
different 0
etiologies 0

The 0
zinc B-gene
finger I-gene
protein I-gene
A20 I-gene
is 0
a 0
tumor B-gene
necrosis I-gene
factor I-gene
( 0
TNF B-gene
) 0
- 0
and 0
interleukin B-gene
1 I-gene
( 0
IL B-gene
- I-gene
1 I-gene
) 0
- 0
inducible 0
protein 0
that 0
negatively 0
regulates 0
nuclear B-gene
factor I-gene
- I-gene
kappa I-gene
B I-gene
( 0
NF B-gene
- I-gene
kappaB I-gene
) 0
- 0
dependent 0
gene 0
expression 0
. 0

The 0
determination 0
of 0
antithrombin B-gene
III I-gene
( 0
AT B-gene
III I-gene
) 0
and 0
its 0
clinical 0
significance 0

Treatments 0
were 0
two 0
adrenocorticotrophin B-gene
( 0
ACTH B-gene
) 0
preparations 0
given 0
intramuscularly 0
at 0
2.2 0
U/kg 0
, 0
one 0
of 0
the 0
ACTH B-gene
preparations 0
given 0
intramuscularly 0
at 0
1 0
U/kg 0
and 0
a 0
synthetic 0
polypeptide 0
with 0
ACTH B-gene
- I-gene
like I-gene
activity 0
( 0
tetracosactrin 0
, 0
cosyntropin 0
) 0
given 0
intravenously 0
at 0
5 0
micrograms/kg 0
. 0

The 0
deviation 0
site 0
is 0
equivalent 0
to 0
the 0
exon 0
1/exon 0
2 0
splice 0
site 0
of 0
the 0
mouse 0
C 0
- 0
subunit 0
. 0

The 0
liver 0
- 0
specific 0
sequence 0
contains 0
unique 0
consensus 0
sites 0
for 0
phosphorylation 0
by 0
cyclic B-gene
AMP I-gene
- I-gene
dependent I-gene
protein I-gene
kinase I-gene
and 0
by 0
protein B-gene
kinase I-gene
C I-gene
. 0

Seizure 0
recurrence 0
( 0
HR 0
1.30 0
; 0
95 0
% 0
CI 0
= 0
0.84 0
, 0
2.01 0
) 0
and 0
antiepileptic 0
drug 0
treatment 0
( 0
HR 0
0.97 0
; 0
95 0
% 0
CI 0
= 0
0.67 0
, 0
1.38 0
) 0
did 0
not 0
influence 0
mortality 0
rate 0
. 0

All 0
patients 0
whose 0
PSA B-gene
levels 0
reached 0
0.1 0
ng./ml 0
. 0

The 0
( 0
0 0
0 0
2 0
) 0
diffraction 0
of 0
the 0
synthesized 0
HAp 0
crystals 0
on 0
a 0
Col 0
fiber 0
showed 0
an 0
around 0
60 0
arching 0
angle 0
, 0
while 0
that 0
on 0
a 0
ChS 0
fiber 0
showed 0
just 0
around 0
10 0
degrees 0
. 0

Fas B-gene
( 0
APO B-gene
- I-gene
1/CD95 I-gene
) 0
, 0
which 0
is 0
a 0
member 0
of 0
the 0
1/CD95 I-gene

Soft 0
independent 0
modelling 0
of 0
class 0
analogy 0
( 0
SIMCA 0
) 0
is 0
applied 0
to 0
identify 0
near 0
- 0
infrared 0
( 0
NIR 0
) 0
spectra 0
of 0
ten 0
excipients 0
used 0
in 0
the 0
pharmaceutical 0
industry 0
. 0

Mutations 0
of 0
SIN4 B-gene
, 0
ROX3 B-gene
, 0
SRB8 B-gene
, 0
SRB9 B-gene
, 0
SRB10 B-gene
, 0
SRB11 B-gene
, 0
and 0
two 0
novel 0
genes 0
, 0
NUT1 B-gene
and 0
NUT2 B-gene
, 0
relieve 0
the 0
requirement 0
of 0
Swi4p B-gene
for 0
expression 0
of 0
this 0
reporter 0
. 0

The 0
IB2 B-gene
gene I-gene
( 0
HGMW 0
- 0
approved 0
symbol 0
MAPK8IP2 B-gene
) 0
maps 0
to 0
human 0
chromosome 0
22q13 0
and 0
contains 0
10 0
coding 0
exons 0
. 0

Implantation 0
is 0
contraindicated 0
for 0
severe 0
dysplasia 0
of 0
the 0
cochlea 0
and 0
for 0
the 0
recently 0
described 0
variety 0
of 0
x 0
- 0
linked 0
deafness 0
with 0
deficient 0
bone 0
at 0
the 0
fundus 0
of 0
the 0
internal 0
auditory 0
meatus 0
. 0

The 0
RsmA B-gene
- I-gene
mutant I-gene
, 0
like 0
its 0
parent 0
, 0
produces 0
N 0
- 0
( 0
3 0
- 0
oxohexanoyl 0
) 0
- 0
L 0
- 0
homoserine 0
lactone 0
( 0
HSL 0
) 0
, 0
a 0
starvation/cell 0
density 0
- 0
sensing 0
signal 0
required 0
for 0
extracellular 0
enzyme 0
production 0
. 0

The 0
101st 0
annual 0
meeting 0
of 0
the 0
Japanese 0
Ophthalmological 0
Society 0
. 0

The 0
other 0
end 0
of 0
this 0
cluster 0
contained 0
the 0
human B-gene
type I-gene
I I-gene
cytokeratin I-gene
K20 B-gene
and 0
K12 B-gene
gene I-gene
loci 0
. 0

In 0
patients 0
in 0
which 0
these 0
criteria 0
were 0
not 0
met 0
only 0
the 0
reproducibility 0
of 0
the 0
VO2 0
obtained 0
in 0
both 0
the 0
P 0
- 0
MET 0
and 0
the 0
C 0
- 0
MET 0
indicated 0
that 0
the 0
maximal 0
VO2 0
for 0
these 0
4 0
patients 0
had 0
been 0
reached 0
. 0

In 0
the 0
case 0
of 0
the 0
pT181 0
plasmid 0
, 0
inactivation 0
of 0
the 0
initiator B-gene
RepC I-gene
protein I-gene
occurs 0
by 0
the 0
attachment 0
of 0
an 0
oligonucleotide 0
to 0
its 0
active 0
tyrosine 0
residue 0
. 0

We 0
found 0
multiple 0
transcription 0
start 0
sites 0
located 0
within 0
a 0
15 0
- 0
base 0
pair 0
region 0
, 0
205 0
base 0
pairs 0
upstream 0
of 0
the 0
translation 0
start 0
codon 0
. 0

Overexpression 0
of 0
either 0
Sp1 B-gene
or 0
phosphorylated B-gene
CREB I-gene
transactivated 0
the 0
mCgA B-gene
promoter I-gene
dose 0
dependently 0
, 0
while 0
coexpression 0
of 0
both 0
transcription 0
factors 0
resulted 0
in 0
an 0
additive 0
mCgA B-gene
promoter I-gene
response 0
. 0
mCgA B-gene
- 0
92 0
to 0
- 0
64 0
bp 0
, 0
comprising 0
the 0
Sp1/Egr B-gene
Sp1/Egr I-gene
- I-gene
1 I-gene
site 0
and 0
the 0
CRE 0
motif 0
, 0
conferred 0
gastrin B-gene
responsiveness 0
to 0
a 0
heterologous B-gene
thymidine I-gene
kinase I-gene
promoter I-gene
system 0
, 0
and 0
therefore 0
functions 0
as 0
a 0
`` 0
true 0
'' 0
enhancer 0
element 0
. 0

Alfalfa 0
phosphorus 0
release 0
kinetics 0
showed 0
high 0
bacterial 0
phosphorus 0
contamination 0
. 0

In 0
conclusion 0
, 0
ORCA3 B-gene
regulates 0
jasmonate 0
- 0
responsive 0
expression 0
of 0
the 0
Str B-gene
gene I-gene
via 0
direct 0
interaction 0
with 0
the 0
JERE 0
. 0

PC12 0
cultures 0
that 0
had 0
been 0
`` 0
primed 0
'' 0
in 0
this 0
way 0
showed 0
an 0
accelerated 0
and 0
augmented 0
differentiation 0
response 0
to B-gene
nerve I-gene
growth I-gene
factor I-gene
. 0

Pseudotumor 0
form 0
of 0
pulmonary 0
nocardia 0
infection 0
( 0
Nocardia 0
nova 0
) 0
in 0
a 0
renal 0
transplant 0
patient 0

Deoxyuridine 0
- 0
suppression 0
test 0
and 0
bone 0
marrow 0
culture 0
for 0
the 0
diagnosis 0
of 0
macrocytic 0
refractory 0
anaemias 0
. 0

A 0
computerized 0
database 0
of 0
veterans 0
discharged 0
from 0
the 0
military 0
after 0
1967 0
was 0
selected 0
as 0
the 0
source 0
because 0
it 0
contains 0
about 0
50 0
% 0
of 0
the 0
total 0
Vietnam 0
era 0
veteran 0
population 0
, 0
is 0
reasonably 0
unbiased 0
, 0
and 0
provides 0
a 0
feasible 0
method 0
for 0
identifying 0
twins 0
. 0

We 0
report 0
that 0
Nim1 B-gene
possesses 0
intrinsic 0
serine B-gene
- I-gene
kinase I-gene
, 0
threonine B-gene
- I-gene
kinase I-gene
and 0
tyrosine B-gene
- I-gene
kinase I-gene
activities 0
. 0

This 0
mutation 0
was 0
associated 0
with 0
reduced 0
or 0
absent 0
expression 0
of 0
TGF B-gene
- I-gene
beta I-gene
RI I-gene
protein I-gene
and 0
p53 B-gene
protein I-gene
in 0
tumor 0
tissues 0
. 0

Keys 0
can 0
be 0
used 0
for 0
identifying 0
species 0
from 0
the 0
European 0
part 0
of 0
the 0
USSR 0
and 0
north 0
- 0
eastern 0
Kazakhstan 0
. 0

Time 0
between 0
tests 0
( 0
usually 0
less 0
than 0
one 0
year 0
) 0
did 0
not 0
affect 0
the 0
correlations 0
, 0
but 0
MMPI 0
response 0
- 0
set 0
variables 0
( 0
L 0
, 0
F 0
, 0
K 0
, 0
F 0
- 0
K 0
) 0
did 0
. 0

Cloning 0
and 0
sequence 0
analysis 0
of 0
a 0
chymotrypsinlike B-gene
protease I-gene
from I-gene
Treponema I-gene
denticola 0
. 0

To 0
initiate 0
our 0
analysis 0
of 0
factors 0
required 0
for 0
eIF B-gene
- I-gene
2 I-gene
alpha I-gene
expression 0
, 0
selected 0
a 0
CAP 0
- 0
proximal 0
element 0
shown 0
by 0
in 0
vivo 0
methylation 0
protection 0
analysis 0
to 0
bind 0
a 0
potential 0
regulatory 0
factor 0
. 0

The 0
isoproterenol 0
infusion 0
was 0
adjusted 0
so 0
that 0
heart 0
rate 0
( 0
HR 0
) 0
was 0
at 0
least 0
30 0
beats/min 0
greater 0
than 0
baseline 0
. 0

The 0
effect 0
of 0
monaural 0
middle 0
ear 0
destruction 0
on 0
postnatal 0
development 0
of 0
mouse 0
inferior 0
colliculus 0
. 0

The 0
specificity 0
and 0
sensitivity 0
of 0
this 0
method 0
( 0
limit 0
of 0
detection 0
in 0
plasma 0
0.025 0
micrograms/mL 0
and 0
< 0
or 0
= 0
0.0125 0
micrograms/mL 0
for 0
febantel 0
and 0
its 0
metabolites 0
, 0
respectively 0
) 0
were 0
sufficiently 0
high 0
to 0
enable 0
us 0
to 0
characterize 0
the 0
time 0
course 0
of 0
the 0
drug 0
in 0
the 0
plasma 0
after 0
oral 0
administration 0
of 0
therapeutic 0
doses 0
to 0
sheep 0
. 0

MATERIALS 0
AND 0
METHODS 0
: 0
A 0
seven 0
- 0
wavelength 0
frequency 0
- 0
domain 0
photon 0
migration 0
probe 0
was 0
used 0
to 0
perform 0
noninvasive 0
NIR 0
measurements 0
in 0
the 0
breasts 0
of 0
28 0
healthy 0
women 0
, 0
both 0
pre 0
- 0
and 0
postmenopausal 0
, 0
aged 0
18 0
- 0
64 0
years 0
. 0

Drug 0
therapy 0
of 0
AAPMC 0
is 0
directed 0
at 0
reducing 0
the 0
amount 0
of 0
Cl 0
. 0
difficile 0
in 0
the 0
colon 0
and 0
promoting 0
normalization 0
of 0
intestinal 0
flora 0
. 0

The 0
results 0
of 0
this 0
study 0
demonstrate 0
that 0
release 0
of 0
a 0
single 0
pulley 0
after 0
repair 0
of 0
the 0
tendons 0
in 0
this 0
area 0
improved 0
gliding 0
excursions 0
of 0
the 0
tendons 0
and 0
reduced 0
resistance 0
to 0
motion 0
of 0
the 0
repaired 0
tendons 0
, 0
and 0
provide 0
support 0
for 0
partial 0
A2 0
pulley 0
incision 0
after 0
repair 0
of 0
the 0
tendons 0
in 0
the 0
area 0
of 0
the 0
pulley 0
. 0

The 0
Ick B-gene
protein B-gene
tyrosine I-gene
kinase I-gene
is 0
not 0
involved 0
in 0
antibody 0
- 0
mediated 0
CD4 B-gene
( 0
CDR3 B-gene
- I-gene
loop I-gene
) 0
signal 0
transduction 0
that 0
inhibits 0
HIV 0
- 0
1 0
transcription 0
. 0

It 0
is 0
targeted 0
to 0
peroxisomes 0
when 0
expressed 0
in 0
mammalian 0
cells 0
and 0
yeast 0
. 0

Whether 0
or 0
not 0
these 0
novel 0
repeated 0
sequences 0
throughout 0
the 0
SMA B-gene
region I-gene
are 0
involved 0
in 0
the 0
disease 0
remains 0
to 0
be 0
determined 0
. 0

All 0
except 0
the 0
last 0
two 0
interventions 0
are 0
physical 0
treatments 0
that 0
create 0
a 0
wound 0
- 0
tissue 0
environment 0
conducive 0
to 0
healing 0
. 0

Consistent 0
with 0
our 0
observation 0
that 0
AP B-gene
- I-gene
1 I-gene
binding 0
does 0
not 0
contribute 0
to 0
c B-gene
- I-gene
Jun I-gene
coactivation 0
is 0
the 0
observation 0
that 0
the 0
activation 0
of 0
PU.1 B-gene
by 0
c B-gene
- I-gene
Jun I-gene
is 0
blocked 0
by 0
overexpression 0
of 0
c B-gene
- I-gene
Fos I-gene
. 0

In 0
a 0
series 0
of 0
papers 0
, 0
the 0
staging 0
system 0
for 0
melanoma 0
was 0
critically 0
analyzed 0
, 0
and 0
many 0
shortcomings 0
were 0
identified 0
. 0

The 0
transcriptional 0
initiation 0
site 0
of 0
RAG1 B-gene
was 0
localized 0
at 0
A 0
, 0
26 0
bp 0
upstream 0
of 0
the 0
putative 0
translational 0
initiation 0
codon 0
, 0
ATG 0
, 0
by 0
the 0
primer 0
extension 0
assay 0
. 0

The 0
levels 0
of 0
products 0
expressed 0
from 0
these 0
chimeric 0
cDNAs 0
in 0
COS 0
cells 0
were 0
assessed 0
by 0
activity 0
assay 0
and 0
by 0
metabolic 0
labeling 0
of 0
the 0
proteins 0
followed 0
by 0
immunoprecipitation 0
and 0
SDS 0
- 0
PAGE 0
. 0

The 0
leucine 0
zipper 0
region 0
of 0
ATF B-gene
proteins I-gene
is 0
also 0
similar 0
to 0
that 0
of 0
the 0
AP B-gene
- I-gene
1/c I-gene
1/c I-gene
- I-gene
jun I-gene
family 0
of 0
transcription 0
factors 0
, 0
whose 0
DNA 0
- 0
binding 0
site 0
differs 0
from 0
the 0
ATF B-gene
- 0
binding 0
site 0
at 0
a 0
single 0
position 0
. 0

Immunoblotting 0
with 0
antiphosphotyrosine 0
antibody 0
showed 0
that 0
many 0
yeast 0
proteins 0
, 0
including 0
the 0
p34CDC28 B-gene
kinase I-gene
, 0
became 0
phosphorylated 0
at 0
tyrosine 0
in 0
cells 0
expressing 0
v B-gene
- I-gene
src I-gene
. 0

22 0
- 0
Veneto 0
Region 0
) 0

Differential 0
transcription 0
of 0
plastome 0
- 0
encoded 0
genes 0
in 0
the 0
mesophyll 0
and 0
bundle 0
- 0
sheath 0
chloroplasts 0
of 0
the 0
monocotyledonous 0
NADP 0
- 0
malic B-gene
enzyme I-gene
- 0
type 0
C4 0
plants 0
maize 0
and 0
Sorghum 0
. 0

AIMS 0
: 0
We 0
postulated 0
that 0
perhexiline 0
, 0
a 0
novel 0
anti 0
- 0
ischaemic 0
agent 0
with 0
an 0
oxygen 0
- 0
sparing 0
metabolic 0
effect 0
in 0
the 0
myocardium 0
( 0
via 0
inhibition 0
of 0
carnitine B-gene
palmitoyltransferase I-gene
- I-gene
1 I-gene
) 0
and 0
no 0
adverse 0
haemodynamic 0
effects 0
, 0
may 0
improve 0
symptomatic 0
status 0
in 0
elderly 0
patients 0
with 0
severe 0
aortic 0
stenosis 0
. 0

Developmentally 0
- 0
regulated 0
interaction 0
of 0
a 0
transcription 0
factor 0
complex 0
containing 0
CDP/cut B-gene
with 0
the 0
CDP/cut I-gene

In 0
this 0
group 0
of 0
patients 0
, 0
the 0
mean 0
LH B-gene
( 0
9.3 0
+/ 0
- 0
5.9 0
IU/l 0
) 0
and 0
sex B-gene
- I-gene
hormone I-gene
binding I-gene
globulin I-gene
( 0
SHBG B-gene
) 0
( 0
54.5 0
+/ 0
- 0
22.9 0
nmol/l 0
) 0
concentrations 0
were 0
significantly 0
greater 0
than 0
those 0
of 0
five 0
normal 0
control 0
subjects 0
( 0
4.7 0
+/ 0
- 0
1.11 0
IU/l 0
and 0
26.0 0
+/ 0
- 0
7.0 0
nmol/l 0
respectively 0
) 0
. 0

IRA2 B-gene
, 0
a 0
second 0
gene 0
of 0
Saccharomyces 0
cerevisiae 0
that 0
encodes 0
a 0
protein 0
with 0
a 0
domain 0
homologous 0
to 0
mammalian 0
ras B-gene
GTPase I-gene
- I-gene
activating I-gene
protein I-gene
. 0

Gastrin B-gene
stimulates 0
transcription 0
of 0
the 0
human B-gene
histidine I-gene
decarboxylase I-gene
( 0
HDC B-gene
) 0
gene 0
through 0
binding 0
to 0
the 0
G B-gene
- I-gene
protein I-gene
- 0
coupled 0
cholecystokinin B-gene
- I-gene
B/gastrin I-gene
B/gastrin I-gene
receptor I-gene
. 0

RESULTS 0
- 0
- 0
The 0
maximal 0
early 0
asthmatic 0
response 0
after 0
allergen 0
with 0
placebo 0
treatment 0
was 0
18.4 0
% 0
( 0
SE 0
4.4 0
% 0
) 0
and 0
with 0
WEB 0
2086 0
18.9 0
% 0
( 0
4.4 0
% 0
) 0
. 0

The 0
3 0
' 0
region 0
of 0
the 0
transcript 0
contained 0
a 0
fully 0
conserved 0
, 0
correctly 0
spliced 0
TCR B-gene
alpha I-gene
C I-gene
region I-gene
which 0
was 0
polyadenylated 0
at 0
the 0
3 0
' 0
end 0
. 0

Structural 0
organization 0
of 0
the 0
human B-gene
Elk1 I-gene
gene I-gene
and 0
its 0
processed 0
pseudogene B-gene
Elk2 I-gene
. 0

Results 0
: 0
hepatic 0
hydatidosis 0
: 0
177 0
patients 0
. 0

Prematurely 0
inactivating 0
p42 B-gene
MAPK I-gene
in 0
egg 0
extracts 0
resulted 0
in 0
a 0
corresponding 0
hastening 0
of 0
the 0
first 0
mitosis 0
. 0

Anxiogenic 0
effects 0
of 0
pentagastrin 0
in 0
patients 0
with 0
social 0
phobia 0
and 0
healthy 0
controls 0
. 0

Dynamic 0
expression 0
of 0
broad B-gene
- I-gene
complex I-gene
isoforms I-gene
mediates 0
temporal 0
control 0
of 0
an 0
ecdysteroid 0
target 0
gene 0
at 0
the 0
onset 0
of 0
Drosophila 0
metamorphosis 0
. 0

Identification 0
of 0
a 0
putative 0
chromosomal 0
replication 0
origin 0
from 0
Helicobacter 0
pylori 0
and 0
its 0
interaction 0
with 0
the 0
initiator B-gene
protein I-gene
DnaA I-gene
. 0

There 0
was 0
91 0
% 0
concordance 0
between 0
ST 0
- 0
RD/RI/LRD 0
201Tl 0
and 0
R 0
- 0
ST/N 0
+ 0
Inf 0
99Tcm 0
- 0
tetrofosmin 0
imaging 0
regarding 0
reversibility 0
. 0

Sub 0
- 0
inhibitory 0
and 0
post 0
- 0
antibiotic 0
effects 0
of 0
spiramycin 0
and 0
erythromycin 0
on 0
Staphylococcus 0
aureus 0
. 0

There 0
remains 0
the 0
physiological 0
problem 0
- 0
- 0
one 0
which 0
has 0
always 0
been 0
foremost 0
in 0
Moruzzi 0
's 0
thinking 0
about 0
the 0
intrinsic 0
regulation 0
of 0
brain 0
activity 0
- 0
- 0
of 0
how 0
the 0
separate 0
actions 0
of 0
the 0
different 0
arousal 0
systems 0
are 0
brought 0
together 0
into 0
a 0
functional 0
whole 0
. 0

Because 0
the 0
variation 0
in 0
the 0
carbohydrate 0
content 0
of 0
human 0
milk 0
is 0
very 0
small 0
, 0
a 0
more 0
simple 0
alternative 0
approach 0
would 0
be 0
to 0
include 0
only 0
an 0
average 0
carbohydrate 0
value 0
for 0
an 0
estimate 0
of 0
energy 0
content 0
. 0

It 0
is 0
suggested 0
that 0
biliary 0
secretion 0
of 0
both 0
TBZ 0
and 0
FBZ 0
and 0
their 0
metabolites 0
may 0
contribute 0
to 0
this 0
recycling 0
. 0

Hyperlipemia 0
has 0
been 0
recently 0
described 0
in 0
children 0
with 0
migraine 0
, 0
being 0
suggested 0
that 0
this 0
alteration 0
is 0
in 0
the 0
base 0
of 0
the 0
disease 0
. 0

BACKGROUND 0
: 0
A 0
thorough 0
understanding 0
of 0
malignant 0
fibrous 0
histiocytoma 0
( 0
MFH 0
) 0
, 0
the 0
most 0
common 0
subtype 0
of 0
soft 0
tissue 0
sarcoma 0
, 0
will 0
lead 0
to 0
improved 0
histologic 0
- 0
specific 0
protocols 0
. 0

The 0
proteins 0
encoded 0
by 0
these 0
genes 0
, 0
called 0
GF14 B-gene
proteins I-gene
, 0
participate 0
in 0
protein/DNA 0
complexes 0
and 0
show 0
more 0
than 0
60 0
% 0
identity 0
with 0
a 0
highly 0
conserved 0
, 0
widely 0
distributed 0
protein 0
family 0
, 0
collectively 0
referred 0
to 0
as 0
14 B-gene
- I-gene
3 I-gene
- I-gene
3 I-gene
proteins 0
. 0

A 0
total 0
of 0
64 0
uncomplicated 0
Type 0
- 0
2 0
diabetic 0
individuals 0
of 0
higher 0
middle 0
class 0
to 0
rich 0
socio 0
- 0
economic 0
status 0
were 0
studied 0
. 0

Using 0
yeast 0
two 0
- 0
hybrid 0
screening 0
, 0
we 0
isolated 0
histone B-gene
H3 I-gene
as 0
an 0
interacting 0
factor 0
of 0
CIA B-gene
. 0

Elevated 0
total 0
serum 0
calcium 0
to 0
a 0
level 0
of 0
11.9 0
+/ 0
- 0
0.2 0
mg/dl 0
( 0
p 0
less 0
than 0
0.001 0
compared 0
to 0
control 0
group 0
) 0
developed 0
in 0
the 0
gentamicin/1,25 0
( 0
OH 0
) 0
2 0
vitamin 0
D3 0
group 0
on 0
day 0
4 0
, 0
2 0
days 0
prior 0
to 0
pronounced 0
structural 0
damage 0
, 0
and 0
continued 0
to 0
be 0
elevated 0
through 0
day 0
7 0
. 0

To 0
investigate 0
the 0
role 0
of 0
this 0
domain 0
in 0
the 0
incorporation 0
of 0
the 0
SIV B-gene
Env I-gene
into 0
virions 0
, 0
we 0
generated 0
a 0
series 0
of 0
SIV B-gene
Env I-gene
mutants I-gene
carrying 0
small 0
in 0
- 0
frame 0
deletions 0
within 0
the 0
cytoplasmic 0
domain 0
. 0

Ozone 0
uptake 0
was 0
assessed 0
in 0
awake 0
, 0
spontaneously 0
breathing 0
Fischer 0
- 0
344 0
Sprague 0
- 0
Dawley 0
, 0
and 0
Long 0
- 0
Evans 0
rats 0
and 0
Hartley 0
guinea 0
pigs 0
to 0
provide 0
data 0
on 0
the 0
dosimetry 0
of 0
O3 0
in 0
small 0
laboratory 0
animals 0
. 0

Treatment 0
of 0
steroid 0
resistant 0
rejection 0
following 0
renal 0
transplantation 0
: 0
benefits 0
and 0
risks 0
of 0
OKT3 B-gene
therapy 0
. 0

SETTING 0
: 0
University 0
research 0
laboratory 0
. 0

On 0
the 0
3rd 0
day 0
after 0
ischemia 0
of 0
the 0
remained 0
kidney 0
for 0
30 0
min 0
, 0
structural 0
components 0
of 0
the 0
walls 0
of 0
the 0
glomerular 0
arterioles 0
and 0
those 0
of 0
the 0
filtration 0
- 0
reabsorption 0
barrier 0
undergo 0
certain 0
ultrastructural 0
changes 0
, 0
that 0
with 0
time 0
elapsed 0
( 0
7 0
, 0
14 0
days 0
) 0
gradually 0
pass 0
away 0
, 0
and 0
amount 0
of 0
cells 0
with 0
hypertrophic 0
processes 0
increases 0
. 0

Non 0
- 0
finger 0
- 0
coding 0
modules 0
conserved 0
among 0
members 0
of 0
subfamilies 0
of 0
zinc B-gene
finger I-gene
genes I-gene
have 0
been 0
described 0
in 0
the 0
murine 0
genome 0
( 0
finger 0
- 0
associated 0
boxes 0
, 0
or 0
FAX 0
domain 0
) 0
and 0
the 0
human 0
genome 0
( 0
Kruppel B-gene
- I-gene
associated I-gene
boxes I-gene
, 0
or 0
KRAB B-gene
domain I-gene
) 0
. 0

Binding 0
of 0
C/EBPs B-gene
to 0
all 0
three 0
spi B-gene
2.3 I-gene
3 I-gene
' I-gene
UTR I-gene
repressor I-gene
sites I-gene
, 0
although 0
rather 0
weak 0
, 0
was 0
confirmed 0
by 0
electrophoretic 0
mobility 0
shift 0
assays 0
that 0
otherwise 0
failed 0
to 0
reveal 0
specific 0
interactions 0
with 0
other 0
liver 0
nuclear 0
proteins 0
in 0
vitro 0
. 0

The 0
newly 0
identified 0
NF B-gene
kappa I-gene
B I-gene
enhancer I-gene
( 0
TGGAAATTCC 0
) 0
is 0
bound 0
by 0
a 0
TNF B-gene
alpha I-gene
- 0
induced 0
nuclear 0
protein 0
and 0
appears 0
to 0
be 0
the 0
key 0
element 0
in 0
rapid 0
transcription 0
induction 0
by 0
TNF B-gene
alpha I-gene
( 0
and 0
TPA 0
) 0
, 0
while 0
transactivation 0
of 0
this 0
element 0
is 0
repressed 0
by 0
the 0
ligand 0
- 0
bound 0
glucocorticoid B-gene
receptor I-gene
. 0

Despite 0
the 0
fact 0
that 0
biochemical 0
estimates 0
of 0
bone 0
turnover 0
indicate 0
that 0
( 0
short 0
- 0
term 0
) 0
administration 0
of 0
rhGH B-gene
and 0
IGF B-gene
- I-gene
I I-gene
stimulates 0
bone 0
metabolism 0
in 0
non 0
- 0
osteoporotic 0
older 0
people 0
, 0
no 0
significant 0
changes 0
have 0
been 0
observed 0
in 0
bone 0
mineral 0
density 0
at 0
the 0
proximal 0
femur 0
. 0

Parental 0
and 0
vector 0
- 0
transfected 0
MCF7 0
cells 0
, 0
which 0
were 0
sensitive 0
to 0
the 0
growth 0
- 0
inhibitory 0
effects 0
of 0
atRA 0
, 0
exhibited 0
atRA 0
- 0
dependent 0
retinoic B-gene
acid I-gene
receptor I-gene
( 0
RAR B-gene
) 0
transactivation 0
and 0
transrepression 0
of 0
12 0
- 0
O 0
- 0
tetradecanoylphorbol 0
- 0
13 0
- 0
acetate 0
- 0
induced 0
AP B-gene
- I-gene
1 I-gene
activity 0
. 0

Chemiluminescence 0
induced 0
by 0
opsonized 0
zymosan 0
increased 0
significantly 0
( 0
P 0
less 0
than 0
0.05 0
) 0
after 0
treatment 0
with 0
bacterial 0
extracts 0
, 0
whereas 0
no 0
significant 0
changes 0
were 0
observed 0
in 0
the 0
fMLP 0
- 0
stimulated 0
PMNs 0
. 0

Using 0
the 0
two 0
- 0
hybrid 0
screening 0
method 0
, 0
we 0
have 0
identified 0
an 0
additional 0
component 0
of 0
the 0
CCAAT B-gene
- I-gene
binding I-gene
factor I-gene
. 0

Our 0
studies 0
suggest 0
that 0
the 0
helicase B-gene
assembly 0
protein 0
is 0
responsible 0
for 0
loading 0
T4 B-gene
gene I-gene
41 I-gene
helicase I-gene
specifically 0
at 0
replication 0
forks 0
, 0
and 0
that 0
its 0
binding 0
sites 0
for 0
each 0
arm 0
must 0
hold 0
more 0
than 0
six 0
, 0
but 0
not 0
more 0
than 0
12 0
nucleotides 0
. 0

These 0
results 0
strongly 0
suggest 0
that 0
HSV 0
- 0
1 0
infection 0
inhibits 0
host 0
cell 0
splicing 0
through 0
the 0
action 0
of 0
ICP27 B-gene
. 0

Sci 0
. 0

In 0
our 0
initial 0
studies 0
, 0
we 0
treated 0
MCF 0
- 0
7 0
cells 0
with 0
paclitaxel 0
, 0
which 0
results 0
in 0
the 0
arrest 0
of 0
cells 0
in 0
G1 0
with 0
4n 0
DNA 0
content 0
( 0
pseudo 0
G1 0
) 0
. 0

A 0
GTP/GDP 0
exchange 0
assay 0
was 0
used 0
to 0
assess 0
the 0
potential 0
role 0
of 0
Ras B-gene
in 0
the 0
pathway 0
leading 0
to 0
ERK B-gene
phosphorylation 0
; 0
DADLE 0
failed 0
to 0
stimulate 0
GTP/GDP 0
exchange 0
in 0
comparison 0
to 0
PMA 0
. 0

The 0
primary 0
structures 0
of 0
the 0
human B-gene
KB I-gene
cell I-gene
( I-gene
FR I-gene
- I-gene
KB1 I-gene
) I-gene
folate I-gene
receptor I-gene
( 0
FR B-gene
) 0
and 0
of 0
a 0
human B-gene
placental I-gene
( I-gene
FR I-gene
- I-gene
P2 I-gene
) I-gene
FR I-gene
, 0
proteins 0
important 0
in 0
cellular 0
accumulation 0
of 0
folates 0
, 0
have 0
been 0
deduced 0
from 0
cDNA 0
sequences 0
. 0

Copyright 0
1999 0
Academic 0
Press 0
. 0

Possible 0
or 0
definite 0
neglect 0
or 0
abuse 0
before 0
36 0
months 0
of 0
age 0
was 0
correlated 0
with 0
low 0
DBH B-gene
activity 0
. 0

The 0
remaining 0
77 0
nucleotides 0
at 0
the 0
3 0
' 0
end 0
of 0
domain 0
II 0
and 0
all 0
of 0
domains 0
III 0
( 0
655 0
nucleotides 0
) 0
and 0
IV 0
( 0
770 0
nucleotides 0
) 0
are 0
not 0
present 0
in 0
DIssE B-gene
RNA I-gene
. 0

Changes 0
in 0
tension 0
were 0
monitored 0
isometrically 0
on 0
spiral 0
strips 0
of 0
freshly 0
obtained 0
bovine 0
basilar 0
arteries 0
. 0

The 0
preparative 0
regimen 0
consisted 0
of 0
fractionated 0
total 0
body 0
irradiation 0
( 0
TBI 0
) 0
and 0
cyclophosphamide 0
( 0
CY 0
) 0
. 0

The 0
dynamics 0
of 0
protozoa 0
were 0
studied 0
in 0
two 0
groups 0
of 0
rumen 0
- 0
fistulated 0
cattle 0
fed 0
on 0
a 0
basal 0
diet 0
of 0
molasses 0
ad 0
lib. 0
, 0
with 0
oaten 0
chaff 0
given 0
at 0
6 0
or 0
18 0
g/kg 0
live 0
weight 0
. 0

Consistent 0
with 0
the 0
large 0
pocket 0
of 0
Rb B-gene
binding 0
to 0
TAF B-gene
( I-gene
II I-gene
) I-gene
250 I-gene
, 0
the 0
large 0
pocket 0
domains 0
of 0
both 0
p107 B-gene
and 0
p130 B-gene
are 0
able 0
to 0
bind 0
to 0
TAF B-gene
( I-gene
II I-gene
) I-gene
250 I-gene
in 0
vivo 0
. 0

Patients 0
with 0
Eales 0
' 0
disease 0
, 0
chorioretinitis 0
, 0
central 0
serous 0
retinopathy 0
, 0
or 0
malignant 0
choroidal 0
melanoma 0
were 0
tested 0
for 0
HLA B-gene
antigen 0
deviation 0
. 0

Comparison 0
of 0
the 0
derived 0
amino 0
acid 0
sequence 0
with 0
that 0
of 0
the 0
HCMV B-gene
UL99 I-gene
gene I-gene
product I-gene
reveals 0
34.8 0
% 0
identity 0
in 0
an 0
overlap 0
of 0
66 0
amino 0
acids 0
. 0

White 0
female 0
cases 0
were 0
more 0
likely 0
to 0
have 0
worked 0
as 0
registered 0
nurses 0
than 0
were 0
the 0
controls 0
( 0
OR 0
= 0
1.9 0
, 0
95 0
% 0
CI 0
= 0
1.0 0
- 0
3.5 0
) 0
. 0

Fentanyl 0
citrate 0
( 0
0.1 0
mL 0
) 0
and 0
2H5 0
- 0
fentanyl 0
( 0
internal 0
standard 0
, 0
0.05 0
mL 0
, 0
100 0
mg/L 0
) 0
were 0
extracted 0
with 0
Toxi 0
- 0
A 0
tubes 0
( 0
Toxi 0
- 0
Lab 0
, 0
Irvine 0
, 0
CA 0
) 0
and 0
analyzed 0
by 0
gas 0
chromatography 0
- 0
mass 0
spectrometry 0
. 0

O5257 B-gene
shows 0
homology 0
with 0
the 0
SAS2 B-gene
protein I-gene
and 0
another 0
hypothetical 0
protein 0
from 0
yeast 0
. 0

Cotransfection 0
of 0
expression 0
plasmids 0
encoding 0
the 0
protein B-gene
kinase I-gene
A I-gene
inhibitor 0
, 0
or 0
an 0
inactive 0
protein B-gene
kinase I-gene
A I-gene
( 0
PKA B-gene
) 0
catalytic 0
beta 0
subunit 0
, 0
inhibited 0
both 0
forskolin 0
and 0
PACAP B-gene
activation 0
of 0
chromogranin B-gene
A I-gene
transcription 0
, 0
revealing 0
that 0
PACAP B-gene
- 0
induced 0
trans 0
- 0
activation 0
is 0
highly 0
dependent 0
on 0
PKA B-gene
. 0

Of 0
all 0
YASR 0
syndromes 0
, 0
the 0
highest 0
stability 0
was 0
for 0
the 0
Anxious/Depressed 0
scale 0
. 0

There 0
was 0
no 0
difference 0
in 0
serum B-gene
albumin I-gene
and 0
transferrin B-gene
levels 0
, 0
but 0
serum B-gene
prealbumin I-gene
levels 0
in 0
the 0
group 0
fed 0
early 0
were 0
more 0
desirable 0
than 0
those 0
of 0
the 0
control 0
group 0
( 0
from 0
15.8 0
+/ 0
- 0
2.5 0
mg/dl 0
to 0
28.9 0
+/ 0
- 0
3.8 0
mg/dl 0
vs 0
from 0
18.0 0
+/ 0
- 0
2.0 0
mg/dl 0
to 0
25.9 0
+/ 0
- 0
3.9 0
mg/dl 0
) 0
. 0

The 0
introduction 0
gives 0
also 0
the 0
history 0
of 0
Research 0
Programme 0
MZ 0
- 0
XVII 0
and 0
its 0
implementation 0
in 0
several 0
regions 0
of 0
Poland 0
. 0

The 0
uap100 B-gene
cis 0
- 0
acting 0
, 0
up 0
- 0
promoter 0
, 0
constitutive 0
mutation 0
is 0
a 0
duplication 0
that 0
comprises 0
two 0
GATA 0
sites 0
and 0
suppresses 0
weakly 0
the 0
AREA B-gene
zinc I-gene
finger I-gene
mutation I-gene
but 0
does 0
not 0
alleviate 0
the 0
need 0
for 0
functional 0
UAY B-gene
and 0
AREA B-gene
proteins I-gene
. 0

Significant 0
differences 0
were 0
observed 0
in 0
the 0
composition 0
of 0
nuclear 0
transcription 0
factors 0
bound 0
to 0
cis 0
- 0
elements 0
within 0
the 0
LDH/C B-gene
proximal I-gene
promoter I-gene
region I-gene
in 0
somatic 0
versus 0
germ 0
cells 0
. 0

We 0
conclude 0
that 0
although 0
the 0
G3 0
sequence 0
contains 0
two 0
protein 0
- 0
binding 0
motifs 0
, 0
the 0
organization 0
of 0
the 0
G3 0
enhancer 0
- 0
like 0
element 0
is 0
not 0
bipartite 0
. 0

With 0
BCPP 0
protocol 0
, 0
12 0
achieved 0
a 0
complete 0
response 0
, 0
11 0
evidenced 0
a 0
75 0
% 0
response 0
, 0
and 0
7 0
displayed 0
a 0
50 0
% 0
response 0
. 0

The 0
effects 0
of 0
tilmicosin 0
administration 0
in 0
the 0
feed 0
at 0
400 0
mg/kg 0
and 0
an 0
injection 0
therapy 0
of 0
clinically 0
diseased 0
pigs 0
with 0
long 0
- 0
acting 0
oxytetracycline 0
( 0
Terramycine 0
LA 0
) 0
at 0
20 0
mg/kg 0
bodyweight 0
were 0
compared 0
. 0

In 0
7 0
men 0
and 0
1 0
woman 0
who 0
died 0
suddenly 0
the 0
functionally 0
important 0
areas 0
of 0
myocardium 0
in 0
the 0
sino 0
- 0
auricular 0
area 0
and 0
the 0
subendocardial 0
layers 0
of 0
left 0
ventricle 0
were 0
obtained 0
by 0
necropsy 0
no 0
more 0
than 0
3 0
h 0
after 0
death 0
, 0
and 0
then 0
prepared 0
for 0
study 0
by 0
electron 0
microscopy 0
. 0

Importantly 0
, 0
a 0
single 0
base 0
change 0
in 0
the 0
fifth 0
position 0
of 0
the 0
c B-gene
- I-gene
fos I-gene
sequence I-gene
( 0
GGTCTnnnAGACC 0
to 0
GGTCA/GnnnAGACC 0
) 0
produced 0
an 0
element 0
that 0
bound 0
the 0
estrogen B-gene
receptor I-gene
and 0
conferred 0
estrogen 0
- 0
dependent 0
transcriptional 0
activation 0
of 0
a 0
reporter 0
gene 0
. 0

A 0
preterm 0
formula 0
with 0
a 0
traditional 0
corn 0
oil/MCT 0
blend 0
containing 0
38 0
% 0
MCTs 0
( 0
MCT 0
group 0
) 0
was 0
compared 0
to 0
a 0
new 0
fat 0
blend 0
, 0
designed 0
to 0
resemble 0
human 0
milk 0
more 0
, 0
containing 0
6 0
% 0
MCTs 0
( 0
LCT 0
group 0
) 0
. 0

The 0
existence 0
of 0
a 0
TFIIIB B-gene
assembly 0
pathway 0
leading 0
to 0
the 0
faithful 0
transcription 0
of 0
natural 0
eukaryotic 0
tRNA 0
genes 0
in 0
the 0
absence 0
of 0
TFIIIC B-gene
provides 0
novel 0
insights 0
into 0
the 0
functional 0
flexibility 0
of 0
the 0
eukaryotic 0
tRNA 0
gene 0
transcription 0
machinery 0
and 0
on 0
its 0
evolution 0
from 0
an 0
ancestral 0
RNA B-gene
polymerase I-gene
III I-gene
system 0
relying 0
on 0
upstream 0
, 0
TATA 0
- 0
centered 0
control 0
elements 0
. 0

Overexpression 0
of 0
N 0
- 0
terminal 0
mutations 0
disturbs 0
mitosis 0
and 0
produces 0
elongated 0
cells 0
, 0
Using 0
a 0
PCR 0
approach 0
, 0
we 0
isolated 0
a 0
putative 0
homologue 0
of 0
Prp4 B-gene
from 0
human 0
and 0
mouse 0
cells 0
. 0

Successive 0
5 0
' 0
deletions 0
of 0
the 0
[ 0
- 0
326 0
; 0
+20 0
] 0
type B-gene
II I-gene
sPLA2 I-gene
promoter I-gene
indicated 0
that 0
the 0
region 0
upstream 0
of 0
position 0
- 0
195 0
inhibits 0
the 0
transcription 0
activity 0
sixfold 0
in 0
HepG2 0
cells 0
but 0
not 0
in 0
HeLa 0
cells 0
. 0

Pyridostigmine 0
pretreatment 0
was 0
supplemented 0
by 0
therapy 0
with 0
two 0
doses 0
of 0
an 0
antidotal 0
combination 0
( 0
A 0
, 0
TM 0
, 0
B 0
) 0
consisting 0
of 0
0.05 0
mg/kg 0
atropine 0
, 0
2.24 0
mg/kg 0
TMB 0
- 0
4 0
, 0
and 0
0.4 0
mg/kg 0
benactyzine 0
which 0
assured 0
survival 0
in 0
five 0
of 0
six 0
animals 0
following 0
three 0
separate 0
exposures 0
to 0
10 0
LD50 0
soman 0
. 0

Electrophoretic 0
mobility 0
shift 0
assays 0
and 0
DNase B-gene
I I-gene
protection 0
analyses 0
revealed 0
that 0
FP B-gene
I I-gene
was 0
bound 0
by 0
the 0
transcription 0
factor 0
PU.1/Spi B-gene
PU.1/Spi I-gene
- I-gene
1 I-gene
. 0

Moreover 0
, 0
the 0
noncoordinate 0
effects 0
of 0
FSK B-gene
on 0
PMA 0
- 0
stimulated 0
MKK B-gene
and 0
MAPK B-gene
activities 0
indicates 0
the 0
presence 0
of 0
a 0
additional 0
distal 0
cAMP 0
- 0
dependent 0
inhibitory 0
mechanisms 0
. 0

Motilin B-gene
serum 0
levels 0
were 0
measured 0
for 0
one 0
hour 0
. 0

Parameters 0
of 0
sperm 0
quality 0
were 0
evaluated 0
before 0
and 0
after 0
freezing/thawing 0
. 0

Comment 0
on 0
`` 0
Critical 0
behavior 0
of 0
a 0
binary 0
mixture 0
of 0
protein 0
and 0
salt 0
water 0
'' 0

Site 0
- 0
directed 0
mutagenesis 0
was 0
conducted 0
to 0
investigate 0
the 0
functional 0
significance 0
of 0
this 0
element 0
and 0
the 0
3 0
' 0
minus 0
- 0
strand 0
terminal 0
sequence 0
`` 0
3' 0
- 0
OH 0
- 0
CCCUAU 0
, 0
'' 0
which 0
contains 0
the 0
minus 0
- 0
strand 0
3' 0
- 0
end 0
sequence 0
`` 0
3' 0
- 0
OH 0
- 0
CC 0
( 0
1 0
- 0
2 0
) 0
( 0
A/U 0
) 0
( 0
A/U 0
) 0
( 0
A/U 0
) 0
'' 0
found 0
in 0
all 0
carmovirus 0
RNAs 0
. 0

Characterization 0
of 0
a 0
nuclear B-gene
deformed I-gene
epidermal I-gene
autoregulatory I-gene
factor I-gene
- I-gene
1 I-gene
( 0
DEAF B-gene
- I-gene
1 I-gene
) 0
- 0
related 0
( 0
NUDR B-gene
) 0
transcriptional 0
regulator 0
protein 0
. 0

Cardiac 0
lesion 0
in 0
exotoxic 0
shock 0

Effect 0
of 0
family 0
visits 0
on 0
the 0
blood 0
pressure 0
and 0
heart 0
rate 0
of 0
patients 0
in 0
the 0
coronary 0
- 0
care 0
unit 0
. 0

Prospects 0
of 0
chemosterilant 0
and 0
genetic 0
control 0
of 0
rodents 0
. 0

Neurological 0
toxicity 0
occurred 0
in 0
8/219 0
patients 0
treated 0
with 0
fludarabine 0
( 0
FAMP 0
) 0
, 0
30 0
mg/m2 0
per 0
day 0
and 0
cytosine 0
arabinoside 0
( 0
Ara 0
- 0
C 0
) 0
, 0
0.5 0
g/m2 0
per 0
hour 0
for 0
2 0
- 0
6 0
hours 0
for 0
5 0
days 0
, 0
for 0
new 0
or 0
relapsed 0
acute 0
leukemia 0
or 0
myelodysplasia 0
. 0

Ondansetron 0
is 0
thus 0
an 0
effective 0
first 0
- 0
line 0
antiemetic 0
in 0
children 0
undergoing 0
chemotherapy 0
, 0
radiotherapy 0
and 0
surgery 0
. 0

Paclitaxel 0
caused 0
a 0
rapid 0
and 0
transient 0
increase 0
in 0
c B-gene
- I-gene
Jun I-gene
NH2 I-gene
- I-gene
terminal I-gene
kinase I-gene
( 0
JNK B-gene
) 0
activity 0
, 0
a 0
proposed 0
mediator 0
of 0
stress 0
activation 0
pathways 0
. 0

Aspirin 0
therapy 0
in 0
the 0
rheumatic 0
diseases 0
. 0

High 0
- 0
level 0
expression 0
of 0
sccypB B-gene
as 0
well 0
as 0
of 0
sccypA B-gene
cloned 0
into 0
the 0
expression 0
vector 0
pIJ702 0
did 0
not 0
produce 0
detectable 0
changes 0
in 0
growth 0
and 0
morphology 0
of 0
S. 0
chrysomallus 0
and 0
S. 0
lividans 0
. 0

Reasons 0
are 0
presented 0
to 0
support 0
the 0
contention 0
that 0
this 0
increase 0
is 0
in 0
part 0
real 0
. 0

Expression 0
of 0
the 0
Hox B-gene
genes I-gene
egl B-gene
- I-gene
5 I-gene
and 0
mab B-gene
- I-gene
5 I-gene
is 0
reduced 0
in 0
lin B-gene
- I-gene
49 I-gene
and 0
lin B-gene
- I-gene
59 I-gene
mutants I-gene
, 0
suggesting 0
lin B-gene
- I-gene
49 I-gene
and 0
lin B-gene
- I-gene
59 I-gene
regulate 0
HOM B-gene
- I-gene
C I-gene
gene I-gene
expression 0
in 0
C. 0
elegans 0
as 0
the 0
trx B-gene
- I-gene
G I-gene
genes I-gene
do 0
in 0
Drosophila 0
. 0
lin B-gene
- I-gene
49 I-gene
and 0
lin B-gene
- I-gene
59 I-gene
transgenes I-gene
are 0
expressed 0
widely 0
throughout 0
C. 0
elegans 0
animals 0
. 0

In 0
cotransfection 0
assays 0
, 0
a 0
small 0
fragment 0
of 0
Sin B-gene
retaining 0
the 0
Src B-gene
- 0
SH3 B-gene
- 0
binding 0
site 0
and 0
one 0
tyrosine 0
- 0
containing 0
motif 0
induced 0
c B-gene
- I-gene
Src I-gene
activation 0
as 0
measured 0
by 0
a 0
transcriptional 0
reporter 0
. 0

TFIIB B-gene
and 0
VDR B-gene
can 0
also 0
interact 0
directly 0
, 0
and 0
these 0
factors 0
synergize 0
to 0
mediate 0
transactivation 0
. 0

In 0
addition 0
, 0
269 0
mice 0
from 0
a 0
( 0
Mus 0
spretus 0
x 0
C57BL/6J 0
) 0
F1 0
x 0
C57BL/6J 0
interspecific 0
backcross 0
were 0
also 0
used 0
to 0
order 0
marker 0
loci 0
and 0
calculate 0
intergene 0
distances 0
for 0
this 0
region 0
. 0

Our 0
findings 0
suggest 0
that 0
AIF 0
may 0
be 0
a 0
morphologic 0
correlate 0
of 0
tumor 0
regression 0
following 0
preoperative 0
cytotoxic 0
chemotherapy 0
. 0

Hypocalcemia 0
is 0
usually 0
due 0
to 0
either 0
a 0
disturbance 0
in 0
the 0
parathyroid B-gene
hormone I-gene
- 0
adenylate B-gene
cyclase I-gene
system 0
or 0
a 0
disturbance 0
in 0
vitamin 0
D 0
metabolism 0
. 0

The 0
system 0
consists 0
of 0
a 0
TV 0
unit 0
compatible 0
to 0
IBM 0
PC/AT 0
and 0
software 0
. 0

Newly 0
hatched 0
F1 0
nymphs 0
of 0
Aiolopus 0
thalassinus 0
( 0
Fabr 0
. 0
) 0
were 0
fed 0
on 0
food 0
treated 0
with 0
various 0
concentrations 0
of 0
HgCl2 0
, 0
CdCl2 0
, 0
and 0
PbCl2 0
until 0
the 0
end 0
of 0
adult 0
life 0
. 0

Reduced 0
concentrations 0
of 0
antithrombin B-gene
III I-gene
, 0
plasminogen B-gene
, 0
( 0
free 0
) 0
protein B-gene
S I-gene
, 0
and 0
protein B-gene
C I-gene
were 0
found 0
in 0
some 0
patients 0
but 0
were 0
not 0
associated 0
with 0
either 0
thrombosis 0
or 0
lupus 0
anticoagulant 0
. 0

UICC 0
criteria 0
) 0
for 0
VM 0
and 0
35 0
% 0
for 0
VE 0
( 0
not 0
significant 0
) 0
. 0

Simvastatin 0
decreased 0
levels 0
of 0
total 0
cholesterol 0
by 0
20.8 0
% 0
, 0
LDL B-gene
cholesterol I-gene
by 0
29.7 0
% 0
, 0
triglycerides 0
by 0
13.6 0
% 0
, 0
apolipoprotein B-gene
B I-gene
by 0
22.4 0
% 0
, 0
alpha 0
- 0
tocopherol 0
by 0
16.2 0
% 0
, 0
beta 0
- 0
carotene 0
by 0
19.5 0
% 0
, 0
and 0
ubiquinol 0
- 0
10 0
by 0
22.0 0
% 0
( 0
P 0
< 0
.001 0
for 0
all 0
) 0
and 0
increased 0
levels 0
of 0
HDL B-gene
cholesterol I-gene
by 0
7.0 0
% 0
( 0
P 0
< 0
.001 0
) 0
and 0
serum B-gene
insulin I-gene
by 0
13.2 0
% 0
( 0
P 0
=.005 0
) 0
. 0

Ultrasonography 0
is 0
a 0
diagnostic 0
alternative 0
which 0
may 0
replace 0
arthrography 0
. 0

Northern 0
blot 0
analysis 0
with 0
GPR37 B-gene
probes 0
revealed 0
a 0
main 0
3.8 0
- 0
kb 0
mRNA 0
and 0
a 0
less 0
abundant 0
8 0
- 0
kb 0
mRNA 0
, 0
both 0
expressed 0
in 0
human 0
brain 0
tissues 0
, 0
particularly 0
in 0
corpus 0
callosum 0
, 0
medulla 0
, 0
putamen 0
, 0
and 0
caudate 0
nucleus 0
. 0

TNF B-gene
- I-gene
alpha I-gene
effect 0
was 0
eliminated 0
by 0
a 0
2 0
- 0
bp 0
substitution 0
mutation 0
in 0
the 0
NF B-gene
- I-gene
kappa I-gene
B1 I-gene
binding I-gene
half I-gene
site I-gene
of 0
the 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
cis I-gene
element I-gene
. 0

Three 0
RasV12 B-gene
mutants I-gene
( 0
S35 B-gene
, 0
G37 B-gene
, 0
and 0
C40 B-gene
) 0
which 0
differ 0
by 0
their 0
ability 0
to 0
bind 0
to 0
Ras B-gene
effectors I-gene
( 0
Raf B-gene
, 0
Ral B-gene
- I-gene
GEFs I-gene
, 0
and 0
the 0
p110 B-gene
subunit I-gene
of I-gene
PI I-gene
3 I-gene
- I-gene
kinase I-gene
, 0
respectively 0
) 0
were 0
able 0
to 0
induce 0
sustained 0
NR 0
cell 0
proliferation 0
, 0
although 0
none 0
of 0
these 0
mutants 0
was 0
reported 0
to 0
transform 0
NIH 0
3T3 0
cells 0
. 0

A 0
possible 0
correlation 0
between 0
mandibular 0
growth 0
retardation 0
and 0
palatal 0
clefting 0
is 0
discussed 0
. 0

Total 0
cross 0
sections 0
for 0
electron 0
scattering 0
by 0
CO2 0
molecules 0
in 0
the 0
energy 0
range 0
400 0
- 0
5000 0
eV 0
. 0

However 0
, 0
depending 0
upon 0
the 0
promoter 0
context 0
, 0
we 0
observed 0
cooperative 0
interactions 0
between 0
the 0
two 0
domains 0
to 0
confer 0
high 0
DNA 0
- 0
binding 0
affinity 0
and 0
specificity 0
. 0

RESEARCH 0
DESIGN 0
AND 0
METHODS 0
: 0
A 0
total 0
of 0
26 0
IDDM 0
patients 0
with 0
normoalbuminuria 0
were 0
randomized 0
into 0
two 0
groups 0
, 0
with 0
one 0
group 0
receiving 0
placebo 0
( 0
n 0
= 0
13 0
, 0
age 0
36 0
+/ 0
- 0
3 0
years 0
, 0
BMI 0
24.5 0
+/ 0
- 0
1.1 0
kg/m2 0
) 0
and 0
the 0
other 0
group 0
receiving 0
an 0
average 0
of 0
15 0
mg 0
lisinopril 0
daily 0
( 0
n 0
= 0
13 0
, 0
age 0
34 0
+/ 0
- 0
2 0
years 0
, 0
BMI 0
24.4 0
+/ 0
- 0
0.9 0
kg/m2 0
) 0
. 0

This 0
experience 0
would 0
recommend 0
consideration 0
of 0
home 0
nutritional 0
support 0
in 0
patients 0
with 0
systemic 0
scleroderma 0
when 0
the 0
disease 0
is 0
relatively 0
stable 0
and 0
no 0
major 0
organ 0
failure 0
is 0
present 0
. 0

Adult 0
- 0
onset 0
parkinsonism 0
has 0
appeared 0
in 0
several 0
previously 0
unaffected 0
members 0
in 0
families 0
with 0
DRD 0
suggesting 0
that 0
this 0
may 0
be 0
an 0
additional 0
phenotypical 0
expression 0
of 0
the 0
disease 0
. 0

Production 0
of 0
VT 0
was 0
also 0
examined 0
retrospectively 0
in 0
32 0
E. 0
coli 0
strains 0
of 0
serotype 0
O26 0
: 0
H11 0
isolated 0
from 0
children 0
with 0
diarrhoea 0
; 0
eight 0
( 0
25 0
% 0
) 0
of 0
them 0
produced 0
moderate 0
to 0
high 0
levels 0
of 0
verotoxin B-gene
1 I-gene
despite 0
several 0
years 0
storage 0
in 0
vitro 0
. 0

The 0
present 0
study 0
deals 0
with 0
the 0
screening 0
of 0
11 0
of 0
these 0
plants 0
against 0
the 0
opportunistic 0
pathogen 0
fungus 0
Candida 0
albicans 0
. 0

The 0
tam B-gene
A I-gene
gene I-gene
of I-gene
Aspergillus I-gene
nidulans I-gene
encodes 0
a 0
739 0
- 0
amino 0
acid 0
protein 0
with 0
similarity 0
to 0
Uga35p/Dal81p/DurLp B-gene
of 0
Saccharomyces 0
cerevisiae 0
. 0

The 0
5' 0
- 0
flanking 0
region 0
of 0
the 0
gene 0
, 0
approximately 0
1.1 0
kbp 0
long 0
, 0
had 0
no 0
known 0
regulatory 0
elements 0
for 0
transcription 0
such 0
as 0
TATA 0
, 0
GC 0
, 0
and 0
CCAAT 0
boxes 0
. 0

The 0
Molteno 0
implant 0
is 0
an 0
effective 0
procedure 0
in 0
the 0
treatment 0
of 0
complicated 0
and 0
refractory 0
cases 0
of 0
glaucoma 0
in 0
high 0
- 0
risk 0
eyes 0
. 0

Two 0
of 0
the 0
three 0
groups 0
were 0
submitted 0
to 0
two 0
different 0
levels 0
of 0
hypoxia 0
( 0
FiO2 0
= 0
0.05 0
, 0
group 0
F5 0
and 0
FiO2 0
= 0
0.1 0
, 0
group 0
F10 0
) 0
and 0
the 0
third 0
to 0
normoxia 0
( 0
FiO2 0
= 0
0.21 0
, 0
group 0
F21 0
) 0
in 0
a 0
thermoneutral 0
and 0
controlled 0
environment 0
. 0

Glutathione B-gene
reductase I-gene
( 0
GR B-gene
) 0
was 0
purified 0
from 0
the 0
cyanobacterium 0
Anabaena 0
PCC 0
7120 0
. 0

Genotype 0
- 0
phenotype 0
correlations 0
in 0
male 0
patients 0
with 0
a 0
partial 0
nullisomy 0
of 0
the 0
X 0
chromosome 0
have 0
suggested 0
that 0
at 0
least 0
one 0
locus 0
involved 0
in 0
MRX 0
is 0
on 0
Xp22.3 0
. 0

On 0
the 0
other 0
hand 0
, 0
NE 0
transport 0
and 0
antagonist 0
( 0
[ 0
125I 0
] 0
RTI 0
- 0
55 0
) 0
binding 0
assays 0
on 0
whole 0
LLC 0
- 0
NET 0
cells 0
treated 0
with 0
tunicamycin 0
reveal 0
a 0
pronounced 0
reduction 0
in 0
NE 0
transport 0
activity 0
and 0
hNET B-gene
membrane 0
density 0
paralleled 0
by 0
an 0
inability 0
of 0
NET B-gene
proteins I-gene
to 0
replenish 0
the 0
higher 0
M 0
( 0
r 0
) 0
hNET B-gene
pool 0
. 0

We 0
have 0
now 0
completed 0
the 0
primary 0
structure 0
of 0
fibrillin B-gene
, 0
elucidated 0
the 0
exon/intron 0
organization 0
of 0
the 0
gene 0
and 0
derived 0
a 0
physical 0
map 0
of 0
the 0
genetic 0
locus 0
. 0

The 0
deduced 0
amino 0
acid 0
sequence 0
of 0
PutR B-gene
( 0
154 0
amino 0
acid 0
residues 0
) 0
showed 0
homology 0
to 0
the 0
small 0
regulatory 0
proteins 0
Lrp B-gene
, 0
BkdR B-gene
, 0
and 0
AsnC B-gene
. 0

NF B-gene
- I-gene
kappaB I-gene
only 0
partially 0
mediates 0
Epstein B-gene
- I-gene
Barr I-gene
virus I-gene
latent I-gene
membrane I-gene
protein I-gene
1 I-gene
activation 0
of 0
B 0
cells 0
. 0

In 0
contrast 0
, 0
stem 0
- 0
loop 0
structures 0
2 0
, 0
3 0
, 0
and 0
4 0
of 0
the 0
3 0
' 0
domain 0
showed 0
great 0
variations 0
in 0
size 0
, 0
sequence 0
, 0
and 0
structure 0
. 0

Whereas 0
Sprague 0
- 0
Dawleys 0
displayed 0
lights 0
- 0
off 0
and 0
lights 0
- 0
on 0
peaks 0
of 0
ingestive 0
activity 0
, 0
only 0
a 0
minority 0
of 0
Fisher 0
- 0
344s 0
displayed 0
a 0
consistent 0
lights 0
- 0
on 0
peak 0
of 0
ingestive 0
activity 0
. 0

The 0
mammalian 0
UPR 0
is 0
mediated 0
by 0
the 0
cis 0
- 0
acting 0
ER 0
stress 0
response 0
element 0
consisting 0
of 0
19 0
nt 0
( 0
CCAATN 0
( 0
9 0
) 0
CCACG 0
) 0
, 0
the 0
CCACG 0
part 0
of 0
which 0
is 0
considered 0
to 0
provide 0
specificity 0
. 0

Effects 0
of 0
dietary 0
lipids 0
on 0
whole 0
- 0
body 0
retention 0
and 0
organ 0
distribution 0
of 0
organic 0
and 0
inorganic 0
mercury 0
in 0
mice 0
. 0

This 0
region 0
shows 0
46 0
% 0
identity 0
with 0
the 0
calmodulin B-gene
- I-gene
binding I-gene
region I-gene
of 0
rat B-gene
brain I-gene
Ca2+/calmodulin I-gene
- I-gene
dependent I-gene
protein I-gene
kinase I-gene
II I-gene
and 0
32 0
% 0
identity 0
with 0
the 0
equivalent 0
region 0
of 0
chicken B-gene
smooth I-gene
muscle I-gene
myosin I-gene
light I-gene
chain I-gene
kinase I-gene
. 0

1H 0
and 0
15N 0
magnetic 0
resonance 0
assignments 0
, 0
secondary 0
structure 0
, 0
and 0
tertiary 0
fold 0
of 0
Escherichia B-gene
coli I-gene
DnaJ I-gene
( I-gene
1 I-gene
- I-gene
78 I-gene
) I-gene
. 0

The 0
effects 0
of 0
inoculum 0
size 0
, 0
medium 0
, 0
temperature 0
, 0
and 0
duration 0
of 0
growth 0
on 0
the 0
in 0
vitro 0
susceptibility 0
testing 0
of 0
Aspergillus 0
fumigatus 0
were 0
investigated 0
using 0
broth 0
micro 0
- 0
and 0
macro 0
- 0
dilution 0
techniques 0
. 0

Copyright 0
1998 0
Academic 0
Press 0
. 0

This 0
dynamic 0
nature 0
may 0
be 0
relevant 0
to 0
the 0
ability 0
of 0
E47 B-gene
both 0
to 0
homodimerize 0
and 0
to 0
heterodimerize 0
with 0
MyoD B-gene
, 0
Id B-gene
, 0
and 0
Tal1 B-gene
. 0

We 0
identified 0
clones 0
of 0
Chlamydomonas 0
genomic 0
DNA 0
that 0
rescued 0
the 0
Ca 0
( 0
2+ 0
) 0
- 0
dependent 0
axonemal 0
microtubule 0
severing 0
defect 0
of 0
fa1 B-gene
mutants I-gene
. 0

STUDY 0
SELECTION 0
: 0
Not 0
applicable 0
. 0

Sequence 0
and 0
deletion 0
analysis 0
of 0
the 0
recombination B-gene
enhancement I-gene
gene I-gene
( 0
ref B-gene
) 0
of 0
bacteriophage 0
P1 0
: 0
evidence 0
for 0
promoter 0
- 0
operator 0
and 0
attenuator 0
- 0
antiterminator 0
control 0
. 0

Viral B-gene
protein I-gene
U I-gene
( 0
Vpu B-gene
) 0
is 0
a 0
protein 0
encoded 0
by 0
human 0
immunodeficiency 0
virus 0
type 0
1 0
( 0
HIV 0
- 0
1 0
) 0
that 0
promotes 0
the 0
degradation 0
of 0
the 0
virus 0
receptor 0
, 0
CD4 B-gene
, 0
and 0
enhances 0
the 0
release 0
of 0
virus 0
particles 0
from 0
cells 0
. 0

There 0
also 0
may 0
be 0
osmotic 0
challenges 0
to 0
mucosal 0
cell 0
function 0
as 0
evidenced 0
by 0
the 0
different 0
reaction 0
rates 0
with 0
hyper 0
- 0
and 0
hypotonic 0
saline 0
. 0

The 0
overall 0
objective 0
response 0
rate 0
( 0
RR 0
) 0
was 0
50 0
% 0
[ 0
95 0
% 0
confidence 0
interval 0
( 0
CI 0
) 0
= 0
29 0
- 0
71 0
% 0
] 0
including 0
four 0
complete 0
responses 0
and 0
eight 0
partial 0
responses 0
. 0

In 0
spite 0
of 0
the 0
variability 0
of 0
DD95 0
with 0
regard 0
to 0
body 0
weight 0
, 0
the 0
recovery 0
of 0
neuromuscular 0
transmission 0
in 0
the 0
patients 0
of 0
the 0
three 0
groups 0
is 0
comparable 0
. 0

SH3A B-gene
competes 0
with 0
the 0
SH3 B-gene
domains I-gene
of 0
Grb2 B-gene
in 0
binding 0
to 0
mSos1 B-gene
, 0
and 0
the 0
intersectin B-gene
- 0
mSos1 B-gene
complex 0
can 0
be 0
separated 0
from 0
Grb2 B-gene
by 0
sucrose 0
gradient 0
centrifugation 0
. 0

Both 0
oligonucleotide 0
cross 0
- 0
competition 0
and 0
antibody 0
supershift 0
experiments 0
established 0
that 0
the 0
double 0
- 0
strand 0
binding 0
protein 0
is 0
equivalent 0
to 0
Sp1 B-gene
. 0

The 0
major 0
transcription 0
start 0
site 0
, 0
designated 0
as 0
+1 0
, 0
was 0
determined 0
by 0
RACE 0
( 0
rapid 0
amplification 0
of 0
cDNA 0
ends 0
) 0
analysis 0
of 0
human 0
liver 0
cDNA 0
and 0
was 0
found 0
to 0
be 0
located 0
50 0
bp 0
upstream 0
from 0
the 0
translation 0
start 0
site 0
. 0

Kerstin 0
takes 0
the 0
abbreviated 0
medical 0
education 0
. 0

Epithelial 0
cells 0
had 0
abnormal 0
and 0
accelerated 0
exfoliation 0
which 0
resulted 0
in 0
multifocal 0
epithelial 0
defects 0
. 0

Influenza 0
virus 0
- 0
induced 0
NF B-gene
- I-gene
kappaB I-gene
- I-gene
dependent I-gene
gene I-gene
expression 0
is 0
mediated 0
by 0
overexpression 0
of 0
viral 0
proteins 0
and 0
involves 0
oxidative 0
radicals 0
and 0
activation 0
of 0
IkappaB B-gene
kinase I-gene
. 0

The 0
Xenopus B-gene
annexin I-gene
II I-gene
heavy I-gene
chain I-gene
lacks 0
the 0
highly 0
conserved 0
tyrosine 0
at 0
position 0
23 0
which 0
is 0
the 0
site 0
of 0
src B-gene
oncogene I-gene
tyrosine B-gene
kinase I-gene
phosphorylation 0
in 0
the 0
murine 0
protein 0
. 0

This 0
demonstrates 0
a 0
relative 0
independence 0
of 0
the 0
given 0
synchronizer 0
of 0
rhythmicity 0
at 0
a 0
tissue 0
level 0
from 0
any 0
influence 0
of 0
the 0
higher 0
regulatory 0
center 0
. 0

Two 0
of 0
the 0
proteins 0
UPRF B-gene
- I-gene
1 I-gene
and 0
UPRF B-gene
- I-gene
2 I-gene
( 0
which 0
is 0
apparently 0
a 0
proteolytic 0
degradation 0
product 0
of 0
UPRF B-gene
- I-gene
1 I-gene
) 0
bind 0
inefficiently 0
to 0
mutant 0
versions 0
of 0
the 0
UPR 0
that 0
are 0
unable 0
to 0
confer 0
responsiveness 0
to 0
unfolded 0
proteins 0
to 0
the 0
( 0
CYC1 B-gene
) 0
promoter 0
. 0

Since 0
nearly 0
all 0
transformants 0
involving 0
homeologous 0
DNAs 0
carried 0
a 0
single 0
recombinant 0
plasmid 0
in 0
both 0
Pms+ B-gene
and 0
Pms B-gene
- I-gene
strains 0
, 0
stable 0
heteroduplex 0
DNA 0
appears 0
less 0
likely 0
than 0
for 0
homologous 0
DNAs 0
. 0

Western 0
and 0
immunocytochemical 0
analysis 0
implied 0
that 0
PREB B-gene
accumulates 0
specifically 0
in 0
GH3 0
cell 0
nuclei 0
. 0

Coronary 0
arteries 0
were 0
found 0
in 0
the 0
biopsy 0
tissue 0
of 0
30 0
( 0
76 0
% 0
) 0
of 0
the 0
39 0
patients 0
who 0
formed 0
the 0
study 0
group 0
. 0

Cotransfection 0
of 0
a 0
junB B-gene
stimulated 0
the 0
basal 0
activity 0
of 0
the 0
alpha B-gene
2 I-gene
( I-gene
I I-gene
) I-gene
collagen I-gene
promoter I-gene
93 0
- 0
fold 0
, 0
respectively 0
. 0

The 0
extraordinary 0
high 0
substrate 0
specificity 0
of 0
rPulA B-gene
together 0
with 0
its 0
thermal 0
stability 0
makes 0
this 0
enzyme 0
a 0
good 0
candidate 0
for 0
biotechnological 0
applications 0
in 0
the 0
starch 0
- 0
processing 0
industry 0
. 0

An 0
atypical 0
form 0
of 0
juvenile 0
myasthenia 0
gravis 0
associated 0
with 0
severe 0
emaciation 0
, 0
muscle 0
atrophy 0
, 0
ophthalmoplegia 0
, 0
bulbar 0
signs 0
and 0
joint 0
contracture 0

Anesthesia 0
was 0
induced 0
by 0
droperidol 0
0.2 0
mg.kg 0
- 0
1 0
, 0
fentanyl 0
50 0
micrograms 0
, 0
thiamylal 0
150 0
- 0
250 0
mg 0
, 0
and 0
succinylcholine 0
1 0
mg.kg 0
- 0
1 0
, 0
and 0
maintained 0
with 0
nitrous 0
oxide 0
and 0
O2 0
( 0
67:33 0
) 0
supplemented 0
with 0
repeated 0
i.v 0
. 0
doses 0
of 0
fentanyl 0
( 0
within 0
15 0
micrograms.kg 0
- 0
1 0
) 0
. 0

In 0
this 0
system 0
, 0
enhancers 0
act 0
primarily 0
to 0
increase 0
the 0
probability 0
of 0
rapid 0
and 0
efficient 0
transcription 0
complex 0
formation 0
and 0
initiation 0
. 0

( 0
i 0
) 0
p60 B-gene
bound 0
fast 0
- 0
migrating 0
, 0
underprocessed 0
wild B-gene
- I-gene
type I-gene
ICP22 I-gene
and 0
ICP22 B-gene
lacking 0
the 0
carboxyl 0
- 0
terminal 0
24 0
amino 0
acids 0
but 0
not 0
ICP22 B-gene
lacking 0
the 0
carboxyl 0
- 0
terminal 0
40 0
amino 0
acids 0
, 0
whereas 0
the 0
previously 0
identified 0
cellular B-gene
protein I-gene
p78 I-gene
( 0
R 0
. 0

Hetero 0
- 0
oligomerization 0
of 0
Smad4 B-gene
with 0
the 0
pathway 0
- 0
restricted 0
SMAD B-gene
proteins I-gene
is 0
essential 0
for 0
Smad4 B-gene
- 0
mediated 0
transcription 0
. 0

This 0
group 0
showed 0
the 0
presence 0
of 0
bacteria 0
infiltrated 0
at 0
the 0
dentinal 0
tubules 0
coronally 0
and 0
into 0
the 0
root 0
canals 0
. 0

Hydroxyl 0
radical 0
footprinting 0
of 0
DNA 0
complexes 0
of 0
the 0
ets B-gene
domain I-gene
of 0
PU.1 B-gene
and 0
its 0
comparison 0
to 0
the 0
crystal 0
structure 0
. 0

Autophosphorylation 0
on 0
the 0
major 0
phosphorylation 0
site 0
Y1235 0
upregulates 0
the 0
kinase 0
activity 0
of 0
the 0
receptor 0
, 0
increasing 0
the 0
Vmax 0
of 0
the 0
phosphotransfer 0
reaction 0
. 0

The 0
generation 0
of 0
dorso 0
- 0
ventral 0
polarity 0
during 0
Drosophila 0
embryogenesis 0
is 0
regulated 0
by 0
the 0
action 0
of 0
12 0
maternally 0
expressed 0
gene 0
products 0
, 0
the 0
dorsal B-gene
group I-gene
. 0

Immunoblot 0
analysis 0
of 0
purified 0
and 0
protease 0
- 0
digested 0
intracellular 0
mature 0
virus 0
( 0
IMV 0
) 0
and 0
extracellular 0
enveloped 0
virus 0
( 0
EEV 0
) 0
showed 0
that 0
the 0
A36R B-gene
proteins I-gene
were 0
present 0
on 0
the 0
surface 0
of 0
EEV 0
with 0
type 0
II 0
membrane 0
topology 0
, 0
but 0
were 0
absent 0
from 0
IMV 0
. 0

To 0
prevent 0
section 0
wrinkles 0
usually 0
encountered 0
with 0
the 0
use 0
of 0
coated 0
single 0
- 0
hole 0
grids 0
, 0
a 0
simple 0
method 0
was 0
developed 0
. 0

An 0
alternative 0
approach 0
to 0
random 0
integration 0
of 0
large 0
DNA 0
fragments 0
into 0
plants 0
is 0
to 0
utilize 0
one 0
of 0
several 0
site 0
- 0
specific 0
recombination 0
( 0
SSR 0
) 0
systems 0
, 0
such 0
as 0
Cre/ B-gene
lox B-gene
. 0

Both 0
v B-gene
- I-gene
Myb I-gene
and 0
c B-gene
- I-gene
Myb I-gene
bind 0
specifically 0
to 0
delta B-gene
E3 I-gene
. 0

After 0
at 0
least 0
one 0
year 0
follow 0
- 0
up 0
, 0
argon 0
laser 0
showed 0
a 0
statistically 0
significant 0
effect 0
( 0
p 0
less 0
of 0
0,01 0
; 0
Kolmogorow 0
- 0
Smirnov 0
test 0
) 0
on 0
the 0
stabilization 0
or 0
the 0
amelioration 0
of 0
visual 0
acuity 0
compared 0
with 0
the 0
non 0
treated 0
group 0
. 0

As 0
part 0
of 0
a 0
large 0
Dutch 0
prospective 0
multicenter 0
study 0
( 0
Netherlands 0
Cooperative 0
Study 0
on 0
the 0
Adequacy 0
of 0
Dialysis 0
- 0
2 0
) 0
, 0
we 0
consecutively 0
included 0
all 0
new 0
patients 0
with 0
end 0
- 0
stage 0
renal 0
disease 0
for 0
whom 0
residual 0
renal 0
function 0
could 0
be 0
obtained 0
0 0
to 0
4 0
weeks 0
before 0
the 0
start 0
of 0
dialysis 0
therapy 0
. 0

Relationship 0
between 0
age 0
- 0
associated 0
endocrine 0
deficiencies 0
and 0
muscle 0
function 0
in 0
elderly 0
women 0
: 0
a 0
cross 0
- 0
sectional 0
study 0
. 0

Intensity 0
variations 0
from 0
the 0
variable 0
TR 0
were 0
removed 0
, 0
and 0
the 0
data 0
were 0
evaluated 0
for 0
correlation 0
with 0
the 0
lateralized 0
stimulus 0
. 0

Improvement 0
of 0
some 0
pharmaceutical 0
properties 0
of 0
clofibrate 0
by 0
cyclodextrin 0
complexation 0
. 0

We 0
assessed 0
cardiovascular 0
variables 0
and 0
blood 0
O2 0
contents 0
in 0
order 0
to 0
characterize 0
O2 0
transport 0
in 0
ponies 0
during 0
treadmill 0
exercise 0
. 0

Somatic 0
and 0
visceral 0
inputs 0
to 0
the 0
thoracic 0
spinal 0
cord 0
of 0
the 0
cat 0
: 0
effects 0
of 0
noxious 0
stimulation 0
of 0
the 0
biliary 0
system 0
. 0

Some 0
of 0
these 0
DNA 0
: 0
protein 0
complexes 0
were 0
also 0
present 0
, 0
but 0
at 0
lower 0
levels 0
, 0
in 0
nuclear 0
extracts 0
from 0
untransformed 0
rat 0
cells 0
suggesting 0
the 0
possible 0
involvement 0
of 0
cellular 0
factors 0
in 0
the 0
mechanism 0
of 0
down 0
- 0
regulation 0
mediated 0
by 0
Ad12 B-gene
E1A I-gene
. 0

We 0
suggest 0
that 0
the 0
induction 0
of 0
IFNA B-gene
promoter I-gene
region I-gene
requires 0
cooperation 0
between 0
alpha B-gene
F1 I-gene
binding I-gene
proteins I-gene
and 0
IRF B-gene
- I-gene
1 I-gene
. 0

Two 0
pharmacokinetic 0
models 0
were 0
compared 0
. 0

Morphine 0
administration 0
acutely 0
reduced 0
plasma 0
clearance 0
of 0
sulfobromophthalein 0
( 0
BSP 0
) 0
in 0
mice 0
and 0
increased 0
hepatic 0
retention 0
of 0
this 0
dye 0
. 0

A 0
Buddhist 0
view 0
of 0
abortion 0
. 0

Cryoglobulinaemia 0
among 0
maintenance 0
haemodialysis 0
patients 0
and 0
its 0
relation 0
to 0
hepatitis 0
C 0
infection 0
. 0

In 0
HepG2 0
cells 0
, 0
SREBP B-gene
- I-gene
1c I-gene
mRNA I-gene
and 0
precursor 0
protein 0
levels 0
were 0
induced 0
by 0
treatment 0
with 0
22 0
( 0
R 0
) 0
- 0
hydroxycholesterol 0
and 0
9 0
- 0
cis 0
- 0
retinoic 0
acid 0
, 0
confirming 0
that 0
endogenous 0
LXR B-gene
- 0
RXR B-gene
activation 0
can 0
induce 0
endogenous B-gene
SREBP I-gene
- I-gene
1c I-gene
expression 0
. 0

The 0
T 0
( 0
CCO2 0
) 0
was 0
related 0
to 0
the 0
PCO2 0
by 0
a 0
Pearson 0
product 0
coefficient 0
of 0
0.79 0
( 0
p 0
< 0
.0005 0
) 0
, 0
with 0
a 0
mean 0
difference 0
of 0
1.94 0
( 0
T 0
( 0
CCO2 0
) 0
> 0
P 0
( 0
CO2 0
) 0
and 0
95 0
% 0
confidence 0
interval 0
of 0
- 0
0.12 0
to 0
4.07 0
. 0

Comparison 0
of 0
the 0
footprint 0
patterns 0
of 0
the 0
mouse B-gene
and I-gene
human I-gene
HPRT I-gene
genes I-gene
demonstrated 0
that 0
the 0
in 0
vivo 0
binding 0
of 0
regulatory 0
proteins 0
between 0
these 0
species 0
is 0
generally 0
conserved 0
but 0
not 0
identical 0
. 0

In 0
this 0
study 0
, 0
we 0
sought 0
to 0
determine 0
the 0
specific 0
effect 0
of 0
HIV B-gene
protease I-gene
inhibitors 0
on 0
patient 0
weight 0
. 0

The 0
cats 0
with 0
stage 0
- 0
2 0
lymphomas 0
that 0
were 0
FeLV 0
- 0
test 0
negative 0
had 0
the 0
best 0
response 0
to 0
treatment 0
. 0

E1 B-gene
recognition 0
sequences 0
in 0
the 0
bovine 0
papillomavirus 0
type 0
1 0
origin 0
of 0
DNA 0
replication 0
: 0
interaction 0
between 0
half 0
sites 0
of 0
the 0
inverted 0
repeats 0
. 0

Phase 0
I 0
study 0
of 0
5 0
- 0
fluorouracil 0
and 0
leucovorin 0
by 0
a 0
14 0
- 0
day 0
circadian 0
infusion 0
in 0
metastatic 0
adenocarcinoma 0
patients 0
. 0

Although 0
polyubiquitin B-gene
chains I-gene
linked 0
through 0
Lys 0
( 0
29 0
) 0
of 0
ubiquitin B-gene
have 0
been 0
implicated 0
in 0
the 0
targeting 0
of 0
certain 0
substrates 0
to 0
proteasomes 0
, 0
the 0
signaling 0
properties 0
of 0
these 0
chains 0
are 0
poorly 0
understood 0
. 0

B B-gene
and 0
C1 B-gene
fusions I-gene
with 0
yeast B-gene
GAL4 I-gene
DNA I-gene
- I-gene
binding I-gene
and I-gene
transcriptional I-gene
activation I-gene
domains I-gene
were 0
also 0
found 0
to 0
interact 0
when 0
synthesized 0
and 0
assayed 0
in 0
yeast 0
. 0

Deletion 0
analysis 0
of 0
the 0
7.3 B-gene
- I-gene
kb I-gene
GATA I-gene
- I-gene
2 I-gene
promoter I-gene
region I-gene
revealed 0
that 0
a 0
1.1 0
- 0
kb 0
DNA 0
sequence 0
is 0
critical 0
for 0
expression 0
of 0
GATA B-gene
- I-gene
2 I-gene
in 0
neurons 0
. 0

In 0
this 0
study 0
, 0
we 0
verified 0
that 0
PI B-gene
3 I-gene
- I-gene
kinase I-gene
associates 0
with 0
the 0
CD4 B-gene
: 0
p56lck B-gene
complex I-gene
as 0
judged 0
by 0
the 0
presence 0
of 0
PI 0
3 0
- 0
phosphate 0
generated 0
from 0
anti B-gene
- I-gene
CD4 I-gene
immunoprecipitates 0
and 0
detected 0
by 0
high 0
- 0
pressure 0
liquid 0
chromatographic 0
analysis 0
. 0

Reality 0
and 0
clinical 0
application 0
of 0
immunoglobulin B-gene
preparations 0

This 0
evidence 0
, 0
together 0
with 0
the 0
ability 0
of 0
a 0
carboxyl 0
- 0
terminal 0
coding 0
sequence 0
starting 0
from 0
the 0
BamHI B-gene
site I-gene
to 0
complement 0
a 0
shy1 B-gene
mutant I-gene
, 0
suggests 0
that 0
the 0
Shy1p B-gene
contains 0
two 0
domains 0
that 0
can 0
be 0
separately 0
expressed 0
to 0
form 0
a 0
functional 0
protein 0
. 0

We 0
have 0
previously 0
shown 0
that 0
UNC B-gene
- I-gene
4 I-gene
expression 0
in 0
the 0
VA 0
motor 0
neurons 0
specifies 0
the 0
wild 0
- 0
type 0
pattern 0
of 0
presynaptic 0
input 0
. 0

However 0
, 0
technical 0
advances 0
have 0
shown 0
the 0
limitations 0
of 0
these 0
tests 0
as 0
tests 0
for 0
IgM B-gene
can 0
be 0
positive 0
because 0
of 0
residual 0
specific 0
IgM B-gene
or 0
even 0
in 0
subjects 0
free 0
of 0
acute 0
infection 0
due 0
to 0
the 0
existence 0
of 0
natural 0
interfering 0
IgM B-gene
. 0

Transesophageal 0
echocardiography 0
risk 0
factors 0
for 0
stroke 0
in 0
nonvalvular 0
atrial 0
fibrillation 0
. 0

Therefore 0
, 0
in 0
VDR B-gene
- 0
mediated 0
transcriptional 0
activation 0
, 0
1,25 0
( 0
OH 0
) 0
2D3 0
binding 0
to 0
VDR B-gene
alters 0
the 0
conformation 0
of 0
the 0
ligand 0
binding 0
domain 0
such 0
that 0
it 0
: 0
( 0
i 0
) 0
engages 0
in 0
strong 0
heterodimerization 0
with 0
RXR B-gene
to 0
facilitate 0
VDRE 0
binding 0
, 0
( 0
ii 0
) 0
influences 0
the 0
RXR B-gene
ligand I-gene
binding I-gene
domain I-gene
such 0
that 0
it 0
is 0
resistant 0
to 0
the 0
binding 0
of 0
9 0
- 0
cis 0
RA 0
but 0
active 0
in 0
recruiting 0
coactivator 0
to 0
its 0
AF 0
- 0
2 0
and 0
( 0
iii 0
) 0
presents 0
the 0
AF 0
- 0
2 0
region 0
in 0
VDR B-gene
for 0
coactivator 0
association 0
. 0

Our 0
case 0
, 0
however 0
, 0
had 0
no 0
histologic 0
evidence 0
of 0
malignancy 0
, 0
no 0
serum B-gene
alpha I-gene
fetoprotein I-gene
at 0
7 0
months 0
of 0
age 0
, 0
and 0
no 0
recurrence 0
at 0
1 0
years 0
. 0

Second 0
, 0
overexpression 0
of 0
RIM11 B-gene
can 0
suppress 0
an 0
ime1 B-gene
missense 0
mutation 0
( 0
ime1 B-gene
- I-gene
L321F I-gene
) 0
but 0
not 0
an 0
ime1 B-gene
deletion 0
. 0

It 0
is 0
always 0
present 0
and 0
has 0
a 0
discrete 0
origin 0
and 0
insertion 0
. 0

We 0
evaluated 0
99mTc 0
- 0
ECD 0
SPECT 0
comparing 0
with 0
rCBF 0
images 0
obtained 0
by 0
PET 0
in 0
12 0
patients 0
with 0
spinocerebellar 0
degeneration 0
( 0
SCD 0
) 0
. 0

Nimodipine 0
( 0
5 0
micrograms/kg 0
) 0
followed 0
by 0
infusion 0
of 0
0.75 0
microgram/kg/min 0
lowered 0
the 0
blood 0
pressure 0
by 0
10 0
% 0
in 0
both 0
normotensive 0
and 0
hypertensive 0
rats 0
; 0
the 0
same 0
dose 0
schedule 0
of 0
nifedipine 0
did 0
not 0
lower 0
MAP 0
. 0

When 0
severe 0
hypoxia 0
was 0
acutely 0
produced 0
by 0
ventilation 0
with 0
low 0
- 0
oxygen 0
mixtures 0
in 0
experimental 0
( 0
PaO2 0
, 0
23.7 0
+/ 0
- 0
1.7 0
torr 0
) 0
and 0
control 0
animals 0
( 0
PaO2 0
, 0
26.3 0
+/ 0
- 0
1.0 0
torr 0
) 0
, 0
plasma B-gene
insulin I-gene
responses 0
were 0
markedly 0
inhibited 0
in 0
both 0
. 0

We 0
have 0
raised 0
antibodies 0
against 0
a 0
peptide 0
specific 0
to 0
the 0
predicted 0
protein 0
product 0
of 0
this 0
second 0
mRNA 0
. 0

Using 0
unidirectional 0
PCR 0
we 0
isolated 0
a 0
361 0
- 0
bp 0
5 0
' 0
promoter 0
region 0
and 0
delineated 0
the 0
intronic 0
/ 0
exonic 0
boundaries 0
which 0
include 0
a 0
non 0
- 0
coding 0
exon 0
1 0
, 0
a 0
single 0
intron 0
, 0
and 0
a 0
coding 0
exon 0
2 0
, 0
a 0
structure 0
that 0
is 0
typical 0
of 0
genes 0
of 0
the 0
RNase B-gene
A I-gene
superfamily I-gene
. 0

Results 0
of 0
these 0
studies 0
indicate 0
that 0
binding 0
of 0
biotin 0
to 0
the 0
protein 0
results 0
in 0
protection 0
of 0
regions 0
of 0
the 0
central 0
domain 0
in 0
the 0
vicinity 0
of 0
the 0
active 0
site 0
and 0
the 0
C 0
- 0
terminal 0
domain 0
from 0
chemical 0
cleavage 0
. 0

The 0
family 0
histories 0
were 0
obtained 0
from 0
the 0
parents 0
. 0

Absence 0
of 0
nitroso 0
formation 0
from 0
( 0
14C 0
) 0
methomyl 0
and 0
sodium 0
nitrite 0
under 0
simulated 0
stomach 0
conditions 0
. 0

The 0
structure 0
of 0
the 0
murine B-gene
Dtk I-gene
gene I-gene
has 0
been 0
determined 0
. 0

Outlook 0
in 0
oral 0
and 0
cutaneous 0
Kaposi 0
's 0
sarcoma 0
. 0

These 0
data 0
demonstrate 0
that 0
oleosin B-gene
gene I-gene
transcription 0
is 0
regulated 0
in 0
a 0
tissue 0
- 0
specific 0
and 0
temporally 0
regulated 0
manner 0
and 0
clearly 0
indicate 0
that 0
oleosin B-gene
protein I-gene
expression 0
is 0
co 0
- 0
ordinated 0
primarily 0
at 0
the 0
transcriptional 0
level 0
. 0

Allergic 0
field 0
: 0
how 0
to 0
detect 0
it 0
? 0

The 0
actual 0
placement 0
of 0
the 0
lesions 0
was 0
determined 0
after 0
mapping 0
of 0
the 0
GPi 0
by 0
microrecording 0
, 0
using 0
stimulation 0
to 0
identify 0
the 0
sensorimotor 0
region 0
and 0
its 0
somatotopic 0
organization 0
. 0

The 0
0.018 0
- 0
inch 0
FloWire 0
provides 0
a 0
high 0
- 0
fidelity 0
continuous 0
Doppler 0
signal 0
. 0

Other 0
recommendations 0
for 0
enhancing 0
the 0
safety 0
of 0
potent 0
antiplatelet 0
agents 0
in 0
a 0
variety 0
of 0
clinical 0
situations 0
are 0
provided 0
. 0

The 0
concepts 0
were 0
developed 0
by 0
Mines 0
and 0
Garrey 0
during 0
the 0
next 0
10 0
years 0
. 0

A 0
new 0
simple 0
identification 0
of 0
rheumatoid B-gene
factor I-gene
on 0
nitrocellulose 0
was 0
developed 0
that 0
allows 0
quantitative 0
detection 0
. 0

Maximum 0
overexpression 0
of 0
holoenzyme 0
activity 0
was 0
achieved 0
by 0
the 0
inclusion 0
in 0
such 0
plasmids 0
of 0
Salmonella 0
typhimurium 0
cysG 0
, 0
which 0
encodes 0
a 0
uroporphyrinogen B-gene
III I-gene
methyltransferase I-gene
required 0
for 0
the 0
synthesis 0
of 0
siroheme 0
, 0
a 0
cofactor 0
for 0
the 0
hemoprotein 0
. 0

Determination 0
of 0
the 0
LD 0
50 0
( 0
30 0
) 0
during 0
infant 0
period 0
and 0
growth 0
period 0

Mutational 0
analysis 0
of 0
yeast B-gene
CEG1 I-gene
demonstrated 0
that 0
four 0
of 0
the 0
five 0
conserved 0
motifs 0
are 0
essential 0
for 0
capping B-gene
enzyme I-gene
function 0
in 0
vivo 0
. 0

Purified 0
phosphorylated 0
PhoP B-gene
( 0
PhoPP B-gene
) 0
had 0
a 0
half 0
- 0
life 0
of 0
approximately 0
2.5 0
h 0
, 0
which 0
was 0
reduced 0
to 0
about 0
15 0
min 0
by 0
addition 0
of 0
the 0
same 0
molar 0
amount 0
of 0
*PhoR B-gene
( 0
the 0
cytoplasmic 0
region 0
of 0
PhoR B-gene
) 0
. 0

We 0
conclude 0
that 0
exercise 0
- 0
induced 0
ST 0
- 0
segment 0
elevation 0
in 0
patients 0
without 0
a 0
history 0
of 0
myocardial 0
infarction 0
or 0
left 0
ventricular 0
aneurysm 0
is 0
caused 0
by 0
coronary 0
spasm 0
of 0
a 0
major 0
coronary 0
vessel 0
. 0

It 0
spans 0
20 0
kilobases 0
, 0
consists 0
of 0
7 0
exons 0
and 0
6 0
introns 0
, 0
and 0
contains 0
a 0
TATA 0
motif 0
24 0
nucleotides 0
upstream 0
of 0
the 0
transcriptional 0
start 0
site 0
. 0

Metastatic 0
tumours 0
of 0
bone 0
in 0
Nigerians 0
. 0

A 0
survey 0
of 0
274 0
late 0
detected 0
cases 0
of 0
CDH 0
born 0
in 0
the 0
years 0
1970 0
- 0
- 0
74 0
is 0
presented 0
. 0

This 0
distinct 0
biochemical 0
difference 0
between 0
STAT5A B-gene
and 0
STAT5B B-gene
was 0
confirmed 0
with 0
purified 0
activated 0
STAT5 B-gene
recombinant I-gene
proteins I-gene
. 0

Enoxacin 0
has 0
been 0
shown 0
to 0
be 0
an 0
effective 0
well 0
tolerated 0
and 0
convenient 0
treatment 0
for 0
gonorrhoea 0
. 0

METHODS 0
: 0
Precision 0
and 0
accuracy 0
were 0
measured 0
using 0
controls 0
and 0
method 0
comparison 0
studies 0
. 0

Important 0
prognostic 0
factors 0
for 0
the 0
results 0
of 0
physiotherapeutic 0
exercises 0
in 0
intermittent 0
claudication 0

Thus 0
, 0
Tax1 B-gene
activates 0
CArG 0
- 0
mediated 0
transcription 0
without 0
mitogenic 0
signals 0
through 0
interaction 0
with 0
a 0
CArG B-gene
- I-gene
binding I-gene
factor I-gene
, 0
p67SRF B-gene
. 0

In 0
5 0
cases 0
, 0
combined 0
sensitization 0
to 0
mercury 0
and 0
other 0
metal 0
salts 0
, 0
particularly 0
gold 0
sodium 0
thiosulfate 0
( 0
GST 0
) 0
and 0
palladium 0
chloride 0
( 0
PDC 0
) 0
, 0
was 0
observed 0
. 0

Amongst 0
53 0
`` 0
inoperable 0
'' 0
( 0
T4 0
, 0
N0 0
, 0
N1 0
, 0
T. 0
, 0
N2 0
, 0
N3 0
) 0
cases 0
, 0
5 0
( 0
10 0
% 0
) 0
had 0
a 0
positive 0
scan 0
and 0
5 0
a 0
doubtful 0
scan 0
. 0

Acyclovir 0
( 0
3 0
% 0
ointment 0
) 0
used 0
topically 0
one 0
to 0
five 0
times 0
a 0
day 0
on 0
acute 0
ocular 0
HSV 0
infection 0
gave 0
beneficial 0
results 0
as 0
measured 0
by 0
a 0
reduction 0
in 0
corneal 0
involvement 0
, 0
conjunctivitis 0
, 0
iritis 0
, 0
and 0
corneal 0
clouding 0
. 0

The 0
efficiency 0
of 0
transfections 0
was 0
normalized 0
relative 0
to 0
the 0
net 0
amount 0
of 0
CAT B-gene
plasmid 0
actually 0
transfected 0
into 0
recipient 0
cells 0
, 0
determined 0
by 0
a 0
modified 0
Southern 0
hybridization 0
procedure 0
. 0

Initial 0
computer 0
based 0
similarity 0
searches 0
identified 0
human B-gene
retinoblastoma I-gene
binding I-gene
protein I-gene
1 I-gene
( 0
RBP B-gene
- I-gene
1 I-gene
) 0
, 0
Drosophila B-gene
melanogaster I-gene
male I-gene
specific I-gene
lethal I-gene
- I-gene
3 I-gene
( 0
Msl B-gene
- I-gene
3 I-gene
) 0
, 0
S. B-gene
pombe I-gene
altered I-gene
polarity I-gene
- I-gene
13 I-gene
( 0
Alp13 B-gene
) 0
and 0
S. B-gene
cerevisiae I-gene
Eaf3p I-gene
, 0
a 0
component 0
of 0
the 0
yeast B-gene
NuA4 I-gene
HAT B-gene
complex 0
( 0
Galarneau 0
et 0
al. 0
, 0
2000 0
. 0

These 0
aa 0
residues 0
correspond 0
to 0
codons 0
59 0
and 0
108 0
in 0
the 0
P. B-gene
falciparum I-gene
DHFR I-gene
active I-gene
site I-gene
in 0
which 0
similar 0
aa 0
substitutions 0
( 0
Cys 0
Arg 0
- 0
59 0
and 0
Ser 0
Asn 0
- 0
108 0
) 0
are 0
associated 0
with 0
pyrimethamine 0
resistance 0
. 0

Efficacy 0
was 0
evaluated 0
in 0
24 0
patients 0
, 0
of 0
whom 0
eight 0
received 0
RD 0
and 0
16 0
SD 0
. 0

Short 0
- 0
term 0
growth 0
: 0
rhythms 0
, 0
chaos 0
, 0
or 0
noise 0
? 0

Sequences 0
homologous 0
to 0
the 0
consensus 0
TUF B-gene
- I-gene
binding I-gene
UAS I-gene
boxes I-gene
are 0
present 0
in 0
the 0
5 0
' 0
flanking 0
regions 0
of 0
both 0
genes 0
. 0

Residues 0
crucial 0
for 0
Ras B-gene
interaction 0
with 0
GDP B-gene
- I-gene
GTP I-gene
exchangers I-gene
. 0

The 0
gene B-gene
atp6 I-gene
, 0
encoding 0
subunit 0
6 0
of 0
the 0
mitochondrial 0
F0 B-gene
- 0
ATPase B-gene
complex 0
, 0
has 0
been 0
characterized 0
from 0
both 0
the 0
normal 0
( 0
fertile 0
) 0
and 0
Ogura 0
( 0
male 0
- 0
sterile 0
) 0
radish 0
cytoplasms 0
in 0
order 0
to 0
determine 0
if 0
previously 0
identified 0
atp6 B-gene
transcriptional 0
differences 0
could 0
play 0
a 0
role 0
in 0
cytoplasmic 0
male 0
sterility 0
. 0

To 0
determine 0
whether 0
the 0
transcript 0
encodes 0
an 0
active 0
enzyme 0
, 0
we 0
developed 0
a 0
novel 0
transient 0
embryonic 0
excision 0
assay 0
in 0
which 0
zebrafish 0
fertilized 0
eggs 0
were 0
co 0
- 0
injected 0
with 0
RNA 0
transcribed 0
in 0
vitro 0
using 0
the 0
Tol2 B-gene
cDNA I-gene
as 0
a 0
template 0
and 0
a 0
plasmid 0
DNA 0
harboring 0
a 0
nonautonomous 0
Tol2 B-gene
element I-gene
, 0
which 0
has 0
a 0
deletion 0
in 0
the 0
transposase B-gene
coding I-gene
region I-gene
. 0

The 0
expression 0
of 0
CAPL B-gene
, 0
a 0
second 0
protein 0
involved 0
in 0
calcium 0
metabolism 0
, 0
was 0
only 0
moderately 0
elevated 0
in 0
the 0
doxorubicin 0
- 0
resistant 0
cells 0
. 0

The 0
reconstituted 0
enzyme 0
binds 0
DNA 0
with 0
an 0
affinity 0
that 0
is 0
approximately 0
20 0
- 0
fold 0
lower 0
than 0
that 0
of 0
the 0
intact 0
topo70 B-gene
. 0

In 0
late 0
October 0
, 0
1974 0
, 0
Staphylococcus 0
aureus 0
postoperative 0
wound 0
infection 0
was 0
recorded 0
in 0
a 0
nonhuman 0
primate 0
( 0
Macaca 0
mulatta 0
) 0
which 0
had 0
recently 0
undergone 0
surgical 0
operation 0
. 0

Thus 0
, 0
the 0
in 0
vivo 0
function 0
of 0
Gle2p B-gene
is 0
strictly 0
coupled 0
to 0
the 0
short 0
GLEBS B-gene
within 0
Nup116p B-gene
which 0
links 0
this 0
putative 0
mRNA 0
transport 0
factor 0
to 0
the 0
nuclear 0
pores 0
. 0

Seminal 0
prolactin B-gene
levels 0
were 0
significantly 0
elevated 0
in 0
all 0
infertile 0
males 0
. 0

The 0
recruitment 0
of 0
constitutively 0
phosphorylated 0
p185 B-gene
( 0
neu B-gene
) 0
and 0
the 0
activated 0
mitogenic 0
pathway 0
proteins 0
to 0
this 0
membrane 0
- 0
microfilament 0
interaction 0
site 0
provides 0
a 0
physical 0
model 0
for 0
integrating 0
the 0
assembly 0
of 0
the 0
mitogenic 0
pathway 0
with 0
the 0
transmission 0
of 0
growth 0
factor 0
signal 0
to 0
the 0
cytoskeleton 0
. 0

The 0
pattern 0
of 0
net B-gene
RNA I-gene
expression 0
in 0
adult 0
mouse 0
tissues 0
is 0
different 0
. 0

Effect 0
of 0
capsaicin 0
on 0
hexobarbital 0
- 0
anesthetized 0
rats 0

Expression 0
of 0
human B-gene
complement I-gene
receptor I-gene
type I-gene
2 I-gene
( 0
CR2/CD21 B-gene
) 0
is 0
primarily 0
restricted 0
to 0
mature 0
B 0
cells 0
and 0
follicular 0
dendritic 0
cells 0
. 0

A 0
physical 0
and 0
genetic 0
map 0
covering 0
the 0
entire 0
RP12 B-gene
candidate I-gene
gene I-gene
region I-gene
was 0
constructed 0
. 0

We 0
found 0
that 0
in 0
premature 0
infants 0
plasminogen B-gene
levels 0
are 0
low 0
; 0
thus 0
, 0
defense 0
against 0
intra 0
- 0
alveolar 0
fibrin B-gene
deposition 0
during 0
birth 0
trauma 0
is 0
reduced 0
. 0

Progestins 0
: 0
present 0
and 0
future 0
. 0

Indeed 0
, 0
DEX 0
also 0
enhanced 0
the 0
RA 0
- 0
dependent 0
increase 0
in 0
RARbeta B-gene
mRNA I-gene
in 0
a 0
cycloheximide 0
- 0
sensitive 0
manner 0
. 0

In 0
both 0
immortalized 0
and 0
normal 0
diploid 0
human 0
cells 0
, 0
wt 0
AAV 0
targeted 0
integration 0
to 0
ch 0
- 0
19 0
. 0

It 0
was 0
found 0
that 0
both 0
versions 0
of 0
the 0
brief 0
SL 0
& 0
amp 0
; 0
shy 0
; 0
ASIA 0
had 0
similar 0
correlations 0
to 0
the 0
target 0
variables 0
as 0
the 0
full 0
scale 0
SL 0
& 0
amp 0
; 0
shy 0
; 0
ASIA 0
. 0

These 0
operons 0
encode 0
subunits 0
of 0
photosystems B-gene
I I-gene
( 0
psa B-gene
) 0
and 0
II 0
( 0
psb B-gene
) 0
, 0
the 0
cytochrome B-gene
bGf I-gene
complex I-gene
( 0
pet B-gene
) 0
, 0
the 0
plastid 0
NAD B-gene
( I-gene
P I-gene
) I-gene
H I-gene
dehydrogenase I-gene
( 0
ndh B-gene
) 0
, 0
and 0
the 0
unidentified 0
open 0
reading 0
frame 0
ycf9 B-gene
. 0

In 0
contrast 0
, 0
dominant B-gene
negative I-gene
Rac I-gene
( 0
N17Rac1 B-gene
) 0
inhibited 0
JNK B-gene
activation 0
by 0
Galpha12 B-gene
in 0
HEK293 0
cells 0
as 0
well 0
as 0
three 0
other 0
cell 0
lines 0
. 0

A 0
major 0
feature 0
of 0
this 0
genomic 0
sequence 0
is 0
the 0
presence 0
of 0
a 0
first 0
intron 0
( 0
Il 0
) 0
, 0
215 0
bp 0
long 0
, 0
located 0
48 0
bp 0
downstream 0
of 0
the 0
translation 0
start 0
ATG 0
codon 0
. 0

We 0
reviewed 0
the 0
different 0
published 0
cases 0
of 0
acute 0
high 0
dose 0
methotrexate 0
neurotoxicity 0
and 0
the 0
different 0
underlying 0
mechanisms 0
. 0

The 0
expected 0
products 0
of 0
the 0
cloned 0
bph B-gene
genes I-gene
, 0
except 0
bphA3 B-gene
, 0
were 0
observed 0
in 0
E. 0
coli 0
in 0
an 0
in 0
vitro 0
transcription 0
- 0
translation 0
system 0
. 0

The 0
immunoreactive 0
antithrombin B-gene
III I-gene
increased 0
significantly 0
while 0
the 0
increase 0
in 0
antithrombin B-gene
III I-gene
activity 0
was 0
insignificant 0
in 0
20 0
male 0
Caucasian 0
Danes 0
upon 0
3 0
weeks 0
supplementation 0
of 0
the 0
diet 0
with 0
10 0
ml 0
daily 0
of 0
a 0
cod 0
liver 0
oil 0
concentrate 0
. 0

Only 0
the 0
27 0
- 0
kDa 0
protein 0
was 0
detected 0
after 0
N B-gene
- I-gene
glycosidase I-gene
treatment 0
, 0
indicating 0
that 0
PLP B-gene
- I-gene
H I-gene
is 0
a 0
glycoprotein 0
. 0

These 0
observed 0
changes 0
were 0
not 0
found 0
when 0
assessing 0
NPY B-gene
level 0
in 0
plasma 0
fluid 0
. 0

In 0
three 0
other 0
patients 0
the 0
electrophysiologic 0
characteristics 0
of 0
atrioventricular 0
conduction 0
prevented 0
a 0
demonstration 0
of 0
these 0
differences 0
. 0

These 0
sequence 0
differences 0
are 0
reflected 0
in 0
differences 0
in 0
gene 0
expression 0
in 0
three 0
cell 0
lines 0
. 0

The 0
10 0
eyes 0
injected 0
with 0
human 0
RPE 0
cells 0
showed 0
STAGE 0
2 0
or 0
less 0
in 0
4 0
weeks 0
. 0

The 0
cumulative 0
dose 0
to 0
nursing 0
staff 0
for 0
the 0
week 0
after 0
treatment 0
was 0
dependent 0
on 0
patient 0
mobility 0
and 0
was 0
estimated 0
at 0
0.08 0
mSv 0
for 0
a 0
self 0
- 0
caring 0
patient 0
to 0
6.3 0
mSv 0
for 0
a 0
totally 0
helpless 0
patient 0
( 0
1840 0
MBq/group 0
A 0
) 0
. 0

The 0
analysis 0
consisted 0
of 0
1 0
) 0
fitting 0
first 0
- 0
and 0
second 0
- 0
order 0
autoregressive 0
models 0
( 0
AR1 0
and 0
AR2 0
) 0
and 0
2 0
) 0
obtaining 0
the 0
power 0
spectra 0
of 0
the 0
data 0
by 0
fast 0
- 0
Fourier 0
transform 0
. 0

Of 0
921 0
specimens 0
, 0
95 0
yielded 0
non 0
- 0
albicans 0
species 0
, 0
mainly 0
from 0
patients 0
with 0
low 0
CD4 B-gene
lymphocyte 0
counts 0
and 0
extensive 0
previous 0
azole 0
exposure 0
. 0

Sequence 0
analysis 0
and 0
electrophoretic 0
mobility 0
shift 0
experiments 0
suggest 0
that 0
GnSE B-gene
response I-gene
elements I-gene
interact 0
, 0
in 0
these 0
two 0
regions 0
, 0
with 0
GATA B-gene
- I-gene
and I-gene
LIM I-gene
- I-gene
related I-gene
factors I-gene
, 0
respectively 0
. 0

The 0
NrfC B-gene
polypeptide I-gene
, 0
M B-gene
( I-gene
r I-gene
) I-gene
24,567 I-gene
, 0
contains 0
16 0
cysteine 0
residues 0
arranged 0
in 0
four 0
clusters 0
typical 0
of 0
the 0
CooF B-gene
super I-gene
- I-gene
family I-gene
of 0
non 0
- 0
haem 0
iron 0
- 0
sulphur 0
proteins 0
. 0

Hamdija 0
Karamehmedovic 0
; 0
Ibn 0
al 0
- 0
Nefis 0
, 0
`` 0
Mudzez 0
al 0
- 0
Kanum 0
'' 0
, 0
Republicki 0
zavod 0
za 0
zdravstvenu 0
zastitu 0
Sarajevo 0
, 0
1961 0
, 0
1 0
- 0
219 0
; 0
Mr 0
ph 0
Samuel 0
Elazar 0
, 0
Ajnija 0
Omanic 0
: 0
`` 0
Bibliografija 0
medicinskih 0
djela 0
u 0
SR 0
BiH 0
do 0
1895 0
. 0
'' 0
Medicinska 0
knjiga 0
Beograd 0
- 0
Zagreb 0
1984 0
; 0
Besides 0
, 0
the 0
great 0
contribution 0
in 0
bibliography 0
was 0
given 0
by 0
dr 0
Lujo 0
Taler 0
, 0
prof. 0
dr 0
. 0

Patients 0
randomized 0
into 0
the 0
active 0
treatment 0
groups 0
A30 0
( 0
n 0
= 0
49 0
) 0
and 0
A60 0
( 0
n 0
= 0
48 0
) 0
received 0
topical 0
treatment 0
with 0
3.0 0
% 0
diclofenac 0
in 0
2.5 0
% 0
hyaluronan 0
gel 0
0.5 0
g 0
twice 0
daily 0
for 0
30 0
or 0
60 0
days 0
, 0
respectively 0
. 0

Southern 0
blot 0
analysis 0
performed 0
on 0
genomic 0
DNA 0
demonstrated 0
altered 0
CpG 0
methylation 0
within 0
intron 0
1 0
in 0
DNA 0
from 0
all 0
BCC 0
compared 0
to 0
normal 0
, 0
mortal 0
human 0
mammary 0
epithelial 0
cells 0
( 0
HMEC 0
) 0
. 0

In 0
addition 0
, 0
both 0
inhibitors 0
blocked 0
phosphatidylcholine 0
hydrolysis 0
and 0
protein B-gene
kinase I-gene
C I-gene
translocation 0
. 0

Human B-gene
PDNP3 I-gene
is 0
expressed 0
in 0
glioma 0
cells 0
, 0
prostate 0
, 0
and 0
uterus 0
, 0
but 0
not 0
in 0
the 0
alimentary 0
tract 0
. 0

13:961 0
- 0
969 0
, 0
1993 0
) 0
suggested 0
that 0
T B-gene
antigen I-gene
could 0
mediate 0
transcriptional 0
activation 0
through 0
interaction 0
with 0
the 0
TATA B-gene
- I-gene
binding I-gene
protein I-gene
, 0
as 0
well 0
as 0
upstream 0
bound 0
transcription 0
factors 0
. 0

Identification 0
of 0
a 0
putative 0
infC B-gene
- 0
rpmI B-gene
- 0
rplT B-gene
operon 0
flanked 0
by 0
long 0
inverted 0
repeats 0
in 0
Mycoplasma 0
fermentans 0
( 0
incognitus 0
strain 0
) 0
. 0

IgE B-gene
antibody I-gene
to 0
twelve 0
common 0
food 0
and 0
inhalant 0
allergens 0
was 0
measured 0
by 0
enzyme 0
- 0
linked 0
immunosorbent 0
assay 0
( 0
ELISA 0
) 0
in 0
the 0
sera 0
of 0
thirteen 0
atopic 0
patients 0
with 0
one 0
or 0
more 0
allergic 0
disorders 0
( 0
asthma 0
occurring 0
in 0
eleven 0
; 0
rhinitis 0
in 0
ten 0
; 0
eczema 0
in 0
six 0
; 0
urticaria 0
in 0
four 0
; 0
mouth 0
and 0
gastro 0
- 0
intestinal 0
symptoms 0
in 0
six 0
) 0
, 0
of 0
twelve 0
non 0
- 0
atopic 0
patients 0
with 0
various 0
clinical 0
symptoms 0
( 0
asthma 0
in 0
four 0
; 0
rhinitis 0
in 0
four 0
; 0
eczema 0
in 0
one 0
; 0
urticaria 0
in 0
two 0
; 0
mouth 0
and 0
gastro 0
- 0
intestinal 0
symptoms 0
in 0
four 0
) 0
and 0
sixteen 0
cord 0
blood 0
sera 0
. 0

Analysis 0
of 0
1 0
Mb 0
of 0
published 0
sequence 0
from 0
the 0
region 0
of 0
conserved 0
synteny 0
on 0
human 0
chromosome 0
5q31 0
- 0
q33 0
identified 0
45 0
gene 0
candidates 0
, 0
including 0
35 0
expressed 0
genes 0
in 0
the 0
human B-gene
IL I-gene
- I-gene
4 I-gene
cytokine I-gene
gene I-gene
cluster 0
. 0

These 0
p21 B-gene
- 0
E2F B-gene
complexes 0
, 0
while 0
present 0
in 0
young 0
G1 0
cells 0
at 0
very 0
low 0
levels 0
, 0
were 0
elevated 0
in 0
senescent 0
cells 0
. 0

The 0
delta 0
Mo 0
+ 0
SV 0
tumor 0
DNAs 0
from 0
B 0
- 0
lineage 0
tumors 0
were 0
typically 0
rearranged 0
at 0
the 0
immunoglobulin B-gene
gene I-gene
loci I-gene
and 0
contained 0
germ 0
line 0
configurations 0
of 0
the 0
T B-gene
- I-gene
cell I-gene
receptor I-gene
beta I-gene
gene I-gene
. 0

An 0
increased 0
incidence 0
of 0
ATN 0
has 0
been 0
reported 0
since 0
the 0
introduction 0
of 0
cyclosporin 0
A 0
. 0

Earlier 0
reports 0
have 0
localized 0
mutations 0
which 0
affect 0
the 0
processing 0
and 0
transport 0
of 0
herpes 0
simplex 0
virus 0
1 0
glycoproteins 0
to 0
a 0
region 0
located 0
between 0
the 0
genes 0
specifying 0
glycoprotein B-gene
B I-gene
and 0
the 0
major 0
viral 0
DNA 0
- 0
binding 0
protein 0
( 0
beta B-gene
8 I-gene
) 0
. 0

Magnetic 0
force 0
and 0
torque 0
at 0
1.5 0
T 0
did 0
not 0
dislodge 0
the 0
GF 0
or 0
result 0
in 0
perforation 0
of 0
canine 0
IVC 0
by 0
the 0
GF 0
. 0

The 0
rec8 B-gene
( I-gene
+ I-gene
) I-gene
, 0
rec10 B-gene
( I-gene
+ I-gene
) I-gene
, 0
and 0
rec11 B-gene
( I-gene
+ I-gene
) I-gene
genes I-gene
of I-gene
the I-gene
fission I-gene
yeast I-gene
Schizosaccharomyces I-gene
pombe I-gene
exhibit 0
similar 0
specificities 0
for 0
meiotic 0
recombination 0
and 0
rec8 B-gene
( I-gene
+ I-gene
) I-gene
is 0
required 0
for 0
sister 0
chromatid 0
cohesion 0
and 0
homolog 0
pairing 0
. 0

Synergistic 0
induction 0
of 0
apoptosis 0
in 0
human 0
leukemia 0
cells 0
( 0
U937 0
) 0
exposed 0
to 0
bryostatin 0
1 0
and 0
the 0
proteasome 0
inhibitor 0
lactacystin 0
involves 0
dysregulation 0
of 0
the 0
PKC/MAPK B-gene
cascade 0
. 0

The 0
formation 0
of 0
a 0
D 0
- 0
loop 0
is 0
an 0
essential 0
step 0
in 0
DNA 0
double 0
- 0
strand 0
break 0
repair 0
through 0
recombination 0
. 0

Using 0
a 0
set 0
of 0
sera 0
for 0
which 0
full 0
chlamydial 0
micro 0
- 0
immunofluorescence 0
results 0
suggested 0
a 0
clear 0
diagnosis 0
, 0
we 0
have 0
evaluated 0
the 0
Chlamydia 0
Spot 0
- 0
IF 0
test 0
( 0
bioMerieux 0
) 0
, 0
which 0
allows 0
a 0
comparison 0
of 0
titres 0
to 0
Chlamydia B-gene
trachomatis I-gene
and I-gene
C. I-gene
psittaci I-gene
antigens I-gene
. 0

ET B-gene
- I-gene
1 I-gene
limited 0
the 0
electrocardiographic 0
evidence 0
of 0
subendocardial 0
ischemia 0
and 0
attenuated 0
contractile 0
dysfunction 0
compared 0
with 0
mechanical 0
stenosis 0
at 0
the 0
same 0
coronary 0
flows 0
, 0
even 0
though 0
lactate 0
flux 0
was 0
similar 0
. 0

The 0
AtNMT1 B-gene
expression 0
profile 0
indicated 0
ubiquity 0
in 0
roots 0
, 0
stem 0
, 0
leaves 0
, 0
flowers 0
, 0
and 0
siliques 0
( 0
approximately 0
1.7 0
kb 0
transcript 0
and 0
approximately 0
50 0
kDa 0
immunoreactive 0
polypeptide 0
) 0
but 0
a 0
greater 0
level 0
in 0
the 0
younger 0
tissue 0
, 0
which 0
are 0
developmentally 0
very 0
active 0
. 0

CONCLUSION 0
: 0
DMIPP 0
detects 0
regionally 0
hypoperfused 0
myocardium 0
, 0
in 0
which 0
agreement 0
between 0
MBF 0
and 0
fatty 0
acid 0
uptake 0
deteriorates 0
. 0

The 0
majority 0
of 0
putative 0
TSC2 B-gene
mutations I-gene
were 0
found 0
in 0
sporadic 0
rather 0
than 0
TSC2 B-gene
- 0
linked 0
families 0
. 0

Thirty 0
- 0
three 0
small 0
glottic 0
carcinomas 0
( 0
T1 0
and 0
small 0
T2 0
; 0
UICC 0
, 0
1978 0
) 0
were 0
examined 0
by 0
malignancy 0
grading 0
using 0
the 0
8 0
- 0
factor 0
system 0
proposed 0
by 0
Jakobsson 0
et 0
al 0
. 0

None 0
of 0
the 0
10 0
sequences 0
has 0
hitherto 0
been 0
recognized 0
as 0
part 0
of 0
the 0
p53 B-gene
signaling 0
pathway 0
. 0

Studies 0
in 0
26 0
patients 0
. 0

Transfection 0
of 0
H B-gene
chain I-gene
loss I-gene
variant I-gene
myeloma 0
with 0
the 0
complete 0
12 0
kb 0
construct 0
, 0
termed 0
238H B-gene
- I-gene
Cmicro I-gene
, 0
resulted 0
in 0
secretion 0
of 0
intact 0
Ig 0
pairing 0
238H B-gene
- I-gene
Cmicro I-gene
, 0
with 0
a 0
lambda B-gene
L I-gene
chain I-gene
; 0
however 0
, 0
transfectant B-gene
Ig I-gene
lacked 0
autoreactivity 0
and 0
pathogenicity 0
. 0

Comparison 0
of 0
the 0
genes 0
coding 0
for 0
mouse 0
and 0
human 0
p36 B-gene
( 0
annexin B-gene
II I-gene
) 0
and 0
mouse 0
, 0
rat 0
and 0
human 0
p35 B-gene
( 0
annexin B-gene
I I-gene
) 0
and 0
pigeon 0
cp35 B-gene
( 0
an 0
annexin B-gene
I I-gene
- I-gene
related I-gene
protein I-gene
) 0
shows 0
strong 0
genomic 0
structural 0
conservation 0
supporting 0
the 0
hypothesis 0
that 0
these 0
genes 0
had 0
a 0
common 0
ancestor 0
. 0

Now 0
: 0
pleasure 0
in 0
work 0

Cerumen 0
management 0
in 0
hearing 0
conservation 0
: 0
the 0
Dallas 0
( 0
Texas 0
) 0
Independent 0
School 0
District 0
program 0
. 0

Mammalian 0
homologues 0
of 0
the 0
Polycomb B-gene
- I-gene
group I-gene
gene I-gene
Enhancer B-gene
of I-gene
zeste I-gene
mediate 0
gene 0
silencing 0
in 0
Drosophila 0
heterochromatin 0
and 0
at 0
S. 0
cerevisiae 0
telomeres 0
. 0

Xanthoepocin 0
, 0
a 0
new 0
antibiotic 0
from 0
Penicillium 0
simplicissimum 0
IFO5762 0
. 0

Additionally 0
, 0
VAHS 0
is 0
often 0
associated 0
with 0
fatal 0
infectious 0
mononucleosis 0
( 0
IM 0
) 0
. 0

In 0
addition 0
, 0
mutations 0
within 0
the 0
Ubx B-gene
unit I-gene
exons I-gene
are 0
known 0
and 0
most 0
of 0
these 0
behave 0
as 0
null 0
alleles 0
. 0

273 0
, 0
27420 0
- 0
27429 0
) 0
a 0
putative 0
peroxisome 0
proliferator 0
- 0
activated 0
receptor 0
response 0
element 0
( 0
PPRE 0
) 0
is 0
present 0
from 0
- 0
458 0
to 0
- 0
474 0
. 0

In 0
T 0
cells 0
these 0
two 0
signal 0
pathways 0
are 0
critical 0
for 0
interleukin B-gene
- I-gene
2 I-gene
production 0
. 0

These 0
results 0
induce 0
that 0
the 0
putative 0
TATA 0
box 0
and 0
initiator 0
are 0
not 0
involved 0
in 0
the 0
promoter 0
activity 0
, 0
and 0
that 0
the 0
vitronectin B-gene
promoter I-gene
lacks 0
the 0
TATA 0
box 0
, 0
initiator 0
and 0
GC 0
box 0
. 0

Both 0
residues 0
are 0
conserved 0
in 0
the 0
three 0
phosphorylated 0
paralogs 0
but 0
are 0
absent 0
in 0
the 0
ones 0
that 0
were 0
not 0
substrates 0
of 0
RsbT B-gene
: 0
YetI B-gene
and 0
YezB B-gene
, 0
each 0
of 0
which 0
bears 0
only 0
one 0
of 0
the 0
conserved 0
residues 0
; 0
and 0
YtvA B-gene
, 0
which 0
lacks 0
both 0
residues 0
and 0
instead 0
possesses 0
an 0
N 0
- 0
terminal 0
PAS B-gene
domain 0
. 0

The 0
role 0
of 0
PORT 0
in 0
the 0
treatment 0
of 0
N2 0
tumours 0
is 0
not 0
clear 0
and 0
may 0
justify 0
further 0
research 0
. 0

The 0
TDx 0
assay 0
for 0
cyclosporine 0
and 0
its 0
metabolites 0
in 0
blood 0
samples 0
compared 0
with 0
HPLC 0
and 0
RIA 0
methods 0
. 0

This 0
is 0
consistent 0
with 0
the 0
need 0
for 0
a 0
nuclear 0
retinoid B-gene
receptor I-gene
function 0
in 0
RA 0
- 0
induced 0
ERK2 B-gene
activation 0
. 0

It 0
was 0
previously 0
shown 0
that 0
Vi B-gene
antigen I-gene
expression 0
was 0
regulated 0
by 0
a 0
system 0
similar 0
to 0
the 0
rcs B-gene
regulatory 0
system 0
involved 0
in 0
colanic 0
acid 0
synthesis 0
in 0
Escherichia 0
coli 0
. 0

However 0
, 0
the 0
molecular 0
mechanisms 0
by 0
which 0
specific 0
cis 0
- 0
and 0
trans 0
- 0
acting 0
factors 0
control 0
activity 0
of 0
the 0
prodynorphin B-gene
promoter I-gene
are 0
not 0
as 0
clearly 0
defined 0
. 0

The 0
gene 0
set 0
in 0
this 0
mitochondrial 0
genome 0
is 0
a 0
subset 0
of 0
that 0
of 0
Reclinomonas 0
americana 0
, 0
an 0
amoeboid 0
protozoan 0
. 0

The 0
library 0
will 0
thus 0
be 0
useful 0
for 0
the 0
selection 0
of 0
cosmid 0
clones 0
which 0
carry 0
CDC B-gene
genes I-gene
from I-gene
yeast I-gene
by 0
complementing 0
first 0
, 0
with 0
the 0
vectorial 0
yeast B-gene
gene I-gene
URA1 I-gene
, 0
the 0
pyrimidine 0
auxotrophy 0
of 0
most 0
cdc B-gene
- 0
strains 0
and 0
then 0
, 0
with 0
the 0
respective 0
CDC B-gene
wild I-gene
- I-gene
type I-gene
genes I-gene
, 0
of 0
the 0
temperature 0
- 0
sensitive 0
mutant 0
alleles 0
. 0

A 0
plasma 0
cell 0
- 0
rich 0
infiltrate 0
was 0
present 0
in 0
the 0
connective 0
tissue 0
cores 0
of 0
the 0
papillae 0
. 0

Peptide 0
competition 0
studies 0
have 0
localized 0
a 0
cyclin B-gene
A I-gene
interaction I-gene
site I-gene
to 0
a 0
Lys381Lys382Leu383Met384Phe385 0
sequence 0
within 0
C 0
- 0
terminal 0
negative 0
regulatory 0
domain 0
of 0
human B-gene
p53 I-gene
. 0

A 0
phase 0
II 0
study 0
was 0
initiated 0
to 0
evaluate 0
the 0
effect 0
of 0
a 0
combination 0
of 0
the 0
pure 0
L 0
- 0
isomer 0
of 0
LV 0
and 0
5 0
- 0
FU 0
along 0
with 0
epirubicin 0
in 0
patients 0
with 0
advanced 0
pancreatic 0
cancer 0
. 0

Attenuated 0
serum 0
cortisol 0
responses 0
were 0
found 0
in 0
six 0
of 0
the 0
patients 0
despite 0
a 0
normal 0
ACTH B-gene
test 0
. 0

While 0
some 0
still 0
automatically 0
refuse 0
all 0
patients 0
with 0
positive 0
mediastinoscopy 0
, 0
most 0
authors 0
still 0
remain 0
very 0
interventionistic 0
for 0
N2 0
patients 0
selected 0
on 0
very 0
accurate 0
criteria 0
that 0
are 0
analyzed 0
above 0
. 0

Inability 0
of 0
niacin 0
to 0
protect 0
from 0
in 0
vivo 0
hyperoxia 0
or 0
in 0
vitro 0
microsomal 0
lipid 0
peroxidation 0
. 0

Sesame 0
seed 0
should 0
also 0
be 0
considered 0
a 0
cause 0
of 0
allergic 0
reactions 0
to 0
drug 0
products 0
and 0
cosmetics 0
. 0

In 0
absence 0
of 0
i.m 0
. 0
medication 0
, 0
levels 0
over 0
1,000 0
U 0
must 0
be 0
carefully 0
screened 0
in 0
order 0
to 0
rule 0
out 0
SNM 0
or 0
organic 0
pathology 0
associated 0
. 0

A 0
yeast 0
mitochondrial 0
translation 0
initiation 0
codon 0
mutation 0
affecting 0
the 0
gene 0
for 0
cytochrome B-gene
oxidase I-gene
subunit I-gene
III I-gene
( 0
COX3 B-gene
) 0
was 0
partially 0
suppressed 0
by 0
a 0
spontaneous 0
nuclear 0
mutation 0
. 0

Patients 0
with 0
endocarditis 0
or 0
vascular 0
infection 0
were 0
more 0
frequently 0
immunocompromised 0
and 0
older 0
than 0
those 0
with 0
acute 0
Q 0
fever 0
. 0

This 0
latter 0
complex 0
reacts 0
with 0
an 0
antibody 0
to 0
serum B-gene
response I-gene
factor I-gene
( 0
SRF B-gene
) 0
and 0
exhibits 0
the 0
same 0
binding 0
characteristics 0
as 0
purified 0
SRF B-gene
. 0

MEASURES 0
: 0
SF 0
- 0
36 0
questionnaires 0
were 0
completed 0
by 0
patients 0
at 0
both 0
initial 0
and 0
discharge 0
examinations 0
. 0

Hormonal 0
replacement 0
therapy 0
for 0
women 0
with 0
a 0
personal 0
history 0
of 0
breast 0
cancer 0
? 0

The 0
human B-gene
SHBG I-gene
proximal I-gene
promoter I-gene
was 0
analyzed 0
by 0
DNase B-gene
I I-gene
footprinting 0
, 0
and 0
the 0
functional 0
significance 0
of 0
6 0
footprinted 0
regions 0
( 0
FP1 0
- 0
FP6 0
) 0
within 0
the 0
proximal 0
promoter 0
was 0
studied 0
in 0
human 0
HepG2 0
hepatoblastoma 0
cells 0
. 0

Endodontic 0
treatment 0
of 0
deciduous 0
teeth 0
using 0
the 0
formocresol 0
amputation 0
method 0

The 0
analysis 0
of 0
results 0
suggests 0
that 0
seroprevalence 0
of 0
Lyme 0
borreliosis 0
in 0
dogs 0
of 0
the 0
Kosice 0
region 0
is 0
not 0
negligible 0
. 0

Mutant 0
beta2 B-gene
- I-gene
adrenergic I-gene
receptors I-gene
with 0
a 0
Tyr 0
- 0
to 0
- 0
Phe 0
substitution 0
at 0
Tyr 0
- 0
350 0
do 0
not 0
display 0
agonist 0
- 0
induced 0
desensitization 0
, 0
Src B-gene
recruitment 0
, 0
or 0
Src B-gene
activation 0
. 0

The 0
feasibility 0
of 0
creating 0
CR1/Ig B-gene
chimeras 0
makes 0
possible 0
a 0
new 0
strategy 0
of 0
targeting 0
complement 0
inhibition 0
by 0
the 0
use 0
of 0
CR1/Ig I-gene

Otosclerosis 0
in 0
monozygotic 0
twins 0
: 0
clinical 0
and 0
genetical 0
analysis 0

The 0
results 0
show 0
that 0
in 0
uninfected 0
NIH 0
- 0
3T3 0
cells 0
Avarol 0
( 0
i 0
) 0
causes 0
a 0
50 0
% 0
reduction 0
of 0
the 0
growth 0
rate 0
only 0
at 0
the 0
high 0
concentration 0
of 0
29.6 0
microM 0
and 0
( 0
ii 0
) 0
is 0
accumulated 0
in 0
the 0
cytoplasm 0
close 0
to 0
the 0
nucleus 0
. 0

Furthermore 0
, 0
disruption 0
of 0
pcr1 B-gene
reduced 0
expression 0
of 0
fbp1 B-gene
, 0
a 0
glucose 0
- 0
repressible 0
gene 0
negatively 0
regulated 0
by 0
PKA B-gene
. 0

This 0
B 0
- 0
box 0
is 0
not 0
present 0
in 0
ETS1 B-gene
, 0
ETS2 B-gene
, 0
PEA3 B-gene
or 0
PU.1 B-gene
and 0
these 0
proteins 0
were 0
unable 0
to 0
form 0
ternary 0
complexes 0
with 0
SRF B-gene
and 0
Egrl B-gene
- 0
SREs 0
or 0
c B-gene
- I-gene
fos I-gene
SRE 0
. 0

Excretion 0
of 0
radiopharmaceuticals 0
into 0
breast 0
milk 0
. 0

It 0
is 0
concluded 0
that 0
the 0
drinking 0
ampules 0
of 0
VP 0
- 0
16 0
- 0
213 0
can 0
be 0
replaced 0
with 0
the 0
new 0
oral 0
capsules 0
with 0
a 0
recommended 0
initial 0
dose 0
of 0
100 0
- 0
130 0
mg/m2 0
given 0
in 0
5 0
- 0
day 0
courses 0
every 0
21 0
- 0
28 0
days 0
. 0

Deletion 0
of 0
the 0
region 0
from 0
amino 0
acid 0
residues 0
2 0
- 0
67 0
in 0
E1A B-gene
, 0
which 0
has 0
been 0
postulated 0
to 0
interact 0
with 0
p300/CBP B-gene
, 0
also 0
abolished 0
the 0
inhibitory 0
effect 0
of 0
p300/CBP I-gene

It 0
was 0
found 0
that 0
on 0
the 0
14th 0
and 0
21st 0
day 0
after 0
cimetidine 0
administration 0
serum B-gene
gastrin I-gene
levels 0
were 0
significantly 0
elevated 0
. 0

Both 0
PMP20 B-gene
gene I-gene
products I-gene
contain 0
the 0
carboxyl 0
- 0
terminal 0
sequence 0
AKL 0
, 0
similar 0
to 0
the 0
putative 0
SKL 0
peroxisomal 0
sorting 0
sequence 0
( 0
Gould 0
, 0
S 0
. 0

After 0
cumulative 0
occlusions 0
of 0
15 0
, 0
30 0
, 0
45 0
, 0
and 0
90 0
min 0
, 0
transmural 0
needle 0
biopsies 0
were 0
taken 0
from 0
the 0
ischemic 0
area 0
to 0
be 0
analyzed 0
for 0
adenine 0
nucleotides 0
, 0
nucleosides 0
, 0
creatine 0
phosphate 0
, 0
and 0
ultrastructural 0
changes 0
. 0

We 0
found 0
both 0
the 0
v B-gene
- I-gene
Ras I-gene
- 0
and 0
PC B-gene
- I-gene
PLC I-gene
- 0
transformed 0
cells 0
to 0
be 0
insensitive 0
to 0
stimulation 0
with 0
platelet B-gene
- I-gene
derived I-gene
growth I-gene
factor I-gene
( 0
PDGF B-gene
) 0
. 0

Although 0
indomethacin 0
is 0
useful 0
for 0
examining 0
the 0
role 0
of 0
cyclooxygenase B-gene
products I-gene
in 0
asthmatic 0
responses 0
, 0
it 0
should 0
not 0
be 0
considered 0
in 0
the 0
treatment 0
of 0
asthma 0
. 0

Furthermore 0
, 0
it 0
was 0
found 0
that 0
the 0
Shb B-gene
- 0
overexpressing 0
cells 0
extended 0
neurites 0
in 0
response 0
to 0
epidermal B-gene
growth I-gene
factor I-gene
. 0

Tre 0
during 0
exercise 0
at 0
35 0
W 0
at 0
23 0
degrees 0
C 0
correlated 0
r 0
= 0
- 0
70 0
with 0
Vo2max 0
and 0
r 0
= 0
0.80 0
with 0
Tre 0
during 0
exercise 0
in 0
heat 0
. 0

Therapeutic 0
iodine 0
125 0
for 0
hyperthyroidism 0
: 0
evidence 0
for 0
a 0
special 0
radiobiological 0
effect 0
on 0
the 0
follicular 0
cell 0
. 0

The 0
biological 0
activity 0
of 0
these 0
mutants 0
was 0
tested 0
by 0
determining 0
their 0
capacity 0
to 0
( 0
i 0
) 0
reconstitute 0
RNA B-gene
polymerase I-gene
activity 0
in 0
vivo 0
by 0
cotransfection 0
with 0
proteins 0
NP B-gene
, 0
PB1 B-gene
, 0
and 0
PA B-gene
and 0
a 0
virion 0
- 0
like 0
RNA 0
encoding 0
the 0
cat B-gene
gene 0
into 0
vaccinia 0
virus 0
T7 0
- 0
infected 0
COS 0
- 0
1 0
cells 0
and 0
( 0
ii 0
) 0
complete 0
with 0
the 0
wild B-gene
- I-gene
type I-gene
PB2 I-gene
activity 0
. 0

Should 0
we 0
use 0
thiazide 0
diuretics 0
in 0
hypertensive 0
patients 0
with 0
non 0
- 0
insulin B-gene
- 0
dependent 0
diabetes 0
mellitus 0
? 0

It 0
appears 0
that 0
the 0
K 0
- 0
ABC 0
is 0
a 0
relatively 0
nonbiased 0
test 0
suitable 0
for 0
the 0
evaluation 0
of 0
both 0
gifted 0
and 0
nongifted 0
children 0
regardless 0
of 0
race 0
or 0
gender 0
. 0

The 0
University 0
of 0
North 0
Carolina 0
caries 0
risk 0
assessment 0
was 0
conducted 0
between 0
1986 0
and 0
1989 0
with 0
5000 0
children 0
initially 0
in 0
grades 0
1 0
and 0
5 0
from 0
low 0
fluoride 0
sites 0
in 0
South 0
Carolina 0
and 0
Maine 0
. 0

Treatment 0
of 0
cells 0
for 0
10 0
min 0
with 0
TNF B-gene
- I-gene
alpha I-gene
resulted 0
in 0
activation 0
of 0
p44/42 B-gene
MAPK 0
, 0
p38 B-gene
, 0
and 0
JNK B-gene
. 0

The 0
coding 0
region 0
of 0
nifA B-gene
was 0
determined 0
using 0
a 0
translational 0
lacZ B-gene
fusion I-gene
and 0
by 0
site 0
- 0
directed 0
mutagenesis 0
to 0
identify 0
which 0
of 0
four 0
in 0
frame 0
AUG 0
codons 0
was 0
used 0
. 0

In 0
phase 0
II 0
studies 0
, 0
MDL 0
72,974A 0
is 0
proving 0
to 0
be 0
a 0
useful 0
adjunct 0
to 0
conventional 0
therapy 0
. 0

A 0
derived 0
RA 0
- 0
resistant 0
line 0
, 0
NT2/D1 0
- 0
R1 0
, 0
is 0
deficient 0
in 0
this 0
activity 0
and 0
is 0
co 0
- 0
resistant 0
to 0
cisplatin 0
. 0

These 0
studies 0
reveal 0
that 0
CREM B-gene
, 0
a 0
tissue 0
- 0
specific 0
factor 0
, 0
is 0
expressed 0
and 0
regulated 0
by 0
gonadotropins B-gene
in 0
the 0
ovary 0
, 0
that 0
the 0
predominant 0
CREM B-gene
transcripts 0
encode 0
the 0
repressor B-gene
protein I-gene
ICER I-gene
, 0
and 0
that 0
ICER B-gene
is 0
capable 0
of 0
inhibiting 0
cAMP 0
- 0
induced 0
expression 0
of 0
the 0
inhibin B-gene
alpha I-gene
- I-gene
subunit I-gene
gene I-gene
. 0

A 0
small 0
molecule 0
ILK B-gene
inhibitor 0
suppresses 0
the 0
phosphorylation 0
of 0
PKB B-gene
at 0
the 0
Ser 0
- 0
473 0
but 0
not 0
the 0
Thr 0
- 0
308 0
site 0
in 0
the 0
PTEN B-gene
mutant 0
cells 0
. 0

Menstrual 0
and 0
lunar 0
cycles 0
. 0

Phenacetin 0
nephritis 0

Both 0
claR B-gene
and 0
car B-gene
are 0
expressed 0
as 0
monocistronic 0
transcripts 0
; 0
the 0
level 0
of 0
transcript 0
declined 0
rapidly 0
after 0
48h 0
in 0
complex 0
media 0
, 0
but 0
low 0
sustained 0
levels 0
of 0
both 0
transcripts 0
were 0
observed 0
in 0
defined 0
GSPG 0
medium 0
until 0
96h 0
. 0
claR B-gene
and 0
car B-gene
were 0
not 0
significantly 0
expressed 0
in 0
mutants 0
disrupted 0
in 0
the 0
ccaR B-gene
gene I-gene
, 0
a 0
regulatory 0
gene 0
that 0
controls 0
positively 0
clavulanic 0
acid 0
and 0
cephamycin 0
biosynthesis 0
. 0

Viral 0
complementary 0
15 B-gene
S I-gene
mRNA I-gene
that 0
directs 0
the 0
synthesis 0
of 0
N B-gene
protein I-gene
and 0
hybridizes 0
to 0
the 0
predicted 0
N B-gene
gene I-gene
DNA 0
has 0
been 0
identified 0
in 0
infected 0
cell 0
extracts 0
. 0

Experiments 0
were 0
performed 0
without 0
polarization 0
or 0
with 0
cathodic 0
and 0
anodic 0
polarization 0
of 0
the 0
adsorbent 0
. 0

Our 0
results 0
suggest 0
that 0
Sp1 B-gene
binding I-gene
site I-gene
can 0
function 0
as 0
a 0
distinct 0
TGF B-gene
- I-gene
beta I-gene
responsive I-gene
element I-gene
for 0
TGF B-gene
- I-gene
beta I-gene
mediated 0
promoter 0
expression 0
and 0
Sp1 B-gene
per 0
se 0
can 0
mediate 0
this 0
response 0
. 0

A 0
positive 0
correlation 0
was 0
also 0
established 0
between 0
the 0
level 0
of 0
FP9C B-gene
binding 0
and 0
the 0
degree 0
of 0
cell 0
differentiation 0
in 0
vitro 0
. 0

In 0
another 0
patient 0
, 0
IRPF 0
recurred 0
in 0
the 0
ureter 0
of 0
a 0
living 0
related 0
renal 0
graft 0
6 0
months 0
after 0
transplantation 0
. 0

Similar 0
to 0
the 0
D B-gene
, 0
B/B B-gene
B/B I-gene
' I-gene
and 0
E B-gene
proteins I-gene
, 0
the 0
F B-gene
and 0
G B-gene
proteins I-gene
do 0
not 0
possess 0
any 0
of 0
the 0
known 0
RNA 0
binding 0
motifs 0
, 0
suggesting 0
that 0
other 0
types 0
of 0
RNA 0
- 0
protein 0
interactions 0
occur 0
in 0
the 0
snRNP 0
core 0
. 0

Ultrasound 0
- 0
guided 0
fine 0
- 0
needle 0
aspiration 0
biopsy 0
( 0
US 0
- 0
FNAB 0
) 0
revealed 0
normal 0
- 0
looking 0
squamous 0
cells 0
. 0

HC B-gene
- I-gene
toxin I-gene
exerts 0
a 0
potent 0
cytostatic 0
effect 0
on 0
plant 0
and 0
animal 0
cells 0
by 0
inhibiting 0
histone B-gene
deacetylase I-gene
. 0

In 0
EGF B-gene
receptor I-gene
- 0
mediated 0
signaling 0
, 0
the 0
protein B-gene
kinase I-gene
PKB/Akt I-gene
and 0
the 0
PKB/Akt I-gene

Blockade 0
of 0
T 0
cell 0
activation 0
using 0
a 0
surface 0
- 0
linked 0
single 0
- 0
chain 0
antibody 0
to 0
CTLA B-gene
- I-gene
4 I-gene
( 0
CD152 B-gene
) 0
. 0

On 0
the 0
basis 0
of 0
this 0
homology 0
, 0
we 0
examined 0
the 0
potential 0
role 0
of 0
c B-gene
- I-gene
Rel I-gene
in 0
controlling 0
IL B-gene
- I-gene
2R I-gene
alpha I-gene
transcription 0
. 0

Site 0
- 0
directed 0
mutagenesis 0
shows 0
that 0
sites 0
throughout 0
the 0
IRE B-gene
alter 0
negative 0
control 0
and 0
IRE B-gene
- I-gene
BP I-gene
binding 0
reflecting 0
the 0
fact 0
that 0
the 0
footprint 0
of 0
the 0
IRE B-gene
- I-gene
BP I-gene
is 0
over 0
the 0
entire 0
IRE B-gene
. 0

However 0
, 0
LXRalpha B-gene
inhibited 0
binding 0
of 0
PPARalpha/RXRalpha B-gene
heterodimers 0
to 0
PPREs 0
, 0
and 0
coexpression 0
of 0
PPARalpha/RXRalpha I-gene

In 0
clinical 0
stroke 0
cardiovascular 0
abnormalities 0
are 0
frequently 0
neglected 0
although 0
they 0
occur 0
more 0
often 0
than 0
it 0
is 0
generally 0
assumed 0
. 0

Complementary 0
DNA 0
libraries 0
from 0
liver 0
and 0
ovary 0
of 0
an 0
immature 0
female 0
channel 0
catfish 0
were 0
screened 0
with 0
a 0
homologous B-gene
ERalpha I-gene
cDNA I-gene
probe 0
. 0

Examination 0
of 0
the 0
Coomassie 0
- 0
stained 0
gels 0
revealed 0
that 0
the 0
capsid 0
- 0
like 0
particles 0
composed 0
of 0
the 0
N11 B-gene
- I-gene
VP1 I-gene
protein 0
did 0
not 0
contain 0
any 0
host 0
- 0
derived 0
VP1 I-gene

Here 0
we 0
show 0
that 0
one 0
nudF B-gene
suppressor I-gene
also 0
suppresses 0
hs 0
- 0
mutations 0
in 0
nudA B-gene
, 0
nudC B-gene
, 0
and 0
nudG B-gene
and 0
deletions 0
in 0
nudA B-gene
and 0
nudF B-gene
. 0

Thus 0
, 0
the 0
potential 0
induction 0
of 0
this 0
gene 0
rearrangement 0
by 0
E1A B-gene
gene I-gene
therapy 0
is 0
unlikely 0
to 0
be 0
clinically 0
significant 0
in 0
the 0
treatment 0
of 0
advanced 0
malignant 0
disease 0
. 0

Our 0
results 0
suggest 0
that 0
Bry1/Skn7 B-gene
can 0
influence 0
the 0
expression 0
of 0
MCB 0
- 0
and 0
SCB 0
- 0
driven 0
gene 0
expression 0
in 0
budding 0
yeast 0
, 0
perhaps 0
including 0
genes 0
involved 0
in 0
cell 0
wall 0
metabolism 0
, 0
via 0
a 0
two 0
- 0
component 0
signal 0
transduction 0
pathway 0
which 0
activates 0
Bry1/Skn7 I-gene

Buspirone 0
therapy 0
for 0
Type 0
A 0
behavior 0
, 0
hostility 0
, 0
and 0
perceived 0
stress 0
in 0
cardiac 0
patients 0
. 0

When 0
furA B-gene
alone 0
was 0
introduced 0
into 0
the 0
Delta 0
( 0
furA B-gene
- 0
katG B-gene
) 0
mutant 0
, 0
survival 0
in 0
mouse 0
lungs 0
was 0
moderately 0
increased 0
, 0
suggesting 0
that 0
FurA B-gene
could 0
regulate 0
genes 0
, 0
other 0
than 0
katG B-gene
, 0
that 0
are 0
involved 0
in 0
pathogenesis 0
. 0

The 0
resulting 0
threshold 0
elevation 0
curves 0
fell 0
into 0
a 0
small 0
number 0
of 0
distinct 0
groups 0
, 0
suggesting 0
the 0
existence 0
of 0
discrete 0
spatial 0
frequency 0
mechanisms 0
in 0
human 0
central 0
vision 0
. 0

Through 0
interactions 0
with 0
the 0
pre 0
- 0
mRNA 0
and 0
the 0
CTD 0
domain 0
of 0
the 0
Polymerase B-gene
II I-gene
, 0
SR B-gene
proteins I-gene
have 0
been 0
shown 0
to 0
regulate 0
alternative 0
splicing 0
. 0

The 0
screen 0
identifies 0
mutants 0
whose 0
growth 0
depends 0
on 0
high 0
levels 0
of 0
expression 0
of 0
that 0
gene 0
. 0

Electrophoretic 0
mobility 0
shift 0
analysis 0
of 0
protein 0
- 0
DNA 0
complexes 0
formed 0
with 0
nuclear 0
proteins 0
isolated 0
from 0
I3C 0
- 0
treated 0
and 0
- 0
untreated 0
cells 0
, 0
in 0
combination 0
with 0
supershift 0
assays 0
using 0
Sp1 B-gene
antibodies I-gene
, 0
demonstrated 0
that 0
the 0
Sp1 B-gene
- I-gene
binding I-gene
site I-gene
in 0
the 0
CDK6 B-gene
promoter I-gene
forms 0
a 0
specific 0
I3C 0
- 0
responsive 0
DNA 0
- 0
protein 0
complex 0
that 0
contains 0
the 0
Sp1 B-gene
transcription I-gene
factor I-gene
. 0

It 0
is 0
suggested 0
that 0
the 0
mechanism 0
of 0
intestinal 0
absorption 0
of 0
vitamin 0
D 0
and 0
25 0
- 0
hydroxy 0
- 0
vitamin 0
D 0
may 0
differ 0
in 0
man 0
, 0
the 0
absorption 0
of 0
25 0
- 0
hydroxy 0
- 0
vitamin 0
D 0
possibly 0
being 0
less 0
dependent 0
on 0
bile 0
acids 0
. 0

In 0
a 0
study 0
in 0
Singapore 0
, 0
Chinese 0
, 0
Malay 0
and 0
Indian 0
patients 0
with 0
pulmonary 0
tuberculosis 0
received 0
2 0
months 0
of 0
daily 0
treatment 0
with 0
streptomycin 0
, 0
isoniazid 0
, 0
rifampicin 0
, 0
and 0
pyrazinamide 0
followed 0
by 0
daily 0
isoniazid 0
, 0
and 0
rifampicin 0
either 0
with 0
pyrazinamide 0
( 0
SHRZ/HRZ 0
) 0
or 0
without 0
it 0
( 0
SHRZ/HR 0
) 0
, 0
allocated 0
at 0
random 0
. 0

However 0
, 0
C/EBP B-gene
beta I-gene
stimulated 0
transcription 0
primarily 0
through 0
the 0
cAMP 0
- 0
responsive 0
element 0
( 0
CRE 0
) 0
, 0
which 0
maps 0
between 0
positions 0
- 0
77 0
to 0
- 0
94 0
, 0
but 0
not 0
at 0
the 0
more 0
5' 0
- 0
binding 0
sites 0
. 0

Helenalin 0
triggers 0
a 0
CD95 B-gene
death I-gene
receptor I-gene
- 0
independent 0
apoptosis 0
that 0
is 0
not 0
affected 0
by 0
overexpression 0
of 0
Bcl B-gene
- I-gene
x I-gene
( I-gene
L I-gene
) I-gene
or 0
Bcl B-gene
- I-gene
2 I-gene
. 0

The 0
observed 0
alterations 0
in 0
lung 0
functions 0
in 0
these 0
subjects 0
indicate 0
that 0
individuals 0
performing 0
heavy 0
continuous 0
exercise 0
are 0
more 0
likely 0
to 0
be 0
affected 0
by 0
lower 0
O3 0
levels 0
. 0

Shields 0
needed 0
for 0
pacemakers 0
. 0

A 0
nationwide 0
record 0
linkage 0
of 0
the 0
Finnish 0
Twin 0
Cohort 0
Study 0
( 0
FTCS 0
) 0
with 0
the 0
Hospital 0
Discharge 0
Registry 0
and 0
the 0
Registry 0
of 0
Rights 0
for 0
Free 0
medication 0
is 0
presented 0
. 0

Results 0
demonstrated 0
that 0
for 0
both 0
S. 0
europaea 0
and 0
A. 0
prostrata 0
, 0
the 0
total 0
number 0
of 0
seeds 0
that 0
germinated 0
decreased 0
throughout 0
the 0
growing 0
season 0
. 0

A 0
personal 0
view 0
of 0
future 0
trends 0
in 0
the 0
field 0
of 0
immunoassay 0
concludes 0
this 0
review 0
. 0

Our 0
results 0
admit 0
that 0
a 0
ribosome 0
scanning 0
mechanism 0
of 0
the 0
MP B-gene
gene I-gene
expression 0
from 0
I 0
( 0
2 0
) 0
sgRNA 0
operates 0
concurrently 0
. 0

This 0
study 0
demonstrates 0
that 0
Fluosol 0
significantly 0
attenuates 0
neutrophil 0
adherence 0
, 0
cytotoxicity 0
, 0
and 0
enzyme 0
release 0
in 0
an 0
in 0
vitro 0
model 0
of 0
microvascular 0
injury 0
. 0

22.6 0
% 0
of 0
patients 0
were 0
found 0
to 0
be 0
positive 0
at 0
histology 0
in 0
the 0
corpus 0
mucosa 0
; 0
all 0
but 0
one 0
of 0
these 0
patients 0
had 0
elevated 0
circulating 0
IgG B-gene
to 0
H. 0
pylori 0
( 0
Group 0
C 0
) 0
. 0

Concerning 0
the 0
practical 0
approach 0
in 0
a 0
clinical 0
setting 0
, 0
it 0
has 0
to 0
be 0
pointed 0
out 0
that 0
with 0
these 0
diseases 0
a 0
hepatitis 0
C 0
infection 0
has 0
to 0
be 0
considered 0
and 0
testing 0
for 0
hepatitis B-gene
C I-gene
antibodies I-gene
and 0
, 0
if 0
positive 0
, 0
hepatitis B-gene
C I-gene
- I-gene
RNA I-gene
is 0
indicated 0
. 0

In 0
order 0
to 0
investigate 0
the 0
effect 0
of 0
the 0
local 0
direct 0
action 0
of 0
danazol 0
upon 0
endometriosis 0
, 0
intravaginal 0
and 0
intrauterine 0
application 0
were 0
tried 0
. 0

Western 0
blot 0
experiments 0
detected 0
SMBP B-gene
as 0
a 0
70 0
kDa 0
protein 0
that 0
may 0
be 0
further 0
cleaved 0
into 0
an 0
active 0
34 0
kDa 0
N 0
- 0
terminal 0
polypeptide 0
. 0

80 0
bp 0
) 0
surrounding 0
the 0
site 0
of 0
transcription 0
initiation 0
. 0

A 0
backward 0
look 0
at 0
urinary 0
tract 0
infections 0
. 0

All 0
the 0
cognate 0
gene 0
clones 0
were 0
constructed 0
, 0
using 0
either 0
PCR 0
products 0
amplified 0
from 0
genomic 0
DNA 0
, 0
or 0
gap 0
- 0
repair 0
. 0

On 0
Western 0
blots 0
, 0
the 0
same 0
antibodies 0
recognized 0
the 0
recombinant 0
protein 0
migrating 0
slightly 0
slower 0
on 0
SDS/PAGE 0
than 0
chicken B-gene
axonin I-gene
- I-gene
1 I-gene
. 0

BCR B-gene
- 0
ABL B-gene
elicits 0
transformation 0
of 0
both 0
fibroblast 0
and 0
hematopoietic 0
cells 0
and 0
blocks 0
apoptosis 0
following 0
cytokine 0
deprivation 0
in 0
various 0
factor 0
- 0
dependent 0
cells 0
. 0

The 0
transcriptional B-gene
transactivator I-gene
( 0
Tas B-gene
) 0
of 0
simian 0
foamy 0
virus 0
type 0
1 0
strongly 0
augments 0
gene 0
expression 0
directed 0
by 0
both 0
the 0
promoter 0
in 0
the 0
viral 0
long 0
terminal 0
repeat 0
and 0
the 0
newly 0
discovered 0
internal 0
promoter 0
located 0
within 0
the 0
env B-gene
gene I-gene
. 0

Analysis 0
of 0
nt 0
sequence 0
was 0
carried 0
out 0
on 0
three 0
out 0
of 0
the 0
more 0
than 0
15 0
of 0
these 0
regions 0
present 0
in 0
the 0
mouse 0
genome 0
. 0

Moreover 0
, 0
site 0
- 0
specific 0
integration 0
of 0
the 0
ITR 0
- 0
flanked 0
DNA 0
was 0
also 0
detected 0
by 0
PCR 0
amplification 0
of 0
the 0
ITR B-gene
- I-gene
aavs1 I-gene
junction I-gene
in 0
transduced 0
human 0
fibroblasts 0
. 0

Finally 0
, 0
we 0
demonstrate 0
that 0
animals 0
carrying 0
a 0
snf B-gene
mutation 0
that 0
converts 0
SNF B-gene
from 0
a 0
bifunctional 0
protein 0
to 0
a 0
U1 B-gene
snRNP I-gene
- I-gene
specific I-gene
protein I-gene
are 0
viable 0
. 0

For 0
this 0
interaction 0
, 0
the 0
C 0
- 0
terminal 0
part 0
of 0
Sp1 B-gene
and 0
the 0
N 0
terminus 0
of 0
E2F1 B-gene
, 0
a 0
domain 0
also 0
present 0
in 0
E2F2 B-gene
and 0
E2F3 B-gene
but 0
absent 0
in 0
E2F4 B-gene
and 0
E2F5 B-gene
, 0
were 0
essential 0
. 0

To 0
gain 0
additional 0
insights 0
into 0
this 0
novel 0
apoptotic 0
checkpoint 0
, 0
we 0
have 0
now 0
characterized 0
the 0
mouse B-gene
survivin I-gene
locus I-gene
. 0

Since 0
RIP140 B-gene
generally 0
down 0
- 0
regulates 0
receptor 0
activity 0
in 0
mammalian 0
cells 0
and 0
specifically 0
down 0
- 0
regulates 0
coactivation 0
mediated 0
by 0
SRC B-gene
- I-gene
1 I-gene
, 0
we 0
propose 0
a 0
model 0
in 0
which 0
RIP140 B-gene
indirectly 0
regulates 0
nuclear B-gene
receptor I-gene
AF I-gene
- I-gene
2 I-gene
activity 0
by 0
competition 0
for 0
coactivators 0
such 0
as 0
SRC B-gene
- I-gene
1 I-gene
. 0

We 0
constructed 0
a 0
stable 0
, 0
doubly 0
transfected 0
cell 0
line 0
( 0
TIS 0
- 0
10 0
) 0
carrying 0
a 0
chromosomally 0
integrated 0
ptetO7 B-gene
- I-gene
CMV I-gene
- I-gene
L I-gene
reporter 0
construct 0
and 0
expressing 0
the 0
TetR B-gene
- 0
KRAB B-gene
protein 0
. 0

Value 0
of 0
bone 0
scintigraphy 0
with 0
Tc99MDP 0
in 0
the 0
early 0
diagnosis 0
of 0
mobilization 0
of 0
the 0
total 0
hip 0
prosthesis 0

Coimmunoprecipitation 0
analysis 0
suggests 0
that 0
these 0
residues 0
likely 0
contribute 0
to 0
the 0
multimerization 0
function 0
required 0
for 0
homomeric 0
complex 0
formation 0
or 0
heteromeric 0
complex 0
formation 0
with 0
p50 B-gene
in 0
that 0
no 0
association 0
of 0
p65 B-gene
delta I-gene
with 0
itself 0
or 0
with 0
p50 B-gene
was 0
evident 0
. 0

The 0
isolation 0
of 0
crt5 B-gene
- I-gene
262 I-gene
, 0
an 0
additional 0
cdc B-gene
allele I-gene
of 0
POL1/CDC17 B-gene
, 0
suggests 0
for 0
the 0
first 0
time 0
that 0
directly 0
blocking 0
DNA 0
replication 0
can 0
provide 0
a 0
signal 0
to 0
induce 0
the 0
DNA 0
damage 0
response 0
. 0
POL1/CDC17 I-gene

Denaturing 0
gradient 0
gel 0
electrophoresis 0
( 0
DGGE 0
) 0
with 0
sequence 0
analysis 0
showed 0
that 0
PGCL4 B-gene
is 0
a 0
major 0
member 0
in 0
the 0
female 0
mammary 0
gland 0
, 0
and 0
in 0
the 0
submaxillary 0
and 0
lachrymal 0
glands 0
of 0
both 0
sexes 0
, 0
while 0
the 0
counterpart 0
in 0
male 0
liver 0
and 0
the 0
coagulate 0
glands 0
was 0
found 0
to 0
be 0
PGCL1 B-gene
. 0

Five 0
sequence 0
variants 0
were 0
identified 0
. 0

If 0
failure 0
to 0
solve 0
invisible 0
displacements 0
was 0
due 0
to 0
increased 0
memory 0
requirements 0
, 0
then 0
the 0
primates 0
should 0
perform 0
at 0
chance 0
level 0
on 0
all 0
3 0
problems 0
. 0

Mouse B-gene
GRK6 I-gene
- I-gene
C I-gene
displays 0
none 0
of 0
these 0
motifs 0
. 0

The 0
cumulative 0
length 0
of 0
the 0
RGSV 0
genome 0
, 0
including 0
RNAs 0
5 0
and 0
6 0
, 0
was 0
25142 0
nt 0
. 0

CTDK1 B-gene
and 0
CTDK2 B-gene
also 0
differ 0
in 0
their 0
protein 0
substrate 0
specificity 0
. 0

ATF 0
is 0
formulated 0
from 0
the 0
prothrombin B-gene
time 0
( 0
PT 0
) 0
, 0
fibrinogen B-gene
transformation 0
rate 0
( 0
FTR 0
) 0
( 0
a 0
representation 0
of 0
thrombin B-gene
activity 0
) 0
, 0
and 0
a 0
consideration 0
of 0
the 0
fibrinogen B-gene
( 0
FBG B-gene
) 0
content 0
of 0
blood 0
plasma 0
. 0

Protease 0
digestion 0
and 0
alkaline 0
extraction 0
of 0
microsomes 0
containing 0
labeled 0
mutant 0
proteins 0
further 0
showed 0
that 0
segment 0
3 0
was 0
sufficient 0
for 0
stable 0
membrane 0
anchoring 0
of 0
the 0
glycoproteins 0
, 0
indicating 0
that 0
this 0
segment 0
may 0
specify 0
the 0
transmembrane 0
domain 0
of 0
the 0
gB B-gene
glycoprotein I-gene
. 0

Peripheral 0
visual 0
acuity 0
with 0
monovision 0
and 0
other 0
contact 0
lens 0
corrections 0
for 0
presbyopia 0
. 0

ORF3 0
appears 0
to 0
encode 0
the 0
homologue 0
of 0
the 0
well 0
- 0
conserved 0
proteasomal B-gene
26S I-gene
regulatory I-gene
subunit I-gene
. 0

87 0
, 0
7270 0
- 0
7274 0
) 0
. 0

Protein 0
binding 0
to 0
UAS1MLS1 B-gene
was 0
observed 0
with 0
extracts 0
from 0
derepressed 0
but 0
not 0
from 0
repressed 0
cells 0
, 0
and 0
could 0
be 0
competed 0
for 0
by 0
an 0
excess 0
of 0
the 0
unlabelled 0
CSRE 0
( 0
ICL1 B-gene
) 0
sequence 0
. 0

This 0
inhibition 0
was 0
due 0
to 0
competition 0
from 0
the 0
EMC 0
virus 0
IRES 0
present 0
in 0
pEP B-gene
- I-gene
2A I-gene
transcripts I-gene
, 0
as 0
well 0
as 0
the 0
expression 0
of 0
proteolytically 0
active 0
2Apro B-gene
. 0

These 0
properties 0
prompted 0
us 0
to 0
investigate 0
Ets B-gene
- I-gene
1 I-gene
expression 0
in 0
32 0
human 0
astroglial 0
tumors 0
of 0
WHO 0
grades 0
I 0
- 0
IV 0
and 0
to 0
correlate 0
the 0
data 0
with 0
the 0
expression 0
pattern 0
of 0
VEGF B-gene
, 0
Flt B-gene
- I-gene
1 I-gene
, 0
and 0
KDR B-gene
. 0

The 0
CydDC B-gene
system I-gene
appears 0
to 0
be 0
the 0
first 0
prokaryotic 0
example 0
of 0
a 0
heterodimeric B-gene
ABC I-gene
transport I-gene
system I-gene
in 0
which 0
each 0
polypeptide 0
contains 0
both 0
hydrophobic 0
and 0
ATP 0
- 0
binding 0
domains 0
. 0

Ionic 0
composition 0
( 0
Na+ 0
, 0
K+ 0
, 0
Ca+2 0
, 0
and 0
Mg2+ 0
) 0
of 0
cerebrospinal 0
fluid 0
and 0
feeding 0
behavior 0
in 0
sheep 0
. 0

Recently 0
we 0
have 0
performed 0
a 0
detailed 0
analysis 0
of 0
specific 0
neuronal 0
populations 0
affected 0
by 0
the 0
mutation 0
which 0
shed 0
new 0
light 0
on 0
the 0
role 0
of 0
Krox B-gene
- I-gene
20 I-gene
in 0
the 0
segmentation 0
and 0
on 0
the 0
physiological 0
consequences 0
of 0
its 0
inactivation 0
. 0

Comparison 0
of 0
the 0
sequences 0
of 0
the 0
alpha B-gene
- I-gene
like I-gene
DNA I-gene
polymerases I-gene
including 0
E. B-gene
coli I-gene
DNA I-gene
polymerase I-gene
II I-gene
showed 0
that 0
there 0
were 0
nine 0
highly 0
conserved 0
regions 0
, 0
and 0
we 0
constructed 0
an 0
unrooted 0
phylogenetic 0
tree 0
of 0
the 0
DNA B-gene
polymerases I-gene
based 0
on 0
the 0
differences 0
in 0
these 0
conserved 0
regions 0
. 0

Guanylyl B-gene
cyclase I-gene
C I-gene
, 0
the 0
apparent 0
guanylin B-gene
receptor I-gene
, 0
was 0
found 0
in 0
abundant 0
amounts 0
in 0
the 0
intestine 0
by 0
Northern 0
analysis 0
, 0
and 0
by 0
the 0
polymerase 0
chain 0
reaction 0
or 0
cDNA 0
cloning 0
it 0
was 0
also 0
found 0
in 0
adrenal 0
gland 0
, 0
airway 0
epithelial 0
cells 0
, 0
brain 0
, 0
and 0
olfactory 0
and 0
tracheal 0
mucosa 0
. 0

Older 0
females 0
had 0
lumbar 0
( 0
0.6 0
+/ 0
- 0
1.3 0
) 0
and 0
TB 0
( 0
1.1 0
+/ 0
- 0
1.1 0
) 0
BMD 0
Z 0
scores 0
greater 0
than 0
0 0
( 0
both 0
, 0
p 0
< 0
0.001 0
) 0
. 0

Mutation 0
of 0
the 0
distal 0
E2F B-gene
binding I-gene
site I-gene
in 0
the 0
cdc25A B-gene
promoter I-gene
abolished 0
E2 B-gene
- 0
induced 0
repression 0
, 0
whereas 0
mutation 0
of 0
the 0
proximal 0
E2F B-gene
site I-gene
or 0
the 0
E2 B-gene
site I-gene
had 0
no 0
effect 0
. 0

Psychopathological 0
, 0
vegetative 0
, 0
and 0
vital 0
parameters 0
were 0
assessed 0
every 0
hour 0
. 0

A 0
new 0
family 0
of 0
rate 0
- 0
adaptive 0
pacemakers 0
accomplishes 0
this 0
circadian 0
rate 0
variation 0
by 0
modeling 0
the 0
patient 0
's 0
sleep 0
- 0
wake 0
cycle 0
using 0
a 0
time 0
- 0
of 0
- 0
day 0
clock 0
inside 0
the 0
device 0
. 0

New 0
strategies 0
are 0
needed 0
to 0
prevent 0
coronary 0
rethrombosis 0
in 0
patients 0
with 0
minimal 0
atherosclerosis 0
after 0
thrombolytic 0
therapy 0
for 0
acute 0
myocardial 0
infarction 0
. 0

METHODS 0
AND 0
RESULTS 0
: 0
With 0
an 0
array 0
of 0
112 0
unipole 0
, 0
epicardial 0
maps 0
of 0
electrically 0
induced 0
AF 0
in 0
6 0
dogs 0
( 0
acute 0
group 0
) 0
, 0
self 0
- 0
sustained 0
AF 0
in 0
6 0
dogs 0
( 0
chronic 0
group 0
) 0
, 0
and 0
sinus 0
rhythm 0
and 0
atrial 0
pacing 0
in 0
3 0
dogs 0
( 0
control 0
group 0
) 0
were 0
analyzed 0
before 0
and 0
after 0
creating 0
linear 0
radiofrequency 0
ablation 0
lesions 0
in 0
both 0
atria 0
that 0
eliminated 0
the 0
AF 0
. 0

The 0
mitochondrial B-gene
tyrosyl I-gene
- I-gene
tRNA I-gene
synthetase I-gene
of 0
Podospora 0
anserina 0
is 0
a 0
bifunctional 0
enzyme 0
active 0
in 0
protein 0
synthesis 0
and 0
RNA 0
splicing 0
. 0

We 0
found 0
that 0
the 0
central 0
nonconserved 0
region 0
of 0
the 0
large 0
subunit 0
is 0
not 0
essential 0
for 0
function 0
and 0
likely 0
acts 0
as 0
a 0
spacer 0
between 0
the 0
conserved 0
N 0
- 0
and 0
C 0
- 0
terminal 0
regions 0
. 0

Further 0
comparative 0
analysis 0
identified 0
an 0
ADNP B-gene
paralog 0
( 0
33 0
% 0
identity 0
and 0
46 0
% 0
similarity 0
) 0
, 0
indicating 0
that 0
these 0
genes 0
belong 0
to 0
a 0
novel 0
protein 0
family 0
with 0
a 0
nine 0
- 0
zinc 0
finger 0
motif 0
followed 0
by 0
a 0
homeobox 0
domain 0
. 0

Surprisingly 0
, 0
apo B-gene
- I-gene
iso I-gene
- I-gene
1 I-gene
- I-gene
cytochrome I-gene
c I-gene
is 0
absent 0
in 0
cyc3 B-gene
- I-gene
strains 0
, 0
although 0
apo B-gene
- I-gene
iso I-gene
- I-gene
2 I-gene
- I-gene
cytochrome I-gene
c I-gene
is 0
present 0
at 0
approximately 0
the 0
same 0
level 0
at 0
which 0
holo B-gene
- I-gene
iso I-gene
- I-gene
2 I-gene
- I-gene
cytochrome I-gene
c I-gene
is 0
found 0
in 0
CYC3+ B-gene
strains 0
. 0

A 0
role 0
for 0
phosphatidylinositol B-gene
3 I-gene
- I-gene
kinase I-gene
in 0
the 0
regulation 0
of 0
beta B-gene
1 I-gene
integrin I-gene
activity 0
by 0
the 0
CD2 B-gene
antigen 0
. 0

The 0
cluster 0
was 0
mapped 0
to 0
nucleotides 0
- 0
464 0
to 0
- 0
434 0
( 0
relative 0
to 0
nucleotide 0
A 0
in 0
the 0
initiation 0
codon 0
) 0
in 0
genomic 0
DNA 0
. 0

All 0
the 0
previously 0
mapped 0
structural 0
protein 0
- 0
encoding 0
genes 0
of 0
phage 0
LL 0
- 0
H 0
were 0
included 0
in 0
the 0
sequence 0
. 0

An 0
exception 0
is 0
the 0
Bcl B-gene
- I-gene
6 I-gene
gene I-gene
, 0
encoding 0
a 0
transcription 0
factor 0
, 0
which 0
was 0
found 0
to 0
be 0
mutated 0
in 0
normal 0
human 0
memory 0
B 0
cells 0
. 0

Nature 0
and 0
incidence 0
of 0
conditioned 0
responses 0
in 0
a 0
methadone 0
population 0
: 0
a 0
comparison 0
of 0
laboratory 0
, 0
clinic 0
, 0
and 0
naturalistic 0
settings 0
. 0

Serum 0
PRL B-gene
concentrations 0
significantly 0
increased 0
after 0
MCP 0
administration 0
in 0
normal 0
women 0
, 0
hyperprolactinemic 0
patients 0
with 0
normal 0
sella 0
and 0
patients 0
with 0
microadenoma 0
, 0
but 0
not 0
in 0
macroadenoma 0
patients 0
with 0
and 0
without 0
suprasellar 0
expansion 0
( 0
SSE 0
) 0
. 0

Fourteen 0
Centers 0
participated 0
in 0
this 0
trial 0
. 0

In 0
cells 0
stably 0
transfected 0
with 0
G B-gene
alpha I-gene
i I-gene
- I-gene
2 I-gene
or 0
G B-gene
alpha I-gene
i I-gene
- I-gene
3 I-gene
gene I-gene
5' 0
- 0
flanking 0
sequences 0
fused 0
to 0
firefly 0
luciferase B-gene
cDNA 0
reporter 0
, 0
temporal 0
10 0
- 0
15 0
- 0
fold 0
transcriptional 0
activation 0
of 0
both 0
genes 0
occurred 0
before 0
cellular 0
polarization 0
. 0

A 0
gene 0
( 0
FMR B-gene
- I-gene
1 I-gene
) 0
was 0
identified 0
within 0
a 0
four 0
cosmid 0
contig 0
of 0
YAC 0
DNA 0
that 0
expresses 0
a 0
4.8 0
kb 0
message 0
in 0
human 0
brain 0
. 0

These 0
include 0
not 0
only 0
antioxidants 0
, 0
N B-gene
- I-gene
methyl I-gene
- I-gene
D I-gene
- I-gene
aspartate I-gene
receptor I-gene
antagonists 0
, 0
inhibitors 0
of 0
glutamate 0
release 0
, 0
calcium 0
channel 0
blockers 0
, 0
polyamine 0
antagonists 0
, 0
and 0
nitric B-gene
oxide I-gene
synthase I-gene
inhibitors 0
, 0
but 0
cannabinoids 0
, 0
aspirin 0
, 0
melatonin 0
, 0
and 0
vitamin 0
B 0
- 0
12 0
. 0

In 0
conclusion 0
, 0
ANH 0
had 0
no 0
negative 0
effects 0
on 0
the 0
endocrine 0
stress 0
response 0
during 0
orthopedic 0
surgery 0
under 0
epidural 0
anesthesia 0
. 0

Both 0
genes B-gene
ARO3 I-gene
and 0
ARO4 B-gene
are 0
strongly 0
regulated 0
under 0
the 0
general 0
control 0
regulatory 0
system 0
. 0

Calculation 0
of 0
energy 0
levels 0
, 0
E1 0
transition 0
amplitudes 0
, 0
and 0
parity 0
violation 0
in 0
francium 0
. 0

A 0
homologue 0
of 0
the 0
MAP/ERK B-gene
family 0
of 0
protein 0
kinase 0
genes 0
is 0
expressed 0
in 0
vegetative 0
and 0
in 0
female 0
reproductive 0
organs 0
of 0
Petunia 0
hybrida 0
. 0

Significance 0
of 0
esophagocardiac 0
reflexes 0
for 0
inducing 0
thoracic 0
pain 0

Northern 0
blot 0
analysis 0
confirmed 0
that 0
ADAMTS B-gene
- I-gene
1 I-gene
was 0
up 0
- 0
regulated 0
in 0
both 0
metaphyseal 0
( 0
14 0
- 0
to 0
35 0
- 0
fold 0
) 0
and 0
diaphyseal 0
( 0
4.2 0
- 0
fold 0
) 0
bone 0
1 0
h 0
after 0
PTH B-gene
- I-gene
( I-gene
1 I-gene
- I-gene
38 I-gene
) I-gene
injection 0
and 0
returned 0
to 0
control 0
levels 0
by 0
24 0
h 0
. 0

The 0
findings 0
in 0
the 0
human 0
multiple 0
myeloma 0
cell 0
lines 0
represent 0
the 0
first 0
examples 0
of 0
B 0
cells 0
with 0
downregulated 0
PU.1 B-gene
expression 0
and 0
apparently 0
contradict 0
observations 0
in 0
the 0
murine 0
system 0
in 0
which 0
PU.1 B-gene
is 0
expressed 0
and 0
active 0
in 0
plasmacytoma 0
cell 0
lines 0
. 0

Northern 0
blot 0
analysis 0
identified 0
retina 0
- 0
specific 0
transcripts 0
of 0
3.0 0
kb 0
for 0
rod B-gene
G I-gene
alpha I-gene
t I-gene
and 0
2.6 0
kb 0
for 0
cone B-gene
G I-gene
alpha I-gene
t I-gene
. 0

The 0
STP1 B-gene
locus I-gene
is 0
located 0
on 0
chromosome 0
IV 0
close 0
to 0
at 0
least 0
two 0
other 0
genes 0
involved 0
in 0
RNA 0
splicing 0
: 0
PRP3 B-gene
and 0
SPP41 B-gene
. 0

Both 0
sequence 0
analysis 0
and 0
restriction 0
fragment 0
length 0
polymorphism 0
analysis 0
revealed 0
a 0
high 0
degree 0
of 0
sequence 0
( 0
97 0
% 0
homology 0
) 0
and 0
structural 0
similarity 0
among 0
members 0
of 0
the 0
ART B-gene
- 0
CH B-gene
family 0
, 0
indicating 0
their 0
common 0
origin 0
and 0
recent 0
penetration 0
into 0
chicken 0
DNA 0
. 0

This 0
interesting 0
exon 0
junction 0
resulted 0
in 0
novel 0
deduced 0
amino 0
terminal 0
open 0
reading 0
frames 0
, 0
which 0
are 0
completely 0
in 0
- 0
frame 0
with 0
sequences 0
located 0
further 0
downstream 0
. 0

We 0
investigated 0
the 0
pattern 0
of 0
evolution 0
of 0
bronchial 0
albumin B-gene
, 0
IgA B-gene
, 0
and 0
IgG B-gene
levels 0
in 0
ventilated 0
ICU 0
patients 0
in 0
relation 0
to 0
nosocomial 0
pneumonia 0
. 0

The 0
presence 0
of 0
highly 0
correlated 0
frequencies 0
provided 0
strong 0
evidence 0
of 0
a 0
medium 0
- 0
frequency 0
pattern 0
generator 0
which 0
may 0
remain 0
operative 0
beyond 0
the 0
neonatal 0
period 0
. 0

Pancreatic 0
expression 0
of 0
the 0
glucagon B-gene
gene I-gene
depends 0
on 0
multiple 0
transcription 0
factors 0
interacting 0
with 0
at 0
least 0
three 0
DNA 0
control 0
elements 0
: 0
G1 0
, 0
the 0
upstream 0
promoter 0
element 0
, 0
and 0
G2 0
and 0
G3 0
, 0
two 0
enhancer 0
- 0
like 0
sequences 0
. 0

Before 0
and 0
6 0
and 0
12 0
months 0
after 0
H. 0
pylori 0
eradication 0
the 0
patients 0
were 0
evaluated 0
for 0
fasting 0
gastrinemia 0
and 0
pepsinogen B-gene
I I-gene
, 0
basal 0
and 0
peak 0
acid 0
output 0
, 0
and 0
detailed 0
histological 0
assessment 0
including 0
the 0
ECL 0
cell 0
proliferative 0
patterns 0
. 0

Thus 0
, 0
CARP B-gene
is 0
a 0
YB B-gene
- I-gene
1 I-gene
associated I-gene
factor I-gene
and 0
represents 0
the 0
first 0
identified 0
cardiac 0
- 0
restricted 0
downstream 0
regulatory 0
gene 0
in 0
the 0
homeobox 0
gene 0
Nkx2 B-gene
- I-gene
5 I-gene
pathway 0
and 0
may 0
serve 0
as 0
a 0
negative 0
regulator 0
of 0
HF B-gene
- I-gene
1 I-gene
- 0
dependent 0
pathways 0
for 0
ventricular 0
muscle 0
gene 0
expression 0
. 0

Barium 0
mucosal 0
coating 0
was 0
judged 0
to 0
be 0
better 0
in 0
the 0
members 0
to 0
whom 0
magnesium 0
sulphate 0
was 0
administered 0
( 0
p 0
= 0
0.0007 0
) 0
. 0

Structure 0
and 0
chromosomal 0
localization 0
of 0
the 0
human 0
gene 0
of 0
the 0
phosphotyrosyl B-gene
phosphatase I-gene
activator I-gene
( 0
PTPA B-gene
) 0
of 0
protein B-gene
phosphatase I-gene
2A I-gene
. 0

This 0
article 0
expands 0
the 0
analysis 0
of 0
a 0
numeric 0
example 0
included 0
in 0
the 0
SAS 0
GLM 0
procedure 0
to 0
cover 0
several 0
crucial 0
statistical 0
aspects 0
relevant 0
to 0
ANCOVA 0
, 0
and 0
to 0
highlight 0
the 0
meaning 0
of 0
the 0
statistical 0
results 0
obtained 0
. 0

The 0
PEP4 B-gene
gene I-gene
was 0
isolated 0
from 0
a 0
genomic 0
DNA 0
library 0
by 0
complementation 0
of 0
the 0
pep4 B-gene
- I-gene
3 I-gene
mutation 0
. 0

These 0
results 0
suggest 0
that 0
panretinal 0
photocoagulation 0
offers 0
a 0
highly 0
effective 0
means 0
of 0
dealing 0
with 0
early 0
and 0
moderately 0
advanced 0
cases 0
of 0
angle 0
neovascularization 0
. 0

Bilateral 0
renal 0
oncocytoma 0
in 0
a 0
Greyhound 0
dog 0
. 0

Membrane 0
depolarization 0
is 0
a 0
critical 0
element 0
of 0
neuronal 0
signaling 0
. 0

The 0
E. 0
multilocularis/Mongolian 0
gerbil 0
system 0
can 0
replace 0
the 0
natural 0
canid 0
hosts 0
as 0
a 0
new 0
way 0
to 0
obtain 0
infective 0
eggs 0
and 0
to 0
analyze 0
host 0
- 0
parasite 0
interactions 0
. 0

The 0
Fugu 0
rubripes 0
( 0
Fugu 0
) 0
gene 0
fragment 0
was 0
used 0
to 0
isolate 0
the 0
GH B-gene
gene I-gene
from 0
a 0
Fugu 0
genomic 0
library 0
. 0

For 0
the 0
first 0
time 0
also 0
a 0
genomic 0
sequence 0
for 0
a 0
red B-gene
algal I-gene
lhc I-gene
gene I-gene
is 0
presented 0
. 0

All 0
such 0
polypeptides 0
containing 0
263 0
or 0
more 0
residues 0
derived 0
from 0
the 0
C 0
- 0
terminus 0
of 0
P130gag B-gene
- 0
fps B-gene
( 0
i.e 0
. 0
residues 0
920 0
- 0
1182 0
) 0
were 0
enzymatically 0
active 0
as 0
tyrosine B-gene
kinases I-gene
. 0

Were 0
this 0
hypothesis 0
correct 0
, 0
the 0
requirement 0
for 0
elF4A B-gene
should 0
correlate 0
with 0
the 0
degree 0
of 0
mRNA 0
secondary 0
structure 0
. 0

Comparison 0
with 0
the 0
data 0
of 0
clinical 0
development 0
and 0
hemodynamic 0
results 0

Localized 0
Bicaudal B-gene
- I-gene
C I-gene
RNA I-gene
encodes 0
a 0
protein 0
containing 0
a 0
KH 0
domain 0
, 0
the 0
RNA 0
binding 0
motif 0
of 0
FMR1 B-gene
. 0

Despite 0
a 0
lowering 0
of 0
her 0
plasma 0
ACTH B-gene
concentration 0
during 0
therapy 0
with 0
valproic 0
acid 0
, 0
the 0
patient 0
's 0
tumour 0
showed 0
no 0
evidence 0
of 0
regression 0
while 0
she 0
was 0
taking 0
the 0
drug 0
. 0

This 0
is 0
the 0
first 0
report 0
which 0
clearly 0
proved 0
CEA B-gene
synthesis 0
in 0
the 0
cells 0
of 0
HCC 0
. 0

NASA 0
CR 0
- 0
1223 0
. 0

2 0
. 0

The 0
classic 0
sterol 0
regulatory 0
cis 0
element 0
( 0
sre 0
- 0
1 0
) 0
in 0
the 0
LDL B-gene
receptor I-gene
promoter 0
mediates 0
sterol B-gene
regulatory I-gene
element I-gene
binding I-gene
protein I-gene
( 0
SREBP B-gene
) 0
- 0
binding 0
and 0
the 0
effects 0
of 0
insulin B-gene
and 0
platelet B-gene
derived I-gene
growth I-gene
factor I-gene
( 0
PDGF B-gene
) 0
. 0

The 0
D443N B-gene
substitution I-gene
is 0
an 0
activating 0
mutation 0
that 0
increases 0
the 0
activity 0
of 0
SCAP B-gene
and 0
renders 0
it 0
resistant 0
to 0
inhibition 0
by 0
25 0
- 0
hydroxycholesterol 0
. 0

Transcriptional 0
modulation 0
of 0
the 0
anti B-gene
- I-gene
apoptotic I-gene
protein I-gene
BCL I-gene
- I-gene
XL I-gene
by 0
the 0
paired B-gene
box I-gene
transcription I-gene
factors I-gene
PAX3 B-gene
and 0
PAX3/FKHR B-gene
. 0

5.3 0
+/ 0
- 0
6.6 0
for 0
risperidone 0
( 0
P 0
= 0
0.09 0
) 0
. 0

CONCLUSIONS 0
: 0
This 0
study 0
shows 0
that 0
the 0
annual 0
rate 0
of 0
de 0
novo 0
aneurysm 0
formation 0
is 0
relatively 0
high 0
( 0
0.89 0
% 0
) 0
and 0
that 0
the 0
cumulative 0
risk 0
becomes 0
significant 0
after 0
9 0
years 0
. 0

In 0
this 0
case 0
myogenic 0
factors 0
are 0
not 0
initially 0
expressed 0
and 0
these 0
migratory 0
cells 0
are 0
characterized 0
by 0
the 0
expression 0
of 0
the 0
paired B-gene
- 0
box 0
gene 0
Pax3 B-gene
. 0

In 0
those 0
patients 0
who 0
before 0
transplantation 0
were 0
serological 0
negative 0
for 0
CMV 0
but 0
had 0
received 0
organs 0
from 0
CMV B-gene
- I-gene
IgG I-gene
positive 0
donors 0
, 0
the 0
incidence 0
of 0
the 0
disease 0
was 0
highest 0
. 0

The 0
fecal 0
excretion 0
is 0
found 0
to 0
be 0
only 0
one 0
third 0
of 0
that 0
measured 0
in 0
urine 0
. 0

This 0
ERD 0
is 0
recorded 0
over 0
the 0
contralateral 0
central 0
region 0
. 0

We 0
report 0
the 0
sequence 0
of 0
a 0
7941 0
bp 0
DNA 0
fragment 0
from 0
the 0
left 0
arm 0
of 0
chromosome 0
VII 0
of 0
Saccharomyces 0
cerevisiae 0
which 0
contains 0
four 0
open 0
reading 0
frames 0
( 0
ORFs 0
) 0
of 0
greater 0
than 0
100 0
amino 0
acid 0
residues 0
. 0

Tax B-gene
was 0
demonstrated 0
to 0
interact 0
directly 0
with 0
CREB1 B-gene
but 0
not 0
with 0
other 0
bZIP B-gene
proteins I-gene
, 0
including 0
CREB2 B-gene
and 0
Jun B-gene
. 0

Forty 0
- 0
five 0
per 0
cent 0
of 0
the 0
dose 0
was 0
excreted 0
as 0
methyldopa 0
as 0
opposed 0
to 0
18 0
% 0
normally 0
seen 0
after 0
oral 0
methyldopa 0
dosages 0
. 0

Standing 0
values 0
: 0
placebo 0
114/79 0
; 0
BHT 0
- 0
933 0
92/67 0
. 0

Zoonotic 0
areas 0
in 0
which 0
HIV 0
co 0
- 0
infection 0
is 0
common 0
could 0
also 0
be 0
at 0
risk 0
as 0
sandflies 0
can 0
become 0
infected 0
from 0
co 0
- 0
infected 0
individuals 0
. 0

In 0
cases 0
in 0
which 0
it 0
was 0
identified 0
, 0
insulitis 0
affected 0
23 0
% 0
of 0
islets 0
containing 0
insulin B-gene
, 0
but 0
affected 0
only 0
1 0
% 0
of 0
islets 0
which 0
were 0
insulin B-gene
deficient 0
, 0
thus 0
supporting 0
the 0
concept 0
that 0
insulitis 0
represents 0
an 0
immunologically 0
mediated 0
destruction 0
of 0
insulin B-gene
secreting 0
B 0
cells 0
. 0

Each 0
fusion 0
leads 0
, 0
in 0
principle 0
, 0
to 0
the 0
same 0
effect 0
: 0
The 0
ret B-gene
tyrosine I-gene
kinase I-gene
is 0
uncoupled 0
from 0
its 0
stringent 0
physiological 0
regulation 0
by 0
replacement 0
of 0
its 0
5 0
' 0
end 0
and 0
is 0
aberrantly 0
activated 0
by 0
the 0
5 0
' 0
parts 0
of 0
fused 0
genes 0
in 0
thyrocytes 0
that 0
do 0
not 0
normally 0
express 0
ret B-gene
tyrosine I-gene
kinase I-gene
. 0

Proteins 0
PBP B-gene
- I-gene
1 I-gene
and 0
PBP B-gene
- I-gene
2 I-gene
bind 0
to 0
two 0
of 0
the 0
three 0
promoter 0
elements 0
in 0
the 0
trypanosomatid 0
Leptomonas 0
seymouri 0
. 0

Induction 0
of 0
interferon B-gene
- I-gene
alpha I-gene
( 0
IFNalpha B-gene
) 0
gene 0
expression 0
in 0
virus 0
- 0
infected 0
cells 0
requires 0
phosphorylation 0
- 0
induced 0
activation 0
of 0
the 0
transcription 0
factors 0
IRF3 B-gene
and 0
IRF7 B-gene
. 0

The 0
differences 0
of 0
percentages 0
for 0
HIV 0
- 0
1 0
infection 0
in 0
intravenous 0
drug 0
users 0
( 0
IVDU 0
) 0
were 0
67.7 0
% 0
and 0
in 0
non 0
IVDU 0
were 0
3.8 0
% 0
with 0
a 0
significant 0
statistical 0
difference 0
( 0
chi 0
2 0
= 0
557.5 0
; 0
p 0
< 0
0.0001 0
) 0
. 0

Humoral 0
immunity 0
is 0
altered 0
with 0
the 0
drop 0
in 0
IgG B-gene
levels 0
. 0

The 0
vicinity 0
of 0
large 0
industrial 0
emissions 0
of 0
lead 0
, 0
where 0
mean 0
Pb 0
- 0
B 0
concentrations 0
were 0
usually 0
twice 0
as 0
high 0
as 0
in 0
rural 0
areas 0
of 0
the 0
Katowice 0
voivodship 0
. 0

( 0
control 0
hearts 0
) 0
. 0

Thus 0
, 0
BCR B-gene
ligation 0
initiates 0
a 0
PI B-gene
3 I-gene
- I-gene
kinase/Akt/GSK I-gene
kinase/Akt/GSK I-gene

Effect 0
of 0
a 0
new 0
positive 0
inotropic 0
agent 0
( 0
OPC 0
- 0
8212 0
) 0
on 0
intracellular 0
potential 0
of 0
isolated 0
canine 0
ventricular 0
papillary 0
muscle 0

Although 0
several 0
other 0
signal 0
transduction 0
molecules 0
also 0
contain 0
tandemly 0
occurring 0
SH3 B-gene
and 0
SH2 B-gene
domains I-gene
, 0
the 0
function 0
of 0
these 0
closely 0
spaced 0
domains 0
is 0
not 0
well 0
understood 0
. 0

At 0
the 0
same 0
acoustic 0
power 0
, 0
the 0
rate 0
of 0
chloride 0
formation 0
with 0
20 0
kHz 0
ultrasound 0
was 0
greater 0
when 0
a 0
probe 0
with 0
a 0
larger 0
tip 0
area 0
was 0
used 0
, 0
but 0
significantly 0
less 0
than 0
the 0
rate 0
with 0
900 0
kHz 0
. 0

This 0
is 0
the 0
first 0
report 0
demonstrating 0
specificity 0
at 0
the 0
level 0
of 0
the 0
energy 0
coupling 0
proteins 0
of 0
the 0
PTS 0
. 0

The 0
R260A 0
mutant 0
, 0
as 0
expected 0
, 0
was 0
unable 0
to 0
support 0
mRNA 0
synthesis 0
in 0
vitro 0
in 0
a 0
transcription 0
reconstitution 0
reaction 0
as 0
well 0
as 0
transcription 0
in 0
vivo 0
of 0
a 0
minigenome 0
using 0
a 0
reverse 0
genetic 0
approach 0
. 0

As 0
expected 0
, 0
the 0
QOLS 0
- 0
N 0
had 0
a 0
lower 0
correlation 0
with 0
physical 0
health 0
( 0
r 0
= 0
0.24 0
, 0
p 0
< 0
0.000 0
) 0
and 0
self 0
- 0
reported 0
symptoms 0
( 0
r 0
= 0
- 0
0.20 0
, 0
p 0
< 0
0.001 0
) 0
, 0
and 0
a 0
higher 0
correlation 0
with 0
mental 0
health 0
( 0
r 0
= 0
0.52 0
, 0
p 0
< 0
0.000 0
) 0
. 0

Human B-gene
epidermal I-gene
growth I-gene
factor I-gene
( 0
EGF B-gene
) 0
, 0
a 0
naturally 0
occurring 0
protein 0
, 0
has 0
been 0
implicated 0
in 0
the 0
protection 0
of 0
gastrointestinal 0
mucosal 0
integrity 0
. 0

Elevated 0
potassium 0
stimulation 0
of 0
GAL B-gene
mRNA I-gene
was 0
completely 0
blocked 0
, 0
but 0
pituitary 0
adenylyl B-gene
cyclase I-gene
- I-gene
activating I-gene
polypeptide I-gene
and 0
histamine 0
stimulations 0
were 0
only 0
partially 0
blocked 0
, 0
by 0
cycloheximide 0
. 0

DNA 0
elements 0
recognizing 0
NF B-gene
- I-gene
Y I-gene
and 0
Sp1 B-gene
regulate 0
the 0
human B-gene
multidrug I-gene
- I-gene
resistance I-gene
gene I-gene
promoter I-gene
. 0

We 0
constructed 0
a 0
series 0
of 0
chimeric 0
genes 0
containing 0
part 0
of 0
the 0
first 0
exon 0
and 0
increasingly 0
longer 0
5 0
' 0
flanking 0
sequences 0
of 0
the 0
ODC B-gene
gene I-gene
fused 0
to 0
either 0
bacterial B-gene
chloramphenicol I-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
or 0
luciferase B-gene
reporter I-gene
genes I-gene
. 0

To 0
investigate 0
this 0
possibility 0
, 0
we 0
conducted 0
split 0
- 0
visual 0
- 0
field 0
studies 0
in 0
which 0
we 0
manipulated 0
stimulus 0
sets 0
, 0
recognition 0
task 0
, 0
and 0
exposure 0
duration 0
. 0

Like 0
pimethixene 0
and 0
cyproheptadine 0
, 0
WA 0
335 0
has 0
no 0
distinct 0
antagonistic 0
qualities 0
against 0
bradykinin B-gene
. 0

To 0
explore 0
the 0
mechanism 0
of 0
insulin B-gene
receptor I-gene
phosphorylation 0
we 0
have 0
used 0
NIH3T3 0
cells 0
transfected 0
with 0
two 0
receptor 0
constructs 0
: 0
one 0
encoding 0
a 0
chimeric 0
receptor 0
composed 0
of 0
the 0
extracellular 0
domain 0
of 0
the 0
human B-gene
EGF I-gene
receptor I-gene
and 0
the 0
cytosolic 0
domain 0
of 0
the 0
human B-gene
insulin I-gene
receptor I-gene
beta I-gene
- I-gene
subunit I-gene
, 0
and 0
a 0
second 0
construct 0
encoding 0
a 0
kinase 0
- 0
defiecient 0
human B-gene
insulin I-gene
receptor I-gene
. 0

Additional 0
simulations 0
account 0
for 0
interactions 0
of 0
spatial 0
frequency 0
with 0
stimulus 0
duration 0
, 0
effects 0
of 0
adaptation 0
, 0
and 0
properties 0
of 0
residual 0
traces 0
, 0
as 0
opposed 0
to 0
visual 0
persistence 0
. 0

A 0
DNA 0
fragment 0
that 0
complements 0
the 0
uvs B-gene
- I-gene
2 I-gene
mutation 0
was 0
subcloned 0
by 0
monitoring 0
its 0
ability 0
to 0
transform 0
the 0
uvs B-gene
- I-gene
2 I-gene
mutant I-gene
to 0
MMS 0
resistance 0
. 0

This 0
cell 0
line 0
expresses 0
productively 0
rearranged 0
immunoglobulin B-gene
genes I-gene
as 0
well 0
as 0
the 0
Oct B-gene
- I-gene
2 I-gene
gene I-gene
at 0
high 0
levels 0
which 0
are 0
comparable 0
to 0
those 0
observed 0
in 0
activated 0
murine 0
splenic 0
B 0
cells 0
. 0

Back 0
- 0
ground 0
factors 0
which 0
affect 0
the 0
outcome 0
of 0
steroid 0
withdrawal 0
therapy 0
in 0
patients 0
with 0
chronic 0
type 0
B 0
hepatitis 0
- 0
- 0
statistical 0
evaluation 0
of 0
the 0
importance 0
of 0
the 0
mode 0
of 0
HBV 0
transmission 0

Effect 0
of 0
food 0
on 0
hemodynamics 0
. 0

PTP1 B-gene
- 0
lacZ B-gene
studies 0
indicate 0
that 0
PTP1 B-gene
is 0
spatially 0
localized 0
to 0
prestalk 0
and 0
anterior 0
- 0
like 0
cell 0
types 0
. 0

Morphologic 0
evidence 0
that 0
rhe 0
renal 0
calyx 0
and 0
pelvis 0
control 0
ureteric 0
activity 0
in 0
the 0
rabbit 0
. 0

Human B-gene
alcohol I-gene
dehydrogenase I-gene
( 0
ADH B-gene
) 0
exists 0
as 0
a 0
heterogeneous 0
group 0
of 0
isozymes 0
capable 0
of 0
oxidizing 0
a 0
wide 0
variety 0
of 0
aliphatic 0
and 0
aromatic 0
alcohols 0
. 0

We 0
reviewed 0
81 0
patients 0
with 0
dementia 0
and 0
autopsy 0
findings 0
of 0
Alzheimer 0
's 0
disease 0
( 0
AD 0
) 0
to 0
identify 0
patients 0
with 0
seizures 0
or 0
myoclonus 0
after 0
onset 0
of 0
dementia 0
. 0

The 0
second 0
system 0
( 0
VacFix 0
) 0
uses 0
a 0
0.15 0
mm 0
thick 0
plastic 0
bag 0
loosely 0
filled 0
with 0
1 0
mm 0
polysterol 0
spheres 0
. 0

Expression 0
in 0
all 0
lines 0
was 0
decreased 0
by 0
the 0
inclusion 0
of 0
regions 0
further 0
upstream 0
, 0
and 0
extinguished 0
by 0
the 0
inclusion 0
of 0
the 0
first 0
intron 0
. 0

These 0
results 0
indicate 0
that 0
the 0
changes 0
in 0
the 0
patient 0
's 0
thyroid 0
scan 0
and 0
RAIU 0
were 0
attributable 0
to 0
the 0
presence 0
of 0
TSAb 0
. 0

U 0
. 0

A 0
Laboratory 0
Manual 0
, 0
2nd 0
ed 0
. 0

In 0
the 0
case 0
of 0
a 0
moderate 0
buccal 0
Class 0
II 0
tendency 0
, 0
55 0
% 0
of 0
the 0
molars 0
were 0
in 0
a 0
Class 0
I 0
relationship 0
when 0
evaluated 0
from 0
the 0
lingual 0
side 0
, 0
whereas 0
45 0
% 0
belonged 0
to 0
mild 0
( 0
1st 0
degrees 0
) 0
Class 0
II 0
with 0
molar 0
rotations 0
present 0
in 0
81 0
% 0
of 0
the 0
cases 0
. 0

The 0
resulting 0
score 0
, 0
which 0
allowed 0
the 0
disease 0
to 0
be 0
expressed 0
as 0
a 0
continuous 0
variable 0
, 0
was 0
effectively 0
utilized 0
to 0
see 0
the 0
correlations 0
between 0
the 0
severity 0
of 0
coronary 0
arterial 0
disease 0
( 0
CAD 0
) 0
and 0
individual 0
risk 0
factors/risk 0
markers 0
. 0

The 0
gene 0
encoding 0
the 0
cellulase B-gene
( 0
Avicelase B-gene
) 0
Cel1 B-gene
from 0
Streptomyces 0
reticuli 0
and 0
analysis 0
of 0
protein 0
domains 0
. 0

A 0
protein 0
which 0
promotes 0
DNA 0
strand 0
transfer 0
between 0
linear 0
double 0
- 0
stranded 0
M13mp19 0
DNA 0
and 0
single 0
- 0
stranded 0
viral 0
M13mp19 0
DNA 0
has 0
been 0
isolated 0
from 0
recA B-gene
- I-gene
E.coli 0
. 0

We 0
speculate 0
that 0
the 0
enhancing 0
effect 0
of 0
glucose 0
and 0
galactose 0
on 0
fructose 0
absorption 0
may 0
be 0
due 0
to 0
activation 0
of 0
the 0
fructose B-gene
carrier I-gene
. 0

The 0
nutraceuticals 0
of 0
specific 0
vitamins 0
, 0
minerals 0
, 0
phytoestrogens 0
, 0
and 0
essential 0
fatty 0
acid 0
supplementations 0
are 0
a 0
vital 0
component 0
of 0
the 0
risk 0
reduction 0
health 0
program 0
. 0

Thus 0
, 0
in 0
V. 0
furnissii 0
, 0
the 0
E. B-gene
coli I-gene
manX I-gene
equivalent I-gene
comprises 0
two 0
genes 0
, 0
which 0
are 0
separated 0
in 0
the 0
genome 0
by 0
two 0
other 0
genes 0
of 0
the 0
ptsM B-gene
complex I-gene
. 0

An 0
scrR B-gene
promoter I-gene
fragment I-gene
, 0
which 0
dose 0
not 0
contain 0
a 0
sequence 0
resembling 0
OB B-gene
, 0
was 0
not 0
shifted 0
by 0
the 0
fusion 0
protein 0
. 0

Ectopic 0
expression 0
of 0
cyclin B-gene
D1 I-gene
in 0
progestin 0
- 0
inhibited 0
cells 0
led 0
to 0
the 0
reappearance 0
of 0
the 0
120 0
- 0
kDa 0
active 0
form 0
of 0
cyclin B-gene
E I-gene
- 0
Cdk2 B-gene
preceding 0
the 0
resumption 0
of 0
cell 0
cycle 0
progression 0
. 0

We 0
screened 0
an 0
A. 0
thaliana 0
cDNA 0
library 0
, 0
whose 0
inserts 0
are 0
under 0
the 0
control 0
of 0
the 0
galactose 0
- 0
inducible 0
GAL10 B-gene
promoter I-gene
, 0
for 0
cDNAs 0
which 0
enabled 0
YDH8 0
cells 0
to 0
grow 0
at 0
the 0
restrictive 0
temperature 0
. 0

The 0
mouse B-gene
alpha I-gene
A I-gene
- I-gene
CRYBP1 I-gene
gene I-gene
specifies 0
a 0
2,688 0
- 0
amino 0
acid 0
protein 0
with 0
72 0
% 0
amino 0
acid 0
identity 0
to 0
its 0
human 0
homologue 0
, 0
PRDII B-gene
- I-gene
BF1 I-gene
. 0

Sequence 0
analysis 0
revealed 0
that 0
Hv B-gene
- I-gene
p68 I-gene
belongs 0
to 0
the 0
large 0
family 0
of 0
FAD B-gene
- I-gene
dependent I-gene
glucose I-gene
methanol I-gene
choline I-gene
oxidoreductases I-gene
and 0
that 0
it 0
shares 0
significant 0
sequence 0
identity 0
( 0
> 0
67 0
% 0
) 0
with 0
the 0
alcohol B-gene
oxidases I-gene
of 0
the 0
methylotrophic 0
yeasts 0
. 0

Therefore 0
, 0
we 0
have 0
reevaluated 0
the 0
age 0
- 0
related 0
changes 0
in 0
serum B-gene
leptin I-gene
levels 0
and 0
their 0
relationship 0
with 0
adiposity 0
and 0
androgen 0
levels 0
in 0
a 0
large 0
group 0
of 0
community 0
dwelling 0
men 0
. 0

The 0
1 0
- 0
year 0
and 0
2 0
- 0
year 0
survival 0
rates 0
for 0
the 0
patients 0
with 0
N0 0
- 0
3 0
significantly 0
exceeded 0
those 0
of 0
N4 0
patients 0
. 0

While 0
reviewing 0
gastric 0
specimens 0
from 0
215 0
baboons 0
, 0
we 0
found 0
diffuse 0
giant 0
mucosal 0
folds 0
in 0
2 0
specimens 0
and 0
multiple 0
giant 0
mucosal 0
nodules 0
in 0
another 0
3 0
. 0

Morphologically 0
, 0
corrugation 0
of 0
the 0
internal 0
elastic 0
lamina 0
of 0
vessels 0
was 0
often 0
observed 0
in 0
the 0
vehicle 0
- 0
treated 0
group 0
, 0
but 0
was 0
not 0
prominent 0
in 0
the 0
GLNVA 0
- 0
treated 0
groups 0
or 0
healthy 0
controls 0
. 0

Transcripts 0
initiating 0
at 0
the 0
CAGT 0
motif 0
( 0
proximal 0
transcripts 0
) 0
were 0
abolished 0
by 0
deletion 0
of 0
the 0
proximal 0
TATA 0
box 0
located 0
at 0
- 0
29 0
relative 0
to 0
CAGT 0
. 0

The 0
phenomena 0
of 0
nursing 0
are 0
deeply 0
rooted 0
in 0
the 0
human 0
condition 0
. 0

Coronatine B-gene
( 0
COR B-gene
) 0
is 0
a 0
plasmid 0
- 0
encoded 0
phytotoxin 0
synthesized 0
by 0
several 0
pathovars 0
of 0
phytopathogenic 0
Pseudomonas 0
syringae 0
. 0

It 0
has 0
become 0
clear 0
that 0
there 0
is 0
not 0
one 0
mediator 0
responsible 0
for 0
ALI 0
, 0
but 0
rather 0
a 0
complex 0
interplay 0
exists 0
between 0
diverse 0
proinflammatory 0
( 0
e.g. 0
, 0
lipopolysaccharide 0
, 0
complement 0
products 0
, 0
cytocains 0
, 0
chemocains 0
, 0
reactive 0
oxygen 0
species 0
and 0
arachidonic 0
acid 0
products 0
) 0
and 0
anti 0
- 0
inflammatory 0
( 0
IL B-gene
- I-gene
10 I-gene
, 0
IL B-gene
- I-gene
1 I-gene
- I-gene
RA I-gene
, 0
PGI2 0
) 0
mediators 0
. 0

Not 0
only 0
will 0
it 0
substantially 0
reduce 0
incident 0
cases 0
of 0
hepatitis 0
B 0
for 0
the 0
next 0
decade 0
, 0
it 0
will 0
also 0
provide 0
a 0
framework 0
for 0
the 0
successful 0
introduction 0
of 0
future 0
adolescent 0
vaccine 0
initiatives 0
in 0
Australia 0
. 0

Radioactively 0
labeled 0
microspheres 0
were 0
used 0
to 0
determine 0
and 0
compare 0
the 0
hemodynamic 0
effects 0
of 0
sodium 0
nitroprusside 0
( 0
SNP 0
) 0
, 0
nitroglycerin 0
( 0
NTG 0
) 0
, 0
and 0
deep 0
enflurane 0
anesthesia 0
on 0
oral 0
tissues 0
during 0
controlled 0
hypotension 0
when 0
compared 0
with 0
controls 0
. 0

We 0
conclude 0
that 0
the 0
MMF 0
lesion 0
is 0
secondary 0
to 0
intramuscular 0
injection 0
of 0
aluminium 0
hydroxide 0
- 0
containing 0
vaccines 0
, 0
shows 0
both 0
long 0
- 0
term 0
persistence 0
of 0
aluminium 0
hydroxide 0
and 0
an 0
ongoing 0
local 0
immune 0
reaction 0
, 0
and 0
is 0
detected 0
in 0
patients 0
with 0
systemic 0
symptoms 0
which 0
appeared 0
subsequently 0
to 0
vaccination 0
. 0

Advisory 0
Committee 0
report 0
recommends 0
that 0
US 0
make 0
amends 0
for 0
human 0
radiation 0
experiments 0
. 0

An 0
evaluation 0
of 0
a 0
positive 0
control 0
for 0
platelet 0
neutralization 0
procedure 0
testing 0
with 0
seven 0
commercial 0
activated 0
partial 0
thromboplastin B-gene
time 0
reagents 0
. 0

Transmission 0
of 0
mutans 0
streptococci 0
to 0
infants 0
following 0
short 0
term 0
application 0
of 0
an 0
iodine 0
- 0
NaF 0
solution 0
to 0
mothers 0
' 0
dentition 0
. 0

Glycoprotein 0
biosynthesis 0
in 0
Saccharomyces 0
cerevisiae 0
: 0
ngd29 B-gene
, 0
an 0
N 0
- 0
glycosylation 0
mutant 0
allelic 0
to 0
och1 B-gene
having 0
a 0
defect 0
in 0
the 0
initiation 0
of 0
outer 0
chain 0
formation 0
. 0

However 0
, 0
no 0
consensus 0
on 0
indications 0
exists 0
and 0
, 0
according 0
to 0
the 0
literature 0
, 0
results 0
are 0
contradictory 0
. 0

The 0
effects 0
of 0
erythrosine 0
( 0
Red 0
3 0
) 0
, 0
rose 0
bengal 0
B 0
( 0
Red 0
105 0
) 0
and 0
thyroidectomy 0
on 0
the 0
development 0
of 0
thyroid 0
tumor 0
were 0
examined 0
in 0
male 0
Wistar 0
rats 0
treated 0
with 0
N 0
- 0
bis 0
( 0
2 0
- 0
hydroxypropyl 0
) 0
nitrosamine 0
( 0
DHPN 0
) 0
. 0

The 0
region 0
surrounding 0
the 0
ZNF35 B-gene
zinc I-gene
finger I-gene
protein I-gene
gene I-gene
on 0
3p21 0
is 0
of 0
particular 0
interest 0
, 0
as 0
this 0
region 0
of 0
chromosome 0
3 0
is 0
frequently 0
involved 0
in 0
rearrangements 0
and/or 0
deletions 0
associated 0
with 0
various 0
human 0
tumors 0
including 0
lung 0
and 0
renal 0
carcinoma 0
. 0

In 0
contrast 0
, 0
no 0
change 0
in 0
the 0
level 0
of 0
either 0
p53 B-gene
or 0
activation 0
of 0
mdm2 B-gene
protein I-gene
by 0
p53 B-gene
was 0
observed 0
in 0
hamster 0
UV61 0
cells 0
after 0
UV 0
exposure 0
. 0

Complete 0
activation 0
of 0
signal B-gene
transducer I-gene
and I-gene
activator I-gene
of I-gene
transcription I-gene
1 I-gene
( 0
STAT1 B-gene
) 0
requires 0
phosphorylation 0
at 0
both 0
Y701 0
and 0
a 0
conserved 0
PMS 0
( 0
727 0
) 0
P 0
sequence 0
. 0

It 0
is 0
believed 0
that 0
the 0
operation 0
is 0
effective 0
because 0
it 0
cuts 0
the 0
spinothalamic 0
tract 0
( 0
STT 0
) 0
, 0
a 0
primary 0
pathway 0
carrying 0
nociceptive 0
information 0
from 0
the 0
spinal 0
cord 0
to 0
the 0
brain 0
in 0
humans 0
. 0

On 0
the 0
basis 0
of 0
experiments 0
with 0
mutant 0
virus 0
and 0
transfection 0
with 0
isolated 0
genes 0
, 0
the 0
herpes B-gene
simplex I-gene
virus I-gene
immediate I-gene
- I-gene
early I-gene
gene I-gene
product 0
ICP4 B-gene
is 0
known 0
to 0
positively 0
regulate 0
the 0
transcription 0
of 0
viral B-gene
early I-gene
and I-gene
late I-gene
genes I-gene
and 0
negatively 0
regulate 0
expression 0
from 0
its 0
own 0
promoter 0
. 0

Alcohol 0
abuse 0
and 0
treatment 0
resistance 0
in 0
skin 0
disease 0
. 0

These 0
data 0
suggest 0
that 0
reduction 0
in 0
PRA 0
may 0
have 0
contributed 0
to 0
the 0
hemodynamic 0
effects 0
of 0
this 0
peak B-gene
III I-gene
PDE I-gene
inhibitor 0
. 0

However 0
, 0
studies 0
using 0
the 0
A20 B-gene
promoter I-gene
demonstrated 0
that 0
LMP1 B-gene
transcriptionally 0
activates 0
the 0
A20 B-gene
gene I-gene
through 0
cis 0
- 0
acting 0
kappa B-gene
B I-gene
sites I-gene
. 0

The 0
first 0
270 0
bp 0
of 0
the 0
promoter 0
region 0
were 0
sequenced 0
and 0
found 0
to 0
contain 0
a 0
CATAA 0
box 0
rather 0
than 0
a 0
TATAA 0
box 0
and 0
several 0
DNA 0
motifs 0
found 0
in 0
activation 0
genes 0
. 0

This 0
study 0
investigated 0
if 0
signal 0
- 0
averaged 0
low 0
amplitude 0
atrial 0
potentials 0
predict 0
atrial 0
fibrillation 0
or 0
flutter 0
( 0
AFF 0
) 0
. 0

The 0
reduced 0
expression 0
caused 0
by 0
multimerization 0
of 0
UAS2 0
in 0
the 0
native 0
promoter 0
was 0
observed 0
only 0
in 0
the 0
presence 0
of 0
ADR1 B-gene
. 0

Finally 0
, 0
we 0
tested 0
whether 0
activation 0
by 0
either 0
of 0
these 0
factors 0
is 0
dependent 0
on 0
components 0
of 0
the 0
SAGA B-gene
complex I-gene
. 0

One 0
child 0
, 0
recently 0
fed 0
, 0
vomited 0
a 0
small 0
amount 0
of 0
breast 0
milk 0
after 0
a 0
short 0
period 0
of 0
crying 0
and 0
apparently 0
had 0
a 0
laryngospasm 0
, 0
shown 0
by 0
a 0
sudden 0
drop 0
in 0
the 0
PtcO2 0
level 0
without 0
any 0
other 0
signs 0
of 0
discomfort 0
. 0

The 0
central 0
venous 0
O2 0
saturation 0
test 0
in 0
acute 0
pulmonary 0
fat 0
embolism 0
. 0

Such 0
unique 0
recognition 0
capabilities 0
are 0
generated 0
with 0
minimal 0
alterations 0
in 0
the 0
CDR3 B-gene
loops 0
of 0
the 0
TCR B-gene
. 0

Sequence 0
comparisons 0
reveal 0
that 0
the 0
P. B-gene
woesei I-gene
GTP I-gene
- I-gene
binding I-gene
protein I-gene
is 0
strikingly 0
related 0
in 0
sequence 0
to 0
eubacterial B-gene
FtsZ I-gene
and 0
is 0
marginally 0
more 0
similar 0
to 0
eukaryotic B-gene
tubulins I-gene
than 0
are 0
bacterial B-gene
FtsZ I-gene
proteins I-gene
. 0

Additional 0
transection 0
of 0
both 0
ADN 0
eliminated 0
the 0
remaining 0
sigmoidal 0
correlation 0
between 0
MAP 0
and 0
RSNA 0
with 0
further 0
increases 0
in 0
resting 0
MAP 0
and 0
RSNA 0
. 0

Cross 0
- 0
talk 0
between 0
transcription 0
factors 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
and 0
C/EBP B-gene
in 0
the 0
transcriptional 0
regulation 0
of 0
genes 0
. 0

FDP 0
- 0
1 0
( 0
200 0
micrograms.kg 0
- 0
1 0
) 0
of 0
intracoronary 0
injection 0
increased 0
collateral 0
flow 0
, 0
reduced 0
systemic 0
artery 0
resistance 0
, 0
and 0
coronary 0
systolic 0
pressure 0
in 0
infarcted 0
region 0
and 0
the 0
area 0
of 0
infarction 0
decreased 0
from 0
28.9 0
+/ 0
- 0
1.3 0
% 0
to 0
15.3 0
+/ 0
- 0
1.2 0
% 0
( 0
P 0
< 0
0.01 0
, 0
n 0
= 0
6 0
) 0
. 0

The 0
results 0
of 0
these 0
experiments 0
indicated 0
that 0
charcoal 0
, 0
imbiber 0
beads 0
, 0
and 0
the 0
anion 0
exchanges 0
resins 0
, 0
Dowex 0
XFS 0
- 0
4022 0
and 0
Dowex 0
SBR 0
- 0
C1 0
, 0
would 0
not 0
be 0
useful 0
agents 0
for 0
increasing 0
the 0
amount 0
of 0
dieldrin 0
eliminated 0
via 0
feces 0
( 0
droppings 0
) 0
of 0
chickens 0
. 0

Neither 0
raw 0
nor 0
retrograded 0
resistant 0
starch 0
lowers 0
fasting 0
serum 0
cholesterol 0
concentrations 0
in 0
healthy 0
normolipidemic 0
subjects 0
. 0

A 0
regression 0
analysis 0
showed 0
that 0
86 0
% 0
of 0
the 0
variance 0
in 0
weight 0
gain 0
was 0
predicted 0
by 0
two 0
leading 0
indicators 0
in 0
the 0
middle 0
phase 0
of 0
treatment 0
. 0

Heterologous 0
hybridization 0
with 0
a 0
rps12 B-gene
gene I-gene
specific 0
probe 0
from 0
Euglena 0
has 0
revealed 0
the 0
presence 0
of 0
rps12 B-gene
homologous I-gene
sequences I-gene
within 0
the 0
inverted 0
repeat 0
of 0
Spirodela 0
chloroplast 0
DNA 0
on 0
the 0
fragment B-gene
BamHI I-gene
- I-gene
V I-gene
. 0

In 0
6 0
patients 0
( 0
9 0
kidneys 0
) 0
irrigation 0
with 0
Solution 0
G 0
in 0
the 0
renal 0
pelvis 0
was 0
performed 0
for 0
the 0
dissolution 0
of 0
their 0
infectious 0
stones 0
. 0

Derepression 0
of 0
RAR B-gene
signaling 0
by 0
expressing 0
a 0
dominant 0
- 0
negative 0
corepressor 0
resulted 0
in 0
embryos 0
that 0
exhibited 0
phenotypes 0
similar 0
to 0
those 0
treated 0
by 0
RA 0
. 0

Flux 0
of 0
the 0
paramyxovirus 0
hemagglutinin B-gene
- 0
neuraminidase B-gene
glycoprotein 0
through 0
the 0
endoplasmic 0
reticulum 0
activates 0
transcription 0
of 0
the 0
GRP78 B-gene
- 0
BiP B-gene
gene 0
. 0

Within 0
the 0
final 0
11 0
amino 0
acids 0
there 0
are 0
5 0
aromatic 0
, 0
2 0
basic 0
, 0
and 0
no 0
acidic 0
residues 0
and 0
it 0
has 0
been 0
proposed 0
that 0
these 0
residues 0
stack 0
with 0
and 0
electrostatically 0
interact 0
with 0
the 0
kinked 0
DNA 0
at 0
the 0
site 0
of 0
a 0
pyrimidine 0
dimer 0
. 0

The 0
influence 0
of 0
different 0
temperatures 0
between 0
13 0
degrees 0
C 0
and 0
45 0
degrees 0
C 0
on 0
coagulation 0
factors 0
in 0
vitro 0
was 0
studied 0
by 0
measuring 0
clotting 0
time 0
with 0
the 0
recalcification 0
time 0
, 0
partial 0
thromboplastin B-gene
time 0
( 0
PTT 0
) 0
, 0
and 0
thromboplastin B-gene
time 0
test 0
. 0

Recombinant 0
propeptides 0
containing 0
mutations 0
of 0
one 0
of 0
the 0
three 0
tryptophan 0
residues 0
were 0
three 0
orders 0
of 0
magnitude 0
less 0
effective 0
as 0
inhibitors 0
of 0
mature B-gene
cathepsin I-gene
S I-gene
than 0
the 0
wild 0
- 0
type 0
propeptide 0
. 0

Molecular 0
cloning 0
of 0
cDNAs 0
encoding 0
alpha 0
- 0
subunits 0
of 0
guanine B-gene
nucleotide I-gene
- I-gene
binding I-gene
regulatory I-gene
proteins I-gene
( 0
G B-gene
- I-gene
proteins I-gene
) 0
has 0
revealed 0
the 0
existence 0
of 0
nine 0
species 0
of 0
alpha 0
- 0
subunits 0
. 0

In 0
all 0
cases 0
, 0
a 0
large 0
fraction 0
of 0
soluble 0
Al 0
became 0
insoluble 0
in 0
the 0
stomach 0
after 0
ingestion 0
. 0

The 0
free 0
fraction 0
of 0
amitriptyline 0
( 0
AT 0
) 0
, 0
measured 0
by 0
equilibrium 0
dialysis 0
in 0
plasma 0
from 0
29 0
AT 0
- 0
treated 0
depressed 0
patients 0
, 0
was 0
5.4 0
- 0
9.8 0
% 0
( 0
mean 0
7.7 0
% 0
) 0
, 0
which 0
was 0
the 0
same 0
as 0
the 0
values 0
in 0
26 0
healthy 0
controls 0
( 0
4.9 0
- 0
9.6 0
% 0
, 0
mean 0
7.6 0
% 0
) 0
. 0

The 0
prominent 0
fracture 0
of 0
women 0
older 0
than 0
75 0
years 0
is 0
the 0
hip 0
fracture 0
( 0
type 0
II 0
osteoporosis 0
) 0
. 0

AU 0
- 0
rich 0
elements 0
in 0
the 0
3' 0
- 0
untranslated 0
region 0
of 0
a 0
new 0
mucin B-gene
- I-gene
type I-gene
gene I-gene
family 0
of 0
Trypanosoma 0
cruzi 0
confers 0
mRNA 0
instability 0
and 0
modulates 0
translation 0
efficiency 0
. 0

Under 0
anaerobic 0
conditions 0
( 0
a 0
50 0
- 0
day 0
experiment 0
) 0
these 0
organisms 0
degraded 0
15 0
- 0
18 0
% 0
of 0
the 0
TEM 0
, 0
20 0
- 0
25 0
% 0
of 0
some 0
alkanes 0
, 0
and 0
15 0
- 0
18 0
% 0
of 0
selected 0
polycyclic 0
aromatic 0
hydrocarbons 0
. 0

They 0
cause 0
temporary 0
disability 0
, 0
invalidity 0
and 0
mortality 0
of 0
a 0
great 0
part 0
of 0
the 0
productive 0
population 0
, 0
significantly 0
damaging 0
the 0
economic 0
status 0
of 0
the 0
country 0
. 0

We 0
then 0
isolated 0
the 0
full 0
- 0
length 0
coding 0
region 0
of 0
the 0
human B-gene
BACH1 I-gene
gene I-gene
using 0
expressed 0
sequence 0
tags 0
, 0
reverse 0
transcription 0
- 0
polymerase 0
chain 0
reaction 0
and 0
rapid 0
amplification 0
of 0
cDNA 0
ends 0
. 0

In 0
addition 0
, 0
wild 0
- 0
type 0
and 0
mutated 0
DNA 0
templates 0
were 0
used 0
as 0
probes 0
in 0
DNase B-gene
I I-gene
protection 0
experiments 0
to 0
determine 0
sites 0
of 0
protein 0
- 0
DNA 0
interaction 0
. 0

CONCLUSIONS 0
- 0
- 0
Postlumbar 0
puncture 0
headache 0
may 0
be 0
mediated 0
by 0
the 0
release 0
of 0
substance B-gene
P I-gene
triggered 0
by 0
lumbar 0
puncture 0
, 0
in 0
patients 0
predisposed 0
to 0
headache 0
by 0
a 0
hypersensitivity 0
to 0
substance B-gene
P I-gene
. 0

The 0
repeats 0
are 0
highly 0
conserved 0
both 0
within 0
a 0
given 0
element 0
as 0
well 0
as 0
between 0
different 0
members 0
of 0
the 0
family 0
( 0
less 0
than 0
10 0
% 0
divergence 0
) 0
. 0

They 0
are 0
found 0
to 0
have 0
several 0
advantages 0
over 0
the 0
conventional 0
indices 0
of 0
skewness 0
and 0
kurtosis 0
( 0
square 0
root 0
of 0
b1 0
and 0
b2 0
) 0
and 0
no 0
serious 0
drawbacks 0
. 0

Second 0
, 0
CGGA 0
- 0
containing 0
sequences 0
placed 0
at 0
- 0
88 0
in 0
the 0
delta B-gene
MTV I-gene
- I-gene
CAT I-gene
reporter I-gene
plasmid 0
conferred 0
insulin B-gene
responsiveness 0
to 0
the 0
mammary B-gene
tumor I-gene
virus I-gene
promoter I-gene
. 0

Hemorrheological 0
evaluation 0
and 0
proposed 0
pharmacological 0
uses 0
. 0

Stimulation 0
of 0
the 0
endosteal 0
bone 0
formation 0
rate 0
was 0
mainly 0
impaired 0
in 0
D 0
- 0
depleted 0
rats 0
, 0
resulting 0
in 0
trabecular 0
bone 0
loss 0
, 0
which 0
, 0
in 0
- 0
D 0
mother 0
rats 0
, 0
was 0
associated 0
with 0
decreased 0
bone 0
ash 0
and 0
total 0
bone 0
calcium 0
. 0

Biochemical 0
status 0
was 0
examined 0
using 0
erythrocyte 0
enzyme 0
function 0
and 0
blood 0
vitamin 0
levels 0
. 0

The 0
Polycomb B-gene
group I-gene
proteins I-gene
are 0
involved 0
in 0
maintenance 0
of 0
the 0
silenced 0
state 0
of 0
several 0
developmentally 0
regulated 0
genes 0
. 0

Repeated 0
interferon B-gene
- I-gene
beta I-gene
( 0
IFN B-gene
- I-gene
beta I-gene
) 0
silencer 0
B 0
motifs 0
and 0
a 0
lysozyme B-gene
silencer I-gene
1 I-gene
motif I-gene
have 0
been 0
found 0
in 0
the 0
CD95 B-gene
gene I-gene
at 0
approximately 0
- 0
1,600 0
and 0
- 0
1,100 0
, 0
respectively 0
. 0

We 0
find 0
that 0
Fus3p B-gene
and 0
Kss1p B-gene
both 0
control 0
G1 0
arrest 0
through 0
multiple 0
functions 0
that 0
operate 0
in 0
parallel 0
with 0
Far1p B-gene
. 0

The 0
Id4 B-gene
protein I-gene
contains 0
a 0
HLH 0
domain 0
highly 0
conserved 0
among 0
the 0
dnHLH B-gene
proteins I-gene
from 0
mouse 0
and 0
drosophila 0
. 0

The 0
proliferative 0
potential 0
of 0
the 0
pilocytic 0
astrocytoma 0
: 0
the 0
relation 0
between 0
MIB B-gene
- I-gene
1 I-gene
labeling 0
and 0
clinical 0
and 0
neuro 0
- 0
radiological 0
follow 0
- 0
up 0
. 0

Desensitization 0
of 0
the 0
growth B-gene
hormone I-gene
- 0
induced 0
Janus B-gene
kinase I-gene
2 I-gene
( 0
Jak B-gene
2 I-gene
) 0
/signal B-gene
transducer I-gene
and I-gene
activator I-gene
of I-gene
transcription I-gene
5 I-gene
( 0
Stat5 B-gene
) 0
- 0
signaling 0
pathway 0
requires 0
protein 0
synthesis 0
and 0
phospholipase B-gene
C I-gene
. 0

The 0
aim 0
of 0
our 0
study 0
was 0
to 0
determine 0
whether 0
exercise 0
training 0
can 0
augment 0
left 0
ventricular 0
diastolic 0
filling 0
at 0
rest 0
and 0
during 0
exercise 0
in 0
patients 0
with 0
ischemic 0
cardiomyopathy 0
and 0
whether 0
any 0
correlation 0
exists 0
between 0
changes 0
in 0
diastolic 0
filling 0
and 0
changes 0
in 0
exercise 0
tolerance 0
. 0

Alterations 0
in 0
TCR B-gene
- 0
MHC B-gene
contacts 0
subsequent 0
to 0
cross 0
- 0
recognition 0
of 0
class B-gene
I I-gene
MHC I-gene
and 0
singly 0
substituted 0
peptide 0
variants 0
. 0

Scalp 0
blood 0
flow 0
was 0
recorded 0
by 0
a 0
laser 0
Doppler 0
flow 0
sensor 0
that 0
was 0
incorporated 0
in 0
the 0
transcutaneous 0
PO2 0
electrode 0
. 0

There 0
is 0
an 0
overall 0
functional 0
similarity 0
between 0
IL B-gene
- I-gene
6 I-gene
and 0
c B-gene
- I-gene
fos I-gene
promoters I-gene
, 0
since 0
transfection 0
of 0
excess 0
amounts 0
of 0
either 0
promoter 0
DNA 0
into 0
intact 0
HeLa 0
cells 0
modulates 0
the 0
function 0
of 0
the 0
heterologous 0
promoter 0
construct 0
. 0

Detailed 0
comparison 0
of 0
the 0
sequences 0
of 0
cp35 B-gene
and 0
human B-gene
calpactin I-gene
II I-gene
shows 0
that 0
the 0
only 0
substantial 0
sequence 0
dissimilarity 0
is 0
a 0
domain 0
encoding 0
amino 0
acids 0
between 0
residues 0
20 0
and 0
40 0
which 0
includes 0
a 0
tyrosine 0
phosphorylation 0
site 0
in 0
the 0
human 0
molecule 0
, 0
along 0
with 0
other 0
residues 0
of 0
possible 0
physiological 0
significance 0
. 0

Power 0
deposition 0
by 0
inverse 0
- 0
bremsstrahlung 0
is 0
modeled 0
with 0
a 0
scheme 0
based 0
on 0
Gaussian 0
quadrature 0
to 0
accommodate 0
a 0
deposition 0
rate 0
whose 0
spatial 0
variation 0
is 0
highly 0
nonuniform 0
. 0

However 0
, 0
the 0
malaria 0
vectors 0
Anopheles 0
funestus 0
and 0
An 0
. 0
gambiae 0
have 0
both 0
become 0
more 0
abundant 0
during 0
the 0
1970s 0
and 0
1980s 0
and 0
sporozoite 0
- 0
positive 0
specimens 0
of 0
both 0
have 0
been 0
found 0
. 0

Greer 0
, 0
and 0
L.A 0
. 0

Expression 0
of 0
Msx B-gene
- I-gene
1 I-gene
and 0
Msx B-gene
- I-gene
2 I-gene
has 0
been 0
studied 0
during 0
development 0
of 0
the 0
osteoblast 0
phenotype 0
, 0
but 0
the 0
role 0
of 0
Dlx B-gene
in 0
this 0
context 0
and 0
in 0
the 0
regulation 0
of 0
bone 0
- 0
expressed 0
genes 0
is 0
unknown 0
. 0

The 0
salt 0
sensitivity 0
of 0
the 0
interaction 0
indicated 0
that 0
two 0
ion 0
pairs 0
are 0
involved 0
in 0
the 0
association 0
of 0
Zn2+ 0
( 0
NC 0
- 0
F1 0
) 0
with 0
polynucleotide 0
, 0
whereas 0
one 0
ion 0
pair 0
is 0
found 0
in 0
the 0
metal 0
- 0
free 0
peptide 0
- 0
nucleic 0
acid 0
complex 0
. 0

Histopathologically 0
, 0
( 0
mice 0
killed 0
with 0
high 0
doses 0
of 0
GMC 0
- 0
II 0
, 0
given 0
orally 0
) 0
there 0
were 0
diffuse 0
hyperemia 0
of 0
the 0
liver 0
, 0
parenchymal 0
degeneration 0
of 0
the 0
kidney 0
tubuli 0
epithelium 0
, 0
and 0
edema 0
and 0
emphysema 0
of 0
the 0
lungs 0
. 0

Cytochemical 0
and 0
ultrastructural 0
observations 0
on 0
the 0
tegument 0
of 0
the 0
trematode 0
Megalodiscus 0
temperatus 0
. 0

The 0
overall 0
rate 0
of 0
biohydrogenation 0
of 0
C18:2 0
was 0
14.3 0
% 0
/h 0
, 0
but 0
declined 0
1.2 0
% 0
/h 0
for 0
each 0
percentage 0
unit 0
increase 0
in 0
C18:2 0
added 0
to 0
the 0
substrate 0
. 0

Transient 0
thyrotoxicosis 0
in 0
primary 0
anti 0
- 0
phospholipid 0
syndrome 0
. 0

The 0
highest 0
TTX B-gene
content 0
is 0
10.0 0
microg/g 0
in 0
N. 0
livescens 0
. 0

The 0
BUR 0
was 0
set 0
at 0
20/min 0
and 0
the 0
IT 0
at 0
.5 0
seconds 0
. 0

In 0
this 0
study 0
, 0
to 0
elucidate 0
the 0
possible 0
mechanism 0
of 0
action 0
of 0
EM 0
, 0
we 0
examined 0
the 0
effect 0
of 0
the 0
drug 0
on 0
the 0
expression 0
of 0
neutrophil 0
adhesion 0
molecules 0
such 0
as 0
L B-gene
- I-gene
selectin I-gene
and 0
Mac B-gene
- I-gene
1 I-gene
. 0

It 0
contains 0
31 0
exons 0
and 0
a 0
high 0
proportion 0
of 0
class 0
0 0
introns 0
, 0
alternative 0
splicing 0
of 0
which 0
results 0
in 0
significant 0
levels 0
of 0
variant 0
transcripts 0
that 0
maintain 0
the 0
original 0
open 0
reading 0
frame 0
of 0
MRP B-gene
mRNA I-gene
. 0

This 0
nuclear/organellar 0
gene 0
transfer 0
event 0
is 0
strikingly 0
similar 0
to 0
the 0
experimentally 0
accessible 0
process 0
of 0
nuclear 0
integration 0
of 0
introduced 0
heterologous 0
DNA 0
. 0

Under 0
control 0
conditions 0
, 0
pretreatment 0
with 0
lithium 0
during 0
7 0
days 0
did 0
not 0
modify 0
the 0
hyperlocomotion 0
produced 0
by 0
d 0
- 0
amphetamine 0
. 0

We 0
also 0
show 0
that 0
the 0
products 0
of 0
both 0
the 0
GIY B-gene
- I-gene
YIG I-gene
ORF 0
and 0
the 0
non 0
- 0
canonical 0
LAGLI B-gene
- I-gene
DADG I-gene
- I-gene
GIY I-gene
- I-gene
YIG I-gene
ORF 0
, 0
which 0
is 0
generated 0
by 0
its 0
integration 0
, 0
have 0
endonuclease 0
activities 0
which 0
recognize 0
and 0
cut 0
the 0
insertion 0
site 0
of 0
the 0
optional 0
sequence 0
. 0

This 0
article 0
describes 0
a 0
program 0
that 0
resulted 0
in 0
a 0
75 0
- 0
percent 0
reduction 0
of 0
inventory 0
over 0
a 0
five 0
- 0
year 0
interval 0
. 0

Risk 0
ratios 0
decreased 0
with 0
increasing 0
age 0
and 0
increased 0
with 0
number 0
of 0
breast 0
biopsies 0
, 0
family 0
history 0
of 0
breast 0
cancer 0
, 0
estrogen 0
use 0
, 0
time 0
between 0
screenings 0
, 0
no 0
comparison 0
with 0
previous 0
mammograms 0
, 0
and 0
the 0
radiologist 0
's 0
tendency 0
to 0
call 0
mammograms 0
abnormal 0
. 0

The 0
pharmacokinetics 0
were 0
best 0
described 0
by 0
a 0
two 0
- 0
compartment 0
open 0
model 0
giving 0
distribution 0
half 0
- 0
lives 0
of 0
0.31 0
h 0
and 0
1.53 0
h 0
, 0
and 0
elimination 0
half 0
- 0
lives 0
of 0
69.7 0
h 0
and 0
60.3 0
h 0
for 0
oxolinic 0
acid 0
and 0
oxytetracycline 0
, 0
respectively 0
. 0

However 0
, 0
the 0
relative 0
substrate 0
specificity 0
of 0
RSK3 B-gene
differed 0
from 0
that 0
reported 0
for 0
other 0
isoforms 0
. 0

This 0
study 0
demonstrates 0
a 0
novel 0
link 0
between 0
alterations 0
in 0
platelet B-gene
- I-gene
derived I-gene
growth I-gene
factor I-gene
( 0
PDGF B-gene
) 0
regulation 0
of 0
ornithine B-gene
decarboxylase I-gene
( 0
ODC B-gene
) 0
expression 0
during 0
malignant 0
conversion 0
. 0

Fosinopril 0
decreased 0
blood 0
pressure 0
from 0
174/101 0
mm 0
Hg 0
to 0
149/88 0
mm 0
Hg 0
in 0
patients 0
with 0
diastolic 0
hypertension 0
and 0
from 0
182/86 0
mm 0
Hg 0
to 0
151/80 0
mm 0
Hg 0
in 0
patients 0
with 0
ISH 0
. 0

187 0
- 0
200 0
. 0

Loss 0
of 0
pRb B-gene
or 0
p107 B-gene
binding 0
results 0
in 0
the 0
loss 0
of 0
transforming 0
activity 0
. 0

Influence 0
of 0
huanglian 0
used 0
in 0
combination 0
with 0
huangqin 0
and 0
gancao 0
on 0
the 0
erythrocytic 0
osmotic 0
fragilitas 0
of 0
experimental 0
glucose B-gene
- I-gene
6 I-gene
- I-gene
phosphate I-gene
dehydrogenase I-gene
deficiency 0
in 0
rats 0
] 0
OBJECTIVE 0
: 0
To 0
study 0
the 0
influence 0
of 0
common 0
combination 0
of 0
Huanglian 0
( 0
Coptis 0
chinensis 0
) 0
on 0
the 0
erythrocytic 0
osmotic 0
fragilitas 0
of 0
glucose B-gene
- I-gene
6 I-gene
- I-gene
phosphate I-gene
dehydrogenase I-gene
( 0
G6PD B-gene
) 0
deficiency 0
in 0
rats 0
. 0

Inhibitory 0
receptors 0
are 0
characterized 0
by 0
the 0
presence 0
of 0
a 0
characteristic 0
sequence 0
known 0
as 0
an 0
immunoreceptor 0
tyrosine 0
- 0
based 0
inhibitory 0
motif 0
( 0
ITIM 0
) 0
in 0
their 0
cytoplasmic 0
tail 0
. 0

Comparison 0
of 0
Healon 0
and 0
Amvisc 0
. 0

2,4 0
- 0
and 0
2,6 0
- 0
toluenediamine 0
in 0
hydrolysed 0
plasma 0
and 0
urine 0
after 0
test 0
- 0
chamber 0
exposure 0
of 0
humans 0
to 0
2,4 0
- 0
and 0
2,6 0
- 0
toluene 0
diisocyanate 0
. 0

The 0
role 0
of 0
the 0
medical 0
facilities 0
in 0
the 0
prognosis 0
of 0
the 0
patient 0
with 0
tetanus 0
specially 0
the 0
importance 0
of 0
considering 0
at 0
the 0
same 0
time 0
the 0
severity 0
of 0
the 0
disease 0
and 0
the 0
characteristics 0
of 0
the 0
therapy 0
deserve 0
further 0
study 0
in 0
order 0
to 0
contribute 0
to 0
the 0
development 0
of 0
the 0
medical 0
assistance 0
to 0
the 0
patients 0
with 0
tetanus 0
. 0

Interaction 0
between 0
the 0
tobacco 0
DNA 0
- 0
binding 0
activity 0
CBF B-gene
and 0
the 0
cyt B-gene
- I-gene
1 I-gene
promoter I-gene
element I-gene
of 0
the 0
Agrobacterium 0
tumefaciens 0
T 0
- 0
DNA 0
gene 0
T B-gene
- I-gene
CYT I-gene
correlates 0
with 0
cyt B-gene
- I-gene
1 I-gene
directed 0
gene 0
expression 0
in 0
multiple 0
tobacco 0
tissue 0
types 0
. 0

These 0
results 0
suggest 0
that 0
repetitive 0
GAA 0
sequences 0
enhance 0
splicing 0
by 0
binding 0
a 0
protein 0
complex 0
containing 0
a 0
sequence 0
- 0
specific 0
RNA 0
binding 0
protein 0
and 0
a 0
general 0
splicing 0
activator 0
that 0
, 0
in 0
turn 0
, 0
recruit 0
additional 0
SR B-gene
proteins I-gene
. 0

Organization 0
of 0
exons 0
suggests 0
that 0
, 0
similar 0
to 0
the 0
human B-gene
VEGF I-gene
gene I-gene
, 0
alternative 0
splicing 0
generates 0
the 0
120 0
- 0
, 0
164 0
- 0
, 0
and 0
188 0
- 0
amino 0
acid 0
isoforms 0
, 0
but 0
does 0
not 0
predict 0
a 0
fourth 0
VEGF B-gene
isoform I-gene
corresponding 0
to 0
human B-gene
VEGF206 I-gene
. 0

The 0
papers 0
provide 0
a 0
broad 0
perspective 0
of 0
MPAs 0
and 0
include 0
social 0
, 0
economic 0
, 0
cultural 0
, 0
biological 0
and 0
statistical 0
components 0
. 0

The 0
great 0
cardiac 0
vein 0
flow 0
became 0
zero 0
due 0
to 0
the 0
cardiac 0
arrest 0
and 0
remained 0
at 0
zero 0
for 0
a 0
moment 0
( 0
dead 0
time 0
) 0
after 0
the 0
initiation 0
of 0
reperfusion 0
. 0

CONCLUSIONS 0
: 0
These 0
results 0
suggest 0
that 0
histamine B-gene
- I-gene
2 I-gene
receptor I-gene
activation 0
mechanisms 0
may 0
not 0
be 0
involved 0
in 0
postoperative 0
IL B-gene
- I-gene
6 I-gene
synthesis 0
. 0

Issues 0
discussed 0
include 0
the 0
validity 0
of 0
the 0
MMPI 0
Mf 0
scale 0
, 0
questions 0
of 0
sample 0
representativeness 0
, 0
whether 0
`` 0
straights 0
'' 0
can 0
do 0
adequate 0
research 0
on 0
homosexuality 0
, 0
differences 0
in 0
heterosexual 0
and 0
homosexual 0
sexuality 0
, 0
the 0
role 0
of 0
subculture 0
acculturation 0
in 0
homosexual 0
psychological 0
adjustment 0
, 0
and 0
the 0
use 0
of 0
cluster 0
- 0
analysis 0
to 0
generate 0
typologies 0
of 0
homosexualities 0
. 0

Our 0
data 0
suggest 0
that 0
some 0
defects 0
observed 0
in 0
BS 0
, 0
WS 0
or 0
RTS 0
are 0
the 0
consequence 0
of 0
unrestrained 0
recombination 0
. 0

LAC9 B-gene
is 0
a 0
DNA 0
- 0
binding 0
protein 0
that 0
regulates 0
transcription 0
of 0
the 0
lactose B-gene
- I-gene
galactose I-gene
regulon I-gene
in 0
Kluyveromyces 0
lactis 0
. 0

Some 0
cells 0
were 0
excited 0
, 0
others 0
inhibited 0
by 0
, 0
and 0
only 0
some 0
were 0
directionally 0
sensitive 0
to 0
the 0
optomotor 0
stimulus 0
. 0

We 0
have 0
cloned 0
the 0
cDNA 0
for 0
the 0
SLBP B-gene
from 0
humans 0
, 0
mice 0
, 0
and 0
frogs 0
, 0
using 0
the 0
recently 0
developed 0
yeast 0
three 0
- 0
hybrid 0
system 0
. 0

The 0
molecular 0
event 0
( 0
s 0
) 0
underlying 0
the 0
functional 0
specificities 0
of 0
these 0
receptors 0
( 0
in 0
regulating 0
the 0
expression 0
of 0
their 0
native 0
target 0
genes 0
) 0
is 0
a 0
very 0
important 0
issue 0
that 0
remains 0
poorly 0
understood 0
. 0

Alternative 0
splicing 0
of 0
the 0
human B-gene
serotonin I-gene
transporter I-gene
gene I-gene
. 0

Nuclear 0
proteins 0
bound 0
the 0
cad B-gene
+55/+75 I-gene
element I-gene
in 0
a 0
cell 0
cycle 0
- 0
dependent 0
manner 0
in 0
electromobility 0
shift 0
assays 0
; 0
antibodies 0
specific 0
to 0
USF B-gene
and 0
Max B-gene
blocked 0
the 0
DNA 0
- 0
binding 0
activity 0
of 0
different 0
growth 0
- 0
regulated 0
protein 0
- 0
DNA 0
complexes 0
. 0

For 0
Thermus 0
strain 0
ZO5 B-gene
dihydroorotase I-gene
( 0
DHOase B-gene
; 0
encoded 0
by 0
pyrC B-gene
) 0
, 0
the 0
highest 0
similarity 0
scores 0
( 0
about 0
40 0
% 0
identity 0
) 0
were 0
obtained 0
with 0
DHOases B-gene
from 0
B. 0
caldolyticus 0
and 0
Bacillus 0
subtilis 0
. 0

This 0
difference 0
between 0
SP B-gene
- I-gene
1 I-gene
and 0
SP B-gene
- I-gene
2 I-gene
peptides I-gene
was 0
not 0
due 0
to 0
their 0
differential 0
uptake 0
by 0
cell 0
, 0
since 0
approximately 0
100 0
times 0
more 0
SP B-gene
- I-gene
2 I-gene
peptide I-gene
could 0
be 0
found 0
in 0
cytoplasmic 0
extracts 0
than 0
SP B-gene
- I-gene
1 I-gene
peptide I-gene
in 0
experiments 0
using 0
radiolabeled 0
peptides 0
. 0

The 0
product 0
of 0
one 0
gene 0
, 0
Bv80 B-gene
, 0
has 0
a 0
single 0
divergent 0
copy 0
of 0
a 0
sequence 0
of 0
149 0
amino 0
acids 0
( 0
approx 0
. 0

The 0
carboxy 0
- 0
proximal 0
regions 0
of 0
the 0
VP1 B-gene
, 0
which 0
contain 0
very 0
low 0
amino 0
acid 0
homology 0
, 0
displayed 0
evidence 0
of 0
conservation 0
in 0
structural 0
features 0
such 0
as 0
a 0
hydrophilic 0
, 0
highly 0
basic 0
domain 0
. 0

The 0
sequences 0
at 0
- 0
10 0
and 0
- 0
35 0
relative 0
to 0
the 0
transcriptional 0
starting 0
site 0
showed 0
55 0
% 0
homology 0
with 0
the 0
consensus 0
sequences 0
of 0
the 0
Escherichia B-gene
coli I-gene
sigma I-gene
70 I-gene
- I-gene
type I-gene
promoter I-gene
. 0

The 0
two 0
ORFs 0
had 0
significant 0
similarity 0
with 0
the 0
putative 0
replication 0
protein 0
from 0
plasmid 0
pTiK12 0
of 0
Thiobacillus 0
intermedius 0
and 0
other 0
CoIE2 0
- 0
related 0
plasmids 0
. 0

A 0
clinical 0
double 0
- 0
blind 0
trial 0
of 0
topical 0
miconazole 0
and 0
clotrimazole 0
against 0
superficial 0
fungal 0
infections 0
and 0
erythrasma 0
. 0

Lumbar 0
spine 0
bone 0
mineral 0
density 0
( 0
BMD 0
) 0
by 0
dual 0
- 0
energy 0
X 0
- 0
ray 0
absorptiometry 0
( 0
DXA 0
) 0
increased 0
by 0
0.6 0
% 0
, 0
3.6 0
% 0
and 0
8.1 0
% 0
after 0
48 0
weeks 0
in 0
groups 0
L 0
, 0
M 0
and 0
H 0
respectively 0
, 0
responses 0
in 0
groups 0
M 0
and 0
H 0
being 0
significantly 0
higher 0
than 0
in 0
L 0
( 0
p 0
< 0
0.05 0
, 0
Mann 0
- 0
Whitney 0
U 0
- 0
test 0
) 0
. 0

A 0
genomic 0
clone 0
representing 0
the 0
5 0
' 0
part 0
of 0
the 0
message 0
was 0
also 0
isolated 0
. 0

This 0
unusual 0
behaviour 0
may 0
be 0
explained 0
by 0
the 0
18 B-gene
amino I-gene
acid I-gene
- I-gene
long I-gene
CDR I-gene
- I-gene
H3 I-gene
and 0
could 0
be 0
of 0
value 0
in 0
the 0
design 0
of 0
'single 0
domain 0
' 0
antibodies 0
. 0

Bleeding 0
was 0
successfully 0
prevented 0
in 0
28 0
patients 0
with 0
the 0
use 0
of 0
a 0
combined 0
treatment 0
incorporating 0
IV 0
desmopressin 0
, 0
an 0
antifibrinolytic 0
agent 0
( 0
tranexamic 0
acid 0
) 0
, 0
and 0
local 0
methods 0
( 0
surgical 0
glue 0
and 0
compression 0
techniques 0
) 0
. 0

Northern 0
blot 0
analysis 0
demonstrated 0
that 0
the 0
genes 0
are 0
transcribed 0
separately 0
. 0

CONCLUSIONS 0
: 0
Systemic 0
factors 0
that 0
increase 0
bone 0
mineral 0
density 0
appear 0
to 0
be 0
involved 0
in 0
the 0
pathogenesis 0
of 0
ossification 0
of 0
the 0
posterior 0
longitudinal 0
ligament 0
, 0
and 0
these 0
factors 0
may 0
be 0
activated 0
after 0
middle 0
age 0
. 0

FdsR B-gene
purified 0
to 0
homogeneity 0
after 0
overexpression 0
of 0
fdsR B-gene
in 0
E. 0
coli 0
is 0
a 0
130 0
kDa 0
homotetramer 0
binding 0
to 0
the 0
fds B-gene
control 0
region 0
located 0
between 0
the 0
fdsR B-gene
and 0
fdsG B-gene
genes I-gene
. 0

Surgical 0
methods 0
in 0
the 0
treatment 0
of 0
rhinophyma 0
. 0

The 0
adeno 0
- 0
associated 0
virus 0
type 0
2 0
( 0
AAV 0
- 0
2 0
) 0
Rep78/Rep68 B-gene
regulatory 0
proteins 0
are 0
pleiotropic 0
effectors 0
of 0
viral 0
and 0
cellular 0
DNA 0
replication 0
, 0
of 0
cellular 0
transformation 0
by 0
viral 0
and 0
cellular 0
oncogenes 0
, 0
and 0
of 0
homologous 0
and 0
heterologous 0
gene 0
expression 0
. 0

We 0
show 0
here 0
that 0
Spb1p B-gene
is 0
able 0
to 0
bind 0
[ 0
( 0
3 0
) 0
H 0
] 0
AdoMet 0
in 0
vitro 0
, 0
suggesting 0
that 0
it 0
is 0
a 0
novel 0
methylase 0
, 0
whose 0
possible 0
substrates 0
will 0
be 0
discussed 0
. 0

Low 0
temperature 0
( 0
8 0
degrees 0
C 0
) 0
impairs 0
secretory 0
activity 0
, 0
again 0
independently 0
of 0
the 0
photoperiod 0
selected 0
. 0

These 0
data 0
suggest 0
that 0
weight 0
gain 0
or 0
increased 0
caloric 0
intake 0
, 0
in 0
contrast 0
to 0
its 0
large 0
effect 0
on 0
peripheral 0
thyroid 0
function 0
, 0
has 0
relatively 0
little 0
effect 0
on 0
CNS B-gene
TRH I-gene
activity 0
. 0

Hematopoietic B-gene
progenitor I-gene
kinase I-gene
1 I-gene
( 0
HPK1 B-gene
) 0
is 0
a 0
member 0
of 0
the 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
kinase I-gene
kinase I-gene
kinase I-gene
( 0
MAP4K B-gene
) 0
family 0
and 0
an 0
upstream 0
activator 0
of 0
the 0
c B-gene
- I-gene
Jun I-gene
N I-gene
- I-gene
terminal I-gene
kinase I-gene
( 0
JNK B-gene
) 0
signaling 0
cascade 0
. 0

We 0
conclude 0
that 0
the 0
outcome 0
of 0
patients 0
with 0
uterine 0
MMMT 0
is 0
mainly 0
influenced 0
by 0
the 0
initial 0
stage 0
and 0
the 0
type 0
of 0
epithelial 0
component 0
. 0

Increased 0
susceptibility 0
of 0
aphasics 0
to 0
a 0
distractor 0
task 0
in 0
the 0
recall 0
of 0
verbal 0
commands 0
. 0

Here 0
we 0
show 0
that 0
inhibition 0
occurs 0
with 0
a 0
NS1 B-gene
- 0
Rev B-gene
chimera 0
in 0
which 0
the 0
78 0
amino 0
- 0
terminal 0
amino 0
acids 0
of 0
the 0
NS1A B-gene
protein I-gene
comprising 0
its 0
entire 0
RNA 0
- 0
binding 0
domain 0
is 0
deleted 0
, 0
thereby 0
establishing 0
that 0
this 0
carboxyl 0
portion 0
of 0
the 0
NS1A B-gene
protein I-gene
can 0
function 0
as 0
an 0
independent 0
effector 0
domain 0
. 0

We 0
hypothesized 0
that 0
conjugated 0
estrogens 0
, 0
which 0
contain 0
several 0
vasoactive 0
estrogenic 0
compounds 0
, 0
may 0
favorably 0
influence 0
the 0
vasomotor 0
response 0
to 0
acetylcholine 0
in 0
men 0
. 0

Calcium 0
bilirubinate 0
crystals 0
were 0
seen 0
in 0
gallbladder 0
bile 0
or 0
wall 0
scrapings 0
of 0
7 0
of 0
8 0
TPN 0
animals 0
but 0
in 0
none 0
of 0
the 0
controls 0
( 0
P 0
less 0
than 0
0.001 0
) 0
. 0

Because 0
c B-gene
- I-gene
myb I-gene
encodes 0
a 0
transcriptional 0
activator 0
that 0
functions 0
via 0
DNA 0
binding 0
, 0
it 0
is 0
likely 0
that 0
c B-gene
- I-gene
myb I-gene
exerts 0
its 0
biological 0
activity 0
by 0
regulating 0
the 0
transcription 0
of 0
genes 0
required 0
for 0
DNA 0
synthesis 0
and 0
cell 0
cycle 0
progression 0
. 0

Alcohol 0
and 0
stomach 0
diseases 0

Thus 0
integration B-gene
host I-gene
factor I-gene
is 0
required 0
for 0
normal 0
type B-gene
1 I-gene
fimbriae I-gene
phase 0
variation 0
in 0
E. 0
coli 0
. 0

Multiple 0
attempts 0
aimed 0
at 0
disruption 0
of 0
the 0
chromosomal B-gene
fabG I-gene
gene I-gene
were 0
unsuccessful 0
. 0

In 0
our 0
case 0
the 0
development 0
of 0
the 0
tumor 0
at 0
the 0
posterior 0
side 0
of 0
the 0
prostate 0
, 0
the 0
lack 0
of 0
PSA B-gene
immunoreactivity 0
and 0
the 0
presence 0
of 0
mucinous 0
glands 0
, 0
sometimes 0
`` 0
endocervical 0
- 0
like 0
'' 0
, 0
could 0
suggest 0
an 0
origin 0
from 0
embryonic 0
mullerian 0
remnants 0
in 0
the 0
prostatic 0
utricle 0
rather 0
than 0
urogenital 0
sinus 0
. 0

Analysis 0
of 0
the 0
DNA 0
- 0
binding 0
and 0
transcriptional 0
activation 0
functions 0
of 0
human B-gene
Fli I-gene
- I-gene
1 I-gene
protein I-gene
. 0

The 0
second 0
patient 0
was 0
successfully 0
treated 0
with 0
intravenous 0
prostaglandin 0
F2 0
alpha 0
( 0
PGF2 0
alpha 0
) 0
. 0

Salts 0
of 0
these 0
four 0
metal 0
ions 0
may 0
be 0
added 0
to 0
the 0
growth 0
medium 0
to 0
facilitate 0
selective 0
isolation 0
of 0
Acinetobacter 0
. 0

DESIGN 0
- 0
- 0
A 0
randomised 0
double 0
blind 0
placebo 0
controlled 0
parallel 0
arm 0
trial 0
. 0

Base 0
substitutions 0
within 0
this 0
NFIL B-gene
- I-gene
6 I-gene
site I-gene
resulted 0
in 0
virtual 0
elimination 0
of 0
LPS 0
- 0
induced 0
IL B-gene
- I-gene
1 I-gene
beta I-gene
gene I-gene
transcription 0
. 0

Different 0
clinical 0
variants 0
of 0
the 0
empty 0
sella 0
turcica 0
syndrome 0
are 0
demonstrated 0
, 0
including 0
variants 0
resultant 0
from 0
substitution 0
therapy 0
of 0
thyroid 0
hypofunction 0
, 0
from 0
dopamine 0
agonist 0
therapy 0
for 0
hyperprolactinemic 0
hypogonadism 0
, 0
from 0
radiotherapy 0
of 0
hypophyseal 0
adenoma 0
. 0

Repeated 0
time 0
course 0
studies 0
in 0
the 0
same 0
patient 0
were 0
reproducible 0
although 0
the 0
absolute 0
concentrations 0
showed 0
some 0
variation 0
. 0

Our 0
data 0
suggest 0
that 0
association 0
of 0
TBP B-gene
with 0
the 0
TATA 0
box 0
may 0
be 0
regulated 0
, 0
directly 0
or 0
indirectly 0
, 0
by 0
a 0
substrate 0
of 0
Snf1 B-gene
. 0

Site 0
- 0
directed 0
mutagenesis 0
of 0
the 0
T4 B-gene
endonuclease I-gene
V I-gene
gene I-gene
: 0
role 0
of 0
lysine 0
- 0
130 0
. 0

Simulations 0
of 0
velocities 0
, 0
vorticity 0
, 0
pressure 0
and 0
certain 0
stress 0
values 0
were 0
developed 0
by 0
a 0
computer 0
and 0
displayed 0
for 0
man 0
- 0
machine 0
interaction 0
. 0

Together 0
, 0
these 0
results 0
implicate 0
Fal1p B-gene
in 0
the 0
18S B-gene
rRNA I-gene
maturation 0
pathway 0
rather 0
than 0
in 0
translation 0
initiation 0
. 0

TRAF2 B-gene
has 0
previously 0
been 0
demonstrated 0
to 0
activate 0
both 0
transcription 0
factor 0
nuclear B-gene
factor I-gene
kappaB I-gene
( 0
NFkappaB B-gene
) 0
and 0
the 0
c B-gene
- I-gene
Jun I-gene
N I-gene
- I-gene
terminal I-gene
kinase/stress I-gene
kinase/stress I-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
( 0
JNK/SAPK B-gene
) 0
pathway 0
, 0
which 0
in 0
turn 0
stimulates 0
JNK/SAPK I-gene

Electrophysiology 0
and 0
pharmacology 0
of 0
epicardial 0
, 0
endocardial 0
, 0
and 0
M 0
cells 0
. 0

The 0
data 0
suggest 0
that 0
compromised 0
fibrinolytic 0
capacity 0
may 0
be 0
a 0
contributing 0
factor 0
in 0
the 0
development 0
of 0
thrombosis 0
in 0
patients 0
with 0
the 0
lupus 0
anticoagulant 0
. 0

Human 0
psychophysical 0
analysis 0
of 0
receptive 0
field 0
- 0
like 0
properties 0
- 0
- 0
II 0
. 0

Furthermore 0
, 0
agonist 0
action 0
at 0
a 0
5 B-gene
- I-gene
HT1 I-gene
receptor I-gene
and 0
antagonist 0
action 0
at 0
5 B-gene
- I-gene
HT2 I-gene
receptors I-gene
both 0
appear 0
to 0
contribute 0
to 0
antidepressant 0
- 0
like 0
activity 0
on 0
the 0
DRL 0
72 0
- 0
s 0
schedule 0
. 0

Heliox 0
improves 0
pulsus 0
paradoxus 0
and 0
peak 0
expiratory 0
flow 0
in 0
nonintubated 0
patients 0
with 0
severe 0
asthma 0
. 0

Response 0
surface 0
methodology 0
was 0
employed 0
to 0
describe 0
the 0
relationship 0
between 0
soman 0
- 0
induced 0
incapacitation 0
and 0
the 0
ATR/DZ 0
or 0
ATR/SCP 0
dosages 0
. 0

Both 0
DMP2 B-gene
and 0
DMP3 B-gene
are 0
closely 0
localized 0
on 0
mouse 0
chromosome 0
5q21 0
, 0
corresponding 0
to 0
human 0
chromosome 0
4q21 0
. 0

A 0
kinetic 0
model 0
for 0
99mTc 0
- 0
DMSA 0
in 0
the 0
rat 0
. 0

Together 0
with 0
the 0
up 0
- 0
regulation 0
of 0
the 0
cAMP B-gene
response I-gene
element I-gene
modulator I-gene
protein I-gene
( 0
CREM B-gene
) 0
mRNA 0
and 0
protein 0
levels 0
demonstrated 0
previously 0
in 0
CREB B-gene
mutant I-gene
mice 0
, 0
we 0
suggest 0
that 0
the 0
up 0
- 0
regulation 0
of 0
CREB B-gene
beta I-gene
may 0
also 0
contribute 0
to 0
compensation 0
within 0
the 0
CREB/ATF B-gene
family 0
of 0
transcription 0
factors 0
, 0
when 0
CREB/ATF I-gene

To 0
examine 0
the 0
effect 0
of 0
the 0
cAMP 0
signal 0
transduction 0
pathway 0
on 0
transcription 0
of 0
the 0
gene 0
encoding 0
the 0
catalytic 0
subunit 0
of 0
glucose B-gene
- I-gene
6 I-gene
- I-gene
phosphatase I-gene
( 0
G6Pase B-gene
) 0
, 0
G6Pase B-gene
- 0
chloramphenicol B-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
fusion 0
genes 0
were 0
transiently 0
transfected 0
into 0
either 0
the 0
liver 0
- 0
derived 0
HepG2 0
or 0
kidney 0
- 0
derived 0
LLC 0
- 0
PK 0
cell 0
line 0
. 0

The 0
structural 0
intestinal 0
defects 0
are 0
presumed 0
to 0
be 0
the 0
result 0
of 0
defective 0
collagen B-gene
synthesis 0
in 0
these 0
hereditary 0
connective 0
tissue 0
disorders 0
. 0

Letter 0
: 0
Dehydrated 0
test 0
strip 0
for 0
the 0
detection 0
of 0
yeasts 0
. 0

Galactorrhoea 0
is 0
a 0
rare 0
presentation 0
of 0
an 0
empty 0
sella 0
syndrome 0
. 0

The 0
transition 0
from 0
expression 0
of 0
early 0
meiotic 0
genes 0
to 0
expression 0
of 0
middle 0
sporulation 0
- 0
specific 0
genes 0
occurs 0
at 0
about 0
the 0
time 0
that 0
cells 0
exit 0
from 0
pachytene 0
and 0
form 0
the 0
meiosis 0
I 0
spindle 0
. 0

Mutations 0
away 0
from 0
splice 0
site 0
recognition 0
sequences 0
might 0
cis 0
- 0
modulate 0
alternative 0
splicing 0
of 0
goat 0
alpha B-gene
s1 I-gene
- I-gene
casein I-gene
transcripts I-gene
. 0

These 0
Tlr B-gene
family I-gene
members I-gene
, 0
unlike 0
others 0
reported 0
to 0
date 0
, 0
were 0
identified 0
within 0
a 0
genomic 0
database 0
. 0

Fig1p B-gene
and 0
Fig2p B-gene
are 0
likely 0
to 0
act 0
at 0
the 0
cell 0
surface 0
as 0
Fig1 B-gene
: 0
: 0
beta B-gene
- I-gene
gal I-gene
and 0
Fig2 B-gene
: 0
:beta B-gene
- I-gene
gal I-gene
fusion I-gene
proteins I-gene
localize 0
to 0
the 0
periphery 0
of 0
mating 0
cells 0
. 0

There 0
is 0
little 0
supportive 0
evidence 0
that 0
ACE B-gene
inhibitors 0
( 0
captopril 0
or 0
enalapril 0
) 0
are 0
teratogenic 0
. 0

These 0
results 0
suggest 0
that 0
the 0
PVB 0
therapy 0
is 0
not 0
sufficient 0
to 0
cure 0
the 0
cases 0
with 0
choriocarcinoma 0
element 0
or 0
bulky 0
metastasis 0
. 0

Evaluation 0
of 0
gamma B-gene
- I-gene
glutamyl I-gene
transpeptidase I-gene
in 0
myocardial 0
infarction 0
. 0

The 0
yjr041c B-gene
delta I-gene
haploid 0
cells 0
gave 0
rise 0
to 0
microcolonies 0
comprising 0
about 0
20 0
to 0
50 0
cells 0
. 0

Mean 0
latency 0
periods 0
were 0
29.6 0
among 0
insulators 0
, 0
35.4 0
among 0
dock 0
workers 0
, 0
43.7 0
in 0
a 0
heterogeneous 0
group 0
defined 0
as 0
various 0
, 0
46.4 0
in 0
non 0
- 0
shipbuilding 0
industry 0
workers 0
, 0
49.4 0
in 0
shipyard 0
workers 0
, 0
51.7 0
among 0
women 0
with 0
a 0
history 0
of 0
domestic 0
exposure 0
to 0
asbestos 0
, 0
and 0
56.2 0
in 0
people 0
employed 0
in 0
maritime 0
trades 0
. 0

Influence 0
of 0
dietary 0
supplementation 0
with 0
Streptococcus 0
faecium 0
M 0
- 0
74 0
on 0
broiler 0
body 0
weight 0
, 0
feed 0
conversion 0
, 0
carcass 0
characteristics 0
, 0
and 0
intestinal 0
microbial 0
colonization 0
. 0

Two 0
plasmids 0
, 0
one 0
containing 0
the 0
amino 0
terminus 0
of 0
P 0
fused 0
to 0
the 0
DNA 0
- 0
binding 0
domain 0
of 0
the 0
yeast 0
transactivator 0
, 0
GAL4 B-gene
, 0
and 0
the 0
other 0
containing 0
the 0
amino 0
terminus 0
of 0
NP B-gene
fused 0
to 0
the 0
herpesvirus 0
transactivator 0
, 0
VP16 B-gene
, 0
were 0
transfected 0
in 0
COS 0
- 0
1 0
cells 0
along 0
with 0
a 0
chloramphenicol B-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
reporter 0
plasmid 0
containing 0
GAL4 B-gene
DNA 0
- 0
binding 0
sites 0
. 0

7 0
- 0
Nitroindazole 0
( 0
7NI 0
) 0
, 0
a 0
relatively 0
selective 0
neuronal 0
nitric B-gene
oxide I-gene
synthase I-gene
( 0
nNOS B-gene
) 0
inhibitor 0
. 0
was 0
intraperitoneally 0
administered 0
to 0
the 0
guinea 0
pigs 0
30 0
minutes 0
before 0
the 0
onset 0
of 0
local 0
anoxia 0
. 0

New 0
protein 0
- 0
free 0
products 0
for 0
diet 0
therapy 0
in 0
chronic 0
renal 0
insufficiency 0

Impact 0
of 0
cytokine 0
gene 0
polymorphisms 0
on 0
outcomes 0
of 0
coronary 0
artery 0
bypass 0
graft 0
surgery 0
. 0

The 0
human 0
protein 0
binds 0
most 0
strongly 0
to 0
the 0
SH3 B-gene
domain I-gene
from 0
the 0
abl B-gene
proto I-gene
- I-gene
oncogene I-gene
. 0

Adequacy 0
of 0
the 0
Haldane 0
transformation 0
in 0
the 0
computation 0
of 0
exercise 0
V 0
O2 0
in 0
man 0
. 0

Covariates 0
were 0
lower 0
extremity 0
range 0
of 0
motion 0
and 0
sensory 0
status 0
. 0

Like 0
troponin B-gene
Cs I-gene
and 0
calmodulins B-gene
, 0
PfCPK B-gene
also 0
contains 0
four 0
EF 0
hand 0
calcium 0
- 0
binding 0
motifs 0
. 0

Roller 0
pumps 0
, 0
coronary 0
suction 0
and 0
an 0
open 0
cardiotomy 0
reservoir 0
were 0
used 0
. 0

Akt B-gene
- 0
dependent 0
antiapoptotic 0
action 0
of 0
insulin B-gene
is 0
sensitive 0
to 0
farnesyltransferase 0
inhibitor 0
. 0

LT B-gene
- I-gene
beta I-gene
transcription 0
is 0
maximal 0
in 0
the 0
thymic 0
medulla 0
and 0
in 0
splenic 0
white 0
pulp 0
. 0

Ultrastructure 0
and 0
toxin 0
formation 0
of 0
Cor 0
. 0
diphtheriae 0
PW 0
- 0
8 0
cultured 0
in 0
the 0
presence 0
of 0
penicillin 0

Our 0
data 0
indicate 0
that 0
the 0
various 0
subunits 0
of 0
the 0
human 0
P B-gene
- I-gene
TEFb I-gene
complex 0
may 0
play 0
distinct 0
roles 0
at 0
multiple 0
stages 0
to 0
mediate 0
Tat B-gene
activation 0
of 0
HIV 0
- 0
1 0
transcription 0
elongation 0
. 0

The 0
organelles 0
synthesize 0
their 0
own 0
set 0
of 0
Fe/S B-gene
proteins I-gene
, 0
and 0
they 0
initiate 0
the 0
generation 0
of 0
extramitochondrial B-gene
Fe/S I-gene
proteins I-gene
. 0

Ras B-gene
involvement 0
in 0
signal 0
transduction 0
by 0
the 0
serotonin B-gene
5 I-gene
- I-gene
HT2B I-gene
receptor I-gene
. 0

Engineering 0
temperature 0
- 0
sensitive 0
SH3 B-gene
domains I-gene
. 0

Orlistat 0
is 0
a 0
specific 0
lipase B-gene
inhibitor 0
that 0
impairs 0
fat 0
absorption 0
, 0
thereby 0
reducing 0
fat 0
uptake 0
. 0

We 0
identify 0
YY1 B-gene
recognition 0
sequences 0
within 0
the 0
vitamin 0
D 0
response 0
element 0
( 0
VDRE 0
) 0
of 0
the 0
osteocalcin B-gene
gene I-gene
that 0
are 0
critical 0
for 0
YY1 B-gene
- 0
dependent 0
repression 0
of 0
vitamin 0
D 0
- 0
enhanced 0
promoter 0
activity 0
. 0

The 0
nine 0
subjects 0
were 0
treated 0
in 0
random 0
sequence 0
with 0
cimetidine 0
0 0
- 0
8 0
- 0
1 0
- 0
0 0
g 0
on 0
one 0
day 0
and 0
placebo 0
capsules 0
on 0
the 0
other 0
. 0

ORF3 0
encodes 0
a 0
putative 0
periplasmic B-gene
c I-gene
- I-gene
type I-gene
cytochrome I-gene
with 0
a 0
molecular 0
mass 0
of 0
94 0
, 0
000 0
Da 0
and 0
contains 0
seven 0
c 0
- 0
heme 0
- 0
binding 0
motifs 0
but 0
shows 0
no 0
sequence 0
homology 0
to 0
occ B-gene
or 0
ORF1 0
. 0

The 0
mutant 0
strain 0
carries 0
three 0
tandem 0
copies 0
of 0
the 0
18 0
bp 0
sequence 0
that 0
is 0
duplicated 0
in 0
the 0
amdI66 B-gene
mutation 0
. 0

The 0
rat 0
anococcygeus 0
muscle 0
was 0
used 0
in 0
postsynaptic 0
studies 0
. 0

The 0
HPV 0
E1 B-gene
and 0
E2 B-gene
proteins 0
along 0
with 0
cellular 0
factors 0
, 0
are 0
required 0
for 0
replication 0
of 0
the 0
viral 0
genome 0
. 0

Multiple 0
organ 0
failure 0
( 0
MOF 0
) 0
following 0
major 0
trauma 0
occurs 0
in 0
response 0
to 0
perfusion 0
deficits 0
, 0
a 0
persistent 0
inflammatory 0
focus 0
, 0
or 0
a 0
persistent 0
focus 0
of 0
dead 0
and/or 0
injured 0
tissue 0
. 0

( 0
i 0
) 0
Several 0
ribosomal 0
proteins 0
were 0
synthesized 0
in 0
substantial 0
excess 0
. 0

These 0
results 0
suggest 0
that 0
camptothecin 0
resistance 0
in 0
CEM/DOX 0
cells 0
is 0
due 0
to 0
different 0
mechanism 0
( 0
s 0
) 0
than 0
topoisomerase B-gene
- 0
or 0
P B-gene
- I-gene
glycoprotein I-gene
- 0
associated 0
multidrug 0
resistance 0
. 0

The 0
detection 0
limits 0
obtained 0
by 0
using 0
the 0
mixed 0
eluent 0
were 0
0.05 0
- 0
0.13 0
mg/L 0
, 0
several 0
times 0
lower 0
than 0
those 0
obtained 0
by 0
using 0
single 0
KHPh 0
eluent 0
. 0

Here 0
we 0
report 0
the 0
fabrication 0
of 0
single 0
- 0
molecule 0
transistors 0
based 0
on 0
individual 0
C60 0
molecules 0
connected 0
to 0
gold 0
electrodes 0
. 0

Because 0
of 0
gut 0
fermentation 0
, 0
a 0
substantial 0
portion 0
( 0
16 0
- 0
80 0
% 0
) 0
of 0
N 0
is 0
absorbed 0
as 0
ammonia 0
N 0
( 0
NH3N 0
) 0
. 0

At 0
1 0
min 0
postalfentanil 0
, 0
N2O 0
caused 0
significantly 0
more 0
rigidity 0
than 0
100 0
% 0
O2 0
( 0
p 0
< 0
0.001 0
) 0
. 0

By 0
contrast 0
, 0
CIS B-gene
failed 0
to 0
affect 0
the 0
IL B-gene
- I-gene
9 I-gene
response 0
. 0

Interestingly 0
, 0
PMA 0
- 0
, 0
PDGF B-gene
- 0
, 0
and 0
serum 0
- 0
induced 0
GHR B-gene
proteolysis 0
was 0
associated 0
with 0
substantial 0
decreases 0
in 0
GH B-gene
- 0
induced 0
activation 0
of 0
Janus B-gene
kinase I-gene
- I-gene
2 I-gene
, 0
which 0
were 0
also 0
prevented 0
by 0
IC3 0
. 0

The 0
centromeric 0
dodeca 0
- 0
satellite 0
of 0
Drosophila 0
forms 0
altered 0
DNA 0
structures 0
in 0
vitro 0
in 0
which 0
its 0
purine 0
- 0
rich 0
strand 0
( 0
G 0
- 0
strand 0
) 0
forms 0
stable 0
fold 0
- 0
back 0
structures 0
, 0
while 0
the 0
complementary 0
C 0
- 0
strand 0
remains 0
unstructured 0
. 0

The 0
Aspergillus B-gene
uvsH I-gene
gene I-gene
encodes 0
a 0
product 0
homologous 0
to 0
yeast B-gene
RAD18 I-gene
and 0
Neurospora B-gene
UVS I-gene
- I-gene
2 I-gene
. 0

These 0
data 0
also 0
suggest 0
the 0
existence 0
of 0
a 0
mechanism 0
by 0
which 0
regulatory 0
subunits 0
modulate 0
the 0
PI B-gene
3 I-gene
- I-gene
kinase I-gene
- 0
mediated 0
signals 0
, 0
independent 0
of 0
the 0
kinase 0
activity 0
, 0
possibly 0
through 0
subcellular 0
localization 0
of 0
the 0
catalytic 0
subunit 0
or 0
interaction 0
with 0
additional 0
signaling 0
molecules 0
. 0

A 0
continuous 0
- 0
flow 0
BIPAP 0
system 0
consists 0
of 0
a 0
high 0
- 0
flow 0
CPAP 0
system 0
, 0
a 0
reservoir 0
bag 0
, 0
and 0
a 0
pneumatically 0
controlled 0
membrane 0
valve 0
in 0
the 0
expiratory 0
limb 0
. 0

This 0
study 0
demonstrates 0
that 0
the 0
exposure 0
to 0
sulphur 0
mustard 0
results 0
in 0
very 0
low 0
androgen 0
levels 0
and 0
hypo 0
- 0
responsiveness 0
to 0
GnRH B-gene
in 0
the 0
first 0
five 0
weeks 0
and 0
normalization 0
by 0
the 0
twelfth 0
week 0
after 0
injury 0
. 0

The 0
A3B3 0
domain 0
had 0
a 0
mass 0
of 0
34,462 0
, 0
with 0
a 0
glycosylation 0
mass 0
of 0
14,900 0
, 0
in 0
good 0
agreement 0
with 0
seven 0
N 0
- 0
linked 0
glycosylation 0
sites 0
of 0
average 0
mass 0
2100 0
. 0

In 0
the 0
present 0
study 0
we 0
prospectively 0
compared 0
side 0
effects 0
occurring 0
in 0
12 0
patients 0
after 0
the 0
first 0
administration 0
of 0
low 0
- 0
dose 0
OKT3 0
( 0
0.5 0
mg 0
twice 0
daily 0
) 0
induction 0
therapy 0
with 0
those 0
in 0
10 0
patients 0
who 0
were 0
treated 0
with 0
a 0
conventional 0
dose 0
of 0
OKT3 0
( 0
5 0
mg 0
daily 0
) 0
for 0
acute 0
rejection 0
. 0

Plasma B-gene
prolactin I-gene
concentrations 0
during 0
incubation 0
, 0
25.8 0
+/ 0
- 0
2.3 0
ng/ml 0
, 0
decreased 0
to 0
baseline 0
levels 0
, 0
10.8 0
+/ 0
- 0
1.9 0
ng/ml 0
, 0
within 0
24 0
hr 0
after 0
nestbox 0
removal 0
. 0

Our 0
findings 0
suggest 0
that 0
resting 0
Tl 0
- 0
201 0
scintigraphy 0
has 0
limited 0
value 0
in 0
the 0
detection 0
of 0
coronary 0
artery 0
disease 0
in 0
patients 0
with 0
Hurler 0
syndrome 0
. 0

Exit 0
from 0
mitosis 0
in 0
Drosophila 0
syncytial 0
embryos 0
requires 0
proteolysis 0
and 0
cyclin B-gene
degradation 0
, 0
and 0
is 0
associated 0
with 0
localized 0
dephosphorylation 0
. 0

Also 0
, 0
residues 0
273 0
to 0
287 0
, 0
which 0
are 0
identical 0
in 0
sequence 0
to 0
a 0
15 0
- 0
amino 0
- 0
acid 0
segment 0
near 0
the 0
carboxy 0
terminus 0
of 0
the 0
simian B-gene
foamy I-gene
virus I-gene
transcriptional I-gene
activator I-gene
Taf I-gene
, 0
can 0
independently 0
enhance 0
the 0
activity 0
of 0
the 0
minimal 0
activator 0
region 0
. 0

The 0
effect 0
of 0
buthionine 0
sulfoximine 0
( 0
BSO 0
) 0
and 0
disulfiram 0
( 0
DSF 0
) 0
on 0
the 0
urotoxicity 0
induced 0
by 0
cyclophosphamide 0
( 0
CPA 0
) 0
was 0
examined 0
in 0
mice 0
. 0

METHOD 0
: 0
Six 0
instruments 0
were 0
reviewed 0
: 0
the 0
Berg 0
Balance 0
Scale 0
( 0
Berg 0
) 0
, 0
the 0
Clinical 0
Test 0
of 0
Sensory 0
Interaction 0
and 0
Balance 0
( 0
CTSIB 0
) 0
, 0
the 0
Functional 0
Reach 0
Test 0
, 0
the 0
Tinetti 0
Balance 0
Test 0
of 0
the 0
Performance 0
- 0
Oriented 0
Assessment 0
of 0
Mobility 0
Problems 0
( 0
Tinetti 0
) 0
, 0
the 0
Timed 0
`` 0
Up 0
and 0
Go 0
'' 0
Test 0
( 0
TU 0
& 0
GT 0
) 0
, 0
and 0
the 0
Physical 0
Performance 0
Test 0
( 0
PPT 0
) 0
. 0

The 0
side 0
effect 0
of 0
pulmonary 0
fibrosis 0
occurs 0
in 0
20 0
to 0
30 0
percent 0
of 0
patients 0
receiving 0
this 0
drug 0
. 0

Of 0
the 0
47 0
women 0
with 0
AGCUS 0
, 0
16 0
had 0
intraepithelial 0
or 0
invasive 0
neoplasms 0
( 0
34 0
% 0
; 0
95 0
% 0
confidence 0
interval 0
, 0
21 0
- 0
49 0
% 0
) 0
, 0
including 0
9 0
low 0
or 0
high 0
grade 0
squamous 0
intraepithelial 0
lesions 0
, 0
1 0
adenocarcinoma 0
in 0
situ 0
of 0
the 0
cervix 0
, 0
3 0
adenocarcinomas 0
of 0
the 0
cervix 0
, 0
2 0
adenocarcinomas 0
of 0
the 0
endometrium 0
and 0
1 0
adenoid 0
basal 0
cell 0
carcinoma 0
of 0
the 0
cervix 0
. 0

Interestingly 0
, 0
these 0
`` 0
activation 0
- 0
defective 0
'' 0
mutants 0
segregated 0
into 0
two 0
classes 0
: 0
1 0
) 0
those 0
that 0
were 0
unable 0
to 0
form 0
dimers 0
but 0
that 0
could 0
still 0
form 0
higher 0
order 0
oligomers 0
and 0
transform 0
cells 0
, 0
and 0
2 0
) 0
those 0
that 0
were 0
defective 0
for B-gene
PDGF I-gene
- 0
R 0
binding 0
and 0
were 0
transformation 0
- 0
incompetent 0
. 0

Thus 0
in 0
this 0
study 0
we 0
used 0
in 0
vitro 0
methods 0
to 0
directly 0
evaluate 0
whether 0
isolated 0
human 0
saphenous 0
vein 0
segments 0
respond 0
to 0
vasoconstrictor 0
agents 0
at 0
arterial 0
pressure 0
levels 0
. 0

Genomic 0
Southern 0
blot 0
analysis 0
suggests 0
that 0
the 0
human 0
haploid 0
genome 0
contains 0
a 0
single 0
Gs B-gene
alpha I-gene
gene I-gene
. 0

Four 0
cDNAs 0
( 0
Kox4 B-gene
, 0
Kox7 B-gene
, 0
Kox12 B-gene
, 0
and 0
Kox15 B-gene
) 0
were 0
identified 0
that 0
match 0
one 0
or 0
more 0
genomic 0
clones 0
; 0
these 0
matches 0
were 0
confirmed 0
by 0
nucleotide 0
sequence 0
analysis 0
. 0

The 0
facilitation 0
started 0
preceding 0
the 0
onset 0
of 0
electromyographic 0
activity 0
of 0
the 0
masseter 0
muscle 0
. 0

Reactivation 0
of 0
hepatitis 0
B 0
virus 0
replication 0
is 0
a 0
rare 0
event 0
during 0
the 0
natural 0
history 0
of 0
chronic 0
hepatitis 0
B 0
. 0

SETTING 0
- 0
- 0
Hospital 0
laboratories 0
in 0
the 0
United 0
States 0
submitting 0
pneumococcal 0
isolates 0
to 0
the 0
CDC 0
between 0
October 0
1 0
, 0
1991 0
, 0
and 0
September 0
30 0
, 0
1992 0
. 0

To 0
determine 0
whether 0
transcription 0
of 0
orfX 0
and 0
vfr B-gene
are 0
controlled 0
by 0
the 0
same 0
mechanisms 0
that 0
control 0
transcription 0
of 0
the 0
region 0
of 0
the 0
divergent 0
ORF 0
( 0
dorf 0
) 0
and 0
of 0
crp B-gene
, 0
we 0
compared 0
the 0
vfr B-gene
- 0
orfX 0
and 0
crp B-gene
- 0
dorf 0
intergenic 0
regions 0
. 0

Cotransfection 0
with 0
C/EBPbeta B-gene
and 0
GATA B-gene
- I-gene
1 I-gene
expression 0
vectors 0
produced 0
a 0
5 0
- 0
fold 0
increase 0
compared 0
with 0
cotransfection 0
with 0
the 0
C/EBPbeta B-gene
or 0
GATA B-gene
- I-gene
1 I-gene
expression 0
vectors 0
individually 0
. 0

One 0
of 0
these 0
clones 0
encodes 0
Xenopus B-gene
N I-gene
- I-gene
ras I-gene
. 0

Eighteen 0
patients 0
with 0
advanced 0
epidermoid 0
carcinoma 0
of 0
the 0
head 0
and 0
neck 0
were 0
entered 0
into 0
a 0
phase 0
II 0
trial 0
of 0
N 0
- 0
Methylformamide 0
( 0
NMF 0
) 0
, 0
800 0
mg/M2 0
IV 0
daily 0
for 0
5 0
days 0
every 0
4 0
weeks 0
. 0

Total 0
body 0
water 0
and 0
distribution 0
space 0
of 0
Na24 0
in 0
women 0
with 0
various 0
body 0
weight 0

Transient 0
cotransfection 0
analyses 0
indicate 0
that 0
the 0
cooperative 0
association 0
of 0
NF B-gene
- I-gene
IL I-gene
- I-gene
6 I-gene
and 0
RelA B-gene
with 0
the 0
IL B-gene
- I-gene
8 I-gene
promoter I-gene
results 0
in 0
synergistic 0
transcriptional 0
activation 0
. 0

Sera 0
from 0
33 0
newborn 0
infants 0
with 0
gestational 0
ages 0
ranging 0
from 0
27 0
to 0
41 0
weeks 0
were 0
tested 0
by 0
radioimmunoassay 0
for 0
IgG B-gene
antibodies 0
to 0
surface 0
antigens 0
of 0
group 0
B 0
streptococci 0
( 0
GBS 0
) 0
types 0
Ia 0
, 0
Ib 0
, 0
II 0
and 0
III 0
. 0

On 0
average 0
, 0
rCMRglc 0
values 0
were 0
23 0
% 0
below 0
control 0
values 0
for 0
all 0
regions 0
studied 0
, 0
with 0
the 0
greatest 0
differences 0
in 0
posterior 0
brain 0
regions 0
( 0
visual 0
association 0
cortex 0
, 0
primary 0
visual 0
cortex 0
, 0
and 0
parietal 0
cortex 0
) 0
and 0
thalamus 0
. 0

The 0
NF1 B-gene
family I-gene
members 0
and 0
HNF4 B-gene
interacted 0
with 0
overlapping 0
sequences 0
of 0
the 0
L 0
- 0
II 0
element 0
, 0
wherein 0
the 0
5 0
' 0
half 0
- 0
site 0
was 0
more 0
critical 0
for 0
NF1 B-gene
binding 0
, 0
and 0
the 0
3 0
' 0
site 0
was 0
more 0
important 0
for 0
HNF4 B-gene
binding 0
. 0

The 0
shear 0
bond 0
strength 0
recorded 0
for 0
the 0
Novabond 0
system 0
was 0
significantly 0
lower 0
( 0
17 0
MPa 0
) 0
. 0

The 0
IR4 0
ORF 0
exhibits 0
significant 0
homology 0
to 0
the 0
immediate B-gene
- I-gene
early I-gene
gene I-gene
US1 B-gene
( 0
ICP22 B-gene
) 0
of 0
herpes 0
simplex 0
virus 0
type 0
1 0
and 0
to 0
the 0
ICP22 B-gene
homologs 0
of 0
varicella 0
- 0
zoster 0
virus 0
( 0
ORF63 B-gene
) 0
, 0
pseudorabies 0
virus 0
( 0
RSp40 B-gene
) 0
, 0
and 0
equine 0
herpesvirus 0
4 0
( 0
ORF4 0
) 0
. 0

Psoriasis 0
on 0
tumor 0
. 0

VP4 B-gene
differentially 0
regulates 0
TRAF2 B-gene
signaling 0
, 0
disengaging 0
JNK B-gene
activation 0
while 0
directing 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
to 0
effect 0
rotavirus 0
- 0
specific 0
cellular 0
responses 0
. 0

From 0
the 0
autopsy 0
findings 0
, 0
in 0
5 0
out 0
of 0
the 0
remaining 0
23 0
expired 0
patients 0
, 0
Legionella 0
pneumonia 0
seemed 0
to 0
be 0
successfully 0
treated 0
, 0
but 0
other 0
disease 0
or 0
other 0
bacterial 0
pneumonia 0
put 0
an 0
end 0
to 0
the 0
patients 0
. 0

We 0
found 0
a 0
prevalence 0
of 0
eating 0
disorders 0
of 0
5.9 0
% 0
( 0
lifetime 0
prevalence 0
of 0
10 0
% 0
) 0
, 0
irrespective 0
of 0
gender 0
and 0
type 0
of 0
diabetes 0
; 0
4.1 0
% 0
of 0
the 0
whole 0
sample 0
reported 0
intentional 0
insulin B-gene
undertreatment 0
or 0
omission 0
. 0

NER 0
was 0
also 0
measured 0
by 0
a 0
plasmid 0
host 0
cell 0
re 0
- 0
activation 0
assay 0
using 0
a 0
vector 0
containing 0
a 0
luciferase B-gene
reporter I-gene
gene I-gene
. 0

Also 0
, 0
like 0
TUB B-gene
, 0
it 0
has 0
a 0
wider 0
pattern 0
of 0
tissue 0
expression 0
than 0
either 0
TULP1 B-gene
or 0
TULP2 B-gene
. 0

Accuracy 0
and 0
predictive 0
value 0
of 0
ultrasound 0
in 0
acute 0
rejection 0
. 0

Moist 0
healing 0
versus 0
wet 0
- 0
to 0
- 0
dry 0
. 0

Flicker 0
thresholds 0
were 0
measured 0
from 0
1 0
to 0
40 0
Hz 0
with 0
a 0
vertical 0
- 0
line 0
target 0
used 0
for 0
the 0
asynchrony 0
thresholds 0
. 0

Despite 0
the 0
same 0
decreases 0
or 0
increases 0
in 0
MAP 0
, 0
RSNA 0
was 0
attenuated 0
after 0
15 0
and 0
30 0
min 0
of 0
propofol 0
infusion 0
in 0
both 0
groups 0
compared 0
with 0
control 0
( 0
P 0
< 0
0.05 0
) 0
. 0

Ganglia 0
are 0
cysts 0
which 0
frequently 0
occur 0
in 0
the 0
proximity 0
of 0
joints 0
. 0

Fractional 0
Ca 0
retention 0
was 0
measured 0
from 0
the 0
72 0
- 0
h 0
postdose 0
WBR 0
divided 0
by 0
WBR 0
at 0
time 0
0 0
. 0

Activity 0
was 0
reconstituted 0
, 0
however 0
, 0
by 0
combining 0
fractions 0
that 0
were 0
enriched 0
in 0
the 0
two 0
components 0
. 0

Acute 0
morphine 0
treatment 0
did 0
not 0
increase 0
the 0
locomotor 0
activity 0
of 0
mice 0
withdrawn 0
for 0
1 0
day 0
, 0
after 0
withdrawal 0
for 0
3 0
days 0
the 0
increase 0
was 0
similar 0
to 0
that 0
in 0
controls 0
, 0
and 0
after 0
5 0
days 0
the 0
increase 0
was 0
clearly 0
larger 0
than 0
in 0
controls 0
. 0

A 0
significant 0
and 0
specific 0
reduction 0
in 0
binaural 0
peak 0
amplitude 0
and 0
area 0
of 0
the 0
echo 0
- 0
evoked 0
middle 0
- 0
latency 0
component 0
Pa 0
was 0
observed 0
. 0

Non 0
- 0
dialyzable 0
transfer B-gene
factor I-gene

Gene B-gene
1 I-gene
of I-gene
the I-gene
murine I-gene
coronavirus I-gene
, I-gene
MHV I-gene
- I-gene
A59 I-gene
, 0
encodes 0
approximately 0
800 0
kDa 0
of 0
protein 0
products 0
within 0
two 0
overlapping 0
open 0
reading 0
frames 0
( 0
ORFs 0
1a 0
and 0
1b 0
) 0
. 0

Stress 0
thallium 0
- 0
201 0
myocardial 0
imaging 0
was 0
used 0
in 0
two 0
angina 0
- 0
free 0
patients 0
with 0
severe 0
congestive 0
heart 0
failure 0
to 0
identify 0
clinically 0
silent 0
areas 0
of 0
ischemic 0
myocardium 0
and 0
to 0
distinguish 0
between 0
scar 0
and 0
reversibly 0
ischemic 0
myocardium 0
as 0
a 0
cause 0
for 0
akinesia 0
of 0
left 0
ventricular 0
wall 0
segments 0
. 0

To 0
understand 0
this 0
dramatic 0
effect 0
, 0
we 0
examined 0
the 0
localization 0
of 0
SR B-gene
proteins I-gene
and 0
found 0
that 0
SC35 B-gene
was 0
shifted 0
to 0
the 0
cytoplasm 0
in 0
sky1Delta B-gene
yeast 0
, 0
although 0
this 0
phenomenon 0
was 0
not 0
obvious 0
with 0
ASF/SF2 B-gene
, 0
indicating 0
that 0
nuclear 0
import 0
of 0
ASF/SF2 I-gene

GH B-gene
stimulated 0
the 0
activity 0
of 0
promoter 0
fragments 0
with 0
5' 0
- 0
ends 0
between 0
nucleotide 0
( 0
nt 0
) 0
- 0
2001 0
and 0
nt 0
- 0
653 0
by 0
1.9 0
- 0
to 0
2.7 0
- 0
fold 0
. 0

The 0
6.5 0
- 0
kb 0
genomic 0
fragment 0
contains 0
the 0
complete 0
coding 0
region 0
of 0
MyoD B-gene
, 0
distributed 0
over 0
three 0
exons 0
, 0
plus 0
2.3 0
kb 0
of 0
5' 0
- 0
noncoding 0
sequence 0
and 0
1.4 0
kb 0
of 0
3' 0
- 0
noncoding 0
sequence 0
. 0

These 0
observations 0
demonstrate 0
that 0
KSR B-gene
is 0
capable 0
of 0
uncoupling 0
the 0
MAP B-gene
kinase I-gene
activation 0
from 0
its 0
target 0
phosphorylation 0
, 0
and 0
thus 0
provide 0
a 0
novel 0
mechanism 0
for 0
modulating 0
the 0
Ras B-gene
- 0
MAP B-gene
kinase I-gene
signaling 0
pathway 0
. 0

Since 0
1985 0
the 0
combination 0
of 0
chlorambucil 0
( 0
10 0
mg 0
daily 0
, 0
initially 0
for 0
six 0
weeks 0
, 0
then 0
alternating 0
fortnights 0
for 0
12 0
weeks 0
) 0
and 0
interferon B-gene
- I-gene
alpha I-gene
2b I-gene
( 0
Schering 0
- 0
Plough 0
; 0
2 0
x 0
10 0
( 0
6 0
) 0
U/m2 0
three 0
times 0
weekly 0
by 0
subcutaneous 0
injection 0
for 0
18 0
weeks 0
) 0
has 0
been 0
compared 0
in 0
a 0
randomised 0
trial 0
with 0
chlorambucil 0
alone 0
in 0
previously 0
untreated 0
patients 0
with 0
stage 0
III 0
or 0
IV 0
follicular 0
lymphoma 0
. 0

Correlation 0
of 0
alpha 0
activity 0
between 0
the 0
frontal 0
and 0
occipital 0
cortex 0
. 0

Nonetheless 0
, 0
the 0
majority 0
were 0
located 0
within 0
three 0
short 0
sequences 0
at 0
the 0
N 0
terminus 0
, 0
middle 0
, 0
and 0
C 0
terminus 0
that 0
are 0
phylogenetically 0
conserved 0
among 0
all 0
known 0
eubacterial 0
and 0
chloroplast 0
versions 0
of 0
this 0
protein 0
. 0

All 0
other 0
cysts 0
showed 0
a 0
unilocular 0
, 0
purely 0
cystic 0
pattern 0
, 0
with 0
homogeneous 0
fluids 0
, 0
although 0
the 0
T2 0
relaxation 0
times 0
of 0
four 0
lesions 0
overlapped 0
those 0
of 0
odontogenic 0
keratocysts 0
. 0

Processing 0
MES 0
data 0
requires 0
large 0
bit 0
manipulations 0
and 0
heavy 0
memory 0
storage 0
requirements 0
. 0

Recombinant B-gene
caspases I-gene
are 0
typically 0
produced 0
in 0
Escherichia 0
coli 0
expression 0
systems 0
with 0
the 0
attendant 0
problems 0
of 0
solubilization 0
, 0
re 0
- 0
folding 0
and 0
activation 0
of 0
the 0
protease 0
. 0

Nuclear 0
runoff 0
assays 0
show 0
that 0
complementation 0
by 0
HPV16 B-gene
E7 I-gene
restores 0
the 0
ability 0
of 0
the 0
E1A B-gene
mutants I-gene
to 0
stimulate 0
early B-gene
gene I-gene
expression 0
at 0
the 0
level 0
of 0
transcription 0
. 0

The 0
effect 0
of 0
deferoxamine 0
B 0
on 0
the 0
blood 0
sugar 0
behavior 0
in 0
intravenous 0
glucose 0
loading 0
in 0
healthy 0
persons 0

Constructs 0
containing 0
fragments 0
of 0
the 0
upstream 0
region 0
of 0
the 0
cytotactin B-gene
gene I-gene
fused 0
to 0
a 0
promoterless 0
gene 0
for 0
chloramphenicol B-gene
acetyltransferase I-gene
were 0
transiently 0
transfected 0
into 0
chicken 0
embryo 0
fibroblasts 0
to 0
define 0
functional 0
promoter 0
sequences 0
. 0

Like 0
the 0
human B-gene
erythrocyte I-gene
P4.2 I-gene
, 0
mouse B-gene
erythrocyte I-gene
P4.2 I-gene
contains 0
regions 0
strikingly 0
homologous 0
with 0
the 0
transglutaminase 0
( 0
TGase 0
) 0
proteins 0
although 0
it 0
too 0
most 0
likely 0
lacks 0
TGase 0
crosslinking 0
activity 0
. 0

The 0
rate 0
for 0
Arm 0
III 0
( 0
CAF 0
therapy 0
) 0
was 0
61.5 0
% 0
( 0
32/52 0
) 0
, 0
a 0
little 0
higher 0
than 0
that 0
for 0
the 0
other 0
two 0
. 0

The 0
CHL B-gene
1 I-gene
( 0
CTF B-gene
1 I-gene
) 0
gene 0
product 0
of 0
Saccharomyces 0
cerevisiae 0
is 0
important 0
for 0
chromosome 0
transmission 0
and 0
normal 0
cell 0
cycle 0
progression 0
in 0
G2/M 0
. 0

We 0
have 0
analyzed 0
the 0
function 0
of 0
these 0
putative 0
SL 0
structures 0
in 0
RNA 0
translation 0
by 0
constructing 0
chimeric B-gene
chloramphenicol I-gene
acetyltransferase I-gene
( B-gene
CAT I-gene
) I-gene
RNAs I-gene
, 0
flanked 0
either 0
by 0
both 0
5' 0
- 0
and 0
3' 0
- 0
terminal 0
sequence 0
domains 0
from 0
the 0
RV 0
genome 0
or 0
several 0
deletion 0
derivatives 0
of 0
the 0
same 0
sequences 0
. 0

Mutating 0
this 0
sequence 0
eliminated 0
complex 0
formation 0
and 0
markedly 0
reduced 0
basal 0
and 0
cAMP 0
- 0
dependent 0
promoter 0
activity 0
of 0
transfected 0
reporter 0
genes 0
. 0

The 0
average 0
cumulative 0
UVA 0
dose 0
was 0
65 0
J/cm2 0
; 0
40 0
patients 0
had 0
received 0
more 0
than 0
200 0
J/cm2 0
. 0

The 0
induction 0
of 0
the 0
composite 0
H B-gene
- I-gene
PK/Tag I-gene
and 0
PK/Tag I-gene

For 0
routine 0
medical 0
applications 0
, 0
no 0
sophisticated 0
adjustment 0
of 0
the 0
CHESS 0
pulse 0
is 0
needed 0
, 0
as 0
reported 0
in 0
previous 0
methods 0
. 0

Here 0
we 0
report 0
the 0
cloning 0
of 0
the 0
hemF B-gene
gene I-gene
, 0
encoding 0
the 0
aerobic 0
coproporphyrinogen B-gene
III I-gene
oxidase I-gene
from I-gene
Escherichia I-gene
coli I-gene
, 0
by 0
functional 0
complementation 0
of 0
a 0
Saccharomyces B-gene
cerevisiae I-gene
HEM13 I-gene
mutant I-gene
. 0

Efficacy 0
of 0
probiotic 0
feed 0
additives 0
: 0
guidelines 0
for 0
the 0
evaluation 0
of 0
the 0
efficiency 0
of 0
microorganisms 0
in 0
dogs 0
, 0
cats 0
, 0
and 0
horses 0
] 0
Probiotic 0
microorganisms 0
are 0
frequently 0
in 0
use 0
as 0
feed 0
additives 0
for 0
farm 0
and 0
pet 0
animals 0
. 0

We 0
analyzed 0
the 0
contribution 0
of 0
the 0
three 0
different 0
types 0
of 0
UV 0
- 0
inducible 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
( I-gene
MAP I-gene
) I-gene
kinases I-gene
( 0
ERK B-gene
, 0
JNK/SAPK B-gene
, 0
and 0
JNK/SAPK I-gene

The 0
largest 0
age 0
adjusted 0
differences 0
between 0
men 0
with 0
low 0
and 0
normal 0
mood 0
were 0
for 0
the 0
AH4 0
( 0
3 0
points 0
, 0
t 0
= 0
5.6 0
, 0
p 0
< 0
0.0001 0
) 0
and 0
the 0
CAMCOG 0
( 0
2 0
points 0
, 0
t 0
= 0
5.8 0
, 0
p 0
< 0
0.0001 0
) 0
. 0

Nucleotide 0
sequencing 0
revealed 0
a 0
2076 0
- 0
base 0
pair 0
open 0
reading 0
frame 0
encoding 0
a 0
692 0
- 0
amino 0
acid 0
protein 0
. 0

HrpE B-gene
is 0
similar 0
to 0
YscL B-gene
of 0
Yersinia 0
spp 0
. 0

Mean 0
total 0
homocysteine 0
( 0
tHcy 0
) 0
was 0
21.1 0
+/ 0
- 0
9.5 0
micromol/L 0
and 0
median 0
concentration 0
was 0
19 0
micromol/L 0
. 0

To 0
facilitate 0
the 0
characterization 0
of 0
NF B-gene
- I-gene
E2 I-gene
functions 0
in 0
human 0
cells 0
, 0
we 0
isolated 0
cDNAs 0
encoding 0
two 0
members 0
of 0
the 0
small B-gene
Maf I-gene
family I-gene
, 0
MafK B-gene
and 0
MafG B-gene
. 0

The 0
immediate 0
5' 0
- 0
flanking 0
region 0
was 0
GC 0
- 0
rich 0
with 0
3 0
SP B-gene
- I-gene
1 I-gene
- I-gene
like I-gene
and 0
2 0
AP B-gene
- I-gene
2 I-gene
sites I-gene
identified 0
in 0
close 0
proximity 0
to 0
the 0
transcription 0
start 0
site 0
. 0

The 0
ZAG1 B-gene
protein I-gene
from 0
in 0
vitro 0
translations 0
binds 0
to 0
a 0
consensus 0
target 0
site 0
that 0
is 0
recognized 0
by 0
the 0
AG B-gene
protein I-gene
. 0

Bone 0
scintigraphy 0
is 0
an 0
excellent 0
screening 0
test 0
for 0
bone 0
lesions 0
and 0
Ga 0
- 0
67 0
scintigraphy 0
is 0
a 0
useful 0
tool 0
for 0
detecting 0
inflammatory 0
lesions 0
. 0

In 0
this 0
first 0
- 0
person 0
account 0
, 0
the 0
author 0
chronicles 0
her 0
experience 0
of 0
being 0
mentally 0
ill 0
and 0
homeless 0
in 0
New 0
York 0
and 0
New 0
Jersey 0
in 0
the 0
early 0
1980s 0
. 0

Pharmacokinetics 0
of 0
skin 0
penetration 0
. 0

Dmyd B-gene
clone 0
encodes 0
a 0
polypeptide 0
of 0
332 0
amino 0
acids 0
with 0
82 0
% 0
identity 0
to 0
MyoD B-gene
in 0
the 0
41 0
amino 0
acids 0
of 0
the 0
putative 0
helix 0
- 0
loop 0
- 0
helix 0
region 0
and 0
100 0
% 0
identity 0
in 0
the 0
13 0
amino 0
acids 0
of 0
the 0
basic 0
domain 0
proposed 0
to 0
contain 0
the 0
essential 0
recognition 0
code 0
for 0
muscle 0
- 0
specific 0
gene 0
activation 0
. 0

Enterotoxin 0
production 0
by 0
staphylococci 0
isolated 0
from 0
foods 0
in 0
France 0
. 0

Binding 0
sites 0
were 0
mapped 0
for 0
each 0
factor 0
. 0

The 0
majority 0
of 0
these 0
cells 0
were 0
also 0
OKT4 B-gene
positive 0
( 0
helper/inducer 0
T 0
lymphocytes 0
) 0
, 0
while 0
the 0
minority 0
were 0
OKT8 B-gene
positive 0
( 0
suppressor/cytotoxic 0
T 0
lymphocytes 0
) 0
. 0

Toxicological 0
effects 0
of 0
dietary 0
Maillard 0
reaction 0
products 0
in 0
the 0
rat 0
. 0

All 0
relapses 0
occurred 0
within 0
the 0
first 0
year 0
and 0
were 0
confined 0
to 0
patients 0
with 0
PS 0
II 0
disease 0
and 0
four 0
or 0
more 0
sites 0
of 0
involvement 0
. 0

These 0
patients 0
developed 0
severe 0
diabetic 0
symptoms 0
including 0
glucose 0
intolerance 0
, 0
weight 0
loss 0
, 0
impaired 0
energy 0
utilization 0
, 0
and 0
nerve 0
and 0
brain 0
disorders 0
that 0
were 0
refractory 0
to 0
insulin B-gene
. 0

Buserelin 0
offers 0
an 0
effective 0
alternative 0
medical 0
treatment 0
of 0
carcinoma 0
of 0
the 0
prostate 0
and 0
, 0
apart 0
from 0
impotence 0
, 0
does 0
not 0
have 0
the 0
side 0
effects 0
of 0
oestrogens 0
. 0

BCV B-gene
mRNAs I-gene
5 I-gene
and I-gene
5 I-gene
- I-gene
1 I-gene
appear 0
to 0
be 0
used 0
for 0
the 0
synthesis 0
of 0
the 0
12.7 0
- 0
and 0
9.5 0
- 0
kDa 0
proteins 0
, 0
respectively 0
, 0
which 0
demonstrates 0
a 0
pattern 0
of 0
expression 0
strikingly 0
different 0
from 0
that 0
utilized 0
by 0
MHV 0
. 0

Consistent 0
with 0
this 0
observation 0
, 0
introduction 0
of 0
Smad B-gene
sites I-gene
into 0
a 0
TGFbeta B-gene
- 0
insensitive 0
LEF1/TCF B-gene
target 0
gene 0
confers 0
cooperative 0
LEF1/TCF I-gene

Recombinant 0
vaccinia 0
viruses 0
that 0
express 0
the 0
bacteriophage B-gene
T3 I-gene
RNA I-gene
polymerase I-gene
( 0
VV B-gene
- I-gene
T3pol I-gene
) 0
or 0
the 0
Escherichia B-gene
coli I-gene
lac I-gene
repressor I-gene
( 0
VV B-gene
- I-gene
lacI I-gene
) 0
under 0
control 0
of 0
the 0
early B-gene
- I-gene
late I-gene
vaccinia I-gene
promoter I-gene
P7.5 I-gene
were 0
constructed 0
. 0

Tritiated 0
1,24,25 0
- 0
trihydroxyvitamin 0
D3 0
was 0
synthesized 0
biologically 0
and 0
used 0
as 0
tracer 0
to 0
monitor 0
the 0
recovery 0
of 0
endogenous 0
metabolite 0
during 0
isolation 0
from 0
serum 0
. 0

In 0
this 0
report 0
, 0
we 0
have 0
examined 0
whether 0
PTP1B B-gene
effects 0
transformation 0
induced 0
by 0
p210 B-gene
bcr B-gene
- 0
abl B-gene
. 0

This 0
study 0
examines 0
LEIBNIZ 0
' 0
idea 0
of 0
Veterinary 0
medicine 0
in 0
a 0
biographical 0
context 0
. 0

Internalization 0
of 0
prolactin B-gene
receptor I-gene
and 0
prolactin B-gene
in 0
transfected 0
cells 0
does 0
not 0
involve 0
nuclear 0
translocation 0
. 0

Using 0
the 0
conflict 0
drinking 0
test 0
as 0
a 0
model 0
, 0
we 0
studied 0
in 0
rats 0
the 0
effect 0
of 0
the 0
nonselective 0
beta B-gene
- I-gene
adrenoceptor I-gene
blockers 0
pindolol 0
and 0
cyanopindolol 0
which 0
bind 0
to 0
5 B-gene
- I-gene
HT1A I-gene
and I-gene
5 I-gene
- I-gene
HT1B I-gene
receptors I-gene
, 0
and 0
of 0
the 0
selective 0
beta B-gene
1 I-gene
- I-gene
and I-gene
beta I-gene
2 I-gene
- I-gene
adrenoceptor I-gene
antagonists 0
betaxolol 0
and 0
ICI 0
118,551 0
, 0
respectively 0
, 0
which 0
have 0
a 0
negligible 0
affinity 0
for 0
5 B-gene
- I-gene
HT I-gene
receptors I-gene
. 0

Rewarding 0
properties 0
of 0
methylphenidate 0
: 0
sensitization 0
by 0
prior 0
exposure 0
to 0
the 0
drug 0
and 0
effects 0
of 0
dopamine B-gene
D1 I-gene
- I-gene
and I-gene
D2 I-gene
- I-gene
receptor I-gene
antagonists 0
. 0

Recently 0
, 0
we 0
have 0
demonstrated 0
that 0
mouse 0
microglial 0
cells 0
, 0
the 0
brain 0
macrophages 0
, 0
express 0
both 0
IL B-gene
- I-gene
15 I-gene
and 0
IL B-gene
- I-gene
15/IL I-gene
- I-gene
2 I-gene
receptors I-gene
. 0

METHODS 0
: 0
Children 0
with 0
attention 0
- 0
deficit/hyperactivity 0
disorder 0
( 0
ADHD 0
; 0
n 0
= 0
282 0
) 0
, 0
all 0
subtypes 0
, 0
ages 0
6 0
to 0
12 0
years 0
, 0
were 0
randomized 0
to 0
placebo 0
( 0
n 0
= 0
90 0
) 0
, 0
immediate 0
- 0
release 0
methylphenidate 0
( 0
IR 0
MPH 0
) 0
3 0
times 0
a 0
day 0
( 0
tid 0
; 0
dosed 0
every 0
4 0
hours 0
; 0
n 0
= 0
97 0
) 0
, 0
or 0
OROS 0
MPH 0
once 0
a 0
day 0
( 0
qd 0
; 0
n 0
= 0
95 0
) 0
in 0
a 0
double 0
- 0
blind 0
, 0
28 0
- 0
day 0
trial 0
. 0

Cell 0
sloughing 0
with 0
proparacaine 0
. 0

The 0
possibility 0
to 0
use 0
this 0
method 0
for 0
common 0
diagnostic 0
problems 0
is 0
indicated 0
. 0

The 0
deduced 0
amino 0
acid 0
sequence 0
of 0
this 0
open 0
reading 0
frame 0
is 0
significantly 0
homologous 0
to 0
the 0
HSV B-gene
1 I-gene
UL49.5 I-gene
gene I-gene
product I-gene
, 0
and 0
as 0
with 0
UL49.5 B-gene
, 0
it 0
contains 0
a 0
potential 0
signal 0
sequence 0
and 0
transmembrane 0
domain 0
characteristic 0
of 0
membrane 0
- 0
associated 0
proteins 0
. 0

Female 0
Wistar 0
rats 0
receiving 0
alcohol 0
( 0
5 0
% 0
) 0
in 0
drinking 0
water 0
during 0
lactation 0
( 0
N 0
= 0
7 0
) 0
were 0
compared 0
to 0
normal 0
controls 0
fed 0
ad 0
libitum 0
( 0
N 0
= 0
6 0
) 0
. 0

Suspected 0
pelvic 0
endometriosis 0
was 0
prospectively 0
evaluated 0
in 0
31 0
women 0
with 0
T1 0
- 0
and 0
T2 0
- 0
weighted 0
conventional 0
spin 0
- 0
echo 0
( 0
CSE 0
) 0
magnetic 0
resonance 0
imaging 0
alone 0
and 0
in 0
combination 0
with 0
T1 0
- 0
weighted 0
fat 0
- 0
suppressed 0
( 0
T1FS 0
) 0
and 0
gadolinium 0
- 0
enhanced 0
T1FS 0
( 0
Gd 0
- 0
T1FS 0
) 0
spin 0
- 0
echo 0
techniques 0
. 0

Eph B-gene
receptors I-gene
and 0
their 0
membrane 0
- 0
associated 0
ephrin B-gene
ligands I-gene
regulate 0
cell 0
- 0
cell 0
interactions 0
during 0
development 0
. 0

A 0
group 0
of 0
factors 0
known 0
as 0
activating B-gene
transcription I-gene
factors I-gene
( 0
ATF B-gene
) 0
have 0
been 0
found 0
to 0
bind 0
to 0
the 0
latter 0
and 0
related 0
sequences 0
found 0
upstream 0
of 0
early 0
adenovirus 0
promoters 0
induced 0
by 0
E1A B-gene
, 0
and 0
these 0
factors 0
are 0
highly 0
homologous 0
to 0
the 0
CREB B-gene
protein I-gene
. 0

Vk8/Jk2 B-gene
and 0
Vk8/Jk2 I-gene

An 0
analysis 0
of 0
the 0
c B-gene
- I-gene
kit I-gene
5 I-gene
' I-gene
flanking I-gene
region I-gene
using 0
the 0
bacterial B-gene
chloramphenicol I-gene
acetyltransferase I-gene
gene I-gene
( 0
CAT B-gene
assay 0
) 0
in 0
human 0
erythroleukemia 0
HEL 0
cells 0
, 0
which 0
express 0
the 0
endogenous 0
c B-gene
- I-gene
kit I-gene
mRNA I-gene
at 0
high 0
levels 0
, 0
showed 0
that 0
a 0
region 0
from 0
- 0
180 0
to 0
- 0
22 0
is 0
important 0
for 0
the 0
expression 0
of 0
the 0
c B-gene
- I-gene
kit I-gene
gene I-gene
. 0

The 0
quantitative 0
analysis 0
of 0
1 0
- 0
alpha 0
- 0
acetylmethadol 0
and 0
its 0
principal 0
metabolites 0
in 0
biological 0
specimens 0
by 0
gas 0
chromatography 0
- 0
chemical 0
ionization 0
- 0
multiple 0
ion 0
monitoring 0
mass 0
spectrometry 0
. 0

Following 0
immunization 0
of 0
transgenic 0
mice 0
, 0
hybrid 0
molecules 0
were 0
isolated 0
from 0
B 0
cell 0
DNA 0
which 0
contained 0
the 0
transgene 0
recombined 0
with 0
the 0
endogenous B-gene
IgH I-gene
locus I-gene
. 0

( 0
LH B-gene
P 0
< 0
0.05 0
, 0
LH/FSH B-gene
P 0
< 0
0.01 0
) 0
. 0

Here 0
we 0
show 0
that 0
expression 0
of 0
KRAB B-gene
domain I-gene
suppresses 0
in 0
vivo 0
the 0
activating 0
function 0
of 0
various 0
defined 0
activating B-gene
transcription I-gene
factors I-gene
, 0
and 0
we 0
demonstrate 0
that 0
the 0
KRAB B-gene
domain I-gene
specifically 0
silences 0
the 0
activity 0
of 0
promoters 0
whose 0
initiation 0
is 0
dependent 0
on 0
the 0
presence 0
of 0
a 0
TATA 0
box 0
. 0

In 0
the 0
renal 0
cortex 0
, 0
spleen 0
, 0
distal 0
colon 0
, 0
ileum 0
, 0
gallbladder 0
, 0
and 0
stomach 0
body 0
, 0
regional 0
O2 0
delivery 0
was 0
significantly 0
decreased 0
with 0
hemodilution 0
to 0
20 0
% 0
in 0
both 0
groups 0
. 0

None 0
of 0
the 0
19 0
women 0
with 0
probable 0
RA 0
and 0
100 0
of 0
the 0
116 0
women 0
with 0
definite 0
RA 0
met 0
the 0
1987 0
criteria 0
. 0

In 0
response 0
to 0
the 0
need 0
for 0
better 0
quantitative 0
estimates 0
of 0
the 0
regional 0
distribution 0
of 0
the 0
active 0
bone 0
marrow 0
organ 0
in 0
infants 0
and 0
children 0
, 0
a 0
method 0
using 0
various 0
anatomical 0
data 0
has 0
been 0
developed 0
. 0

Thus 0
the 0
Hi 0
- 0
RARE 0
represents 0
a 0
new 0
type 0
of 0
RA 0
response 0
element 0
with 0
a 0
role 0
in 0
the 0
modulation 0
of 0
the 0
expression 0
of 0
MHC B-gene
class I-gene
1 I-gene
family 0
genes 0
. 0

RESULTS 0
: 0
Considering 0
an 0
inulin 0
clearance 0
of 0
less 0
than 0
80 0
ml/min/1.73 0
m2 0
, 0
the 0
cut 0
- 0
off 0
value 0
for 0
serum 0
creatinine 0
was 0
11.5 0
mumol/liter 0
for 0
men 0
and 0
90 0
mumol/liter 0
for 0
women 0
. 0

Our 0
results 0
strongly 0
suggest 0
that 0
activation 0
of 0
the 0
beta 0
origin 0
by 0
a 0
distant 0
replication 0
enhancer 0
element 0
requires 0
a 0
small 0
target 0
sequence 0
essential 0
for 0
initiator 0
protein 0
- 0
mediated 0
DNA 0
looping 0
. 0

Three 0
experiments 0
using 0
20 0
microM 0
2 0
- 0
( 0
hydroxyamino 0
) 0
- 0
1 0
- 0
methyl 0
- 0
6 0
- 0
phenylimidazo 0
[ 0
4,5 0
- 0
b 0
] 0
pyridine 0
( 0
N 0
- 0
OH 0
- 0
PhIP 0
) 0
were 0
performed 0
to 0
induce 0
mutations 0
in 0
the 0
dihydrofolate B-gene
reductase I-gene
( 0
DHFR B-gene
) 0
gene 0
of 0
a 0
hemizygous 0
Chinese 0
hamster 0
ovary 0
( 0
CHO 0
) 0
cell 0
line 0
( 0
UA21 0
) 0
. 0

The 0
UL3 B-gene
ORF I-gene
of 0
204 0
amino 0
acids 0
shows 0
significant 0
homology 0
to 0
UL3 B-gene
( 0
nuclear 0
phosphoprotein 0
) 0
of 0
HSV 0
- 0
1 0
( 0
62 0
% 0
) 0
and 0
PRV 0
( 0
53 0
% 0
) 0
. 0

Immunogenicity 0
tested 0
in 0
experiments 0
on 0
guinea 0
pigs 0
and 0
rabbits 0
was 0
not 0
reduced 0
and 0
corresponded 0
to 0
that 0
of 0
the 0
reference 0
STI 0
- 0
1 0
vaccine 0
. 0

In 0
addition 0
, 0
we 0
show 0
that 0
expression 0
of 0
antisense 0
mRNA 0
for 0
p130CAS B-gene
resulted 0
in 0
reversion 0
of 0
the 0
transformed 0
phenotype 0
of 0
all 0
these 0
cell 0
lines 0
. 0

One 0
hundred 0
cDNA 0
clones 0
were 0
sequenced 0
and 0
8 0
RTKs B-gene
were 0
identified 0
, 0
as 0
well 0
as 0
12 0
non 0
- 0
RTKs B-gene
and 0
2 0
serine/threonine B-gene
kinases I-gene
. 0

Supportive 0
therapy 0
with 0
xenogenous 0
peptides 0
in 0
patients 0
with 0
metastatic 0
breast 0
cancer 0
undergoing 0
aggressive 0
chemotherapy 0
( 0
modified 0
AC 0
- 0
protocol 0
) 0
: 0
a 0
prospective 0
, 0
randomized 0
double 0
- 0
blind 0
study 0

The 0
inactive 0
X 0
allele 0
, 0
however 0
, 0
is 0
hypermethylated 0
in 0
leukocytes 0
, 0
presumably 0
reflecting 0
early 0
X 0
inactivation 0
events 0
that 0
become 0
important 0
for 0
gene 0
dosage 0
in 0
expressing 0
lineages 0
. 0

Development 0
of 0
neural 0
control 0
of 0
alimentary 0
motor 0
function 0
in 0
the 0
vertebrates 0
. 0

Studies 0
on 0
nitrogen 0
- 0
containing 0
heterocyclic 0
compounds 0
. 0

Cell 0
rounding 0
was 0
abrogated 0
by 0
expression 0
of 0
either 0
kinase 0
- 0
dead 0
forms 0
of 0
US3 B-gene
PK I-gene
or 0
a 0
mutant 0
protein 0
lacking 0
the 0
acidic 0
cluster 0
in 0
the 0
kinase 0
regulatory 0
domain 0
. 0

The 0
psychosocial 0
features 0
of 0
people 0
using 0
self 0
- 0
ignition 0
as 0
a 0
method 0
of 0
suicide 0
are 0
consistent 0
with 0
those 0
of 0
suicide 0
in 0
general 0
. 0

The 0
genes 0
expressed 0
during 0
the 0
embryonic 0
( 0
zeta B-gene
) 0
or 0
fetal 0
and 0
adult 0
stage 0
( 0
alpha B-gene
2 I-gene
and 0
alpha B-gene
1 I-gene
) 0
can 0
be 0
modified 0
by 0
point 0
mutations 0
which 0
affect 0
either 0
the 0
processing 0
- 0
translation 0
of 0
mRNA 0
or 0
make 0
the 0
polypeptide 0
chains 0
extremely 0
unstable 0
. 0

Acoustic 0
- 0
property 0
measurements 0
of 0
the 0
oxide 0
superconductor 0
BaPb1 0
- 0
xBixO3 0
by 0
the 0
sphere 0
- 0
resonance 0
method 0
. 0

The 0
fusion 0
of 0
AML1 B-gene
to 0
MDS1 B-gene
is 0
in 0
frame 0
, 0
and 0
adds 0
127 0
codons 0
to 0
the 0
interrupted 0
AML1 B-gene
. 0

The 0
ends 0
of 0
the 0
barrel 0
are 0
capped 0
by 0
short 0
helices 0
. 0

Rabbit B-gene
KCC1 I-gene
( 0
rbKCC1 B-gene
) 0
and 0
rat B-gene
KCC1 I-gene
( 0
rtKCC1 B-gene
) 0
were 0
cloned 0
by 0
screening 0
rabbit 0
kidney 0
and 0
rat 0
brain 0
cDNA 0
libraries 0
using 0
homologous 0
cDNA 0
probes 0
. 0

Taken 0
together 0
, 0
these 0
findings 0
demonstrate 0
that 0
ZNF76 B-gene
and 0
ZNF143 B-gene
are 0
two 0
members 0
of 0
a 0
same 0
family 0
of 0
transactivator 0
proteins 0
. 0

This 0
model 0
system 0
exploits 0
the 0
polyomavirus 0
late 0
transcription 0
termination 0
and 0
polyadenylation 0
signals 0
, 0
which 0
are 0
sufficiently 0
weak 0
to 0
allow 0
the 0
production 0
of 0
many 0
multigenome 0
- 0
length 0
primary 0
transcripts 0
with 0
repeating 0
introns 0
, 0
exons 0
, 0
and 0
poly 0
( 0
A 0
) 0
sites 0
. 0

The 0
disorders 0
are 0
accompanied 0
by 0
consistent 0
, 0
but 0
similarly 0
reversible 0
, 0
electroencephalographic 0
changes 0
. 0

Electronic 0
structure 0
and 0
optical 0
properties 0
of 0
the 0
B12O2 0
crystal 0
. 0

A 0
model 0
for 0
oligomerization 0
- 0
dependent 0
subunit 0
folding 0
. 0

The 0
reporter 0
gene 0
with 0
two 0
copies 0
of 0
the 0
wild 0
- 0
type 0
Repeat 0
2 0
+ 0
3 0
sequence 0
was 0
transcribed 0
actively 0
in 0
sterol 0
- 0
deprived 0
cells 0
and 0
was 0
repressed 0
by 0
more 0
than 0
80 0
% 0
when 0
sterols 0
were 0
present 0
. 0

Basic B-gene
helix I-gene
- I-gene
loop I-gene
- I-gene
helix I-gene
proteins I-gene
can 0
act 0
at 0
the 0
E 0
- 0
box 0
within 0
the 0
serum 0
response 0
element 0
of 0
the 0
c B-gene
- I-gene
fos I-gene
promoter I-gene
to 0
influence 0
hormone 0
- 0
induced 0
promoter 0
activation 0
in 0
Sertoli 0
cells 0
. 0

Preventive 0
health 0
counseling 0
tailored 0
to 0
the 0
needs 0
of 0
this 0
group 0
may 0
be 0
most 0
beneficial 0
. 0

Western 0
blot 0
analyses 0
reveals 0
that 0
cJun B-gene
and 0
the 0
C/EBP B-gene
family I-gene
member I-gene
C/EBP B-gene
- I-gene
beta I-gene
are 0
physiologically 0
relevant 0
transcription 0
factors 0
whose 0
expression 0
corresponds 0
with 0
mda B-gene
- I-gene
7 I-gene
mRNA I-gene
expression 0
. 0

Recent 0
developments 0
in 0
the 0
study 0
of 0
growth 0
factors 0
: 0
GRF B-gene
and 0
somatomedins B-gene
. 0

Phenotypic 0
screening 0
of 0
mutations 0
in 0
Pmr1 B-gene
, 0
the 0
yeast B-gene
secretory I-gene
pathway I-gene
Ca2+/Mn2+ I-gene
- I-gene
ATPase I-gene
, 0
reveals 0
residues 0
critical 0
for 0
ion 0
selectivity 0
and 0
transport 0
. 0

IV 0
. 0

Routine 0
and 0
default 0
retrieval 0
home 0
visits 0
were 0
given 0
to 0
ensure 0
maximal 0
drug 0
compliance 0
. 0

This 0
review 0
chronicles 0
the 0
characteristics 0
of 0
deliberate 0
and 0
accidental 0
mass 0
poisonings 0
that 0
occurred 0
in 0
World 0
Wars 0
I 0
and 0
II 0
, 0
in 0
Bhopal 0
, 0
and 0
in 0
other 0
historical 0
cases 0
up 0
to 0
and 0
including 0
modern 0
wars 0
. 0

Thus 0
, 0
an 0
unmodified 0
threonine 0
at 0
position 0
169 0
in 0
Cdc28 B-gene
is 0
important 0
for 0
interaction 0
with 0
G1 B-gene
cyclins I-gene
. 0

These 0
alterations 0
occurred 0
at 0
both 0
the 0
mRNA 0
and 0
protein 0
levels 0
but 0
did 0
not 0
significantly 0
affect 0
the 0
subcellular 0
distribution 0
of 0
any 0
of 0
the 0
four 0
isoforms 0
. 0

Periarteritis 0
nodosa 0
with 0
ruptures 0
of 0
the 0
renal 0
vessels 0
and 0
the 0
persistence 0
of 0
the 0
hepatitis 0
B 0
and 0
C 0
viruses 0
in 0
the 0
blood 0

SETTING 0
: 0
Participants 0
in 0
the 0
Physicians 0
' 0
Health 0
Study 0
, 0
a 0
randomized 0
trial 0
of 0
aspirin 0
and 0
beta 0
- 0
carotene 0
among 0
U.S. 0
male 0
physicians 0
. 0

Treatment 0
of 0
chronic 0
hepatitis 0
B 0
with 0
interferon B-gene
: 0
experience 0
in 0
western 0
countries 0
. 0

Similar 0
to 0
what 0
was 0
observed 0
for 0
P. 0
putida 0
, 0
a 0
psrA B-gene
null 0
mutant 0
of 0
P. 0
aeruginosa 0
also 0
showed 0
a 0
90 0
% 0
reduction 0
in 0
rpoS B-gene
promoter I-gene
activity 0
; 0
both 0
mutants 0
could 0
be 0
complemented 0
for 0
rpoS B-gene
promoter I-gene
activity 0
when 0
the 0
psrA B-gene
gene I-gene
was 0
provided 0
in 0
trans 0
. 0
psrA B-gene
mutants I-gene
of 0
both 0
Pseudomonas 0
species 0
lost 0
the 0
ability 0
to 0
induce 0
rpoS B-gene
expression 0
at 0
stationary 0
phase 0
, 0
but 0
they 0
retained 0
the 0
ability 0
to 0
produce 0
quorum 0
- 0
sensing 0
autoinducer 0
molecules 0
. 0

The 0
increments 0
in 0
median 0
plasma B-gene
secretin I-gene
concentration 0
were 0
1.6 0
, 0
3.0 0
, 0
and 0
6.4 0
pmol 0
x 0
1 0
( 0
- 0
1 0
) 0
after 0
secretin B-gene
, 0
125 0
, 0
250 0
and 0
500 0
fmol 0
x 0
kg 0
- 0
1 0
, 0
and 0
the 0
corresponding 0
15 0
- 0
min 0
bicarbonate 0
output 0
283 0
, 0
442 0
, 0
and 0
1435 0
micromol 0
, 0
respectively 0
. 0

The 0
composition 0
of 0
renal 0
stones 0
analysed 0
by 0
infrared 0
spectroscopy 0
. 0

Programmed 0
peritoneal 0
lavage 0
in 0
suppurative 0
complications 0
of 0
perforated 0
ulcer 0
of 0
the 0
stomach 0

Vibrio 0
cholerae 0
iron 0
transport 0
: 0
haem 0
transport 0
genes 0
are 0
linked 0
to 0
one 0
of 0
two 0
sets 0
of 0
tonB B-gene
, 0
exbB B-gene
, 0
exbD B-gene
genes I-gene
. 0

Zonography 0
in 0
urology 0
( 0
author 0
's 0
transl 0
) 0

Phenazopyridine 0
- 0
induced 0
hemolytic 0
anemia 0
in 0
a 0
patient 0
with 0
G6PD B-gene
deficiency 0
. 0

The 0
novel 0
gene 0
spans 0
16.7 0
kb 0
of 0
genomic 0
sequence 0
and 0
it 0
is 0
formed 0
of 0
11 0
exons 0
and 0
10 0
intervening 0
introns 0
. 0

Overexpression 0
of 0
a 0
HIF B-gene
- I-gene
1alpha I-gene
construct 0
with 0
deletions 0
of 0
the 0
basic 0
domain 0
and 0
carboxy 0
terminus 0
blocked 0
reporter 0
gene 0
activation 0
by 0
endogenous 0
HIF B-gene
- I-gene
1 I-gene
in 0
hypoxic 0
cells 0
. 0

A 0
preformed 0
SREBP B-gene
- I-gene
1a I-gene
: I-gene
[ I-gene
32P I-gene
] I-gene
DNA I-gene
complex I-gene
bound 0
specifically 0
to 0
membrane 0
- 0
immobilized 0
GST B-gene
- 0
CBP B-gene
fusion 0
proteins 0
that 0
contained 0
amino 0
- 0
terminal 0
portions 0
of 0
CBP B-gene
. 0

Extracellular B-gene
protein I-gene
kinase I-gene
A I-gene
as 0
a 0
cancer 0
biomarker 0
: 0
its 0
expression 0
by 0
tumor 0
cells 0
and 0
reversal 0
by 0
a 0
myristate 0
- 0
lacking 0
Calpha 0
and 0
RIIbeta 0
subunit 0
overexpression 0
. 0

By 0
incorporating 0
a 0
stent 0
with 0
posts 0
that 0
pivot 0
about 0
their 0
base 0
, 0
such 0
that 0
a 0
10 0
% 0
expansion 0
at 0
the 0
commissures 0
is 0
realized 0
, 0
we 0
were 0
able 0
to 0
reduce 0
the 0
compressive 0
commissural 0
stressing 0
from 0
250 0
to 0
150 0
kPa 0
. 0

With 0
rats 0
fed 0
on 0
the 0
Zn 0
- 0
sufficient 0
diet 0
, 0
NaFe3+EDTA 0
and 0
Na2EDTA 0
similarly 0
increased 0
the 0
absorption 0
, 0
urinary 0
excretion 0
and 0
retention 0
of 0
Zn 0
but 0
to 0
a 0
lesser 0
extent 0
. 0

The 0
requirement 0
for 0
an 0
essential 0
interaction 0
between 0
NPH B-gene
I I-gene
and 0
H4L B-gene
provides 0
an 0
explanation 0
for 0
the 0
observed 0
restriction 0
of 0
transcription 0
termination 0
to 0
early 0
viral 0
genes 0
. 0

Other 0
clinicopathological 0
features 0
have 0
no 0
definite 0
influence 0
in 0
survival 0
expectancy 0
. 0

Births 0
, 0
marriages 0
, 0
divorces 0
, 0
and 0
deaths 0
for 0
July 0
1997 0
. 0

One 0
day 0
postoperatively 0
, 0
the 0
mononuclear 0
leukocyte 0
beta B-gene
2 I-gene
- I-gene
receptor I-gene
density 0
decreased 0
maximally 0
by 0
45 0
+/ 0
- 0
11 0
% 0
in 0
the 0
enflurane 0
patients 0
, 0
and 0
by 0
53 0
+/ 0
- 0
6 0
% 0
in 0
the 0
neurolept 0
patients 0
. 0

A 0
direct 0
statistically 0
reliable 0
correction 0
of 0
decrease 0
of 0
the 0
enzymes 0
with 0
the 0
initial 0
state 0
of 0
the 0
patients 0
has 0
been 0
established 0
in 0
an 0
analysis 0
of 0
25 0
patients 0
aged 0
from 0
18 0
to 0
60 0
years 0
in 0
prosthesis 0
of+ 0
the 0
mitral 0
valve 0
( 0
n 0
- 0
9 0
) 0
and 0
closed 0
mitral 0
commissurotomy 0
( 0
n 0
- 0
16 0
) 0
. 0

However 0
, 0
it 0
was 0
observed 0
that 0
storage 0
time 0
affected 0
significantly 0
the 0
biochemical 0
changes 0
occurring 0
in 0
the 0
constituents 0
of 0
carrots 0
exposed 0
to 0
gamma 0
- 0
irradiation 0
. 0

Partial 0
proteolysis 0
of 0
cell 0
surface 0
- 0
iodinated 0
B B-gene
- I-gene
G I-gene
molecules I-gene
generates 0
extremely 0
similar 0
patterns 0
of 0
spots 0
, 0
both 0
within 0
and 0
between 0
haplotypes 0
. 0

Here 0
we 0
demonstrate 0
the 0
ability 0
of 0
oligonucleotides 0
containing 0
the 0
C4T 0
sequence 0
to 0
confer 0
heat 0
shock 0
inducibility 0
on 0
the 0
reporter 0
gene 0
and 0
show 0
that 0
the 0
presence 0
of 0
two 0
such 0
elements 0
produces 0
more 0
than 0
additive 0
effects 0
on 0
induction 0
. 0

In 0
the 0
other 0
two 0
groups 0
( 0
NAAR 0
and 0
PLA 0
) 0
, 0
no 0
variation 0
in 0
this 0
serum 0
protease 0
was 0
observed 0
. 0

The 0
KEMAR 0
measurements 0
show 0
that 0
the 0
two 0
models 0
give 0
an 0
improvement 0
of 0
the 0
signal 0
- 0
to 0
- 0
noise 0
ratio 0
of 0
approximately 0
7.5 0
dB 0
in 0
a 0
diffuse 0
sound 0
field 0
. 0

Providing 0
appropriate 0
care 0
to 0
both 0
sexes 0
. 0

An 0
X 0
- 0
linked 0
zinc B-gene
finger I-gene
gene I-gene
mapping 0
to 0
Xq21.1 0
- 0
q21.3 0
closely 0
related 0
to 0
ZFX B-gene
and 0
ZFY B-gene
: 0
possible 0
origins 0
from 0
a 0
common 0
ancestral 0
gene 0
. 0

Mutations 0
that 0
extend 0
the 0
specificity 0
of 0
the 0
endonuclease 0
activity 0
of 0
lambda B-gene
terminase I-gene
. 0

Promoter 0
activity 0
was 0
assayed 0
by 0
transient 0
transfection 0
of 0
luciferase B-gene
reporter I-gene
constructs I-gene
containing 0
nested 0
deletions 0
of 0
the 0
upstream 0
sequence 0
in 0
the 0
human 0
RPE 0
cell 0
lines 0
ARPE19 0
and 0
D407 0
, 0
as 0
well 0
as 0
in 0
the 0
SK 0
- 0
Mel 0
- 0
28 0
and 0
HeLa 0
cell 0
lines 0
. 0

These 0
results 0
suggest 0
an 0
essential 0
role 0
of 0
the 0
binding 0
of 0
HNF B-gene
- I-gene
4 I-gene
and/or 0
HNF B-gene
- I-gene
4 I-gene
- I-gene
related I-gene
nuclear I-gene
factors I-gene
to 0
the 0
6 0
beta 0
A 0
- 0
A 0
site 0
on 0
the 0
basal 0
transcriptional 0
activation 0
of 0
the 0
CYP3A2 B-gene
gene I-gene
in 0
liver 0
cells 0
. 0

A 0
vascular 0
component 0
to 0
impotence 0
was 0
shown 0
to 0
be 0
common 0
in 0
those 0
with 0
neurological 0
impairment 0
, 0
and 0
may 0
alter 0
management 0
. 0

Bandwidth 0
of 0
auditory 0
units 0
in 0
the 0
chick 0
forebrain 0
( 0
field 0
L/Hv 0
complex 0
) 0
was 0
measured 0
with 0
isointensity 0
tone 0
stimuli 0
. 0

Two 0
cases 0
of 0
Paraquat 0
poisoning 0
of 0
anticonservative 0
origin 0
are 0
described 0
. 0

The 0
promoter 0
of 0
this 0
methyltransferase 0
gene 0
lacks 0
an 0
identifiable 0
TATA 0
box 0
but 0
is 0
characterized 0
by 0
a 0
CpG 0
island 0
which 0
begins 0
approximately 0
723 0
nucleotides 0
upstream 0
of 0
the 0
major 0
transcriptional 0
start 0
site 0
and 0
extends 0
through 0
exon 0
1 0
and 0
into 0
the 0
first 0
intron 0
. 0

It 0
also 0
describes 0
the 0
preliminary 0
results 0
of 0
a 0
Phase 0
II 0
trial 0
going 0
on 0
at 0
the 0
Central 0
Institute 0
for 0
Tumors 0
in 0
Zagreb 0
, 0
using 0
a 0
combination 0
of 0
cis 0
- 0
DDP 0
, 0
5 0
- 0
fluorouracil 0
and 0
vincristine 0
. 0

Three 0
patients 0
with 0
Mirizzi 0
type 0
II 0
syndrome 0
and 0
two 0
patients 0
with 0
Mirizzi 0
type 0
I 0
syndrome 0
were 0
treated 0
laparoscopically 0
. 0

The 0
pregnancies 0
were 0
terminated 0
at 0
19 0
and 0
12 0
weeks 0
of 0
gestation 0
, 0
respectively 0
. 0

The 0
treatment 0
with 0
glucocorticoids 0
and 0
immunosuppressants 0
resulted 0
in 0
a 0
more 0
noticeable 0
decrease 0
in 0
the 0
levels 0
of 0
T3 0
and 0
E B-gene
- I-gene
RCF I-gene
. 0

It 0
is 0
concluded 0
that 0
the 0
new 0
class 0
of 0
competitive 0
NMDA B-gene
receptor I-gene
antagonists 0
, 0
exemplified 0
by 0
CGP 0
37849 0
, 0
is 0
the 0
most 0
promising 0
candidate 0
for 0
clinical 0
trials 0
in 0
anxiety 0
disorders 0
. 0

Rapid 0
, 0
sensitive 0
gas 0
chromatographic 0
analysis 0
of 0
8 0
- 0
methoxypsoralen 0
in 0
human 0
plasma 0
. 0

RESULTS 0
: 0
Sixty 0
- 0
one 0
percent 0
of 0
the 0
patients 0
had 0
damage 0
within 0
7 0
years 0
of 0
onset 0
( 0
mean 0
3.8 0
yrs 0
) 0
. 0

In 0
the 0
fungus 0
Neurospora 0
crassa 0
, 0
nit B-gene
- I-gene
2 I-gene
, 0
the 0
major 0
nitrogen 0
regulatory 0
gene 0
, 0
activates 0
the 0
expression 0
of 0
unlinked 0
structural 0
genes 0
that 0
specify 0
nitrogen 0
- 0
catabolic 0
enzymes 0
during 0
conditions 0
of 0
nitrogen 0
limitation 0
. 0

We 0
concluded 0
that 0
HFV 0
can 0
achieve 0
values 0
of 0
CO2 0
elimination 0
close 0
to 0
the 0
estimated 0
metabolic 0
CO2 0
production 0
in 0
normal 0
unintubated 0
subjects 0
over 0
short 0
periods 0
of 0
time 0
. 0

Tetrazepam 0
: 0
a 0
benzodiazepine 0
which 0
dissociates 0
sedation 0
from 0
other 0
benzodiazepine 0
activities 0
. 0

Transcripts 0
appear 0
to 0
be 0
initiated 0
from 0
an 0
upstream 0
promoter 0
, 0
P1 0
, 0
located 0
in 0
front 0
of 0
the 0
tRNA B-gene
( I-gene
met1 I-gene
) I-gene
gene I-gene
and 0
from 0
three 0
internal 0
promoters 0
: 0
P2 0
is 0
located 0
immediately 0
in 0
front 0
of 0
the 0
tRNA B-gene
( I-gene
met2 I-gene
) I-gene
gene I-gene
; 0
PL10 0
is 0
near 0
the 0
beginning 0
of 0
the 0
L1 B-gene
- 0
L10 B-gene
intergenic 0
space 0
, 0
and 0
PL12 0
is 0
at 0
the 0
end 0
of 0
the 0
L10 B-gene
gene I-gene
sequence I-gene
. 0

Nearly 0
1.5 0
million 0
American 0
men 0
age 0
65 0
and 0
older 0
have 0
osteoporosis 0
, 0
and 0
another 0
3.5 0
million 0
are 0
at 0
risk 0
. 0

We 0
have 0
characterized 0
21 0
mutations 0
in 0
the 0
type B-gene
VII I-gene
collagen I-gene
gene I-gene
( 0
COL7A1 B-gene
) 0
encoding 0
the 0
anchoring 0
fibrils 0
, 0
18 0
of 0
which 0
were 0
not 0
previously 0
reported 0
, 0
in 0
patients 0
from 0
15 0
unrelated 0
families 0
with 0
recessive 0
dystrophic 0
epidermolysis 0
bullosa 0
( 0
RDEB 0
) 0
. 0

A 0
case 0
of 0
heterotopic 0
gastric 0
mucosa 0
( 0
pyloric 0
gland 0
) 0
in 0
the 0
wall 0
of 0
the 0
gallbladder 0
was 0
reported 0
. 0

Ribosome 0
association 0
of 0
GCN2 B-gene
protein I-gene
kinase I-gene
, 0
a 0
translational 0
activator 0
of 0
the 0
GCN4 B-gene
gene I-gene
of 0
Saccharomyces 0
cerevisiae 0
. 0

We 0
further 0
examined 0
the 0
interaction 0
of 0
JAK2 B-gene
with 0
the 0
GHR B-gene
cytoplasmic 0
domain 0
by 0
two 0
lines 0
of 0
investigation 0
. 0

These 0
segments 0
may 0
represent 0
pseudogenes 0
. 0

Corresponding 0
oligonucleotides 0
were 0
used 0
to 0
screen 0
a 0
rat 0
liver 0
cDNA 0
library 0
constructed 0
in 0
the 0
plasmid 0
cloning 0
vector 0
, 0
pcDV 0
. 0

A 0
. 0

Extracellular B-gene
regulated I-gene
kinases I-gene
( I-gene
ERK I-gene
) I-gene
1 I-gene
and 0
ERK2 B-gene
are 0
authentic 0
substrates 0
for 0
the 0
dual B-gene
- I-gene
specificity I-gene
protein I-gene
- I-gene
tyrosine I-gene
phosphatase I-gene
VHR I-gene
. 0

The 0
model 0
therefore 0
predicts 0
that 0
1 0
) 0
on 0
- 0
line 0
calculation 0
of 0
airway 0
dead 0
space 0
and 0
end 0
- 0
expired 0
lung 0
volume 0
can 0
be 0
made 0
by 0
the 0
addition 0
of 0
an 0
oxygen 0
sine 0
- 0
wave 0
perturbation 0
component 0
to 0
the 0
mean 0
FIO2 0
; 0
and 0
( 0
2 0
) 0
QS/QT 0
can 0
be 0
measured 0
from 0
the 0
resultant 0
oxygen 0
perturbation 0
sine 0
- 0
wave 0
amplitudes 0
in 0
the 0
expired 0
gas 0
and 0
in 0
arterial 0
and 0
mixed 0
- 0
venous 0
blood 0
and 0
is 0
independent 0
of 0
the 0
mean 0
blood 0
oxygen 0
partial 0
pressure 0
and 0
oxyhemoglobin B-gene
saturation 0
values 0
. 0

An 0
anoerxiant 0
, 0
mazindol 0
suppresses 0
food 0
intake 0
by 0
1 0
) 0
stimulating 0
beta B-gene
- I-gene
adrenergic I-gene
receptors I-gene
, 0
2 0
) 0
inhibiting 0
the 0
feeding 0
center 0
and 0
, 0
3 0
) 0
stimulating 0
the 0
satiety 0
center 0
in 0
the 0
hypothalamus 0
. 0

When 0
patients 0
were 0
admitted 0
within 0
one 0
week 0
of 0
the 0
onset 0
of 0
dark 0
urine 0
, 0
45 0
% 0
were 0
found 0
to 0
be 0
shedding 0
HAV 0
, 0
whereas 0
only 0
11 0
% 0
of 0
specimens 0
obtained 0
from 0
patients 0
admitted 0
during 0
the 0
second 0
week 0
contained 0
virus 0
. 0

Positive 0
effects 0
of 0
radioactive 0
therapy 0
in 0
Guarapari 0

Nevertheless 0
, 0
lower 0
doses 0
which 0
alone 0
were 0
lacking 0
in 0
activity 0
( 0
100 0
- 0
250 0
mg/kg 0
B1 0
and 0
B6 0
, 0
1 0
- 0
2.5 0
mg/kg 0
B12 0
p.o 0
. 0
) 0
dose 0
- 0
dependently 0
potentiated 0
the 0
antinociceptive 0
of 0
diclofenac 0
. 0

Escherichia 0
coli 0
strains 0
carrying 0
recA730 B-gene
( 0
or 0
other 0
recA* B-gene
alleles I-gene
) 0
exhibit 0
dramatic 0
increases 0
in 0
SOS 0
- 0
dependent 0
spontaneous 0
mutator 0
activity 0
. 0

On 0
the 0
contrary 0
i.v 0
. 0
administration 0
of 0
calcitonin B-gene
increased 0
intrapyloric 0
pressure 0
via 0
vagal 0
nerves 0
in 0
atropinized 0
or 0
gallaminized 0
animals 0
. 0

An 0
hcr1 B-gene
null 0
mutant 0
was 0
viable 0
, 0
but 0
showed 0
slight 0
reduction 0
of 0
growth 0
when 0
compared 0
with 0
the 0
wild 0
- 0
type 0
strain 0
. 0

Overall 0
, 0
free 0
- 0
chlorine 0
treatments 0
( 0
0.3 0
or 0
1.0 0
mg/L 0
) 0
showed 0
significantly 0
lower 0
heterotrophic 0
plate 0
numbers 0
than 0
those 0
without 0
free 0
chlorine 0
. 0

This 0
evaluation 0
examines 0
several 0
analytical 0
and 0
cost 0
parameters 0
for 0
five 0
representative 0
assays 0
: 0
IgG B-gene
, 0
IgA B-gene
, 0
IgM B-gene
, 0
phenytoin 0
, 0
and 0
phenobarbital 0
. 0

We 0
have 0
previously 0
identified 0
LIT1 B-gene
, 0
a 0
paternally 0
expressed 0
antisense 0
RNA 0
within 0
the 0
KvLQT1 B-gene
locus I-gene
through 0
a 0
positional 0
screening 0
approach 0
using 0
human 0
monochromosomal 0
hybrids 0
. 0

Here 0
RFX/X2BP/DNA B-gene
complexes 0
were 0
formed 0
on 0
all 0
class 0
II 0
isotypes 0
regardless 0
of 0
the 0
ability 0
of 0
the 0
X 0
box 0
region 0
to 0
bind 0
either 0
factor 0
individually 0
. 0

Developmental 0
slot 0
blots 0
demonstrate 0
that 0
mRNAs 0
corresponding 0
to 0
the 0
three 0
LHM B-gene
cDNAs I-gene
are 0
transcribed 0
from 0
prophase 0
of 0
meiosis 0
I 0
to 0
the 0
uninucleate 0
microspore 0
stage 0
, 0
while 0
Northern 0
analysis 0
reveals 0
these 0
tapetally 0
expressed 0
cDNAs 0
to 0
correspond 0
with 0
transcripts 0
of 0
some 0
500 0
bp 0
. 0

The 0
curse 0
of 0
the 0
Pharaohs 0
. 0

The 0
women 0
in 0
the 0
intermediate 0
calcium 0
group 0
had 0
approximately 0
the 0
same 0
mean 0
BMD 0
values 0
as 0
those 0
in 0
the 0
low 0
calcium 0
group 0
. 0

The 0
enigma 0
of 0
aging 0
bone 0
loss 0
. 0

RESULTS 0
: 0
After 0
lavage 0
, 0
a 0
rapid 0
decrease 0
in 0
arterial 0
pH 0
and 0
PaO2 0
, 0
and 0
an 0
increase 0
in 0
PaCO2 0
and 0
PIP 0
were 0
observed 0
in 0
all 0
animals 0
. 0

In 0
both 0
cell 0
types 0
, 0
insulin B-gene
led 0
to 0
a 0
dose 0
- 0
dependent 0
increase 0
in 0
the 0
association 0
of 0
tyrosine B-gene
phosphorylated I-gene
IRS I-gene
- I-gene
1 I-gene
with 0
the 0
SH2 B-gene
domain I-gene
of 0
the 0
p85 B-gene
regulatory I-gene
subunit I-gene
of 0
PI B-gene
- I-gene
3 I-gene
kinase I-gene
, 0
and 0
also 0
increased 0
the 0
amount 0
of 0
PI B-gene
kinase I-gene
activity 0
detected 0
in 0
anti B-gene
- I-gene
IRS I-gene
- I-gene
1 I-gene
immunoprecipitates 0
. 0

Twelve 0
( 0
92 0
% 0
) 0
showed 0
cognitive 0
dysfunction 0
including 0
impairments 0
in 0
memory 0
, 0
attention 0
, 0
and 0
affective 0
disturbances 0
( 0
anxiety 0
, 0
depression 0
, 0
irritability 0
, 0
and 0
poor 0
frustration 0
tolerance 0
) 0
. 0

These 0
effects 0
were 0
antagonized 0
by 0
prior 0
administration 0
of 0
1 0
- 0
( 0
2 0
- 0
methoxyphenyl 0
) 0
- 0
4 0
- 0
[ 0
- 0
( 0
2 0
- 0
phthalimido 0
) 0
butyl 0
] 0
piperazine 0
) 0
( 0
0.5 0
mg/kg 0
, 0
i.p 0
. 0
) 0
. 0

Transcription 0
initiation 0
from 0
this 0
region 0
was 0
also 0
detected 0
in 0
vivo 0
, 0
when 0
the 0
cloned 0
rRNA 0
gene 0
cluster 0
was 0
present 0
on 0
a 0
multi 0
- 0
copy 0
plasmid 0
. 0

The 0
human B-gene
parvalbumin I-gene
mRNA I-gene
contains 0
the 0
putative 0
polyadenylation 0
signal 0
AATAAA 0
13 0
nucleotides 0
upstream 0
from 0
the 0
polyadenylation 0
site 0
. 0

The 0
effects 0
of 0
dopamine 0
and 0
of 0
dopamine B-gene
D2 I-gene
receptor I-gene
blocker 0
haloperidol 0
on 0
the 0
activity 0
of 0
carotid 0
chemoreceptors 0
were 0
studied 0
in 0
24 0
anesthetized 0
, 0
paralyzed 0
and 0
artificially 0
ventilated 0
newborn 0
kittens 0
aged 0
0 0
- 0
17 0
days 0
. 0

DNMT2 B-gene
binds 0
AdoHcy 0
in 0
the 0
same 0
conformation 0
as 0
confirmed 0
m B-gene
( I-gene
5 I-gene
) I-gene
C I-gene
MTases I-gene
and 0
, 0
while 0
DNMT2 B-gene
shares 0
all 0
sequence 0
and 0
structural 0
features 0
with 0
m B-gene
( I-gene
5 I-gene
) I-gene
C I-gene
MTases I-gene
, 0
it 0
has 0
failed 0
to 0
demonstrate 0
detectable 0
transmethylase 0
activity 0
. 0

Serum B-gene
amyloid I-gene
A I-gene
( 0
SAA B-gene
) 0
is 0
a 0
plasma 0
protein 0
which 0
has 0
been 0
associated 0
with 0
several 0
diseases 0
, 0
including 0
amyloidosis 0
, 0
arthritis 0
, 0
and 0
atherosclerosis 0
, 0
and 0
its 0
abnormal 0
expression 0
, 0
particularly 0
in 0
nonhepatic 0
cells 0
, 0
is 0
implicated 0
in 0
the 0
pathogenesis 0
of 0
these 0
diseases 0
. 0

The 0
standardized 0
incidence 0
in 0
Europeans 0
has 0
risen 0
significantly 0
to 0
4.7/10 0
( 0
5 0
) 0
/year 0
from 0
3.4/10 0
( 0
5 0
) 0
/year 0
in 0
the 0
1970s 0
( 0
chi 0
2 0
= 0
8.1 0
, 0
p 0
less 0
than 0
0.005 0
) 0
. 0

Physical 0
mapping 0
220 0
kb 0
centromeric 0
of 0
the 0
human B-gene
MHC I-gene
and 0
DNA 0
sequence 0
analysis 0
of 0
the 0
43 0
- 0
kb 0
segment 0
including 0
the 0
RING1 B-gene
, 0
HKE6 B-gene
, 0
and 0
HKE4 B-gene
genes I-gene
. 0

The 0
cells 0
arrest 0
in 0
the 0
G1 0
phase 0
of 0
the 0
cell 0
cycle 0
and 0
grow 0
a 0
projection 0
towards 0
one 0
another 0
forming 0
a 0
shmoo 0
projection 0
. 0

Multiple 0
aortic 0
thrombi 0
associated 0
with 0
protein B-gene
C I-gene
and 0
S B-gene
deficiency 0
. 0

However 0
, 0
the 0
optimum 0
compressive 0
strength 0
reached 0
values 0
up 0
to 0
40 0
% 0
higher 0
than 0
CC 0
- 0
free 0
samples 0
. 0

POPULATION 0
AND 0
METHODS 0
: 0
105 0
patients 0
were 0
followed 0
prospectively 0
( 0
male 0
: 0
87 0
% 0
; 0
age 0
: 0
56 0
+/ 0
- 0
10 0
) 0
; 0
clinical 0
evaluation 0
was 0
performed 0
in 0
the 0
1st 0
, 0
3rd 0
and 0
6th 0
month 0
, 0
SEKG 0
in 0
the 0
4th 0
month 0
and 0
recatheterization 0
for 0
angiographic 0
control 0
in 0
the 0
6th 0
month 0
. 0

The 0
practice 0
of 0
measuring 0
of 0
AChE B-gene
levels 0
in 0
acute 0
poisoning 0
is 0
limited 0
. 0

M. 0
, 0
Adrich 0
, 0
Z. 0
, 0
Fournet 0
, 0
B. 0
, 0
Capon 0
, 0
C. 0
, 0
Bonicel 0
, 0
J 0
. 0

Confocal 0
fluorescent 0
microscopy 0
analysis 0
demonstrated 0
that 0
WT 0
, 0
VaI 0
, 0
and 0
VaII 0
all 0
distribute 0
equally 0
to 0
the 0
cell 0
surface 0
while 0
, 0
as 0
expected 0
, 0
a 0
WT 0
mutant 0
lacking 0
the 0
two 0
C 0
- 0
terminal 0
valine 0
residues 0
does 0
not 0
. 0

The 0
amount 0
of 0
ERCC1 B-gene
detectable 0
by 0
immunoblotting 0
is 0
reduced 0
in 0
group 0
1 0
, 0
group 0
4 0
and 0
XP 0
- 0
F 0
extracts 0
. 0

Letter 0
: 0
Ballistocardiography 0
. 0

Metabolic 0
studies 0
of 0
tetrabenazine 0
, 0
a 0
psychotropic 0
drug 0
in 0
animals 0
and 0
man 0
. 0

From 0
the 0
frozen 0
specimen 0
, 0
a 0
large 0
number 0
of 0
sections 0
with 0
good 0
morphologic 0
characteristics 0
may 0
be 0
produced 0
. 0

Gene 0
transcripts 0
are 0
detected 0
on 0
tissues 0
such 0
as 0
bovine 0
liver 0
, 0
kidney 0
, 0
lung 0
, 0
and 0
brain 0
. 0

Plasma B-gene
enteroglucagon I-gene
was 0
measured 0
before 0
and 0
during 0
three 0
hours 0
after 0
a 0
standard 0
meal 0
in 0
21 0
untreated 0
adult 0
patients 0
with 0
suspected 0
coeliac 0
disease 0
who 0
all 0
had 0
villous 0
atrophy 0
of 0
the 0
small 0
intestinal 0
mucosa 0
and 0
malabsorption 0
, 0
and 0
in 0
nine 0
control 0
subjects 0
. 0

In 0
this 0
report 0
, 0
we 0
establish 0
that 0
the 0
heteromeric 0
CCAAT B-gene
- I-gene
binding I-gene
factor I-gene
CBF B-gene
is 0
the 0
major 0
component 0
of 0
the 0
C1 B-gene
- I-gene
binding I-gene
factor I-gene
( 0
C1F B-gene
) 0
in 0
human 0
cells 0
. 0

This 0
growth 0
- 0
inhibitory 0
effect 0
was 0
suppressed 0
by 0
the 0
mpk1 B-gene
delta I-gene
mutation 0
, 0
suggesting 0
that 0
hyperactivation 0
of 0
the 0
Mpk1 B-gene
pathway 0
is 0
toxic 0
to 0
cells 0
. 0

The 0
human B-gene
PAX8 I-gene
gene I-gene
generates 0
at 0
least 0
five 0
different 0
alternatively 0
spliced 0
transcripts 0
encoding 0
different 0
PAX8 B-gene
isoforms I-gene
. 0

The 0
use 0
of 0
specific 0
somatic 0
cell 0
hybrids 0
have 0
allowed 0
us 0
to 0
locate 0
the 0
YAC 0
contig 0
telomeric 0
to 0
the 0
D3F15S2 B-gene
locus I-gene
, 0
in 0
a 0
region 0
which 0
is 0
frequently 0
deleted 0
in 0
lung 0
carcinomas 0
. 0

A 0
close 0
homologue 0
of 0
the 0
APK2a B-gene
gene I-gene
, 0
named 0
APK2b B-gene
, 0
was 0
also 0
isolated 0
from 0
the 0
Arabidopsis 0
cDNA 0
library 0
. 0

Characterization 0
of 0
Chlamydomonas 0
reinhardtii 0
zygote 0
- 0
specific 0
cDNAs 0
that 0
encode 0
novel 0
proteins 0
containing 0
ankyrin B-gene
repeats 0
and 0
WW 0
domains 0
. 0

Subsequent 0
analysis 0
revealed 0
that 0
MyD88 B-gene
possesses 0
a 0
unique 0
modular 0
structure 0
, 0
which 0
consists 0
of 0
an 0
N 0
- 0
terminal 0
`` 0
death 0
domain 0
, 0
'' 0
similar 0
to 0
the 0
intracellular 0
segments 0
of B-gene
TNF I-gene
receptor I-gene
1 0
and B-gene
Fas I-gene
, 0
and 0
a 0
C 0
- 0
terminal 0
region 0
related 0
to 0
the 0
cytoplasmic 0
domains 0
of 0
the B-gene
Drosophila I-gene
morphogen I-gene
Toll I-gene
and 0
vertebrate B-gene
interleukin I-gene
- I-gene
1 I-gene
receptors I-gene
. 0

A. 0
nidulans 0
transformants 0
secreted 0
high 0
amounts 0
of 0
PGI B-gene
and 0
PGII B-gene
in 0
comparison 0
to 0
the 0
previously 0
characterized 0
A. 0
niger 0
transformants 0
and 0
a 0
novel 0
polygalacturonase B-gene
( 0
PGC B-gene
) 0
was 0
produced 0
at 0
high 0
levels 0
by 0
A. 0
nidulans 0
transformed 0
with 0
the 0
subcloned 0
pgaC B-gene
gene I-gene
. 0

Role 0
of 0
zinc B-gene
- I-gene
finger I-gene
proteins I-gene
Sp1 I-gene
and 0
zif268/egr B-gene
zif268/egr I-gene
- I-gene
1 I-gene
in 0
transcriptional 0
regulation 0
of 0
the 0
human B-gene
synaptobrevin I-gene
II I-gene
gene I-gene
. 0

However 0
, 0
the 0
recovery 0
curve 0
of 0
the 0
R2 0
component 0
of 0
the 0
blink 0
reflex 0
diminished 0
in 0
patients 0
with 0
tension 0
- 0
type 0
headache 0
compared 0
with 0
the 0
other 0
groups 0
. 0

The 0
GvpE B-gene
protein I-gene
involved 0
in 0
the 0
regulation 0
of 0
gas 0
vesicles 0
synthesis 0
in 0
halophilic 0
archaea 0
has 0
been 0
identified 0
as 0
the 0
transcriptional 0
activator 0
for 0
the 0
promoter 0
located 0
upstream 0
of 0
the 0
gvpA B-gene
gene I-gene
encoding 0
the 0
major 0
gas 0
vesicle 0
structural 0
protein 0
GvpA B-gene
. 0

TFIIIB B-gene
assembles 0
autonomously 0
on 0
the 0
upstream 0
promoter 0
of 0
the 0
yeast B-gene
U6 I-gene
snRNA I-gene
( 0
SNR6 B-gene
) 0
gene 0
in 0
vitro 0
, 0
through 0
the 0
interaction 0
of 0
its 0
TBP B-gene
subunit I-gene
with 0
a 0
consensus 0
TATA 0
box 0
located 0
at 0
base 0
pair 0
- 0
30 0
. 0

Effect 0
of 0
bromocriptine 0
and 0
metoclopramide 0
on 0
serum B-gene
prolactin I-gene
levels 0
in 0
patients 0
with 0
amyotrophic 0
lateral 0
sclerosis 0
. 0

Experience 0
in 0
using 0
the 0
Romashka 0
- 0
1 0
laser 0
surgical 0
unit 0
in 0
treating 0
suppurative 0
wounds 0

At 0
a 0
cutoff 0
point 0
for 0
KISA 0
% 0
of 0
100 0
, 0
280 0
of 0
281 0
participants 0
( 0
99.6 0
% 0
) 0
were 0
correctly 0
classified 0
. 0

To 0
evaluate 0
the 0
effect 0
of 0
selective 0
thromboxane 0
A2 0
blockade 0
on 0
clinical 0
findings 0
and 0
platelet 0
reactivity 0
in 0
refractory 0
unstable 0
angina 0
, 0
OKY 0
- 0
046 0
( 0
600 0
mg/day 0
, 0
p.o 0
. 0
) 0
was 0
administered 0
to 0
another 0
14 0
patients 0
with 0
refractory 0
unstable 0
angina 0
in 0
addition 0
to 0
the 0
conventional 0
therapy 0
. 0

The 0
AP B-gene
- I-gene
1 I-gene
recruited 0
by 0
ARF1.GTP B-gene
is 0
released 0
from 0
the 0
Golgi 0
membrane 0
by 0
treatment 0
with 0
1 0
M 0
Tris 0
- 0
HCl 0
( 0
pH 0
7 0
) 0
or 0
upon 0
reincubation 0
at 0
37 0
degreesC 0
, 0
whereas 0
AP B-gene
- I-gene
1 I-gene
recruited 0
with 0
GTPgammaS 0
or 0
by 0
a 0
constitutively 0
active 0
point 0
mutant 0
, 0
ARF1 B-gene
( I-gene
Q71L I-gene
) I-gene
, 0
remains 0
membrane 0
bound 0
after 0
either 0
treatment 0
. 0

In 0
K562 0
cells 0
, 0
using 0
the 0
bicistronic 0
vector 0
, 0
selection 0
with 0
colchicine 0
led 0
to 0
at 0
least 0
20 0
- 0
fold 0
higher 0
expression 0
of 0
the 0
MDR1 B-gene
gene I-gene
product I-gene
than 0
did 0
selection 0
with 0
G418 0
, 0
suggesting 0
that 0
the 0
stringent 0
MDR1 B-gene
selection 0
system 0
is 0
very 0
efficient 0
for 0
obtaining 0
overexpression 0
of 0
foreign 0
genes 0
. 0

A 0
surge 0
in 0
the 0
rate 0
of 0
ascorbyl 0
radical 0
production 0
, 0
directly 0
correlated 0
with 0
oxyradical 0
stress 0
and 0
an 0
abrupt 0
fall 0
in 0
superoxide B-gene
dismutase I-gene
activity 0
in 0
the 0
granuloma 0
, 0
indicates 0
'switching 0
on 0
' 0
of 0
a 0
free 0
radical 0
- 0
dependent 0
machinery 0
for 0
the 0
formation 0
of 0
granuloma 0
after 0
vasectomy 0
. 0

The 0
vaccine 0
was 0
highly 0
immunogenic 0
, 0
since 0
111 0
of 0
113 0
patients 0
( 0
98 0
% 0
) 0
produced 0
anti B-gene
- I-gene
HBs I-gene
( 0
10 0
mIU/ml 0
or 0
more 0
) 0
. 0

Papillomavirus 0
type 0
16 0
oncogenes 0
downregulate 0
expression 0
of 0
interferon B-gene
- 0
responsive 0
genes 0
and 0
upregulate 0
proliferation 0
- 0
associated 0
and 0
NF B-gene
- I-gene
kappaB I-gene
- 0
responsive 0
genes 0
in 0
cervical 0
keratinocytes 0
. 0

A 0
model 0
for 0
the 0
SMase B-gene
- 0
sphingomyelin 0
complex 0
structure 0
was 0
built 0
to 0
investigate 0
how 0
the 0
SMase B-gene
specifically 0
recognizes 0
its 0
substrate 0
. 0

MADS B-gene
- I-gene
box I-gene
genes I-gene
in 0
plants 0
are 0
a 0
diverse 0
class 0
of 0
transcription 0
factors 0
that 0
are 0
involved 0
in 0
regulating 0
developmental 0
processes 0
, 0
particularly 0
meristem 0
and 0
organ 0
identity 0
during 0
floral 0
development 0
. 0

RESULTS 0
: 0
In 0
the 0
test 0
data 0
set 0
, 0
the 0
single 0
- 0
sample 0
model 0
was 0
confirmed 0
to 0
give 0
excellent 0
estimation 0
of 0
the 0
AUC 0
: 0
AUC 0
( 0
mg/ml 0
x 0
min 0
) 0
= 0
0.93 0
x 0
C3h 0
+ 0
0.47 0
( 0
MPE 0
% 0
= 0
4.4 0
% 0
, 0
RMSE 0
% 0
= 0
8.9 0
% 0
) 0
. 0

Our 0
results 0
show 0
that 0
a 0
combination 0
of 0
Pfu B-gene
exo I-gene
( I-gene
- I-gene
) I-gene
at 0
the 0
primer 0
extension 0
step 0
and 0
Taq B-gene
at 0
the 0
PCR 0
amplification 0
step 0
is 0
ideal 0
for 0
in 0
vivo 0
DNA 0
analysis 0
and 0
DNA 0
damage 0
mapping 0
using 0
LMPCR 0
. 0

KU 0
- 0
1257 0
also 0
significantly 0
accelerated 0
the 0
healing 0
of 0
acetic 0
acid 0
- 0
induced 0
duodenal 0
ulcers 0
as 0
well 0
as 0
famotidine 0
and 0
roxatidine 0
acetate 0
. 0

Prolongation 0
of 0
prothrombin B-gene
time 0
was 0
not 0
due 0
to 0
depletion 0
of 0
vitamin 0
K 0
- 0
dependent 0
coagulation 0
factors 0
or 0
manifest 0
fibrinolysis 0
, 0
but 0
due 0
to 0
the 0
presence 0
of 0
circulating 0
fibrinogen B-gene
fibrinmonomer I-gene
- 0
FDP 0
complexes 0
. 0

Clostridium 0
botulinum 0
in 0
marine 0
sediment 0

Upstream B-gene
stimulatory I-gene
factor I-gene
USF B-gene
is 0
a 0
human 0
transcriptional 0
activation 0
factor 0
, 0
which 0
uses 0
a 0
basic/helix 0
- 0
loop 0
- 0
helix/ 0
leucin 0
zipper 0
( 0
b/HLH/Z 0
) 0
motif 0
to 0
homodimerize 0
and 0
recognize 0
specific 0
sequences 0
in 0
the 0
promoter 0
region 0
of 0
both 0
nuclear 0
and 0
viral 0
genes 0
transcribed 0
by 0
RNA B-gene
polymerase I-gene
II I-gene
. 0

Fusion 0
of 0
mouse B-gene
CD8+ I-gene
class B-gene
I I-gene
MHC I-gene
- 0
restricted 0
T 0
cells 0
with 0
the 0
BW5147 0
thymoma 0
invariably 0
yields 0
CD8 B-gene
- I-gene
hybridomas 0
in 0
which 0
RNA 0
transcribed 0
from 0
the 0
CD8 B-gene
alpha I-gene
( 0
Lyt B-gene
- I-gene
2 I-gene
) 0
gene 0
is 0
undetectable 0
. 0

Consistent 0
with 0
this 0
hypothesis 0
, 0
alpha1 B-gene
- I-gene
PDX I-gene
prevents 0
cleavage 0
of 0
BMP B-gene
- I-gene
4 I-gene
in 0
an 0
oocyte 0
translation 0
assay 0
. 0

Convergence 0
of 0
trigeminal 0
input 0
with 0
visceral 0
and 0
phrenic 0
inputs 0
on 0
primate 0
C1 0
- 0
C2 0
spinothalamic 0
tract 0
neurons 0
. 0

In 0
this 0
study 0
we 0
cloned 0
the 0
cDNA 0
of 0
AD1 B-gene
Ag I-gene
from 0
a 0
rat 0
basophilic 0
leukemia 0
2H3 0
cDNA 0
library 0
. 0

Several 0
sequences 0
resembling 0
binding 0
sites 0
for 0
liver 0
- 0
and 0
fat 0
body 0
- 0
specific 0
transcription 0
factors 0
were 0
identified 0
within 0
1 0
kb 0
upstream 0
and 0
downstream 0
of 0
the 0
gene 0
. 0

Root 0
surface 0
caries 0
incidence 0
in 0
the 0
groups 0
inoculated 0
with 0
A. 0
viscosus 0
and 0
A. 0
viscosus 0
plus 0
S. 0
sobrinus 0
did 0
not 0
differ 0
. 0

METHODS 0
AND 0
RESULTS 0
: 0
The 0
QTd 0
and 0
JTd 0
intervals 0
in 0
39 0
children 0
with 0
long 0
QT 0
syndrome 0
were 0
compared 0
to 0
those 0
of 0
50 0
normal 0
age 0
- 0
matched 0
children 0
. 0

The 0
prgX B-gene
gene I-gene
is 0
adjacent 0
to 0
prgQ B-gene
which 0
provides 0
the 0
promoter 0
for 0
prgB B-gene
expression 0
. 0

A 0
Frank 0
vectorcardiogram 0
was 0
recorded 0
before 0
and 0
every 0
15 0
- 0
30 0
minutes 0
for 0
10 0
hours 0
after 0
the 0
occlusion 0
. 0

The 0
treatment 0
of 0
Sudeck 0
's 0
atrophy 0
in 0
the 0
upper 0
limb 0
by 0
sympathetic 0
blockade 0
. 0

Frequency 0
of 0
recurrence 0
of 0
fibroids 0
after 0
myomectomy 0
has 0
been 0
evaluated 0
in 0
145 0
women 0
( 0
median 0
age 0
38 0
years 0
, 0
range 0
21 0
- 0
52 0
) 0
who 0
underwent 0
myomectomy 0
. 0

There 0
is 0
a 0
good 0
correlation 0
between 0
the 0
occurrence 0
in 0
any 0
particular 0
vascular 0
segment 0
of 0
the 0
transient 0
contractile 0
response 0
and 0
intrinsic 0
tone 0
as 0
assessed 0
by 0
relaxation 0
to 0
papaverine 0
( 0
10 0
( 0
- 0
6 0
) 0
M 0
) 0
. 0

The 0
antimicrobial 0
of 0
choice 0
for 0
initial 0
prophylactic 0
therapy 0
among 0
asymptomatic 0
pregnant 0
women 0
exposed 0
to 0
Bacillus 0
anthracis 0
is 0
ciprofloxacin 0
, 0
500 0
mg 0
twice 0
a 0
day 0
for 0
60 0
days 0
. 0

Spontaneous 0
coronary 0
artery 0
spasm 0
during 0
coronary 0
angiography 0
in 0
a 0
patient 0
with 0
exercise 0
- 0
induced 0
ST 0
segment 0
elevation 0
. 0

Nickel 0
release 0
from 0
tools 0
on 0
the 0
Swedish 0
market 0
. 0

There 0
was 0
no 0
correlation 0
between 0
starting 0
platelet 0
- 0
associated 0
IgG B-gene
levels 0
or 0
changes 0
in 0
platelet 0
- 0
associated 0
IgG B-gene
levels 0
with 0
therapy 0
and 0
the 0
increment 0
in 0
the 0
patient 0
's 0
platelet 0
count 0
. 0

The 0
receptor 0
for 0
CSF B-gene
- I-gene
1 I-gene
, 0
c B-gene
- I-gene
Fms I-gene
, 0
is 0
expressed 0
in 0
osteoclasts 0
, 0
possesses 0
intrinsic 0
tyrosine B-gene
- I-gene
kinase I-gene
activity 0
, 0
and 0
signals 0
via 0
rapid 0
phosphorylation 0
of 0
selected 0
proteins 0
. 0

In 0
a 0
rat 0
model 0
of 0
SAH 0
, 0
we 0
assessed 0
BBB 0
changes 0
by 0
means 0
of 0
the 0
quantitative 0
[ 0
14C 0
] 0
- 0
alpha 0
- 0
aminoisobutyric 0
acid 0
technique 0
. 0

BAG B-gene
- I-gene
1 I-gene
also 0
prevented 0
growth 0
arrest 0
following 0
UV 0
- 0
irradiation 0
- 0
induced 0
genotoxic 0
injury 0
without 0
interfering 0
with 0
accumulation 0
of 0
p53 B-gene
protein I-gene
or 0
p21 B-gene
( 0
waf B-gene
- I-gene
1 I-gene
) 0
expression 0
. 0

During 0
the 0
last 0
three 0
days 0
of 0
the 0
study 0
, 0
mean 0
urine 0
osmolality 0
( 0
Uosm 0
) 0
and 0
free 0
water 0
reabsorption 0
( 0
TCH2O 0
) 0
increased 0
significantly 0
: 0
[ 0
formula 0
: 0
see 0
text 0
] 0
. 0

[ 0
( 0
OP 0
) 0
2Cu 0
] 0
+ 0
also 0
detected 0
protections 0
in 0
the 0
C 0
alpha 0
- 0
helix 0
, 0
the 0
interdomain 0
hinge 0
, 0
and 0
beta 0
- 0
strands 0
2 0
- 0
7 0
. 0

When 0
O 0
- 0
2A/c B-gene
- I-gene
myc I-gene
cells 0
underwent 0
terminal 0
differentiation 0
APprog B-gene
complexes I-gene
were 0
lost 0
and 0
conventional 0
AP B-gene
- I-gene
1 I-gene
DNA 0
- 0
binding 0
activity 0
became 0
evident 0
, 0
particularly 0
in 0
astrocytes 0
. 0

The 0
gene 0
, 0
from 0
the 0
initiator 0
methionine 0
to 0
the 0
polyadenylation 0
site 0
, 0
is 0
contained 0
within 0
13 0
244 0
basepairs 0
and 0
contains 0
19 0
exons 0
. 0

To 0
study 0
structural 0
diversity 0
of 0
the 0
three 0
homologous 0
loci 0
encoding 0
a 0
KN1 B-gene
- I-gene
like I-gene
homeobox I-gene
protein I-gene
in 0
the 0
hexaploid 0
wheat 0
genome 0
, 0
we 0
isolated 0
clones 0
from 0
a 0
cDNA 0
library 0
of 0
young 0
spikes 0
of 0
Japanese 0
common 0
wheat 0
cultivar 0
'Norin 0
26 0
' 0
. 0

Treatment 0
is 0
based 0
on 0
antifungal 0
drugs 0
, 0
most 0
frequently 0
nystatin 0
, 0
amphotericin 0
B 0
and 0
ketoconazole 0
. 0

Controversy 0
exists 0
regarding 0
both 0
the 0
natural 0
life 0
cycle 0
for 0
this 0
parasite 0
as 0
well 0
as 0
the 0
species 0
identity 0
of 0
opossum 0
Sarcocystis 0
. 0

Here 0
we 0
report 0
that 0
components 0
of 0
the 0
Ras/Raf/MAPK B-gene
pathway 0
are 0
constitutively 0
activated 0
in 0
these 0
Ras/Raf/MAPK I-gene

Unfractionated 0
heparin 0
( 0
UFH 0
) 0
given 0
at 0
a 0
dose 0
of 0
0.3 0
mg 0
x 0
kg 0
- 0
1 0
bolus 0
+ 0
0.3 0
mg 0
x 0
kg 0
- 0
1 0
x 0
h 0
- 0
1 0
infusion 0
did 0
not 0
improve 0
the 0
incidence 0
of 0
reperfusion 0
or 0
lower 0
the 0
incidence 0
of 0
reocclusion 0
. 0

The 0
quantification 0
limit 0
was 0
50 0
ng/ml 0
for 0
each 0
of 0
PHT 0
, 0
m 0
- 0
HPPH 0
and 0
p 0
- 0
HPPH 0
. 0

Plasma B-gene
hemopexin I-gene
homeostasis 0
during 0
the 0
acute 0
phase 0
response 0
. 0

Our 0
aim 0
was 0
to 0
check 0
whether 0
, 0
during 0
PG 0
- 0
DS 0
administration 0
, 0
serum 0
lipase B-gene
activity 0
changes 0
simultaneously 0
with 0
serum 0
amylase B-gene
activity 0
, 0
and 0
, 0
if 0
so 0
, 0
what 0
the 0
reason 0
is 0
for 0
the 0
detected 0
change 0
. 0

( 0
i 0
) 0
The 0
chimeric 0
gene 0
consisting 0
of 0
the 0
coding 0
and 0
5 0
' 0
nontranslated 0
leader 0
regions 0
of 0
the 0
TK B-gene
gene I-gene
fused 0
to 0
portions 0
of 0
the 0
domain 0
of 0
alpha B-gene
gene I-gene
0 I-gene
extending 0
largely 0
upstream 0
from 0
the 0
site 0
of 0
initiation 0
of 0
transcription 0
of 0
alpha B-gene
gene I-gene
0 I-gene
was 0
regulated 0
in 0
the 0
same 0
fashion 0
as 0
the 0
alpha B-gene
4 I-gene
- I-gene
and I-gene
alpha I-gene
27 I-gene
- I-gene
TK I-gene
chimeras 0
. 0

Cytokines 0
and 0
steroid 0
hormones 0
use 0
different 0
sets 0
of 0
signal 0
transduction 0
pathways 0
, 0
which 0
seem 0
to 0
be 0
unrelated 0
. 0

This 0
is 0
the 0
most 0
northern 0
and 0
, 0
at 0
the 0
same 0
time 0
largest 0
, 0
Q 0
fever 0
epidemic 0
recorded 0
in 0
Germany 0
over 0
the 0
last 0
28 0
years 0
. 0

Genetic 0
analysis 0
of 0
the 0
role 0
of 0
herpes B-gene
simplex I-gene
virus I-gene
type I-gene
1 I-gene
glycoprotein I-gene
K I-gene
in 0
infectious 0
virus 0
production 0
and 0
egress 0
. 0

The 0
5 0
' 0
half 0
of 0
the 0
EWS B-gene
gene I-gene
has 0
recently 0
been 0
described 0
to 0
be 0
fused 0
to 0
the 0
3 0
' 0
regions 0
of 0
genes 0
encoding 0
the 0
DNA 0
- 0
binding 0
domain 0
of 0
several 0
transcriptional 0
regulators 0
, 0
including 0
ATF1 B-gene
, 0
FLI B-gene
- I-gene
1 I-gene
, 0
and 0
ERG B-gene
, 0
in 0
several 0
human 0
tumors 0
. 0

We 0
used 0
high 0
- 0
resolution 0
ultrasound 0
to 0
characterize 0
postprandial 0
antral 0
excursion 0
characteristics 0
in 0
15 0
healthy 0
volunteers 0
. 0

Multivariable 0
logistic 0
regression 0
showed 0
that 0
mean 0
blood 0
glucose 0
level 0
for 0
the 0
first 0
2 0
days 0
( 0
p 0
= 0
0.002 0
) 0
, 0
obesity 0
( 0
p 0
< 0
0.002 0
) 0
, 0
and 0
use 0
of 0
the 0
internal 0
mammary 0
artery 0
( 0
p 0
< 0
0.02 0
) 0
were 0
all 0
independent 0
predictors 0
of 0
deep 0
wound 0
infection 0
. 0

Fine 0
tangled 0
pili 0
expressed 0
by 0
Haemophilus 0
ducreyi 0
are 0
a 0
novel 0
class 0
of 0
pili 0
. 0

CONCLUSIONS 0
: 0
The 0
RRM 0
is 0
one 0
of 0
the 0
most 0
common 0
and 0
best 0
characterized 0
RNA 0
- 0
binding 0
motifs 0
. 0

Torsion 0
of 0
the 0
contralateral 0
testis 0
5 0
years 0
after 0
orchiopexy 0
. 0

Serum 0
levels 0
of 0
total 0
and 0
specific B-gene
immunoglobulin I-gene
E I-gene
( 0
IgE B-gene
) 0
have 0
been 0
determined 0
by 0
radioimmunoassays 0
in 0
sixty 0
- 0
nine 0
allergic 0
subjects 0
. 0

The 0
largest 0
one 0
probably 0
corresponds 0
to 0
the 0
precursor 0
form 0
of 0
PS2 B-gene
in 0
E. 0
coli 0
. 0

Transcriptional 0
analysis 0
indicates 0
that 0
human B-gene
TBP I-gene
functions 0
poorly 0
at 0
promoters 0
recognized 0
by 0
RNA B-gene
polymerases I-gene
I I-gene
and I-gene
III I-gene
and 0
at 0
RNA B-gene
Pol I-gene
II I-gene
promoters I-gene
lacking 0
a 0
conventional 0
TATA 0
element 0
. 0

Elements 0
of 0
the 0
hAT B-gene
transposon I-gene
family I-gene
, 0
such 0
as 0
the 0
maize B-gene
activator I-gene
( 0
Ac B-gene
) 0
, 0
have 0
been 0
discovered 0
in 0
a 0
large 0
number 0
of 0
eukaryotic 0
species 0
. 0

The 0
identification 0
of 0
SRP54sc B-gene
and 0
SRP54sp B-gene
provides 0
the 0
first 0
evidence 0
for 0
SRP B-gene
related 0
proteins 0
in 0
yeast 0
. 0

We 0
have 0
isolated 0
two 0
H19 B-gene
cDNAs I-gene
( 0
AP B-gene
and 0
ES B-gene
) 0
that 0
contain 0
this 0
ORF4 0
and 0
correspond 0
to 0
incomplete 0
copies 0
of 0
the 0
unique 0
2.3 B-gene
kb I-gene
H19 I-gene
RNA I-gene
. 0

Urease B-gene
activity 0
, 0
judged 0
as 0
the 0
amount 0
of 0
ammonia 0
production 0
from 0
urea 0
, 0
could 0
be 0
measured 0
at 0
25 0
ng 0
per 0
tube 0
( 0
S/N 0
= 0
1.5 0
) 0
with 0
Jack B-gene
bean I-gene
meal I-gene
urease I-gene
. 0

Radioimmunoassay 0
of 0
plasma B-gene
gonadotropins I-gene
; 0
problems 0
of 0
specificity 0

Tissue 0
expansion 0
was 0
used 0
successfully 0
to 0
prepare 0
adequate 0
soft 0
tissue 0
for 0
closure 0
following 0
a 0
difficult 0
clubfoot 0
correction 0
. 0

Legionella B-gene
antibodies I-gene
in 0
domestic 0
animals 0

In 0
a 0
previous 0
study 0
of 0
transforming B-gene
growth I-gene
factor I-gene
- I-gene
beta1 I-gene
- 0
mediated 0
inhibition 0
of 0
the 0
cyclin B-gene
A I-gene
promoter I-gene
, 0
we 0
mapped 0
the 0
inhibitory 0
effect 0
to 0
the 0
ATF B-gene
site I-gene
; 0
in 0
the 0
present 0
study 0
of 0
IFN B-gene
- I-gene
gamma I-gene
treatment 0
, 0
functional 0
analysis 0
by 0
transient 0
transfection 0
showed 0
that 0
inhibition 0
of 0
the 0
cyclin B-gene
A I-gene
promoter I-gene
persisted 0
despite 0
mutation 0
of 0
the 0
ATF B-gene
, 0
NF B-gene
- I-gene
Y I-gene
, 0
or 0
CDE 0
elements 0
. 0

No 0
significant 0
difference 0
was 0
seen 0
found 0
between 0
the 0
two 0
groups 0
in 0
the 0
degree 0
of 0
postoperative 0
deterioration 0
in 0
cardiopulmonary 0
function 0
or 0
in 0
interleukin B-gene
- I-gene
6 I-gene
levels 0
. 0

We 0
show 0
that 0
GCNF B-gene
binds 0
to 0
one 0
of 0
the 0
two 0
DRO 0
sequences 0
in 0
the 0
Prm1 B-gene
promoter I-gene
, 0
and 0
to 0
the 0
DRO 0
sequence 0
in 0
the 0
Prm2 B-gene
promoter I-gene
in 0
a 0
specific 0
manner 0
. 0

The 0
strategy 0
uses 0
RNA B-gene
ligase I-gene
to 0
add 0
DNA 0
oligonucleotide 0
priming 0
sites 0
to 0
the 0
RNA 0
for 0
subsequent 0
reverse 0
transcription 0
and 0
PCR 0
( 0
RNA B-gene
ligase I-gene
, 0
reverse 0
transcription 0
- 0
PCR 0
, 0
or 0
RL/RT/PCR 0
) 0
. 0

From 0
1977 0
to 0
1985 0
, 0
42 0
patients 0
with 0
squamous 0
cell 0
carcinoma 0
of 0
the 0
anal 0
canal 0
were 0
treated 0
with 0
mitomycin 0
C 0
( 0
15 0
mg/m2 0
) 0
and 0
5 0
- 0
fluorouracil 0
( 0
750 0
mg/m2 0
) 0
on 0
day 0
1 0
, 0
5 0
- 0
FU 0
( 0
750 0
mg/m2/d 0
) 0
alone 0
on 0
days 0
2 0
to 0
5 0
, 0
and 0
radiation 0
therapy 0
( 0
3000 0
cGy 0
) 0
on 0
days 0
7 0
to 0
28 0
. 0

Effect 0
of 0
choline 0
magnesium 0
trisalicylate 0
on 0
prostacyclin 0
production 0
by 0
isolated 0
vascular 0
tissue 0
of 0
the 0
rat 0
. 0

The 0
magnitude 0
of 0
all 0
four 0
parameters 0
increased 0
in 0
an 0
exponential 0
fashion 0
with 0
increasing 0
sperm 0
number 0
up 0
to 0
400 0
x 0
10 0
( 0
6 0
) 0
per 0
ejaculate 0
. 0

A 0
sharp 0
transition 0
from 0
a 0
random 0
chaotic 0
state 0
to 0
a 0
correlated 0
turbulent 0
state 0
of 0
finite 0
coherence 0
time 0
is 0
found 0
when 0
the 0
Rayleigh 0
number 0
becomes 0
larger 0
than 0
a 0
critical 0
value 0
Ra 0
( 0
c 0
) 0
approximately 0
equal 0
to 0
5 0
x 0
10 0
( 0
7 0
) 0
. 0

In 0
HMEC 0
stably 0
transfected 0
with 0
an 0
ER B-gene
mutant I-gene
containing 0
a 0
deletion 0
in 0
the 0
second 0
zinc 0
finger 0
of 0
the 0
DNA 0
- 0
binding 0
domain 0
, 0
E 0
and 0
HT 0
had 0
different 0
effects 0
on 0
EBBP B-gene
gene I-gene
expression 0
; 0
EBBP B-gene
regulation 0
by 0
E 0
was 0
dramatically 0
reduced 0
while 0
the 0
effects 0
of 0
HT 0
were 0
augmented 0
. 0

6 0
h 0
after 0
ingestion 0
of 0
aspirin 0
on 0
day 0
1 0
to 0
day 0
14 0
, 0
both 0
TX 0
and 0
PGI2 0
levels 0
also 0
significantly 0
decreased 0
( 0
p 0
< 0
0.0001 0
) 0
. 0

When 0
transfected 0
into 0
HepG2 0
cells 0
, 0
which 0
lack 0
C/EBP B-gene
alpha I-gene
, 0
the 0
mouse B-gene
ob I-gene
promoter I-gene
was 0
only 0
weakly 0
active 0
. 0

Desarrollo 0
de 0
un 0
modelo 0
matematico 0
general 0
para 0
los 0
procesos 0
fermentativos 0
, 0
Cinetica 0
de 0
la 0
degradacion 0
anaerobia 0
, 0
Ph.D 0
. 0

NF B-gene
- I-gene
kappaB I-gene
DNA 0
- 0
protein 0
binding 0
and 0
ICAM B-gene
- I-gene
1 I-gene
promoter I-gene
activity 0
were 0
enhanced 0
by 0
IL B-gene
- I-gene
1beta I-gene
and 0
these 0
effects 0
were 0
inhibited 0
by 0
tyrphostin 0
23 0
, 0
but 0
not 0
by 0
PD 0
98059 0
or 0
SB 0
203580 0
. 0

In 0
murine 0
cells 0
, 0
FPGS B-gene
expression 0
is 0
controlled 0
by 0
two 0
promoters 0
that 0
, 0
as 0
we 0
show 0
here 0
, 0
vary 0
substantially 0
in 0
their 0
efficiency 0
, 0
at 0
least 0
in 0
the 0
context 0
of 0
a 0
reporter 0
gene 0
assay 0
. 0

Quantitative 0
measurement 0
of 0
antigamma B-gene
globulin I-gene
factors I-gene
( 0
rheumatoid B-gene
factors I-gene
) 0
using 0
laser 0
- 0
nephelometry 0
in 0
comparison 0
with 0
the 0
latex 0
agglutination 0
test 0
and 0
the 0
Waaler 0
- 0
Rose 0
test 0

Disruption 0
of 0
INP53 B-gene
, 0
but 0
not 0
the 0
related 0
INP51 B-gene
and 0
INP52 B-gene
genes I-gene
, 0
resulted 0
in 0
alpha B-gene
- I-gene
factor I-gene
maturation 0
defects 0
and 0
exacerbated 0
alpha B-gene
- I-gene
factor I-gene
maturation 0
defects 0
when 0
combined 0
with 0
chc1 B-gene
- I-gene
521 I-gene
. 0

The 0
complete 0
nucleotide 0
sequence 0
of 0
odontoglossum 0
ringspot 0
virus 0
( 0
Cy 0
- 0
1 0
strain 0
) 0
genomic 0
RNA 0
. 0

Paradoxically 0
there 0
is 0
a 0
decrease 0
in 0
the 0
level 0
of 0
soluble B-gene
A I-gene
beta I-gene
secreted 0
from 0
the 0
cells 0
. 0

When 0
translated 0
in 0
- 0
frame 0
with 0
PKC B-gene
zeta I-gene
, 0
a 0
stop 0
codon 0
is 0
located 0
28 0
amino 0
acids 0
towards 0
the 0
N 0
- 0
terminus 0
of 0
the 0
divergence 0
point 0
and 0
the 0
intervening 0
sequence 0
lacks 0
an 0
expected 0
initiating 0
methionine 0
. 0
psi B-gene
PKC I-gene
zeta I-gene
is 0
non 0
- 0
functional 0
in 0
terms 0
of 0
protein 0
synthesis 0
since 0
Western 0
blotting 0
with 0
an 0
antibody 0
directed 0
against 0
the 0
C 0
- 0
terminus 0
of 0
PKC B-gene
zeta I-gene
failed 0
to 0
reveal 0
a 0
protein 0
smaller 0
than 0
PKC B-gene
zeta I-gene
, 0
and 0
synthetic 0
psi B-gene
PKC I-gene
zeta I-gene
RNA I-gene
failed 0
to 0
support 0
protein 0
synthesis 0
in 0
a 0
translation 0
system 0
in 0
vitro 0
. 0

Comparative 0
ultrafiltration 0
( 0
UF 0
) 0
studies 0
with 0
BiGG 0
and 0
standard 0
lactate 0
( 0
La 0
) 0
solutions 0
in 0
rabbits 0
showed 0
that 0
net 0
UF 0
with 0
La 0
solution 0
peaked 0
at 0
2 0
h 0
and 0
decreased 0
significantly 0
at 0
4 0
h 0
and 0
6 0
h 0
. 0

The 0
B. B-gene
aphidicola I-gene
argS I-gene
- I-gene
rrn I-gene
DNA I-gene
fragments I-gene
from 0
endosymbionts 0
from 0
seven 0
species 0
of 0
aphids 0
had 0
promoter 0
activities 0
in 0
E. 0
coli 0
which 0
ranged 0
from 0
6 0
to 0
135 0
% 0
of 0
that 0
observed 0
with 0
a 0
comparable 0
DNA 0
fragment 0
of 0
E. B-gene
coli I-gene
rrnB I-gene
. 0

CONCLUSIONS 0
: 0
These 0
principally 0
structural 0
studies 0
support 0
the 0
hypothesis 0
that 0
the 0
thrombus 0
is 0
a 0
self 0
- 0
sustaining 0
entity 0
that 0
may 0
have 0
significance 0
in 0
the 0
pathophysiologic 0
mechanism 0
of 0
abdominal 0
aortic 0
aneurysms 0
. 0

The 0
authors 0
report 0
about 0
the 0
exeresis 0
of 0
a 0
pyelonephrictic 0
left 0
small 0
kidney 0
with 0
laparoscopic 0
surgery 0
. 0

AMPK B-gene
is 0
a 0
heterotrimer 0
composed 0
of 0
a 0
catalytic 0
subunit 0
( 0
alpha 0
) 0
and 0
two 0
regulatory 0
subunits 0
( 0
beta 0
and 0
gamma 0
) 0
. 0

The 0
genes 0
encoding 0
these 0
carotenoids 0
in 0
E. 0
herbicola 0
Eho13 0
are 0
clustered 0
in 0
a 0
7 0
kb 0
DNA 0
fragment 0
. 0

Genetic 0
diagnosis 0
of 0
respiratory 0
diseases 0

Whereas 0
mutant B-gene
6C4 I-gene
specified 0
a 0
wild B-gene
- I-gene
type I-gene
- I-gene
size I-gene
Pol I-gene
protein I-gene
, 0
we 0
detected 0
no 0
full B-gene
- I-gene
length I-gene
Pol I-gene
protein I-gene
in 0
7E4 0
- 0
infected 0
cell 0
extracts 0
. 0

Incidence 0
of 0
beta 0
- 0
thalassemia 0
carriers 0
and 0
those 0
deficient 0
in 0
erythrocyte B-gene
glucose I-gene
- I-gene
6 I-gene
- I-gene
phosphate I-gene
dehydrogenase I-gene
in 0
the 0
greater 0
Buenos 0
Aires 0
area 0

Other 0
toxicities 0
attributed 0
to 0
CPT 0
- 0
11 0
included 0
dehydration 0
, 0
nausea 0
, 0
vomiting 0
, 0
and 0
asthenia 0
. 0

JCAHO 0
moves 0
to 0
rewrite 0
many 0
rules 0
to 0
lessen 0
hospitals 0
' 0
regulatory 0
burden 0
. 0

A 0
phylogenetic 0
comparison 0
of 0
32 0
species 0
showed 0
minor 0
differences 0
in 0
the 0
apoB B-gene
mRNA I-gene
sequence I-gene
, 0
and 0
the 0
apoB B-gene
mRNA I-gene
from 0
31 0
species 0
was 0
robustly 0
edited 0
in 0
vitro 0
. 0

The 0
expression 0
pattern 0
of 0
the 0
reporter 0
gene 0
was 0
compared 0
to 0
that 0
of 0
the 0
endogenous B-gene
PDGFbeta I-gene
r I-gene
gene I-gene
. 0

These 0
transcripts 0
directed 0
the 0
synthesis 0
of 0
three 0
proteins 0
: 0
the 0
virus B-gene
trans I-gene
- I-gene
activator I-gene
protein I-gene
( 0
EIAV B-gene
Tat I-gene
) 0
encoded 0
by 0
ORF 0
S1 0
, 0
a 0
protein 0
of 0
unknown 0
function 0
encoded 0
by 0
ORF 0
S2 0
, 0
and 0
the 0
virus 0
envelope B-gene
glycoprotein I-gene
. 0

In 0
addition 0
, 0
because 0
SB203580 0
had 0
no 0
effect 0
of 0
TNF B-gene
- 0
or 0
ceramide 0
- 0
induced 0
apoptosis 0
, 0
our 0
results 0
strongly 0
argue 0
against 0
a 0
role 0
for 0
p38 B-gene
MAPK I-gene
in 0
the 0
induction 0
of 0
TNF B-gene
- 0
- 0
or 0
ceramide 0
- 0
induced 0
apoptosis 0
. 0

Seven 0
Zebu 0
cattle 0
were 0
also 0
exposed 0
to 0
challenge 0
at 0
the 0
same 0
time 0
. 0

To 0
study 0
the 0
signaling 0
pathways 0
that 0
regulate 0
cytoskeletal 0
rearrangements 0
in 0
T 0
lymphocytes 0
, 0
we 0
set 0
up 0
a 0
conjugate 0
formation 0
assay 0
using 0
Jurkat 0
T 0
cells 0
as 0
effectors 0
and 0
cell 0
- 0
sized 0
latex 0
beads 0
coated 0
with 0
various 0
antibodies 0
as 0
artificial 0
APCs 0
. 0

YACs 0
, 0
BACs 0
, 0
cosmids 0
, 0
and 0
STSs 0
are 0
defined 0
to 0
aid 0
in 0
further 0
study 0
of 0
this 0
gene 0
. 0

The 0
average 0
coefficient 0
of 0
variation 0
between 0
assays 0
for 0
gas 0
chromatography 0
mass 0
spectrometry 0
was 0
5.8 0
% 0
and 0
for 0
radioimmunoassay 0
was 0
12.3 0
% 0
, 0
while 0
the 0
average 0
coefficient 0
of 0
variation 0
within 0
assays 0
for 0
gas 0
chromatography 0
mass 0
spectrometry 0
was 0
4.9 0
% 0
and 0
for 0
radioimmunoassay 0
6.9 0
% 0
. 0

This 0
chimera 0
transduced 0
IL B-gene
- I-gene
4 I-gene
- 0
specific 0
signals 0
in 0
response 0
to 0
IL B-gene
- I-gene
2 I-gene
binding 0
and 0
dramatically 0
enhanced 0
type 0
2 0
responses 0
( 0
IL B-gene
- I-gene
4 I-gene
, 0
IL B-gene
- I-gene
5 I-gene
, 0
and 0
immunoglobulin B-gene
E I-gene
production 0
) 0
upon 0
in 0
vitro 0
TCR B-gene
stimulation 0
or 0
in 0
vivo 0
antigen 0
challenge 0
. 0

Soggy B-gene
, 0
a 0
spermatocyte 0
- 0
specific 0
gene 0
, 0
lies 0
3.8 0
kb 0
upstream 0
of 0
and 0
antipodal 0
to 0
TEAD B-gene
- I-gene
2 I-gene
, 0
a 0
transcription 0
factor 0
expressed 0
at 0
the 0
beginning 0
of 0
mouse 0
development 0
. 0

We 0
previously 0
demonstrated 0
that 0
AKT2 B-gene
, 0
a 0
member 0
of 0
protein B-gene
kinase I-gene
B I-gene
family I-gene
, 0
is 0
activated 0
by 0
a 0
number 0
of 0
growth 0
factors 0
via 0
Ras B-gene
and 0
PI B-gene
3 I-gene
- I-gene
kinase I-gene
signaling 0
pathways 0
. 0

This 0
demonstrates 0
the 0
presence 0
of 0
a 0
PKC B-gene
- 0
dependent 0
pathway 0
which 0
functions 0
independently 0
from 0
Lck B-gene
in 0
MAP B-gene
kinase I-gene
activation 0
. 0

Finally 0
, 0
transfection 0
of 0
Grb10 B-gene
genes I-gene
with 0
specific 0
mutations 0
in 0
their 0
SH2 B-gene
domains I-gene
induces 0
apoptosis 0
in 0
HTC 0
- 0
IR 0
and 0
COS 0
- 0
7 0
cells 0
. 0

Small B-gene
t I-gene
also 0
inhibited 0
the 0
dephosphorylation 0
of 0
cAMP B-gene
- I-gene
dependent I-gene
protein I-gene
kinase I-gene
( 0
PKA B-gene
) 0
- 0
phosphorylated 0
CREB B-gene
in 0
rat 0
liver 0
nuclear 0
extracts 0
. 0

Physical 0
map 0
of 0
the 0
genome 0
of 0
sonchus 0
yellow 0
net 0
virus 0
, 0
a 0
plant 0
rhabdovirus 0
with 0
six 0
genes 0
and 0
conserved 0
gene 0
junction 0
sequences 0
. 0

It 0
is 0
an 0
untested 0
argument 0
that 0
conventional 0
beta B-gene
- I-gene
adrenoceptor I-gene
antagonists 0
possess 0
unwanted 0
metabolic 0
effects 0
that 0
may 0
counter 0
some 0
of 0
their 0
potential 0
cardiac 0
benefits 0
. 0

However 0
, 0
it 0
is 0
not 0
easy 0
to 0
establish 0
the 0
diagnosis 0
of 0
thoracic 0
MFH 0
. 0

An 0
11.5 0
- 0
kb 0
intron 0
is 0
found 0
at 0
the 0
end 0
of 0
transmembrane 0
6 0
, 0
and 0
the 0
rest 0
of 0
the 0
ORF 0
is 0
in 0
exon 0
3 0
. 0

To 0
assay 0
for 0
sequences 0
that 0
could 0
potentially 0
regulate 0
Xenopus B-gene
proenkephalin I-gene
expression 0
, 0
we 0
transfected 0
constructs 0
that 0
contained 0
upstream 0
genomic 0
sequences 0
linked 0
to 0
the 0
CAT B-gene
reporter I-gene
gene I-gene
into 0
various 0
eukaryotic 0
cell 0
lines 0
. 0

It 0
is 0
also 0
conceivable 0
that 0
elevated 0
insulin B-gene
levels 0
may 0
cause 0
hypertriglyceridaemia 0
and 0
possibly 0
other 0
abnormalities 0
of 0
lipid 0
metabolism 0
. 0

The 0
effects 0
of 0
different 0
sources 0
of 0
commercial 0
rations 0
on 0
the 0
humoral 0
immune 0
response 0
of 0
broilers 0
to 0
Newcastle 0
disease 0
vaccination 0
. 0

To 0
quantify 0
the 0
normal 0
coupling 0
patterns 0
, 0
fresh 0
cadaveric 0
human 0
lumbar 0
spine 0
specimens 0
( 0
L1 0
- 0
S1 0
) 0
were 0
used 0
. 0

Deletion 0
mutations 0
were 0
constructed 0
, 0
removing 0
residues 0
2 0
- 0
30 0
, 0
31 0
- 0
60 0
, 0
61 0
- 0
90 0
, 0
and 0
49 0
- 0
78 0
of 0
the 0
N 0
- 0
terminal 0
cytoplasmic 0
domain 0
, 0
as 0
well 0
as 0
a 0
missense 0
mutation 0
of 0
a 0
dileucine 0
motif 0
. 0

When 0
the 0
measured 0
beta B-gene
- I-gene
galactosidase I-gene
activity 0
in 0
the 0
pWP 0
- 0
transfected 0
cells 0
was 0
normalized 0
to 0
the 0
pCH110 0
- 0
transfected 0
cells 0
( 0
an 0
appropriate 0
control 0
if 0
the 0
SV40 B-gene
early I-gene
region I-gene
promoter I-gene
functions 0
constitutively 0
in 0
various 0
cell 0
lines 0
) 0
, 0
the 0
results 0
suggested 0
that 0
the 0
promoter 0
region 0
of 0
the 0
PLP B-gene
gene I-gene
contains 0
the 0
information 0
necessary 0
for 0
initiation 0
of 0
transcription 0
in 0
a 0
C6 0
cell 0
- 0
specific 0
manner 0
. 0

Indigenous 0
microbial 0
flora 0
and 0
the 0
large 0
intestine 0
in 0
tadpoles 0
. 0

3 0
patients 0
with 0
acute 0
leukaemia 0
, 0
HLA B-gene
antibodies 0
and 0
thrombocytopenia 0
refractory 0
to 0
random 0
donor 0
platelet 0
transfusions 0
were 0
treated 0
with 0
high 0
- 0
dose 0
i.v 0
. 0
immunoglobulin B-gene
. 0

Plasma B-gene
renin I-gene
activity 0
in 0
end 0
- 0
stage 0
kidney 0
disease 0
. 0

Computer 0
system 0
trains 0
employees 0
to 0
meet 0
JCAHO 0
safety 0
ED 0
requirements 0
. 0

The 0
temporal 0
sequence 0
of 0
organ 0
failure 0
was 0
lung 0
, 0
clotting 0
system 0
, 0
kidney 0
, 0
and 0
liver 0
. 0

All 0
of 0
this 0
region 0
is 0
part 0
of 0
a 0
prominent 0
CpG 0
island 0
that 0
may 0
be 0
acting 0
as 0
an 0
extended 0
, 0
enhancer 0
- 0
independent 0
promoter 0
. 0

One 0
function 0
of 0
p53 B-gene
is 0
in 0
regulating 0
cell 0
cycle 0
check 0
- 0
point 0
control 0
after 0
DNA 0
damage 0
. 0

100 0
. 0

IGF B-gene
- I-gene
I I-gene
levels 0
were 0
measured 0
in 0
the 0
CSF 0
of 0
11 0
children 0
with 0
autism 0
( 0
4 0
females 0
, 0
7 0
males 0
; 0
mean 0
age 0
3.8 0
years 0
, 0
SD 0
1.1 0
) 0
using 0
a 0
sensitive 0
radioimmunoassay 0
method 0
and 0
compared 0
with 0
levels 0
in 0
11 0
control 0
participants 0
( 0
6 0
females 0
, 0
5 0
males 0
; 0
mean 0
age 0
3.8 0
years 0
) 0
. 0

The 0
XPR2 B-gene
gene I-gene
from 0
Yarrowia 0
lipolytica 0
encodes 0
an 0
inducible 0
alkaline B-gene
extracellular I-gene
protease I-gene
. 0

Two 0
closely 0
related 0
groups 0
of 0
transcripts 0
, 0
Sagrp1 B-gene
and 0
Sagrp2 B-gene
, 0
controlled 0
by 0
a 0
circadian 0
rhythm 0
have 0
been 0
isolated 0
. 0

In 0
patients 0
autografted 0
in 0
CR1 0
, 0
the 0
transplant 0
- 0
related 0
mortality 0
( 0
TRM 0
) 0
was 0
15 0
+/ 0
- 0
4 0
% 0
, 0
the 0
relapse 0
incidence 0
( 0
RI 0
) 0
was 0
58 0
+/ 0
- 0
5 0
% 0
, 0
the 0
leukaemia 0
- 0
free 0
survival 0
( 0
LFS 0
) 0
was 0
36 0
+/ 0
- 0
5 0
% 0
and 0
the 0
overall 0
survival 0
was 0
47 0
+/ 0
- 0
5 0
% 0
at 0
3 0
years 0
. 0

However 0
, 0
H19 B-gene
and 0
IGF2 B-gene
lie 0
within 0
a 0
larger 0
imprinted 0
domain 0
, 0
and 0
the 0
gene 0
specificity 0
of 0
H19 B-gene
epimutation 0
has 0
been 0
a 0
persistent 0
question 0
. 0

Antibiotics 0
and 0
CDCA 0
- 0
mediation 0
are 0
essential 0
for 0
symptomatic 0
therapy 0
. 0

The 0
effectiveness 0
and 0
pathogenetic 0
expediency 0
of 0
correcting 0
disorders 0
of 0
lipid 0
metabolism 0
in 0
atherosclerosis 0
with 0
enterosorbents 0
is 0
substantiated 0
. 0

Adaptive 0
effects 0
of 0
repeated 0
immersion 0
exposure 0
on 0
the 0
human 0
body 0

The 0
human 0
cDNA 0
was 0
cloned 0
and 0
sequenced 0
; 0
it 0
was 0
shown 0
to 0
have 0
an 0
open 0
reading 0
frame 0
encoding 0
a 0
296 0
- 0
amino 0
- 0
acid 0
protein 0
in 0
which 0
could 0
be 0
identified 0
four 0
peptides 0
previously 0
identified 0
by 0
micro 0
- 0
sequencing 0
purified 0
protein 0
. 0

Octamer 0
recognition 0
is 0
mediated 0
by 0
the 0
POU B-gene
domain 0
, 0
a 0
conserved 0
structural 0
motif 0
which 0
- 0
- 0
like 0
the 0
zinc 0
finger 0
and 0
leucine 0
zipper 0
- 0
- 0
defines 0
a 0
family 0
of 0
related 0
transcription 0
factors 0
. 0

Copyright 0
1998 0
The 0
Association 0
for 0
the 0
Study 0
of 0
Animal 0
Behaviour 0
. 0

Dipetalonema 0
( 0
Acanthocheilonema 0
) 0
didelphis 0
sp 0
. 0
n 0
. 0

Forty 0
- 0
five 0
patients 0
with 0
recent 0
- 0
onset 0
hyperthyroidism 0
( 0
< 0
12 0
weeks 0
) 0
were 0
sex 0
and 0
menopause 0
stratified 0
and 0
randomly 0
allocated 0
to 0
treatment 0
with 0
carbimazole 0
( 0
Neotomizol 0
) 0
, 0
carbimazole 0
plus 0
low 0
dose 0
CT 0
( 0
Calsynar 0
; 0
100 0
IU/day 0
, 0
2 0
days/week 0
) 0
, 0
or 0
carbimazole 0
plus 0
high 0
dose 0
CT 0
( 0
Calsynar 0
; 0
100 0
IU/day 0
, 0
14 0
days/month 0
) 0
. 0

The 0
promyelocytic B-gene
leukemia I-gene
protein I-gene
interacts 0
with 0
Sp1 B-gene
and 0
inhibits 0
its 0
transactivation 0
of 0
the 0
epidermal B-gene
growth I-gene
factor I-gene
receptor I-gene
promoter 0
. 0

CTP 0
, 0
GDP 0
, 0
GTP 0
, 0
ITP 0
) 0
did 0
not 0
affect 0
the 0
response 0
. 0

Here 0
, 0
we 0
characterize 0
TCR/CD48 B-gene
and 0
TCR/CD48 I-gene

We 0
also 0
show 0
that 0
psbH B-gene
and 0
psbT B-gene
are 0
transcribed 0
from 0
the 0
upstream 0
psbB B-gene
gene I-gene
promoter I-gene
, 0
and 0
that 0
the 0
psbH B-gene
mRNA I-gene
has 0
its 0
own 0
target 0
sequence 0
for 0
Mbb1 B-gene
function 0
. 0

Thus 0
, 0
it 0
appears 0
that 0
moxalactam 0
is 0
a 0
reliable 0
and 0
useful 0
antibiotic 0
for 0
the 0
treatment 0
of 0
complicated 0
urinary 0
tract 0
infections 0
. 0

In 0
the 0
second 0
, 0
37 0
students 0
were 0
given 0
trimethoprim/sulphamethoxazole 0
( 0
160 0
mg 0
TMP 0
- 0
SMX 0
800 0
mg 0
) 0
, 0
38 0
TMP 0
( 0
200 0
mg 0
) 0
, 0
and 0
in 0
35 0
a 0
placebo 0
was 0
given 0
b.i.d 0
. 0
for 0
five 0
days 0
. 0

CONCLUSION 0
: 0
Men 0
presenting 0
with 0
urethritis 0
and 0
women 0
presenting 0
with 0
PID 0
both 0
have 0
significantly 0
greater 0
peripheral 0
blood 0
mononuclear 0
cell 0
proliferative 0
responses 0
to 0
the 0
DK20 0
strain 0
of 0
C 0
trachomatis 0
than 0
controls 0
. 0

The 0
infection 0
of 0
cells 0
with 0
Moloney 0
murine 0
leukemia 0
virus 0
( 0
M 0
- 0
MuLV 0
) 0
causes 0
an 0
increase 0
in 0
specific 0
cellular 0
gene 0
products 0
, 0
including 0
the 0
major B-gene
histocompatibility I-gene
complex I-gene
( I-gene
MHC I-gene
) I-gene
class I-gene
I I-gene
antigens I-gene
. 0

Apparent 0
Buschke 0
- 0
Loewenstein 0
tumour 0
of 0
the 0
penis 0
. 0

The 0
orthologs 0
of 0
the 0
Y B-gene
( I-gene
1 I-gene
) I-gene
and 0
Y B-gene
( I-gene
2 I-gene
) I-gene
subtypes I-gene
display 0
high 0
amino 0
acid 0
sequence 0
identities 0
between 0
pig 0
, 0
human 0
, 0
and 0
mouse 0
( 0
92 0
% 0
- 0
94 0
% 0
) 0
, 0
whereas 0
the 0
Y B-gene
( I-gene
4 I-gene
) I-gene
, 0
Y B-gene
( I-gene
5 I-gene
) I-gene
, 0
and 0
y B-gene
( I-gene
6 I-gene
) I-gene
subtypes I-gene
display 0
lower 0
identities 0
( 0
76 0
% 0
- 0
87 0
% 0
) 0
. 0

In 0
NIH 0
3T3 0
fibroblasts 0
the 0
high 0
affinity 0
IL B-gene
- I-gene
2R I-gene
bearing 0
a 0
deletion 0
of 0
a 0
region 0
rich 0
in 0
acidic 0
amino 0
acids 0
( 0
the 0
`` 0
acidic 0
'' 0
region 0
) 0
in 0
the B-gene
IL I-gene
- I-gene
2R I-gene
beta I-gene
- I-gene
chain I-gene
failed 0
to 0
induce 0
the 0
tyrosine 0
phosphorylation 0
of B-gene
MAP I-gene
kinase I-gene
as 0
well 0
as 0
the 0
expression 0
of 0
the 0
all 0
three 0
nuclear 0
proto 0
- 0
oncogenes 0
. 0

Activation 0
of 0
the 0
cytotactin B-gene
promoter I-gene
by 0
the 0
homeobox B-gene
- I-gene
containing I-gene
gene I-gene
Evx I-gene
- I-gene
1 I-gene
. 0

Of 0
the 0
private 0
practices 0
accredited 0
in 0
August 0
1995 0
, 0
40.6 0
per 0
cent 0
( 0
122 0
) 0
participated 0
. 0

Enhanced 0
phospholipid 0
hydrolysis 0
with 0
free 0
fatty 0
acid 0
and 0
thromboxane 0
accumulation 0
, 0
increased 0
release 0
of 0
excitatory 0
amino 0
acids 0
, 0
and 0
decreased 0
tissue 0
magnesium 0
levels 0
may 0
each 0
serve 0
to 0
worsen 0
secondary 0
tissue 0
damage 0
and 0
diminish 0
neurologic 0
recovery 0
after 0
spinal 0
cord 0
injury 0
associated 0
with 0
acute 0
alcohol 0
intoxication 0
. 0

This 0
suggests 0
that 0
the 0
ratio 0
of 0
IL B-gene
- I-gene
6 I-gene
to 0
IL B-gene
- I-gene
10 I-gene
may 0
be 0
used 0
to 0
predict 0
the 0
injury 0
severity 0
after 0
trauma 0
. 0

With 0
six 0
reports 0
in 0
the 0
literature 0
that 0
show 0
there 0
is 0
an 0
order 0
to 0
melanoma 0
nodal 0
metastases 0
and 0
that 0
the 0
SLN 0
histology 0
is 0
reflective 0
of 0
the 0
histology 0
of 0
the 0
remainder 0
of 0
the 0
nodal 0
basin 0
, 0
the 0
more 0
conservative 0
SLN 0
biopsy 0
can 0
be 0
performed 0
to 0
adequately 0
stage 0
nodally 0
the 0
patient 0
with 0
melanoma 0
. 0

In 0
addition 0
, 0
a 0
double 0
mutant 0
( 0
E482A 0
, 0
D489A 0
) 0
which 0
removed 0
negative 0
charges 0
along 0
one 0
side 0
of 0
the 0
helix 0
had 0
negligible 0
effects 0
on 0
fusion 0
activity 0
. 0

Escherichia 0
coli 0
cells 0
expressing 0
a 0
mutant B-gene
glyV I-gene
( 0
glycine B-gene
tRNA I-gene
) 0
gene 0
have 0
a 0
UVM 0
- 0
constitutive 0
phenotype 0
: 0
implications 0
for 0
mechanisms 0
underlying 0
the 0
mutA B-gene
or 0
mutC B-gene
mutator I-gene
effect 0
. 0

Titres 0
of 0
antistreptolysin B-gene
O I-gene
in 0
mothers 0
of 0
children 0
affected 0
with 0
Down 0
's 0
syndrome 0
. 0

Synthetic 0
studies 0
on 0
furan 0
derivatives 0
by 0
the 0
wittig 0
reaction 0

Positive 0
linear 0
correlations 0
were 0
found 0
when 0
the 0
AUC 0
( 0
0 0
- 0
12 0
) 0
( 0
r 0
= 0
0.68 0
; 0
P 0
less 0
than 0
0.01 0
) 0
, 0
the 0
maximum 0
plasma 0
concentration 0
( 0
r 0
= 0
0.34 0
; 0
P 0
less 0
than 0
0.01 0
) 0
, 0
the 0
minimum 0
plasma 0
concentration 0
( 0
r 0
= 0
0.55 0
; 0
P 0
less 0
than 0
0.01 0
) 0
, 0
and 0
the 0
elimination 0
t1/2 0
( 0
r 0
= 0
0.46 0
; 0
P 0
less 0
than 0
0.01 0
) 0
were 0
regressed 0
with 0
age 0
. 0

Furthermore 0
, 0
the 0
social 0
learning 0
theory 0
of 0
depression 0
, 0
developed 0
by 0
Lewinsohn 0
, 0
is 0
described 0
. 0

Intramolecular 0
interaction 0
is 0
believed 0
to 0
result 0
in 0
the 0
formation 0
of 0
MxA B-gene
monomers I-gene
, 0
whereas 0
intermolecular 0
interaction 0
may 0
induce 0
the 0
formation 0
of 0
large B-gene
MxA I-gene
oligomers I-gene
. 0

Analysis 0
of 0
a 0
Het B-gene
- 0
mutation 0
in 0
Anabaena 0
sp 0
. 0
strain 0
PCC 0
7120 0
implicates 0
a 0
secondary 0
metabolite 0
in 0
the 0
regulation 0
of 0
heterocyst 0
spacing 0
. 0

He 0
presented 0
with 0
left 0
lower 0
abdominal 0
pain 0
and 0
hematoma 0
after 0
a 0
fall 0
. 0

To 0
this 0
end 0
we 0
generated 0
a 0
detailed 0
physical 0
map 0
of 0
the 0
genomic 0
region 0
spanning 0
between 0
sequence 0
- 0
tagged 0
site 0
markers 0
D16S518 B-gene
and 0
D16S516 B-gene
. 0

The 0
kinetics 0
of 0
erythromycin 0
( 0
E. 0
) 0
was 0
studied 0
in 0
16 0
patients 0
with 0
different 0
degrees 0
of 0
impairment 0
of 0
renal 0
function 0
after 0
a 0
single 0
intravenous 0
dose 0
. 0

Lasting 0
paraplegia 0
caused 0
by 0
loss 0
of 0
lumbar 0
spinal 0
cord 0
interneurons 0
in 0
rats 0
: 0
no 0
direct 0
correlation 0
with 0
motor 0
neuron 0
loss 0
. 0

Gold 0
flaxseed 0
( 0
whole 0
or 0
ground 0
) 0
fed 0
at 0
levels 0
of 0
5 0
or 0
15 0
% 0
were 0
compared 0
to 0
a 0
1.5 0
% 0
menhaden 0
oil 0
or 0
a 0
typical 0
control 0
layer 0
ration 0
. 0

The 0
study 0
drugs 0
( 0
combination 0
vinblastine 0
- 0
CCNU 0
and 0
single 0
- 0
agent 0
triazinate 0
or 0
dactinomycin 0
) 0
failed 0
to 0
provide 0
any 0
meaningful 0
antitumor 0
activity 0
for 0
these 0
patients 0
with 0
advanced 0
renal 0
cell 0
cancer 0
. 0

Some 0
CHOP B-gene
- 0
C/EBP B-gene
heterodimers 0
apparently 0
bind 0
to 0
alternative 0
DNA 0
sequence 0
and 0
thereby 0
regulate 0
the 0
transcription 0
of 0
other 0
genes 0
. 0

Furthermore 0
, 0
addition 0
of 0
the 0
recombinant B-gene
NF I-gene
- I-gene
YA I-gene
subunit I-gene
restores 0
NF B-gene
- I-gene
Y I-gene
binding 0
. 0

Our 0
data 0
provide 0
the 0
first 0
evidence 0
that 0
differential 0
splicing 0
in 0
the 0
extracellular 0
region 0
of 0
a 0
receptor 0
gene 0
generates 0
receptor 0
variants 0
with 0
different 0
ligand 0
- 0
binding 0
specificities 0
. 0

Intrathecal 0
injections 0
of 0
small 0
volumes 0
of 0
the 0
alpha B-gene
2 I-gene
- I-gene
adrenoceptor I-gene
agonists 0
, 0
xylazine 0
and 0
clonidine 0
, 0
into 0
the 0
cervical 0
region 0
of 0
the 0
spinal 0
cord 0
of 0
conscious 0
unrestrained 0
sheep 0
produced 0
a 0
dose 0
- 0
dependent 0
analgesia 0
of 0
the 0
forelimbs 0
as 0
measured 0
using 0
a 0
mechanical 0
pressure 0
device 0
. 0

The 0
specificity 0
of 0
the 0
transcriptional 0
activation 0
by 0
ISGF3 B-gene
is 0
mediated 0
by 0
specific 0
elements 0
termed 0
IFN B-gene
- I-gene
stimulatory I-gene
response I-gene
element I-gene
( 0
ISRE B-gene
) 0
located 0
in 0
the 0
promoter 0
region 0
of 0
IFN B-gene
- 0
inducible 0
genes 0
. 0

Clinical 0
development 0
of 0
interleukin B-gene
- I-gene
10 I-gene
. 0

Estrogen 0
has 0
positive 0
effects 0
on 0
mood 0
, 0
sexual 0
function 0
, 0
target 0
end 0
organs 0
and 0
cognitive 0
function 0
, 0
and 0
may 0
play 0
an 0
important 0
role 0
in 0
the 0
etiology 0
of 0
Alzheimer 0
's 0
Disease 0
by 0
acting 0
to 0
prevent 0
amyloid 0
plaque 0
formation 0
, 0
oxidative 0
stress 0
, 0
or 0
deterioration 0
of 0
the 0
cholinergic 0
neurotransmitter 0
system 0
. 0

The 0
system 0
consists 0
of 0
a 0
microcomputer 0
and 0
six 0
laboratory 0
analyzers 0
: 0
a 0
blood 0
gas 0
analyzer 0
, 0
a 0
flame 0
photometer 0
, 0
a 0
plasma 0
osmotic 0
pressure 0
meter 0
, 0
a 0
chloride 0
ion 0
titrator 0
, 0
a 0
blood 0
sugar 0
analyzer 0
, 0
and 0
a 0
hemoglobin B-gene
concentration 0
and 0
saturation 0
meter 0
. 0

Of 0
these 0
, 0
23 0
( 0
13.6 0
% 0
) 0
were 0
due 0
to 0
GIB 0
( 0
Upper 0
GIB 0
= 0
19 0
, 0
Lower 0
GIB 0
= 0
4 0
) 0
. 0

Hence 0
the 0
GAP1 B-gene
gene I-gene
encodes 0
a 0
protein 0
with 0
characteristics 0
typical 0
of 0
integral 0
membrane 0
proteins 0
translocating 0
ligants 0
across 0
cellular 0
membranes 0
. 0

Soluble 0
fibrin B-gene
monomer 0
complexes 0
in 0
thromboembolism 0

S16 0
, 0
16.8 0
% 0
, 0
P 0
= 0
0.001 0
) 0
. 0

Microenvironments 0
dominated 0
by 0
cyanobacteria 0
( 0
BPC 0
) 0
had 0
a 0
higher 0
pH 0
( 0
pH 0
7 0
- 0
8 0
) 0
than 0
those 0
dominated 0
by 0
lichen 0
( 0
LTL 0
) 0
( 0
pH 0
4.5 0
- 0
5.5 0
) 0
. 0

Saturated 0
fatty 0
acids 0
induce 0
a 0
1.6 0
- 0
fold 0
increase 0
in 0
transcription 0
activity 0
, 0
whereas 0
a 0
large 0
family 0
of 0
unsaturated 0
fatty 0
acids 0
repress 0
OLE1 B-gene
transcription 0
as 0
much 0
as 0
60 0
- 0
fold 0
. 0

A 0
third 0
GEF B-gene
, 0
GRP3 B-gene
( 0
KIAA0846 B-gene
) 0
, 0
activated 0
both 0
Ras B-gene
and 0
Rap1 B-gene
and 0
shared 0
significant 0
sequence 0
homology 0
with 0
the 0
calcium 0
- 0
and 0
diacylglycerol 0
- 0
activated 0
GEFs B-gene
, 0
GRP1 B-gene
and 0
GRP2 B-gene
. 0

We 0
have 0
determined 0
the 0
molecular 0
organization 0
and 0
transcription 0
start 0
points 0
( 0
tsp 0
) 0
for 0
the 0
murine 0
gene 0
( 0
TK B-gene
) 0
encoding 0
thymidine B-gene
kinase I-gene
. 0

Effect 0
of 0
gentamycin 0
on 0
the 0
kidney 0
functional 0
state 0
in 0
experimental 0
pyelonephritis 0

The 0
time 0
- 0
dependent 0
changes 0
in 0
measured 0
facility 0
of 0
outflow 0
or 0
`` 0
washout 0
phenomenon 0
'' 0
appeared 0
to 0
result 0
from 0
the 0
gradual 0
dissolution 0
of 0
the B-gene
hyaluronidase I-gene
- 0
sensitive 0
component 0
of 0
the 0
barriers 0
to 0
aqueous 0
outflow 0
in 0
the 0
canine 0
eye 0
. 0

Melioidosis 0
in 0
Sika 0
deer 0
( 0
Cervus 0
nippon 0
nippon 0
) 0
. 0

Many 0
human 0
malignant 0
cells 0
lack 0
methylthioadenosine B-gene
phosphorylase I-gene
( 0
MTAP B-gene
) 0
enzyme 0
activity 0
. 0

Nucleocapsid 0
structure 0
and 0
thermostability 0
of 0
the 0
virion 0
, 0
nucleocapsid 0
and 0
polymerase 0
complex 0
. 0

We 0
propose 0
2 0
separate 0
PAI B-gene
- I-gene
1 I-gene
inductory 0
pathways 0
for 0
PMA 0
and 0
IL B-gene
- I-gene
1alpha I-gene
in 0
HepG2 0
, 0
both 0
involving 0
protein B-gene
tyrosine I-gene
kinase I-gene
activation 0
; 0
the 0
serum 0
- 0
induced 0
signaling 0
pathway 0
may 0
( 0
partially 0
) 0
overlap 0
with 0
the 0
PMA 0
- 0
activated 0
protein B-gene
kinase I-gene
C/mitogen I-gene
C/mitogen I-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
kinase I-gene
pathway 0
, 0
leading 0
to 0
c B-gene
- I-gene
Jun I-gene
homodimer I-gene
binding 0
to 0
the 0
PAI B-gene
- I-gene
1 I-gene
TRE 0
. 0

Crude 0
drugs 0
from 0
aquatic 0
plants 0
. 0

Recurrence 0
of 0
the 0
hepatic 0
cyst 0
after 0
partial 0
excision 0
and 0
drainage 0
was 0
complicated 0
by 0
fistula 0
formation 0
between 0
the 0
cyst 0
and 0
the 0
duodenum 0
. 0

These 0
data 0
show 0
that 0
tyrosine 0
phosphorylation 0
by 0
FES B-gene
affects 0
the 0
interaction 0
of 0
BCR B-gene
with 0
multiple 0
signaling 0
partners 0
and 0
suggest 0
a 0
general 0
role 0
for 0
BCR B-gene
in 0
non 0
- 0
receptor 0
protein B-gene
- I-gene
tyrosine I-gene
kinase I-gene
regulation 0
and 0
signal 0
transduction 0
. 0

Reversal 0
of 0
'refractory 0
septic 0
shock 0
' 0
by 0
infusion 0
of 0
amrinone 0
and 0
angiotensin B-gene
II I-gene
in 0
an 0
anthracycline 0
- 0
treated 0
patient 0
. 0

Replication 0
regions 0
from 0
plant 0
- 0
pathogenic 0
Pseudomonas 0
syringae 0
plasmids 0
are 0
similar 0
to 0
ColE2 0
- 0
related 0
replicons 0
. 0

Comparison 0
of 0
dose 0
volume 0
histograms 0
revealed 0
that 0
the 0
6 0
- 0
field 0
plan 0
spared 0
relatively 0
more 0
heart 0
whereas 0
the 0
8 0
- 0
field 0
plan 0
spared 0
relatively 0
more 0
lung 0
. 0

STUDY 0
OBJECTIVE 0
: 0
to 0
characterize 0
gas 0
exchange 0
and 0
cardiopulmonary 0
performance 0
during 0
maximal 0
progressive 0
arm 0
crank 0
exercise 0
. 0

At 0
9 0
months 0
postpartum 0
, 0
serum 0
fT4 0
and 0
fT3 0
levels 0
were 0
low 0
normal 0
( 0
8.0 0
and 0
1.7 0
pmol/L 0
, 0
respectively 0
) 0
, 0
but 0
TSH B-gene
was 0
not 0
raised 0
( 0
0.4 0
mU/L 0
) 0
. 0

The 0
most 0
frequent 0
abnormality 0
was 0
GH B-gene
deficiency 0
( 0
six 0
cases 0
) 0
, 0
followed 0
by 0
gonadotropin B-gene
( 0
four 0
cases 0
) 0
, 0
cortisol 0
( 0
four 0
cases 0
) 0
, 0
and 0
TSH B-gene
( 0
one 0
case 0
) 0
, 0
whereas 0
four 0
patients 0
showed 0
high 0
serum B-gene
PRL I-gene
values 0
. 0

In 0
the 0
normal 0
controls 0
the 0
plasma B-gene
FPA I-gene
level 0
( 0
mean 0
+/ 0
- 0
SD 0
) 0
was 0
1.43 0
+/ 0
- 0
0.46 0
ng/ml 0
. 0

The 0
nramp2 B-gene
gene I-gene
is 0
comprised 0
of 0
17 0
exons 0
and 0
spans 0
more 0
than 0
36 0
kb 0
. 0

Studies 0
on 0
recurrences 0
in 0
gingival 0
hyperplasia 0

BACKGROUND 0
: 0
In 0
lung 0
protective 0
strategy 0
, 0
positive 0
end 0
- 0
expiratory 0
pressure 0
( 0
PEEP 0
) 0
slightly 0
higher 0
than 0
the 0
Pflex 0
( 0
the 0
airway 0
pressure 0
corresponding 0
to 0
the 0
lower 0
inflection 0
point 0
( 0
LIP 0
) 0
on 0
the 0
inspiratory 0
pressure 0
- 0
volume 0
( 0
P 0
- 0
V 0
) 0
curve 0
measured 0
with 0
ZEEP 0
) 0
is 0
generally 0
recommended 0
. 0

Effect 0
of 0
a 0
constant 0
magnetic 0
field 0
on 0
different 0
models 0
of 0
carcinogenesis 0

FACS 0
analysis 0
demonstrated 0
that 0
MCs 0
had 0
reached 0
middle 0
to 0
late 0
G1 0
phase 0
of 0
cell 0
cycle 0
progression 0
at 0
this 0
timepoint 0
. 0

Nuclear 0
export 0
of 0
proteins 0
in 0
plants 0
: 0
AtXPO1 B-gene
is 0
the 0
export 0
receptor 0
for 0
leucine 0
- 0
rich 0
nuclear 0
export 0
signals 0
in 0
Arabidopsis 0
thaliana 0
. 0

Strains 0
carrying 0
a 0
snf1 B-gene
mutation I-gene
are 0
unable 0
to 0
grow 0
on 0
sucrose 0
, 0
galactose 0
, 0
maltose 0
, 0
melibiose 0
, 0
or 0
nonfermentable 0
carbon 0
sources 0
; 0
utilization 0
of 0
these 0
carbon 0
sources 0
is 0
regulated 0
by 0
glucose 0
repression 0
. 0

Similarly 0
, 0
beta B-gene
adrenoceptors I-gene
blockade 0
has 0
been 0
shown 0
to 0
be 0
of 0
value 0
in 0
achieving 0
continence 0
in 0
a 0
small 0
group 0
of 0
patients 0
. 0

The 0
contractile 0
effects 0
of 0
oxytocin B-gene
, 0
prostaglandin 0
F2 0
alpha 0
and 0
their 0
combined 0
use 0
on 0
human 0
pregnant 0
myometrium 0
were 0
studied 0
in 0
vitro 0
. 0

Effectively 0
, 0
the 0
upstream 0
, 0
housekeeping 0
- 0
type 0
promoter 0
responds 0
to 0
FIXK B-gene
and 0
positively 0
regulates 0
the 0
downstream 0
, 0
sigma B-gene
54 I-gene
- I-gene
type I-gene
promoter I-gene
. 0

Km 0
values 0
of 0
the 0
uncoupled 0
enzymes 0
IIGlc B-gene
for 0
glucose 0
ranged 0
from 0
0.5 0
to 0
2.5 0
mM 0
, 0
2 0
orders 0
of 0
magnitude 0
higher 0
than 0
the 0
value 0
of 0
normal 0
IIGlc B-gene
. 0

Measurement 0
of 0
protein 0
in 0
natural 0
rubber 0
latex 0
. 0

Disruption 0
of 0
PML B-gene
subnuclear I-gene
domains I-gene
by 0
the 0
acidic B-gene
IE1 I-gene
protein I-gene
of 0
human 0
cytomegalovirus 0
is 0
mediated 0
through 0
interaction 0
with 0
PML B-gene
and 0
may 0
modulate 0
a 0
RING 0
finger 0
- 0
dependent 0
cryptic 0
transactivator 0
function 0
of 0
PML B-gene
. 0

The 0
fate 0
of 0
ochratoxin 0
A 0
during 0
malting 0
and 0
brewing 0
. 0

To 0
further 0
investigate 0
the 0
role 0
of 0
PKR B-gene
in 0
transcriptional 0
signaling 0
, 0
we 0
expressed 0
the 0
wild B-gene
type I-gene
human I-gene
PKR I-gene
and 0
a 0
catalytically 0
inactive 0
dominant 0
negative 0
PKR B-gene
mutant I-gene
in 0
the 0
murine 0
pre 0
- 0
B 0
lymphoma 0
70Z/3 0
cells 0
. 0

Consistent 0
with 0
other 0
experiments 0
with 0
these 0
compounds 0
, 0
cocaine 0
was 0
the 0
most 0
potent 0
of 0
the 0
group 0
. 0

Atrial 0
dissociation 0
. 0

It 0
is 0
envisaged 0
that 0
the 0
WHOQOL 0
- 0
BREF 0
will 0
be 0
most 0
useful 0
in 0
studies 0
that 0
require 0
a 0
brief 0
assessment 0
of 0
quality 0
of 0
life 0
, 0
for 0
example 0
, 0
in 0
large 0
epidemiological 0
studies 0
and 0
clinical 0
trials 0
where 0
quality 0
of 0
life 0
is 0
of 0
interest 0
. 0

Hepatitis B-gene
B I-gene
immune I-gene
globulins I-gene
and 0
HIV B-gene
antibodies I-gene
. 0

One 0
cytoplasmic 0
target 0
which 0
reflects 0
the 0
functional 0
state 0
of 0
the 0
plastids 0
is 0
protein B-gene
kinase I-gene
C I-gene
. 0

A 0
360 0
- 0
bp 0
DNA 0
fragment 0
located 0
over 0
500 0
bp 0
upstream 0
from 0
the 0
cfl B-gene
transcriptional 0
start 0
site 0
was 0
used 0
in 0
DNase B-gene
I I-gene
protection 0
assays 0
to 0
define 0
the 0
specific 0
bases 0
bound 0
by 0
CorR B-gene
. 0

A 0
relationship 0
between 0
the 0
immunological 0
changes 0
and 0
the 0
disease 0
stage 0
was 0
discovered 0
: 0
the 0
index 0
of 0
the 0
3H 0
- 0
thymidine 0
incorporation 0
was 0
found 0
to 0
be 0
67.9 0
at 0
the 0
stage 0
of 0
disease 0
exacerbation 0
, 0
and 0
208.8 0
at 0
the 0
stage 0
of 0
remission 0
; 0
the 0
complement 0
titre 0
reached 0
, 0
respectively 0
, 0
46.64 0
+/ 0
- 0
5.28 0
and 0
112.0 0
+/ 0
- 0
6.0 0
units 0
per 0
ml 0
. 0

In 0
the 0
spontaneous 0
abortion 0
group 0
, 0
the 0
levels 0
of 0
PAPP B-gene
- I-gene
A I-gene
were 0
significantly 0
lower 0
than 0
in 0
normal 0
pregnancy 0
but 0
higher 0
than 0
in 0
non 0
- 0
pregnant 0
controls 0
. 0

Maximum 0
likelihood 0
estimation 0
in 0
covariance 0
structure 0
analysis 0
with 0
truncated 0
data 0
. 0

The 0
gene 0
encoding 0
rat 0
peptidylglycine B-gene
alpha I-gene
- I-gene
amidating I-gene
monooxygenase I-gene
( 0
PAM B-gene
) 0
contains 0
26 0
protein 0
- 0
coding 0
exons 0
. 0

Whether 0
this 0
lack 0
of 0
preferential 0
repair 0
has 0
to 0
be 0
explained 0
by 0
a 0
defect 0
in 0
repair 0
or 0
in 0
general 0
transcription 0
is 0
unclear 0
at 0
present 0
. 0

Pretreatment 0
of 0
human 0
skin 0
with 0
tRA 0
inhibited 0
UV 0
induction 0
of 0
c B-gene
- I-gene
Jun I-gene
protein I-gene
and 0
, 0
consequently 0
, 0
AP B-gene
- I-gene
1 I-gene
. 0
c B-gene
- I-gene
Jun I-gene
protein I-gene
inhibition 0
occurred 0
via 0
a 0
posttranscriptional 0
mechanism 0
, 0
since 0
tRA 0
did 0
not 0
inhibit 0
UV 0
induction 0
of 0
c B-gene
- I-gene
Jun I-gene
mRNA I-gene
. 0

MUS81 B-gene
encodes 0
a 0
novel 0
helix B-gene
- I-gene
hairpin I-gene
- I-gene
helix I-gene
protein I-gene
involved 0
in 0
the 0
response 0
to 0
UV 0
- 0
and 0
methylation 0
- 0
induced 0
DNA 0
damage 0
in 0
Saccharomyces 0
cerevisiae 0
. 0

All 0
possessed 0
cutaneous 0
receptive 0
fields 0
on 0
the 0
distal 0
segments 0
of 0
digits 0
2 0
, 0
3 0
, 0
or 0
4 0
. 0

In 0
situ 0
hybridization 0
reveals 0
strong 0
signals 0
for 0
Zep B-gene
mRNA I-gene
in 0
the 0
cerebellum 0
and 0
olfactory 0
bulb 0
with 0
moderate 0
signals 0
detected 0
in 0
the 0
hippocampus 0
and 0
cortex 0
. 0

A 0
series 0
of 0
sequence 0
fragments 0
were 0
placed 0
5 0
' 0
to 0
the 0
chloramphenicol B-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
reporter 0
gene 0
and 0
ability 0
to 0
mediate 0
transcription 0
of 0
CAT B-gene
in 0
response 0
to 0
IFN B-gene
gamma I-gene
or 0
LPS 0
treatment 0
was 0
studied 0
following 0
transient 0
transfection 0
in 0
the 0
macrophage 0
- 0
like 0
cell 0
line 0
RAW 0
264.7 0
. 0

A 0
GT 0
- 0
rich 0
sequence 0
binding 0
the 0
transcription B-gene
factor I-gene
Sp1 I-gene
is 0
crucial 0
for 0
high 0
expression 0
of 0
the 0
human B-gene
type I-gene
VII I-gene
collagen I-gene
gene I-gene
( 0
COL7A1 B-gene
) 0
in 0
fibroblasts 0
and 0
keratinocytes 0
. 0

Using 0
in 0
vivo 0
genomic 0
dimethyl 0
sulfate 0
and 0
KMnO4 0
footprinting 0
, 0
we 0
showed 0
that 0
the 0
promoter 0
region 0
is 0
differentially 0
protected 0
, 0
depending 0
upon 0
which 0
holoenzyme 0
is 0
bound 0
. 0

We 0
conclude 0
that 0
these 0
cDNAs 0
belong 0
to 0
a 0
novel 0
GST B-gene
class 0
hereby 0
designated 0
Kappa 0
, 0
with 0
the 0
rat B-gene
GST I-gene
subunit I-gene
13 I-gene
gene I-gene
designated 0
rGSTK1 B-gene
and 0
the 0
human 0
gene 0
being 0
called 0
hGSTK1 B-gene
. 0

At 0
onset 0
of 0
first 0
post 0
- 0
weaning 0
estrus 0
, 0
sows 0
received 0
either 0
an 0
intravulval 0
injection 0
of 0
3.75 0
mg 0
of 0
prostaglandin 0
analogue 0
( 0
PGF 0
) 0
or 0
, 0
served 0
as 0
a 0
non 0
- 0
injected 0
control 0
( 0
CON 0
) 0
. 0

Tbx6 B-gene
maps 0
to 0
chromosome 0
7 0
and 0
does 0
not 0
appear 0
to 0
be 0
linked 0
to 0
any 0
known 0
mutation 0
. 0

Before 0
therapy 0
was 0
started 0
, 0
trabecular 0
bone 0
alterations 0
could 0
be 0
observed 0
which 0
were 0
typical 0
for 0
Paget 0
's 0
disease 0
of 0
bone 0
as 0
there 0
were 0
bulky 0
trabeculare 0
, 0
increased 0
remodelling 0
surfaces 0
and 0
giant 0
osteoclasts 0
. 0

At 0
11.5 0
years 0
of 0
follow 0
- 0
up 0
, 0
521 0
major 0
coronary 0
disease 0
events 0
had 0
occurred 0
, 0
261 0
fatal 0
and 0
260 0
non 0
- 0
fatal 0
. 0

However 0
, 0
additional 0
studies 0
on 0
cell 0
lines 0
and 0
whole 0
animals 0
are 0
required 0
to 0
understand 0
GnRH B-gene
signaling 0
in 0
the 0
context 0
of 0
other 0
hormones 0
during 0
the 0
reproductive 0
cycle 0
of 0
mouse 0
and 0
human 0
. 0

Total 0
meso 0
- 0
pore 0
volume 0
and 0
surface 0
area 0
ranged 0
from 0
0.004 0
- 0
0.08 0
cm3 0
g 0
( 0
- 0
1 0
) 0
and 0
from 0
0.33 0
- 0
6.9 0
m2 0
g 0
( 0
- 0
1 0
) 0
respectively 0
, 0
accounting 0
for 0
up 0
33 0
% 0
of 0
the 0
BET 0
surface 0
area 0
. 0

Contraindications 0
to 0
adenosine 0
and 0
drug 0
interactions 0
are 0
noted 0
in 0
this 0
article 0
. 0

The 0
extent 0
of 0
the 0
odontoblast 0
process 0
in 0
human 0
dentin 0
. 0

On 0
transfer 0
from 0
glucose 0
, 0
succinate 0
, 0
malate 0
, 0
or 0
glycerol 0
medium 0
to 0
citrate 0
medium 0
, 0
the 0
Cit+ 0
Escherichia 0
coli 0
strains 0
showed 0
a 0
delay 0
of 0
36 0
to 0
48 0
h 0
before 0
growth 0
. 0

The 0
index 0
patient 0
, 0
a 0
10 0
- 0
year 0
- 0
old 0
boy 0
, 0
presents 0
typical 0
symptoms 0
of 0
OPD 0
type 0
I 0
together 0
with 0
bowing 0
of 0
the 0
long 0
bones 0
and 0
abnormalities 0
of 0
the 0
thorax 0
and 0
spinal 0
column 0
. 0

After 0
enzymatic 0
hydrolysis 0
of 0
the 0
water 0
soluble 0
fraction 0
, 0
it 0
is 0
shown 0
that 0
28 0
% 0
is 0
again 0
extractable 0
by 0
DCM 0
of 0
which 0
57 0
% 0
consists 0
of 0
unchanged 0
SC4453 0
which 0
is 0
therefore 0
the 0
main 0
partner 0
of 0
conjugated 0
products 0
. 0

Additionally 0
, 0
the 0
members 0
of 0
this 0
family 0
display 0
strong 0
sequence 0
homologies 0
between 0
their 0
larger 0
C 0
- 0
terminal 0
effector 0
binding/oligomerization 0
domains 0
. 0

Microalbuminuria 0
: 0
a 0
marker 0
of 0
systemic 0
disease 0
. 0

Long 0
- 0
term 0
ambulatory 0
measurement 0
of 0
transcutaneous 0
arterial 0
CO2 0
pressure 0
( 0
PCO2 0
) 0
offers 0
an 0
opportunity 0
to 0
test 0
directly 0
the 0
co 0
- 0
occurrence 0
of 0
panic 0
and 0
hyperventilation 0
under 0
natural 0
conditions 0
. 0

An 0
association 0
was 0
found 0
between 0
zafirlukast 0
plasma 0
concentrations 0
and 0
increases 0
in 0
PC8SRaw 0
10 0
h 0
after 0
treatment 0
( 0
p 0
= 0
0.001 0
) 0
. 0

Most 0
interestingly 0
, 0
although 0
the 0
effector 0
plasmid 0
containing 0
the 0
ICP27 B-gene
gene I-gene
had 0
little 0
effect 0
on 0
its 0
own 0
, 0
two 0
different 0
and 0
marked 0
effects 0
depending 0
on 0
the 0
target 0
were 0
observed 0
when 0
ICP27 B-gene
was 0
combined 0
with 0
ICP4 B-gene
or 0
ICP0 B-gene
or 0
both 0
. 0

Water 0
pair 0
and 0
three 0
- 0
body 0
potential 0
of 0
spectroscopic 0
quality 0
from 0
Ab 0
initio 0
calculations 0

Because 0
the 0
wa B-gene
- I-gene
2 I-gene
mutation I-gene
was 0
mapped 0
previously 0
to 0
the 0
vicinity 0
of 0
the 0
EGF/TGF B-gene
- I-gene
alpha I-gene
receptor I-gene
( 0
EGFR B-gene
) 0
gene 0
on 0
mouse 0
chromosome 0
11 0
, 0
we 0
hypothesized 0
that 0
the 0
wa B-gene
- I-gene
2 I-gene
phenotype I-gene
might 0
result 0
from 0
a 0
defect 0
in 0
either 0
the 0
expression 0
or 0
activity 0
of 0
EGFR B-gene
, 0
or 0
both 0
. 0

4 0
) 0
Mutation 0
of 0
the 0
three 0
extracellular 0
cysteine 0
residues 0
of 0
GFKAR B-gene
beta I-gene
indicated 0
that 0
the 0
two 0
conserved 0
cysteine 0
residues 0
( 0
C305 0
and 0
C385 0
) 0
, 0
located 0
between 0
two 0
transmembrane 0
segments 0
, 0
form 0
a 0
solvent 0
- 0
accessible 0
disulfide 0
bond 0
. 0

R 0
of 0
the 0
chest 0
wall 0
was 0
maximum 0
( 0
35.6 0
cmH2O.L 0
- 0
1.sec 0
- 0
1 0
+/ 0
- 0
2.2 0
SE 0
) 0
at 0
0.2 0
Hz 0
- 0
10 0
ml 0
and 0
decreased 0
with 0
increasing 0
f 0
and 0
VT 0
, 0
although 0
the 0
VT 0
effect 0
diminished 0
at 0
the 0
higher 0
f 0
. 0

Time 0
dependence 0
of 0
frequency 0
potentiation 0
in 0
the 0
isolated 0
guinea 0
- 0
pig 0
's 0
atrium 0
. 0

Comparison 0
of 0
the 0
predicted 0
amino 0
acid 0
sequence 0
with 0
that 0
of 0
the 0
Drosophila B-gene
virilis I-gene
gene I-gene
shows 0
that 0
several 0
blocks 0
of 0
amino 0
acid 0
sequence 0
have 0
been 0
very 0
highly 0
conserved 0
. 0

The 0
N 0
- 0
terminal 0
exon1 0
had 0
no 0
homology 0
at 0
the 0
amino 0
acid 0
level 0
with 0
NGFI B-gene
- I-gene
B I-gene
, 0
the 0
mammalian 0
homologue 0
. 0

Although 0
RAD17 B-gene
, 0
RAD24 B-gene
and 0
MEC3 B-gene
are 0
not 0
required 0
for 0
cell 0
cycle 0
arrest 0
when 0
S 0
phase 0
is 0
inhibited 0
by 0
hydroxyurea 0
( 0
HU 0
) 0
, 0
they 0
do 0
contribute 0
to 0
the 0
viability 0
of 0
yeast 0
cells 0
grown 0
in 0
the 0
presence 0
of 0
HU 0
, 0
possibly 0
because 0
they 0
are 0
required 0
for 0
the 0
repair 0
of 0
HU 0
- 0
induced 0
DNA 0
damage 0
. 0

Single 0
oblique 0
- 0
view 0
mammography 0
for 0
periodic 0
screening 0
for 0
breast 0
cancer 0
in 0
women 0
. 0

Conventional 0
toxicological 0
considerations 0
suggest 0
that 0
the 0
adverse 0
health 0
effects 0
of 0
any 0
necessary 0
increase 0
in 0
coal 0
combustion 0
effluents 0
would 0
be 0
greatest 0
per 0
unit 0
of 0
coal 0
in 0
those 0
areas 0
which 0
are 0
most 0
heavily 0
populated 0
and 0
have 0
the 0
highest 0
preexisting 0
levels 0
of 0
the 0
gas 0
- 0
aerosol 0
complex 0
. 0

The 0
arterial 0
blood 0
pressure 0
was 0
measured 0
by 0
using 0
bloody 0
method 0
in 0
anesthizied 0
animals 0
. 0

Nicotinic B-gene
receptor I-gene
antagonists 0
mecamylamine 0
( 0
0.5 0
and 0
1 0
mg/kg 0
) 0
and 0
hexamethonium 0
( 0
5 0
and 0
10 0
mg/kg 0
) 0
reduced 0
the 0
response 0
induced 0
by 0
nicotine 0
( 0
0.25 0
mg/kg 0
) 0
. 0

The 0
present 0
work 0
represents 0
an 0
attempt 0
to 0
develop 0
a 0
method 0
for 0
measuring 0
relative 0
blood 0
flow 0
in 0
intestinal 0
capillaries 0
, 0
by 0
the 0
use 0
of 0
sodium 0
fluorescein 0
( 0
Na 0
- 0
F 0
) 0
as 0
an 0
indicator 0
substance 0
. 0

The 0
matrix 0
of 0
the 0
CBs 0
contains 0
the 0
diagnostic 0
protein 0
p80 B-gene
- 0
coilin B-gene
, 0
which 0
is 0
colocalized 0
with 0
the 0
U7 B-gene
small I-gene
nuclear I-gene
ribonucleoprotein I-gene
( 0
snRNP 0
) 0
, 0
whereas 0
the 0
attached 0
and 0
embedded 0
B 0
- 0
snurposomes 0
contain 0
splicing 0
snRNPs 0
. 0

Tritium 0
concentrations 0
in 0
environmental 0
water 0
samples 0
were 0
found 0
to 0
be 0
determined 0
within 0
an 0
accuracy 0
of 0
10 0
% 0
by 0
this 0
method 0
when 0
Vi/Vf 0
was 0
14 0
- 0
25 0
. 0

The 0
results 0
of 0
this 0
study 0
suggest 0
that 0
in 0
patients 0
with 0
syndrome 0
X 0
, 0
myocardial 0
ischemia 0
frequently 0
develops 0
during 0
daily 0
life 0
; 0
silent 0
ischemia 0
is 0
an 0
important 0
component 0
of 0
this 0
syndrome 0
; 0
and 0
increased 0
oxygen 0
demand 0
in 0
the 0
presence 0
of 0
impaired 0
coronary 0
vasodilatory 0
capacity 0
is 0
not 0
the 0
only 0
cause 0
of 0
myocardial 0
ischemia 0
. 0

Two 0
patients 0
with 0
Ewing 0
's 0
sarcoma 0
relapsed 0
( 0
1 0
patient 0
with 0
both 0
local 0
and 0
distant 0
failure 0
) 0
at 0
26 0
and 0
58 0
months 0
and 0
were 0
again 0
rendered 0
disease 0
- 0
free 0
with 0
surgery 0
, 0
total 0
body 0
irradiation 0
and 0
further 0
chemotherapy 0
. 0

In 0
this 0
study 0
, 0
the 0
subcellular 0
location 0
, 0
domain 0
structure 0
, 0
and 0
biochemical 0
function 0
of 0
metaxin B-gene
were 0
investigated 0
. 0

Long 0
- 0
term 0
renal 0
function 0
in 0
on 0
- 0
heart 0
- 0
beating 0
donor 0
kidney 0
transplantation 0
: 0
a 0
single 0
- 0
center 0
experience 0
. 0

When 0
single 0
- 0
point 0
mutation 0
was 0
introduced 0
to 0
each 0
GC 0
box 0
, 0
EBS B-gene
, 0
and 0
GT 0
box 0
in 0
PFP9a20 B-gene
, 0
at 0
least 0
3 0
- 0
fold 0
less 0
CAT B-gene
activity 0
was 0
observed 0
in 0
CTLL 0
- 0
R8 0
cells 0
. 0

Thirty 0
- 0
three 0
percent 0
had 0
elevated 0
titers 0
( 0
above 0
1:20 0
dilution 0
) 0
. 0

There 0
is 0
, 0
however 0
, 0
uncertainty 0
as 0
to 0
how 0
results 0
obtained 0
in 0
recent 0
experiments 0
scale 0
up 0
to 0
landscape 0
and 0
regional 0
levels 0
and 0
generalize 0
across 0
ecosystem 0
types 0
and 0
processes 0
. 0

Chest 0
X 0
- 0
P 0
revealed 0
an 0
abnormal 0
shadow 0
in 0
the 0
left 0
upper 0
lobe 0
. 0

Despite 0
these 0
high 0
initial 0
rates 0
of 0
transcription 0
, 0
of 0
all 0
the 0
promoter 0
constructs 0
only 0
LAT B-gene
- 0
LTR 0
was 0
able 0
to 0
remain 0
transcriptionally 0
active 0
after 0
the 0
establishment 0
of 0
a 0
latent 0
state 0
. 0

Unestablished 0
quail 0
myoblasts 0
were 0
infected 0
with 0
a 0
retroviral 0
vector 0
encoding 0
the 0
oncogenic 0
form 0
of 0
H B-gene
- I-gene
Ras I-gene
in 0
order 0
to 0
investigate 0
the 0
mechanism 0
by 0
which 0
this 0
oncoprotein 0
interferes 0
with 0
terminal 0
differentiation 0
. 0

Exhaled 0
NO 0
was 0
assessed 0
by 0
controlled 0
- 0
flow 0
chemoluminescence 0
after 0
adjusting 0
for 0
trapped 0
air 0
and 0
after 0
generating 0
pressure 0
in 0
the 0
oral 0
cavity 0
that 0
was 0
sufficient 0
to 0
close 0
the 0
soft 0
palate 0
( 0
Eco 0
Physics 0
CLD 0
77 0
AM 0
analyzer 0
) 0
. 0

SATB1 B-gene
interacted 0
with 0
CDP B-gene
through 0
its 0
DNA 0
- 0
binding 0
domain 0
, 0
as 0
demonstrated 0
by 0
glutathione B-gene
S I-gene
- I-gene
transferase I-gene
( 0
GST B-gene
) 0
pull 0
- 0
down 0
assays 0
. 0

Both 0
the 0
inactive 0
domain B-gene
II I-gene
P68 I-gene
mutant I-gene
and 0
the 0
deletion 0
mutant 0
lacking 0
aa 0
91 0
- 0
243 0
were 0
less 0
inhibitory 0
to 0
growth 0
in 0
yeast 0
due 0
to 0
the 0
reduced 0
ability 0
to 0
phosphorylate 0
initiation B-gene
factor I-gene
2 I-gene
alpha I-gene
in 0
vivo 0
. 0

Applying 0
the 0
experience 0
mentioned 0
above 0
, 0
4 0
- 0
META 0
was 0
used 0
to 0
bond 0
a 0
proprietary 0
photocuring 0
microfilled 0
composite 0
material 0
to 0
Class 0
V 0
cavities 0
in 0
freshly 0
extracted 0
human 0
teeth 0
. 0

As 0
the 0
mechanism 0
of 0
the 0
intractability 0
, 0
cell 0
function 0
involved 0
in 0
the 0
defense 0
against 0
infection 0
was 0
evaluated 0
. 0

IV 0
. 0

A 0
Premenstrual 0
Syndrome 0
, 0
the 0
late 0
luteal 0
phase 0
disorder 0
of 0
DSM 0
- 0
IIIR 0
criteria 0
, 0
was 0
identified 0
in 0
6 0
% 0
of 0
the 0
women 0
. 0

After 0
5 0
- 0
h 0
thermal 0
induction 0
of 0
cells 0
carrying 0
the 0
runaway 0
recombinant 0
pBS1 0
, 0
protein B-gene
B2 I-gene
constituted 0
40 0
% 0
of 0
the 0
soluble 0
protein 0
fraction 0
of 0
the 0
cells 0
. 0

These 0
results 0
indicate 0
that 0
patients 0
with 0
SS 0
and 0
evidence 0
of 0
exercise 0
- 0
induced 0
ST 0
- 0
segment 0
depression 0
may 0
have 0
decreased 0
myocardial 0
oxygen 0
supply 0
due 0
to 0
low 0
hemoglobin B-gene
levels 0
and 0
increased 0
myocardial 0
oxygen 0
demand 0
( 0
elevated 0
double 0
products 0
) 0
when 0
compared 0
to 0
subjects 0
with 0
SS 0
who 0
do 0
not 0
have 0
exercise 0
- 0
induced 0
ST 0
- 0
segment 0
depression 0
. 0

The 0
highest 0
concentration 0
of 0
respirable 0
mineral 0
fibres 0
was 0
found 0
during 0
the 0
overhaul 0
of 0
a 0
truck 0
with 0
asbestos 0
insulation 0
; 0
respirable 0
fibre 0
concentration 0
reached 0
the 0
value 0
of 0
5 0
f/cm3 0
, 0
and 0
total 0
dust 0
concentration 0
- 0
the 0
value 0
of 0
about 0
80 0
mg/m3 0
. 0

Changes 0
in 0
the 0
size 0
and 0
organisation 0
of 0
the 0
brain 0
in 0
man 0
and 0
his 0
ancestors 0
. 0

Mechanisms 0
of 0
action 0
of 0
local 0
anaesthetics 0
. 0

Gastric 0
secretory 0
inhibition 0
induced 0
by 0
three 0
methyl 0
analogs 0
of 0
prostaglandin 0
E2 0
administered 0
intragastrically 0
to 0
man 0
. 0

By 0
contrast 0
, 0
footprint 0
II 0
at 0
position 0
- 0
125 0
is 0
common 0
to 0
both 0
HeLa 0
and 0
GH3 0
cell 0
extracts 0
and 0
overlies 0
a 0
15 0
- 0
base 0
- 0
pair 0
sequence 0
found 0
in 0
all 0
members 0
of 0
the 0
growth B-gene
hormone I-gene
gene I-gene
family I-gene
. 0

DNA 0
sequence 0
of 0
the 0
UL6 B-gene
to 0
UL20 B-gene
genes I-gene
of 0
infectious 0
laryngotracheitis 0
virus 0
and 0
characterization 0
of 0
the 0
UL10 B-gene
gene I-gene
product I-gene
as 0
a 0
nonglycosylated 0
and 0
nonessential 0
virion 0
protein 0
. 0

Unlike 0
LANA1 B-gene
, 0
LANA2 B-gene
does 0
not 0
elicit 0
a 0
serologic 0
response 0
from 0
patients 0
with 0
KS 0
, 0
PEL 0
, 0
or 0
CD 0
as 0
measured 0
by 0
Western 0
blot 0
hybridization 0
. 0

CD4 B-gene
degradation 0
mediated 0
by 0
Vpu B-gene
does 0
not 0
require 0
the 0
ER 0
chaperone 0
calnexin B-gene
and 0
is 0
dependent 0
on 0
an 0
intact 0
ubiquitin B-gene
- 0
conjugating 0
system 0
. 0

A 0
deletion 0
analysis 0
of 0
the 0
FAS1 B-gene
promoter I-gene
lacking 0
the 0
previously 0
characterized 0
inositol/choline 0
- 0
responsive 0
- 0
element 0
motif 0
defined 0
a 0
region 0
( 0
nucleotides 0
- 0
760 0
to 0
- 0
850 0
) 0
responsible 0
for 0
most 0
of 0
the 0
remaining 0
activation 0
potency 0
. 0

Promoter 0
constructs 0
containing 0
mutations 0
in 0
the 0
PTRE B-gene
sequence I-gene
that 0
selectively 0
abolished 0
the 0
binding 0
of 0
either 0
one 0
or 0
both 0
complexes 0
exerted 0
opposite 0
effects 0
on 0
the 0
transcriptional 0
activity 0
of 0
trypsin B-gene
promoters I-gene
in 0
A. 0
gambiae 0
and 0
Aedes 0
aegypti 0
cell 0
lines 0
. 0

This 0
preliminary 0
study 0
reports 0
an 0
initial 0
evaluation 0
of 0
HMPAO 0
- 0
SPECT 0
imaging 0
for 0
assessing 0
regional 0
alterations 0
in 0
brain 0
function 0
during 0
opiate 0
dependence 0
and 0
withdrawal 0
. 0

The 0
revaluation 0
at 0
the 0
end 0
of 0
the 0
study 0
showed 0
a 0
good 0
compliance 0
for 0
the 0
proposed 0
diet 0
scheme 0
by 0
children 0
, 0
but 0
a 0
poor 0
compliance 0
by 0
their 0
families 0
. 0

Cytostatic 0
activity 0
of 0
some 0
essential 0
oils 0
against 0
HEp 0
- 0
2 0
cells 0
. 0

Custom 0
- 0
made 0
orthoses 0
play 0
an 0
invaluable 0
role 0
in 0
achieving 0
a 0
wide 0
range 0
of 0
therapeutic 0
goals 0
: 0
improving 0
function 0
and 0
pinch 0
, 0
stabilizing 0
individual 0
joints 0
, 0
preventing 0
positional 0
contractures 0
, 0
protecting 0
joints 0
from 0
trauma 0
, 0
stretching 0
the 0
intrinsic 0
muscles 0
, 0
correcting 0
joint 0
- 0
and 0
soft 0
- 0
tissue 0
contractures 0
, 0
and 0
controlling 0
inflammation 0
. 0

Excess 0
recombinant B-gene
PTB I-gene
squelches 0
the 0
splicing 0
switch 0
and 0
reestablishes 0
exon 0
skipping 0
as 0
the 0
predominant 0
splicing 0
pathway 0
. 0

Among 0
women 0
, 0
plasma B-gene
factor I-gene
VII I-gene
: 0
Ag 0
was 0
inversely 0
associated 0
with 0
income 0
. 0

We 0
concluded 0
that 0
these 0
results 0
support 0
the 0
feasibility 0
and 0
usefulness 0
of 0
N 0
- 0
of 0
- 0
1 0
RCT 0
in 0
rheumatology 0
practice 0
. 0

K562 0
erythroleukemia 0
cells 0
stably 0
transfected 0
with 0
constructs 0
containing 0
the 0
human B-gene
Agamma I-gene
- I-gene
globin I-gene
promoter I-gene
linked 0
to 0
an 0
enhanced B-gene
green I-gene
fluorescent I-gene
protein I-gene
( 0
EGFP B-gene
) 0
reporter 0
, 0
with 0
or 0
without 0
HS2 0
, 0
were 0
analyzed 0
for 0
EGFP B-gene
expression 0
by 0
flow 0
cytometry 0
. 0

Recently 0
, 0
we 0
demonstrated 0
that 0
platelet B-gene
- I-gene
derived I-gene
growth I-gene
factor I-gene
( I-gene
PDGF I-gene
) I-gene
- I-gene
beta I-gene
receptor I-gene
stimulation 0
, 0
but 0
not 0
various 0
other 0
growth 0
factors 0
, 0
inhibits 0
transcription 0
of 0
alpha1D B-gene
- 0
, 0
but 0
not 0
alpha1A B-gene
- 0
or 0
alpha1B B-gene
- I-gene
ARs I-gene
, 0
resulting 0
in 0
reduced 0
norepinephrine 0
- 0
mediated 0
SMC 0
growth 0
. 0

( 0
A 0
short 0
account 0
of 0
Karl 0
Touton 0
's 0
life 0
is 0
also 0
included 0
. 0
) 0
After 0
reviewing 0
the 0
historical 0
development 0
of 0
the 0
concept 0
of 0
giant 0
cells 0
and 0
current 0
interpretations 0
of 0
their 0
nature 0
, 0
the 0
unitarian 0
view 0
of 0
polykaryons 0
now 0
favored 0
by 0
workers 0
in 0
the 0
field 0
is 0
extended 0
to 0
include 0
also 0
the 0
`` 0
xanthelasmatic 0
giant 0
cell 0
'' 0
of 0
Touton 0
, 0
whose 0
characteristic 0
appearance 0
is 0
determined 0
merely 0
by 0
the 0
presence 0
of 0
demonstrable 0
lipid 0
in 0
the 0
cytoplasm 0
. 0

It 0
has 0
also 0
been 0
previously 0
demonstrated 0
that 0
LPS 0
treatment 0
of 0
splenic 0
B 0
cells 0
from 0
athymic 0
mice 0
results 0
in 0
a 0
decrease 0
in 0
steady 0
state 0
mRNA 0
encoding 0
the 0
A B-gene
alpha I-gene
class I-gene
II I-gene
protein I-gene
. 0

After 0
birth 0
, 0
there 0
was 0
a 0
significantly 0
higher 0
increase 0
of 0
IgA B-gene
and 0
IgM B-gene
anti I-gene
- I-gene
M. I-gene
leprae I-gene
antibody I-gene
activity 0
in 0
sera 0
taken 0
3 0
- 0
6 0
months 0
after 0
birth 0
from 0
babies 0
of 0
Group 0
1 0
compared 0
to 0
Group 0
2 0
, 0
but 0
the 0
IgA B-gene
and 0
IgM B-gene
activity 0
in 0
sera 0
taken 0
after 0
6 0
months 0
of 0
age 0
showed 0
the 0
same 0
increase 0
in 0
the 0
two 0
groups 0
. 0

Serum 0
estriol 0
levels 0
during 0
beta B-gene
- I-gene
receptor I-gene
agonist 0
infusion 0
in 0
the 0
third 0
trimester 0
of 0
pregnancy 0
. 0

These 0
tiny 0
premature 0
infants 0
also 0
received 0
PN 0
for 0
significantly 0
longer 0
periods 0
of 0
time 0
, 0
and 0
the 0
longer 0
the 0
infusions 0
were 0
administered 0
the 0
greater 0
was 0
the 0
risk 0
of 0
cholestasis 0
developing 0
. 0

We 0
show 0
that 0
sae1 B-gene
- I-gene
1 I-gene
and 0
sae3 B-gene
- I-gene
1 I-gene
mutations I-gene
each 0
confer 0
a 0
distinct 0
defect 0
in 0
meiotic 0
recombination 0
. 0
sae1 B-gene
- I-gene
1 I-gene
produces 0
recombinants 0
but 0
very 0
slowly 0
and 0
ultimately 0
to 0
less 0
than 0
half 0
the 0
wild 0
- 0
type 0
level 0
; 0
sae3 B-gene
- I-gene
1 I-gene
makes 0
persistent 0
hyper 0
- 0
resected 0
meiotic 0
double 0
- 0
strand 0
breaks 0
and 0
has 0
a 0
severe 0
defect 0
in 0
formation 0
of 0
recombinants 0
. 0

Patients 0
in 0
the 0
mucinous 0
cyst 0
group 0
had 0
significantly 0
lower 0
CA B-gene
125 I-gene
cystic 0
fluid 0
levels 0
compared 0
with 0
women 0
with 0
endometriomas 0
and 0
dermoids 0
( 0
P 0
& 0
lt 0
; 0
0.05 0
) 0
. 0

The 0
brains 0
were 0
processed 0
according 0
to 0
the 0
tetramethylbenzidine 0
( 0
TMB 0
) 0
protocol 0
of 0
Mesulam 0
( 0
'78 0
) 0
and 0
studied 0
with 0
darkfield 0
microscopy 0
. 0

Analysis 0
of 0
WT1 B-gene
target I-gene
gene I-gene
expression 0
in 0
stably 0
transfected 0
cell 0
lines 0
. 0

Some 0
may 0
affect 0
the 0
folding 0
pathway 0
or 0
the 0
affinity 0
for 0
chaperonins B-gene
. 0

Amniotic 0
fluid 0
ionic 0
concentration 0
in 0
response 0
to 0
chronic 0
fetal B-gene
vasopressin I-gene
infusion 0
. 0

The 0
use 0
of 0
bentonite 0
in 0
the 0
compounding 0
of 0
hydrogels 0

VBP B-gene
and 0
a1/EBP B-gene
could 0
mediate 0
the 0
high 0
rates 0
of 0
ALV 0
and 0
RSV B-gene
LTR I-gene
- 0
enhanced 0
transcription 0
in 0
bursal 0
lymphoma 0
cells 0
and 0
many 0
other 0
cell 0
types 0
. 0

Insulin B-gene
therapy 0
has 0
been 0
expanded 0
by 0
development 0
of 0
human B-gene
insulin I-gene
and 0
new 0
modes 0
of 0
injection 0
, 0
including 0
insulin B-gene
pumps 0
. 0

Also 0
, 0
anti B-gene
- I-gene
HIV I-gene
gp120 I-gene
and 0
anti B-gene
- I-gene
CD4 I-gene
crosslinking 0
induced 0
a 0
10 0
- 0
15 0
- 0
fold 0
increase 0
in 0
levels 0
of 0
both 0
PI B-gene
3 I-gene
- I-gene
and I-gene
PI I-gene
4 I-gene
- I-gene
kinase I-gene
activity 0
in 0
anti B-gene
- I-gene
CD4 I-gene
precipitates 0
. 0

The 0
genomic 0
organization 0
in 0
this 0
region 0
is 0
similar 0
to 0
the 0
neural 0
- 0
restricted 0
family 0
members 0
, 0
Hel B-gene
- I-gene
N1 I-gene
( 0
ELAVL2 B-gene
) 0
and 0
mHuD B-gene
( 0
Elavl4 B-gene
) 0
. 0

Chronic 0
active 0
hepatitis 0
and 0
pregnancy 0
. 0

42nd 0
annual 0
meeting 0
of 0
the 0
American 0
Academy 0
of 0
Oral 0
Pathology 0
. 0

CONCLUSION 0
: 0
The 0
biodistribution 0
of 0
111In 0
IgG B-gene
is 0
similar 0
to 0
that 0
of 0
99mTc 0
- 0
HMPAO 0
- 0
labeled 0
leukocytes 0
. 0

In 0
vitro 0
DNA 0
binding 0
assays 0
indicate 0
that 0
the 0
elements 0
identified 0
can 0
specifically 0
interact 0
with 0
c B-gene
- I-gene
Ets I-gene
- I-gene
1 I-gene
protein I-gene
. 0

The 0
BCL B-gene
- I-gene
6 I-gene
POZ 0
domain 0
and 0
other 0
POZ 0
domains 0
interact 0
with 0
the 0
co 0
- 0
repressors 0
N B-gene
- I-gene
CoR I-gene
and 0
SMRT B-gene
. 0

Since 0
it 0
is 0
often 0
necessary 0
to 0
resort 0
to 0
thoracotomy 0
as 0
a 0
final 0
step 0
in 0
making 0
such 0
a 0
diagnosis 0
, 0
we 0
have 0
sought 0
a 0
procedure 0
that 0
is 0
simpler 0
while 0
capable 0
of 0
providing 0
the 0
same 0
information 0
. 0

On 0
the 0
optic 0
tentacle 0
- 0
gonadal 0
axis 0
in 0
the 0
control 0
of 0
the 0
male 0
- 0
phase 0
ovotestis 0
in 0
the 0
slug 0
( 0
Ariolimax 0
californicus 0
) 0
. 0

The 0
protein B-gene
kinase I-gene
C I-gene
inhibitor 0
GF 0
- 0
109203X 0
abolished 0
the 0
activation 0
by 0
phorbol 0
ester 0
and 0
inhibited 0
the 0
effect 0
of 0
CCK B-gene
by 0
78 0
% 0
but 0
had 0
no 0
effect 0
on 0
EGF B-gene
- 0
activated 0
MAPK B-gene
activity 0
. 0

Four 0
multicannulated 0
Holstein 0
steers 0
( 0
initial 0
BW 0
424 0
+/ 0
- 0
16 0
kg 0
) 0
were 0
used 0
in 0
a 0
4 0
x 0
4 0
Latin 0
square 0
to 0
determine 0
the 0
influence 0
of 0
protein 0
supplementation 0
on 0
forage 0
intake 0
, 0
site 0
and 0
extent 0
of 0
digestion 0
, 0
and 0
nutrient 0
flow 0
in 0
steers 0
consuming 0
dormant 0
bluestem 0
- 0
range 0
forage 0
( 0
2.3 0
% 0
CP 0
) 0
. 0

These 0
morphological 0
changes 0
are 0
associated 0
with 0
a 0
marked 0
induction 0
of 0
P450arom B-gene
gene I-gene
expression 0
. 0

This 0
residue 0
, 0
although 0
located 0
55 0
rather 0
than 0
35 0
residues 0
NH2 0
- 0
terminal 0
of 0
the 0
essential 0
glutamate 0
, 0
is 0
undoubtedly 0
the 0
analog 0
of 0
the 0
second 0
aspartate 0
of 0
the 0
Asp 0
- 0
Asp 0
- 0
35 0
- 0
Glu 0
motif 0
found 0
in 0
other 0
family 0
members 0
. 0

DNase B-gene
I I-gene
protection 0
analysis 0
as 0
well 0
as 0
oligonucleotide 0
competition 0
experiments 0
indicate 0
that 0
this 0
binding 0
is 0
sequence 0
specific 0
. 0

METHOD 0
: 0
After 0
eligibility 0
, 0
patients 0
were 0
randomly 0
allocated 0
in 0
one 0
of 0
the 0
following 0
groups 0
: 0
M 0
= 0
methylprednisolone 0
30 0
mg.kg 0
- 0
1 0
over 0
1 0
hour 0
, 0
followed 0
by 0
5.4 0
mg.kg 0
- 0
1.h 0
- 0
1 0
for 0
23 0
hours 0
, 0
N 0
= 0
nimodipine 0
0.015 0
mg.kg 0
- 0
1.h 0
- 0
1 0
over 0
2 0
hours 0
followed 0
by 0
0.03 0
mg.kg 0
- 0
1.h 0
- 0
1 0
for 0
7 0
days 0
, 0
MN 0
or 0
P 0
. 0

We 0
have 0
shown 0
previously 0
that 0
EGF B-gene
receptor I-gene
activation 0
stimulates 0
gastrin B-gene
gene 0
expression 0
through 0
a 0
GC 0
- 0
rich 0
element 0
called 0
gERE 0
. 0

To 0
determine 0
cis 0
- 0
acting 0
elements 0
controlling 0
the 0
rat 0
B B-gene
- I-gene
50/GAP I-gene
50/GAP I-gene
- I-gene
43 I-gene
gene 0
expression 0
, 0
the 0
genomic 0
DNA 0
encoding 0
exon 0
1 0
and 0
the 0
5 0
' 0
flanking 0
sequence 0
was 0
isolated 0
. 0

The 0
traW B-gene
gene I-gene
of I-gene
the I-gene
Escherichia I-gene
coli I-gene
K I-gene
- I-gene
12 I-gene
sex I-gene
factor I-gene
, 0
F 0
, 0
encodes 0
one 0
of 0
the 0
numerous 0
proteins 0
required 0
for 0
conjugative 0
transfer 0
of 0
this 0
plasmid 0
. 0

Profilins B-gene
IIa I-gene
and I-gene
IIb I-gene
are 0
also 0
present 0
in 0
humans 0
, 0
suggesting 0
that 0
all 0
mammals 0
have 0
three 0
profilin B-gene
isoforms I-gene
. 0

Results 0
on 0
the 0
use 0
of 0
amiodarone 0
in 0
the 0
prevention 0
of 0
paroxysmal 0
AF 0
have 0
been 0
equivocal 0
; 0
this 0
may 0
be 0
attributed 0
to 0
differences 0
in 0
defining 0
paroxysmal 0
AF 0
. 0

Nuclear 0
localization 0
of 0
this 0
SNF2 B-gene
- I-gene
like I-gene
putative 0
helicase B-gene
is 0
dependent 0
on 0
a 0
nuclear 0
localization 0
sequence 0
located 0
in 0
the 0
NH2 0
- 0
terminal 0
region 0
. 0

Expression 0
of 0
these 0
chemokines 0
is 0
similar 0
in 0
that 0
both 0
require 0
the 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
element I-gene
and 0
additional 0
regions 0
such 0
as 0
the 0
CAAT/enhancer B-gene
binding I-gene
protein I-gene
( 0
C/EBP B-gene
) 0
element 0
of 0
the 0
IL B-gene
- I-gene
8 I-gene
promoter I-gene
. 0

Any 0
opacity 0
on 0
a 0
chest 0
radiograph 0
has 0
a 0
wide 0
differential 0
diagnosis 0
. 0

Levels 0
of 0
p53 B-gene
were 0
substantially 0
increased 0
by 0
E1A B-gene
expression 0
during 0
adenovirus 0
infection 0
. 0

This 0
pathway 0
has 0
been 0
reported 0
to 0
mediate 0
heterodimer 0
interactions 0
with 0
the 0
proapoptotic 0
regulator 0
, 0
Bad B-gene
. 0

The 0
toxicity 0
of 0
copper 0
to 0
the 0
collembolan 0
Folsomia 0
fimetaria 0
L. 0
was 0
studied 0
in 0
soil 0
incubated 0
with 0
copper 0
sulfate 0
for 0
different 0
periods 0
before 0
the 0
introduction 0
of 0
collembolans 0
, 0
to 0
assess 0
the 0
effect 0
of 0
aging 0
of 0
contamination 0
on 0
the 0
toxicity 0
of 0
copper 0
. 0

Earlier 0
published 0
data 0
, 0
indicating 0
Sp1 B-gene
binding 0
to 0
the 0
R1 B-gene
alpha/beta I-gene
regions I-gene
, 0
could 0
not 0
be 0
confirmed 0
, 0
suggesting 0
that 0
the 0
R1 0
initiator 0
element 0
may 0
function 0
independent 0
of 0
Sp1 B-gene
. 0

We 0
sought 0
to 0
test 0
whether 0
a 0
prolonged 0
infusion 0
of 0
magnesium 0
sulfate 0
( 0
MgSO 0
( 0
4 0
) 0
; 0
40 0
mmol/24 0
hours 0
) 0
would 0
normalize 0
QT 0
interval 0
variability 0
in 0
patients 0
with 0
compensated 0
heart 0
failure 0
. 0

Using 0
probes 0
containing 0
C/EBP B-gene
- I-gene
binding I-gene
sites I-gene
from 0
the 0
iNOS B-gene
gene I-gene
revealed 0
further 0
binding 0
of 0
different 0
complexes 0
, 0
all 0
of 0
which 0
were 0
strongly 0
inducible 0
by 0
cAMP 0
and 0
to 0
a 0
lower 0
extent 0
also 0
by 0
IL B-gene
- I-gene
1beta I-gene
. 0

Long 0
- 0
term 0
follow 0
- 0
up 0
of 0
kidney 0
donors 0
: 0
a 0
longitudinal 0
study 0
. 0

Gore 0
& 0
Associates 0
, 0
Inc. 0
) 0
standard 0
wall 0
graft 0
segments 0
varying 0
in 0
length 0
from 0
4 0
to 0
12 0
cm 0
. 0

This 0
report 0
describes 0
the 0
isolation 0
and 0
recombinant 0
expression 0
of 0
a 0
cDNA 0
clone 0
encoding 0
HER4 B-gene
, 0
the 0
fourth 0
member 0
of 0
the 0
human B-gene
epidermal I-gene
growth I-gene
factor I-gene
receptor I-gene
( 0
EGFR B-gene
) 0
family 0
. 0

Precision 0
of 0
data 0
from 0
models 0
of 0
sodium 0
kinetics 0
in 0
hemodialysis 0

Cytochrome B-gene
bd I-gene
biosynthesis 0
in 0
Escherichia 0
coli 0
: 0
the 0
sequences 0
of 0
the 0
cydC B-gene
and 0
cydD B-gene
genes I-gene
suggest 0
that 0
they 0
encode 0
the 0
components 0
of 0
an 0
ABC B-gene
membrane I-gene
transporter I-gene
. 0

We 0
exposed 0
Dorper 0
- 0
cross 0
ewes 0
at 0
approximately 0
120 0
- 0
135 0
days 0
of 0
gestation 0
to 0
a 0
hot 0
( 0
40 0
degrees 0
C 0
, 0
60 0
% 0
relative 0
humidity 0
) 0
and 0
a 0
cold 0
( 0
4 0
degrees 0
C 0
, 0
90 0
% 0
relative 0
humidity 0
) 0
environment 0
and 0
to 0
treadmill 0
exercise 0
( 0
2.1 0
km/h 0
, 0
5 0
degrees 0
gradient 0
) 0
and 0
measured 0
fetal 0
lamb 0
and 0
ewe 0
body 0
temperatures 0
using 0
previously 0
implanted 0
abdominal 0
radiotelemeters 0
. 0

Amino 0
- 0
terminal 0
polymorphisms 0
of 0
the 0
human B-gene
beta I-gene
2 I-gene
- I-gene
adrenergic I-gene
receptor I-gene
impart 0
distinct 0
agonist 0
- 0
promoted 0
regulatory 0
properties 0
. 0

A 0
brief 0
discussion 0
for 0
the 0
relationship 0
among 0
these 0
formulas 0
is 0
given 0
. 0

The 0
embryology 0
of 0
the 0
vertebral 0
column 0
is 0
reviewed 0
briefly 0
, 0
and 0
the 0
origin 0
of 0
each 0
anomaly 0
of 0
the 0
C2 0
vertebra 0
is 0
traced 0
to 0
one 0
of 0
the 0
two 0
early 0
stages 0
in 0
development 0
as 0
follows 0
: 0
1 0
) 0
the 0
formation 0
of 0
the 0
mesenchymal 0
vertebra 0
or 0
2 0
) 0
its 0
induction 0
to 0
cartilage 0
. 0

Visualization 0
of 0
the 0
cells 0
by 0
phase 0
contrast 0
microscopy 0
indicated 0
that 0
murine B-gene
PKCepsilon I-gene
expression 0
in 0
the 0
presence 0
of 0
glycerol 0
resulted 0
in 0
a 0
significant 0
increase 0
in 0
the 0
number 0
of 0
yeast 0
cells 0
exhibiting 0
very 0
small 0
buds 0
. 0

12 0
per 0
cent 0
was 0
observed 0
with 0
the 0
use 0
of 0
tetracycline 0
and 0
4 0
- 0
epianhydrotetracycline 0
in 0
doses 0
of 0
1000 0
and 0
100gamma 0
per 0
embryo 0
respectively 0
. 0

The 0
DNA 0
- 0
binding 0
proteins 0
are 0
without 0
effect 0
on 0
the 0
transcription 0
of 0
plasmids 0
lacking 0
binding 0
sites 0
or 0
when 0
the 0
binding 0
sites 0
are 0
located 0
further 0
upstream 0
. 0

The 0
duration 0
of 0
PGE2 0
and 0
PGF2 0
alpha 0
elevations 0
as 0
well 0
as 0
the 0
peak 0
values 0
were 0
influenced 0
by 0
day 0
of 0
the 0
cycle 0
. 0

One 0
hundred 0
men 0
who 0
received 0
alpha 0
- 0
tocopherol 0
were 0
matched 0
on 0
age 0
, 0
study 0
center 0
, 0
and 0
length 0
of 0
time 0
between 0
blood 0
draws 0
to 0
100 0
men 0
who 0
received 0
a 0
placebo 0
. 0

Serum B-gene
angiogenin I-gene
concentrations 0
in 0
young 0
patients 0
with 0
diabetes 0
mellitus 0
. 0

Bodily 0
referents 0
and 0
the 0
experience 0
of 0
affect 0
. 0

We 0
studied 0
about 0
the 0
histological 0
findings 0
of 0
the 0
kidneys 0
including 0
of 0
the 0
infiltrated 0
macrophages 0
in 0
one 0
hour 0
post 0
- 0
transplantation 0
kidney 0
biopsies 0
( 0
one 0
hour 0
biopsies 0
) 0
and 0
re 0
- 0
biopsies 0
on 0
11 0
patients 0
. 0

The 0
human B-gene
lbc I-gene
oncogene I-gene
product I-gene
is 0
a 0
guanine B-gene
nucleotide I-gene
exchange I-gene
factor I-gene
that 0
specifically 0
activates 0
the 0
Rho B-gene
small I-gene
GTP I-gene
binding I-gene
protein I-gene
, 0
thus 0
resulting 0
in 0
biologically 0
active 0
, 0
GTP 0
- 0
bound 0
Rho B-gene
, 0
which 0
in 0
turn 0
mediates 0
actin B-gene
cytoskeletal 0
reorganization 0
, 0
gene 0
transcription 0
, 0
and 0
entry 0
into 0
the 0
mitotic 0
S 0
phase 0
. 0

RESULTS 0
: 0
There 0
were 0
no 0
significant 0
differences 0
in 0
the 0
mean 0
serum 0
vitamin 0
A 0
, 0
E 0
concentrations 0
and 0
vitamin 0
E/cholesterol 0
ratio 0
between 0
pregnant 0
women 0
with 0
normal 0
hemoglobin B-gene
and 0
hemoglobinopathies 0
, 0
while 0
confounding 0
variables 0
that 0
might 0
affect 0
serum 0
vitamin 0
levels 0
i.e 0
. 0
maternal 0
age 0
, 0
gravida 0
, 0
BMI 0
, 0
gestational 0
age 0
, 0
hematocrit 0
, 0
hemoglobin B-gene
, 0
mean 0
corpuscular 0
hemoglobin B-gene
concentration 0
and 0
blood 0
group 0
were 0
not 0
different 0
. 0

These 0
data 0
indicate 0
that 0
SB 0
203580 0
sensitive 0
p38 B-gene
MAP I-gene
kinases I-gene
are 0
not 0
involved 0
in 0
okadaic 0
acid 0
mediated 0
increases 0
in 0
TRE 0
DNA 0
binding 0
and 0
transactivation 0
. 0

In 0
contrast 0
, 0
group 0
II 0
showed 0
a 0
significant 0
improvement 0
in 0
peak 0
VO2 0
with 0
rate 0
adaptive 0
AV 0
delay 0
compared 0
to 0
fixed 0
AV 0
delay 0
programming 0
( 0
P 0
less 0
than 0
0.05 0
) 0
. 0

This 0
vector 0
should 0
be 0
applicable 0
for 0
high 0
- 0
throughput 0
characterization 0
of 0
new 0
open 0
reading 0
frames 0
found 0
in 0
genome 0
sequencing 0
. 0

Each 0
patient 0
was 0
seen 0
for 0
5 0
to 0
13 0
postsurgical 0
maintenance 0
visits 0
. 0

Evidence 0
for 0
a 0
role 0
of 0
Smad6 B-gene
in 0
chick 0
cardiac 0
development 0
. 0

The 0
overall 0
response 0
rate 0
including 0
CR 0
and 0
PR 0
was 0
23.5 0
% 0
( 0
4/17 0
) 0
. 0

Left 0
ventricular 0
responses 0
to 0
dopamine 0
in 0
dilated 0
cardiomyopathy 0
as 0
assessed 0
by 0
two 0
- 0
dimensional 0
echocardiography 0
and 0
compared 0
with 0
findings 0
of 0
thallium 0
- 0
201 0
scintigraphy 0
. 0

RESULTS 0
: 0
Lateral 0
PF 0
OA 0
was 0
more 0
common 0
than 0
medial 0
PF 0
OA 0
( 0
P 0
< 0
0.0001 0
) 0
. 0

Moreover 0
, 0
we 0
show 0
that 0
GATA B-gene
- I-gene
1 I-gene
and 0
Sp1 B-gene
synergize 0
from 0
a 0
distance 0
in 0
constructs 0
designed 0
to 0
mimic 0
the 0
architecture 0
of 0
globin B-gene
locus I-gene
control I-gene
regions I-gene
and 0
downstream 0
globin B-gene
promoters I-gene
. 0

After 0
5,850 0
C14 0
BP 0
, 0
the 0
decrease 0
in 0
Acer 0
stands 0
could 0
be 0
attributed 0
to 0
fire 0
as 0
suggested 0
by 0
the 0
strong 0
increase 0
in 0
Betula 0
and 0
by 0
the 0
delayed 0
expansion 0
of 0
Pinus 0
cembra 0
. 0

4.7 0
+/ 0
- 0
0.6 0
micromol 0
. 0
kg 0
- 0
1 0
. 0
min 0
- 0
1 0
) 0
but 0
was 0
not 0
changed 0
by 0
training 0
. 0

A 0
wide 0
conservation 0
of 0
iscSUA B-gene
genes I-gene
in 0
nature 0
and 0
evidence 0
that 0
NifU B-gene
and 0
NifS B-gene
participate 0
in 0
the 0
mobilization 0
of 0
iron 0
and 0
sulfur 0
for 0
nitrogenase B-gene
- 0
specific 0
iron 0
- 0
sulfur 0
cluster 0
formation 0
suggest 0
that 0
the 0
products 0
of 0
the 0
iscSUA B-gene
genes I-gene
could 0
play 0
a 0
general 0
role 0
in 0
the 0
formation 0
or 0
repair 0
of 0
iron 0
- 0
sulfur 0
clusters 0
. 0

RET/PTC B-gene
oncogenes 0
, 0
generated 0
by 0
chromosomal 0
rearrangements 0
in 0
papillary 0
thyroid 0
carcinomas 0
, 0
are 0
constitutively 0
activated 0
versions 0
of 0
RET/PTC I-gene

Diclofenac 0
sodium 0
: 0
blood 0
concentration 0
of 0
the 0
slow 0
- 0
release 0
form 0
and 0
influence 0
on 0
the 0
metabolism 0
of 0
kallikrein B-gene
. 0

The 0
unc B-gene
- I-gene
101 I-gene
, 0
sli B-gene
- I-gene
1 I-gene
, 0
and 0
rok B-gene
- I-gene
1 I-gene
genes I-gene
encode 0
a 0
distinct 0
set 0
of 0
negative 0
regulators 0
of 0
vulval 0
differentiation 0
. 0

Optimized 0
USF B-gene
and 0
MYC B-gene
DNA 0
- 0
binding 0
sites 0
, 0
which 0
differ 0
in 0
the 0
nucleotides 0
bordering 0
the 0
hexanucleotide 0
box 0
displace 0
the 0
E B-gene
- I-gene
C4 I-gene
factor I-gene
in 0
competition 0
assays 0
but 0
with 0
lesser 0
efficiency 0
than 0
the 0
E B-gene
- I-gene
C4 I-gene
site I-gene
itself 0
. 0

Fluorescent 0
in 0
situ 0
hybridization 0
( 0
FISH 0
) 0
analysis 0
showed 0
that 0
the 0
novel 0
regions 0
involved 0
in 0
the 0
NFKB2 B-gene
rearrangement 0
originated 0
from 0
chromosome 0
7q34 0
, 0
thus 0
implying 0
the 0
occurrence 0
of 0
a 0
t 0
( 0
7 0
; 0
10 0
) 0
( 0
q34 0
; 0
q24 0
) 0
reciprocal 0
chromosomal 0
translocation 0
. 0

DESIGN 0
: 0
Intradermally 0
injected 0
human 0
squamous 0
cell 0
carcinoma 0
cells 0
were 0
grown 0
to 0
40 0
to 0
80 0
mm3 0
in 0
athymic 0
nude 0
mice 0
and 0
irradiated 0
with 0
675 0
- 0
nm 0
light 0
( 0
75 0
J/cm2 0
, 0
75 0
mW/cm2 0
) 0
24 0
hours 0
after 0
the 0
intraperitoneal 0
injection 0
of 0
SiPc 0
IV 0
( 0
1.0 0
mg/kg 0
) 0
. 0

The 0
effects 0
of 0
space 0
radiation 0
are 0
partially 0
known 0
on 0
astronauts 0
, 0
but 0
much 0
remains 0
to 0
be 0
discovered 0
. 0

First 0
, 0
the 0
amino 0
- 0
terminal 0
regulatory 0
arm 0
of 0
the 0
GDI B-gene
binds 0
to 0
the 0
switch 0
I 0
and 0
II 0
domains 0
of 0
Cdc42 B-gene
leading 0
to 0
the 0
inhibition 0
of 0
both 0
GDP 0
dissociation 0
and 0
GTP 0
hydrolysis 0
. 0

There 0
are 0
two 0
regulatory 0
regions 0
between 0
the 0
US3 B-gene
and 0
the 0
US6 B-gene
transcription I-gene
units I-gene
. 0

In 0
the 0
virus 0
- 0
infected 0
cells 0
, 0
translation 0
of 0
the 0
M1 B-gene
protein I-gene
was 0
reduced 0
to 0
10 0
to 0
20 0
% 0
of 0
that 0
of 0
the 0
wild 0
- 0
type 0
virus 0
; 0
however 0
, 0
the 0
translation 0
of 0
neither 0
the 0
nucleoprotein 0
nor 0
NS1 B-gene
was 0
significantly 0
interfered 0
with 0
, 0
indicating 0
the 0
important 0
role 0
of 0
NS1 B-gene
in 0
translational 0
stimulation 0
of 0
the 0
M1 B-gene
protein I-gene
. 0

Thus 0
, 0
the 0
predicted 0
M3 0
ORF 0
is 0
a 0
functional 0
gene 0
that 0
encodes 0
an 0
abundant 0
secreted 0
protein 0
which 0
is 0
a 0
candidate 0
for 0
interacting 0
with 0
host 0
cellular 0
receptors 0
or 0
cytokines 0
. 0

There 0
was 0
a 0
positive 0
correlation 0
between 0
change 0
from 0
baseline 0
in 0
parietal 0
lobe 0
gray 0
- 0
matter 0
cytosolic 0
choline 0
, 0
expressed 0
in 0
terms 0
of 0
choline/creatine 0
resonance 0
ratios 0
, 0
and 0
cognitive 0
performance 0
as 0
measured 0
with 0
the 0
Alzheimer 0
's 0
Disease 0
Assessment 0
Scale 0
Cognitive 0
Subscale 0
. 0

The 0
protein 0
encoded 0
by 0
the 0
NF2 B-gene
gene I-gene
has 0
a 0
similarity 0
to 0
ezrin B-gene
, 0
radixin B-gene
and 0
moesin B-gene
( 0
ERM B-gene
) 0
proteins 0
that 0
link 0
membrane 0
proteins 0
to 0
the 0
cytoskeleton 0
. 0

80 0
v B-gene
- I-gene
ets I-gene
- 0
encoded 0
amino 0
- 0
acids 0
located 0
immediately 0
after 0
the 0
v B-gene
- I-gene
myb/v I-gene
myb/v I-gene
- I-gene
ets I-gene
junction 0
are 0
not 0
found 0
in 0
P54/56c B-gene
P54/56c I-gene
- I-gene
ets I-gene
, 0
the 0
translation 0
product 0
of 0
the 0
c B-gene
- I-gene
ets I-gene
proto I-gene
- I-gene
oncogene I-gene
, 0
nor 0
in 0
a 0
set 0
of 0
cellular 0
proteins 0
of 0
64 0
, 0
62 0
, 0
and 0
60 0
kDa 0
related 0
to 0
but 0
distinct 0
from 0
P54/56c B-gene
P54/56c I-gene
- I-gene
ets I-gene
. 0

Secretogranin B-gene
II I-gene
( 0
SgII B-gene
) 0
is 0
a 0
secretory 0
polypeptide 0
stored 0
in 0
large 0
dense 0
core 0
vesicles 0
of 0
neuroendocrine 0
and 0
neuronal 0
cells 0
. 0

In 0
contrast 0
translocation 0
of 0
G1 B-gene
to 0
the 0
Golgi 0
was 0
not 0
observed 0
when 0
G1 B-gene
was 0
coexpressed 0
with 0
NSm B-gene
, 0
although 0
NSm B-gene
itself 0
was 0
still 0
detected 0
in 0
the 0
Golgi 0
. 0

The 0
results 0
show 0
that 0
while 0
a 0
larger 0
polypeptide 0
substrate 0
carrying 0
the 0
HD1/3C B-gene
site I-gene
was 0
processed 0
more 0
efficiently 0
than 0
a 0
polypeptide 0
substrate 0
carrying 0
the 0
POL/Zn B-gene
site I-gene
, 0
cleavage 0
of 0
the 0
synthetic 0
peptide 0
substrates 0
containing 0
these 0
two 0
cleavage 0
sites 0
occurred 0
at 0
similar 0
efficiencies 0
. 0

GBF1 B-gene
and 0
GBF2 B-gene
mRNA I-gene
is 0
present 0
in 0
light 0
and 0
dark 0
grown 0
leaves 0
as 0
well 0
as 0
in 0
roots 0
. 0

In 0
this 0
technique 0
, 0
the 0
posterior 0
wall 0
of 0
the 0
neopharynx 0
consists 0
only 0
of 0
the 0
prevertebral 0
tissue 0
, 0
while 0
the 0
flap 0
forms 0
the 0
anterior 0
and 0
lateral 0
walls 0
. 0

These 0
data 0
may 0
indicate 0
redundancy 0
between 0
members 0
of 0
the 0
NGFI B-gene
- I-gene
B/Nurr1/Nor1 I-gene
subfamily 0
and 0
could 0
explain 0
why 0
no 0
phenotypic 0
disturbances 0
have 0
yet 0
been 0
found 0
in 0
mice 0
in 0
which 0
the 0
B/Nurr1/Nor1 I-gene

Activation 0
of 0
the 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
( 0
MAPK B-gene
) 0
pathway 0
enhances 0
long 0
- 0
range 0
transactivation 0
by 0
the 0
beta B-gene
- I-gene
globin I-gene
locus I-gene
control I-gene
region I-gene
( 0
LCR 0
) 0
( 0
W 0
. 0

The 0
gp41 B-gene
peptide I-gene
( I-gene
Glu I-gene
- I-gene
Leu I-gene
- I-gene
Asp I-gene
- I-gene
Lys I-gene
- I-gene
Trp I-gene
- I-gene
Ala I-gene
) I-gene
fused 0
to 0
the 0
C 0
- 0
terminus 0
of 0
Sj B-gene
GST I-gene
forms 0
a 0
loop 0
stabilized 0
by 0
symmetry 0
- 0
related 0
GSTs B-gene
. 0

The 0
GST B-gene
- 0
CBL B-gene
- 0
LZIP B-gene
fusion 0
protein 0
contains 0
a 0
binding 0
site 0
for 0
the 0
SH2 B-gene
domain I-gene
of 0
the 0
p85 B-gene
subunit I-gene
of 0
phosphatidylinositol B-gene
3 I-gene
- I-gene
kinase I-gene
, 0
which 0
mapped 0
to 0
Tyr731 0
, 0
which 0
is 0
present 0
in 0
the 0
sequence 0
YEAM 0
. 0

The 0
testes 0
of 0
8 0
specimens 0
of 0
Triturus 0
marmoratus 0
were 0
collected 0
during 0
each 0
month 0
of 0
1987 0
and 0
processed 0
for 0
electron 0
microscopy 0
and 0
light 0
microscopy 0
demonstration 0
of 0
testosterone 0
( 0
T 0
) 0
following 0
the 0
ABC B-gene
( 0
avidin B-gene
- I-gene
biotin I-gene
peroxidase I-gene
complex I-gene
) 0
method 0
. 0

We 0
have 0
generated 0
transgenic 0
fly 0
strains 0
with 0
mutations 0
affecting 0
specific 0
TRA B-gene
- I-gene
2 I-gene
isoforms I-gene
to 0
investigate 0
their 0
individual 0
roles 0
in 0
regulating 0
the 0
alternative 0
processing 0
of 0
doublesex B-gene
, 0
exuperantia B-gene
and 0
tra B-gene
- I-gene
2 I-gene
pre I-gene
- I-gene
mRNA I-gene
. 0

Few 0
triers 0
or 0
users 0
had 0
received 0
SLT 0
counseling 0
from 0
their 0
dentist 0
despite 0
high 0
dental 0
utilization 0
rates 0
. 0

There 0
has 0
been 0
no 0
significant 0
toxicity 0
associated 0
with 0
repeated 0
5 0
- 0
FU 0
instillation 0
into 0
the 0
airway 0
. 0

He 0
had 0
complained 0
of 0
fever 0
and 0
right 0
hypochondralgia 0
2 0
months 0
after 0
being 0
operated 0
for 0
appendicitis 0
. 0

Thus 0
, 0
apoptosis 0
in 0
hematopoietic 0
cells 0
is 0
the 0
end 0
result 0
of 0
a 0
conflict 0
between 0
death 0
and 0
survival 0
signals 0
, 0
rather 0
than 0
a 0
simple 0
death 0
by 0
default 0
. 0

Changes 0
in 0
testicular 0
testosterone 0
and 0
acid 0
and 0
alkaline B-gene
phosphatase I-gene
activity 0
in 0
testis 0
and 0
accessory 0
sex 0
organs 0
after 0
induction 0
of 0
varicocele 0
in 0
Noble 0
rats 0
. 0

The 0
reconstituted 0
RNA B-gene
polymerases I-gene
containing 0
the 0
mutant 0
alpha 0
subunits 0
were 0
examined 0
for 0
their 0
response 0
to 0
transcription 0
activation 0
by 0
cAMP B-gene
- I-gene
CRP I-gene
and 0
the 0
rrnBP1 B-gene
UP I-gene
element I-gene
. 0

Changes 0
in 0
the 0
greater 0
omentum 0
of 0
mice 0
of 0
different 0
strains 0
after 0
intraperitoneal 0
immunization 0
with 0
sheep 0
erythrocytes 0
. 0

In 0
patients 0
, 0
750 0
mL 0
of 0
saline 0
lowered 0
DL 0
( 0
CO 0
) 0
( 0
- 0
8 0
% 0
, 0
P 0
< 0
0.01 0
versus 0
baseline 0
) 0
, 0
D 0
( 0
M 0
) 0
( 0
- 0
10 0
% 0
, 0
P 0
< 0
0.01 0
versus 0
baseline 0
) 0
, 0
aldosterone 0
( 0
- 0
29 0
% 0
, 0
P 0
< 0
0.01 0
versus 0
baseline 0
) 0
, 0
renin B-gene
( 0
- 0
52 0
% 0
, 0
P 0
< 0
0.01 0
versus 0
baseline 0
) 0
, 0
and 0
hematocrit 0
( 0
- 0
6 0
% 0
, 0
P 0
< 0
0.05 0
versus 0
baseline 0
) 0
and 0
increased 0
V 0
( 0
C 0
) 0
( 0
20 0
% 0
, 0
P 0
< 0
0.01 0
versus 0
baseline 0
) 0
, 0
without 0
changing 0
rap 0
and 0
wpp 0
. 0

Reversible 0
pressure 0
- 0
induced 0
amorphization 0
in 0
solid 0
C70 0
: 0
Raman 0
and 0
photoluminescence 0
study 0
. 0

Antibodies 0
against 0
REAP B-gene
- I-gene
1 I-gene
inhibit 0
in 0
vitro 0
RNA 0
editing 0
reactions 0
confirming 0
its 0
role 0
in 0
RNA 0
editing 0
. 0

The 0
more 0
severe 0
the 0
CRF 0
, 0
the 0
more 0
likely 0
that 0
total 0
HDL B-gene
and 0
HDL2 B-gene
cholesterol I-gene
will 0
be 0
low 0
. 0

A 0
conventional 0
N 0
- 0
terminal 0
signal 0
sequence 0
was 0
not 0
detected 0
in 0
the 0
NodO B-gene
protein I-gene
. 0

Mean 0
CD4 B-gene
percentages 0
were 0
lower 0
postpartum 0
( 0
21.9 0
+/ 0
- 0
3.4 0
) 0
than 0
prepartum 0
( 0
45.1 0
+/ 0
- 0
6.7 0
) 0
in 0
all 0
five 0
patients 0
studied 0
, 0
although 0
proliferative 0
responses 0
to 0
the 0
mitogens B-gene
phytohemagglutinin I-gene
and I-gene
pokeweed I-gene
were 0
unchanged 0
during 0
the 0
study 0
period 0
. 0

Significance 0
of 0
the 0
determination 0
of 0
vascular 0
tonus 0
in 0
the 0
differential 0
diagnosis 0
of 0
rheumatic 0
and 0
arteriosclerotic 0
lesions 0
of 0
the 0
heart 0
and 0
vessels 0
in 0
middle 0
- 0
aged 0
and 0
elderly 0
persons 0
with 0
fibrillation 0
arrhythmia 0

The 0
disease 0
processes 0
that 0
affect 0
transplant 0
patients 0
both 0
before 0
and 0
after 0
transplantation 0
are 0
not 0
seen 0
frequently 0
in 0
the 0
general 0
practice 0
of 0
gastroenterology 0
. 0

In 0
Experiment 0
2 0
, 0
levels 0
were 0
: 0
amprolium 0
and 0
ethopabate 0
, 0
.02 0
% 0
; 0
salinomycin 0
, 0
55 0
mg/kg 0
; 0
monensin 0
, 0
99 0
mg/kg 0
; 0
and 0
lasalocid 0
, 0
110 0
mg/kg 0
. 0

This 0
duplicated 0
genomic 0
region 0
is 0
also 0
linked 0
tightly 0
to 0
D1Z2 B-gene
, 0
a 0
genetic 0
marker 0
containing 0
a 0
highly 0
polymorphic 0
VNTR 0
( 0
variable 0
number 0
tandem 0
repeat 0
) 0
consisting 0
of 0
an 0
unusual 0
40 0
- 0
bp 0
reiterated 0
sequence 0
. 0

The 0
level 0
of 0
transcription 0
generated 0
by 0
all 0
of 0
these 0
activators 0
is 0
greater 0
than 0
the 0
sum 0
of 0
the 0
levels 0
generated 0
by 0
individual 0
factors 0
, 0
a 0
phenomenon 0
designated 0
transcriptional 0
synergy 0
. 0

Aspartame 0
is 0
a 0
synthetic 0
sweetener 0
commonly 0
used 0
in 0
soft 0
drinks 0
and 0
many 0
foods 0
. 0

Under 0
control 0
conditions 0
and 0
in 0
the 0
presence 0
of 0
3 0
micromol/kg 0
MIB 0
and 0
VER 0
the 0
maximal 0
effect 0
of 0
noradrenaline 0
was 0
reached 0
at 0
0.1 0
micromol/kg 0
whereas 0
in 0
the 0
presence 0
of 0
10 0
micromol/kg 0
MIB 0
and 0
VER 0
it 0
was 0
reached 0
at 0
a 0
dose 0
of 0
1 0
micromol/kg 0
. 0

The 0
highly 0
conserved 0
region 0
of 0
U6 B-gene
snRNA I-gene
has 0
a 0
structural 0
similarity 0
with 0
the 0
catalytic 0
domain 0
of 0
the 0
negative 0
strand 0
of 0
the 0
satellite 0
RNA 0
of 0
tobacco 0
ring 0
spot 0
virus 0
[ 0
( 0
- 0
) 0
sTRSV 0
] 0
, 0
suggesting 0
that 0
the 0
highly 0
conserved 0
region 0
of 0
U6 B-gene
snRNA I-gene
forms 0
the 0
catalytic 0
center 0
. 0

By 0
computed 0
homology 0
search 0
, 0
we 0
noticed 0
significant 0
similarities 0
between 0
US3 B-gene
PK I-gene
and 0
p21 B-gene
- I-gene
activated I-gene
kinase I-gene
( 0
PAK B-gene
) 0
, 0
which 0
is 0
activated 0
by 0
the 0
Cdc42 B-gene
or 0
Rac B-gene
. 0

Using 0
transgenic 0
lines 0
a 0
detailed 0
analysis 0
of 0
the 0
Hoxa B-gene
- I-gene
7 I-gene
enhancer 0
- 0
directed 0
expression 0
during 0
embryogenesis 0
was 0
performed 0
. 0
lacZ B-gene
expression 0
was 0
first 0
detected 0
in 0
the 0
allantois 0
at 0
day 0
7.5 0
p.c 0
. 0
and 0
in 0
mesoderm 0
and 0
ectoderm 0
at 0
day 0
8.5 0
of 0
gestation 0
. 0

Its 0
phosphorylation 0
strongly 0
potentiates 0
its 0
ability 0
to 0
activate 0
transcription 0
of 0
the 0
c B-gene
- I-gene
fos I-gene
promoter I-gene
through 0
a 0
ternary 0
complex 0
assembled 0
on 0
the 0
c B-gene
- I-gene
fos I-gene
serum I-gene
response I-gene
element I-gene
. 0

Drosophila B-gene
melanogaster I-gene
casein I-gene
kinase I-gene
II I-gene
( 0
DmCKII B-gene
) 0
is 0
composed 0
of 0
catalytic 0
( 0
alpha 0
) 0
and 0
regulatory 0
( 0
beta 0
) 0
subunits 0
associated 0
as 0
an 0
alpha2beta2 0
heterotetramer 0
. 0

Inhibition 0
of 0
DNA B-gene
topoisomerase I-gene
II I-gene
alpha I-gene
gene I-gene
expression 0
by 0
the 0
p53 B-gene
tumor I-gene
suppressor I-gene
. 0

These 0
conditions 0
may 0
determine 0
an 0
increase 0
in 0
the 0
level 0
of 0
indoor 0
pollutants 0
( 0
tobacco 0
smoke 0
, 0
gases 0
produced 0
by 0
cooling 0
processes 0
etc 0
. 0
) 0
and 0
of 0
allergens 0
derived 0
from 0
mites 0
, 0
domestic 0
animals 0
and 0
cockroaches 0
. 0

Vav B-gene
and 0
Dbl B-gene
are 0
members 0
of 0
a 0
novel 0
class 0
of 0
oncogene 0
proteins 0
that 0
share 0
significant 0
sequence 0
identity 0
in 0
a 0
approximately 0
250 0
- 0
amino 0
- 0
acid 0
domain 0
, 0
designated 0
the 0
Dbl B-gene
homology I-gene
domain I-gene
. 0

METHODS 0
: 0
Levels 0
of 0
sIL B-gene
- I-gene
2R I-gene
were 0
measured 0
simultaneously 0
in 0
plasma 0
and 0
pleural 0
fluid 0
in 0
111 0
patients 0
with 0
pleural 0
effusions 0
of 0
unknown 0
causes 0
. 0

HCVR 0
- 0
L 0
significantly 0
increased 0
dVAS/dPCO2 0
to 0
4.9 0
+/ 0
- 0
0.7 0
mm/Torr 0
compared 0
to 0
HCVR 0
- 0
S 0
( 0
p 0
< 0
0.05 0
) 0
. 0

Right 0
- 0
sided 0
hemiplegia 0
of 0
5 0
years 0
duration 0
occurred 0
in 0
the 0
remaining 0
case 0
. 0

Studies 0
on 0
the 0
excretion 0
of 0
selenium 0
in 0
urine 0
and 0
feces 0
and 0
distribution 0
in 0
the 0
organs 0
of 0
rats 0
by 0
a 0
method 0
of 0
radioactivity 0
measurement 0

The 0
LIF B-gene
appeared 0
to 0
be 0
released 0
by 0
the 0
patient 0
's 0
peripheral 0
blood 0
lymphocytes 0
when 0
cultured 0
with 0
optimal 0
doses 0
of 0
propranolol 0
. 0

In 0
addition 0
, 0
the 0
findings 0
confirmed 0
previous 0
studies 0
which 0
showed 0
that 0
monkeys 0
with 0
total 0
bilateral 0
striatectomies 0
could 0
require 0
the 0
ability 0
to 0
execute 0
accurate 0
visually 0
guided 0
reaches 0
. 0

The 0
greatest 0
risk 0
of 0
preterm 0
prelabour 0
rupture 0
of 0
membranes 0
( 0
PPROM 0
) 0
is 0
preterm 0
delivery 0
. 0

The 0
2.3 B-gene
x I-gene
10 I-gene
( I-gene
3 I-gene
) I-gene
base I-gene
SUF12+ I-gene
transcript I-gene
contains 0
an 0
open 0
reading 0
frame 0
sufficient 0
to 0
encode 0
a 0
88 0
x 0
10 0
( 0
3 0
) 0
Mr 0
protein 0
. 0

This 0
regulation 0
is 0
mediated 0
by 0
several 0
kinases 0
that 0
phosphorylate 0
specific 0
residues 0
in 0
the 0
different 0
functional 0
domains 0
of 0
the 0
p53 B-gene
molecule I-gene
. 0

In 0
group 0
I 0
during 0
the 0
pain 0
free 0
period 0
26 0
of 0
81 0
patients 0
had 0
positive 0
thallium 0
- 0
201 0
scans 0
, 0
whereas 0
20 0
patients 0
had 0
an 0
abnormal 0
ECG 0
at 0
that 0
time 0
; 0
during 0
angina 0
18 0
patients 0
had 0
transient 0
ECG 0
changes 0
. 0

We 0
examined 0
the 0
contribution 0
of 0
the 0
M B-gene
- I-gene
MuLV I-gene
enhancers I-gene
to 0
the 0
transcriptional 0
activity 0
and 0
pathogenesis 0
of 0
M 0
- 0
MuLV 0
by 0
constructing 0
LTRs 0
containing 0
heterologous 0
enhancer 0
elements 0
. 0

Acute 0
respiratory 0
distress 0
syndrome 0
. 0

Serum 0
creatinine B-gene
kinase I-gene
activity 0
was 0
7,800 0
- 0
17,500 0
U/l 0
, 0
making 0
acute 0
muscle 0
damage 0
likely 0
, 0
probably 0
rhabdomyolysis 0
. 0

Transcriptional 0
regulation 0
of 0
the 0
murine B-gene
k I-gene
- I-gene
fgf I-gene
gene I-gene
. 0

Fetal 0
arterial 0
and 0
sagittal 0
sinus 0
pH 0
, 0
base 0
excess 0
, 0
po2 0
, 0
and 0
oxygen 0
saturation 0
decreased 0
, 0
and 0
hydrogen 0
ion 0
concentrations 0
and 0
pco2 0
increased 0
during 0
asphyxia 0
alone 0
and 0
asphyxia 0
plus 0
isoflurane 0
- 0
oxygen 0
. 0

To 0
clarify 0
the 0
difference 0
, 0
both 0
the 0
Crk B-gene
II I-gene
and 0
Crk B-gene
II I-gene
- I-gene
23 I-gene
, 0
proteins 0
were 0
expressed 0
in 0
E. 0
coli 0
and 0
examined 0
their 0
binding 0
capacity 0
in 0
vitro 0
. 0

Growth B-gene
hormone I-gene
exerts 0
its 0
effects 0
on 0
the 0
ovarian 0
follicular 0
cycle 0
directly 0
or 0
by 0
local 0
production 0
of 0
insulin B-gene
- I-gene
like I-gene
growth I-gene
factor I-gene
1 I-gene
( 0
IGF B-gene
- I-gene
1 I-gene
) 0
. 0

For 0
the 0
most 0
part 0
, 0
only 0
aerobic 0
microbial 0
degradation 0
systems 0
have 0
been 0
reported 0
so 0
far 0
. 0

This 0
is 0
mediated 0
by 0
vascular 0
remodeling 0
, 0
an 0
active 0
process 0
that 0
results 0
in 0
a 0
change 0
in 0
the 0
geometry 0
of 0
the 0
blood 0
vessel 0
. 0

The 0
results 0
suggest 0
that 0
the 0
posterior 0
wall 0
is 0
more 0
compliant 0
than 0
the 0
anterior 0
wall 0
( 0
that 0
is 0
, 0
for 0
a 0
given 0
difference 0
in 0
transmural 0
pressure 0
, 0
the 0
local 0
segment 0
length 0
change 0
of 0
the 0
posterior 0
wall 0
was 0
greater 0
) 0
. 0

Although 0
cardiac 0
output 0
decreased 0
slightly 0
with 0
PCF 0
, 0
hemodynamic 0
changes 0
due 0
to 0
PCF 0
were 0
unlikely 0
to 0
account 0
for 0
the 0
observed 0
fall 0
in 0
PaO2 0
. 0

Swarming 0
of 0
Moraxella 0

Two 0
patient 0
groups 0
were 0
studied 0
: 0
Type 0
I 0
- 0
- 0
with 0
a 0
new 0
ePTFE 0
graft 0
; 0
and 0
Type 0
II 0
- 0
- 0
with 0
thrombectomy 0
and/or 0
revision 0
of 0
a 0
previously 0
placed 0
ePTFE 0
graft 0
. 0

No 0
consensus 0
binding 0
sequence 0
could 0
be 0
discerned 0
in 0
these 0
fragments 0
and 0
bound 0
factor 0
is 0
in 0
rapid 0
equilibrium 0
with 0
unbound 0
. 0

As 0
a 0
quantitative 0
index 0
of 0
cochlear 0
function 0
, 0
2f1 0
- 0
f2 0
distortion 0
- 0
product 0
otoacoustic 0
emissions 0
( 0
DPOAEs 0
) 0
were 0
monitored 0
systematically 0
over 0
time 0
in 0
three 0
groups 0
of 0
rabbits 0
, 0
with 0
each 0
group 0
experiencing 0
a 0
unique 0
paradigm 0
that 0
incorporated 0
repeated 0
exposure 0
to 0
the 0
low 0
- 0
frequency 0
tone 0
. 0

Quasidiatomic 0
study 0
of 0
Ly 0
- 0
alpha 0
- 0
producing 0
H2 0
+ 0
- 0
Ne 0
collisions 0
at 0
keV 0
energies 0
. 0

Detailed 0
analysis 0
of 0
the 0
predicted 0
amino 0
acid 0
sequence 0
revealed 0
sequence 0
elements 0
which 0
are 0
conserved 0
in 0
many 0
DNA B-gene
and I-gene
RNA I-gene
polymerases I-gene
. 0

139La 0
NQR 0
relaxation 0
and 0
microSR 0
study 0
of 0
Zn 0
- 0
doping 0
effects 0
in 0
La2CuO4 0
. 0

We 0
have 0
previously 0
reported 0
the 0
first 0
isolation 0
of 0
a 0
c B-gene
- I-gene
myc I-gene
- I-gene
null I-gene
cell 0
line 0
. 0

Our 0
study 0
investigated 0
the 0
hypothesis 0
that 0
the 0
combination 0
of 0
a 0
high 0
NaCl 0
diet 0
and 0
social 0
isolation 0
stress 0
would 0
increase 0
systolic 0
blood 0
pressure 0
( 0
SBP 0
) 0
and 0
endogenous 0
sodium 0
pump 0
ligands 0
( 0
SPL 0
) 0
, 0
ouabainlike 0
compound 0
( 0
OLC 0
) 0
, 0
and 0
marinobufagenin 0
( 0
MBG 0
) 0
. 0

Percentage 0
incremental 0
18 0
- 0
OHB 0
responses 0
to 0
metoclopramide 0
were 0
greater 0
( 0
P 0
less 0
than 0
0.01 0
) 0
in 0
the 0
subjects 0
after 0
5 0
days 0
on 0
a 0
200 0
- 0
meq 0
sodium 0
intake 0
than 0
after 0
5 0
days 0
on 0
a 0
10 0
- 0
meq 0
sodium 0
intake 0
. 0

An 0
additional 0
stimulation 0
of 0
D1 B-gene
receptors I-gene
by 0
giving 0
SKF38393 0
30 0
min 0
later 0
produced 0
an 0
almost 0
continuous 0
pattern 0
of 0
jaw 0
openings 0
but 0
less 0
closure 0
movements 0
from 0
the 0
rest 0
position 0
, 0
and 0
the 0
openings 0
were 0
accompanied 0
by 0
frequent 0
tongue 0
protrusions 0
. 0

PURPOSE 0
: 0
Second 0
malignant 0
neoplasms 0
( 0
SMNs 0
) 0
are 0
a 0
rare 0
occurrence 0
after 0
the 0
successful 0
treatment 0
of 0
childhood 0
cancer 0
. 0

A 0
p53 B-gene
cDNA I-gene
deletion 0
mutant 0
( 0
delta 0
pro 0
AE 0
) 0
, 0
which 0
lacks 0
this 0
entire 0
proline 0
- 0
rich 0
domain 0
( 0
deleted 0
for 0
amino 0
acids 0
62 0
- 0
91 0
) 0
, 0
was 0
created 0
and 0
characterized 0
for 0
a 0
variety 0
of 0
p53 B-gene
functions 0
. 0

Mutations 0
in 0
nifR1 B-gene
( 0
ntrC B-gene
) 0
and 0
nifR4 B-gene
( 0
rpoN B-gene
, 0
encoding 0
sigma54 B-gene
) 0
had 0
no 0
influence 0
on 0
xdh B-gene
gene I-gene
expression 0
. 0

Candidate 0
factors 0
have 0
been 0
identified 0
by 0
the 0
observation 0
that 0
changes 0
in 0
glucocorticoid 0
induction 0
parameters 0
in 0
CV 0
- 0
1 0
cells 0
could 0
be 0
reproduced 0
by 0
varying 0
the 0
cellular 0
levels 0
of 0
coactivators 0
[ 0
transcriptional B-gene
intermediary I-gene
factor I-gene
2 I-gene
( 0
TIF2 B-gene
) 0
, 0
steroid B-gene
receptor I-gene
coactivator I-gene
1 I-gene
( 0
SRC B-gene
- I-gene
1 I-gene
) 0
, 0
and 0
amplified B-gene
in I-gene
breast I-gene
cancer I-gene
1 I-gene
( 0
AIB1 B-gene
) 0
] 0
, 0
comodulator 0
[ 0
CREB B-gene
- I-gene
binding I-gene
protein I-gene
( 0
CBP B-gene
) 0
] 0
, 0
or 0
corepressor 0
[ 0
silencing B-gene
mediator I-gene
for I-gene
retinoid I-gene
and I-gene
thyroid I-gene
- I-gene
hormone I-gene
receptors I-gene
( 0
SMRT B-gene
) 0
] 0
without 0
concomitant 0
increases 0
in 0
GR B-gene
. 0

The 0
pyridostigmine 0
inhibited 0
AChE B-gene
recovered 0
only 0
in 0
the 0
100 0
mumol 0
kg 0
- 0
1 0
kg 0
oxime 0
groups 0
at 0
the 0
end 0
of 0
the 0
experiment 0
. 0

We 0
compared 0
retrospectively 0
the 0
efficacy 0
of 0
granulocyte B-gene
colony I-gene
stimulating I-gene
factor I-gene
( 0
G B-gene
- I-gene
CSF I-gene
) 0
alone 0
with 0
chemotherapy 0
plus 0
G B-gene
- I-gene
CSF I-gene
in 0
mobilizing 0
CD34 B-gene
- 0
positive 0
cells 0
in 0
patients 0
with 0
malignant 0
lymphoma 0
. 0

An 0
additional 0
dose 0
of 0
20 0
- 0
25 0
Gy 0
was 0
delivered 0
to 0
the 0
site 0
of 0
original 0
involvement 0
using 0
an 0
implant 0
when 0
feasible 0
. 0

Activation 0
of 0
the 0
receptor 0
induces 0
Ret B-gene
phosphorylation 0
that 0
leads 0
the 0
survival 0
- 0
promoting 0
effects 0
. 0

Adenovirus 0
infection 0
of 0
hepatoma 0
cells 0
inhibited 0
transcription 0
of 0
the 0
phosphoenolpyruvate B-gene
carboxykinase I-gene
( 0
GTP 0
) 0
( 0
EC B-gene
4.1.1.32 I-gene
) 0
( 0
PEPCK B-gene
) 0
gene 0
and 0
virtually 0
eliminated 0
transcription 0
of 0
a 0
chimeric 0
gene 0
which 0
contained 0
the 0
PEPCK B-gene
promoter I-gene
linked 0
to 0
the 0
structural 0
gene 0
for 0
chloramphenicol B-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
. 0

Circulating 0
immune 0
complexes 0
were 0
determined 0
by 0
the 0
method 0
of 0
phagocytosis 0
and 0
immunofluorescence 0
. 0

LCCH1 B-gene
was 0
identical 0
to 0
the 0
Rdl B-gene
gene I-gene
, 0
a 0
known 0
GABA B-gene
receptor I-gene
subunit I-gene
gene I-gene
from 0
D. 0
melanogaster 0
, 0
whereas 0
LCCH2 B-gene
and 0
LCCH3 B-gene
were 0
novel 0
D. 0
melanogaster 0
sequences 0
that 0
exhibited 0
structural 0
similarity 0
to 0
other 0
members 0
of 0
the 0
ligand B-gene
- I-gene
gated I-gene
chloride I-gene
channel I-gene
gene I-gene
family I-gene
. 0

In 0
this 0
report 0
, 0
we 0
investigated 0
whether 0
the 0
cleavage 0
of 0
the 0
RRKR 0
motif 0
of 0
MT B-gene
- I-gene
MMP1 I-gene
by 0
Golgi B-gene
- I-gene
associated I-gene
furin I-gene
is 0
analogous 0
to 0
a 0
similar 0
enzyme 0
activation 0
mechanism 0
observed 0
with 0
stromelysin B-gene
- I-gene
3 I-gene
. 0

Lifestyle 0
characteristics 0
were 0
ascertained 0
by 0
a 0
self 0
- 0
administered 0
questionnaire 0
. 0

The 0
oxalate B-gene
oxidase I-gene
method 0
results 0
in 0
a 0
mean 0
and 0
reference 0
interval 0
for 0
oxalate 0
excretion 0
that 0
are 0
comparable 0
with 0
those 0
by 0
isotope 0
dilution 0
, 0
gas 0
- 0
chromatographic 0
, 0
colorimetric 0
, 0
and 0
other 0
enzymic 0
procedures 0
. 0

Normal 0
replication 0
of 0
DNA B-gene
A I-gene
still 0
carrying 0
the 0
AC3 B-gene
ORF I-gene
mutation 0
was 0
found 0
in 0
extracts 0
from 0
these 0
plants 0
. 0

Kohtz 0
, 0
J 0
. 0

These 0
data 0
are 0
discussed 0
in 0
the 0
context 0
of 0
the 0
pathogenesis 0
and 0
differential 0
diagnosis 0
of 0
EEC 0
. 0

These 0
data 0
suggest 0
that 0
the 0
fibrinogen B-gene
gamma I-gene
chain I-gene
region I-gene
Gly190 I-gene
- I-gene
Val202 I-gene
functions 0
as 0
a 0
minimal 0
recognition 0
sequence 0
for 0
the 0
leukocyte 0
integrin 0
CD11b/CD18 B-gene
. 0

OBJECTIVE 0
: 0
The 0
audiologic 0
presentation 0
of 0
vestibular 0
schwannoma 0
( 0
VS 0
) 0
associated 0
with 0
neurofibromatosis 0
type 0
2 0
( 0
NF2 0
) 0
has 0
not 0
been 0
well 0
characterized 0
. 0

Siglec B-gene
- I-gene
9 I-gene
is 0
predicted 0
to 0
contain 0
three 0
extracellular 0
immunoglobulin B-gene
- I-gene
like I-gene
domains I-gene
that 0
comprise 0
an 0
N B-gene
- I-gene
terminal I-gene
V I-gene
- I-gene
set I-gene
domain I-gene
and 0
two 0
C2 B-gene
- I-gene
set I-gene
domains I-gene
, 0
a 0
transmembrane 0
region 0
and 0
a 0
cytoplasmic 0
tail 0
containing 0
two 0
putative 0
tyrosine 0
- 0
based 0
signaling 0
motifs 0
. 0

Development 0
of 0
P 0
carinii 0
pneumonia 0
was 0
associated 0
with 0
the 0
stage 0
of 0
Kaposi 0
's 0
sarcoma 0
, 0
B 0
subtype 0
disease 0
, 0
and 0
the 0
presence 0
of 0
0.20 0
X 0
10 0
( 0
9 0
) 0
/L 0
( 0
200/mm3 0
) 0
or 0
fewer 0
CD4 B-gene
cells 0
at 0
study 0
entry 0
. 0

Dermatophagoides 0
farinae 0
- 0
sensitized 0
lymphocytes 0
in 0
asthmatic 0
children 0
as 0
evaluated 0
by 0
interleukin B-gene
- I-gene
2 I-gene
( 0
IL B-gene
- I-gene
2 I-gene
) 0
production 0
and 0
acquisition 0
of 0
IL B-gene
- I-gene
2 I-gene
responsiveness 0

Adenocarcinoma 0
and 0
large 0
cell 0
carcinoma 0
have 0
a 0
worse 0
prognosis 0
than 0
squamous 0
cell 0
carcinoma 0
in 0
the 0
T1N1 0
and 0
T2N1 0
subsets 0
. 0

The 0
DNA 0
element 0
through 0
which 0
EBNA B-gene
- I-gene
3C I-gene
activates 0
the 0
LMP B-gene
- I-gene
1 I-gene
promoter I-gene
includes 0
a 0
Spi B-gene
- I-gene
1/Spi I-gene
1/Spi I-gene
- I-gene
B I-gene
binding 0
site 0
, 0
previously 0
characterized 0
as 0
an 0
important 0
EBNA B-gene
- I-gene
2 I-gene
response I-gene
element I-gene
. 0

Based 0
on 0
PCR 0
strategies 0
and 0
expression 0
studies 0
, 0
we 0
define 0
the 0
genomic 0
organization 0
of 0
the 0
FUT8b B-gene
gene I-gene
. 0

Cord 0
formation 0
in 0
BACTEC 0
7H12 0
medium 0
for 0
rapid 0
, 0
presumptive 0
identification 0
of 0
Mycobacterium 0
tuberculosis 0
complex 0
. 0

The 0
effect 0
of 0
the 0
NMDA B-gene
- I-gene
receptor I-gene
antagonist 0
( 0
+/ 0
- 0
) 0
- 0
CPP 0
on 0
the 0
conditioned 0
- 0
reflex 0
activation 0
of 0
an 0
operant 0
reaction 0
in 0
the 0
brain 0
electrical 0
self 0
- 0
stimulation 0
test 0
in 0
rats 0

Treatment 0
with 0
H7 0
did 0
not 0
affect 0
IL B-gene
- I-gene
4R I-gene
- 0
mediated 0
immediate 0
signaling 0
events 0
such 0
as 0
tyrosine 0
phosphorylation 0
of 0
Jak1 B-gene
, 0
Jak3 B-gene
, 0
insulin B-gene
receptor I-gene
substrate I-gene
( I-gene
IRS I-gene
) I-gene
- I-gene
1 I-gene
and 0
IRS B-gene
- I-gene
2 I-gene
, 0
or 0
tyrosine 0
phosphorylation 0
and 0
DNA 0
binding 0
of 0
Stat6 B-gene
. 0

( 0
1982 0
) 0
. 0

Vasodilation 0
in 0
congestive 0
heart 0
failure 0
is 0
an 0
established 0
therapeutic 0
principal 0
. 0

The 0
translational 0
product 0
of 0
UL26.5 B-gene
is 0
infected B-gene
- I-gene
cell I-gene
protein I-gene
35c I-gene
, I-gene
d I-gene
( 0
ICP35c B-gene
, I-gene
d I-gene
) 0
( 0
F 0
. 0

Our 0
experience 0
suggests 0
that 0
T2 0
weighting 0
is 0
adequate 0
and 0
is 0
the 0
method 0
of 0
choice 0
for 0
the 0
early 0
recognition 0
of 0
necrosis 0
of 0
the 0
lunate 0
. 0

Minor 0
changes 0
within 0
the 0
transmembrane 0
domains 0
( 0
TMs 0
) 0
sometimes 0
produced 0
major 0
effects 0
and 0
more 0
drastic 0
changes 0
in 0
the 0
TMs 0
ablated 0
surface 0
expression 0
entirely 0
. 0

Molecular 0
analysis 0
of 0
the 0
mannitol 0
operon 0
of 0
Clostridium 0
acetobutylicum 0
encoding 0
a 0
phosphotransferase 0
system 0
and 0
a 0
putative 0
PTS 0
- 0
modulated 0
regulator 0
. 0

Mammalian 0
chromosome 0
ends 0
contain 0
long 0
arrays 0
of 0
TTAGGG 0
repeats 0
that 0
are 0
complexed 0
to 0
a 0
telomere 0
specific 0
protein 0
, 0
the 0
TTAGGG B-gene
repeat I-gene
binding I-gene
factor I-gene
, 0
TRF1 B-gene
. 0

HPV 0
- 0
16 0
MARs 0
are 0
context 0
dependent 0
transcriptional 0
enhancers 0
, 0
and 0
activated 0
expression 0
of 0
HPV 0
- 0
16 0
oncogenes 0
dependent 0
on 0
chromosomal 0
integration 0
may 0
positively 0
select 0
tumorigenic 0
cells 0
during 0
the 0
multistep 0
etiology 0
of 0
cervical 0
cancer 0
. 0

Vancomycin 0
and 0
tetracycline 0
eliminated 0
toxin 0
in 0
stools 0
and 0
delayed 0
death 0
. 0

This 0
combination 0
is 0
considered 0
pathognomonic 0
for 0
factitious 0
hyperinsulinism 0
. 0

The 0
duration 0
of 0
naloxone 0
appears 0
to 0
be 0
dose 0
- 0
related 0
, 0
statistically 0
significant 0
up 0
to 0
approximately 0
1.5 0
hr 0
. 0

In 0
the 0
present 0
study 0
, 0
we 0
report 0
the 0
entire 0
genomic 0
structure 0
of 0
KCNQ1 B-gene
, 0
which 0
consists 0
of 0
19 0
exons 0
spanning 0
400 0
kb 0
on 0
chromosome 0
11p15.5 0
. 0

A 0
comparison 0
between 0
attenuation 0
- 0
corrected 0
and 0
- 0
uncorrected 0
transmission 0
- 0
emission 0
SPECT 0
images 0
obtained 0
with 0
Tl 0
- 0
201 0
in 0
CAD 0
patients 0

Reconstruction 0
time 0
for 0
a 0
64 0
x 0
64 0
matrix 0
is 0
approximately 0
45 0
s/transaxial 0
slice 0
. 0

The 0
hyperpigmentation 0
is 0
linked 0
to 0
the 0
presence 0
of 0
numerous 0
single 0
melanosomes 0
and 0
polymelanosomes 0
in 0
keratinocytes 0
at 0
all 0
levels 0
of 0
the 0
epidermis 0
, 0
and 0
in 0
dermal 0
Factor B-gene
XIIIa I-gene
- 0
positive 0
dendrocytes 0
. 0

The 0
immediate 0
and 0
remote 0
results 0
of 0
surgical 0
treatment 0
of 0
renal 0
adenocarcinomas 0
. 0

Six 0
patients 0
underwent 0
an 0
electrophysiologic 0
study 0
. 0

In 0
agreement 0
with 0
this 0
, 0
archaea 0
appear 0
to 0
lack 0
eIF5 B-gene
, 0
eIF2B B-gene
and 0
the 0
lysine 0
- 0
rich 0
binding 0
domain 0
for 0
these 0
factors 0
in 0
their 0
eIF2beta B-gene
homolog I-gene
. 0

However 0
, 0
the 0
MCMI 0
- 0
III 0
group 0
profile 0
was 0
significantly 0
lower 0
in 0
magnitude 0
compared 0
with 0
the 0
MCMI 0
- 0
II 0
. 0

Spen B-gene
is 0
the 0
only 0
known 0
homeotic B-gene
protein I-gene
with 0
RNP 0
binding 0
motifs 0
, 0
which 0
indicates 0
that 0
splicing 0
, 0
transport 0
, 0
or 0
other 0
RNA 0
regulatory 0
steps 0
are 0
involved 0
in 0
the 0
diversification 0
of 0
segmental 0
morphology 0
. 0

The 0
existence 0
of 0
universal 0
non 0
- 0
specific 0
mechanism 0
of 0
action 0
of 0
external 0
factors 0
upon 0
the 0
living 0
tissue 0
based 0
on 0
the 0
DEL 0
- 0
reaction 0
is 0
suggested 0
. 0

The 0
impairment 0
of 0
the 0
nocturnal 0
secretion 0
was 0
related 0
to 0
the 0
subjects 0
' 0
age 0
and 0
, 0
for 0
the 0
GH B-gene
secretory 0
pattern 0
only 0
, 0
also 0
to 0
the 0
MMSE 0
score 0
. 0

In 0
this 0
study 0
, 0
we 0
cloned 0
the 0
full 0
- 0
length 0
cDNA 0
of 0
mouse 0
PAX4 B-gene
by 0
RACE 0
( 0
rapid 0
amplification 0
of 0
cDNA 0
ends 0
) 0
using 0
RNA 0
from 0
MIN6 0
cells 0
, 0
a 0
mouse 0
insulinoma 0
cell 0
line 0
. 0

Sixteen 0
patients 0
( 0
25.4 0
% 0
) 0
encountered 0
rejection 0
while 0
weaning 0
at 0
median 0
period 0
of 0
9.5 0
months 0
( 0
range 0
, 0
1 0
- 0
63 0
months 0
) 0
from 0
the 0
start 0
of 0
weaning 0
. 0

Earlier 0
nonoptical 0
methods 0
probably 0
did 0
not 0
include 0
the 0
portion 0
of 0
the 0
film 0
that 0
contained 0
mucus 0
. 0

Antibodies 0
specific 0
to 0
the 0
different 0
members 0
of 0
the 0
Jun B-gene
and 0
Fos B-gene
family I-gene
of I-gene
transcription I-gene
factors I-gene
show 0
that 0
, 0
in 0
gel 0
retardation 0
assays 0
, 0
a 0
Jun B-gene
- I-gene
like I-gene
factor I-gene
is 0
a 0
component 0
of 0
the 0
H3.2 B-gene
specific I-gene
complex I-gene
. 0

CONCLUSIONS 0
: 0
Results 0
of 0
this 0
study 0
suggest 0
that 0
both 0
male 0
and 0
female 0
soldiers 0
who 0
are 0
diagnosed 0
with 0
chlamydia 0
infections 0
have 0
relatively 0
high 0
risks 0
of 0
reinfection 0
through 0
their 0
20s 0
. 0

Here 0
we 0
report 0
that 0
point 0
mutations 0
of 0
the 0
Abd B-gene
- I-gene
B I-gene
gene I-gene
in 0
trans 0
suppress 0
the 0
Fab B-gene
- I-gene
7 I-gene
phenotype I-gene
in 0
a 0
pairing 0
- 0
dependent 0
manner 0
and 0
thus 0
represent 0
a 0
type 0
of 0
transvection 0
. 0

The 0
glucose 0
effect 0
on 0
the 0
pyruvate B-gene
kinase I-gene
gene I-gene
is 0
reversibly 0
antagonized 0
by 0
agents 0
increasing 0
intracellular 0
cAMP 0
. 0

Here 0
, 0
we 0
report 0
the 0
isolation 0
of 0
a 0
new 0
spindle 0
checkpoint 0
gene 0
, 0
mph1 B-gene
( 0
Mps1p B-gene
- I-gene
like I-gene
pombe I-gene
homolog I-gene
) 0
, 0
in 0
the 0
fission 0
yeast 0
Schizosaccharomyces 0
pombe 0
, 0
that 0
is 0
required 0
for 0
checkpoint 0
activation 0
in 0
response 0
to 0
spindle 0
defects 0
. 0
mph1 B-gene
functions 0
upstream 0
of 0
mad2 B-gene
, 0
a 0
previously 0
characterized 0
component 0
of 0
the 0
spindle 0
checkpoint 0
. 0

In 0
addition 0
, 0
measurements 0
of 0
shielded 0
and 0
unshielded 0
syringes 0
containing 0
99mTc 0
- 0
labelled 0
radiopharmaceuticals 0
were 0
carried 0
out 0
. 0

Combination 0
chemotherapy 0
in 0
advanced 0
ovarian 0
cancer 0
. 0

The 0
results 0
in 0
the 0
untreated 0
patients 0
demonstrate 0
the 0
primary 0
importance 0
of 0
bulk 0
reduction 0
at 0
initial 0
laparotomy 0
. 0

Vertebrate 0
U6 B-gene
small I-gene
nuclear I-gene
RNA I-gene
( 0
snRNA 0
) 0
loci 0
exemplify 0
a 0
novel 0
class 0
of 0
polymerase B-gene
III I-gene
- 0
transcribed 0
genes 0
that 0
lack 0
an 0
intragenic 0
control 0
region 0
( 0
ICR 0
) 0
. 0

The 0
well 0
- 0
trained 0
group 0
was 0
measured 0
once 0
in 0
the 0
respiration 0
chamber 0
for 0
36 0
h 0
according 0
to 0
the 0
same 0
protocol 0
. 0

PtdIns B-gene
( I-gene
4,5 I-gene
) I-gene
P2 I-gene
synthesis 0
, 0
on 0
the 0
other 0
hand 0
, 0
is 0
only 0
moderately 0
affected 0
even 0
in 0
fab1Delta B-gene
mutants I-gene
. 0

Protein 0
sequencing 0
, 0
electrophoretic 0
mobility 0
shift 0
assay 0
, 0
and 0
immunoblot 0
analyses 0
identify 0
p54 B-gene
and 0
p47/48 B-gene
as 0
members 0
of 0
the 0
hepatocyte B-gene
nuclear I-gene
factor I-gene
3 I-gene
( 0
HNF3 B-gene
[ 0
forkhead B-gene
] 0
) 0
family 0
of 0
transcription 0
factors 0
. 0
p54 B-gene
belongs 0
to 0
the 0
subfamily 0
of 0
HNF3 B-gene
beta I-gene
proteins I-gene
, 0
while 0
p47/48 B-gene
binding 0
activity 0
includes 0
HNF3 B-gene
gamma I-gene
. 0

Molecular 0
analysis 0
indicated 0
that 0
inactivation 0
of 0
H B-gene
- I-gene
2L I-gene
expression 0
in 0
nearly 0
every 0
null 0
clone 0
resulted 0
from 0
an 0
apparent 0
deletion 0
or 0
rearrangement 0
of 0
5' B-gene
- I-gene
flanking I-gene
and I-gene
5' I-gene
- I-gene
coding I-gene
H I-gene
- I-gene
2L I-gene
sequences I-gene
, 0
with 0
breakpoints 0
consistently 0
mapping 0
to 0
within 0
a 0
550 0
bp 0
GC 0
- 0
rich 0
region 0
between 0
exon 0
1 0
and 0
the 0
middle 0
of 0
intron 0
2 0
. 0

CBD 0
exploration 0
was 0
avoided 0
in 0
7 0
patients 0
with 0
normal 0
POC 0
. 0

These 0
mutations 0
prevent 0
FKBP12 B-gene
- 0
rapamycin 0
binding 0
to 0
TOR2 B-gene
, 0
as 0
assayed 0
with 0
the 0
two 0
- 0
hybrid 0
system 0
. 0

The 0
psbA B-gene
gene I-gene
encodes 0
the 0
D1 B-gene
protein I-gene
of 0
photosystem B-gene
II I-gene
, 0
which 0
is 0
synthesized 0
at 0
very 0
high 0
rates 0
in 0
the 0
light 0
in 0
order 0
to 0
replace 0
photodamaged 0
protein 0
. 0

The 0
TCR B-gene
beta I-gene
enhancer I-gene
was 0
active 0
on 0
both 0
the 0
minimal B-gene
simian I-gene
virus I-gene
40 I-gene
promoter I-gene
and 0
a 0
TCR B-gene
beta I-gene
variable I-gene
gene I-gene
promoter I-gene
in 0
both 0
TCR B-gene
alpha/beta I-gene
+ 0
and 0
TCR B-gene
gamma/delta I-gene
+ 0
T 0
cells 0
. 0

Fibrosis 0
of 0
the 0
adjacent 0
myocardium 0
was 0
seen 0
in 0
five 0
cases 0
. 0

Symptoms 0
, 0
skin 0
- 0
prick 0
tests 0
( 0
SPT 0
) 0
with 0
environmental 0
allergens 0
and 0
Pt 0
salt 0
, 0
total 0
serum B-gene
IgE I-gene
, 0
lung 0
function 0
, 0
and 0
bronchial 0
hyperresponsiveness 0
were 0
assessed 0
by 0
standard 0
procedures 0
. 0

These 0
findings 0
suggest 0
that 0
T3R B-gene
can 0
repress 0
or 0
activate 0
transcription 0
while 0
tethered 0
to 0
the 0
LBD 0
of 0
GAL4 B-gene
- 0
RXR B-gene
and 0
that 0
heterodimerization 0
can 0
occur 0
in 0
vivo 0
without 0
stabilization 0
by 0
hormone 0
response 0
elements 0
. 0

During 0
4 0
% 0
O2 0
ventilation 0
, 0
baseline 0
pulmonary 0
vascular 0
resistance 0
( 0
PVR 0
) 0
and 0
the 0
dilator 0
response 0
to 0
both 0
ACh 0
and 0
SNP 0
were 0
greater 0
in 0
2D 0
lungs 0
. 0

HGF B-gene
treatment 0
increased 0
cyclin B-gene
A I-gene
, 0
cyclin B-gene
G1 I-gene
and 0
nuclear 0
transcriptional 0
factor 0
( 0
NFkappaB B-gene
) 0
protein 0
expression 0
. 0

Surprisingly 0
, 0
in 0
adult 0
animals 0
, 0
the 0
suprabasal 0
expression 0
of 0
dnRXR B-gene
alpha I-gene
significantly 0
reduced 0
the 0
ability 0
of 0
topically 0
applied 0
tRA 0
to 0
stimulate 0
proliferation 0
of 0
undifferentiated 0
keratinocytes 0
in 0
the 0
basal 0
layer 0
of 0
epidermis 0
. 0

A 0
third 0
- 0
order 0
polynominal 0
fit 0
showed 0
a 0
good 0
correlation 0
for 0
the 0
parameter 0
Q* 0
and 0
MTT 0
, 0
whereas 0
T 0
and 0
SImax 0
were 0
found 0
to 0
have 0
a 0
poor 0
correlation 0
. 0

This 0
article 0
focuses 0
on 0
a 0
general 0
approach 0
to 0
the 0
use 0
of 0
ARV 0
agents 0
. 0

Although 0
FKH2 B-gene
is 0
redundant 0
with 0
FKH1 B-gene
in 0
controlling 0
pseudohyphal 0
growth 0
, 0
the 0
two 0
genes 0
have 0
different 0
functions 0
in 0
silencing 0
HMRa B-gene
. 0

These 0
results 0
demonstrate 0
the 0
extensive 0
homology 0
in 0
sequence 0
among 0
light 0
chains 0
of 0
IgM B-gene
kappa I-gene
autoantibodies I-gene
and 0
indicate 0
that 0
a 0
particular 0
V B-gene
kappa I-gene
germ I-gene
line I-gene
gene I-gene
, 0
kappa B-gene
IIIb I-gene
, 0
is 0
expressed 0
as 0
a 0
phylogenetic 0
response 0
to 0
certain 0
self 0
antigens 0
or 0
as 0
part 0
of 0
a 0
selection 0
process 0
by 0
which 0
these 0
autoimmune 0
responses 0
are 0
regulated 0
. 0

The 0
aim 0
of 0
the 0
present 0
study 0
was 0
to 0
investigate 0
the 0
influence 0
of 0
long 0
term 0
intravenous 0
administration 0
of 0
naftidrofuryl 0
( 0
Dusodril 0
- 0
Lipha 0
Arzn 0
) 0
twice 0
daily 0
in 0
a 0
dose 0
of 0
200 0
mg 0
in 0
continuous 0
, 0
4 0
- 0
hour 0
infusion 0
in 0
500 0
ml 0
0.9 0
% 0
NaCl 0
to 0
the 0
patients 0
suffering 0
from 0
a 0
peripheral 0
arterial 0
occlusive 0
disease 0
( 0
PAOD 0
) 0
in 0
a 0
clinical 0
condition 0
with 0
special 0
attention 0
paid 0
to 0
transcutaneous 0
partial 0
oxygen 0
pressure 0
measurements 0
( 0
tcPO2 0
) 0
and 0
rheographic 0
parameters 0
. 0

We 0
concluded 0
that 0
RXR B-gene
- I-gene
gamma I-gene
induced 0
terminal 0
differentiation 0
in 0
SCC 0
lines 0
, 0
suggesting 0
a 0
potential 0
tumor 0
suppressor 0
function 0
for 0
this 0
transcription 0
factor 0
. 0

Finally 0
, 0
there 0
is 0
now 0
appropriate 0
recognition 0
of 0
the 0
pivotal 0
role 0
of 0
BP 0
reduction 0
in 0
forestalling 0
pressure 0
- 0
related 0
cardiovascular 0
complications 0
, 0
even 0
among 0
high 0
- 0
risk 0
persons 0
with 0
diabetes 0
mellitus 0
and 0
renal 0
insufficiency 0
. 0

RNA 0
determinants 0
required 0
for 0
L4 B-gene
- 0
mediated 0
attenuation 0
control 0
of 0
the 0
S10 B-gene
r I-gene
- I-gene
protein I-gene
operon I-gene
of I-gene
Escherichia I-gene
coli I-gene
. 0

The 0
psh3 B-gene
( I-gene
+ I-gene
) I-gene
gene I-gene
encodes 0
a 0
protein 0
of 0
215 0
amino 0
acids 0
, 0
which 0
shares 0
a 0
high 0
degree 0
of 0
structural 0
and 0
functional 0
similarity 0
with 0
Shr3p B-gene
. 0

A 0
very 0
large 0
PC 0
LAN 0
as 0
the 0
basis 0
for 0
a 0
hospital 0
information 0
system 0
. 0

A 0
rapid 0
mixing 0
device 0
for 0
quasielastic 0
light 0
scattering 0
studies 0
of 0
reacting 0
systems 0
. 0

After 0
institution 0
of 0
insulin B-gene
treatment 0
, 0
diabetic 0
control 0
was 0
improved 0
as 0
demonstrated 0
by 0
decreasing 0
levels 0
of 0
HbA1 B-gene
. 0

It 0
is 0
not 0
tested 0
yet 0
, 0
whether 0
the 0
extent 0
of 0
glaucoma 0
damage 0
should 0
be 0
better 0
quantified 0
using 0
reference 0
plane 0
1 0
or 0
2 0
. 0

Based 0
on 0
the 0
deduced 0
amino 0
acid 0
sequence 0
identity 0
we 0
designated 0
GAPC1 B-gene
and 0
GAPC2 B-gene
as 0
group 0
I 0
( 0
97 0
% 0
identical 0
) 0
and 0
GAPC3 B-gene
and 0
GAPC4 B-gene
as 0
group 0
II 0
( 0
99.4 0
% 0
identical 0
) 0
. 0

In 0
analogy 0
to 0
human B-gene
CD70 I-gene
, 0
mCD70 B-gene
transcript I-gene
levels 0
are 0
strongly 0
but 0
transiently 0
up 0
- 0
regulated 0
during 0
lymphocyte 0
activation 0
, 0
which 0
is 0
in 0
line 0
with 0
a 0
role 0
for 0
the 0
CD27 B-gene
- I-gene
CD70 I-gene
receptor I-gene
pair 0
early 0
in 0
the 0
immune 0
response 0
. 0

Both 0
parameters 0
were 0
determined 0
in 0
an 0
individual 0
eye 0
by 0
applying 0
the 0
dye 0
first 0
by 0
iontophoresis 0
and 0
then 0
by 0
intravitreal 0
injection 0
, 0
which 0
allows 0
the 0
influence 0
of 0
fluorescein 0
glucuronide 0
on 0
the 0
fluorophotometric 0
measurements 0
to 0
be 0
excluded 0
. 0

Phase 0
I 0
clinical 0
trial 0
with 0
a 0
combination 0
of 0
methotrexate 0
and 0
mitomycin 0
C 0
. 0

A 0
total 0
of 0
114 0
animals 0
were 0
infected 0
by 0
E. 0
coli 0
O2 0
: 0
K1 0
: 0
H4 0
by 0
the 0
hematogenic 0
route 0
. 0

Expression 0
of 0
a 0
cDNA 0
clone 0
in 0
yeast 0
containing 0
a 0
large 0
portion 0
of 0
the 0
open 0
reading 0
frame 0
produced 0
cAMP B-gene
PDEase I-gene
activity 0
identical 0
in 0
properties 0
to 0
the 0
Drosophila 0
enzyme 0
affected 0
by 0
the 0
dnc B-gene
mutation I-gene
. 0

CONCLUSIONS 0
: 0
These 0
results 0
suggest 0
that 0
, 0
by 0
interacting 0
with 0
cellular 0
transcription 0
factors 0
and 0
cofactors 0
, 0
vIRF B-gene
- I-gene
2 I-gene
may 0
modulate 0
the 0
expression 0
of 0
the 0
early 0
inflammatory 0
genes 0
and 0
potentially 0
deregulate 0
the 0
immune 0
system 0
. 0

It 0
has 0
been 0
demonstrated 0
that 0
stimulation 0
of 0
the 0
pontomesencephalic 0
parabrachial 0
region 0
( 0
PBR 0
) 0
by 0
microinjection 0
of 0
cholinergic 0
drugs 0
or 0
electricity 0
in 0
the 0
cat 0
produces 0
potent 0
pain 0
suppression 0
which 0
is 0
not 0
antagonized 0
by 0
the 0
opiate 0
antagonist 0
, 0
naloxone 0
. 0

AIMS 0
: 0
The 0
aim 0
of 0
this 0
study 0
was 0
to 0
assess 0
static 0
and 0
dynamic 0
bone 0
changes 0
in 0
patients 0
suffering 0
from 0
rickets 0
. 0

The 0
homeodomain B-gene
transcription I-gene
factor I-gene
CDP/cut B-gene
interacts 0
with 0
the 0
cell 0
cycle 0
regulatory 0
element 0
of 0
CDP/cut I-gene

K. 0
, 0
Weiss 0
, 0
M 0
. 0

Thus 0
, 0
IF 0
- 0
laser 0
therapy 0
has 0
a 0
certain 0
antioxidative 0
effect 0
by 0
increasing 0
SOD B-gene
activity 0
in 0
RA 0
patients 0
' 0
blood 0
cells 0
and 0
reducing 0
the 0
production 0
of 0
highly 0
reactive 0
oxygen 0
and 0
nitrogen 0
forms 0
. 0

During 0
hexamethylene 0
bisactamide 0
( 0
HMBA 0
) 0
- 0
induced 0
differentiation 0
of 0
murine 0
erythroleukemia 0
( 0
MEL 0
) 0
cells 0
erythroid 0
genes 0
are 0
transcriptionally 0
activated 0
while 0
c B-gene
- I-gene
myb I-gene
and 0
several 0
other 0
nuclear 0
proto 0
- 0
oncogenes 0
are 0
down 0
- 0
regulated 0
. 0

We 0
now 0
report 0
identification 0
and 0
analysis 0
of 0
transcriptional 0
activities 0
mediated 0
by 0
three 0
cis 0
- 0
acting 0
sites 0
within 0
a 0
90 0
- 0
bp 0
portion 0
of 0
the 0
rDNA 0
enhancer 0
designated 0
the 0
modulator 0
region 0
. 0

Background 0
reduction 0
with 0
various 0
agents 0
had 0
a 0
prominent 0
effect 0
on 0
DTIn1 0
as 0
well 0
as 0
99mTc 0
- 0
DTPA 0
biodistribution 0
. 0

Influence 0
of 0
copper 0
addition 0
. 0

In 0
human 0
WI38 0
cells 0
, 0
the 0
E1B B-gene
19K I-gene
gene I-gene
mutant I-gene
viruses 0
had 0
a 0
substantial 0
growth 0
advantage 0
over 0
the 0
wild 0
- 0
type 0
virus 0
, 0
yielding 0
500 0
- 0
fold 0
- 0
higher 0
titers 0
. 0

The 0
cooperation 0
between 0
health 0
and 0
hospital 0
services 0

The 0
N 0
- 0
terminal 0
sequence 0
of 0
the 0
extracellular B-gene
MEP20 I-gene
, 0
TKVAS B-gene
, 0
was 0
found 0
at 0
aa 0
194 0
- 0
198 0
within 0
the 0
ORF 0
. 0

Furthermore 0
, 0
mutations 0
in 0
element 0
II 0
result 0
in 0
changes 0
in 0
the 0
RNA 0
structure 0
near 0
element 0
III 0
, 0
consistent 0
with 0
a 0
long 0
- 0
range 0
interaction 0
that 0
may 0
promote 0
translation 0
. 0

( 0
We 0
observed 0
a 0
ferritin B-gene
value 0
as 0
high 0
as 0
47 0
mg/L 0
in 0
one 0
patient 0
. 0
) 0
Results 0
with 0
all 0
these 0
kits 0
did 0
not 0
inter 0
- 0
compare 0
well 0
for 0
ferritin B-gene
concentrations 0
greater 0
than 0
300 0
micrograms/L 0
, 0
a 0
finding 0
that 0
casts 0
further 0
doubt 0
on 0
the 0
controversial 0
use 0
of 0
serum B-gene
ferritin I-gene
measurement 0
in 0
cases 0
of 0
iron 0
overload 0
. 0

Most 0
other 0
differences 0
between 0
these 0
two 0
Leporipoxviruses 0
are 0
located 0
in 0
the 0
telomeres 0
. 0

The 0
Tat B-gene
protein I-gene
coded 0
by 0
human 0
immunodeficiency 0
virus 0
( 0
HIV 0
) 0
is 0
a 0
strong 0
activator 0
of 0
viral 0
gene 0
expression 0
from 0
the 0
long 0
terminal 0
repeat 0
( 0
LTR 0
) 0
. 0

A 0
. 0

This 0
case 0
report 0
describes 0
the 0
treatment 0
of 0
a 0
patient 0
with 0
periodontosis 0
. 0

Upstream 0
tissue B-gene
inhibitor I-gene
of I-gene
metalloproteinases I-gene
- I-gene
1 I-gene
( I-gene
TIMP I-gene
- I-gene
1 I-gene
) I-gene
element I-gene
- I-gene
1 I-gene
, 0
a 0
novel 0
and 0
essential 0
regulatory 0
DNA 0
motif 0
in 0
the 0
human B-gene
TIMP I-gene
- I-gene
1 I-gene
gene I-gene
promoter I-gene
, 0
directly 0
interacts 0
with 0
a 0
30 0
- 0
kDa 0
nuclear 0
protein 0
. 0

We 0
propose 0
that 0
U73 B-gene
is 0
involved 0
in 0
methylation 0
of 0
the 0
G1739 0
residue 0
of 0
the 0
human B-gene
28S I-gene
rRNA I-gene
. 0

Also 0
, 0
the 0
placebo 0
nondepressed 0
patients 0
had 0
significantly 0
better 0
treatment 0
outcome 0
compared 0
with 0
the 0
placebo 0
depressed 0
patients 0
. 0

Animals 0
were 0
divided 0
into 0
six 0
equal 0
groups 0
as 0
follows 0
: 0
( 0
1 0
) 0
no 0
oral 0
drug 0
( 0
water 0
) 0
, 0
no 0
hemodilution 0
, 0
no 0
IV 0
drug 0
( 0
saline 0
) 0
; 0
( 0
2 0
) 0
oral 0
water 0
, 0
hemodilution 0
, 0
IV 0
saline 0
; 0
( 0
3 0
) 0
oral 0
water 0
, 0
no 0
hemodilution 0
, 0
IV 0
propranolol 0
; 0
( 0
4 0
) 0
oral 0
water 0
, 0
hemodilution 0
, 0
IV 0
propranolol 0
; 0
( 0
5 0
) 0
oral 0
propranolol 0
, 0
no 0
hemodilution 0
, 0
IV 0
saline 0
; 0
and 0
( 0
6 0
) 0
oral 0
propranolol 0
, 0
hemodilution 0
, 0
IV 0
saline 0
. 0

We 0
found 0
4 0
highly 0
conserved 0
regions 0
to 0
vertebrate B-gene
Hsp90 I-gene
exclusively 0
and 0
27 0
amino 0
acids 0
conserved 0
among 0
but 0
differing 0
between 0
Hsp90 B-gene
alpha I-gene
and 0
Hsp90 B-gene
beta I-gene
sequences I-gene
. 0

Four 0
newborns 0
in 0
this 0
group 0
became 0
HBsAg B-gene
carriers 0
. 0

It 0
tends 0
to 0
be 0
higher 0
between 0
frazioni 0
of 0
the 0
same 0
community 0
than 0
between 0
communities 0
. 0

In 0
previous 0
studies 0
, 0
we 0
showed 0
that 0
the 0
nuclear 0
import 0
of 0
SREBP B-gene
- I-gene
2 I-gene
occurs 0
via 0
the 0
direct 0
interaction 0
of 0
importin B-gene
beta I-gene
with 0
the 0
HLH 0
- 0
Zip 0
domain 0
. 0

The 0
destruction 0
of 0
the 0
mesometrium 0
did 0
not 0
lengthen 0
the 0
oestrous 0
cycle 0
. 0

Ftz B-gene
, 0
on 0
the 0
other 0
hand 0
, 0
influences 0
Ftz B-gene
- 0
F1 B-gene
activity 0
by 0
interacting 0
with 0
its 0
AF 0
- 0
2 0
domain 0
in 0
a 0
manner 0
that 0
mimics 0
a 0
nuclear 0
receptor 0
coactivator 0
. 0

Type 0
C 0
units 0
summate 0
the 0
responses 0
to 0
the 0
two 0
- 0
tone 0
stimulus 0
, 0
and 0
show 0
little 0
or 0
no 0
inhibitory 0
influences 0
. 0

19 0
, 0
4967 0
- 0
4973 0
) 0
. 0

CONCLUSIONS 0
: 0
In 0
the 0
majority 0
of 0
patients 0
with 0
severe 0
ulcerative 0
colitis 0
, 0
circulating 0
concentrations 0
of 0
NOX 0
are 0
increased 0
at 0
presentation 0
and 0
fall 0
promptly 0
during 0
parenteral 0
steroid 0
therapy 0
, 0
irrespective 0
of 0
clinical 0
outcome 0
. 0

A 0
cDNA 0
for 0
human B-gene
microfibril I-gene
- I-gene
associated I-gene
glycoprotein I-gene
- I-gene
2 I-gene
( 0
MAGP B-gene
- I-gene
2 I-gene
) 0
was 0
used 0
to 0
screen 0
a 0
human 0
leukocyte 0
genomic 0
DNA 0
library 0
in 0
EMBL 0
- 0
3 0
vector 0
. 0

Screening 0
of 0
a 0
human 0
foetal 0
brain 0
genomic 0
DNA 0
library 0
allowed 0
us 0
to 0
isolate 0
an 0
EcoRI B-gene
- 0
EcoRI B-gene
fragment 0
containing 0
6 0
kb 0
of 0
the 0
5' 0
- 0
flanking 0
region 0
, 0
the 0
open 0
reading 0
frame 0
and 0
4 0
kb 0
of 0
the 0
3' 0
- 0
flanking 0
region 0
of 0
the 0
alpha2C4 B-gene
gene I-gene
. 0

Using 0
gel 0
retardation 0
analysis 0
, 0
four 0
binding 0
sites 0
for 0
Rap1p B-gene
have 0
been 0
identified 0
within 0
the 0
promoter 0
of 0
the 0
RAP1 B-gene
gene I-gene
. 0

They 0
are 0
transduced 0
through 0
TM 0
to 0
the 0
cytoplasmic 0
portion 0
( 0
cytoloops 0
and 0
the 0
C 0
- 0
terminal 0
tail 0
) 0
of 0
the 0
receptor 0
and 0
then 0
, 0
transferred 0
to 0
cytoplasmic 0
signaling 0
molecules 0
, 0
such 0
as 0
G B-gene
protein I-gene
. 0

Sgs B-gene
- I-gene
4 I-gene
is 0
one 0
of 0
the 0
eight 0
known 0
genes 0
coding 0
for 0
larval 0
secretion 0
proteins 0
in 0
Drosophila 0
melanogaster 0
. 0

Unlike 0
CSK B-gene
, 0
the 0
SH3 B-gene
domain I-gene
of 0
HYL B-gene
was 0
unique 0
since 0
the 0
ALYDY 0
motif 0
was 0
absent 0
. 0

This 0
enzyme 0
is 0
distinct 0
from 0
other 0
known 0
E3s B-gene
, 0
including 0
E3 B-gene
alpha/UBR1 I-gene
, 0
alpha/UBR1 I-gene

RESULTS 0
: 0
Although 0
low 0
levels 0
of 0
vIRF B-gene
- I-gene
2 I-gene
mRNAs I-gene
can 0
be 0
detected 0
in 0
the 0
HHV 0
- 0
8 0
- 0
positive 0
BCBL 0
- 0
1 0
tumor 0
cell 0
line 0
, 0
12 0
- 0
0 0
- 0
tetradecanoylphorbol 0
- 0
13 0
- 0
acetate 0
( 0
TPA 0
) 0
treatment 0
does 0
not 0
stimulate 0
expression 0
of 0
vIRF B-gene
- I-gene
2 I-gene
gene I-gene
together 0
with 0
primary 0
lytic 0
cycle 0
genes 0
. 0

Primary 0
TJRs 0
were 0
clinically 0
evaluated 0
for 0
degree 0
of 0
osteoarthrosis 0
. 0

We 0
suggest 0
that 0
this 0
relatively 0
small 0
deletion 0
affects 0
a 0
segment 0
containing 0
3 B-gene
' I-gene
VH I-gene
genes I-gene
with 0
important 0
regulatory 0
functions 0
, 0
the 0
loss 0
of 0
which 0
leads 0
to 0
the 0
ali 0
phenotype 0
. 0

Apoptosis 0
triggered 0
through 0
Fas B-gene
and 0
F/F B-gene
was 0
inhibited 0
by 0
coexpression 0
of 0
CrmA B-gene
and 0
p35 B-gene
, 0
but 0
not 0
Bcl B-gene
- I-gene
xL I-gene
. 0

Expression 0
of 0
Helios B-gene
was 0
detected 0
in 0
the 0
earliest 0
hematopoietic 0
sites 0
of 0
the 0
embryo 0
, 0
in 0
hematopoietic 0
stem 0
cells 0
in 0
the 0
adult 0
and 0
was 0
subsequently 0
restricted 0
to 0
a 0
subset 0
of 0
cells 0
in 0
the 0
T 0
cell 0
lineage 0
. 0

It 0
produced 0
extrapyramidal 0
disturbances 0
in 0
nearly 0
every 0
subject 0
, 0
the 0
most 0
common 0
being 0
akathisia 0
and 0
the 0
most 0
severe 0
, 0
in 0
the 0
case 0
of 0
one 0
individual 0
, 0
being 0
acute 0
dystonia 0
. 0

Electron 0
microscopy 0
of 0
pH 0
7.5 0
- 0
treated 0
TMV 0
particles 0
incubated 0
in 0
SPN B-gene
- 0
treated 0
wheatgerm 0
extract 0
or 0
rabbit 0
reticulocyte 0
lysate 0
, 0
showed 0
that 0
approximately 0
10 0
% 0
of 0
virions 0
complexed 0
with 0
one 0
ribosome 0
and 0
approximately 0
10 0
% 0
with 0
two 0
bound 0
ribosomes 0
, 0
confirming 0
that 0
omega 0
at 0
least 0
had 0
been 0
uncoated 0
. 0

The 0
absorbance 0
of 0
the 0
eluent 0
was 0
monitored 0
at 0
254 0
nm 0
. 0

As 0
anticipated 0
, 0
both 0
intracellular 0
p54 B-gene
- 0
SAPKbeta B-gene
activation 0
and 0
Bcl B-gene
- I-gene
2 I-gene
phosphorylation 0
are 0
blocked 0
by 0
co 0
- 0
transfection 0
with 0
the 0
MAP B-gene
kinase I-gene
specific 0
phosphatase 0
MKP3/PYST1 B-gene
. 0

All 0
patients 0
studied 0
were 0
pregnant 0
women 0
and 0
their 0
delivered 0
children 0
. 0

PRP20 B-gene
is 0
related 0
, 0
both 0
in 0
structure 0
and 0
function 0
, 0
to 0
the 0
RCC1 B-gene
gene I-gene
of 0
mammals 0
and 0
the 0
PIM1 B-gene
gene I-gene
of 0
Schizosaccharomyces 0
pombe 0
, 0
both 0
of 0
which 0
appear 0
to 0
regulate 0
entry 0
into 0
mitosis 0
and 0
chromosome 0
condensation 0
. 0

Using 0
this 0
oligonucleotide 0
as 0
a 0
probe 0
, 0
an 0
8 0
- 0
kilobase 0
HindIII B-gene
fragment 0
of 0
genomic 0
DNA 0
was 0
isolated 0
and 0
subjected 0
to 0
Sanger 0
dideoxy 0
DNA 0
sequencing 0
. 0

The 0
Rep B-gene
proteins I-gene
of 0
adeno 0
- 0
associated 0
virus 0
type 0
2 0
( 0
AAV 0
) 0
are 0
known 0
to 0
bind 0
to 0
Rep B-gene
recognition I-gene
sequences I-gene
( 0
RRSs B-gene
) 0
in 0
the 0
AAV 0
inverted 0
terminal 0
repeats 0
( 0
ITRs 0
) 0
, 0
the 0
AAV B-gene
p5 I-gene
promoter I-gene
, 0
and 0
the 0
preferred 0
AAV 0
integration 0
site 0
in 0
human 0
chromosome 0
19 0
, 0
called 0
AAVS1 0
. 0

The 0
electrocardiogram 0
in 0
tachycardia 0
. 0

It 0
is 0
noteworthy 0
that 0
under 0
more 0
physiological 0
conditions 0
mimicking 0
the 0
cellular 0
GDP/GTP 0
ratio 0
, 0
Raf B-gene
enhances 0
the 0
GEF B-gene
- 0
stimulated 0
GDP/GTP 0
exchange 0
on 0
Ha B-gene
- I-gene
Ras I-gene
, 0
in 0
agreement 0
with 0
the 0
sequestration 0
of 0
Ras.GTP B-gene
by 0
Raf B-gene
. 0

In 0
this 0
study 0
, 0
we 0
show 0
that 0
HNF B-gene
- I-gene
4 I-gene
, 0
a 0
member 0
of 0
the 0
steroid B-gene
hormone I-gene
receptor I-gene
superfamily I-gene
, 0
binds 0
the 0
AF B-gene
- I-gene
1 I-gene
site I-gene
on 0
the 0
apoB B-gene
promoter I-gene
and 0
through 0
it 0
activates 0
transcription 0
in 0
transient 0
transfection 0
assays 0
in 0
both 0
liver 0
and 0
non 0
- 0
liver 0
cell 0
lines 0
, 0
HepG2 0
and 0
HeLa 0
, 0
respectively 0
. 0

In 0
Cos 0
7 0
cells 0
transfected 0
with 0
oCRF1var B-gene
, 0
cAMP 0
accumulation 0
was 0
only 0
observed 0
at 0
the 0
highest 0
concentration 0
of 0
oCRF B-gene
utilized 0
( 0
100 0
nM 0
) 0
. 0

Usefulness 0
of 0
glucocorticoids 0
in 0
the 0
treatment 0
of 0
congestive 0
heart 0
failure 0

RESULTS 0
: 0
In 0
76 0
trials 0
, 0
5,351 0
patients 0
received 0
24 0
different 0
regimens 0
of 0
droperidol 0
. 0

The 0
local 0
median 0
scores 0
( 0
ranges 0
) 0
of 0
the 0
above 0
tests 0
were 0
as 0
follows 0
- 0
AMT 0
: 0
9 0
( 0
6 0
- 0
10 0
) 0
; 0
CMMS 0
: 0
25 0
( 0
16 0
- 0
28 0
) 0
; 0
SBT 0
: 0
2 0
( 0
0 0
- 0
10 0
) 0
; 0
WL 0
- 0
i 0
: 0
17 0
( 0
8 0
- 0
27 0
) 0
; 0
WL 0
- 0
d 0
: 0
5 0
( 0
0 0
- 0
10 0
) 0
; 0
WL 0
- 0
r 0
: 0
9 0
( 0
1 0
- 0
10 0
) 0
; 0
ST 0
: 0
13 0
( 0
6 0
- 0
25 0
) 0
; 0
BNT 0
: 0
14 0
( 0
10 0
- 0
15 0
) 0
; 0
CPT 0
: 0
1 0
( 0
0 0
- 0
3 0
) 0
; 0
BDT 0
: 0
19 0
( 0
0 0
- 0
42 0
) 0
; 0
OAT 0
: 0
20 0
( 0
3 0
- 0
33 0
) 0
. 0

The 0
organization 0
of 0
the 0
MBP B-gene
- I-gene
A I-gene
gene I-gene
is 0
very 0
similar 0
to 0
the 0
arrangement 0
of 0
the 0
gene 0
encoding 0
the 0
highly 0
homologous B-gene
pulmonary I-gene
surfactant I-gene
apoprotein I-gene
, 0
although 0
one 0
of 0
the 0
intron 0
positions 0
is 0
shifted 0
by 0
a 0
single 0
amino 0
acid 0
. 0

Plasma B-gene
renin I-gene
activity 0
in 0
essential 0
arterial 0
hypertension 0
. 0

In 0
vitro 0
, 0
cytokine 0
- 0
or 0
hypoxia 0
- 0
induced 0
up 0
- 0
regulation 0
of 0
Fas B-gene
expression 0
is 0
associated 0
with 0
RTC 0
apoptosis 0
. 0

These 0
results 0
suggest 0
that 0
the 0
Reg1 B-gene
- 0
Glc7 B-gene
phosphatase 0
is 0
a 0
cytoplasmic 0
component 0
of 0
the 0
machinery 0
responsible 0
for 0
returning 0
Snf1 B-gene
kinase I-gene
activity 0
to 0
its 0
basal 0
level 0
and 0
reestablishing 0
glucose 0
repression 0
. 0

To 0
explore 0
further 0
the 0
role 0
of 0
the 0
carboxyl 0
- 0
terminal 0
domain 0
in 0
determining 0
the 0
cell 0
cycle 0
function 0
of 0
CDC34 B-gene
, 0
we 0
constructed 0
and 0
characterized 0
genes 0
encoding 0
chimeric B-gene
E2s I-gene
incorporating 0
sequences 0
from 0
CDC34 B-gene
and 0
the 0
related 0
but 0
functionally 0
distinct 0
E2 B-gene
RAD6 B-gene
( 0
UBC2 B-gene
) 0
. 0

In 0
F9 0
, 0
which 0
is 0
a 0
prototype 0
of 0
embryonal 0
carcinoma 0
cells 0
expressing 0
hst B-gene
, 0
the 0
expression 0
of 0
hst B-gene
gene I-gene
is 0
positively 0
regulated 0
by 0
a 0
downstream 0
octamer 0
motif 0
that 0
functions 0
as 0
an 0
enhancer 0
. 0

Furthermore 0
, 0
rubella B-gene
IgM I-gene
antibody I-gene
was 0
never 0
detected 0
after 0
immunization 0
in 0
women 0
who 0
were 0
HAI 0
- 0
negative 0
and 0
LA 0
- 0
positive 0
during 0
pregnancy 0
. 0

Since 0
simian B-gene
virus I-gene
40 I-gene
( I-gene
SV40 I-gene
) I-gene
large I-gene
T I-gene
antigen I-gene
and 0
human B-gene
papillomavirus I-gene
type I-gene
16 I-gene
( I-gene
HPV16 I-gene
) I-gene
E7 I-gene
protein I-gene
also 0
bind 0
host 0
regulatory 0
factors 0
, 0
we 0
investigated 0
whether 0
these 0
viral 0
proteins 0
can 0
complement 0
E1A B-gene
mutants I-gene
which 0
are 0
defective 0
in 0
early 0
gene 0
activation 0
. 0

Only 0
viable 0
bacteria 0
at 0
a 0
high 0
concentration 0
induced 0
purulent 0
otitis 0
media 0
, 0
which 0
was 0
culture 0
positive 0
in 0
58 0
% 0
of 0
the 0
cases 0
on 0
day 0
4 0
. 0

Results 0
indicated 0
that 0
hobbies/leisure 0
activities 0
, 0
mobility 0
, 0
transport 0
, 0
social 0
relationships 0
, 0
working 0
capacity 0
, 0
energy 0
and 0
doing 0
things 0
slower 0
were 0
aspects 0
relevant 0
to 0
IPF 0
patients 0
' 0
QOL 0
. 0

Residues 0
that 0
affect 0
PLCbeta B-gene
and 0
adenylyl B-gene
cyclase I-gene
II I-gene
activity 0
are 0
found 0
on 0
opposite 0
sides 0
of 0
the 0
central 0
tunnel 0
, 0
suggesting 0
that 0
PLC B-gene
and 0
adenylyl B-gene
cyclase I-gene
, 0
like 0
the 0
alpha 0
subunit 0
, 0
make 0
many 0
contacts 0
on 0
the 0
top 0
surface 0
. 0

One 0
new 0
ORF 0
, 0
YBR0224 B-gene
, 0
was 0
detected 0
, 0
coding 0
for 0
a 0
protein 0
with 0
918 0
amino 0
acids 0
. 0

The 0
law 0
and 0
the 0
chiropractor 0
. 0

A 0
distinct 0
5' 0
- 0
sequence 0
in 0
clone 0
hMIWC2 0
suggested 0
an 0
alternative 0
upstream 0
transcription 0
initiation 0
site 0
. 0

Rectal 0
temperatures 0
after 0
the 0
walk 0
were 0
greater 0
( 0
P 0
< 0
.001 0
) 0
in 0
native 0
Simmental 0
( 0
39.87 0
+/ 0
- 0
.05 0
degrees 0
C 0
) 0
than 0
in 0
Bos 0
indicus 0
( 0
39.46 0
+/ 0
- 0
.05 0
degrees 0
C 0
) 0
. 0

98 0
, 0
93 0
- 0
98 0
) 0
. 0

However 0
, 0
the 0
pre3 B-gene
- I-gene
2 I-gene
mutation I-gene
strengthened 0
phenotypes 0
induced 0
by 0
other 0
20 B-gene
S I-gene
proteasomal I-gene
mutations I-gene
, 0
indicating 0
that 0
the 0
peptidylglutamyl 0
peptide 0
- 0
hydrolyzing 0
activity 0
has 0
to 0
fulfill 0
some 0
rescue 0
functions 0
. 0

A 0
mammalian 0
protein 0
called 0
RFX B-gene
or 0
NF B-gene
- I-gene
X I-gene
binds 0
to 0
the 0
X 0
box 0
( 0
or 0
X1 0
box 0
) 0
in 0
the 0
promoters 0
of 0
a 0
number 0
of 0
major B-gene
histocompatibility I-gene
( I-gene
MHC I-gene
) I-gene
class I-gene
II I-gene
genes I-gene
. 0

This 0
result 0
suggests 0
that 0
the 0
target 0
protein 0
specificity 0
of 0
E2s B-gene
can 0
be 0
altered 0
by 0
the 0
addition 0
of 0
appropriate 0
C 0
- 0
terminal 0
extensions 0
, 0
thus 0
providing 0
a 0
way 0
to 0
modify 0
the 0
selectivity 0
of 0
the 0
ubiquitin B-gene
system 0
. 0

This 0
pattern 0
of 0
expression 0
and 0
differential 0
processing 0
suggests 0
a 0
role 0
for 0
inrpk1 B-gene
in 0
some 0
aspect 0
of 0
SD 0
photoperiodic 0
- 0
induced 0
flowering 0
in 0
morning 0
glory 0
. 0

Co 0
- 0
expression 0
of 0
a 0
gag B-gene
- 0
TRalpha B-gene
fusion 0
protein 0
in 0
AEV 0
- 0
transformed 0
cells 0
and 0
addition 0
of 0
ligand 0
derepresses 0
CAII B-gene
transcription 0
. 0

A 0
400 0
- 0
bp 0
fragment 0
( 0
bp 0
- 0
339 0
through 0
+71 0
) 0
of 0
the 0
CD22 B-gene
promoter I-gene
region I-gene
was 0
subcloned 0
into 0
a 0
pGEM 0
- 0
chloramphenicol B-gene
acetyltransferase I-gene
vector 0
and 0
after 0
transfection 0
into 0
B 0
and 0
T 0
cells 0
was 0
found 0
to 0
be 0
active 0
in 0
both 0
B 0
and 0
T 0
cells 0
. 0

This 0
suggests 0
that 0
the 0
duration 0
of 0
varicocele 0
per 0
se 0
could 0
affect 0
DHT 0
seminal 0
plasma 0
levels 0
. 0

Five 0
RNA 0
transcripts 0
of 0
about 0
1.2 0
to 0
1.7 0
kilobases 0
were 0
mapped 0
to 0
a 0
part 0
of 0
the 0
genome 0
of 0
insect 0
iridescent 0
virus 0
type 0
6 0
( 0
Chilo 0
iridescent 0
virus 0
; 0
CIV 0
) 0
between 0
genome 0
coordinates 0
0.832 0
and 0
0.856 0
within 0
the 0
EcoRI B-gene
DNA I-gene
fragment I-gene
F I-gene
. 0

Cutting 0
the 0
intraorbital 0
nerves 0
produced 0
a 0
temporary 0
retrieval 0
impairment 0
that 0
was 0
indistinguishable 0
from 0
that 0
produced 0
by 0
intramystacial 0
lidocaine 0
injection 0
. 0

The 0
comparisons 0
of 0
swimming 0
performance 0
before 0
and 0
after 0
treatments 0
with 0
deltamethrin 0
have 0
shown 0
a 0
significant 0
effect 0
on 0
locomotory 0
ability 0
of 0
rainbow 0
trout 0
which 0
at 0
the 0
end 0
of 0
strong 0
exposure 0
( 0
e.g 0
. 0

Increased 0
trabecular 0
spacing 0
, 0
such 0
as 0
it 0
occurs 0
in 0
osteoporosis 0
, 0
reduces 0
the 0
spatial 0
field 0
inhomogeneity 0
and 0
thus 0
prolongs 0
T2* 0
, 0
which 0
has 0
been 0
shown 0
both 0
in 0
vitro 0
and 0
in 0
vivo 0
. 0

Decidual/trophoblast B-gene
prolactin I-gene
- I-gene
related I-gene
protein I-gene
: 0
characterization 0
of 0
gene 0
structure 0
and 0
cell 0
- 0
specific 0
expression 0
. 0

Thus 0
, 0
the 0
cognitive 0
performance 0
of 0
elderly 0
subjects 0
could 0
be 0
trained 0
to 0
a 0
large 0
extent 0
. 0

The 0
map 0
is 0
based 0
on 0
the 0
CEPH 0
reference 0
pedigrees 0
and 0
includes 0
over 0
4000 0
new 0
genotypes 0
, 0
our 0
previously 0
reported 0
data 0
plus 0
29 0
allele 0
systems 0
from 0
the 0
published 0
CEPH 0
version 0
5 0
database 0
, 0
and 0
was 0
constructed 0
using 0
the 0
program 0
package 0
CRI 0
- 0
MAP 0
. 0

RMR 0
was 0
positively 0
correlated 0
with 0
TEF 0
( 0
r 0
= 0
0.613 0
, 0
p 0
< 0
0.01 0
) 0
and 0
net 0
TEF 0
( 0
r 0
= 0
0.648 0
, 0
p 0
< 0
0.005 0
) 0
in 0
the 0
luteal 0
but 0
not 0
the 0
follicular 0
phase 0
. 0

132 0
varix 0
ligations 0
were 0
performed 0
during 0
44 0
separate 0
EVL 0
sessions 0
. 0

Nine 0
individuals 0
who 0
were 0
stable 0
after 0
1 0
month 0
of 0
therapy 0
at 0
low 0
dosage 0
were 0
randomized 0
to 0
a 0
further 0
month 0
of 0
therapy 0
at 0
low 0
or 0
high 0
dosage 0
, 0
during 0
which 0
one 0
of 0
four 0
at 0
high 0
dosage 0
had 0
a 0
partial 0
response 0
, 0
and 0
none 0
of 0
five 0
at 0
low 0
dosage 0
manifested 0
response 0
. 0

A 0
factor 0
present 0
in 0
nuclear 0
extracts 0
of 0
wounded 0
potato 0
tubers 0
was 0
found 0
to 0
bind 0
specifically 0
to 0
nucleotides 0
located 0
between 0
- 0
135 0
to 0
- 0
105 0
, 0
suggesting 0
that 0
this 0
region 0
contains 0
important 0
cis 0
- 0
regulatory 0
elements 0
. 0

Two 0
genes 0
from 0
the 0
family 0
encoding 0
mouse B-gene
ribosomal I-gene
protein I-gene
S16 I-gene
were 0
cloned 0
, 0
sequenced 0
, 0
and 0
analyzed 0
. 0

Bile 0
reflux 0
demonstrated 0
by 0
99m 0
Tc 0
disofenin 0
. 0

The 0
mode 0
of 0
action 0
is 0
often 0
suggested 0
as 0
an 0
explanation 0
for 0
the 0
different 0
slopes 0
of 0
concentration 0
- 0
effect 0
curves 0
. 0

Two 0
full 0
- 0
length 0
clones 0
( 0
pBCH1 0
and 0
pBCH2 0
) 0
were 0
isolated 0
. 0

In 0
dehydrated 0
animals 0
at 0
Ta 0
38 0
degrees 0
C 0
, 0
Tb 0
and 0
EWL 0
were 0
both 0
significantly 0
altered 0
( 0
P 0
less 0
than 0
0.001 0
) 0
from 0
the 0
normally 0
hydrated 0
state 0
and 0
were 0
measured 0
at 0
39.9 0
+/ 0
- 0
0.2 0
degree 0
C 0
and 0
0.84 0
+/ 0
- 0
0.09 0
W 0
. 0
kg 0
- 0
1 0
respectively 0
. 0

The 0
optimum 0
cooling 0
rate 0
from 0
RT 0
to 0
5 0
degrees 0
C 0
resulting 0
in 0
maximum 0
survival 0
of 0
human 0
spermatozoa 0
was 0
found 0
to 0
be 0
0.5 0
to 0
1 0
degree 0
per 0
minute 0
when 0
cooled 0
from 0
RT 0
to 0
5 0
degrees 0
C 0
and 0
subsequently 0
frozen 0
- 0
thawed 0
in 0
liquid 0
nitrogen 0
( 0
LN2 0
) 0
. 0

Replacement 0
of 0
a 0
valine 0
( 0
V68 0
) 0
in 0
the 0
ETS B-gene
domain 0
of 0
SAP1a B-gene
by 0
aspartic 0
acid 0
( 0
as 0
found 0
in 0
c B-gene
- I-gene
Ets I-gene
- I-gene
1 I-gene
, 0
Elk B-gene
- I-gene
1 I-gene
, 0
and 0
Net B-gene
) 0
enhanced 0
ternary 0
complex 0
formation 0
by 0
more 0
than 0
60 0
- 0
fold 0
. 0

Methylprednisolone 0
and 0
U 0
- 0
74006F 0
were 0
equally 0
effective 0
at 0
preventing 0
neurological 0
dysfunction 0
compared 0
to 0
the 0
control 0
group 0
( 0
p 0
less 0
than 0
0.01 0
) 0
; 0
U 0
- 0
78517F 0
was 0
slightly 0
less 0
effective 0
than 0
U 0
- 0
74006F 0
and 0
methylprednisolone 0
but 0
was 0
significantly 0
better 0
than 0
vehicle 0
in 0
preventing 0
neurological 0
dysfunction 0
. 0

Comparison 0
between 0
the 0
Ricketts 0
and 0
Bimler 0
therapeutic 0
technics 0
in 0
the 0
treatment 0
of 0
cases 0
of 0
class 0
II 0
, 0
division 0
I 0
mmalocclusion 0

Sample 0
size 0
requirement 0
for 0
repeated 0
measurements 0
in 0
continuous 0
data 0
. 0

Transfection 0
assays 0
using 0
the 0
first 0
600 0
bp 0
of 0
the 0
upstream 0
nucleotide 0
sequences 0
indicated 0
that 0
a 0
region 0
from 0
- 0
75 0
to 0
- 0
120 0
was 0
necessary 0
for 0
the 0
ALDH2 B-gene
gene I-gene
expression 0
, 0
and 0
especially 0
NF B-gene
- I-gene
Y/CP1 I-gene
binding 0
site 0
from 0
- 0
92 0
to 0
- 0
96 0
( 0
CCAAT 0
box 0
) 0
is 0
important 0
in 0
the 0
expression 0
of 0
the 0
gene 0
. 0

We 0
report 0
five 0
of 0
13 0
evaluable 0
patients 0
undergoing 0
allogeneic 0
sibling 0
BM 0
or 0
PBSC 0
transplantation 0
for 0
MM 0
between 0
1990 0
and 0
1997 0
who 0
met 0
the 0
criteria 0
for 0
adjuvant 0
alpha B-gene
- I-gene
IFN I-gene
therapy 0
. 0

Both 0
the 0
5 0
' 0
and 0
3 0
' 0
untranslated 0
regions 0
also 0
show 0
significant 0
similarity 0
to 0
the 0
murine 0
gene 0
, 0
with 0
79 0
and 0
70 0
% 0
sequence 0
identity 0
, 0
respectively 0
. 0

Plasma 0
Pi 0
, 0
tibia 0
breaking 0
strength 0
, 0
and 0
percentage 0
of 0
tibia 0
ash 0
were 0
increased 0
by 0
raising 0
dietary 0
Pav 0
in 0
the 0
presence 0
of 0
.392 0
% 0
A1 0
with 0
either 0
level 0
of 0
Ca 0
. 0

A 0
minimal 0
region 0
which 0
stimulates 0
origin 0
function 0
mapped 0
to 0
50 0
amino 0
acids 0
within 0
the 0
C 0
- 0
terminus 0
of 0
Abf1p B-gene
. 0

Hepatocyte B-gene
growth I-gene
factor I-gene
( 0
HGF B-gene
) 0
is 0
an 0
inducible 0
cytokine 0
that 0
is 0
essential 0
for 0
the 0
normal 0
growth 0
and 0
development 0
of 0
various 0
tissues 0
, 0
such 0
as 0
the 0
liver 0
. 0

OBJECTIVE 0
: 0
To 0
summarise 0
quantitatively 0
the 0
association 0
between 0
moderate 0
alcohol 0
intake 0
and 0
biological 0
markers 0
of 0
risk 0
of 0
coronary 0
heart 0
disease 0
and 0
to 0
predict 0
how 0
these 0
changes 0
would 0
lower 0
the 0
risk 0
. 0

( 0
1991 0
) 0
EMBO 0
J 0
. 0

Tissue 0
- 0
specific 0
gene 0
regulation 0
of 0
eukaryotic 0
organisms 0
is 0
to 0
a 0
large 0
extent 0
mediated 0
by 0
transcription 0
factors 0
that 0
interact 0
with 0
genomic 0
DNA 0
sequences 0
in 0
a 0
sequence 0
- 0
specific 0
manner 0
. 0

Teratospermia 0
is 0
therefore 0
an 0
important 0
factor 0
in 0
evaluating 0
fertilization 0
capacity 0
. 0

Genomic 0
DNA 0
blot 0
analysis 0
indicates 0
that 0
the 0
trout B-gene
L2 I-gene
locus I-gene
has 0
a 0
cluster 0
- 0
like 0
organization 0
similar 0
to 0
the 0
trout B-gene
L1 I-gene
locus I-gene
and 0
the 0
IgL B-gene
locus I-gene
of 0
several 0
teleost 0
fish 0
. 0

Genetic 0
polymorphisms 0
in 0
the 0
5' 0
- 0
flanking 0
region 0
change 0
transcriptional 0
regulation 0
of 0
the 0
human B-gene
cytochrome I-gene
P450IIE1 I-gene
gene I-gene
. 0

As 0
exogenously 0
expressed 0
PKR B-gene
can 0
form 0
heterodimers 0
with 0
endogenous B-gene
PKR I-gene
, 0
the 0
results 0
obtained 0
on 0
the 0
functional 0
characterization 0
of 0
mutant 0
forms 0
of 0
PKR B-gene
have 0
been 0
taken 0
with 0
caution 0
. 0

Basal 0
JNK B-gene
MAPK I-gene
kinase I-gene
activity 0
was 0
also 0
specifically 0
induced 0
by 0
deltaEGFR B-gene
, 0
which 0
correlated 0
with 0
increased 0
phosphorylation 0
of 0
a 0
54 B-gene
- I-gene
kDa I-gene
JNK2 I-gene
protein I-gene
observed 0
in 0
deltaEGFR B-gene
- 0
containing 0
cells 0
. 0

Isolation 0
and 0
properties 0
of 0
Drosophila B-gene
melanogaster I-gene
ferritin I-gene
- 0
- 0
molecular 0
cloning 0
of 0
a 0
cDNA 0
that 0
encodes 0
one 0
subunit 0
, 0
and 0
localization 0
of 0
the 0
gene 0
on 0
the 0
third 0
chromosome 0
. 0

The 0
single 0
- 0
copy 0
U20 B-gene
sequence I-gene
is 0
located 0
on 0
the 0
same 0
DNA 0
strand 0
as 0
the 0
nucleolin B-gene
mRNA I-gene
. 0

Maximum 0
baroreceptor 0
activity 0
measured 0
at 0
140 0
mm 0
Hg 0
and 0
the 0
slope 0
of 0
the 0
pressure 0
- 0
activity 0
curve 0
were 0
reduced 0
in 0
atherosclerotic 0
( 0
n 0
= 0
15 0
) 0
compared 0
with 0
normal 0
( 0
n 0
= 0
13 0
) 0
rabbits 0
( 0
425 0
+/ 0
- 0
34 0
versus 0
721 0
+/ 0
- 0
30 0
spikes 0
per 0
second 0
and 0
6.2 0
+/ 0
- 0
0.6 0
versus 0
10.8 0
+/ 0
- 0
0.8 0
spikes 0
per 0
second 0
per 0
mm 0
Hg 0
, 0
respectively 0
, 0
P 0
< 0
.05 0
) 0
. 0

The 0
effective 0
use 0
of 0
superoxide B-gene
dismutase I-gene
from 0
human 0
erythrocytes 0
in 0
the 0
late 0
stages 0
of 0
experimental 0
influenza 0
infection 0

EMT B-gene
was 0
localized 0
to 0
chromosome 0
5q31 0
- 0
32 0
, 0
a 0
region 0
that 0
contains 0
the 0
genes 0
for 0
several 0
growth 0
factors 0
and 0
receptors 0
as 0
well 0
as 0
early 0
activation 0
genes 0
, 0
particularly 0
those 0
involved 0
in 0
the 0
hematopoietic 0
system 0
. 0

However 0
, 0
neither 0
SF B-gene
- I-gene
1 I-gene
nor 0
NGF B-gene
- I-gene
IB I-gene
alone 0
, 0
binding 0
as 0
monomers 0
, 0
increases 0
transcription 0
. 0

Both 0
purH B-gene
and 0
purD B-gene
genes I-gene
constitute 0
a 0
single 0
operon 0
and 0
are 0
coregulated 0
in 0
expression 0
by 0
purines 0
as 0
other 0
purine B-gene
genes I-gene
are 0
. 0

Fluorescence 0
in 0
situ 0
hybridization 0
was 0
used 0
to 0
investigate 0
the 0
physical 0
distribution 0
and 0
revealed 0
that 0
both 0
retrotransposon 0
families 0
are 0
present 0
on 0
all 0
sugar 0
beet 0
chromosomes 0
and 0
largely 0
excluded 0
from 0
chromosomal 0
regions 0
harbouring 0
the 0
18S B-gene
- 0
5.8S B-gene
- 0
25S B-gene
rRNA 0
genes 0
. 0

Application 0
of 0
the 0
method 0
using 0
an 0
11 0
- 0
year 0
microseismicity 0
record 0
revealed 0
systematic 0
spatial 0
and 0
temporal 0
changes 0
in 0
the 0
slip 0
rate 0
that 0
were 0
synchronous 0
with 0
earthquake 0
activity 0
and 0
other 0
independent 0
measures 0
of 0
fault 0
- 0
zone 0
slip 0
. 0

Furthermore 0
, 0
we 0
have 0
identified 0
the 0
major 0
open 0
reading 0
frame 0
( 0
RF4 0
; 0
2.3 0
kb 0
) 0
as 0
being 0
essential 0
for 0
activation 0
, 0
and 0
we 0
have 0
shown 0
that 0
the 0
NF B-gene
kappa I-gene
B I-gene
, 0
SP1 B-gene
, 0
and 0
TATA 0
box 0
motifs 0
in 0
the 0
human B-gene
immunodeficiency I-gene
virus I-gene
LTR I-gene
are 0
all 0
required 0
for 0
full 0
induction 0
of 0
the 0
promoter 0
by 0
the 0
HHV B-gene
- I-gene
6 I-gene
- I-gene
encoded I-gene
transactivator I-gene
. 0

Two 0
conserved 0
motifs 0
, 0
W89RKRRY94 0
and 0
P156KKIKP161 0
, 0
seemed 0
to 0
act 0
as 0
nuclear 0
addressing 0
signals 0
. 0

All 0
testosterone 0
treatments 0
raised 0
plasma 0
testosterone 0
concentrations 0
above 0
control 0
and 0
pretreatment 0
levels 0
( 0
testosterone 0
and 0
synovex 0
+ 0
testosterone 0
> 0
synovex 0
> 0
control 0
; 0
all 0
P 0
< 0
0.05 0
) 0
. 0

The 0
educational 0
program 0
was 0
the 0
significant 0
factor 0
that 0
influenced 0
the 0
change 0
of 0
concern 0
trajectories 0
, 0
and 0
the 0
recurrent/non 0
- 0
recurrent 0
factor 0
influenced 0
the 0
change 0
of 0
concern 0
only 0
in 0
pamphlet 0
group 0
. 0

Biol 0
. 0

Snails 0
infected 0
with 0
three 0
or 0
five 0
miracidia 0
produced 0
more 0
metacercariae 0
than 0
those 0
infected 0
with 0
a 0
single 0
miracidium 0
. 0

Evidence 0
that 0
the 0
AT1A B-gene
receptor I-gene
activates 0
transcription B-gene
factor I-gene
- I-gene
Stat91 I-gene
and/or 0
a 0
related 0
protein 0
. 0

Two 0
estimates 0
of 0
the 0
fractal 0
exponent 0
are 0
considered 0
which 0
do 0
not 0
suffer 0
from 0
this 0
limit 0
: 0
one 0
derived 0
from 0
the 0
Allan 0
variance 0
, 0
which 0
was 0
developed 0
by 0
the 0
authors 0
, 0
and 0
one 0
based 0
on 0
the 0
periodogram 0
. 0

The 0
full 0
- 0
length 0
cDNA 0
was 0
cloned 0
and 0
sequenced 0
, 0
and 0
the 0
inferred 0
amino 0
acid 0
sequence 0
was 0
found 0
to 0
encode 0
a 0
novel 0
protein 0
, 0
which 0
we 0
named 0
cystatin B-gene
M I-gene
, 0
with 0
40 0
% 0
homology 0
to 0
human B-gene
family I-gene
2 I-gene
cystatins I-gene
and 0
similar 0
overall 0
structure 0
. 0

Thus 0
, 0
oxyR B-gene
mutants I-gene
are 0
locked 0
on 0
for 0
Ag43 B-gene
expression 0
, 0
whereas 0
dam B-gene
mutants I-gene
are 0
locked 0
off 0
for 0
Ag43 B-gene
expression 0
. 0

GH B-gene
induced 0
rapid 0
tyrosine 0
phosphorylation 0
of 0
a 0
protein 0
at 0
approximately 0
93 0
kDa 0
in 0
normal 0
fibroblasts 0
, 0
and 0
Western 0
blotting 0
with 0
STAT B-gene
- I-gene
specific I-gene
antibodies I-gene
revealed 0
STAT5 B-gene
activation 0
( 0
phosphorylation 0
) 0
by 0
GH 0
. 0

The 0
team 0
physician 0
and 0
conditioning 0
of 0
athletes 0
for 0
sports 0
: 0
a 0
consensus 0
statement 0
. 0

Experimental 0
exposure 0
of 0
poults 0
with 0
each 0
of 0
two 0
strains 0
representing 0
the 0
rarely 0
reported 0
capsular 0
group 0
B 0
indicated 0
that 0
both 0
were 0
virulent 0
. 0

A 0
drop 0
of 0
methylprednisolone 0
acetate 0
or 0
vehicle 0
constituent 0
was 0
placed 0
on 0
the 0
dissected 0
plantar 0
nerve 0
proximal 0
to 0
the 0
stimulating 0
electrodes 0
after 0
recording 0
control 0
responses 0
( 0
A 0
- 0
fibre 0
volley 0
in 0
the 0
sciatic 0
nerve 0
and 0
C 0
- 0
fibre 0
evoked 0
reflex 0
discharge 0
in 0
flexor 0
motoneurons 0
) 0
. 0

Case 0
of 0
nephrotic 0
syndrome 0
caused 0
by 0
gold 0
preparations 0

Pax B-gene
- I-gene
6 I-gene
constructs 0
lacking 0
the 0
C 0
- 0
terminal 0
activation 0
domain 0
repressed 0
betaB1 B-gene
- I-gene
crystallin I-gene
promoter I-gene
activity 0
as 0
effectively 0
as 0
the 0
full 0
- 0
length 0
protein 0
, 0
but 0
the 0
PD B-gene
alone 0
or 0
Pax B-gene
- I-gene
6 I-gene
( I-gene
5a I-gene
) I-gene
, 0
a 0
splice 0
variant 0
with 0
an 0
altered 0
PD B-gene
affecting 0
its 0
DNA 0
binding 0
specificity 0
, 0
did 0
not 0
. 0

It 0
is 0
considered 0
important 0
, 0
therefore 0
, 0
when 0
treating 0
diabetic 0
patients 0
with 0
peripheral 0
neuropathy 0
not 0
to 0
assume 0
that 0
the 0
diabetes 0
itself 0
is 0
the 0
cause 0
in 0
all 0
cases 0
. 0

A 0
retrospective 0
study 0
of 0
clozapine 0
and 0
electroencephalographic 0
abnormalities 0
in 0
schizophrenic 0
patients 0
. 0

While 0
working 0
on 0
the 0
toxicity 0
of 0
war 0
gases 0
. 0
he 0
formulated 0
'Haber 0
's 0
rule 0
' 0
, 0
also 0
known 0
as 0
C 0
x 0
T= 0
constant 0
in 0
order 0
to 0
characterize 0
the 0
toxicity 0
of 0
an 0
inhalant 0
. 0

Furthermore 0
, 0
the 0
regulation 0
conferred 0
on 0
a 0
reporter 0
gene 0
in 0
Drosophila 0
by 0
three 0
closely 0
related 0
sequences 0
demonstrates 0
that 0
even 0
subtle 0
sequence 0
changes 0
within 0
an 0
E 0
box 0
or 0
flanking 0
bases 0
have 0
dramatic 0
consequences 0
on 0
the 0
overall 0
repertoire 0
of 0
proteins 0
that 0
can 0
bind 0
in 0
vivo 0
. 0

The 0
Sensititre 0
MIC 0
panels 0
containing 0
meropenem 0
offer 0
a 0
convenient 0
and 0
valid 0
alternative 0
to 0
the 0
NCCLS 0
reference 0
method 0
for 0
the 0
susceptibility 0
testing 0
of 0
potential 0
pathogens 0
likely 0
to 0
be 0
recovered 0
from 0
mixed 0
infections 0
. 0

Two 0
putative 0
ATP 0
- 0
binding 0
domains 0
were 0
identified 0
, 0
one 0
in 0
the 0
amino 0
- 0
terminal 0
half 0
of 0
the 0
argA B-gene
- I-gene
encoded I-gene
protein I-gene
and 0
the 0
other 0
in 0
the 0
carboxy 0
- 0
terminal 0
half 0
. 0

Previously 0
, 0
we 0
identified 0
two 0
human B-gene
SMC I-gene
family I-gene
proteins I-gene
, 0
hCAP B-gene
- I-gene
C I-gene
and 0
hCAP B-gene
- I-gene
E I-gene
, 0
which 0
form 0
a 0
heterodimeric 0
complex 0
( 0
hCAP B-gene
- I-gene
C I-gene
- 0
hCAP B-gene
- I-gene
E I-gene
) 0
in 0
the 0
cell 0
. 0

There 0
were 0
no 0
major 0
postoperative 0
complications 0
and 0
at 0
follow 0
- 0
up 0
of 0
the 0
13 0
patients 0
at 0
10 0
to 0
26 0
months 0
after 0
operation 0
the 0
results 0
were 0
satisfactory 0
. 0

The 0
interleukin B-gene
- I-gene
2 I-gene
receptor I-gene
alpha I-gene
( 0
IL B-gene
- I-gene
2R I-gene
alpha I-gene
) 0
chain 0
gene 0
contains 0
a 0
sequence 0
similar 0
to 0
the 0
immunoglobulin B-gene
( I-gene
Ig I-gene
) I-gene
kappa I-gene
( 0
kappa 0
) 0
enhancer 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
binding I-gene
site I-gene
. 0

( 0
1996 0
) 0
J 0
. 0

The 0
presence 0
of 0
a 0
short 0
( 0
70 0
bp 0
) 0
intron 0
near 0
the 0
N 0
- 0
terminus 0
of 0
the 0
atX B-gene
gene I-gene
was 0
predicted 0
that 0
contains 0
the 0
canonical 0
GT 0
and 0
AG 0
dinucleotides 0
at 0
its 0
5' 0
- 0
and 0
3' 0
- 0
splicing 0
junctions 0
. 0

Studies 0
on 0
the 0
reaction 0
of 0
cytochrome B-gene
c I-gene
with 0
corticosteroids 0
. 0

In 0
accordance 0
with 0
Ann 0
Arbor 0
classification 0
, 0
we 0
observed 0
12 0
CS 0
IA 0
( 0
21.3 0
% 0
) 0
, 0
2 0
CS 0
IB 0
( 0
3.5 0
% 0
) 0
, 0
14 0
CS 0
IIA 0
( 0
25.4 0
% 0
) 0
and 0
27 0
CS 0
IIB 0
( 0
49.7 0
% 0
) 0
. 0

The 0
results 0
can 0
be 0
summarized 0
as 0
follows 0
. 0

The 0
level 0
of 0
expression 0
of 0
the 0
PDE B-gene
protein I-gene
was 0
monitored 0
by 0
immunoblot 0
analysis 0
using 0
two 0
specific 0
cAMP B-gene
- I-gene
PDE I-gene
polyclonal I-gene
antibodies I-gene
and 0
by 0
measuring 0
the 0
PDE B-gene
activity 0
. 0

HL B-gene
is 0
hypothesized 0
to 0
directly 0
couple 0
HDL B-gene
lipid 0
metabolism 0
to 0
tissue/cellular 0
lipid 0
metabolism 0
. 0

The 0
analysis 0
of 0
the 0
organization 0
of 0
the 0
sequence 0
of 0
the 0
human 0
ABP/DAO B-gene
gene 0
reveals 0
that 0
the 0
2.4 0
- 0
kilobase 0
messenger 0
RNA 0
is 0
transcribed 0
from 0
two 0
close 0
origins 0
identifying 0
the 0
proximal 0
promoter 0
. 0

Rottlerin 0
also 0
inhibited 0
the 0
activation 0
of 0
MAP B-gene
kinase I-gene
kinase I-gene
( 0
MEK B-gene
) 0
in 0
response 0
to 0
activated 0
Raf B-gene
, 0
but 0
had 0
no 0
effect 0
upon 0
c B-gene
- I-gene
Raf I-gene
activity 0
or 0
ERK B-gene
activation 0
by 0
activated 0
MEK B-gene
. 0

Especially 0
if 0
the 0
number 0
of 0
dimensions 0
of 0
the 0
samples 0
is 0
large 0
, 0
it 0
can 0
be 0
said 0
that 0
BPN 0
is 0
better 0
than 0
k 0
- 0
NN 0
in 0
classification 0
ability 0
. 0

Several 0
DNA 0
clones 0
were 0
obtained 0
by 0
this 0
procedure 0
, 0
one 0
of 0
which 0
, 0
clone 0
18 0
, 0
is 0
reported 0
and 0
characterized 0
here 0
. 0

Immunoprecipitation 0
of 0
cell 0
lysates 0
with 0
anti B-gene
- I-gene
phosphotyrosine I-gene
and 0
immunoblotting 0
showed 0
phosphorylated 0
forms 0
of 0
the 0
mitogenic 0
pathway 0
proteins 0
Shc B-gene
and 0
MAPK B-gene
in 0
addition 0
to 0
p185 B-gene
( 0
neu B-gene
) 0
, 0
suggesting 0
that 0
the 0
Ras B-gene
to 0
MAPK B-gene
mitogenic 0
pathway 0
is 0
activated 0
. 0

The 0
sequence 0
immediately 0
upstream 0
of 0
the 0
translation 0
start 0
site 0
was 0
G 0
+ 0
C 0
rich 0
( 0
greater 0
than 0
75 0
% 0
) 0
and 0
contained 0
a 0
consensus 0
CCAAT 0
sequence 0
despite 0
the 0
absence 0
of 0
a 0
TATA 0
box 0
. 0

The 0
development 0
of 0
various 0
pathological 0
lesions 0
in 0
thymus 0
, 0
spleen 0
, 0
lymph 0
nodes 0
and 0
bone 0
- 0
marrow 0
is 0
frequently 0
observed 0
. 0

RESULTS 0
: 0
After 0
3 0
weeks 0
of 0
therapy 0
, 0
the 0
patient 0
had 0
an 0
increase 0
in 0
platelet 0
count 0
from 0
a 0
baseline 0
of 0
5,000 0
to 0
8,000/microliter 0
to 0
a 0
maximal 0
level 0
of 0
33,000/microliter 0
. 0

In 0
the 0
latter 0
, 0
the 0
cells 0
and 0
adjacent 0
matrix 0
had 0
several 0
characteristics 0
of 0
fibrocartilage 0
, 0
including 0
chondrocytes 0
. 0

Radiation 0
sensitivity 0
of 0
rats 0
irradiated 0
in 0
a 0
condition 0
of 0
hypoxia 0

When 0
the 0
opioid 0
antagonist 0
was 0
administered 0
to 0
animals 0
24 0
hr 0
after 0
termination 0
of 0
single 0
or 0
multiple 0
exposures 0
to 0
restraint 0
, 0
NALT 0
- 0
induced 0
increases 0
in 0
basal 0
plasma B-gene
LH I-gene
were 0
significantly 0
attenuated 0
in 0
the 0
chronically 0
stressed 0
rats 0
compared 0
to 0
animals 0
subjected 0
to 0
stress 0
only 0
once 0
or 0
not 0
at 0
all 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
250 0
WORDS 0
) 0

Furthermore 0
, 0
CBP/p300 B-gene
stimulated 0
both 0
CBP/p300 I-gene

Analysis 0
of 0
exon 0
2 0
of 0
the 0
factor B-gene
IX I-gene
gene I-gene
revealed 0
a 0
C 0
- 0
- 0
> 0
T 0
mutation 0
in 0
codon 0
10 0
of 0
the 0
propeptide 0
region 0
, 0
resulting 0
in 0
the 0
substitution 0
of 0
alanine 0
by 0
valine 0
. 0

In 0
contrast 0
to 0
the 0
restricted 0
tissue 0
expression 0
of 0
gonadotropin B-gene
and 0
TSH B-gene
receptors I-gene
in 0
gonads 0
and 0
thyroid 0
, 0
respectively 0
, 0
LGR4 B-gene
is 0
expressed 0
in 0
diverse 0
tissues 0
including 0
ovary 0
, 0
testis 0
, 0
adrenal 0
, 0
placenta 0
, 0
thymus 0
, 0
spinal 0
cord 0
, 0
and 0
thyroid 0
, 0
whereas 0
LGR5 B-gene
is 0
found 0
in 0
muscle 0
, 0
placenta 0
, 0
spinal 0
cord 0
, 0
and 0
brain 0
. 0

We 0
now 0
show 0
that 0
purified 0
recombinant 0
c B-gene
- I-gene
sis/PDGF I-gene
can 0
induce 0
this 0
binding 0
activity 0
which 0
we 0
have 0
termed 0
sis/PDGF I-gene

Antinuclear 0
antibodies 0
, 0
rheumatoid B-gene
factor I-gene
and 0
C B-gene
- I-gene
reactive I-gene
protein I-gene
in 0
serum 0
of 0
normal 0
women 0
using 0
oral 0
contraceptives 0
. 0

We 0
report 0
here 0
that 0
AChE B-gene
activity 0
tends 0
to 0
decrease 0
in 0
individuals 0
sampled 0
in 0
tanks 0
at 0
a 0
salinity 0
of 0
30 0
per 0
thousand 0
as 0
temperature 0
increases 0
. 0

The 0
relationship 0
between 0
donor 0
status 0
for 0
antibody 0
to 0
hepatitis B-gene
B I-gene
core I-gene
antigen I-gene
and 0
the 0
occurrence 0
of 0
non 0
- 0
A 0
, 0
non 0
- 0
B 0
posttransfusion 0
hepatitis 0
in 0
the 0
recipient 0
was 0
prospectively 0
studied 0
in 0
112 0
patients 0
undergoing 0
open 0
- 0
heart 0
surgery 0
who 0
were 0
followed 0
for 0
6.5 0
months 0
after 0
surgery 0
. 0

Both 0
control 0
and 0
Mn 0
- 0
exposed 0
quail 0
accumulated 0
5 0
to 0
10 0
times 0
more 0
Mn 0
in 0
their 0
livers 0
than 0
similarly 0
treated 0
rodents 0
. 0

These 0
data 0
suggested 0
that 0
mutant B-gene
PS1 I-gene
may 0
cause 0
disease 0
as 0
a 0
result 0
of 0
reduction 0
in 0
PS1 B-gene
function 0
. 0

In 0
response 0
to 0
phosphorus 0
limitation 0
, 0
the 0
fungus 0
Neurospora 0
crassa 0
synthesizes 0
a 0
number 0
of 0
enzymes 0
that 0
function 0
to 0
bring 0
more 0
phosphate 0
into 0
the 0
cell 0
. 0

IL B-gene
- I-gene
6 I-gene
was 0
detected 0
in 0
the 0
urine 0
of 0
52 0
% 0
of 0
children 0
with 0
pyelonephritis 0
compared 0
with 0
15 0
% 0
of 0
other 0
children 0
( 0
P 0
< 0
0.001 0
) 0
. 0

The 0
effects 0
of 0
pretreatment 0
with 0
the 0
non 0
- 0
competitive 0
NMDA 0
antagonist 0
( 0
+ 0
) 0
MK 0
- 0
801 0
on 0
the 0
behavioral 0
alterations 0
induced 0
by 0
repeated 0
restraint 0
stress 0
were 0
investigated 0
. 0

Radiation 0
was 0
delivered 0
in 0
a 0
single 0
4 0
- 0
mJ 0
pulse 0
of 0
200 0
microseconds 0
duration 0
by 0
means 0
of 0
an 0
articulated 0
zirconium 0
fluoride 0
optical 0
fibre 0
and 0
a 0
320 0
- 0
microns 0
quartz 0
- 0
fibre 0
tip 0
. 0

MsEPV 0
genes 0
with 0
putative 0
functions 0
in 0
prevention 0
and 0
repair 0
of 0
DNA 0
damage 0
include 0
a 0
complete 0
base 0
excision 0
repair 0
pathway 0
( 0
uracil B-gene
DNA I-gene
glycosylase I-gene
, 0
AP B-gene
endonuclease I-gene
, 0
DNA B-gene
polymerase I-gene
beta I-gene
, 0
and 0
an 0
NAD+ B-gene
- I-gene
dependent I-gene
DNA I-gene
ligase I-gene
) 0
, 0
a 0
photoreactivation 0
repair 0
pathway 0
( 0
cyclobutane B-gene
pyrimidine I-gene
dimer I-gene
photolyase I-gene
) 0
, 0
a 0
LINE B-gene
- I-gene
type I-gene
reverse I-gene
transcriptase I-gene
, 0
and 0
a 0
mutT B-gene
homologue I-gene
. 0

In 0
isolated 0
olfactory 0
cilia 0
certain 0
odorants 0
elicit 0
a 0
rapid 0
and 0
transient 0
cAMP 0
response 0
, 0
terminated 0
by 0
a 0
concerted 0
process 0
which 0
requires 0
the 0
action 0
of 0
two 0
protein 0
kinases 0
, 0
protein B-gene
kinase I-gene
A I-gene
( 0
PKA B-gene
) 0
and 0
a 0
receptor B-gene
- I-gene
specific I-gene
kinase I-gene
( 0
GRK3 B-gene
) 0
( 0
Schleicher 0
, 0
S. 0
, 0
Boekhoff 0
, 0
I 0
. 0

The 0
results 0
corroborate 0
the 0
proposed 0
physiological 0
function 0
of 0
CCoAOMT B-gene
in 0
elicited 0
plant 0
cells 0
and 0
may 0
shed 0
new 0
light 0
on 0
the 0
sequential 0
action 0
of 0
trans 0
- 0
active 0
factors 0
in 0
the 0
regulation 0
of 0
phenylpropanoid 0
genes 0
. 0

Two 0
hundred 0
and 0
eighty 0
- 0
three 0
patients 0
, 0
217 0
females 0
( 0
median 0
age 0
24 0
years 0
, 0
range 0
0.5 0
- 0
73 0
) 0
and 0
66 0
males 0
( 0
median 0
age 0
20 0
years 0
, 0
range 0
0.75 0
- 0
72 0
) 0
, 0
were 0
examined 0
. 0

Pneumatic 0
dilation 0
of 0
the 0
lower 0
esophageal 0
sphincter 0
was 0
accomplished 0
by 0
endoscopic 0
visualization 0
and 0
positioning 0
of 0
a 0
modified 0
polyurethane 0
dilator 0
( 0
90 0
F 0
diameter 0
) 0
without 0
fluoroscopy 0
in 0
17 0
consecutive 0
patients 0
with 0
advanced 0
symptomatic 0
achalasia 0
. 0

The 0
organotins 0
. 0

A 0
series 0
of 0
mutations 0
were 0
constructed 0
within 0
the 0
E2 B-gene
open 0
reading 0
frame 0
which 0
delete 0
various 0
regions 0
of 0
the 0
conserved 0
DNA 0
binding 0
and 0
transactivation 0
domains 0
as 0
well 0
as 0
the 0
internal 0
hinge 0
region 0
. 0

These 0
data 0
indicate 0
that 0
chromatic 0
processing 0
in 0
areas 0
V1 0
and 0
V2 0
is 0
normal 0
after 0
V4 0
lesions 0
and 0
, 0
together 0
with 0
the 0
behavioural 0
evidence 0
, 0
that 0
these 0
areas 0
are 0
sufficient 0
for 0
some 0
basic 0
aspects 0
of 0
colour 0
perception 0
. 0

The 0
Cryotherapy 0
for 0
Retinopathy 0
of 0
Prematurity 0
Study 0
has 0
shown 0
that 0
this 0
number 0
can 0
be 0
halved 0
with 0
treatment 0
. 0

The 0
non B-gene
- I-gene
major I-gene
histocompatibility I-gene
complex I-gene
( 0
MHC B-gene
) 0
- 0
encoded 0
CD1 B-gene
family I-gene
has 0
recently 0
emerged 0
as 0
a 0
new 0
antigen 0
- 0
presenting 0
system 0
that 0
is 0
distinct 0
from 0
either 0
MHC B-gene
class I-gene
I I-gene
or I-gene
class I-gene
II I-gene
molecules I-gene
. 0

Nitroglycerin 0
( 0
glyceryl 0
trinitrate 0
) 0
as 0
a 0
monoamine B-gene
oxidase I-gene
inhibitor 0
. 0

Doxazosin 0
produced 0
increases 0
in 0
both 0
mean 0
and 0
maximum 0
urinary 0
flow 0
rates 0
of 0
1.01 0
ml/s 0
and 0
3.2 0
ml/s 0
respectively 0
, 0
compared 0
with 0
0.21 0
ml/s 0
and 0
2.2 0
ml/s 0
on 0
placebo 0
. 0

We 0
determined 0
the 0
complete 0
nucleotide 0
sequence 0
of 0
the 0
gypsy B-gene
element I-gene
present 0
at 0
the 0
forked B-gene
locus I-gene
of 0
Drosophila 0
melanogaster 0
in 0
the 0
f1 0
allele 0
. 0

Cloning 0
and 0
nucleotide 0
sequence 0
analysis 0
reveals 0
that 0
BUR6 B-gene
encodes 0
a 0
homolog 0
of 0
DRAP1 B-gene
( 0
also 0
called 0
NC2alpha B-gene
) 0
, 0
a 0
mammalian 0
repressor 0
of 0
basal 0
transcription 0
. 0

The 0
ATF/CRE B-gene
site 0
is 0
also 0
essential 0
for 0
CD4 B-gene
promoter I-gene
activation 0
by 0
forskolin 0
, 0
an 0
activator 0
of 0
adenylate B-gene
cyclase I-gene
. 0

These 0
results 0
point 0
towards 0
post 0
- 0
translational 0
steric 0
and/or 0
allosteric 0
control 0
of 0
EKLF B-gene
function 0
that 0
may 0
be 0
important 0
not 0
just 0
for 0
its 0
DNA 0
binding 0
ability 0
, 0
but 0
also 0
for 0
its 0
potential 0
to 0
interact 0
with 0
other 0
proteins 0
that 0
fully 0
establish 0
the 0
correct 0
stereospecific 0
array 0
leading 0
to 0
efficient 0
switching 0
of 0
beta B-gene
- I-gene
globin I-gene
transcription 0
during 0
development 0
. 0

They 0
are 0
growth 0
- 0
inhibited 0
by 0
TGF B-gene
- I-gene
beta1 I-gene
. 0

Chronic 0
active 0
hepatitis 0
and 0
cirrhosis 0
of 0
the 0
liver 0
. 0

Colonization 0
increased 0
with 0
level 0
of 0
care 0
: 0
from 0
9 0
per 0
cent 0
in 0
independent 0
residents 0
of 0
apartments 0
to 0
60 0
per 0
cent 0
in 0
patients 0
on 0
an 0
acute 0
hospital 0
ward 0
( 0
P 0
less 0
than 0
0.0001 0
) 0
. 0

Interaction 0
of 0
the 0
v B-gene
- I-gene
rel I-gene
protein I-gene
with 0
an 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
DNA I-gene
binding I-gene
site I-gene
. 0

CVO2 0
saturation 0
is 0
a 0
reliable 0
and 0
sensitive 0
method 0
for 0
detecting 0
blood 0
loss 0
. 0

In 0
the 0
Saccharomyces B-gene
cerevisiae I-gene
actin I-gene
intron I-gene
a 0
silent 0
branch 0
point 0
- 0
like 0
sequence 0
( 0
UACUAAG 0
) 0
is 0
located 0
7 0
nt 0
upstream 0
of 0
the 0
canonical 0
sequence 0
. 0

The 0
elevated 0
levels 0
of 0
inositol 0
phosphates 0
resulting 0
from 0
N B-gene
( I-gene
epi I-gene
) I-gene
alpha I-gene
qQ209L I-gene
expression 0
were 0
similar 0
to 0
those 0
obtained 0
with 0
carbachol 0
activation 0
of 0
the 0
M1 B-gene
muscarinic I-gene
acetylcholine I-gene
receptor I-gene
. 0

To 0
increase 0
the 0
number 0
of 0
circulating 0
polymorphonuclear 0
neutrophils 0
, 0
the 0
patient 0
was 0
treated 0
with 0
recombinant 0
granulocyte B-gene
- I-gene
macrophage I-gene
colony I-gene
- I-gene
stimulating I-gene
factor I-gene
( 0
GM B-gene
- I-gene
CSF I-gene
) 0
at 0
a 0
dose 0
of 0
2 0
micrograms 0
protein/kg 0
bodyweight 0
s.c./12 0
h 0
. 0

PrRP B-gene
rapidly 0
and 0
transiently 0
activated 0
extracellular B-gene
signal I-gene
- I-gene
regulated I-gene
protein I-gene
kinase I-gene
( 0
ERK B-gene
) 0
in 0
both 0
types 0
of 0
cells 0
. 0

Nevertheless 0
, 0
PEG 0
influenced 0
in 0
vitro 0
drug 0
availability 0
considerably 0
, 0
by 0
increasing 0
both 0
drug 0
solubility 0
and 0
dissolution 0
rate 0
. 0

Reversible 0
topology 0
of 0
a 0
bifunctional 0
transmembrane 0
protein 0
depends 0
upon 0
the 0
charge 0
balance 0
around 0
its 0
transmembrane 0
domain 0
. 0

We 0
have 0
documented 0
previously 0
that 0
glucocorticoid 0
hormones 0
modulate 0
the 0
posttranslational 0
localization 0
of 0
cell 0
surface 0
mouse 0
mammary 0
tumor 0
virus 0
( 0
MMTV 0
) 0
glycoproteins 0
in 0
the 0
viral 0
- 0
infected 0
M1.54 0
rat 0
HTC 0
hepatoma 0
cell 0
line 0
. 0

Contrast 0
radiography 0
appears 0
to 0
be 0
an 0
especially 0
inaccurate 0
method 0
to 0
document 0
PUD 0
in 0
CF 0
because 0
the 0
duodenal 0
mucosa 0
typically 0
appears 0
nodular 0
and 0
distorted 0
with 0
poor 0
definition 0
of 0
the 0
mucosal 0
folds 0
. 0

Spodoptera 0
frugiperda 0
( 0
Sf9 0
) 0
cells 0
have 0
proved 0
a 0
suitable 0
cell 0
system 0
in 0
which 0
to 0
study 0
this 0
association 0
and 0
to 0
produce 0
recombinant B-gene
CR3 I-gene
, 0
and 0
we 0
show 0
here 0
that 0
another 0
lepidopteran 0
cell 0
line 0
, 0
Trichoplusia 0
niTN 0
- 0
5B1 0
- 0
4 0
( 0
High 0
- 0
Five 0
) 0
cells 0
, 0
allows 0
the 0
recovery 0
of 0
large 0
amounts 0
of 0
functional B-gene
recombinant I-gene
CR3 I-gene
. 0

Using 0
the 0
standard 0
scoring 0
, 0
children 0
with 0
full 0
scale 0
IQ 0
< 0
or 0
= 0
84 0
on 0
the 0
Wechsler 0
Preschool 0
and 0
Primary 0
Scale 0
of 0
Intelligence 0
at 0
age 0
4 0
- 0
5 0
years 0
were 0
poorly 0
identified 0
( 0
sensitivity 0
54 0
% 0
) 0
from 0
the 0
composite 0
S 0
- 0
B 0
IV 0
score 0
at 0
age 0
3 0
. 0

The 0
relation 0
between 0
the 0
changes 0
of 0
bone 0
density 0
and 0
the 0
level 0
of 0
blood 0
calcium 0
, 0
blood 0
phosphorus 0
and 0
alkaline B-gene
phosphatase I-gene
( 0
AKP B-gene
) 0
as 0
well 0
as 0
the 0
metabolism 0
of 0
vitamin 0
D 0
was 0
studied 0
. 0

To 0
clarify 0
the 0
mechanisms 0
that 0
regulate 0
transcription 0
of 0
the 0
GTP B-gene
cyclohydrolase I-gene
I I-gene
gene I-gene
and 0
to 0
generate 0
multiple 0
species 0
of 0
mRNA 0
, 0
we 0
isolated 0
genomic 0
DNA 0
clones 0
for 0
the 0
human 0
and 0
mouse 0
GTP B-gene
cyclohydrolase I-gene
I I-gene
genes I-gene
. 0

Perception 0
of 0
sweetness 0
can 0
not 0
be 0
used 0
to 0
accurately 0
meter 0
the 0
metabolizable 0
energy 0
or 0
nutritive 0
value 0
of 0
a 0
food 0
. 0

These 0
results 0
suggest 0
that 0
termination 0
is 0
a 0
highly 0
specific 0
event 0
, 0
and 0
not 0
merely 0
a 0
consequence 0
of 0
decreased 0
stability 0
of 0
the 0
EC 0
. 0

All 0
sows 0
nursed 0
nine 0
pigs 0
. 0

When 0
labeled 0
by 0
the 0
described 0
method 0
, 0
99mTc 0
on 0
DTPA 0
coupled 0
antibodies 0
shows 0
instability 0
in 0
serum 0
but 0
superior 0
stability 0
than 0
99mTc 0
on 0
antibodies 0
without 0
the 0
attached 0
DTPA 0
. 0

The 0
crystal 0
structure 0
of 0
the 0
yeast 0
Phe B-gene
- I-gene
tRNAPhe I-gene
ternary I-gene
complex I-gene
with 0
Thermus 0
aquaticus 0
EF B-gene
- I-gene
Tu I-gene
- 0
GDPNP 0
( 0
Phe B-gene
- I-gene
TC I-gene
) 0
has 0
previously 0
been 0
determined 0
as 0
one 0
representative 0
of 0
this 0
general 0
yet 0
highly 0
discriminating 0
complex 0
formation 0
. 0

Our 0
results 0
indicate 0
that 0
GCN4 B-gene
contains 0
two 0
activation 0
domains 0
of 0
similar 0
potency 0
that 0
can 0
function 0
independently 0
to 0
promote 0
high 0
- 0
level 0
transcription 0
of 0
the 0
target 0
genes 0
HIS3 B-gene
and 0
HIS4 B-gene
. 0

U.S.A 0
. 0

Human B-gene
plastin I-gene
genes I-gene
. 0

Role 0
of 0
the 0
CCAAT/enhancer B-gene
binding I-gene
protein I-gene
- I-gene
alpha I-gene
transcription I-gene
factor I-gene
in 0
the 0
glucocorticoid 0
stimulation 0
of 0
p21waf1/cip1 B-gene
gene 0
promoter 0
activity 0
in 0
growth 0
- 0
arrested 0
rat 0
hepatoma 0
cells 0
. 0

We 0
also 0
demonstrate 0
that 0
a 0
p110RB1 B-gene
mutant I-gene
, 0
which 0
is 0
refractory 0
to 0
cell 0
cycle 0
phosphorylation 0
but 0
intact 0
in 0
E1a/large B-gene
E1a/large I-gene
T I-gene
antigen I-gene
- 0
binding 0
properties 0
, 0
represses 0
EIIaE B-gene
with 0
50 0
- 0
to 0
80 0
- 0
fold 0
greater 0
efficiency 0
than 0
wild B-gene
- I-gene
type I-gene
p110RB1 I-gene
. 0

For 0
the 0
target 0
stimuli 0
, 0
P3 0
amplitude 0
and 0
latency 0
were 0
negatively 0
correlated 0
and 0
most 0
tightly 0
coupled 0
over 0
the 0
frontal 0
- 0
central 0
and 0
right 0
medial/lateral 0
recording 0
sites 0
. 0

We 0
have 0
characterized 0
a 0
new 0
cDNA 0
, 0
33k 0
- 0
6 0
, 0
potentially 0
encoding 0
a 0
tobacco B-gene
33 I-gene
kDa I-gene
chloroplast I-gene
RNP I-gene
( I-gene
cp33 I-gene
) I-gene
homologue I-gene
. 0

Though 0
it 0
has 0
been 0
established 0
that 0
skinfold 0
anthropometry 0
has 0
severe 0
limitations 0
as 0
a 0
method 0
of 0
deriving 0
total 0
body 0
fat 0
( 0
TBF 0
) 0
, 0
the 0
possibility 0
that 0
the 0
problem 0
might 0
be 0
related 0
more 0
to 0
the 0
assumptions 0
implicit 0
in 0
densitometry 0
has 0
to 0
be 0
addressed 0
. 0

Gene B-gene
GPR I-gene
51 I-gene
was 0
localized 0
by 0
radiation 0
hybrid 0
mapping 0
to 0
chromosome 0
9 0
, 0
4.81 0
cR 0
from 0
the 0
WI 0
- 0
8684 0
marker 0
, 0
and 0
proximal 0
to 0
the 0
hereditary B-gene
sensory I-gene
neuropathy I-gene
type I-gene
1 I-gene
locus I-gene
. 0

A 0
) 0
During 0
O2 0
- 0
ischemia 0
both 0
extracellular 0
[ 0
K+ 0
] 0
and 0
change 0
of 0
pH 0
in 0
the 0
subepicardium 0
are 0
significantly 0
less 0
than 0
in 0
the 0
midmyocardium 0
. 0

Some 0
of 0
these 0
physiological 0
responses 0
are 0
regulated 0
via 0
activation 0
of 0
transcription 0
factors 0
such 0
as 0
activator B-gene
protein I-gene
1 I-gene
( 0
AP B-gene
- I-gene
1 I-gene
) 0
. 0

The 0
1.6 0
- 0
kb 0
cDNA 0
( 0
CBF B-gene
- I-gene
A I-gene
) 0
encoding 0
285 0
amino 0
acids 0
( 0
aa 0
) 0
was 0
obtained 0
, 0
and 0
a 0
beta B-gene
- I-gene
galactosidase I-gene
fusion I-gene
protein I-gene
, 0
bacterially 0
produced 0
from 0
the 0
cDNA 0
, 0
bound 0
to 0
DNA 0
fragments 0
containing 0
several 0
CArG 0
boxes 0
. 0

Alveoli 0
- 0
capillary 0
diffusion 0
. 0

The 0
pattern 0
of 0
expression 0
of 0
this 0
and 0
other 0
Chi26/Chi33 B-gene
chimeric 0
promoters 0
suggest 0
that 0
the 0
Chi26/Chi33 I-gene

Interobserver 0
agreement 0
of 0
the 0
Nottingham 0
histologic 0
grading 0
scheme 0
for 0
infiltrating 0
duct 0
carcinoma 0
breast 0
. 0

We 0
have 0
demonstrated 0
that 0
the 0
specific 0
determination 0
and 0
identification 0
of 0
plasma 0
FbDP B-gene
alone 0
is 0
not 0
sufficient 0
to 0
follow 0
the 0
effectiveness 0
of 0
thrombolytic 0
therapy 0
. 0

To 0
determine 0
the 0
role 0
of 0
the 0
transmembrane 0
region 0
of 0
HN B-gene
on 0
fusion 0
- 0
promoting 0
activity 0
, 0
mutant B-gene
HN I-gene
proteins I-gene
were 0
expressed 0
and 0
their 0
biological 0
activities 0
examined 0
. 0

Thus 0
, 0
transgene 0
expression 0
directed 0
by 0
both 0
the 0
human 0
and 0
mouse B-gene
Rb I-gene
promoters I-gene
is 0
restricted 0
to 0
a 0
subset 0
of 0
tissues 0
in 0
which 0
Rb B-gene
is 0
normally 0
expressed 0
during 0
embryogenesis 0
. 0

The 0
cDNA 0
is 0
predicted 0
to 0
encode 0
a 0
polypeptide 0
of 0
298 0
amino 0
acids 0
that 0
is 0
homologous 0
to 0
the 0
Y B-gene
- I-gene
box I-gene
( I-gene
inverted I-gene
CCAAT I-gene
) I-gene
family I-gene
of I-gene
DNA I-gene
- I-gene
binding I-gene
transcription I-gene
factors I-gene
. 0

RAP B-gene
has 0
been 0
shown 0
to 0
be 0
a 0
useful 0
vaccine 0
target 0
site 0
, 0
and 0
RIP B-gene
and 0
inhibitory 0
AIPs B-gene
as 0
therapeutic 0
molecules 0
to 0
prevent 0
and 0
suppress 0
S. 0
aureus 0
infections 0
. 0

First 0
, 0
mutations 0
in 0
the 0
IFNgamma B-gene
- I-gene
activated I-gene
sequence I-gene
( 0
GAS B-gene
) 0
, 0
either 0
multimerized 0
or 0
in 0
the 0
context 0
of 0
the 0
1.7 B-gene
- I-gene
kb I-gene
IRF I-gene
- I-gene
1 I-gene
promoter I-gene
, 0
failed 0
to 0
mediate 0
a 0
PRL B-gene
response 0
, 0
showing 0
that 0
the 0
IRF B-gene
- I-gene
1 I-gene
GAS B-gene
is 0
a 0
target 0
of 0
PRL B-gene
signaling 0
. 0

However 0
, 0
both 0
RAR B-gene
- 0
and 0
RXR B-gene
- 0
specific 0
ligands 0
increase 0
CaSki 0
number 0
by 0
> 0
or 0
= 0
20 0
% 0
. 0

Tight 0
- 0
binding 0
band 0
structure 0
calculations 0
for 0
beta 0
- 0
MNX 0
( 0
M 0
= 0
Zr 0
, 0
X 0
= 0
Cl 0
, 0
Br 0
; 0
M 0
= 0
Hf 0
, 0
X 0
= 0
Cl 0
) 0
, 0
ZrCl 0
, 0
and 0
Y 0
( 0
2 0
) 0
C 0
( 0
2 0
) 0
Br 0
( 0
2 0
) 0
are 0
reported 0
. 0

The 0
same 0
high 0
degree 0
of 0
sequence 0
homology 0
between 0
the 0
two 0
F. 0
diplosiphon 0
PC B-gene
alpha I-gene
and 0
PC B-gene
beta I-gene
sequences I-gene
( 0
85 0
and 0
77 0
% 0
, 0
respectively 0
) 0
was 0
found 0
at 0
both 0
the 0
nucleotide 0
and 0
amino 0
acid 0
levels 0
, 0
and 0
similar 0
results 0
were 0
obtained 0
for 0
interspecies 0
comparisons 0
. 0

Interestingly 0
, 0
the 0
expression 0
of 0
Id4 B-gene
in 0
Sertoli 0
cells 0
is 0
only 0
detectable 0
after 0
stimulation 0
with 0
FSH B-gene
or 0
cAMP 0
. 0

On 0
the 0
basis 0
of 0
the 0
physical 0
interactions 0
between 0
Sxl B-gene
and 0
Snf B-gene
, 0
we 0
present 0
a 0
model 0
for 0
Sxl B-gene
splicing 0
regulation 0
. 0

It 0
thus 0
seems 0
likely 0
that 0
genistein 0
affects 0
a 0
common 0
pathway 0
downstream 0
of 0
these 0
signals 0
. 0

LiF 0
thermoluminescence 0
dosimeters 0
( 0
TLD 0
) 0
in 0
chip 0
form 0
were 0
placed 0
onto 0
1 0
eyelid 0
, 0
the 0
skin 0
over 0
the 0
thyroid 0
, 0
and 0
the 0
patient 0
's 0
clothes 0
covering 0
the 0
region 0
of 0
breasts 0
and 0
ovaries 0
of 0
female 0
patients 0
and 0
the 0
testicles 0
of 0
male 0
patients 0
. 0

Several 0
positive 0
clones 0
were 0
isolated 0
, 0
one 0
of 0
which 0
encoded 0
the 0
C 0
- 0
terminal 0
253 0
amino 0
acids 0
of 0
a 0
putative 0
RNA B-gene
helicase I-gene
, 0
a 0
DEAD B-gene
box I-gene
protein I-gene
designated 0
DDX3 B-gene
. 0

The 0
related 0
tumor 0
suppressor 0
, 0
p130 B-gene
, 0
also 0
effects 0
this 0
function 0
. 0
p107 B-gene
levels 0
increase 0
substantially 0
as 0
cells 0
progress 0
through 0
S 0
phase 0
. 0
p107 B-gene
induction 0
of 0
E2F B-gene
DNA 0
binding 0
was 0
observed 0
primarily 0
in 0
S 0
phase 0
cells 0
coincident 0
with 0
the 0
increase 0
in 0
p107 B-gene
protein I-gene
levels 0
. 0

We 0
conclude 0
from 0
these 0
observations 0
that 0
the 0
cTnC B-gene
3'Ile I-gene
element I-gene
is 0
a 0
composite 0
enhancer 0
that 0
functions 0
through 0
the 0
combined 0
interactions 0
of 0
at 0
least 0
five 0
regulatory 0
elements 0
and 0
their 0
cognate 0
binding 0
factors 0
: 0
three 0
or 0
four 0
E 0
- 0
boxes 0
, 0
a 0
MEF B-gene
- I-gene
2 I-gene
site I-gene
, 0
and 0
a 0
MEF B-gene
- I-gene
3 I-gene
site I-gene
. 0

These 0
data 0
suggest 0
that 0
the 0
secreted 0
, 0
truncated 0
receptor 0
encoded 0
by 0
the 0
2.6 B-gene
- I-gene
kb I-gene
c I-gene
- I-gene
erbB I-gene
transcript I-gene
can 0
bind 0
to 0
TGF B-gene
alpha I-gene
and 0
may 0
play 0
an 0
important 0
growth 0
- 0
regulatory 0
function 0
in 0
vitro 0
. 0

In 0
this 0
paper 0
we 0
review 0
evidence 0
on 0
smoking 0
and 0
lung 0
cancer 0
among 0
Latinos 0
, 0
including 0
findings 0
from 0
several 0
unpublished 0
studies 0
and 0
technical 0
reports 0
. 0

Although 0
several 0
large 0
waterborne 0
outbreaks 0
occurred 0
during 0
the 0
past 0
decade 0
, 0
most 0
were 0
in 0
small 0
communities 0
. 0

Many 0
of 0
the 0
metabolic 0
effects 0
induced 0
by 0
thiazide 0
diuretics 0
, 0
however 0
, 0
can 0
be 0
limited 0
by 0
the 0
use 0
of 0
low 0
doses 0
. 0

Uptake 0
of 0
colicins B-gene
required 0
different 0
domains 0
in 0
TonB B-gene
, 0
for 0
colicin B-gene
B I-gene
and I-gene
M I-gene
around 0
residue 0
160 0
and 0
for 0
colicin B-gene
Ia I-gene
, 0
a 0
domain 0
closer 0
to 0
the 0
C 0
- 0
terminal 0
end 0
. 0

A 0
phase 0
II 0
study 0
of 0
interferon B-gene
- I-gene
alpha I-gene
, 0
interleukin B-gene
- I-gene
2 I-gene
and 0
5 0
- 0
fluorouracil 0
in 0
advanced 0
renal 0
carcinoma 0
: 0
clinical 0
data 0
and 0
laboratory 0
evidence 0
of 0
protease 0
activation 0
. 0

Three 0
putative 0
ORFs 0
have 0
significant 0
homology 0
with 0
known 0
proteins 0
: 0
L0968 B-gene
is 0
a 0
new 0
member 0
of 0
the 0
very 0
large 0
'seripauperins B-gene
' I-gene
family 0
, 0
comprising 0
at 0
least 0
20 0
yeast 0
members 0
; 0
L1313 B-gene
is 0
a 0
new 0
ABC B-gene
transporter I-gene
highly 0
homologous 0
to 0
the 0
yeast 0
cadmium 0
resistance 0
protein 0
Ycf1p B-gene
and 0
to 0
the 0
human B-gene
multidrug I-gene
resistance I-gene
protein I-gene
hMRP1 B-gene
; 0
the 0
C 0
- 0
terminal 0
part 0
of 0
L1325 B-gene
present 0
in 0
our 0
sequence 0
is 0
very 0
homologous 0
to 0
the 0
fruit 0
fly 0
abdominal 0
segment 0
formation 0
protein 0
Pumilio B-gene
. 0

Previously 0
, 0
we 0
reported 0
the 0
identification 0
of 0
a 0
23 0
- 0
kD 0
protein 0
that 0
interacts 0
with 0
zyxin B-gene
in 0
vitro 0
( 0
Sadler 0
et 0
al. 0
, 0
1992 0
) 0
. 0

Most 0
significantly 0
, 0
the 0
cyclin B-gene
E I-gene
- 0
Cdk2 B-gene
complex 0
is 0
maximally 0
active 0
at 0
the 0
G1/S 0
transition 0
, 0
and 0
overexpression 0
of 0
cyclin B-gene
E I-gene
decreases 0
the 0
time 0
it 0
takes 0
the 0
cell 0
to 0
complete 0
G1 0
and 0
enter 0
S 0
phase 0
. 0

In 0
this 0
report 0
, 0
we 0
demonstrate 0
that 0
FRS2 B-gene
forms 0
a 0
complex 0
with 0
the 0
N B-gene
- I-gene
terminal I-gene
SH2 I-gene
domain I-gene
of 0
the 0
protein B-gene
tyrosine I-gene
phosphatase I-gene
Shp2 I-gene
in 0
response 0
to 0
FGF B-gene
stimulation 0
. 0

In 0
static 0
conditions 0
, 0
body 0
sway 0
was 0
assessed 0
using 0
a 0
conventional 0
force 0
platform 0
with 0
eyes 0
open 0
and 0
with 0
eyes 0
closed 0
. 0

Antiserum 0
raised 0
against 0
rat B-gene
liver I-gene
S6 I-gene
kinase I-gene
specifically 0
immunoprecipitates 0
the 0
purified 0
32P 0
- 0
labeled 0
H4 0
hepatoma 0
insulin 0
- 0
stimulated 0
S6 B-gene
kinase I-gene
. 0

In 0
vitro 0
, 0
SHIP B-gene
catalyzes 0
the 0
conversion 0
of 0
the 0
phosphoinositide B-gene
3 I-gene
- I-gene
kinase I-gene
( 0
PI3K B-gene
) 0
product 0
phosphatidylinositol 0
3,4 0
, 0
5 0
- 0
trisphosphate 0
( 0
PIP3 0
) 0
into 0
phosphatidylinositol 0
3,4 0
- 0
bisphosphate 0
. 0

A 0
species 0
comparison 0
of 0
cDNA 0
sequences 0
and 0
isolation 0
of 0
a 0
genomic 0
clone 0
. 0

The 0
study 0
of 0
the 0
intensity 0
of 0
pain 0
evoked 0
by 0
heat 0
is 0
relatively 0
exhaustive 0
: 0
the 0
influence 0
of 0
various 0
local 0
, 0
stimulus 0
- 0
dependent 0
or 0
general 0
factors 0
upon 0
threshold 0
values 0
has 0
been 0
well 0
studied 0
, 0
as 0
has 0
the 0
relation 0
between 0
pain 0
and 0
stimulus 0
intensities 0
. 0

However 0
, 0
they 0
had 0
no 0
cross 0
- 0
resistance 0
to 0
quinolone 0
, 0
josamycin 0
and 0
tylosin 0
. 0

A 0
search 0
was 0
conducted 0
for 0
suppressors 0
of 0
the 0
inositol 0
auxotrophic 0
phenotype 0
of 0
the 0
ino4 B-gene
- I-gene
8 I-gene
mutant I-gene
of 0
yeast 0
. 0

Diabetic 0
osteopathy 0
. 0

A 0
simple 0
technique 0
for 0
obtaining 0
ultra 0
- 0
thin 0
sections 0
of 0
coccidian 0
oocysts 0
is 0
reported 0
. 0

These 0
data 0
, 0
taken 0
together 0
, 0
suggest 0
that 0
CRF B-gene
produces 0
its 0
behavioral 0
activating 0
and 0
anxiogenic 0
effects 0
, 0
at 0
least 0
in 0
part 0
, 0
by 0
increasing 0
the 0
activity 0
of 0
LC 0
noradrenergic 0
neurons 0
. 0

Moyamoya 0
is 0
an 0
intriguing 0
and 0
controversial 0
syndrome 0
. 0

An 0
ethnic 0
analysis 0
was 0
made 0
of 0
8947 0
cases 0
of 0
primary 0
central 0
nervous 0
system 0
( 0
CNS 0
) 0
tumors 0
seen 0
at 0
the 0
Armed 0
Forces 0
Institute 0
of 0
Pathology 0
( 0
AFIP 0
) 0
, 0
Washington 0
, 0
DC 0
, 0
from 0
1971 0
to 0
1985 0
. 0

SN 0
- 0
38 0
rebound 0
concentrations 0
were 0
observed 0
in 0
many 0
courses 0
at 0
about 0
0.5 0
to 0
1 0
hour 0
following 0
the 0
end 0
of 0
the 0
i.v 0
. 0
infusion 0
, 0
which 0
is 0
suggestive 0
of 0
enterohepatic 0
recycling 0
. 0

Kondo 0
effect 0
in 0
Cu 0
( 0
Fe 0
) 0
films 0
. 0

The 0
S3 B-gene
protein I-gene
also 0
contains 0
a 0
DNA 0
repair 0
activity 0
, 0
efficiently 0
processing 0
8 0
- 0
oxoguanine 0
residues 0
in 0
DNA 0
via 0
an 0
N B-gene
- I-gene
glycosylase/apurinic I-gene
glycosylase/apurinic I-gene
- I-gene
apyrimidinic I-gene
( I-gene
AP I-gene
) I-gene
lyase I-gene
activity 0
. 0

The 0
orf2 0
gene 0
product 0
is 0
a 0
protein 0
of 0
79 0
amino 0
acids 0
with 0
characteristics 0
similar 0
to 0
those 0
of 0
the 0
Tat B-gene
( 0
transactivator B-gene
) 0
proteins 0
of 0
the 0
ungulate 0
lentiviruses 0
. 0

This 0
paper 0
describes 0
a 0
longitudinal 0
study 0
in 0
which 0
clinical 0
parameters 0
and 0
aspartate B-gene
aminotransferase I-gene
( 0
AST B-gene
) 0
in 0
gingival 0
crevicular 0
fluid 0
( 0
GCF 0
) 0
were 0
monitored 0
bimonthly 0
over 0
a 0
6 0
- 0
12 0
months 0
period 0
in 0
970 0
sites 0
from 0
7 0
treated 0
periodontitis 0
patients 0
. 0

Our 0
results 0
show 0
that 0
unlike 0
the 0
case 0
for 0
sos1 B-gene
, 0
sos2 B-gene
gene I-gene
function 0
is 0
dispensable 0
for 0
normal 0
mouse 0
development 0
, 0
growth 0
, 0
and 0
fertility 0
. 0

This 0
finding 0
is 0
of 0
importance 0
because 0
it 0
completes 0
an 0
explanation 0
for 0
central 0
near 0
- 0
location 0
errors 0
in 0
the 0
partial 0
- 0
report 0
bar 0
- 0
probe 0
task 0
. 0

Patients 0
were 0
treated 0
with 0
either 0
4.8 0
million 0
units 0
of 0
procaine 0
penicillin 0
with 0
1 0
g 0
probenecid 0
, 0
3.5 0
or 0
4.5 0
g 0
of 0
ampicillin 0
with 0
1 0
g 0
probenecid 0
, 0
or 0
9.5 0
g 0
of 0
tetracycline 0
given 0
over 0
4 0
days 0
. 0

Here 0
, 0
we 0
analyzed 0
the 0
interaction 0
of 0
the 0
Lactococcus B-gene
lactis I-gene
Ll.LtrB I-gene
group I-gene
II I-gene
intron I-gene
endonuclease I-gene
with 0
its 0
DNA 0
target 0
site 0
by 0
DNA 0
footprinting 0
and 0
modification 0
- 0
interference 0
approaches 0
. 0

Treatment 0
of 0
JEA2 0
cells 0
with 0
interleukin B-gene
( I-gene
IL I-gene
) I-gene
- I-gene
7 I-gene
induces 0
CBLB B-gene
phosphorylation 0
as 0
well 0
. 0

Plasmid 0
pNK21 0
, 0
in 0
which 0
2.05 0
- 0
kb 0
sequence 0
covering 0
the 0
region 0
encoding 0
the 0
nitrilase B-gene
was 0
was 0
placed 0
under 0
the 0
control 0
of 0
the 0
lac B-gene
promoter I-gene
, 0
directed 0
overproduction 0
of 0
enzymatically B-gene
active I-gene
nitrilase I-gene
in 0
response 0
to 0
addition 0
of 0
isopropyl 0
beta 0
- 0
D 0
- 0
thiogalactopyranoside 0
in 0
Escherichia 0
coli 0
. 0

Penicillamine 0
- 0
induced 0
myasthenia 0
gravis 0
associated 0
with 0
antibodies 0
to 0
acetylcholine B-gene
receptor I-gene
. 0

UV 0
cross 0
- 0
linking 0
and 0
Southwestern 0
analysis 0
suggested 0
that 0
KTP1 B-gene
is 0
a 0
DNA 0
- 0
binding 0
protein 0
clearly 0
distinct 0
from 0
AP2 B-gene
, 0
and 0
this 0
protein 0
may 0
be 0
responsible 0
for 0
the 0
basal 0
keratinocyte 0
- 0
specific 0
expression 0
of 0
the 0
BPAG1 B-gene
gene I-gene
. 0

In 0
frozen 0
sections 0
the 0
spots 0
appear 0
as 0
blue 0
labelled 0
neurones 0
with 0
a 0
light 0
microscope 0
, 0
or 0
as 0
a 0
brilliant 0
red 0
neurones 0
surrounded 0
by 0
reddish 0
tissue 0
with 0
a 0
fluorescence 0
microscope 0
. 0

CONCLUSIONS 0
: 0
Elevation 0
of 0
TBARS 0
and 0
decrease 0
of 0
GSH 0
show 0
the 0
presence 0
of 0
oxidative 0
stress 0
during 0
the 0
PFD 0
treatment 0
with 0
hemodiafilter 0
SG3 0
. 0

Like 0
the 0
DMA B-gene
, 0
but 0
unlike 0
all 0
other 0
mammalian B-gene
class I-gene
II I-gene
A I-gene
genes I-gene
, 0
the 0
zebrafish 0
gene 0
codes 0
for 0
two 0
cysteine 0
residues 0
which 0
might 0
potentially 0
be 0
involved 0
in 0
the 0
formation 0
of 0
a 0
disulfide 0
bond 0
in 0
the 0
alpha 0
1 0
domain 0
. 0

For 0
any 0
given 0
age 0
, 0
high 0
- 0
stressed 0
plantaris 0
tendons 0
were 0
of 0
a 0
higher 0
fatigue 0
quality 0
than 0
low 0
- 0
stressed 0
extensor 0
tendons 0
. 0

A 0
mutated B-gene
ABF1 I-gene
site I-gene
that 0
displays 0
a 0
very 0
low 0
affinity 0
for 0
ABF1 B-gene
does 0
not 0
functionally 0
replace 0
the 0
ILV1 B-gene
REB1 B-gene
site I-gene
. 0

It 0
is 0
of 0
interest 0
that 0
, 0
aside 0
from 0
starvation 0
, 0
the 0
nutrition 0
catastrophes 0
of 0
the 0
past 0
, 0
including 0
scurvy 0
( 0
vitamin 0
C 0
deficiency 0
) 0
resulting 0
from 0
lack 0
of 0
fresh 0
vegetables 0
and 0
fruit 0
and 0
beriberi 0
( 0
vitamin 0
B1 0
deficiency 0
) 0
from 0
consumption 0
of 0
polished 0
rice 0
, 0
are 0
forgotten 0
and 0
only 0
of 0
interest 0
as 0
history 0
. 0

In 0
contrast 0
, 0
overexpression 0
of 0
the 0
DREB2A B-gene
cDNA I-gene
induced 0
weak 0
expression 0
of 0
the 0
target 0
genes 0
under 0
unstressed 0
conditions 0
and 0
caused 0
growth 0
retardation 0
of 0
the 0
transgenic 0
plants 0
. 0

In 0
vitro 0
, 0
c B-gene
- I-gene
Src I-gene
phosphorylated 0
FAK B-gene
Tyr I-gene
- I-gene
925 I-gene
in 0
a 0
glutathione B-gene
S I-gene
- I-gene
transferase I-gene
- 0
FAK B-gene
C 0
- 0
terminal 0
domain 0
fusion 0
protein 0
, 0
whereas 0
FAK 0
did 0
not 0
. 0

The 0
aetiology 0
and 0
management 0
of 0
diabetic 0
impotence 0
is 0
well 0
- 0
documented 0
; 0
the 0
effects 0
of 0
diabetes 0
on 0
female 0
sexuality 0
are 0
not 0
so 0
clear 0
. 0

The 0
percentage 0
distribution 0
of 0
types 0
of 0
fixation 0
disparity 0
curves 0
was 0
found 0
to 0
be 0
similar 0
to 0
some 0
previous 0
studies 0
, 0
with 0
a 0
higher 0
prevalence 0
of 0
Type 0
I 0
curve 0
( 0
64.3 0
% 0
) 0
, 0
followed 0
by 0
Type 0
II 0
( 0
28.6 0
% 0
) 0
and 0
Type 0
III 0
( 0
7.1 0
% 0
) 0
curves 0
. 0

1.23 0
) 0
as 0
a 0
PPARalpha B-gene
- I-gene
interacting I-gene
protein I-gene
. 0

Reading 0
disability 0
in 0
twins 0
. 0

Analysis 0
of 0
the 0
5 0
' 0
and 0
3 0
' 0
termini 0
of 0
the 0
transcripts 0
produced 0
in 0
vivo 0
from 0
the 0
puf B-gene
operon I-gene
of I-gene
R. I-gene
sphaeroides I-gene
PUF B-gene
delta I-gene
348 I-gene
- I-gene
420 I-gene
( 0
three 0
transcripts 0
; 0
0.59 0
, 0
0.64 0
, 0
and 0
2.63 0
kilobases 0
) 0
lacking 0
the 0
puf 0
- 0
intercistronic 0
terminator 0
structure 0
were 0
identical 0
to 0
those 0
of 0
the 0
corresponding 0
puf B-gene
transcripts I-gene
derived 0
from 0
wild 0
- 0
type 0
R. 0
sphaeroides 0
2.4.1 0
( 0
four 0
transcripts 0
; 0
0.50 0
, 0
0.66 0
, 0
0.71 0
, 0
and 0
2.7 0
kilobases 0
) 0
showing 0
that 0
the 0
transcripts 0
begin 0
and 0
end 0
at 0
the 0
same 0
sites 0
. 0

The 0
mean 0
amount 0
of 0
blood 0
loss 0
prior 0
to 0
time 0
of 0
injection 0
was 0
4.5 0
units 0
( 0
a 0
range 0
of 0
3 0
to 0
10 0
units 0
) 0
. 0

Several 0
of 0
the 0
drugs 0
used 0
in 0
the 0
management 0
of 0
MAC 0
have 0
been 0
associated 0
with 0
significant 0
drug 0
interactions 0
involving 0
the 0
cytochrome B-gene
P450 I-gene
( 0
CYP B-gene
) 0
enzyme 0
system 0
. 0

Therapy 0
and 0
prevention 0
of 0
irreversible 0
shock 0
with 0
pharmacological 0
doses 0
of 0
some 0
corticosteroids 0

Suppression 0
of 0
the 0
cka1 B-gene
delta I-gene
cka2 I-gene
- I-gene
8 I-gene
mutant I-gene
phenotype 0
occurs 0
by 0
interaction 0
of 0
CKB1 B-gene
with 0
the 0
defective 0
, 0
cka2 B-gene
- I-gene
8 I-gene
- 0
encoded 0
, 0
catalytic 0
subunit 0
. 0

Historically 0
, 0
Cyps B-gene
were 0
first 0
identified 0
by 0
their 0
ability 0
to 0
bind 0
the 0
immunosuppressive 0
agent 0
cyclosporin 0
A 0
( 0
CsA 0
) 0
with 0
high 0
affinity 0
; 0
they 0
later 0
were 0
found 0
to 0
have 0
peptidyl B-gene
- I-gene
prolyl I-gene
cis I-gene
- I-gene
trans I-gene
isomerase I-gene
( 0
PPIase B-gene
) 0
activity 0
, 0
which 0
catalyzes 0
the 0
folding 0
of 0
oligopeptides 0
at 0
proline 0
- 0
peptide 0
bonds 0
in 0
vitro 0
and 0
may 0
be 0
important 0
for 0
protein 0
folding 0
in 0
vivo 0
. 0

Reduced 0
glutathione 0
in 0
whole 0
blood 0
decreases 0
within 0
a 0
blood 0
Se 0
range 0
of 0
1.01 0
to 0
2.28 0
micrograms 0
in 0
the 0
high 0
Se 0
area 0
. 0

Promoter 0
elements 0
and 0
transcriptional 0
control 0
of 0
the 0
mouse B-gene
acetylcholinesterase I-gene
gene I-gene
. 0

To 0
our 0
knowledge 0
108 0
cases 0
of 0
EAT 0
treated 0
by 0
catheter 0
ablation 0
of 0
the 0
ectopic 0
focus 0
are 0
reported 0
in 0
the 0
literature 0
with 0
a 0
success 0
rate 0
superior 0
to 0
90 0
% 0
. 0

The 0
authors 0
report 0
two 0
cases 0
of 0
orbital 0
cavernous 0
hemangioma 0
diagnosed 0
by 0
Tc 0
- 0
99m 0
RBC 0
SPECT 0
. 0

250 0
, 0
302 0
- 0
311 0
] 0
. 0

Arterial 0
compliance 0
measurements 0
using 0
intraarterial 0
pulse 0
contour 0
analysis 0
and 0
a 0
modified 0
Windkessel 0
model 0
were 0
carried 0
out 0
in 0
19 0
patients 0
with 0
isolated 0
systolic 0
hypertension 0
( 0
> 0
or 0
= 0
160/ 0
< 0
or 0
= 0
90 0
mm 0
Hg 0
) 0
and 0
compared 0
to 0
measurements 0
in 0
29 0
patients 0
with 0
essential 0
hypertension 0
( 0
diastolic 0
blood 0
pressure 0
[ 0
BP 0
] 0
> 0
or 0
= 0
95 0
mm 0
Hg 0
) 0
and 0
47 0
normotensive 0
control 0
subjects 0
. 0

The 0
relationship 0
between 0
CSF B-gene
somatostatin I-gene
and 0
peripheral 0
thyroid 0
hormones 0
was 0
assessed 0
in 0
11 0
affectively 0
ill 0
patients 0
before 0
and 0
during 0
carbamazepine 0
treatment 0
. 0

Based 0
on 0
the 0
requirement 0
for 0
CREM/ICER B-gene
and 0
CREM/ICER I-gene

Since 0
the 0
early 0
1900s 0
, 0
a 0
genetic 0
hypothesis 0
has 0
been 0
suggested 0
. 0

Kettin B-gene
is 0
a 0
large 0
modular 0
protein 0
associated 0
with 0
thin 0
filaments 0
in 0
the 0
Z 0
- 0
disc 0
region 0
of 0
insect 0
muscles 0
. 0

To 0
probe 0
the 0
inter 0
- 0
relationship 0
between 0
the 0
virion 0
- 0
anchoring 0
function 0
and 0
the 0
oligomerization 0
function 0
, 0
we 0
constructed 0
two 0
serotype 0
3 0
( 0
T3 0
) 0
sigma B-gene
1 I-gene
deletion 0
mutants 0
in 0
SV40 0
expression 0
vectors 0
, 0
one 0
lacking 0
the 0
hydrophobic 0
tail 0
and 0
the 0
hinge 0
, 0
and 0
the 0
other 0
lacking 0
an 0
adjacent 0
region 0
which 0
constituted 0
part 0
of 0
the 0
coiled 0
- 0
coil 0
. 0

This 0
is 0
the 0
first 0
description 0
of 0
an 0
integron 0
located 0
on 0
a 0
composite 0
transposon 0
. 0

By 0
means 0
of 0
early 0
detection 0
and 0
correction 0
of 0
the 0
possible 0
causes 0
, 0
the 0
goal 0
of 0
increasing 0
therapeutic 0
efficacy 0
can 0
be 0
achieved 0
. 0

METHODS 0
: 0
Single 0
white 0
flash 0
ERG 0
, 0
photopic 0
ERG 0
, 0
scotopic 0
ERG 0
and 0
flicker 0
ERG 0
were 0
recorded 0
in 0
30 0
cases 0
of 0
unilateral 0
CRVO 0
. 0

RESULT 0
( 0
S 0
) 0
: 0
A 0
prospective 0
study 0
was 0
conducted 0
with 0
44 0
cycles 0
for 0
34 0
couples 0
with 0
nafarelin 0
acetate 0
( 0
group 0
1 0
) 0
and 0
47 0
cycles 0
for 0
40 0
couples 0
with 0
buserelin 0
acetate 0
( 0
group 0
2 0
) 0
with 0
a 0
long 0
IVF 0
protocol 0
; 0
68 0
cycles 0
for 0
46 0
couples 0
with 0
nafarelin 0
acetate 0
( 0
group 0
3 0
) 0
and 0
56 0
cycles 0
for 0
39 0
couples 0
with 0
buserelin 0
acetate 0
( 0
group 0
4 0
) 0
with 0
a 0
short 0
IVF 0
protocol 0
; 0
39 0
cycles 0
for 0
32 0
couples 0
with 0
nafarelin 0
acetate 0
( 0
group 0
5 0
) 0
and 0
50 0
cycles 0
for 0
30 0
couples 0
with 0
buserelin 0
acetate 0
( 0
group 0
6 0
) 0
with 0
a 0
long 0
ICSI 0
protocol 0
; 0
and 0
87 0
cycles 0
for 0
60 0
couples 0
with 0
nafarelin 0
acetate 0
( 0
group 0
7 0
) 0
and 0
81 0
cycles 0
for 0
61 0
couples 0
with 0
buserelin 0
acetate 0
( 0
group 0
8 0
) 0
with 0
a 0
short 0
ICSI 0
protocol 0
. 0

Mutations 0
in 0
the 0
beta B-gene
- I-gene
galactosidase I-gene
gene I-gene
result 0
in 0
the 0
lysosomal 0
storage 0
disorders 0
GM1 0
- 0
gangliosidosis 0
and 0
Morquio 0
B 0
syndrome 0
. 0

Angiographic 0
follow 0
- 0
up 0
was 0
obtained 0
in 0
92 0
% 0
of 0
patients 0
with 0
a 0
primary 0
success 0
of 0
angioplasty 0
. 0

However 0
, 0
it 0
is 0
only 0
loosely 0
associated 0
, 0
or 0
not 0
associated 0
, 0
with 0
viral 0
particles 0
. 0
gp170 B-gene
is 0
generated 0
by 0
an 0
alternatively 0
spliced 0
Env B-gene
mRNA I-gene
using 0
a 0
splice 0
donor 0
and 0
splice 0
acceptor 0
pair 0
localized 0
within 0
the 0
env B-gene
open I-gene
reading I-gene
frame I-gene
( I-gene
ORF I-gene
) I-gene
, 0
which 0
is 0
normally 0
used 0
to 0
generate 0
Bell B-gene
and 0
Bet B-gene
transcripts I-gene
derived 0
from 0
the 0
internal 0
promoter 0
within 0
the 0
env B-gene
ORF I-gene
. 0
gp170 B-gene
is 0
expressed 0
at 0
a 0
level 0
30 0
to 0
50 0
% 0
of 0
the 0
Env B-gene
precursor I-gene
gp130 B-gene
. 0

They 0
are 0
both 0
insensitive 0
to 0
inhibitors 0
of 0
serine B-gene
and I-gene
aspartyl I-gene
proteinases I-gene
but 0
are 0
sensitive 0
to 0
sulfhydryl 0
reagents 0
and 0
0.5 0
mM 0
ZnCl2 0
. 0

The 0
Brassica B-gene
BTH1 I-gene
gene I-gene
may 0
correspond 0
to 0
the 0
Arabidopsis B-gene
TH I-gene
- I-gene
1 I-gene
gene I-gene
. 0

Electron 0
microscopic 0
visualization 0
of 0
the 0
general 0
population 0
of 0
active 0
genes 0
in 0
flies 0
overexpressing 0
hnRNP B-gene
proteins I-gene
also 0
indicated 0
that 0
the 0
great 0
majority 0
of 0
genes 0
seemed 0
normal 0
in 0
terms 0
of 0
cotranscriptional 0
RNA 0
processing 0
events 0
, 0
although 0
there 0
were 0
a 0
few 0
abnormalities 0
consistent 0
with 0
rare 0
exon 0
- 0
skipping 0
events 0
. 0

ESR 0
spectra 0
of 0
Er3+ 0
in 0
SmB6 0
single 0
crystals 0
: 0
Dynamic 0
Jahn 0
- 0
Teller 0
effect 0
in 0
a 0
mixed 0
- 0
valence 0
compound 0
. 0

T. 0
infestans 0
, 0
T. 0
delpontei 0
, 0
T. 0
rubrovaria 0
, 0
T. 0
sordida 0
, 0
T. 0
guasayana 0
and 0
T. 0
vitticeps 0
from 0
infestans 0
subgroup 0
and 0
T. 0
pallidipennis 0
from 0
rubrofasciata 0
, 0
were 0
studied 0
. 0

When 0
the 0
same 0
single 0
- 0
amino 0
- 0
acid 0
mutations 0
were 0
directly 0
introduced 0
into 0
the 0
parental 0
PV/CBV4 0
- 0
2A 0
genome 0
, 0
chimeric 0
viruses 0
with 0
a 0
large 0
- 0
plaque 0
phenotype 0
and 0
a 0
wild 0
- 0
type 0
PV 0
- 0
like 0
growth 0
pattern 0
were 0
obtained 0
upon 0
transfection 0
, 0
an 0
observation 0
demonstrating 0
that 0
these 0
point 0
mutations 0
alone 0
had 0
a 0
drastic 0
effect 0
on 0
the 0
growth 0
of 0
the 0
PV/CBV4 0
chimeric 0
virus 0
. 0

These 0
results 0
indicate 0
that 0
the 0
2127 0
- 0
bp 0
cDNA 0
encodes 0
a 0
functional 0
feline 0
L/B/K B-gene
- I-gene
type I-gene
ALP I-gene
expressed 0
on 0
cell 0
surfaces 0
via 0
phosphatidylinositol 0
- 0
glycan 0
linkage 0
. 0

Clinical 0
experience 0
gained 0
from 0
a 0
combined 0
study 0
of 0
252Cf 0
brachytherapy 0
by 0
the 0
staff 0
- 0
members 0
of 0
the 0
Research 0
Institute 0
of 0
Medical 0
Radiology 0
, 0
USSR 0
AMS 0
, 0
was 0
generalized 0
. 0

When 0
the 0
VBP B-gene
- I-gene
1 I-gene
protein I-gene
was 0
solely 0
expressed 0
, 0
it 0
located 0
to 0
the 0
cytoplasm 0
and 0
did 0
not 0
localize 0
to 0
the 0
nucleus 0
. 0

Inhibition 0
of 0
endogenous B-gene
Cdk2 I-gene
by 0
dominant B-gene
negative I-gene
Cdk2 I-gene
attenuated 0
phosphorylation 0
of 0
Thr447 0
, 0
Thr490 0
and 0
Thr497 0
, 0
but 0
had 0
no 0
effect 0
upon 0
Ser581 0
modification 0
. 0

Treatment 0
of 0
excessive 0
bleeding 0
after 0
cardiopulmonary 0
bypass 0
was 0
based 0
on 0
an 0
algorithm 0
using 0
point 0
- 0
of 0
- 0
care 0
testing 0
with 0
whole 0
blood B-gene
prothrombin I-gene
time 0
, 0
activated 0
partial 0
thromboplastin B-gene
time 0
, 0
heparinase B-gene
activated 0
clotting 0
time 0
, 0
and 0
platelet 0
count 0
. 0

Endocarditis 0
remains 0
a 0
life 0
- 0
threatening 0
disease 0
with 0
substantial 0
morbidity 0
and 0
mortality 0
. 0

Association 0
between 0
diaphragm 0
use 0
and 0
asymptomatic 0
bacteriuria 0
. 0

The 0
high 0
prevalence 0
of 0
atrial 0
septal 0
defect 0
in 0
tetralogy 0
of 0
Fallot 0
is 0
cited 0
as 0
a 0
possible 0
analogy 0
because 0
right 0
ventricular 0
pressure 0
is 0
high 0
and 0
right 0
ventricular 0
compliance 0
is 0
low 0
from 0
birth 0
. 0

Experience 0
in 0
a 0
Kenya 0
district 0
hospital 0

Moreover 0
, 0
we 0
studied 0
the 0
relationship 0
between 0
initial 0
percentage 0
of 0
bone 0
marrow 0
plasma 0
cells 0
and 0
prognosis 0
. 0

Analysis 0
of 0
larger 0
cDNA 0
clones 0
demonstrates 0
that 0
there 0
are 0
at 0
least 0
two 0
isoforms 0
of 0
RIP14 B-gene
that 0
differ 0
in 0
the 0
N 0
- 0
terminal 0
( 0
A 0
and 0
B 0
) 0
and 0
hinge 0
( 0
D 0
) 0
domains 0
. 0

A 0
genomic 0
clone 0
of 0
the 0
chicken B-gene
osteopontin I-gene
- I-gene
encoding I-gene
gene I-gene
( 0
opn B-gene
) 0
was 0
isolated 0
and 0
found 0
to 0
be 0
organized 0
as 0
follows 0
: 0
an 0
untranslated 0
5 0
' 0
exon 0
; 0
a 0
signal 0
peptide 0
; 0
a 0
recognition 0
sequence 0
for 0
phosphorylation 0
by 0
casein B-gene
kinase I-gene
II I-gene
; 0
a 0
domain 0
containing 0
a 0
possible 0
O 0
- 0
linkage 0
site 0
for 0
glycosylation 0
; 0
a 0
second 0
casein B-gene
kinase I-gene
II I-gene
phosphorylation I-gene
site I-gene
; 0
an 0
exon 0
containing 0
three 0
functional 0
regions 0
, 0
the 0
poly 0
- 0
Asp 0
sequence 0
of 0
seven 0
consecutive 0
Asp 0
residues 0
, 0
the 0
RGD B-gene
integrin I-gene
recognition I-gene
site I-gene
and 0
a 0
potential 0
N 0
- 0
linkage 0
site 0
for 0
glycosylation 0
; 0
and 0
a 0
large 0
C 0
- 0
terminal 0
exon 0
which 0
also 0
contains 0
a 0
potential 0
N 0
- 0
linkage 0
site 0
for 0
glycosylation 0
. 0

The 0
entire 0
coding 0
region 0
of 0
an 0
ovine B-gene
endometrial I-gene
oxytocin I-gene
receptor I-gene
( 0
OTR B-gene
) 0
cDNA 0
was 0
generated 0
by 0
PCR 0
, 0
subcloned 0
into 0
the 0
SV40 B-gene
major I-gene
late I-gene
promoter I-gene
expression 0
vector 0
pSVLJ 0
and 0
transiently 0
expressed 0
in 0
Cos 0
- 0
7 0
cells 0
. 0

Copyright 0
1999 0
Academic 0
Press 0
. 0

Critical 0
review 0
of 0
tests 0
for 0
the 0
HBs B-gene
antigen I-gene
in 0
the 0
detection 0
of 0
infectious 0
blood 0

Diff 0
- 0
Quik 0
stain 0
for 0
Tzanck 0
smears 0
. 0

Disease 0
- 0
free 0
interval 0
was 0
greater 0
in 0
node 0
- 0
negative 0
Lx 0
patients 0
for 0
both 0
T1 0
( 0
P 0
less 0
than 0
0.007 0
) 0
and 0
T2 0
( 0
P 0
less 0
than 0
0.05 0
) 0
presentations 0
. 0

Deletion 0
analysis 0
defines 0
distinct 0
functional 0
domains 0
for 0
protein 0
- 0
protein 0
and 0
nucleic 0
acid 0
interactions 0
in 0
the 0
ORF1 B-gene
protein I-gene
of 0
mouse 0
LINE B-gene
- I-gene
1 I-gene
. 0

Allergen 0
- 0
stimulated 0
levels 0
of 0
PGD2 0
were 0
1274 0
+/ 0
- 0
565 0
versus 0
1468 0
+/ 0
- 0
679 0
after 0
prednisone 0
; 0
likewise 0
, 0
allergen 0
- 0
stimulated 0
5 0
- 0
HETE 0
levels 0
were 0
95 0
+/ 0
- 0
21 0
versus 0
82 0
+/ 0
- 0
21 0
; 0
those 0
of 0
LTE4 0
were 0
54 0
+/ 0
- 0
20 0
versus 0
91 0
+/ 0
- 0
51 0
; 0
and 0
those 0
of 0
15 0
- 0
HETE 0
were 0
63 0
+/ 0
- 0
19 0
versus 0
60 0
+/ 0
- 0
25 0
. 0

To 0
confirm 0
the 0
data 0
obtained 0
using 0
the 0
HPLC 0
- 0
ESI 0
- 0
MS 0
procedure 0
, 0
fractions 0
of 0
the 0
glycosides 0
from 0
four 0
berries 0
were 0
separated 0
, 0
hydrolyzed 0
, 0
silylated 0
and 0
the 0
sugars 0
were 0
analyzed 0
using 0
gas 0
chromatography 0
- 0
mass 0
spectrometry 0
. 0

Usefulness 0
of 0
computerized 0
tomography 0
in 0
hemodialysis 0
patients 0
. 0

Prevalence 0
of 0
use 0
, 0
claims 0
volume 0
, 0
and 0
expenditures 0
were 0
compared 0
for 0
cisapride 0
, 0
proton 0
pump 0
inhibitors 0
, 0
histamine B-gene
- I-gene
2 I-gene
receptor I-gene
antagonists 0
, 0
and 0
the 0
prokinetic 0
agent 0
metoclopramide 0
during 0
these 0
periods 0
. 0

However 0
, 0
the 0
quasiparticle 0
scattering 0
rate 0
tau 0
( 0
- 0
1 0
) 0
is 0
such 0
that 0
Planck 0
's 0
over 0
2pi/tau 0
approximately 0
6t 0
( 0
perpendicular 0
) 0
, 0
implying 0
that 0
kappa 0
- 0
( 0
BEDT 0
- 0
TTF 0
) 0
2Cu 0
( 0
NCS 0
) 0
( 0
2 0
) 0
meets 0
the 0
criterion 0
used 0
to 0
identify 0
interlayer 0
incoherence 0
. 0

The 0
deduced 0
gene 0
product 0
was 0
found 0
to 0
have 0
significant 0
sequence 0
similarity 0
to 0
the 0
yeast B-gene
and I-gene
prokaryotic I-gene
RNA I-gene
polymerase I-gene
subunits I-gene
involved 0
with 0
subunit 0
assembly 0
. 0

In 0
two 0
of 0
these 0
nine 0
patients 0
, 0
a 0
decrease 0
in 0
dyskinesia 0
score 0
was 0
observed 0
without 0
a 0
concomitant 0
worsening 0
of 0
parkinsonian 0
symptoms 0
, 0
whereas 0
in 0
the 0
remaining 0
seven 0
, 0
full 0
parkinsonian 0
akinesia 0
followed 0
THDL 0
administration 0
. 0

However 0
, 0
an 0
analogous 0
myristoylated 0
peptide 0
derived 0
from 0
c B-gene
- I-gene
Yes I-gene
also 0
has 0
no 0
inhibitory 0
activity 0
. 0

The 0
expression 0
of 0
the 0
leukocyte B-gene
EL I-gene
- I-gene
246 I-gene
antigen I-gene
was 0
regulated 0
in 0
the 0
same 0
manner 0
as 0
L B-gene
- I-gene
selectin I-gene
and 0
EL B-gene
- I-gene
246 I-gene
recognized 0
anti B-gene
- I-gene
L I-gene
- I-gene
selectin I-gene
mAb I-gene
affinity 0
- 0
purified 0
antigen 0
in 0
SDS/PAGE 0
Western 0
blot 0
analysis 0
. 0

A 0
proposed 0
method 0
. 0

The 0
two 0
SH3 B-gene
domains I-gene
are 0
separated 0
by 0
a 0
54 0
amino 0
acid 0
linker 0
region 0
, 0
whose 0
length 0
is 0
highly 0
conserved 0
in 0
xenopus 0
, 0
chicken 0
, 0
and 0
mamalian B-gene
Crk I-gene
II I-gene
proteins I-gene
. 0

A 0
clinical 0
trial 0
of 0
a 0
new 0
mitomycin 0
C 0
derivative 0
, 0
KW 0
- 0
2083 0
( 0
7 0
- 0
N 0
- 0
( 0
p 0
- 0
hydroxyphenyl 0
) 0
- 0
mitomycin 0
C 0
) 0

In 0
patients 0
with 0
active 0
TB 0
, 0
cytokines 0
that 0
were 0
elevated 0
in 0
serum 0
were 0
IFN B-gene
- I-gene
gamma I-gene
, 0
IL B-gene
- I-gene
6 I-gene
and 0
IL B-gene
- I-gene
10 I-gene
. 0

Overexpression 0
of 0
p50 B-gene
in 0
transient 0
cotransfection 0
studies 0
using 0
the 0
proximal 0
CRP B-gene
promoter I-gene
( 0
- 0
125/+9 0
) 0
linked 0
to 0
a 0
luciferase B-gene
reporter I-gene
caused 0
a 0
3 0
- 0
fold 0
increase 0
of 0
luciferase B-gene
activity 0
, 0
while 0
C/EBPbeta B-gene
overexpression 0
caused 0
an 0
18 0
- 0
fold 0
increase 0
; 0
simultaneous 0
overexpression 0
of 0
both 0
transcription 0
factors 0
increased 0
luciferase B-gene
activity 0
approximately 0
600 0
- 0
fold 0
. 0

Complexities 0
in 0
the 0
host 0
- 0
pathogen 0
interactions 0
during 0
actual 0
infection 0
with 0
Gram 0
- 0
negative 0
bacteria 0
may 0
account 0
for 0
the 0
difficulties 0
in 0
demonstrating 0
this 0
phenomena 0
in 0
vivo 0
. 0

PKCI B-gene
- I-gene
1 I-gene
is 0
a 0
member 0
of 0
the 0
HIT B-gene
family I-gene
of 0
proteins 0
, 0
shown 0
by 0
sequence 0
identity 0
to 0
be 0
conserved 0
in 0
a 0
broad 0
range 0
of 0
organisms 0
including 0
mycoplasma 0
, 0
plants 0
, 0
and 0
humans 0
. 0

6,320 0
cells/mm3 0
, 0
respectively 0
; 0
P 0
less 0
than 0
.005 0
) 0
; 0
twelve 0
( 0
86 0
% 0
) 0
of 0
the 0
14 0
inmates 0
who 0
developed 0
AIDS 0
had 0
counts 0
of 0
less 0
than 0
5,000 0
cells/mm3 0
, 0
compared 0
with 0
only 0
six 0
( 0
14 0
% 0
) 0
of 0
the 0
42 0
controls 0
( 0
P 0
less 0
than 0
.00001 0
) 0
. 0

Hpr1 B-gene
forms 0
, 0
together 0
with 0
Tho2 B-gene
, 0
Mft1 B-gene
, 0
and 0
Thp2 B-gene
, 0
the 0
THO B-gene
complex I-gene
, 0
which 0
controls 0
transcription 0
elongation 0
and 0
genome 0
stability 0
in 0
Saccharomyces 0
cerevisiae 0
. 0

A 0
new 0
model 0
for 0
objective 0
assessment 0
of 0
cervical 0
ripening 0
: 0
the 0
effect 0
of 0
prostaglandin 0
E2 0
and 0
prelabor 0
contractility 0
. 0

Insulin B-gene
- 0
secreting 0
islet 0
- 0
cell 0
tumours 0
of 0
the 0
pancreas 0
. 0

Suprapubic 0
and 0
intravesical 0
methods 0

Previous 0
work 0
established 0
that 0
the 0
TAL1 B-gene
proteins I-gene
are 0
phosphorylated 0
exclusively 0
on 0
serine 0
and 0
identified 0
Ser122 0
as 0
a 0
substrate 0
for 0
the 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
ERK B-gene
- I-gene
1 I-gene
. 0

The 0
use 0
of 0
ALAD B-gene
activity 0
and 0
EP 0
as 0
cumulative 0
lead 0
exposure 0
indicators 0
is 0
suggested 0
. 0

Immunofluorescence 0
obtained 0
using 0
antibodies 0
against 0
alphaI B-gene
SigmaI/++betaI I-gene
SigmaI I-gene
spectrin I-gene
and 0
Abl B-gene
tyrosine I-gene
kinase I-gene
but 0
not 0
against 0
alphaII/betaII B-gene
spectrin I-gene
colocalized 0
with 0
the 0
overexpressed 0
green B-gene
fluorescent I-gene
protein I-gene
- 0
SH3 B-gene
- I-gene
binding I-gene
protein I-gene
. 0

CONCLUSIONS 0
: 0
The 0
present 0
study 0
showed 0
it 0
is 0
possible 0
to 0
use 0
a 0
modified 0
Stroop 0
task 0
as 0
a 0
measure 0
of 0
implicit 0
processing 0
of 0
alcohol 0
stimuli 0
. 0

Furthermore 0
, 0
the 0
rapid 0
light 0
- 0
mediated 0
increase 0
of 0
CPRF B-gene
proteins I-gene
was 0
insensitive 0
to 0
transcriptional 0
inhibitors 0
, 0
suggesting 0
that 0
a 0
post 0
- 0
transcriptional 0
mechanism 0
controls 0
CPRF B-gene
accumulation 0
. 0

43 0
% 0
, 0
6/14 0
; 0
P 0
= 0
0.013 0
) 0
, 0
whereas 0
, 0
in 0
RCC 0
samples 0
with 0
VHL B-gene
methylation 0
or 0
mutation 0
, 0
the 0
frequency 0
of 0
3p14 0
- 0
p21 0
LOH 0
did 0
not 0
differ 0
from 0
that 0
of 0
sp25 0
- 0
p26 0
( 0
72 0
% 0
, 0
18/25 0
vs 0
. 0

One 0
patient 0
had 0
chronic 0
dysphoria 0
and 0
one 0
encephalopatia 0
toxica 0
. 0

A 0
single 0
clone 0
, 0
which 0
was 0
conserved 0
and 0
had 0
near 0
- 0
perfect 0
homology 0
to 0
eight 0
human/rodent 0
expressed 0
sequence 0
tags 0
, 0
was 0
used 0
as 0
template 0
for 0
5 0
' 0
and 0
3 0
' 0
rapid 0
amplification 0
of 0
cDNA 0
ends 0
and 0
SPICE 0
( 0
system 0
for 0
polymerase 0
chain 0
reaction 0
amplification 0
of 0
cDNA 0
ends 0
) 0
reactions 0
to 0
obtain 0
the 0
3.6 0
- 0
kb 0
cDNA 0
, 0
LGL2 B-gene
( 0
Genbank B-gene
, I-gene
AF I-gene
110195 I-gene
) 0
encoding 0
a 0
deduced 0
polypeptide 0
( 0
lgl2 B-gene
) 0
of 0
963 0
amino 0
acids 0
. 0

Effect 0
of 0
dimethyl 0
sulfoxide 0
on 0
cooling 0
rates 0
of 0
unrestrained 0
rats 0
. 0

The 0
GIS 0
software 0
program 0
, 0
ArcView 0
, 0
was 0
used 0
for 0
spatial 0
analysis 0
and 0
distance 0
calculations 0
. 0
chi2 0
Tests 0
were 0
used 0
to 0
compare 0
the 0
distribution 0
of 0
the 0
characteristics 0
between 0
intersection 0
and 0
midblock 0
collisions 0
. 0

We 0
have 0
analyzed 0
the 0
role 0
of 0
the 0
HU B-gene
protein I-gene
in 0
invertasome 0
assembly 0
when 0
the 0
enhancer 0
is 0
located 0
at 0
variable 0
positions 0
close 0
to 0
one 0
of 0
the 0
recombination 0
sites 0
. 0

We 0
compared 0
these 0
responses 0
for 0
six 0
hatchling 0
and 0
eight 0
adult 0
Chrysemys 0
picta 0
from 0
an 0
Ohio 0
population 0
. 0

The 0
likelihood 0
of 0
death 0
was 0
more 0
than 0
3 0
times 0
higher 0
among 0
patients 0
in 0
the 0
ERA 0
- 0
II 0
group 0
( 0
mortality 0
risk 0
ratio 0
3.82 0
[ 0
95 0
% 0
CI 0
1.48 0
% 0
to 0
9.84 0
] 0
, 0
p 0
= 0
0.006 0
) 0
. 0

Pros 0
and 0
cons 0
of 0
selective 0
inhibition 0
of 0
cyclooxygenase B-gene
- I-gene
2 I-gene
versus 0
dual 0
lipoxygenase/cyclooxygenase B-gene
inhibition 0
: 0
is 0
two 0
better 0
than 0
one 0
? 0

INTERNET 0
is 0
literally 0
a 0
world 0
of 0
data 0
, 0
dialogue 0
, 0
and 0
discourse 0
on 0
any 0
topic 0
imaginable 0
, 0
right 0
at 0
your 0
fingertips 0
. 0

Here 0
we 0
show 0
that 0
the 0
nucleotide 0
in 0
the 0
middle 0
of 0
the 0
anticodon 0
( 0
i.e. 0
, 0
psi 0
35 0
) 0
also 0
contributes 0
to 0
the 0
suppressor 0
efficiency 0
displayed 0
by 0
cytoplasmic B-gene
tRNA I-gene
( I-gene
Tyr I-gene
) I-gene
. 0

We 0
established 0
that 0
, 0
in 0
unstimulated 0
lymphocytes 0
, 0
the 0
Src B-gene
homology I-gene
2 I-gene
( 0
SH2 B-gene
) 0
and 0
SH3 B-gene
domain I-gene
- I-gene
containing I-gene
protein I-gene
Grb2 B-gene
and 0
the 0
p85 B-gene
subunit 0
of 0
phosphatidylinositol B-gene
3 I-gene
- I-gene
kinase I-gene
, 0
associate 0
constitutively 0
with 0
Cbl B-gene
via 0
their 0
SH3 B-gene
domains I-gene
. 0

In 0
addition 0
, 0
Fc B-gene
epsilon I-gene
R1 I-gene
cross 0
- 0
linking 0
activates 0
PI B-gene
3 I-gene
- I-gene
kinase I-gene
. 0

Similarly 0
, 0
an 0
increase 0
in 0
CAT B-gene
expression 0
from 0
the 0
same 0
construct 0
( 0
pBLCAT 0
- 0
ENDOA B-gene
) 0
was 0
also 0
observed 0
in 0
7AQS2.1 0
cells 0
. 0

Indirect 0
determination 0
of 0
maximal 0
O2 0
consumption 0
in 0
man 0
. 0

The 0
two 0
complexes 0
were 0
detected 0
with 0
a 0
similar 0
activation 0
kinetics 0
upon 0
IL B-gene
- I-gene
4 I-gene
stimulation 0
. 0

Although 0
the 0
occurrence 0
of 0
any 0
ventricular 0
ectopic 0
activity 0
, 0
as 0
detected 0
by 0
either 0
or 0
both 0
methods 0
, 0
was 0
common 0
, 0
the 0
incidence 0
was 0
significantly 0
higher 0
( 0
P 0
less 0
than 0
0.001 0
) 0
in 0
patients 0
with 0
coronary 0
heart 0
disease 0
( 0
86 0
percent 0
; 0
77/90 0
) 0
, 0
as 0
compared 0
to 0
that 0
in 0
normal 0
subjects 0
( 0
40 0
percent 0
; 0
12/30 0
) 0
. 0

The 0
frequency 0
of 0
eating 0
dark 0
- 0
meat 0
fish 0
was 0
positively 0
associated 0
with 0
serum 0
eicosapentaenoic 0
acid 0
and 0
docosahexaenoic 0
acid 0
, 0
omega3 0
fatty 0
acids 0
, 0
and 0
inversely 0
associated 0
with 0
serum 0
stearic 0
acid 0
and 0
linoleic 0
acid 0
. 0

These 0
8 B-gene
- I-gene
oxoguanine I-gene
DNA I-gene
glycosylases I-gene
, 0
hOgg1 B-gene
( 0
human 0
) 0
and 0
mOgg1 B-gene
( 0
murine 0
) 0
, 0
are 0
homologous 0
to 0
each 0
other 0
and 0
to 0
yeast B-gene
Ogg1 I-gene
. 0

HDE B-gene
was 0
found 0
to 0
be 0
exclusively 0
targeted 0
to 0
and 0
imported 0
into 0
peroxisomes 0
in 0
both 0
heterologous 0
expression 0
systems 0
. 0

Taken 0
together 0
, 0
these 0
results 0
indicate 0
that 0
ICSBP B-gene
and 0
PU.1 B-gene
are 0
critical 0
elements 0
for 0
IL B-gene
- I-gene
18 I-gene
gene I-gene
expression 0
. 0

Model 0
experiments 0
on 0
pheasants 0
using 0
single 0
doses 0
of 0
the 0
insecticide 0
( 0
Lindane 0
) 0
the 0
herbicide 0
( 0
Terbutryn 0
) 0
a 0
mineral 0
fertilizer 0
( 0
calcium 0
ammonium 0
nitrate 0
) 0
and 0
the 0
fungicide 0
( 0
HCB 0
) 0
. 0

The 0
main 0
side 0
- 0
effects 0
were 0
myelosuppression 0
, 0
mucositis 0
and 0
peripheral 0
neuropathy 0
, 0
which 0
were 0
all 0
common 0
and 0
often 0
severe 0
. 0

The 0
decision 0
support 0
system 0
uses 0
the 0
network 0
at 0
its 0
core 0
and 0
helps 0
not 0
only 0
in 0
reaching 0
a 0
diagnosis 0
but 0
also 0
in 0
finding 0
the 0
optimal 0
way 0
to 0
reach 0
that 0
diagnosis 0
. 0

Metapsychiatry 0
is 0
a 0
term 0
born 0
of 0
necessity 0
to 0
designate 0
the 0
important 0
but 0
hitherto 0
unclassified 0
interface 0
between 0
psychiatry 0
and 0
mysticism 0
. 0

Repression 0
was 0
strictly 0
dependent 0
on 0
the 0
presence 0
of 0
upstream 0
Oshox1 B-gene
binding 0
sites 0
in 0
the 0
reporter 0
gene 0
constructs 0
and 0
a 0
function 0
of 0
the 0
N 0
- 0
terminal 0
region 0
of 0
Oshox1 B-gene
, 0
preceding 0
the 0
homeodomain B-gene
. 0

Experimental 0
studies 0
and 0
clinical 0
application 0
of 0
plasma B-gene
ACTH I-gene
radioimmunoassay 0
kit 0
without 0
extraction 0
process 0

Defects 0
in 0
RT6 B-gene
expression 0
coincide 0
with 0
increased 0
susceptibility 0
in 0
animal 0
models 0
for 0
insulin B-gene
- 0
dependent 0
diabetes 0
mellitus 0
and 0
other 0
autoimmune 0
diseases 0
. 0

By 0
cloning 0
genes 0
encoding 0
benzene 0
- 0
degradative 0
enzymes 0
, 0
we 0
found 0
that 0
strain 0
JS150 0
also 0
carries 0
genes 0
for 0
a 0
toluene/benzene B-gene
- I-gene
2 I-gene
- I-gene
monooxygenase I-gene
. 0

Thus 0
G17 B-gene
targets 0
the 0
c B-gene
- I-gene
fos I-gene
promoter I-gene
CArG I-gene
sequence I-gene
via 0
Rho B-gene
A I-gene
- 0
dependent 0
pathways 0
, 0
and 0
Rho B-gene
A I-gene
appears 0
to 0
play 0
an 0
important 0
role 0
in 0
the 0
regulation 0
of 0
the 0
trophic 0
action 0
of 0
G17 B-gene
. 0

By 0
contrast 0
with 0
ama B-gene
- I-gene
1 I-gene
, 0
rpc B-gene
- I-gene
1 I-gene
was 0
not 0
deleted 0
by 0
mDf4 0
or 0
larger 0
deficiencies 0
examined 0
, 0
indicating 0
that 0
these 0
genes 0
are 0
no 0
closer 0
than 0
150 0
kb 0
. 0

Expression 0
of 0
the 0
bacteriophage B-gene
T4 I-gene
DNA I-gene
terminase I-gene
genes I-gene
16 I-gene
and I-gene
17 I-gene
yields 0
multiple 0
proteins 0
. 0

Rat B-gene
p8 I-gene
mRNA I-gene
was 0
discovered 0
because 0
of 0
its 0
strong 0
activation 0
in 0
pancreas 0
during 0
the 0
acute 0
phase 0
of 0
pancreatitis 0
. 0

Dual 0
signal 0
peptides 0
mediate 0
the 0
signal B-gene
recognition I-gene
particle/Sec I-gene
- 0
independent 0
insertion 0
of 0
a 0
thylakoid 0
membrane 0
polyprotein 0
, 0
particle/Sec I-gene

Sequence 0
divergence 0
of 0
approximately 0
16 0
% 0
reduced 0
transformation 0
frequencies 0
by 0
at 0
least 0
10 0
- 0
fold 0
. 0

During 0
subsequent 0
CS 0
- 0
alone 0
trials 0
, 0
the 0
responses 0
of 0
( 0
+ 0
) 0
MK 0
- 0
801 0
- 0
injected 0
mice 0
were 0
extinguished 0
as 0
easily 0
as 0
those 0
of 0
saline 0
- 0
injected 0
mice 0
. 0

The 0
three 0
respective 0
time 0
control 0
groups 0
( 0
C5 0
, 0
C10 0
, 0
and 0
C15 0
) 0
were 0
injected 0
with 0
saline 0
solution 0
. 0

Next 0
, 0
to 0
examine 0
the 0
regulation 0
mechanism 0
of 0
CD44/ERM B-gene
interaction 0
in 0
vivo 0
, 0
we 0
reexamined 0
the 0
immunoprecipitated 0
CD44/ERM I-gene

Ten 0
patients 0
( 0
aged 0
28 0
- 0
76 0
years 0
) 0
with 0
a 0
terminal 0
jejunostomy 0
located 0
within 0
the 0
first 0
meter 0
of 0
jejunum 0
were 0
treated 0
by 0
infusion 0
of 0
an 0
elemental 0
diet 0
into 0
the 0
distal 0
small 0
bowel 0
( 0
IEDDSB 0
) 0
. 0

The 0
illuminator 0
uses 0
a 0
grain 0
- 0
of 0
- 0
wheat 0
light 0
bulb 0
and 0
an 0
adjustable 0
bulb 0
holder 0
fashioned 0
from 0
bent 0
paper 0
clips 0
. 0

The 0
goals 0
of 0
these 0
experiments 0
were 0
to 0
determine 0
whether 0
lactational 0
anestrus 0
would 0
be 0
prolonged 0
by 0
a 0
48 0
- 0
h 0
fast 0
at 0
days 0
13 0
and 0
14 0
postpartum 0
( 0
pp 0
) 0
and 0
, 0
if 0
so 0
, 0
to 0
determine 0
whether 0
this 0
effect 0
could 0
be 0
reversed 0
by 0
treatment 0
with 0
the 0
Ob B-gene
protein I-gene
leptin B-gene
. 0

The 0
kinetics 0
of 0
[ 0
14C 0
] 0
NG 0
in 0
the 0
blood 0
of 0
the 0
dosed 0
animals 0
was 0
followed 0
. 0

RESULTS 0
: 0
In 0
patients 0
with 0
necrotising 0
fasciitis 0
the 0
arterial 0
PO2 0
rose 0
about 0
7 0
- 0
fold 0
whereas 0
the 0
arterial 0
PCO2 0
increased 0
only 0
slightly 0
during 0
exposure 0
to 0
2.5 0
absolute 0
atmospheres 0
( 0
ATA 0
) 0
of 0
oxygen 0
. 0

Coronary 0
arteriographies 0
and 0
ventriculographies 0
corresponding 0
to 0
274 0
consecutive 0
patients 0
( 0
January 0
, 0
1975 0
- 0
October 0
, 0
1978 0
) 0
with 0
significant 0
coronary 0
lesions 0
are 0
reviewed 0
. 0

The 0
data 0
show 0
that 0
processing 0
time 0
as 0
a 0
function 0
of 0
intensity 0
is 0
modified 0
not 0
only 0
at 0
the 0
retina 0
but 0
also 0
at 0
later 0
processing 0
sites 0
. 0

Lag 0
phases 0
were 0
14.89 0
hours 0
+/ 0
- 0
0.77 0
, 0
13.33 0
hours 0
+/ 0
- 0
0.50 0
, 0
20.22 0
hours 0
+/ 0
- 0
0.76 0
, 0
and 0
20.00 0
hours 0
+/ 0
- 0
0.79 0
, 0
respectively 0
, 0
for 0
endothelial 0
cell 0
- 0
induced 0
LDL B-gene
oxidation 0
. 0

Therefore 0
, 0
the 0
Ogg1 B-gene
protein I-gene
is 0
a 0
eukaryotic 0
DNA B-gene
glycosylase/AP I-gene
glycosylase/AP I-gene
lyase I-gene
. 0

Being 0
implicated 0
in 0
insulin B-gene
and 0
GK B-gene
gene I-gene
regulations 0
as 0
a 0
common 0
transcription 0
factor 0
, 0
IPF1/STF B-gene
IPF1/STF I-gene
- I-gene
1/PDX I-gene
1/PDX I-gene
- I-gene
1 I-gene
is 0
likely 0
to 0
play 0
an 0
essential 0
role 0
in 0
maintaining 0
normal 0
beta 0
- 0
cell 0
functions 0
. 0

MATERIAL 0
AND 0
METHODS 0
: 0

Salt 0
wars 0
. 0

Finally 0
, 0
synthetic 0
peptides 0
corresponding 0
to 0
the 0
mutant 0
proteins 0
were 0
assessed 0
for 0
the 0
ability 0
to 0
act 0
as 0
substrates 0
for 0
PR B-gene
. 0

As 0
an 0
approach 0
to 0
the 0
determination 0
of 0
structure 0
- 0
function 0
relationships 0
in 0
the 0
PRP4 B-gene
protein I-gene
, 0
we 0
have 0
isolated 0
more 0
than 0
fifty 0
new 0
alleles 0
of 0
the 0
PRP4 B-gene
gene I-gene
through 0
random 0
and 0
site 0
- 0
directed 0
mutagenesis 0
, 0
and 0
have 0
analyzed 0
the 0
phenotypes 0
of 0
many 0
of 0
them 0
. 0

Brainstem 0
auditory 0
evoked 0
potential 0
responses 0
( 0
BAEPs 0
) 0
were 0
recorded 0
from 0
CZ 0
- 0
A1 0
and 0
CZ 0
- 0
A2 0
scalp 0
regions 0
in 0
23 0
hypertensive 0
and 0
14 0
normotensive 0
subjects 0
. 0

Although 0
the 0
Gly252Arg 0
substitution 0
observed 0
in 0
UM 0
: 0
JG5 0
is 0
non 0
- 0
conservative 0
, 0
it 0
was 0
not 0
possible 0
to 0
distinguish 0
whether 0
it 0
is 0
a 0
mutation 0
or 0
a 0
polymorphism 0
. 0

Two 0
SH2 B-gene
domains I-gene
of 0
p120 B-gene
Ras B-gene
GTPase B-gene
- I-gene
activating I-gene
protein I-gene
bind 0
synergistically 0
to 0
tyrosine 0
phosphorylated 0
p190 B-gene
Rho 0
GTPase B-gene
- I-gene
activating I-gene
protein I-gene
. 0
p120 B-gene
GTPase B-gene
- I-gene
activating I-gene
protein I-gene
( 0
GAP B-gene
) 0
is 0
a 0
negative 0
regulator 0
of 0
Ras B-gene
that 0
functions 0
at 0
a 0
key 0
relay 0
point 0
in 0
signal 0
transduction 0
pathways 0
that 0
control 0
cell 0
proliferation 0
. 0

Phosphorylation 0
of 0
the 0
ras B-gene
GTPase B-gene
- I-gene
activating I-gene
protein I-gene
( 0
GAP B-gene
) 0
by 0
the 0
p93c B-gene
- I-gene
fes I-gene
protein B-gene
- I-gene
tyrosine I-gene
kinase I-gene
in 0
vitro 0
and 0
formation 0
of 0
GAP B-gene
- 0
fes B-gene
complexes 0
via 0
an 0
SH2 B-gene
domain 0
- 0
dependent 0
mechanism 0
. 0

This 0
resulted 0
in 0
a 0
shift 0
of 0
C1/C2 0
, 0
so 0
that 0
the 0
effect 0
of 0
collagen B-gene
was 0
more 0
pronounced 0
( 0
maximal 0
increase 0
of 0
C1/C2 0
= 0
134 0
% 0
) 0
than 0
ADP 0
( 0
maximal 0
increase 0
of 0
C1/C2 0
= 0
79 0
% 0
) 0
. 0

A 0
significant 0
increase 0
of 0
gastric 0
mucosal 0
permeability 0
was 0
observed 0
in 0
six 0
normal 0
human 0
subjects 0
after 0
instillation 0
of 0
ethanol 0
( 0
20 0
percent 0
v/v 0
) 0
. 0

Analysis 0
of 0
domain 0
deletion 0
mutants 0
demonstrated 0
strong 0
synergy 0
between 0
the 0
RRM 0
and 0
a 0
central 0
degenerate 0
RRM 0
repeat 0
in 0
binding 0
to 0
RNA 0
. 0

Overexpression 0
of 0
eIF4E B-gene
transforms 0
cells 0
, 0
and 0
mutations 0
in 0
eIF4E B-gene
arrest 0
cells 0
in 0
G 0
, 0
in 0
cdc33 B-gene
mutants I-gene
. 0

ZF87 B-gene
specifically 0
binds 0
the 0
ME1a1 0
element 0
with 0
higher 0
affinity 0
than 0
the 0
ME1a2 0
element 0
. 0

The 0
unusual 0
properties 0
of 0
TRAC B-gene
activity 0
and 0
its 0
relationship 0
, 0
if 0
any 0
, 0
with 0
the 0
enigmatic 0
Ku B-gene
protein I-gene
, 0
are 0
discussed 0
. 0

Structure 0
of 0
the 0
connective 0
stroma 0
of 0
the 0
epididymis 0
in 0
the 0
zebu 0

Characterization 0
of 0
regions 0
of 0
fibronectin B-gene
besides 0
the 0
arginine 0
- 0
glycine 0
- 0
aspartic 0
acid 0
sequence 0
required 0
for 0
adhesive 0
function 0
of 0
the 0
cell 0
- 0
binding 0
domain 0
using 0
site 0
- 0
directed 0
mutagenesis 0
. 0

These 0
data 0
suggest 0
that 0
multiple 0
genetic 0
recombination 0
among 0
bacteriophages 0
with 0
different 0
immunities 0
took 0
place 0
to 0
generate 0
the 0
prophage 0
VT1 0
- 0
Sakai 0
. 0

Transient 0
- 0
expression 0
assay 0
analysis 0
of 0
subclones 0
of 0
pPstI 0
- 0
G 0
localized 0
the 0
trans 0
- 0
active 0
factor 0
to 0
a 0
3.0 B-gene
- I-gene
kilobase I-gene
XbaI I-gene
fragment I-gene
. 0

We 0
used 0
an 0
immobilized 0
template 0
- 0
based 0
assay 0
to 0
examine 0
transcription 0
termination 0
by 0
VA1 B-gene
, 0
7SL B-gene
, 0
and 0
Alu B-gene
class I-gene
III I-gene
templates 0
and 0
the 0
role 0
of 0
transcript 0
release 0
in 0
the 0
pol B-gene
III I-gene
terminator 0
- 0
dependent 0
inhibition 0
of 0
processing 0
of 0
B1 B-gene
- 0
Alu B-gene
transcripts 0
. 0

Concentrations 0
of 0
platelet 0
nitrite 0
and 0
total 0
nitrate/nitrite 0
were 0
determined 0
using 0
simple 0
and 0
sensitive 0
nitrate/nitrite 0
fluorometric 0
assay 0
techniques 0
. 0

Using 0
a 0
GTP 0
- 0
dependent 0
, 0
brefeldin 0
A 0
- 0
sensitive 0
in 0
vitro 0
AP B-gene
- I-gene
1 I-gene
binding 0
assay 0
, 0
we 0
have 0
determined 0
here 0
the 0
parameters 0
of 0
the 0
AP B-gene
- I-gene
1 I-gene
binding 0
reaction 0
. 0

By 0
using 0
methanol 0
- 0
0.15 0
M 0
borate 0
buffer 0
of 0
pH 0
8.0 0
, 0
cate B-gene
- I-gene
chol I-gene
- I-gene
O I-gene
- I-gene
methyltransferase I-gene
activity 0
might 0
be 0
assayed 0
. 0

Replacement 0
of 0
Val20 0
- 0
Leu21 0
with 0
Ala 0
- 0
Ala 0
produced 0
a 0
dimeric B-gene
RII I-gene
beta I-gene
protein I-gene
that 0
binds 0
AKAP75 B-gene
approximately 0
4 0
% 0
as 0
avidly 0
as 0
wild B-gene
- I-gene
type I-gene
RII I-gene
beta I-gene
. 0

Plasmodium 0
vivax 0
malaria 0
. 0

Postcontrast 0
images 0
were 0
also 0
acquired 0
in 0
the 0
sagittal 0
( 0
six 0
patients 0
) 0
and 0
coronal 0
( 0
three 0
patients 0
) 0
planes 0
. 0

Conservation 0
of 0
this 0
zinc 0
finger 0
motif 0
from 0
yeast 0
to 0
mouse 0
and 0
human 0
implies 0
functional 0
importance 0
. 0

In 0
vitro 0
death 0
assays 0
with 0
transient 0
overexpression 0
of 0
deletion 0
constructs 0
of 0
both 0
isoforms 0
using 0
beta B-gene
- I-gene
galactosidase I-gene
as 0
a 0
reporter 0
gene 0
in 0
MCF7 0
cells 0
suggest 0
the 0
following 0
: 0
1 0
) 0
the 0
nucleotide 0
binding 0
domain 0
may 0
act 0
as 0
a 0
negative 0
regulator 0
of 0
the 0
killing 0
activity 0
of 0
DEFCAP B-gene
; 0
2 0
) 0
the 0
LRR/CARD B-gene
represents 0
a 0
putative 0
constitutively 0
active 0
inducer 0
of 0
apoptosis 0
; 0
3 0
) 0
the 0
killing 0
activity 0
of 0
LRR/CARD I-gene

Here 0
, 0
we 0
provide 0
direct 0
evidence 0
that 0
the 0
meiotic 0
defect 0
caused 0
by 0
either 0
unregulated 0
cAPK B-gene
activity 0
or 0
unregulated 0
ran1+ B-gene
kinase I-gene
activity 0
is 0
due 0
to 0
inability 0
to 0
induce 0
transcription 0
of 0
the 0
mei2+ B-gene
gene I-gene
, 0
which 0
is 0
required 0
for 0
meiotic 0
initiation 0
. 0

Sailer 0
, 0
K 0
. 0

The 0
terminal 0
a 0
sequence 0
of 0
the 0
herpes 0
simplex 0
virus 0
genome 0
contains 0
the 0
promoter 0
of 0
a 0
gene 0
located 0
in 0
the 0
repeat 0
sequences 0
of 0
the 0
L 0
component 0
. 0

The 0
Caenorhabditis B-gene
elegans I-gene
NK I-gene
- I-gene
2 I-gene
class I-gene
homeoprotein I-gene
CEH I-gene
- I-gene
22 I-gene
is 0
involved 0
in 0
combinatorial 0
activation 0
of 0
gene 0
expression 0
in 0
pharyngeal 0
muscle 0
. 0

As 0
tat B-gene
itself 0
dramatically 0
increases 0
HIV 0
- 0
1 0
gene 0
expression 0
, 0
it 0
too 0
is 0
presumably 0
regulated 0
in 0
the 0
latent 0
state 0
, 0
and 0
may 0
also 0
be 0
activated 0
by 0
mitogenic 0
stimulation 0
. 0

The 0
CBS B-gene
- I-gene
1 I-gene
gene I-gene
was 0
mapped 0
to 0
human 0
chromosome 0
10p12 0
between 0
markers 0
WI B-gene
- I-gene
8535 I-gene
and 0
WI B-gene
- I-gene
4724 I-gene
, 0
and 0
is 0
tightly 0
linked 0
to 0
the 0
two 0
STRP 0
markers 0
of 0
D10S1789 B-gene
and 0
D10S550 B-gene
. 0

We 0
have 0
previously 0
described 0
the 0
partial 0
purification 0
of 0
Ap4A B-gene
hydrolase I-gene
from 0
S. 0
pombe 0
[ 0
Robinson 0
, 0
de 0
la 0
Pena 0
and 0
Barnes 0
( 0
1993 0
) 0
Biochim 0
. 0

Both 0
flavoproteins 0
are 0
active 0
as 0
AhpC B-gene
reductases I-gene
and 0
mediate 0
electron 0
transfer 0
, 0
resulting 0
in 0
the 0
NADH 0
- 0
dependent 0
reduction 0
of 0
hydrogen 0
peroxide 0
and 0
cumene 0
hydroperoxide 0
. 0

Together 0
, 0
these 0
results 0
indicate 0
that 0
YTS1 B-gene
is 0
a 0
bifunctional 0
protein 0
active 0
in 0
both 0
splicing 0
and 0
protein 0
synthesis 0
. 0

The 0
first 0
operon 0
, 0
orf1 0
- 0
tolQRA B-gene
, 0
is 0
iron 0
regulated 0
throughout 0
growth 0
, 0
but 0
iron 0
- 0
regulated 0
expression 0
of 0
tolB B-gene
and 0
oprL B-gene
fusions I-gene
occurs 0
only 0
in 0
late 0
log 0
phase 0
. 0

Thus 0
, 0
STK1 B-gene
is 0
most 0
likely 0
the 0
human B-gene
homologue I-gene
of I-gene
MO15 I-gene
. 0

The 0
human B-gene
IFI16 I-gene
gene I-gene
is 0
a 0
member 0
of 0
an 0
interferon B-gene
- 0
inducible 0
family 0
of 0
mouse 0
and 0
human 0
genes 0
closely 0
linked 0
on 0
syntenic 0
regions 0
of 0
chromosome 0
1 0
. 0

Late 0
results 0
in 0
the 0
treatment 0
of 0
urotuberculosis 0

Blood 0
samples 0
for 0
determination 0
of 0
fibrinolytic 0
activity 0
and 0
factor B-gene
VIII I-gene
in 0
plasma 0
were 0
obtained 0
before 0
and 0
immediately 0
after 0
the 0
end 0
of 0
compression 0
and 0
application 0
of 0
a 0
stocking 0
, 0
respectively 0
. 0

Exon 0
A1a 0
encodes 0
most 0
of 0
the 0
5' 0
- 0
untranslated 0
region 0
. 0

Methylation 0
interference 0
analysis 0
established 0
at 0
single 0
nucleotide 0
resolution 0
that 0
purified 0
recombinant 0
Fos B-gene
and 0
Jun B-gene
proteins I-gene
bind 0
in 0
a 0
sequence 0
- 0
specific 0
manner 0
to 0
the 0
AP B-gene
- I-gene
1 I-gene
sites I-gene
within 0
the 0
VDRE 0
and 0
OC B-gene
box I-gene
. 0

Also 0
, 0
PTx B-gene
had 0
no 0
effect 0
on 0
shear 0
- 0
dependent 0
activation 0
of 0
JNK B-gene
. 0

Cardiovascular 0
effects 0
in 0
man 0
of 0
intravenous 0
prizidilol 0
hydrochloride 0
( 0
SK 0
& 0
F 0
92657 0
) 0
; 0
a 0
new 0
antihypertensive 0
agent 0
. 0

The 0
human B-gene
p18 I-gene
gene I-gene
spans 0
at 0
least 0
7.5 0
kb 0
and 0
is 0
composed 0
of 0
three 0
exons 0
, 0
two 0
of 0
which 0
encode 0
the 0
p18 B-gene
protein I-gene
. 0

Partial 0
characterization 0
of 0
the 0
CCAAT 0
box 0
in 0
the 0
promoter 0
of 0
the 0
hLGFBP B-gene
- I-gene
1 I-gene
gene I-gene
: 0
interaction 0
with 0
negatively 0
acting 0
transcription 0
factors 0
in 0
decidualized 0
human 0
endometrial 0
stromal 0
cells 0
. 0

Footprints 0
on 0
the 0
HPV B-gene
18 I-gene
enhancer I-gene
show 0
five 0
protected 0
regions 0
with 0
homologies 0
to 0
NF1 B-gene
, 0
AP1 B-gene
and 0
EFII B-gene
transcription I-gene
factor I-gene
binding I-gene
motifs I-gene
. 0

These 0
cDNAs 0
were 0
found 0
to 0
be 0
derived 0
from 0
the 0
3 0
'' 0
- 0
untranslated 0
region 0
( 0
3 0
'' 0
- 0
UTR 0
) 0
of 0
the B-gene
methyl I-gene
- I-gene
CpG I-gene
- I-gene
binding I-gene
protein I-gene
2 I-gene
gene I-gene
gene I-gene
( I-gene
MeCP2 I-gene
) 0
. 0

A 0
simple 0
algorithm 0
fitting 0
the 0
data 0
for 0
the 0
moving 0
192Ir 0
source 0
is 0
proposed 0
. 0

Univariate 0
and 0
multivariate 0
analysis 0
was 0
used 0
to 0
calculate 0
the 0
5 0
- 0
year 0
survival 0
probabilities 0
with 0
respect 0
to 0
the 0
following 0
variables 0
: 0
age 0
( 0
< 0
or 0
= 0
65 0
, 0
> 0
65 0
) 0
, 0
sex 0
, 0
depth 0
of 0
invasion 0
( 0
mucosal 0
, 0
submucosal 0
) 0
tumor 0
location 0
( 0
upper 0
, 0
middle 0
and 0
lower 0
third 0
) 0
, 0
gross 0
appearance 0
( 0
type 0
I 0
, 0
type 0
II 0
and 0
type 0
III 0
) 0
, 0
size 0
( 0
< 0
or 0
= 0
1.5 0
cm 0
, 0
> 0
1.5 0
cm 0
) 0
, 0
presence 0
or 0
absence 0
of 0
lymph 0
node 0
metastasis 0
, 0
histological 0
type 0
( 0
intestinal 0
, 0
diffuse 0
) 0
, 0
extent 0
of 0
lymphadenectomy 0
( 0
limited 0
or 0
extended 0
) 0
, 0
and 0
type 0
of 0
gastrectomy 0
( 0
total 0
or 0
distal 0
subtotal 0
) 0
. 0

Preventing 0
the 0
heterosexual 0
spread 0
of 0
HIV 0
into 0
this 0
vulnerable 0
population 0
is 0
a 0
formidable 0
public 0
health 0
challenge 0
. 0

Carotid 0
body 0
chemoreceptor 0
activity 0
as 0
recorded 0
from 0
the 0
petrosal 0
ganglion 0
in 0
cats 0
. 0

The 0
first 0
decision 0
in 0
management 0
is 0
to 0
consider 0
cardioversion 0
which 0
can 0
be 0
achieved 0
in 0
suitable 0
cases 0
electrically 0
, 0
or 0
pharmacologically 0
with 0
a 0
class 0
Ic 0
antiarrhythmic 0
drug 0
like 0
flecainide 0
or 0
propafenone 0
. 0

Several 0
studies 0
have 0
demonstrated 0
that 0
the 0
corticotropin B-gene
- I-gene
releasing I-gene
factor I-gene
test 0
( 0
CRF B-gene
) 0
is 0
useful 0
for 0
the 0
aetiological 0
diagnosis 0
of 0
Cushing 0
's 0
syndrome 0
: 0
in 0
Cushing 0
's 0
disease 0
, 0
as 0
opposed 0
to 0
ectopic 0
ACTH B-gene
secretion 0
syndrome 0
, 0
the 0
hypothalamus 0
- 0
pituitary 0
- 0
adrenal 0
( 0
HPA 0
) 0
axis 0
can 0
still 0
be 0
stimulated 0
by 0
CRF B-gene
. 0

The 0
NF B-gene
- I-gene
kappaB/Rel I-gene
transcription 0
factors 0
participate 0
in 0
the 0
activation 0
of 0
immune 0
system 0
regulatory 0
genes 0
and 0
kappaB/Rel I-gene

These 0
three 0
chromosomes 0
share 0
the 0
transferrin B-gene
gene I-gene
( 0
TF B-gene
) 0
, 0
the 0
myosin B-gene
light I-gene
polypeptide I-gene
3 I-gene
gene I-gene
( 0
MYL3 B-gene
) 0
, 0
and 0
the 0
acylpeptide B-gene
hydrolase I-gene
gene I-gene
( 0
APEH B-gene
) 0
. 0

The 0
preference 0
for 0
third 0
base 0
codon 0
in 0
Y 0
position 0
prolines 0
is 0
U 0
for 0
the 0
alpha B-gene
2 I-gene
( I-gene
VI I-gene
) I-gene
collagen I-gene
as 0
it 0
is 0
for 0
the 0
human B-gene
fibrillar I-gene
collagen I-gene
genes I-gene
. 0

BK B-gene
- 0
induced 0
translocation 0
and 0
overexpression 0
of 0
PKC B-gene
isoforms I-gene
as 0
well 0
as 0
coexpression 0
of 0
inactive 0
or 0
constitutively 0
active 0
mutants 0
of 0
different 0
PKC B-gene
isozymes I-gene
provided 0
evidence 0
for 0
a 0
role 0
of 0
the 0
diacylglycerol 0
- 0
sensitive 0
PKCs B-gene
alpha I-gene
and I-gene
epsilon I-gene
in 0
BK B-gene
signaling 0
toward 0
MAPK B-gene
. 0

The 0
rate 0
of 0
decrease 0
of 0
PRA 0
after 0
REM 0
onset 0
closely 0
approximates 0
the 0
most 0
recent 0
estimations 0
of 0
PRA 0
half 0
- 0
life 0
, 0
which 0
suggests 0
that 0
REM 0
onset 0
is 0
associated 0
with 0
a 0
virtual 0
cessation 0
in 0
renin B-gene
production 0
. 0

The 0
second 0
( 0
control 0
) 0
group 0
was 0
represented 0
by 0
cases 0
diagnosed 0
as 0
HSIL 0
by 0
cytology 0
. 0

Clinical 0
trial 0
endpoints 0
based 0
on 0
magnitude 0
of 0
reduction 0
in 0
HIV 0
- 0
1 0
RNA 0
levels 0
provide 0
an 0
important 0
complement 0
to 0
endpoints 0
based 0
on 0
percentage 0
of 0
patients 0
achieving 0
complete 0
virologic 0
suppression 0
. 0

The 0
psi B-gene
zeta I-gene
gene I-gene
has 0
a 0
nonsense 0
mutation 0
in 0
exon 0
1 0
but 0
has 0
identical 0
promoter 0
sequence 0
and 0
RNA 0
processing 0
sites 0
to 0
the 0
zeta B-gene
gene I-gene
, 0
raising 0
the 0
possibility 0
that 0
both 0
psi B-gene
zeta I-gene
and 0
zeta B-gene
are 0
transcriptionally 0
active 0
. 0

The 0
expression 0
of 0
cor14b B-gene
was 0
strongly 0
impaired 0
in 0
the 0
barley 0
albino 0
mutant 0
an 0
, 0
suggesting 0
the 0
involvement 0
of 0
a 0
plastidial 0
factor 0
in 0
the 0
control 0
of 0
gene 0
expression 0
. 0

Pulse 0
monitors 0
in 0
outpatient 0
dental 0
anaesthesia 0
. 0

Synthesis 0
of 0
2 0
- 0
( 0
2' 0
- 0
thiazolyl 0
) 0
alkanebenzimidazoles 0
- 0
- 0
potential 0
anthelmintics 0

Wild 0
type 0
MEKK1 B-gene
enhances 0
promoter 0
activity 0
and 0
the 0
activity 0
can 0
be 0
inhibited 0
by 0
dominant 0
negative 0
MEKK1 B-gene
, 0
MEK1 B-gene
, 0
MEK7 B-gene
, 0
MEK3 B-gene
, 0
p38/RK B-gene
, 0
and 0
p38/RK I-gene

Tax B-gene
and 0
the 0
active 0
Tax B-gene
mutants I-gene
were 0
able 0
to 0
abrogate 0
the 0
G1 0
arrest 0
and 0
apoptosis 0
induced 0
by 0
p53 B-gene
, 0
and 0
this 0
effect 0
does 0
not 0
correlate 0
with 0
an 0
altered 0
localization 0
of 0
nuclear B-gene
p53 I-gene
or 0
with 0
the 0
disruption 0
of 0
p53 B-gene
- I-gene
DNA I-gene
complexes I-gene
. 0

Chronic 0
, 0
recurrent 0
multifocal 0
osteomyelitis 0
. 0

Our 0
current 0
study 0
aims 0
at 0
clarifying 0
the 0
role 0
of 0
myristoylation 0
in 0
caveolar 0
targeting 0
using 0
well 0
- 0
characterized 0
acylation 0
mutants 0
of 0
two 0
model 0
proteins 0
, 0
namely 0
Gi1 B-gene
alpha I-gene
and 0
c B-gene
- I-gene
Src I-gene
. 0

Single 0
substitutions 0
of 0
three 0
highly 0
conserved 0
phenylalanine 0
residues 0
( 0
Phe 0
- 0
15 0
, 0
Phe 0
- 0
17 0
, 0
Phe 0
- 0
27 0
) 0
by 0
alanine 0
and 0
substitution 0
of 0
one 0
histidine 0
( 0
His 0
- 0
29 0
) 0
by 0
glutamine 0
, 0
all 0
located 0
within 0
the 0
putative 0
RNA 0
- 0
binding 0
sites 0
RNP B-gene
- I-gene
1 I-gene
and 0
RNP B-gene
- I-gene
2 I-gene
, 0
abolished 0
the 0
nucleic 0
acid 0
- 0
binding 0
activity 0
of 0
CspB B-gene
. 0

The 0
lack 0
of 0
heterozygous 0
positions 0
essentially 0
facilitates 0
on 0
the 0
one 0
hand 0
the 0
data 0
analysis 0
and 0
on 0
the 0
other 0
hand 0
the 0
detection 0
of 0
new 0
alleles 0
. 0

BACKGROUND 0
: 0
The 0
extract 0
of 0
medicinal 0
plants 0
containing 0
curcumin 0
is 0
traditionally 0
believed 0
to 0
have 0
a 0
positive 0
contraction 0
effect 0
on 0
the 0
human 0
gall 0
- 0
bladder 0
. 0

Moreover 0
, 0
the 0
formation 0
of 0
the 0
complex 0
between 0
IclR B-gene
and 0
the 0
operator/promoter 0
region 0
has 0
been 0
found 0
to 0
be 0
impaired 0
by 0
phosphoenol 0
pyruvate 0
but 0
insensitive 0
to 0
acetate 0
, 0
acetyl 0
- 0
CoA 0
, 0
pyruvate 0
, 0
and 0
oxaloacetate 0
. 0

Immunoprecipitation 0
of 0
spinophilin B-gene
or 0
neurabin B-gene
from 0
crude 0
brain 0
extracts 0
selectively 0
coprecipitated 0
PP1gamma B-gene
( I-gene
1 I-gene
) I-gene
over 0
PP1beta B-gene
. 0

Most 0
important 0
, 0
after 0
all 0
, 0
is 0
not 0
the 0
ionization 0
technique 0
but 0
the 0
stage 0
with 0
a 0
47.1 0
% 0
five 0
- 0
year 0
survival 0
rate 0
in 0
T1N0 0
as 0
compared 0
to 0
T2N0 0
with 0
28.6 0
% 0
and 0
T1N1 0
with 0
19.4 0
% 0
. 0

The 0
encoded 0
Arabidopsis B-gene
U3 I-gene
snRNAs I-gene
can 0
be 0
folded 0
into 0
a 0
secondary 0
structure 0
which 0
is 0
more 0
similar 0
to 0
that 0
of 0
U3 B-gene
RNAs I-gene
from 0
lower 0
eukaryotes 0
rather 0
than 0
from 0
metazoa 0
. 0

Cytokinetics 0
of 0
the 0
Krebs 0
2 0
carcinoma 0
. 0

We 0
investigated 0
whether 0
two 0
WT1 B-gene
splice I-gene
variants I-gene
lacking 0
or 0
including 0
a 0
three 0
- 0
amino 0
- 0
acid 0
( 0
KTS 0
) 0
insertion 0
between 0
the 0
third 0
and 0
fourth 0
zinc 0
finger 0
in 0
the 0
DNA 0
- 0
binding 0
domain 0
could 0
repress 0
the 0
IR B-gene
promoter I-gene
in 0
vitro 0
. 0

These 0
back 0
mutations 0
led 0
to 0
a 0
modest 0
decrease 0
in 0
kinase 0
activity 0
, 0
decreased 0
tumorigenic 0
potential 0
in 0
chickens 0
, 0
and 0
an 0
unexpected 0
increase 0
in 0
transforming 0
activity 0
in 0
rat 0
cells 0
. 0

Extragonadal 0
endodermal 0
sinus 0
tumors 0
in 0
the 0
head 0
and 0
neck 0
are 0
very 0
rare 0
. 0

Plasma 0
NE 0
and 0
E 0
increased 0
to 0
significantly 0
higher 0
values 0
after 0
15 0
min 0
in 0
the 0
young 0
subjects 0
: 0
1.68 0
+/ 0
- 0
0.18 0
vs 0
. 0

Utility 0
of 0
thallium 0
- 0
201 0
scintigraphy 0
in 0
detecting 0
right 0
ventricular 0
dysfunction 0
in 0
pulmonary 0
embolism 0
. 0

E. 0
granulosus 0
infection 0
has 0
been 0
confirmed 0
in 0
25 0
patients 0
( 0
20.6 0
% 0
) 0
, 0
in 0
16 0
cases 0
by 0
finding 0
parasite 0
protoscoleces 0
or 0
hooks 0
and 0
in 0
nine 0
cases 0
by 0
detection 0
of 0
an 0
antigen 0
specific 0
for 0
E. B-gene
granulosus I-gene
, I-gene
antigen I-gene
5 I-gene
( 0
Ag5 B-gene
) 0
. 0

Transcription 0
of 0
FN B-gene
promoter I-gene
- 0
chloramphenicol B-gene
acetyltransferase I-gene
fusion 0
genes 0
carrying 0
the 0
base 0
substitution 0
in 0
one 0
or 0
more 0
of 0
these 0
G 0
- 0
rich 0
sequences 0
both 0
in 0
vivo 0
and 0
in 0
vitro 0
revealed 0
that 0
the 0
base 0
substitution 0
in 0
any 0
G 0
- 0
rich 0
sequence 0
results 0
in 0
reduction 0
of 0
promoter 0
activity 0
, 0
although 0
the 0
downstream 0
GC 0
box 0
( 0
GCd 0
) 0
plays 0
a 0
primary 0
role 0
. 0

Teboroxime 0
is 0
a 0
new 0
boronic 0
acid 0
adduct 0
of 0
technetium 0
dioxime 0
( 0
BATO 0
) 0
compound 0
that 0
demonstrates 0
favorable 0
characteristics 0
in 0
preliminary 0
studies 0
. 0

We 0
tested 0
several 0
growth 0
regulatory 0
genes 0
that 0
are 0
repressed 0
in 0
senescent 0
cells 0
for 0
ability 0
to 0
restore 0
activity 0
to 0
T B-gene
[ I-gene
K1 I-gene
] I-gene
. 0

It 0
is 0
our 0
conclusion 0
that 0
Sonoclot 0
coagulation 0
analysis 0
is 0
unlikely 0
to 0
identify 0
patients 0
with 0
prolonged 0
bleeding 0
time 0
in 0
whom 0
platelet 0
count 0
and 0
other 0
coagulation 0
factors 0
are 0
normal 0
. 0

The 0
single 0
copy 0
flotillin B-gene
- I-gene
1 I-gene
gene I-gene
is 0
located 0
at 0
6p21.3 0
in 0
the 0
MHC B-gene
class I-gene
I I-gene
region I-gene
and 0
consists 0
of 0
13 0
exons 0
over 0
15 0
kb 0
. 0

Low 0
plasma 0
glucose 0
concentrations 0
that 0
may 0
or 0
may 0
not 0
be 0
sufficiently 0
low 0
to 0
result 0
in 0
symptoms 0
can 0
be 0
observed 0
as 0
a 0
concomitant 0
of 0
several 0
diverse 0
diseases 0
. 0

However 0
, 0
patients 0
with 0
DPX 0
should 0
be 0
observed 0
for 0
the 0
potential 0
occurrence 0
of 0
an 0
associated 0
condition 0
. 0

The 0
effects 0
of 0
castor 0
oil 0
, 0
alone 0
, 0
as 0
well 0
as 0
in 0
combination 0
with 0
PGI2 0
and 0
indomethacin 0
on 0
gastrointestinal 0
functions 0
have 0
been 0
examined 0
in 0
rats 0
. 0

Effect 0
of 0
TNF B-gene
, 0
IL B-gene
- I-gene
1 I-gene
, 0
and 0
IL B-gene
- I-gene
6 I-gene
on 0
the 0
proliferation 0
of 0
human 0
Tenon 0
's 0
capsule 0
fibroblasts 0
in 0
tissue 0
culture 0
. 0

Previous 0
analysis 0
of 0
this 0
motif 0
in 0
the 0
lactose B-gene
permease I-gene
( 0
A 0
. 0

Also 0
, 0
the 0
RVW 0
hypertrophy 0
, 0
the 0
IVS 0
hypertrophy 0
, 0
and 0
the 0
RV 0
high 0
pressure 0
load 0
to 0
the 0
LV 0
through 0
the 0
IVS 0
may 0
be 0
related 0
to 0
the 0
small 0
LV 0
, 0
high 0
EF 0
, 0
and 0
abnormal 0
two 0
chamber 0
inflow 0
in 0
the 0
PS 0
group 0
before 0
BV 0
. 0

Several 0
reports 0
assert 0
that 0
prolactin B-gene
affects 0
the 0
delta 0
5 0
and 0
delta 0
4 0
pathways 0
through 0
its 0
effect 0
on 0
the 0
activity 0
of 0
3beta B-gene
- I-gene
hydroxysteroid I-gene
dehydrogenase I-gene
( 0
3beta B-gene
- I-gene
OHSD I-gene
) 0
. 0

Acidosis 0
provoked 0
by 0
30 0
% 0
CO2 0
irreversibly 0
increased 0
the 0
BDRT 0
, 0
however 0
the 0
TRT 0
were 0
not 0
changed 0
. 0

In 0
each 0
study 0
group 0
, 0
elevated 0
levels 0
of 0
serum 0
I 0
were 0
observed 0
. 0

A 0
decrease 0
was 0
also 0
found 0
of 0
the 0
levels 0
of 0
total 0
cholesterol 0
and 0
LDL B-gene
- I-gene
cholesterol I-gene
. 0

Sequencing 0
of 0
this 0
fragment 0
showed 0
that 0
the 0
MRP13 B-gene
coding 0
region 0
specifies 0
a 0
324 0
- 0
amino 0
- 0
acid 0
basic 0
protein 0
with 0
a 0
calculated 0
Mr 0
of 0
37,366 0
. 0

Low 0
serum B-gene
C3 I-gene
values 0
were 0
observed 0
in 0
all 0
11 0
children 0
at 0
some 0
stage 0
of 0
their 0
illness 0
. 0

In 0
spite 0
of 0
the 0
presence 0
of 0
a 0
physician 0
, 0
the 0
real 0
pathology 0
of 0
an 0
indian 0
population 0
of 0
Colombie 0
is 0
not 0
very 0
well 0
known 0
. 0

During 0
chordotonal 0
organ 0
development 0
, 0
the 0
3 0
' 0
enhancer 0
directs 0
expression 0
in 0
proneural 0
clusters 0
; 0
whereas 0
successive 0
modular 0
enhancers 0
located 0
in 0
the 0
5 0
' 0
region 0
drive 0
tissue 0
- 0
specific 0
expression 0
in 0
chordotonal 0
organ 0
precursors 0
in 0
the 0
embryo 0
and 0
larval 0
leg 0
, 0
wing 0
and 0
antennal 0
imaginal 0
discs 0
. 0

Is 0
conventional 0
sperm 0
analysis 0
of 0
any 0
use 0
? 0
The 0
computerised 0
records 0
of 0
867 0
couples 0
were 0
used 0
to 0
investigate 0
the 0
prognostic 0
significance 0
of 0
semen 0
volume 0
, 0
motility 0
, 0
density 0
and 0
morphology 0
. 0

The 0
effect 0
of 0
guaiphenesin 0
on 0
absorption 0
and 0
bioavailability 0
of 0
paracetamol 0
from 0
composite 0
analgesic 0
preparations 0
. 0

Detailed 0
comparison 0
of 0
the 0
urinary 0
excretion 0
of 0
purines 0
in 0
a 0
patient 0
with 0
the 0
Lesch 0
- 0
Nyhan 0
syndrome 0
and 0
a 0
control 0
subject 0
. 0

Antisense 0
oligonucleotides 0
complementary 0
to 0
the 0
5 0
' 0
end 0
of 0
PKC B-gene
- I-gene
zeta I-gene
mRNA I-gene
sequences I-gene
significantly 0
reduced 0
the 0
collagen B-gene
lattice 0
- 0
stimulated 0
alpha2 0
and 0
MMP B-gene
- I-gene
1 I-gene
mRNA I-gene
levels 0
. 0

Furthermore 0
, 0
ERK B-gene
phosphorylation 0
was 0
substantially 0
prolonged 0
in 0
LC/BRY 0
- 0
treated 0
cells 0
compared 0
to 0
those 0
exposed 0
to 0
BRY 0
alone 0
, 0
and 0
pretreatment 0
with 0
the 0
highly 0
specific 0
MEK B-gene
inhibitors 0
, 0
PD98059 0
, 0
U0126 0
, 0
and 0
SL327 0
, 0
opposed 0
ERK B-gene
activation 0
while 0
protecting 0
cells 0
from 0
LC/BRY 0
- 0
induced 0
lethality 0
. 0

The 0
most 0
valid 0
method 0
was 0
the 0
AXB 0
bearing 0
with 0
the 0
cephalometric 0
clinical 0
diagnosis 0
a 0
90.91 0
% 0
concordance 0
. 0

However 0
, 0
coligation 0
of 0
Fc B-gene
gamma I-gene
RIIB1 I-gene
with 0
B B-gene
cell I-gene
Ag I-gene
receptors I-gene
( 0
BCR B-gene
) 0
inhibits 0
BCR B-gene
- 0
mediated 0
signaling 0
by 0
a 0
mechanism 0
that 0
may 0
involve 0
recruitment 0
of 0
phosphatases B-gene
SHP I-gene
- I-gene
1 I-gene
, 0
SHP B-gene
- I-gene
2 I-gene
, 0
and 0
the 0
SH2 B-gene
containing I-gene
inositol I-gene
5'phosphatase I-gene
( 0
SHIP B-gene
) 0
to 0
the 0
phosphorylated 0
Fc B-gene
gamma I-gene
RIIB1 I-gene
immunoreceptor I-gene
tyrosine I-gene
- I-gene
based I-gene
inhibitory I-gene
motif I-gene
. 0

At 0
the 0
first 0
phase 0
( 0
1 0
- 0
43 0
ms 0
for 0
the 0
VMN 0
and 0
1 0
- 0
10 0
ms 0
for 0
the 0
LN 0
) 0
the 0
hypothalamic 0
- 0
cortical 0
responses 0
completely 0
inhibited 0
the 0
formation 0
of 0
the 0
VC 0
response 0
to 0
the 0
light 0
stimulus 0
. 0

The 0
slope 0
of 0
QD 0
versus 0
QEMF 0
for 0
the 0
four 0
tubes 0
was 0
near 0
unity 0
. 0

The 0
sequence 0
of 0
the 0
127 B-gene
residue I-gene
NrfF I-gene
polypeptide I-gene
, I-gene
M I-gene
( I-gene
r I-gene
) I-gene
14,522 I-gene
, 0
is 0
strikingly 0
similar 0
to 0
the 0
CcI2 B-gene
protein I-gene
of 0
R. 0
capsulatus 0
, 0
especially 0
in 0
the 0
putative 0
haem 0
- 0
binding 0
motif 0
, 0
RCPQCQNQN 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
400 0
WORDS 0
) 0

When 0
cotransfected 0
with 0
the 0
HIV B-gene
LTR I-gene
CAT B-gene
into 0
CV 0
- 0
1 0
cells 0
, 0
both 0
the 0
pCD41 B-gene
and 0
pGD41 B-gene
clones 0
trans 0
- 0
activated 0
the 0
HIV B-gene
LTR I-gene
. 0

From 0
this 0
comparison 0
of 0
aa 0
sequences 0
, 0
the 0
ATPK7 B-gene
protein I-gene
is 0
considered 0
to 0
be 0
a 0
member 0
of 0
a 0
novel 0
subfamily 0
of 0
Ser/Thr B-gene
PKs I-gene
in 0
plants 0
. 0

It 0
is 0
very 0
probable 0
that 0
this 0
change 0
was 0
due 0
to 0
mechanical 0
effects 0
induced 0
by 0
injecting 0
a 0
hypertonic 0
solution 0
of 0
MT 0
- 0
141 0
at 0
a 0
rate 0
of 0
70 0
- 0
- 0
130 0
ml/dog 0
. 0

Both 0
viruses 0
express 0
the 0
mil B-gene
/raf B-gene
oncogene 0
product 0
as 0
a 0
gag B-gene
- I-gene
fusion I-gene
polyprotein 0
, 0
while 0
the 0
myc B-gene
oncogene 0
of 0
MH2 0
is 0
expressed 0
via 0
a 0
subgenomic 0
mRNA 0
. 0

Furthermore 0
the 0
aldosterone 0
stimulating 0
effect 0
of 0
low 0
sodium 0
diet 0
( 0
17 0
children 0
) 0
, 0
severe 0
and 0
prolonged 0
vomiting 0
( 0
19 0
children 0
) 0
and 0
synthetic 0
ACTH B-gene
( 0
10 0
children 0
) 0
has 0
been 0
studied 0
by 0
our 0
modified 0
method 0
. 0

Transmural 0
metabolic 0
heterogeneity 0
at 0
high 0
cardiac 0
work 0
states 0
. 0

A 0
flow 0
probe 0
for 0
direct 0
measurement 0
of 0
blood 0
flow 0
of 0
the 0
mitral 0
valve 0
was 0
devised 0
. 0

The 0
adoption 0
of 0
a 0
twisted 0
structure 0
of 0
importin B-gene
- I-gene
beta I-gene
is 0
essential 0
for 0
the 0
protein 0
- 0
protein 0
interaction 0
required 0
for 0
nuclear 0
transport 0
. 0

Liver 0
disease 0
and 0
HCV 0
infection 0
after 0
transplantation 0
of 0
organs 0
from 0
hepatitis B-gene
C I-gene
antibody I-gene
positive 0
donors 0
. 0

To 0
investigate 0
whether 0
the 0
two 0
RPG B-gene
- I-gene
boxes I-gene
mediate 0
transcription 0
activation 0
of 0
both 0
the 0
L46 B-gene
and 0
S24 B-gene
gene I-gene
, 0
two 0
experimental 0
strategies 0
were 0
followed 0
: 0
cloning 0
of 0
the 0
respective 0
genes 0
on 0
multicopy 0
vectors 0
and 0
construction 0
of 0
fusion 0
genes 0
. 0

Electrophoretic 0
mobility 0
shift 0
assays 0
demonstrated 0
that 0
sequences 0
within 0
this 0
region 0
bind 0
members 0
of 0
the 0
Sp1 B-gene
family I-gene
of I-gene
transcription I-gene
factors I-gene
. 0

The 0
prevalence 0
of 0
antibodies 0
to 0
HRES B-gene
- I-gene
1 I-gene
peptides I-gene
pep14 I-gene
- I-gene
24 I-gene
and I-gene
pep117 I-gene
- I-gene
127 I-gene
was 0
determined 0
in 0
65 0
normal 0
blood 0
donors 0
and 0
146 0
patients 0
with 0
immunological 0
disorders 0
. 0

SCOF B-gene
- I-gene
1 I-gene
localized 0
to 0
the 0
nucleus 0
but 0
did 0
not 0
bind 0
directly 0
to 0
either 0
C 0
- 0
repeat/dehydration 0
( 0
CRT/DRE 0
) 0
or 0
ABA 0
responsive 0
element 0
( 0
ABRE 0
) 0
, 0
cis 0
- 0
acting 0
DNA 0
regulatory 0
elements 0
present 0
in 0
COR B-gene
gene I-gene
promoters I-gene
. 0

To 0
date 0
, 0
6 0
mammalian 0
GRKs B-gene
have 0
been 0
identified 0
by 0
molecular 0
cloning 0
. 0

OBJECTIVE 0
: 0
To 0
report 0
a 0
case 0
of 0
fulminant 0
neuropathy 0
with 0
severe 0
quadriparesis 0
associated 0
with 0
vincristine 0
chemotherapy 0
. 0

The 0
1.5 0
- 0
Mb 0
region 0
was 0
covered 0
by 0
137 0
cosmids 0
with 0
a 0
minimum 0
overlap 0
set 0
of 0
52 0
cosmids 0
assigned 0
to 0
17 0
bins 0
and 0
9 0
contigs 0
. 0

Homodimers 0
of 0
RIP60 B-gene
( 0
replication B-gene
initiation I-gene
- I-gene
region I-gene
protein I-gene
60 I-gene
kDA I-gene
) 0
purified 0
from 0
nuclear 0
extract 0
bind 0
two 0
ATT 0
- 0
rich 0
sites 0
in 0
oribeta 0
and 0
foster 0
the 0
formation 0
of 0
a 0
twisted 0
720 0
bp 0
DNA 0
loop 0
in 0
vitro 0
. 0

Effect 0
of 0
age 0
on 0
glucose 0
, 0
reducing 0
sugars 0
and 0
plasma B-gene
insulin I-gene
in 0
blood 0
of 0
milk 0
- 0
fed 0
calves 0
. 0

Principal 0
component 0
analysis 0
using 0
psychosocial 0
factors 0
in 0
women 0
showed 0
two 0
psychosocial 0
structures 0
, 0
i.e 0
. 0
the 0
second 0
principal 0
( 0
high 0
SOC 0
, 0
high 0
lifestyle 0
, 0
and 0
low 0
stress 0
) 0
and 0
the 0
4th 0
principal 0
components 0
( 0
high 0
supernatural 0
HLC 0
, 0
and 0
high 0
PHLC 0
) 0
. 0

In 0
response 0
to 0
acoustical 0
stimulation 0
the 0
properties 0
of 0
response 0
latency 0
, 0
discharge 0
pattern 0
, 0
frequency 0
tuning 0
, 0
binaural 0
interaction 0
, 0
and 0
habituation 0
were 0
examined 0
to 0
allow 0
an 0
appraisal 0
of 0
the 0
differentiation 0
of 0
the 0
MGB 0
by 0
electrophysiological 0
means 0
. 0

These 0
two 0
enhancer 0
elements 0
also 0
enhanced 0
transcription 0
when 0
fused 0
separately 0
to 0
the 0
basal 0
promoter 0
region 0
of 0
the 0
chicken B-gene
vimentin I-gene
gene I-gene
. 0

Availability 0
of 0
a 0
less 0
palatable 0
diet 0
( 0
chow 0
) 0
following 0
presentation 0
of 0
palatable 0
diets 0
will 0
not 0
result 0
in 0
diminished 0
caloric 0
intake 0
, 0
body 0
weight 0
, 0
obesity 0
and 0
hyperinsulinemia 0
. 0

Residues 0
of 0
Stauffer 0
R 0
- 0
3828 0
and 0
its 0
oxygen 0
analogue 0
in 0
the 0
body 0
tissues 0
of 0
cattle 0
fed 0
R 0
- 0
3828 0
in 0
the 0
diet 0
. 0

Type 0
II 0
neuroleptanalgesia 0
in 0
odonto 0
- 0
stomatology 0

In 0
addition 0
, 0
there 0
was 0
an 0
increase 0
in 0
the 0
amount 0
of 0
p120 B-gene
Ras I-gene
- 0
specific 0
GTPase B-gene
- I-gene
activating I-gene
protein I-gene
( 0
GAP B-gene
) 0
and 0
GAP B-gene
- 0
associated 0
p190 0
. 0

OBJECTIVE 0
: 0
Respiratory 0
- 0
related 0
electromyographic 0
( 0
EMG 0
) 0
activity 0
of 0
the 0
superior 0
pharyngeal 0
constrictor 0
( 0
SPC 0
) 0
muscle 0
was 0
analyzed 0
during 0
the 0
early 0
stage 0
of 0
forced 0
breathing 0
. 0

Glutathione B-gene
reductase I-gene
activities 0
in 0
liver 0
, 0
kidney 0
, 0
lung 0
, 0
and 0
brain 0
were 0
not 0
affected 0
by 0
diet 0
. 0

LIP 0
and 0
DIP 0
are 0
less 0
common 0
IIPs 0
, 0
both 0
characterized 0
by 0
ground 0
- 0
glass 0
attenuation 0
. 0

Healthy 0
subjects 0
received 0
the 0
following 0
regimens 0
, 0
dosed 0
to 0
steady 0
state 0
: 0
trovafloxacin 0
300 0
mg/24 0
h 0
; 0
ciprofloxacin 0
400 0
mg/12 0
h 0
; 0
trovafloxacin 0
300 0
mg/24 0
h 0
plus 0
cefepime 0
2 0
g/12 0
h 0
, 0
and 0
ciprofloxacin 0
400 0
mg/12 0
h 0
plus 0
cefepime 0
2 0
g/12 0
h 0
. 0

The 0
data 0
obtained 0
with 0
cellular 0
RNA 0
from 0
HepG2 0
cells 0
demonstrated 0
that 0
transcription 0
is 0
initiated 0
891 0
bases 0
upstream 0
of 0
the 0
translation 0
- 0
start 0
site 0
and 0
that 0
the 0
polyadenylation 0
site 0
is 0
located 0
550 0
bases 0
downstream 0
of 0
the 0
stop 0
codon 0
. 0

To 0
investigate 0
possible 0
roles 0
for 0
HCP B-gene
during 0
late 0
erythroid 0
differentiation 0
, 0
effects 0
of 0
manipulating 0
HCP B-gene
expression 0
or 0
recruitment 0
on 0
EPO B-gene
- 0
induced 0
hemoglobinization 0
in 0
erythroleukemic 0
SKT6 0
cells 0
have 0
been 0
investigated 0
. 0

To 0
investigate 0
the 0
role 0
of 0
bHLH B-gene
proteins I-gene
in 0
MC3T3 0
- 0
E1 0
osteoblasts 0
, 0
which 0
undergo 0
a 0
developmental 0
sequence 0
in 0
vitro 0
, 0
we 0
analyzed 0
the 0
transcriptional 0
control 0
of 0
osteocalcin B-gene
gene I-gene
expression 0
by 0
stable 0
transfection 0
of 0
an 0
osteocalcin B-gene
promoter I-gene
- 0
luciferase B-gene
chimeric 0
gene 0
( 0
p637OC B-gene
- I-gene
luc I-gene
) 0
and 0
assessed 0
the 0
role 0
of 0
E 0
- 0
box 0
cis 0
- 0
acting 0
elements 0
in 0
osteocalcin B-gene
promoter I-gene
by 0
DNA 0
binding 0
assays 0
. 0

Genetic 0
linkage 0
mapping 0
of 0
the 0
CYP11A1 B-gene
gene I-gene
encoding 0
the 0
cholesterol 0
side 0
- 0
chain 0
cleavage 0
P450scc B-gene
close 0
to 0
the 0
CYP1A1 B-gene
gene I-gene
and 0
D15S204 B-gene
in 0
the 0
chromosome 0
15q22.33 0
- 0
q23 0
region 0
. 0

Expression 0
, 0
characterization 0
, 0
and 0
genomic 0
structure 0
of 0
carp B-gene
JAK1 I-gene
kinase I-gene
gene I-gene
. 0

Jornvall 0
, 0
B 0
. 0

Copyright 0
1998 0
Academic 0
Press 0
. 0

Three 0
modern 0
hematology 0
analyzers 0
( 0
Abbott 0
Cell 0
- 0
Dyn 0
3000 0
, 0
Coulter 0
STKS 0
, 0
and 0
Sysmex 0
NE 0
- 0
8000 0
) 0
with 0
high 0
throughput 0
and 0
5 0
- 0
part 0
differential 0
capability 0
were 0
evaluated 0
using 0
a 0
protocol 0
designed 0
by 0
a 0
quality 0
team 0
. 0

Effect 0
of 0
prostaglandin 0
E2 0
on 0
experimental 0
atherosclerosis 0
. 0

The 0
tro B-gene
operon I-gene
is 0
flanked 0
by 0
a 0
Holliday B-gene
structure I-gene
DNA I-gene
helicase I-gene
homolog 0
( 0
upstream 0
) 0
and 0
two 0
ORFs 0
representing 0
a 0
purine B-gene
nucleoside I-gene
phosphorylase I-gene
homolog 0
and 0
tpp15 B-gene
, 0
a 0
previously 0
characterized 0
gene 0
encoding 0
a 0
membrane 0
lipoprotein 0
( 0
downstream 0
) 0
. 0

However 0
, 0
a 0
few 0
sites 0
in 0
the 0
genomes 0
of 0
EC 0
cells 0
permit 0
M B-gene
- I-gene
MuLVneo I-gene
delta I-gene
Enh I-gene
proviral 0
expression 0
. 0

We 0
have 0
been 0
developing 0
a 0
digital 0
fluoroscopic 0
imaging 0
system 0
to 0
replace 0
the 0
portal 0
films 0
that 0
are 0
currently 0
used 0
to 0
verify 0
patient 0
positioning 0
during 0
radiotherapy 0
treatments 0
. 0

We 0
have 0
utilized 0
transient 0
transfections 0
, 0
mutation 0
analysis 0
, 0
electromobility 0
gel 0
- 0
shifts 0
, 0
and 0
immunoblot 0
analysis 0
to 0
test 0
the 0
hypothesis 0
that 0
expression 0
of 0
the 0
CTalpha B-gene
gene I-gene
is 0
controlled 0
in 0
part 0
by 0
the 0
binding 0
of 0
three 0
trans 0
- 0
acting 0
nuclear 0
factors 0
, 0
Sp1 B-gene
, 0
Sp2 B-gene
, 0
and 0
Sp3 B-gene
. 0

Determinants 0
of 0
recurrent 0
ischaemia 0
and 0
revascularisation 0
procedures 0
after 0
thrombolysis 0
with 0
recombinant 0
tissue B-gene
plasminogen I-gene
activator I-gene
in 0
primary 0
coronary 0
occlusion 0
. 0

Interestingly 0
, 0
unlike 0
PAK65 B-gene
, 0
HPK1 B-gene
does 0
not 0
contain 0
the 0
small B-gene
GTPase I-gene
Rac1/Cdc42 B-gene
- 0
binding 0
domain 0
and 0
does 0
not 0
bind 0
to 0
either 0
Rac1/Cdc42 I-gene

Transformations 0
with 0
circular 0
plasmids 0
yielded 0
slowly 0
and 0
irregularly 0
growing 0
geneticin 0
- 0
resistant 0
mycelia 0
in 0
which 0
1 0
% 0
of 0
nuclei 0
contained 0
plasmid 0
sequences 0
. 0

Using 0
a 0
combined 0
pharmacokinetic 0
- 0
pharmacodynamic 0
model 0
, 0
the 0
impact 0
of 0
various 0
factors 0
on 0
the 0
effective 0
bioavailability 0
and 0
on 0
its 0
estimation 0
, 0
using 0
the 0
intravenous 0
- 0
to 0
- 0
oral 0
dose 0
ratio 0
required 0
to 0
produce 0
the 0
same 0
area 0
under 0
the 0
response 0
time 0
curve 0
after 0
acute 0
administration 0
, 0
are 0
explored 0
. 0

We 0
found 0
that 0
in 0
anesthetized 0
, 0
paralyzed 0
cats 0
, 0
the 0
visual 0
evoked 0
potential 0
( 0
VEP 0
) 0
was 0
dependent 0
only 0
on 0
magnitude 0
of 0
delta 0
C 0
at 0
each 0
pattern 0
transition 0
, 0
and 0
was 0
independent 0
of 0
the 0
starting 0
or 0
ending 0
contrast 0
level 0
. 0

Plasmid 0
pSP64E6E7 0
which 0
contains 0
the 0
reading 0
frames 0
of 0
both 0
E6 B-gene
and 0
E7 B-gene
was 0
constructed 0
in 0
order 0
to 0
study 0
the 0
expression 0
of 0
both 0
proteins 0
in 0
a 0
coupled 0
transcription/rabbit 0
reticulocyte 0
translation 0
system 0
. 0

A 0
99m 0
Tc 0
bone 0
scan 0
showed 0
a 0
focal 0
area 0
of 0
an 0
increased 0
uptake 0
at 0
the 0
site 0
of 0
the 0
mass 0
below 0
the 0
calcaneus 0
. 0

In 0
addition 0
, 0
FOP B-gene
- 0
FGFR1 B-gene
- 0
expressing 0
cells 0
show 0
constitutive 0
phosphorylation 0
of 0
the 0
positive 0
regulator 0
of 0
translation 0
p70S6 B-gene
kinase I-gene
; 0
this 0
phosphorylation 0
is 0
inhibited 0
by 0
PI3 B-gene
- I-gene
kinase I-gene
and 0
mTOR B-gene
( 0
mammalian B-gene
target I-gene
of I-gene
rapamycin I-gene
) 0
inhibitors 0
. 0

As 0
a 0
test 0
of 0
this 0
hypothesis 0
, 0
we 0
predicted 0
that 0
mice 0
which 0
have 0
altered 0
expression 0
of 0
class 0
I 0
gene 0
products 0
, 0
the 0
beta2 B-gene
- I-gene
microglobulin I-gene
knockout 0
mice 0
, 0
[ B-gene
beta2m I-gene
( I-gene
- I-gene
/ I-gene
- I-gene
) I-gene
] I-gene
, 0
would 0
develop 0
Fe 0
overload 0
. 0

The 0
synthesis 0
of 0
endo 0
- 0
adduct 0
[ 0
4aS,5S,8R,8aR 0
, 0
SS 0
] 0
- 0
9d 0
resulting 0
from 0
cycloaddition 0
on 0
the 0
substituted 0
C 0
( 0
2 0
) 0
- 0
C 0
( 0
3 0
) 0
double 0
bond 0
was 0
achieved 0
in 0
a 0
chemo 0
- 0
and 0
diastereoselective 0
way 0
from 0
quinone 0
1d 0
in 0
the 0
presence 0
of 0
ZnBr 0
( 0
2 0
) 0
. 0

Mad3 B-gene
and 0
Mad4 B-gene
: 0
novel 0
Max B-gene
- 0
interacting 0
transcriptional 0
repressors 0
that 0
suppress 0
c B-gene
- I-gene
myc I-gene
dependent 0
transformation 0
and 0
are 0
expressed 0
during 0
neural 0
and 0
epidermal 0
differentiation 0
. 0

Maximal 0
Expiratory 0
Flow 0
Rates 0
such 0
as 0
Peak 0
Expiratory 0
Flow 0
Rate 0
( 0
PEFR 0
) 0
, 0
rates 0
at 0
25 0
% 0
, 0
50 0
% 0
and 0
75 0
% 0
of 0
forced 0
vital 0
capacity 0
( 0
V 0
max 0
25 0
% 0
, 0
V 0
max 0
50 0
% 0
and 0
V 0
max 0
75 0
% 0
) 0
and 0
forced 0
expiratory 0
flow 0
during 0
the 0
middle 0
half 0
of 0
forced 0
vital 0
capacity 0
( 0
FEF 0
25 0
- 0
75 0
% 0
) 0
were 0
measured 0
in 0
273 0
healthy 0
non 0
- 0
smoking 0
adults 0
( 0
144 0
males 0
, 0
129 0
females 0
) 0
aged 0
15 0
- 0
63 0
years 0
living 0
in 0
Madras 0
. 0

This 0
polypeptide 0
includes 0
the 0
first 0
three 0
zinc 0
fingers 0
of 0
the 0
TFIIIA B-gene
DNA I-gene
binding I-gene
domain I-gene
. 0

Transcription 0
of 0
eukaryotic 0
tRNA 0
genes 0
is 0
dependent 0
on 0
the 0
A 0
- 0
and 0
B 0
- 0
Box 0
internal 0
control 0
regions 0
( 0
ICRs 0
) 0
and 0
the 0
upstream 0
transcription 0
modulatory 0
region 0
. 0

This 0
dose 0
of 0
Na3 0
citrate 0
produced 0
no 0
clinical 0
symptoms 0
suggestive 0
of 0
hypocalcaemia 0
in 0
these 0
subjects 0
, 0
even 0
though 0
the 0
use 0
of 0
acid 0
- 0
citrate 0
- 0
dextrose 0
, 0
NIH 0
formula 0
A 0
( 0
ACD 0
- 0
A 0
) 0
under 0
identical 0
conditions 0
has 0
been 0
reported 0
to 0
reduce 0
significantly 0
the 0
level 0
of 0
total 0
calcium 0
in 0
serum 0
, 0
and 0
concomitantly 0
increase 0
the 0
number 0
or 0
reactions 0
occurring 0
in 0
donors 0
. 0

Cough 0
- 0
CPR 0
, 0
a 0
deep 0
rhythmic 0
forceful 0
cough 0
repeated 0
30 0
- 0
60 0
times 0
per 0
minute 0
, 0
can 0
be 0
an 0
effective 0
resuscitative 0
technique 0
during 0
emergencies 0
occurring 0
in 0
the 0
cardiac 0
catheterization 0
laboratory 0
. 0

The 0
gene 0
encoding 0
the 0
Neisseria B-gene
lactamica I-gene
III I-gene
DNA I-gene
methyltransferase I-gene
( 0
M.NlaIII B-gene
) 0
which 0
recognizes 0
the 0
sequence 0
CATG 0
has 0
been 0
cloned 0
and 0
expressed 0
in 0
Escherichia 0
coli 0
. 0

A 0
multivariant 0
study 0
of 0
pituitary 0
adenoma 0
, 0
obtainment 0
of 0
two 0
logistic 0
regression 0
equations 0
as 0
an 0
auxiliary 0
support 0
in 0
the 0
diagnosis 0
of 0
these 0
tumors 0
. 0

Increased 0
TRE 0
DNA 0
binding 0
failed 0
to 0
lead 0
to 0
increased 0
transactivation 0
correlating 0
with 0
the 0
inability 0
of 0
SB 0
203580 0
to 0
increase 0
phosphorylation 0
of 0
these 0
AP B-gene
- I-gene
1 I-gene
proteins I-gene
. 0

APL 0
patients 0
showed 0
a 0
low 0
, 0
yet 0
variable 0
, 0
level 0
of 0
JEM B-gene
- I-gene
1 I-gene
mRNA I-gene
in 0
bone 0
marrow 0
. 0

The 0
cDNA 0
clones 0
encode 0
a 0
polypeptide 0
of 0
657 0
amino 0
acids 0
with 0
a 0
bHLH 0
( 0
basic 0
- 0
helix 0
- 0
loop 0
- 0
helix 0
) 0
domain 0
, 0
characteristic 0
of 0
a 0
large 0
family 0
of 0
transcription 0
factors 0
, 0
and 0
a 0
PAS B-gene
( 0
Per B-gene
- 0
Arnt B-gene
- 0
Sim B-gene
) 0
domain 0
in 0
the 0
amino 0
- 0
terminal 0
half 0
region 0
. 0

We 0
propose 0
that 0
the 0
cDNA 0
encodes 0
an 0
apical 0
plasma 0
membrane 0
protein 0
that 0
plays 0
a 0
role 0
in 0
the 0
functional 0
expression 0
of 0
the 0
amiloride 0
- 0
sensitive 0
epithelial 0
sodium 0
channel 0
. 0

Nedocromil 0
sodium 0
shifted 0
the 0
severity 0
of 0
the 0
early 0
allergic 0
reaction 0
( 0
EAR 0
) 0
from 0
mean 0
- 0
34.8 0
% 0
to 0
- 0
6.9 0
% 0
and 0
inhibited 0
the 0
later 0
allergic 0
reaction 0
( 0
LAR 0
) 0
from 0
- 0
30.5 0
% 0
to 0
+0.4 0
% 0
( 0
p 0
less 0
than 0
0.005 0
) 0
. 0

Values 0
of 0
K1 0
and 0
Vd 0
were 0
significantly 0
increased 0
in 0
the 0
tumour 0
tissue 0
. 0

The 0
binding 0
of 0
PTB B-gene
was 0
antagonistic 0
to 0
the 0
binding 0
of 0
U2AF B-gene
to 0
the 0
enhancer 0
- 0
located 0
pyrimidine 0
tract 0
. 0

Our 0
results 0
separate 0
these 0
factors 0
into 0
four 0
regulatory 0
classes 0
: 0
( 0
i 0
) 0
constitutive 0
factors 0
, 0
such 0
as 0
Oct B-gene
- I-gene
1 I-gene
and 0
probably 0
Sp1 B-gene
, 0
that 0
are 0
expressed 0
in 0
thymocytes 0
at 0
all 0
stages 0
; 0
( 0
ii 0
) 0
inducible 0
factors 0
, 0
such 0
as 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
and 0
complexes 0
binding 0
to 0
the 0
region 0
of 0
a 0
CD28 B-gene
response I-gene
element I-gene
, 0
that 0
can 0
be 0
activated 0
in 0
all 0
thymocytes 0
, 0
including 0
those 0
cells 0
( 0
CD4+ B-gene
CD8+ B-gene
TcRlow B-gene
) 0
that 0
can 0
undergo 0
selection 0
; 0
( 0
iii 0
) 0
inducible 0
factors 0
, 0
such 0
as 0
NF B-gene
- I-gene
AT I-gene
and 0
AP B-gene
- I-gene
1 I-gene
, 0
that 0
can 0
be 0
activated 0
in 0
mature 0
( 0
CD4+ B-gene
CD8 B-gene
- I-gene
TcRhigh B-gene
) 0
and 0
immature 0
( 0
CD4 B-gene
- I-gene
CD8 B-gene
- I-gene
TcR B-gene
- I-gene
) 0
thymocytes 0
alike 0
but 0
not 0
in 0
the 0
transitional 0
stages 0
when 0
the 0
cells 0
( 0
CD4+ B-gene
CD8+ B-gene
TcRlow B-gene
) 0
are 0
subject 0
to 0
selection 0
; 0
and 0
( 0
iv 0
) 0
a 0
factor 0
containing 0
CREB B-gene
, 0
which 0
can 0
be 0
activated 0
in 0
thymocytes 0
of 0
all 0
developmental 0
stages 0
by 0
culture 0
but 0
does 0
not 0
require 0
specific 0
induction 0
. 0

Similar 0
tissue 0
- 0
specific 0
patterns 0
are 0
observed 0
with 0
a 0
fusion 0
between 0
the 0
caufliflower B-gene
mosaic I-gene
virus I-gene
35S I-gene
RNA I-gene
promotor I-gene
and 0
the 0
GUS B-gene
gene I-gene
. 0

The 0
results 0
obtained 0
show 0
that 0
expression 0
of 0
the 0
gene 0
is 0
low 0
at 0
23 0
degrees 0
C 0
and 0
is 0
induced 0
rapidly 0
at 0
37 0
degrees 0
C 0
. 0

However 0
, 0
in 0
each 0
case 0
in 0
which 0
either 0
the 0
DQ B-gene
alpha I-gene
- I-gene
or I-gene
DQ I-gene
beta I-gene
- I-gene
chain I-gene
was 0
exchanged 0
, 0
major 0
alterations 0
or 0
reversals 0
of 0
this 0
pattern 0
of 0
interaction 0
were 0
observed 0
. 0

Two 0
methods 0
for 0
the 0
routine 0
determination 0
of 0
blood 0
hemoglobin B-gene
oxygen 0
affinity 0
are 0
described 0
. 0

The 0
cause 0
for 0
the 0
increase 0
in 0
plasma B-gene
ANP I-gene
levels 0
in 0
the 0
active 0
phase 0
remains 0
to 0
be 0
determined 0
. 0

The 0
effects 0
on 0
survival 0
of 0
adjuvant 0
treatments 0
, 0
including 0
pre 0
- 0
or 0
postoperative 0
systemic 0
or 0
postoperative 0
intra 0
- 0
arterial 0
chemotherapy 0
, 0
are 0
currently 0
under 0
evaluation 0
. 0

Malformations 0
of 0
the 0
regenerating 0
optic 0
tectum 0
of 0
larvae 0
of 0
the 0
Egyptian 0
toad 0
, 0
Bufo 0
regularis 0
Reuss 0
. 0

Immunological 0
studies 0
also 0
failed 0
to 0
demonstrate 0
any 0
significant 0
change 0
except 0
for 0
a 0
significant 0
increase 0
of 0
natural 0
killer 0
( 0
NK 0
) 0
cell 0
activity 0
after 0
IFN B-gene
- I-gene
gamma I-gene
infusion 0
. 0

We 0
have 0
used 0
systemic 0
application 0
of 0
the 0
ototoxic 0
drug 0
amikacin 0
, 0
to 0
induce 0
total 0
cochlear 0
haircell 0
loss 0
in 0
the 0
chinchilla 0
, 0
in 0
order 0
to 0
create 0
an 0
animal 0
model 0
of 0
profound 0
deafness 0
. 0

BACKGROUND 0
- 0
- 0
Platelet B-gene
activating I-gene
factor I-gene
( 0
PAF B-gene
) 0
has 0
been 0
implicated 0
in 0
the 0
pathogenesis 0
of 0
airway 0
hyperresponsiveness 0
in 0
asthma 0
. 0

To 0
be 0
a 0
nurse 0
. 0

Chronic 0
granulocytic 0
leukemia 0
in 0
children 0
. 0

Charcot 0
joints 0
. 0

Recombinant B-gene
apoA I-gene
- I-gene
I I-gene
protein I-gene
recovered 0
from 0
the 0
soluble 0
fraction 0
of 0
the 0
bacterial 0
cell 0
pellet 0
was 0
purified 0
to 0
greater 0
than 0
95 0
% 0
homogeneity 0
by 0
reversed 0
- 0
phase 0
high 0
- 0
performance 0
liquid 0
chromatography 0
. 0

Kaposi 0
's 0
sarcoma 0
- 0
associated 0
herpesvirus/human 0
herpesvirus 0
- 0
8 0
ORF50 B-gene
gene 0
product 0
contains 0
a 0
potent 0
C 0
- 0
terminal 0
activation 0
domain 0
which 0
activates 0
gene 0
expression 0
via 0
a 0
specific 0
target 0
sequence 0
. 0

Comparison 0
of 0
the 0
5 0
' 0
flanking 0
regions 0
of 0
the 0
mouse B-gene
J I-gene
kappa I-gene
elements I-gene
, 0
including 0
the 0
conserved 0
putative 0
recombination 0
target 0
sequences 0
, 0
shows 0
no 0
obvious 0
differences 0
consistent 0
with 0
the 0
variation 0
in 0
recombinational 0
efficiency 0
, 0
so 0
we 0
conclude 0
that 0
, 0
although 0
the 0
consensus 0
heptamer 0
and 0
nonamer 0
signals 0
may 0
be 0
sufficient 0
to 0
identify 0
a 0
recombination 0
site 0
, 0
the 0
probability 0
that 0
that 0
site 0
will 0
be 0
used 0
depends 0
also 0
on 0
other 0
determinants 0
. 0

Further 0
interventions 0
were 0
: 0
nephrectomy 0
( 0
2x 0
) 0
, 0
resection 0
and 0
ligation 0
of 0
the 0
inferior 0
vena 0
cava 0
( 0
1x 0
) 0
, 0
resection 0
and 0
replacement 0
of 0
the 0
left 0
renal 0
vein 0
( 0
1x 0
) 0
. 0

Herein 0
, 0
we 0
report 0
that 0
CRE 0
- 0
decoy 0
oligonucleotide 0
treatment 0
results 0
in 0
an 0
increase 0
in 0
the 0
p53 B-gene
protein I-gene
level 0
in 0
MCF 0
- 0
7 0
human 0
breast 0
cancer 0
cells 0
that 0
express 0
wild 0
- 0
type 0
p53 B-gene
. 0

Competition 0
and 0
methylation 0
interference 0
assays 0
showed 0
that 0
the 0
binding 0
site 0
for 0
the 0
novel 0
factor 0
was 0
limited 0
to 0
nucleotides 0
in 0
the 0
3 0
' 0
half 0
of 0
the 0
kappa B-gene
B I-gene
site I-gene
. 0

We 0
have 0
introduced 0
the 0
same 0
change 0
in 0
a 0
yeast B-gene
tRNA I-gene
( I-gene
Trp I-gene
) I-gene
gene I-gene
and 0
demonstrated 0
that 0
the 0
tRNA 0
acts 0
as 0
an 0
efficient 0
amber 0
suppressor 0
in 0
vivo 0
. 0

Both 0
proteins 0
share 0
sequence 0
similarity 0
with 0
the 0
myelin B-gene
- I-gene
associated I-gene
glycoprotein I-gene
, 0
an 0
adhesion 0
molecule 0
of 0
oligodendrocytes 0
and 0
Schwann 0
cells 0
that 0
has 0
been 0
implicated 0
in 0
the 0
process 0
of 0
myelination 0
, 0
raising 0
the 0
important 0
question 0
of 0
whether 0
myelin B-gene
- I-gene
associated I-gene
glycoprotein I-gene
is 0
also 0
a 0
sialic B-gene
acid I-gene
- I-gene
binding I-gene
protein I-gene
. 0

The 0
predicted 0
5 0
' 0
and 0
3 0
' 0
ends 0
of 0
the 0
transcript 0
are 0
in 0
very 0
good 0
agreement 0
with 0
the 0
previously 0
determined 0
size 0
of 0
the 0
LEU3 B-gene
message 0
. 0

These 0
clones 0
contain 0
most 0
of 0
the 0
exon 0
of 0
cyclin B-gene
D2 I-gene
except 0
exon 0
5 0
. 0

By 0
24 0
h 0
, 0
there 0
was 0
no 0
significant 0
difference 0
in 0
FFA 0
levels 0
from 0
shams 0
. 0

The 0
clr1 B-gene
locus I-gene
regulates 0
the 0
expression 0
of 0
the 0
cryptic B-gene
mating I-gene
- I-gene
type I-gene
loci I-gene
of I-gene
fission I-gene
yeast I-gene
. 0

The 0
odds 0
of 0
atopy 0
( 0
defined 0
as 0
a 0
positive 0
test 0
for 0
at 0
least 0
one 0
of 0
the 0
antigens 0
) 0
were 0
5 0
times 0
higher 0
( 0
odds 0
ratio 0
= 0
7.0 0
; 0
95 0
% 0
confidence 0
interval 0
= 0
1.6 0
- 0
31.1 0
% 0
; 0
p 0
= 0
0.01 0
) 0
in 0
the 0
uninfected 0
group 0
, 0
after 0
taking 0
into 0
account 0
the 0
potential 0
influence 0
of 0
gender 0
and 0
age 0
. 0

In 0
mouse 0
, 0
two 0
high 0
- 0
affinity 0
binding 0
sites 0
with 0
an 0
apparent 0
dissociation 0
constant 0
( 0
Kd 0
) 0
of 0
50 0
to 0
100 0
nM 0
have 0
been 0
mapped 0
in 0
the 0
5 0
' 0
ETS B-gene
upstream 0
from 0
the 0
early 0
pre 0
- 0
rRNA 0
processing 0
site 0
. 0

As 0
much 0
thrombin B-gene
was 0
formed 0
during 0
cardiopulmonary 0
bypass 0
( 0
measured 0
by 0
the 0
prothrombin B-gene
activation I-gene
fragment I-gene
F1 I-gene
+ I-gene
2 I-gene
and 0
thrombin B-gene
- 0
antithrombin B-gene
complexes 0
) 0
as 0
in 0
normal 0
patients 0
, 0
showing 0
that 0
factor B-gene
XII I-gene
was 0
not 0
necessary 0
for 0
thrombin B-gene
generation 0
. 0

This 0
article 0
reviews 0
current 0
concepts 0
of 0
pathophysiology 0
and 0
summarises 0
clinical 0
features 0
, 0
natural 0
history 0
and 0
available 0
treatments 0
. 0

Pendulin B-gene
, 0
a 0
Drosophila 0
protein 0
with 0
cell 0
cycle 0
- 0
dependent 0
nuclear 0
localization 0
, 0
is 0
required 0
for 0
normal 0
cell 0
proliferation 0
. 0

The 0
phosphatase 0
active 0
site 0
is 0
located 0
within 0
residues 0
367 0
- 0
374 0
. 0

The 0
central 0
region 0
of 0
the 0
sarcomere 0
, 0
coincident 0
with 0
the 0
M 0
line 0
, 0
was 0
selectively 0
labeled 0
with 0
antibodies 0
to 0
the 0
short 0
C 0
- 0
terminal 0
form 0
. 0

Moreover 0
, 0
antibody 0
binding 0
to 0
the 0
same 0
two 0
determinants 0
was 0
also 0
inhibited 0
when 0
ZAP B-gene
- I-gene
70 I-gene
or 0
the 0
SH2 B-gene
domains I-gene
bound 0
to 0
the 0
zeta 0
chain 0
or 0
to 0
a 0
2pY B-gene
- I-gene
ITAM I-gene
. 0

Interleukin B-gene
- I-gene
1 I-gene
increased 0
the 0
noradrenaline 0
release 0
. 0

A 0
representative 0
group 0
of 0
patients 0
undergoing 0
open 0
radical 0
nephrectomy 0
for 0
clinical 0
T1 0
, 0
T2 0
lesions 0
was 0
also 0
identified 0
. 0

These 0
findings 0
indicate 0
that 0
KCTG 0
can 0
contribute 0
to 0
improved 0
monitoring 0
in 0
high 0
- 0
risk 0
pregnancies 0
. 0

These 0
extrachromosomal 0
copies 0
can 0
be 0
isolated 0
as 0
covalently 0
closed 0
molecules 0
with 0
lengths 0
around 0
3mu 0
. 0

Significant 0
reductions 0
were 0
noted 0
in 0
vertical 0
GRFs 0
per 0
newton 0
of 0
body 0
weight 0
exerted 0
at 0
10 0
% 0
( 0
P 0
= 0
0.0009 0
) 0
and 0
20 0
% 0
( 0
P 0
= 0
0.0383 0
) 0
of 0
stance 0
phase 0
and 0
in 0
anteroposterior 0
GRFs 0
exerted 0
at 0
10 0
% 0
( 0
P 0
= 0
0.0009 0
) 0
and 0
50 0
% 0
( 0
P 0
= 0
0.0033 0
) 0
of 0
stance 0
phase 0
when 0
ambulation 0
was 0
compared 0
with 0
and 0
without 0
the 0
orthotic 0
device 0
. 0

Similar 0
immunological 0
disturbances 0
were 0
observed 0
in 0
SCI 0
but 0
not 0
in 0
the 0
PC2 0
subgroup 0
, 0
i.e 0
. 0
patients 0
examined 0
later 0
than 0
6 0
months 0
after 0
injury 0
. 0

Trimethylcolchicinic 0
acid 0
methyl 0
ether 0
d 0
- 0
tartrate 0
( 0
TMCA 0
; 0
NSC 0
- 0
36351 0
) 0
was 0
administered 0
daily 0
by 0
mouth 0
to 0
71 0
patients 0
with 0
malignant 0
lymphomas 0
. 0

After 0
multivariate 0
analysis 0
, 0
TWA 0
correlated 0
with 0
age 0
( 0
P 0
= 0
0.02 0
) 0
and 0
LV 0
function 0
( 0
P 0
= 0
0.002 0
) 0
and 0
occurred 0
more 0
often 0
in 0
patients 0
after 0
nonanterior 0
MI 0
( 0
P 0
= 0
0.03 0
) 0
. 0

In 0
rats 0
exposed 0
to 0
Cd 0
for 0
30 0
d 0
, 0
the 0
levels 0
of 0
urinary 0
excretion 0
of 0
cAMP 0
after 0
treatment 0
with 0
parathyroid B-gene
hormone I-gene
( 0
PTH B-gene
) 0
, 0
parathyroidectomy 0
( 0
PTX 0
) 0
, 0
or 0
1 0
alpha 0
- 0
hydroxycholecalciferol 0
( 0
1 0
alpha 0
- 0
OH 0
- 0
D3 0
) 0
showed 0
almost 0
the 0
same 0
patterns 0
as 0
those 0
of 0
control 0
rats 0
: 0
the 0
response 0
of 0
urinary 0
cAMP 0
to 0
treatment 0
with 0
PTH B-gene
was 0
not 0
influenced 0
by 0
continuous 0
oral 0
administration 0
of 0
Cd 0
. 0

Receptor B-gene
- I-gene
type I-gene
serine/threonine I-gene
kinases I-gene
( 0
RSKs B-gene
) 0
have 0
been 0
organized 0
into 0
two 0
distinct 0
classes 0
known 0
as 0
types 0
I 0
and 0
II 0
on 0
the 0
basis 0
of 0
sequence 0
similarity 0
. 0

In 0
the 0
remaining 0
91 0
patients 0
( 0
group 0
2 0
) 0
, 0
Pseudomonas 0
( 0
18 0
) 0
, 0
coagulase B-gene
- 0
negative 0
Staphylococci 0
( 0
15 0
) 0
, 0
Staphylococcus 0
epidermidis 0
( 0
23 0
) 0
, 0
Staphylococcus 0
aureus 0
( 0
16 0
) 0
, 0
Corynebacterium 0
species 0
( 0
12 0
) 0
, 0
and 0
others 0
( 0
seven 0
) 0
were 0
isolated 0
. 0

This 0
cDNA 0
corresponded 0
to 0
FGF B-gene
- I-gene
binding I-gene
protein I-gene
( 0
FGF B-gene
- I-gene
BP I-gene
) 0
, 0
a 0
secreted 0
protein 0
previously 0
shown 0
to 0
bind 0
acidic 0
and 0
basic B-gene
FGF I-gene
and 0
to 0
modulate 0
their 0
activities 0
. 0

Electrophoretic 0
mobility 0
- 0
shift 0
assays 0
using 0
oligonucleotides 0
derived 0
from 0
these 0
sites 0
demonstrated 0
formation 0
of 0
specific 0
DNA 0
- 0
protein 0
complexes 0
. 0

For 0
the 0
P B-gene
transcript I-gene
from 0
phage 0
with 0
the 0
G 0
( 0
- 0
) 0
orientation 0
, 0
full 0
termination 0
activity 0
required 0
both 0
the 0
region 0
containing 0
the 0
stem 0
- 0
loop 0
structure 0
and 0
upstream 0
sequences 0
. 0

One 0
day 0
after 0
injection 0
48 0
% 0
of 0
the 0
injected 0
activity 0
was 0
in 0
the 0
skeleton 0
, 0
9.3 0
% 0
in 0
the 0
liver 0
, 0
3 0
% 0
in 0
the 0
kidneys 0
and 0
4.4 0
% 0
in 0
the 0
rest 0
of 0
the 0
organs 0
. 0

Of 0
these 0
four 0
PP2C B-gene
genes I-gene
, 0
the 0
expression 0
of 0
the 0
PP2Cbeta B-gene
gene I-gene
has 0
been 0
reported 0
to 0
be 0
tissue 0
- 0
specific 0
and 0
development 0
- 0
dependent 0
. 0

Combined 0
chemotherapy 0
with 0
VM 0
26 0
and 0
BCNU 0
for 0
recurrent 0
malignant 0
gliomas 0
after 0
operation 0
and 0
irradiation 0
. 0

Administration 0
of 0
FR 0
34235 0
reduced 0
aortic 0
blood 0
pressure 0
and 0
increased 0
cardiac 0
output 0
in 0
anesthetized 0
dogs 0
with 0
an 0
ameroid 0
- 0
induced 0
coronary 0
artery 0
occlusion 0
. 0

Alternative 0
immune B-gene
globulin I-gene
preparation 0
when 0
standard 0
immune B-gene
serum I-gene
globulin I-gene
is 0
not 0
available 0
. 0

Two 0
sibs 0
with 0
identical 0
features 0
of 0
short 0
- 0
limbed 0
dwarfism 0
, 0
a 0
normal 0
skull 0
and 0
face 0
and 0
normal 0
intelligence 0
are 0
described 0
. 0

Effect 0
of 0
a 0
high 0
sugar 0
intake 0
on 0
some 0
metabolic 0
and 0
regulatory 0
indicators 0
in 0
young 0
men 0
. 0

In 0
the 0
second 0
group 0
the 0
untreated 0
fellow 0
eye 0
was 0
microscopically 0
intact 0
, 0
but 0
was 0
shown 0
( 0
as 0
the 0
treated 0
eye 0
) 0
to 0
alter 0
the 0
concentration 0
of 0
uronic 0
acid 0
in 0
different 0
parts 0
of 0
the 0
sclera 0
. 0

Amplification 0
of 0
4q21 0
- 0
q22 0
and 0
the 0
MXR B-gene
gene I-gene
in 0
independently 0
derived 0
mitoxantrone 0
- 0
resistant 0
cell 0
lines 0
. 0

Expression 0
of 0
putative 0
constitutively 0
active 0
forms 0
of 0
DdMEK1 B-gene
in 0
a 0
ddmek1 B-gene
null 0
background 0
is 0
capable 0
, 0
at 0
least 0
partially 0
, 0
of 0
complementing 0
the 0
small 0
aggregate 0
size 0
defect 0
and 0
the 0
ability 0
to 0
activate 0
guanylyl B-gene
cyclase I-gene
. 0

Quantitative 0
Tl 0
- 0
201 0
analysis 0
after 0
stress 0
has 0
also 0
shown 0
viable 0
myocardium 0
in 0
most 0
mild 0
to 0
moderate 0
( 0
51 0
% 0
to 0
85 0
% 0
of 0
normal 0
uptake 0
) 0
irreversible 0
Tl 0
- 0
201 0
defects 0
. 0

However 0
, 0
ADAR1 B-gene
and 0
the 0
related 0
deaminase B-gene
ADAR2 I-gene
showed 0
significant 0
expression 0
in 0
all 0
regions 0
of 0
the 0
brain 0
examined 0
, 0
including 0
cortex 0
, 0
hippocampus 0
, 0
olfactory 0
bulb 0
, 0
and 0
striatum 0
, 0
where 0
the 0
5 B-gene
- I-gene
HT2CR I-gene
pre I-gene
- I-gene
mRNA I-gene
was 0
extensively 0
edited 0
. 0

Psychophysical 0
evidence 0
is 0
given 0
for 0
the 0
existence 0
of 0
two 0
distinct 0
systems 0
in 0
human 0
vision 0
: 0
a 0
fast 0
, 0
sign 0
- 0
invariant 0
system 0
concerned 0
with 0
extracting 0
contours 0
and 0
a 0
slower 0
, 0
sign 0
- 0
sensitive 0
system 0
concerned 0
with 0
assigning 0
surface 0
color 0
. 0

Five 0
girls 0
with 0
Turner 0
's 0
syndrome 0
aged 0
12 0
to 0
17 0
years 0
showed 0
LH B-gene
values 0
( 0
5.0 0
- 0
14.5 0
IU/12 0
h 0
) 0
at 0
the 0
upper 0
end 0
of 0
or 0
slightly 0
above 0
the 0
normal 0
range 0
and 0
pathologically 0
high 0
values 0
( 0
22.2 0
- 0
43.5 0
IU/12 0
h 0
) 0
for 0
FSH B-gene
. 0

Thirty 0
- 0
seven 0
patients 0
with 0
severe 0
temporal 0
lobe 0
epilepsy 0
were 0
studied 0
interictally 0
with 0
[ 0
18F 0
] 0
fluorodeoxyglucose 0
- 0
PET 0
in 0
each 0
of 0
three 0
conditions 0
: 0
resting 0
, 0
during 0
emotional 0
speech 0
, 0
and 0
while 0
performing 0
a 0
visual 0
recognition 0
task 0
. 0

The 0
sequence 0
of 0
Vac1p B-gene
contains 0
two 0
putative 0
zinc 0
- 0
binding 0
RING 0
motifs 0
, 0
a 0
zinc 0
finger 0
motif 0
, 0
and 0
a 0
coiled 0
- 0
coil 0
motif 0
. 0

Serum 0
concentrations 0
of 0
hormones 0
in 0
patients 0
classified 0
as 0
C 0
were 0
characteristically 0
and 0
inclined 0
to 0
be 0
hypergonadotropic 0
and 0
hypoestrogenic 0
. 0

Kinase 0
renaturation 0
tests 0
designed 0
to 0
detect 0
reactivated 0
protein 0
kinases 0
after 0
electrophoresis 0
in 0
sodium 0
dodecyl 0
sulfate 0
- 0
polyacrylamide 0
gels 0
revealed 0
the 0
presence 0
of 0
a 0
60 0
- 0
kDa 0
kinase 0
in 0
the 0
washed 0
immunoprecipitate 0
obtained 0
from 0
liver 0
cytosol 0
using 0
anti B-gene
- I-gene
AHR I-gene
antibody I-gene
( 0
IgG B-gene
) 0
and 0
protein 0
A/G/agarose 0
beads 0
but 0
not 0
when 0
a 0
nonspecific 0
IgG B-gene
was 0
used 0
instead 0
of 0
anti B-gene
- I-gene
AHR I-gene
antibody I-gene
. 0

The 0
immune 0
response 0
seems 0
to 0
be 0
partially 0
responsible 0
for 0
both 0
protection 0
and 0
the 0
destructive 0
consequences 0
of 0
chlamydial 0
infection 0
. 0

Activated 0
FGFR3 B-gene
predominantly 0
interacts 0
with 0
GRB2.Sos B-gene
in 0
complex 0
with 0
a 0
previously 0
identified 0
90 0
- 0
kDa 0
protein 0
and 0
designated 0
protein B-gene
80K I-gene
- I-gene
H I-gene
. 0

We 0
generated 0
`` 0
signature 0
'' 0
oligonucleotides 0
from 0
these B-gene
CDR3s I-gene
and 0
probed 0
PCR 0
amplified B-gene
V I-gene
kappa I-gene
products I-gene
from 0
the 0
synovium 0
and 0
PBLs 0
of 0
the 0
same 0
patient 0
, 0
and 0
from 0
PBLs 0
and 0
spleen 0
of 0
individuals 0
without 0
rheumatic 0
disease 0
. 0

It 0
was 0
predicted 0
that 0
the 0
Stroop 0
task 0
would 0
trigger 0
greater 0
consumption 0
of 0
ice 0
cream 0
than 0
a 0
fearful 0
film 0
, 0
and 0
that 0
this 0
effect 0
would 0
be 0
more 0
pronounced 0
for 0
binge 0
- 0
eaters 0
than 0
non 0
- 0
binge 0
- 0
eaters 0
. 0

Patients 0
with 0
PLM 0
show 0
excessive 0
daytime 0
sleepiness 0
or 0
insomnia 0
. 0

Plasma B-gene
colony I-gene
- I-gene
stimulating I-gene
factor I-gene
analysis 0
and 0
the 0
clinical 0
significance 0

Structure 0
and 0
regulation 0
of 0
KGD2 B-gene
, 0
the 0
structural 0
gene 0
for 0
yeast B-gene
dihydrolipoyl I-gene
transsuccinylase I-gene
. 0

We 0
identified 0
two 0
potential 0
phosphorylation 0
sites 0
at 0
serine49 0
and 0
serine133 0
, 0
both 0
of 0
which 0
seem 0
to 0
be 0
necessary 0
for 0
Myf B-gene
- I-gene
5 I-gene
activity 0
. 0

Exposure 0
of 0
raft 0
cultures 0
to 0
activators 0
of 0
protein B-gene
kinase I-gene
C I-gene
, 0
such 0
as 0
phorbol 0
esters 0
, 0
results 0
in 0
the 0
further 0
induction 0
of 0
late B-gene
gene I-gene
expression 0
as 0
well 0
as 0
virion 0
assembly 0
. 0

Here 0
we 0
demonstrate 0
that 0
the 0
T B-gene
cell I-gene
antigen I-gene
receptor I-gene
zeta I-gene
- I-gene
chain I-gene
- I-gene
associated I-gene
ZAP I-gene
- I-gene
70 I-gene
kinase I-gene
and 0
T B-gene
cell I-gene
antigen I-gene
receptor I-gene
zeta I-gene
- I-gene
chain I-gene
immunoreceptor I-gene
tyrosine I-gene
- I-gene
based I-gene
activation I-gene
motifs I-gene
are 0
essential 0
for 0
the 0
membrane 0
recruitment 0
of 0
SOS B-gene
and 0
Vav B-gene
. 0

Above 0
this 0
transition 0
temperature 0
the 0
calcium 0
antagonist 0
lowers 0
fm 0
more 0
pronouncedly 0
than 0
below 0
. 0

Behavioral 0
effects 0
of 0
benzodiazepine 0
ligands 0
in 0
non 0
- 0
dependent 0
, 0
diazepam 0
- 0
dependent 0
and 0
diazepam 0
- 0
withdrawn 0
baboons 0
. 0

Gastrointestinal 0
accumulation 0
of 0
indium 0
- 0
111 0
labelled 0
granulocytes 0
in 0
reactive 0
arthritis 0
. 0

TNF B-gene
- I-gene
alpha I-gene
stimulated 0
these 0
changes 0
in 0
part 0
by 0
increasing 0
transcription 0
and 0
stabilization 0
of 0
RNA 0
for 0
amphiregulin B-gene
, 0
an 0
EGF B-gene
receptor I-gene
ligand 0
, 0
and 0
amphiregulin B-gene
directly 0
increased 0
HPV 0
- 0
16 0
E6/E7 B-gene
and 0
E6/E7 I-gene

The 0
JNK/SAPK B-gene
activator 0
JNK/SAPK I-gene

Biochemical 0
analyses 0
revealed 0
that 0
the 0
concentration 0
of 0
norepinephrine 0
was 0
reduced 0
significantly 0
in 0
cortex 0
- 0
hippocampus 0
and 0
olfactory 0
bulb 0
but 0
not 0
in 0
other 0
regions 0
, 0
while 0
dopamine 0
and 0
serotonin 0
levels 0
were 0
not 0
altered 0
in 0
any 0
brain 0
region 0
examined 0
. 0

A 0
mouth 0
asymmetry 0
study 0
. 0

Control 0
oligomers 0
of 0
scrambled 0
sequence 0
but 0
identical 0
base 0
composition 0
were 0
ineffective 0
, 0
and 0
no 0
TFO 0
- 0
induced 0
recombination 0
was 0
seen 0
in 0
a 0
control 0
LTK 0
( 0
- 0
) 0
cell 0
line 0
carrying 0
an 0
otherwise 0
identical 0
dual 0
TK B-gene
gene I-gene
construct I-gene
lacking 0
the 0
30 0
- 0
bp 0
polypurine 0
target 0
site 0
. 0

Transformation 0
of 0
chicken 0
embryo 0
fibroblasts 0
( 0
CEF 0
) 0
with 0
the 0
Gag B-gene
- 0
Crk B-gene
fusion 0
protein 0
results 0
in 0
the 0
elevation 0
of 0
tyrosine 0
phosphorylation 0
on 0
specific 0
cellular 0
proteins 0
with 0
molecular 0
weights 0
of 0
130,000 0
, 0
110,000 0
, 0
and 0
70,000 0
( 0
p130 B-gene
, 0
p110 B-gene
, 0
and 0
p70 B-gene
, 0
respectively 0
) 0
, 0
an 0
event 0
which 0
has 0
been 0
correlated 0
with 0
cell 0
transformation 0
. 0

Tilisolol 0
and 0
carboxymethylcellulose 0
sodium 0
salt 0
( 0
CMC 0
) 0
were 0
used 0
as 0
the 0
model 0
ophthalmic 0
drug 0
and 0
viscous 0
polymer 0
, 0
respectively 0
. 0

OAT 0
has 0
become 0
safer 0
in 0
recent 0
years 0
, 0
particularly 0
if 0
monitored 0
in 0
special 0
anticoagulation 0
clinics 0
. 0

The 0
results 0
were 0
compared 0
with 0
the 0
findings 0
in 0
pair 0
- 0
fed 0
non 0
- 0
treated 0
animals 0
( 0
Control 0
Group 0
) 0
. 0

Our 0
data 0
are 0
in 0
line 0
with 0
the 0
hypothesis 0
that 0
E2F B-gene
functions 0
as 0
a 0
growth 0
- 0
and 0
cell 0
cycle 0
regulated 0
tethering 0
factor 0
between 0
Sp1 B-gene
and 0
the 0
basic 0
transcription 0
machinery 0
. 0

Fetal 0
transplants 0
rescue 0
axial 0
muscle 0
representations 0
in 0
M1 0
cortex 0
of 0
neonatally 0
transected 0
rats 0
that 0
develop 0
weight 0
support 0
. 0

However 0
, 0
to 0
encourage 0
good 0
contact 0
between 0
the 0
farmers 0
and 0
the 0
inseminating 0
personnel 0
, 0
it 0
is 0
beneficial 0
that 0
herdsmen 0
are 0
present 0
when 0
cows 0
are 0
inseminated 0
. 0

Solution 0
of 0
the 0
Boltzmann 0
equation 0
in 0
a 0
random 0
magnetic 0
field 0
. 0

These 0
include 0
the 0
genes 0
, 0
undefined B-gene
1 I-gene
( 0
UD1 B-gene
) 0
, 0
UD2 B-gene
, 0
and 0
UD3 B-gene
, 0
each 0
coding 0
for 0
proteins 0
of 0
unknown 0
function 0
, 0
the 0
ken B-gene
gene I-gene
encoding 0
a 0
new 0
Kruppel B-gene
- I-gene
like I-gene
putative I-gene
transcription I-gene
factor I-gene
, 0
the 0
fly 0
homologues 0
of 0
the 0
mammalian B-gene
mitochondrial I-gene
trifunctional I-gene
enzyme I-gene
( 0
thiolase B-gene
) 0
, 0
and 0
the 0
TAR B-gene
DNA I-gene
- I-gene
binding I-gene
protein I-gene
- I-gene
43 I-gene
( 0
TBPH B-gene
) 0
, 0
the 0
first 0
nonvertebrate 0
member 0
of 0
the 0
transmembrane B-gene
4 I-gene
superfamily I-gene
( 0
TM4SF B-gene
) 0
gene 0
, 0
a 0
new 0
homeodomain B-gene
gene I-gene
, 0
and 0
a 0
gene 0
coding 0
for 0
a 0
putative 0
nuclear 0
binding 0
protein 0
( 0
PNBP 0
) 0
that 0
is 0
homologous 0
to 0
maleless B-gene
, 0
and 0
a 0
Copia B-gene
- I-gene
like I-gene
element I-gene
. 0

It 0
is 0
recommended 0
that 0
area 0
correction 0
be 0
attempted 0
in 0
bioequivalence 0
studies 0
of 0
drugs 0
where 0
high 0
intrasubject 0
variability 0
in 0
clearance 0
is 0
known 0
or 0
suspected 0
. 0

A 0
method 0
for 0
determining 0
the 0
toxicity 0
of 0
neutralizers 0
for 0
antimicrobial 0
agents 0
to 0
A. 0
castellanii 0
was 0
also 0
evaluated 0
. 0

In 0
the 0
present 0
study 0
we 0
use 0
a 0
tnaC B-gene
- 0
UGA 0
- 0
'lacZ B-gene
construct 0
lacking 0
the 0
tnaC B-gene
- 0
tnaA B-gene
spacer 0
region 0
to 0
analyze 0
the 0
effect 0
of 0
TnaC B-gene
synthesis 0
on 0
the 0
behavior 0
of 0
the 0
ribosome 0
that 0
translates 0
tnaC B-gene
. 0

Unlike 0
JNK B-gene
activation 0
, 0
ERK B-gene
activation 0
could 0
not 0
be 0
mapped 0
to 0
specific 0
reovirus 0
gene 0
segments 0
, 0
suggesting 0
that 0
ERK B-gene
activation 0
and 0
JNK B-gene
activation 0
are 0
triggered 0
by 0
different 0
events 0
during 0
virus 0
- 0
host 0
cell 0
interaction 0
. 0

Promoter 0
region 0
of 0
the 0
human B-gene
alpha I-gene
2A I-gene
adrenergic I-gene
receptor I-gene
gene I-gene
. 0

Analysis 0
of 0
deletion 0
and 0
substitution 0
mutations 0
in 0
the 0
MER2 B-gene
5 I-gene
' I-gene
exon I-gene
demonstrates 0
that 0
the 0
unusually 0
large 0
size 0
of 0
this 0
exon 0
plays 0
an 0
important 0
role 0
in 0
splicing 0
regulation 0
. 0

Schottky 0
- 0
barrier 0
heights 0
of 0
Ti 0
and 0
TiSi2 0
on 0
n 0
- 0
type 0
and 0
p 0
- 0
type 0
Si 0
( 0
100 0
) 0
. 0

In 0
- 0
111 0
- 0
BLMC 0
uptake 0
was 0
directly 0
proportional 0
to 0
Ki B-gene
- I-gene
67/MIB I-gene
67/MIB I-gene
- I-gene
1 I-gene
activity 0
and 0
number 0
of 0
mitoses 0
in 0
tumor 0
tissue 0
. 0

The 0
majority 0
of 0
the 0
human B-gene
Ig I-gene
heavy I-gene
chain I-gene
( I-gene
IgH I-gene
) I-gene
constant I-gene
( I-gene
C I-gene
) I-gene
region I-gene
locus I-gene
has 0
been 0
cloned 0
and 0
mapped 0
. 0

On 0
guanidine 0
and 0
the 0
treatment 0
of 0
botulism 0
. 0

Excellent 0
results 0
were 0
recorded 0
in 0
390 0
( 0
83.69 0
% 0
) 0
of 0
the 0
patients 0
, 0
improvement 0
in 0
46 0
( 0
9.87 0
% 0
) 0
where 0
in 0
the 0
majority 0
a 0
varicose 0
complex 0
was 0
involved 0
. 0

By 0
differential 0
screening 0
of 0
a 0
Xenopus 0
laevis 0
egg 0
cDNA 0
library 0
, 0
we 0
have 0
isolated 0
a 0
2,111 0
bp 0
cDNA 0
which 0
corresponds 0
to 0
a 0
maternal 0
mRNA 0
specifically 0
deadenylated 0
after 0
fertilisation 0
. 0

Most 0
of 0
these 0
elements 0
are 0
adjacent 0
to 0
type 0
X 0
telomeric 0
repeats 0
, 0
and 0
regions 0
flanking 0
four 0
of 0
five 0
characterized 0
S. 0
paradoxus 0
insertions 0
carry 0
autonomously 0
replicating 0
sequences 0
. 0

Mutational 0
analysis 0
of 0
the 0
putative 0
effector 0
domain 0
of 0
the 0
GTP B-gene
- I-gene
binding I-gene
Ypt1 I-gene
protein I-gene
in 0
yeast 0
suggests 0
specific 0
regulation 0
by 0
a 0
novel 0
GAP B-gene
activity 0
. 0

We 0
recently 0
described 0
the 0
isolation 0
and 0
characterization 0
of 0
nontoxic 0
PAP B-gene
mutants I-gene
, 0
NT123 0
- 0
2 0
, 0
which 0
has 0
a 0
point 0
mutation 0
( 0
E176V 0
) 0
in 0
the 0
active 0
site 0
that 0
abolishes 0
enzymatic 0
activity 0
, 0
and 0
NT124 0
- 0
3 0
, 0
which 0
has 0
a 0
nonsense 0
mutation 0
that 0
results 0
in 0
deletion 0
of 0
the 0
C 0
- 0
terminal 0
25 0
aa 0
( 0
W237Stop 0
) 0
. 0

This 0
ligand 0
- 0
independent 0
pathway 0
can 0
function 0
through 0
another 0
androgen 0
- 0
regulated 0
promoter 0
as 0
shown 0
by 0
the 0
use 0
of 0
the 0
mouse B-gene
mammary I-gene
tumor I-gene
virus I-gene
MMTV I-gene
- I-gene
CAT I-gene
reporter I-gene
. 0

From 0
the 0
present 0
results 0
a 0
concept 0
of 0
hormone 0
- 0
dependent 0
AR B-gene
activation 0
is 0
proposed 0
, 0
which 0
requires 0
a 0
functional 0
, 0
direct 0
or 0
indirect 0
intramolecular 0
interaction 0
between 0
the 0
TAD 0
and 0
the 0
LBD 0
. 0

All 0
patients 0
were 0
peritonitis 0
- 0
free 0
at 0
least 0
6 0
weeks 0
before 0
each 0
PET 0
. 0

After 0
control 0
for 0
body 0
mass 0
index 0
, 0
trait 0
anxiety 0
and 0
anger 0
- 0
in 0
remained 0
independent 0
predictors 0
of 0
diastolic 0
blood 0
pressure 0
among 0
the 0
women 0
. 0

Studies 0
on 0
low 0
- 0
dose 0
oral 0
contraceptives 0
: 0
cervical 0
mucus 0
and 0
plasma 0
hormone 0
changes 0
in 0
relation 0
to 0
circulating 0
D 0
- 0
norgestrel 0
and 0
17alpha 0
ethynyl 0
- 0
estradiol 0
concentrations 0
. 0

The 0
predicted 0
vav B-gene
oncogene I-gene
protein I-gene
sequence I-gene
exhibits 0
several 0
motifs 0
reminiscent 0
of 0
transcriptional 0
factors 0
. 0

The 0
platelet B-gene
membrane I-gene
glycoprotein I-gene
IIb/IIIa I-gene
receptor I-gene
inhibitor 0
abciximab 0
is 0
used 0
for 0
the 0
treatment 0
of 0
patients 0
undergoing 0
high 0
- 0
risk 0
percutaneous 0
coronary 0
interventions 0
and 0
is 0
used 0
in 0
approximately 0
one 0
third 0
of 0
coronary 0
interventions 0
in 0
the 0
United 0
States 0
and 0
a 0
growing 0
number 0
of 0
procedures 0
in 0
Europe 0
. 0

The 0
mean 0
times 0
to 0
LNR 0
in 0
these 0
groups 0
were 0
42.0 0
months 0
( 0
range 0
, 0
3.0 0
- 0
194.5 0
months 0
) 0
and 0
49.0 0
months 0
( 0
range 0
, 0
3.6 0
- 0
209.0 0
months 0
) 0
respectively 0
. 0

Ultraviolet 0
crosslinking 0
experiments 0
using 0
element 0
B 0
revealed 0
the 0
specific 0
binding 0
of 0
two 0
proteins 0
of 0
approximately 0
43 0
and 0
80 0
kDa 0
. 0

The 0
cells 0
were 0
densely 0
ciliated 0
, 0
each 0
cilium 0
showing 0
a 0
typical 0
9+2 0
fibrilar 0
pattern 0
. 0

Searching 0
the 0
human 0
DNA 0
data 0
base 0
of 0
expressed 0
sequence 0
tags 0
( 0
EST 0
) 0
revealed 0
novel 0
partial 0
sequences 0
similar 0
to 0
, 0
but 0
distinct 0
from 0
, 0
the 0
sequences 0
of 0
the 0
previously 0
known 0
PEF B-gene
proteins I-gene
. 0

HBO 0
had 0
marked 0
effects 0
on 0
these 0
enzymes 0
: 0
lung B-gene
SOD I-gene
increased 0
( 0
guinea 0
pigs 0
47 0
% 0
, 0
rats 0
88 0
% 0
) 0
and 0
CAT B-gene
and 0
GSHPx B-gene
activities 0
decreased 0
( 0
33 0
% 0
) 0
in 0
brain 0
and 0
lung 0
. 0

RXRalpha/RARalpha B-gene
heterodimers 0
and 0
RXRalpha/RARalpha I-gene

Adenomas 0
in 0
the 0
upper 0
gastrointestinal 0
tract 0
were 0
found 0
in 0
all 0
of 0
the 0
patients 0
: 0
Vater 0
's 0
papilla 0
- 0
- 0
12 0
, 0
duodenum 0
- 0
- 0
nine 0
, 0
and 0
gastric 0
antrum 0
- 0
- 0
seven 0
. 0

A 0
new 0
direct 0
hemagglutination 0
test 0
( 0
HI 0
- 0
GONAVIS 0
) 0
for 0
urinary 0
LH B-gene
was 0
compared 0
with 0
the 0
serum 0
radioimmuno 0
- 0
assay 0
of 0
LH B-gene
. 0

Sucrose 0
produced 0
in 0
source 0
leaves 0
is 0
the 0
predominant 0
carbon 0
source 0
for 0
developing 0
sink 0
tissues 0
in 0
most 0
higher 0
plants 0
. 0

Accumulation 0
of 0
amines 0
in 0
the 0
isolated 0
perfused 0
rabbit 0
lung 0
. 0

They 0
also 0
show 0
that 0
M. 0
malmoense 0
can 0
be 0
isolated 0
from 0
the 0
environment 0
which 0
may 0
be 0
the 0
source 0
of 0
the 0
infection 0
. 0

On 0
the 0
pharmacology 0
of 0
9,10 0
- 0
dihydro 0
- 0
10 0
- 0
( 0
1 0
- 0
methyl 0
- 0
4 0
- 0
piperidylidene 0
) 0
- 0
9 0
- 0
anthrol 0
( 0
WA 0
335 0
) 0
, 0
a 0
histamine 0
and 0
serotonin 0
antagonist 0

This 0
incompatibility 0
phenotype 0
requires 0
the 0
global 0
transcriptional 0
repressor 0
, 0
KorB B-gene
, 0
and 0
the 0
target 0
for 0
incC B-gene
- 0
mediated 0
incompatibility 0
is 0
a 0
KorB B-gene
- I-gene
binding I-gene
site I-gene
( I-gene
O I-gene
( I-gene
B I-gene
) I-gene
) I-gene
. 0

Therefore 0
, 0
a 0
structural 0
interaction 0
between 0
PsaL B-gene
and 0
PsaI B-gene
may 0
stabilize 0
the 0
association 0
of 0
PsaL B-gene
with 0
the 0
photosystem B-gene
I I-gene
core I-gene
. 0

Binding 0
of 0
the 0
TorR B-gene
regulator I-gene
to 0
cis 0
- 0
acting 0
direct 0
repeats 0
activates 0
tor B-gene
operon I-gene
expression 0
. 0

Histological 0
and 0
immunophenotypic 0
studies 0
revealed 0
12 0
large 0
cell 0
lymphomas 0
( 0
11 0
B 0
cell 0
and 0
one 0
T 0
cell 0
) 0
, 0
two 0
small 0
noncleaved 0
cell 0
lymphomas 0
( 0
B 0
- 0
cell 0
phenotype 0
) 0
, 0
and 0
five 0
low 0
grade 0
B 0
- 0
cell 0
lymphomas 0
( 0
two 0
small 0
lymphocytic 0
and 0
three 0
follicular 0
mixed 0
lymphomas 0
) 0
. 0

The 0
subjects 0
were 0
17 0
patients 0
with 0
android 0
obesity 0
( 0
four 0
men 0
and 0
13 0
women 0
) 0
aged 0
21 0
to 0
58 0
years 0
with 0
a 0
body 0
mass 0
index 0
( 0
BMI 0
) 0
ranging 0
from 0
32.0 0
to 0
52.2 0
kg/m2 0
and 0
an 0
abdominal 0
- 0
gluteal 0
ratio 0
greater 0
than 0
1.0 0
. 0

A 0
mean 0
value 0
for 0
HbA1 B-gene
greater 0
than 0
10 0
% 0
was 0
associated 0
with 0
an 0
increased 0
risk 0
of 0
progression 0
of 0
retinopathy 0
and 0
a 0
mean 0
value 0
less 0
than 0
8.7 0
% 0
was 0
associated 0
with 0
a 0
diminished 0
risk 0
. 0

An 0
emended 0
diagnosis 0
of 0
Tylocephalum 0
is 0
proposed 0
excluding 0
this 0
feature 0
, 0
along 0
with 0
distribution 0
of 0
the 0
testes 0
in 0
the 0
preovarian 0
field 0
and 0
circummedullary 0
distribution 0
of 0
vitelline 0
follicles 0
. 0

Role 0
of 0
double B-gene
- I-gene
stranded I-gene
RNA I-gene
- I-gene
dependent I-gene
protein I-gene
kinase I-gene
in 0
mediating 0
hypersensitivity 0
of 0
Fanconi 0
anemia 0
complementation 0
group 0
C 0
cells 0
to 0
interferon B-gene
gamma I-gene
, 0
tumor B-gene
necrosis I-gene
factor I-gene
- I-gene
alpha I-gene
, 0
and 0
double 0
- 0
stranded 0
RNA 0
. 0

Different 0
effects 0
of 0
reoxygenation 0
on 0
the 0
electrical 0
activity 0
of 0
ventricular 0
muscle 0
. 0

Similar 0
observations 0
were 0
obtained 0
when 0
these 0
mutated 0
versions 0
of 0
site 0
A 0
were 0
evaluated 0
by 0
transient 0
cotransfection 0
assays 0
in 0
CV1 0
cells 0
. 0

YLL031c B-gene
is 0
an 0
essential 0
gene 0
. 0

We 0
have 0
measured 0
percentage 0
O3 0
uptake 0
in 0
30 0
adult 0
Sprague 0
- 0
Dawley 0
rats 0
exposed 0
, 0
nose 0
only 0
, 0
for 0
1 0
hr 0
to 0
0.3 0
, 0
0.6 0
, 0
or 0
1.0 0
ppm 0
O3 0
. 0

Threefold 0
risks 0
were 0
observed 0
for 0
men 0
with 0
the 0
highest 0
level 0
of 0
intensity 0
and 0
for 0
those 0
with 0
the 0
highest 0
probability 0
of 0
EMF 0
exposure 0
, 0
although 0
women 0
with 0
heavy 0
EMF 0
exposure 0
did 0
not 0
experience 0
increased 0
risk 0
. 0

Further 0
, 0
cells 0
cotransfected 0
with 0
a 0
UF B-gene
promoter I-gene
- 0
luciferase B-gene
( 0
- 0
1935UF B-gene
- 0
Luc B-gene
) 0
reporter 0
gene 0
and 0
the 0
BTEB B-gene
expression 0
vector 0
had 0
2 0
- 0
fold 0
higher 0
Luc B-gene
activity 0
than 0
those 0
cotransfected 0
with 0
reporter 0
gene 0
and 0
pcDNA 0
- 0
3 0
. 0

Early 0
complement 0
components 0
, 0
C1q B-gene
and 0
C4 B-gene
, 0
and 0
IgA B-gene
secretory 0
piece 0
were 0
absent 0
. 0

Although 0
IRS B-gene
- I-gene
1 I-gene
, I-gene
- I-gene
2 I-gene
, I-gene
and I-gene
- I-gene
4 I-gene
are 0
similar 0
in 0
overall 0
structure 0
, 0
IRS B-gene
- I-gene
3 I-gene
is 0
approximately 0
50 0
% 0
shorter 0
and 0
differs 0
with 0
respect 0
to 0
sites 0
of 0
tyrosine 0
phosphorylation 0
. 0

These 0
results 0
demonstrate 0
a 0
specific 0
association 0
of 0
SIV 0
and 0
HIV B-gene
- I-gene
2 I-gene
nef I-gene
, 0
but 0
not 0
HIV B-gene
- I-gene
1 I-gene
nef I-gene
, 0
with 0
TCRzeta B-gene
. 0

METHODS 0
: 0
We 0
retrospectively 0
analyzed 0
the 0
data 0
of 0
20 0
patients 0
who 0
underwent 0
both 0
gated 0
fluorine 0
18 0
deoxyglucose 0
( 0
FDG 0
) 0
- 0
PET 0
and 0
equilibrium 0
radionuclide 0
angiography 0
( 0
ERNA 0
) 0
. 0

The 0
distinct 0
spatial 0
pattern 0
of 0
expression 0
, 0
and 0
unusual 0
amino 0
acid 0
sequence 0
in 0
its 0
DNA 0
binding 0
domain 0
, 0
may 0
indicate 0
a 0
particular 0
role 0
for 0
DTEF B-gene
- I-gene
1 I-gene
in 0
cell 0
- 0
specific 0
gene 0
regulation 0
. 0

Rac2 B-gene
, 0
a 0
member 0
of 0
the 0
Rho B-gene
family I-gene
of 0
GTPases B-gene
, 0
is 0
highly 0
expressed 0
in 0
myeloid 0
cells 0
and 0
is 0
a 0
regulator 0
of 0
the 0
NADPH B-gene
- I-gene
oxidase I-gene
complex I-gene
. 0

The 0
yeast B-gene
mitochondrial I-gene
Hsp70 I-gene
, 0
Ssc1p B-gene
, 0
functions 0
as 0
a 0
molecular 0
chaperone 0
with 0
its 0
partner 0
proteins 0
, 0
Mdj1p B-gene
( 0
DnaJ B-gene
homologue I-gene
) 0
and 0
Yge1p B-gene
( 0
GrpE B-gene
homologue I-gene
) 0
. 0

The 0
best 0
sequences 0
for 0
pelvic 0
study 0
are 0
, 0
in 0
our 0
experience 0
, 0
IR 0
or 0
short 0
TR 0
spin 0
- 0
echo 0
for 0
T1 0
- 0
weighted 0
images 0
, 0
and 0
spin 0
- 0
echo 0
with 0
1200 0
TR 0
for 0
T2 0
images 0
. 0

We 0
now 0
report 0
that 0
both 0
HSCR B-gene
mutations 0
impair 0
the 0
fixation 0
of 0
Shc B-gene
to 0
RET B-gene
and 0
consequently 0
prevent 0
its 0
phosphorylation 0
. 0

We 0
now 0
describe 0
a 0
HepG2 B-gene
cell I-gene
casein I-gene
kinase I-gene
II I-gene
beta I-gene
subunit I-gene
cDNA I-gene
of 0
2.57 0
kb 0
containing 0
96 0
bases 0
of 0
5 0
' 0
untranslated 0
sequence 0
, 0
645 0
bases 0
of 0
open 0
reading 0
frame 0
, 0
and 0
1832 0
bases 0
of 0
3 0
' 0
untranslated 0
sequence 0
with 0
two 0
polyadenylation 0
consensus 0
signal 0
sequences 0
and 0
two 0
poly 0
( 0
A 0
) 0
stretches 0
. 0

Platelet B-gene
factor I-gene
4 I-gene
levels 0
in 0
patients 0
with 0
coronary 0
artery 0
disease 0
. 0

Serum 0
pituitary 0
and 0
steroid 0
hormone 0
levels 0
in 0
the 0
adult 0
male 0
: 0
one 0
value 0
is 0
as 0
good 0
as 0
the 0
mean 0
of 0
three 0
. 0

Blood 0
ammonia 0
concentration 0
was 0
significantly 0
higher 0
in 0
males 0
at 0
70 0
, 0
80 0
and 0
90 0
% 0
of 0
VO2 0
peak 0
. 0

Here 0
, 0
we 0
describe 0
the 0
crystal 0
structure 0
at 0
2.5 0
A 0
resolution 0
of 0
a 0
fragment 0
of 0
the 0
integrase B-gene
of I-gene
Rous I-gene
sarcoma I-gene
virus I-gene
( I-gene
residues I-gene
49 I-gene
- I-gene
286 I-gene
) I-gene
containing 0
both 0
the 0
conserved 0
catalytic 0
domain 0
and 0
a 0
modulatory 0
DNA 0
- 0
binding 0
domain 0
( 0
C 0
domain 0
) 0
. 0

The 0
effect 0
on 0
kidney 0
length 0
was 0
considerably 0
prolonged 0
compared 0
with 0
the 0
vascular 0
effect 0
. 0

The 0
prevalence 0
of 0
microalbuminuria 0
, 0
defined 0
as 0
an 0
UAER 0
in 0
the 0
range 0
of 0
15 0
- 0
150 0
micrograms 0
min 0
- 0
1 0
in 0
an 0
overnight 0
urine 0
sample 0
, 0
was 0
3 0
% 0
( 0
95 0
% 0
C.I 0
. 0
interval 0
: 0
1.9 0
- 0
4.0 0
) 0
. 0

However 0
, 0
a 0
lesser 0
extent 0
effect 0
was 0
noticed 0
in 0
nonpregnant 0
than 0
seen 0
in 0
pregnant 0
rats 0
. 0

Despite 0
their 0
high 0
degree 0
of 0
sequence 0
similarity 0
, 0
all 0
five 0
RFC B-gene
genes I-gene
are 0
essential 0
for 0
cell 0
proliferation 0
in 0
S. 0
cerevisiae 0
. 0

Rev 0
. 0

The 0
strongly 0
DNA 0
binding 0
p50 B-gene
subunit I-gene
showed 0
only 0
very 0
weak 0
, 0
if 0
any 0
, 0
induction 0
of 0
gene 0
expression 0
. 0

Stability 0
of 0
125 0
I 0
- 0
labeled 0
insulin B-gene
used 0
in 0
radioimmunoassay 0
of 0
insulin B-gene
. 0

Influence 0
of 0
long 0
- 0
term 0
zimelidine 0
treatment 0
on 0
LSD 0
- 0
induced 0
behavioural 0
effects 0
. 0

Using 0
mammalian 0
expression 0
vectors 0
( 0
pRSV 0
- 0
neo 0
and 0
pSV2 0
- 0
neo 0
) 0
, 0
antisense 0
constructs 0
for 0
perforin B-gene
and 0
granzyme B-gene
B I-gene
were 0
independently 0
electroporated 0
into 0
YT 0
- 0
INDY 0
, 0
a 0
human 0
non 0
- 0
MHC B-gene
- 0
restricted 0
, 0
IL B-gene
- I-gene
2 I-gene
- 0
independent 0
, 0
cytotoxic 0
lymphocyte 0
. 0

When 0
targeted 0
to 0
the 0
GAL1 B-gene
promoter I-gene
by 0
fusing 0
with 0
the 0
Gal4p B-gene
DNA I-gene
- I-gene
binding I-gene
domain I-gene
, 0
Sko1p B-gene
acts 0
as 0
an 0
Ssn6/Tup1p B-gene
- 0
dependent 0
repressor 0
regulated 0
by 0
osmotic 0
stress 0
. 0

Like 0
Rev B-gene
- 0
Erb B-gene
, 0
BD73 B-gene
binds 0
as 0
a 0
monomer 0
to 0
a 0
DNA 0
sequence 0
which 0
consists 0
of 0
a 0
specific 0
A/T 0
- 0
rich 0
sequence 0
upstream 0
of 0
the 0
consensus 0
hexameric 0
half 0
- 0
site 0
specified 0
by 0
the 0
P 0
box 0
of 0
the 0
DNA 0
- 0
binding 0
domain 0
. 0

BACKGROUND 0
: 0
Allergic 0
rhinoconjunctivitis 0
is 0
a 0
common 0
disorder 0
, 0
affecting 0
> 0
20 0
% 0
of 0
people 0
of 0
all 0
socioeconomic 0
strata 0
. 0

INTERVENTIONS 0
: 0
Postoperative 0
follow 0
- 0
up 0
consisted 0
of 0
serial 0
determination 0
of 0
different 0
biochemical 0
markers 0
( 0
CK B-gene
, 0
CK B-gene
- I-gene
MB I-gene
, 0
cTnI B-gene
) 0
, 0
ECGs 0
, 0
and 0
echocardiography 0
. 0

The 0
striking 0
similarity 0
in 0
preference 0
for 0
mismatched 0
and 0
weakly 0
paired 0
nucleotides 0
for 0
binding 0
and 0
for 0
excision 0
suggests 0
a 0
functional 0
relationship 0
between 0
binding 0
and 0
cleavage 0
reactions 0
. 0

New 0
results 0
of 0
importance 0
for 0
optimization 0
of 0
the 0
postoperative 0
course 0
] 0
Complications 0
after 0
major 0
surgery 0
may 0
be 0
related 0
to 0
factors 0
in 0
the 0
surgical 0
stress 0
response 0
with 0
endocrine 0
- 0
metabolic 0
and 0
inflammatory 0
changes 0
. 0

Immunoblotting 0
showed 0
that 0
both 0
the 0
( 0
1 0
- 0
404 0
) 0
- 0
peptide 0
and 0
( 0
1 0
- 0
506 0
) 0
- 0
peptide 0
are 0
recognized 0
by 0
95J10 B-gene
, 0
a 0
monoclonal 0
antibody 0
that 0
was 0
previously 0
raised 0
against 0
perlecan B-gene
- I-gene
( I-gene
24 I-gene
- I-gene
404 I-gene
) I-gene
- I-gene
peptide I-gene
expressed 0
in 0
Escherichia 0
coli 0
. 0

Tumor B-gene
necrosis I-gene
factor I-gene
levels 0
were 0
measured 0
by 0
enzyme 0
- 0
linked 0
immunoabsorbent 0
assay 0
in 0
plasma 0
samples 0
obtained 0
from 0
the 0
hyperthermic 0
isolated 0
limb 0
perfusion 0
circuit 0
and 0
systemic 0
circulation 0
. 0

Serum B-gene
alpha I-gene
- I-gene
amylase I-gene
, 0
trypsin B-gene
, 0
trypsin B-gene
inhibitor I-gene
, 0
lipase B-gene
and 0
total 0
protease 0
activity 0
in 0
the 0
pancreatic 0
tissue 0
was 0
studied 0
as 0
indicator 0
of 0
the 0
treatment 0
efficacy 0
with 0
5 0
- 0
fluorouracil 0
electro 0
- 0
cumulation 0
. 0

The 0
possible 0
equivalency 0
of 0
a 0
short 0
form 0
and 0
the 0
long 0
form 0
of 0
the 0
Multiple 0
Affect 0
Adjective 0
Check 0
List 0
- 0
Revised 0
( 0
MAACL 0
- 0
R 0
; 0
Zuckerman 0
& 0
Lubin,1985 0
) 0
was 0
studied 0
by 0
correlating 0
both 0
forms 0
of 0
the 0
MAACL 0
- 0
R 0
with 0
the 0
State 0
Trait 0
Personality 0
Inventory 0
( 0
Spielberger,1995 0
) 0
; 0
the 0
Affect 0
Balance 0
Scale 0
( 0
Bradburn,1969 0
) 0
; 0
and 0
the 0
Sensation 0
Seeking 0
Scale 0
( 0
Zuckerman,1978 0
) 0
. 0

The 0
activity 0
of 0
platelet B-gene
factor I-gene
4 I-gene
in 0
plasma 0
of 0
healthy 0
and 0
high 0
risk 0
newborns 0
. 0

Studies 0
of 0
HS2 B-gene
- I-gene
gamma I-gene
gene I-gene
reporter I-gene
constructs I-gene
carrying 0
CACCC 0
box 0
deletions 0
revealed 0
that 0
the 0
CACCC 0
box 0
sequence 0
of 0
the 0
gamma 0
gene 0
promoter 0
mediates 0
the 0
activation 0
of 0
the 0
gamma 0
gene 0
by 0
FKLF B-gene
. 0

In 0
addition 0
, 0
mrp17 B-gene
- I-gene
1 I-gene
, 0
in 0
combination 0
with 0
some 0
mutations 0
affecting 0
another 0
mitochondrial 0
ribosomal 0
protein 0
, 0
caused 0
a 0
synthetic 0
defective 0
phenotype 0
. 0

Erdheim 0
- 0
Chester 0
disease 0
: 0
a 0
distinct 0
lipoidosis 0
or 0
part 0
of 0
the 0
spectrum 0
of 0
histiocytosis 0
? 0
Erdheim 0
- 0
Chester 0
disease 0
has 0
always 0
been 0
considered 0
a 0
distinct 0
lipoidosis 0
based 0
on 0
clinical 0
and 0
radiographic 0
criteria 0
. 0

The 0
ossification 0
was 0
located 0
on 0
the 0
left 0
side 0
of 0
C3 0
- 0
4 0
. 0

Characterization 0
of 0
human B-gene
activating I-gene
transcription I-gene
factor I-gene
4 I-gene
, 0
a 0
transcriptional 0
activator 0
that 0
interacts 0
with 0
multiple 0
domains 0
of 0
cAMP B-gene
- I-gene
responsive I-gene
element I-gene
- I-gene
binding I-gene
protein I-gene
( 0
CREB B-gene
) 0
- 0
binding 0
protein 0
. 0

If 0
the 0
size 0
of 0
the 0
cystic 0
liver 0
- 0
lesions 0
excludes 0
a 0
curative 0
operative 0
treatment 0
or 0
if 0
the 0
patient 0
refuses 0
surgery 0
, 0
the 0
indication 0
for 0
chemotherapy 0
with 0
mebendazole 0
is 0
given 0
. 0

The 0
Ixodes 0
fauna 0
in 0
the 0
Michourin 0
region 0
, 0
where 0
the 0
pastures 0
in 0
1971 0
were 0
grazed 0
only 0
by 0
sheep 0
, 0
shows 0
the 0
following 0
trends 0
: 0
H. 0
punctata 0
and 0
R. 0
turanicus 0
ticks 0
, 0
which 0
are 0
preferably 0
parasitising 0
in 0
sheep 0
, 0
increase 0
their 0
relative 0
share 0
. 0

The 0
contribution 0
of 0
residues 0
outside 0
the 0
Ras B-gene
binding I-gene
domain I-gene
of 0
Raf B-gene
( 0
RafRBD B-gene
) 0
to 0
Ras B-gene
- 0
Raf B-gene
interaction 0
and 0
Ras B-gene
- 0
dependent 0
Raf B-gene
activation 0
has 0
remained 0
unresolved 0
. 0

We 0
suggest 0
that 0
electrical 0
stimulation 0
of 0
the 0
NTS 0
in 0
rats 0
undergoing 0
such 0
surgical 0
preparation 0
to 0
observe 0
the 0
pressor 0
response 0
and/or 0
increase 0
in 0
pVP 0
, 0
represents 0
a 0
rapid 0
approach 0
for 0
screening 0
the 0
neurosecretory 0
function 0
of 0
the 0
central 0
neural 0
integration 0
to 0
release 0
vasopressin B-gene
. 0

CONCLUSION/INTERPRETATION 0
: 0
We 0
found 0
an 0
increased 0
risk 0
of 0
hip 0
fracture 0
in 0
women 0
younger 0
than 0
75 0
years 0
with 0
Type 0
I 0
diabetes 0
or 0
with 0
Type 0
II 0
diabetes 0
of 0
long 0
duration 0
. 0

Mean 0
24 0
h 0
urinary 0
excretion 0
values 0
confirmed 0
this 0
observation 0
. 0

Here 0
we 0
investigate 0
the 0
mechanism 0
of 0
TPA 0
induction 0
of 0
FGF B-gene
- I-gene
BP I-gene
gene 0
expression 0
in 0
the 0
human 0
ME 0
- 0
180 0
SCC 0
cell 0
line 0
. 0

They 0
represent 0
a 0
physiologically 0
more 0
meaningful 0
pattern 0
than 0
the 0
arithmetic 0
mean 0
with 0
standard 0
deviation 0
. 0

The 0
influence 0
of 0
gas 0
composition 0
in 0
the 0
air 0
cell 0
on 0
pipping 0
and 0
liver 0
metabolism 0
in 0
embryonic 0
chicks 0
. 0

However 0
, 0
FosB B-gene
- I-gene
L I-gene
and 0
FosB B-gene
- I-gene
S I-gene
do 0
not 0
differ 0
in 0
all 0
trans 0
- 0
regulatory 0
properties 0
: 0
Trans 0
- 0
activation 0
of 0
a 0
5x 0
TRE B-gene
- I-gene
CAT I-gene
reporter 0
construct 0
in 0
HeLa 0
and 0
NIH 0
- 0
3T3 0
cells 0
was 0
found 0
with 0
both 0
FosB B-gene
forms 0
. 0

Numerous 0
genes 0
of 0
this 0
family 0
have 0
been 0
identified 0
in 0
animals 0
, 0
with 0
the 0
largest 0
number 0
found 0
in 0
vertebrates 0
. 0

Mineralized 0
bone 0
nodule 0
formation 0
in 0
vitro 0
by 0
cell 0
populations 0
from 0
young 0
adult 0
rabbit 0
alveolar 0
bone 0
. 0

Soluble 0
extracts 0
from 0
FGF B-gene
- 0
treated 0
as 0
compared 0
with 0
quiescent 0
fibroblasts 0
exhibited 0
up 0
to 0
3 0
- 0
fold 0
higher 0
kinase 0
activity 0
towards 0
S6 B-gene
in 0
exogenously 0
added 0
rat B-gene
liver I-gene
40S I-gene
ribosomes I-gene
and 0
a 0
synthetic 0
peptide 0
, 0
RRLSSLRA 0
. 0

In 0
conclusion 0
, 0
when 0
pulmonary 0
abnormalities 0
are 0
found 0
in 0
HTLV 0
- 0
1 0
carriers 0
, 0
we 0
should 0
be 0
careful 0
in 0
determining 0
whether 0
such 0
pulmonary 0
involvements 0
are 0
etiologically 0
related 0
to 0
HTLV 0
- 0
1 0
infection 0
. 0

We 0
found 0
that 0
48 0
% 0
of 0
the 0
patients 0
had 0
their 0
thoracolumbar 0
blood 0
supply 0
based 0
on 0
two 0
anterior 0
radiculospinal 0
arteries 0
the 0
lowest 0
of 0
which 0
was 0
located 0
at 0
, 0
or 0
lower 0
than 0
, 0
T12 0
, 0
and 0
the 0
second 0
and 0
higher 0
one 0
between 0
T6 0
and 0
T10 0
. 0

Cross 0
- 0
species 0
characterization 0
of 0
the 0
promoter B-gene
region I-gene
of I-gene
the I-gene
cystic I-gene
fibrosis I-gene
transmembrane I-gene
conductance I-gene
regulator I-gene
gene I-gene
reveals 0
multiple 0
levels 0
of 0
regulation 0
. 0

The 0
leader 0
peptide 0
was 0
hypothesized 0
to 0
inhibit 0
ribosome 0
release 0
at 0
the 0
tnaC B-gene
stop I-gene
codon I-gene
, 0
thereby 0
blocking 0
Rho B-gene
's 0
access 0
to 0
the 0
transcript 0
. 0

We 0
have 0
isolated 0
a 0
unique 0
murine B-gene
FLT3 I-gene
cDNA I-gene
that 0
codes 0
for 0
a 0
variant 0
isoform 0
of 0
FLT3 B-gene
, 0
devoid 0
of 0
the 0
fifth 0
Ig B-gene
- I-gene
like I-gene
domain I-gene
, 0
by 0
comparison 0
with 0
the 0
prototypic 0
form 0
. 0

Thus 0
, 0
22 0
% 0
of 0
MDS 0
responded 0
to 0
oral 0
PLAC 0
. 0

Plasma B-gene
beta I-gene
- I-gene
thromboglobulin I-gene
( 0
beta B-gene
- I-gene
TG I-gene
) 0
, 0
a 0
platelet 0
- 0
specific 0
protein 0
, 0
is 0
a 0
marker 0
of 0
intravascular 0
platelet 0
degranulation 0
. 0

The 0
Synechococcus B-gene
gene I-gene
rps1 I-gene
encoding 0
S1 B-gene
is 0
located 0
1.1 0
kb 0
downstream 0
from 0
psbB B-gene
, 0
which 0
encodes 0
the 0
photosystem B-gene
II I-gene
P680 I-gene
chlorophyll I-gene
a I-gene
apoprotein I-gene
. 0

Additions 0
of 0
NH4+ 0
up 0
to 0
200 0
micrograms 0
1 0
( 0
- 0
1 0
) 0
were 0
not 0
stimulatory 0
, 0
whereas 0
at 0
1.0 0
mg 0
1 0
( 0
- 0
1 0
) 0
levels 0
, 0
Ke 0
was 0
50 0
% 0
greater 0
than 0
for 0
NO3 0
- 0
enriched 0
medium 0
. 0

Pretreatment 0
with 0
lipid 0
X 0
was 0
not 0
necessary 0
to 0
improve 0
survival 0
: 0
16 0
of 0
17 0
( 0
94 0
% 0
) 0
infected 0
and 0
visibly 0
ill 0
animals 0
that 0
received 0
lipid 0
X 0
and 0
ticarcillin 0
6 0
h 0
after 0
thigh 0
inoculation 0
survived 0
versus 0
30 0
of 0
44 0
( 0
68 0
% 0
) 0
control 0
animals 0
treated 0
with 0
ticarcillin 0
alone 0
( 0
P 0
less 0
than 0
0.0001 0
) 0
. 0

Between 0
1988 0
and 0
1994 0
, 0
data 0
from 0
3 0
large 0
sites 0
revealed 0
a 0
3 0
- 0
5 0
fold 0
increase 0
in 0
the 0
prevalence 0
of 0
antidepressant 0
( 0
ATD 0
) 0
treatment 0
for 0
U.S. 0
youths 0
aged 0
2 0
- 0
19 0
years 0
. 0

4 0
. 0

RESULTS 0
: 0
Analysis 0
by 0
Pearson 0
's 0
correlation 0
showed 0
that 0
the 0
subjects 0
who 0
had 0
higher 0
scores 0
of 0
SSMS 0
during 0
the 0
drum 0
rotation 0
generated 0
the 0
following 0
: 0
a 0
) 0
a 0
higher 0
rating 0
of 0
over 0
- 0
all 0
sickness 0
( 0
r 0
= 0
0.76 0
) 0
; 0
b 0
) 0
a 0
higher 0
ratio 0
of 0
spectral 0
power 0
of 0
EGG 0
at 0
4 0
- 0
9 0
cycles 0
per 0
minute 0
( 0
cpm 0
) 0
between 0
drum 0
rotation 0
and 0
baseline 0
periods 0
( 0
r 0
= 0
0.63 0
) 0
; 0
c 0
) 0
a 0
higher 0
net 0
percent 0
increase 0
of 0
spectral 0
power 0
in 0
the 0
EEG 0
frequency 0
band 0
0.5 0
- 0
4 0
Hz 0
between 0
drum 0
rotation 0
and 0
baseline 0
periods 0
on 0
C3 0
( 0
r 0
= 0
0.29 0
) 0
and 0
C4 0
( 0
r 0
= 0
0.31 0
) 0
; 0
d 0
) 0
a 0
higher 0
ratio 0
of 0
spectral 0
power 0
of 0
EEG 0
frequency 0
band 0
0.5 0
- 0
4 0
Hz 0
between 0
drum 0
rotation 0
and 0
baseline 0
periods 0
on 0
C3 0
( 0
r 0
= 0
0.31 0
) 0
; 0
and 0
e 0
) 0
a 0
higher 0
level 0
of 0
net 0
increase 0
in 0
skin 0
conductance 0
from 0
baseline 0
to 0
drum 0
rotation 0
( 0
r 0
= 0
0.30 0
) 0
. 0

After 0
inhibition 0
of 0
monoamine B-gene
oxidase I-gene
with 0
pargyline 0
( 0
10 0
mg/kg 0
. 0
i.v 0
. 0
) 0
, 0
the 0
effects 0
of 0
tyramine 0
( 0
1000 0
micrograms 0
) 0
injected 0
into 0
the 0
hepatic 0
artery 0
were 0
potentiated 0
. 0

However 0
, 0
the 0
addition 0
of 0
intravenous 0
injection 0
of 0
FPFD 0
101 0
resulted 0
in 0
a 0
marked 0
improvement 0
in 0
their 0
symptoms 0
. 0

We 0
report 0
that 0
Gcn5 B-gene
, 0
a 0
histone B-gene
H3 I-gene
acetylase I-gene
, 0
plays 0
a 0
central 0
role 0
in 0
initiation 0
of 0
meiosis 0
via 0
effects 0
on 0
IME2 B-gene
expression 0
. 0

In 0
the 0
presence 0
of 0
high 0
concentrations 0
( 0
propofol 0
100 0
microg 0
mL 0
- 0
1 0
, 0
thiopental 0
50 0
microg 0
mL 0
- 0
1 0
) 0
marked 0
relaxation 0
was 0
observed 0
( 0
propofol 0
- 0
32 0
% 0
up 0
to 0
- 0
49 0
% 0
, 0
P 0
< 0
0,05 0
; 0
thiopental 0
- 0
23 0
% 0
up 0
to 0
- 0
67 0
% 0
, 0
P 0
< 0
0.05 0
) 0
. 0

In 0
further 0
support 0
of 0
the 0
biological 0
significance 0
of 0
these 0
DNA 0
- 0
protein 0
interactions 0
, 0
the 0
IL2RA B-gene
oligonucleotide 0
from 0
- 0
291 0
to 0
- 0
245 0
proved 0
to 0
be 0
sufficient 0
in 0
either 0
orientation 0
to 0
confer 0
PMA 0
inducibility 0
to 0
the 0
mitogen 0
- 0
insensitive 0
thymidine B-gene
kinase I-gene
gene I-gene
promoter I-gene
in 0
Jurkat 0
cells 0
. 0

The 0
amino 0
acid 0
residues 0
and 0
subdomains 0
important 0
for 0
DNA 0
binding 0
, 0
hormone 0
binding 0
, 0
dimerization 0
, 0
and 0
transactivation 0
are 0
mostly 0
conserved 0
among 0
all 0
VDR B-gene
species 0
. 0

Here 0
, 0
we 0
describe 0
the 0
nucleotide 0
( 0
nt 0
) 0
sequence 0
and 0
genomic 0
organization 0
of 0
ipiB B-gene
and 0
ipiO B-gene
. 0

Specifically 0
, 0
we 0
demonstrate 0
that 0
this 0
25 0
- 0
base 0
pair 0
region 0
mediates 0
the 0
up 0
- 0
regulatory 0
effect 0
of 0
TGF B-gene
- I-gene
beta I-gene
on 0
COL1A2 B-gene
promoter I-gene
activity 0
and 0
allows 0
antagonistic 0
activity 0
of 0
TNF B-gene
- I-gene
alpha I-gene
on 0
the 0
TGF B-gene
- I-gene
beta I-gene
effect 0
. 0

The 0
phosphatidylglycerol/phosphatidylinositol B-gene
transfer I-gene
protein I-gene
( 0
PG/PI B-gene
- I-gene
TP I-gene
) 0
is 0
a 0
new 0
and 0
original 0
phospholipid B-gene
transfer I-gene
protein I-gene
( 0
PLTP B-gene
) 0
isolated 0
from 0
the 0
Deuteromycete 0
, 0
Aspergillus 0
oryzae 0
. 0

A 0
5789 B-gene
- I-gene
nucleotide I-gene
- I-gene
long I-gene
EcoRI I-gene
fragment I-gene
from 0
the 0
genome 0
of 0
Thermotoga 0
maritima 0
, 0
identified 0
by 0
cross 0
- 0
hybridization 0
to 0
L11 B-gene
, 0
L1 B-gene
, 0
L10 B-gene
, 0
and 0
L12 B-gene
ribosomal I-gene
protein I-gene
gene I-gene
sequences I-gene
from I-gene
Escherichia I-gene
coli I-gene
, 0
was 0
cloned 0
and 0
sequenced 0
. 0

Endotoxemia 0
and 0
bacteremia 0
in 0
patients 0
with 0
sepsis 0
syndrome 0
in 0
the 0
intensive 0
care 0
unit 0
. 0

Several 0
35 0
- 0
mm 0
slides 0
of 0
dystrophin B-gene
- 0
, 0
laminin B-gene
- 0
, 0
and 0
concanavalin B-gene
A I-gene
( 0
ConA B-gene
) 0
- 0
stained 0
muscle 0
sections 0
were 0
used 0
to 0
calculate 0
myofiber 0
cross 0
- 0
sectional 0
areas 0
and 0
to 0
compare 0
different 0
techniques 0
and 0
settings 0
of 0
an 0
image 0
capture 0
system 0
. 0

Indeed 0
, 0
after 0
a 0
single 0
oral 0
dose 0
, 0
the 0
role 0
of 0
the 0
mu B-gene
- I-gene
receptor I-gene
agonist 0
component 0
of 0
the 0
antinociceptive 0
effect 0
of 0
tramadol 0
appears 0
to 0
be 0
minor 0
, 0
with 0
most 0
of 0
the 0
analgesic 0
effect 0
being 0
attributable 0
to 0
nonopioid 0
properties 0
of 0
the 0
parent 0
compound 0
. 0

The 0
mRNA 0
for 0
this 0
protein 0
is 0
expressed 0
in 0
the 0
T 0
- 0
ALL 0
cell 0
line 0
Jurkat 0
and 0
has 0
been 0
designated 0
HUG1 B-gene
, 0
for 0
HOX11 B-gene
Upstream I-gene
Gene I-gene
. 0

In 0
solution 0
, 0
[ 0
( 0
125 0
) 0
I 0
] 0
- 0
labeled 0
ankyrin B-gene
was 0
found 0
by 0
ND 0
- 0
PAGE3 0
to 0
enhance 0
the 0
affinity 0
of 0
spectrin B-gene
self 0
- 0
association 0
by 0
10 0
- 0
fold 0
. 0

The 0
MEF B-gene
- I-gene
2 I-gene
proteins I-gene
are 0
a 0
family 0
of 0
transcriptional 0
activators 0
that 0
have 0
been 0
detected 0
in 0
a 0
wide 0
variety 0
of 0
cell 0
types 0
. 0

Jet 0
lag 0
and 0
melatonin 0
. 0

Manual 0
sample 0
clean 0
- 0
up 0
procedures 0
as 0
well 0
as 0
the 0
addition 0
of 0
an 0
internal 0
standard 0
are 0
not 0
needed 0
. 0

Treatment 0
of 0
diabetes 0
and 0
retinal 0
complications 0

In 0
contrast 0
, 0
an 0
N B-gene
- I-gene
terminal I-gene
RNAP I-gene
mutant I-gene
that 0
has 0
a 0
decreased 0
capacity 0
to 0
bind 0
single 0
- 0
stranded 0
RNA 0
forms 0
halted 0
complexes 0
with 0
much 0
lower 0
levels 0
of 0
stability 0
than 0
the 0
WT 0
enzyme 0
, 0
and 0
these 0
complexes 0
are 0
not 0
stabilized 0
by 0
the 0
presence 0
of 0
the 0
NT 0
strand 0
. 0

The 0
densities 0
ranged 0
between 0
2 0
and 0
3976 0
neurites/mm2 0
skin 0
surface 0
, 0
but 0
the 0
overlap 0
between 0
subjects 0
and 0
without 0
PHN 0
was 0
small 0
. 0

The 0
present 0
study 0
demonstrates 0
that 0
the 0
proto B-gene
- I-gene
oncogene I-gene
c I-gene
- I-gene
jun I-gene
represses 0
transcription 0
of 0
the 0
human B-gene
CG I-gene
alpha I-gene
and 0
CG B-gene
beta I-gene
promoters I-gene
. 0
c B-gene
- I-gene
Jun I-gene
repressed 0
the 0
CG B-gene
alpha I-gene
promoter I-gene
through 0
a 0
canonical 0
cAMP 0
response 0
element 0
( 0
CRE 0
) 0
that 0
is 0
known 0
to 0
bind 0
c B-gene
- I-gene
Jun I-gene
and 0
other 0
members 0
of 0
the 0
B B-gene
- I-gene
Zip I-gene
transcription I-gene
factor I-gene
family I-gene
. 0

The 0
mouse 0
lactoferrin B-gene
gene 0
promoter 0
was 0
active 0
in 0
human 0
endometrium 0
carcinoma 0
RL 0
95 0
- 0
2 0
cells 0
and 0
in 0
rat 0
glioma 0
C6 0
cells 0
. 0

This 0
is 0
the 0
first 0
report 0
that 0
the 0
PH B-gene
domain I-gene
of 0
an 0
IRS B-gene
protein I-gene
can 0
function 0
in 0
a 0
dominant 0
negative 0
manner 0
to 0
inhibit 0
insulin B-gene
signaling 0
. 0

Is 0
exposure 0
to 0
a 0
patient 0
with 0
Crohn 0
's 0
disease 0
an 0
environmental 0
factor 0
for 0
developing 0
the 0
disease 0
. 0

These 0
findings 0
suggest 0
that 0
low 0
- 0
power 0
laser 0
irradiation 0
can 0
be 0
used 0
for 0
promotion 0
of 0
vascularization 0
and 0
take 0
of 0
tissue 0
transplants 0
. 0

In 0
experiment 0
1 0
, 0
subjects 0
were 0
required 0
to 0
discriminate 0
male 0
from 0
female 0
faces 0
and 0
no 0
hemispheric 0
asymmetries 0
were 0
found 0
. 0

1 0
. 0

For 0
the 0
albino 0
, 0
both 0
the 0
ST1 0
and 0
ST2 0
spatial 0
responses 0
peak 0
at 0
around 0
0.3 0
cycles 0
deg 0
- 0
1 0
, 0
and 0
both 0
curves 0
are 0
displaced 0
considerably 0
to 0
the 0
low 0
spatial 0
frequency 0
side 0
of 0
the 0
normal 0
ST2 0
spatial 0
response 0
. 0

The 0
scores 0
for 0
these 0
three 0
factors 0
, 0
which 0
corresponded 0
to 0
recognizable 0
dimensions 0
of 0
depressive 0
illness 0
, 0
were 0
then 0
correlated 0
with 0
rCBF 0
. 0

The 0
etiology 0
was 0
established 0
in 0
73 0
( 0
76.8 0
% 0
) 0
out 0
of 0
95 0
cases 0
. 0

Depending 0
on 0
the 0
patient 0
's 0
body 0
position 0
telemetrically 0
measured 0
CSF 0
- 0
pressures 0
varied 0
between 0
- 0
20 0
cmH2O 0
in 0
erect 0
and 0
15 0
cmH2O 0
in 0
supine 0
position 0
. 0

Patients 0
received 0
either 0
sodium 0
cephalothin 0
or 0
placebo 0
intravenously 0
before 0
the 0
procedure 0
and 0
for 0
up 0
to 0
8 0
additional 0
doses 0
. 0

These 0
findings 0
suggest 0
that 0
NMDA B-gene
receptor I-gene
blockade 0
may 0
ameliorate 0
the 0
dyskinetic 0
complications 0
of 0
long 0
- 0
term 0
levodopa 0
therapy 0
, 0
without 0
diminishing 0
the 0
beneficial 0
effects 0
on 0
parkinsonian 0
signs 0
. 0

Before 0
flecainide 0
, 0
all 0
patients 0
had 0
easily 0
inducible 0
VT 0
that 0
was 0
morphologically 0
identical 0
to 0
their 0
spontaneously 0
occurring 0
arrhythmia 0
. 0

In 0
cells 0
infected 0
with 0
a 0
recombinant 0
vaccinia 0
virus 0
expressing 0
HCV 0
structural 0
proteins 0
( 0
core B-gene
, 0
E1 B-gene
, 0
and 0
E2 B-gene
) 0
, 0
DDX3 B-gene
and 0
core B-gene
colocalized 0
in 0
distinct 0
spots 0
in 0
the 0
perinuclear 0
region 0
of 0
the 0
cytoplasm 0
. 0

However 0
, 0
PC12 0
cell 0
clones 0
which 0
expressed 0
p33rsu B-gene
- I-gene
1 I-gene
at 0
an 0
increased 0
level 0
in 0
a 0
regulatable 0
fashion 0
in 0
response 0
to 0
dexamethasone 0
were 0
isolated 0
. 0

Differential 0
decay 0
of 0
a 0
polycistronic 0
Escherichia 0
coli 0
transcript 0
is 0
initiated 0
by 0
RNaseE B-gene
- 0
dependent 0
endonucleolytic 0
processing 0
. 0

An 0
incorrect 0
response 0
on 0
the 0
previous 0
trial 0
enhanced 0
the 0
accuracy 0
in 0
the 0
current 0
trial 0
only 0
in 0
the 0
left 0
visual 0
field 0
( 0
LVF 0
) 0
. 0

The 0
SEC27 B-gene
gene I-gene
was 0
cloned 0
, 0
and 0
the 0
sequence 0
predicts 0
a 0
99.4 0
- 0
kDa 0
protein 0
with 0
45 0
% 0
sequence 0
identity 0
to 0
mammalian 0
beta' B-gene
- I-gene
COP I-gene
. 0

Column 0
chromatographic 0
determination 0
of 0
polymyxin 0
B 0
sulfate 0
. 0

Subgroup 0
analysis 0
failed 0
to 0
show 0
any 0
benefit 0
for 0
etoposide 0
in 0
patients 0
with 0
monocytic 0
or 0
myelomonocytic 0
disease 0
, 0
or 0
in 0
any 0
other 0
diagnostic 0
subgroup 0
. 0

Monosulfates 0
of 0
16 0
- 0
oxygenated 0
ketonic 0
C19 0
steroids 0
in 0
adult 0
human 0
urine 0
. 0

A 0
case 0
of 0
2 0
cancers 0
of 0
the 0
colon 0

Pretoria 0
Pasteurisation 0
is 0
feasible 0
and 0
reliable 0
under 0
a 0
range 0
of 0
conditions 0
. 0

Computer 0
analysis 0
revealed 0
that 0
the 0
human B-gene
protein I-gene
P1 I-gene
sequence I-gene
corresponding 0
to 0
amino 0
acid 0
residues 0
within 0
the 0
N 0
- 0
terminal 0
RNA 0
binding 0
domain 0
displays 0
high 0
homology 0
( 0
greater 0
than 0
54 0
% 0
identity 0
; 0
61 0
to 0
94 0
% 0
similarity 0
) 0
with 0
two 0
animal 0
virus 0
proteins 0
which 0
possess 0
RNA 0
binding 0
activity 0
( 0
vaccinia B-gene
virus I-gene
E3L I-gene
; 0
rotavirus B-gene
VP2 I-gene
) 0
and 0
two 0
proteins 0
of 0
unknown 0
function 0
( 0
murine B-gene
TIK I-gene
; 0
rotavirus B-gene
NS34 I-gene
) 0
, 0
but 0
which 0
are 0
likely 0
RNA 0
binding 0
proteins 0
. 0

C/EBP B-gene
delta I-gene
( 0
NFIL B-gene
- I-gene
6 I-gene
beta I-gene
) 0
was 0
not 0
detected 0
in 0
complexes 0
utilizing 0
extracts 0
from 0
the 0
IL B-gene
- I-gene
1 I-gene
nonproducing 0
T 0
cell 0
line 0
. 0

Noise 0
in 0
STM 0
due 0
to 0
atoms 0
moving 0
in 0
the 0
tunneling 0
space 0
. 0

However 0
, 0
mutations 0
of 0
the 0
C 0
- 0
rich 0
element 0
that 0
disrupted 0
a 0
GC 0
box 0
located 0
on 0
the 0
inverse 0
strand 0
eliminated 0
PMA 0
responsiveness 0
and 0
, 0
in 0
gel 0
mobility 0
shift 0
assays 0
, 0
eliminated 0
binding 0
of 0
Sp1 B-gene
. 0

This 0
is 0
a 0
consensus 0
casein B-gene
kinase I-gene
II I-gene
( 0
CKII B-gene
) 0
site 0
and 0
, 0
using 0
purified 0
wild 0
- 0
type 0
and 0
mutant 0
proteins 0
, 0
we 0
show 0
that 0
it 0
is 0
the 0
main 0
CKII B-gene
site I-gene
in 0
the 0
body 0
of 0
the 0
N 0
- 0
terminal 0
complex 0
- 0
forming 0
region 0
. 0

Down 0
- 0
regulation 0
of 0
Id1 B-gene
mRNA I-gene
correlated 0
with 0
mitogenesis 0
and 0
occurred 0
when 0
quiescent 0
cells 0
were 0
treated 0
with 0
growth 0
factors 0
that 0
activate 0
G B-gene
protein I-gene
- I-gene
coupled I-gene
receptors I-gene
and 0
receptor B-gene
protein I-gene
tyrosine I-gene
kinases I-gene
but 0
not 0
with 0
a 0
non 0
- 0
mitogenic 0
cAMP 0
analog 0
. 0

To 0
study 0
adaptive 0
processes 0
following 0
spinal 0
cord 0
injury 0
, 0
unstructured 0
audiotaped 0
interviews 0
were 0
conducted 0
on 0
an 0
almost 0
daily 0
basis 0
with 0
a 0
30 0
- 0
year 0
- 0
old 0
divorced 0
male 0
during 0
the 0
first 0
3 0
months 0
of 0
his 0
initial 0
comprehensive 0
inpatient 0
rehabilitation 0
. 0

Cloning 0
and 0
characterization 0
of 0
the 0
5 0
' 0
flanking 0
region 0
of 0
human B-gene
ATP I-gene
- I-gene
citrate I-gene
lyase I-gene
gene I-gene
. 0

The 0
broad 0
range 0
protein B-gene
tyrosine I-gene
kinase I-gene
inhibitor 0
genistein 0
and 0
the 0
phosphatidylinositol B-gene
3 I-gene
- I-gene
kinase I-gene
inhibitors 0
wortmannin 0
and 0
LY 0
294002 0
( 0
2 0
- 0
( 0
4 0
- 0
morpholinyl 0
) 0
- 0
8 0
- 0
phenyl 0
- 0
4H 0
- 0
1 0
- 0
benzopyran 0
- 0
4 0
- 0
one 0
) 0
also 0
blocked 0
adenosine B-gene
A3 I-gene
receptor I-gene
stimulation 0
of 0
p42/p44 B-gene
MAPK 0
. 0

Defective 0
concanavalin B-gene
A I-gene
- 0
induced 0
suppression 0
in 0
bancroftian 0
filariasis 0
. 0

Rising 0
antibody 0
titres 0
to 0
the 0
astrovirus 0
particles 0
were 0
demonstrated 0
in 0
one 0
child 0
, 0
and 0
IgM B-gene
was 0
also 0
demonstrated 0
in 0
this 0
patient 0
's 0
serum 0
. 0

Demonstration 0
of 0
changes 0
in 0
fetal 0
liver 0
erythropoiesis 0
using 0
echo 0
- 0
planar 0
magnetic 0
resonance 0
imaging 0
. 0

Conversely 0
the 0
rate 0
of 0
bioavailability 0
was 0
significantly 0
different 0
, 0
because 0
from 0
the 0
Reference 0
patch 0
the 0
release 0
rate 0
is 0
fast 0
in 0
the 0
first 0
24 0
h 0
, 0
leading 0
to 0
an 0
E2 0
peak 0
at 0
8 0
h 0
and 0
to 0
a 0
Cmax 0
in 0
average 0
at 0
23 0
h 0
. 0

Effects 0
of 0
dexamethasone 0
on 0
the 0
development 0
of 0
radiation 0
nephropathy 0
in 0
the 0
rat 0
. 0

Reaction 0
of 0
aromatic/heterocyclic 0
sulfonamides 0
possessing 0
free 0
amino 0
, 0
imino 0
or 0
hydrazino 0
moieties 0
with 0
7 0
- 0
chloro 0
- 0
4 0
- 0
chloromethylcoumarin 0
afforded 0
a 0
series 0
of 0
N 0
- 0
[ 0
( 0
7 0
- 0
chloro 0
- 0
4 0
- 0
coumarinyl 0
) 0
- 0
methyl 0
] 0
- 0
derivatives 0
which 0
showed 0
effective 0
inhibition 0
of 0
three 0
carbonic B-gene
anhydrase I-gene
( 0
CA B-gene
) 0
isozymes 0
. 0

The 0
present 0
study 0
also 0
emphasizes 0
the 0
need 0
of 0
establishing 0
dose 0
- 0
response 0
curves 0
to 0
correctly 0
assess 0
the 0
relative 0
contribution 0
of 0
the 0
different 0
regions 0
of 0
steroid B-gene
hormone I-gene
receptors I-gene
in 0
activation 0
of 0
transcription 0
. 0

( 0
1986 0
) 0
described 0
optic 0
nerve 0
degenerations 0
in 0
patients 0
with 0
Alzheimer 0
's 0
disease 0
and 0
Sadun 0
published 0
a 0
dropout 0
of 0
retinal 0
ganglion 0
cells 0
that 0
range 0
from 0
30 0
% 0
to 0
60 0
% 0
. 0

In 0
addition 0
, 0
these 0
results 0
suggest 0
that 0
the 0
interactions 0
, 0
and 0
consequently 0
the 0
mechanisms 0
, 0
governing 0
transcriptional 0
activation 0
by 0
CTF B-gene
are 0
distinct 0
from 0
those 0
mediating 0
DNA 0
replication 0
. 0

These 0
proteins 0
, 0
called 0
variant B-gene
surface I-gene
glycoproteins I-gene
( 0
VSGs B-gene
) 0
, 0
are 0
expressed 0
from 0
a 0
specific 0
locus 0
, 0
the 0
VSG B-gene
gene I-gene
expression I-gene
site I-gene
( I-gene
ES I-gene
) I-gene
. 0

The 0
temporal 0
changes 0
in 0
the 0
plasma 0
concentration 0
of 0
immunoreactive B-gene
atrial I-gene
natriuretic I-gene
factor I-gene
( 0
iANF B-gene
) 0
were 0
studied 0
in 0
six 0
conscious 0
dogs 0
with 0
an 0
arteriovenous 0
( 0
AV 0
) 0
fistula 0
, 0
a 0
model 0
of 0
chronic 0
high 0
- 0
output 0
heart 0
failure 0
. 0

In 0
situ 0
hybridization 0
of 0
whole 0
- 0
mount 0
mouse 0
embryos 0
with 0
Mex5 B-gene
antisense I-gene
RNA I-gene
provide 0
no 0
evidence 0
for 0
the 0
exclusion 0
of 0
Mex5 B-gene
during 0
embryonic 0
development 0
. 0

Karyo 0
- 0
and 0
cytometric 0
investigations 0
of 0
cortical 0
layer 0
V 0
pyramidal 0
neurons 0
of 0
albino 0
rat 0
after 0
three 0
various 0
fixations 0

The 0
cloning 0
of 0
human B-gene
apo I-gene
B I-gene
- I-gene
100 I-gene
has 0
provided 0
new 0
insights 0
into 0
the 0
structure 0
and 0
physicochemical 0
properties 0
of 0
apo B-gene
B I-gene
- I-gene
100 I-gene
and 0
will 0
facilitate 0
studies 0
on 0
the 0
factors 0
modulating 0
apo B-gene
B I-gene
- I-gene
100 I-gene
biosynthesis 0
and 0
the 0
expression 0
of 0
the 0
apo B-gene
B I-gene
- I-gene
100 I-gene
gene I-gene
in 0
patients 0
with 0
dyslipoproteinemias 0
. 0

In 0
the 0
green 0
unicellular 0
alga 0
Chlamydomonas 0
eugametos 0
, 0
cellular 0
division 0
is 0
readily 0
synchronized 0
by 0
light/dark 0
cycles 0
. 0

Northern 0
blot 0
analysis 0
linked 0
Plk B-gene
expression 0
to 0
the 0
proliferative 0
activity 0
of 0
cells 0
and 0
tissues 0
. 0

A 0
1.5 0
- 0
month 0
- 0
old 0
boy 0
with 0
Sandifer 0
's 0
syndrome 0
is 0
described 0
. 0

A 0
40 0
- 0
fold 0
stimulation 0
of 0
chloramphenicol B-gene
acetyltransferase I-gene
activity 0
mediated 0
by 0
four 0
tandem 0
repeats 0
of 0
the 0
SNE B-gene
could 0
be 0
induced 0
within 0
2 0
h 0
( 0
and 0
up 0
to 0
250 0
- 0
fold 0
within 0
6 0
h 0
) 0
after 0
addition 0
of 0
TPA 0
in 0
DNA 0
- 0
transfected 0
U 0
- 0
937 0
cells 0
, 0
indicating 0
that 0
the 0
stimulation 0
appeared 0
likely 0
to 0
be 0
a 0
true 0
protein B-gene
kinase I-gene
C I-gene
- 0
mediated 0
signal 0
transduction 0
event 0
rather 0
than 0
a 0
differentiation 0
response 0
. 0

A 0
silica 0
- 0
based 0
, 0
fluoride 0
- 0
free 0
placebo 0
containing 0
NaTPP 0
, 0
and 0
a 0
NaF 0
- 0
containing 0
silica 0
- 0
based 0
USP 0
reference 0
standard 0
toothpaste 0
were 0
used 0
as 0
negative 0
and 0
positive 0
control 0
toothpastes 0
, 0
respectively 0
. 0

Molecular 0
cloning 0
of 0
the 0
alpha B-gene
- I-gene
globin I-gene
transcription I-gene
factor I-gene
CP2 B-gene
. 0

The 0
present 0
study 0
tries 0
to 0
associate 0
some 0
of 0
the 0
causes 0
of 0
hot 0
ischaemia 0
during 0
the 0
agony 0
of 0
the 0
corpse 0
donor 0
and 0
to 0
evaluate 0
those 0
that 0
may 0
be 0
caused 0
by 0
sympathetic 0
efference 0
during 0
removal 0
. 0

The 0
cost 0
and 0
effectiveness 0
of 0
nurse 0
education 0
- 0
- 0
1 0
. 0

Between 0
1988 0
and 0
1995 0
, 0
341 0
children 0
with 0
acute 0
myeloid 0
leukaemia 0
( 0
AML 0
) 0
were 0
treated 0
on 0
the 0
Medical 0
Research 0
Council 0
Acute 0
Myeloid 0
Leukaemia 0
Trial 0
( 0
MRC 0
AML10 0
) 0
. 0

Using 0
the 0
yeast 0
two 0
- 0
hybrid 0
system 0
, 0
we 0
have 0
isolated 0
an 0
835 0
amino 0
acid 0
RING 0
finger 0
( 0
C3HC4 0
zinc 0
finger 0
) 0
protein 0
, 0
TIF1 B-gene
beta I-gene
( 0
also 0
named 0
KAP B-gene
- I-gene
1 I-gene
) 0
, 0
that 0
specifically 0
interacts 0
with 0
the 0
KRAB B-gene
domain I-gene
of 0
the 0
human 0
zinc 0
finger 0
factor 0
KOX1/ZNF10 B-gene
. 0

The 0
N 0
- 0
terminal 0
sequences 0
of 0
isoforms 0
beta 0
to 0
epsilon 0
contain 0
a 0
PEST 0
region 0
which 0
could 0
induce 0
rapid 0
intracellular 0
degradation 0
of 0
isoforms 0
beta 0
and 0
delta 0
. 0

Their 0
central 0
projections 0
were 0
indistinguishable 0
from 0
those 0
of 0
control 0
axons 0
in 0
all 0
four 0
trigeminal 0
subnuclei 0
. 0

Typicality 0
is 0
probably 0
a 0
better 0
representation 0
of 0
Alexander 0
, 0
Dunbar 0
and 0
others 0
' 0
conclusions 0
than 0
specificity 0
, 0
which 0
was 0
always 0
too 0
absolute 0
a 0
term 0
. 0

We 0
then 0
developed 0
a 0
yeast 0
artificial 0
chromosome 0
( 0
YAC 0
) 0
contig 0
for 0
this 0
region 0
. 0

In 0
addition 0
to 0
TAK1 B-gene
, 0
TGF B-gene
- I-gene
beta I-gene
also 0
stimulated 0
JNK B-gene
activity 0
. 0

The 0
study 0
was 0
carried 0
out 0
according 0
to 0
the 0
BSI 0
( 0
1980 0
) 0
recommendations 0
for 0
testing 0
restorative 0
materials 0
in 0
vivo 0
. 0

A 0
case 0
report 0
. 0

Sixteen 0
patients 0
on 0
maintenance 0
hemodialysis 0
underwent 0
dialysis 0
with 0
either 0
cuprophane 0
( 0
n 0
= 0
8 0
) 0
or 0
polymethylmethacrylate 0
( 0
PMMA 0
; 0
n 0
= 0
8 0
) 0
membranes 0
for 0
1 0
week 0
and 0
then 0
switched 0
to 0
the 0
opposite 0
membrane 0
during 0
the 0
second 0
week 0
. 0

No 0
significant 0
difference 0
in 0
plasma 0
ET B-gene
levels 0
was 0
found 0
between 0
cardiac 0
and 0
peripheral 0
sampling 0
sites 0
( 0
pulmonary 0
artery 0
; 0
1.07 0
+/ 0
- 0
0.28 0
, 0
right 0
atrium 0
; 0
1.02 0
+/ 0
- 0
0.28 0
, 0
peripheral 0
artery 0
; 0
1.12 0
+/ 0
- 0
0.23 0
, 0
peripheral 0
vein 0
; 0
1.14 0
+/ 0
- 0
0.38 0
fmol/ml 0
: 0
N.S 0
. 0
) 0
, 0
or 0
among 0
patients 0
with 0
uncomplicated 0
MI 0
, 0
unstable 0
angina 0
( 0
1.00 0
+/ 0
- 0
0.32 0
fmol/ml 0
) 0
, 0
and 0
healthy 0
subjects 0
( 0
1.01 0
+/ 0
- 0
0.29 0
fmol/ml 0
) 0
. 0

Oxalates 0
and 0
the 0
digestive 0
tract 0

Analysis 0
of 0
the 0
MCV B-gene
- I-gene
1 I-gene
RPO1 I-gene
revealed 0
high 0
amino 0
acid 0
homologies 0
to 0
the 0
corresponding 0
polypeptides 0
of 0
vaccinia 0
and 0
variola 0
virus 0
. 0

This 0
interaction 0
is 0
functional 0
as 0
it 0
leads 0
to 0
retargeting 0
of 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
p50 B-gene
from 0
the 0
nucleus 0
to 0
the 0
cytoplasm 0
. 0

Point 0
mutations 0
of 0
Stat3 B-gene
within 0
the 0
interacting 0
domains 0
blocked 0
both 0
physical 0
interaction 0
of 0
Stat3 B-gene
with 0
c B-gene
- I-gene
Jun I-gene
and 0
their 0
cooperation 0
in 0
IL B-gene
- I-gene
6 I-gene
- 0
induced 0
transcription 0
directed 0
by 0
the 0
alpha B-gene
( I-gene
2 I-gene
) I-gene
- I-gene
macroglobulin I-gene
enhancer I-gene
. 0

Identification 0
of 0
masked 0
toxins 0
in 0
the 0
exotoxin 0
complex 0
of 0
Staphylococcus 0
pyogenes 0
und 0
Cl 0
. 0
perfringens 0
; 0
significance 0
of 0
their 0
existence 0
for 0
clarifying 0
of 0
the 0
masking 0
mechanism 0

Correlation 0
coefficients 0
between 0
SF 0
thickness 0
and 0
NIR 0
optical 0
density 0
readings 0
at 0
940 0
nm 0
( 0
OD1 0
) 0
and 0
950 0
nm 0
( 0
OD2 0
) 0
wavelengths 0
ranged 0
from 0
r 0
= 0
- 0
0.30 0
( 0
subscapula 0
) 0
to 0
r 0
= 0
- 0
0.67 0
( 0
biceps 0
) 0
for 0
OD1 0
and 0
r 0
= 0
- 0
0.39 0
( 0
axilla 0
) 0
to 0
r 0
= 0
- 0
0.68 0
( 0
biceps 0
) 0
for 0
OD2 0
. 0

Transfer 0
of 0
health 0
care 0
to 0
natives 0
holds 0
much 0
promise 0
, 0
lecturers 0
say 0
. 0

In 0
the 0
second 0
group 0
, 0
which 0
consisted 0
of 0
babies 0
of 0
33 0
to 0
36 0
weeks 0
of 0
gestational 0
age 0
, 0
haptoglobin B-gene
was 0
detected 0
in 0
6 0
infants 0
, 0
with 0
levels 0
less 0
than 0
25 0
mg/dl 0
in 0
3 0
. 0

The 0
clinical 0
picture 0
, 0
the 0
light 0
and 0
electron 0
microscopic 0
appearance 0
, 0
and 0
the 0
histochemical 0
findings 0
are 0
described 0
in 0
six 0
cases 0
of 0
fibroma 0
of 0
tendon 0
sheath 0
. 0

We 0
hypothesize 0
that 0
the 0
ability 0
of 0
these 0
acidic 0
activators 0
to 0
specifically 0
interact 0
with 0
multiple 0
components 0
of 0
the 0
transcription 0
initiation 0
complex 0
likely 0
underlies 0
the 0
dramatic 0
functional 0
synergy 0
exhibited 0
by 0
this 0
class 0
of 0
activation 0
domains 0
in 0
vivo 0
. 0

High 0
and 0
pathological 0
PAI B-gene
- I-gene
1 I-gene
levels 0
before 0
and 0
after 0
the 0
VO 0
test 0
were 0
consistent 0
with 0
a 0
defective 0
fibrinolytic 0
potential 0
due 0
to 0
the 0
inhibitory 0
effect 0
of 0
PAI B-gene
- I-gene
1 I-gene
on 0
plasminogen B-gene
activation 0
. 0

S. 0
aureus 0
leakage 0
into 0
the 0
totally 0
submerged 0
test 0
specimens 0
was 0
detected 0
in 0
1 0
of 0
5 0
samples 0
incubated 0
for 0
4 0
weeks 0
, 0
while 0
no 0
leakage 0
was 0
detected 0
in 0
specimens 0
incubated 0
for 0
3 0
, 0
5 0
, 0
6 0
, 0
7 0
, 0
and 0
8 0
weeks 0
. 0

MAPKK B-gene
kinase/MEKK I-gene
phosphorylates 0
and 0
activates 0
its 0
downstream 0
protein 0
kinase 0
, 0
kinase/MEKK I-gene

The 0
Prompt 0
and 0
Praise 0
condition 0
was 0
superior 0
to 0
the 0
other 0
two 0
conditions 0
in 0
encouraging 0
participation 0
in 0
low 0
- 0
interest 0
recreational 0
activities 0
. 0

The 0
author 0
describes 0
the 0
technique 0
in 0
detail 0
and 0
presents 0
the 0
findings 0
for 0
25 0
patients 0
( 0
10 0
men 0
and 0
15 0
women 0
) 0
examined 0
for 0
suspected 0
ileostomy 0
dysfunction 0
, 0
recurrent 0
Crohn 0
's 0
disease 0
or 0
ileal 0
obstruction 0
remote 0
from 0
the 0
stoma 0
. 0

Biochemical 0
studies 0
have 0
identified 0
a 0
cellular 0
non B-gene
- I-gene
P I-gene
element I-gene
- I-gene
encoded I-gene
DNA I-gene
binding I-gene
protein I-gene
, 0
termed 0
the 0
inverted B-gene
repeat I-gene
binding I-gene
protein I-gene
( 0
IRBP B-gene
) 0
, 0
that 0
specifically 0
interacts 0
with 0
the 0
outer 0
half 0
of 0
the 0
31 0
- 0
bp 0
terminal 0
inverted 0
repeats 0
. 0

These 0
findings 0
suggest 0
that 0
eIF5 B-gene
- 0
eIF2beta B-gene
interaction 0
plays 0
an 0
essential 0
role 0
in 0
eIF5 B-gene
function 0
in 0
eukaryotic 0
cells 0
. 0

The 0
delayed 0
activation 0
of 0
the 0
prostaglandin B-gene
G/H I-gene
synthase I-gene
- I-gene
2 I-gene
promoter 0
in 0
bovine 0
granulosa 0
cells 0
is 0
associated 0
with 0
down 0
- 0
regulation 0
of 0
truncated 0
upstream B-gene
stimulatory I-gene
factor I-gene
- I-gene
2 I-gene
. 0

Nb2 0
- 0
11C 0
cells 0
expressed 0
three 0
PNR B-gene
- I-gene
related I-gene
mRNA I-gene
transcripts I-gene
of 0
2.5 0
, 0
3.0 0
and 0
> 0
10 0
kb 0
. 0

E1A B-gene
+ 0
cHa B-gene
- I-gene
ras I-gene
transformed 0
rat 0
embryo 0
fibroblast 0
cells 0
are 0
characterized 0
by 0
high 0
and 0
constitutive 0
DNA 0
binding 0
activities 0
of 0
AP B-gene
- I-gene
1 I-gene
dimers I-gene
with 0
significantly 0
altered 0
composition 0
. 0

In 0
the 0
present 0
study 0
we 0
have 0
used 0
Southern 0
blot 0
analysis 0
to 0
demonstrate 0
that 0
TSG6 B-gene
is 0
a 0
single 0
- 0
copy 0
gene 0
in 0
the 0
human 0
and 0
murine 0
species 0
. 0

CONCLUSIONS 0
: 0
Latanoprost 0
administered 0
once 0
daily 0
was 0
significantly 0
more 0
effective 0
in 0
reducing 0
IOP 0
compared 0
with 0
unoprostone 0
administered 0
twice 0
daily 0
in 0
patients 0
with 0
POAG 0
and 0
OH 0
. 0

Activation 0
of 0
HIV 0
gene 0
expression 0
by 0
UV 0
must 0
therefore 0
involve 0
additional 0
cellular 0
processes 0
, 0
such 0
as 0
those 0
triggered 0
by 0
DNA 0
damage 0
, 0
for 0
generation 0
of 0
a 0
full 0
gene 0
expression 0
response 0
. 0

One 0
promoter 0
, 0
p53P1 B-gene
, 0
is 0
located 0
100 0
- 0
250 0
bp 0
upstream 0
of 0
the 0
218 0
- 0
bp 0
noncoding 0
first 0
exon 0
; 0
a 0
second 0
, 0
stronger 0
promoter 0
, 0
p53P2 B-gene
, 0
maps 0
within 0
the 0
first 0
intron 0
. 0

Hydropathy 0
analysis 0
of 0
deduced 0
A4 0
amino 0
acid 0
sequence 0
revealed 0
four 0
putative 0
membrane 0
- 0
spanning 0
alpha 0
- 0
helices 0
. 0

This 0
study 0
includes 0
200 0
patients 0
treated 0
from 0
1964 0
to 0
1978 0
, 0
with 0
an 0
age 0
range 0
from 0
15 0
to 0
102 0
years 0
, 0
who 0
required 0
329 0
generators 0
. 0

There 0
is 0
little 0
similarity 0
among 0
the 0
sequences 0
upstream 0
from 0
the 0
CAP 0
site 0
of 0
the 0
Spec2 B-gene
genes I-gene
except 0
the 0
TATA 0
consensus 0
sequence 0
and 0
a 0
repeating 0
trinucleotide 0
, 0
AAC 0
. 0

Radiological 0
imaging 0
such 0
as 0
UGI 0
series 0
and 0
CT 0
scan 0
was 0
useful 0
to 0
arrive 0
at 0
an 0
accurate 0
diagnosis 0
. 0

A 0
case 0
of 0
acquired 0
immune 0
deficiency 0
syndrome 0
before 0
1980 0
. 0

In 0
the 0
promoters 0
of 0
many 0
immediate B-gene
early I-gene
genes I-gene
, 0
including 0
c B-gene
- I-gene
fos I-gene
, 0
CArG 0
DNA 0
regulatory 0
elements 0
mediate 0
basal 0
constituitive 0
expression 0
and 0
rapid 0
and 0
transient 0
serum 0
induction 0
. 0

We 0
propose 0
that 0
optimal 0
transcription 0
of 0
the 0
gD B-gene
gene I-gene
depends 0
on 0
the 0
interaction 0
of 0
ICP4 B-gene
with 0
multiple 0
binding 0
sites 0
across 0
the 0
gene 0
and 0
cellular 0
factors 0
that 0
recognize 0
specific 0
sequence 0
elements 0
in 0
the 0
promoter 0
. 0

Strains 0
lacking 0
a 0
functional B-gene
RPL16A I-gene
gene I-gene
grow 0
as 0
rapidly 0
as 0
wild 0
type 0
, 0
whereas 0
those 0
containing 0
a 0
null 0
allele 0
of 0
RPL16B B-gene
grow 0
more 0
slowly 0
than 0
wild 0
type 0
. 0

Maduromycosis 0
in 0
Italy 0

Cetn1 B-gene
possesses 0
the 0
sequence 0
features 0
of 0
an 0
expressed 0
retroposon 0
: 0
the 0
gene 0
lacks 0
introns 0
, 0
the 0
open 0
reading 0
frame 0
is 0
not 0
interrupted 0
by 0
stop 0
codons 0
, 0
and 0
the 0
coding 0
region 0
is 0
flanked 0
by 0
a 0
pair 0
of 0
direct 0
repeats 0
. 0

Substitutions 0
of 0
Asp11 0
led 0
to 0
dominant 0
lethality 0
. 0

The 0
Sty1 B-gene
kinase I-gene
is 0
stimulated 0
by 0
a 0
variety 0
of 0
different 0
stress 0
conditions 0
including 0
osmotic 0
and 0
oxidative 0
stress 0
and 0
heat 0
shock 0
. 0

Acute 0
toxicity 0
tests 0
were 0
conducted 0
to 0
measure 0
the 0
response 0
of 0
first 0
instar 0
Toxorhynchites 0
splendens 0
to 0
commonly 0
used 0
mosquito 0
adulticides 0
: 0
malathion 0
, 0
naled 0
and 0
resmethrin 0
. 0

We 0
prospectively 0
studied 0
serum B-gene
prolactin I-gene
( 0
PRL B-gene
) 0
elevation 0
after 0
different 0
types 0
of 0
documented 0
seizures 0
in 0
17 0
patients 0
. 0

To 0
further 0
identify 0
the 0
residues 0
responsible 0
for 0
the 0
activity 0
, 0
we 0
isolated 0
the 0
mutant 0
viruses 0
that 0
were 0
not 0
neutralized 0
with 0
the 0
soluble 0
form 0
of 0
MHV B-gene
receptor I-gene
proteins I-gene
, 0
since 0
such 0
mutants 0
were 0
expected 0
to 0
have 0
mutations 0
in 0
amino 0
acids 0
responsible 0
for 0
receptor 0
- 0
binding 0
activity 0
. 0

When 0
lipid 0
X 0
was 0
combined 0
with 0
ticarcillin 0
, 0
survival 0
differences 0
were 0
both 0
significant 0
and 0
prolonged 0
. 0

Furthermore 0
, 0
the 0
secondary 0
stress 0
responses 0
were 0
more 0
pronounced 0
and 0
the 0
ability 0
to 0
recover 0
from 0
them 0
seemed 0
to 0
be 0
impaired 0
in 0
exposed 0
fish 0
as 0
compared 0
to 0
unexposed 0
fish 0
. 0

Focal 0
glomerulosclerosis 0
- 0
like 0
disease 0
with 0
nephrotic 0
syndrome 0
in 0
a 0
horse 0
. 0

In 0
addition 0
, 0
both 0
activated 0
Ral B-gene
- I-gene
GDS I-gene
- I-gene
like I-gene
factor 0
and 0
GDS I-gene

Treatment 0
with 0
polyinosinic 0
- 0
polycytidylic 0
acid 0
to 0
induce 0
expression 0
of 0
Cre B-gene
resulted 0
in 0
complete 0
disruption 0
of 0
the 0
Arnt B-gene
gene I-gene
and 0
loss 0
of 0
ARNT B-gene
messenger I-gene
RNA I-gene
( 0
mRNA 0
) 0
expression 0
in 0
liver 0
. 0

Twelve 0
patients 0
of 0
leprosy 0
with 0
arthritis 0
and 0
161 0
patients 0
without 0
arthritis 0
were 0
studied 0
for 0
immunological 0
parameters 0
like 0
immunoglobulins B-gene
( 0
IgG B-gene
, 0
IgM B-gene
, 0
IgA B-gene
) 0
, 0
C B-gene
- I-gene
reactive I-gene
proteins I-gene
and 0
rheumatoid B-gene
factor I-gene
. 0

The 0
biological 0
functions 0
of 0
rat 0
surfactant B-gene
protein I-gene
A I-gene
( 0
SP B-gene
- I-gene
A I-gene
) 0
, 0
an 0
oligomer 0
composed 0
of 0
18 0
polypeptide 0
subunits 0
derived 0
from 0
a 0
single 0
gene 0
, 0
are 0
dependent 0
on 0
intact 0
disulfide 0
bonds 0
. 0

DIC 0
and 0
low 0
grade 0
fibrinolysis 0
may 0
account 0
for 0
the 0
coagulation 0
abnormalities 0
of 0
the 0
syndrome 0
. 0

All 0
depressive 0
groups 0
showed 0
improved 0
error 0
measures 0
post 0
- 0
treatment 0
. 0

Plasmid 0
subclones 0
of 0
the 0
hr1a B-gene
- 0
containing 0
AcMNPV 0
HindIII B-gene
- 0
N 0
fragment 0
were 0
examined 0
for 0
their 0
ability 0
to 0
replicate 0
in 0
virus 0
- 0
infected 0
( 0
Spodoptera 0
frugiperda 0
) 0
Sf9 0
cells 0
, 0
and 0
to 0
stimulate 0
transcription 0
when 0
linked 0
in 0
cis 0
with 0
a 0
39K B-gene
gene I-gene
promoter I-gene
- I-gene
beta I-gene
- I-gene
glucuronidase I-gene
fusion I-gene
and 0
cotransfected 0
into 0
cells 0
along 0
with 0
a 0
plasmid 0
( 0
ple 0
- 0
1 0
) 0
containing 0
the 0
gene 0
encoding 0
the 0
trans 0
- 0
acting 0
factor 0
IE B-gene
- I-gene
1 I-gene
. 0

This 0
new 0
receptor 0
, 0
TOR B-gene
( 0
thymus B-gene
orphan I-gene
receptor I-gene
) 0
, 0
is 0
most 0
closely 0
related 0
in 0
both 0
its 0
DNA 0
- 0
binding 0
domain 0
and 0
ligand 0
- 0
binding 0
domain 0
, 0
90 0
% 0
and 0
53 0
% 0
, 0
respectively 0
, 0
to 0
ROR B-gene
alpha/RZR I-gene
alpha/RZR I-gene
alpha I-gene
and 0
clusters 0
with 0
these 0
two 0
receptors 0
and 0
RZR B-gene
beta I-gene
in 0
a 0
phylogenetic 0
tree 0
, 0
when 0
both 0
the 0
DNA 0
- 0
binding 0
domain 0
and 0
the 0
ligand 0
- 0
binding 0
domain 0
sequences 0
of 0
nuclear 0
receptors 0
are 0
compared 0
. 0

Immunofluorescence 0
tests 0
for 0
Borrelia B-gene
burgdorferi I-gene
serum I-gene
antibodies I-gene
had 0
positive 0
results 0
, 0
but 0
G 0
- 0
penicillin 0
treatment 0
was 0
ineffective 0
. 0

Laser 0
soldering 0
with 0
exogenous 0
fibrinogen B-gene
is 0
feasible 0
without 0
topical 0
administration 0
of 0
additional 0
clotting 0
agents 0
, 0
significantly 0
improves 0
the 0
bursting 0
strength 0
of 0
primary 0
laser 0
welded 0
anastomoses 0
, 0
and 0
appears 0
to 0
result 0
from 0
urokinase B-gene
- 0
resistant 0
fibrinogen B-gene
cross 0
- 0
linking 0
. 0

Raman 0
scattering 0
from 0
VO2 0
single 0
crystals 0
: 0
A 0
study 0
of 0
the 0
effects 0
of 0
surface 0
oxidation 0
. 0

Left 0
ventricular 0
insufficiency 0
requires 0
two 0
SP/patient 0
, 0
with 0
good 0
results 0
in 0
approximately 0
81 0
p. 0
cent 0
. 0

Overexpression 0
of 0
wild 0
type 0
and 0
SeCys/Cys 0
mutant 0
of 0
human B-gene
thioredoxin I-gene
reductase I-gene
in 0
E. 0
coli 0
: 0
the 0
role 0
of 0
selenocysteine 0
in 0
the 0
catalytic 0
activity 0
. 0

50 0
- 0
fold 0
increase 0
in 0
foreign 0
protein 0
production 0
. 0

A 0
rare 0
tRNA B-gene
- I-gene
Arg I-gene
( I-gene
CCU I-gene
) I-gene
that 0
regulates 0
Ty1 B-gene
element I-gene
ribosomal 0
frameshifting 0
is 0
essential 0
for 0
Ty1 B-gene
retrotransposition 0
in 0
Saccharomyces 0
cerevisiae 0
. 0

In 0
addition 0
, 0
putative 0
binding 0
sites 0
for 0
SH3 B-gene
and 0
SH2 B-gene
domains I-gene
are 0
present 0
in 0
the 0
amino 0
- 0
terminal 0
half 0
of 0
the 0
molecule 0
. 0

The 0
technique 0
used 0
by 0
this 0
system 0
involves 0
a 0
transient 0
, 0
externally 0
applied 0
increase 0
in 0
resistance 0
to 0
breathing 0
. 0

Copyright 0
1999 0
Academic 0
Press 0
. 0

Vorozole 0
( 0
Rivizor 0
) 0
is 0
a 0
potent 0
and 0
stereospecific 0
inhibitor 0
of 0
aromatase B-gene
having 0
shown 0
promising 0
endocrine 0
effects 0
in 0
phase 0
I 0
studies 0
. 0

Mapping 0
the 0
5 0
' 0
and 0
3 0
' 0
termini 0
of 0
TED B-gene
RNAs I-gene
indicated 0
that 0
the 0
LTRs 0
have 0
a 0
retroviral 0
U3 0
- 0
R 0
- 0
U5 0
structural 0
organization 0
that 0
is 0
capable 0
of 0
directing 0
the 0
synthesis 0
of 0
transcripts 0
that 0
represent 0
potential 0
substrates 0
for 0
reverse 0
transcription 0
and 0
intermediates 0
in 0
transposition 0
. 0

A 0
Meis1 B-gene
cDNA I-gene
clone 0
that 0
encoded 0
a 0
novel 0
member 0
of 0
the 0
homeobox B-gene
gene I-gene
family I-gene
was 0
identified 0
. 0

Cellular 0
lysates 0
were 0
analyzed 0
for 0
luciferase B-gene
and 0
beta B-gene
- I-gene
galactosidase I-gene
activities 0
. 0

The 0
protein 0
contains 0
a 0
SHAQKYF 0
amino 0
acid 0
signature 0
motif 0
in 0
the 0
second 0
myb B-gene
- I-gene
like I-gene
repeat I-gene
, 0
which 0
is 0
highly 0
conserved 0
in 0
a 0
number 0
of 0
recently 0
identified 0
plant B-gene
myb I-gene
- I-gene
related I-gene
genes I-gene
, 0
thus 0
defining 0
a 0
new 0
class 0
of 0
plant 0
DNA 0
- 0
binding 0
proteins 0
. 0

However 0
, 0
sphincter 0
length 0
decreased 0
with 0
age 0
from 0
24.3 0
to 0
14.8 0
mm. 0
, 0
maximal 0
urethral 0
pressure 0
from 0
88.7 0
to 0
55 0
cm 0
. 0
water 0
and 0
maximal 0
urethral 0
pressure 0
during 0
voluntary 0
contraction 0
from 0
221.4 0
to 0
166.3 0
cm 0
. 0
water 0
. 0

The 0
DF3/MUC1 B-gene
gene 0
encodes 0
a 0
DF3/MUC1 I-gene

A 0
cephalothoracophagus 0
disymmetros 0
buffalo 0
calf 0
. 0

In 0
32 0
of 0
them 0
the 0
results 0
of 0
an 0
exercise 0
performance 0
test 0
based 0
on 0
heart 0
rate 0
response 0
to 0
submaximal 0
exercise 0
( 0
VO2 0
, 0
170 0
[ 0
bpm 0
] 0
) 0
was 0
compared 0
with 0
another 0
index 0
of 0
physical 0
performance 0
capacity 0
, 0
which 0
is 0
independent 0
from 0
heart 0
rate 0
: 0
the 0
ventilatory 0
threshold 0
. 0

Treatment 0
with 0
KP 0
- 0
45 0
preparation 0
usually 0
resulted 0
in 0
partial 0
regression 0
of 0
tumor 0
growth 0
, 0
accompanied 0
by 0
improvement 0
of 0
the 0
clinical 0
state 0
of 0
these 0
patients 0
, 0
as 0
well 0
as 0
reappearance 0
of 0
normal 0
values 0
of 0
blood 0
picture 0
and 0
biochemical 0
parameters 0
. 0

Electromobility 0
shift 0
analysis 0
using 0
oligonucleotides 0
encompassing 0
the 0
proximal 0
, 0
distal 0
, 0
and 0
BED/AP B-gene
- I-gene
1 I-gene
- 0
binding 0
regions 0
failed 0
to 0
demonstrate 0
selective 0
transactivation 0
after 0
CD2 B-gene
signaling 0
of 0
LPMC 0
. 0

Four 0
families 0
of 0
homing B-gene
endonucleases I-gene
have 0
been 0
identified 0
, 0
including 0
the 0
LAGLIDADG B-gene
, 0
the 0
His B-gene
- I-gene
Cys I-gene
box I-gene
, 0
the 0
GIY B-gene
- I-gene
YIG I-gene
and 0
the 0
H B-gene
- I-gene
N I-gene
- I-gene
H I-gene
endonucleases I-gene
. 0

The 0
use 0
of 0
aluminum 0
hydroxide 0
was 0
associated 0
with 0
an 0
increase 0
in 0
fecal 0
fluoride 0
excretion 0
and 0
a 0
decrease 0
in 0
net 0
absorption 0
of 0
fluoride 0
regardless 0
of 0
the 0
intake 0
fluoride 0
, 0
calcium 0
, 0
phosphorus 0
, 0
or 0
magnesium 0
. 0

Administration 0
of 0
SnCl2 0
and 0
ZnSO4 0
( 0
group 0
V 0
) 0
resulted 0
in 0
a 0
decrease 0
of 0
ALA B-gene
- I-gene
D I-gene
activity 0
and 0
in 0
an 0
increase 0
in 0
CP 0
- 0
U 0
. 0

Coexistence 0
of 0
Turner 0
's 0
syndrome 0
and 0
schizophrenia 0

A 0
selectable 0
marker 0
for 0
transformation 0
was 0
constructed 0
by 0
transcriptional 0
fusion 0
of 0
a 0
Ustilago B-gene
maydis I-gene
heat I-gene
shock I-gene
gene I-gene
promoter I-gene
with 0
the 0
hygromycin B-gene
B I-gene
phosphotransferase I-gene
gene I-gene
of I-gene
Escherichia I-gene
coli I-gene
. 0

Moreover 0
, 0
FACT B-gene
specifically 0
interacts 0
with 0
nucleosomes 0
and 0
histone 0
H2A/H2B B-gene
dimers 0
, 0
indicating 0
that 0
it 0
may 0
work 0
by 0
promoting 0
nucleosome 0
disassembly 0
upon 0
transcription 0
. 0

All 0
exon/intron 0
splice 0
junctions 0
follow 0
the 0
GT/AG 0
rule 0
. 0

Acetoacetate B-gene
decarboxylase I-gene
( 0
ADC B-gene
) 0
( 0
EC4.1.1.4 B-gene
) 0
of 0
Clostridium 0
acetobutylicum 0
DSM 0
792 0
was 0
purified 0
to 0
homogeneity 0
, 0
and 0
its 0
first 0
25 0
N 0
- 0
terminal 0
amino 0
acids 0
were 0
determined 0
. 0

These 0
studies 0
suggest 0
that 0
tandem 0
alpha 0
- 0
helices 0
located 0
near 0
the 0
C 0
- 0
terminus 0
of 0
PC B-gene
- I-gene
TP I-gene
facilitate 0
membrane 0
binding 0
and 0
extraction 0
of 0
phosphatidylcholines 0
. 0

In 0
this 0
study 0
, 0
we 0
investigated 0
the 0
mechanism 0
by 0
which 0
Tax B-gene
activates 0
gene 0
expression 0
in 0
conjunction 0
with 0
members 0
of 0
the 0
ATF/CREB B-gene
family 0
. 0

Repression 0
of 0
the 0
herpes B-gene
simplex I-gene
virus I-gene
1 I-gene
alpha I-gene
4 I-gene
gene I-gene
by 0
its 0
gene 0
product 0
( 0
ICP4 B-gene
) 0
within 0
the 0
context 0
of 0
the 0
viral 0
genome 0
is 0
conditioned 0
by 0
the 0
distance 0
and 0
stereoaxial 0
alignment 0
of 0
the 0
ICP4 B-gene
DNA I-gene
binding I-gene
site I-gene
relative 0
to 0
the 0
TATA 0
box 0
. 0

We 0
studied 0
18 0
dogs 0
, 0
anaesthetised 0
and 0
spontaneously 0
breathing 0
both 0
room 0
air 0
and 0
after 0
the 0
inhalation 0
of 0
a 0
gas 0
mixture 0
containing 0
10 0
% 0
CO2 0
, 0
20.9 0
% 0
O2 0
, 0
and 0
69.1 0
% 0
N2 0
, 0
to 0
determine 0
the 0
role 0
of 0
histamine 0
, 0
serotonin 0
, 0
and 0
acidaemia 0
in 0
pulmonary 0
hypertension 0
produced 0
by 0
hypercapnia 0
. 0

Disaster 0
medicine 0

In 0
both 0
liver 0
and 0
pancreatic 0
islet 0
, 0
glucokinase B-gene
is 0
subject 0
to 0
inhibition 0
by 0
a 0
regulatory 0
protein 0
( 0
GCKR B-gene
) 0
. 0

At 0
promoters 0
that 0
initiate 0
with 0
+1 0
GGG 0
, 0
T7 B-gene
RNAP I-gene
synthesizes 0
a 0
ladder 0
of 0
poly 0
( 0
G 0
) 0
products 0
as 0
a 0
result 0
of 0
slippage 0
of 0
the 0
transcript 0
on 0
the 0
three 0
C 0
residues 0
in 0
the 0
template 0
strand 0
from 0
+1 0
to 0
+3 0
. 0

Transcription 0
analysis 0
of 0
the 0
EcoRI B-gene
D I-gene
region I-gene
of 0
the 0
baculovirus 0
Autographa 0
californica 0
nuclear 0
polyhedrosis 0
virus 0
identifies 0
an 0
early 0
4 0
- 0
kilobase 0
RNA 0
encoding 0
the 0
essential 0
p143 B-gene
gene I-gene
. 0

Vectorcardiography 0
in 0
coronary 0
patients 0
with 0
the 0
electrocardiographic 0
RS 0
segment 0
in 0
the 0
V1 0
lead 0

In 0
this 0
second 0
clinical 0
paper 0
, 0
the 0
genetic 0
features 0
of 0
the 0
case 0
of 0
microphthalmia 0
in 0
sheep 0
reported 0
by 0
Wagenaar 0
is 0
discussed 0
in 0
greater 0
detail 0
. 0

Both 0
the 0
arterial 0
and 0
venous 0
thrombi 0
were 0
clearly 0
discernible 0
at 0
2 0
to 0
8 0
h 0
after 0
injection 0
of 0
99Tcm 0
- 0
SZ 0
- 0
51 0
. 0

First 0
aid 0
. 0

However 0
, 0
the 0
blend 0
of 0
Metanil 0
yellow 0
and 0
Orange 0
II 0
( 0
1:1 0
) 0
resulted 0
in 0
the 0
D1 0
50.value 0
of 0
288 0
min 0
. 0

A 0
novel 0
protein B-gene
kinase I-gene
C I-gene
( 0
PKC B-gene
) 0
- 0
interacting 0
protein 0
was 0
identified 0
by 0
the 0
yeast 0
two 0
- 0
hybrid 0
screening 0
using 0
the 0
regulatory 0
domain 0
of 0
PKC B-gene
beta I-gene
I I-gene
as 0
a 0
bait 0
. 0

In 0
this 0
study 0
, 0
we 0
show 0
that 0
the 0
activating 0
effect 0
of 0
this 0
mutation 0
is 0
not 0
the 0
result 0
of 0
creating 0
an 0
exonic 0
splicing 0
enhancer 0
( 0
ESE 0
) 0
or 0
disrupting 0
a 0
putative 0
secondary 0
structure 0
. 0

The 0
architecture 0
of 0
the 0
hRap1 B-gene
Myb B-gene
domain I-gene
is 0
very 0
close 0
to 0
that 0
of 0
each 0
of 0
the 0
Myb B-gene
domains I-gene
from 0
TRF1 B-gene
, 0
scRap1p B-gene
and 0
c B-gene
- I-gene
Myb I-gene
. 0

This 0
was 0
tragically 0
highlighted 0
by 0
the 0
death 0
of 0
a 0
17 0
year 0
old 0
dental 0
nurse 0
after 0
taking 0
a 0
single 0
1 0
g 0
tablet 0
of 0
sodium 0
nitrite 0
. 0

However 0
, 0
this 0
posttranslational 0
modification 0
of 0
the 0
gar2 B-gene
protein I-gene
does 0
not 0
appear 0
to 0
be 0
essential 0
for 0
normal 0
production 0
of 0
18S B-gene
rRNA I-gene
. 0

The 0
BRSV B-gene
L I-gene
gene I-gene
is 0
6573 0
nt 0
in 0
length 0
and 0
the 0
derived 0
polypeptide 0
has 0
2162 0
aa 0
. 0

BRAP2 B-gene
also 0
shares 0
significant 0
homology 0
with 0
a 0
hypothetical 0
protein 0
from 0
yeast 0
Saccharomyces 0
cerevisiae 0
, 0
especially 0
in 0
the 0
zinc 0
finger 0
region 0
. 0

We 0
have 0
isolated 0
and 0
determined 0
the 0
complete 0
nucleotide 0
sequence 0
of 0
another 0
operon 0
, 0
cpeCD B-gene
, 0
that 0
encodes 0
the 0
linker 0
proteins 0
associated 0
with 0
phycoerythrin B-gene
hexamers I-gene
in 0
the 0
phycobilisome B-gene
. 0

Here 0
, 0
we 0
describe 0
the 0
results 0
of 0
a 0
detailed 0
study 0
aimed 0
at 0
identifying 0
the 0
gene 0
or 0
genes 0
responsible 0
for 0
the 0
rapid 0
growth 0
- 0
arrest 0
response 0
obtained 0
with 0
human 0
chromosome 0
- 0
9 0
. 0

A 0
novel 0
Cdc42Hs B-gene
mutant I-gene
induces 0
cellular 0
transformation 0
. 0

We 0
identified 0
Tyr 0
( 0
112 0
) 0
and 0
Leu 0
( 0
175 0
) 0
within 0
the 0
RNA 0
- 0
binding 0
domain 0
of 0
the 0
U1 B-gene
70K I-gene
protein I-gene
to 0
be 0
cross 0
- 0
linked 0
to 0
G 0
( 0
28 0
) 0
and 0
U 0
( 0
30 0
) 0
in 0
stem 0
- 0
loop 0
I 0
, 0
respectively 0
. 0

In 0
general 0
, 0
the 0
scallop 0
extract 0
potentiated 0
phototactic 0
suppression 0
. 0

Magnetic 0
field 0
influence 0
on 0
central 0
nervous 0
system 0
function 0
. 0

Only 0
Staphylococcus 0
xylosus 0
SX63 0
was 0
detected 0
as 0
a 0
strain 0
with 0
high 0
adherence 0
activity 0
. 0

Macrophages 0
: 0
modulators 0
of 0
immunity 0
. 0

METHODS 0
: 0
The 0
Die 0
Deutsche 0
Diabetes 0
Dialyse 0
Studie 0
is 0
a 0
prospective 0
randomized 0
placebo 0
- 0
controlled 0
trial 0
that 0
tests 0
the 0
hypothesis 0
that 0
atorvastatin 0
, 0
a 0
hydroxymethyl B-gene
- I-gene
glutaryl I-gene
coenzyme I-gene
A I-gene
reductase I-gene
inhibitor 0
, 0
decreases 0
the 0
rate 0
of 0
cardiovascular 0
mortality 0
and 0
of 0
nonfatal 0
myocardial 0
infarction 0
in 0
patients 0
with 0
type 0
2 0
diabetes 0
who 0
have 0
been 0
on 0
hemodialysis 0
treatment 0
for 0
no 0
more 0
than 0
two 0
years 0
. 0

An 0
OD 0
650 0
greater 0
than 0
0.15 0
appears 0
to 0
be 0
a 0
rapid 0
, 0
reliable 0
indicator 0
of 0
fetal 0
lung 0
maturity 0
. 0

This 0
high 0
dose 0
5 0
- 0
FU 0
+ 0
Act 0
- 0
D 0
protocol 0
was 0
effective 0
for 0
drug 0
resistant 0
cases 0
with 0
MEA 0
protocol 0
. 0

Therefore 0
, 0
it 0
appears 0
that 0
GCN2 B-gene
protein I-gene
kinase I-gene
function 0
is 0
stimulated 0
posttranslationally 0
in 0
amino 0
acid 0
- 0
starved 0
cells 0
. 0

CSEn B-gene
stimulated 0
transcription 0
of 0
a 0
variety 0
of 0
promoters 0
, 0
including 0
the 0
hCS B-gene
, 0
human B-gene
growth I-gene
hormone I-gene
, 0
thymidine B-gene
kinase I-gene
, 0
and 0
Rous B-gene
sarcoma I-gene
virus I-gene
promoters I-gene
, 0
in 0
human 0
choriocarcinoma 0
cell 0
lines 0
( 0
BeWo 0
and 0
JEG 0
- 0
3 0
) 0
but 0
not 0
HeLa 0
cells 0
or 0
rat 0
somatolactotrophes 0
( 0
GC 0
) 0
. 0

HIV 0
- 0
2 0
in 0
Spain 0
. 0

Reversal 0
of 0
mefloquine 0
resistance 0
in 0
rodent 0
Plasmodium 0
. 0

Airborne 0
rabies 0
encephalitis 0
: 0
demonstration 0
of 0
rabies 0
virus 0
in 0
the 0
human 0
central 0
nervous 0
system 0
. 0

No 0
promoter 0
activity 0
could 0
be 0
detected 0
with 0
various 0
mouse B-gene
Fli I-gene
- I-gene
1 I-gene
promoter I-gene
- 0
CAT B-gene
constructs 0
containing 0
600 0
bp 0
of 0
the 0
5 0
' 0
flanking 0
region 0
, 0
the 0
complete 0
exon 0
1 0
, 0
the 0
5 0
' 0
end 0
of 0
intron 0
1 0
and/or 0
retroviral 0
LTR 0
sequence 0
. 0

We 0
now 0
show 0
that 0
the 0
FRAP B-gene
Ser2035 0
- 0
- 0
> 0
Ala 0
mutant 0
displays 0
similar 0
binding 0
affinity 0
when 0
compared 0
with 0
the 0
wild 0
- 0
type 0
protein 0
, 0
whereas 0
all 0
other 0
mutations 0
at 0
this 0
site 0
, 0
including 0
mimics 0
of 0
phosphoserine 0
, 0
abolish 0
binding 0
, 0
presumably 0
due 0
to 0
either 0
unfavorable 0
steric 0
interactions 0
or 0
induced 0
conformational 0
changes 0
. 0

These 0
findings 0
suggest 0
that 0
the 0
mechanism 0
of 0
ribosomal 0
frameshifting 0
at 0
the 0
PVM 0
signal 0
is 0
different 0
from 0
the 0
one 0
described 0
by 0
the 0
'simultaneous 0
slippage 0
' 0
model 0
in 0
that 0
only 0
the 0
string 0
of 0
four 0
adenosine 0
nucleotides 0
represents 0
the 0
slippery 0
sequence 0
involved 0
in 0
a 0
- 0
1 0
P 0
- 0
site 0
slippage 0
. 0

The 0
fru B-gene
gene I-gene
has 0
seven 0
exons 0
spanning 0
15 0
- 0
kb 0
encoding 0
two 0
transcripts 0
with 0
ORFs 0
of 0
841 0
and 0
695 0
amino 0
acids 0
. 0

This 0
sequence 0
can 0
interact 0
with 0
at 0
least 0
two 0
proteins 0
in 0
a 0
fibroblast 0
nuclear 0
extract 0
that 0
have 0
binding 0
characteristics 0
of 0
an 0
Ets B-gene
family I-gene
protein I-gene
and 0
a 0
serum B-gene
response I-gene
factor I-gene
- I-gene
like I-gene
protein I-gene
. 0

Response 0
properties 0
of 0
single 0
units 0
in 0
the 0
accessory 0
optic 0
system 0
of 0
the 0
dark 0
- 0
reared 0
cat 0
. 0

Effect 0
of 0
tetracycline 0
on 0
the 0
glycogen 0
- 0
producing 0
function 0
of 0
the 0
liver 0
and 0
intestinal 0
microflora 0
in 0
white 0
mice 0

Significantly 0
higher 0
levels 0
of 0
vitamin 0
C 0
and 0
catalase B-gene
activity 0
were 0
found 0
in 0
vegetarians 0
( 0
C 0
- 0
63.6 0
and 0
86.5 0
mumol/l 0
; 0
CAT 0
- 0
1497 0
and 0
1313 0
U/ml 0
for 0
males 0
and 0
females 0
, 0
respectively 0
) 0
when 0
compared 0
to 0
nonvegetarians 0
( 0
C 0
- 0
41.3 0
and 0
54.4 0
mumol/l 0
; 0
CAT 0
- 0
1192 0
and 0
1086 0
U/ml 0
) 0
. 0

However 0
, 0
only 0
plasma B-gene
fibrinogen I-gene
concentrations 0
showed 0
statistically 0
significant 0
positive 0
associations 0
with 0
IMT 0
in 0
both 0
groups 0
. 0

METHODS 0
. 0

Presently 0
, 0
we 0
made 0
chain 0
pair 0
switch 0
, 0
chimeric 0
, 0
and 0
site 0
mutant B-gene
gamma I-gene
delta I-gene
TCRs I-gene
and 0
transfected 0
them 0
into 0
TCR 0
- 0
mutant 0
Jurkat 0
T 0
cells 0
to 0
examine 0
the 0
effects 0
of 0
changing 0
the 0
TCR B-gene
gamma I-gene
junctional I-gene
region I-gene
sequences I-gene
on 0
reactivity 0
to 0
prenyl B-gene
pyrophosphate I-gene
Ags I-gene
. 0

The 0
molecular 0
dynamics 0
simulations 0
provide 0
insight 0
into 0
the 0
conformational 0
flexibility 0
of 0
these 0
analogs 0
. 0

Modified 0
Grocott 0
's 0
methenamine 0
silver 0
nitrate 0
method 0
for 0
quick 0
staining 0
of 0
Pneumocystis 0
carinii 0
. 0

The 0
control 0
of 0
human B-gene
aromatase I-gene
expression 0
is 0
complex 0
in 0
that 0
several 0
promoters 0
drive 0
aromatase B-gene
expression 0
in 0
a 0
tissue 0
- 0
specific 0
manner 0
. 0

Surprisingly 0
, 0
although 0
Mist1 B-gene
binds 0
to 0
E 0
- 0
boxes 0
in 0
vivo 0
, 0
the 0
Mist1 B-gene
protein I-gene
lacks 0
a 0
functional 0
transcription 0
activation 0
domain 0
. 0

Selective 0
upper 0
abdominal 0
sympathectomy 0
increased 0
basal 0
acid 0
output 0
in 0
rats 0
but 0
was 0
without 0
effect 0
on 0
stimulated 0
acid 0
output 0
, 0
serum B-gene
gastrin I-gene
concentration 0
, 0
and 0
gastric B-gene
mucosal I-gene
histidine I-gene
decarboxylase I-gene
activity 0
. 0

To 0
isolate 0
genes 0
that 0
contain 0
zinc 0
finger 0
motifs 0
, 0
a 0
human 0
brain 0
cDNA 0
library 0
was 0
screened 0
with 0
an 0
oligonucleotide 0
complementary 0
to 0
the 0
conserved 0
`` 0
linker 0
'' 0
sequence 0
between 0
adjacent 0
zinc 0
fingers 0
. 0

Transforming B-gene
growth I-gene
factor I-gene
beta I-gene
activates 0
the 0
promoter 0
of 0
cyclin B-gene
- I-gene
dependent I-gene
kinase I-gene
inhibitor 0
p15INK4B B-gene
through 0
an 0
Sp1 B-gene
consensus I-gene
site I-gene
. 0

Thus 0
, 0
in 0
addition 0
to 0
the 0
previously 0
characterized 0
FAS B-gene
- I-gene
binding I-gene
factor I-gene
1 I-gene
interacting 0
with 0
the 0
inositol/choline 0
- 0
responsive 0
- 0
element 0
motif 0
, 0
a 0
second 0
motif 0
common 0
to 0
the 0
promoter 0
regions 0
of 0
both 0
FAS B-gene
genes I-gene
could 0
be 0
identified 0
. 0

Kluyveromyces 0
lactis 0
, 0
a 0
budding 0
yeast 0
related 0
to 0
Saccharomyces 0
cerevisiae 0
, 0
can 0
grow 0
on 0
a 0
wider 0
variety 0
of 0
substrates 0
and 0
shows 0
less 0
sensitivity 0
to 0
glucose 0
repression 0
than 0
does 0
Saccharomyces 0
cerevisiae 0
. 0

Sociological 0
analysis 0
of 0
the 0
family 0
. 0

Like 0
other 0
known 0
GCD B-gene
genes I-gene
, 0
GCD14 B-gene
and 0
GCD15 B-gene
are 0
therefore 0
probably 0
required 0
for 0
general 0
translation 0
initiation 0
in 0
addition 0
to 0
their 0
roles 0
in 0
GCN4 B-gene
- 0
specific 0
translational 0
control 0
. 0

Sorting 0
information 0
to 0
the 0
chloroplastic 0
inner 0
envelope 0
is 0
contained 0
in 0
an 0
NH2 0
- 0
proximal 0
part 0
of 0
mature B-gene
IEP110 I-gene
( 0
110N B-gene
) 0
. 0

Both 0
algorithms 0
have 0
been 0
implemented 0
and 0
applied 0
to 0
data 0
simulated 0
for 0
a 0
scanner 0
with 0
a 0
large 0
axial 0
aperture 0
( 0
30 0
degrees 0
) 0
, 0
and 0
also 0
to 0
data 0
acquired 0
with 0
the 0
ECAT 0
HR 0
and 0
the 0
ECAT 0
HR+ 0
scanners 0
. 0

BACKGROUND 0
: 0
Murine B-gene
Nramp I-gene
is 0
a 0
candidate 0
for 0
the 0
macrophage 0
resistance 0
gene 0
Ity/Lsh/Bcg B-gene
. 0

Serum 0
zinc 0
and 0
copper 0
levels 0
and 0
urine 0
copper 0
concentrations 0
in 0
men 0
were 0
significantly 0
lower 0
than 0
in 0
women 0
, 0
while 0
there 0
were 0
no 0
differences 0
in 0
serum 0
or 0
urinary 0
zinc 0
and 0
copper 0
levels 0
with 0
age 0
. 0

Pregnancy 0
was 0
ensued 0
in 0
4 0
cases 0
in 0
group 0
I 0
. 0

CONCLUSION 0
: 0
In 0
these 0
patients 0
control 0
of 0
ventricular 0
response 0
rate 0
with 0
either 0
HBA 0
+ 0
VVIR 0
pacemaker 0
or 0
atrioventricular 0
modifying 0
drugs 0
+ 0
VVI 0
pacemaker 0
will 0
lead 0
to 0
a 0
significant 0
improvement 0
in 0
exercise 0
duration 0
and 0
quality 0
of 0
life 0
. 0

Western 0
immunoblot 0
analysis 0
detected 0
p55gag B-gene
and 0
its 0
cleavage 0
products 0
p39 B-gene
and 0
p27 B-gene
in 0
purified 0
particles 0
derived 0
by 0
expression 0
of 0
gag B-gene
and 0
gag B-gene
- 0
pol B-gene
, 0
respectively 0
. 0

These 0
three 0
phases 0
of 0
cyclin B-gene
E I-gene
association 0
with 0
chromatin 0
may 0
facilitate 0
the 0
diverse 0
activities 0
of 0
cyclin B-gene
E I-gene
- 0
- 0
Cdk2 B-gene
in 0
initiating 0
replication 0
, 0
blocking 0
rereplication 0
, 0
and 0
allowing 0
resetting 0
of 0
origins 0
after 0
mitosis 0
. 0

It 0
has 0
been 0
shown 0
that 0
renin B-gene
secretion 0
is 0
stimulated 0
by 0
endothelin B-gene
, 0
a 0
recently 0
discovered 0
peptide 0
with 0
strong 0
vasoconstrictive 0
properties 0
and 0
stimulating 0
effects 0
on 0
renin B-gene
secretion 0
. 0

A 0
higher 0
percentage 0
of 0
children 0
with 0
cerebral 0
malaria 0
( 0
40 0
per 0
cent 0
) 0
than 0
with 0
non 0
- 0
cerebral 0
malaria 0
( 0
29 0
per 0
cent 0
) 0
or 0
controls 0
( 0
20 0
per 0
cent 0
) 0
also 0
had 0
either 0
serum B-gene
ferritin I-gene
< 0
100 0
micrograms/l 0
and 0
inflammation 0
or 0
sTfR B-gene
> 0
7.3 0
mg/l 0
or 0
both 0
. 0

Patients 0
received 0
BPB 0
using 0
bupivacaine 0
2 0
mg 0
kg 0
- 0
1 0
with 0
adrenaline 0
1 0
in 0
200,000 0
, 0
either 0
with 0
or 0
without 0
hyaluronidase B-gene
3000 0
iu 0
, 0
in 0
a 0
volume 0
of 0
0.5 0
ml 0
per 0
2.54 0
cm 0
of 0
the 0
patient 0
's 0
height 0
. 0

The 0
rifampicin 0
resistance 0
of 0
uvsW B-gene
- 0
repressed 0
replication 0
suggests 0
that 0
it 0
involves 0
either 0
tertiary 0
initiation 0
or 0
some 0
novel 0
mode 0
of 0
initiation 0
. 0

Association 0
between 0
hyperhomocysteinemia 0
and 0
ischemic 0
heart 0
disease 0
in 0
Sri 0
Lankans 0
. 0

These 0
findings 0
suggest 0
that 0
the 0
proteolipids 0
of 0
the 0
vacuolar B-gene
H+ I-gene
- I-gene
ATPases I-gene
were 0
evolved 0
in 0
parallel 0
with 0
the 0
eubacterial 0
proteolipid 0
, 0
from 0
a 0
common 0
ancestral 0
gene 0
that 0
underwent 0
gene 0
duplication 0
. 0

Coexpression 0
of 0
c B-gene
- I-gene
Rel I-gene
in 0
combination 0
with 0
ATF B-gene
- I-gene
1 I-gene
, 0
CREB2 B-gene
, 0
or 0
ATF B-gene
- I-gene
1/CREB2 I-gene
leads 0
to 0
synergistic 0
transactivation 0
of 0
a 0
1/CREB2 I-gene

Characterization 0
of 0
a 0
cDNA B-gene
encoding I-gene
CNN I-gene
predicts 0
a 0
novel 0
structural 0
protein 0
with 0
three 0
leucine 0
zipper 0
motifs 0
and 0
several 0
coiled 0
- 0
coil 0
domains 0
exhibiting 0
limited 0
homology 0
to 0
the 0
rod 0
portion 0
of 0
myosin B-gene
. 0

It 0
is 0
suggested 0
that 0
the 0
loss 0
of 0
weight 0
, 0
the 0
decrease 0
in 0
food 0
intake 0
and 0
the 0
increase 0
in 0
brain 0
MOPEG 0
- 0
SO4 0
induced 0
by 0
cyanamide 0
reflect 0
possible 0
anorectic 0
properties 0
of 0
the 0
drug 0
. 0

The 0
differential 0
diagnosis 0
of 0
mineral 0
oil 0
lipidosis 0
in 0
lymph 0
nodes 0
with 0
reaction 0
to 0
radiopaque 0
oils 0
and 0
Whipple 0
's 0
disease 0
is 0
discussed 0
. 0

The 0
serum 0
levels 0
of 0
cortisol 0
and 0
prolactin B-gene
after 0
nasal 0
instillation 0
of 0
a 0
suspension 0
of 0
vaginal 0
exudate 0
showed 0
lower 0
values 0
than 0
in 0
control 0
conditions 0
( 0
nasal 0
instillation 0
of 0
saline 0
) 0
. 0

This 0
enhancer 0
element 0
functioned 0
in 0
a 0
position 0
- 0
and 0
orientation 0
- 0
independent 0
manner 0
both 0
on 0
the 0
Pax B-gene
- I-gene
QNR I-gene
P0 I-gene
promoter I-gene
and 0
the 0
heterologous B-gene
thymidine I-gene
kinase I-gene
promoter I-gene
. 0

The 0
data 0
when 0
used 0
to 0
stimulate 0
the 0
collection 0
of 0
the 0
information 0
at 0
antenatal 0
or 0
postnatal 0
visits 0
, 0
nonetheless 0
provide 0
an 0
accurate 0
description 0
of 0
under 0
- 0
3 0
mortality 0
trends 0
and 0
differences 0
for 0
the 0
two 0
periods 0
examined 0
- 0
- 0
before 0
1984 0
and 0
before 0
1989 0
. 0

The 0
BHV B-gene
- I-gene
1 I-gene
UL24 I-gene
, 0
UL25 B-gene
, 0
UL26 B-gene
and 0
UL26.5 B-gene
transcripts I-gene
all 0
terminated 0
at 0
a 0
common 0
3' 0
- 0
polyadenylation 0
site 0
and 0
varied 0
significantly 0
in 0
their 0
relative 0
abundance 0
. 0

A 0
. 0

Ligand 0
binding 0
of 0
multi 0
- 0
chain 0
antigen 0
receptors 0
and 0
hematopoietin/cytokine B-gene
receptors 0
results 0
in 0
rapid 0
activation 0
of 0
protein B-gene
tyrosine I-gene
kinase I-gene
( 0
PTK B-gene
) 0
- 0
dependent 0
signalling 0
molecules 0
such 0
as 0
phosphatidylinositol B-gene
3 I-gene
- I-gene
kinase I-gene
( 0
PI B-gene
3 I-gene
- I-gene
kinase I-gene
) 0
. 0

Post 0
- 0
CPB 0
cardiac 0
index 0
was 0
superior 0
in 0
group 0
B 0
( 0
3.9+/ 0
- 0
0.3 0
vs 0
. 0

The 0
regulatory 0
genes 0
cnrYXH B-gene
have 0
been 0
cloned 0
, 0
overexpressed 0
, 0
and 0
purified 0
in 0
Escherichia 0
coli 0
. 0

Cognitive 0
measures 0
of 0
attention 0
included 0
the 0
Stroop 0
and 0
Controlled 0
Oral 0
Word 0
Association 0
Test 0
using 0
the 0
letters 0
`` 0
C 0
, 0
'' 0
`` 0
F 0
, 0
'' 0
and 0
`` 0
L 0
'' 0
( 0
COWAT 0
, 0
CFL 0
version 0
) 0
. 0

The 0
objectives 0
of 0
this 0
study 0
were 0
1 0
) 0
to 0
quantify 0
the 0
comparative 0
structural 0
static 0
and 0
fatigue 0
properties 0
of 0
the 0
pointe 0
shoe 0
toe 0
box 0
, 0
and 0
2 0
) 0
to 0
evaluate 0
the 0
preferred 0
shoe 0
characteristics 0
as 0
determined 0
by 0
a 0
survey 0
of 0
local 0
dancers 0
. 0

When 0
linked 0
to 0
the 0
herpes 0
simplex 0
thymidine B-gene
kinase I-gene
minimal 0
promoter 0
, 0
this 0
fragment 0
acts 0
as 0
an 0
enhancing 0
element 0
in 0
Rcho 0
but 0
not 0
GC 0
cells 0
. 0

We 0
report 0
on 0
a 0
case 0
of 0
a 0
43 0
- 0
old 0
- 0
male 0
with 0
a 0
bronchogenic 0
cyst 0
in 0
the 0
distal 0
esophagus 0
, 0
which 0
was 0
misdiagnosed 0
as 0
a 0
malignant 0
esophageal 0
tumor 0
based 0
on 0
preoperative 0
imaging 0
and 0
high 0
levels 0
of 0
the 0
tumor 0
markers 0
CA B-gene
19 I-gene
- I-gene
9 I-gene
and 0
CA B-gene
125 I-gene
. 0

Oscillatory 0
flow 0
is 0
reestablished 0
in 0
the 0
model 0
at 0
the 0
capillary 0
- 0
cerebrospinal 0
fluid 0
and 0
capillary 0
- 0
venous 0
interfaces 0
. 0

This 0
substrate 0
was 0
cleaved 0
efficiently 0
in 0
trans 0
by 0
protease B-gene
3C I-gene
derived 0
from 0
another 0
recombinant 0
vaccinia 0
virus 0
expressing 0
a 0
3C B-gene
precursor I-gene
protein I-gene
. 0

Human B-gene
and I-gene
murine I-gene
cytotoxic I-gene
T I-gene
lymphocyte I-gene
serine I-gene
proteases I-gene
: 0
subsite 0
mapping 0
with 0
peptide 0
thioester 0
substrates 0
and 0
inhibition 0
of 0
enzyme 0
activity 0
and 0
cytolysis 0
by 0
isocoumarins 0
. 0

The 0
human B-gene
Fc I-gene
gamma I-gene
receptor I-gene
gene I-gene
Fc B-gene
gamma I-gene
RIIA I-gene
is 0
expressed 0
in 0
platelets 0
, 0
neutrophils 0
, 0
monocytes 0
and 0
macrophages 0
. 0

Like 0
the 0
nuclear 0
envelope 0
, 0
the 0
intranuclear 0
double 0
membrane 0
lamellae 0
enclosed 0
a 0
defined 0
cisterna 0
that 0
was 0
interrupted 0
by 0
pores 0
but 0
, 0
unlike 0
the 0
nuclear 0
envelope 0
pores 0
, 0
they 0
lacked 0
NPCs 0
. 0

Regulation 0
of 0
the 0
human B-gene
stress I-gene
response I-gene
gene I-gene
GADD153 I-gene
expression 0
: 0
role 0
of 0
ETS1 B-gene
and 0
FLI B-gene
- I-gene
1 I-gene
gene I-gene
products I-gene
. 0

On 0
days 0
7 0
, 0
21 0
, 0
and 0
35 0
postinoculation 0
( 0
PI 0
) 0
, 0
all 0
birds 0
received 0
sheep 0
erythrocytes 0
intravenously 0
. 0

The 0
higher 0
level 0
of 0
calories 0
was 0
attained 0
by 0
an 0
increased 0
intake 0
of 0
carbohydrates 0
. 0

However 0
, 0
it 0
is 0
now 0
suggested 0
that 0
the 0
use 0
of 0
more 0
slowly 0
digested 0
starchy 0
foods 0
may 0
have 0
positive 0
health 0
benefits 0
. 0

Each 0
receptor 0
must 0
therefore 0
engage 0
a 0
unique 0
subset 0
of 0
the 0
available 0
signaling 0
elements 0
- 0
- 0
at 0
least 0
partly 0
through 0
the 0
selection 0
of 0
proteins 0
with 0
src B-gene
- I-gene
homology I-gene
2 I-gene
domains I-gene
( 0
SH2 B-gene
proteins I-gene
) 0
. 0

Hence 0
, 0
it 0
is 0
perhaps 0
not 0
necessary 0
to 0
perform 0
spinal 0
puncture 0
if 0
the 0
only 0
purpose 0
is 0
to 0
determine 0
the 0
CSF/serum 0
ratio 0
. 0

NSAIDS 0
and 0
the 0
microcirculation 0
of 0
the 0
stomach 0
. 0

Highly 0
significant 0
similarities 0
were 0
detected 0
between 0
the 0
N 0
- 0
terminal 0
region 0
of 0
P30 B-gene
and 0
those 0
of 0
GENA B-gene
[ 0
the 0
product 0
of 0
another 0
unidentified 0
gene 0
( 0
geneA B-gene
) 0
located 0
upstream 0
of 0
the 0
aceEF B-gene
- 0
lpd B-gene
operon 0
] 0
, 0
and 0
GNTR B-gene
( 0
a 0
putative 0
transcriptional 0
repressor 0
of 0
the 0
gluconate B-gene
operon I-gene
of 0
Bacillus 0
subtilis 0
) 0
. 0

Promoting 0
fat 0
utilisation 0
by 0
reducing 0
the 0
carbohydrate 0
- 0
fat 0
ratio 0
of 0
the 0
TPN 0
reduces 0
free 0
radical 0
activity 0
to 0
a 0
similar 0
extent 0
as 0
fat 0
exclusion 0
. 0

It 0
is 0
postulated 0
that 0
the 0
synthesis 0
of 0
the 0
peptidoglycan 0
layer 0
was 0
affected 0
by 0
the 0
antimetabolites 0
since 0
the 0
morphological 0
effects 0
were 0
strikingly 0
similar 0
to 0
those 0
caused 0
by 0
treatment 0
of 0
E. 0
cloacae 0
with 0
disodium 0
edetate 0
plus 0
lysozyme B-gene
. 0

The 0
selective 0
5 B-gene
- I-gene
HT2 I-gene
receptor I-gene
blocker 0
ketanserin 0
was 0
found 0
to 0
reduce 0
maximal 0
urethral 0
pressures 0
in 0
healthy 0
females 0
by 0
about 0
40 0
% 0
without 0
reducing 0
blood 0
pressure 0
. 0

RESULTS 0
: 0
Of 0
10,709,701 0
chemistry 0
specimens 0
submitted 0
to 0
the 0
participating 0
laboratories 0
during 0
the 0
data 0
collection 0
period 0
, 0
37,208 0
( 0
0.35 0
% 0
) 0
were 0
rejected 0
prior 0
to 0
testing 0
. 0

Interestingly 0
, 0
VDR B-gene
was 0
able 0
to 0
bind 0
to 0
VDREs 0
with 0
high 0
affinity 0
and 0
to 0
fully 0
activate 0
transcription 0
in 0
intact 0
yeast 0
cells 0
in 0
the 0
presence 0
of 0
the 0
retinoid B-gene
X I-gene
receptor I-gene
( 0
RXR B-gene
) 0
. 0

The 0
newly 0
identified 0
repressor 0
element 0
is 0
a 0
rare 0
example 0
of 0
a 0
naturally 0
occurring 0
perfect 0
palindromic 0
binding 0
motif 0
for 0
the 0
NF B-gene
- I-gene
kappa I-gene
B/Rel I-gene
family 0
of 0
transcription 0
factors 0
. 0

UV 0
- 0
cross 0
- 0
linking 0
studies 0
suggested 0
that 0
these 0
two 0
complexes 0
represent 0
one 0
and 0
two 0
molecules 0
of 0
ADR1 B-gene
bound 0
to 0
DNA 0
. 0

Finally 0
, 0
the 0
conservation 0
of 0
the 0
two 0
residues 0
most 0
sensitive 0
to 0
mutations 0
( 0
Y949 0
and 0
Y953 0
) 0
in 0
TM11 0
, 0
and 0
in 0
the 0
homologous 0
TM5 0
, 0
of 0
all 0
mammalian B-gene
P I-gene
- I-gene
gps I-gene
and 0
also 0
in 0
other 0
ABC B-gene
transporters I-gene
, 0
suggests 0
that 0
these 0
residues 0
and 0
domains 0
may 0
play 0
an 0
important 0
role 0
in 0
structural 0
as 0
well 0
as 0
mechanistic 0
aspects 0
common 0
to 0
this 0
family 0
of 0
proteins 0
. 0

SF1/mBBP B-gene
utilizes 0
a 0
SF1/mBBP I-gene

The 0
in 0
vivo 0
response 0
of 0
the 0
PacC B-gene
- I-gene
like I-gene
decamers I-gene
to 0
external 0
pH 0
was 0
dependent 0
on 0
the 0
status 0
of 0
the 0
pH 0
- 0
regulated 0
activator 0
YlRim101p B-gene
, 0
which 0
is 0
homologous 0
to 0
the 0
A. 0
nidulans 0
PacC B-gene
regulator 0
. 0

Spongiosa 0
regeneration 0
in 0
the 0
millipore 0
chamber 0

MTX 0
therapy 0
decreased 0
Ga 0
- 0
67 0
uptake 0
in 0
liver 0
, 0
tumor 0
, 0
and 0
muscle 0
. 0

Each 0
of 0
these 0
materials 0
were 0
placed 0
by 0
means 0
of 0
three 0
different 0
placement 0
techniques 0
( 0
Bulk 0
pack 0
, 0
Horizontal 0
layering 0
and 0
Vertical 0
layering 0
) 0
into 0
class 0
II 0
cavities 0
in 0
extracted 0
human 0
molars 0
. 0

In 0
contrast 0
, 0
the 0
sequences 0
essential 0
for 0
the 0
transcription 0
of 0
EFT1 B-gene
were 0
localized 0
to 0
the 0
region 0
between 0
the 0
start 0
ATG 0
and 0
the 0
stop 0
codon 0
of 0
the 0
VPS17 B-gene
gene I-gene
that 0
terminates 0
267 0
nt 0
upstream 0
on 0
the 0
same 0
strand 0
. 0

No 0
transactivation 0
of 0
the 0
ovalbumin B-gene
promoter I-gene
( 0
pLovTATA B-gene
) 0
template 0
control 0
was 0
observed 0
. 0

Removal 0
of 0
cyclin B-gene
- I-gene
dependant I-gene
kinases I-gene
( 0
cdks B-gene
) 0
or 0
cdk2 B-gene
from 0
these 0
extracts 0
using 0
affinity 0
matrices 0
severely 0
inhibits 0
initiation 0
of 0
S 0
phase 0
. 0

Consistent 0
with 0
this 0
hypothesis 0
, 0
stimulation 0
of 0
A B-gene
( I-gene
2A I-gene
) I-gene
- I-gene
R I-gene
or 0
PKA B-gene
enhanced 0
nuclear B-gene
aPKC I-gene
activity 0
. 0

Foreign 0
DNA 0
inserts 0
contained 0
within 0
the 0
fowlpox 0
virus 0
sequence 0
were 0
transferred 0
to 0
the 0
viral 0
genome 0
by 0
homologous 0
recombination 0
occurring 0
in 0
cells 0
infected 0
with 0
a 0
fowlpox 0
virus 0
temperature 0
- 0
sensitive 0
mutant 0
and 0
transfected 0
with 0
both 0
wild 0
- 0
type 0
viral 0
DNA 0
and 0
plasmid 0
DNA 0
. 0

JCAHO 0
to 0
use 0
ORYX 0
data 0
to 0
detect 0
sentinel 0
events 0
. 0

Comparisons 0
of 0
the 0
efficacy 0
of 0
benazepril 0
and 0
hydrochlorothiazide 0
alone 0
and 0
in 0
combination 0
have 0
shown 0
that 0
benazepril 0
20 0
mg 0
once 0
daily 0
is 0
as 0
effective 0
as 0
or 0
more 0
effective 0
in 0
lowering 0
diastolic 0
blood 0
pressure 0
than 0
hydrochlorothiazide 0
25 0
mg 0
once 0
daily 0
and 0
that 0
the 0
combination 0
of 0
benazepril 0
20 0
mg 0
and 0
hydrochlorothiazide 0
25 0
mg 0
has 0
a 0
possibly 0
synergistic 0
effect 0
on 0
diastolic 0
blood 0
pressure 0
. 0

Carcinoma B-gene
- I-gene
related I-gene
protein I-gene
production 0
may 0
have 0
played 0
a 0
role 0
in 0
the 0
development 0
of 0
the 0
observed 0
renal 0
lesions 0
. 0

METHODS 0
: 0
The 0
study 0
population 0
included 0
70 0
patients 0
with 0
acute 0
coronary 0
syndromes 0
( 0
14 0
with 0
recent 0
acute 0
myocardial 0
infarction 0
and 0
56 0
with 0
unstable 0
angina 0
pectoris 0
) 0
, 0
105 0
patients 0
with 0
stable 0
angina 0
pectoris 0
, 0
and 0
75 0
control 0
subjects 0
. 0

Single 0
amino 0
acid 0
substitutions 0
were 0
shown 0
to 0
result 0
from 0
the 0
mutations 0
pdr1 B-gene
- I-gene
2 I-gene
( 0
M308I 0
) 0
, 0
pdr1 B-gene
- I-gene
3 I-gene
( 0
F815S 0
) 0
, 0
pdr1 B-gene
- I-gene
6 I-gene
( 0
K302Q 0
) 0
, 0
pdr1 B-gene
- I-gene
7 I-gene
( 0
P298A 0
) 0
and 0
pdr1 B-gene
- I-gene
8 I-gene
( 0
L1036 0
W 0
) 0
, 0
whereas 0
the 0
intragenic 0
suppressor 0
mutant 0
pdr1 B-gene
- I-gene
100 I-gene
is 0
deleted 0
for 0
the 0
two 0
amino 0
acids 0
L537 0
and 0
A538 0
. 0

However 0
, 0
no 0
statistical 0
difference 0
in 0
the 0
Ca/P 0
ratio 0
, 0
carbon 0
concentration 0
and 0
surface 0
energy 0
were 0
observed 0
with 0
different 0
heat 0
treatments 0
. 0

These 0
motions 0
were 0
found 0
in 0
the 0
N 0
- 0
and 0
C 0
- 0
terminal 0
tails 0
, 0
in 0
segment 0
33 0
- 0
35 0
which 0
forms 0
the 0
turn 0
between 0
beta 0
- 0
strands 0
S1 0
and 0
S2 0
, 0
and 0
residues 0
47 0
- 0
52 0
located 0
in 0
a 0
long 0
loop 0
preceding 0
strand 0
S3 0
. 0

Enterobius 0
vermicularis 0
eggs 0
were 0
demonstrated 0
during 0
microscopic 0
examination 0
of 0
a 0
smear 0
taken 0
from 0
the 0
posterior 0
fornix 0
of 0
the 0
vagina 0
. 0

Differentiation 0
of 0
porcine 0
mycoplasma 0
strains 0
by 0
means 0
of 0
a 0
simple 0
paper 0
chromatography 0
test 0
. 0

D. 0
, 0
Hughes 0
, 0
F 0
. 0

We 0
further 0
showed 0
a 0
significant 0
repression 0
of 0
promoter 0
activity 0
( 0
> 0
40 0
fold 0
) 0
by 0
E2 B-gene
- I-gene
2 I-gene
( 0
lacking 0
the 0
amino 0
acid 0
sequence 0
RSRS 0
) 0
when 0
the 0
E47 B-gene
reporter I-gene
construct I-gene
, 0
containing 0
a 0
hexameric 0
E 0
- 0
box 0
site 0
, 0
was 0
used 0
. 0

Sequence 0
analysis 0
of 0
AEBP2 B-gene
cDNA I-gene
revealed 0
that 0
it 0
encodes 0
a 0
protein 0
containing 0
three 0
Gli B-gene
- 0
Kruppel B-gene
( 0
Cys2 0
- 0
His2 0
) 0
- 0
type 0
zinc 0
fingers 0
. 0

METHODS 0
: 0
The 0
prevalence 0
of 0
haemagglutination B-gene
inhibiting I-gene
( I-gene
HI I-gene
) I-gene
antibodies I-gene
to 0
JE 0
virus 0
( 0
JEV 0
) 0
, 0
West 0
Nile 0
virus 0
( 0
WNV 0
) 0
and 0
dengue 0
- 0
2 0
virus 0
( 0
DEN 0
- 0
2 0
) 0
was 0
detected 0
by 0
HI 0
test 0
and 0
IgM B-gene
antibody I-gene
capture 0
ELISA 0
( 0
MAC 0
ELISA 0
) 0
was 0
performed 0
to 0
determine 0
recent 0
infections 0
with 0
JE 0
virus 0
. 0

To 0
elucidate 0
the 0
mechanism 0
of 0
these 0
hormonal 0
effects 0
, 0
we 0
have 0
studied 0
the 0
regulatory 0
regions 0
of 0
the 0
PFK B-gene
- I-gene
2 I-gene
gene I-gene
in 0
transfection 0
experiments 0
. 0

Tryptophan 0
induction 0
prevents 0
Rho B-gene
- 0
dependent 0
transcription 0
termination 0
in 0
the 0
leader 0
region 0
of 0
the 0
operon 0
. 0

An 0
in 0
vitro 0
Raf B-gene
- I-gene
1 I-gene
kinase I-gene
assay 0
, 0
however 0
, 0
failed 0
to 0
detect 0
LPS 0
- 0
induced 0
Raf B-gene
- I-gene
1 I-gene
kinase I-gene
activity 0
in 0
RAW 0
264.7 0
cells 0
, 0
suggesting 0
that 0
in 0
RAW 0
264.7 0
cells 0
, 0
Raf B-gene
- I-gene
1 I-gene
kinase I-gene
is 0
not 0
an 0
activating 0
component 0
of 0
the 0
LPS 0
signaling 0
pathway 0
regulating 0
MAPK B-gene
activity 0
or 0
sIL B-gene
- I-gene
1Ra I-gene
promoter I-gene
activity 0
. 0

Subjects 0
were 0
73 0
male 0
and 0
female 0
employees 0
of 0
the 0
Xerox 0
Corporation 0
joining 0
a 0
newly 0
developed 0
health 0
fitness 0
program 0
. 0

The 0
LT B-gene
- I-gene
beta I-gene
gene I-gene
is 0
expressed 0
in 0
lymphoid 0
cells 0
and 0
organs 0
, 0
but 0
little 0
is 0
known 0
about 0
its 0
inducible 0
regulation 0
. 0

Dose 0
- 0
dependent 0
pharmacokinetics 0
: 0
emphasis 0
on 0
phase 0
I 0
metabolism 0
. 0

There 0
were 0
no 0
differences 0
in 0
the 0
incidence 0
of 0
fractured 0
zonas 0
. 0

Our 0
Northern 0
and 0
Southern 0
blot 0
analyses 0
of 0
meningiomas 0
clearly 0
suggest 0
the 0
CLH B-gene
- I-gene
22 I-gene
gene I-gene
may 0
be 0
involved 0
in 0
the 0
tumor 0
development 0
and 0
can 0
be 0
considered 0
as 0
a 0
candidate 0
for 0
a 0
tumor 0
suppressor 0
. 0

The 0
difference 0
between 0
the 0
results 0
in 0
the 0
high 0
dose 0
AHLG B-gene
and 0
in 0
the 0
control 0
group 0
was 0
significant 0
( 0
p 0
less 0
than 0
0.05 0
) 0
. 0

The 0
stress/BHV 0
- 0
1 0
model 0
resulted 0
in 0
a 0
mild 0
respiratory 0
infection 0
in 0
all 0
calves 0
with 0
no 0
difference 0
observed 0
between 0
treatment 0
groups 0
. 0

Cytomegalovirus 0
infection 0
- 0
- 0
modern 0
diagnosis 0

Genomic 0
organization 0
of 0
the 0
human B-gene
multidrug I-gene
resistance I-gene
( I-gene
MDR1 I-gene
) I-gene
gene I-gene
and 0
origin 0
of 0
P B-gene
- I-gene
glycoproteins I-gene
. 0

The 0
pepI B-gene
gene I-gene
was 0
overexpressed 0
in 0
Escherichia 0
coli 0
. 0

Deep 0
bite 0
CL 0
II 0
Div 0
. 0

Negative 0
modulation 0
of 0
alpha1 B-gene
( I-gene
I I-gene
) I-gene
procollagen I-gene
gene I-gene
expression 0
in 0
human 0
skin 0
fibroblasts 0
: 0
transcriptional 0
inhibition 0
by 0
interferon B-gene
- I-gene
gamma I-gene
. 0

Yet 0
IL B-gene
- I-gene
2 I-gene
and 0
IFN B-gene
- I-gene
gamma I-gene
production 0
are 0
independently 0
regulated 0
, 0
as 0
demonstrated 0
by 0
their 0
differential 0
expression 0
in 0
certain 0
T 0
cell 0
subsets 0
, 0
suggesting 0
that 0
the 0
regulatory 0
elements 0
in 0
these 0
two 0
genes 0
must 0
differ 0
. 0

In 0
summary 0
, 0
FGFR3 B-gene
signaling 0
pathway 0
utilizes 0
two 0
GRB2 B-gene
- I-gene
containing I-gene
complexes I-gene
; 0
Shc.GRB2.Sos B-gene
and 0
Shc.GRB2.Sos I-gene

Resistance 0
to 0
Mup 0
was 0
classified 0
as 0
low 0
( 0
minimal 0
inhibitory 0
concentration 0
[ 0
MIC 0
] 0
> 0
or 0
= 0
8 0
microg/mL 0
) 0
or 0
high 0
( 0
MIC 0
> 0
or 0
= 0
512 0
microg/mL 0
) 0
degree 0
. 0

STUDY 0
DESIGN 0
: 0
Retrospective 0
review 0
. 0

One 0
had 0
a 0
48 0
- 0
hour 0
cycle 0
and 0
the 0
other 0
a 0
24 0
- 0
hour 0
cycle 0
. 0

1 0
The 0
effects 0
of 0
high 0
doses 0
of 0
piretanide 0
, 0
a 0
new 0
diuretic 0
agent 0
chemically 0
related 0
to 0
frusemide 0
and 0
bumetanide 0
were 0
evaluated 0
in 0
twelve 0
patients 0
with 0
severe 0
chronic 0
renal 0
insufficiency 0
( 0
creatinine 0
clearance 0
below 0
25 0
ml/min 0
) 0
. 0

S1 B-gene
nuclease I-gene
protection 0
mapping 0
and 0
primer 0
extension 0
analysis 0
allowed 0
us 0
to 0
propose 0
that 0
the 0
A 0
residue 0
located 0
19 0
bp 0
upstream 0
from 0
the 0
translation 0
initiation 0
codon 0
is 0
the 0
site 0
of 0
transcription 0
initiation 0
. 0

Various 0
stimuli 0
inactivate 0
IkappaB B-gene
alpha I-gene
by 0
triggering 0
phosphorylation 0
of 0
the 0
N 0
- 0
terminal 0
residues 0
Ser32 0
and 0
Ser36 0
. 0

A 0
mouse 0
brain 0
cDNA 0
library 0
in 0
lambdagt11 0
was 0
screened 0
for 0
this 0
association 0
, 0
and 0
two 0
positive 0
clones 0
encoding 0
tyrosine B-gene
phosphatase I-gene
SH B-gene
- I-gene
PTP2 I-gene
were 0
isolated 0
. 0

Intensive 0
therapy 0
of 0
viral 0
hepatitis 0

Adjusting 0
a 0
steady 0
- 0
state 0
warfarin 0
dose 0
depends 0
on 0
the 0
measured 0
INR 0
values 0
and 0
clinical 0
factors 0
: 0
the 0
dose 0
does 0
not 0
need 0
to 0
be 0
adjusted 0
for 0
a 0
single 0
INR 0
that 0
is 0
slightly 0
out 0
of 0
range 0
, 0
and 0
most 0
changes 0
should 0
alter 0
the 0
total 0
weekly 0
dose 0
by 0
5 0
% 0
to 0
20 0
% 0
. 0

Successful 0
resolution 0
of 0
progressive 0
multifocal 0
leukoencephalopathy 0
after 0
combination 0
therapy 0
with 0
cidofovir 0
and 0
cytosine 0
arabinoside 0
. 0

The 0
DFGF B-gene
- I-gene
R I-gene
protein I-gene
may 0
thus 0
participate 0
in 0
receiving 0
spatial 0
cues 0
that 0
guide 0
tracheal 0
cell 0
outgrowth 0
. 0

FTF 0
( 0
Joint 0
Council 0
of 0
Civil 0
Servants 0
and 0
Functionaries 0
) 0
: 0
clarification 0
about 0
membership 0
in 0
the 0
main 0
organizations 0

The 0
differences 0
in 0
binding 0
( 0
Kdapp 0
) 0
, 0
incorporation 0
, 0
and 0
extension 0
kinetics 0
of 0
8 0
- 0
oxo 0
- 0
dGTP 0
compared 0
to 0
normal 0
dNTP 0
incorporation 0
at 0
template 0
8 0
- 0
oxo 0
- 0
G 0
adducts 0
indicate 0
that 0
polymerase 0
fidelity 0
does 0
not 0
depend 0
solely 0
upon 0
the 0
overall 0
geometry 0
of 0
Watson 0
- 0
Crick 0
base 0
pairs 0
and 0
reflects 0
the 0
asymmetry 0
of 0
the 0
enzyme 0
active 0
site 0
. 0

Retroviral 0
vector 0
producer 0
cell 0
populations 0
and 0
cell 0
clones 0
were 0
established 0
for 0
each 0
chLTR B-gene
vector 0
, 0
and 0
all 0
were 0
capable 0
of 0
yielding 0
high 0
vector 0
titers 0
( 0
> 0
10 0
( 0
5 0
) 0
G418R B-gene
cfu/ml 0
on 0
NIH 0
- 0
3T3 0
) 0
. 0

None 0
of 0
these 0
patients 0
developed 0
clinical 0
events 0
before 0
disappearance 0
of 0
the 0
phospholipid 0
- 0
dependent 0
inhibitors 0
of 0
coagulation 0
. 0

A 0
high 0
titer 0
of 0
anti B-gene
- I-gene
HBc I-gene
, 0
thus 0
suggested 0
to 0
be 0
an 0
indicator 0
of 0
persistent 0
hepatitis 0
B 0
virus 0
infection 0
, 0
was 0
found 0
rarely 0
in 0
seronegative 0
patients 0
with 0
chronic 0
hepatitis 0
, 0
non 0
- 0
alcoholic 0
cirrhosis 0
, 0
or 0
alcoholic 0
liver 0
diseases 0
. 0

Using 0
beta B-gene
1 I-gene
- I-gene
AR I-gene
- 0
luciferase B-gene
reporter 0
recombinants 0
, 0
we 0
have 0
previously 0
determined 0
that 0
important 0
beta B-gene
1 I-gene
- I-gene
AR I-gene
genetic 0
elements 0
controlling 0
expression 0
within 0
the 0
C6 0
glioma 0
cell 0
line 0
are 0
contained 0
within 0
the 0
region 0
- 0
396 0
to 0
- 0
299 0
, 0
relative 0
to 0
the 0
translational 0
start 0
site 0
. 0

It 0
is 0
not 0
well 0
known 0
that 0
giant 0
cell 0
arteritis 0
can 0
cause 0
fatal 0
complications 0
due 0
to 0
rupture 0
of 0
aortic 0
aneurysms 0
or 0
cerebral 0
and 0
myocardial 0
infarctions 0
. 0

Temporal 0
recruitment 0
of 0
the 0
mSin3A B-gene
- 0
histone B-gene
deacetylase I-gene
corepressor 0
complex 0
to 0
the 0
ETS B-gene
domain I-gene
transcription I-gene
factor I-gene
Elk B-gene
- I-gene
1 I-gene
. 0

By 0
screening 0
a 0
human 0
testis 0
cDNA 0
library 0
with 0
a 0
probe 0
containing 0
the 0
mouse B-gene
PEA3 I-gene
ETS B-gene
domain 0
, 0
we 0
isolated 0
a 0
2.2 0
kb 0
clone 0
containing 0
a 0
510 0
AA 0
open 0
reading 0
frame 0
. 0

It 0
is 0
also 0
affected 0
by 0
the 0
HAP2/3/4 B-gene
transcription I-gene
factor I-gene
complex I-gene
and 0
by 0
SNF1 B-gene
and 0
SSN6 B-gene
. 0

The 0
gene 0
is 0
predicted 0
to 0
encode 0
an 0
880 0
- 0
amino 0
- 0
acid 0
protein 0
which 0
contains 0
two 0
C2H2 0
zinc 0
fingers 0
, 0
a 0
nuclear 0
localization 0
sequence 0
and 0
two 0
transcriptional 0
activation 0
domains 0
. 0

These 0
results 0
indicate 0
that 0
H B-gene
- I-gene
2RIIBP I-gene
( 0
i 0
) 0
is 0
a 0
member 0
of 0
the 0
superfamily 0
of 0
nuclear B-gene
hormone I-gene
receptors I-gene
and 0
( 0
ii 0
) 0
may 0
regulate 0
not 0
only 0
MHC B-gene
class I-gene
I I-gene
genes I-gene
but 0
also 0
genes 0
containing 0
the 0
ERE 0
and 0
related 0
sequences 0
. 0

Relaxant 0
effect 0
of 0
prostaglandin 0
E1 0
( 0
PGE1 0
) 0
and 0
papaverine 0
( 0
PAP 0
) 0
were 0
measured 0
in 0
strips 0
of 0
corpus 0
cavernosum 0
smooth 0
muscle 0
taken 0
from 0
a 0
healthy 0
control 0
group 0
of 0
men 0
( 0
A 0
; 0
n 0
= 0
5 0
) 0
, 0
from 0
arteriogenically 0
impotent 0
men 0
( 0
B 0
; 0
n 0
= 0
6 0
) 0
and 0
from 0
additionally 0
diabetic 0
impotent 0
men 0
( 0
C 0
; 0
n 0
= 0
5 0
) 0
with 0
venous 0
leakage 0
. 0

The 0
sensitivity 0
of 0
central B-gene
dopamine I-gene
receptors I-gene
was 0
assessed 0
with 0
the 0
growth B-gene
hormone I-gene
response 0
to 0
apomorphine 0
application 0
. 0

Pathogenesis 0
of 0
fever 0
. 0

The 0
occurrence 0
of 0
the 0
different 0
types 0
of 0
TCRB B-gene
rearrangement 0
patterns 0
has 0
implications 0
for 0
PCR 0
- 0
based 0
clonality 0
assessment 0
and 0
for 0
PCR 0
- 0
based 0
detection 0
of 0
minimal 0
residual 0
disease 0
via 0
TCRB B-gene
gene I-gene
analysis 0
. 0

In 0
many 0
other 0
contractile 0
protein 0
gene 0
families 0
, 0
genes 0
encoding 0
cardiac 0
isoforms 0
are 0
expressed 0
early 0
in 0
skeletal 0
muscle 0
development 0
and 0
are 0
later 0
repressed 0
. 0

The 0
NH2 0
- 0
terminal 0
fragments 0
were 0
tested 0
for 0
susceptibility 0
to 0
modification 0
with 0
Nalpha 0
- 0
( 0
3 0
- 0
maleimidylpropionyl 0
) 0
biocytin 0
, 0
which 0
attaches 0
a 0
biotin 0
group 0
to 0
cysteine 0
sulfhydryls 0
. 0

Directional 0
growth 0
of 0
a 0
smectic 0
- 0
A 0
- 0
smectic 0
- 0
B 0
interface 0
lying 0
along 0
a 0
forbidden 0
orientation 0
. 0

METHODS 0
: 0
We 0
performed 0
nasal 0
mupirocin 0
treatment 0
on 0
10 0
infants 0
who 0
were 0
MRSA 0
- 0
positive 0
either 0
in 0
the 0
nose 0
or 0
the 0
pharynx 0
and 0
evaluated 0
the 0
effect 0
of 0
mupirocin 0
on 0
the 0
eradication 0
of 0
MRSA 0
. 0

TOM1 B-gene
encodes 0
a 0
member 0
of 0
the 0
hect B-gene
- 0
domain 0
- 0
containing 0
E3 B-gene
ubiquitin B-gene
- I-gene
protein I-gene
ligase I-gene
family 0
that 0
is 0
required 0
for 0
growth 0
at 0
elevated 0
temperatures 0
. 0

Purified 0
preparations 0
of 0
all 0
four 0
AGT 0
mutants 0
showed 0
an 0
approximately 0
similar 0
degree 0
( 0
74 0
- 0
120 0
- 0
fold 0
) 0
of 0
reduction 0
in 0
the 0
rate 0
of 0
reaction 0
with 0
O6 0
- 0
benzylguanine 0
. 0

These 0
results 0
demonstrate 0
that 0
m2 B-gene
receptors I-gene
couple 0
to 0
both 0
G B-gene
alpha I-gene
i2 I-gene
and 0
G B-gene
alpha I-gene
i3 I-gene
in 0
vivo 0
and 0
that 0
this 0
interaction 0
is 0
integral 0
to 0
both 0
positive 0
and 0
negative 0
regulatory 0
pathways 0
leading 0
to 0
activation 0
of 0
PLC B-gene
and 0
desensitization 0
of 0
receptor 0
signaling 0
. 0

This 0
is 0
the 0
first 0
clinical 0
case 0
report 0
of 0
NIHF 0
due 0
to 0
fetal 0
Kasabach 0
- 0
Merritt 0
syndrome 0
that 0
was 0
prenatally 0
diagnosed 0
by 0
sonography 0
, 0
computerized 0
tomography 0
, 0
and 0
percutaneous 0
umbilical 0
blood 0
sampling 0
. 0

The 0
cholesterol B-gene
7alpha I-gene
- I-gene
hydroxylase I-gene
gene I-gene
( 0
CYP7A B-gene
) 0
is 0
transcriptionally 0
regulated 0
by 0
a 0
number 0
of 0
factors 0
, 0
including 0
hormones 0
, 0
bile 0
acids 0
, 0
and 0
diurnal 0
rhythm 0
. 0

Restriction 0
mapping 0
showed 0
that 0
the 0
two 0
recombinant 0
plasmids 0
shared 0
an 0
EcoRI B-gene
fragment I-gene
of 0
8.9 0
kb 0
. 0

Two 0
mutants 0
, 0
mapping 0
at 0
the 0
HindIII B-gene
site I-gene
( 0
between 0
the 0
consensus 0
sequences 0
) 0
of 0
the 0
pSC101 B-gene
tetA I-gene
promoter I-gene
, 0
were 0
studied 0
: 0
MA2 0
corresponds 0
to 0
a 0
4 0
bp 0
deletion 0
between 0
positions 0
- 0
12 0
and 0
- 0
15 0
; 0
B30 0
bears 0
a 0
44 0
bp 0
insertion 0
C 0
( 0
TA 0
) 0
21 0
G 0
at 0
the 0
HindIII B-gene
site I-gene
. 0

Meq/c B-gene
Meq/c I-gene
- I-gene
Jun I-gene
heterodimers 0
bind 0
to 0
an 0
AP1 B-gene
- I-gene
like I-gene
sequence I-gene
in 0
the 0
meq B-gene
promoter I-gene
region I-gene
with 0
an 0
affinity 0
much 0
greater 0
than 0
that 0
of 0
Meq/Meq B-gene
or 0
Meq/Meq I-gene

Infra 0
- 0
red 0
spectroscopy 0
of 0
tissues 0
in 0
the 0
700 0
- 0
400 0
cm 0
- 0
1 0
region 0
. 0

Although 0
no 0
detectable 0
phenotypes 0
are 0
associated 0
with 0
a 0
disruption 0
allele 0
of 0
ABP1 B-gene
, 0
mutations 0
that 0
create 0
a 0
requirement 0
for 0
this 0
protein 0
have 0
now 0
been 0
isolated 0
in 0
the 0
previously 0
identified 0
gene B-gene
SAC6 I-gene
and 0
in 0
two 0
new 0
genes 0
, 0
SLA1 B-gene
and 0
SLA2 B-gene
. 0

Comparison 0
of 0
bioreactive 0
and 0
immunoreactive 0
gastrin B-gene
. 0

The 0
claustrocortical 0
connection 0
was 0
investigated 0
in 0
13 0
cats 0
with 0
selective 0
injections 0
of 0
30 0
% 0
HRP 0
in 0
the 0
three 0
subdivisions 0
of 0
the 0
auditory 0
cortex 0
. 0
( 0
ABSTRACT 0
TRUNCATED 0
AT 0
400 0
WORDS 0
) 0

The 0
authors 0
report 0
a 0
case 0
of 0
a 0
painful 0
wrist 0
related 0
to 0
a 0
`` 0
Manieux 0
muscle 0
'' 0
of 0
the 0
dorsal 0
aspect 0
of 0
the 0
hand 0
. 0

A 0
significant 0
reduction 0
in 0
total 0
cellular 0
p27 B-gene
protein I-gene
levels 0
and 0
a 0
moderate 0
reduction 0
in 0
p27 B-gene
mRNA I-gene
are 0
observed 0
, 0
but 0
no 0
changes 0
in 0
Cdk B-gene
regulatory 0
kinases 0
and 0
phosphatases 0
occur 0
. 0

This 0
result 0
, 0
together 0
with 0
the 0
fact 0
that 0
unrearranged B-gene
V I-gene
kappa I-gene
genes I-gene
are 0
transcriptionally 0
silent 0
, 0
suggests 0
that 0
structural 0
features 0
of 0
both 0
the 0
V B-gene
kappa I-gene
and 0
C B-gene
kappa I-gene
loci I-gene
contribute 0
to 0
the 0
overall 0
transcriptional 0
efficiency 0
of 0
a 0
rearranged B-gene
V I-gene
kappa I-gene
- I-gene
C I-gene
kappa I-gene
gene I-gene
. 0

Level 0
II 0
mosaicism 0
occurred 0
in 0
0.9 0
per 0
cent 0
of 0
CVS 0
mesenchyme 0
and 0
1.5 0
per 0
cent 0
of 0
amniotic 0
fluid 0
cultures 0
and 0
in 0
general 0
was 0
not 0
perceived 0
to 0
be 0
of 0
sufficient 0
concern 0
to 0
warrant 0
cytogenetic 0
follow 0
- 0
up 0
studies 0
. 0

Measures 0
of 0
sedation 0
, 0
BIS 0
, 0
deltaBIS 0
( 0
absolute 0
change 0
of 0
BIS 0
after 0
a 0
painful 0
stimulus 0
) 0
, 0
memory 0
, 0
and 0
drug 0
concentration 0
were 0
obtained 0
at 0
each 0
target 0
drug 0
concentration 0
. 0

There 0
are 0
three 0
types 0
of 0
problems 0
: 0
problems 0
arising 0
before 0
the 0
drug 0
enters 0
the 0
body 0
( 0
solubilization 0
, 0
stabilization 0
and 0
improved 0
acceptability 0
) 0
; 0
problems 0
associated 0
with 0
the 0
penetration 0
and 0
fate 0
of 0
the 0
drug 0
in 0
the 0
body 0
( 0
absorption 0
, 0
barrier 0
crossing 0
, 0
duration 0
of 0
action 0
) 0
; 0
problems 0
relating 0
to 0
the 0
therapeutic 0
target 0
( 0
selective 0
local 0
delivery 0
) 0
. 0

The 0
structure 0
elucidation 0
of 0
the 0
iridoid 0
compounds 0
2 0
and 0
3 0
are 0
discussed 0
in 0
detail 0
. 0

Characterization 0
of 0
trinucleotide 0
- 0
and 0
tandem 0
repeat 0
- 0
containing 0
transcripts 0
obtained 0
from 0
human 0
spinal 0
cord 0
cDNA 0
library 0
by 0
high 0
- 0
density 0
filter 0
hybridization 0
. 0

CONCLUSION 0
: 0
Urbanisation 0
is 0
associated 0
with 0
an 0
increase 0
in 0
the 0
prevalence 0
rates 0
of 0
some 0
risk 0
behaviours 0
. 0

The 0
authors 0
emphasize 0
absence 0
of 0
specific 0
signs 0
of 0
vagal 0
involvement 0
, 0
importance 0
for 0
diagnosis 0
of 0
surgical 0
extirpation 0
, 0
and 0
mildness 0
of 0
post 0
operative 0
course 0
. 0

Growth 0
factors 0
promote 0
cell 0
survival 0
through 0
phosphorylation 0
of 0
Bad B-gene
, 0
resulting 0
in 0
its 0
dissociation 0
from 0
Bcl B-gene
- I-gene
2 I-gene
and 0
Bcl B-gene
- I-gene
x I-gene
( I-gene
L I-gene
) I-gene
and 0
its 0
association 0
with 0
14 B-gene
- I-gene
3 I-gene
- I-gene
3tau I-gene
. 0

Both 0
in 0
the 0
Federal 0
Republic 0
of 0
Germany 0
and 0
in 0
some 0
neighbouring 0
countries 0
the 0
epizootic 0
situation 0
of 0
Aujeszky 0
's 0
disease 0
has 0
been 0
unsatisfactory 0
for 0
a 0
long 0
time 0
, 0
especially 0
in 0
areas 0
with 0
a 0
high 0
pig 0
density 0
. 0

The 0
sensitivity 0
of 0
99mTc 0
- 0
IgG B-gene
scintigraphy 0
ranged 0
between 0
71 0
% 0
and 0
100 0
% 0
. 0

Acad 0
. 0

Aggravation 0
of 0
peripheral 0
- 0
blood 0
cytopenia 0
during 0
the 0
first 0
weeks 0
and 0
hypocellularity 0
of 0
bone 0
- 0
marrow 0
aspirates 0
at 0
the 0
end 0
of 0
therapy 0
suggest 0
that 0
low 0
- 0
dose 0
Ara 0
C 0
exerts 0
its 0
main 0
activity 0
by 0
suppression 0
of 0
leukaemic 0
growth 0
, 0
rather 0
than 0
by 0
induction 0
of 0
differentiation 0
in 0
malignant 0
cells 0
. 0

Those 0
participating 0
in 0
this 0
investigation 0
( 0
65 0
centers 0
= 0
79 0
% 0
) 0
received 0
a 0
series 0
of 0
computer 0
disks 0
containing 0
50 0
99mTc 0
- 0
DMSA 0
studies 0
. 0

Probiotics 0
, 0
prebiotics 0
, 0
vaccination 0
, 0
and 0
acidification 0
of 0
drinking 0
water 0
were 0
assessed 0
as 0
means 0
of 0
reducing 0
Salmonella 0
. 0

Mutation 0
of 0
this 0
threonine 0
to 0
isoleucine 0
had 0
no 0
observable 0
effect 0
on 0
either 0
nuclear 0
localization 0
of 0
E1 B-gene
or 0
DNA 0
replication 0
of 0
the 0
intact 0
viral 0
genome 0
. 0

The 0
inhibition 0
of 0
monoamine B-gene
oxidase I-gene
( 0
MAO B-gene
) 0
by 0
tranylcypromine 0
was 0
studied 0
in 0
6 0
healthy 0
volunteers 0
given 0
increasing 0
doses 0
of 0
10 0
, 0
15 0
, 0
20 0
and 0
25 0
mg/day 0
over 0
a 0
4 0
- 0
week 0
period 0
. 0

Myocardial 0
technetium 0
- 0
99m 0
- 0
teboroxime 0
uptake 0
during 0
adenosine 0
- 0
induced 0
hyperemia 0
in 0
dogs 0
with 0
either 0
a 0
critical 0
or 0
mild 0
coronary 0
stenosis 0
: 0
comparison 0
to 0
thallium 0
- 0
201 0
and 0
regional 0
blood 0
flow 0
. 0

Both 0
atracurium 0
1 0
- 0
100 0
mumol 0
litre 0
- 0
1 0
and 0
laudanosine 0
1 0
- 0
50 0
mumol 0
litre 0
- 0
1 0
enhanced 0
the 0
release 0
of 0
3H 0
- 0
NA 0
evoked 0
by 0
field 0
stimulation 0
( 0
2 0
Hz 0
, 0
24 0
stimuli 0
) 0
, 0
but 0
did 0
not 0
affect 0
resting 0
release 0
. 0

The 0
recovery 0
of 0
xanthomegnin 0
added 0
to 0
corn 0
samples 0
at 0
levels 0
of 0
0.75 0
- 0
- 0
9.6 0
mg/kg 0
averaged 0
41 0
% 0
with 0
a 0
coefficient 0
of 0
variation 0
of 0
25 0
% 0
. 0

Because 0
of 0
the 0
data 0
, 0
we 0
suggest 0
that 0
LAC9 B-gene
contacts 0
positions 0
6 0
, 0
7 0
, 0
and 0
8 0
, 0
both 0
plus 0
and 0
minus 0
, 0
of 0
the 0
UAS 0
, 0
which 0
are 0
separated 0
by 0
more 0
than 0
one 0
turn 0
of 0
the 0
DNA 0
helix 0
, 0
and 0
twists 0
part 0
way 0
around 0
the 0
DNA 0
, 0
thus 0
protecting 0
the 0
broad 0
region 0
of 0
the 0
minor 0
groove 0
between 0
the 0
major 0
- 0
groove 0
contacts 0
. 0

Istanbul 0
, 0
Turkey 0
. 0

After 0
Northern 0
blot 0
hybridization 0
, 0
two 0
Cx31 B-gene
transcripts I-gene
of I-gene
2.2 I-gene
and I-gene
1.8 I-gene
kb I-gene
were 0
detected 0
in 0
total 0
RNA 0
of 0
the 0
human 0
keratinocyte 0
cell 0
line 0
HaCaT 0
and 0
two 0
transcripts 0
of 0
2.2 0
and 0
1.9 0
kb 0
in 0
total 0
RNA 0
of 0
E6/E7 B-gene
transfected 0
human 0
keratinocytes 0
( 0
HEK 0
cells 0
) 0
. 0

While 0
differential 0
expression 0
of 0
the 0
two 0
transcripts 0
was 0
not 0
found 0
, 0
the 0
promoter 0
controlling 0
LT1/LT2 B-gene
transcription 0
is 0
regulated 0
in 0
a 0
cell 0
cycle 0
- 0
dependent 0
manner 0
. 0

SYC1 B-gene
( 0
suppressor B-gene
of I-gene
yeast I-gene
cbf5 I-gene
- I-gene
1 I-gene
) 0
was 0
identified 0
as 0
a 0
multicopy 0
suppressor 0
of 0
cbf5 B-gene
- I-gene
1 I-gene
and 0
subsequently 0
was 0
found 0
to 0
be 0
identical 0
to 0
RRN3 B-gene
, 0
an 0
RNA B-gene
polymerase I-gene
I I-gene
transcription I-gene
factor I-gene
. 0

Developmental 0
regulation 0
of 0
expression 0
of 0
the 0
malate B-gene
synthase I-gene
gene I-gene
in 0
transgenic 0
plants 0
. 0

All 0
three 0
SSV 0
- 0
transformed 0
cells 0
secreted 0
v B-gene
- I-gene
sis I-gene
gene I-gene
product I-gene
( 0
p44 B-gene
) 0
. 0
p44 B-gene
was 0
secreted 0
but 0
remained 0
tightly 0
associated 0
with 0
the 0
cell 0
surface 0
. 0

We 0
also 0
identified 0
a 0
DNA 0
fragment 0
, 0
10.7 0
kbp 0
upstream 0
from 0
the 0
first 0
coding 0
exon 0
of 0
human B-gene
aFGF I-gene
, 0
whose 0
sequence 0
is 0
conserved 0
in 0
both 0
the 0
primate 0
and 0
rodent 0
genomes 0
. 0

In 0
this 0
respect 0
, 0
the 0
promoter 0
structure 0
of 0
COX B-gene
genes I-gene
resemble 0
those 0
of 0
many 0
house 0
- 0
keeping 0
genes 0
. 0

The 0
predicted 0
amino 0
acid 0
sequence 0
of 0
the 0
FlaB2 B-gene
polypeptide I-gene
was 0
92 0
% 0
identical 0
to 0
that 0
of 0
T. B-gene
pallidum I-gene
FlaB2 I-gene
, 0
with 0
a 0
76 0
% 0
identity 0
at 0
the 0
nucleotide 0
level 0
. 0

These 0
data 0
demonstrate 0
that 0
CCTalpha B-gene
can 0
be 0
regulated 0
by 0
lipids 0
by 0
two 0
independent 0
domains 0
: 0
( 0
i 0
) 0
the 0
three 0
amphipathic 0
alpha 0
- 0
helical 0
repeats 0
that 0
interact 0
with 0
both 0
neutral 0
and 0
anionic 0
lipid 0
mixtures 0
and 0
( 0
ii 0
) 0
the 0
last 0
57 0
residues 0
that 0
interact 0
with 0
anionic 0
lipids 0
. 0

Ion 0
- 0
Bernstein 0
- 0
wave 0
heating 0
and 0
improved 0
confinement 0
in 0
the 0
Alcator 0
C 0
tokamak 0
. 0

Of 0
3841 0
serum 0
samples 0
from 0
sows 0
received 0
from 0
the 0
Tennessee 0
State 0
Diagnostic 0
Laboratory 0
in 0
1991 0
- 0
1992 0
, 0
1130 0
were 0
positive 0
for 0
Toxoplasma B-gene
gondii I-gene
antibody I-gene
. 0

Morphometry 0
of 0
the 0
intestine 0
of 0
the 0
pig 0
. 0

The 0
subjects 0
were 0
started 0
on 0
indomethacin 0
25 0
mg 0
thrice 0
daily 0
. 0

Human B-gene
parvovirus I-gene
B19 I-gene
gene I-gene
expression 0
from 0
the 0
viral B-gene
p6 I-gene
promoter I-gene
( 0
B19p6 B-gene
) 0
is 0
restricted 0
to 0
primary 0
human 0
hematopoietic 0
cells 0
undergoing 0
erythroid 0
differentiation 0
. 0

To 0
further 0
study 0
the 0
role 0
of 0
tTG B-gene
in 0
liver 0
disease 0
, 0
we 0
initiated 0
investigations 0
into 0
the 0
effect 0
of 0
a 0
proinflammatory 0
mediator 0
, 0
tumor B-gene
necrosis I-gene
factor I-gene
( I-gene
TNF I-gene
) I-gene
- I-gene
alpha I-gene
, 0
on 0
tTG B-gene
activity 0
in 0
cultured 0
liver 0
cells 0
. 0

The 0
atopic 0
disposition 0
, 0
indicated 0
by 0
positive 0
skin 0
reactions 0
and 0
IgE B-gene
antibody 0
titers 0
etc. 0
, 0
and 0
the 0
bronchial 0
reactivity 0
to 0
inhaled 0
acetylcholine 0
were 0
examined 0
on 0
the 0
following 0
three 0
groups 0
: 0
( 0
1 0
) 0
20 0
young 0
adults 0
with 0
a 0
history 0
of 0
childhood 0
asthma 0
who 0
have 0
been 0
symptom 0
- 0
free 0
for 0
more 0
than 0
4 0
yr 0
; 0
( 0
2 0
) 0
20 0
current 0
asthmatics 0
, 0
and 0
( 0
3 0
) 0
20 0
healthy 0
young 0
adults 0
. 0

Continuous 0
arterial 0
blood 0
sampling 0
method 0
based 0
on 0
the 0
microsphere 0
model 0
was 0
used 0
as 0
a 0
quantitative 0
rCBF 0
measurement 0
. 0

Members 0
of 0
the 0
steroid/hormone B-gene
nuclear I-gene
receptor I-gene
superfamily I-gene
regulate 0
target 0
gene 0
transcription 0
via 0
recognition 0
and 0
association 0
with 0
specific 0
cis 0
- 0
acting 0
sequences 0
of 0
DNA 0
, 0
called 0
hormone 0
response 0
elements 0
( 0
HREs 0
) 0
. 0

Thomas 0
, 0
S.S 0
. 0

In 0
addition 0
to 0
these 0
cases 0
, 0
patients 0
w 0
with 0
high 0
Loa 0
microfilaremia 0
also 0
developed 0
milder 0
neurologic 0
manifestations 0
causing 0
functional 0
impairment 0
lasting 0
for 0
at 0
least 0
one 0
week 0
after 0
treatment 0
. 0

The 0
patient 0
demographics 0
( 0
means 0
+/ 0
- 0
standard 0
deviations 0
) 0
were 0
as 0
follows 0
: 0
age 0
, 0
57 0
+/ 0
- 0
12 0
years 0
; 0
sex 0
, 0
nine 0
males 0
and 0
three 0
females 0
; 0
APACHE 0
II 0
score 0
, 0
15 0
+/ 0
- 0
3 0
; 0
diagnosis 0
, 0
9 0
of 0
12 0
patients 0
with 0
pneumonia 0
. 0

Patients 0
with 0
binocular 0
pregeniculate 0
visual 0
loss 0
, 0
patients 0
with 0
balanced 0
binocular 0
pregeniculate 0
loss 0
without 0
RAPD 0
, 0
and 0
patients 0
with 0
monocular 0
pregeniculate 0
visual 0
loss 0
had 0
significantly 0
larger 0
pupils 0
than 0
age 0
- 0
matched 0
controls 0
. 0

In 0
contrast 0
, 0
corticotropin B-gene
releasing I-gene
factor I-gene
( 0
CRF B-gene
) 0
, 0
injected 0
centrally 0
produces 0
a 0
suppression 0
of 0
punished 0
and 0
non 0
- 0
punished 0
responding 0
in 0
the 0
conflict 0
test 0
consistent 0
with 0
its 0
hypothesized 0
role 0
in 0
mediating 0
behavioral 0
responses 0
to 0
stress 0
. 0

Analysis 0
of 0
replicative 0
intermediates 0
shows 0
that 0
plasmid 0
YRp7 0
, 0
which 0
contains 0
the 0
chromosomal 0
replicator 0
ARS1 0
, 0
initiates 0
bidirectional 0
replication 0
in 0
a 0
100 0
bp 0
region 0
within 0
the 0
sequence 0
required 0
for 0
autonomous 0
replication 0
in 0
vivo 0
. 0

Tag B-gene
expression 0
induced 0
apoptosis 0
in 0
mammary 0
epithelial 0
cells 0
during 0
late 0
pregnancy 0
. 0

Concentrations 0
of 0
Co 0
, 0
Cu 0
, 0
Fe 0
, 0
Hg 0
, 0
Mn 0
, 0
Sb 0
, 0
Se 0
and 0
Zn 0
in 0
IAEA 0
milk 0
( 0
dry 0
) 0
standard 0
A 0
- 0
11 0
were 0
re 0
- 0
evaluated 0
with 0
the 0
help 0
of 0
instrumental 0
and 0
radiochemical 0
neutron 0
activation 0
analysis 0
( 0
NAA 0
) 0
. 0

Here 0
we 0
show 0
that 0
these 0
sequences 0
are 0
essential 0
for 0
processing 0
of 0
U18 B-gene
and 0
snR38 B-gene
snoRNAs I-gene
and 0
that 0
they 0
compensate 0
for 0
the 0
lack 0
of 0
a 0
canonical 0
terminal 0
stem 0
. 0

In 0
serum 0
- 0
starved 0
NIH 0
3T3 0
cells 0
, 0
v B-gene
- I-gene
raf I-gene
increased 0
mdr1 B-gene
promoter I-gene
activity 0
approximately 0
10 0
- 0
fold 0
compared 0
to 0
a 0
v B-gene
- I-gene
raf I-gene
frame 0
- 0
shift 0
control 0
. 0

An 0
insertion 0
sequence 0
element 0
( 0
IS1170 0
) 0
was 0
identified 0
upstream 0
of 0
the 0
nimC B-gene
gene I-gene
. 0

Two 0
genes 0
( 0
ptsI B-gene
and 0
ptsA B-gene
) 0
that 0
encode 0
homologues 0
of 0
the 0
energy 0
coupling 0
Enzyme B-gene
I I-gene
of 0
the 0
phosphoenolpyruvate B-gene
- I-gene
dependent I-gene
sugar I-gene
- I-gene
transporting I-gene
phosphotransferase I-gene
system 0
( 0
PTS 0
) 0
have 0
previously 0
been 0
identified 0
on 0
the 0
Escherichia 0
coli 0
chromosome 0
. 0

We 0
show 0
that 0
the 0
upstream 0
region 0
of 0
the 0
beta B-gene
- I-gene
MyHC I-gene
gene I-gene
( 0
- 0
5518 0
to 0
- 0
2490 0
relative 0
to 0
the 0
transcriptional 0
start 0
site 0
) 0
directed 0
high 0
levels 0
of 0
transcriptional 0
activity 0
only 0
when 0
stably 0
integrated 0
, 0
but 0
not 0
when 0
expressed 0
extrachromosomally 0
in 0
transient 0
assays 0
. 0

Although 0
the 0
cDNAs 0
of 0
HMG B-gene
- I-gene
14 I-gene
and 0
HMG B-gene
- I-gene
17 I-gene
do 0
not 0
cross 0
- 0
hybridize 0
, 0
they 0
have 0
several 0
similar 0
structural 0
features 0
: 0
the 0
open 0
reading 0
frame 0
comprises 0
only 0
23 0
% 0
of 0
the 0
transcripts 0
, 0
the 0
5' 0
- 0
untranslated 0
region 0
is 0
extremely 0
GC 0
rich 0
whereas 0
the 0
3' 0
- 0
untranslated 0
region 0
is 0
unusually 0
long 0
and 0
AT 0
rich 0
. 0

A 0
minimal 0
pheromone 0
induction 0
domain 0
, 0
delineated 0
as 0
residues 0
301 0
to 0
335 0
of 0
Ste12p B-gene
, 0
is 0
dependent 0
on 0
the 0
pheromone 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
( I-gene
MAP I-gene
) I-gene
kinase I-gene
pathway 0
for 0
induction 0
activity 0
. 0

The 0
IFNAR B-gene
chain I-gene
interacts 0
with 0
both 0
IFN B-gene
- I-gene
alpha I-gene
2 I-gene
and 0
IFN B-gene
- I-gene
beta I-gene
, 0
as 0
demonstrated 0
by 0
cross 0
- 0
linking 0
. 0

To 0
assess 0
the 0
effect 0
on 0
thrombus 0
growth 0
, 0
we 0
determined 0
the 0
accretion 0
of 0
125I 0
- 0
labeled 0
fibrinogen B-gene
onto 0
autologous 0
non 0
- 0
radioactive 0
thrombi 0
preformed 0
in 0
the 0
jugular 0
veins 0
of 0
rabbits 0
. 0

In 0
the 0
other 0
two 0
cases 0
, 0
fluoxetine 0
adjunct 0
produced 0
benefits 0
with 0
no 0
additional 0
side 0
effects 0
. 0

This 0
radiolabeled 0
, 0
900 0
- 0
bp 0
amplicon 0
was 0
used 0
as 0
a 0
hybridization 0
probe 0
to 0
screen 0
a 0
cDNA 0
library 0
constructed 0
from 0
poly 0
( 0
A 0
) 0
( 0
+ 0
) 0
RNA 0
isolated 0
from 0
induced 0
Taxus 0
cells 0
, 0
from 0
which 0
a 0
full 0
- 0
length 0
transacetylase 0
sequence 0
was 0
obtained 0
. 0

Similarly 0
, 0
TAM B-gene
- I-gene
67 I-gene
reverted 0
the 0
morphology 0
of 0
the 0
AdoMetDC B-gene
- I-gene
antisense I-gene
expressors I-gene
. 0

For 0
the 0
second 0
phase 0
, 0
it 0
was 0
12.5 0
wk 0
for 0
RIR 0
and 0
10 0
for 0
WL 0
males 0
, 0
whereas 0
it 0
was 0
5 0
wk 0
for 0
RIR 0
and 0
6 0
for 0
WL 0
females 0
. 0

TFEC B-gene
RNA I-gene
is 0
found 0
in 0
many 0
tissues 0
of 0
adult 0
rats 0
, 0
but 0
the 0
relative 0
concentrations 0
of 0
TFEC B-gene
and 0
TFE3 B-gene
RNAs I-gene
vary 0
considerably 0
in 0
these 0
different 0
tissues 0
. 0

RESULTS 0
: 0
Three 0
patients 0
did 0
not 0
tolerate 0
PPI 0
medication 0
and 0
were 0
managed 0
by 0
treatment 0
with 0
type 0
2 0
histamine 0
( 0
H2 0
) 0
blockers 0
. 0

VLA B-gene
- I-gene
4 I-gene
integrin I-gene
cross 0
- 0
linking 0
on 0
human 0
monocytic 0
THP 0
- 0
1 0
cells 0
induces 0
tissue 0
factor 0
expression 0
by 0
a 0
mechanism 0
involving 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
. 0

Diethyldithiocarbamate 0
and 0
amphetamine 0
stereotype 0
behavior 0
. 0

This 0
result 0
, 0
together 0
with 0
the 0
fact 0
that 0
unrearranged B-gene
V I-gene
kappa I-gene
genes I-gene
are 0
transcriptionally 0
silent 0
, 0
suggests 0
that 0
structural 0
features 0
of 0
both 0
the 0
V B-gene
kappa I-gene
and 0
C B-gene
kappa I-gene
loci I-gene
contribute 0
to 0
the 0
overall 0
transcriptional 0
efficiency 0
of 0
a 0
rearranged 0
V B-gene
kappa I-gene
- 0
C B-gene
kappa I-gene
gene 0
. 0

Oct B-gene
- I-gene
1 I-gene
is 0
a 0
ubiquitously 0
expressed 0
regulatory 0
gene 0
of 0
the 0
POU B-gene
domain I-gene
family I-gene
. 0

Both 0
RNA14 B-gene
and 0
RNA15 B-gene
wild I-gene
- I-gene
type I-gene
genes I-gene
, 0
when 0
cloned 0
on 0
a 0
multicopy 0
plasmid 0
, 0
are 0
able 0
to 0
suppress 0
the 0
temperature 0
- 0
sensitive 0
phenotype 0
of 0
strains 0
bearing 0
either 0
the 0
rna14 B-gene
or 0
the 0
rna15 B-gene
mutation I-gene
, 0
suggesting 0
that 0
the 0
encoded 0
proteins 0
could 0
interact 0
with 0
each 0
other 0
. 0

Recent 0
studies 0
have 0
concentrated 0
on 0
the 0
methods 0
of 0
preparation 0
of 0
coffee 0
, 0
which 0
vary 0
from 0
country 0
to 0
country 0
. 0

In 0
addition 0
, 0
while 0
GCN1 B-gene
is 0
required 0
in 0
vivo 0
for 0
phosphorylation 0
of 0
eIF B-gene
- I-gene
2 I-gene
alpha I-gene
by 0
GCN2 B-gene
, 0
cell 0
extracts 0
from 0
gcn1 B-gene
delta I-gene
strains 0
contained 0
wild 0
- 0
type 0
levels 0
of 0
GCN2 B-gene
eIF B-gene
- I-gene
2 I-gene
alpha I-gene
- 0
kinase 0
activity 0
. 0

Seven 0
patients 0
were 0
without 0
a 0
syndromic 0
diagnosis 0
. 0

Experimental 0
production 0
of 0
a 0
syndrome 0
analogous 0
to 0
hydramnios 0
in 0
the 0
rat 0
fetus 0

The 0
phP1 B-gene
mutation 0
was 0
induced 0
by 0
insertion 0
of 0
a 0
1.2 0
- 0
kb 0
P B-gene
element I-gene
into 0
the 0
5 0
' 0
transcribed 0
nontranslated 0
region 0
of 0
the 0
proximal 0
polyhomeotic B-gene
gene I-gene
. 0

By 0
contrast 0
, 0
clonidine 0
( 0
1 0
micrograms/kg 0
) 0
elicited 0
an 0
immediate 0
and 0
prolonged 0
fall 0
in 0
blood 0
pressure 0
and 0
heart 0
rate 0
when 0
given 0
into 0
the 0
vertebral 0
artery 0
, 0
but 0
not 0
intravenously 0
. 0

Forty 0
- 0
eight 0
pregnant 0
adult 0
and 0
122 0
fetal 0
guinea 0
pigs 0
were 0
sacrificed 0
at 0
intervals 0
throughout 0
gestation 0
and 0
the 0
carcasses 0
analyzed 0
for 0
a 0
variety 0
of 0
growth 0
parameters 0
. 0

To 0
investigate 0
the 0
in 0
vivo 0
role 0
of 0
this 0
chimeric B-gene
bZIP I-gene
protein I-gene
in 0
oncogenic 0
transformation 0
, 0
its 0
expression 0
was 0
directed 0
to 0
the 0
lymphoid 0
compartments 0
of 0
transgenic 0
mice 0
. 0

The 0
MALDI 0
- 0
TOF 0
experiment 0
, 0
however 0
, 0
proved 0
to 0
be 0
superior 0
to 0
the 0
GC 0
experiment 0
, 0
particularly 0
with 0
regard 0
to 0
baseline 0
resolution 0
of 0
unsaturated 0
acids 0
. 0

The 0
mean 0
serum 0
CDT 0
increased 0
from 0
8.5 0
( 0
SD 0
2.2 0
) 0
U/l 0
to 0
16.6 0
( 0
SD 0
7.2 0
) 0
U/l 0
( 0
P 0
< 0
0.001 0
) 0
. 0

In 0
female 0
toads 0
, 0
Bufo 0
bufo 0
, 0
feeding 0
at 0
different 0
rates 0
, 0
the 0
uncorrected 0
value 0
of 0
n 0
was 0
0.44 0
, 0
when 0
metabolism 0
and 0
growth 0
were 0
expressed 0
as 0
kJ 0
kJ 0
- 0
1 0
. 0

In 0
contrast 0
, 0
vRel B-gene
lacks 0
a 0
strong 0
C 0
- 0
terminal 0
gene 0
activation 0
function 0
, 0
since 0
a 0
LexA B-gene
fusion I-gene
protein I-gene
containing 0
C B-gene
- I-gene
terminal I-gene
vRel I-gene
sequences I-gene
alone 0
only 0
weakly 0
activated 0
transcription 0
. 0

Our 0
study 0
reveals 0
a 0
consequence 0
of 0
adhesion 0
receptor 0
- 0
mediated 0
signaling 0
in 0
T 0
cells 0
, 0
which 0
is 0
potentially 0
important 0
in 0
the 0
regulation 0
of 0
T 0
cell 0
activation 0
, 0
including 0
production 0
of 0
cytokines 0
and 0
expression 0
of 0
proto 0
- 0
oncogenes 0
, 0
many 0
of 0
which 0
are 0
controlled 0
through 0
3 0
' 0
AU 0
- 0
rich 0
elements 0
. 0

Assessment 0
of 0
ammonia 0
and 0
urea 0
blood 0
content 0
in 0
metabolic 0
acid 0
- 0
base 0
disorders 0
in 0
white 0
rats 0
. 0

3 0
- 0
5 0
- 0
fold 0
increases 0
in 0
EGF B-gene
receptor I-gene
but 0
not 0
p185 B-gene
( 0
neu B-gene
) 0
tyrosine 0
phosphorylation 0
occur 0
following 0
Gi B-gene
- I-gene
coupled I-gene
receptor I-gene
stimulation 0
. 0

So 0
it 0
is 0
sometimes 0
more 0
convenient 0
to 0
use 0
the 0
back 0
Radon 0
transform 0
R 0
- 0
1 0
and 0
then 0
to 0
correct 0
the 0
result 0
, 0
taking 0
into 0
account 0
attenuation 0
. 0

Immune 0
and 0
clinical 0
impact 0
of 0
Lactobacillus 0
acidophilus 0
on 0
asthma 0
. 0

These 0
results 0
indicate 0
that 0
( 0
1 0
) 0
RXR B-gene
- 0
TR B-gene
heterodimers 0
play 0
a 0
role 0
in 0
basal 0
transactivation 0
and 0
T3 0
suppression 0
of 0
negatively 0
regulated 0
genes 0
, 0
and 0
( 0
2 0
) 0
RXRs B-gene
increase 0
the 0
dominant 0
negative 0
effect 0
of 0
some 0
mutant 0
TRs B-gene
on 0
specific 0
negative 0
TREs 0
. 0

Injections 0
of 0
PD 0
solutions 0
with 0
13.6 0
, 0
22.7 0
, 0
and 0
38.6 0
g/liter 0
of 0
glucose 0
reduced 0
the 0
ingestion 0
of 0
sucrose 0
by 0
12.4 0
% 0
, 0
23.6 0
% 0
and 0
36.1 0
% 0
, 0
respectively 0
, 0
but 0
did 0
not 0
affect 0
the 0
ingestion 0
of 0
protein 0
. 0

To 0
examine 0
the 0
functional 0
relationship 0
between 0
distinct 0
cis 0
- 0
active 0
elements 0
within 0
the 0
distal 0
enhancer 0
region 0
of 0
the 0
rat B-gene
PRL I-gene
gene I-gene
, 0
we 0
have 0
used 0
deletional 0
and 0
mutational 0
analysis 0
of 0
that 0
region 0
in 0
transient 0
transfection 0
studies 0
in 0
GH3 0
pituitary 0
tumor 0
cells 0
. 0

While 0
there 0
is 0
growing 0
evidence 0
that 0
perception 0
and 0
imagery 0
share 0
common 0
neural 0
substrates 0
, 0
the 0
fact 0
that 0
D.F 0
. 0
shows 0
intact 0
visual 0
imagery 0
in 0
the 0
face 0
of 0
a 0
massive 0
perceptual 0
deficit 0
in 0
form 0
vision 0
challenges 0
recent 0
suggestions 0
that 0
these 0
two 0
psychological 0
processes 0
share 0
common 0
input 0
pathways 0
in 0
early 0
vision 0
. 0

Site 0
- 0
directed 0
mutagenesis 0
of 0
the 0
conserved 0
cysteine 0
residue 0
( 0
tom1C3235A B-gene
) 0
in 0
the 0
hect B-gene
- I-gene
domain I-gene
, 0
supposed 0
to 0
be 0
necessary 0
for 0
thioester 0
- 0
bond 0
formation 0
with 0
ubiquitin B-gene
, 0
abolished 0
the 0
gene 0
function 0
. 0

The 0
Seldinger 0
technique 0
for 0
difficult 0
transurethral 0
catheterization 0
: 0
a 0
gentle 0
alternative 0
to 0
suprapubic 0
puncture 0
( 0
Br 0
J 0
Surg 0
2000 0
; 0
87 0
: 0
1729 0
- 0
30 0
) 0
. 0

Gingival 0
retraction 0
for 0
class 0
V 0
restorations 0
. 0

The 0
amino 0
acid 0
sequence 0
of 0
the 0
protein 0
encoded 0
by 0
MSK1 B-gene
is 0
homologous 0
to 0
yeast B-gene
cytoplasmic I-gene
lysyl I-gene
- I-gene
tRNA I-gene
synthetase I-gene
and 0
to 0
the 0
product 0
of 0
the 0
herC B-gene
gene I-gene
, 0
which 0
has 0
recently 0
been 0
suggested 0
to 0
code 0
for 0
the 0
Escherichia 0
coli 0
enzyme 0
. 0

In 0
contrast 0
to 0
p62 B-gene
( 0
dok B-gene
) 0
, 0
DOKL B-gene
lacks 0
YxxP 0
motifs 0
in 0
the 0
C 0
terminus 0
and 0
does 0
not 0
bind 0
to 0
Ras B-gene
GTPase I-gene
- I-gene
activating I-gene
protein I-gene
( 0
RasGAP B-gene
) 0
upon 0
phosphorylation 0
. 0

The 0
presence 0
of 0
chloroquine 0
in 0
saliva 0
from 0
seven 0
healthy 0
volunteers 0
for 0
21 0
days 0
after 0
a 0
single 0
600 0
mg 0
oral 0
dose 0
of 0
the 0
drug 0
was 0
established 0
by 0
chromatographic 0
and 0
spectroscopic 0
methods 0
. 0

In 0
vitro 0
binding 0
studies 0
previously 0
showed 0
that 0
NF B-gene
- I-gene
kappa I-gene
B I-gene
p50 B-gene
homodimer 0
binds 0
the 0
switch B-gene
nuclear I-gene
B I-gene
- I-gene
site I-gene
protein I-gene
( 0
SNIP B-gene
) 0
of 0
the 0
S B-gene
gamma I-gene
3 I-gene
tandem I-gene
repeat I-gene
. 0

If 0
, 0
however 0
, 0
myocardial 0
stunning 0
is 0
severe 0
, 0
and 0
it 0
involves 0
large 0
parts 0
of 0
the 0
LV 0
and 0
thus 0
impairs 0
global 0
LV 0
function 0
, 0
it 0
can 0
be 0
reversed 0
with 0
inotropic 0
agents 0
and 0
procedures 0
. 0

Similarly 0
, 0
interfering 0
with 0
MEKK B-gene
, 0
which 0
lies 0
upstream 0
of 0
JNK1 B-gene
, 0
using 0
a 0
dominant 0
negative 0
expression 0
vector 0
reduced 0
MMP B-gene
- I-gene
9 I-gene
promoter I-gene
activity 0
over 0
the 0
same 0
concentration 0
range 0
which 0
repressed 0
the 0
AP B-gene
- I-gene
1 I-gene
- 0
thymidine B-gene
kinase I-gene
CAT B-gene
reporter 0
construct 0
. 0

The 0
7.2 B-gene
kb I-gene
EcoRI I-gene
fragment I-gene
of I-gene
AfMNPV I-gene
was 0
cloned 0
and 0
the 0
nucleotide 0
sequences 0
of 0
the 0
polyhedrin B-gene
coding 0
region 0
and 0
its 0
flanking 0
regions 0
were 0
determined 0
. 0

Joint 0
ultrasonography 0
demonstrating 0
thickening 0
of 0
synoviae 0
and 0
tendons 0
has 0
become 0
a 0
useful 0
non 0
- 0
invasive 0
diagnostic 0
tool 0
, 0
although 0
it 0
is 0
not 0
specific 0
for 0
beta B-gene
2 I-gene
- I-gene
M I-gene
amyloidosis 0
, 0
and 0
results 0
depend 0
on 0
observer 0
experience 0
. 0

Sequence 0
analyses 0
revealed 0
a 0
partial 0
941 0
bp 0
cDNA 0
that 0
encoded 0
a 0
313 0
- 0
amino 0
- 0
acid 0
polypeptide 0
. 0

Estimating 0
the 0
health 0
care 0
costs 0
of 0
smokers 0
. 0

Although 0
paclitaxel 0
alone 0
failed 0
to 0
induce 0
p38 B-gene
MAPK 0
activation 0
, 0
subsequent 0
( 0
but 0
not 0
prior 0
) 0
exposure 0
to 0
PD98059 0
induced 0
a 0
dramatic 0
increase 0
in 0
p38 B-gene
MAPK 0
phosphorylation 0
. 0

The 0
cyclin B-gene
- I-gene
dependent I-gene
kinase I-gene
Cdk2 B-gene
associates 0
with 0
cyclins B-gene
A I-gene
, I-gene
D I-gene
, I-gene
and I-gene
E I-gene
and 0
has 0
been 0
implicated 0
in 0
the 0
control 0
of 0
the 0
G1 0
to 0
S 0
phase 0
transition 0
in 0
mammals 0
. 0

Sequences 0
within 0
the 0
UAS2 0
element 0
of 0
the 0
ENO2 B-gene
gene I-gene
bound 0
a 0
second 0
protein 0
which 0
corresponded 0
to 0
the 0
ABFI B-gene
( 0
autonomously B-gene
replicating I-gene
sequence I-gene
- I-gene
binding I-gene
factor I-gene
) 0
protein 0
. 0

Videoanalysis 0
confirms 0
the 0
ballistic 0
character 0
of 0
the 0
initial 0
phase 0
of 0
the 0
reaching 0
movement 0
. 0

Toward 0
this 0
end 0
, 0
we 0
used 0
two 0
cultured 0
colon 0
cancer 0
cell 0
lines 0
; 0
one 0
( 0
RKO 0
) 0
has 0
a 0
transcriptionally 0
activated 0
u B-gene
- I-gene
PAR I-gene
gene I-gene
, 0
and 0
the 0
other 0
( 0
GEO 0
) 0
overexpresses 0
the 0
receptor 0
only 0
after 0
phorbol 0
ester 0
treatment 0
. 0

Early 0
detection 0
and 0
signs 0
of 0
hepatoangiosarcoma 0
among 0
vinyl 0
chloride 0
workers 0
. 0

Many 0
retroviruses 0
, 0
including 0
the 0
human 0
and 0
simian 0
immunodeficiency 0
viruses 0
, 0
contain 0
a 0
leucine 0
zipper 0
- 0
like 0
repeat 0
in 0
a 0
highly 0
conserved 0
region 0
of 0
the 0
external 0
domain 0
of 0
the 0
transmembrane 0
( 0
TM 0
) 0
glycoprotein 0
. 0

Conversion 0
of 0
an 0
NF B-gene
- I-gene
kappaB I-gene
into 0
a 0
GABP B-gene
binding 0
site 0
is 0
likely 0
to 0
have 0
occurred 0
also 0
during 0
the 0
worldwide 0
spread 0
of 0
HIV 0
- 0
1 0
, 0
as 0
we 0
noticed 0
the 0
same 0
LTR 0
modification 0
in 0
subtype 0
E 0
isolates 0
from 0
Thailand 0
. 0

Bedbug 0
( 0
Cimex 0
lectularius 0
) 0
samples 0
adult 0
and 0
nymphs 0
either 0
engorged 0
or 0
starved 0
from 0
Central 0
Security 0
Forces 0
sleeping 0
wards 0
, 0
laboratory 0
animal 0
house 0
and 0
control 0
samples 0
from 0
laboratory 0
reared 0
colonies 0
were 0
ground 0
and 0
subjected 0
to 0
ELISA 0
test 0
of 0
hepatitis B-gene
B I-gene
surface I-gene
antigen I-gene
together 0
with 0
276 0
serum 0
samples 0
from 0
the 0
recruits 0
slept 0
in 0
those 0
wards 0
. 0

Ciprofloxacin 0
attained 0
a 0
peak 0
serum 0
concentration 0
of 0
1.2 0
mg/l 0
and 0
a 0
serum 0
half 0
- 0
life 0
of 0
34 0
min 0
. 0

As 0
usual 0
tests 0
, 0
such 0
as 0
`` 0
time 0
'' 0
of 0
cephalin 0
are 0
slightly 0
sensible 0
to 0
LMW 0
- 0
Hep 0
, 0
only 0
anti 0
- 0
Xa 0
activity 0
can 0
be 0
used 0
. 0

Although 0
they 0
are 0
similar 0
to 0
the 0
IL9R B-gene
gene I-gene
( 0
approximately 0
90 0
% 0
identity 0
) 0
, 0
none 0
of 0
these 0
copies 0
encodes 0
a 0
functional 0
receptor 0
: 0
none 0
of 0
them 0
contains 0
sequences 0
homologous 0
to 0
the 0
5 0
' 0
flanking 0
region 0
or 0
exon 0
1 0
of 0
the 0
IL9R B-gene
gene I-gene
, 0
and 0
the 0
remaining 0
ORFs 0
have 0
been 0
inactivated 0
by 0
various 0
point 0
mutations 0
and 0
deletions 0
. 0

In 0
two 0
patients 0
, 0
a 0
male 0
homosexual 0
and 0
an 0
hemophiliac 0
, 0
thrombocytopenia 0
was 0
associated 0
with 0
AIDS 0
- 0
related 0
complex 0
. 0

Choline B-gene
acetyltransferase I-gene
immunohistochemistry 0
combined 0
with 0
the 0
retrograde 0
transport 0
of 0
horseradish B-gene
peroxidase I-gene
showed 0
that 0
the 0
reticular 0
and 0
mediodorsal 0
thalamic 0
nuclei 0
of 0
the 0
cat 0
receive 0
an 0
important 0
input 0
from 0
cholinergic 0
and 0
non 0
- 0
cholinergic 0
neurons 0
of 0
substantia 0
innominata 0
and 0
adjacent 0
structures 0
in 0
the 0
basal 0
forebrain 0
. 0

Mortality 0
among 0
patients 0
with 0
CAVB 0
is 0
still 0
high 0
and 0
has 0
not 0
declined 0
within 0
the 0
last 0
decade 0
. 0

We 0
conclude 0
that 0
in 0
the 0
presence 0
of 0
fatty 0
acids 0
in 0
the 0
medium 0
transcription 0
of 0
SPS19 B-gene
is 0
directly 0
regulated 0
by 0
both 0
Pip2p B-gene
- 0
Oaf1p B-gene
and 0
Adr1p B-gene
. 0

The 0
purified 0
RAG1 B-gene
protein I-gene
overexpressed 0
in 0
E.coli 0
exhibited 0
the 0
expected 0
cleavage 0
activity 0
when 0
combined 0
with 0
RAG2 B-gene
purified 0
from 0
transfected 0
293T 0
cells 0
. 0

Serum 0
triglycerides 0
also 0
showed 0
an 0
increase 0
from 0
birth 0
to 0
6 0
months 0
of 0
age 0
, 0
but 0
a 0
decrease 0
from 0
6 0
months 0
to 0
1 0
years 0
of 0
age 0
. 0

These 0
mutant B-gene
rps7 I-gene
leaders 0
were 0
ligated 0
into 0
an 0
aadA 0
expression 0
cassette 0
and 0
transformed 0
into 0
the 0
chloroplast 0
of 0
C. 0
reinhardtii 0
and 0
into 0
E. 0
coli 0
. 0

The 0
use 0
of 0
medication 0
is 0
of 0
minor 0
importance 0
in 0
the 0
treatment 0
of 0
flight 0
phobia 0
. 0

We 0
previously 0
described 0
the 0
upregulation 0
of 0
the 0
MT2 B-gene
antigen I-gene
during 0
urodele 0
limb 0
regeneration 0
and 0
characterized 0
the 0
MT2 B-gene
antigen I-gene
as 0
a 0
310 0
- 0
to 0
325 0
- 0
kDa 0
chondroitin 0
- 0
sulfated 0
glycoprotein 0
with 0
a 0
core 0
protein 0
of 0
285 0
- 0
300 0
kDa 0
. 0

Southern 0
blot 0
analysis 0
following 0
reverse 0
transcription 0
and 0
PCR 0
showed 0
that 0
B2R B-gene
is 0
expressed 0
in 0
most 0
mouse 0
tissues 0
, 0
except 0
the 0
liver 0
and 0
spleen 0
, 0
which 0
is 0
consistent 0
with 0
the 0
wide 0
distribution 0
of 0
B2R B-gene
activity 0
as 0
deduced 0
from 0
pharmacological 0
studies 0
. 0

The 0
dynamics 0
of 0
N 0
- 0
interaction 0
and 0
N 0
- 0
retention 0
during 0
3 0
hr 0
CPB 0
was 0
quantified 0
with 0
autologous 0
In 0
- 0
111 0
labeled 0
neutrophils 0
( 0
INN 0
) 0
in 0
4 0
groups 0
of 0
20 0
Yorkshire 0
pigs 0
( 0
28 0
- 0
35 0
kg 0
, 0
5 0
sham 0
; 0
5 0
CPB 0
, 0
1 0
hr 0
; 0
5 0
CPB 0
, 0
3 0
hr 0
and 0
5 0
CPB 0
with 0
heparinized 0
circuit 0
, 0
3 0
hr 0
) 0
; 0
anesthetized 0
pigs 0
were 0
injected 0
with 0
INN 0
( 0
500 0
- 0
650 0
microCi 0
) 0
, 0
30 0
min 0
before 0
CPB 0
and 0
heparinized 0
, 0
and 0
underwent 0
CPB 0
with 0
a 0
roller 0
pump 0
, 0
a 0
hollow 0
fiber 0
OX 0
( 0
Bentley 0
CM 0
50 0
, 0
5.0 0
m2 0
) 0
and 0
AF 0
( 0
Bentley 0
AF 0
025 0
, 0
0.25 0
m2 0
) 0
at 0
2.5 0
- 0
3.6 0
l/min 0
for 0
3 0
hr 0
. 0

The 0
effect 0
of 0
the 0
negative 0
regulatory 0
element 0
is 0
negated 0
by 0
the 0
viral B-gene
IE2 I-gene
protein I-gene
( 0
L 0
. 0

Cloning 0
of 0
the 0
GATA B-gene
- I-gene
binding I-gene
protein I-gene
that 0
regulates 0
endothelin B-gene
- I-gene
1 I-gene
gene I-gene
expression 0
in 0
endothelial 0
cells 0
. 0

John 0
's 0
wort 0

In 0
contrast 0
SF B-gene
, 0
but 0
not 0
GM B-gene
- I-gene
CSF I-gene
or 0
IL B-gene
- I-gene
3 I-gene
, 0
induced 0
tyrosine 0
phosphorylation 0
of 0
phospholipase B-gene
C I-gene
- I-gene
gamma I-gene
( 0
PLC B-gene
- I-gene
gamma I-gene
) 0
. 0

Using 0
the 0
interaction 0
- 0
trap 0
assay 0
to 0
identify 0
candidate 0
proteins 0
that 0
bind 0
the 0
cytoplasmic 0
region 0
of 0
the 0
LAR B-gene
transmembrane I-gene
protein I-gene
tyrosine I-gene
phosphatase I-gene
( 0
PT B-gene
- I-gene
Pase I-gene
) 0
, 0
we 0
isolated 0
a 0
cDNA 0
encoding 0
a 0
2861 0
- 0
amino 0
acid 0
protein 0
termed 0
Trio B-gene
that 0
contains 0
three 0
enzyme 0
domains 0
: 0
two 0
functional 0
GEF B-gene
domains I-gene
and 0
a 0
protein B-gene
serine/threonine I-gene
kinase I-gene
( 0
PSK B-gene
) 0
domain 0
. 0

The 0
role 0
of 0
the 0
putative 0
C2 B-gene
domain 0
of 0
Nedd4 B-gene
has 0
not 0
been 0
elucidated 0
. 0

The 0
effect 0
on 0
FIV B-gene
LTR I-gene
promoter I-gene
activity 0
of 0
progressively 0
deleting 0
these 0
nuclear 0
factor 0
binding 0
sites 0
was 0
examined 0
by 0
linking 0
LTR 0
deletion 0
mutants 0
to 0
the 0
chloramphenicol B-gene
acetyltransferase I-gene
( 0
CAT B-gene
) 0
gene 0
. 0

Additionally 0
, 0
these 0
findings 0
have 0
important 0
implications 0
for 0
the 0
understanding 0
of 0
the 0
mechanisms 0
of 0
HIV 0
- 0
1 0
latency 0
and 0
reactivation 0
. 0

Furthermore 0
, 0
we 0
show 0
that 0
Nck B-gene
- I-gene
2 I-gene
is 0
capable 0
of 0
recognizing 0
several 0
key 0
components 0
of 0
growth B-gene
factor I-gene
receptor I-gene
kinase I-gene
- 0
signaling 0
pathways 0
including 0
EGF B-gene
receptors I-gene
, 0
PDGF B-gene
receptor I-gene
- I-gene
beta I-gene
, 0
and 0
IRS B-gene
- I-gene
1 I-gene
. 0

The 0
average 0
mean 0
difference 0
compared 0
with 0
the 0
low 0
and 0
the 0
intermediate 0
calcium 0
group 0
was 0
11 0
% 0
for 0
the 0
femoral 0
neck 0
, 0
8 0
- 0
11 0
% 0
for 0
the 0
lumbar 0
spine 0
and 0
5 0
- 0
6 0
% 0
for 0
total 0
body 0
BMDs 0
. 0

Although 0
the 0
number 0
of 0
kits 0
has 0
increased 0
, 0
the 0
precision 0
has 0
improved 0
, 0
showing 0
that 0
more 0
robust 0
methods 0
are 0
now 0
employed 0
. 0

The 0
predicted 0
amino 0
acid 0
sequence 0
contained 0
all 0
consensus 0
regions 0
for 0
S B-gene
- I-gene
adenosyl I-gene
methionine I-gene
methyltransferases I-gene
and 0
presented 0
26 0
% 0
identity 0
with 0
Saccharomyces B-gene
cerevisiae I-gene
DHHB I-gene
- I-gene
methyltransferase I-gene
and 0
38 0
% 0
identity 0
with 0
the 0
rat 0
protein 0
, 0
as 0
well 0
as 0
with 0
a 0
bacterial 0
( 0
Escherichia 0
coli 0
and 0
Salmonella 0
typhimurium 0
) 0
methyltransferase B-gene
encoded 0
by 0
the 0
UBIG B-gene
gene I-gene
. 0

To 0
investigate 0
its 0
transcription 0
, 0
1.1 0
kilobases 0
of 0
the 0
5' 0
- 0
flanking 0
sequence 0
were 0
fused 0
to 0
a 0
luciferase B-gene
reporter I-gene
gene I-gene
. 0

A 0
selective 0
transcriptional 0
induction 0
system 0
for 0
mammalian 0
cells 0
based 0
on 0
Gal4 B-gene
- 0
estrogen B-gene
receptor I-gene
fusion 0
proteins 0
. 0

PATIENT 0
( 0
S 0
) 0
: 0
Two 0
hundred 0
thirty 0
- 0
eight 0
patients 0
with 0
RPLs 0
, 0
48 0
patients 0
with 0
recurrent 0
IVF 0
- 0
ET 0
failure 0
and 0
179 0
nonpregnant 0
and 0
120 0
pregnant 0
control 0
group 0
women 0
. 0

The 0
effects 0
of 0
oxalate 0
- 0
containing 0
products 0
on 0
the 0
exposed 0
dentine 0
surface 0
: 0
an 0
SEM 0
investigation 0
. 0

The 0
cyanobacterial B-gene
phycobilisome I-gene
is 0
a 0
large 0
protein 0
complex 0
located 0
on 0
the 0
photosynthetic 0
membrane 0
. 0

Up 0
to 0
1988 0
, 0
145 0
cases 0
had 0
been 0
reported 0
in 0
literature 0
and 0
32 0
cases 0
in 0
our 0
country 0
. 0

Lamivudine 0
therapy 0
for 0
acute 0
hepatitis 0
B 0
infection 0
following 0
peripheral 0
blood 0
stem 0
cell 0
transplantation 0
. 0

Disorganization 0
scores 0
of 0
the 0
hypertrophy 0
zone 0
and 0
trabecular 0
bone 0
were 0
low 0
, 0
approaching 0
normal 0
( 0
P 0
< 0
0.05 0
) 0
, 0
for 0
turkey 0
poults 0
fed 0
on 0
diets 0
with 0
phytase B-gene
supplementation 0
, 0
and 0
tibial 0
abnormality 0
scores 0
were 0
linearly 0
decreased 0
( 0
P 0
< 0
0.001 0
) 0
as 0
nP 0
levels 0
increased 0
( 0
zero 0
score 0
is 0
considered 0
normal 0
) 0
. 0

The 0
collicular 0
labels 0
found 0
after 0
injections 0
within 0
the 0
MST 0
area 0
exhibited 0
their 0
distribution 0
over 0
the 0
deep 0
SC 0
subdivision 0
, 0
whereas 0
they 0
spared 0
all 0
the 0
superficial 0
layers 0
but 0
the 0
deep 0
part 0
of 0
the 0
SO 0
. 0

Modern 0
aspects 0
of 0
shock 0
- 0
treatment 0
in 0
extensive 0
burns 0
( 0
author 0
's 0
transl 0
) 0

UVB 0
- 0
induced 0
association 0
of 0
tumor B-gene
necrosis I-gene
factor I-gene
( I-gene
TNF I-gene
) I-gene
receptor I-gene
1/TNF I-gene
1/TNF I-gene
receptor I-gene
- I-gene
associated I-gene
factor I-gene
- I-gene
2 I-gene
mediates 0
activation 0
of 0
Rel B-gene
proteins I-gene
. 0

Mapping 0
of 0
the 0
region 0
in 0
KAP B-gene
- I-gene
1 I-gene
required 0
for 0
HP1 B-gene
interaction 0
showed 0
that 0
amino 0
acid 0
substitutions 0
which 0
abolish 0
HP1 B-gene
binding 0
in 0
vitro 0
reduce 0
KAP B-gene
- I-gene
1 I-gene
mediated 0
repression 0
in 0
vivo 0
. 0

However 0
, 0
whether 0
this 0
was 0
associated 0
with 0
spleen 0
removal 0
after 0
adjustment 0
for 0
risk 0
factors 0
was 0
not 0
determined 0
. 0

Taken 0
together 0
, 0
these 0
data 0
suggest 0
that 0
the 0
Smad3/Smad4 B-gene
complex 0
has 0
at 0
least 0
two 0
separable 0
nuclear 0
functions 0
: 0
it 0
forms 0
a 0
rapid 0
, 0
yet 0
transient 0
sequence 0
- 0
specific 0
DNA 0
binding 0
complex 0
, 0
and 0
it 0
potentiates 0
Smad3/Smad4 I-gene

However 0
, 0
one 0
activity 0
binds 0
preferentially 0
to 0
G+C 0
- 0
rich 0
promoters 0
, 0
and 0
another 0
activity 0
appears 0
to 0
bind 0
preferentially 0
to 0
only 0
two 0
of 0
the 0
promoters 0
tested 0
. 0

The 0
donors 0
of 0
10 0
patients 0
were 0
ABO 0
- 0
incompatible 0
, 0
and 0
for 0
five 0
pairs 0
the 0
ABO 0
incompatibility 0
was 0
major 0
. 0

In 0
treatments 0
R1 0
and 0
R2 0
, 0
feed 0
quality 0
was 0
restricted 0
by 0
withholding 0
concentrates 0
for 0
3 0
and 0
4.5 0
mo 0
, 0
respectively 0
. 0

The 0
major 0
promoter 0
element 0
of 0
the 0
Xenopus B-gene
laevis I-gene
5S I-gene
RNA I-gene
gene I-gene
is 0
located 0
within 0
the 0
transcribed 0
region 0
of 0
the 0
gene 0
and 0
forms 0
the 0
binding 0
site 0
for 0
the 0
transcription 0
initiation 0
factor 0
TFIIIA B-gene
. 0

However 0
, 0
in 0
transient 0
transfection 0
assays 0
, 0
a 0
truncation 0
of 0
as 0
little 0
as 0
15 0
Nurr1 B-gene
COOH 0
- 0
terminal 0
amino 0
acids 0
diminished 0
transcriptional 0
activation 0
of 0
B1A B-gene
- 0
thymidine B-gene
kinase I-gene
- 0
chloramphenicol B-gene
acetyltransferase I-gene
reporter 0
. 0

Small 0
cell 0
tumors 0
in 0
children 0
: 0
contribution 0
to 0
the 0
solution 0
of 0
the 0
problem 0
of 0
differential 0
diagnosis 0
with 0
immunohistochemistry 0
and 0
electron 0
microscopy 0

Four 0
experiments 0
examined 0
the 0
role 0
of 0
the 0
cholinergic 0
projections 0
from 0
the 0
septum 0
and 0
vertical 0
limb 0
nucleus 0
of 0
the 0
diagonal 0
band 0
of 0
Broca 0
( 0
VDB 0
) 0
in 0
acquisition 0
and 0
performance 0
of 0
a 0
conditional 0
visual 0
discrimination 0
. 0

Deletion 0
of 0
this 0
consensus 0
element 0
from 0
the 0
spo6 B-gene
promoter I-gene
abolished 0
the 0
transcription 0
of 0
spo6+ B-gene
and 0
resulted 0
in 0
a 0
sporulation 0
deficiency 0
. 0

This 0
region 0
does 0
not 0
contain 0
a 0
consensus 0
estrogen 0
response 0
element 0
, 0
and 0
ER B-gene
binding 0
to 0
this 0
DNA 0
sequence 0
was 0
not 0
observed 0
. 0

We 0
have 0
previously 0
reported 0
that 0
analgesic 0
doses 0
of 0
morphine 0
accelerate 0
mortality 0
of 0
rats 0
exposed 0
to 0
hemorrhage 0
( 0
Feuerstein 0
and 0
Siren 0
: 0
Circ 0
Shock 0
19:293 0
- 0
300 0
, 0
1986 0
) 0
. 0

Microsporum 0
persicolor 0
, 0
an 0
easily 0
misinterpreted 0
dermatophyt 0

When 0
they 0
were 0
exposed 0
to 0
intermittent 0
schedules 0
of 0
punishment 0
( 0
fixed 0
- 0
interval 0
[ 0
FI 0
] 0
120 0
s 0
or 0
FI 0
300 0
s 0
) 0
, 0
SIB 0
for 0
all 0
but 0
1 0
of 0
the 0
participants 0
increased 0
to 0
levels 0
similar 0
to 0
those 0
observed 0
during 0
baseline 0
. 0

These 0
results 0
suggest 0
that 0
1a B-gene
, 0
which 0
also 0
interacts 0
independently 0
with 0
the 0
ER 0
and 0
viral 0
RNA 0
, 0
is 0
a 0
key 0
organizer 0
of 0
RNA 0
replication 0
complex 0
assembly 0
. 0

Here 0
we 0
examine 0
the 0
population 0
of 0
gammaS B-gene
transcripts I-gene
in 0
adult 0
human 0
lens 0
and 0
the 0
structure 0
of 0
the 0
human B-gene
CRYGS I-gene
genes I-gene
. 0

PKK B-gene
exists 0
in 0
three 0
discernible 0
forms 0
at 0
steady 0
state 0
: 0
an 0
underphosphorylated 0
form 0
of 0
100 0
kDa 0
; 0
a 0
soluble 0
, 0
cytosolic 0
, 0
phosphorylated 0
form 0
of 0
110 0
kDa 0
; 0
and 0
a 0
phosphorylated 0
, 0
detergent 0
- 0
insoluble 0
form 0
of 0
112 0
kDa 0
. 0

The 0
lamina 0
densa 0
was 0
always 0
interrupted 0
by 0
numerous 0
small 0
gaps 0
and 0
in 0
some 0
areas 0
the 0
basement 0
membrane 0
could 0
not 0
be 0
identified 0
over 0
a 0
long 0
distance 0
. 0

The 0
human B-gene
CA11 I-gene
gene I-gene
appears 0
to 0
be 0
located 0
between 0
the 0
secretor B-gene
type I-gene
alpha I-gene
( I-gene
1,2 I-gene
) I-gene
- I-gene
fucosyltransferase I-gene
gene I-gene
cluster I-gene
( 0
FUT1 B-gene
- 0
FUT2 B-gene
- 0
FUT2P B-gene
) 0
and 0
the 0
D B-gene
- I-gene
site I-gene
binding I-gene
protein I-gene
gene I-gene
( 0
DBP B-gene
) 0
on 0
chromosome 0
19q13.3 0
. 0

A 0
score 0
( 0
APACHE 0
II 0
) 0
was 0
calculated 0
to 0
assess 0
the 0
severity 0
of 0
disease 0
. 0

To 0
determine 0
the 0
role 0
of 0
elevated 0
FAK B-gene
expression 0
in 0
facilitating 0
epidermal B-gene
growth I-gene
factor I-gene
( 0
EGF B-gene
) 0
- 0
stimulated 0
human 0
adenocarcinoma 0
( 0
A549 0
) 0
cell 0
motility 0
, 0
antisense 0
oligonucleotides 0
were 0
used 0
to 0
reduce 0
FAK B-gene
protein I-gene
expression 0
> 0
75 0
% 0
. 0

Evaluation 0
of 0
materials 0
and 0
technics 0
in 0
vascular 0
surgery 0
using 0
111 0
- 0
Indium 0

Functional 0
importance 0
of 0
a 0
properly 0
folded 0
surface 0
loop 0
covering 0
the 0
catalytic 0
center 0
. 0

Hypoxia 0
decreased 0
the 0
rate 0
of 0
spontaneous 0
impulse 0
initiation 0
in 0
SA 0
nodal 0
fibers 0
by 0
decreasing 0
the 0
slope 0
of 0
diastolic 0
depolarization 0
. 0

Radiative 0
corrections 0
to 0
pi 0
l2 0
decays 0
. 0

The 0
availability 0
of 0
a 0
commercial 0
program 0
( 0
PCNONLIN 0
) 0
is 0
needed 0
to 0
carry 0
out 0
matrix 0
handling 0
calculations 0
. 0

The 0
levels 0
of 0
TPAR1 B-gene
mRNAs I-gene
were 0
dramatically 0
down 0
- 0
regulated 0
in 0
regenerating 0
rat 0
liver 0
when 0
compared 0
to 0
normal 0
adult 0
liver 0
. 0

In 0
the 0
postoperative 0
patient 0
with 0
tetralogy 0
of 0
Fallot 0
with 0
symptomatic 0
ventricular 0
arrhythmias 0
, 0
it 0
is 0
concluded 0
that 0
electrophysiologic 0
study 0
is 0
useful 0
in 0
reproducing 0
clinical 0
episodes 0
of 0
VT 0
and 0
in 0
selecting 0
effective 0
antiarrhythmic 0
medication 0
; 0
a 0
small 0
number 0
of 0
patients 0
with 0
ventricular 0
premature 0
complexes 0
alone 0
will 0
have 0
inducible 0
sustained 0
VT 0
during 0
electrophysiologic 0
study 0
; 0
prognosis 0
of 0
these 0
patients 0
may 0
be 0
improved 0
by 0
treatment 0
that 0
results 0
in 0
prevention 0
of 0
VT 0
induction 0
; 0
and 0
in 0
patients 0
with 0
right 0
ventricular 0
hypertension 0
, 0
VT 0
is 0
likely 0
to 0
be 0
refractory 0
to 0
drug 0
treatment 0
. 0

Hip 0
fracture 0
mortality 0
and 0
prospective 0
payment 0
system 0
. 0

Primary 0
care 0
programs 0
for 0
the 0
indigent 0
. 0

In 0
human 0
myxoid 0
liposarcoma 0
, 0
a 0
chromosomal 0
rearrangement 0
leads 0
to 0
fusion 0
of 0
the 0
growth 0
- 0
arresting 0
and 0
DNA 0
- 0
damage 0
- 0
inducible 0
transcription 0
factor 0
CHOP B-gene
( 0
GADD153 B-gene
) 0
to 0
a 0
peptide 0
fragment 0
encoded 0
by 0
the 0
TLS B-gene
gene I-gene
. 0

Categorisation 0
of 0
the 0
different 0
substructures 0
within 0
the 0
sections 0
allows 0
them 0
to 0
be 0
analysed 0
and 0
displayed 0
separately 0
. 0

Authors 0
present 0
the 0
anatomical 0
variations 0
of 0
the 0
course 0
of 0
the 0
inferior 0
mesenteric 0
artery 0
and 0
its 0
branches 0
in 0
62 0
human 0
fetus 0
. 0

This 0
mechanism 0
seems 0
to 0
be 0
involved 0
in 0
VIP B-gene
- 0
induced 0
PRL B-gene
gene I-gene
regulation 0
. 0

The 0
only 0
quantities 0
which 0
were 0
significantly 0
different 0
between 0
appendicitis 0
and 0
a 0
normal 0
appendix 0
were 0
sex 0
, 0
duration 0
of 0
symptoms 0
, 0
anorexia 0
and 0
vomiting 0
. 0

Signaling 0
through 0
mitogen B-gene
- I-gene
activated I-gene
protein I-gene
kinase I-gene
and 0
Rac/Rho B-gene
does 0
not 0
duplicate 0
the 0
effects 0
of 0
activated 0
Rac/Rho I-gene

The 0
survival 0
of 0
patients 0
with 0
a 0
short 0
bowel 0
, 0
even 0
if 0
they 0
need 0
long 0
- 0
term 0
parenteral 0
nutrition 0
, 0
is 0
good 0
. 0

Unlike 0
these 0
contaminant 0
- 0
responsive 0
T 0
cells 0
, 0
those 0
that 0
are 0
truly 0
specific 0
for 0
natural 0
AChR B-gene
epitopes I-gene
appear 0
less 0
heterogeneous 0
and 0
therefore 0
more 0
suitable 0
targets 0
for 0
selective 0
immunotherapy 0
. 0

CONCLUSIONS 0
: 0
This 0
initial 0
experience 0
indicates 0
that 0
there 0
is 0
short 0
- 0
to 0
middle 0
- 0
term 0
efficiency 0
and 0
safety 0
when 0
using 0
GKS 0
to 0
treat 0
MTLE 0
. 0

A 0
Brassica 0
cDNA 0
clone 0
encoding 0
a 0
bifunctional 0
hydroxymethylpyrimidine B-gene
kinase/thiamin I-gene
kinase/thiamin I-gene
- I-gene
phosphate I-gene
pyrophosphorylase I-gene
involved 0
in 0
thiamin 0
biosynthesis 0
. 0

The 0
aims 0
of 0
this 0
study 0
were 0
to 0
examine 0
whether 0
the 0
EORTC 0
( 0
European 0
Organisation 0
for 0
Research 0
and 0
Treatment 0
of 0
Cancer 0
) 0
QLQ 0
- 0
C30 0
core 0
questionnaire 0
alone 0
could 0
distinguish 0
between 0
two 0
clinically 0
different 0
groups 0
of 0
patients 0
and 0
to 0
design 0
a 0
module 0
, 0
which 0
included 0
relevant 0
patient 0
- 0
defined 0
gastric 0
cancer 0
- 0
specific 0
variables 0
. 0

The 0
goal 0
of 0
our 0
work 0
was 0
to 0
determine 0
hearing 0
thresholds 0
in 0
patients 0
with 0
hearing 0
impairment 0
due 0
to 0
hereditary 0
motor 0
and 0
sensory 0
neuropathy 0
( 0
HMSN 0
I 0
) 0
. 0

Causal 0
modeling 0
combines 0
theory 0
and 0
research 0
, 0
and 0
because 0
the 0
interpretation 0
of 0
data 0
is 0
possible 0
only 0
within 0
the 0
context 0
of 0
the 0
proposed 0
theory 0
, 0
it 0
offers 0
an 0
important 0
method 0
for 0
advancing 0
the 0
science 0
while 0
maintaining 0
the 0
specificity 0
of 0
the 0
practice 0
. 0

